PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Burke, SJ; Collier, JJ; Scott, DK				Burke, Susan J.; Collier, J. Jason; Scott, Donald K.			cAMP opposes the glucose-mediated induction of the L-PK gene by preventing the recruitment of a complex containing ChREBP, HNF4 alpha, and CBP	FASEB JOURNAL			English	Article						transcription; repression; promoter; signaling	PYRUVATE-KINASE GENE; ELEMENT-BINDING PROTEIN; PANCREATIC BETA-CELLS; FATTY-ACID SYNTHASE; TRANSCRIPTION FACTOR; CYCLIC-AMP; C-MYC; EXPRESSION; CREB; COACTIVATORS	Glucose-mediated activation of the L-type pyruvate kinase (L-PK) gene is repressed by cAMP, making this an excellent model for studying the mechanism by which these contrary signals regulate gene expression. Using the 832/13 rat insulinoma cell line, we demonstrate using RNA interference and chromatin immunoprecipitation that carbohydrate response element binding protein (ChREBP), hepatic nuclear factor 4 alpha (HNF4 alpha), and the coactivator CREB binding protein (CBP) are required for the glucose response of the L-PK gene and are recruited to the promoter by glucose. The cAMP agonist forskolin blocked the glucose-mediated induction of the L-PK gene in a PKA-dependent manner and blocked the recruitment of ChREBP, HNF4 alpha, and CBP to the L-PK promoter, while simultaneously recruiting CBP to the cAMP-inducible gene, nuclear receptor subfamily 4, group A, member 2 (NR4A2). Overexpression of CBP, but not ChREBP, reversed the cAMP repression of the L-PK gene. In addition, CBP augmented the glucose response of the L-PK promoter. We conclude that cAMP and glucose signaling converge on a complex containing ChREBP, HNF4 alpha, and CBP, and that cAMP acts by disrupting this transcriptional complex assembled by glucose-derived signals.-Burke, S. J., Collier, J. J., Scott, D. K. cAMP opposes the glucose-mediated induction of the L-PK gene by preventing the recruitment of a complex containing ChREBP, HNF4 alpha, and CBP. FASEB J. 23, 2855-2865 (2009). www.fasebj.org	[Scott, Donald K.] Univ Pittsburgh, Dept Med, Div Endocrinol, Pittsburgh, PA 15261 USA; [Collier, J. Jason] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA; [Collier, J. Jason] Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Durham, NC USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Duke University; Duke University	Scott, DK (corresponding author), Univ Pittsburgh, Dept Med, Div Endocrinol, E1147 BST,200 Lothrop St, Pittsburgh, PA 15261 USA.	dks23@pitt.edu	Collier, Susan J/N-1959-2017; Collier, James/N-1958-2017	Collier, Susan J/0000-0003-2571-4416; 				Adamson AW, 2006, BIOCHEM J, V399, P285, DOI 10.1042/BJ20060659; BERGOT MO, 1992, NUCLEIC ACIDS RES, V20, P1871, DOI 10.1093/nar/20.8.1871; Billin AN, 1999, J BIOL CHEM, V274, P36344, DOI 10.1074/jbc.274.51.36344; Chan HM, 2001, J CELL SCI, V114, P2363; Collier JJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE48, DOI 10.1152/ajpendo.00357.2006; Collier JJ, 2006, DIABETES, V55, P1398, DOI 10.2337/db05-1000; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Davies MN, 2008, J BIOL CHEM, V283, P24029, DOI 10.1074/jbc.M801539200; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Geisberg JV, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh148; Gourdon L, 1999, FEBS LETT, V459, P9, DOI 10.1016/S0014-5793(99)01203-X; GUERRA MJMD, 1993, MOL CELL BIOL, V13, P7725, DOI 10.1128/MCB.13.12.7725; Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Horwitz KB, 1996, MOL ENDOCRINOL, V10, P1167, DOI 10.1210/me.10.10.1167; Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101; Jambal P, 2003, J BIOL CHEM, V278, P23055, DOI 10.1074/jbc.M212450200; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Li MV, 2008, MOL ENDOCRINOL, V22, P1658, DOI 10.1210/me.2007-0560; Li MV, 2006, DIABETES, V55, P1179, DOI 10.2337/db05-0822; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; LIU ZR, 1993, J BIOL CHEM, V268, P12787; Luo GY, 2000, MOL ENDOCRINOL, V14, P114, DOI 10.1210/me.14.1.114; Ma L, 2005, J BIOL CHEM, V280, P12019, DOI 10.1074/jbc.M413063200; MARIE S, 1993, J BIOL CHEM, V268, P23881; Sakiyama H, 2008, J BIOL CHEM, V283, P24899, DOI 10.1074/jbc.M804308200; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Stoeckman AK, 2004, J BIOL CHEM, V279, P15662, DOI 10.1074/jbc.M311301200; TOMKINS GM, 1975, SCIENCE, V189, P760, DOI 10.1126/science.169570; Tsatsos NG, 2006, BIOCHEM BIOPH RES CO, V340, P449, DOI 10.1016/j.bbrc.2005.12.029; UHLER MD, 1986, J BIOL CHEM, V261, P5360; Wang HY, 2002, J BIOL CHEM, V277, P32746, DOI 10.1074/jbc.M201635200; Xavier GD, 2006, J LIPID RES, V47, P2482, DOI 10.1194/jlr.M600289-JLR200; Xu W, 2007, EMBO J, V26, P2890, DOI 10.1038/sj.emboj.7601734; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Yoshida E, 1997, BIOCHEM BIOPH RES CO, V241, P664, DOI 10.1006/bbrc.1997.7871	37	31	32	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					2855	2865		10.1096/fj.08-126631	http://dx.doi.org/10.1096/fj.08-126631			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19406844				2022-12-25	WOS:000270241000008
J	Castro, MO; Pomin, VH; Santos, LL; Vilela-Silva, ACES; Hirohashi, N; Pol-Fachin, L; Verli, H; Mourao, PAS				Castro, Michelle O.; Pomin, Vitor H.; Santos, Livia L.; Vilela-Silva, Ana-Cristina E. S.; Hirohashi, Noritaka; Pol-Fachin, Laercio; Verli, Hugo; Mourao, Paulo A. S.			A Unique 2-Sulfated beta-Galactan from the Egg Jelly of the Sea Urchin Glyptocidaris crenularis CONFORMATION FLEXIBILITY VERSUS INDUCTION OF THE SPERM ACROSOME REACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BASED MECHANISM; PLICATA CHORDATA-TUNICATA; FUCOSE SULFATE POLYMER; MILD ACID-HYDROLYSIS; ACROSOME REACTION; SPECIES RECOGNITION; MOLECULAR-DYNAMICS; AQUEOUS-SOLUTIONS; HEPARIN; FERTILIZATION	Sulfated polysaccharides from the egg jelly of sea urchins act as species-specific inducers of the sperm acrosome reaction, which is a rare molecular mechanism of carbohydrate-induced signal-transduction event in animal cells. The sea urchin polysaccharides differ in monosaccharide composition (L-fucose or L-galactose), glycosylation, and sulfation sites, but they are always in the alpha-anomeric configuration. Herein, structural analysis of the polysaccharide from the sea urchin Glyptocidaris crenularis surprisingly revealed a unique sulfated beta-D-galactan composed by (3-beta-D-Galp-2(OSO3)-1 -> 3-beta-D-Galp-1)(n) repeating units. Subsequently, we used the G. crenularis galactan to compare different 2-sulfated polysaccharides as inducers of the acrosome reaction using homologous and heterologous sperm. We also tested the effect of chemically over-sulfated galactans. Intriguingly, the anomeric configuration of the glycosidic linkage rather than the monosaccharide composition (galactose or fucose) is the preferential structural requirement for the effect of these polysaccharides on sea urchin fertilization. Nuclear magnetic resonance and molecular dynamics indicate that sulfated alpha-galactan or alpha-fucan have less dynamic structural behavior, exhibiting fewer conformational populations, with an almost exclusive conformational state with glycosidic dihedral angles Phi/Psi = -102 degrees/131 degrees. The preponderant conformer observed in the sulfated alpha-galactan or alpha-fucan is not observed among populations in the beta-form despite its more flexible structure in solution. Possibly, a proper spatial arrangement is required for interaction of the sea urchin-sulfated polysaccharides with the specific sperm receptor.	[Castro, Michelle O.; Pomin, Vitor H.; Santos, Livia L.; Mourao, Paulo A. S.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil; [Vilela-Silva, Ana-Cristina E. S.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941590 Rio De Janeiro, Brazil; [Castro, Michelle O.; Pomin, Vitor H.; Santos, Livia L.; Vilela-Silva, Ana-Cristina E. S.; Verli, Hugo; Mourao, Paulo A. S.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Lab Tecido Conjunt, BR-21941590 Rio De Janeiro, Brazil; [Hirohashi, Noritaka] Ochanomizu Univ, Grad Sch Humanities & Sci, Genet Counseling Course, Tokyo 1128610, Japan; [Verli, Hugo] Univ Fed Rio Grande do Sul, Fac Farm, BR-91500970 Porto Alegre, RS, Brazil; [Pol-Fachin, Laercio; Verli, Hugo] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Programa Posgrad Biol Celular & Mol, BR-91500970 Porto Alegre, RS, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Ochanomizu University; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Mourao, PAS (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Caixa Postal 68041, BR-21941590 Rio De Janeiro, Brazil.	pmourao@hucff.ufrj.br	Verli, Hugo/G-8703-2012; Verli, Hugo/AAZ-2148-2021; Mourao, Paulo/AAA-5386-2020	Verli, Hugo/0000-0002-4796-8620; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior.	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior.(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior.	ALBANO RM, 1986, J BIOL CHEM, V261, P758; Alves AP, 1997, J BIOL CHEM, V272, P6965, DOI 10.1074/jbc.272.11.6965; Alves AP, 1998, GLYCOBIOLOGY, V8, P939, DOI 10.1093/glycob/8.9.939; Amornrut C, 1999, CARBOHYD RES, V321, P121, DOI 10.1016/S0008-6215(99)00188-3; Becker CF, 2007, J MOL GRAPH MODEL, V26, P391, DOI 10.1016/j.jmgm.2007.01.008; Becker CF, 2005, CARBOHYD RES, V340, P1499, DOI 10.1016/j.carres.2005.03.018; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Biermann CH, 2004, EVOL DEV, V6, P353, DOI 10.1111/j.1525-142X.2004.04043.x; Bilan MI, 2007, CARBOHYD RES, V342, P586, DOI 10.1016/j.carres.2006.11.008; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Farias EHC, 2008, GLYCOBIOLOGY, V18, P250, DOI 10.1093/glycob/cwm139; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; GERWIG GJ, 1979, CARBOHYD RES, V77, P1, DOI 10.1016/S0008-6215(00)83788-X; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hirai E., 1963, Science Reports of the Tohoku University, V29, P369; Hirohashi N, 2003, BIOCHEM BIOPH RES CO, V304, P285, DOI 10.1016/S0006-291X(03)00587-4; Hirohashi N, 2002, BIOCHEM BIOPH RES CO, V296, P833, DOI 10.1016/S0006-291X(02)00941-5; Hirohashi N, 2002, BIOCHEM BIOPH RES CO, V298, P403, DOI 10.1016/S0006-291X(02)02441-5; Hirohashi N, 2002, J BIOL CHEM, V277, P8041, DOI 10.1074/jbc.M110661200; Hirohashi N, 2002, J BIOL CHEM, V277, P1182, DOI 10.1074/jbc.M108046200; KABAT EA, 1971, EXPT IMMUNOCHEMISTRY, P505; KIRCHER HW, 1960, ANAL CHEM, V32, P1103, DOI 10.1021/ac60165a016; Mourao PAS, 2007, BRAZ J MED BIOL RES, V40, P5, DOI 10.1590/S0100-879X2007000100002; MOURAO PAS, 1987, EUR J BIOCHEM, V166, P431, DOI 10.1111/j.1432-1033.1987.tb13534.x; MULLOY B, 1994, J BIOL CHEM, V269, P22113; Pereira MS, 2002, CARBOHYD RES, V337, P2231, DOI 10.1016/S0008-6215(02)00215-X; Pol-Fachin L, 2008, CARBOHYD RES, V343, P1435, DOI 10.1016/j.carres.2008.04.016; Pomin VH, 2005, GLYCOBIOLOGY, V15, P1376, DOI 10.1093/glycob/cwj030; Pomin VH, 2005, GLYCOBIOLOGY, V15, P369, DOI 10.1093/glycob/cwi021; RAVENSCROFT N, 1995, EUR J BIOCHEM, V227, P889, DOI 10.1111/j.1432-1033.1995.tb20215.x; SAITO H, 1968, J BIOL CHEM, V243, P1536; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Su YH, 2006, MOL BIOL CELL, V17, P114, DOI 10.1091/mbc.e05-08-0820; Usov AI, 1997, CARBOHYD RES, V303, P93, DOI 10.1016/S0008-6215(97)00136-5; VACQUIER VD, 1977, P NATL ACAD SCI USA, V74, P2456, DOI 10.1073/pnas.74.6.2456; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Verli H, 2005, J MOL GRAPH MODEL, V24, P203, DOI 10.1016/j.jmgm.2005.07.002; Verli H, 2004, CARBOHYD RES, V339, P281, DOI 10.1016/j.carres.2003.09.026; VIEIRA RP, 1991, J BIOL CHEM, V266, P13530; Vilela-Silva ACES, 2002, J BIOL CHEM, V277, P379, DOI 10.1074/jbc.M108496200; Vilela-Silva ACES, 1999, GLYCOBIOLOGY, V9, P927, DOI 10.1093/glycob/9.9.927; Vilela-Silva ACES, 2008, INT J DEV BIOL, V52, P551, DOI 10.1387/ijdb.072531av; WOODS RJ, 1995, CURR OPIN STRUC BIOL, V5, P591, DOI 10.1016/0959-440X(95)80049-2	45	37	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18790	18800		10.1074/jbc.M109.005702	http://dx.doi.org/10.1074/jbc.M109.005702			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19403528	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000267711500028
J	Martins, M; Rodrigues-Lima, F; Dairou, J; Lamouri, A; Malagnac, F; Silar, P; Dupret, JM				Martins, Marta; Rodrigues-Lima, Fernando; Dairou, Julien; Lamouri, Aazdine; Malagnac, Fabienne; Silar, Philippe; Dupret, Jean-Marie			An Acetyltransferase Conferring Tolerance to Toxic Aromatic Amine Chemicals MOLECULAR AND FUNCTIONAL STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYLAMINE N-ACETYLTRANSFERASES; PODOSPORA-ANSERINA; FILAMENTOUS FUNGI; GENOME SEQUENCE; SOIL; DIURON; MICE; METABOLISM; EXPRESSION; GENERATION	Aromatic amines (AA) are a major class of environmental pollutants that have been shown to have genotoxic and cytotoxic potentials toward most living organisms. Fungi are able to tolerate a diverse range of chemical compounds including certain AA and have long been used as models to understand general biological processes. Deciphering the mechanisms underlying this tolerance may improve our understanding of the adaptation of organisms to stressful environments and pave the way for novel pharmaceutical and/or biotechnological applications. We have identified and characterized two arylamine N-acetyltransferase (NAT) enzymes (PaNAT1 and PaNAT2) from the model fungus Podospora anserina that acetylate a wide range of AA. Targeted gene disruption experiments revealed that PaNAT2 was required for the growth and survival of the fungus in the presence of toxic AA. Functional studies using the knock-out strains and chemically acetylated AA indicated that tolerance of P. anserina to toxic AA was due to the N-acetylation of these chemicals by PaNAT2. Moreover, we provide proof-of-concept remediation experiments where P. anserina, through its PaNAT2 enzyme, is able to detoxify the highly toxic pesticide residue 3,4-dichloroaniline in experimentally contaminated soil samples. Overall, our data show that a single xenobiotic-metabolizing enzyme can mediate tolerance to a major class of pollutants in a eukaryotic species. These findings expand the understanding of the role of xenobiotic-metabolizing enzyme and in particular of NATs in the adaptation of organisms to their chemical environment and provide a basis for new systems for the bioremediation of contaminated soils.	[Martins, Marta; Rodrigues-Lima, Fernando; Dairou, Julien; Dupret, Jean-Marie] Univ Paris 07, Lab Reponses Mol & Cellulaires Xenobiot, CNRS, Unite Biol Fonct & Adaptat,EAC 7059, F-75205 Paris 13, France; [Martins, Marta; Rodrigues-Lima, Fernando; Dairou, Julien; Malagnac, Fabienne; Silar, Philippe; Dupret, Jean-Marie] Univ Paris 07, UFR Sci Vivant, F-75013 Paris, France; [Lamouri, Aazdine] Univ Paris 07, Lab Interfaces Traitements Org & Dynam Syst, CNRS, UMR 7086, F-75013 Paris, France; [Lamouri, Aazdine] Univ Paris 07, UFR Chim, F-75013 Paris, France; [Malagnac, Fabienne; Silar, Philippe] Univ Paris 11, CNRS, UMR 8621, Inst Genet & Microbiol, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Dupret, JM (corresponding author), Univ Paris 07, Lab Reponses Mol & Cellulaires Xenobiot, CNRS, Unite Biol Fonct & Adaptat,EAC 7059, Batiment Buffon,3Eme Etage,4 Rue Marie Andree Lag, F-75205 Paris 13, France.	jean-marie.dupret@univ-paris-diderot.fr	Martins, Marta/A-9905-2013	Martins, Marta/0000-0003-0429-9380; silar, philippe/0000-0003-0104-987X; Malagnac, Fabienne/0000-0003-1139-7691	Association pour la Recherche sur le Cancer (ARC); la Caisse d'Assurance Maladie des Professions Liberales de Province; Universite Paris Diderot- Paris 7; Universite Paris 11-Sud	Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); la Caisse d'Assurance Maladie des Professions Liberales de Province; Universite Paris Diderot- Paris 7; Universite Paris 11-Sud	This work was supported by grants from the Association pour la Recherche sur le Cancer (ARC) and la Caisse d'Assurance Maladie des Professions Liberales de Province and running grants from Universite Paris Diderot- Paris 7 and Universite Paris 11-Sud.	[Anonymous], 2005, 11 US DEP HLTH HUM S; Brazier-Hicks M, 2005, PLANT J, V42, P556, DOI 10.1111/j.1365-313X.2005.02398.x; Brooke EW, 2003, BIOORGAN MED CHEM, V11, P1227, DOI 10.1016/S0968-0896(02)00642-9; Cornish VA, 2003, PHARMACOGENOMICS J, V3, P169, DOI 10.1038/sj.tpj.6500170; D'Annibale A, 2006, APPL ENVIRON MICROB, V72, P28, DOI 10.1128/AEM.72.1.28-36.2006; DUPRET JM, 1992, J BIOL CHEM, V267, P7381; Dupret JM, 2005, CURR MED CHEM, V12, P311, DOI 10.2174/0929867053363289; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Gan JP, 2004, JNCI-J NATL CANCER I, V96, P1425, DOI 10.1093/jnci/djh274; Giacomazzi S, 2004, CHEMOSPHERE, V56, P1021, DOI 10.1016/j.chemosphere.2004.04.061; GLENN AE, 2009, J APPL MICR IN PRESS; Gooddy DC, 2002, SCI TOTAL ENVIRON, V297, P67, DOI 10.1016/S0048-9697(02)00079-7; Hein DW, 2000, TOXICOL LETT, V112, P349, DOI 10.1016/S0378-4274(99)00226-X; HULZEBOS EM, 1993, ENVIRON TOXICOL CHEM, V12, P1079, DOI 10.1002/etc.5620120614; Kim D, 2005, ANNU REV PHARMACOL, V45, P27, DOI 10.1146/annurev.pharmtox.45.120403.100010; Malagnac F, 2007, EUKARYOT CELL, V6, P2323, DOI 10.1128/EC.00083-07; Martins M, 2008, J MOL BIOL, V383, P549, DOI 10.1016/j.jmb.2008.08.035; Palmiotto G, 2001, CHEMOSPHERE, V43, P355, DOI 10.1016/S0045-6535(00)00109-0; RIZET GEORGES, 1952, REV CYTOL ET BIOL VEG, V13, P51; Rodrigues-Lima F, 2006, MOL MICROBIOL, V60, P505, DOI 10.1111/j.1365-2958.2006.05114.x; Rodrigues-Lima F, 2002, BIOCHEM BIOPH RES CO, V293, P783, DOI 10.1016/S0006-291X(02)00299-1; Silar P, 1999, GENETICS, V151, P87; Silar P, 2005, MYCOL RES, V109, P137, DOI 10.1017/S0953756204002230; Silar P, 2001, GENETICS, V158, P1477; Silar P, 1995, FUNG GENET NEWSLETT, V42, P73, DOI DOI 10.4148/1941-4765.1353; Sim E, 2008, DRUG METAB REV, V40, P479, DOI [10.1080/03602530802186603, 10.1080/03602530802186603 ]; Stadler M, 2008, MYCOL RES, V112, P127, DOI 10.1016/j.mycres.2007.12.002; Sugamori KS, 2006, DRUG METAB DISPOS, V34, P1697, DOI 10.1124/dmd.106.010819; Sugamori KS, 2003, MOL PHARMACOL, V64, P170, DOI 10.1124/mol.64.1.170; Teeri TT, 2004, NAT BIOTECHNOL, V22, P679, DOI 10.1038/nbt0604-679; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; Tixier C, 2002, CHEMOSPHERE, V46, P519, DOI 10.1016/S0045-6535(01)00193-X; Tortella GR, 2005, CRIT REV MICROBIOL, V31, P197, DOI 10.1080/10408410500304066; Voelker D, 2008, AQUAT TOXICOL, V86, P112, DOI 10.1016/j.aquatox.2007.10.007; Westwood IM, 2005, BIOCHEM J, V385, P605, DOI 10.1042/BJ20041330	35	37	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18726	18733		10.1074/jbc.M109.015230	http://dx.doi.org/10.1074/jbc.M109.015230			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19416981	Green Published, hybrid			2022-12-25	WOS:000267711500022
J	Plo, I; Lopez, B				Plo, I.; Lopez, B.			AKT1 represses gene conversion induced by different genotoxic stresses and induces supernumerary centrosomes and aneuploidy in hamster ovary cells	ONCOGENE			English	Article						AKT1; BRCA1; homologous recombination; aneuploidy; centrosome; breast and ovary cancer	STRAND BREAK REPAIR; HOMOLOGOUS RECOMBINATION; MAMMALIAN RAD51; DNA-DAMAGE; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; CANCER SUSCEPTIBILITY; G1 CHECKPOINT; BRCA1; PHOSPHORYLATION; INSTABILITY	The oncogenic kinase AKT1 is frequently overexpressed or activated in sporadic breast and ovarian cancers. In human breast tumors, we have previously shown that AKT1 represses homologous recombination (HR) induced by one double-strand break (DSB). To further analyze the impact of AKT1 on HR, we ectopically expressed wildtype or mutant forms of AKT1 in a hamster ovary cell line containing an intrachromosomal substrate for monitoring HR. In this cell line, AKT1 repressed HR induced by different genotoxic stresses including ionizing radiation, UV-C and one single DSB introduced into the intrachromosomal substrate. Consistently, AKT1 disrupted RAD51 foci formation, showing that AKT1 specifically affects gene conversion. Concomitantly, AKT1 represses both BRCA1 foci formation and HR stimulation resulting from BRCA1 overexpression, showing that AKT1 affects BRCA1-mediated HR functions, also in another species (hamster) and in another type of cell tissue (ovary cells). Finally, consistent with the HR defects, active AKT1 expression induces supernumerary centrosomes and aneuploidy. In addition to its impact on cell proliferation and apoptosis, the present data propose a novel oncogenic function for AKT1, by producing genomic instability as a consequence of HR repression. Oncogene (2009) 28, 2231-2237; doi: 10.1038/onc.2009.85; published online 27 April 2009	[Plo, I.; Lopez, B.] CEA, CNRS, Inst Radiobiol Cellulaire & Mol, UMR 217, F-92265 Fontenay Aux Roses, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Lopez, B (corresponding author), CEA, CNRS, Inst Radiobiol Cellulaire & Mol, UMR, 18 Route Panorama,BAT 05, F-92265 Fontenay Aux Roses, France.	bernard.lopez@cea.fr	Lopez, Bernard S/O-7308-2017; Plo, Isabelle/C-9056-2017; Plo, Isabelle/AAT-6742-2021	Lopez, Bernard S/0000-0001-5088-0155; Plo, Isabelle/0000-0002-5915-6910; 	La Ligue Nationale contre le Cancer 'Equipes labellisees, La Ligue; l'Agence Nationale de la Recherche; ARC fellowship	La Ligue Nationale contre le Cancer 'Equipes labellisees, La Ligue; l'Agence Nationale de la Recherche(French National Research Agency (ANR)); ARC fellowship(Australian Research Council)	We thank Dr Hemmings (Friedrich Miescher Institute, Basel, Switzerland) for providing us the wtAKT1, myrAKT1 and kdAKT1 expression vectors, and Dr Jasin (Sloan-Kettering Institute, NYC, USA) for providing us with the CHO-DRA10 cell line and the I-SceI expression plasmid. This work was supported by La Ligue Nationale contre le Cancer 'Equipes labellisees, La Ligue 2005 and 2008' and by l'Agence Nationale de la Recherche. IP was a recipient of an ARC fellowship.	Altiok S, 1999, J BIOL CHEM, V274, P32274, DOI 10.1074/jbc.274.45.32274; Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Bertrand P, 2003, ONCOGENE, V22, P7587, DOI 10.1038/sj.onc.1206998; Daboussi F, 2005, ONCOGENE, V24, P3691, DOI 10.1038/sj.onc.1208438; Deans B, 2003, CANCER RES, V63, P8181; Deng CX, 2002, ONCOGENE, V21, P6222, DOI 10.1038/sj.onc.1205713; Griffin CS, 2000, NAT CELL BIOL, V2, P757, DOI 10.1038/35036399; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Hinton CV, 2007, EXP CELL RES, V313, P1735, DOI 10.1016/j.yexcr.2007.03.008; Hut HMJ, 2003, MOL BIOL CELL, V14, P1993, DOI 10.1091/mbc.E02-08-0510; Ivanov EL, 1996, GENETICS, V142, P693; Kraakman-van der Zwet M, 2002, MOL CELL BIOL, V22, P669, DOI 10.1128/MCB.22.2.669-679.2002; Lambert S, 2000, EMBO J, V19, P3090, DOI 10.1093/emboj/19.12.3090; Lambert S, 2002, ONCOGENE, V21, P4065, DOI 10.1038/sj.onc.1205535; Lee H, 1999, MOL CELL, V4, P1, DOI 10.1016/S1097-2765(00)80182-3; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Liu N, 1998, MOL CELL, V1, P783, DOI 10.1016/S1097-2765(00)80078-7; Miralem T, 2003, MOL CELL BIOL, V23, P579, DOI 10.1128/MCB.23.2.579-593.2003; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Plo I, 2008, CANCER RES, V68, P9404, DOI 10.1158/0008-5472.CAN-08-0861; Saintigny Y, 2007, ONCOGENE, V26, P2769, DOI 10.1038/sj.onc.1210075; Saintigny Y, 1999, ONCOGENE, V18, P3553, DOI 10.1038/sj.onc.1202941; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; WANG YY, 1988, MOL CELL BIOL, V8, P196, DOI 10.1128/MCB.8.1.196; Xiang T, 2008, CANCER RES, V68, P10040, DOI 10.1158/0008-5472.CAN-08-3009; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yang HL, 2006, CANCER RES, V66, P3096, DOI 10.1158/0008-5472.CAN-05-3620; Zhang JR, 2004, MOL CELL BIOL, V24, P708, DOI 10.1128/MCB.24.2.708-718.2004	32	17	17	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2009	28	22					2231	2237		10.1038/onc.2009.85	http://dx.doi.org/10.1038/onc.2009.85			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	453VF	19398948				2022-12-25	WOS:000266640300005
J	Goulding, MQ				Goulding, Morgan Q.			Cell Lineage of the Ilyanassa Embryo: Evolutionary Acceleration of Regional Differentiation during Early Development	PLOS ONE			English	Article								Cell lineage studies in mollusk embryos have documented numerous variations on the lophotrochozoan theme of spiral cleavage. In the experimentally tractable embryo of the mud snail Ilyanassa, cell lineage has previously been described only up to the 29-cell stage. Here I provide a chronology of cell divisions in Ilyanassa to the stage of 84 cells (about 16 hours after first cleavage at 23 degrees C), and show spatial arrangements of identified nuclei at stages ranging from 27 to 84 cells. During this period the spiral cleavage pattern gives way to a bilaterally symmetric, dorsoventrally polarized pattern of mitotic timing and geometry. At the same time, the mesentoblast cell 4d rapidly proliferates to form twelve cells lying deep to the dorsal ectoderm. The onset of epiboly coincides with a period of mitotic quiescence throughout the ectoderm. As in other gastropod embryos, cell cycle lengths vary widely and predictably according to cell identity, and many of the longest cell cycles occur in small daughters of highly asymmetric divisions. While Ilyanassa shares many features of embryonic cell lineage with two other caenogastropod genera, Crepidula and Bithynia, it is distinguished by a general tendency toward earlier and more pronounced diversification of cell division pattern along axes of later differential growth.			Goulding, MQ (corresponding author), Univ Oregon, Dept Phys, Eugene, OR 97403 USA.	goulding@uoregon.edu			Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM049869] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049869] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ackermann C, 2005, J MORPHOL, V266, P258, DOI 10.1002/jmor.10375; ARNOLDS WJA, 1983, ROUX ARCH DEV BIOL, V192, P75, DOI 10.1007/BF00848483; Casteel D. B., 1904, P ACAD NAT SCI PHILA, V56, P325; CATHER JN, 1963, CARYOLOGIA, V16, P663, DOI 10.1080/00087114.1963.10796106; Child CM, 1900, ARCH ENTWICKLUNG ORG, V9, P587, DOI 10.1007/BF02156195; CLEMENT AC, 1967, J EXP ZOOL, V166, P77, DOI 10.1002/jez.1401660109; CLEMENT AC, 1986, INT J INVER REP DEV, V9, P155, DOI 10.1080/01688170.1986.10510193; CLEMENT AC, 1962, J EXP ZOOL, V149, P193, DOI 10.1002/jez.1401490304; CLEMENT AC, 1986, INT J INVER REP DEV, V9, P139, DOI 10.1080/01688170.1986.10510192; CLEMENT AC, 1952, J EXP ZOOL, V121, P593, DOI 10.1002/jez.1401210310; Collier J.R., 1981, P217; Conklin E. G., 1907, P ACAD NAT SCI PHILA, V59, P320; Conklin Edwin G., 1902, Journal of the Academy of Natural Sciences of Philadelphia Ser 2, V12; Conklin EG, 1897, J MORPHOL, V13, P1, DOI DOI 10.1002/JMOR.1050130102; CONRAD GW, 1974, DEV BIOL, V36, P363, DOI 10.1016/0012-1606(74)90058-X; COSTELLO DP, 1945, J EXP ZOOL, V100, P19, DOI 10.1002/jez.1401000103; CRAIG MM, 1986, INT J INVER REP DEV, V9, P209, DOI 10.1080/01688170.1986.10510197; Crampton H.E., 1896, ARCH ENTWICKLUNGSMEC, V3, P1; Damen P, 1996, MECH DEVELOP, V56, P41, DOI 10.1016/0925-4773(96)00510-2; Dictus WJAG, 1997, MECH DEVELOP, V62, P213, DOI 10.1016/S0925-4773(97)00666-7; Dohle W, 1999, HYDROBIOLOGIA, V402, P267, DOI 10.1023/A:1003709129576; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Eleath H., 1899, ZOOL JB ABT ANAT ONT, V12, P567; FREEMAN G, 1992, J EVOLUTION BIOL, V5, P205, DOI 10.1046/j.1420-9101.1992.5020205.x; Gonzales EE, 2007, DEV GENES EVOL, V217, P105, DOI 10.1007/s00427-006-0118-z; Goulding M, 2003, DEVELOPMENT, V130, P1181, DOI 10.1242/dev.00322; Hejnol A, 2007, DEV BIOL, V305, P63, DOI 10.1016/j.ydbio.2007.01.044; Henry JJ, 1999, HYDROBIOLOGIA, V402, P255, DOI 10.1023/A:1003756912738; Henry JQ, 2006, DEV BIOL, V297, P295, DOI 10.1016/j.ydbio.2006.04.441; Holmes SJ, 1900, J MORPHOL, V16, P369, DOI 10.1002/jmor.1050160205; Kingsley EP, 2007, EVOL DEV, V9, P527, DOI 10.1111/j.1525-142X.2007.00194.x; LABORDUS V, 1986, J EXP ZOOL, V239, P65, DOI 10.1002/jez.1402390109; Lambert JD, 2001, DEVELOPMENT, V128, P45; MARTINDALE MQ, 1986, INT J INVER REP DEV, V9, P229, DOI 10.1080/01688170.1986.10510198; Maslakova SA, 2004, DEV BIOL, V267, P342, DOI 10.1016/j.ydbio.2003.10.022; MEISENHEIMER J, 1901, Z WISS ZOOL ABT A, V4, P1; Morgan TH, 1933, J EXP ZOOL, V64, P433, DOI 10.1002/jez.1400640305; Page LR, 2003, J EXP ZOOL PART B, V297B, P11, DOI 10.1002/jez.b.00012; Ponder Winston F., 2008, P331; Rabinowitz JS, 2008, CURR BIOL, V18, P331, DOI 10.1016/j.cub.2008.01.055; Render J, 1997, DEV BIOL, V189, P301, DOI 10.1006/dbio.1997.8654; RENDER J, 1989, DEV BIOL, V132, P241, DOI 10.1016/0012-1606(89)90220-0; RENDER J, 1991, DEVELOPMENT, V113, P495; Robert H., 1902, ARCH ZOOL EXP GEN, V3, P18; Smirthwaite JJ, 2007, EVOL DEV, V9, P122, DOI 10.1111/j.1525-142X.2007.00143.x; Sweet HC, 1998, DEVELOPMENT, V125, P4033; TOMLINSON SG, 1987, INT J INVER REP DEV, V12, P253, DOI 10.1080/01688170.1987.10510325; VANDAM WI, 1986, J MORPHOL, V188, P289, DOI 10.1002/jmor.1051880304; vandenBiggelaar JAM, 1996, EVOLUTION, V50, P1520, DOI 10.1111/j.1558-5646.1996.tb03925.x; VANDENBIGGELAAR JAM, 1993, J MORPHOL, V216, P121, DOI 10.1002/jmor.1052160203; VANDENBIGGELAAR JAM, 1979, DEV BIOL, V68, P462, DOI 10.1016/0012-1606(79)90218-5; vandenBiggelaar JAM, 1996, DEV BIOL, V174, P423, DOI 10.1006/dbio.1996.0085; VANDENBIGGELAAR JAM, 1977, J MORPHOL, V154, P157, DOI 10.1002/jmor.1051540111; VANDONGEN CA, 1974, P K NED AKAD C BIOL, V77, P57; Watase S, 1891, J MORPHOL, V4, P247; Wierzejski A, 1905, Z WISS ZOOL ABT A, V83, P502; Wilson EB, 1892, J MORPHOL, V6, P361	57	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2009	4	5							e5506	10.1371/journal.pone.0005506	http://dx.doi.org/10.1371/journal.pone.0005506			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VY	19430530	Green Published, Green Submitted, gold			2022-12-25	WOS:000266009700011
J	Heg, D; Jutzeler, E; Mitchell, JS; Hamilton, IM				Heg, Dik; Jutzeler, Eva; Mitchell, Jeremy S.; Hamilton, Ian M.			Helpful Female Subordinate Cichlids Are More Likely to Reproduce	PLOS ONE			English	Article							SOCIAL-STATUS; HELPING-BEHAVIOR; DIRECT BENEFITS; MALE HELPERS; RELATEDNESS; EVOLUTION; FISH; RECIPROCITY; GROWTH; STAY	Background: In many cooperatively breeding vertebrates, subordinates assist a dominant pair to raise the dominants' offspring. Previously, it has been suggested that subordinates may help in payment for continued residency on the territory (the 'pay-to-stay hypothesis'), but payment might also be reciprocated or might allow subordinates access to reproductive opportunities. Methodology/Principal Findings: We measured dominant and subordinate female alloparental brood care and reproductive success in four separate experiments and show that unrelated female dominant and subordinate cichlid fish care for each other's broods (alloparental brood care), but that there is no evidence for reciprocal 'altruism' (no correlation between alloparental care received and given). Instead, subordinate females appear to pay with alloparental care for own direct reproduction. Conclusions/Significance: Our results suggest subordinate females pay with alloparental care to ensure access to the breeding substrate and thereby increase their opportunities to lay their own clutches. Subordinates' eggs are laid, on average, five days after the dominant female has produced her first brood. We suggest that immediate reproductive benefits need to be considered in tests of the pay-to-stay hypothesis.			Heg, D (corresponding author), Univ Bern, Dept Behav Ecol, Inst Ecol & Evolut, Hinterkappelen, Switzerland.	dik.heg@iee.unibe.ch	Hamilton, Ian Michael/A-4949-2012	Hamilton, Ian Michael/0000-0002-1198-3431; Heg, Dik/0000-0002-8766-7945				Armitage KB, 2000, P NATL ACAD SCI USA, V97, P12149, DOI 10.1073/pnas.200196097; Awata S, 2006, BEHAV ECOL, V17, P372, DOI 10.1093/beheco/arj043; Balshine-Earn S, 1998, BEHAV ECOL, V9, P432, DOI 10.1093/beheco/9.5.432; Bender N, 2006, HORM BEHAV, V50, P173, DOI 10.1016/j.yhbeh.2006.02.009; Bergmuller R, 2007, BEHAV PROCESS, V76, P61, DOI 10.1016/j.beproc.2007.07.001; Bergmuller R, 2005, P ROY SOC B-BIOL SCI, V272, P325, DOI 10.1098/rspb.2004.2960; Bergmuller R, 2005, ANIM BEHAV, V69, P19, DOI 10.1016/j.anbehav.2004.05.009; Bshary R, 2002, ECOL LETT, V5, P130, DOI 10.1046/j.1461-0248.2002.00295.x; Canestrari D, 2005, BEHAV ECOL SOCIOBIOL, V57, P422, DOI 10.1007/s00265-004-0879-1; Dierkes P, 2008, BEHAV ECOL SOCIOBIOL, V62, P1581, DOI 10.1007/s00265-008-0587-3; Dierkes P, 2005, ECOL LETT, V8, P968, DOI 10.1111/j.1461-0248.2005.00801.x; Field J, 2000, NATURE, V404, P869, DOI 10.1038/35009097; Fitzpatrick JL, 2006, BEHAV ECOL, V17, P25, DOI 10.1093/beheco/ari090; Foster KR, 2006, TRENDS ECOL EVOL, V21, P57, DOI 10.1016/j.tree.2005.11.020; GASTON AJ, 1978, AM NAT, V112, P1091, DOI 10.1086/283348; Hamilton IM, 2008, J FISH BIOL, V72, P1079, DOI 10.1111/j.1095-8649.2007.01787.x; Hamilton IM, 2007, BEHAV ECOL, V18, P467, DOI 10.1093/beheco/arl108; Hamilton IM, 2005, BEHAVIOUR, V142, P1591, DOI 10.1163/156853905774831846; Hamilton IM, 2004, BEHAV ECOL, V15, P585, DOI 10.1093/beheco/arh047; Hamilton IM, 2005, P ROY SOC B-BIOL SCI, V272, P445, DOI 10.1098/rspb.2004.2961; Heg D, 2006, BEHAV ECOL, V17, P419, DOI 10.1093/beheco/arj056; Heg D, 2005, BEHAVIOUR, V142, P1615, DOI 10.1163/156853905774831891; Heg D, 2005, ETHOLOGY, V111, P1017, DOI 10.1111/j.1439-0310.2005.01135.x; Heg D, 2004, P ROY SOC B-BIOL SCI, V271, pS505, DOI 10.1098/rsbl.2004.0232; Heg D, 2004, P ROY SOC B-BIOL SCI, V271, P2367, DOI 10.1098/rspb.2004.2855; Heg D, 2008, BIOL LETTERS, V4, P606, DOI 10.1098/rsbl.2008.0365; Heg D, 2008, MOL ECOL, V17, P4359, DOI 10.1111/j.1365-294X.2008.03920.x; Heg D, 2008, BEHAV ECOL SOCIOBIOL, V62, P1249, DOI 10.1007/s00265-008-0553-0; Heg D, 2006, ENVIRON BIOL FISH, V76, P265, DOI 10.1007/s10641-006-9032-5; Hoeksema JD, 2003, P ROY SOC B-BIOL SCI, V270, P913, DOI 10.1098/rspb.2002.2312; Khan MZ, 2000, BEHAV ECOL SOCIOBIOL, V47, P376, DOI 10.1007/s002650050680; Koenig W.D., 2004, ECOLOGY EVOLUTION CO; LIGON JD, 1983, ANIM BEHAV, V31, P480, DOI 10.1016/S0003-3472(83)80069-4; LIGON JD, 1978, NATURE, V276, P496, DOI 10.1038/276496a0; Manson JH, 2004, ANIM BEHAV, V67, P493, DOI 10.1016/j.anbehav.2003.05.009; Melis AP, 2006, SCIENCE, V311, P1297, DOI 10.1126/science.1123007; MILINSKI M, 1987, NATURE, V325, P433, DOI 10.1038/325433a0; Norusis M.J, 2007, SPSS 15 0 ADV STAT P; PUSEY AE, 1994, BEHAV ECOL, V5, P362, DOI 10.1093/beheco/5.4.362; RABENOLD KN, 1985, BEHAV ECOL SOCIOBIOL, V17, P1, DOI 10.1007/BF00299422; Richardson DS, 2002, EVOLUTION, V56, P2313; SCHURCH R, 2008, THESIS U BERN SWITZE; Seddon N, 2005, MOL ECOL, V14, P3573, DOI 10.1111/j.1365-294X.2005.02675.x; Solomon N. G., 1997, COOPERATIVE BREEDING; Stiver KA, 2005, P ROY SOC B-BIOL SCI, V272, P1593, DOI 10.1098/rspb.2005.3123; TABORSKY M, 1985, BEHAVIOUR, V95, P45, DOI 10.1163/156853985X00046; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Van Horn RC, 2004, MOL ECOL, V13, P449, DOI 10.1046/j.1365-294X.2003.02071.x; Watts DP, 2002, BEHAVIOUR, V139, P343, DOI 10.1163/156853902760102708; Werner NY, 2003, BEHAV ECOL, V14, P749, DOI 10.1093/beheco/arg067; WILKINSON GS, 1984, NATURE, V308, P181, DOI 10.1038/308181a0	51	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5458	10.1371/journal.pone.0005458	http://dx.doi.org/10.1371/journal.pone.0005458			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421320	Green Published, gold			2022-12-25	WOS:000265836900014
J	Rusconi, E; Gonzaga, M; Adriani, M; Braun, C; Haggard, P				Rusconi, Elena; Gonzaga, Mirandola; Adriani, Michela; Braun, Christoph; Haggard, Patrick			Know Thyself: Behavioral Evidence for a Structural Representation of the Human Body	PLOS ONE			English	Article							PARIETAL CORTEX; PARTS; AGNOSIA; MEMORY; SIZE	Background: Representing one's own body is often viewed as a basic form of self-awareness. However, little is known about structural representations of the body in the brain. Methods and Findings: We developed an inter-manual version of the classical "in-between'' finger gnosis task: participants judged whether the number of untouched fingers between two touched fingers was the same on both hands, or different. We thereby dissociated structural knowledge about fingers, specifying their order and relative position within a hand, from tactile sensory codes. Judgments following stimulation on homologous fingers were consistently more accurate than trials with no or partial homology. Further experiments showed that structural representations are more enduring than purely sensory codes, are used even when number of fingers is irrelevant to the task, and moreover involve an allocentric representation of finger order, independent of hand posture. Conclusions: Our results suggest the existence of an allocentric representation of body structure at higher stages of the somatosensory processing pathway, in addition to primary sensory representation.			Rusconi, E (corresponding author), UCL, Inst Cognit Neurosci, London, England.	p.haggard@ucl.ac.uk	Braun, Christoph/E-4561-2010; Braun, Christoph/J-4160-2014; Haggard, Patrick/A-5081-2010	Braun, Christoph/0000-0002-7836-4010; Braun, Christoph/0000-0002-7836-4010; Haggard, Patrick/0000-0001-7798-793X				Azanon E, 2008, CURR BIOL, V18, P1044, DOI 10.1016/j.cub.2008.06.045; BENEDETTI F, 1985, J EXP PSYCHOL HUMAN, V11, P517, DOI 10.1037/0096-1523.11.4.517; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Buxbaum LJ, 2001, COGNITIVE NEUROPSYCH, V18, P289, DOI 10.1080/02643290126172; Corradi-Dell'Acqua C, 2008, CEREB CORTEX, V18, P2879, DOI 10.1093/cercor/bhn046; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Fitzgerald PJ, 2006, J NEUROSCI, V26, P6485, DOI 10.1523/JNEUROSCI.5061-05.2006; Gainotti G, 1972, Cortex, V8, P364; GALLACE A, 2008, EXP BRAIN R IN PRESS; Gallace A, 2008, BRAIN RES, V1190, P132, DOI 10.1016/j.brainres.2007.11.014; Gallace A, 2008, PERCEPTION, V37, P782, DOI 10.1068/p5767; Gerstmann J, 1940, ARCH NEURO PSYCHIATR, V44, P398, DOI 10.1001/archneurpsyc.1940.02280080158009; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Guariglia C, 2002, NEUROPSYCHOLOGIA, V40, P1744, DOI 10.1016/S0028-3932(02)00013-1; Harris JA, 2002, J NEUROSCI, V22, P8720; Harris JA, 2001, J NEUROSCI, V21, P8262, DOI 10.1523/JNEUROSCI.21-20-08262.2001; IRIKI A, 2008, PHILOS T R SOC B, V27, P2229; KINSBOURNE M, 1962, BRAIN, V85, P47, DOI 10.1093/brain/85.1.47; Mayer E, 1999, BRAIN, V122, P1107, DOI 10.1093/brain/122.6.1107; OGDEN JA, 1985, BRAIN, V108, P1009, DOI 10.1093/brain/108.4.1009; Poeck K, 1971, Cortex, V7, P254; Rusconi E, 2005, NEUROPSYCHOLOGIA, V43, P1609, DOI 10.1016/j.neuropsychologia.2005.01.009; Rushworth MFS, 1997, EXP BRAIN RES, V117, P311, DOI 10.1007/s002210050225; SEMENZA C, 1985, NEUROPSYCHOLOGIA, V23, P161, DOI 10.1016/0028-3932(85)90101-0; SIRIGU A, 1991, BRAIN, V114, P629, DOI 10.1093/brain/114.1.629; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; Taylor-Clarke M, 2004, NAT NEUROSCI, V7, P219, DOI 10.1038/nn1199; Tucha O, 1997, J NEUROL NEUROSUR PS, V63, P399, DOI 10.1136/jnnp.63.3.399	28	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5418	10.1371/journal.pone.0005418	http://dx.doi.org/10.1371/journal.pone.0005418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	440GG	19412538	Green Published, gold, Green Submitted			2022-12-25	WOS:000265688200006
J	Trumbower, RD; Krutky, MA; Yang, BS; Perreault, EJ				Trumbower, Randy D.; Krutky, Matthew A.; Yang, Bing-Shiang; Perreault, Eric J.			Use of Self-Selected Postures to Regulate Multi-Joint Stiffness During Unconstrained Tasks	PLOS ONE			English	Article							HUMAN ANKLE STIFFNESS; SYSTEM-IDENTIFICATION; REFLEX CONTRIBUTIONS; ARM STIFFNESS; SHORT-LATENCY; STABILITY; DYNAMICS; ADAPTATION; VARIABILITY; MODULATION	Backgound: The human motor system is highly redundant, having more kinematic degrees of freedom than necessary to complete a given task. Understanding how kinematic redundancies are utilized in different tasks remains a fundamental question in motor control. One possibility is that they can be used to tune the mechanical properties of a limb to the specific requirements of a task. For example, many tasks such as tool usage compromise arm stability along specific directions. These tasks only can be completed if the nervous system adapts the mechanical properties of the arm such that the arm, coupled to the tool, remains stable. The purpose of this study was to determine if posture selection is a critical component of endpoint stiffness regulation during unconstrained tasks. Methodology/Principal Findings: Three-dimensional (3D) estimates of endpoint stiffness were used to quantify limb mechanics. Most previous studies examining endpoint stiffness adaptation were completed in 2D using constrained postures to maintain a non-redundant mapping between joint angles and hand location. Our hypothesis was that during unconstrained conditions, subjects would select arm postures that matched endpoint stiffness to the functional requirements of the task. The hypothesis was tested during endpoint tracking tasks in which subjects interacted with unstable haptic environments, simulated using a 3D robotic manipulator. We found that arm posture had a significant effect on endpoint tracking accuracy and that subjects selected postures that improved tracking performance. For environments in which arm posture had a large effect on tracking accuracy, the self-selected postures oriented the direction of maximal endpoint stiffness towards the direction of the unstable haptic environment. Conclusions/Significance: These results demonstrate how changes in arm posture can have a dramatic effect on task performance and suggest that postural selection is a fundamental mechanism by which kinematic redundancies can be exploited to regulate arm stiffness in unconstrained tasks.			Trumbower, RD (corresponding author), Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA.	e-perreault@northwestern.edu	Trumbower, Randy/C-1334-2016; Perreault, Eric/B-7632-2009; Trumbower, Randy/O-1321-2019	Trumbower, Randy/0000-0002-2282-9974	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007418] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K25HD044720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053813] Funding Source: NIH RePORTER; NICHD NIH HHS [T32 HD007418, K25 HD044720] Funding Source: Medline; NINDS NIH HHS [NS053813, R01 NS053813] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLUM JHJ, 1982, EXP BRAIN RES, V48, P153; Bendat J.S., 2000, RANDOM DATA ANAL MEA; Biess A, 2007, J NEUROSCI, V27, P13045, DOI 10.1523/JNEUROSCI.4334-06.2007; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Cohen RG, 2009, EXP BRAIN RES, V193, P69, DOI 10.1007/s00221-008-1596-1; Darainy M, 2004, J NEUROPHYSIOL, V92, P3344, DOI 10.1152/jn.00596.2004; de Vlugt E, 2002, BIOL CYBERN, V87, P10, DOI 10.1007/s00422-002-0311-8; DIETZ V, 1994, ELECTROEN CLIN NEURO, V93, P49, DOI 10.1016/0168-5597(94)90091-4; DOEMGES F, 1992, J PHYSIOL-LONDON, V447, P575, DOI 10.1113/jphysiol.1992.sp019019; FLASH T, 1990, EXP BRAIN RES, V82, P315; Franklin DW, 2007, J NEUROSCI, V27, P7705, DOI 10.1523/JNEUROSCI.0968-07.2007; Franklin DW, 2004, J NEUROPHYSIOL, V92, P3097, DOI 10.1152/jn.00364.2004; Franklin DW, 2003, EXP BRAIN RES, V152, P211, DOI 10.1007/s00221-003-1540-3; Franklin DW, 2003, EXP BRAIN RES, V151, P145, DOI 10.1007/s00221-003-1443-3; Gomi H, 1998, J NEUROSCI, V18, P8965; Gribble PL, 2003, J NEUROPHYSIOL, V89, P2396, DOI 10.1152/jn.01020.2002; HOGAN N, 1985, BIOL CYBERN, V52, P315, DOI 10.1007/BF00355754; Kearney RE, 1997, IEEE T BIO-MED ENG, V44, P493, DOI 10.1109/10.581944; KEARNEY RE, 1990, CLIN BIOMECH, V5, P205, DOI 10.1016/0268-0033(90)90004-P; Kimura T, 2006, J NEUROSCI, V26, P9272, DOI 10.1523/JNEUROSCI.3886-05.2006; Lenarcic J, 1999, LAB ROBOTICS AUTOMAT, V11, P272, DOI 10.1002/(SICI)1098-2728(1999)11:5<272::AID-LRA5>3.0.CO;2-L; Linde Van der RQ, 2002, HAPTICMASTER NEW HIG, P1; Ljung L., 1999, SYSTEM IDENTIFICATIO; MILNER TE, 1993, EXP BRAIN RES, V94, P522; Milner TE, 2002, EXP BRAIN RES, V143, P406, DOI 10.1007/s00221-002-1001-4; Mirbagheri MM, 2000, EXP BRAIN RES, V135, P423, DOI 10.1007/s002210000534; MUSSAIVALDI FA, 1985, J NEUROSCI, V5, P2732; Perreault EJ, 2000, IEEE ENG MED BIOL, V19, P53, DOI 10.1109/51.887246; Perreault EJ, 1999, BIOL CYBERN, V80, P327, DOI 10.1007/s004220050529; Perreault EJ, 2004, EXP BRAIN RES, V157, P507, DOI 10.1007/s00221-004-1864-7; Perreault EJ, 2001, EXP BRAIN RES, V141, P312, DOI 10.1007/s002210100880; Perreault EJ, 2008, J NEUROPHYSIOL, V99, P2101, DOI 10.1152/jn.01094.2007; Politis DN, 1998, IEEE SIGNAL PROC MAG, V15, P39, DOI 10.1109/79.647042; PRESS W, 1992, NUMERICAN RECIPES C; R Core Team, 2022, R LANG ENV STAT COMP; Rancourt D, 2001, J MOTOR BEHAV, V33, P351, DOI 10.1080/00222890109601919; Rancourt D, 2001, J MOTOR BEHAV, V33, P193, DOI 10.1080/00222890109603150; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Schouten AC, 2001, BIOL CYBERN, V84, P143, DOI 10.1007/s004220000202; Sciavicco L., 2000, MODELLING CONTROL RO, Vsecond; SINKJAER T, 1988, J NEUROPHYSIOL, V60, P1110, DOI 10.1152/jn.1988.60.3.1110; SOECHTING JF, 1995, J NEUROSCI, V15, P6271; TSUJI T, 1995, BIOL CYBERN, V72, P475, DOI 10.1007/BF00199890; Winter D, 2005, BIOMECHANICS MOTOR C	44	58	59	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5411	10.1371/journal.pone.0005411	http://dx.doi.org/10.1371/journal.pone.0005411			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440GG	19412540	Green Published, gold, Green Submitted			2022-12-25	WOS:000265688200004
J	Bohm, M; Hutchings, MR; White, PCL				Boehm, Monika; Hutchings, Michael R.; White, Piran C. L.			Contact Networks in a Wildlife-Livestock Host Community: Identifying High-Risk Individuals in the Transmission of Bovine TB among Badgers and Cattle	PLOS ONE			English	Article							TUBERCULOSIS MYCOBACTERIUM-BOVIS; MELES-MELES; DISEASE; MOVEMENTS; INFECTION; PROXIMITY; DYNAMICS; PATTERNS; DENSITY; MAMMALS	Background: The management of many pathogens, which are of concern to humans and their livestock, is complicated by the pathogens' ability to cross-infect multiple host species, including wildlife. This has major implications for the management of such diseases, since the dynamics of infection are dependent on the rates of both intra- and inter-specific transmission. However, the difficulty of studying transmission networks in free-living populations means that the relative opportunities for intra- versus inter-specific disease transmission have not previously been demonstrated empirically within any wildlife-livestock disease system. Methodology/Principal Findings: Using recently-developed proximity data loggers, we quantify both intra- and interspecific contacts in a wildlife-livestock disease system, using bovine tuberculosis (bTB) in badgers and cattle in the UK as our example. We assess the connectedness of individuals within the networks in order to identify whether there are certain 'high-risk' individuals or groups of individuals for disease transmission within and between species. Our results show that contact patterns in both badger and cattle populations vary widely, both between individuals and over time. We recorded only infrequent interactions between badger social groups, although all badgers fitted with data loggers were involved in these inter-group contacts. Contacts between badgers and cattle occurred more frequently than contacts between different badger groups. Moreover, these inter-specific contacts involved those individual cows, which were highly connected within the cattle herd. Conclusions/Significance: This work represents the first continuous time record of wildlife-host contacts for any free-living wildlife-livestock disease system. The results highlight the existence of specific individuals with relatively high contact rates in both livestock and wildlife populations, which have the potential to act as hubs in the spread of disease through complex contact networks. Targeting testing or preventive measures at high-contact groups and individuals within livestock populations would enhance the effectiveness and efficiency of disease management strategies.			White, PCL (corresponding author), Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England.	PCLW1@york.ac.uk	Böhm, Monika/E-1153-2018; White, Piran C.L./F-5091-2010; White, Piran Crawfurd Limond/AAH-6851-2021; Hutchings, Mike/P-6836-2019	Böhm, Monika/0000-0003-0585-0832; White, Piran Crawfurd Limond/0000-0002-7496-5775; Hutchings, Mike/0000-0003-3338-471X				Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Ball F, 1997, ANN APPL PROBAB, V7, P46; BENHAM PFJ, 1989, BRIT VET J, V145, P226, DOI 10.1016/0007-1935(89)90075-4; Bohm M, 2008, J ANIM ECOL, V77, P735, DOI 10.1111/j.1365-2656.2008.01377.x; Bowers RG, 1997, J THEOR BIOL, V187, P95, DOI 10.1006/jtbi.1997.0418; Brennan ML, 2008, PREV VET MED, V84, P242, DOI 10.1016/j.prevetmed.2007.12.009; Buesching CD, 2003, BEHAVIOUR, V140, P965, DOI 10.1163/156853903322589597; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; COWAN DP, 1987, J ANIM ECOL, V56, P779, DOI 10.2307/4948; Davidson RS, 2008, J THEOR BIOL, V253, P424, DOI 10.1016/j.jtbi.2008.03.021; Day TD, 2000, APPL ANIM BEHAV SCI, V70, P157, DOI 10.1016/S0168-1591(00)00144-1; *DEFR, 2007, OPT VACC CATTL BOV T; *DEFR, 2005, GOV STRAT FRAM SUST; *DEFR BOV TB HUSB, 2007, ADV HUSB BEST PRACT; Delahay RJ, 2000, J ANIM ECOL, V69, P428, DOI 10.1046/j.1365-2656.2000.00406.x; DONCASTER CP, 1990, J THEOR BIOL, V143, P431, DOI 10.1016/S0022-5193(05)80020-7; Fenton A, 2005, EMERG INFECT DIS, V11, P1815, DOI 10.3201/eid1112.050306; Gallagher J, 2000, RES VET SCI, V69, P203, DOI 10.1053/rvsc.2000.0422; Gannon BW, 2007, RES VET SCI, V82, P169, DOI 10.1016/j.rvsc.2006.07.011; Garnett BT, 2003, APPL ANIM BEHAV SCI, V80, P1, DOI 10.1016/S0168-1591(02)00204-6; Garnett BT, 2002, P ROY SOC B-BIOL SCI, V269, P1487, DOI 10.1098/rspb.2002.2072; Gavier-Widen D, 2001, VET REC, V148, P299, DOI 10.1136/vr.148.10.299; Gilbert M, 2005, NATURE, V435, P491, DOI 10.1038/nature03548; Goodman E.L., 2007, THESIS U YORK YORK; Gopal R, 2006, VET REC, V159, P265, DOI 10.1136/vr.159.9.265; Green DM, 2008, P R SOC B, V275, P1001, DOI 10.1098/rspb.2007.1601; HARRIS S, 1992, J ZOOL, V228, P679, DOI 10.1111/j.1469-7998.1992.tb04467.x; Holt RD, 2003, ECOL LETT, V6, P837, DOI 10.1046/j.1461-0248.2003.00501.x; *ISG, 2007, BOV TB SCI EV; Ji WH, 2005, J APPL ECOL, V42, P595, DOI 10.1111/j.1365-2664.2005.01026.x; Kao RR, 2007, J R SOC INTERFACE, V4, P907, DOI 10.1098/rsif.2007.1129; Keeling M, 2005, THEOR POPUL BIOL, V67, P1, DOI 10.1016/j.tpb.2004.08.002; Kiss IZ, 2008, J R SOC INTERFACE, V5, P791, DOI 10.1098/rsif.2007.1272; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129; MUIRHEAD RH, 1974, VET REC, V95, P552, DOI 10.1136/vr.95.24.552; Nolan A., 1994, VET MICROBIOL, V43, P256; PALPHRAMAND KL, 2005, THESIS U YORK YORK; Prange S, 2006, WILDLIFE SOC B, V34, P1333, DOI 10.2193/0091-7648(2006)34[1333:NRFTDO]2.0.CO;2; Roper TJ, 2001, BEHAVIOUR, V138, P173, DOI 10.1163/15685390151074366; Sauter CM, 1995, NEW ZEAL VET J, V43, P301, DOI 10.1080/00480169./1995.35910; *SIRTR LTD, 2006, SIRTR PROX LOGG INF; Swain DL, 2007, APPL ANIM BEHAV SCI, V102, P1, DOI 10.1016/j.applanim.2006.03.008; Totton SC, 2002, J WILDLIFE DIS, V38, P313, DOI 10.7589/0090-3558-38.2.313; Turner J, 2008, J THEOR BIOL, V254, P45, DOI 10.1016/j.jtbi.2008.05.007; Tuyttens FAM, 2001, J APPL ECOL, V38, P1114, DOI 10.1046/j.1365-2664.2001.00665.x; Vonhof MJ, 2004, ANIM BEHAV, V68, P507, DOI 10.1016/j.anbehav.2003.08.025; WHITE PCL, 1993, P ROY SOC B-BIOL SCI, V253, P277, DOI 10.1098/rspb.1993.0114; WHITE PCL, 1994, J ANIM ECOL, V63, P315, DOI 10.2307/5550; White PCL, 2008, TRENDS MICROBIOL, V16, P420, DOI 10.1016/j.tim.2008.06.005; WILESMITH JW, 1982, J HYG-CAMBRIDGE, V89, P195, DOI 10.1017/S002217240007073X; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Woolhouse MEJ, 2005, BIOL LETTERS, V1, P350, DOI 10.1098/rsbl.2005.0331; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	53	154	154	3	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5016	10.1371/journal.pone.0005016	http://dx.doi.org/10.1371/journal.pone.0005016			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401755	Green Published, gold			2022-12-25	WOS:000265601100001
J	Tanaka, S; Tani, T; Ribot, J; O'Hashi, K; Imamura, K				Tanaka, Shigeru; Tani, Toshiki; Ribot, Jerome; O'Hashi, Kazunori; Imamura, Kazuyuki			A Postnatal Critical Period for Orientation Plasticity in the Cat Visual Cortex	PLOS ONE			English	Article								Orientation selectivity of primary visual cortical neurons is an important requisite for shape perception. Although numerous studies have been previously devoted to a question of how orientation selectivity is established and elaborated in early life, how the susceptibility of orientation plasticity to visual experience changes in time remains unclear. In the present study, we showed a postnatal sensitive period profile for the modifiability of orientation selectivity in the visual cortex of kittens reared with head-mounted goggles for stable single-orientation exposure. When goggle rearing (GR) started at P16-P30, 2 weeks of GR induced a marked over-representation of the exposed orientation, and 2 more weeks of GR consolidated the altered orientation maps. GR that started later than P50, in turn, induced the under-representation of the exposed orientation. Orientation plasticity in the most sensitive period was markedly suppressed by cortical infusion of NMDAR antagonist. The present study reveals that the plasticity and consolidation of orientation selectivity in an early life are dynamically regulated in an experience-dependent manner.			Tanaka, S (corresponding author), RIKEN, Brain Sci Inst, Lab Visual Neurocomp, Wako, Saitama, Japan.	shigeru@riken.jp		Ribot, Jerome/0000-0003-1227-4773				BEAR MF, 1990, J NEUROSCI, V10, P909; BLAKEMORE C, 1970, NATURE, V228, P477, DOI 10.1038/228477a0; BLAKEMORE C, 1975, J PHYSIOL-LONDON, V248, P663, DOI 10.1113/jphysiol.1975.sp010995; BONHOEFFER T, 1995, EUR J NEUROSCI, V7, P1973, DOI 10.1111/j.1460-9568.1995.tb00720.x; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Buller AL, 1997, EUR J PHARMACOL, V320, P87, DOI 10.1016/S0014-2999(96)00880-1; CARLSON M, 1986, DEV BRAIN RES, V25, P71, DOI 10.1016/0165-3806(86)90153-7; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; CREUTZFELDT OD, 1975, SCIENCE, V188, P1025, DOI 10.1126/science.1145187; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; FREGNAC Y, 1988, NATURE, V333, P367, DOI 10.1038/333367a0; Gilbert CD, 1996, P NATL ACAD SCI USA, V93, P615, DOI 10.1073/pnas.93.2.615; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Godde B, 2002, P NATL ACAD SCI USA, V99, P6352, DOI 10.1073/pnas.082407499; Gordon JA, 1996, J NEUROSCI, V16, P3274; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; HIRSCH HVB, 1970, SCIENCE, V168, P869, DOI 10.1126/science.168.3933.869; Huang Y, 2008, J NEUROSCI, V28, P7074, DOI 10.1523/JNEUROSCI.0899-08.2008; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Imamura K, 1999, P ROY SOC B-BIOL SCI, V266, P1507, DOI 10.1098/rspb.1999.0808; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; Kasamatsu T, 1997, BRAIN RES PROTOC, V1, P57, DOI 10.1016/S1385-299X(96)00008-6; KASAMATSU T, 1976, SCIENCE, V194, P206, DOI 10.1126/science.959850; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; Liu CH, 2008, NEURON, V58, P340, DOI 10.1016/j.neuron.2008.02.020; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; Mower GD, 2003, MOL BRAIN RES, V119, P19, DOI 10.1016/j.molbrainres.2003.08.007; O'Hasi K, 2007, NEUROSCI RES, V58, P86, DOI 10.1016/j.neures.2007.01.005; Ohki K, 2000, CEREB CORTEX, V10, P593, DOI 10.1093/cercor/10.6.593; OLSON CR, 1980, EXP BRAIN RES, V39, P17; RATZLAFF EH, 1991, J NEUROSCI METH, V36, P127, DOI 10.1016/0165-0270(91)90038-2; RAUSCHECKER JP, 1991, PHYSIOL REV, V71, P587, DOI 10.1152/physrev.1991.71.2.587; RAUSCHECKER JP, 1981, J PHYSIOL-LONDON, V310, P215, DOI 10.1113/jphysiol.1981.sp013545; Ribot J, 2006, J NEUROSCI METH, V153, P8, DOI 10.1016/j.jneumeth.2005.09.016; Ringach DL, 1997, VISION RES, V37, P2455, DOI 10.1016/S0042-6989(96)00247-7; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; STRYKER MP, 1978, J NEUROPHYSIOL, V41, P896, DOI 10.1152/jn.1978.41.4.896; Tanaka S, 2006, NEUROIMAGE, V30, P462, DOI 10.1016/j.neuroimage.2005.09.056; Tanaka S, 2004, NEURAL NETWORKS, V17, P1363, DOI 10.1016/j.neunet.2004.06.014; Tanaka S, 2007, J NEUROSCI METH, V160, P206, DOI 10.1016/j.jneumeth.2006.09.004; Tran DH, 2007, NEUROPHARMACOLOGY, V53, P252, DOI 10.1016/j.neuropharm.2007.05.005; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Yokoo T, 2001, NEUROIMAGE, V14, P1309, DOI 10.1006/nimg.2001.0950	46	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5380	10.1371/journal.pone.0005380	http://dx.doi.org/10.1371/journal.pone.0005380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401781	Green Published, gold, Green Submitted			2022-12-25	WOS:000265601100017
J	Du, HD; Daphne, LV; Ginder, V; Jebb, SA; Forouhi, NG; Wareham, NJ; Halkjaer, J; Tjonneland, A; Overvad, K; Jakobsen, MU; Buijsse, B; Steffen, A; Palli, D; Masala, G; Saris, WHM; Sorensen, TIA; Feskens, EJM				Du, Huaidong; Daphne, L. van der A.; Ginder, Vanessa; Jebb, Susan A.; Forouhi, Nita G.; Wareham, Nicholas J.; Halkjaer, Jytte; Tjonneland, Anne; Overvad, Kim; Jakobsen, Marianne Uhre; Buijsse, Brian; Steffen, Annika; Palli, Domenico; Masala, Giovanna; Saris, Wim H. M.; Sorensen, Thorkild I. A.; Feskens, Edith J. M.			Dietary Energy Density in Relation to Subsequent Changes of Weight and Waist Circumference in European Men and Women	PLOS ONE			English	Article								Background: Experimental studies show that a reduction in dietary energy density (ED) is associated with reduced energy intake and body weight. However, few observational studies have investigated the role of ED on long-term weight and waist circumference change. Methods and Principal Findings: This population-based prospective cohort study included 89,432 participants from five European countries with mean age 53 years (range: 20-78 years) at baseline and were followed for an average of 6.5 years (range: 1.9-12.5 years). Participants were free of cancer, cardiovascular diseases and diabetes at baseline. ED was calculated as the energy intake (kcal) from foods divided by the weight (g) of foods. Multiple linear regression analyses were performed to investigate the associations of ED with annual weight and waist circumference change. Mean ED was 1.7 kcal/g and differed across study centers. After adjusting for baseline anthropometrics, demographic and lifestyle factors, follow-up duration and energy from beverages, ED was not associated with weight change, but significantly associated with waist circumference change overall. For 1 kcal/g ED, the annual weight change was -42 g/year [95% confidence interval (CI): -112, 28] and annual waist circumference change was 0.09 cm/year [95% CI: 0.01, 0.18]. In participants with baseline BMI<25 kg/m(2), 1 kcal/g ED was associated with a waist circumference change of 0.17 cm/year [95% CI: 0.09, 0.25]. Conclusion: Our results suggest that lower ED diets do not prevent weight gain but have a weak yet potentially beneficial effect on the prevention of abdominal obesity as measured by waist circumference.			Du, HD (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands.	huaidong.du@rivm.nl	Masala, Giovanna/AAC-5474-2022; Feskens, Edith JM/A-3757-2012; Feskens, Edith/ABI-1446-2020; Jakobsen, Marianne Uhre/I-8550-2018; Steffen, Annika/H-7709-2018; Buijsse, Brian/E-5079-2011; Steffen, Annika/E-8540-2016	Masala, Giovanna/0000-0002-5758-9069; Feskens, Edith/0000-0001-5819-2488; Jakobsen, Marianne Uhre/0000-0001-6518-4136; Steffen, Annika/0000-0003-4072-9245; Steffen, Annika/0000-0003-4072-9245; Du, Huaidong/0000-0002-9814-0049; Tjonneland, Anne/0000-0003-4385-2097; tumino, rosario/0000-0003-2666-414X; Forouhi, Nita/0000-0002-5041-248X; Jebb, Susan/0000-0001-9190-2920; Overvad, Kim/0000-0001-6429-7921; PALLI, Domenico/0000-0002-5558-2437	MRC [MC_U105960389] Funding Source: UKRI; Medical Research Council [MC_U105960389] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bes-Rastrollo M, 2008, AM J CLIN NUTR, V88, P769, DOI 10.1093/ajcn/88.3.769; Brustad M, 2003, EUR J CLIN NUTR, V57, P107, DOI 10.1038/sj.ejcn.1601498; Cox DN, 2000, INT J OBESITY, V24, P49, DOI 10.1038/sj.ijo.0801084; Day N, 1999, BRIT J CANCER, V80, P95; Ello-Martin JA, 2007, AM J CLIN NUTR, V85, P1465, DOI 10.1093/ajcn/85.6.1465; Ferrari P, 2008, INT J EPIDEMIOL, V37, P368, DOI 10.1093/ije/dym242; Goris AHC, 2000, AM J CLIN NUTR, V71, P130; Haftenberger M, 2002, PUBLIC HEALTH NUTR, V5, P1147, DOI 10.1079/PHN2002396; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P39, DOI 10.1001/jama.295.1.39; Iqbal SI, 2006, OBESITY, V14, P106, DOI 10.1038/oby.2006.13; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; Johnson L, 2008, INT J OBESITY, V32, P586, DOI 10.1038/sj.ijo.0803746; Kant AK, 2005, INT J OBESITY, V29, P950, DOI 10.1038/sj.ijo.0802980; Kien CL, 2004, AM J CLIN NUTR, V80, P876, DOI 10.1093/ajcn/80.4.876; Ledikwe JH, 2007, AM J CLIN NUTR, V85, P1212, DOI 10.1093/ajcn/85.5.1212; Ledikwe JH, 2006, AM J CLIN NUTR, V83, P1362, DOI 10.1093/ajcn/83.6.1362; Ledikwe JH, 2005, J NUTR, V135, P273, DOI 10.1093/jn/135.2.273; Ludwig DS, 2007, LANCET, V369, P890, DOI 10.1016/S0140-6736(07)60427-9; Ma YS, 2005, AM J EPIDEMIOL, V161, P359, DOI 10.1093/aje/kwi051; Macdiarmid J, 1998, NUTR RES REV, V11, P231, DOI 10.1079/NRR19980017; Mattisson I, 2005, BRIT J NUTR, V94, P832, DOI 10.1079/BJN20051573; McCaffrey TA, 2008, AM J CLIN NUTR, V87, P1230, DOI 10.1093/ajcn/87.5.1230; McCrory MA, 2006, PHYSIOL BEHAV, V87, P451, DOI 10.1016/j.physbeh.2004.10.025; Mendoza JA, 2007, DIABETES CARE, V30, P974, DOI 10.2337/dc06-2188; Molag ML, 2007, AM J EPIDEMIOL, V166, P1468, DOI 10.1093/aje/kwm236; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Murakami K, 2007, NUTRITION, V23, P798, DOI 10.1016/j.nut.2007.08.014; Prentice AM, 1996, INT J OBESITY, V20, pS18; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Rinaldi S, 2006, INT J CANCER, V118, P2832, DOI 10.1002/ijc.21730; Rolls BJ, 2005, OBES RES, V13, P1052, DOI 10.1038/oby.2005.123; Saris WHM, 2005, OBES REV, V6, P175, DOI 10.1111/j.1467-789x.2005.00200.x; Savage JS, 2008, AM J CLIN NUTR, V88, P677, DOI 10.1093/ajcn/88.3.677; Slimani N, 2007, EUR J CLIN NUTR, V61, P1037, DOI 10.1038/sj.ejcn.1602679; Slimani N, 2002, PUBLIC HEALTH NUTR, V5, P1125, DOI 10.1079/PHN2002395; Slimani N, 1999, COMPUT METH PROG BIO, V58, P251, DOI 10.1016/S0169-2607(98)00088-1; Stookey JD, 2001, EUR J CLIN NUTR, V55, P349, DOI 10.1038/sj.ejcn.1601163; *USDA, 2005, NUTR YOUR HLTH DIET; Verschuren WMM, 2008, INT J EPIDEMIOL, V37, P1236, DOI 10.1093/ije/dym292; Westerterp-Plantenga MS, 2001, BRIT J NUTR, V85, P351, DOI 10.1079/BJN2000272; WHO/FAO, 2003, DIET NUTR; WILLETT WC, 1994, AM J CLIN NUTR, V59, p171S, DOI 10.1093/ajcn/59.1.171S	42	54	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2009	4	4							e5339	10.1371/journal.pone.0005339	http://dx.doi.org/10.1371/journal.pone.0005339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VI	19396357	Green Published, Green Submitted, gold			2022-12-25	WOS:000265514600004
J	Gokce, O; Runne, H; Kuhn, A; Luthi-Carter, R				Gokce, Ozgun; Runne, Heike; Kuhn, Alexandre; Luthi-Carter, Ruth			Short-Term Striatal Gene Expression Responses to Brain-Derived Neurotrophic Factor Are Dependent on MEK and ERK Activation	PLOS ONE			English	Article								Background: Brain-derived neurotrophic factor (BDNF) is believed to be an important regulator of striatal neuron survival, differentiation, and plasticity. Moreover, reduction of BDNF delivery to the striatum has been implicated in the pathophysiology of Huntington's disease. Nevertheless, many essential aspects of BDNF responses in striatal neurons remain to be elucidated. Methodology/Principal Findings: In this study, we assessed the relative contributions of multipartite intracellular signaling pathways to the short-term induction of striatal gene expression by BDNF. To identify genes regulated by BDNF in these GABAergic cells, we first used DNA microarrays to quantify their transcriptomic responses following 3 h of BDNF exposure. The signal transduction pathways underlying gene induction were subsequently dissected using pharmacological agents and quantitative real-time PCR. Gene expression responses to BDNF were abolished by inhibitors of TrkB (K252a) and calcium (chelator BAPTA-AM and transient receptor potential cation channel [TRPC] antagonist SKF-96365). Interestingly, inhibitors of mitogen-activated protein kinase kinases 1 and 2 (MEK1/2) and extracellular signal-regulated kinase ERK also blocked the BDNF-mediated induction of all tested BDNF-responsive genes. In contrast, inhibitors of nitric oxide synthase (NOS), phosphotidylinositol-3-kinase (PI3K), and CAMK exhibited less prevalent, gene-specific effects on BDNF-induced RNA expression. At the nuclear level, the activation of both Elk-1 and CREB showed MEK dependence. Importantly, MEK-dependent activation of transcription was shown to be required for BDNF-induced striatal neurite outgrowth, providing evidence for its contribution to striatal neuron plasticity. Conclusions: These results show that the MEK/ERK pathway is a major mediator of neuronal plasticity and other important BDNF-dependent striatal functions that are fulfilled through the positive regulation of gene expression.			Gokce, O (corresponding author), Ecole Polytech Fed Lausanne, Lab Funct Neurogen, Brain Mind Inst, CH-1015 Lausanne, Switzerland.	ruth.luthi-carter@epfl.ch		gokce, ozgun/0000-0001-6319-404X; Kuhn, Alexandre/0000-0003-3839-5282				Alder J, 2003, J NEUROSCI, V23, P10800; Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanquet PR, 1997, J BIOL CHEM, V272, P24133, DOI 10.1074/jbc.272.39.24133; Bogush A, 2007, J BIOL CHEM, V282, P7352, DOI 10.1074/jbc.M606508200; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Canals JM, 2004, J NEUROSCI, V24, P7727, DOI 10.1523/JNEUROSCI.1197-04.2004; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Donai H, 2003, NEUROSCI RES, V47, P399, DOI 10.1016/j.neures.2003.08.004; Drees F, 2008, CURR OPIN NEUROBIOL, V18, P53, DOI 10.1016/j.conb.2008.05.007; Egea J, 2000, MOL CELL BIOL, V20, P1931, DOI 10.1128/MCB.20.6.1931-1946.2000; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Gao X, 2009, EXP NEUROL, V215, P178, DOI 10.1016/j.expneurol.2008.10.009; Gartner AG, 2002, P NATL ACAD SCI USA, V99, P6386, DOI 10.1073/pnas.092129699; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gavalda N, 2004, MOL CELL NEUROSCI, V25, P460, DOI 10.1016/j.mcn.2003.11.012; Gharami K, 2008, J NEUROCHEM, V105, P369, DOI 10.1111/j.1471-4159.2007.05137.x; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; Hashimoto T, 2005, J NEUROSCI, V25, P372, DOI 10.1523/JNEUROSCI.4035-04.2005; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Hottinger AF, 2000, J NEUROSCI, V20, P5587, DOI 10.1523/JNEUROSCI.20-15-05587.2000; Ivkovic S, 1999, J NEUROSCI, V19, P5409; Jia YC, 2007, NAT NEUROSCI, V10, P559, DOI 10.1038/nn1870; Kajiya M, 2008, J BIOL CHEM, V283, P16259, DOI 10.1074/jbc.M800668200; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Kim B, 1997, J BIOL CHEM, V272, P21268, DOI 10.1074/jbc.272.34.21268; Levkovitz Y, 2002, J NEUROSCI, V22, P3845, DOI 10.1523/JNEUROSCI.22-10-03845.2002; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Lynch G, 2007, J NEUROSCI, V27, P4424, DOI 10.1523/JNEUROSCI.5113-06.2007; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Monteggia LM, 2007, BIOL PSYCHIAT, V61, P187, DOI 10.1016/j.biopsych.2006.03.021; Nakao N, 1995, DEV BRAIN RES, V90, P92, DOI 10.1016/0165-3806(96)83489-4; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Ouimet CC, 1998, BRAIN RES, V808, P8, DOI 10.1016/S0006-8993(98)00724-0; Pandey SC, 2008, J NEUROSCI, V28, P2589, DOI 10.1523/JNEUROSCI.4752-07.2008; PARENT A, 1983, NEUROSCIENCE, V10, P1137, DOI 10.1016/0306-4522(83)90104-5; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Riccio A, 2006, MOL CELL, V21, P283, DOI 10.1016/j.molcel.2005.12.006; Ring RH, 2006, J NEUROBIOL, V66, P361, DOI 10.1002/neu.20223; Runne H, 2008, J NEUROSCI, V28, P9723, DOI 10.1523/JNEUROSCI.3044-08.2008; SMITS A, 1991, P NATL ACAD SCI USA, V88, P8159, DOI 10.1073/pnas.88.18.8159; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Spencer TK, 2008, MOL CELL NEUROSCI, V38, P110, DOI 10.1016/j.mcn.2008.02.005; Steiner P, 2002, J CELL BIOL, V157, P1197, DOI 10.1083/jcb.200202022; Strand AD, 2007, J NEUROSCI, V27, P11758, DOI 10.1523/JNEUROSCI.2461-07.2007; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; VENTIMIGLIA R, 1995, EUR J NEUROSCI, V7, P213, DOI 10.1111/j.1460-9568.1995.tb01057.x; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Zala D, 2005, NEUROBIOL DIS, V20, P785, DOI 10.1016/j.nbd.2005.05.017; Zheng F, 2009, J NEUROSCI RES, V87, P380, DOI 10.1002/jnr.21863; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003; Zucker B, 2005, HUM MOL GENET, V14, P179, DOI 10.1093/hmg/ddi014	59	46	47	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5292	10.1371/journal.pone.0005292	http://dx.doi.org/10.1371/journal.pone.0005292			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390590	Green Published, gold, Green Submitted			2022-12-25	WOS:000265514200011
J	Wadia, JS; Schaller, M; Williamson, RA; Dowdy, SF				Wadia, Jehangir S.; Schaller, Monica; Williamson, R. Anthony; Dowdy, Steven F.			Pathologic Prion Protein Infects Cells by Lipid-Raft Dependent Macropinocytosis	PLOS ONE			English	Article							SUBCELLULAR TRAFFICKING; N-TERMINUS; PRP; MECHANISMS; PEPTIDES; MICE; NEURODEGENERATION; NEUROTOXICITY; TRANSDUCTION; CHOLESTEROL	Transmissible spongiform encephalopathies, including variant-Creutzfeldt-Jakob disease (vCJD) in humans and bovine spongiform encephalopathies in cattle, are fatal neurodegenerative disorders characterized by protein misfolding of the host cellular prion protein (PrPC) to the infectious scrapie form (PrPSc). However, the mechanism that exogenous PrPSc infects cells and where pathologic conversion of PrPC to the PrPSc form occurs remains uncertain. Here we report that similar to the mechanism of HIV-1 TAT-mediated peptide transduction, processed mature, full length PrP contains a conserved N-terminal cationic domain that stimulates cellular uptake by lipid raft-dependent, macropinocytosis. Inhibition of macropinocytosis by three independent means prevented cellular uptake of recombinant PrP; however, it did not affect recombinant PrP cell surface association. In addition, fusion of the cationic N-terminal PrP domain to a Cre recombinase reporter protein was sufficient to promote both cellular uptake and escape from the macropinosomes into the cytoplasm. Inhibition of macropinocytosis was sufficient to prevent conversion of PrPC to the pathologic PrPSc form in N2a cells exposed to strain RML PrPSc infected brain homogenates, suggesting that a critical determinant of PrPC conversion occurs following macropinocytotic internalization and not through mere membrane association. Taken together, these observations provide a cellular mechanism that exogenous pathological PrPSc infects cells by lipid raft dependent, macropinocytosis.	[Wadia, Jehangir S.; Dowdy, Steven F.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Wadia, Jehangir S.; Dowdy, Steven F.] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Schaller, Monica; Williamson, R. Anthony] Scripps Res Inst, Dept Immunol, La Jolla, CA USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Scripps Research Institute	Wadia, JS (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	sdowdy@ucsd.edu	wadia, jay/AAQ-9944-2021	Schaller, Monica/0000-0002-5002-2238				Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Bate C, 2004, J BIOL CHEM, V279, P14983, DOI 10.1074/jbc.M313061200; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Cai SR, 2006, EUR J PHARM SCI, V27, P311, DOI 10.1016/j.ejps.2005.10.011; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Ford MJ, 2002, NEUROSCIENCE, V113, P177, DOI 10.1016/S0306-4522(02)00155-0; Gilch S, 2006, MOL CELL NEUROSCI, V31, P346, DOI 10.1016/j.mcn.2005.10.008; Gilch S, 2007, FEBS J, V274, P5834, DOI 10.1111/j.1742-4658.2007.06105.x; Griffiths RE, 2007, BLOOD, V110, P4518, DOI 10.1182/blood-2007-04-085183; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Harris D A, 1999, Curr Issues Mol Biol, V1, P65; Horonchik L, 2005, J BIOL CHEM, V280, P17062, DOI 10.1074/jbc.M500122200; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P2333, DOI 10.1073/pnas.94.6.2333; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Kiachopoulos S, 2004, TRAFFIC, V5, P426, DOI 10.1111/j.1398-9219.2004.00185.x; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Lofgren I, 2008, FASEB J, V22; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Magalhaes AC, 2005, J NEUROSCI, V25, P5207, DOI 10.1523/JNEUROSCI.0653-05.2005; Magzoub M, 2006, BIOCHEM BIOPH RES CO, V348, P379, DOI 10.1016/j.bbrc.2006.07.065; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Medina-Kauwe LK, 2007, ADV DRUG DELIVER REV, V59, P798, DOI 10.1016/j.addr.2007.06.009; Morris MC, 2008, BIOL CELL, V100, P201, DOI 10.1042/BC20070116; Murriel Christopher L, 2006, Expert Opin Drug Deliv, V3, P739, DOI 10.1517/17425247.3.6.739; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; Nunziante M, 2003, CHEMBIOCHEM, V4, P1268, DOI 10.1002/cbic.200300704; Nunziante M, 2003, J BIOL CHEM, V278, P3726, DOI 10.1074/jbc.M206313200; OLIVER JM, 1984, METHOD ENZYMOL, V108, P336; Pan T, 2002, BIOCHEM J, V368, P81, DOI 10.1042/BJ20020773; Parkyn CJ, 2008, J CELL SCI, V121, P773, DOI 10.1242/jcs.021816; Perez M, 1998, BIOCHEM J, V335, P369, DOI 10.1042/bj3350369; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; SHYNG SL, 1994, J CELL BIOL, V125, P1239, DOI 10.1083/jcb.125.6.1239; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Tatzelt J, 2007, FEBS J, V274, P606, DOI 10.1111/j.1742-4658.2007.05633.x; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Walmsley AR, 2003, J BIOL CHEM, V278, P37241, DOI 10.1074/jbc.M302036200; WATTS JC, 2006, PLOS PATHOG E, V26, P152; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Weissmann C, 2003, BRIT MED BULL, V66, P43, DOI 10.1093/bmb/66.1.43; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731	53	54	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2008	3	10							e3314	10.1371/journal.pone.0003314	http://dx.doi.org/10.1371/journal.pone.0003314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RV	19390657	gold, Green Submitted, Green Published			2022-12-25	WOS:000264797300005
J	Gao, ZG; Yin, J; Zhang, J; He, Q; McGuinness, OP; Ye, JP				Gao, Zhanguo; Yin, Jun; Zhang, Jin; He, Qing; McGuinness, Owen P.; Ye, Jianping			Inactivation of NF-kappa B p50 Leads to Insulin Sensitization in Liver through Post-translational Inhibition of p70S6K	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR INHIBITION; BETA LINKS INFLAMMATION; IKK-BETA; RECEPTOR SUBSTRATE-1; MAMMALIAN TARGET; TRANSCRIPTIONAL ACTIVATOR; SERINE PHOSPHORYLATION; CELL-PROLIFERATION; RAPAMYCIN PATHWAY; SKELETAL-MUSCLE	In this study, we investigated the metabolic phenotype of the NF-kappa B p50 knock-out (p50-KO) mice. Compared with wild type mice, the p50-KO mice had an increase in food intake, but a decrease in body fat content. On chow diet, their blood glucose dropped much more than the wild type (WT) mice in the insulin tolerance test. Their glucose infusion rate was 30% higher than that of the WT mice in the hyperinsulinemic-euglycemic clamp. Their hepatic glucose production was suppressed more actively by insulin, and their insulin-induced glucose uptake was not altered in skeletal muscle or adipose tissue. In the liver, their p70S6K (S6K1) protein was significantly lower, and tumor necrosis factor-alpha (TNF-alpha) expression was much higher. Their S6K1 protein was reduced by TNF-alpha treatment in the primary culture of hepatocytes. S6K1 reduction was blocked by the proteasome inhibitor MG132. In their livers, IKK2 (IKK beta) activity was reduced together with IKK gamma. Their S6K1 degradation was dependent on IKK2 deficiency. Reconstitution of the S6K1 protein in their liver blocked the increase in insulin sensitivity. S6K1 degradation was not observed in hepatocytes of the WT mice. The data suggest that inactivation of NF-kappa B p50 leads to suppression of IKK2 activity in the liver. IKK2 deficiency leads to S6K1 inhibition through TNF-induced protein degradation. The S6K1 reduction may contribute to insulin sensitivity in p50-KO mice. This study suggests that hepatic S6K1 may be a drug target in the treatment of insulin resistance.	[Gao, Zhanguo; Yin, Jun; Zhang, Jin; He, Qing; Ye, Jianping] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [McGuinness, Owen P.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Vanderbilt University	Ye, JP (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.	yej@pbrc.edu	Ye, Jianping/N-1998-2017	Ye, Jianping/0000-0003-3875-365X	National Institutes of Health [DK68036]; American Diabetes Association Research [7-07-RA-189]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078188, P30DK072476, R56DK068036, U24DK059637, R01DK068036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Research(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK68036 ( to J. Y.). This work was also supported by the American Diabetes Association Research Award 7-07-RA-189 ( to J.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; BALLARD DW, 1992, P NATL ACAD SCI USA, V89, P1875, DOI 10.1073/pnas.89.5.1875; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bohuslav J, 1998, J CLIN INVEST, V102, P1645, DOI 10.1172/JCI3877; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Carlson CJ, 2004, BIOCHEM BIOPH RES CO, V316, P533, DOI 10.1016/j.bbrc.2004.02.082; Doi TS, 1997, J EXP MED, V185, P953, DOI 10.1084/jem.185.5.953; Esposito DL, 2001, ENDOCRINOLOGY, V142, P2833, DOI 10.1210/en.142.7.2833; Gao ZG, 2006, J BIOL CHEM, V281, P4540, DOI 10.1074/jbc.M507784200; Gao ZG, 2003, J BIOL CHEM, V278, P24944, DOI 10.1074/jbc.M300423200; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Gao ZG, 2007, AM J PHYSIOL-ENDOC M, V292, pE84, DOI 10.1152/ajpendo.00178.2006; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Herschkovitz A, 2007, J BIOL CHEM, V282, P18018, DOI 10.1074/jbc.M610949200; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Jhaveri KA, 2006, AM J PHYSIOL-REG I, V291, pR1516, DOI 10.1152/ajpregu.00262.2006; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Krebs M, 2007, DIABETES, V56, P1600, DOI 10.2337/db06-1016; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Liu HY, 2007, J BIOL CHEM, V282, P14205, DOI 10.1074/jbc.M609701200; Lu ZY, 2006, NEUROSCIENCE, V139, P965, DOI 10.1016/j.neuroscience.2005.12.062; Mauro C, 2006, J BIOL CHEM, V281, P18482, DOI 10.1074/jbc.M601502200; OPIPARI AW, 1992, J BIOL CHEM, V267, P12424; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Panasyuk G, 2008, BIOCHEM BIOPH RES CO, V369, P339, DOI 10.1016/j.bbrc.2008.02.016; Patti ME, 2004, NAT MED, V10, P1049, DOI 10.1038/nm1004-1049; RUBEN SM, 1992, MOL CELL BIOL, V12, P444, DOI 10.1128/MCB.12.2.444; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Tharappel JC, 2003, TOXICOL SCI, V75, P300, DOI 10.1093/toxsci/kfg201; Tharappel JC, 2008, TOXICOL APPL PHARM, V226, P338, DOI 10.1016/j.taap.2007.09.019; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Wang ML, 2008, BIOCHEM BIOPH RES CO, V369, P382, DOI 10.1016/j.bbrc.2008.02.032; Wunderlich FT, 2008, P NATL ACAD SCI USA, V105, P1297, DOI 10.1073/pnas.0707849104; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	46	36	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18368	18376		10.1074/jbc.M109.007260	http://dx.doi.org/10.1074/jbc.M109.007260			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19433583	Green Published, hybrid			2022-12-25	WOS:000267712400049
J	Sava, IG; Zhang, FM; Toma, I; Theilacker, C; Li, BZ; Baumert, TF; Holst, O; Linhardt, RJ; Huebner, J				Sava, Irina G.; Zhang, Fuming; Toma, Ioana; Theilacker, Christian; Li, Boyangzhi; Baumert, Thomas F.; Holst, Otto; Linhardt, Robert J.; Huebner, Johannes			Novel Interactions of Glycosaminoglycans and Bacterial Glycolipids Mediate Binding of Enterococci to Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; ALPHA-C-PROTEIN; LIPOTEICHOIC ACID; STAPHYLOCOCCUS-AUREUS; CAPSULAR POLYSACCHARIDE; STREPTOCOCCUS-PYOGENES; EPITHELIAL-CELLS; HOST-CELLS; FAECALIS; INFECTIONS	Enterococcus faecalis is among the most important nosocomial pathogens. The intestinal mucosa is considered to be the main site used by these bacteria for entrance and dissemination. A better understanding of the mechanisms involved in colonization and invasion of enterococci may help to devise methods to prevent infections in hospitalized patients. Glycosaminoglycans, which are present on the surface of all eukaryotic cells, were investigated with regard to their role as host receptors for adhesion of E. faecalis. Competitive binding assays, enzymatic digestion, and reduction of the sulfation of the glycosaminoglycan chains indicated that heparin and heparan sulfate, but not chondroitin sulfate B, played important roles in adhesion of E. faecalis 12030 to Caco2 cells. By using proteinases and carbohydrate oxidation by sodium meta-periodate to modify the bacterial surface, it could be demonstrated that a sugar-containing molecule rather than a protein is the bacterial ligand mediating adhesion to eukaryotic cells. Preincubation of Caco2 cells with the enterococcal glycolipid diglucosyldiacylglycerol but not other carbohydrate cell wall components inhibited bacterial binding. These results may indicate that heparin and/or heparan sulfate on host epithelial cells and diglucosyldiacylglycerol, either itself or as a partial structure of lipoteichoic acid, are involved in enterococcal adhesion to colonic epithelia, the first step in translocation from the intestinal tract.	[Huebner, Johannes] Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, D-79106 Freiburg, Germany; [Zhang, Fuming; Li, Boyangzhi; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Zhang, Fuming; Li, Boyangzhi; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biol & Chem & Biol Engn, Troy, NY 12180 USA; [Baumert, Thomas F.] INSERM, U748, Strasbourg, France; [Baumert, Thomas F.] Univ Strasbourg, F-67000 Strasbourg, France; [Baumert, Thomas F.] Hop Univ Strasbourg, Serv Hepatogastroenterol, F-67000 Strasbourg, France; [Holst, Otto] Leibniz Ctr Med & Biosci, Div Struct Biochem, Res Ctr, D-23845 Borstel, Germany	University of Freiburg; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Forschungszentrum Borstel	Huebner, J (corresponding author), Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, Hugstetter Str 55, D-79106 Freiburg, Germany.	johannes.huebner@uniklinik-freiburg.de	Li, Boyangzi/B-4813-2012; Baumert, Thomas/ABF-4718-2020	Baumert, Thomas/0000-0002-8864-2168; Theilacker, Christian/0000-0003-0821-9202; Huebner, Johannes/0000-0003-1232-4646	National Institutes of Health [AI050667, GM-38060]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI050667 ( to J. H.) and GM-38060 ( to R. J. L.).	AlvarezDominguez C, 1997, INFECT IMMUN, V65, P78; Auperin TC, 2005, J BIOL CHEM, V280, P18245, DOI 10.1074/jbc.M412391200; BAEUERLE PA, 1986, BIOCHEM BIOPH RES CO, V141, P870, DOI 10.1016/S0006-291X(86)80253-4; Baldassarri L, 2006, INT J ARTIF ORGANS, V29, P402, DOI 10.1177/039139880602900410; Baldassarri L, 2005, J INFECT DIS, V191, P1253, DOI 10.1086/428778; BANERJEE SN, 1991, AM J MED S3B, V0091, P00086; Baron MJ, 2004, J BIOL CHEM, V279, P24714, DOI 10.1074/jbc.M402164200; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Barth H, 2006, J VIROL, V80, P10579, DOI 10.1128/JVI.00941-06; BEACHEY EH, 1979, J IMMUNOL, V122, P189; BEACHEY EH, 1979, INFECT IMMUN, V23, P618, DOI 10.1128/IAI.23.3.618-625.1979; Behling-Kelly E, 2006, INFECT IMMUN, V74, P5311, DOI 10.1128/IAI.00614-06; Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bocharova TV, 2001, GLASS PHYS CHEM+, V27, P48, DOI 10.1023/A:1009559820794; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; CHOI SH, 1989, INFECT IMMUN, V57, P3834, DOI 10.1128/IAI.57.12.3834-3840.1989; COURTNEY HS, 1992, MICROB PATHOGENESIS, V12, P199, DOI 10.1016/0882-4010(92)90054-R; Doran KS, 2005, J CLIN INVEST, V115, P2499, DOI 10.1172/JCI23829; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Fallgren C, 2001, CURR MICROBIOL, V43, P57, DOI 10.1007/s002840010260; FISCHER W, 1990, GLYCOLIPIDS PHOSPHOG, P123; Fleckenstein JM, 2002, INFECT IMMUN, V70, P1530, DOI 10.1128/IAI.70.3.1530-1537.2002; Frick IM, 2003, EUR J BIOCHEM, V270, P2303, DOI 10.1046/j.1432-1033.2003.03600.x; Grundling A, 2007, J BACTERIOL, V189, P2521, DOI 10.1128/JB.01683-06; Gu L, 2008, BIOCHEM BIOPH RES CO, V369, P1061, DOI 10.1016/j.bbrc.2008.02.160; GUZMAN CA, 1991, MICROB PATHOGENESIS, V11, P399, DOI 10.1016/0882-4010(91)90036-A; Hancock LE, 2002, P NATL ACAD SCI USA, V99, P1574, DOI 10.1073/pnas.032448299; Hess DJ, 2006, MED MICROBIOL IMMUN, V195, P133, DOI 10.1007/s00430-005-0007-5; Huebner J, 1999, INFECT IMMUN, V67, P1213, DOI 10.1128/IAI.67.3.1213-1219.1999; LANDRY SL, 1989, AM J INFECT CONTROL, V17, P323, DOI 10.1016/0196-6553(89)90001-1; MAEKAWA S, 1992, MICROBIOL IMMUNOL, V36, P671, DOI 10.1111/j.1348-0421.1992.tb02070.x; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Munoz EM, 2004, ARTERIOSCL THROM VAS, V24, P1549, DOI 10.1161/01.ATV.0000137189.22999.3f; Murray BE, 2000, NEW ENGL J MED, V342, P710, DOI 10.1056/NEJM200003093421007; MURRAY BE, 1993, J BACTERIOL, V175, P5216, DOI 10.1128/JB.175.16.5216-5223.1993; OFEK I, 1982, J BACTERIOL, V149, P426, DOI 10.1128/JB.149.2.426-433.1982; OFEK I, 2003, BACTERIAL ADHESION A, P177; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Rostand KS, 1997, INFECT IMMUN, V65, P1; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Sievert DM, 2008, CLIN INFECT DIS, V46, P668, DOI 10.1086/527392; Spillmann D, 2001, BIOCHIMIE, V83, P811, DOI 10.1016/S0300-9084(01)01290-1; Theilacker C, 2006, INFECT IMMUN, V74, P5703, DOI 10.1128/IAI.00570-06; Theilacker C, 2009, MOL MICROBIOL, V71, P1055, DOI [10.1111/j.1365-2958.2008.06587.x, 10.1111/j.1365-2958.2009.06587.x]; Tonnaer ELGM, 2006, MICROBES INFECT, V8, P316, DOI 10.1016/j.micinf.2005.06.028; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946	47	42	42	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18194	18201		10.1074/jbc.M901460200	http://dx.doi.org/10.1074/jbc.M901460200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19395379	hybrid, Green Published			2022-12-25	WOS:000267712400031
J	Formentini, L; Macchiarulo, A; Cipriani, G; Camaioni, E; Rapizzi, E; Pellicciari, R; Moroni, F; Chiarugi, A				Formentini, Laura; Macchiarulo, Antonio; Cipriani, Giulia; Camaioni, Emidio; Rapizzi, Elena; Pellicciari, Roberto; Moroni, Flavio; Chiarugi, Alberto			Poly(ADP-ribose) Catabolism Triggers AMP-dependent Mitochondrial Energy Failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING FACTOR; INDUCED CELL-DEATH; ADP/ATP CARRIER; PAR POLYMER; ADP-RIBOSE; GLYCOHYDROLASE; NUCLEAR; NAD(+); METABOLISM; INHIBITORS	Upon massive DNA damage, hyperactivation of the nuclear enzyme poly(ADP-ribose) polymerase (PARP)-1 causes severe depletion of intracellular NAD and ATP pools as well as mitochondrial dysfunction. Thus far, the molecular mechanisms contributing to PARP-1-dependent impairment of mitochondrial functioning have not been identified. We found that degradation of the PARP-1 product poly(ADP-ribose) through the concerted actions of poly(ADP-ribose) glycohydrolase and NUDIX (nucleoside diphosphate-X) hydrolases leads to accumulation of AMP. The latter, in turn, inhibits the ADP/ATP translocator, prompting mitochondrial energy failure. For the first time, our findings identify NUDIX hydrolases as key enzymes involved in energy derangement during PARP-1 hyperactivity. Also, these data disclose unanticipated AMP-dependent impairment of mitochondrial exchange of adenine nucleotides, which can be of relevance to organelle functioning and disease pathogenesis.	[Moroni, Flavio; Chiarugi, Alberto] Univ Florence, Dept Preclin & Clin Pharmacol, I-50139 Florence, Italy; [Macchiarulo, Antonio; Camaioni, Emidio; Pellicciari, Roberto] Univ Perugia, Dept Med Chem & Drug Technol, I-06100 Perugia, Italy; [Rapizzi, Elena] Univ Florence, Dept Biochem Sci, I-50139 Florence, Italy	University of Florence; University of Perugia; University of Florence	Chiarugi, A (corresponding author), Univ Florence, Dept Pharmacol, Viale Pieraccini 6, I-50139 Florence, Italy.	alberto.chiarugi@unifi.it	Macchiarulo, Antonio/L-2846-2017; Camaioni, Emidio/AAK-3138-2020	Macchiarulo, Antonio/0000-0001-9535-4183; Camaioni, Emidio/0000-0002-8529-0849; Formentini, Laura/0000-0001-5641-821X	Italian Ministry of University and Research PRIN; Fondazione Italiana Sclerosi Multipla; Ente Cassa di Risparmio di Firenze	Italian Ministry of University and Research PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze)	This study was supported by grants from the Italian Ministry of University and Research PRIN 2007, Fondazione Italiana Sclerosi Multipla, and Ente Cassa di Risparmio di Firenze.	Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Chiarugi A, 2002, TRENDS PHARMACOL SCI, V23, P122, DOI 10.1016/S0165-6147(00)01902-7; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; Cohausz O, 2008, CELL MOL LIFE SCI, V65, P644, DOI 10.1007/s00018-008-7516-5; Cortes U, 2004, MOL CELL BIOL, V24, P7163, DOI 10.1128/MCB.24.16.7163-7178.2004; Cozzi A, 2006, J CEREBR BLOOD F MET, V26, P684, DOI 10.1038/sj.jcbfm.9600222; Cuzzocrea S, 2005, FASEB J, V19, P558, DOI 10.1096/fj.04-3117com; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Davidovic L, 2001, EXP CELL RES, V268, P7, DOI 10.1006/excr.2001.5263; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Formentini L, 2008, BRIT J PHARMACOL, V155, P1235, DOI 10.1038/bjp.2008.370; Hasmann M, 2003, CANCER RES, V63, P7436; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; JACOBSON EL, 1994, MOL CELL BIOCHEM, V138, P207, DOI 10.1007/BF00928463; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kennedy HJ, 1999, BIOCHEM J, V342, P275, DOI 10.1042/0264-6021:3420275; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Klingenberg M, 2007, BIOCHIMIE, V89, P1042, DOI 10.1016/j.biochi.2007.02.010; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kroemer G, 1997, CELL DEATH DIFFER, V4, P443, DOI 10.1038/sj.cdd.4400266; Lu XCM, 2003, BRAIN RES, V978, P99, DOI 10.1016/S0006-8993(03)02774-4; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Murphy MP, 2001, BBA-BIOENERGETICS, V1504, P1, DOI 10.1016/S0005-2728(00)00234-6; Nury H, 2006, ANNU REV BIOCHEM, V75, P713, DOI 10.1146/annurev.biochem.75.103004.142747; Oei SL, 2000, J BIOL CHEM, V275, P23234, DOI 10.1074/jbc.M002429200; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Rapizzi E, 2004, MOL PHARMACOL, V66, P890, DOI 10.1124/mol.104.000968; Rapizzi E, 2002, J CELL BIOL, V159, P613, DOI 10.1083/jcb.200205091; RAPPE AK, 1992, J AM CHEM SOC, V114, P10024, DOI 10.1021/ja00051a040; Rossi L, 2002, BIOCHIMIE, V84, P1229; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; TANUMA S, 1989, BIOCHEM BIOPH RES CO, V163, P1047, DOI 10.1016/0006-291X(89)92327-9; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; WEIDEMAN.MJ, 1970, EUR J BIOCHEM, V16, P313, DOI 10.1111/j.1432-1033.1970.tb01086.x; Ying WH, 2001, P NATL ACAD SCI USA, V98, P12227, DOI 10.1073/pnas.211202598; Ying WH, 2003, BIOCHEM BIOPH RES CO, V308, P809, DOI 10.1016/S0006-291X(03)01483-9; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zha MW, 2006, J MOL BIOL, V364, P1021, DOI 10.1016/j.jmb.2006.09.078; Zhang J, 2002, DRUG FUTURE, V27, P371, DOI 10.1358/dof.2002.027.04.669101	50	77	79	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17668	17676		10.1074/jbc.M109.002931	http://dx.doi.org/10.1074/jbc.M109.002931			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19411252	hybrid, Green Published			2022-12-25	WOS:000267202500033
J	Cheong, SM; Kim, H; Han, JK				Cheong, Seong-Moon; Kim, Hyunjoon; Han, Jin-Kwan			Identification of a Novel Negative Regulator of Activin/Nodal Signaling in Mesendodermal Formation of Xenopus Embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; GERM-LAYER SPECIFICATION; E3 UBIQUITIN LIGASE; TGF-BETA RECEPTOR; FATE SPECIFICATION; PTB DOMAINS; I RECEPTOR; GROWTH; SMAD7; DEGRADATION	Phosphotyrosine binding (PTB) domains, which are found in a large number of proteins, have been implicated in signal transduction mediated by growth factor receptors. However, the in vivo roles of these PTB-containing proteins remain to be investigated. Here, we show that Xdpcp (Xenopus dok-PTB containing protein) has a pivotal role in regulating mesendoderm formation in Xenopus, and negatively regulates the activin/nodal signaling pathway. We isolated cDNA for xdpcp and examined its potential role in Xenopus embryogenesis. We found that Xdpcp is strongly expressed in the animal hemisphere at the cleavage and blastula stages. The overexpression of xdpcp RNA affects activin/nodal signaling, which causes defects in mesendoderm formation. In addition, loss of Xdpcp function by injection of morpholino oligonucleotides leads to the expansion of the mesodermal territory. Moreover, we found that axis duplication by ventrally forced expression of activin is recovered by coexpression with Xdpcp. In addition, Xdpcp inhibits the phosphorylation and nuclear translocation of Smad2. Furthermore, we also found that Xdpcp interacts with Alk4, a type I activin receptor, and inhibits activin/nodal signaling by disturbing the interaction between Smad2 and Alk4. Taken together, these results indicate that Xdpcp regulates activin/nodal signaling that is essential for mesendoderm specification.	[Cheong, Seong-Moon; Kim, Hyunjoon; Han, Jin-Kwan] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, Kyungbuk, South Korea	Pohang University of Science & Technology (POSTECH)	Han, JK (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, San 31, Pohang 790784, Kyungbuk, South Korea.	jkh@postech.ac.kr	Kim, Hyunjoon/AAK-3154-2021	Kim, Hyunjoon/0000-0002-0207-1190	National RD Program; Ministry of Health Welfare; Republic of Korea [0720150]; Brain Korea	National RD Program; Ministry of Health Welfare; Republic of Korea; Brain Korea(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea Grant 0720150, and the Brain Korea 21 project.	Bell E, 2003, DEVELOPMENT, V130, P1381, DOI 10.1242/dev.00344; BLAIKIE P, 1994, J BIOL CHEM, V269, P32031; Cheong SM, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-63; Conery AR, 2004, NAT CELL BIOL, V6, P366, DOI 10.1038/ncb1117; DIKIC I, 1995, J BIOL CHEM, V270, P15125, DOI 10.1074/jbc.270.25.15125; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Funaba M, 2000, MOL ENDOCRINOL, V14, P1583, DOI 10.1210/me.14.10.1583; GUSTAFSON TA, 1995, MOL CELL BIOL, V15, P2500; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; Hocevar BA, 2001, EMBO J, V20, P2789, DOI 10.1093/emboj/20.11.2789; HUANG HC, 1995, EMBO J, V14, P5965, DOI 10.1002/j.1460-2075.1995.tb00285.x; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Kuratomi G, 2005, BIOCHEM J, V386, P461, DOI 10.1042/BJ20040738; Margolis B, 1999, KIDNEY INT, V56, P1230, DOI 10.1046/j.1523-1755.1999.00700.x; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Munoz-Sanjuan I, 2001, DEV BIOL, V237, P1, DOI 10.1006/dbio.2001.0350; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NIEUWKOOP PD, 1994, NORMAL TABLE XENOPUS, P163; ONEILL TJ, 1994, MOL CELL BIOL, V14, P6433, DOI 10.1128/MCB.14.10.6433; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Sasai N, 2008, CELL, V133, P878, DOI 10.1016/j.cell.2008.03.035; Seo SR, 2004, EMBO J, V23, P3780, DOI 10.1038/sj.emboj.7600398; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shi WB, 2004, J CELL BIOL, V164, P291, DOI 10.1083/jcb.200307151; Song KY, 2006, EMBO J, V25, P58, DOI 10.1038/sj.emboj.7600917; Suri C, 2005, DEVELOPMENT, V132, P2733, DOI 10.1242/dev.01865; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Valdimarsdottir G, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-16; Watabe T, 1995, GENE DEV, V9, P3038, DOI 10.1101/gad.9.24.3038; Yamakawa N, 2002, EMBO J, V21, P1684, DOI 10.1093/emboj/21.7.1684; Yun CH, 2007, DEVELOPMENT, V134, P769, DOI 10.1242/dev.02778; Zhang C, 2007, DIFFERENTIATION, V75, P536, DOI 10.1111/j.1432-0436.2007.00190.x; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06	41	2	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17052	17060		10.1074/jbc.M109.007443	http://dx.doi.org/10.1074/jbc.M109.007443			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19389709	Green Published, hybrid			2022-12-25	WOS:000266962400043
J	Astanehe, A; Finkbeiner, MR; Hojabrpour, P; To, K; Fotovati, A; Shadeo, A; Stratford, AL; Lam, WL; Berquin, IM; Duronio, V; Dunn, SE				Astanehe, A.; Finkbeiner, M. R.; Hojabrpour, P.; To, K.; Fotovati, A.; Shadeo, A.; Stratford, A. L.; Lam, W. L.; Berquin, I. M.; Duronio, V.; Dunn, S. E.			The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1	ONCOGENE			English	Article						breast cancer; invasion; PI3K; PIK3CA; uPA; YB-1	RIBOSOMAL S6 KINASE; BREAST-CANCER CELLS; MAMMARY EPITHELIAL-CELLS; GROWTH-FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; PLASMINOGEN-ACTIVATOR; HEMATOPOIETIC-CELLS; OVARIAN-CANCER; HIGH-FREQUENCY; COPY NUMBER	PIK3CA, which codes for the p110 alpha catalytic subunit of phosphatidylinositol-3-kinase (PI3K), is implicated as an oncogene. Despite importance of PIK3CA in cancer, little is known about what drives up its expression in tumor cells. We recently characterized the PIK3CA promoter and reported that it is transcriptionally silenced by the tumor suppressor protein p53. In the present study, we demonstrate that PIK3CA can be induced by the oncogenic transcription factor Y-box binding protein-1(YB-1). Three YB-1-responsive elements were identified on the PIK3CA promoter using chromatin immunoprecipitation and electrophoretic mobility shift assays. Interestingly, silencing YB-1 with siRNA in models of basal-like breast cancer decreased p110 alpha protein levels regardless of whether PIK3CA was wild type, amplified or mutated. This decrease in p110 alpha led to a reduction in PI3K activity and the downstream signaling primarily through p90 ribosomal S6 kinase and S6 ribosomal protein. Disruption in PIK3CA-dependent signaling suppressed cellular invasion correlative with loss of urokinase plasminogen activator (uPA). Similarly, silencing YB-1 suppressed invasion and uPA production however this was reversible through the introduction of constitutively active PIK3CA. In conclusion, YB-1 is the first reported oncogene to induce the expression of PIK3CA through transcriptional control of its promoter. Oncogene (2009) 28, 2406-2418; doi:10.1038/onc.2009.81; published online 11 May 2009	[Astanehe, A.; Finkbeiner, M. R.; To, K.; Fotovati, A.; Stratford, A. L.; Dunn, S. E.] Univ British Columbia, Lab Oncogen Res, Dept Pediat, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [Astanehe, A.; Finkbeiner, M. R.; To, K.; Fotovati, A.; Stratford, A. L.; Dunn, S. E.] Univ British Columbia, Dept Expt Med, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [Hojabrpour, P.; Duronio, V.] Univ British Columbia, Dept Med, Jack Bell Res Ctr, Vancouver, BC V5Z 4H4, Canada; [Shadeo, A.; Lam, W. L.] Univ British Columbia, Dept Canc Genet & Dev Biol, British Columbia Canc Res Ctr, Vancouver, BC V5Z 4H4, Canada; [Berquin, I. M.] Wake Forest Univ, Dept Canc Biol, Winston Salem, NC 27109 USA	Child & Family Research Institute; University of British Columbia; Child & Family Research Institute; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; Wake Forest University	Dunn, SE (corresponding author), Univ British Columbia, Lab Oncogen Res, Dept Pediat, Child & Family Res Inst, 950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	sedunn@interchange.ubc.ca		Shadeo, Ashleen/0000-0002-0866-0519	National Cancer Institute of Canada (SED) [RO1 CA114017-01A1]; Canadian Institute of Health Research; Canadian Breast Cancer Research Alliance IDEA; Canadian Institute of Health Research MD/PhD; Michael Smith Foundation for Health Research Studentships.; NATIONAL CANCER INSTITUTE [R01CA114017] Funding Source: NIH RePORTER	National Cancer Institute of Canada (SED); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Research Alliance IDEA; Canadian Institute of Health Research MD/PhD(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research Studentships.(Michael Smith Foundation for Health Research); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Cancer Institute of Canada (SED), RO1 CA114017-01A1 (SED and IB), Canadian Institute of Health Research (VD), Canadian Breast Cancer Research Alliance IDEA (WL). AA was supported by the Canadian Institute of Health Research MD/PhD and the Michael Smith Foundation for Health Research Studentships.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Astanehe A, 2008, J CELL SCI, V121, P664, DOI 10.1242/jcs.013029; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Clark DE, 2005, CANCER RES, V65, P3108; Deleeuw RJ, 2007, GASTROENTEROLOGY, V132, P1902, DOI 10.1053/j.gastro.2007.03.036; DIDIER DK, 1988, P NATL ACAD SCI USA, V85, P7322, DOI 10.1073/pnas.85.19.7322; Dunn SE, 2001, CANCER RES, V61, P1367; Finkbeiner MR, 2009, ONCOGENE, V28, P1421, DOI 10.1038/onc.2008.485; Ghoda L, 1997, J BIOL CHEM, V272, P21281, DOI 10.1074/jbc.272.34.21281; GOLD MR, 1994, J BIOL CHEM, V269, P5403; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Habibi G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2156; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; Horn S, 2008, ONCOGENE, V27, P4096, DOI 10.1038/onc.2008.40; Hui RCY, 2008, MOL CELL BIOL, V28, P5886, DOI 10.1128/MCB.01265-07; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Samuels Y, 2004, CELL CYCLE, V3, P1221, DOI 10.4161/cc.3.10.1164; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shadeo A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1370; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; She QB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003065; Sliva D, 2002, J BIOL CHEM, V277, P3150, DOI 10.1074/jbc.M109579200; Smith JA, 2005, CANCER RES, V65, P1027; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stratford AL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1767; Stratford AL, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2202; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; Ueki K, 2002, MOL CELL BIOL, V22, P965, DOI 10.1128/MCB.22.3.965-977.2002; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Woo MMM, 2007, IN VITRO CELL DEV-AN, V43, P7, DOI 10.1007/s11626-006-9002-4; Wu GJ, 2005, BREAST CANCER RES, V7, pR609, DOI 10.1186/bcr1262; Wu Joyce, 2007, Transl Oncogenomics, V2, P49; Wu J, 2006, CANCER RES, V66, P4872, DOI 10.1158/0008-5472.CAN-05-3561; Yehiely F, 2006, TRENDS MOL MED, V12, P537, DOI 10.1016/j.molmed.2006.09.004; Zhang HJ, 2008, BREAST CANCER RES TR, V112, P217, DOI 10.1007/s10549-007-9847-6; Zhao JJ, 2006, P NATL ACAD SCI USA, V103, P16296, DOI 10.1073/pnas.0607899103	44	59	59	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2009	28	25					2406	2418		10.1038/onc.2009.81	http://dx.doi.org/10.1038/onc.2009.81			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	462HS	19430491				2022-12-25	WOS:000267342400005
J	Parnas, O; Zipin-Roitman, A; Mazor, Y; Liefshitz, B; Ben-Aroya, S; Kupiec, M				Parnas, Oren; Zipin-Roitman, Adi; Mazor, Yuval; Liefshitz, Batia; Ben-Aroya, Shay; Kupiec, Martin			The Elg1 Clamp Loader Plays a Role in Sister Chromatid Cohesion	PLOS ONE			English	Article								Mutations in the ELG1 gene of yeast lead to genomic instability, manifested in high levels of genetic recombination, chromosome loss, and gross chromosomal rearrangements. Elg1 shows similarity to the large subunit of the Replication Factor C clamp loader, and forms a RFC-like (RLC) complex in conjunction with the 4 small RFC subunits. Two additional RLCs exist in yeast: in one of them the large subunit is Ctf18, and in the other, Rad24. Ctf18 has been characterized as the RLC that functions in sister chromatid cohesion. Here we present evidence that the Elg1 RLC (but not Rad24) also plays an important role in this process. A genetic screen identified the cohesin subunit Mcd1/Scc1 and its loader Scc2 as suppressors of the synthetic lethality between elg1 and ctf4. We describe genetic interactions between ELG1 and genes encoding cohesin subunits and their accessory proteins. We also show that defects in Elg1 lead to higher precocious sister chromatid separation, and that Ctf18 and Elg1 affect cohesion via a joint pathway. Finally, we localize both Ctf18 and Elg1 to chromatin and show that Elg1 plays a role in the recruitment of Ctf18. Our results suggest that Elg1, Ctf4, and Ctf18 may coordinate the relative movement of the replication fork with respect to the cohesin ring.			Parnas, O (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, Ramat Aviv, Israel.	martin@post.tau.ac.il		Mazor, Yuval/0000-0001-5072-0928				Agarwal R, 2002, GENE DEV, V16, P1371, DOI 10.1101/gad.971402; Banerjee S, 2007, BIOCHEM BIOPH RES CO, V362, P546, DOI 10.1016/j.bbrc.2007.07.126; Bellaoui M, 2003, EMBO J, V22, P4304, DOI 10.1093/emboj/cdg406; Ben Aroya S, 2005, DNA REPAIR, V4, P409, DOI 10.1016/j.dnarep.2004.08.003; Ben-Aroya S, 2003, P NATL ACAD SCI USA, V100, P9906, DOI 10.1073/pnas.1633757100; Celic I, 2008, GENETICS, V179, P1769, DOI 10.1534/genetics.108.088914; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Green CM, 2000, CURR BIOL, V10, P39, DOI 10.1016/S0960-9822(99)00263-8; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Heidinger-Pauli JM, 2008, MOL CELL, V31, P47, DOI 10.1016/j.molcel.2008.06.005; Hiraga S, 2006, EMBO J, V25, P1505, DOI 10.1038/sj.emboj.7601038; IRNIGER S, 1995, CELL, V81, P269, DOI 10.1016/0092-8674(95)90337-2; Kanellis P, 2003, CURR BIOL, V13, P1583, DOI 10.1016/S0960-9822(03)00578-5; Kim J, 2005, NUCLEIC ACIDS RES, V33, P4078, DOI 10.1093/nar/gki728; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Koren A, 2003, CURR GENET, V43, P62, DOI 10.1007/s00294-003-0373-8; KOUPRINA N, 1994, GENETICS, V138, P1067; KOUPRINA N, 1992, MOL CELL BIOL, V12, P5736, DOI 10.1128/MCB.12.12.5736; KOUPRINA NY, 1988, YEAST, V4, P257, DOI 10.1002/yea.320040404; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Liefshitz B, 1998, MUTAT RES-DNA REPAIR, V407, P135, DOI 10.1016/S0921-8777(97)00070-0; Majka J, 2003, P NATL ACAD SCI USA, V100, P2249, DOI 10.1073/pnas.0437148100; Maradeo ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004707; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MILES J, 1992, MOL CELL BIOL, V12, P5724, DOI 10.1128/MCB.12.12.5724; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Ogiwara H, 2007, NUCLEIC ACIDS RES, V35, P353, DOI 10.1093/nar/gkl1027; Scholes DT, 2001, GENETICS, V159, P1449; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Smith S, 2004, P NATL ACAD SCI USA, V101, P9039, DOI 10.1073/pnas.0403093101; Smolikov S, 2004, P NATL ACAD SCI USA, V101, P1656, DOI 10.1073/pnas.0307796100; SPENCER F, 1990, GENETICS, V124, P237; Stead K, 2003, J CELL BIOL, V163, P729, DOI 10.1083/jcb.200305080; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Xu H, 2007, GENETICS, V176, P1417, DOI 10.1534/genetics.107.072876	47	54	54	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2009	4	5							e5497	10.1371/journal.pone.0005497	http://dx.doi.org/10.1371/journal.pone.0005497			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VY	19430531	Green Submitted, Green Published, gold			2022-12-25	WOS:000266009700003
J	Dalin, P; Kindvall, O; Bjorkman, C				Dalin, Peter; Kindvall, Oskar; Bjorkman, Christer			Reduced Population Control of an Insect Pest in Managed Willow Monocultures	PLOS ONE			English	Article								Background: There is a general belief that insect outbreak risk is higher in plant monocultures than in natural and more diverse habitats, although empirical studies investigating this relationship are lacking. In this study, using density data collected over seven years at 40 study sites, we compare the temporal population variability of the leaf beetle Phratora vulgatissima between willow plantations and natural willow habitats. Methodology/Principal Findings: The study was conducted in 1999-2005. The density of adult P. vulgatissima was estimated in the spring every year by a knock-down sampling technique. We used two measures of population variability, CV and PV, to compare temporal variations in leaf beetle density between plantation and natural habitat. Relationships between density and variability were also analyzed to discern potential underlying processes behind stability in the two systems. The results showed that the leaf beetle P. vulgatissima had a greater temporal population variability and outbreak risk in willow plantations than in natural willow habitats. We hypothesize that the greater population stability observed in the natural habitat was due to two separate processes operating at different levels of beetle density. First, stable low population equilibrium can be achieved by the relatively high density of generalist predators observed in natural stands. Second, stable equilibrium can also be imposed at higher beetle density due to competition, which occurs through depletion of resources (plant foliage) in the natural habitat. In willow plantations, competition is reduced mainly because plants grow close enough for beetle larvae to move to another plant when foliage is consumed. Conclusion/Significance: To our knowledge, this is the first empirical study confirming that insect pest outbreak risk is higher in monocultures. The study suggests that comparative studies of insect population dynamics in different habitats may improve our ability to predict insect pest outbreaks and could facilitate the development of sustainable pest control in managed systems.			Dalin, P (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	dalin@msi.ucsb.edu						Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Bjorkman C, 2006, AGR FOREST ENTOMOL, V8, P97, DOI 10.1111/j.1461-9555.2006.00288.x; Bjorkman C, 2004, ECOL APPL, V14, P1624, DOI 10.1890/03-5341; Bjorkman C, 2003, J INSECT BEHAV, V16, P747, DOI 10.1023/B:JOIR.0000018318.37306.a8; Bjorkman C., 2000, Agricultural and Forest Entomology, V2, P131, DOI 10.1046/j.1461-9563.2000.00058.x; Cumming GS, 2006, BIOL CONSERV, V131, P533, DOI 10.1016/j.biocon.2006.02.025; Dalin P, 2006, B ENTOMOL RES, V96, P629, DOI 10.1017/BER2006465; Dalin P, 2004, AGR FOREST ENTOMOL, V6, P105, DOI 10.1111/j.1461-9555.2004.00211.x; Dalin P, 2003, OECOLOGIA, V134, P112, DOI 10.1007/s00442-002-1093-3; DALIN P, 2004, THESIS SWEDISH U AGR; Dalin P, 2006, ANIM BEHAV, V72, P1025, DOI 10.1016/j.anbehav.2006.02.017; DENNO RF, 1995, ANNU REV ENTOMOL, V40, P297, DOI 10.1146/annurev.en.40.010195.001501; DWYER G, 1994, AM NAT, V143, P533, DOI 10.1086/285619; GASTON KJ, 1994, PHILOS T R SOC B, V345, P335, DOI 10.1098/rstb.1994.0114; Hawkins BA, 1999, OIKOS, V86, P493, DOI 10.2307/3546654; Heath JP, 2006, OIKOS, V115, P573; JULKUNENTIITTO R, 1986, PHYTOCHEMISTRY, V25, P663, DOI 10.1016/0031-9422(86)88020-7; Lin BB, 2008, BIOSCIENCE, V58, P847, DOI 10.1641/B580911; Liu WC, 2007, THEOR POPUL BIOL, V72, P86, DOI 10.1016/j.tpb.2007.01.002; MURDOCH WW, 1994, ECOLOGY, V75, P271, DOI 10.2307/1939533; Peacock L, 2001, ENTOMOL EXP APPL, V98, P195, DOI 10.1023/A:1018991802435; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Roschewitz I, 2005, J APPL ECOL, V42, P873, DOI 10.1111/j.1365-2664.2005.01072.x; Sinclair ARE, 1996, OIKOS, V75, P164, DOI 10.2307/3546240; Thies C, 1999, SCIENCE, V285, P893, DOI 10.1126/science.285.5429.893; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Underwood N, 2002, AM NAT, V160, P20, DOI 10.1086/340602; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wilby A, 2002, ECOL LETT, V5, P353, DOI 10.1046/j.1461-0248.2002.00331.x	30	34	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5487	10.1371/journal.pone.0005487	http://dx.doi.org/10.1371/journal.pone.0005487			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424439	Green Published, gold, Green Submitted			2022-12-25	WOS:000265933800017
J	Efeyan, A; Murga, M; Martinez-Pastor, B; Ortega-Molina, A; Soria, R; Collado, M; Fernandez-Capetillo, O; Serrano, M				Efeyan, Alejo; Murga, Matilde; Martinez-Pastor, Barbara; Ortega-Molina, Ana; Soria, Rebeca; Collado, Manuel; Fernandez-Capetillo, Oscar; Serrano, Manuel			Limited Role of Murine ATM in Oncogene-Induced Senescence and p53-Dependent Tumor Suppression	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; K-RAS ONCOGENE; ATAXIA-TELANGIECTASIA; P53; ACTIVATION; CANCER; GENE; MYC; TUMORIGENESIS; INDUCTION	Recent studies in human fibroblasts have provided a new general paradigm of tumor suppression according to which oncogenic signaling produces DNA damage and this, in turn, results in ATM/p53-dependent cellular senescence. Here, we have tested this model in a variety of murine experimental systems. Overexpression of oncogenic Ras in murine fibroblasts efficiently induced senescence but this occurred in the absence of detectable DNA damage signaling, thus suggesting a fundamental difference between human and murine cells. Moreover, lung adenomas initiated by endogenous levels of oncogenic K-Ras presented abundant senescent cells, but undetectable DNA damage signaling. Accordingly, K-Ras-driven adenomas were also senescent in Atm-null mice, and the tumorigenic progression of these lesions was only modestly accelerated by Atm-deficiency. Finally, we have examined chemically-induced fibrosarcomas, which possess a persistently activated DNA damage response and are highly sensitive to the activity of p53. We found that the absence of Atm favored genomic instability in the resulting tumors, but did not affect the persistent DNA damage response and did not impair p53-dependent tumor suppression. All together, we conclude that oncogene-induced senescence in mice may occur in the absence of a detectable DNA damage response. Regarding murine Atm, our data suggest that it plays a minor role in oncogene-induced senescence or in p53-dependent tumor suppression, being its tumor suppressive activity probably limited to the maintenance of genomic stability.			Efeyan, A (corresponding author), Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, Madrid, Spain.	ofernandez@cnio.es; mserrano@cnio.es	Collado, Manuel/K-8140-2014; Serrano, Manuel/H-2634-2015; Efeyan, Alejo/J-8197-2016; Fernandez-Capetillo, Oscar/H-3508-2015; Murga, Matilde/B-3499-2018	Collado, Manuel/0000-0002-0330-0880; Serrano, Manuel/0000-0001-7177-9312; Efeyan, Alejo/0000-0002-3806-6799; Fernandez-Capetillo, Oscar/0000-0002-2690-6885; ORTEGA-MOLINA, ANA/0000-0003-2782-8994	European Research Council [233270] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		Bailey SL, 2008, MOL CANCER RES, V6, P1185, DOI 10.1158/1541-7786.MCR-07-2009; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bowen TJ, 2005, CANCER RES, V65, P8736, DOI 10.1158/0008-5472.CAN-05-1598; CARBONE G, 1991, INT J CANCER, V47, P619, DOI 10.1002/ijc.2910470423; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Efeyan A, 2007, CANCER RES, V67, P7350, DOI 10.1158/0008-5472.CAN-07-0200; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Efeyan A, 2006, NATURE, V443, P159, DOI 10.1038/443159a; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; EVA A, 1983, SCIENCE, V220, P955, DOI 10.1126/science.6302839; Evan GI, 2009, CURR OPIN GENET DEV, V19, P25, DOI 10.1016/j.gde.2008.11.009; Frappart PO, 2006, NEUROMOL MED, V8, P495, DOI 10.1385/NMM:8:4:495; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Ito K, 2007, J IMMUNOL, V178, P103, DOI 10.4049/jimmunol.178.1.103; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kelly-Spratt KS, 2004, PLOS BIOL, V2, P1138, DOI 10.1371/journal.pbio.0020242; Kwong LN, 2008, ONCOGENE, V27, P1013, DOI 10.1038/sj.onc.1210708; Liao MJ, 1999, MOL CELL BIOL, V19, P3095; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lu S, 2006, CARCINOGENESIS, V27, P848, DOI 10.1093/carcin/bgi302; Maclean KH, 2007, MOL CANCER RES, V5, P705, DOI 10.1158/1541-7786.MCR-07-0058; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Matheu A, 2004, GENE DEV, V18, P2736, DOI 10.1101/gad.310304; Mavrou A, 2008, ANTICANCER RES, V28, P401; Meuwissen R, 2005, GENE DEV, V19, P643, DOI 10.1101/gad.1284505; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Palmero I, 2001, METHOD ENZYMOL, V333, P247; Pantoja C, 1999, ONCOGENE, V18, P4974, DOI 10.1038/sj.onc.1202880; Pusapati RV, 2006, P NATL ACAD SCI USA, V103, P1446, DOI 10.1073/pnas.0507367103; Reimann M, 2007, BLOOD, V110, P2996, DOI 10.1182/blood-2007-02-075614; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Shen KC, 2005, CANCER RES, V65, P8747, DOI 10.1158/0008-5472.CAN-05-1471; Shimokado K, 1998, JPN J CANCER RES, V89, P269, DOI 10.1111/j.1349-7006.1998.tb00558.x; Swarbrick A, 2008, P NATL ACAD SCI USA, V105, P5402, DOI 10.1073/pnas.0801505105; Umesako S, 2005, BREAST CANCER RES, V7, pR164, DOI 10.1186/bcr968; Wang YA, 1997, P NATL ACAD SCI USA, V94, P14590, DOI 10.1073/pnas.94.26.14590; Watanabe H, 1999, JPN J CANCER RES, V90, P40, DOI 10.1111/j.1349-7006.1999.tb00663.x; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411	55	42	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2009	4	5							e5475	10.1371/journal.pone.0005475	http://dx.doi.org/10.1371/journal.pone.0005475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JH	19421407	Green Submitted, gold, Green Published			2022-12-25	WOS:000265837000009
J	Ounpraseuth, S; Rafferty, TM; McDonald-Phillips, RE; Gammill, WM; Siegel, ER; Wheeler, KL; Nilsson, EA; Cooney, CA				Ounpraseuth, Songthip; Rafferty, Tonya M.; McDonald-Phillips, Rachel E.; Gammill, Whitney M.; Siegel, Eric R.; Wheeler, Kristin L.; Nilsson, Erik A.; Cooney, Craig A.			A Method to Quantify Mouse Coat-Color Proportions	PLOS ONE			English	Article							AGOUTI GENE-EXPRESSION; GERM-LINE TRANSMISSION; EMBRYONIC STEM-CELLS; DNA METHYLATION; MUTATIONS; PHENOTYPE; AGREEMENT; GENOME; SITES; LOCUS	Coat-color proportions and patterns in mice are used as assays for many processes such as transgene expression, chimerism, and epigenetics. In many studies, coat-color readouts are estimated from subjective scoring of individual mice. Here we show a method by which mouse coat color is quantified as the proportion of coat shown in one or more digital images. We use the yellow-agouti mouse model of epigenetic variegation to demonstrate this method. We apply this method to live mice using a conventional digital camera for data collection. We use a raster graphics editing program to convert agouti regions of the coat to a standard, uniform, brown color and the yellow regions of the coat to a standard, uniform, yellow color. We use a second program to quantify the proportions of these standard colors. This method provides quantification that relates directly to the visual appearance of the live animal. It also provides an objective analysis with a traceable record, and it should allow for precise comparisons of mouse coats and mouse cohorts within and between studies.			Ounpraseuth, S (corresponding author), Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR 72205 USA.	CooneyCraigA@uams.edu		Cooney, Craig/0000-0003-4279-557X; Siegel, Eric/0000-0001-9824-6612	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG020641] Funding Source: NIH RePORTER; NIA NIH HHS [P01AG20641, P01 AG020641] Funding Source: Medline; NIDDK NIH HHS [R01DK63945, R01 DK063945] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Badger TM, 2008, EXP BIOL MED, V233, P1242, DOI 10.3181/0802-RM-60; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Castilho A, 1999, J CELL SCI, V112, P4397; Cooney CA, 2002, J NUTR, V132, p2393S; COONEY CA, 2006, NUTRIGENOMICS CONCEP, P219; Cropley JE, 2006, P NATL ACAD SCI USA, V103, P17308, DOI 10.1073/pnas.0607090103; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; Fayers P., 2007, QUALITY LIFE ASSESSM; Gaudet F, 2004, MOL CELL BIOL, V24, P1640, DOI 10.1128/MCB.24.4.1640-1648.2004; Grahn RA, 2005, ANIM GENET, V36, P67, DOI 10.1111/j.1365-2052.2005.01239.x; Hochedlinger K, 2004, GENE DEV, V18, P1875, DOI 10.1101/gad.1213504; Koji T, 2008, HISTOCHEM CELL BIOL, V130, P917, DOI 10.1007/s00418-008-0487-7; KOLLER BH, 1989, P NATL ACAD SCI USA, V86, P8927, DOI 10.1073/pnas.86.22.8927; Komashko VM, 2008, GENOME RES, V18, P521, DOI 10.1101/gr.074609.107; Leakey TI, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn210; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Mynatt RL, 2001, AM J PHYSIOL-CELL PH, V280, pC954, DOI 10.1152/ajpcell.2001.280.4.C954; R Core Team, 2022, R LANG ENV STAT COMP; SCHUIRMANN DJ, 1987, J PHARMACOKINET BIOP, V15, P657, DOI 10.1007/BF01068419; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Trut LN, 1999, AM SCI, V87, P160, DOI 10.1511/1999.20.813; VANBELLE G, 2002, STAT RULES THUMB, P65; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Ware CB, 2003, TRANSGENIC RES, V12, P743, DOI 10.1023/B:TRAG.0000005246.35812.c8; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Wolff GL, 1999, PHYSIOL GENOMICS, V1, P151, DOI 10.1152/physiolgenomics.1999.1.3.151; WOLFF GL, 1978, GENETICS, V88, P529; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Wu M, 1997, P NATL ACAD SCI USA, V94, P890, DOI 10.1073/pnas.94.3.890; Yan Pearlly S., 2009, V507, P89, DOI 10.1007/978-1-59745-522-0_8	38	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5414	10.1371/journal.pone.0005414	http://dx.doi.org/10.1371/journal.pone.0005414			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404391	Green Published, Green Submitted, gold			2022-12-25	WOS:000265614900023
J	Wei, JX; Yang, J; Sun, JF; Jia, LT; Zhang, Y; Zhang, HZ; Li, X; Meng, YL; Yao, LB; Yang, AG				Wei, Jun-Xia; Yang, Jie; Sun, Ji-Feng; Jia, Lin-Tao; Zhang, Yong; Zhang, Hui-Zhong; Li, Xia; Meng, Yan-Ling; Yao, Li-Bo; Yang, An-Gang			Both Strands of siRNA Have Potential to Guide Posttranscriptional Gene Silencing in Mammalian Cells	PLOS ONE			English	Article							PASSENGER-STRAND; RNAI; EXPRESSION; SURVIVIN; CLEAVAGE; DICER; TRBP	Despite the widespread application of RNA interference (RNAi) as a research tool for diverse purposes, the key step of strand selection of siRNAs during the formation of RNA-induced silencing complex (RISC) remains poorly understood. Here, using siRNAs targeted to the complementary region of Survivin and the effector protease receptor 1 (EPR-1), we show that both strands of the siRNA duplex can find their target mRNA and are equally eligible for assembly into Argonaute 2 (Ago2) of RISC in HEK293 cells. Transfection of the synthetic siRNA duplexes with different thermodynamic profiles or short hairpin RNA (shRNA) vectors that generate double-stranded RNAs (dsRNAs), permitting processing specifically from either the 59 or 39 end of the incipient siRNA, results in the degradation of the respective target mRNAs of either strand of the siRNA duplex with comparable efficiencies. Thus, while most RNAi reactions may follow the thermodynamic asymmetry rule in strand selection, our study suggests an exceptional mode for certain siRNAs in which both strands of the duplex are competent in sponsoring RNAi, and implies additional factors that might dictate the RNAi targets.			Wei, JX (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Dept Biochem & Mol Biol, Xian 710032, Peoples R China.	agyang@fmmu.edu.cn	meng, yan/GSE-2653-2022; Meng, Yan/HGC-0394-2022					ALTIERI DC, 1995, FASEB J, V9, P860, DOI 10.1096/fasebj.9.10.7615156; Altieri DC, 2001, TRENDS MOL MED, V7, P542, DOI 10.1016/S1471-4914(01)02243-2; Ambrosini G, 1998, J BIOL CHEM, V273, P11177, DOI 10.1074/jbc.273.18.11177; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chiu YL, 2003, RNA, V9, P1034, DOI 10.1261/rna.5103703; Clark PR, 2008, NUCLEIC ACIDS RES, V36, P1081, DOI 10.1093/nar/gkm630; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hong J, 2008, BIOCHEM BIOPH RES CO, V368, P703, DOI 10.1016/j.bbrc.2008.01.116; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; JONATHAN BP, 2006, CURR BIOL, V16, P530; JULIANA ML, 2004, RNA, V10, P766; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Mahotka C, 1999, CANCER RES, V59, P6097; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; OZGUR AO, 2007, LEUKEMIA RES, V31, P1495; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shinozawa I, 2000, LEUKEMIA RES, V24, P965, DOI 10.1016/S0145-2126(00)00065-5; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; TETSUHISA Y, 2001, MED ELECT MICROSC, V34, P12; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	30	31	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5382	10.1371/journal.pone.0005382	http://dx.doi.org/10.1371/journal.pone.0005382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401777	Green Published, gold, Green Submitted			2022-12-25	WOS:000265601100019
J	Reuter, S; Schnockel, U; Schroter, R; Schober, O; Pavenstadt, H; Schafers, M; Gabriels, G; Schlatter, E				Reuter, Stefan; Schnoeckel, Uta; Schroeter, Rita; Schober, Otmar; Pavenstaedt, Hermann; Schaefers, Michael; Gabrieels, Gert; Schlatter, Eberhard			Non-Invasive Imaging of Acute Renal Allograft Rejection in Rats Using Small Animal F-18-FDG-PET	PLOS ONE			English	Article								Background: At present, renal grafts are the most common solid organ transplants world-wide. Given the importance of renal transplantation and the limitation of available donor kidneys, detailed analysis of factors that affect transplant survival are important. Despite the introduction of new and effective immunosuppressive drugs, acute cellular graft rejection (AR) is still a major risk for graft survival. Nowadays, AR can only be definitively by renal biopsy. However, biopsies carry a risk of renal transplant injury and loss. Most important, they can not be performed in patients taking anticoagulant drugs. Methodology/Principal Findings: We present a non-invasive, entirely image-based method to assess AR in an allogeneic rat renal transplantation model using small animal positron emission tomography (PET) and 18 F-fluorodeoxyglucose (FDG). 3 h after i.v. injection of 30 MBq FDG into adult uni-nephrectomized, allogeneically transplanted rats, tissue radioactivity of renal parenchyma was assessed in vivo by a small animal PET-scanner (post operative day (POD) 1,2,4, and 7) and post mortem dissection. The mean radioactivity (cps/mm(3) tissue) as well as the percent injected dose (%ID) was compared between graft and native reference kidney. Results were confirmed by histological and autoradiographic analysis. Healthy rats, rats with acute CSA nephrotoxicity, with acute tubular necrosis, and syngeneically transplanted rats served as controls. FDG-uptake was significantly elevated only in allogeneic grafts from POD 1 on when compared to the native kidney (%ID graft POD 1: 0.54 +/- 0.06; POD 2: 0.58 +/- 0.12; POD 4: 0.81 +/- 0.06; POD 7: 0.77 +/- 0.1; CTR: 0.22 +/- 0.01, n = 3-28). Renal FDG-uptake in vivo correlated with the results obtained by micro-autoradiography and the degree of inflammatory infiltrates observed in histology. Conclusions/Significance: We propose that graft FDG-PET imaging is a new option to non-invasively, specifically, early detect, and follow-up acute renal rejection. This method is potentially useful to improve post-transplant rejection monitoring.			Reuter, S (corresponding author), Univ Klinikum Munster, Med Klin & Poliklin D, Munster, Germany.	sreuter@uni-muenster.de						Blodgett TM, 2007, RADIOLOGY, V242, P360, DOI 10.1148/radiol.2422051113; Bos R, 2002, J CLIN ONCOL, V20, P379, DOI 10.1200/JCO.20.2.379; Broekema M, 2007, J AM SOC NEPHROL, V18, P165, DOI 10.1681/ASN.2005070730; Chapman JR, 2005, J AM SOC NEPHROL, V16, P3015, DOI 10.1681/ASN.2005050463; Dubovsky EV, 1999, SEMIN NUCL MED, V29, P175, DOI 10.1016/S0001-2998(99)80007-5; El-Mekresh M, 2001, BJU INT, V87, P295, DOI 10.1046/j.1464-410x.2001.00113.x; Fischer T, 2006, NEPHROL DIAL TRANSPL, V21, P2921, DOI 10.1093/ndt/gfl313; Gabriels G, 2003, TRANSPLANTATION, V75, P689, DOI 10.1097/01.TP.0000044111.12370.ED; Gallon L, 2006, CLIN J AM SOC NEPHRO, V1, P539, DOI 10.2215/CJN.01741105; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Heaf JG, 2000, EUR J NUCL MED, V27, P871, DOI 10.1007/s002590000281; Kaim AH, 2002, RADIOLOGY, V223, P446, DOI 10.1148/radiol.2232010914; Kim KJ, 2003, INVEST RADIOL, V38, P473, DOI 10.1097/00004424-200308000-00001; Kirkpantur A, 2008, TRANSPL P, V40, P104, DOI 10.1016/j.transproceed.2007.11.032; Massy ZA, 1996, KIDNEY INT, V49, P518, DOI 10.1038/ki.1996.74; MATAS AJ, 1994, TRANSPLANTATION, V57, P857, DOI 10.1097/00007890-199403270-00015; Meier-Kriesche HU, 2000, TRANSPLANTATION, V70, P1098, DOI 10.1097/00007890-200010150-00018; Meller J, 2007, J NUCL MED, V48, P35; Opelz G, 2008, TRANSPLANTATION, V85, P661, DOI 10.1097/TP.0b013e3181661695; Pellegrino D, 2005, J NUCL MED, V46, P1522; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Reuter S, 2008, PFLUG ARCH EUR J PHY, V456, P1075, DOI 10.1007/s00424-008-0484-7; Rush D, 2006, CLIN J AM SOC NEPHRO, V1, P138, DOI 10.2215/CJN.00390705; Sarwal M, 2003, NEW ENGL J MED, V349, P125, DOI 10.1056/NEJMoa035588; Schafers KP, 2005, J NUCL MED, V46, P996; Schnockel U, 2008, EUR J NUCL MED MOL I, V35, P2267, DOI 10.1007/s00259-008-0878-y; Schwarz A, 2008, AM J TRANSPLANT, V8, P826, DOI 10.1111/j.1600-6143.2008.02160.x; Sis B, 2006, J CLIN PATHOL, V59, P377, DOI 10.1136/jcp.2005.029181; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Velic A, 2005, AM J TRANSPLANT, V5, P1276, DOI 10.1111/j.1600-6143.2005.00890.x; Velic A, 2004, J AM SOC NEPHROL, V15, P967, DOI 10.1097/01.ASN.0000117287.74203.89; Xue JL, 2001, J AM SOC NEPHROL, V12, P2753, DOI 10.1681/ASN.V12122753	33	38	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5296	10.1371/journal.pone.0005296	http://dx.doi.org/10.1371/journal.pone.0005296			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390685	Green Published, Green Submitted, gold			2022-12-25	WOS:000265514400002
J	Ward, DR; Dear, FM; Ward, IA; Anderson, SI; Spergel, DJ; Smith, PA; Ebling, FJP				Ward, Daniel R.; Dear, Fiona M.; Ward, Ian A.; Anderson, Susan I.; Spergel, Daniel J.; Smith, Paul A.; Ebling, Francis J. P.			Innervation of Gonadotropin-Releasing Hormone Neurons by Peptidergic Neurons Conveying Circadian or Energy Balance Information in the Mouse	PLOS ONE			English	Article								Background: Secretion of gonadotropin-releasing hormone (GnRH) produced in neurons in the basal forebrain is the primary regulator of reproductive maturation and function in mammals. Peptidergic signals relating to circadian timing and energy balance are an important influence on the reproductive axis. The aim of this study was to investigate the innervation of GnRH neurons by peptidergic neurons. Methodology/Principal Findings: Immunohistochemistry and confocal microscopy were used to detect appositions of peptidergic fibers (NPY, beta-endorphin, MCH) associated with energy balance and metabolic status in transgenic mice expressing a green fluorescent protein reporter construct in GnRH neurons. The frequency of these appositions was compared to those of vasoactive intestinal peptide (VIP), a hypothalamic neuropeptide likely to convey circadian timing information to the GnRH secretory system. The majority of GnRH neurons (73-87%) were closely apposed by fibers expressing NPY, beta-endorphin, or MCH, and a significant proportion of GnRH neurons (28%) also had close contacts with VIP-ir fibers. Conclusions/Significance: It is concluded that GnRH neurons in the mouse receive a high frequency of direct modulatory inputs from multiple hypothalamic peptide systems known to be important in conveying circadian information and signalling energy balance.			Ward, DR (corresponding author), Univ Nottingham, Sch Med, Sch Biomed Sci, Nottingham, England.	fran.ebling@nottingham.ac.uk	Oka, Yoshitaka/C-9670-2010; Ebling, Francis/Q-6193-2019; Ebling, Francis/A-1900-2013; Spergel, David N/A-4410-2011	Oka, Yoshitaka/0000-0002-3482-3051; Ebling, Francis/0000-0002-7316-9582; Ebling, Francis/0000-0002-7316-9582; Spergel, David N/0000-0002-5151-0006; Smith, Paul/0000-0002-8710-6830; Spergel, Daniel/0000-0002-5753-4332	Biotechnology and Biological Sciences Research Council [BB/E020437/1] Funding Source: Medline; BBSRC [BB/E020437/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Bittman EL, 1996, AM J PHYSIOL-REG I, V271, pR64, DOI 10.1152/ajpregu.1996.271.1.R64; Campbell RE, 2001, NEUROENDOCRINOLOGY, V74, P106, DOI 10.1159/000054676; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chiocchio SR, 2001, BIOL REPROD, V64, P1466, DOI 10.1095/biolreprod64.5.1466; Christian CA, 2008, ENDOCRINOLOGY, V149, P3130, DOI 10.1210/en.2007-1098; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Crown A, 2007, NEUROENDOCRINOLOGY, V86, P175, DOI 10.1159/000109095; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; Dardente H, 2004, MOL BRAIN RES, V124, P143, DOI 10.1016/j.molbrainres.2004.01.010; DELAIGLESIA HO, 1995, NEUROREPORT, V6, P1715, DOI 10.1097/00001756-199509000-00004; Ebling FJP, 2005, REPRODUCTION, V129, P675, DOI 10.1530/rep.1.00367; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Gerhold LM, 2006, ENDOCRINOLOGY, V147, P2197, DOI 10.1210/en.2005-1262; Gonzalez MI, 1997, NEUROENDOCRINOLOGY, V66, P254, DOI 10.1159/000127246; Gore AC, 2004, ENDOCRINOLOGY, V145, P4016, DOI 10.1210/en.2004-0855; Hakansson ML, 1998, J NEUROSCI, V18, P559; HERBERT J, 1993, PROG NEUROBIOL, V41, P723, DOI 10.1016/0301-0082(93)90033-O; Herbison AE, 2001, MOL CELL ENDOCRINOL, V185, P185, DOI 10.1016/S0303-7207(01)00618-9; HORTON RJE, 1989, J ENDOCRINOL, V122, P509, DOI 10.1677/joe.0.1220509; Horvath TL, 1998, BRAIN RES, V795, P277, DOI 10.1016/S0006-8993(98)00208-X; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; KALRA SP, 1992, FRONT NEUROENDOCRIN, V13, P1; KALRA SP, 1984, OPIOID MODULATION EN, P171; Kamiji MM, 2007, ENDOCR REV, V28, P664, DOI 10.1210/er.2007-0003; Kiyoshi K, 1998, CELL TISSUE RES, V293, P39, DOI 10.1007/s004410051096; Kriegsfeld LJ, 2002, J NEUROENDOCRINOL, V14, P685, DOI 10.1046/j.1365-2826.2002.00818.x; Li C, 1999, ENDOCRINOLOGY, V140, P5382, DOI 10.1210/en.140.11.5382; Matsumoto S, 2006, P NATL ACAD SCI USA, V103, P4140, DOI 10.1073/pnas.0508881103; Maywood ES, 1997, EUR J NEUROSCI, V9, P1739, DOI 10.1111/j.1460-9568.1997.tb01531.x; McBriar MD, 2007, CURR TOP MED CHEM, V7, P1440, DOI 10.2174/156802607782194752; MIKKELSEN JD, 1994, BRAIN RES, V656, P95, DOI 10.1016/0006-8993(94)91370-6; MILLER GM, 1994, NEUROENDOCRINOLOGY, V59, P277, DOI 10.1159/000126669; Ng KL, 2005, SCIENCE, V308, P1923, DOI 10.1126/science.1112103; ODONOHUE TL, 1979, BRAIN RES, V176, P101, DOI 10.1016/0006-8993(79)90873-4; Ojeda SR, 2006, ENDOCRINOLOGY, V147, P1166, DOI 10.1210/en.2005-1136; Raposinho PD, 2000, NEUROENDOCRINOLOGY, V71, P2, DOI 10.1159/000054514; Raposinho PD, 1999, ENDOCRINOLOGY, V140, P4046, DOI 10.1210/en.140.9.4046; Sannella MI, 1997, ENDOCRINOLOGY, V138, P1667, DOI 10.1210/en.138.4.1667; Schneider JE, 2004, PHYSIOL BEHAV, V81, P289, DOI 10.1016/j.physbeh.2004.02.007; Schuhler S, 2006, PEPTIDES, V27, P301, DOI 10.1016/j.peptides.2005.03.060; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Smith MJ, 2000, ENDOCRINOLOGY, V141, P4317, DOI 10.1210/en.141.11.4317; Spergel DJ, 1999, J NEUROSCI, V19, P2037; Suter KJ, 2000, ENDOCRINOLOGY, V141, P412, DOI 10.1210/en.141.1.412; Takenoya F, 2006, PEPTIDES, V27, P2885, DOI 10.1016/j.peptides.2006.05.012; TILLET Y, 1989, J CHEM NEUROANAT, V2, P319; Todman MG, 2005, NEUROSCIENCE, V132, P703, DOI 10.1016/j.neuroscience.2005.01.035; Tritos NA, 2001, BRAIN RES, V895, P160, DOI 10.1016/S0006-8993(01)02066-2; Tsukamura H, 2000, J NEUROENDOCRINOL, V12, P529, DOI 10.1046/j.1365-2826.2000.00482.x; Turi GF, 2003, ENDOCRINOLOGY, V144, P4967, DOI 10.1210/en.2003-0470; VanderBeek EM, 1997, J COMP NEUROL, V384, P569, DOI 10.1002/(SICI)1096-9861(19970811)384:4<569::AID-CNE6>3.0.CO;2-0; VANDERBEEK EM, 1993, J NEUROENDOCRINOL, V5, P137; Williamson-Hughes PS, 2005, BRAIN RES, V1041, P117, DOI 10.1016/j.brainres.2004.11.066; Yang Y, 2005, ACTA PHARMACOL SIN, V26, P976, DOI 10.1111/j.1745-7254.2005.00118.x; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; YOSHIDA M, 1988, ARCH HISTOL CYTOL, V51, P175, DOI 10.1679/aohc.51.175	59	37	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5322	10.1371/journal.pone.0005322	http://dx.doi.org/10.1371/journal.pone.0005322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390688	gold, Green Published, Green Submitted			2022-12-25	WOS:000265514400010
J	Zheng, LS; Wang, F; Li, YH; Zhang, X; Chen, LM; Liang, YJ; Dai, CL; Yan, YY; Tao, LY; Mi, YJ; Yang, AK; To, KKW; Fu, LW				Zheng, Li-sheng; Wang, Fang; Li, Yu-hong; Zhang, Xu; Chen, Li-ming; Liang, Yong-ju; Dai, Chun-ling; Yan, Yan-yan; Tao, Li-yang; Mi, Yan-jun; Yang, An-kui; To, Kenneth Kin Wah; Fu, Li-wu			Vandetanib (Zactima, ZD6474) Antagonizes ABCC1-and ABCG2-Mediated Multidrug Resistance by Inhibition of Their Transport Function	PLOS ONE			English	Article								Background: ABCC1 and ABCG2 are ubiquitous ATP-binding cassette transmembrane proteins that play an important role in multidrug resistance (MDR). In this study, we evaluated the possible interaction of vandetanib, an orally administered drug inhibiting multiple receptor tyrosine kinases, with ABCC1 and ABCG2 in vitro. Methodology and Principal Findings: MDR cancer cells overexpressing ABCC1 or ABCG2 and their sensitive parental cell lines were used. MTT assay showed that vandetanib had moderate and almost equal-potent anti-proliferative activity in both sensitive parental and MDR cancer cells. Concomitant treatment of MDR cells with vandetanib and specific inhibitors of ABCC1 or ABCG2 did not alter their sensitivity to the former drug. On the other hand, clinically attainable but non-toxic doses of vandetanib were found to significantly enhance the sensitivity of MDR cancer cells to ABCC1 or ABCG2 substrate antitumor drugs. Flow cytometric analysis showed that vandetanib treatment significantly increase the intracellular accumulation of doxorubicin and rhodamine 123, substrates of ABCC1 and ABCG2 respectively, in a dose-dependent manner (P < 0.05). However, no significant effect was shown in sensitive parental cell lines. Reverse transcription-PCR and Western blot analysis showed that vandetanib did not change the expression of ABCC1 and ABCG2 at both mRNA and protein levels. Furthermore, total and phosphorylated forms of AKT and ERK1/2 remained unchanged after vandetanib treatment in both sensitive and MDR cancer cells. Conclusions: Vandetanib is unlikely to be a substrate of ABCC1 or ABCG2. It overcomes ABCC1- and ABCG2-mediated drug resistance by inhibiting the transporter activity, independent of the blockade of AKT and ERK1/2 signal transduction pathways.			Zheng, LS (corresponding author), Sun Yat Sen Univ, Res Dept, State Key Lab Oncol S China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	Fulw@mail.sysu.edu.cn	wang, fang/GYD-4295-2022; Fu, Liwu/AAE-8835-2020; To, Kenneth K W/M-4500-2013	To, Kenneth K W/0000-0003-2755-0283				Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Bakos E, 2007, PFLUG ARCH EUR J PHY, V453, P621, DOI 10.1007/s00424-006-0160-8; Bianco C, 2006, CLIN CANCER RES, V12, P7099, DOI 10.1158/1078-0432.CCR-06-0833; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Brendel C, 2007, LEUKEMIA, V21, P1267, DOI 10.1038/sj.leu.2404638; Bunting KD, 2002, STEM CELLS, V20, P11, DOI 10.1002/stem.200011; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; Cabebe Elwyn, 2007, Curr Treat Options Oncol, V8, P15, DOI 10.1007/s11864-007-0022-4; Carlomagno F, 2002, CANCER RES, V62, P7284; Checkley D, 2003, BRIT J CANCER, V89, P1889, DOI 10.1038/sj.bjc.6601386; Chen LM, 2004, ONCOL RES, V14, P355, DOI 10.3727/0965040041292378; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Dai CL, 2008, CANCER RES, V68, P7905, DOI 10.1158/0008-5472.CAN-08-0499; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Fetsch PA, 2006, CANCER LETT, V235, P84, DOI 10.1016/j.canlet.2005.04.024; Fu LW, 2004, CANCER CHEMOTH PHARM, V53, P349, DOI 10.1007/s00280-003-0742-5; Giannelli G, 2006, BIOCHEM PHARMACOL, V71, P479, DOI 10.1016/j.bcp.2005.11.005; Hegedus T, 2002, BBA-MOL BASIS DIS, V1587, P318, DOI 10.1016/S0925-4439(02)00095-9; Herbst RS, 2007, EXPERT OPIN INV DRUG, V16, P239, DOI 10.1517/13543784.16.2.239; Heymach JV, 2006, CLIN CANCER RES, V12, p4441S, DOI 10.1158/1078-0432.CCR-06-0286; Holden SN, 2005, ANN ONCOL, V16, P1391, DOI 10.1093/annonc/mdi247; Kitazaki T, 2005, LUNG CANCER, V49, P337, DOI 10.1016/j.lungcan.2005.03.035; Knuefermann C, 2003, ONCOGENE, V22, P3205, DOI 10.1038/sj.onc.1206394; Levitzki A, 1999, PHARMACOL THERAPEUT, V82, P231, DOI 10.1016/S0163-7258(98)00066-7; Litman T, 2001, CELL MOL LIFE SCI, V58, P931, DOI 10.1007/PL00000912; Matsurnori Y, 2006, ONCOL RES, V16, P15, DOI 10.3727/000000006783981260; McCarty MF, 2004, MOL CANCER THER, V3, P1041; Mi Y, 2007, BRIT J CANCER, V97, P934, DOI 10.1038/sj.bjc.6603985; Miyake K, 1999, CANCER RES, V59, P8; Morelli MP, 2005, ANN ONCOL, V16, P61, DOI 10.1093/annonc/mdi910; Nakanishi T, 2006, BLOOD, V108, P678, DOI 10.1182/blood-2005-10-4020; Navolanic PM, 2003, INT J ONCOL, V22, P237; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Rabindran SK, 2000, CANCER RES, V60, P47; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rich JN, 2005, CLIN CANCER RES, V11, P8145, DOI 10.1158/1078-0432.CCR-05-0319; Robey RW, 2003, BRIT J CANCER, V89, P1971, DOI 10.1038/sj.bjc.6601370; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Ryan AJ, 2005, BRIT J CANCER, V92, pS6, DOI 10.1038/sj.bjc.6602603; Sequist LV, 2007, ONCOLOGIST, V12, P325, DOI 10.1634/theoncologist.12-3-325; Shi Z, 2006, CANCER BIOL THER, V5, P39, DOI 10.4161/cbt.5.1.2236; Shi Z, 2007, CANCER RES, V67, P11012, DOI 10.1158/0008-5472.CAN-07-2686; Shibuya M, 2006, ENDOTHELIUM-J ENDOTH, V13, P63, DOI 10.1080/10623320600697955; SUMIZAWA T, 1994, SOMAT CELL MOLEC GEN, V20, P423, DOI 10.1007/BF02257459; Tamura T, 2006, J THORAC ONCOL, V1, P1002, DOI 10.1097/01243894-200611000-00014; Troiani T, 2007, CLIN CANCER RES, V13, P6450, DOI 10.1158/1078-0432.CCR-07-1094; Volk EL, 2002, CANCER RES, V62, P5035; Wedge SR, 2002, CANCER RES, V62, P4645; West KA, 2002, DRUG RESIST UPDATE, V5, P234, DOI 10.1016/S1368-7646(02)00120-6; Yang CH, 2005, CANCER RES, V65, P6943, DOI 10.1158/0008-5472.CAN-05-0641; Yano S, 2005, CLIN CANCER RES, V11, P8789, DOI 10.1158/1078-0432.CCR-05-0674; Zhou S, 2002, P NATL ACAD SCI USA, V99, P12339, DOI 10.1073/pnas.192276999; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	55	77	81	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5172	10.1371/journal.pone.0005172	http://dx.doi.org/10.1371/journal.pone.0005172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390592	Green Submitted, Green Published, gold			2022-12-25	WOS:000265514200001
J	Das, R; Chowdhury, S; Mazhab-Jafari, MT; SilDas, S; Selvaratnam, R; Melacini, G				Das, Rahul; Chowdhury, Somenath; Mazhab-Jafari, Mohammad T.; SilDas, Soumita; Selvaratnam, Rajeevan; Melacini, Giuseppe			Dynamically Driven Ligand Selectivity in Cyclic Nucleotide Binding Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; N-15 NMR RELAXATION; CHEMICAL-EXCHANGE; REGULATORY SUBUNIT; GLOBULAR-PROTEINS; STRUCTURE REVEALS; STRUCTURAL BASIS; CAMP; ACTIVATION; MECHANISM	One of the mechanisms that minimize the aberrant cross-talk between cAMP-and cGMP-dependent signaling pathways relies on the selectivity of cAMP binding domains (CBDs). For instance, the CBDs of two critical eukaryotic cAMP receptors, i.e. protein kinase A (PKA) and the exchange protein activated by cAMP (EPAC), are both selectively activated by cAMP. However, the mechanisms underlying their cAMP versus cGMP selectivity are quite distinct. In PKA this selectivity is controlled mainly at the level of ligand affinity, whereas in EPAC it is mostly determined at the level of allostery. Currently, the molecular basis for these different selectivity mechanisms is not fully understood. We have therefore comparatively analyzed by NMR the cGMP-bound states of the essential CBDs of PKA and EPAC, revealing key differences between them. Specifically, cGMP binds PKA preserving the same syn base orientation as cAMP at the price of local steric clashes, which lead to a reduced affinity for cGMP. Unlike PKA, cGMP is recognized by EPAC in an anti conformation and generates several short and long range perturbations. Although these effects do not alter significantly the structure of the EPAC CBD investigated, remarkable differences in dynamics between the cAMP-and cGMP-bound states are detected for the ionic latch region. These observations suggest that one of the determinants of cGMP antagonism in EPAC is the modulation of the entropic control of inhibitory interactions and illustrate the pivotal role of allostery in determining signaling selectivity as a function of dynamic changes, even in the absence of significant affinity variations.	[Melacini, Giuseppe] McMaster Univ, Dept Chem & Biochem, Hamilton, ON L8S 4M1, Canada; McMaster Univ, Dept Biomed Sci, Hamilton, ON L8S 4M1, Canada	McMaster University; McMaster University	Melacini, G (corresponding author), McMaster Univ, Dept Chem & Biochem, 1280 Main St W, Hamilton, ON L8S 4M1, Canada.	melacin@mcmaster.ca	Chowdhury, Somenath/I-7846-2015; Das, Rahul/AAU-5123-2020; SELVARATNAM, RAJEEVAN/H-5289-2011	Das, Rahul/0000-0001-7841-8229; SELVARATNAM, RAJEEVAN/0000-0003-4457-616X; Chowdhury, Somenath/0000-0002-3693-1427; Mazhab-Jafari, Mohammad T./0000-0003-0207-5877	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research. This paper is dedicated to the memory of Professor Richard Haslam.	Abu-Abed M, 2007, PROTEINS, V69, P112, DOI 10.1002/prot.21446; Aden J, 2007, J AM CHEM SOC, V129, P14003, DOI 10.1021/ja075055g; Atkinson RA, 2004, PROG NUCL MAG RES SP, V44, P141, DOI 10.1016/j.pnmrs.2004.01.001; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Bernado P, 2002, J BIOMOL NMR, V23, P139, DOI 10.1023/A:1016359412284; CAVANAGH J, 1996, PROTEIN NMR SPECTROS, P100; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Das R, 2007, P NATL ACAD SCI USA, V104, P93, DOI 10.1073/pnas.0609033103; Das R, 2007, J BIOL CHEM, V282, P581, DOI 10.1074/jbc.M607706200; Das R, 2006, J AM CHEM SOC, V128, P8406, DOI 10.1021/ja060046d; Das R, 2008, J BIOL CHEM, V283, P19691, DOI 10.1074/jbc.M802164200; de la Torre JG, 2001, BIOPHYS CHEM, V93, P159, DOI 10.1016/S0301-4622(01)00218-6; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desvaux H, 1999, PROG NUCL MAG RES SP, V35, P295, DOI 10.1016/S0079-6565(99)00011-4; Eghbalnia HR, 2005, J BIOMOL NMR, V32, P219, DOI 10.1007/s10858-005-7944-6; Esposito V, 2006, J BIOMOL NMR, V36, P64, DOI 10.1007/s10858-006-9050-9; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Fischer MWF, 1998, PROG NUCL MAG RES SP, V33, P207, DOI 10.1016/S0079-6565(98)00023-5; Goddard T. D., 2006, SPARKY VERSION 3; GRONENBORN AM, 1981, FEBS LETT, V136, P160, DOI 10.1016/0014-5793(81)81237-9; Harper SM, 2008, J BIOL CHEM, V283, P6501, DOI 10.1074/jbc.M707849200; Houben K, 2005, J MOL BIOL, V349, P621, DOI 10.1016/j.jmb.2005.04.007; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Kannan N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r264; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kim C, 2006, EUR J CELL BIOL, V85, P651, DOI 10.1016/j.ejcb.2006.02.004; Kornev AP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000056; Mazhab-Jafari MT, 2007, J AM CHEM SOC, V129, P14482, DOI 10.1021/ja0753703; Mulder FAA, 2004, BIOCHEMISTRY-US, V43, P5930, DOI 10.1021/bi0495331; NI F, 1994, PROG NUCL MAG RES SP, V26, P517, DOI 10.1016/0079-6565(94)90000-0; OTTING G, 1989, J MAGN RESON, V85, P586, DOI 10.1016/0022-2364(89)90249-7; PALMER AG, 1998, CURVEFIT; Passner JM, 1997, P NATL ACAD SCI USA, V94, P2843, DOI 10.1073/pnas.94.7.2843; Pelligrino DA, 1998, PROG NEUROBIOL, V56, P1, DOI 10.1016/S0301-0082(98)00009-4; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Rehmann H, 2003, J BIOL CHEM, V278, P38548, DOI 10.1074/jbc.M306292200; Rehmann H, 2008, NATURE, V455, P124, DOI 10.1038/nature07187; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Renner C, 2002, J BIOMOL NMR, V23, P23, DOI 10.1023/A:1015385910220; Rodriguez JC, 2004, J BIOMOL NMR, V30, P155, DOI 10.1023/B:JNMR.0000048857.44219.c3; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Segui-Lines G, 2007, ANALYST, V132, P741, DOI 10.1039/b705469f; SHABB JB, 1991, J BIOL CHEM, V266, P24320; SHABB JB, 1990, J BIOL CHEM, V265, P16031; Stevens SY, 2001, NAT STRUCT BIOL, V8, P947, DOI 10.1038/nsb1101-947; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Vialle-Printems C, 2000, J MAGN RESON, V142, P276, DOI 10.1006/jmre.1999.1954; VONDEVEN FJM, 1995, MULTIDIMENSIONAL NMR, P99; Wang X, 1997, J NEUROCHEM, V68, P443; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; Wu J, 2004, STRUCTURE, V12, P1057, DOI 10.1016/j.str.2004.03.022; Yip GNB, 2004, J MAGN RESON, V171, P25, DOI 10.1016/j.jmr.2004.06.021; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922	57	66	66	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23682	23696		10.1074/jbc.M109.011700	http://dx.doi.org/10.1074/jbc.M109.011700			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19403523	Green Published, hybrid			2022-12-25	WOS:000269180000054
J	Phelan, MM; Thai, CT; Soares, DC; Ogata, RT; Barlow, PN; Bramham, J				Phelan, Marie M.; Thai, Chuong-Thu; Soares, Dinesh C.; Ogata, Ronald T.; Barlow, Paul N.; Bramham, Janice			Solution Structure of Factor I-like Modules from Complement C7 Reveals a Pair of Follistatin Domains in Compact Pseudosymmetric Arrangement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PROTEIN-SEQUENCE; CHEMICAL-SHIFT; C345C DOMAIN; BINDING; COMPONENT; NMR; MECHANISM; SOFTWARE; INSIGHTS	Factor I-like modules (FIMs) of complement proteins C6, C7, and factor I participate in protein-protein interactions critical to the progress of a complement-mediated immune response to infections and other trauma. For instance, the carboxyl-terminal FIM pair of C7 (C7-FIMs) binds to the C345C domain of C5 and its activated product, C5b, during self-assembly of the cytolytic membrane-attack complex. FIMs share sequence similarity with follistatin domains (FDs) of known three-dimensional structure, suggesting that FIM structures could be reliably modeled. However, conflicting disulfide maps, inconsistent orientations of subdomains within FDs, and the presence of binding partners in all FD structures led us to determine the three-dimensional structure of C7-FIMs by NMR spectroscopy. The solution structure reveals that each FIM within C7 contains a small amino-terminal FOLN subdomain connected to a larger carboxyl-terminal KAZAL domain. The open arrangement of the subdomains within FIMs resembles that of first FDs within structures of tandem FDs but differs from the more compact subdomain arrangement of second or third FDs. Unexpectedly, the two C7-FIMs pack closely together with an approximate 2-fold rotational symmetry that is rarely seen in module pairs and has not been observed in FD-containing proteins. Interfaces between subdomains and between modules include numerous hydrophobic and electrostatic contributions, suggesting that this is a physiologically relevant conformation that persists in the context of the parent protein. Similar interfaces were predicted in a homology-based model of the C6-FIM pair. The C7-FIM structures also facilitated construction of a model of the single FIM of factor I.	[Phelan, Marie M.; Soares, Dinesh C.; Barlow, Paul N.; Bramham, Janice] Univ Edinburgh, Edinburgh Biomol NMR Unit, Edinburgh EH9 3JJ, Midlothian, Scotland; [Barlow, Paul N.; Bramham, Janice] Univ Edinburgh, Ctr Translat & Chem Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Thai, Chuong-Thu; Ogata, Ronald T.] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA; [Soares, Dinesh C.] Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; Torrey Pines Institute for Molecular Studies, California; University of Edinburgh	Bramham, J (corresponding author), Univ Edinburgh, Edinburgh Biomol NMR Unit, W Mains Rd, Edinburgh EH9 3JJ, Midlothian, Scotland.	janice.bramham@ed.ac.uk	Barlow, Paul N/G-2853-2011; Soares, Dinesh C/A-4425-2012	Soares, Dinesh C/0000-0001-7557-0495	National Institutes of Health; Medical Research Council of the United Kingdom; Wellcome Trust and Scottish Universities Life Sciences Alliance; MRC [G0500940] Funding Source: UKRI; Medical Research Council [G0500940] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust and Scottish Universities Life Sciences Alliance; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported, in whole or in part, by a National Institutes of Health grant (to R.T.O.). This work was also supported by a Medical Research Council of the United Kingdom grant (to M. M. P.) and funds from the Wellcome Trust and Scottish Universities Life Sciences Alliance (to J.B.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARLOW PN, 1993, J MOL BIOL, V232, P268, DOI 10.1006/jmbi.1993.1381; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bohana-Kashtan O, 2004, MOL IMMUNOL, V41, P583, DOI 10.1016/j.molimm.2004.04.007; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Bramham J, 2005, J BIOL CHEM, V280, P10636, DOI 10.1074/jbc.M413126200; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; BUNGER AT, 1998, ACTA CRYSTALLOGR D, V54, P905; Chamberlain D, 1998, BIOCHEMISTRY-US, V37, P13918, DOI 10.1021/bi9805184; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; COOPER NR, 1970, J EXP MED, V132, P775, DOI 10.1084/jem.132.4.775; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DISCIPIO RG, 1988, J BIOL CHEM, V263, P549; DiScipio RG, 1999, J BIOL CHEM, V274, P31811, DOI 10.1074/jbc.274.45.31811; DISCIPIO RG, 1983, J BIOL CHEM, V258, P629; DISCIPIO RG, 1989, J BIOL CHEM, V264, P16197; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; ENGEL J, 1989, FEBS LETT, V251, P1, DOI 10.1016/0014-5793(89)81417-6; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Fredslund F, 2008, NAT IMMUNOL, V9, P753, DOI 10.1038/ni.1625; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gabdoulline RR, 2003, NUCLEIC ACIDS RES, V31, P3349, DOI 10.1093/nar/gkg588; Gabdoulline RR, 1999, TRENDS BIOCHEM SCI, V24, P285, DOI 10.1016/S0968-0004(99)01412-7; GOLDLUST MB, 1974, J IMMUNOL, V113, P998; Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h; GOTZE O, 1970, J EXP MED, V132, P898, DOI 10.1084/jem.132.5.898; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HAMMER CH, 1975, P NATL ACAD SCI USA, V72, P5076, DOI 10.1073/pnas.72.12.5076; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Harrison PM, 1996, J MOL BIOL, V264, P603, DOI 10.1006/jmbi.1996.0664; HEIDEN W, 1993, J COMPUT AID MOL DES, V7, P503, DOI 10.1007/BF00124359; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HIGGINS JMG, 1995, J IMMUNOL, V155, P5777; Hohenester E, 2002, MATRIX BIOL, V21, P115, DOI 10.1016/S0945-053X(01)00191-3; Hohenester E, 1997, EMBO J, V16, P3778, DOI 10.1093/emboj/16.13.3778; Hohenester E, 2008, P NATL ACAD SCI USA, V105, P18273, DOI 10.1073/pnas.0808452105; Husler T, 1996, BIOCHEMISTRY-US, V35, P3263, DOI 10.1021/bi952862w; Innis CA, 2003, J BIOL CHEM, V278, P39969, DOI 10.1074/jbc.M211284200; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lengweiler S, 1997, BBA-PROTEIN STRUCT M, V1342, P13, DOI 10.1016/S0167-4838(97)00072-1; Lerch TF, 2007, J BIOL CHEM, V282, P15930, DOI 10.1074/jbc.M700737200; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NILGES M, 1995, J MOL BIOL, V245, P645, DOI 10.1006/jmbi.1994.0053; NORMAN DG, 1991, J MOL BIOL, V219, P717, DOI 10.1016/0022-2836(91)90666-T; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; PEITSCH MC, 1990, MOL IMMUNOL, V27, P589, DOI 10.1016/0161-5890(90)90001-G; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Phelan MM, 2009, BIOMOL NMR ASSIGN, V3, P49, DOI 10.1007/s12104-008-9139-z; PODACK ER, 1978, J IMMUNOL, V121, P484; Ponting CP, 1999, CURR BIOL, V9, pR911, DOI 10.1016/S0960-9822(00)80102-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sasaki T, 1998, EMBO J, V17, P1625, DOI 10.1093/emboj/17.6.1625; Saunders RE, 2007, HUM MUTAT, V28, P222, DOI 10.1002/humu.20435; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; Soares DC, 2005, STRUCTURAL BIOLOGY OF THE COMPLEMENT SYSTEM, P19; Soares DC, 2005, PROTEIN ENG DES SEL, V18, P379, DOI 10.1093/protein/gzi039; Stamler R, 2008, J BIOL CHEM, V283, P32831, DOI 10.1074/jbc.M801266200; Thai CT, 2005, J IMMUNOL, V174, P6227, DOI 10.4049/jimmunol.174.10.6227; Thai CT, 2004, J IMMUNOL, V173, P4547, DOI 10.4049/jimmunol.173.7.4547; Thai CT, 2003, J IMMUNOL, V171, P6565, DOI 10.4049/jimmunol.171.12.6565; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Ullman CG, 1997, BIOCHEM J, V326, P939, DOI 10.1042/bj3260929v; Varret M, 1998, NUCLEIC ACIDS RES, V26, P248, DOI 10.1093/nar/26.1.248; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803	77	11	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19637	19649		10.1074/jbc.M901993200	http://dx.doi.org/10.1074/jbc.M901993200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19419965	hybrid, Green Published			2022-12-25	WOS:000267908300055
J	Fabrick, J; Oppert, C; Lorenzen, MD; Morris, K; Oppert, B; Jurat-Fuentes, JL				Fabrick, Jeff; Oppert, Cris; Lorenzen, Marce D.; Morris, Kaley; Oppert, Brenda; Jurat-Fuentes, Juan Luis			A Novel Tenebrio molitor Cadherin Is a Functional Receptor for Bacillus thuringiensis Cry3Aa Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORDER MEMBRANE-VESICLES; DROSOPHILA S2 CELLS; DELTA-ENDOTOXIN; HELIOTHIS-VIRESCENS; MANDUCA-SEXTA; CRY1A TOXINS; INSECT RESISTANCE; PORE FORMATION; LARVAL MIDGUT; HELICOVERPA-ARMIGERA	Cry toxins produced by the bacterium Bacillus thuringiensis are effective biological insecticides. Cadherin-like proteins have been reported as functional Cry1A toxin receptors in Lepidoptera. Here we present data that demonstrate that a coleopteran cadherin is a functional Cry3Aa toxin receptor. The Cry3Aa receptor cadherin was cloned from Tenebrio molitor larval midgut mRNA, and the predicted protein, TmCad1, has domain structure and a putative toxin binding region similar to those in lepidopteran cadherin B. thuringiensis receptors. A peptide containing the putative toxin binding region from TmCad1 bound specifically to Cry3Aa and promoted the formation of Cry3Aa toxin oligomers, proposed to be mediators of toxicity in lepidopterans. Injection of TmCad1-specific double-stranded RNA into T. molitor larvae resulted in knockdown of the TmCad1 transcript and conferred resistance to Cry3Aa toxicity. These data demonstrate the functional role of TmCad1 as a Cry3Aa receptor in T. molitor and reveal similarities between the mode of action of Cry toxins in Lepidoptera and Coleoptera.	[Lorenzen, Marce D.; Oppert, Brenda] ARS, USDA, GMPRC, Manhattan, KS 66502 USA; [Fabrick, Jeff] ARS, USDA, US Arid Land Agr Res Ctr, Maricopa, AZ 85238 USA; [Oppert, Cris; Jurat-Fuentes, Juan Luis] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37996 USA; [Morris, Kaley] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Kansas State University	Oppert, B (corresponding author), ARS, USDA, GMPRC, 1515 Coll Ave, Manhattan, KS 66502 USA.	bso@ksu.edu	Jurat-Fuentes, Juan Luis/A-5104-2014	Jurat-Fuentes, Juan Luis/0000-0002-8945-1814; Fabrick, Jeffrey/0000-0002-3893-9545; Lorenzen, Marce/0000-0003-2318-1388				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BELFIORE CJ, 1994, BIOCHEM BIOPH RES CO, V200, P359, DOI 10.1006/bbrc.1994.1456; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Carroll J, 1997, J INVERTEBR PATHOL, V70, P41, DOI 10.1006/jipa.1997.4656; CARROLL J, 1989, BIOCHEM J, V261, P99, DOI 10.1042/bj2610099; Chen J, 2007, P NATL ACAD SCI USA, V104, P13901, DOI 10.1073/pnas.0706011104; Dorsch JA, 2002, INSECT BIOCHEM MOLEC, V32, P1025, DOI 10.1016/S0965-1748(02)00040-1; Fabrick JA, 2007, INSECT BIOCHEM MOLEC, V37, P97, DOI 10.1016/j.ibmb.2006.10.010; FELSENSTEIN J, 1989, SCIENCE, V246, P941, DOI 10.1126/science.246.4932.941; Flannagan RD, 2005, INSECT BIOCHEM MOLEC, V35, P33, DOI 10.1016/j.ibmb.2004.10.001; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gassmann AJ, 2009, ANNU REV ENTOMOL, V54, P147, DOI 10.1146/annurev.ento.54.110807.090518; Gomez I, 2007, PEPTIDES, V28, P169, DOI 10.1016/j.peptides.2006.06.013; Gomez I, 2002, FEBS LETT, V513, P242, DOI 10.1016/S0014-5793(02)02321-9; Gomez I, 2006, J BIOL CHEM, V281, P34032, DOI 10.1074/jbc.M604721200; Hara H, 2003, FEBS LETT, V538, P29, DOI 10.1016/S0014-5793(03)00117-0; Hua G, 2004, J BIOL CHEM, V279, P28051, DOI 10.1074/jbc.M400237200; Hua G, 2004, INSECT BIOCHEM MOLEC, V34, P193, DOI 10.1016/j.ibmb.2003.10.006; Hua G, 2008, BIOCHEMISTRY-US, V47, P5101, DOI 10.1021/bi7023578; Jimenez-Juarez N, 2007, J BIOL CHEM, V282, P21222, DOI 10.1074/jbc.M701314200; Jurat-Fuentes JL, 2004, BIOCHEMISTRY-US, V43, P14299, DOI 10.1021/bi048500i; Jurat-Fuentes JL, 2001, APPL ENVIRON MICROB, V67, P323, DOI 10.1128/AEM.67.1.323-329.2001; Jurat-Fuentes JL, 2006, BIOCHEMISTRY-US, V45, P9688, DOI 10.1021/bi0606703; KOLLER CN, 1992, BIOCHEM BIOPH RES CO, V184, P692, DOI 10.1016/0006-291X(92)90645-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luo K, 1999, APPL ENVIRON MICROB, V65, P457; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Ochoa-Campuzano C, 2007, BIOCHEM BIOPH RES CO, V362, P437, DOI 10.1016/j.bbrc.2007.07.197; Pacheco S, 2009, PEPTIDES, V30, P583, DOI 10.1016/j.peptides.2008.08.006; Park Y, 2009, APPL ENVIRON MICROB, V75, P3086, DOI 10.1128/AEM.00268-09; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Prabhakar S, 2007, INSECT MOL BIOL, V16, P455, DOI 10.1111/j.1365-2583.2007.00740.x; Rausell C, 2007, BBA-BIOMEMBRANES, V1768, P2293, DOI 10.1016/j.bbamem.2007.06.014; Rausell C, 2004, BBA-BIOMEMBRANES, V1660, P99, DOI 10.1016/j.bbamem.2003.11.004; Rice ME., 2004, PLANT HLTH PROG, DOI [10.1094/PHP-2004-0301-01-RV, DOI 10.1094/PHP-2004-0301-01-RV]; Sayed A, 2007, INSECT MOL BIOL, V16, P591, DOI 10.1111/j.1365-2583.2007.00755.x; Soberon M, 2007, SCIENCE, V318, P1640, DOI 10.1126/science.1146453; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tsuda Y, 2003, BIOCHEM J, V369, P697, DOI 10.1042/BJ20021401; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Xie RY, 2005, J BIOL CHEM, V280, P8416, DOI 10.1074/jbc.M408403200; Xu XJ, 2008, J INVERTEBR PATHOL, V97, P27, DOI 10.1016/j.jip.2007.04.009; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; XU Z, 2009, PEST MANAG IN PRESS; Zhang X, 2005, CELL DEATH DIFFER, V12, P1407, DOI 10.1038/sj.cdd.4401675; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103	47	86	97	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18401	18410		10.1074/jbc.M109.001651	http://dx.doi.org/10.1074/jbc.M109.001651			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19416969	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000267712400052
J	Bottova, I; Hehl, AB; Stefanic, S; Fabrias, G; Casas, J; Schraner, E; Pieters, J; Sonda, S				Bottova, Iveta; Hehl, Adrian B.; Stefanic, Sasa; Fabrias, Gemma; Casas, Josefina; Schraner, Elisabeth; Pieters, Jean; Sonda, Sabrina			Host Cell P-glycoprotein Is Essential for Cholesterol Uptake and Replication of Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE; NEOSPORA-CANINUM; DENSITY-LIPOPROTEIN; ESTERIFICATION; MEMBRANE; ACCUMULATION; TRANSPORTERS; VACUOLE; SPHINGOMYELIN; SPHINGOLIPIDS	P-glycoprotein (P-gp) is a membrane-bound efflux pump that actively exports a wide range of compounds from the cell and is associated with the phenomenon of multidrug resistance. However, the role of P-gp in normal physiological processes remains elusive. Using P-gp-deficient fibroblasts, we showed that P-gp was critical for the replication of the intracellular parasite Toxoplasma gondii but was not involved in invasion of host cells by the parasite. Importantly, we found that the protein participated in the transport of host-derived cholesterol to the intracellular parasite. T. gondii replication in P-gp-deficient host cells not only resulted in reduced cholesterol content in the parasite but also altered its sphingolipid metabolism. In addition, we found that different levels of P-gp expression modified the cholesterol metabolism in uninfected fibroblasts. Collectively our findings reveal a key and previously undocumented role of P-gp in host-parasite interaction and suggest a physiological role for P-gp in cholesterol trafficking in mammalian cells.	[Bottova, Iveta; Hehl, Adrian B.; Stefanic, Sasa; Sonda, Sabrina] Univ Zurich, Inst Parasitol, CH-8057 Zurich, Switzerland; [Schraner, Elisabeth] Univ Zurich, Inst Vet Anat, CH-8057 Zurich, Switzerland; [Fabrias, Gemma; Casas, Josefina] CSIC, Inst Quim Avancada Catalunya, ES-08034 Barcelona, Spain; [Pieters, Jean] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Zurich; University of Zurich; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); University of Basel	Sonda, S (corresponding author), Univ Zurich, Inst Parasitol, Winterthurerstr 266A, CH-8057 Zurich, Switzerland.	sabrina.sonda@vetparas.uzh.ch	Casas, Josefina/L-7934-2014; Stefanic, Sasa/AAF-3063-2020	Fabrias, Gemma/0000-0001-7162-3772; Hehl, Adrian/0000-0002-2110-4445; Pieters, Jean/0000-0002-5284-9757; Stefanic, Sasa/0000-0001-7367-1831	Marie Heim-Vogtlin Foundation; Fondation Pierre Mercier pour la Science; Roche and Novartis; Bundesamt fur Bildung and Wissenschaft [C03.0007]; Swiss National Foundation	Marie Heim-Vogtlin Foundation; Fondation Pierre Mercier pour la Science; Roche and Novartis; Bundesamt fur Bildung and Wissenschaft; Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by grants from the Marie Heim-Vogtlin Foundation, Fondation Pierre Mercier pour la Science, Roche and Novartis (to S. S.), Bundesamt fur Bildung and Wissenschaft C03.0007 COST Action 857 (to A. B. H.), and the Swiss National Foundation (to J. P.).	Aleman C, 2003, CANCER RES, V63, P3084; Blackmore CG, 2001, MOL MEMBR BIOL, V18, P97, DOI 10.1080/09687680010030200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown RE, 1998, J CELL SCI, V111, P1; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; CURRIER SJ, 1992, J BIOL CHEM, V267, P25153; Debry P, 1997, J BIOL CHEM, V272, P1026, DOI 10.1074/jbc.272.2.1026; Fu D, 2007, AM J PHYSIOL-CELL PH, V292, pC1543, DOI 10.1152/ajpcell.00068.2006; Fuchs N, 1998, J PARASITOL, V84, P753, DOI 10.2307/3284583; Garrigues A, 2002, P NATL ACAD SCI USA, V99, P10347, DOI 10.1073/pnas.162366399; Gottesman MM, 1995, ANNU REV GENET, V29, P607, DOI 10.1146/annurev.ge.29.120195.003135; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hemphill A, 1996, INFECT IMMUN, V64, P4279, DOI 10.1128/IAI.64.10.4279-4287.1996; Hemphill A, 1996, PARASITOLOGY, V112, P183, DOI 10.1017/S0031182000084754; Kim H, 1997, AM J PHYSIOL-CELL PH, V273, pC687, DOI 10.1152/ajpcell.1997.273.2.C687; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; Lencer WI, 2005, BBA-MOL CELL RES, V1746, P314, DOI 10.1016/j.bbamcr.2005.07.007; Leppimaki P, 1998, BIOCHEM J, V335, P285, DOI 10.1042/bj3350285; Lerch PG, 1996, VOX SANG, V71, P155, DOI 10.1046/j.1423-0410.1996.7130155.x; Liscovitch M, 2000, TRENDS BIOCHEM SCI, V25, P530, DOI 10.1016/S0968-0004(00)01668-6; London M, 2004, J BIOL CHEM, V279, P9997, DOI 10.1074/jbc.M309992200; Loo TW, 1999, BIOCHEM CELL BIOL, V77, P11, DOI 10.1139/bcb-77-1-11; Luker GD, 1999, J BIOL CHEM, V274, P6979, DOI 10.1074/jbc.274.11.6979; Luker GD, 2001, J LIPID RES, V42, P1389; Martin AM, 2007, J EUKARYOT MICROBIOL, V54, P25, DOI 10.1111/j.1550-7408.2006.00230.x; Maubon D, 2008, TRENDS PARASITOL, V24, P299, DOI 10.1016/j.pt.2008.03.012; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; McFadden DC, 1997, ANTIMICROB AGENTS CH, V41, P1849, DOI 10.1128/AAC.41.9.1849; Monaghan P, 2003, J MICROSC-OXFORD, V212, P62, DOI 10.1046/j.1365-2818.2003.01245.x; Mordue DG, 1999, EXP PARASITOL, V92, P87, DOI 10.1006/expr.1999.4412; Munoz-Olaya JM, 2008, CHEMMEDCHEM, V3, P946, DOI 10.1002/cmdc.200700325; Orlowski S, 2006, CELL MOL LIFE SCI, V63, P1038, DOI 10.1007/s00018-005-5554-9; Ridgway ND, 2000, BBA-MOL CELL BIOL L, V1484, P129, DOI 10.1016/S1388-1981(00)00006-8; Santini MT, 2001, BBA-MOL CELL BIOL L, V1531, P111, DOI 10.1016/S1388-1981(01)00093-2; Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Sehgal A, 2005, TRAFFIC, V6, P1125, DOI 10.1111/j.1600-0854.2005.00348.x; Silverman JA, 1997, ANTIMICROB AGENTS CH, V41, P1859, DOI 10.1128/AAC.41.9.1859; Sonda S, 2001, J BIOL CHEM, V276, P34434, DOI 10.1074/jbc.M105025200; Underwood KW, 1996, J LIPID RES, V37, P1556; van Veen HW, 1998, BBA-BIOENERGETICS, V1365, P31, DOI 10.1016/S0005-2728(98)00039-5; WARNER GJ, 1995, J BIOL CHEM, V270, P5772, DOI 10.1074/jbc.270.11.5772; Wijnholds J, 2000, J CLIN INVEST, V105, P279, DOI 10.1172/JCI8267; Wild P, 2001, MICROSC RES TECHNIQ, V53, P313, DOI 10.1002/jemt.1098; Zhang M, 2001, J BIOL CHEM, V276, P3417, DOI 10.1074/jbc.M005393200	46	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17438	17448		10.1074/jbc.M809420200	http://dx.doi.org/10.1074/jbc.M809420200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19389707	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000267202500010
J	Karytinos, A; Forneris, F; Profumo, A; Ciossani, G; Battaglioli, E; Binda, C; Mattevi, A				Karytinos, Aristotele; Forneris, Federico; Profumo, Antonella; Ciossani, Giuseppe; Battaglioli, Elena; Binda, Claudia; Mattevi, Andrea			A Novel Mammalian Flavin-dependent Histone Demethylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOAMINE-OXIDASE; CHROMATIN MODIFICATIONS; MODIFYING ENZYMES; STRUCTURAL BASIS; LSD1; MECHANISM; RECOGNITION; DOMAIN; COREST; CODE	Methylation of Lys residues on histone proteins is a well known and extensively characterized epigenetic mark. The recent discovery of lysine-specific demethylase 1 (LSD1) demonstrated that lysine methylation can be dynamically controlled. Among the histone demethylases so far identified, LSD1 has the unique feature of functioning through a flavin-dependent amine oxidation reaction. Data base analysis reveals that mammalian genomes contain a gene (AOF1, for amine-oxidase flavin-containing domain 1) that is homologous to the LSD1-coding gene. Here, we demonstrate that the protein encoded by AOF1 represents a second mammalian flavin-dependent histone demethylase, named LSD2. The new demethylase is strictly specific for mono-and dimethylated Lys(4) of histone H3, recognizes a long stretch of the H3 N-terminal tail, senses the presence of additional epigenetic marks on the histone substrate, and is covalently inhibited by tranylcypromine. As opposed to LSD1, LSD2 does not form a biochemically stable complex with the C-terminal domain of the corepressor protein CoREST. Furthermore, LSD2 contains a CW-type zinc finger motif with potential zinc-binding sites that are not present in LSD1. We conclude that mammalian LSD2 represents a new flavin-dependent H3-Lys(4) demethylase that features substrate specificity properties highly similar to those of LSD1 but is very likely to be part of chromatin-remodeling complexes that are distinct from those involving LSD1.	[Karytinos, Aristotele; Forneris, Federico; Ciossani, Giuseppe; Binda, Claudia; Mattevi, Andrea] Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; [Profumo, Antonella] Univ Pavia, Dipartimento Chim Gen, I-27100 Pavia, Italy; [Battaglioli, Elena] Univ Milan, Dipartimento Biol & Genet Sci Med, I-20133 Milan, Italy	University of Pavia; University of Pavia; University of Milan	Binda, C (corresponding author), Univ Pavia, Dipartimento Genet & Microbiol, Via Ferrata 1, I-27100 Pavia, Italy.	binda@ipvgen.unipv.it; mattevi@ipvgen.unipv.it	battaglioli, elena/H-9350-2017; Forneris, Federico/B-1145-2011; Forneris, Federico/AAL-5361-2020; mattevi, andrea/K-5464-2012; Mattevi, Andrea/R-4469-2019	Forneris, Federico/0000-0002-7818-1804; Forneris, Federico/0000-0002-7818-1804; mattevi, andrea/0000-0002-9523-7128; Mattevi, Andrea/0000-0002-9523-7128; Ciossani, Giuseppe/0000-0001-5293-4292; Binda, Claudia/0000-0003-2038-9845; Battaglioli, Elena/0000-0001-9168-7212	Italian Ministry of Science; FIRB programs; Fondazione Cariplo; Italian Association for Cancer Research	Italian Ministry of Science(Ministry of Education, Universities and Research (MIUR)); FIRB programs; Fondazione Cariplo(Fondazione Cariplo); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Italian Ministry of Science PRIN06 and FIRB programs, Fondazione Cariplo, and the Italian Association for Cancer Research.	Aliverti A, 1999, METH MOL B, V131, P9; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Anand R, 2007, J BIOL CHEM, V282, P35425, DOI 10.1074/jbc.R700027200; Binda C, 2002, J BIOL CHEM, V277, P23973, DOI 10.1074/jbc.R200005200; Binda C, 2003, P NATL ACAD SCI USA, V100, P9750, DOI 10.1073/pnas.1633804100; Da GP, 2006, P NATL ACAD SCI USA, V103, P2057, DOI 10.1073/pnas.0510949103; Edmondson DE, 2004, CURR MED CHEM, V11, P1983, DOI 10.2174/0929867043364784; Forneris F, 2005, FEBS LETT, V579, P2203, DOI 10.1016/j.febslet.2005.03.015; Forneris F, 2005, J BIOL CHEM, V280, P41360, DOI 10.1074/jbc.M509549200; Forneris F, 2008, TRENDS BIOCHEM SCI, V33, P181, DOI 10.1016/j.tibs.2008.01.003; Forneris F, 2007, J BIOL CHEM, V282, P20070, DOI 10.1074/jbc.C700100200; Forneris F, 2006, J BIOL CHEM, V281, P35289, DOI 10.1074/jbc.M607411200; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lall S, 2007, NAT STRUCT MOL BIOL, V14, P1110, DOI 10.1038/nsmb1107-1110; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lizcano JM, 2000, ANAL BIOCHEM, V286, P75, DOI 10.1006/abio.2000.4782; Marmorstein R, 2009, BBA-GENE REGUL MECH, V1789, P58, DOI 10.1016/j.bbagrm.2008.07.009; Mimasu S, 2008, BIOCHEM BIOPH RES CO, V366, P15, DOI 10.1016/j.bbrc.2007.11.066; Perry J, 2003, TRENDS BIOCHEM SCI, V28, P576, DOI 10.1016/j.tibs.2003.09.007; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Schmidt DMZ, 2007, BIOCHEMISTRY-US, V46, P4408, DOI 10.1021/bi0618621; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Smith BC, 2009, BBA-GENE REGUL MECH, V1789, P45, DOI 10.1016/j.bbagrm.2008.06.005; SMITH TA, 1988, PROGR POLYAMINE RES; Yang MJ, 2006, MOL CELL, V23, P377, DOI 10.1016/j.molcel.2006.07.012; Zhou XF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-294; Zlatanova J, 2009, STRUCTURE, V17, P160, DOI 10.1016/j.str.2008.12.016	34	193	229	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17775	17782		10.1074/jbc.M109.003087	http://dx.doi.org/10.1074/jbc.M109.003087			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19407342	Green Published, hybrid			2022-12-25	WOS:000267202500043
J	Wu, JB; Chen, K; Ou, XM; Shih, JC				Wu, Jason B.; Chen, Kevin; Ou, Xiao-Ming; Shih, Jean C.			Retinoic Acid Activates Monoamine Oxidase B Promoter in Human Neuronal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGE-RELATED-CHANGES; MAO ACTIVITY; TRANSCRIPTION FACTORS; NUCLEAR RECEPTORS; RESPONSE-ELEMENT; GENE-EXPRESSION; RAT-BRAIN; SP1; DIFFERENTIATION; LOCALIZATION	Monoamine oxidase (MAO) B deaminates a number of biogenic and dietary amines and plays an important role in many biological processes. Among hormonal regulations of MAO B, we have recently found that retinoic acid (RA) significantly activates both MAOB promoter activity and mRNA expression in a human neuroblastoma BE(2) C cell line. RA activates MAO B promoter in both concentration- and time-dependent manners, which is mediated through retinoic acid receptor alpha (RAR alpha) and retinoid X receptor alpha (RXR alpha). There are four retinoic acid response elements (RAREs) as identified in the MAO B 2-kb promoter, and mutation of the third RARE reduced RA-induced MAO B promoter activation by 50%, suggesting this element is important. Electrophoretic mobility shift analysis and chromatin immunoprecipitation assay demonstrated that RAR alpha specifically binds to the third RARE both in vitro and in vivo. Moreover, transient transfection and luciferase assays revealed that Sp1 enhances but not essentially required for the RA activation of MAO B through two clusters of Sp1-binding sites in the MAO B promoter. RAR alpha physically interacts with Sp1 via zinc finger domains in Sp1 as determined by co-immunoprecipitation assay. Further, RAR alpha was shown to be recruited by Sp1 and to form a transcriptional regulation complex with Sp1 in the Sp1-binding sites of natural MAO B promoter. Taken together, this study provides evidence for the first time showing the stimulating effect of RA on MAO B and new insight into the molecular mechanisms of MAO B regulation by hormones.	[Shih, Jean C.] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Shih, Jean C.] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA; [Ou, Xiao-Ming] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 USA	University of Southern California; University of Southern California; University of Mississippi; University of Mississippi Medical Center	Shih, JC (corresponding author), Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, PSC 518,1985 Zonal Ave, Los Angeles, CA 90089 USA.	jcshih@usc.edu	Chen, Kevin/GYU-8963-2022; Wu, Jason Boyang/I-5780-2013		National Institute of Mental Health [R0 1MH67968, R01 MH39085]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH039085, R01MH067968] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institute of Mental Health Grants R0 1MH67968 and R01 MH39085. This work was also supported by the Boyd and Elsie Welin Professorship.	Altucci L, 2001, TRENDS ENDOCRIN MET, V12, P460, DOI 10.1016/S1043-2760(01)00502-1; ARAI Y, 1988, J NEURAL TRANSM, V72, P99, DOI 10.1007/BF01250233; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Cao XH, 2004, MOL CELL BIOL, V24, P9705, DOI 10.1128/MCB.24.22.9705-9725.2004; Cheng YH, 2008, J CLIN ENDOCR METAB, V93, P1915, DOI 10.1210/jc.2007-1536; DEKLOET ER, 1990, J STEROID BIOCHEM, V37, P387, DOI 10.1016/0960-0760(90)90489-8; DESAIYAJNIK V, 1993, MOL CELL BIOL, V13, P5057, DOI 10.1128/MCB.13.8.5057; DEVOR EJ, 1993, AM J MED GENET, V48, P209, DOI 10.1002/ajmg.1320480407; Ekici M, 2008, J BIOL CHEM, V283, P9257, DOI 10.1074/jbc.M709388200; FARAJ BA, 1994, ALCOHOL CLIN EXP RES, V18, P1114, DOI 10.1111/j.1530-0277.1994.tb00090.x; Fazi F, 2005, ONCOGENE, V24, P1820, DOI 10.1038/sj.onc.1208286; FOWLER CJ, 1980, J NEURAL TRANSM, V49, P1, DOI 10.1007/BF01249185; Hao H, 2003, BLOOD, V101, P4551, DOI 10.1182/blood-2002-10-3174; HOLSCHNEIDER DP, 1998, PSYCHOPHARMOCOLOGY 4; Hong JS, 2008, BIOCHEM J, V410, P49, DOI 10.1042/BJ20070904; HUGGENVIK JI, 1993, MOL ENDOCRINOL, V7, P543, DOI 10.1210/me.7.4.543; Husmann M, 2000, BIOCHEM J, V352, P763, DOI 10.1042/0264-6021:3520763; Jahng JW, 1997, SYNAPSE, V25, P30; Jiang HB, 2006, J BIOL CHEM, V281, P8591, DOI 10.1074/jbc.M510926200; JOHNSTON JP, 1968, BIOCHEM PHARMACOL, V17, P1285, DOI 10.1016/0006-2952(68)90066-X; Jungert K, 2007, CANCER RES, V67, P1563, DOI 10.1158/0008-5472.CAN-06-1670; Knoll J, 1972, Adv Biochem Psychopharmacol, V5, P393; LEW AM, 1994, J BIOL CHEM, V269, P12007; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luque JM, 1995, J COMP NEUROL, V363, P665, DOI 10.1002/cne.903630410; Nicotra A, 2002, CELL BIOCHEM FUNCT, V20, P87, DOI 10.1002/cbf.955; Oreland L., 1993, MONOAMINE OXIDASE BA, P219; Ou XM, 2004, J BIOL CHEM, V279, P21021, DOI 10.1074/jbc.M312638200; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; Prochazka H, 2003, WORLD J BIOL PSYCHIA, V4, P35, DOI 10.3109/15622970309167909; Ren MQ, 2005, MOL CELL BIOL, V25, P10591, DOI 10.1128/MCB.25.23.10591-10603.2005; RIEDERER P, 1983, ACTA NEUROL SCAND, V68, P43, DOI 10.1111/j.1600-0404.1983.tb01516.x; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; Rotheneder H, 1999, J MOL BIOL, V293, P1005, DOI 10.1006/jmbi.1999.3213; Salahpour A, 2007, BIOL PSYCHIAT, V61, P65, DOI 10.1016/j.biopsych.2006.03.020; SAURA J, 1994, J NEURAL TRANSM-SUPP, P89; SAURA J, 1994, NEUROBIOL AGING, V15, P399, DOI 10.1016/0197-4580(94)90071-X; SCHNEIDER G, 1981, ARCH PSYCHIAT NERVEN, V230, P5, DOI 10.1007/BF00343762; SHIH JC, 1991, NEUROPSYCHOPHARMACOL, V4, P1; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; Subramaniam N, 2003, BIOCHEM J, V370, P1087, DOI 10.1042/BJ20020471; Suzuki Y, 1999, BLOOD, V93, P4264, DOI 10.1182/blood.V93.12.4264.412k27_4264_4276; Van der Burg B, 1999, INT J DEV BIOL, V43, P735; van Wageningen S, 2008, BLOOD, V111, P1634, DOI 10.1182/blood-2007-04-081125; VANSANT G, 1995, P NATL ACAD SCI USA, V92, P8229, DOI 10.1073/pnas.92.18.8229; WESTLUND KN, 1988, NEUROSCIENCE, V25, P439, DOI 10.1016/0306-4522(88)90250-3; WILLOUGHBY J, 1988, J NEURAL TRANSM, V74, P29, DOI 10.1007/BF01243573; Wong WK, 2003, J BIOL CHEM, V278, P36227, DOI 10.1074/jbc.M305549200; Wong WK, 2002, J BIOL CHEM, V277, P22222, DOI 10.1074/jbc.M202844200; Wong WK, 2001, MOL PHARMACOL, V59, P852, DOI 10.1124/mol.59.4.852; Yen A, 1998, CANCER RES, V58, P3163; Zhang ZP, 2006, MOL ENDOCRINOL, V20, P1547, DOI 10.1210/me.2005-0252; ZHU QS, 1992, J NEUROSCI, V12, P4437	54	30	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16723	16735		10.1074/jbc.M901779200	http://dx.doi.org/10.1074/jbc.M901779200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19401466	hybrid, Green Published			2022-12-25	WOS:000266962400007
J	Neuhaus, EM; Zhang, WY; Gelis, L; Deng, Y; Noldus, J; Hatt, H				Neuhaus, Eva M.; Zhang, Weiyi; Gelis, Lian; Deng, Ying; Noldus, Joachim; Hatt, Hanns			Activation of an Olfactory Receptor Inhibits Proliferation of Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; MULTIGENE FAMILY; GENE FAMILY; EXPRESSION; ANDROGEN; PSGR; TESTOSTERONE; PROGRESSION; MICROARRAY; MOUSE	Olfactory receptors (ORs) are expressed not only in the sensory neurons of the olfactory epithelium, where they detect volatile substances, but also in various other tissues where their potential functions are largely unknown. Here, we report the physiological characterization of human OR51E2, also named prostate-specific G-protein-coupled receptor (PSGR) due to its reported up-regulation in prostate cancer. We identified androstenone derivatives as ligands for the recombinant receptor. PSGR can also be activated with the odorant beta-ionone. Activation of the endogenous receptor in prostate cancer cells by the identified ligands evoked an intracellular Ca2+ increase. Exposure to beta-ionone resulted in the activation of members of the MAPK family and inhibition of cell proliferation. Our data give support to the hypothesis that because PSGR signaling could reduce growth of prostate cancer cells, specific receptor ligands might therefore be potential candidates for prostate cancer treatment.	[Neuhaus, Eva M.; Zhang, Weiyi; Gelis, Lian; Deng, Ying; Hatt, Hanns] Ruhr Univ Bochum, Dept Cell Physiol, D-44780 Bochum, Germany; [Noldus, Joachim] Ruhr Univ Bochum, Marienhosp Herne, Dept Urol, D-44627 Herne, Germany	Ruhr University Bochum; Ruhr University Bochum; St. Marien Hospital	Neuhaus, EM (corresponding author), Ruhr Univ Bochum, Dept Cell Physiol, Univ Str 150, D-44780 Bochum, Germany.	eva.neuhaus@rub.de	Neuhaus, Eva M./L-1428-2015	Neuhaus, Eva M./0000-0003-3363-1231	Deutsche Forschungsgemeinschaft [SFB642]; Max-Planck-Research School for Chemical Biology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck-Research School for Chemical Biology	This study was supported by Grant SFB642 from the Deutsche Forschungsgemeinschaft (to E. M. N. and H. H.) and a grant from the Max-Planck-Research School for Chemical Biology.	Ben-Josef E, 1999, J UROLOGY, V161, P970, DOI 10.1016/S0022-5347(01)61831-7; Braun T, 2007, GASTROENTEROLOGY, V132, P1890, DOI 10.1053/j.gastro.2007.02.036; BRODIE AMH, 1983, J STEROID BIOCHEM, V19, P53, DOI 10.1016/S0022-4731(83)80006-5; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck L B, 1992, Curr Opin Neurobiol, V2, P282, DOI 10.1016/0959-4388(92)90116-3; Chay CH, 2002, UROLOGY, V60, P760, DOI 10.1016/S0090-4295(02)01969-6; Cooper CR, 2003, CANCER-AM CANCER SOC, V97, P739, DOI 10.1002/cncr.11181; Dai J, 2002, CLIN CANCER RES, V8, P2399; DANZO BJ, 1991, ENDOCRINOLOGY, V129, P690, DOI 10.1210/endo-129-2-690; Duncan RE, 2004, BIOCHEM PHARMACOL, V68, P1739, DOI 10.1016/j.bcp.2004.06.022; Elson CE, 1999, P SOC EXP BIOL MED, V221, P294, DOI 10.1046/j.1525-1373.1999.d01-87.x; Falkenstein E, 2000, J CLIN ENDOCR METAB, V85, P2072, DOI 10.1210/jc.85.5.2072; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Firestein Stuart, 2004, Sci STKE, V2004, ppe15; Fukuda N, 2004, J CELL SCI, V117, P5835, DOI 10.1242/jcs.01507; Godara G, 2005, PROSTATE, V65, P27, DOI 10.1002/pros.20252; HALVORSON M, 1990, ARCH BIOCHEM BIOPHYS, V277, P166, DOI 10.1016/0003-9861(90)90566-H; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Lee LF, 2001, MOL CELL BIOL, V21, P8385, DOI 10.1128/MCB.21.24.8385-8397.2001; Long RM, 2005, CLIN SCI, V108, P1, DOI 10.1042/CS20040241; Losel RM, 2003, PHYSIOL REV, V83, P965, DOI 10.1152/physrev.00003.2003; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Mo HB, 1999, J NUTR, V129, P804, DOI 10.1093/jn/129.4.804; NAGATA K, 1986, DRUG METAB DISPOS, V14, P559; Neuhaus EM, 2006, CHEM SENSES, V31, P445, DOI 10.1093/chemse/bjj049; Sacchettini JC, 1997, SCIENCE, V277, P1788, DOI 10.1126/science.277.5333.1788; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Taub JS, 2003, CANCER RES, V63, P2037; Vanderhaeghen P, 1997, GENOMICS, V39, P239, DOI 10.1006/geno.1996.4490; Wang JH, 2006, PROSTATE, V66, P847, DOI 10.1002/pros.20389; Weng JS, 2005, INT J CANCER, V113, P811, DOI 10.1002/ijc.20635; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Xu LL, 2000, CANCER RES, V60, P6568; Xu LL, 2006, PROSTATE CANCER P D, V9, P56, DOI 10.1038/sj.pcan.4500836; Yuan TTT, 2001, GENE, V278, P41, DOI 10.1016/S0378-1119(01)00709-0; Zhang XH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r86; Zhang XM, 2004, P NATL ACAD SCI USA, V101, P14168, DOI 10.1073/pnas.0405350101	37	170	177	5	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16218	16225		10.1074/jbc.M109.012096	http://dx.doi.org/10.1074/jbc.M109.012096			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19389702	Green Published, hybrid			2022-12-25	WOS:000266730900019
J	Pino, SC; O'Sullivan-Murphy, B; Lidstone, EA; Yang, C; Lipson, KL; Jurczyk, A; Dilorio, P; Brehm, MA; Mordes, JP; Greiner, DL; Rossini, AA; Bortell, R				Pino, Steven C.; O'Sullivan-Murphy, Bryan; Lidstone, Erich A.; Yang, Chaoxing; Lipson, Kathryn L.; Jurczyk, Agata; Dilorio, Philip; Brehm, Michael A.; Mordes, John P.; Greiner, Dale L.; Rossini, Aldo A.; Bortell, Rita			CHOP Mediates Endoplasmic Reticulum Stress-Induced Apoptosis in Gimap5-Deficient T Cells	PLOS ONE			English	Article								Gimap5 (GTPase of the immunity-associated protein 5) has been linked to the regulation of T cell survival, and polymorphisms in the human GIMAP5 gene associate with autoimmune disorders. The BioBreeding diabetes-prone (BBDP) rat has a mutation in the Gimap5 gene that leads to spontaneous apoptosis of peripheral T cells by an unknown mechanism. Because Gimap5 localizes to the endoplasmic reticulum (ER), we hypothesized that absence of functional Gimap5 protein initiates T cell death through disruptions in ER homeostasis. We observed increases in ER stress-associated chaperones in T cells but not thymocytes or B cells from Gimap5(-/-) BBDP rats. We then discovered that ER stress-induced apoptotic signaling through C/EBP-homologous protein (CHOP) occurs in Gimap5(-/-) T cells. Knockdown of CHOP by siRNA protected Gimap5(-/-) T cells from ER stress-induced apoptosis, thereby identifying a role for this cellular pathway in the T cell lymphopenia of the BBDP rat. These findings indicate a direct relationship between Gimap5 and the maintenance of ER homeostasis in the survival of T cells.			Pino, SC (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA.	rita.bortell@umassmed.edu		Brehm, Michael/0000-0001-6813-3262; O'Sullivan-Murphy, Bryan/0000-0002-1426-5013	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK025306, P30DK032520, R01DK025306, R01DK066447, R01DK049106] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK049106, R01 DK025306, DK32520,, P30 DK032520, DK066447, R01 DK066447, DK49106, DK25306] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Araki E, 2003, EXP BIOL MED, V228, P1213, DOI 10.1177/153537020322801018; Blankenhorn EP, 2005, DIABETES, V54, P1233, DOI 10.2337/diabetes.54.4.1233; Borgese N, 2006, CURR OPIN CELL BIOL, V18, P358, DOI 10.1016/j.ceb.2006.06.008; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Daheron L, 2001, NUCLEIC ACIDS RES, V29, P1308, DOI 10.1093/nar/29.6.1308; Dalberg U, 2007, INT IMMUNOL, V19, P447, DOI 10.1093/intimm/dxm009; Faitova J, 2006, CELL MOL BIOL LETT, V11, P488, DOI 10.2478/s11658-006-0040-4; Gallegos AM, 2006, IMMUNOL REV, V209, P290, DOI 10.1111/j.0105-2896.2006.00348.x; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hellquist A, 2007, J MED GENET, V44, P314, DOI 10.1136/jmg.2006.046185; Hornum L, 2002, DIABETES, V51, P1972, DOI 10.2337/diabetes.51.6.1972; Iwakoshi NN, 1998, J IMMUNOL, V160, P5838; Jung CC, 1999, IMMUNOLOGY, V98, P590, DOI 10.1046/j.1365-2567.1999.00907.x; KAABA SA, 1995, IMMUNOL LETT, V47, P209, DOI 10.1016/0165-2478(95)00088-5; Kaneko M, 2003, LIFE SCI, V74, P199, DOI 10.1016/j.lfs.2003.09.007; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Keita M, 2007, BIOCHEM BIOPH RES CO, V361, P481, DOI 10.1016/j.bbrc.2007.07.048; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Krucken J, 2004, GENE, V341, P291, DOI 10.1016/j.gene.2004.07.005; Lang JA, 2004, EUR J IMMUNOL, V34, P2396, DOI 10.1002/eji.200324751; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; MacMurray AJ, 2002, GENOME RES, V12, P1029, DOI 10.1101/gr.412702; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; Michalkiewicz M, 2004, PHYSIOL GENOMICS, V19, P228, DOI 10.1152/physiolgenomics.00126.2004; Mordes JP, 2004, ILAR J, V45, P278, DOI 10.1093/ilar.45.3.278; Mordes JP, 2002, DIABETES, V51, P3254, DOI 10.2337/diabetes.51.11.3254; MORDES JP, 2009, MAMM GENOME IN PRESS; Nakanishi K, 2005, J CELL BIOL, V169, P555, DOI 10.1083/jcb.200412024; Nitta T, 2006, PLOS BIOL, V4, P593, DOI 10.1371/journal.pbio.0040103; Nitta T, 2007, TRENDS IMMUNOL, V28, P58, DOI 10.1016/j.it.2006.12.002; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Pandarpurkar M, 2003, P NATL ACAD SCI USA, V100, P10382, DOI 10.1073/pnas.1832170100; Pino SC, 2008, CELL STRESS CHAPERON, V13, P421, DOI 10.1007/s12192-008-0038-0; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Ramanathan S, 1998, J IMMUNOL, V160, P5757; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Rigby MR, 1996, DIABETES, V45, P1419, DOI 10.2337/diabetes.45.10.1419; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Rossini AA, 2004, DIABETES, V53, P267, DOI 10.2337/diabetes.53.2.267; Sandal T, 2003, MOL BIOL CELL, V14, P3292, DOI 10.1091/mbc.e02-10-0700; Sato N, 2000, NAT CELL BIOL, V2, P863, DOI 10.1038/35046500; Scheu S, 2006, NAT IMMUNOL, V7, P644, DOI 10.1038/ni1338; Schnell S, 2006, BLOOD, V108, P591, DOI 10.1182/blood-2005-11-4616; Schulteis RD, 2008, BLOOD, V112, P4905, DOI 10.1182/blood-2008-03-146555; Shin JH, 2007, GENES IMMUN, V8, P503, DOI 10.1038/sj.gene.6364413; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Willerford DM, 1996, CURR OPIN GENET DEV, V6, P603, DOI 10.1016/S0959-437X(96)80090-6; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200	52	42	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5468	10.1371/journal.pone.0005468	http://dx.doi.org/10.1371/journal.pone.0005468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424493	Green Published, Green Submitted, gold			2022-12-25	WOS:000265933800005
J	Schley, D; Gubbins, S; Paton, DJ				Schley, David; Gubbins, Simon; Paton, David J.			Quantifying the Risk of Localised Animal Movement Bans for Foot-and-Mouth Disease	PLOS ONE			English	Article							VACCINATION STRATEGIES; UK FOOT; EPIDEMIOLOGY; OUTBREAK; SPREAD	The maintenance of disease-free status from Foot-and-Mouth Disease is of significant socio-economic importance to countries such as the UK. The imposition of bans on the movement of susceptible livestock following the discovery of an outbreak is deemed necessary to prevent the spread of what is a highly contagious disease, but has a significant economic impact on the agricultural community in itself. Here we consider the risk of applying movement restrictions only in localised zones around outbreaks in order to help evaluate how quickly nation-wide restrictions could be lifted after notification. We show, with reference to the 2001 and 2007 UK outbreaks, that it would be practical to implement such a policy provided the basic reproduction ratio of known infected premises can be estimated. It is ultimately up to policy makers and stakeholders to determine the acceptable level of risk, involving a cost benefit analysis of the potential outcomes, but quantifying the risk of spread from different sized zones is a prerequisite for this. The approach outlined is relevant to the determination of control zones and vaccination policies and has the potential to be applied to future outbreaks of other diseases.			Schley, D (corresponding author), Inst Anim Hlth, Pirbright Lab, Surrey, England.	David.Schley@bbsrc.ac.uk		Gubbins, Simon/0000-0003-0538-4173	BBSRC [BBS/E/I/00001320] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [IAH1320, BBS/E/I/00001320] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; Anderson I., 2002, FOOT MOUTH DIS 2001; Anderson I., 2008, FOOT MOUTH DIS 2007; BANKOWSKI BM, 2006, UNDERSTANDING FMDV T; Barnett PV, 1999, VET J, V158, P6, DOI 10.1053/tvjl.1998.0338; Cottam EM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000050; *DEFR, 2007, BLUET DIS CONT PLANS; *DEFR, 2007, REC FMD FREE STAT UK; *DEFR, 2007, FMD EP REP EV 30 SEP; DONALDSON AI, 1982, VET REC, V110, P53, DOI 10.1136/vr.110.3.53; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Haydon DT, 2004, NAT REV MICROBIOL, V2, P675, DOI 10.1038/nrmicro960; Kao RR, 2001, VET REC, V148, P746, DOI 10.1136/vr.148.24.746; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Kitching RP, 2007, NATURE, V445, pE12, DOI 10.1038/nature05604; Risk Solutions, 2005, FMD CBA EP MOD SPEC; SPRATT B, 2007, CONTRIBUTION FOOT AN; Ster IC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000502; Tildesley MJ, 2006, NATURE, V440, P83, DOI 10.1038/nature04324; Wingfield A, 2006, VET REC, V158, P706, DOI 10.1136/vr.158.20.706-a; Woolhouse M, 2001, NATURE, V411, P258, DOI 10.1038/35077149; 2003, OFF J EUR UNION L, V306	22	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5481	10.1371/journal.pone.0005481	http://dx.doi.org/10.1371/journal.pone.0005481			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424494	Green Published, gold, Green Submitted			2022-12-25	WOS:000265933800013
J	Melchers, A; Stockl, L; Radszewski, J; Anders, M; Krenzlin, H; Kalischke, C; Scholz, R; Jordan, A; Nebrich, G; Klose, J; Sperling, K; Digweed, M; Demuth, I				Melchers, Anna; Stoeckl, Lars; Radszewski, Janina; Anders, Marco; Krenzlin, Harald; Kalischke, Candy; Scholz, Regina; Jordan, Andreas; Nebrich, Grit; Klose, Joachim; Sperling, Karl; Digweed, Martin; Demuth, Ilja			A Systematic Proteomic Study of Irradiated DNA Repair Deficient Nbn-Mice	PLOS ONE			English	Article								The Background: NBN gene codes for the protein nibrin, which is involved in the detection and repair of DNA double strand breaks (DSBs). The NBN gene is essential in mammals. Methodology/Principal Findings: We have used a conditional null mutant mouse model in a proteomics approach to identify proteins with modified expression levels after 4 Gy ionizing irradiation in the absence of nibrin in vivo. Altogether, amongst,8,000 resolved proteins, 209 were differentially expressed in homozygous null mutant mice in comparison to control animals. One group of proteins significantly altered in null mutant mice were those involved in oxidative stress and cellular redox homeostasis (p<0.0001). In substantiation of this finding, analysis of Nbn null mutant fibroblasts indicated an increased production of reactive oxygen species following induction of DSBs. Conclusions/Significance: In humans, biallelic hypomorphic mutations in NBN lead to Nijmegen breakage syndrome (NBS), an autosomal recessive genetic disease characterised by extreme radiosensitivity coupled with growth retardation, immunoinsufficiency and a very high risk of malignancy. This particularly high cancer risk in NBS may be attributable to the compound effect of a DSB repair defect and oxidative stress.			Melchers, A (corresponding author), Charite Univ Med Berlin, Inst Humangenet, Ctr Biomed Nanotechnol, Campus Virchow Klinikum, D-13353 Berlin, Germany.	ilja.demuth@charite.de	Krenzlin, Harald/AAM-5444-2020; Krenzlin, Harald/AAS-7602-2020; Demuth, Ilja/ABD-5352-2021	Demuth, Ilja/0000-0002-4340-2523				Adema AD, 2003, INT J RADIAT BIOL, V79, P655, DOI 10.1080/09553000310001596968; ANTONOV AV, 2008, NUCL ACIDS RES; Barzilai A, 2002, DNA REPAIR, V1, P3, DOI 10.1016/S1568-7864(01)00007-6; Barzilai A, 2007, ANTIOXID REDOX SIGN, V9, P211, DOI 10.1089/ars.2007.9.211; Bertram C, 2008, BIOL CHEM, V389, P211, DOI 10.1515/BC.2008.031; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; CARTER SG, 1982, BIOCHEMISTRY-US, V21, P5475, DOI 10.1021/bi00265a015; CEDERVALL B, 1995, RADIAT RES, V143, P8, DOI 10.2307/3578920; Cerosaletti K, 2006, MOL CELL BIOL, V26, P1691, DOI 10.1128/MCB.26.5.1691-1699.2006; Cloos J, 1996, CARCINOGENESIS, V17, P327, DOI 10.1093/carcin/17.2.327; Demuth I, 2007, ONCOGENE, V26, P7792, DOI 10.1038/sj.onc.1210876; Demuth I, 2004, HUM MOL GENET, V13, P2385, DOI 10.1093/hmg/ddh278; Demuth I, 2008, DNA REPAIR, V7, P1192, DOI 10.1016/j.dnarep.2008.03.020; Dikomey E, 1998, INT J RADIAT BIOL, V73, P269, DOI 10.1080/095530098142365; Dumon-Jones V, 2003, CANCER RES, V63, P7263; Frappart PO, 2005, NAT MED, V11, P538, DOI 10.1038/nm1228; Gallagher BM, 2007, FREE RADICAL BIO MED, V42, P1270, DOI 10.1016/j.freeradbiomed.2007.01.023; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Hecht SM, 2000, J NAT PROD, V63, P158, DOI 10.1021/np990549f; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; JANSSEN YMW, 1993, LAB INVEST, V69, P261; Kasten-Pisula U, 2005, INT J RADIAT BIOL, V81, P409, DOI 10.1080/09553000500140498; Kirsch M, 2001, FASEB J, V15, P1569, DOI 10.1096/fj.00-0823hyp; Klose J, 2002, NAT GENET, V30, P385, DOI 10.1038/ng861; Kraakman-van der Zwet M, 1999, MUTAT RES-DNA REPAIR, V434, P17, DOI 10.1016/S0921-8777(99)00009-9; Kracker S, 2005, P NATL ACAD SCI USA, V102, P1584, DOI 10.1073/pnas.0409191102; Kruger L, 2007, CARCINOGENESIS, V28, P107, DOI 10.1093/carcin/bgl126; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Liu J, 2007, FEBS LETT, V581, P5043, DOI 10.1016/j.febslet.2007.09.042; Liu SX, 2001, P NATL ACAD SCI USA, V98, P1643, DOI 10.1073/pnas.031482998; Manevich Y, 2005, FREE RADICAL BIO MED, V38, P1422, DOI 10.1016/j.freeradbiomed.2005.02.011; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; Mattow J, 2006, ELECTROPHORESIS, V27, P1683, DOI 10.1002/elps.200500703; Mukherjee SK, 1997, EUR J PHARMACOL, V330, P27, DOI 10.1016/S0014-2999(97)00171-4; Nebrich G, 2007, ELECTROPHORESIS, V28, P1607, DOI 10.1002/elps.200600656; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Park EC, 2006, PREP BIOCHEM BIOTECH, V36, P19, DOI 10.1080/10826060500388470; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Reichenbach J, 1999, CLIN EXP IMMUNOL, V117, P535; Sullivan KE, 1997, CLIN IMMUNOL IMMUNOP, V82, P43, DOI 10.1006/clin.1996.4275; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Vanlangenakker N, 2008, CURR MOL MED, V8, P207, DOI 10.2174/156652408784221306; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Yang YG, 2006, EMBO J, V25, P5527, DOI 10.1038/sj.emboj.7601411; YI M, 1990, CANCER LETT, V54, P43, DOI 10.1016/0304-3835(90)90089-G; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	48	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5423	10.1371/journal.pone.0005423	http://dx.doi.org/10.1371/journal.pone.0005423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440GG	19412544	Green Published, gold, Green Submitted			2022-12-25	WOS:000265688200010
J	Esteban, V; Heringer-Walther, S; Sterner-Kock, A; de Bruin, R; van den Engel, S; Wang, Y; Mezzano, S; Egido, J; Schultheiss, HP; Ruiz-Ortega, M; Walther, T				Esteban, Vanesa; Heringer-Walther, Silvia; Sterner-Kock, Anja; de Bruin, Ron; van den Engel, Sandra; Wang, Yong; Mezzano, Sergio; Egido, Jesus; Schultheiss, Heinz-Peter; Ruiz-Ortega, Marta; Walther, Thomas			Angiotensin-(1-7) and the G Protein-Coupled Receptor Mas Are Key Players in Renal Inflammation	PLOS ONE			English	Article							HEMATOPOIETIC RECOVERY; MICE LACKING; KIDNEY; NEPHROPATHY; ACTIVATION; EXPRESSION; CHEMOKINES; BLOCKADE; FIBROSIS; SYSTEM	Angiotensin (Ang) II mediates pathophysiologial changes in the kidney. Ang-(1-7) by interacting with the G protein-coupled receptor Mas may also have important biological activities. In this study, renal deficiency for Mas diminished renal damage in models of renal insufficiency as unilateral ureteral obstruction and ischemia/reperfusion injury while the infusion of Ang-(1-7) to wild-type mice pronounced the pathological outcome by aggravating the inflammatory response. Mas deficiency inhibited NF-kappa B activation and thus the elevation of inflammation-stimulating cytokines, while Ang-(1-7) infusion had proinflammatory properties in experimental models of renal failure as well as under basal conditions. The Ang-(1-7)-mediated NF-kappa B activation was Mas dependent but did not involve Ang II receptors. Therefore, the blockade of the NF-kappa B-activating properties of the receptor Mas could be a new strategy in the therapy of failing kidney.			Esteban, V (corresponding author), Univ Autonoma Madrid, Fdn Jimenez Diaz, Cellular Biol Renal Dis Lab, Madrid, Spain.	thomas.walther@hyms.ac.uk	Esteban, Vanesa/J-8075-2012; Ruiz-Ortega, Marta/D-3584-2012; Ortega, Marta Ruiz/AAN-2136-2020; ruiz-ortega, marta/D-3584-2012	Esteban, Vanesa/0000-0002-7500-6277; Ruiz-Ortega, Marta/0000-0002-1495-6535; Ortega, Marta Ruiz/0000-0002-1495-6535; ruiz-ortega, marta/0000-0002-1403-2690				Alcazar JM, 2000, AM J KIDNEY DIS, V36, P883, DOI 10.1053/ajkd.2000.19077; Alenina N, 2002, J HISTOCHEM CYTOCHEM, V50, P691, DOI 10.1177/002215540205000510; AMBROZ C, 1991, BIOCHIM BIOPHYS ACTA, V1133, P107, DOI 10.1016/0167-4889(91)90248-V; Burgelova M, 2005, KIDNEY INT, V67, P1453, DOI 10.1111/j.1523-1755.2005.00222.x; Casas JP, 2005, LANCET, V366, P2026, DOI 10.1016/S0140-6736(05)67814-2; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Ellefson DD, 2004, CANCER CHEMOTH PHARM, V53, P15, DOI 10.1007/s00280-003-0710-0; Esteban V, 2004, J AM SOC NEPHROL, V15, P1514, DOI 10.1097/01.ASN.0000130564.75008.F5; Ferrario CM, 2003, CURR HYPERTENS REP, V5, P129, DOI 10.1007/s11906-003-0069-y; Ferrario CM, 2002, J HYPERTENS, V20, P805, DOI 10.1097/00004872-200205000-00004; Ferreira AJ, 2006, REGUL PEPTIDES, V137, P128, DOI 10.1016/j.regpep.2006.06.005; Gembardt F, 2008, FASEB J, V22, P3068, DOI 10.1096/fj.08-108316; Inan MS, 2003, CONTRIB NEPHROL, V139, P90; Iwata M, 2005, AM J PHYSIOL-HEART C, V289, pH2356, DOI 10.1152/ajpheart.00317.2005; JACKSON TR, 1988, NATURE, V335, P437, DOI 10.1038/335437a0; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Kostenis E, 2005, CIRCULATION, V111, P1806, DOI 10.1161/01.CIR.0000160867.23556.7D; Langeveld B, 2005, HYPERTENSION, V45, P138, DOI 10.1161/01.HYP.0000149382.83973.c2; Loot AE, 2002, CIRCULATION, V105, P1548, DOI 10.1161/01.CIR.0000013847.07035.B9; Ma J, 1998, KIDNEY INT, V53, P937, DOI 10.1111/j.1523-1755.1998.00893.x; MacKinnon M, 2006, AM J KIDNEY DIS, V48, P8, DOI 10.1053/j.ajkd.2006.04.077; MCLACHLAN N, 1994, ACTA CYTOL, V38, P531; Mezzano S, 2004, NEPHROL DIAL TRANSPL, V19, P2505, DOI 10.1093/ndt/gfh207; Padi SSV, 2002, PHARMACOL RES, V45, P413, DOI 10.1006/phrs.2002.0959; Rodgers K, 2003, CANCER CHEMOTH PHARM, V51, P97, DOI 10.1007/s00280-002-0509-4; Rodriguez-Iturbe B, 2006, NEPHROL DIAL TRANSPL, V21, P260, DOI 10.1093/ndt/gfi319; Ruiz-Ortega M, 2006, NEPHROL DIAL TRANSPL, V21, P16, DOI 10.1093/ndt/gfi265; Ruiz-Ortega M, 2006, CURR OPIN NEPHROL HY, V15, P159, DOI 10.1097/01.mnh.0000203190.34643.d4; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Satoh M, 2001, J AM SOC NEPHROL, V12, P317, DOI 10.1681/ASN.V122317; Schoolwerth AC, 2005, ADV CHRONIC KIDNEY D, V12, P418, DOI 10.1053/j.ackd.2005.07.012; Segerer S, 2003, CURR OPIN NEPHROL HY, V12, P243, DOI 10.1097/00041552-200305000-00004; Segerer S, 2007, SEMIN NEPHROL, V27, P260, DOI 10.1016/j.semnephrol.2007.02.003; Segerer S, 2005, THESCIENTIFICWORLDJO, V5, P835, DOI 10.1100/tsw.2005.105; Tallant EA, 2005, AM J PHYSIOL-HEART C, V289, pH1560, DOI 10.1152/ajpheart.00941.2004; Taneda S, 2003, J AM SOC NEPHROL, V14, P968, DOI 10.1097/01.ASN.0000054498.83125.90; Thorp Micah L, 2006, Dis Manag, V9, P115, DOI 10.1089/dis.2006.9.115; Walther T, 1998, J BIOL CHEM, V273, P11867, DOI 10.1074/jbc.273.19.11867; Walther T, 2000, BRAZ J MED BIOL RES, V33, P1, DOI 10.1590/S0100-879X2000000100001; Walther T, 2007, CIRCULATION, V115, P333, DOI 10.1161/CIRCULATIONAHA.106.643296; Wolf G, 2006, KIDNEY INT, V70, P1914, DOI 10.1038/sj.ki.5001846; WREFORD NG, 1995, MICROSC RES TECHNIQ, V32, P423, DOI 10.1002/jemt.1070320505	42	95	102	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5406	10.1371/journal.pone.0005406	http://dx.doi.org/10.1371/journal.pone.0005406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404405	gold, Green Published, Green Submitted			2022-12-25	WOS:000265614900017
J	Rossy, J; Schlicht, D; Engelhardt, B; Niggli, V				Rossy, Jeremie; Schlicht, Dominique; Engelhardt, Britta; Niggli, Verena			Flotillins Interact with PSGL-1 in Neutrophils and, upon Stimulation, Rapidly Organize into Membrane Domains Subsequently Accumulating in the Uropod	PLOS ONE			English	Article								Background: Neutrophils polarize and migrate in response to chemokines. Different types of membrane microdomains (rafts) have been postulated to be present in rear and front of polarized leukocytes and disruption of rafts by cholesterol sequestration prevents leukocyte polarization. Reggie/flotillin-1 and -2 are two highly homologous proteins that are ubiquitously enriched in detergent resistant membranes and are thought to shape membrane microdomains by forming homo- and hetero-oligomers. It was the goal of this study to investigate dynamic membrane microdomain reorganization during neutrophil activation. Methodology/Principal Findings: We show now, using immunofluorescence staining and co-immunoprecipitation, that endogenous flotillin-1 and -2 colocalize and associate in resting spherical and polarized primary neutrophils. Flotillins redistribute very early after chemoattractant stimulation, and form distinct caps in more than 90% of the neutrophils. At later time points flotillins accumulate in the uropod of polarized cells. Chemotactic peptide-induced redistribution and capping of flotillins requires integrity and dynamics of the actin cytoskeleton, but does not involve Rho-kinase dependent signaling related to formation of the uropod. Both flotillin isoforms are involved in the formation of this membrane domain, as uropod location of exogenously expressed flotillins is dramatically enhanced by co-overexpression of tagged flotillin-1 and -2 in differentiated HL-60 cells as compared to cells expressing only one tagged isoform. Flotillin-1 and -2 associate with P-selectin glycoprotein ligand 1 (PSGL-1) in resting and in stimulated neutrophils as shown by colocalization and co-immunoprecipitation. Neutrophils isolated from PSGL-1-deficient mice exhibit flotillin caps to the same extent as cells isolated from wild type animals, implying that PSGL-1 is not required for the formation of the flotillin caps. Finally we show that stimulus-dependent redistribution of other uropod-located proteins, CD43 and ezrin/radixin/moesin, occurs much slower than that of flotillins and PSGL-1. Conclusions/Significance: These results suggest that flotillin-rich actin-dependent membrane microdomains are importantly involved in neutrophil uropod formation and/or stabilization and organize uropod localization of PSGL-1.			Rossy, J (corresponding author), Univ Bern, Dept Pathol, CH-3000 Bern, Switzerland.	verena.niggli@pathology.unibe.ch	Engelhardt, Britta/K-7267-2014; Rossy, Jeremie/N-8554-2016	Engelhardt, Britta/0000-0003-3059-9846; Rossy, Jeremie/0000-0002-5128-5283				Abbal C, 2006, BLOOD, V108, P3352, DOI 10.1182/blood-2006-04-013912; Alonso-Lebrero JL, 2000, BLOOD, V95, P2413, DOI 10.1182/blood.V95.7.2413.007k17_2413_2419; Babuke T, 2007, EUR J CELL BIOL, V86, P525, DOI 10.1016/j.ejcb.2007.03.003; BOYUM A, 1968, SCAND J CLIN LAB S97, V21, P1; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Charest PG, 2007, BIOCHEM J, V401, P377, DOI 10.1042/BJ20061432; Chichili GR, 2007, J BIOL CHEM, V282, P36682, DOI 10.1074/jbc.M702959200; Cooper KM, 2008, MOL BIOL CELL, V19, P3180, DOI 10.1091/mbc.E08-02-0225; Engelhardt B, 2005, J IMMUNOL, V175, P1267, DOI 10.4049/jimmunol.175.2.1267; Frick M, 2007, CURR BIOL, V17, P1151, DOI 10.1016/j.cub.2007.05.078; Giri B, 2007, EUR J IMMUNOL, V37, P2104, DOI 10.1002/eji.200636680; Gomez-Mouton C, 2004, J CELL BIOL, V164, P759, DOI 10.1083/jcb.200309101; Gupta N, 2006, NAT IMMUNOL, V7, P625, DOI 10.1038/ni1337; Hauert AB, 2002, INT J BIOCHEM CELL B, V34, P838, DOI 10.1016/S1357-2725(02)00010-9; Hoehne M, 2005, MOL CELL NEUROSCI, V30, P326, DOI 10.1016/j.mcn.2005.07.007; Jockusch BM, 2006, TRENDS CELL BIOL, V16, P391, DOI 10.1016/j.tcb.2006.06.006; Kimura A, 2001, P NATL ACAD SCI USA, V98, P9098, DOI 10.1073/pnas.151252898; Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S; Langhorst MF, 2007, FEBS LETT, V581, P4697, DOI 10.1016/j.febslet.2007.08.074; Langhorst MF, 2006, FASEB J, V20, P711, DOI 10.1096/fj.05-4760fje; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; LORANT DE, 1995, J CLIN INVEST, V96, P171, DOI 10.1172/JCI118018; Ma YQ, 2004, BLOOD, V104, P2549, DOI 10.1182/blood-2004-03-1108; Manes S, 2003, TRENDS IMMUNOL, V24, P320, DOI 10.1016/S1471-4906(03)00137-6; Miner JJ, 2008, BLOOD, V112, P2035, DOI 10.1182/blood-2008-04-149468; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Niggli V, 2003, J CELL SCI, V116, P813, DOI 10.1242/jcs.00306; Niggli V, 1999, FEBS LETT, V445, P69, DOI 10.1016/S0014-5793(99)00098-8; Niggli V, 2004, EXP CELL RES, V296, P358, DOI 10.1016/j.yexcr.2004.02.015; Niggli V, 2003, INT J BIOCHEM CELL B, V35, P1619, DOI 10.1016/S1357-2725(03)00144-4; Nuzzi Paul A, 2007, Methods Mol Biol, V370, P23; Parent CA, 2004, CURR OPIN CELL BIOL, V16, P4, DOI 10.1016/j.ceb.2003.11.008; Pierini LM, 2003, J BIOL CHEM, V278, P10831, DOI 10.1074/jbc.M212386200; Rajendran L, 2003, P NATL ACAD SCI USA, V100, P8241, DOI 10.1073/pnas.1331629100; Serrador JM, 2002, EUR J IMMUNOL, V32, P1560, DOI 10.1002/1521-4141(200206)32:6<1560::AID-IMMU1560>3.0.CO;2-U; Seveau S, 1997, J CELL SCI, V110, P1465; Seveau S, 2001, MOL BIOL CELL, V12, P3550, DOI 10.1091/mbc.12.11.3550; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Viola A, 2007, NAT REV IMMUNOL, V7, P889, DOI 10.1038/nri2193; Xu JS, 2005, P NATL ACAD SCI USA, V102, P6884, DOI 10.1073/pnas.0502106102; Yanagida M, 2007, PROTEOMICS, V7, P2398, DOI 10.1002/pmic.200700056; Yoshinaga-Ohara N, 2002, EXP CELL RES, V278, P112, DOI 10.1006/excr.2002.5571	45	46	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5403	10.1371/journal.pone.0005403	http://dx.doi.org/10.1371/journal.pone.0005403			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404397	Green Published, gold			2022-12-25	WOS:000265614900014
J	Zhang, PP; Allahverdiyeva, Y; Eisenhut, M; Aro, EM				Zhang, Pengpeng; Allahverdiyeva, Yagut; Eisenhut, Marion; Aro, Eva-Mari			Flavodiiron Proteins in Oxygenic Photosynthetic Organisms: Photoprotection of Photosystem II by Flv2 and Flv4 in Synechocystis sp PCC 6803	PLOS ONE			English	Article							INORGANIC CARBON LIMITATION; GENE-EXPRESSION; ELECTRON-TRANSPORT; NITRIC-OXIDE; SP PCC-6803; LIGHT; PHOTOINHIBITION; FLAVOPROTEINS; INACTIVATION; RUBREDOXIN	Background: Flavodiiron proteins (FDPs) comprise a group of modular enzymes that function in oxygen and nitric oxide detoxification in Bacteria and Archaea. The FDPs in cyanobacteria have an extra domain as compared to major prokaryotic enzymes. The physiological role of cyanobacteria FDPs is mostly unknown. Of the four putative flavodiiron proteins (Flv1-4) in the cyanobacterium Synechocystis sp. PCC 6803, a physiological function in Mehler reaction has been suggested for Flv1 and Flv3. Principal Findings: We demonstrate a novel and crucial function for Flv2 and Flv4 in photoprotection of photosystem II (PSII) in Synechocystis. It is shown that the expression of Flv2 and Flv4 is high under air level of CO2 and negligible at elevated CO2. Moreover, the rate of accumulation of flv2 and flv4 transcripts upon shift of cells from high to low CO2 is strongly dependent on light intensity. Characterization of FDP inactivation mutants of Synechocystis revealed a specific decline in PSII centers and impaired translation of the D1 protein in Delta flv2 and Delta flv4 when grown at air level CO2 whereas at high CO2 the Flvs were dispensable. Delta flv2 and Delta flv4 were also more susceptible to high light induced inhibition of PSII than WT or Delta flv1 and Delta flv3. Significance: Analysis of published sequences revealed the presence of cyanobacteria-like FDPs also in some oxygenic photosynthetic eukaryotes like green algae, mosses and lycophytes. Our data provide evidence that Flv2 and Flv4 have an important role in photoprotection of water-splitting PSII against oxidative stress when the cells are acclimated to air level CO2. It is conceivable that the function of FDPs has changed during evolution from protection against oxygen in anaerobic microbes to protection against reactive oxygen species thus making the sustainable function of oxygen evolving PSII possible. Higher plants lack FDPs and distinctly different mechanisms have evolved for photoprotection of PSII.			Zhang, PP (corresponding author), Univ Turku, Dept Biol Plant Physiol & Mol Biol, Turku, Finland.	evaaro@utu.fi	Aro, Eva-Mari/Q-8664-2017; Allahverdiyeva, Yagut/I-5652-2013	Aro, Eva-Mari/0000-0002-2922-1435; Allahverdiyeva, Yagut/0000-0002-9262-1757				Allahverdiyeva Y, 2004, EUR J BIOCHEM, V271, P3523, DOI 10.1111/j.0014-2956.2004.04287.x; Andersson JO, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148/6/27; Andersson JO, 2003, CURR BIOL, V13, P94, DOI 10.1016/S0960-9822(03)00003-4; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Baroli I, 1998, PLANTA, V205, P288, DOI 10.1007/s004250050323; CHEN L, 1993, BIOCHEM BIOPH RES CO, V193, P100, DOI 10.1006/bbrc.1993.1595; Eisenhut M, 2007, PLANT PHYSIOL, V144, P1946, DOI 10.1104/pp.107.103341; Folea IM, 2008, FEBS LETT, V582, P249, DOI 10.1016/j.febslet.2007.12.012; Frazao C, 2000, NAT STRUCT BIOL, V7, P1041; Gomes CM, 1997, J BIOL CHEM, V272, P22502, DOI 10.1074/jbc.272.36.22502; Gomes CM, 2002, J BIOL CHEM, V277, P25273, DOI 10.1074/jbc.M203886200; Helman Y, 2003, CURR BIOL, V13, P230, DOI 10.1016/S0960-9822(03)00046-0; Hihara Y, 2001, PLANT CELL, V13, P793, DOI 10.1105/tpc.13.4.793; Huang LX, 2002, J BACTERIOL, V184, P6845, DOI 10.1128/JB.184.24.6845-6858.2002; Kawasaki S, 2004, FEBS LETT, V571, P21, DOI 10.1016/j.febslet.2004.06.047; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li H, 2004, J BACTERIOL, V186, P3331, DOI 10.1128/JB.186.11.3331-3345.2004; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; McGinn PJ, 2003, PLANT PHYSIOL, V132, P218, DOI 10.1104/pp.102.019349; Mulo P, 1997, PLANT MOL BIOL, V33, P1059, DOI 10.1023/A:1005765305956; Nishiyama Y, 2006, BBA-BIOENERGETICS, V1757, P742, DOI 10.1016/j.bbabio.2006.05.013; NOLLING J, 1995, EUR J BIOCHEM, V231, P628, DOI 10.1111/j.1432-1033.1995.0628d.x; Sarti P, 2004, CELL MOL LIFE SCI, V61, P618, DOI 10.1007/s00018-003-3413-8; Sicora CI, 2006, BBA-BIOENERGETICS, V1757, P47, DOI 10.1016/j.bbabio.2005.11.002; Singh M, 2008, INDIAN J BIOCHEM BIO, V45, P237; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vicente JB, 2002, BIOCHEM BIOPH RES CO, V294, P82, DOI 10.1016/S0006-291X(02)00434-5; Vicente JB, 2008, METHOD ENZYMOL, V437, P21, DOI 10.1016/S0076-6879(07)37002-X; Vicente JB, 2008, METHOD ENZYMOL, V437, P3, DOI 10.1016/S0076-6879(07)37001-8; Wang H, 2004, J BIOL CHEM, V279, P1468, DOI 10.1074/jbc.M309106200; Wasserfallen A, 1998, EUR J BIOCHEM, V254, P325, DOI 10.1046/j.1432-1327.1998.2540325.x; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Zhang PP, 2007, MOL MICROBIOL, V65, P728, DOI 10.1111/j.1365-2958.2007.05822.x; Zhang PP, 2004, PLANT CELL, V16, P3326, DOI 10.1105/tpc.104.026526	35	123	124	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5331	10.1371/journal.pone.0005331	http://dx.doi.org/10.1371/journal.pone.0005331			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390625	Green Published, gold, Green Submitted			2022-12-25	WOS:000265514400017
J	Zhang, TT; Song, KW; Hekmat-Nejad, M; Morris, DG; Wong, BR				Zhang, Tingting; Song, Kyung W.; Hekmat-Nejad, Mohammad; Morris, David G.; Wong, Brian R.			A Modeling-Derived Hypothesis on Chronicity in Respiratory Diseases: Desensitized Pathogen Recognition Secondary to Hyperactive IRAK/TRAF6 Signaling	PLOS ONE			English	Article								Several chronic respiratory diseases exhibit hyperactive immune responses in the lung: abundant inflammatory mediators; infiltrating neutrophils, macrophages, lymphocytes and other immune cells; and increased level of proteases. Such diseases include cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD) and severe/neutrophilic asthma. Paradoxically, patients with these diseases are also susceptible to detrimental bacterial infection and colonization. In this paper, we seek to explain how a positive feedback mechanism via IL-8 could lead to desensitization of epithelial cells to pathogen recognition thus perpetuating bacterial colonization and chronic disease states in the lung. Such insight was obtained from mathematical modeling of the IRAK/TRAF6 signaling module, and is consistent with existing clinical evidence. The potential implications for targeted treatment regimes for these persistent respiratory diseases are explored.			Zhang, TT (corresponding author), Roche Palo Alto LLC, Palo Alto, CA USA.	tingting.zhang@roche.com						Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Barnes PJ, 2004, PHARMACOL REV, V56, P515, DOI 10.1124/pr.56.4.2; Bartlett Jennifer A., 2008, V15, P147, DOI 10.1159/000136349; Carrabino S, 2006, J CYST FIBROS, V5, P113, DOI 10.1016/j.jcf.2005.12.003; Chung KF, 2008, EUR RESPIR J, V31, P1334, DOI 10.1183/09031936.00018908; Hajjar AM, 2005, AM J RESP CELL MOL, V33, P470, DOI 10.1165/rcmb.2005-0199OC; Hartl D, 2007, NAT MED, V13, P1423, DOI 10.1038/nm1690; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Liu G, 2007, J IMMUNOL, V179, P4125, DOI 10.4049/jimmunol.179.6.4125; Liu Y, 2005, J MOL EVOL, V61, P691, DOI 10.1007/s00239-005-0039-x; Machen TE, 2006, AM J PHYSIOL-CELL PH, V291, pC218, DOI 10.1152/ajpcell.00605.2005; Malerba M, 2006, THORAX, V61, P129, DOI 10.1136/thx.2005.043471; Manna SK, 2005, J BIOL CHEM, V280, P7010, DOI 10.1074/jbc.M410994200; Mizukami Y, 2005, NAT MED, V11, P992, DOI 10.1038/nm1294; ODA K, 2006, MOL SYST BIOL, V2, pNI137; Pavord ID, 2007, THORAX, V62, P193, DOI 10.1136/thx.2006.065805; RENDA T, 2007, EUR RESPIR J; Rocha-De-Souza CM, 2008, INFECT IMMUN, V76, P4489, DOI 10.1128/IAI.00270-08; Roth M, 2008, INT J TUBERC LUNG D, V12, P375; Sauro Herbert M., 2003, OMICS A Journal of Integrative Biology, V7, P355, DOI 10.1089/153623103322637670; Sebban H, 2006, BIOCHEM PHARMACOL, V72, P1153, DOI 10.1016/j.bcp.2006.08.006; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Shannon J, 2008, CHEST, V133, P420, DOI 10.1378/chest.07-1881; SIBLEY CD, 2008, P NATL ACAD SCI; Simpson JL, 2007, THORAX, V62, P211, DOI 10.1136/thx.2006.061358; SONG KW, 2009, MOL IMMUNOL; Sun Y, 2006, INFECT IMMUN, V74, P5325, DOI 10.1128/IAI.00645-06; van de Sande WWJ, 2007, J IMMUNOL, V179, P3065, DOI 10.4049/jimmunol.179.5.3065; Verhaeghe C, 2007, BIOCHEM PHARMACOL, V73, P1982, DOI 10.1016/j.bcp.2007.03.019; Vij N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004664; Walsh DE, 2001, J BIOL CHEM, V276, P35494, DOI 10.1074/jbc.M103543200; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; Zhang Z, 2005, INFECT IMMUN, V73, P7151, DOI 10.1128/IAI.73.11.7151-7160.2005	34	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5332	10.1371/journal.pone.0005332	http://dx.doi.org/10.1371/journal.pone.0005332			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390631	Green Published, Green Submitted, gold			2022-12-25	WOS:000265514400018
J	Bomberger, JM; Barnaby, RL; Stanton, BA				Bomberger, Jennifer M.; Barnaby, Roxanna L.; Stanton, Bruce A.			The Deubiquitinating Enzyme USP10 Regulates the Post-endocytic Sorting of Cystic Fibrosis Transmembrane Conductance Regulator in Airway Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL; REVERSIBLE UBIQUITINATION; GENE-PRODUCT; PROTEIN; CFTR; TRAFFICKING; MEMBRANE; TRANSPORT; PATHWAY; DOMAIN	The cystic fibrosis transmembrane conductance regulator (CFTR), a member of the ABC transporter superfamily, is a cyclic AMP-regulated chloride channel and a regulator of other ion channels and transporters. In epithelial cells CFTR is rapidly endocytosed from the apical plasma membrane and efficiently recycles back to the plasma membrane. Because ubiquitination targets endocytosed CFTR for degradation in the lysosome, deubiquitinating enzymes (DUBs) are likely to facilitate CFTR recycling. Accordingly, the aim of this study was to identify DUBs that regulate the post-endocytic sorting of CFTR. Using an activity-based chemical screen to identify active DUBs in human airway epithelial cells, we demonstrated that Ubiquitin Specific Protease-10 (USP10) is located in early endosomes and regulates the deubiquitination of CFTR and its trafficking in the post-endocytic compartment. small interference RNA-mediated knockdown of USP10 increased the amount of ubiquitinated CFTR and its degradation in lysosomes, and reduced both apical membrane CFTR and CFTR-mediated chloride secretion. Moreover, a dominant negative USP10 (USP10-C424A) increased the amount of ubiquitinated CFTR and its degradation, whereas overexpression of wt-USP10 decreased the amount of ubiquitinated CFTR and increased the abundance of CFTR. These studies demonstrate a novel function for USP10 in facilitating the deubiquitination of CFTR in early endosomes and thereby enhancing the endocytic recycling of CFTR.	[Bomberger, Jennifer M.; Barnaby, Roxanna L.; Stanton, Bruce A.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Physiol, Hanover, NH 03755 USA	Dartmouth College	Bomberger, JM (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Physiol, 604 Remsen Bldg, Hanover, NH 03755 USA.	jbomberger@dartmouth.edu			National Institutes of Health [5T32DK007301, 5R01DK45581]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 5T32DK007301 and 5R01DK45581 (to B. A. S.). This work was also supported by Cystic Fibrosis Foundation Grants BOMBER08F0 (to J.M.B.) and STANTO07R0 (to B. A. S.).	Ameen N, 2007, J CYST FIBROS, V6, P1, DOI 10.1016/j.jcf.2006.09.002; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Bomberger JM, 2005, J BIOL CHEM, V280, P9297, DOI 10.1074/jbc.M413786200; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Boulkroun S, 2008, AM J PHYSIOL-RENAL, V295, pF889, DOI 10.1152/ajprenal.00001.2008; Butterworth MB, 2007, J BIOL CHEM, V282, P37885, DOI 10.1074/jbc.M707989200; Chang CT, 2005, J PHYSIOL-LONDON, V562, P271, DOI 10.1113/jphysiol.2004.077933; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Cohen M, 2003, J BIOL CHEM, V278, P51989, DOI 10.1074/jbc.C300451200; Cohen M, 2003, NAT CELL BIOL, V5, P661, DOI 10.1038/ncb1003; Fakitsas P, 2007, J AM SOC NEPHROL, V18, P1084, DOI 10.1681/ASN.2006080902; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Gesbert F, 2005, BIOCHEM BIOPH RES CO, V334, P474, DOI 10.1016/j.bbrc.2005.06.121; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Lahr TF, 2000, PFLUG ARCH EUR J PHY, V439, P610, DOI 10.1007/s004240050984; Lorenzo ME, 2002, J VIROL, V76, P5522, DOI 10.1128/JVI.76.11.5522-5531.2002; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Millard SM, 2006, J CELL BIOL, V173, P463, DOI 10.1083/jcb.200602082; Monami G, 2008, J CELL PHYSIOL, V216, P426, DOI 10.1002/jcp.21405; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Saxena S, 2005, BIOCHEM BIOPH RES CO, V337, P1219, DOI 10.1016/j.bbrc.2005.09.186; Saxena SK, 2006, BIOCHEM BIOPH RES CO, V346, P259, DOI 10.1016/j.bbrc.2006.05.102; Schlieker C, 2005, J VIROL, V79, P15582, DOI 10.1128/JVI.79.24.15582-15585.2005; Schmitz C, 2005, MOL BIOL CELL, V16, P1319, DOI 10.1091/mbc.E04-05-0425; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Soncini C, 2001, ONCOGENE, V20, P3869, DOI 10.1038/sj.onc.1204553; Swiatecka-Urban A, 2006, AM J PHYSIOL-CELL PH, V290, pC862, DOI 10.1152/ajpcell.00108.2005; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Swiatecka-Urban A, 2004, J BIOL CHEM, V279, P38025, DOI 10.1074/jbc.M403141200; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Urbe S, 2006, BIOCHEM SOC T, V34, P754, DOI 10.1042/BST0340754; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; Wicks SJ, 2006, BIOCHEM SOC T, V34, P761, DOI 10.1042/BST0340761; Wicks SJ, 2005, ONCOGENE, V24, P8080, DOI 10.1038/sj.onc.1208944; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wolde M, 2007, J BIOL CHEM, V282, P8099, DOI 10.1074/jbc.M611049200	44	82	90	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18778	18789		10.1074/jbc.M109.001685	http://dx.doi.org/10.1074/jbc.M109.001685			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19398555	Green Published, hybrid			2022-12-25	WOS:000267711500027
J	Fiermonte, G; Paradies, E; Todisco, S; Marobbio, CMT; Palmieri, F				Fiermonte, Giuseppe; Paradies, Eleonora; Todisco, Simona; Marobbio, Carlo M. T.; Palmieri, Ferdinando			A Novel Member of Solute Carrier Family 25 (SLC25A42) Is a Transporter of Coenzyme A and Adenosine 3 ',5 '-Diphosphate in Human Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE TRANSLOCATOR; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-CHARACTERIZATION; BACTERIAL EXPRESSION; TISSUE DISTRIBUTION; MAMMALIAN MITOCHONDRIA; ENDOPLASMIC-RETICULUM; BOVINE MITOCHONDRIA; PHOSPHATE CARRIER; ADP/ATP CARRIER	Mitochondrial carriers are a family of proteins that transport metabolites, nucleotides, and cofactors across the inner mitochondrial membrane thereby connecting cytosolic and matrix functions. The essential cofactor coenzyme A (CoA) is synthesized outside the mitochondrial matrix and therefore must be transported into mitochondria where it is required for a number of fundamental processes. In this work we have functionally identified and characterized SLC25A42, a novel human member of the mitochondrial carrier family. The SLC25A42 gene (Haitina, T., Lindblom, J., Renstrom, T., and Fredriksson, R., 2006, Genomics 88, 779-790) was overexpressed in Escherichia coli, purified, and reconstituted into phospholipid vesicles. Its transport properties, kinetic parameters, and targeting to mitochondria demonstrate that SLC25A42 protein is a mitochondrial transporter for CoA and adenosine 3',5'-diphosphate. SLC25A42 catalyzed only a counter-exchange transport, exhibited a high transport affinity for CoA, dephospho-CoA, ADP, and adenosine 3',5'-diphosphate, was saturable and inhibited by bongkrekic acid and other inhibitors of mitochondrial carriers to various degrees. The main physiological role of SLC25A42 is to import CoA into mitochondria in exchange for intramitochondrial (deoxy) adenine nucleotides and adenosine 3',5'-diphosphate. This is the first time that a mitochondrial carrier for CoA and adenosine 3',5'-diphosphate has been characterized biochemically.	[Fiermonte, Giuseppe; Paradies, Eleonora; Todisco, Simona; Marobbio, Carlo M. T.; Palmieri, Ferdinando] Univ Bari, Dept Pharmacobiol, Biochem & Mol Biol Lab, I-70125 Bari, Italy; [Fiermonte, Giuseppe; Palmieri, Ferdinando] CNR, Inst Biomembranes & Bioenerget, I-70125 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR)	Palmieri, F (corresponding author), Via Orabona 4, I-70125 Bari, Italy.	fpalm@farmbiol.uniba.it	Paradies, Eleonora/K-4606-2014; Fiermonte, Giuseppe/D-3680-2018; MAROBBIO, Carlo/G-5775-2015; Todisco, Simona/AAU-2091-2021	Paradies, Eleonora/0000-0002-1668-7148; Fiermonte, Giuseppe/0000-0002-6764-9395; MAROBBIO, Carlo/0000-0002-2516-0321; 	Ministero dell'Universitae della Ricerca (MIUR); Center of Excellence in Genomics, Apulia Region; University of Bari; Italian Human ProteomeNet [RBRN07BMCT_009]	Ministero dell'Universitae della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Center of Excellence in Genomics, Apulia Region; University of Bari; Italian Human ProteomeNet	This work was supported by grants from the Ministero dell'Universitae della Ricerca (MIUR), the Center of Excellence in Genomics, Apulia Region, the University of Bari, and the Italian Human ProteomeNet no. RBRN07BMCT_009 (MIUR).	Agrimi G, 2004, BIOCHEM J, V379, P183, DOI 10.1042/BJ20031664; Bedhomme M, 2005, J BIOL CHEM, V280, P34823, DOI 10.1074/jbc.M506045200; BREMER J, 1972, EUR J BIOCHEM, V25, P90, DOI 10.1111/j.1432-1033.1972.tb01684.x; Brix J, 1999, J BIOL CHEM, V274, P16522, DOI 10.1074/jbc.274.23.16522; Chiesa A, 2001, BIOCHEM J, V355, P1, DOI 10.1042/0264-6021:3550001; Cronan JE, 2005, FEBS LETT, V579, P4892, DOI 10.1016/j.febslet.2005.07.077; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; Fiermonte G, 1998, J BIOL CHEM, V273, P22782, DOI 10.1074/jbc.273.35.22782; FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293; Fiermonte G, 1992, DNA Seq, V3, P71, DOI 10.3109/10425179209033999; Fiore C, 1998, BIOCHIMIE, V80, P137, DOI 10.1016/S0300-9084(98)80020-5; Floyd S, 2007, MOL BIOL CELL, V18, P3545, DOI 10.1091/mbc.e06-12-1109; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; HADDOCK BA, 1970, BIOCHEM J, V119, P565, DOI 10.1042/bj1190565; Haitina T, 2006, GENOMICS, V88, P779, DOI 10.1016/j.ygeno.2006.06.016; HELDT HW, 1965, BIOCHEM Z, V343, P433; IDELLWENGER JA, 1978, J BIOL CHEM, V253, P4310; Joshi AK, 2003, J BIOL CHEM, V278, P33142, DOI 10.1074/jbc.M305459200; KLINGENBERG M, 1989, ARCH BIOCHEM BIOPHYS, V270, P1, DOI 10.1016/0003-9861(89)90001-5; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; KRAMER R, 1980, BIOCHEMISTRY-US, V19, P556; Leonardi R, 2007, P NATL ACAD SCI USA, V104, P1494, DOI 10.1073/pnas.0607621104; Leroch M, 2008, PLANT CELL, V20, P438, DOI 10.1105/tpc.107.057554; NEUBURGER M, 1984, ARCH BIOCHEM BIOPHYS, V229, P253, DOI 10.1016/0003-9861(84)90151-6; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; Palmieri F, 2006, BBA-BIOENERGETICS, V1757, P1249, DOI 10.1016/j.bbabio.2006.05.023; Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341; Palmieri L, 2001, EMBO J, V20, P5049, DOI 10.1093/emboj/20.18.5049; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; PFAFF E, 1968, EUR J BIOCHEM, V6, P66, DOI 10.1111/j.1432-1033.1968.tb00420.x; Picault N, 2004, TRENDS PLANT SCI, V9, P138, DOI 10.1016/j.tplants.2004.01.007; Prohl C, 2001, MOL CELL BIOL, V21, P1089, DOI 10.1128/MCB.21.4.1089-1097.2001; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; SIKORSKI RS, 1989, GENETICS, V122, P19; TAHILIANI AG, 1987, J BIOL CHEM, V262, P11607; TAHILIANI AG, 1987, J MOL CELL CARDIOL, V19, P1161, DOI 10.1016/S0022-2828(87)80526-6; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; Traba J, 2009, BIOCHEM J, V418, P125, DOI 10.1042/BJ20081262; Visser WF, 2002, BIOCHEM BIOPH RES CO, V299, P494, DOI 10.1016/S0006-291X(02)02663-3; Vozza A, 2004, J BIOL CHEM, V279, P20850, DOI 10.1074/jbc.M313610200; ZARA V, 1992, J BIOL CHEM, V267, P12077; Zhang L, 2003, J BIOL CHEM, V278, P40067, DOI 10.1074/jbc.M306121200; Zhyvoloup A, 2003, J BIOL CHEM, V278, P50316, DOI 10.1074/jbc.M307763200	47	104	106	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18152	18159		10.1074/jbc.M109.014118	http://dx.doi.org/10.1074/jbc.M109.014118			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19429682	hybrid, Green Published			2022-12-25	WOS:000267712400026
J	Graham, SA; Jegouzo, SAF; Yan, S; Powlesland, AS; Brady, JP; Taylor, ME; Drickamer, K				Graham, Sarah A.; Jegouzo, Sabine A. F.; Yan, Sheng; Powlesland, Alex S.; Brady, Jacob P.; Taylor, Maureen E.; Drickamer, Kurt			Prolectin, a Glycan-binding Receptor on Dividing B Cells in Germinal Centers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTIN; DC-SIGN; CARBOHYDRATE-RECOGNITION; STRUCTURAL BASIS; IMMUNE-RESPONSES; LANGERHANS CELLS; LIGAND-BINDING; IDENTIFICATION; PROTEINS; ORGANIZATION	Prolectin, a previously undescribed glycan-binding receptor, has been identified by re-screening of the human genome for genes encoding proteins containing potential C-type carbohydrate-recognition domains. Glycan array analysis revealed that the carbohydrate-recognition domain in the extracellular domain of the receptor binds glycans with terminal alpha-linked mannose or fucose residues. Prolectin expressed in fibroblasts is found at the cell surface, but unlike many glycan-binding receptors it does not mediate endocytosis of a neoglycoprotein ligand. However, compared with other known glycan-binding receptors, the receptor contains an unusually large intracellular domain that consists of multiple sequence motifs, including phosphorylated tyrosine residues, that allow it to interact with signaling molecules such as Grb2. Immunohistochemistry has been used to demonstrate that prolectin is expressed on a specialized population of proliferating B cells in germinal centers. Thus, this novel receptor has the potential to function in carbohydrate-mediated communication between cells in the germinal center.	[Graham, Sarah A.; Jegouzo, Sabine A. F.; Yan, Sheng; Powlesland, Alex S.; Brady, Jacob P.; Taylor, Maureen E.; Drickamer, Kurt] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Dept Life Sci, London SW7 2AZ, England	Imperial College London	Drickamer, K (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Dept Life Sci, Biochem Bldg, London SW7 2AZ, England.	k.drickamer@imperial.ac.uk	Graham, Sarah/G-7765-2014; Brady, Jacob/AAB-3738-2019	Graham, Sarah/0000-0003-2521-2416; Brady, Jacob/0000-0002-9316-7226; Jegouzo, Sabine/0000-0001-7768-0102; Yan, Sheng/0000-0003-2308-6540; Taylor, Maureen/0000-0001-8300-4987; Drickamer, Kurt/0000-0001-5026-5996	Wellcome Trust [075565]; National Institutes of Health [GM062116]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant 075565 from the Wellcome Trust (to M. E. T. and K. D.). This work was also supported, in part, by National Institutes of Health Grant GM062116 to the Consortium for Functional Glycomics.	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Appelmelk BJ, 2003, J IMMUNOL, V170, P1635, DOI 10.4049/jimmunol.170.4.1635; CHARDIN P, 1995, FEBS LETT, V369, P47, DOI 10.1016/0014-5793(95)00578-W; Coombs PJ, 2005, J BIOL CHEM, V280, P22993, DOI 10.1074/jbc.M504197200; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Dam TK, 2008, BIOCHEMISTRY-US, V47, P8470, DOI 10.1021/bi801208b; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Drickamer K, 2003, METHOD ENZYMOL, V362, P560; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Feinberg H, 2005, J BIOL CHEM, V280, P1327, DOI 10.1074/jbc.M409925200; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Powlesland AS, 2006, J BIOL CHEM, V281, P20440, DOI 10.1074/jbc.M601925200; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Stambach NS, 2003, GLYCOBIOLOGY, V13, P401, DOI 10.1093/glycob/cwg045; Taylor PR, 2005, TRENDS IMMUNOL, V26, P104, DOI 10.1016/j.it.2004.12.001; Thanaraj TA, 2001, NUCLEIC ACIDS RES, V29, P2581, DOI 10.1093/nar/29.12.2581; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Wragg S, 1999, J BIOL CHEM, V274, P35400, DOI 10.1074/jbc.274.50.35400; Wurzburg BA, 2006, STRUCTURE, V14, P1049, DOI 10.1016/j.str.2006.03.017	31	19	20	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18537	18544		10.1074/jbc.M109.012807	http://dx.doi.org/10.1074/jbc.M109.012807			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19419970	Green Published, hybrid			2022-12-25	WOS:000267712400064
J	Guo, P; Zhao, KW; Dong, XY; Sun, XD; Dong, JT				Guo, Peng; Zhao, Ke-Wen; Dong, Xue-Yuan; Sun, Xiaodong; Dong, Jin-Tang			Acetylation of KLF5 Alters the Assembly of p15 Transcription Factors in Transforming Growth Factor-beta-mediated Induction in Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDK INHIBITOR P15(INK4B); KRUPPEL-LIKE FACTOR-5; TGF-BETA; TUMOR-SUPPRESSOR; BREAST-CANCER; C-MYC; SMAD; COACTIVATORS; HOMEOSTASIS; EXPRESSION	KLF5 plays important roles in a variety of cellular processes including proliferation and differentiation. Recently KLF5 was shown to reverse its function in proliferative and p15 regulation upon transforming growth factor-beta (TGF beta)-mediated acetylation. To understand how KLF5 acetylation functions in TGF beta-induced p15 transcription, we characterized the interactions of KLF5 with other transcription factors and promoter DNA elements in the context of TGF beta. KLF5 interacted with Smad2-4 and Miz-1 in a TGF beta-independent manner, but interacted with Myc only when TGF beta was activated, and at least some of the interactions had an additive effect on TGF beta-induced p15 transcription. Oligo pulldown assays showed that binding of Myc to the Inr element was KLF5-dependent, and TGF beta could enhance the binding when more KLF5 was available. Furthermore, TGF beta-induced an interaction between KLF5 and the p300 acetylase, and acetylation of KLF5 was necessary for Smad4 to associate with p300. Failure in KLF5 acetylation not only prevented p300-assembled Smad4-KLF5 complex formation on p15 promoter but also affected the binding of Smad4 and FOXO3 on the p15 promoter in vivo. These findings suggest that without TGF beta, some KLF5 associates with Smads in the nucleus and other KLF5 associates with Miz-1 on the p15 promoter to repress its transcription. Activation of TGF beta recruits p300 to the KLF5-Smad complex to acetylate KLF5, and the complex with acetylated KLF5 binds to the Smad binding element and alters the binding of other factors to p15 promoter to induce its transcription.	Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Emory University; Emory University	Dong, JT (corresponding author), 1365-C Clifton Rd,Rm C4080, Atlanta, GA 30322 USA.	jdong2@emory.edu	Guo, Peng/GWC-0572-2022; guo, peng/AAG-4052-2019	Guo, Peng/0000-0002-4575-8443; Dong, Jin-Tang/0000-0003-2349-5782	National Institutes of Health [R01CA087921]; Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE [R01CA087921] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA087921. This work was also supported by the Georgia Cancer Coalition.	Bateman NW, 2004, J BIOL CHEM, V279, P12093, DOI 10.1074/jbc.M311532200; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chen C, 2002, ONCOGENE, V21, P6567, DOI 10.1038/sj.onc.1205817; Chen C, 2003, PROSTATE, V55, P81, DOI 10.1002/pros.10205; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Guo P, 2009, J BIOL CHEM, V284, P6071, DOI 10.1074/jbc.M806270200; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; LI JM, 1995, J BIOL CHEM, V270, P26750, DOI 10.1074/jbc.270.45.26750; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Miyamoto S, 2003, MOL CELL BIOL, V23, P8528, DOI 10.1128/MCB.23.23.8528-8541.2003; Nandan MO, 2008, GASTROENTEROLOGY, V134, P120, DOI 10.1053/j.gastro.2007.10.023; Ranganathan P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-98; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Simonsson M, 2006, J BIOL CHEM, V281, P39870, DOI 10.1074/jbc.M607868200; Topper JN, 1998, P NATL ACAD SCI USA, V95, P9506, DOI 10.1073/pnas.95.16.9506; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; Xie L, 2003, BREAST CANCER RES, V5, pR187, DOI 10.1186/bcr640; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	32	58	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18184	18193		10.1074/jbc.M109.007096	http://dx.doi.org/10.1074/jbc.M109.007096			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19419955	Green Published, hybrid			2022-12-25	WOS:000267712400030
J	Zhang, XX; Dowd, DR; Moore, MC; Kranenburg, TA; Meester-Smoor, MA; Zwarthoff, EC; MacDonald, PN				Zhang, Xiaoxue; Dowd, Diane R.; Moore, Meika C.; Kranenburg, Tanya A.; Meester-Smoor, Magda A.; Zwarthoff, Ellen C.; MacDonald, Paul N.			Meningioma 1 Is Required for Appropriate Osteoblast Proliferation, Motility, Differentiation, and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; VITAMIN-D-RECEPTOR; NF-KAPPA-B; OSTEOCLAST DIFFERENTIATION; ANIMAL-MODEL; MN1; EXPRESSION; GENE; OSTEOPROTEGERIN; TRANSCRIPTION	The vitamin D endocrine system is essential for calcium and phosphate homeostasis and skeletal mineralization. The 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3) hormone binds to the vitamin D receptor (VDR) to regulate gene expression. These gene products in turn mediate the actions of 1,25(OH) D-2(3) in mineral-regulating target cells such as the osteoblast. We showed previously that meningioma 1 (MN1) is a novel target of 1,25(OH)(2)D-3 in MG-63 osteoblastic cells and that it is a coactivator for VDR-mediated transcription (Sutton, A. L., Zhang, X., Ellison, T. I., and MacDonald, P. N. (2005) Mol. Endocrinol. 19, 2234-2244). However, the functional significance of MN1 in osteoblastic cell biology is largely unknown. Here, we demonstrate that MN1 expression is increased dramatically during differentiation of primary osteoblastic cells. Using calvarial osteoblasts derived from wild-type and MN1 knock-out mice, we provide data supporting an essential role of MN1 in maintaining appropriate osteoblast proliferation, differentiation, and function. MN1 knock-out osteoblasts displayed altered morphology, decreased growth rate, impaired motility, and attenuated 1,25(OH)(2)D-3/VDR-mediated transcription as well as reduced alkaline phosphatase activity and mineralized nodule formation. MN1 null osteoblasts were also impaired in supporting osteoclastogenesis in co-culture studies presumably because of marked reduction in the RANKL: OPG ratio in the MN1 null cells. Mechanistic studies supported a transcriptional role for MN1 in controlling RANKL gene expression through activation of the RANKL promoter. Cumulatively, these studies indicate an important role for MN1 in maintaining the appropriate maturation and function of calvarial osteoblasts.	[Zhang, Xiaoxue; Dowd, Diane R.; Moore, Meika C.; MacDonald, Paul N.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Kranenburg, Tanya A.] St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Meester-Smoor, Magda A.; Zwarthoff, Ellen C.] Erasmus MC, Josephine Nefkens Inst, Dept Pathol, NL-3000 DR Rotterdam, Netherlands	Case Western Reserve University; St Jude Children's Research Hospital; Erasmus University Rotterdam; Erasmus MC	MacDonald, PN (corresponding author), Case Western Reserve Univ, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	paul.macdonald@case.edu	Kranenburg, Tanya/F-7138-2012	Kranenburg, Tanya/0000-0002-5329-4968	National Institutes of Health [RO1DK53980, RO1DK071769]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053980, R01DK071769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1DK53980 and RO1DK071769 ( to P. N. M.).	Aubin JE, 1998, J CELL BIOCHEM, P73, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<73::AID-JCB11>3.0.CO;2-L; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Bord S, 2003, BONE, V32, P136, DOI 10.1016/S8756-3282(02)00953-5; Bove PF, 2008, J BIOL CHEM, V283, P17919, DOI 10.1074/jbc.M709914200; BUIJS A, 1995, ONCOGENE, V10, P1511; Carella C, 2007, LEUKEMIA, V21, P1679, DOI 10.1038/sj.leu.2404778; Carella C, 2006, LEUKEMIA, V20, P1582, DOI 10.1038/sj.leu.2404298; Dardenne O, 2001, ENDOCRINOLOGY, V142, P3135, DOI 10.1210/en.142.7.3135; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; DEPREZ RHL, 1995, ONCOGENE, V10, P1521; Divieti P, 1998, J BONE MINER RES, V13, P1835, DOI 10.1359/jbmr.1998.13.12.1835; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Ellison TI, 2007, J BIOL CHEM, V282, P10953, DOI 10.1074/jbc.M609717200; Galibert L, 1998, J BIOL CHEM, V273, P34120, DOI 10.1074/jbc.273.51.34120; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Hassan MQ, 2007, MOL CELL BIOL, V27, P3337, DOI 10.1128/MCB.01544-06; Heuser M, 2007, BLOOD, V110, P1639, DOI 10.1182/blood-2007-03-080523; Heuser M, 2006, BLOOD, V108, P3898, DOI 10.1182/blood-2006-04-014845; Horwood NJ, 1998, ENDOCRINOLOGY, V139, P4743, DOI 10.1210/en.139.11.4743; Jurutka PW, 2007, J BONE MINER RES, V22, pV2, DOI 10.1359/JBMR.07S216; Kassem M, 2008, ARCH BIOCHEM BIOPHYS, V473, P183, DOI 10.1016/j.abb.2008.03.028; Kawagoe H, 2005, BLOOD, V106, P4278, DOI 10.1182/blood-2005-04-1674; Kawagoe H, 2005, BLOOD, V106, P4269, DOI 10.1182/blood-2005-04-1679; Kawai S, 2007, J BONE MINER RES, V22, P1362, DOI 10.1359/JBMR.070602; Kim HH, 1999, FEBS LETT, V443, P297, DOI 10.1016/S0014-5793(98)01731-1; Kim S, 2006, MOL CELL BIOL, V26, P6469, DOI 10.1128/MCB.00353-06; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Liu WJ, 2008, DEVELOPMENT, V135, P3959, DOI 10.1242/dev.025304; Meester-Smoor MA, 2005, MOL CELL BIOL, V25, P4229, DOI 10.1128/MCB.25.10.4229-4236.2005; Meester-Smoor MA, 2008, CARCINOGENESIS, V29, P2025, DOI 10.1093/carcin/bgn168; Meester-Smoor MA, 2007, J MOL ENDOCRINOL, V38, P113, DOI 10.1677/jme.1.02110; Miyamoto Takeshi, 2003, Keio J Med, V52, P1; Mrak E, 2007, J ENDOCRINOL, V192, P639, DOI 10.1677/joe.1.07073; Mrozek K, 2007, CURR OPIN HEMATOL, V14, P106, DOI 10.1097/MOH.0b013e32801684c7; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Samee N, 2007, CRIT REV EUKAR GENE, V17, P173, DOI 10.1615/CritRevEukarGeneExpr.v17.i3.10; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Sutton ALM, 2005, MOL ENDOCRINOL, V19, P2234, DOI 10.1210/me.2005-0081; Sutton ALM, 2003, MOL ENDOCRINOL, V17, P777, DOI 10.1210/me.2002-0363; Sutton ALM, 2008, MOL ENDOCRINOL, V22, P1370, DOI 10.1210/me.2007-0363; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; van Wely KHM, 2003, ONCOGENE, V22, P699, DOI 10.1038/sj.onc.1206124; Xing LP, 2005, BIOCHEM BIOPH RES CO, V328, P709, DOI 10.1016/j.bbrc.2004.11.072; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	46	15	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18174	18183		10.1074/jbc.M109.001354	http://dx.doi.org/10.1074/jbc.M109.001354			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19386590	hybrid, Green Published			2022-12-25	WOS:000267712400029
J	Nishida, A; Andoh, A; Inatomi, O; Fujiyama, Y				Nishida, Atsushi; Andoh, Akira; Inatomi, Osamu; Fujiyama, Yoshihide			Interleukin-32 Expression in the Pancreas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; PROTEIN-KINASE KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; PERIACINAR MYOFIBROBLASTS; IL-6 PRODUCTION; CELL-DEATH; TNF-ALPHA; IN-VITRO; GENE	Interleukin (IL)-32 is a recently described proinflammatory cytokine characterized by the induction of nuclear factor (NF)-kappa B activation. We studied IL-32 expression in human pancreatic tissue and pancreatic cancer cell lines. Tissue samples were obtained surgically. IL-32 expression was evaluated by standard immunohistochemical procedures. IL-32 mRNA expression was analyzed by Northern blotting and real time PCR analyses. IL-32 was weakly immunoexpressed by pancreatic duct cells. In the inflamed lesions of chronic pancreas, the ductal expression of IL-32 was markedly increased. A strong expression of IL-32 alpha was detected in the pancreatic cancer cells. In pancreatic cancer cell lines (PANC-1, MIA PaCa-2, and BxPC-3 cells), the expression of IL-32 mRNA and protein was enhanced by IL-1 beta, interferon (IFN)-gamma, and tumor necrosis factor (TNF)-alpha. An inhibitor of phosphatidylinositol 3-kinase (LY294002) significantly suppressed the IL-1 beta-, IFN-gamma- and TNF-alpha-induced IL-32 mRNA expression. The blockade of NF-kappa B and activated protein-1 activation markedly suppressed the IL-1 beta-, IFN-gamma-, and/or TNF-alpha-induced IL-32 mRNA expression. Furthermore, IL-32-specific small interfering RNA significantly decreased the uptake of [H-3] thymidine and increased the annexin V-positive population (apoptotic cells) in PANC-1 cells. IL-32 knockdown also suppressed the mRNA expression of antiapoptotic proteins (Bcl-2, Bcl-xL, and Mcl-1). Pancreatic duct cells are the local source of IL-32, and IL-32 may play an important role in inflammatory responses and pancreatic cancer growth.	[Nishida, Atsushi; Andoh, Akira; Inatomi, Osamu; Fujiyama, Yoshihide] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 5202192, Japan	Shiga University of Medical Science	Nishida, A (corresponding author), Shiga Univ Med Sci, Dept Med, Otsu, Shiga 5202192, Japan.	andoh@belle.shiga-med.ac.jp	Andoh, Akira/AAB-9303-2022	Inatomi, Osamu/0000-0002-5837-6575				Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Andoh A, 2000, GASTROENTEROLOGY, V119, P211, DOI 10.1053/gast.2000.8538; Andoh A, 2002, BBA-MOL CELL RES, V1591, P69, DOI 10.1016/S0167-4889(02)00250-1; APTE SS, 1995, GENOMICS, V26, P592, DOI 10.1016/0888-7543(95)80180-T; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Cagnard N, 2005, EUR CYTOKINE NETW, V16, P289; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen Q, 2006, VITAM HORM, V74, P207, DOI 10.1016/S0083-6729(06)74008-0; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Choi JD, 2009, IMMUNOLOGY, V126, P535, DOI 10.1111/j.1365-2567.2008.02917.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DAHL CA, 1992, J IMMUNOL, V148, P597; Detlefsen S, 2008, AM J SURG PATHOL, V32, P986, DOI 10.1097/PAS.0b013e31815d2583; Dinarello CA, 2006, ANN RHEUM DIS, V65, P61, DOI 10.1136/ard.2006.058511; Fang J, 2007, CELL SIGNAL, V19, P2487, DOI 10.1016/j.cellsig.2007.07.025; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gukovsky I, 2004, GASTROENTEROLOGY, V126, P554, DOI 10.1053/j.gastro.2003.11.017; Hata K, 2002, AM J PHYSIOL-GASTR L, V282, pG1035, DOI 10.1152/ajpgi.00494.2001; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Kim KH, 2008, J IMMUNOL METHODS, V333, P38, DOI 10.1016/j.jim.2007.12.017; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Kundu M, 2006, PLOS MED, V3, P1210, DOI 10.1371/journal.pmed.0030274; Li JX, 2004, J CELL BIOL, V165, P77, DOI 10.1083/jcb.200401004; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Netea MG, 2005, P NATL ACAD SCI USA, V102, P16309, DOI 10.1073/pnas.0508237102; Netea MG, 2006, PLOS MED, V3, P1310, DOI 10.1371/journal.pmed.0030277; Novick D, 2006, P NATL ACAD SCI USA, V103, P3316, DOI 10.1073/pnas.0511206103; Obara H, 2000, ARTERIOSCL THROM VAS, V20, P2198, DOI 10.1161/01.ATV.20.10.2198; Peloponese JM, 2006, J BIOL CHEM, V281, P8927, DOI 10.1074/jbc.M510598200; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Satoh K, 1998, PANCREAS, V16, P468, DOI 10.1097/00006676-199805000-00002; Shimada M, 2002, J IMMUNOL, V168, P861, DOI 10.4049/jimmunol.168.2.861; Shioya M, 2007, CLIN EXP IMMUNOL, V149, P480, DOI 10.1111/j.1365-2249.2007.03439.x; Shoda H, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2074; Singh VP, 2001, J CLIN INVEST, V108, P1387, DOI 10.1172/JCI200112874; Sinicrope FA, 2008, CLIN CANCER RES, V14, P4128, DOI 10.1158/1078-0432.CCR-07-5160; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Tang CH, 2007, J IMMUNOL, V179, P1292, DOI 10.4049/jimmunol.179.2.1292; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Watanabe H, 2005, GASTROENTEROLOGY, V128, P1391, DOI 10.1053/j.gastro.2005.03.016; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yasumoto H, 2001, GENE THER, V8, P1682, DOI 10.1038/sj.gt.3301590; YUNIS AA, 1977, INT J CANCER, V19, P128, DOI 10.1002/ijc.2910190118; Zawalich WS, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740247	50	86	96	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17868	17876		10.1074/jbc.M900368200	http://dx.doi.org/10.1074/jbc.M900368200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19386602	hybrid, Green Published			2022-12-25	WOS:000267202500052
J	Struewing, IT; Durham, SN; Barnett, CD; Mao, CD				Struewing, Ian T.; Durham, Samuel N.; Barnett, Corey D.; Mao, Catherine D.			Enhanced Endothelial Cell Senescence by Lithium-induced Matrix Metalloproteinase-1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR; GLYCOGEN-SYNTHASE KINASE-3-BETA; ONCOGENE-INDUCED SENESCENCE; BETA-CATENIN; TRANSCRIPTIONAL ACTIVATION; EXTRACELLULAR-MATRIX; GENE; TARGET; MMP-1; WNT	Endothelial cell (EC) senescence and dysfunction occurring after chronic injury and inflammation are highly associated with the development and progression of cardiovascular diseases. However, the factors involved in the establishment of EC senescence remain poorly understood. We have previously shown that lithium, an inhibitor of glycogen synthase kinase (GSK)-3 beta and activator of the Wnt/beta-catenin signaling pathway, induces an EC senescent-like phenotype. Herein, we show that lithium induces a rapid and pronounced up-regulation of the matrix metalloproteinase (MMP)-1, an inflammation and senescent cell marker, at the mRNA and protein levels, whereas the induction of two other senescent cell markers is either weak (interleukin-8) or delayed ( plasminogen activator inhibitor-1). Lithium effect on MMP-1 expression is also specific among other MMPs and not mediated by GSK3 beta inhibition. Lithium affects MMP-1 expression mainly at the transcriptional level but neither the AP1/Ets regulatory sites nor the redox sensitive (-1607/2G) site in MMP-1 promoter are involved in lithium-dependent MMP-1 regulation. However, down-regulation of p53, a target of lithium in EC, dampens both basal and lithium-induced MMP-1 expression, which further links MMP-1 up-regulation with the establishment of cell senescence. Although increased MMP-1 levels are usually associated with angiogenesis in enabled proliferative EC, the exogenous addition of activated MMP-1 on lithium-arrested EC increases the number of EC positive for the senescent-associated-beta-galactosidase marker. Conversely, down-regulation of MMP-1 expression by small interfering RNAs blunts the lithium-dependent increase in senescent-associated-beta-galactosidase positive cells. Altogether our data indicate that lithium-induced MMP-1 may participate in the reinforcement of EC senescence and reveal a novel mechanism for lithium-induced tissue remodeling.	[Struewing, Ian T.; Durham, Samuel N.; Barnett, Corey D.; Mao, Catherine D.] Univ Kentucky, Grad Ctr Nutr Sci, Lexington, KY 40506 USA	University of Kentucky	Mao, CD (corresponding author), Univ Kentucky, Grad Ctr Nutr Sci, Lexington, KY 40506 USA.	cdmao2@uky.edu			National Institutes of Health [HL68698]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068698] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL68698 (to C. D. M.).	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; BELMAKER R H, 1990, Pharmacology and Toxicology Supplement, V66, P76; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Bertram C, 2008, EXP GERONTOL, V43, P209, DOI 10.1016/j.exger.2007.11.007; Binder BR, 2008, IMMUNOL LETT, V118, P116, DOI 10.1016/j.imlet.2008.03.017; Bower KE, 2004, ONCOGENE, V23, P8805, DOI 10.1038/sj.onc.1208109; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brandes RP, 2005, CARDIOVASC RES, V66, P286, DOI 10.1016/j.cardiores.2004.12.027; Brenneisen P, 1998, J BIOL CHEM, V273, P5279, DOI 10.1074/jbc.273.9.5279; Brinckerhoff CE, 2000, CLIN CANCER RES, V6, P4823; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Chen J, 2006, AM J PHYSIOL-HEART C, V290, pH1729, DOI 10.1152/ajpheart.01103.2005; COMI P, 1995, EXP CELL RES, V219, P304, DOI 10.1006/excr.1995.1232; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Cui J, 2007, NEUROSCIENCE, V144, P1447, DOI 10.1016/j.neuroscience.2006.11.010; Damalas A, 2001, EMBO J, V20, P4912, DOI 10.1093/emboj/20.17.4912; De Freitas DM, 2006, ACCOUNTS CHEM RES, V39, P283, DOI 10.1021/ar030197a; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599; Frederick JP, 2008, P NATL ACAD SCI USA, V105, P11605, DOI 10.1073/pnas.0801182105; Frederiks WM, 2004, J HISTOCHEM CYTOCHEM, V52, P711, DOI 10.1369/jhc.4R6251.2004; Freeman MP, 2006, AM J MED, V119, P478, DOI 10.1016/j.amjmed.2005.11.003; Gustavson MD, 2004, MOL CARCINOGEN, V41, P125, DOI 10.1002/mc.20049; Hampel B, 2006, EXP GERONTOL, V41, P474, DOI 10.1016/j.exger.2006.03.001; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Kang MK, 2003, EXP CELL RES, V287, P272, DOI 10.1016/S0014-4827(03)00061-2; Kim MK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004864; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; KUNZ C, 1995, NUCLEIC ACIDS RES, V23, P3710, DOI 10.1093/nar/23.18.3710; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Leclerc S, 2001, J BIOL CHEM, V276, P251, DOI 10.1074/jbc.M002466200; Lee RT, 1996, ARTERIOSCL THROM VAS, V16, P1070, DOI 10.1161/01.ATV.16.8.1070; Levy L, 2002, J BIOL CHEM, V277, P42386, DOI 10.1074/jbc.M207418200; Mao CD, 2001, J BIOL CHEM, V276, P26180, DOI 10.1074/jbc.M101188200; Marchenko GN, 2002, BIOCHEM J, V363, P253, DOI 10.1042/0264-6021:3630253; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; McColl G, 2008, J BIOL CHEM, V283, P350, DOI 10.1074/jbc.M705028200; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Mira E, 2004, J CELL SCI, V117, P1847, DOI 10.1242/jcs.01035; Mook ORF, 2003, J HISTOCHEM CYTOCHEM, V51, P821, DOI 10.1177/002215540305100613; Mu XC, 1998, J CELL PHYSIOL, V174, P90, DOI 10.1002/(SICI)1097-4652(199801)174:1<90::AID-JCP10>3.0.CO;2-S; Nelson KK, 2004, FREE RADICAL BIO MED, V37, P768, DOI 10.1016/j.freeradbiomed.2004.06.008; Nelson KK, 2006, J BIOL CHEM, V281, P14100, DOI 10.1074/jbc.M601820200; Nemeth ZH, 2002, J BIOL CHEM, V277, P7713, DOI 10.1074/jbc.M109711200; NIKKARI ST, 1995, CIRCULATION, V92, P1393, DOI 10.1161/01.CIR.92.6.1393; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Pardo A, 2005, INT J BIOCHEM CELL B, V37, P283, DOI 10.1016/j.biocel.2004.06.017; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Pilcher HR, 2003, NATURE, V425, P118, DOI 10.1038/425118a; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Rao JS, 2007, CANCER RES, V67, P4956, DOI 10.1158/0008-5472.CAN-07-0380; Rutter JL, 1997, J CELL BIOCHEM, V66, P322, DOI 10.1002/(SICI)1097-4644(19970901)66:3<322::AID-JCB5>3.3.CO;2-D; Rutter JL, 1998, CANCER RES, V58, P5321; Ryves WJ, 2001, BIOCHEM BIOPH RES CO, V280, P720, DOI 10.1006/bbrc.2000.4169; Seo YH, 2008, AGING CELL, V7, P894, DOI 10.1111/j.1474-9726.2008.00436.x; Sobel BE, 2003, ARTERIOSCL THROM VAS, V23, P1979, DOI 10.1161/01.ATV.0000091250.53231.4D; Struewing IT, 2007, FEBS J, V274, P2749, DOI 10.1111/j.1742-4658.2007.05809.x; Sun YB, 2004, J CELL BIOCHEM, V92, P258, DOI 10.1002/jcb.20044; Takahashi M, 2002, ONCOGENE, V21, P5861, DOI 10.1038/sj.onc.1205755; Uemura S, 2001, CIRC RES, V88, P1291, DOI 10.1161/hh1201.092042; Vines A, 2006, J BIOL CHEM, V281, P16985, DOI 10.1074/jbc.M602446200; Wenk J, 1999, J BIOL CHEM, V274, P25869, DOI 10.1074/jbc.274.36.25869; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Xu M, 2008, MOL CELL BIOL, V28, P1713, DOI 10.1128/MCB.01360-07; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Ye XF, 2007, MOL CELL, V27, P183, DOI 10.1016/j.molcel.2007.05.034; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200	72	31	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17595	17606		10.1074/jbc.M109.001735	http://dx.doi.org/10.1074/jbc.M109.001735			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19407340	Green Published, hybrid			2022-12-25	WOS:000267202500025
J	Podoly, E; Shalev, DE; Shenhar-Tsarfaty, S; Bennett, ER; Ben Assayag, E; Wilgus, H; Livnah, O; Soreq, H				Podoly, Erez; Shalev, Deborah E.; Shenhar-Tsarfaty, Shani; Bennett, Estelle R.; Ben Assayag, Einor; Wilgus, Harvey; Livnah, Oded; Soreq, Hermona			The Butyrylcholinesterase K Variant Confers Structurally Derived Risks for Alzheimer Pathology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT HUMAN BUTYRYLCHOLINESTERASE; AMYLOID BETA-PROTEIN; FORMATION IN-VITRO; CASCADE HYPOTHESIS; MOLECULAR-FORMS; SENILE PLAQUES; DISEASE; ACETYLCHOLINESTERASE; BRAIN; CHOLINESTERASES	The K variant of butyrylcholinesterase (BChE-K, 20% incidence) is a long debated risk factor for Alzheimer disease ( AD). The A539T substitution in BChE-K is located at the C terminus, which is essential both for BChE tetramerization and for its capacity to attenuate beta-amyloid (A beta) fibril formation. Here, we report that BChE-K is inherently unstable as compared with the "usual" BChE (BChE-U), resulting in reduced hydrolytic activity and predicting prolonged acetylcholine maintenance and protection from AD. A synthetic peptide derived from the C terminus of BChE-K (BSP-K), which displayed impaired intermolecular interactions, was less potent in suppressing A beta oligomerization than its BSP-U counterpart. Correspondingly, highly purified recombinant human rBChE-U monomers suppressed beta-amyloid fibril formation less effectively than dimers, which also protected cultured neuroblastoma cells from A beta neurotoxicity. Dual activity structurally derived changes due to the A539T substitution can thus account for both neuroprotective characteristics caused by sustained acetylcholine levels and elevated AD risk due to inefficient interference with amyloidogenic processes.	[Soreq, Hermona] Hebrew Univ Jerusalem, Dept Biol Chem, Alexander Silberman Life Sci Inst, IL-91904 Jerusalem, Israel; [Podoly, Erez; Shalev, Deborah E.; Livnah, Oded] Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, IL-91904 Jerusalem, Israel; [Shenhar-Tsarfaty, Shani; Ben Assayag, Einor] Tel Aviv Univ, Sackler Fac Med, Sourasky Med Ctr, Dept Neurol, IL-69978 Tel Aviv, Israel; [Wilgus, Harvey] PharmAthene Canada Inc, Montreal, PQ H4S 2C8, Canada	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Soreq, H (corresponding author), Hebrew Univ Jerusalem, Dept Biol Chem, Alexander Silberman Life Sci Inst, Safra Campus, IL-91904 Jerusalem, Israel.	soreq@cc.huji.ac.il	Shalev, Deborah E/AAY-2873-2021; Bennett, Estelle R/A-5067-2017	Shenhar-Tsarfaty, Shani/0000-0002-8268-1799; Soreq, Hermona/0000-0002-0955-526X	Hurwitz Fund	Hurwitz Fund	This work was supported by a grant from the Hurwitz Fund ( to H. S.).	Altamirano CV, 1999, CHEM-BIOL INTERACT, V119, P53, DOI 10.1016/S0009-2797(99)00013-7; ARENDT T, 1992, NEUROCHEM INT, V21, P381, DOI 10.1016/0197-0186(92)90189-X; ARPAGAUS M, 1990, BIOCHEMISTRY-US, V29, P124, DOI 10.1021/bi00453a015; Babbes ARH, 2008, BIOCHEMISTRY-US, V47, P6969, DOI 10.1021/bi800636q; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; BARTELS CF, 1992, AM J HUM GENET, V50, P1086; Ben Assayag E, 2006, THROMB HAEMOSTASIS, V95, P428, DOI 10.1160/THOS-08-0578; Bergmeyer H.U., 1963, METHOD ENZYMAT AN, P736; Berson A, 2008, BRAIN, V131, P109, DOI 10.1093/brain/awm276; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Blong RM, 1997, BIOCHEM J, V327, P747, DOI 10.1042/bj3270747; Bon S, 2003, NEUROCHEM RES, V28, P523, DOI 10.1023/A:1022821306722; Bush AI, 2008, NEUROTHERAPEUTICS, V5, P421, DOI 10.1016/j.nurt.2008.05.001; CARSON KA, 1991, BRAIN RES, V540, P204, DOI 10.1016/0006-8993(91)90508-S; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Diamant S, 2006, P NATL ACAD SCI USA, V103, P8628, DOI 10.1073/pnas.0602922103; Dvir H, 2004, EMBO J, V23, P4394, DOI 10.1038/sj.emboj.7600425; EDWARDS JA, 1983, BIOCHIM BIOPHYS ACTA, V742, P509, DOI 10.1016/0167-4838(83)90268-6; Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020; Gatke MR, 2002, SCAND J CLIN LAB INV, V62, P375, DOI 10.1080/00365510260296537; Ghebremedhin E, 2002, NEUROSCI LETT, V320, P25, DOI 10.1016/S0304-3940(02)00014-9; Glabe C, 2001, J MOL NEUROSCI, V17, P137, DOI 10.1385/JMN:17:2:137; GomezRamos P, 1997, MOL CHEM NEUROPATHOL, V30, P161, DOI 10.1007/BF02815095; Guillozet AL, 1997, ANN NEUROL, V42, P909, DOI 10.1002/ana.410420613; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heise H, 2008, J MOL BIOL, V380, P444, DOI 10.1016/j.jmb.2008.05.026; Holmes C, 2005, J NEUROL NEUROSUR PS, V76, P640, DOI 10.1136/jnnp.2004.039321; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P13603, DOI 10.1073/pnas.0702756104; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; LANSBURY PT, 1992, BIOCHEMISTRY-US, V31, P6865, DOI 10.1021/bi00145a001; Lee HG, 2004, ANN NY ACAD SCI, V1019, P1, DOI 10.1196/annals.1297.001; Li H, 2008, BIOCHEM J, V411, P425, DOI 10.1042/BJ20071551; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Lopez OL, 2002, J NEUROL NEUROSUR PS, V72, P310, DOI 10.1136/jnnp.72.3.310; Mancuso M, 2007, ANTIOXID REDOX SIGN, V9, P1631, DOI 10.1089/ars.2007.1761; MORAN MA, 1993, ACTA NEUROPATHOL, V85, P362, DOI 10.1007/BF00334445; Ngamelue MN, 2007, ACTA CRYSTALLOGR F, V63, P723, DOI 10.1107/S1744309107037335; Nicolet Y, 2003, J BIOL CHEM, V278, P41141, DOI 10.1074/jbc.M210241200; O'Brien KK, 2003, PHARMACOGENETICS, V13, P231, DOI 10.1097/00008571-200304000-00008; Ofek K, 2007, J MOL MED, V85, P1239, DOI 10.1007/s00109-007-0226-x; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; PERRY EK, 1978, NEUROPATH APPL NEURO, V4, P273, DOI 10.1111/j.1365-2990.1978.tb00545.x; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Podoly E, 2008, NEURODEGENER DIS, V5, P232, DOI 10.1159/000113711; Pratico D, 2008, ANN NY ACAD SCI, V1147, P70, DOI 10.1196/annals.1427.010; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Soto P, 2007, BIOPHYS J, V93, P3015, DOI 10.1529/biophysj.107.112086; Tidow H, 2007, P NATL ACAD SCI USA, V104, P12324, DOI 10.1073/pnas.0705069104; Wagner R, 1996, J MAGN RESON SER A, V123, P119, DOI 10.1006/jmra.1996.0222; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; WRIGHT CI, 1993, ANN NEUROL, V34, P373, DOI 10.1002/ana.410340312; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zhu XW, 2004, LANCET NEUROL, V3, P219, DOI 10.1016/S1474-4422(04)00707-0	56	76	76	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17170	17179		10.1074/jbc.M109.004952	http://dx.doi.org/10.1074/jbc.M109.004952			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19383604	hybrid, Green Published			2022-12-25	WOS:000266962400055
J	Noh, T; Gabet, Y; Cogan, J; Shi, YF; Tank, A; Sasaki, T; Criswell, B; Dixon, A; Lee, C; Tam, J; Kohler, T; Segev, E; Kockeritz, L; Woodgett, J; Muller, R; Chai, Y; Smith, E; Bab, I; Frenkel, B				Noh, Tommy; Gabet, Yankel; Cogan, Jon; Shi, Yunfan; Tank, Archana; Sasaki, Tomoyo; Criswell, Braden; Dixon, Alexis; Lee, Christopher; Tam, Joseph; Kohler, Thomas; Segev, Eran; Kockeritz, Lisa; Woodgett, James; Mueller, Ralph; Chai, Yang; Smith, Elisheva; Bab, Itai; Frenkel, Baruch			Lef1 Haploinsufficient Mice Display a Low Turnover and Low Bone Mass Phenotype in a Gender- and Age-Specific Manner	PLOS ONE			English	Article								We investigated the role of Lef1, one of the four transcription factors that transmit Wnt signaling to the genome, in the regulation of bone mass. Microcomputed tomographic analysis of 13- and 17-week-old mice revealed significantly reduced trabecular bone mass in Lef1(+/-) females compared to littermate wild-type females. This was attributable to decreased osteoblast activity and bone formation as indicated by histomorphometric analysis of bone remodeling. In contrast to females, bone mass was unaffected by Lef1 haploinsufficiency in males. Similarly, females were substantially more responsive than males to haploinsufficiency in Gsk3 beta, a negative regulator of the Wnt pathway, displaying in this case a high bone mass phenotype. Lef1 haploinsufficiency also led to low bone mass in males lacking functional androgen receptor (AR) (tfm mutants). The protective skeletal effect of AR against Wnt-related low bone mass is not necessarily a result of direct interaction between the AR and Wnt signaling pathways, because Lef1(+/-) female mice had normal bone mass at the age of 34 weeks. Thus, our results indicate an age- and gender-dependent role for Lef1 in regulating bone formation and bone mass in vivo. The resistance to Lef1 haploinsufficiency in males with active AR and in old females could be due to the reduced bone turnover in these mice.			Noh, T (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA.	frenkel@usc.edu	Müller, Ralph/A-1198-2008; Woodgett, Jim/F-1087-2010; Gabet, Yankel/I-6244-2019	Müller, Ralph/0000-0002-5811-7725; Woodgett, Jim/0000-0003-3731-5797; Gabet, Yankel/0000-0002-7494-0631; Cogan, Jon/0000-0001-9327-8711	CIHR [74711] Funding Source: Medline; NCI NIH HHS [CA62528-01, C06 CA062528] Funding Source: Medline; NCRR NIH HHS [RR14514-01, C06 RR10600-01, C06 RR014514] Funding Source: Medline; NIAMS NIH HHS [R01 AR047052, AR047052] Funding Source: Medline; NATIONAL CANCER INSTITUTE [C06CA062528] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR014514, C06RR010600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047052] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Akhter MP, 2004, BONE, V35, P162, DOI 10.1016/j.bone.2004.02.018; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Bab I. A., 2007, MICROTOMOGRAPHIC ATL; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Bajayo A, 2005, P NATL ACAD SCI USA, V102, P12956, DOI 10.1073/pnas.0502562102; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; DeMambro VE, 2008, ENDOCRINOLOGY, V149, P2051, DOI 10.1210/en.2007-1068; Dubrow S. A., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P166; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Galceran J, 2000, DEVELOPMENT, V127, P469; Galceran J, 1999, GENE DEV, V13, P709, DOI 10.1101/gad.13.6.709; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Glass DA, 2006, CURR TOP DEV BIOL, V73, P43, DOI 10.1016/S0070-2153(05)73002-7; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Harte D, 1998, J NONLINEAR SCI, V8, P581, DOI 10.1007/s003329900060; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; Juttner KV, 2007, BONE, V41, P25, DOI 10.1016/j.bone.2007.03.012; Kahler RA, 2006, J CELL BIOCHEM, V97, P969, DOI 10.1002/jcb.20702; Kahler RA, 2003, J BIOL CHEM, V278, P11937, DOI 10.1074/jbc.M211443200; Kamiya N, 2008, DEVELOPMENT, V135, P3801, DOI 10.1242/dev.025825; Kang HY, 2004, J BONE MINER RES, V19, P1181, DOI 10.1359/JBMR.040306; Korinek V, 1998, MOL CELL BIOL, V18, P1248, DOI 10.1128/MCB.18.3.1248; Kugimiya F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000837; LECLERC N, 2007, J CELL BIOCH; Leclerc N, 2008, J CELL BIOCHEM, V103, P1938, DOI 10.1002/jcb.21587; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; Liu XH, 2007, ANN NY ACAD SCI, V1116, P423, DOI 10.1196/annals.1402.017; Liu XH, 2007, CANCER RES, V67, P5747, DOI 10.1158/0008-5472.CAN-07-0478; LYON MF, 1970, NATURE, V227, P1217, DOI 10.1038/2271217a0; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MacDonald H, 2006, BONE, V39, P598, DOI 10.1016/j.bone.2006.02.057; Matsumoto C, 2006, BONE, V38, P220, DOI 10.1016/j.bone.2005.08.019; Migliaccio A, 2007, ONCOGENE, V26, P6619, DOI 10.1038/sj.onc.1210487; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Mishina Y, 2004, J BIOL CHEM, V279, P27560, DOI 10.1074/jbc.M404222200; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Nantermet PV, 2004, J BIOL CHEM, V279, P1310, DOI 10.1074/jbc.M310206200; Neu CM, 2001, BONE, V28, P227, DOI 10.1016/S8756-3282(00)00429-4; Ohnaka K, 2004, BIOCHEM BIOPH RES CO, V318, P259, DOI 10.1016/j.bbrc.2004.04.025; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Pantschenko AG, 2005, J BONE MINER RES, V20, P1414, DOI 10.1359/JBMR.050315; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; PENNYPACKER B, 2008, BONE; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Ruegsegger P, 1996, CALCIFIED TISSUE INT, V58, P24, DOI 10.1007/s002239900006; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Singh R, 2006, ENDOCRINOLOGY, V147, P141, DOI 10.1210/en.2004-1649; Smith E, 2005, J BIOL CHEM, V280, P2388, DOI 10.1074/jbc.M406294200; Smith E, 2002, J BIOL CHEM, V277, P18191, DOI 10.1074/jbc.M109708200; Staal FJT, 2001, EUR J IMMUNOL, V31, P285, DOI 10.1002/1521-4141(200101)31:1<285::AID-IMMU285>3.3.CO;2-4; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; Vandenput L, 2004, J BONE MINER RES, V19, P1462, DOI 10.1359/JBMR.040505; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Wang FS, 2005, ENDOCRINOLOGY, V146, P2415, DOI 10.1210/en.2004-1050; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wu YL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000586; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1; Yirmiya R, 2006, P NATL ACAD SCI USA, V103, P16876, DOI 10.1073/pnas.0604234103	71	49	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2009	4	5							e5438	10.1371/journal.pone.0005438	http://dx.doi.org/10.1371/journal.pone.0005438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440RC	19412553	Green Published, gold, Green Submitted			2022-12-25	WOS:000265716400005
J	Turriziani, P; Oliveri, M; Bonni, S; Koch, G; Smirni, D; Cipolotti, L				Turriziani, Patrizia; Oliveri, Massimiliano; Bonni, Sonia; Koch, Giacomo; Smirni, Daniela; Cipolotti, Lisa			Exploring the Relationship between Semantics and Space	PLOS ONE			English	Article							MENTAL NUMBER LINE; SPATIAL NEGLECT; PARIETAL RTMS; BISECTION; REPRESENTATION; PSEUDONEGLECT; ATTENTION; SEQUENCES; COGNITION; PICTURES	The asymmetric distribution of human spatial attention has been repeatedly documented in both patients and healthy controls. Biases in the distribution of attention and/or in the mental representation of space may also affect some aspects of language processing. We investigated whether biases in attention and/or mental representation of space affect semantic representations. In particular, we investigated whether semantic judgments could be modulated by the location in space where the semantic information was presented and the role of the left and right parietal cortices in this task. Healthy subjects were presented with three pictures arranged horizontally (one middle and two outer pictures) of items belonging to the same semantic category. Subjects were asked to indicate the spatial position in which the semantic distance between the outer and middle pictures was smaller. Subjects systematically overestimated the semantic distance of items presented in the right side of space. We explored the neural correlates underpinning this bias using rTMS over the left and right parietal cortex. rTMS of the left parietal cortex selectively reduced this rightward bias. Our findings suggest the existence of an attentional and/or mental representational bias in semantic judgments, similar to that observed for the processing of space and numbers. Spatial manipulation of semantic material results in the activation of specialised attentional resources located in the left hemisphere.			Turriziani, P (corresponding author), Univ Palermo, Dipartimento Psicol, Palermo, Italy.	p.turriziani@unipa.it	Oliveri, Massimiliano/HDO-5602-2022; Koch, Giacomo/G-3155-2012; Smirni, Daniela/R-3445-2019	Smirni, Daniela/0000-0002-4410-2047; cipolotti, lisa/0000-0001-5838-3647; Turriziani, Patrizia/0000-0003-4802-280X; KOch, Giacomo/0000-0001-6155-9439				BISIACH E, 1978, CORTEX, V14, P129, DOI 10.1016/S0010-9452(78)80016-1; Bjoertomt O, 2002, BRAIN, V125, P2012, DOI 10.1093/brain/awf211; BOWERS D, 1980, NEUROPSYCHOLOGIA, V18, P491, DOI 10.1016/0028-3932(80)90151-7; Buchanan L, 2001, PSYCHON B REV, V8, P531, DOI 10.3758/BF03196189; Cappelletti M, 2007, NEUROPSYCHOLOGIA, V45, P2989, DOI 10.1016/j.neuropsychologia.2007.05.014; CHATTERJEE A, 1995, NEUROPSYCHOLOGIA, V33, P643, DOI 10.1016/0028-3932(94)00134-B; Coslett HB, 1999, NEUROPSYCHOLOGIA, V37, P695, DOI 10.1016/S0028-3932(98)00116-X; Cristescu TC, 2006, NEUROIMAGE, V33, P1178, DOI 10.1016/j.neuroimage.2006.08.017; Danckert J, 2007, J COGNITIVE NEUROSCI, V19, P1706, DOI 10.1162/jocn.2007.19.10.1706; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Dell'acqua R, 2000, BEHAV RES METH INS C, V32, P588, DOI 10.3758/BF03200832; Doricchi F, 2005, NAT NEUROSCI, V8, P1663, DOI 10.1038/nn1563; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; Fierro B, 2000, NEUROREPORT, V11, P1519, DOI 10.1097/00001756-200005150-00030; Fink GR, 2000, NEUROLOGY, V54, P1324, DOI 10.1212/WNL.54.6.1324; Fink GR, 2001, NEUROIMAGE, V14, pS59, DOI 10.1006/nimg.2001.0819; Fischer MH, 2001, TRENDS COGN SCI, V5, P460, DOI 10.1016/S1364-6613(00)01790-3; Fischer MH, 1996, COGNITIVE BRAIN RES, V4, P163, DOI 10.1016/S0926-6410(96)00029-8; Fischer MH, 2000, PERCEPTION, V29, P337; Gevers W, 2003, COGNITION, V87, pB87, DOI 10.1016/S0010-0277(02)00234-2; Gobel SM, 2006, NEUROPSYCHOLOGIA, V44, P860, DOI 10.1016/j.neuropsychologia.2005.09.007; Gross C.G., 1995, NEUROSCIENTIST, V1, P43, DOI [10.1177/107385849500100107, DOI 10.1177/107385849500100107]; Halligan PW, 2003, TRENDS COGN SCI, V7, P125, DOI 10.1016/S1364-6613(03)00032-9; HEILMAN KM, 1993, CLIN NEUROPSYCHOLOGY, P268; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Karnath HO, 2004, CEREB CORTEX, V14, P1164, DOI 10.1093/cercor/bhh076; Kinsbourne M, 1970, Trans Am Neurol Assoc, V95, P143; Kinsbourne M., 1993, UNILATERAL NEGLECT C, DOI DOI 10.4324/9780203765258; Lee BH, 2004, NEUROPSYCHOLOGIA, V42, P1715, DOI 10.1016/j.neuropsychologia.2004.02.015; Lee SY, 2004, MOL CELLS, V17, P174; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Mohr C, 2007, NEUROPSYCHOLOGIA, V45, P295, DOI 10.1016/j.neuropsychologia.2006.07.003; Nicholls MER, 2007, BRAIN RES, V1152, P130, DOI 10.1016/j.brainres.2007.03.036; Oliveri M, 2004, NEUROLOGY, V63, P2139, DOI 10.1212/01.WNL.0000145975.58478.6D; Pexman PM, 2007, PSYCHOL SCI, V18, P401, DOI 10.1111/j.1467-9280.2007.01913.x; Priftis K, 2006, J COGNITIVE NEUROSCI, V18, P680, DOI 10.1162/jocn.2006.18.4.680; Rinaldi C, 2003, NEUROREPORT, V14, P1381, DOI 10.1097/00001756-200307180-00020; Rinaldi MC, 2006, NEUROPSYCHOLOGIA, V44, P556, DOI 10.1016/j.neuropsychologia.2005.07.007; Siakaluk PD, 2003, MEM COGNITION, V31, P100, DOI 10.3758/BF03196086; Siman-Tov T, 2007, J NEUROSCI, V27, P11271, DOI 10.1523/JNEUROSCI.0599-07.2007; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Vigliocco G, 2004, COGNITIVE PSYCHOL, V48, P422, DOI 10.1016/j.cogpsych.2003.09.001; Vuilleumier P, 2004, CORTEX, V40, P399, DOI 10.1016/S0010-9452(08)70134-5; Zannino GD, 2006, COGN NEUROPSYCHOL, V23, P515, DOI 10.1080/02643290542000067; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a; Zorzi M, 2006, NEUROPSYCHOLOGIA, V44, P1061, DOI 10.1016/j.neuropsychologia.2005.10.025	46	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2009	4	4							e5319	10.1371/journal.pone.0005319	http://dx.doi.org/10.1371/journal.pone.0005319			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437VI	19396359	gold, Green Published			2022-12-25	WOS:000265514600003
J	Dotan-Cohen, D; Letovsky, S; Melkman, AA; Kasif, S				Dotan-Cohen, Dikla; Letovsky, Stan; Melkman, Avraham A.; Kasif, Simon			Biological Process Linkage Networks	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; SEMANTIC SIMILARITY MEASURES; SACCHAROMYCES-CEREVISIAE; FUNCTION PREDICTION; GENE ONTOLOGY; YEAST; EXPRESSION; DISCOVERY; DATABASE; MODULES	Background: The traditional approach to studying complex biological networks is based on the identification of interactions between internal components of signaling or metabolic pathways. By comparison, little is known about interactions between higher order biological systems, such as biological pathways and processes. We propose a methodology for gleaning patterns of interactions between biological processes by analyzing protein-protein interactions, transcriptional co-expression and genetic interactions. At the heart of the methodology are the concept of Linked Processes and the resultant network of biological processes, the Process Linkage Network (PLN). Results: We construct, catalogue, and analyze different types of PLNs derived from different data sources and different species. When applied to the Gene Ontology, many of the resulting links connect processes that are distant from each other in the hierarchy, even though the connection makes eminent sense biologically. Some others, however, carry an element of surprise and may reflect mechanisms that are unique to the organism under investigation. In this aspect our method complements the link structure between processes inherent in the Gene Ontology, which by its very nature is species-independent. As a practical application of the linkage of processes we demonstrate that it can be effectively used in protein function prediction, having the power to increase both the coverage and the accuracy of predictions, when carefully integrated into prediction methods. Conclusions: Our approach constitutes a promising new direction towards understanding the higher levels of organization of the cell as a system which should help current efforts to re-engineer ontologies and improve our ability to predict which proteins are involved in specific biological processes.			Dotan-Cohen, D (corresponding author), Ben Gurion Univ Negev, Dept Comp Sci, IL-84105 Beer Sheva, Israel.	dotna@cs.bgu.ac.il		Melkman, Avraham/0000-0002-6832-0102	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003367, R33HG002850] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER; NHGRI NIH HHS [1R33HG002850-01A1, R01 HG003367-01A1, R01 HG003367, R33 HG002850] Funding Source: Medline; NLM NIH HHS [U54 LM008748] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Battle A, 2005, J COMPUT BIOL, V12, P909, DOI 10.1089/cmb.2005.12.909; Bork P, 2004, CURR OPIN STRUC BIOL, V14, P292, DOI 10.1016/j.sbi.2004.05.003; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Guo X, 2006, BIOINFORMATICS, V22, P967, DOI 10.1093/bioinformatics/btl042; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hishigaki H, 2001, YEAST, V18, P523, DOI 10.1002/yea.706; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Huynen MA, 2003, CURR OPIN CELL BIOL, V15, P191, DOI 10.1016/S0955-0674(03)00009-7; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Karaoz U, 2004, P NATL ACAD SCI USA, V101, P2888, DOI 10.1073/pnas.0307326101; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Larochelle M, 2006, MOL CELL BIOL, V26, P6690, DOI 10.1128/MCB.02450-05; Lin D, 1998, P INT C MACH LEARN; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; LU JL, 2007, TRENDS BIOCHEM SCI, V32, P320; Lubovac Z, 2006, PROTEINS, V64, P948, DOI 10.1002/prot.21071; Luo F, 2007, BIOINFORMATICS, V23, P207, DOI 10.1093/bioinformatics/btl562; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stavreva DA, 2006, MOL CELL BIOL, V26, P5131, DOI 10.1128/MCB.02227-05; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Wong SL, 2004, P NATL ACAD SCI USA, V101, P15682, DOI 10.1073/pnas.0406614101; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303	40	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5313	10.1371/journal.pone.0005313	http://dx.doi.org/10.1371/journal.pone.0005313			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390589	Green Published, Green Submitted, gold			2022-12-25	WOS:000265514200023
J	Bosgraaf, L; Van Haastert, PJM				Bosgraaf, Leonard; Van Haastert, Peter J. M.			The Ordered Extension of Pseudopodia by Amoeboid Cells in the Absence of External Cues	PLOS ONE			English	Article								Eukaryotic cells extend pseudopodia for movement. In the absence of external cues, cells move in random directions, but with a strong element of persistence that keeps them moving in the same direction Persistence allows cells to disperse over larger areas and is instrumental to enter new environments where spatial cues can lead the cell. Here we explore cell movement by analyzing the direction, size and timing of similar to 2000 pseudopodia that are extended by Dictyostelium cells. The results show that pseudpopod are extended perpendicular to the surface curvature at the place where they emerge. The location of new pseudopods is not random but highly ordered. Two types of pseudopodia may be formed: frequent splitting of an existing pseudopod, or the occasional extension of a de novo pseudopod at regions devoid of recent pseudopod activity. Split-pseudopodia are extended at similar to 60 degrees relative to the previous pseudopod, mostly as alternating Right/Left/Right steps leading to relatively straight zigzag runs. De novo pseudopodia are extended in nearly random directions thereby interrupting the zigzag runs. Persistence of cell movement is based on the ratio of split versus de novo pseudopodia. We identify PLA2 and cGMP signaling pathways that modulate this ratio of splitting and de novo pseudopodia, and thereby regulate the dispersal of cells. The observed ordered extension of pseudopodia in the absence of external cues provides a fundamental insight into the coordinated movement of cells, and might form the basis for movement that is directed by internal or external cues.			Bosgraaf, L (corresponding author), Univ Groningen, Dept Cell Biochem, Haren, Netherlands.	P.J.M.van.haastert@rug.nl						Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Blagg SL, 2003, CURR BIOL, V13, P1480, DOI 10.1016/S0960-9822(03)00580-3; Bosgraaf L, 2002, EMBO J, V21, P4560, DOI 10.1093/emboj/cdf438; BOSGRAAF L, 2009, QUIMP3 AUTOMATED PSE; BOSGRAAF L, 2009, CELL MOTIL IN PRESS; Chen LF, 2003, MOL BIOL CELL, V14, P5028, DOI 10.1091/mbc.E03-05-0339; Chen LF, 2007, DEV CELL, V12, P603, DOI 10.1016/j.devcel.2007.03.005; Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; CODLING EA, 2008, J R SOC INTERFACE, V15, P15; Dormann D, 2002, CELL MOTIL CYTOSKEL, V52, P221, DOI 10.1002/cm.10048; GAIL MH, 1970, BIOPHYS J, V10, P980, DOI 10.1016/S0006-3495(70)86347-0; HALL RL, 1977, J MATH BIOL, V4, P327, DOI 10.1007/BF00275081; Janetopoulos C, 2008, FEBS LETT, V582, P2075, DOI 10.1016/j.febslet.2008.04.035; Kamimura Y, 2008, CURR BIOL, V18, P1034, DOI 10.1016/j.cub.2008.06.068; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Loovers HM, 2006, MOL BIOL CELL, V17, P1503, DOI 10.1091/mbc.E05-09-0825; Maeda YT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003734; PATLAK CLIFFORD S., 1953, BULL MATH BIOPHYS, V15, P311, DOI 10.1007/BF02476407; Pegtel DM, 2007, CURR BIOL, V17, P1623, DOI 10.1016/j.cub.2007.08.035; Pollard TD, 2003, NATURE, V422, P741, DOI 10.1038/nature01598; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; POTEL MJ, 1979, J CELL SCI, V36, P281; SWANSON JA, 1982, CELL, V28, P225, DOI 10.1016/0092-8674(82)90340-3; Takagi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002648; Tang L, 2008, GENE DEV, V22, P2278, DOI 10.1101/gad.1694508; van Haastert PJM, 2007, J CELL BIOL, V177, P809, DOI 10.1083/jcb.200701134; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Veltman DM, 2008, J CELL BIOL, V180, P747, DOI 10.1083/jcb.200709180; Veltman DM, 2006, MOL BIOL CELL, V17, P3921, DOI 10.1091/mbc.E06-05-0381; Xu JS, 2005, P NATL ACAD SCI USA, V102, P6884, DOI 10.1073/pnas.0502106102	32	131	132	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5253	10.1371/journal.pone.0005253	http://dx.doi.org/10.1371/journal.pone.0005253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384419	gold, Green Published, Green Submitted			2022-12-25	WOS:000265513900009
J	Cao, PR; Hanai, J; Tanksale, P; Imamura, S; Sukhatme, VP; Lecker, SH				Cao, Peirang; Hanai, Jun-ichi; Tanksale, Preeti; Imamura, Shintaro; Sukhatme, Vikas P.; Lecker, Stewart H.			Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect	FASEB JOURNAL			English	Article						atrophy; farnesylation	DEPENDENT CARDIAC-HYPERTROPHY; SKELETAL-MUSCLE; IGF-I; GENE-EXPRESSION; KINASE; MYOPATHY; PATHWAY; CELLS; INHIBITION; RHEB	Statins are widely used to treat hypercholesterolemia but can lead to a number of side effects in muscle, including rhabdomyolysis. Our recent findings implicated the induction of atrogin-1, a gene required for the development of muscle atrophy, in statin-induced muscle damage. Since statins inhibit many biochemical reactions besides cholesterol synthesis, we sought to define the statin-inhibited pathways responsible for atrogin-1 expression and muscle damage. We report here that lovastatin-induced atrogin-1 expression and muscle damage in cultured mouse myotubes and zebrafish can be prevented in the presence of geranylgeranol but not farnesol. Further, inhibitors of the transfer of geranylgeranyl isoprene units to protein targets cause statin muscle damage and atrogin-1 induction in cultured cells and in fish. These findings support the concept that dysfunction of small GTP-binding proteins lead to statin-induced muscle damage since these molecules require modification by geranylgeranyl moieties for their cellular localization and activity. Collectively, our animal and in vitro findings shed light on the molecular mechanism of statin-induced myopathy and suggest that atrogin-1 may be regulated by novel signaling pathways.-Cao, P., Hanai, J., Tanksale, P., Imamura, S., Sukhatme, V. P., Lecker, S. H. Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect. FASEB J. 23, 2844-2854 (2009). www.fasebj.org	[Cao, Peirang; Hanai, Jun-ichi; Tanksale, Preeti; Sukhatme, Vikas P.; Lecker, Stewart H.] Beth Israel Deaconess Med Ctr, Div Renal, Dept Med, Boston, MA 02215 USA; [Hanai, Jun-ichi; Sukhatme, Vikas P.] Beth Israel Deaconess Med Ctr, Div Interdisciplinary Med & Biotechnol, Dept Med, Boston, MA 02215 USA; [Imamura, Shintaro] Natl Res Inst Fisheries Sci, Food Technol & Biochem Div, Yokohama, Kanagawa, Japan	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Japan Fisheries Research & Education Agency (FRA)	Lecker, SH (corresponding author), Beth Israel Deaconess Med Ctr, Div Renal, Dept Med, DA517,330 Brookline Ave, Boston, MA 02215 USA.	slecker@bidmc.harvard.edu	cao, peirang/AAH-1746-2019; Sukhatme, Vikas/W-2776-2019	cao, peirang/0000-0003-4729-5478; 	U.S. National Institutes of Health [DK062307]; Beth Israel Deaconess Medical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062307] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beth Israel Deaconess Medical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the V.P.S. laboratory and the Alfred L. Goldberg laboratory (Harvard Medical School, Boston, MA, USA) for their useful discussions. We also thank Eriko Koshimizu and Nathaniel Doro for technical support. This work was supported by grants from the U.S. National Institutes of Health (DK062307) to S. H. L. and seed funds from Beth Israel Deaconess Medical Center to V.P.S.	Antons KA, 2006, AM J MED, V119, P400, DOI 10.1016/j.amjmed.2006.02.007; Attaix D, 2005, INT J BIOCHEM CELL B, V37, P1962, DOI 10.1016/j.biocel.2005.04.009; Baba TT, 2008, J MUSCLE RES CELL M, V29, P127, DOI 10.1007/s10974-008-9146-9; Baker SK, 2001, CLIN INVEST MED, V24, P258; Baker SK, 2005, MUSCLE NERVE, V31, P572, DOI 10.1002/mus.20291; Ballantyne CM, 2003, ARCH INTERN MED, V163, P553, DOI 10.1001/archinte.163.5.553; Bdolah Y, 2007, AM J PHYSIOL-REG I, V292, pR971, DOI 10.1152/ajpregu.00617.2006; Berthold HK, 2006, DRUG SAFETY, V29, P703, DOI 10.2165/00002018-200629080-00007; Birely J, 2005, DEV BIOL, V280, P162, DOI 10.1016/j.ydbio.2005.01.012; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220; Buettner C, 2008, PHARMACOGENOMICS, V9, P1133, DOI 10.2217/14622416.9.8.1133; Buettner C, 2008, J GEN INTERN MED, V23, P1182, DOI 10.1007/s11606-008-0636-7; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Crick DC, 1997, BIOCHEM BIOPH RES CO, V237, P483, DOI 10.1006/bbrc.1997.7145; CROW MT, 1986, DEV BIOL, V118, P333, DOI 10.1016/0012-1606(86)90002-3; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Fernandez M, 2005, J MOL ENDOCRINOL, V34, P699, DOI 10.1677/jme.1.01703; Flint OP, 1997, TOXICOL APPL PHARM, V145, P91, DOI 10.1006/taap.1997.8131; Foley KA, 2004, AM J CARDIOL, V93, P193, DOI 10.1016/j.amjcard.2003.09.035; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Graham DJ, 2004, JAMA-J AM MED ASSOC, V292, P2585, DOI 10.1001/jama.292.21.2585; Hanai J, 2002, J CELL BIOL, V158, P529, DOI 10.1083/jcb.200203064; Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741; Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180; Holstein SA, 2006, CANCER CHEMOTH PHARM, V57, P155, DOI 10.1007/s00280-005-0013-8; Ivorra' C, 2006, GENE DEV, V20, P307, DOI 10.1101/gad.349506; Kaufmann P, 2006, CELL MOL LIFE SCI, V63, P2415, DOI 10.1007/s00018-006-6235-z; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Lamperti C, 2005, ARCH NEUROL-CHICAGO, V62, P1709, DOI 10.1001/archneur.62.11.1709; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Liao JK, 2002, J CLIN INVEST, V110, P285, DOI 10.1172/JCI200216421; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Marcoff L, 2007, J AM COLL CARDIOL, V49, P2231, DOI 10.1016/j.jacc.2007.02.049; Matzno S, 1997, J LIPID RES, V38, P1639; Maurer-Stroh S, 2007, PLOS COMPUT BIOL, V3, P634, DOI 10.1371/journal.pcbi.0030066; Mieulet V, 2007, AM J PHYSIOL-CELL PH, V293, pC712, DOI 10.1152/ajpcell.00499.2006; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; NAMBUDIRI AMD, 1980, J BIOL CHEM, V255, P5894; O'Meara JG, 2004, ARCH INTERN MED, V164, P1313, DOI 10.1001/archinte.164.12.1313; Okuno Y, 2002, BLOOD, V100, P4420, DOI 10.1182/blood-2002-03-0788; PAN HY, 1990, J CLIN PHARMACOL, V30, P1128, DOI 10.1002/j.1552-4604.1990.tb01856.x; Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009; Pizon V, 2000, ONCOGENE, V19, P6074, DOI 10.1038/sj.onc.1203984; Ren ZB, 1997, BIOCHEM PHARMACOL, V54, P113, DOI 10.1016/S0006-2952(97)00151-2; Romano D, 2006, ENDOCRINOLOGY, V147, P6036, DOI 10.1210/en.2006-0325; Sakamoto K, 2007, FASEB J, V21, P4087, DOI 10.1096/fj.07-8713com; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Siddals KW, 2004, J BIOL CHEM, V279, P38353, DOI 10.1074/jbc.M404838200; Staffa JA, 2002, NEW ENGL J MED, V346, P539, DOI 10.1056/NEJM200202143460721; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Tomasetti M, 1999, BIOFACTORS, V9, P231, DOI 10.1002/biof.5520090218; Ulucan C, 2007, AM J PHYSIOL-HEART C, V293, pH1662, DOI 10.1152/ajpheart.00159.2007; Urso ML, 2005, ARTERIOSCL THROM VAS, V25, P2560, DOI 10.1161/01.ATV.0000190608.28704.71; Van Kolen K, 2006, CELL SIGNAL, V18, P1169, DOI 10.1016/j.cellsig.2005.09.005; Wang L, 2001, J BIOL CHEM, V276, P37242, DOI 10.1074/jbc.M105089200; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Yang HM, 2005, J CELL BIOCHEM, V94, P1058, DOI 10.1002/jcb.20371	64	80	82	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					2844	2854		10.1096/fj.08-128843	http://dx.doi.org/10.1096/fj.08-128843			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19406843	Green Published			2022-12-25	WOS:000270241000007
J	Jiang, YJ; Uchida, Y; Lu, B; Kim, P; Mao, C; Akiyama, M; Elias, PM; Holleran, WM; Grunfeld, C; Feingold, KR				Jiang, Yan J.; Uchida, Yoshikazu; Lu, Biao; Kim, Peggy; Mao, Cungui; Akiyama, Masashi; Elias, Peter M.; Holleran, Walter M.; Grunfeld, Carl; Feingold, Kenneth R.			Ceramide Stimulates ABCA12 Expression via Peroxisome Proliferator-activated Receptor delta in Human Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY BARRIER HOMEOSTASIS; CULTURED HUMAN KERATINOCYTES; PROTEIN-KINASE PATHWAYS; CASSETTE TRANSPORTER 1; HARLEQUIN ICHTHYOSIS; TANGIER-DISEASE; INDUCED APOPTOSIS; GENE-EXPRESSION; EPIDERMAL LIPIDS; LXR ACTIVATORS	ABCA12 (ATP binding cassette transporter, family 12) is a cellular membrane transporter that facilitates the delivery of glucosylceramides to epidermal lamellar bodies in keratinocytes, a process that is critical for permeability barrier formation. Following secretion of lamellar bodies into the stratum corneum, glucosylceramides are metabolized to ceramides, which comprise similar to 50% of the lipid in stratum corneum. Gene mutations of ABCA12 underlie harlequin ichthyosis, a devastating skin disorder characterized by abnormal lamellar bodies and a severe barrier abnormality. Recently we reported that peroxisome proliferator-activated receptor (PPAR) and liver X receptor activators increase ABCA12 expression in human keratinocytes. Here we demonstrate that ceramide (C-2-Cer and C-6-Cer), but not C-8-glucosylceramides, sphingosine, or ceramide 1-phosphate, increases ABCA12 mRNA expression in a dose- and time-dependent manner. Inhibitors of glucosylceramide synthase, sphingomyelin synthase, and ceramidase and small interfering RNA knockdown of human alkaline ceramidase, which all increase endogenous ceramide levels, also increased ABCA12 mRNA levels. Moreover, simultaneous treatment with C-6-Cer and each of these same inhibitors additively increased ABCA12 expression, indicating that ceramide is an important inducer of ABCA12 expression and that the conversion of ceramide to other sphingolipids or metabolites is not required. Finally, both exogenous and endogenous ceramides preferentially stimulate PPAR delta expression (but not other PPARs or liver X receptors), whereas PPAR delta knockdown by siRNA transfection specifically diminished the ceramide-induced increase in ABCA12 mRNA levels, indicating that PPAR delta is a mediator of the ceramide effect. Together, these results show that ceramide, an important lipid component of epidermis, up-regulates ABCA12 expression via the PPAR delta-mediated signaling pathway, providing a substrate-driven, feed-forward mechanism for regulating this key lipid transporter.	[Jiang, Yan J.; Lu, Biao; Kim, Peggy; Grunfeld, Carl; Feingold, Kenneth R.] Univ Calif San Francisco, No Calif Inst Res & Educ, Vet Affairs Med Ctr, Metab Sect, San Francisco, CA 94121 USA; [Uchida, Yoshikazu; Elias, Peter M.; Holleran, Walter M.] Univ Calif San Francisco, No Calif Inst Res & Educ, Vet Affairs Med Ctr, Dermatol Res Unit, San Francisco, CA 94121 USA; [Mao, Cungui] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Akiyama, Masashi] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido 0608638, Japan	Northern California Institute for Research & Education; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Northern California Institute for Research & Education; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Medical University of South Carolina; Hokkaido University	Jiang, YJ (corresponding author), Dept Vet Affairs Med Ctr, Metab Sect 111F, 4150 Clement St, San Francisco, CA 94121 USA.	yan.jiang@med.va.gov	Akiyama, Masashi/I-1122-2012	Uchida, Yoshikazu/0000-0002-4980-3416	National Institutes of Health [AR39448, AR049932]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049932, P01AR039448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR39448 and AR049932. This work was also supported by the Medical Research Service, Department of Veterans Affairs at San Francisco.	Akiyama M, 2005, J CLIN INVEST, V115, P1777, DOI 10.1172/JCI24834; Akiyama M, 2007, J INVEST DERMATOL, V127, P568, DOI 10.1038/sj.jid.5700617; Akiyama M, 2006, ARCH DERMATOL, V142, P914, DOI 10.1001/archderm.142.7.914; Allikmets R, 1997, NAT GENET, V17, P122, DOI 10.1038/ng0997-122b; Bielawska A, 1996, J BIOL CHEM, V271, P12646, DOI 10.1074/jbc.271.21.12646; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Chang KCN, 2008, MOL ENDOCRINOL, V22, P2407, DOI 10.1210/me.2008-0232; Chen CC, 2001, MOL PHARMACOL, V59, P493, DOI 10.1124/mol.59.3.493; Deigner HP, 2001, FASEB J, V15, P807, DOI 10.1096/fj.15.3.807; Elias P. M., 2006, EPIDERMAL LAMELLAR B, P261; Feingold KR, 2007, J LIPID RES, V48, P2531, DOI 10.1194/jlr.R700013-JLR200; Fishelevich R, 2006, J IMMUNOL, V176, P2590, DOI 10.4049/jimmunol.176.4.2590; Geilen GC, 1997, J BIOL CHEM, V272, P8997, DOI 10.1074/jbc.272.14.8997; GRAYSON S, 1985, J INVEST DERMATOL, V85, P289, DOI 10.1111/1523-1747.ep12276826; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Holleran WM, 2006, FEBS LETT, V580, P5456, DOI 10.1016/j.febslet.2006.08.039; HOLLERAN WM, 1991, J CLIN INVEST, V88, P1338, DOI 10.1172/JCI115439; HOLLERAN WM, 1990, J LIPID RES, V31, P1655; Houben E, 2006, J LIPID RES, V47, P1063, DOI 10.1194/jlr.M600001-JLR200; Hovnanian A, 2005, J CLIN INVEST, V115, P1708, DOI 10.1172/JCI25736; Jiang YJ, 2008, J INVEST DERMATOL, V128, P104, DOI 10.1038/sj.jid.5700944; Jiang YJ, 2006, J LIPID RES, V47, P2248, DOI 10.1194/jlr.M600163-JLR200; Kelsell DP, 2005, AM J HUM GENET, V76, P794; Komori H, 2000, FEBS LETT, V475, P247, DOI 10.1016/S0014-5793(00)01696-3; LAMPE MA, 1983, J LIPID RES, V24, P131; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Lefevre C, 2003, HUM MOL GENET, V12, P2369, DOI 10.1093/hmg/ddg235; Liu YY, 2008, FASEB J, V22, P2541, DOI 10.1096/fj.07-092981; Man MQ, 2006, J INVEST DERMATOL, V126, P386, DOI 10.1038/sj.jid.5700046; Merrill AH, 2001, ENVIRON HEALTH PERSP, V109, P283, DOI 10.2307/3435020; MERRILL AH, 1993, J BIOL CHEM, V268, P27299; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Moskowitz DG, 2004, J PEDIATR-US, V145, P82, DOI 10.1016/j.jpeds.2004.03.052; Murate T, 2002, J BIOL CHEM, V277, P9936, DOI 10.1074/jbc.M111594200; NEISH AS, 1995, J BIOL CHEM, V270, P28903, DOI 10.1074/jbc.270.48.28903; QuilletMary A, 1997, J BIOL CHEM, V272, P21388, DOI 10.1074/jbc.272.34.21388; Reunanen N, 1998, J BIOL CHEM, V273, P5137, DOI 10.1074/jbc.273.9.5137; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Schmuth M, 2004, J INVEST DERMATOL, V122, P971, DOI 10.1111/j.0022-202X.2004.22412.x; Schmuth M, 2008, J LIPID RES, V49, P499, DOI 10.1194/jlr.R800001-JLR200; Selzner M, 2001, CANCER RES, V61, P1233; Shulenin S, 2004, NEW ENGL J MED, V350, P1296, DOI 10.1056/NEJMoa032178; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Subbaramaiah K, 1998, J BIOL CHEM, V273, P32943, DOI 10.1074/jbc.273.49.32943; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Uchida Y, 2003, J INVEST DERMATOL, V120, P662, DOI 10.1046/j.1523-1747.2003.12098.x; Uchida Y, 2002, J LIPID RES, V43, P1293, DOI 10.1194/jlr.M100442-JLR200; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Vielhaber G, 2001, J INVEST DERMATOL, V117, P1126, DOI 10.1046/j.0022-202x.2001.01527.x; WAKITA H, 1994, ARCH DERMATOL RES, V286, P350, DOI 10.1007/BF00402228; Westergaard M, 2001, J INVEST DERMATOL, V116, P702, DOI 10.1046/j.1523-1747.2001.01329.x; WESTWICK JK, 1995, J BIOL CHEM, V270, P22689, DOI 10.1074/jbc.270.39.22689; Yanagi T, 2008, HUM MOL GENET, V17, P3075, DOI 10.1093/hmg/ddn204; Zhao Y, 1996, MOL ENDOCRINOL, V10, P1350, DOI 10.1210/me.10.11.1350; Zuo Y, 2008, J BIOL CHEM, V283, P36624, DOI 10.1074/jbc.M807377200	58	36	37	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18942	18952		10.1074/jbc.M109.006973	http://dx.doi.org/10.1074/jbc.M109.006973			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19429679	Green Published, hybrid			2022-12-25	WOS:000267711500044
J	Koodathingal, P; Jaffe, NE; Kraut, DA; Prakash, S; Fishbain, S; Herman, C; Matouschek, A				Koodathingal, Prakash; Jaffe, Neil E.; Kraut, Daniel A.; Prakash, Sumit; Fishbain, Susan; Herman, Christophe; Matouschek, Andreas			ATP-dependent Proteases Differ Substantially in Their Ability to Unfold Globular Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ESCHERICHIA-COLI LON; YEAST SACCHAROMYCES-CEREVISIAE; FTSH-MEDIATED PROTEOLYSIS; CLPXP DEGRADATION MACHINE; HEAT-SHOCK-PROTEIN; AAA PLUS PROTEASE; END RULE PATHWAY; 26 S PROTEASOME; DIHYDROFOLATE-REDUCTASE; SUBSTRATE-RECOGNITION	ATP-dependent proteases control the concentrations of hundreds of regulatory proteins and remove damaged or misfolded proteins from cells. They select their substrates primarily by recognizing sequence motifs or covalent modifications. Once a substrate is bound to the protease, it has to be unfolded and translocated into the proteolytic chamber to be degraded. Some proteases appear to be promiscuous, degrading substrates with poorly defined targeting signals, which suggests that selectivity may be controlled at additional levels. Here we compare the abilities of representatives from all classes of ATP-dependent proteases to unfold a model substrate protein and find that the unfolding abilities range over more than 2 orders of magnitude. We propose that these differences in unfolding abilities contribute to the fates of substrate proteins and may act as a further layer of selectivity during protein destruction.	[Koodathingal, Prakash; Jaffe, Neil E.; Kraut, Daniel A.; Prakash, Sumit; Fishbain, Susan; Matouschek, Andreas] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Koodathingal, Prakash; Jaffe, Neil E.; Kraut, Daniel A.; Prakash, Sumit; Fishbain, Susan; Matouschek, Andreas] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Herman, Christophe] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Baylor College of Medicine	Matouschek, A (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2205 Tech Dr, Evanston, IL 60208 USA.	matouschek@northwestern.edu	Prakash, Sumit/B-2679-2009; Matouschek, Andreas/L-9379-2013	Prakash, Sumit/0000-0002-0608-3420; Matouschek, Andreas/0000-0001-6016-2341; Kraut, Daniel/0000-0002-4428-5832	National Science Foundation [MCB 426913]; National Institutes of Health [R01GM64003]; Gillson Longenbaugh Foundation; Robert H. Lurie Comprehensive Cancer Center at Northwestern; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063004] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gillson Longenbaugh Foundation; Robert H. Lurie Comprehensive Cancer Center at Northwestern; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Science Foundation Grant MCB 426913 and by National Institutes of Health Grant R01GM64003. This work was also supported by The Gillson Longenbaugh Foundation, the Robert H. Lurie Comprehensive Cancer Center at Northwestern	Asahara Y, 2000, J BIOCHEM, V127, P931, DOI 10.1093/oxfordjournals.jbchem.a022689; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; Benaroudj N, 2000, NAT CELL BIOL, V2, P833, DOI 10.1038/35041081; BESSMAN MJ, 1963, METHOD ENZYMOL, V6, P166, DOI 10.1016/0076-6879(63)06160-7; Bolon DN, 2004, MOL CELL, V13, P443, DOI 10.1016/S1097-2765(04)00027-9; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Burton RE, 2005, NAT STRUCT MOL BIOL, V12, P245, DOI 10.1038/nsmb898; Burton RE, 2003, PROTEIN SCI, V12, P893, DOI 10.1110/ps.0237603; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Chiba S, 2000, EMBO REP, V1, P47, DOI 10.1093/embo-reports/kvd005; Choy JS, 2007, J BACTERIOL, V189, P6564, DOI 10.1128/JB.00860-07; Dougan DA, 2003, MOL CELL, V12, P373, DOI 10.1016/j.molcel.2003.08.012; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; ENDO T, 1988, EMBO J, V7, P1153, DOI 10.1002/j.1460-2075.1988.tb02925.x; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Forster A, 2003, EMBO J, V22, P4356, DOI 10.1093/emboj/cdg436; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gonciarz-Swiatek M, 1999, J BIOL CHEM, V274, P13999, DOI 10.1074/jbc.274.20.13999; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; Gottesman S, 1996, ANNU REV GENET, V30, P465, DOI 10.1146/annurev.genet.30.1.465; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Gur E, 2008, P NATL ACAD SCI USA, V105, P16113, DOI 10.1073/pnas.0808802105; HARTLEY RW, 1989, TRENDS BIOCHEM SCI, V14, P450, DOI 10.1016/0968-0004(89)90104-7; HARTLEY RW, 1975, BIOCHEMISTRY-US, V14, P2367, DOI 10.1021/bi00682a015; Herman C, 1998, GENE DEV, V12, P1348, DOI 10.1101/gad.12.9.1348; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; HERMAN C, 1995, P NATL ACAD SCI USA, V92, P3516, DOI 10.1073/pnas.92.8.3516; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hoffman L, 1996, J BIOL CHEM, V271, P32538, DOI 10.1074/jbc.271.51.32538; Hori O, 2002, J CELL BIOL, V157, P1151, DOI 10.1083/jcb.200108103; Hoskins JR, 2002, P NATL ACAD SCI USA, V99, P11037, DOI 10.1073/pnas.172378899; Hoskins JR, 2000, J BIOL CHEM, V275, P35361, DOI 10.1074/jbc.M006288200; Huang SH, 1999, NAT STRUCT BIOL, V6, P1132; Ishii Y, 2000, J BIOCHEM-TOKYO, V127, P837, DOI 10.1093/oxfordjournals.jbchem.a022677; Ishikawa T, 2001, P NATL ACAD SCI USA, V98, P4328, DOI 10.1073/pnas.081543698; Iwakura M, 2000, NAT STRUCT BIOL, V7, P580, DOI 10.1038/76811; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Jenal U, 2003, CURR OPIN MICROBIOL, V6, P163, DOI 10.1016/S1369-5274(03)00029-8; JOHNSTON JA, 1995, J BIOL CHEM, V270, P8172, DOI 10.1074/jbc.270.14.8172; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Jubete Y, 1996, J BIOL CHEM, V271, P30798, DOI 10.1074/jbc.271.48.30798; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kenniston JA, 2005, P NATL ACAD SCI USA, V102, P1390, DOI 10.1073/pnas.0409634102; Kenniston JA, 2004, J STRUCT BIOL, V146, P130, DOI 10.1016/j.jsb.2003.10.023; KIHARA A, 1995, P NATL ACAD SCI USA, V92, P4532, DOI 10.1073/pnas.92.10.4532; Kihara A, 1999, EMBO J, V18, P2970, DOI 10.1093/emboj/18.11.2970; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Kobiler O, 2004, J STRUCT BIOL, V146, P72, DOI 10.1016/j.jsb.2003.10.021; Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315; Kwon AR, 2004, J STRUCT BIOL, V146, P141, DOI 10.1016/j.jsb.2003.11.003; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; LopezHernandez E, 1996, FOLD DES, V1, P43, DOI 10.1016/S1359-0278(96)00011-9; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Matouschek A, 1997, EMBO J, V16, P6727, DOI 10.1093/emboj/16.22.6727; MAURIZI MR, 1994, METHOD ENZYMOL, V244, P314; Mogk A, 2004, J STRUCT BIOL, V146, P90, DOI 10.1016/j.jsb.2003.10.009; MUROFF I, 1990, EMBO J, V9, P2765, DOI 10.1002/j.1460-2075.1990.tb07464.x; Navon A, 2001, MOL CELL, V8, P1339, DOI 10.1016/S1097-2765(01)00407-5; Okuno T, 2006, GENES CELLS, V11, P261, DOI 10.1111/j.1365-2443.2006.00940.x; Ondrovicova G, 2005, J BIOL CHEM, V280, P25103, DOI 10.1074/jbc.M502796200; PHILLIPS TA, 1984, J BACTERIOL, V159, P283, DOI 10.1128/JB.159.1.283-287.1984; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Rajagopalan PTR, 2002, P NATL ACAD SCI USA, V99, P13481, DOI 10.1073/pnas.172501499; Reid BG, 2001, P NATL ACAD SCI USA, V98, P3768, DOI 10.1073/pnas.071043698; Rep M, 1996, SCIENCE, V274, P103, DOI 10.1126/science.274.5284.103; ROOD JI, 1980, GENE, V8, P255, DOI 10.1016/0378-1119(80)90003-7; Rosen R, 2002, FEMS MICROBIOL LETT, V207, P9, DOI 10.1111/j.1574-6968.2002.tb11020.x; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Sato T, 2005, P NATL ACAD SCI USA, V102, P17999, DOI 10.1073/pnas.0504495102; Savel'ev AS, 1998, J BIOL CHEM, V273, P20596, DOI 10.1074/jbc.273.32.20596; SEIFRIED SE, 1988, J BIOL CHEM, V263, P13511; Seong IS, 1999, FEBS LETT, V456, P211, DOI 10.1016/S0014-5793(99)00935-7; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Sim KL, 2002, MOL CELL PROTEOMICS, V1, P983, DOI 10.1074/mcp.M200032-MCP200; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Singh SK, 1999, BIOCHEMISTRY-US, V38, P14906, DOI 10.1021/bi991615f; Smith CK, 1999, P NATL ACAD SCI USA, V96, P6678, DOI 10.1073/pnas.96.12.6678; SUZUKI CK, 1994, SCIENCE, V264, P273, DOI 10.1126/science.8146662; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tian L, 2005, NAT STRUCT MOL BIOL, V12, P1045, DOI 10.1038/nsmb1018; TOMOYASU T, 1995, EMBO J, V14, P2551, DOI 10.1002/j.1460-2075.1995.tb07253.x; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; van Dijl JM, 1998, P NATL ACAD SCI USA, V95, P10584, DOI 10.1073/pnas.95.18.10584; van Dyck L, 1998, GENE DEV, V12, P1515, DOI 10.1101/gad.12.10.1515; Van Dyck L, 1999, CELL MOL LIFE SCI, V56, P825, DOI 10.1007/s000180050029; VANDYCK L, 1994, J BIOL CHEM, V269, P238; Vineyard D, 2006, BIOCHEMISTRY-US, V45, P4602, DOI 10.1021/bi052377t; Vineyard D, 2005, BIOCHEMISTRY-US, V44, P1671, DOI 10.1021/bi048618z; von Janowsky B, 2005, BIOL CHEM, V386, P1307, DOI 10.1515/BC.2005.149; WAGNER I, 1994, EMBO J, V13, P5135, DOI 10.1002/j.1460-2075.1994.tb06843.x; Wah DA, 2002, CHEM BIOL, V9, P1237, DOI 10.1016/S1074-5521(02)00268-5; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; WEISSBRUMMER B, 1982, CELL, V29, P527, DOI 10.1016/0092-8674(82)90169-6; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wilcox AJ, 2005, P NATL ACAD SCI USA, V102, P15435, DOI 10.1073/pnas.0507324102; Wu WF, 1999, J BACTERIOL, V181, P3681, DOI 10.1128/JB.181.12.3681-3687.1999; Yoo SJ, 1996, BIOCHEM BIOPH RES CO, V229, P531, DOI 10.1006/bbrc.1996.1838; Zwickl P, 2000, CURR OPIN STRUC BIOL, V10, P242, DOI 10.1016/S0959-440X(00)00075-0; Zwickl P, 1999, J BIOL CHEM, V274, P26008, DOI 10.1074/jbc.274.37.26008; ZWICKL P, 1992, BIOCHEMISTRY-US, V31, P964, DOI 10.1021/bi00119a004	112	58	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18674	18684		10.1074/jbc.M900783200	http://dx.doi.org/10.1074/jbc.M900783200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19383601	hybrid, Green Published			2022-12-25	WOS:000267711500016
J	Valdes, R; Arastu-Kapur, S; Landfear, SM; Shinde, U				Valdes, Raquel; Arastu-Kapur, Shirin; Landfear, Scott M.; Shinde, Ujwal			An ab Initio Structural Model of a Nucleoside Permease Predicts Functionally Important Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSINE-GUANOSINE TRANSPORTER; LEISHMANIA-DONOVANI; NUCLEOBASE TRANSPORT; CHIMERIC CONSTRUCTS; MUTATIONAL ANALYSIS; CRYSTAL-STRUCTURE; LACTOSE PERMEASE; ESCHERICHIA-COLI; DEFICIENT MUTANT; PROTEIN	Permeases belonging to the equilibrative nucleoside transporter family promote uptake of nucleosides and/or nucleobases into a wide range of eukaryotes and mediate the uptake of a variety of drugs used in the treatment of cancer, heart disease, AIDS, and parasitic infections. No experimental three-dimensional structure exists for any of these permeases, and they are not present in prokaryotes, the source of many membrane proteins used in crystal structure determination. To generate a structural model for such a transporter, the LdNT1.1 nucleoside permease from the parasitic protozoan Leishmania donovani was modeled using ab initio computation. Site-directed mutations that strongly impair transport or that alter substrate specificity map to the central pore of the ab initio model, whereas mutations that have less pronounced phenotypes map to peripheral positions. The model suggests that aromatic residues present in transmembrane helices 1, 2, and 7 may interact to form an extracellular gate that closes the permeation pathway in the inward oriented conformation. Mutation of two of these three residues abrogated transport activity, consistent with the prediction of the model. The ab initio model is similar to one derived previously using threading analysis, a distinct computational approach, supporting the overall accuracy of both models. However, significant differences in helix orientation and residue position between the two models are apparent, and the mutagenesis data suggest that the ab initio model represents an improvement regarding structural details over the threading model. The putative gating interaction may also help explain differences in substrate specificity between members of this family.	[Valdes, Raquel; Landfear, Scott M.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA; [Arastu-Kapur, Shirin; Shinde, Ujwal] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Landfear, SM (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	landfear@ohsu.edu; shindeu@ohsu.edu		Landfear, Scott/0000-0002-1643-6664	National Institutes of Health [AI44138]; National Science Foundation [0746589]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI44138 (to S. M. L.). This work was also supported by National Science Foundation Grant 0746589 (to U. S.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Arastu-Kapur S, 2005, J BIOL CHEM, V280, P2213, DOI 10.1074/jbc.M408224200; Arastu-Kapur S, 2003, J BIOL CHEM, V278, P33327, DOI 10.1074/jbc.M305141200; Bonneau R, 2002, J MOL BIOL, V322, P65, DOI 10.1016/S0022-2836(02)00698-8; Bradley P, 2005, PROTEINS, V61, P128, DOI 10.1002/prot.20729; Brooijmans N, 2003, ANNU REV BIOPH BIOM, V32, P335, DOI 10.1146/annurev.biophys.32.110601.142532; Carter NS, 2008, ADV EXP MED BIOL, V625, P141, DOI 10.1007/978-0-387-77570-8_12; Carter NS, 2000, J BIOL CHEM, V275, P20935, DOI 10.1074/jbc.M002418200; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; Gschwend DA, 1996, J MOL RECOGNIT, V9, P175, DOI 10.1002/(SICI)1099-1352(199603)9:2<175::AID-JMR260>3.0.CO;2-D; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Jones DT, 1998, FEBS LETT, V423, P281, DOI 10.1016/S0014-5793(98)00095-7; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; Kong W, 2004, CURR DRUG METAB, V5, P63, DOI 10.2174/1389200043489162; LEBOWITZ JH, 1994, METHOD CELL BIOL, V45, P65; LEBOWITZ JH, 1990, P NATL ACAD SCI USA, V87, P9736, DOI 10.1073/pnas.87.24.9736; Liu W, 2006, MOL BIOCHEM PARASIT, V150, P300, DOI 10.1016/j.molbiopara.2006.09.002; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; MURRAY AW, 1971, ANNU REV BIOCHEM, V40, P811, DOI 10.1146/annurev.bi.40.070171.004115; Papageorgiou I, 2008, INT J PARASITOL, V38, P641, DOI 10.1016/j.ijpara.2007.10.005; Rose JB, 2008, PHYSIOLOGY, V23, P41, DOI 10.1152/physiol.00036.2007; Sanchez MA, 2004, MOL MEMBR BIOL, V21, P11, DOI 10.1080/0968768031000140845; SenGupta DJ, 2004, BIOCHEM PHARMACOL, V67, P453, DOI 10.1016/j.bcp.2003.09.018; SenGupta DJ, 2002, BIOCHEMISTRY-US, V41, P1512, DOI 10.1021/bi015833w; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Sundaram M, 1998, J BIOL CHEM, V273, P21519, DOI 10.1074/jbc.273.34.21519; Sundaram M, 2001, BIOCHEMISTRY-US, V40, P8146, DOI 10.1021/bi0101805; Valdes R, 2004, BIOCHEMISTRY-US, V43, P6793, DOI 10.1021/bi049873m; Valdes R, 2006, J BIOL CHEM, V281, P22647, DOI 10.1074/jbc.M602366200; Vasudevan G, 1998, P NATL ACAD SCI USA, V95, P9873, DOI 10.1073/pnas.95.17.9873; Vasudevan G, 2001, P NATL ACAD SCI USA, V98, P6092, DOI 10.1073/pnas.101537298; Visser F, 2005, J BIOL CHEM, V280, P11025, DOI 10.1074/jbc.M410348200; Visser F, 2005, MOL PHARMACOL, V67, P1291, DOI 10.1124/mol.104.005884; Visser F, 2002, J BIOL CHEM, V277, P395, DOI 10.1074/jbc.M105324200; VISSER F, 2002, BIOCH CELL BIOL, V80, P701; Visser F, 2007, J BIOL CHEM, V282, P14148, DOI 10.1074/jbc.M701735200; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yao SYM, 2002, J BIOL CHEM, V277, P24938, DOI 10.1074/jbc.M200966200; Yao SYM, 2001, BIOCHEM J, V353, P387, DOI 10.1042/0264-6021:3530387; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Zhou YG, 2008, P NATL ACAD SCI USA, V105, P3774, DOI 10.1073/pnas.0800825105	44	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					19067	19076		10.1074/jbc.M109.017947	http://dx.doi.org/10.1074/jbc.M109.017947			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19429678	Green Published, hybrid			2022-12-25	WOS:000267711500055
J	Coffin, SR; Reich, NO				Coffin, Stephanie R.; Reich, Norbert O.			Escherichia coli DNA Adenine Methyltransferase THE STRUCTURAL BASIS OF PROCESSIVE CATALYSIS AND INDIRECT READ-OUT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II RESTRICTION ENDONUCLEASES; GATC-FLANKING SEQUENCES; ECORI ENDONUCLEASE; DAM METHYLTRANSFERASE; SUBSTRATE-RECOGNITION; PROTEIN INTERACTIONS; SITES; METHYLATION; SPECIFICITY; CONTACTS	We have investigated the structural basis of processive GATC methylation by the Escherichia coli DNA adenine methyltransferase, which is critical in chromosome replication and mismatch repair. We determined the contribution of the orthologically conserved phosphate interactions involving residues Arg(95), Asn(126), Asn(132), Arg(116), and Lys(139), which directly contact the DNA outside the cognate recognition site (GATC) to processive catalysis, and that of residue Arg(137), which is not conserved and contacts the DNA backbone within the GATC sequence. Alanine substitutions at the conserved positions have large impacts on processivity yet do not impact k(cat)/K-m(DNA) or DNA affinity (K-D(DNA)). However, these mutants cause large preferences for GATC sites varying in flanking sequences when considering the pre-steady state efficiency constant k(chem)/K-D(DNA). These changes occur mainly at the level of the methylation rate constant, which results in the observed decreases in processive catalysis. Thus, processivity and catalytic efficiency (k(cat)/K-m(DNA)) are uncoupled in these mutants. These results reveal that the binding energy involved in DNA recognition contributes to the assembly of the active site rather than tight binding. Furthermore, the conserved residues (Arg(95), Asn(126), Asn(132), and Arg(116)) repress the modulation of the response of the enzyme to flanking sequence effects. Processivity impacted mutants do not show substrate-induced dimerization as is observed for the wild type enzyme. This study describes the structural means by which an enzyme that does not completely enclose its substrate has evolved to achieve processive catalysis, and how interactions with DNA flanking the recognition site alter this processivity.	[Coffin, Stephanie R.; Reich, Norbert O.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Reich, Norbert O.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Reich, NO (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.	reich@chem.ucsb.edu						Alonso A, 2005, J BACTERIOL, V187, P7901, DOI 10.1128/JB.187.23.7901-7911.2005; BERGERAT A, 1989, J BIOL CHEM, V264, P4064; Bheemanaik S, 2006, BIOCHEM J, V399, P177, DOI 10.1042/BJ20060854; Bilcock DT, 1999, J BIOL CHEM, V274, P36379, DOI 10.1074/jbc.274.51.36379; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Coffin SR, 2008, J BIOL CHEM, V283, P20106, DOI 10.1074/jbc.M802502200; Gillette WK, 2000, J MOL BIOL, V299, P1245, DOI 10.1006/jmbi.2000.3827; Gormley NA, 2000, J BIOL CHEM, V275, P6928, DOI 10.1074/jbc.275.10.6928; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Handa V, 2005, J MOL BIOL, V348, P1103, DOI 10.1016/j.jmb.2005.02.044; HERMAN GE, 1982, J BIOL CHEM, V257, P2605; Heusipp G, 2007, INT J MED MICROBIOL, V297, P1, DOI 10.1016/j.ijmm.2006.10.002; Horton JR, 2006, J MOL BIOL, V358, P559, DOI 10.1016/j.jmb.2006.02.028; Horton JR, 2005, CELL, V121, P349, DOI 10.1016/j.cell.2005.02.021; Hubscher U, 2000, TRENDS BIOCHEM SCI, V25, P143, DOI 10.1016/S0968-0004(99)01523-6; JACK WE, 1982, P NATL ACAD SCI-BIOL, V79, P4010, DOI 10.1073/pnas.79.13.4010; Jen-Jacobson Linda, 1997, Biopolymers, V44, P153, DOI 10.1002/(SICI)1097-0282(1997)44:2<153::AID-BIP4>3.0.CO;2-U; JenJacobson L, 1996, EMBO J, V15, P2870, DOI 10.1002/j.1460-2075.1996.tb00648.x; JENJACOBSON L, 1986, CELL, V45, P619, DOI 10.1016/0092-8674(86)90294-1; Jin LH, 1999, J MOL BIOL, V285, P361, DOI 10.1006/jmbi.1998.2311; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Joshi HK, 2006, J BIOL CHEM, V281, P23852, DOI 10.1074/jbc.M512339200; LESSER DR, 1990, SCIENCE, V250, P776, DOI 10.1126/science.2237428; Lobner-Olesen A, 2005, CURR OPIN MICROBIOL, V8, P154, DOI 10.1016/j.mib.2005.02.009; LOHMAN TM, 1980, BIOCHEMISTRY-US, V19, P3522, DOI 10.1021/bi00556a017; Mashhoon N, 2006, J BIOMOL SCREEN, V11, P497, DOI 10.1177/1087057106287933; MODRICH P, 1991, ANNU REV GENET, V25, P229, DOI 10.1146/annurev.ge.25.120191.001305; Naumann TA, 2008, CHEMBIOCHEM, V9, P194, DOI 10.1002/cbic.200700561; Oshima T, 2002, MOL MICROBIOL, V45, P673, DOI 10.1046/j.1365-2958.2002.03037.x; Pan CQ, 1996, J MOL BIOL, V264, P675, DOI 10.1006/jmbi.1996.0669; Peterson SN, 2006, J MOL BIOL, V355, P459, DOI 10.1016/j.jmb.2005.11.003; Pingoud A, 2001, NUCLEIC ACIDS RES, V29, P3705, DOI 10.1093/nar/29.18.3705; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Stanford NP, 2000, EMBO J, V19, P6546, DOI 10.1093/emboj/19.23.6546; Tavazoie S, 1998, NAT BIOTECHNOL, V16, P566, DOI 10.1038/nbt0698-566; TAYLOR JD, 1992, BIOCHEMISTRY-US, V31, P90, DOI 10.1021/bi00116a014; Tchernaenko V, 2003, J MOL BIOL, V326, P737, DOI 10.1016/S0022-2836(02)01468-7; Urig S, 2002, J MOL BIOL, V319, P1085, DOI 10.1016/S0022-2836(02)00371-6; VANCLEVE MD, 1992, BIOCHEMISTRY-US, V31, P334, DOI 10.1021/bi00117a004; VONHIPPEL PH, 1994, ANN NY ACAD SCI, V726, P118; WANG MX, 1992, NATURE, V360, P606, DOI 10.1038/360606a0; Watson ME, 2004, MOL MICROBIOL, V53, P651, DOI 10.1111/j.1365-2958.2004.04140.x; Wenz C, 1996, J BIOL CHEM, V271, P5565, DOI 10.1074/jbc.271.10.5565; Wu H, 2006, ORAL MICROBIOL IMMUN, V21, P238, DOI 10.1111/j.1399-302X.2006.00284.x; WYMAN C, 1995, CURR BIOL, V5, P334, DOI 10.1016/S0960-9822(95)00065-0; Yang Z, 2003, NAT STRUCT BIOL, V10, P849, DOI 10.1038/nsb973; Zinoviev VV, 2007, BIOL CHEM, V388, P1199, DOI 10.1515/BC.2007.142; Zinoviev VV, 2004, MOL BIOL+, V38, P737, DOI 10.1023/B:MBIL.0000043943.07792.80	49	7	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18390	18400		10.1074/jbc.M109.005876	http://dx.doi.org/10.1074/jbc.M109.005876			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19419959	Green Published, hybrid			2022-12-25	WOS:000267712400051
J	Huang, TH; Wu, FT; Loeb, GB; Hsu, R; Heidersbach, A; Brincat, A; Horiuchi, D; Lebbink, RJ; Mo, YY; Goga, A; McManus, MT				Huang, Tzu-Hsuan; Wu, Fangting; Loeb, Gabriel B.; Hsu, Ruby; Heidersbach, Amy; Brincat, Allison; Horiuchi, Dai; Lebbink, Robert J.; Mo, Yin-Yuan; Goga, Andrei; McManus, Michael T.			Up-regulation of miR-21 by HER2/neu Signaling Promotes Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; TUMOR-SUPPRESSOR GENE; BREAST-CANCER; TRANSCRIPTION FACTOR; MICRORNA-21 TARGETS; PROSTATE-CANCER; EXPRESSION; ACTIVATION; OVEREXPRESSION; METASTASIS	The cell surface receptor tyrosine kinase HER2/neu enhances tumor metastasis. Recent studies suggest that deregulated microRNA (miRNA) expression promotes invasion and metastasis of cancer cells; we therefore explored the possibility that HER2/neu signaling induces the expression of specific miRNAs involved in this process. We identified a putative oncogenic miRNA, miR-21, whose expression is correlated with HER2/neu up-regulation and is functionally involved in HER2/neu-induced cell invasion. We show that miR-21 is up-regulated via the MAPK (ERK1/2) pathway upon stimulation of HER2/neu signaling in breast cancer cells, and overexpression of other ERK1/2 activators such as RASV12 or ID-1 is sufficient to induce miR-21 up-regulation in HER2/neu-negative breast cancer cells. Furthermore, the metastasis suppressor protein PDCD4(programmed cell death 4) is down-regulated by miR-21 in breast cancer cells expressing HER2/neu. Our data reveal a mechanism for HER2/neu-induced cancer cell invasion via miRNA deregulation. In addition, our results identify miR-21 as a potential therapeutic target for the prevention of breast cancer invasion and metastasis.	[Huang, Tzu-Hsuan; Loeb, Gabriel B.; Hsu, Ruby; Heidersbach, Amy; Brincat, Allison; Lebbink, Robert J.; McManus, Michael T.] Univ Calif San Francisco, Dept Microbiol & Immunol, Div Hematol & Oncol, San Francisco, CA 94143 USA; [Horiuchi, Dai; Goga, Andrei] Univ Calif San Francisco, Dept Med, Div Hematol & Oncol, San Francisco, CA 94143 USA; [Wu, Fangting; Mo, Yin-Yuan] So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62794 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Southern Illinois University System; Southern Illinois University	McManus, MT (corresponding author), 513 Parnassus Ave,Box 0534,HSW Rm 1053A, San Francisco, CA 94143 USA.	michael.mcmanus@ucsf.edu	Mo, Yin-Yuan/B-6141-2011; Lebbink, Robert Jan/GNH-5209-2022; Mo, Yin-Yuan/R-8255-2019; mcmanus, michael/AAB-1239-2020	mcmanus, michael/0000-0003-3013-6569; Lebbink, Robert Jan/0000-0002-1981-0420	National Institutes of Health [P50-CA58207, K08-CA104032]; Susan G. Komen Foundation; Sandler Program in Biological Sciences; Sandler Family Foundation; NATIONAL CANCER INSTITUTE [P50CA058207, K08CA104032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Sandler Program in Biological Sciences; Sandler Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants P50-CA58207 and K08-CA104032. This work was also supported by funds from the Susan G. Komen Foundation and the Sandler Program in Biological Sciences (to A. G.). We thank the Sandler Family Foundation for the Sandler postdoctoral research fellowship award (to T. H. H.) for supporting this research.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Bohm M, 2003, ONCOGENE, V22, P4905, DOI 10.1038/sj.onc.1206710; Bosc DG, 2001, ONCOGENE, V20, P6215, DOI 10.1038/sj.onc.1204820; Carvalho I, 2005, BREAST CANCER RES, V7, pR788, DOI 10.1186/bcr1304; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chavez-Blanco A, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-59; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Desprez PY, 1998, MOL CELL BIOL, V18, P4577, DOI 10.1128/MCB.18.8.4577; Egeblad M, 2000, INT J CANCER, V86, P617, DOI 10.1002/(SICI)1097-0215(20000601)86:5<617::AID-IJC3>3.3.CO;2-Q; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Fong S, 2003, P NATL ACAD SCI USA, V100, P13543, DOI 10.1073/pnas.2230238100; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Goga A, 2007, NAT MED, V13, P820, DOI 10.1038/nm1606; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hellawell GO, 2002, CANCER RES, V62, P2942; Huang TH, 2006, J PHARMACOL EXP THER, V316, P983, DOI 10.1124/jpet.105.095513; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Ling MT, 2002, ONCOGENE, V21, P8498, DOI 10.1038/sj.onc.1206007; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Nieves-Alicea R, 2009, BREAST CANCER RES TR, V114, P203, DOI 10.1007/s10549-008-9993-5; Paumelle R, 2002, ONCOGENE, V21, P2309, DOI 10.1038/sj.onc.1205297; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Smalley KSM, 2003, INT J CANCER, V104, P527, DOI 10.1002/ijc.10978; Subbaramaiah K, 2002, J BIOL CHEM, V277, P18649, DOI 10.1074/jbc.M111415200; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tan M, 1997, CANCER RES, V57, P1199; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wu FT, 2007, MOL CANCER THER, V6, P1823, DOI 10.1158/1535-7163.MCT-06-0771; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	48	157	175	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18515	18524		10.1074/jbc.M109.006676	http://dx.doi.org/10.1074/jbc.M109.006676			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19419954	Green Published, hybrid			2022-12-25	WOS:000267712400062
J	Makkonen, KM; Pasonen-Seppanen, S; Torronen, K; Tammi, MI; Carlberg, C				Makkonen, Katri M.; Pasonen-Seppanen, Sanna; Torronen, Kari; Tammi, Markku I.; Carlberg, Carsten			Regulation of the Hyaluronan Synthase 2 Gene by Convergence in Cyclic AMP Response Element-binding Protein and Retinoid Acid Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; PHOSPHORYLATED CREB; SOMATOSTATIN GENE; NUCLEAR RECEPTORS; CELLS; ACTIVATION; EXPRESSION; COACTIVATORS; EPIDERMIS; PROMOTER	The human hyaluronan synthase 2 (HAS2) gene encodes for an enzyme making hyaluronan, altered concentrations of which are associated with many pathological situations including wounding, several inflammatory conditions, and malignant tumors. In this study we showed that HAS2 is a primary target of the cAMP activator forskolin and the nuclear hormone all-trans-retinoic acid ( RA). The first 2250 bp of the promoter contain three response elements (REs) for the transcription factor CREB1 as well as two REs for the nuclear receptor RAR. Chromatin immunoprecipitation and re-chromatin immunoprecipitation assays using selected fragments of the promoter containing the putative REs showed that forskolin and all-trans-RA modulate the formation of complexes between CREB1 and RAR with various co-regulators at the predicted sites. Interestingly, CREB1 complexes are regulated by all-trans-RA as are RAR complexes by forskolin. Reporter gene assays using nested promoter fragments supported these findings. Forskolin and all-trans-RA co-stimulation reduced the binding of CREB1, RAR, and the co-repressor nuclear receptor co-repressor 1 (NCoR1), but enhanced the association of co-activators MED1 and CREB-binding protein (CBP). RNA interference experiments suggested that MED1 and NCoR1 are central for the all-trans-RA induction of the HAS2 gene and CBP dominates its forskolin response. In general, our findings suggest a convergence of CREB1 and RAR signaling, and demonstrate the individual character of each RE in terms of co-regulator use.	[Carlberg, Carsten] Univ Luxembourg, Life Sci Res Unit, L-1511 Luxembourg, Luxembourg; [Makkonen, Katri M.; Carlberg, Carsten] Univ Kuopio, Dept Biosci, FIN-70211 Kuopio, Finland; [Pasonen-Seppanen, Sanna; Torronen, Kari; Tammi, Markku I.] Univ Kuopio, Dept Biomed, FIN-70211 Kuopio, Finland	University of Luxembourg; University of Eastern Finland; University of Eastern Finland	Carlberg, C (corresponding author), Univ Luxembourg, Life Sci Res Unit, 162A,Ave Faiencerie, L-1511 Luxembourg, Luxembourg.	carsten.carlberg@uni.lu	Tammi, Markku/AAQ-7878-2021; Carlberg, Carsten/C-9075-2011	Carlberg, Carsten/0000-0003-2633-0684	Academy of Finland; Juselius Foundation; EVO Fund of Kuopio University Hospital	Academy of Finland(Academy of Finland); Juselius Foundation; EVO Fund of Kuopio University Hospital	This work was supported by grants from the Academy of Finland ( to C. C. and M. I. T.), the Juselius Foundation ( to C. C. and M. I. T.), and EVO Fund of Kuopio University Hospital ( to M. I. T.).	Aggarwal S, 2006, MOL BIOL CELL, V17, P566, DOI 10.1091/mbc.E05-06-0519; Apostolou E, 2008, MOL CELL, V29, P154, DOI 10.1016/j.molcel.2008.01.008; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Burke LJ, 2000, FASEB J, V14, P1876, DOI 10.1096/fj.99-0943rev; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; CHAMBON P, 1993, GENE, V135, P223, DOI 10.1016/0378-1119(93)90069-F; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Dunlop TW, 2004, J STEROID BIOCHEM, V89-90, P257, DOI 10.1016/j.jsbmb.2004.03.079; Euskirchen G, 2004, MOL CELL BIOL, V24, P3804, DOI 10.1128/MCB.24.9.3804-3814.2004; Glass CK, 2000, GENE DEV, V14, P121; Goentzel BJ, 2006, BIOCHEM J, V396, P347, DOI 10.1042/BJ20051782; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Jacobson A, 2000, BIOCHEM J, V348, P29, DOI 10.1042/0264-6021:3480029; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Karvinen S, 2003, J BIOL CHEM, V278, P49495, DOI 10.1074/jbc.M310445200; Li J, 2008, ARCH ORAL BIOL, V53, P60, DOI 10.1016/j.archoralbio.2007.07.011; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Monslow J, 2004, J BIOL CHEM, V279, P20576, DOI 10.1074/jbc.M312666200; Monslow J, 2006, J BIOL CHEM, V281, P18043, DOI 10.1074/jbc.M510467200; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Pienimaki JP, 2001, J BIOL CHEM, V276, P20428, DOI 10.1074/jbc.M007601200; Richards JP, 1996, J BIOL CHEM, V271, P13716, DOI 10.1074/jbc.271.23.13716; Rilla K, 2005, J BIOL CHEM, V280, P31890, DOI 10.1074/jbc.M504736200; Saavalainen K, 2005, J BIOL CHEM, V280, P14636, DOI 10.1074/jbc.M500206200; Saavalainen K, 2007, J BIOL CHEM, V282, P11530, DOI 10.1074/jbc.M607871200; SCHRADER M, 1993, NUCLEIC ACIDS RES, V21, P1231, DOI 10.1093/nar/21.5.1231; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; Si JT, 2002, BLOOD, V100, P4401, DOI 10.1182/blood-2001-12-0374; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Tammi R, 2005, J INVEST DERMATOL, V124, P898, DOI 10.1111/j.0022-202X.2005.23697.x; Tammi RH, 2008, SEMIN CANCER BIOL, V18, P288, DOI 10.1016/j.semcancer.2008.03.005; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zhang W, 2000, BIOCHEM J, V349, P91, DOI 10.1042/0264-6021:3490091	43	39	41	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18270	18281		10.1074/jbc.M109.012492	http://dx.doi.org/10.1074/jbc.M109.012492			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19416972	Green Published, hybrid			2022-12-25	WOS:000267712400040
J	Masoudi, R; Ioannou, MS; Coughlin, MD; Pagadala, P; Neet, KE; Clewes, O; Allen, SJ; Dawbarn, D; Fahnestock, M				Masoudi, Raheleh; Ioannou, Maria S.; Coughlin, Michael D.; Pagadala, Promila; Neet, Kenneth E.; Clewes, Oliver; Allen, Shelley J.; Dawbarn, David; Fahnestock, Margaret			Biological Activity of Nerve Growth Factor Precursor Is Dependent upon Relative Levels of Its Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPOCAMPAL-NEURONS; PROTEIN EXPRESSION; NEUROTROPHIN RECEPTOR; SIGNAL-TRANSDUCTION; ALZHEIMERS-DISEASE; P75-MEDIATED DEATH; ESCHERICHIA-COLI; SENSORY NEURONS; FACTOR COMPLEX; CELL-SURVIVAL	Nerve growth factor (NGF) is produced as a precursor called pro-nerve growth factor (proNGF), which is secreted by many tissues and is the predominant form of NGF in the central nervous system. In Alzheimer disease brain, cholinergic neurons degenerate and can no longer transport NGF as efficiently, leading to an increase in untransported NGF in the target tissue. The protein that accumulates in the target tissue is proNGF, not the mature form. The role of this precursor is controversial, and both neurotrophic and apoptotic activities have been reported for recombinant proNGFs. Differences in the protein structures, protein expression systems, methods used for protein purification, and methods used for bioassay may affect the activity of these proteins. Here, we show that proNGF is neurotrophic regardless of mutations or tags, and no matter how it is purified or in which system it is expressed. However, although proNGF is neurotrophic under our assay conditions for primary sympathetic neurons and for pheochromocytoma (PC12) cells, it is apoptotic for unprimed PC12 cells when they are deprived of serum. The ratio of tropomyosin-related kinase A to p75 neurotrophin receptor is low in unprimed PC12 cells compared with primed PC12 cells and sympathetic neurons, altering the balance of proNGF-induced signaling to favor apoptosis. We conclude that the relative level of proNGF receptors determines whether this precursor exhibits neurotrophic or apoptotic activity.	[Masoudi, Raheleh; Fahnestock, Margaret] McMaster Univ, Dept Biol, Hamilton, ON L8N 3Z5, Canada; [Ioannou, Maria S.; Fahnestock, Margaret] McMaster Univ, Grad Program Neurosci, Hamilton, ON L8N 3Z5, Canada; [Coughlin, Michael D.; Fahnestock, Margaret] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON L8N 3Z5, Canada; [Pagadala, Promila; Neet, Kenneth E.] Rosalind Franklin Univ Med & Sci, N Chicago, IL 60064 USA; [Clewes, Oliver; Allen, Shelley J.; Dawbarn, David] Univ Bristol, Bristol BS1 3NY, Avon, England	McMaster University; McMaster University; McMaster University; Rosalind Franklin University Medical & Science; University of Bristol	Fahnestock, M (corresponding author), 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	fahnest@mcmaster.ca	Pagadala, Promila/AAA-3367-2020; Fahnestock, Margaret/I-3578-2017	Fahnestock, Margaret/0000-0002-6815-0529; Allen, Shelley/0000-0001-7870-740X	Canadian Institutes of Health Research [MOP-64382]; Ministry of Science of Iran; Natural Sciences and Engineering Research Council of Canada; United States Public Health Services [NS24380]; National Institutes of Health; Bristol Research into Alzheimer's and Care of the Elderly; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024380] Funding Source: NIH RePORTER; Alzheimers Research UK [ART-PG2002-3] Funding Source: researchfish; Alzheimer&quot;s Society [106] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ministry of Science of Iran; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); United States Public Health Services(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bristol Research into Alzheimer's and Care of the Elderly; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Alzheimer&quot;s Society	This work was supported in part by Canadian Institutes of Health Research Grant MOP-64382 (to M. F.), a scholarship from the Ministry of Science of Iran (to R. M.), a scholarship from the Natural Sciences and Engineering Research Council of Canada (to M. S. I.), United States Public Health Services Grant NS24380 (to K. E. N.) from the National Institutes of Health, and the Bristol Research into Alzheimer's and Care of the Elderly.	Al-Samarrai TH, 2007, PROTEIN EXPRES PURIF, V53, P289, DOI 10.1016/j.pep.2007.01.008; Aloyz RS, 1998, J CELL BIOL, V143, P1691, DOI 10.1083/jcb.143.6.1691; Althaus HH, 2006, J NEUROCHEM, V98, P506, DOI 10.1111/j.1471-4159.2006.03891.x; BARRETT GL, 1994, P NATL ACAD SCI USA, V91, P6501, DOI 10.1073/pnas.91.14.6501; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Bierl MA, 2005, NEUROSCI LETT, V380, P133, DOI 10.1016/j.neulet.2005.01.029; Bierl MA, 2007, NEUROBIOL AGING, V28, P122, DOI 10.1016/j.neurobiolaging.2005.11.008; Boutilier J, 2008, J BIOL CHEM, V283, P12709, DOI 10.1074/jbc.M710018200; Brann AB, 2002, J BIOL CHEM, V277, P9812, DOI 10.1074/jbc.M109862200; Buttigieg H, 2007, EXP NEUROL, V204, P832, DOI 10.1016/j.expneurol.2006.12.011; Chen Y, 1997, MOL CELL ENDOCRINOL, V127, P129, DOI 10.1016/S0303-7207(96)04001-4; Clewes O, 2008, J NEUROCHEM, V107, P1124, DOI 10.1111/j.1471-4159.2008.05698.x; DARLING TLJ, 1983, COLD SPRING HARB SYM, V48, P427, DOI 10.1101/SQB.1983.048.01.047; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; Delsite R, 1999, PROSTATE, V41, P39, DOI 10.1002/(SICI)1097-0045(19990915)41:1<39::AID-PROS6>3.0.CO;2-E; EDWARDS RH, 1988, J BIOL CHEM, V263, P6810; Fahnestock M, 2004, PROG BRAIN RES, V146, P101, DOI 10.1016/S0079-6123(03)46007-X; Fahnestock M, 2004, J NEUROCHEM, V89, P581, DOI 10.1111/j.1471-4159.2004.02360.x; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Farhadi HF, 2000, J NEUROSCI, V20, P4059; Friedman WJ, 2000, J NEUROSCI, V20, P6340, DOI 10.1523/JNEUROSCI.20-17-06340.2000; GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Hamanoue M, 1999, MOL CELL NEUROSCI, V14, P28, DOI 10.1006/mcne.1999.0770; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hayashi K, 2007, EUR J ORAL SCI, V115, P344, DOI 10.1111/j.1600-0722.2007.00480.x; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Hunt I, 2005, PROTEIN EXPRES PURIF, V40, P1, DOI 10.1016/j.pep.2004.10.018; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Ledent P, 1997, FEBS LETT, V413, P194, DOI 10.1016/S0014-5793(97)00908-3; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Pagadala PC, 2006, P NATL ACAD SCI USA, V103, P17939, DOI 10.1073/pnas.0604139103; Pedraza CE, 2005, AM J PATHOL, V166, P533, DOI 10.1016/S0002-9440(10)62275-4; Peng SY, 2004, J NEUROPATH EXP NEUR, V63, P641, DOI 10.1093/jnen/63.6.641; PETRIDES PE, 1986, J NEUROCHEM, V46, P721, DOI 10.1111/j.1471-4159.1986.tb13031.x; RAMAGE P, 2002, LIFE SCI NEWS, V11, P1; Rattenholl A, 2001, EUR J BIOCHEM, V268, P3296, DOI 10.1046/j.1432-1327.2001.02232.x; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Seidah NG, 1996, BIOCHEM J, V314, P951, DOI 10.1042/bj3140951; SUTER U, 1991, EMBO J, V10, P2395, DOI 10.1002/j.1460-2075.1991.tb07778.x; Volosin M, 2008, J NEUROSCI, V28, P9870, DOI 10.1523/JNEUROSCI.2841-08.2008; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Yardley G, 2000, EXP DERMATOL, V9, P283, DOI 10.1034/j.1600-0625.2000.009004283.x; Yoon SO, 1998, J NEUROSCI, V18, P3273; Zhukovsky EA, 2004, NATURE, V427, P413, DOI 10.1038/427413a	52	106	109	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18424	18433		10.1074/jbc.M109.007104	http://dx.doi.org/10.1074/jbc.M109.007104			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19389705	hybrid, Green Published			2022-12-25	WOS:000267712400054
J	Jian, WY; Lee, SH; Williams, MV; Blair, IA				Jian, Wenying; Lee, Seon Hwa; Williams, Michelle V.; Blair, Ian A.			5-Lipoxygenase-mediated Endogenous DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONIZATION MASS-SPECTROMETRY; CHIRAL LIPIDOMICS ANALYSIS; ARACHIDONIC-ACID; ARTERIAL-WALL; CELL LINES; CANCER; EXPRESSION; ATHEROSCLEROSIS; PATHWAY; LIPOXYGENASE	Lipoxygenases (LOs) convert polyunsaturated fatty acids into lipid hydroperoxides. Homolytic decomposition of lipid hydroperoxides gives rise to endogenous genotoxins such as 4-oxo-2(E)-nonenal, which cause the formation of mutagenic DNA adducts. Chiral lipidomics analysis was employed to show that a 5-LO-derived lipid hydroperoxide was responsible for endogenous DNA-adduct formation. The study employed human lymphoblastoid CESS cells, which expressed both 5-LO and the required 5-LO-activating protein (FLAP). The major lipid peroxidation product was 5(S)-hydroperoxy-6,8,11,14-(E,Z,Z,Z)-eicosatetraenoic acid, which was analyzed as its reduction product, 5(S)-hydroxy-6,8,11,14-(E,Z,Z,Z)-eicosatetraenoic acid (5(S)-HETE)). Concentrations of 5(S)-HETE increased from 0.07 +/- 0.01 to 45.50 +/- 4.05 pmol/10(7) cells upon stimulation of the CESS cells with calcium ionophore A23187. There was a concomitant increase in the 4-oxo-2(E)-nonenal-derived DNA-adduct, heptanone-etheno-2'-deoxyguanosine (H epsilon dGuo) from 2.41 +/- 0.35 to 6.31 +/- 0.73 adducts/10(7) normal bases. Biosynthesis of prostaglandins, 11(R)-hydroxy-5,8,12,14-(Z,Z,E,Z)-eicosatetraenoic acid, and 15(R,S)-hydroxy-5,8,11,13-(Z,Z,Z,E)-eicosatetraenoic acid revealed that there was cyclooxygenase ( COX) activity in the CESS cells. Western blot analysis revealed that COX-1 was expressed by the cells, but there was no COX-2 or 15-LO-1. FLAP inhibitor reduced H epsilon dGuo-adducts and 5(S)-HETE to basal levels. In contrast, aspirin, which had no effect on 5(S)-HETE, blocked the formation of prostaglandins, 15-HETE, and 11-HETE but did not inhibit H epsilon dGuo-adduct formation. These data showed that 5-LO was the enzyme responsible for the generation of the H epsilon dGuo DNA-adduct in CESS cells.	[Blair, Ian A.] Univ Penn, Sch Med, Ctr Canc Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Blair, IA (corresponding author), Univ Penn, Sch Med, Ctr Canc Pharmacol, 854 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.		Blair, Ian A/B-3320-2010	Lee, Seon Hwa/0000-0003-1095-5516	National Institutes of Health [RO1CA091016, P30ES013508]; NATIONAL CANCER INSTITUTE [R01CA091016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1CA091016 and P30ES013508.	Andreassi MG, 2003, MUTAT RES-REV MUTAT, V543, P67, DOI 10.1016/S1383-5742(02)00089-3; Blair IA, 2001, EXP GERONTOL, V36, P1473, DOI 10.1016/S0531-5565(01)00133-4; Blair IA, 2008, J BIOL CHEM, V283, P15545, DOI 10.1074/jbc.R700051200; Catalano A, 2004, FASEB J, V18, P1740, DOI 10.1096/fj.04-2258fje; Chaitidis P, 1998, FEBS LETT, V434, P437, DOI 10.1016/S0014-5793(98)01024-2; Chen XX, 2006, CURR CANCER DRUG TAR, V6, P613, DOI 10.2174/156800906778742451; Cook-Moreau JM, 2007, IMMUNOLOGY, V122, P157, DOI 10.1111/j.1365-2567.2007.02621.x; ELMAKHOURHOJEIJ Y, 1994, PROSTAGLANDINS, V48, P21, DOI 10.1016/0090-6980(94)90093-0; Fairweather DeLisa, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P80, DOI 10.2174/187152908783884957; Goossens L, 2007, CURR TOP MED CHEM, V7, P283, DOI 10.2174/156802607779941369; Gupta S, 2001, CANCER-AM CANCER SOC, V91, P737, DOI 10.1002/1097-0142(20010215)91:4<737::AID-CNCR1059>3.0.CO;2-F; Hamberg M, 1998, ARCH BIOCHEM BIOPHYS, V349, P376, DOI 10.1006/abbi.1997.0443; Heaney ML, 2008, CANCER RES, V68, P8031, DOI 10.1158/0008-5472.CAN-08-1490; Hennig R, 2002, AM J PATHOL, V161, P421, DOI 10.1016/S0002-9440(10)64198-3; Hicks A, 2007, EXPERT OPIN INV DRUG, V16, P1909, DOI 10.1517/13543784.16.12.1909; Hong SH, 1999, CANCER RES, V59, P2223; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Jian WY, 2007, CHEM RES TOXICOL, V20, P1008, DOI 10.1021/tx700001t; Jian WY, 2005, FREE RADICAL BIO MED, V39, P1162, DOI 10.1016/j.freeradbiomed.2005.06.008; Jian WY, 2005, CHEM RES TOXICOL, V18, P599, DOI 10.1021/tx049693d; Kuhn H, 2002, PROSTAG OTH LIPID M, V68-9, P263, DOI 10.1016/S0090-6980(02)00035-7; Kuhn H, 2002, FREE RADICAL BIO MED, V33, P154, DOI 10.1016/S0891-5849(02)00855-9; KUHN H, 1993, BIOCHIM BIOPHYS ACTA, V1168, P73, DOI 10.1016/0005-2760(93)90268-E; Lee SH, 2007, CHEM RES TOXICOL, V20, P1665, DOI 10.1021/tx700130p; Lee SH, 2007, METHOD ENZYMOL, V433, P159, DOI 10.1016/S0076-6879(07)33009-7; Lee SH, 2001, SCIENCE, V292, P2083, DOI 10.1126/science.1059501; Lee SH, 2005, PROSTAG OTH LIPID M, V77, P141, DOI 10.1016/j.prostaglandins.2004.01.009; Lee SH, 2005, J BIOL CHEM, V280, P28337, DOI 10.1074/jbc.M504178200; Lee SH, 2003, RAPID COMMUN MASS SP, V17, P2168, DOI 10.1002/rcm.1170; Lee SH, 2001, TRENDS CARDIOVAS MED, V11, P148, DOI 10.1016/S1050-1738(01)00094-9; Levine M, 1996, P NATL ACAD SCI USA, V93, P3704, DOI 10.1073/pnas.93.8.3704; Li N, 2005, CLIN CANCER RES, V11, P2089, DOI 10.1158/1078-0432.CCR-04-1684; Loft S, 2006, CARCINOGENESIS, V27, P1245, DOI 10.1093/carcin/bgi313; Lotzer K, 2005, BBA-MOL CELL BIOL L, V1736, P30, DOI 10.1016/j.bbalip.2005.07.001; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martinet W, 2002, CIRCULATION, V106, P927, DOI 10.1161/01.CIR.0000026393.47805.21; Mehrabian M, 2003, CURR OPIN LIPIDOL, V14, P447, DOI 10.1097/00041433-200310000-00005; Murphy RC, 2007, BIOCHEM J, V405, P379, DOI 10.1042/BJ20070289; Oe T, 2003, J BIOL CHEM, V278, P42098, DOI 10.1074/jbc.M308167200; Ohtsubo T, 2007, DNA REPAIR, V6, P760, DOI 10.1016/j.dnarep.2007.01.003; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Peters-Golden M, 2005, ANN ALLERG ASTHMA IM, V94, P609, DOI 10.1016/S1081-1206(10)61317-8; Peters-Golden M, 2008, CURR ALLERGY ASTHM R, V8, P367, DOI 10.1007/s11882-008-0057-z; Pollack M, 2006, CHEM RES TOXICOL, V19, P1074, DOI 10.1021/tx0600503; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; Rioux N, 1998, CARCINOGENESIS, V19, P1393, DOI 10.1093/carcin/19.8.1393; ROUZER CA, 1990, J BIOL CHEM, V265, P1436; Sayre LM, 2006, DRUG METAB REV, V38, P651, DOI 10.1080/03602530600959508; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; SCHULAM PG, 1990, J IMMUNOL, V144, P2696; Serrano-Mollar Anna, 2005, Current Drug Targets - Inflammation and Allergy, V4, P151, DOI 10.2174/1568010053586354; Sharma J. N., 2006, Inflammopharmacology, V14, P10, DOI 10.1007/s10787-006-1496-6; Shen JH, 1996, J CLIN INVEST, V98, P2201, DOI 10.1172/JCI119029; Spanbroek R, 2003, P NATL ACAD SCI USA, V100, P1238, DOI 10.1073/pnas.242716099; Steele VE, 1999, CANCER EPIDEM BIOMAR, V8, P467; Werz Oliver, 2002, Current Drug Targets - Inflammation and Allergy, V1, P23, DOI 10.2174/1568010023344959; WOODS JW, 1993, J EXP MED, V178, P1935, DOI 10.1084/jem.178.6.1935; Woodside JV, 2005, P NUTR SOC, V64, P543, DOI 10.1079/PNS2005464; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Zhao L, 2004, TRENDS CARDIOVAS MED, V14, P191, DOI 10.1016/j.tcm.2004.04.003; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099; Zhu PJ, 2008, RAPID COMMUN MASS SP, V22, P432, DOI 10.1002/rcm.3380	62	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16799	16807		10.1074/jbc.M109.011841	http://dx.doi.org/10.1074/jbc.M109.011841			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19390118	Green Published, hybrid			2022-12-25	WOS:000266962400016
J	Lee, DS; Park, JT; Kim, HM; Ko, JS; Son, HH; Gronostajski, RM; Cho, MI; Choung, PH; Park, JC				Lee, Dong-Seol; Park, Jong-Tae; Kim, Hyun-Man; Ko, Jea Seung; Son, Ho-Hyun; Gronostajski, Richard M.; Cho, Moon-Il; Choung, Pill-Hoon; Park, Joo-Cheol			Nuclear Factor I-C Is Essential for Odontogenic Cell Proliferation and Odontoblast Differentiation during Tooth Root Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; DENTIN MATRIX PROTEINS; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; SMAD PROTEINS; GENE PROMOTER; APOPTOSIS; TRANSCRIPTION; EXPRESSION; MICE	Our previous studies have demonstrated that nuclear factor I-C (NFI-C) null mice developed short molar roots that contain aberrant odontoblasts and abnormal dentin formation. Based on these findings, we performed studies to elucidate the function of NFI-C in odontoblasts. Initial studies demonstrated that aberrant odontoblasts become dissociated and trapped in an osteodentin- like mineralized tissue. Abnormal odontoblasts exhibit strong bone sialoprotein expression but a decreased level of dentin sialophosphoprotein expression when compared with wild type odontoblasts. Loss of Nfic results in an increase in p-Smad2/3 expression in aberrant odontoblasts and pulp cells in the subodontoblastic layer in vivo and primary pulp cells from Nfic-deficient mice in vitro. Cell proliferation analysis of both cervical loop and ectomesenchymal cells of the Nfic-deficient mice revealed significantly decreased proliferative activity compared with wild type mice. In addition, Nfic-deficient primary pulp cells showed increased expression of p21 and p16 but decreased expression of cyclin D1 and cyclin B1, strongly suggesting cell growth arrest caused by a lack of Nfic activity. Analysis of the pulp and abnormal dentin in Nfic-deficient mice revealed an increase in apoptotic activity. Further, Nfic-deficient primary pulp cells exhibited an increase in caspase-8 and -3 activation, whereas the cleaved form of Bid was hardly detected. These results indicate that the loss of Nfic leads to the suppression of odontogenic cell proliferation and differentiation and induces apoptosis of aberrant odontoblasts during root formation, thereby contributing to the formation of short roots.	[Lee, Dong-Seol; Park, Jong-Tae; Kim, Hyun-Man; Ko, Jea Seung; Park, Joo-Cheol] Seoul Natl Univ, Sch Dent, Dept Oral Histol Dev Biol, Dent Res Inst, Seoul 110749, South Korea; [Choung, Pill-Hoon] Seoul Natl Univ, Sch Dent, Tooth Bioengn Natl Res Lab, Seoul 110749, South Korea; [Gronostajski, Richard M.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY 14214 USA; [Gronostajski, Richard M.] SUNY Buffalo, Sch Med & Biomed Sci, Program Neurosci, Buffalo, NY 14214 USA; [Cho, Moon-Il] SUNY Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY 14214 USA	Seoul National University (SNU); Seoul National University (SNU); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Park, JC (corresponding author), Seoul Natl Univ, Sch Dent, Dept Oral Histol Dev Biol, Dent Res Inst, 28 Yeonkun Dong, Seoul 110749, South Korea.	jcapark@snu.ac.kr	Self, Casey J/B-6871-2011; Park, Joo Cheol/D-6437-2012; Lee, Dong-Seol/GLN-3829-2022	Park, Joo Cheol/0000-0002-3162-7557; Gronostajski, Richard/0000-0003-4264-208X	Korea Science and Engineering Foundation [M1060000283-06J0000-28310]; Ministry of Science and Technology, Korea Science and Engineering Foundation [M1064601000206N4601-00210]; Korean government (MOST); Korea Research Foundation [KRF-2008-314-E00214]; Korean Government (MOEHRD, Basic Research Promotion Fund)	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Ministry of Science and Technology, Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korean government (MOST)(Ministry of Science & Technology (MOST), Republic of KoreaKorean Government); Korea Research Foundation(National Research Foundation of Korea); Korean Government (MOEHRD, Basic Research Promotion Fund)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government)	This work was supported in part by Grant M1060000283-06J0000-28310 from the Korea Science and Engineering Foundation through the National Research Laboratory Program funded by the Ministry of Science and Technology, Korea Science and Engineering Foundation Grant M1064601000206N4601-00210 funded by the Korean government (MOST), and Korea Research Foundation Grant KRF-2008-314-E00214 funded by the Korean Government (MOEHRD, Basic Research Promotion Fund).	Bronckers ALJJ, 2000, HISTOCHEM CELL BIOL, V113, P293, DOI 10.1007/s004180000137; Butler WT, 1998, EUR J ORAL SCI, V106, P204, DOI 10.1111/j.1600-0722.1998.tb02177.x; Chaudhry AZ, 1997, DEV DYNAM, V208, P313; Chen F, 2007, DEVELOPMENT, V134, P2969, DOI 10.1242/dev.006221; Couble ML, 2000, CALCIFIED TISSUE INT, V66, P129, DOI 10.1007/PL00005833; Cox LS, 1997, J PATHOL, V183, P134, DOI 10.1002/(SICI)1096-9896(199710)183:2<134::AID-PATH960>3.0.CO;2-D; Driller K, 2007, MOL CELL BIOL, V27, P3855, DOI 10.1128/MCB.02293-06; Gong JG, 2003, CANCER RES, V63, P3340; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Grunder A, 2002, MECH DEVELOP, V112, P69, DOI 10.1016/S0925-4773(01)00640-2; Hanks CT, 1998, CONNECT TISSUE RES, V37, P233, DOI 10.3109/03008209809002442; Harada H, 2002, DEVELOPMENT, V129, P1533; He WX, 2005, ARCH ORAL BIOL, V50, P929, DOI 10.1016/j.archoralbio.2005.03.004; He WX, 2004, ARCH ORAL BIOL, V49, P911, DOI 10.1016/j.archoralbio.2004.05.005; Hwang YC, 2008, J MOL HISTOL, V39, P153, DOI 10.1007/s10735-007-9148-8; Iozzo RV, 1997, J BIOL CHEM, V272, P5219, DOI 10.1074/jbc.272.8.5219; Kaneko H, 1999, CELL TISSUE RES, V298, P95, DOI 10.1007/s004419900061; Lee KY, 2002, J BIOCHEM MOL BIOL, V35, P47; Luan XH, 2006, DEV DYNAM, V235, P1167, DOI 10.1002/dvdy.20674; Matalova E, 2004, J DENT RES, V83, P11, DOI 10.1177/154405910408300103; Miyazaki T, 2008, ARCH HISTOL CYTOL, V71, P131, DOI 10.1679/aohc.71.131; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; NAGATA K, 1982, P NATL ACAD SCI-BIOL, V79, P6438, DOI 10.1073/pnas.79.21.6438; Ogata Y, 1997, J CELL BIOCHEM, V65, P501, DOI 10.1002/(SICI)1097-4644(19970615)65:4<501::AID-JCB6>3.0.CO;2-S; Ouellet S, 2006, NUCLEIC ACIDS RES, V34, P6472, DOI 10.1093/nar/gkl861; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; Park JC, 2007, J PERIODONTOL, V78, P1795, DOI 10.1902/jop.2007.060363; Philchenkov AA, 2003, BIOCHEMISTRY-MOSCOW+, V68, P365, DOI 10.1023/A:1023635510363; Sanchez-Capelo A, 2005, CYTOKINE GROWTH F R, V16, P15, DOI 10.1016/j.cytogfr.2004.11.002; Schultz DR, 2003, SEMIN ARTHRITIS RHEU, V32, P345, DOI 10.1053/sarh.2003.50005; Schuster N, 2002, CELL TISSUE RES, V307, P1, DOI 10.1007/s00441-001-0479-6; Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0; Sharpe P T, 2001, Adv Dent Res, V15, P4; Shigemura N, 2001, HISTOCHEM J, V33, P253, DOI 10.1023/A:1017900305661; Shigemura N, 1999, HISTOCHEM J, V31, P367, DOI 10.1023/A:1003796023992; Shu TZ, 2003, J NEUROSCI, V23, P203; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Smith AJ, 1998, EUR J ORAL SCI, V106, P179, DOI 10.1111/j.1600-0722.1998.tb02173.x; SMITH AJ, 1990, J BIOL BUCCALE, V18, P123; Smith AJ, 2001, CRIT REV ORAL BIOL M, V12, P425, DOI 10.1177/10454411010120050501; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Steele-Perkins G, 2003, MOL CELL BIOL, V23, P1075, DOI 10.1128/MCB.23.3.1075-1084.2003; Stefancsik R, 2003, DNA SEQUENCE, V14, P233, DOI 10.1080/1085566031000141126; Sun ZL, 1998, CONNECT TISSUE RES, V37, P251, DOI 10.3109/03008209809002443; TENCATE AR, 1986, J DENT RES, V65, P1087, DOI 10.1177/00220345860650080901; Thyagarajan T, 2001, J BIOL CHEM, V276, P11016, DOI 10.1074/jbc.M010502200; Tomlinson DC, 2004, ENDOCRINOLOGY, V145, P1988, DOI 10.1210/en.2003-0842; Unterbrink A, 2002, CONNECT TISSUE RES, V43, P354, DOI 10.1080/03008200290000565; Vermelin L, 1996, EUR J ORAL SCI, V104, P547, DOI 10.1111/j.1600-0722.1996.tb00140.x; Yokohama-Tamaki T, 2006, DEVELOPMENT, V133, P1359, DOI 10.1242/dev.02307; Zeichner-David M, 2003, DEV DYNAM, V228, P651, DOI 10.1002/dvdy.10404; Zimmermann KC, 2001, PHARMACOL THERAPEUT, V92, P57, DOI 10.1016/S0163-7258(01)00159-0; zur Nieden NI, 2003, DIFFERENTIATION, V71, P18, DOI 10.1046/j.1432-0436.2003.700602.x	53	81	82	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17293	17303		10.1074/jbc.M109.009084	http://dx.doi.org/10.1074/jbc.M109.009084			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19386589	hybrid, Green Published			2022-12-25	WOS:000266962400065
J	Barroso-Gonzalez, J; El Jaber-Vazdekis, N; Garcia-Exposito, L; Machado, JD; Zarate, R; Ravelo, AG; Estevez-Braun, A; Valenzuela-Fernandez, A				Barroso-Gonzalez, Jonathan; El Jaber-Vazdekis, Nabil; Garcia-Exposito, Laura; Machado, Jose-David; Zarate, Rafael; Ravelo, Angel G.; Estevez-Braun, Ana; Valenzuela-Fernandez, Agustin			The Lupane-type Triterpene 30-Oxo-calenduladiol Is a CCR5 Antagonist with Anti-HIV-1 and Anti-chemotactic Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC CELL MATURATION; C CHEMOKINE RECEPTOR-5; HIV-1 INFECTION; T-CELLS; THERAPEUTIC TARGETS; BETULINIC ACID; SMALL-MOLECULE; HIGHLY POTENT; INFLAMMATION; ENTRY	The existence of drug-resistant human immunodeficiency virus (HIV) viruses in patients receiving antiretroviral treatment urgently requires the characterization and development of new antiretroviral drugs designed to inhibit resistant viruses and to complement the existing antiretroviral strategies against AIDS. We assayed several natural or semi-synthetic lupane-type pentacyclic triterpenes in their ability to inhibit HIV-1 infection in permissive cells. We observed that the 30-oxo-calenduladiol triterpene, compound 1, specifically impaired R5-tropic HIV-1 envelope-mediated viral infection and cell fusion in permissive cells, without affecting X4-tropic virus. This lupane derivative competed for the binding of a specific anti-CCR5 monoclonal antibody or the natural CCL5 chemokine to the CCR5 viral coreceptor with high affinity. 30-Oxo-calenduladiol seems not to interact with the CD4 antigen, the main HIV receptor, or the CXCR4 viral coreceptor. Our results suggest that compound 1 is a specific CCR5 antagonist, because it binds to the CCR5 receptor without triggering cell signaling or receptor internalization, and inhibits RANTES (regulated on activation normal T cell expressed and secreted)-mediated CCR5 internalization, intracellular calcium mobilization, and cell chemotaxis. Furthermore, compound 1 appeared not to interact with beta-chemokine receptors CCR1, CCR2b, CCR3, or CCR4. Thereby, the 30-oxo-calenduladiol-associated anti-HIV-1 activity against R5-tropic virus appears to rely on the selective occupancy of the CCR5 receptor to inhibit CCR5-mediated HIV-1 infection. Therefore, it is plausible that the chemical structure of 30-oxo-calenduladiol or other related dihydroxylated lupane-type triterpenes could represent a good model to develop more potent anti-HIV-1 molecules to inhibit viral infection by interfering with early fusion and entry steps in the HIV life cycle.	[Barroso-Gonzalez, Jonathan; El Jaber-Vazdekis, Nabil; Zarate, Rafael; Ravelo, Angel G.; Estevez-Braun, Ana] Univ La Laguna, Inst Univ Bioorgan, San Cristobal la Laguna 38206, Spain; [Barroso-Gonzalez, Jonathan; Garcia-Exposito, Laura; Machado, Jose-David; Valenzuela-Fernandez, Agustin] Univ La Laguna, Fac Med, Inst Tecnol Biomed,Lab Inmunol Celular & Viral, Dept Med Fis & Farmacol,Unidad Farmacol, Tenerife 38071, Spain; [Barroso-Gonzalez, Jonathan; El Jaber-Vazdekis, Nabil; Garcia-Exposito, Laura; Zarate, Rafael; Ravelo, Angel G.; Estevez-Braun, Ana; Valenzuela-Fernandez, Agustin] Hosp Univ La Candelaria, ICIC, Tenerife 38010, Spain	Universidad de la Laguna; Universidad de la Laguna	Estevez-Braun, A (corresponding author), Univ La Laguna, Inst Univ Bioorgan, San Cristobal la Laguna 38206, Spain.	aestebra@ull.es; avalenzu@ull.es	el jaber vazdekis, nabil/J-8108-2014; Machado, José David/N-5210-2014; Valenzuela-Fernández, Agustín/B-6219-2014; Valenzuela-Fernández, Agustín/P-1638-2019; Barroso, Jonathan/T-9295-2017; Estevez-Braun, Ana/A-8122-2015	el jaber vazdekis, nabil/0000-0002-8669-4730; Machado, José David/0000-0003-3531-7051; Valenzuela-Fernández, Agustín/0000-0002-2585-8703; Valenzuela-Fernández, Agustín/0000-0002-2585-8703; Barroso, Jonathan/0000-0001-9167-6660; Estevez-Braun, Ana/0000-0001-5279-7099; Garcia Exposito, Laura/0000-0002-8172-7986	Ministerio de Ciencia e Innovacion, Spain [SAF2008-01729]; Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) [24508/05, FIPSE-24661/07]; Consejeria de Industria; Comercio y Nuevas Tecnologias del Gobierno Autonomo de Canarias, Spain [IDT-TF-06/066]; Fundacion Mutua Madrilena, Spain; Canary Islands Cancer Research Institute (ICIC); Spanish Ministry of Education and Science (MEC) [SAF 2006-06720]; Fundacion Canaria de Investigacion y Salud (FUNCIS) [PI56/07]; CajaCanarias; Fondo Social Europeo [RYC2002-694, RYC2002-3018]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE); Consejeria de Industria; Comercio y Nuevas Tecnologias del Gobierno Autonomo de Canarias, Spain; Fundacion Mutua Madrilena, Spain; Canary Islands Cancer Research Institute (ICIC); Spanish Ministry of Education and Science (MEC)(Spanish Government); Fundacion Canaria de Investigacion y Salud (FUNCIS); CajaCanarias; Fondo Social Europeo(European Social Fund (ESF)European Commission)	This work was supported in part by Ministerio de Ciencia e Innovacion, Spain, Grant SAF2008-01729, Fundacion para la Investigacion y Prevencion del SIDA en Espana Grants Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE)-24508/05 and FIPSE-24661/07, Consejeria de Industria, Comercio y Nuevas Tecnologias del Gobierno Autonomo de Canarias, Spain, Grant IDT-TF-06/066, and the Fundacion Mutua Madrilena, Spain. This work was also supported by the Canary Islands Cancer Research Institute (ICIC), and project SAF 2006-06720 from the Spanish Ministry of Education and Science (MEC).; Supported by associated Fellowship Fundacion Canaria de Investigacion y Salud (FUNCIS)-PI56/07.; Supported by a predoctoral fellowship from CajaCanarias.; Supported Fondo Social Europeo Grant RYC2002-694.	Aiken C, 2005, TRENDS MOL MED, V11, P31, DOI 10.1016/j.molmed.2004.11.001; Alakurtti S, 2006, EUR J PHARM SCI, V29, P1, DOI 10.1016/j.ejps.2006.04.006; Azenshtein E, 2002, CANCER RES, V62, P1093; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Barrero-Villar M, 2008, J IMMUNOL, V181, P6882, DOI 10.4049/jimmunol.181.10.6882; Barroso-Gonzalez J, 2009, J BIOL CHEM, V284, P2419, DOI 10.1074/jbc.M805311200; Blanpain C, 2003, J BIOL CHEM, V278, P5179, DOI 10.1074/jbc.M205684200; Cascieri MA, 2000, CURR OPIN CHEM BIOL, V4, P420, DOI 10.1016/S1367-5931(00)00113-7; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cichewicz RH, 2004, MED RES REV, V24, P90, DOI 10.1002/med.10053; Condra JH, 2002, ANNU REV MED, V53, P541, DOI 10.1146/annurev.med.53.082901.104110; Connolly JD, 2000, NAT PROD REP, V17, P463, DOI 10.1039/b003456h; Delgado-Mendez P, 2008, BIOORGAN MED CHEM, V16, P1425, DOI 10.1016/j.bmc.2007.10.071; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Frantz S, 2005, NATURE, V437, P942, DOI 10.1038/437942a; Gutierrez F, 2007, J NAT PROD, V70, P1049, DOI 10.1021/np070019g; Horuk R, 2009, NAT REV DRUG DISCOV, V8, P23, DOI 10.1038/nrd2734; Horuk R, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000921; Inciardi JA, 2005, AIDS CARE, V17, pS1, DOI 10.1080/09540120500120435; Kallings LO, 2008, J INTERN MED, V263, P218, DOI 10.1111/j.1365-2796.2007.01910.x; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kuehn BM, 2006, JAMA-J AM MED ASSOC, V296, P29, DOI 10.1001/jama.296.1.29; Lee B, 1999, J BIOL CHEM, V274, P9617, DOI 10.1074/jbc.274.14.9617; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Mesa-Siverio D, 2005, TETRAHEDRON, V61, P429, DOI 10.1016/j.tet.2004.10.074; Mesa-Siverio D, 2003, EUR J ORG CHEM, V2003, P4243, DOI 10.1002/ejoc.200300284; Neukirch H, 2005, CHEM BIODIVERS, V2, P657, DOI 10.1002/cbdv.200590042; Nunez MJ, 2005, J NAT PROD, V68, P1018, DOI 10.1021/np058016w; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Perrin D.D., 1988, PURIFICATION LAB CHE; Pleskoff O, 1997, SCIENCE, V276, P1874, DOI 10.1126/science.276.5320.1874; Pohlmann S, 2006, CURR PHARM DESIGN, V12, P1963, DOI 10.2174/138161206777442155; Princen K, 2005, CYTOKINE GROWTH F R, V16, P659, DOI 10.1016/j.cytogfr.2005.05.009; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Schroder C, 2007, J IMMUNOL, V179, P2289, DOI 10.4049/jimmunol.179.4.2289; Seto M, 2006, J MED CHEM, V49, P2037, DOI 10.1021/jm0509703; Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5; Sozzani S, 1998, J IMMUNOL, V161, P1083; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Suzaki Y, 2008, EUR RESPIR J, V31, P783, DOI 10.1183/09031936.00111507; UNAIDS, 2008, REP GLOB AIDS EP; Valenzuela-Fernandez A, 2005, MOL BIOL CELL, V16, P5445, DOI 10.1091/mbc.e05-04-0354; Valenzuela-Fernandez A, 2002, J BIOL CHEM, V277, P15677, DOI 10.1074/jbc.M111388200; Valenzuela-Fernandez A, 2001, J BIOL CHEM, V276, P26550, DOI 10.1074/jbc.M100411200; van Deventer HW, 2008, AM J PATHOL, V173, P253, DOI 10.2353/ajpath.2008.070732; van Deventer HW, 2005, CANCER RES, V65, P3374, DOI 10.1158/0008-5472.CAN-04-2616; Watson C, 2005, MOL PHARMACOL, V67, P1268, DOI 10.1124/mol.104.008565; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681; Wu LJ, 1997, J EXP MED, V186, P1373, DOI 10.1084/jem.186.8.1373; Wysocki CA, 2005, BLOOD, V106, P3300, DOI 10.1182/blood-2005-04-1632; Zhou YH, 1998, J IMMUNOL, V160, P4018	57	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16609	16620		10.1074/jbc.M109.005835	http://dx.doi.org/10.1074/jbc.M109.005835			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19386595	Green Published, hybrid			2022-12-25	WOS:000266730900057
J	Hickey, CM; Stroupe, C; Wickner, W				Hickey, Christopher M.; Stroupe, Christopher; Wickner, William			The Major Role of the Rab Ypt7p in Vacuole Fusion Is Supporting HOPS Membrane Association	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEX RING DOMAIN; SACCHAROMYCES-CEREVISIAE; YEAST VACUOLE; SNARE COMPLEX; REGULATORY LIPIDS; DOCKING; PROTEINS; REQUIRES; KINASE; GTPASE	Yeast vacuole fusion requires soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs), the Rab GTPase Ypt7p, vacuolar lipids, Sec17p and Sec18p, and the homotypic fusion and vacuole protein sorting complex (HOPS). HOPS is a multisubunit protein with direct affinities for SNAREs, vacuolar lipids, and the GTP-bound form of Ypt7p; each of these affinities contributes to HOPS association with the organelle. Using all-purified components, we have reconstituted fusion, but the Rab Ypt7p was not required. We now report that phosphorylation of HOPS by the vacuolar kinase Yck3p blocks HOPS binding to vacuolar lipids, making HOPS membrane association and the ensuing fusion depend on the presence of Ypt7p. In accord with this finding in the reconstituted fusion reaction, the inactivation of Ypt7p by the GTPase-activating protein Gyp1-46p only blocks the fusion of purified vacuoles when Yck3p is present and active. Thus, although Ypt7p may contribute to other fusion functions, its central role is to bind HOPS to the membrane.	[Hickey, Christopher M.; Stroupe, Christopher; Wickner, William] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Wickner, W (corresponding author), Dartmouth Med Sch, Dept Biochem, 7200 Vail Bldg, Hanover, NH 03755 USA.	Bill.Wickner@dartmouth.edu			National Institutes of Health [RO1GM23377]; National Institutes of Health Training Grants [T32GM008704, T32AR007576]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008704, R01GM023377] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM23377 through the NIGMS (to W. W) and by National Institutes of Health Training Grants T32GM008704 and T32AR007576 ( to C. M. H.).	Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; Anand VC, 2009, MOL BIOL CELL, V20, P1592, DOI 10.1091/mbc.E08-08-0819; Ballew N, 2005, MOL BIOL CELL, V16, P1839, DOI 10.1091/mbc.E04-08-0725; Brett CL, 2008, J CELL BIOL, V182, P1141, DOI 10.1083/jcb.200801001; Cabrera M, 2009, MOL BIOL CELL, V20, P1937, DOI 10.1091/mbc.E08-09-0943; Cao XC, 1998, EMBO J, V17, P2156, DOI 10.1093/emboj/17.8.2156; Collins KM, 2005, EMBO J, V24, P1775, DOI 10.1038/sj.emboj.7600658; Dirac-Svejstrup AB, 2000, J CELL BIOL, V150, P475, DOI 10.1083/jcb.150.3.475; Dulubova I, 2001, NAT STRUCT BIOL, V8, P258, DOI 10.1038/85012; Eitzen G, 2000, EMBO J, V19, P6713, DOI 10.1093/emboj/19.24.6713; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Gietz RD, 1995, METHOD MOL CELL BIOL, V5, P255; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; HAAS A, 1994, J CELL BIOL, V126, P87, DOI 10.1083/jcb.126.1.87; HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x; Haas A, 1996, EMBO J, V15, P3296, DOI 10.1002/j.1460-2075.1996.tb00694.x; Haas Albert, 1995, Methods in Cell Science, V17, P283, DOI 10.1007/BF00986234; Jones EW, 2002, METHOD ENZYMOL, V351, P127; JONES EW, 1991, METHOD ENZYMOL, V194, P428; LaGrassa TJ, 2005, J CELL BIOL, V168, P401, DOI 10.1083/jcb.200407141; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LYONS PD, 2009, BIOSCI REP IN PRESS; Mace T, 2005, EMBO J, V24, P3235, DOI 10.1038/sj.emboj.7600799; Markgraf DF, 2007, FEBS LETT, V581, P2125, DOI 10.1016/j.febslet.2007.01.090; Mayer A, 2000, MOL BIOL CELL, V11, P807, DOI 10.1091/mbc.11.3.807; Meiringer CTA, 2006, METHODS, V40, P171, DOI 10.1016/j.ymeth.2006.06.020; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; Olesen K, 2000, YEAST, V16, P1035, DOI 10.1002/1097-0061(200008)16:11<1035::AID-YEA606>3.0.CO;2-P; Ostrowicz CW, 2008, AUTOPHAGY, V4, P5, DOI 10.4161/auto.5054; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; Price A, 2000, J CELL BIOL, V148, P1223, DOI 10.1083/jcb.148.6.1223; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Starai VJ, 2008, MOL BIOL CELL, V19, P2500, DOI 10.1091/mbc.E08-01-0077; Starai VJ, 2007, P NATL ACAD SCI USA, V104, P13551, DOI 10.1073/pnas.0704741104; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; Sun BM, 2004, MOL BIOL CELL, V15, P1397, DOI 10.1091/mbc.E03-09-0682; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; WADA Y, 1992, J BIOL CHEM, V267, P18665; Wang L, 2003, J CELL BIOL, V160, P365, DOI 10.1083/jcb.200209095; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	47	56	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16118	16125		10.1074/jbc.M109.000737	http://dx.doi.org/10.1074/jbc.M109.000737			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19386605	hybrid, Green Published			2022-12-25	WOS:000266730900008
J	Martinez-Nunez, RT; Louafi, F; Friedmann, PS; Sanchez-Elsner, T				Martinez-Nunez, Rocio T.; Louafi, Fethi; Friedmann, Peter S.; Sanchez-Elsner, Tilman			MicroRNA-155 Modulates the Pathogen Binding Ability of Dendritic Cells (DCs) by Down-regulation of DC-specific Intercellular Adhesion Molecule-3 Grabbing Non-integrin (DC-SIGN)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; T-CELLS; (ICAM-3)-GRABBING NONINTEGRIN; TRANS-INFECTION; RECEPTOR; PU.1; TRANSCRIPTION; MACROPHAGE; EXPRESSION; ANTIGEN	MicroRNA-155 (miR-155) has been involved in the response to inflammation in macrophages and lymphocytes. Here we show how miR-155 participates in the maturation of human dendritic cells (DC) and modulates pathogen binding by down-regulating DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN), after directly targeting the transcription factor PU.1. During the maturation of DCs, miR-155 increases up to 130-fold, whereas PU.1 protein levels decrease accordingly. We establish that human PU.1 is a direct target for miR-155 and localize the target sequence for miR-155 in the 3'-untranslated region of PU.1. Also, overexpression of miR-155 in the THP1 monocytic cell line decreases PU.1 protein levels and DC-SIGN at both the mRNA and protein levels. We prove a link between the down-regulation of PU.1 and reduced transcriptional activity of the DC-SIGN promoter, which is likely to be the basis for its reduced mRNA expression, after miR-155 overexpression. Finally, we show that, by reducing DC-SIGN in the cellular membrane, miR-155 is involved in regulating pathogen binding as dendritic cells exhibited the lower binding capacity for fungi and HIV protein gp-120 when the levels of miR-155 were higher. Thus, our results suggest a mechanism by which miR-155 regulates proteins involved in the cellular immune response against pathogens that could have clinical implications in the way pathogens enter the human organism.	[Martinez-Nunez, Rocio T.; Louafi, Fethi; Friedmann, Peter S.; Sanchez-Elsner, Tilman] Univ Southampton, Sch Med, Div Infect Inflammat & Repair, Southampton SO16 6YD, Hants, England; Southampton Gen Hosp, Southampton SO16 6YD, Hants, England	University of Southampton; University of Southampton	Sanchez-Elsner, T (corresponding author), Gen Hosp MP 813, Tremona Rd, Southampton SO16 6YD, Hants, England.	T.Sanchez-Elsner@soton.ac.uk		Sanchez-Elsner, Tilman/0000-0003-1915-2410; Martinez-Nunez, Rocio Teresa/0000-0003-2507-4738	Wessex [M14]	Wessex	This work was supported by Wessex Medical Research Grant M14.	Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Anderson KL, 1998, BLOOD, V91, P3702, DOI 10.1182/blood.V91.10.3702; Arrighi JF, 2004, J EXP MED, V200, P1279, DOI 10.1084/jem.20041356; Bakri Y, 2005, BLOOD, V105, P2707, DOI 10.1182/blood-2004-04-1448; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bulliard Y, 2006, J BIOL CHEM, V281, P35742, DOI 10.1074/jbc.M602843200; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; Caparros E, 2006, BLOOD, V107, P3950, DOI 10.1182/blood-2005-03-1252; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Colmenares M, 2002, J BIOL CHEM, V277, P36766, DOI 10.1074/jbc.M205270200; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; Deiva K, 2006, AIDS RES HUM RETROV, V22, P1152, DOI 10.1089/aid.2006.22.1152; Dominguez-Soto A, 2005, J BIOL CHEM, V280, P33123, DOI 10.1074/jbc.M503401200; Fisher RC, 1998, STEM CELLS, V16, P25, DOI 10.1002/stem.160025; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Lanoue A, 2004, J EXP MED, V200, P1383, DOI 10.1084/jem.20040795; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Martin MM, 2006, J BIOL CHEM, V281, P18277, DOI 10.1074/jbc.M601496200; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Puig-Kroger A, 2004, J BIOL CHEM, V279, P25680, DOI 10.1074/jbc.M311516200; Ralser M, 2006, BIOCHEM BIOPH RES CO, V347, P747, DOI 10.1016/j.bbrc.2006.06.151; Rappocciolo G, 2006, PLOS PATHOG, V2, P691, DOI 10.1371/journal.ppat.0020070; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Serrano-Gomez D, 2008, J BIOL CHEM, V283, P3889, DOI 10.1074/jbc.M706004200; Spear GT, 2003, IMMUNOLOGY, V110, P80, DOI 10.1046/j.1365-2567.2003.01707.x; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tailleux L, 2005, PLOS MED, V2, P1269, DOI 10.1371/journal.pmed.0020381; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wallet MA, 2005, CLIN MED RES, V3, P166, DOI 10.3121/cmr.3.3.166; Wang SK, 2008, P NATL ACAD SCI USA, V105, P3690, DOI 10.1073/pnas.0712326105; Wieland CW, 2007, MICROBES INFECT, V9, P134, DOI 10.1016/j.micinf.2006.10.018	45	175	197	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16334	16342		10.1074/jbc.M109.011601	http://dx.doi.org/10.1074/jbc.M109.011601			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19386588	Green Published, hybrid			2022-12-25	WOS:000266730900031
J	Gammoh, N; Isaacson, E; Tomaic, V; Jackson, DJ; Doorbar, J; Banks, L				Gammoh, N.; Isaacson, E.; Tomaic, V.; Jackson, D. J.; Doorbar, J.; Banks, L.			Inhibition of HPV-16 E7 oncogenic activity by HPV-16 E2	ONCOGENE			English	Article						HPV; E7; centrosomes; pRb	HUMAN-PAPILLOMAVIRUS TYPE-16; TRANSCRIPTIONAL ACTIVATOR; RETINOBLASTOMA PROTEIN; CENTROSOME DUPLICATION; GENOMIC INSTABILITY; HUMAN KERATINOCYTES; CERVICAL-CANCER; IN-VIVO; E6; ONCOPROTEIN	Human papillomavirus (HPV) E7 is essential in inducing S-phase progression in differentiating epithelial cells. We have previously shown that HPV-16 E7 activity can be controlled by a direct interaction with the viral transcriptional activator E2, thereby inhibiting transforming potential of E7. We have extended these analyses to show that E2 induces a generalized re-localization of E7 within the cell nucleus, one potential consequence of which is the inhibition of E7-induced degradation of pRb. Most importantly, we show that E2 can also inhibit the ability of E7 to induce centrosome abnormalities, thus preventing aberrant mitoses. Taken together, these studies highlight the central importance of E2 in controlling the functions of E7, independently of the ability of E2 to regulate transcription. Oncogene (2009) 28, 2299-2304; doi: 10.1038/onc.2009.78; published online 4 May 2009	[Gammoh, N.; Tomaic, V.; Banks, L.] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; [Isaacson, E.; Jackson, D. J.; Doorbar, J.] MRC Natl Inst Med Res, Div Virol, London, England	International Center for Genetic Engineering & Biotechnology (ICGEB); MRC National Institute for Medical Research	Banks, L (corresponding author), Int Ctr Genet Engn & Biotechnol, Padriciano 99, I-34012 Trieste, Italy.	doorba@nimr.mrc.ac.uk; banks@icgeb.org			Associazione Italiana per la Ricerca sul Cancro; UK Medical Research Council; Medical Research Council [MC_U117584278] Funding Source: researchfish; MRC [MC_U117584278] Funding Source: UKRI	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Daniela Gardiol, David Pim and Miranda Thomas for comments on the paper. We also thank Karl Munger for providing anti-HPV-16 E7 monoclonal antibody. This work was supported in part by a research grant from the Associazione Italiana per la Ricerca sul Cancro. EI, DJ and JD were supported by the UK Medical Research Council.	Araujo FD, 2005, J VIROL, V79, P11382, DOI 10.1128/JVI.79.17.11382-11391.2005; Boyer SN, 1996, CANCER RES, V56, P4620; Donaldson MM, 2007, J VIROL, V81, P4338, DOI 10.1128/JVI.02353-06; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Duensing S, 2000, P NATL ACAD SCI USA, V97, P10002, DOI 10.1073/pnas.170093297; Duensing S, 2004, ONCOGENE, V23, P8206, DOI 10.1038/sj.onc.1208012; Duensing S, 2003, J VIROL, V77, P12331, DOI 10.1128/JVI.77.22.12331-12335.2003; Duensing S, 2001, J VIROL, V75, P7712, DOI 10.1128/JVI.75.16.7712-7716.2001; Funk JO, 1997, GENE DEV, V11, P2090, DOI 10.1101/gad.11.16.2090; Gammoh N, 2006, J VIROL, V80, P1787, DOI 10.1128/JVI.80.4.1787-1797.2006; Grm HS, 2005, ONCOGENE, V24, P5149, DOI 10.1038/sj.onc.1208701; He WX, 2003, J VIROL, V77, P10566, DOI 10.1128/JVI.77.19.10566-10574.2003; HECK DV, 1992, P NATL ACAD SCI USA, V89, P4442, DOI 10.1073/pnas.89.10.4442; Kurg R, 2005, J VIROL, V79, P10528, DOI 10.1128/JVI.79.16.10528-10539.2005; Massimi P, 1999, ONCOGENE, V18, P7748, DOI 10.1038/sj.onc.1203208; Patel D, 2004, CANCER RES, V64, P1299, DOI 10.1158/0008-5472.CAN-03-2917; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Yoshinouchi M, 2003, MOL THER, V8, P762, DOI 10.1016/j.ymthe.2003.08.004	18	20	21	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 11	2009	28	23					2299	2304		10.1038/onc.2009.78	http://dx.doi.org/10.1038/onc.2009.78			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	456XM	19421149				2022-12-25	WOS:000266886300006
J	Egger, B; Steinke, D; Tarui, H; De Mulder, K; Arendt, D; Borgonie, G; Funayama, N; Gschwentner, R; Hartenstein, V; Hobmayer, B; Hooge, M; Hrouda, M; Ishida, S; Kobayashi, C; Kuales, G; Nishimura, O; Pfister, D; Rieger, R; Salvenmoser, W; Smith, J; Technau, U; Tyler, S; Agata, K; Salzburger, W; Ladurner, P				Egger, Bernhard; Steinke, Dirk; Tarui, Hiroshi; De Mulder, Katrien; Arendt, Detlev; Borgonie, Gaetan; Funayama, Noriko; Gschwentner, Robert; Hartenstein, Volker; Hobmayer, Bert; Hooge, Matthew; Hrouda, Martina; Ishida, Sachiko; Kobayashi, Chiyoko; Kuales, Georg; Nishimura, Osamu; Pfister, Daniela; Rieger, Reinhard; Salvenmoser, Willi; Smith, Julian, III; Technau, Ulrich; Tyler, Seth; Agata, Kiyokazu; Salzburger, Walter; Ladurner, Peter			To Be or Not to Be a Flatworm: The Acoel Controversy	PLOS ONE			English	Article							PLANARIAN STEM-CELLS; BASAL POSITION; ACOELOMORPH FLATWORMS; MITOCHONDRIAL GENOME; MACROSTOMUM-LIGNANO; BILATERIAN ANIMALS; S-PHASE; PLATYHELMINTHES; REGENERATION; SUPPORT	Since first described, acoels were considered members of the flatworms (Platyhelminthes). However, no clear synapomorphies among the three large flatworm taxa - the Catenulida, the Acoelomorpha and the Rhabditophora have been characterized to date. Molecular phylogenies, on the other hand, commonly positioned acoels separate from other flatworms. Accordingly, our own multi-locus phylogenetic analysis using 43 genes and 23 animal species places the acoel flatworm Isodiametra pulchra at the base of all Bilateria, distant from other flatworms. By contrast, novel data on the distribution and proliferation of stem cells and the specific mode of epidermal replacement constitute a strong synapomorphy for the Acoela plus the major group of flatworms, the Rhabditophora. The expression of a piwi-like gene not only in gonadal, but also in adult somatic stem cells is another unique feature among bilaterians. These two independent stem-cell-related characters put the Acoela into the Platyhelminthes-Lophotrochozoa clade and account for the most parsimonious evolutionary explanation of epidermal cell renewal in the Bilateria. Most available multigene analyses produce conflicting results regarding the position of the acoels in the tree of life. Given these phylogenomic conflicts and the contradiction of developmental and morphological data with phylogenomic results, the monophyly of the phylum Platyhelminthes and the position of the Acoela remain unresolved. By these data, both the inclusion of Acoela within Platyhelminthes, and their separation from flatworms as basal bilaterians are well-supported alternatives.			Egger, B (corresponding author), Univ Innsbruck, Inst Zool, A-6020 Innsbruck, Austria.	styler@maine.edu; agata@mdb.biophys.kyoto-u.ac.jp; walter.salzburger@unibas.ch; peter.ladurner@uibk.ac.at	Steinke, Dirk/D-4700-2009; Nishimura, Osamu/AAC-1236-2020; Salzburger, Walter/G-1598-2011	Nishimura, Osamu/0000-0003-1969-2580; Salzburger, Walter/0000-0002-9988-1674; Ladurner, Peter/0000-0002-0323-9266; Technau, Ulrich/0000-0003-4472-8258; Steinke, Dirk/0000-0002-8992-575X; Funayama, Noriko/0000-0002-6253-9795; Egger, Bernhard/0000-0001-6353-9458; Agata, Kiyokazu/0000-0002-5195-2576				Baguna J, 2004, BIOESSAYS, V26, P1046, DOI 10.1002/bies.20113; BAGUNA J, 1989, DEVELOPMENT, V107, P77; Baguna J, 2008, PHILOS T R SOC B, V363, P1481, DOI 10.1098/rstb.2007.2238; Bode A, 2006, CELL TISSUE RES, V325, P577, DOI 10.1007/s00441-006-0196-2; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; DROBYSHEVA IM, 1988, FORTSCHR ZOOL, V36, P97; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Egger B, 2006, DEV GENES EVOL, V216, P565, DOI 10.1007/s00427-006-0069-4; Ehlers U., 1992, Microfauna Marina, V7, P311; Ehlers U, 1985, PHYLOGENETISCHE SYST; Gschwentner R, 2001, CELL TISSUE RES, V304, P401, DOI 10.1007/s004410100375; Guo TX, 2006, DEV CELL, V11, P159, DOI 10.1016/j.devcel.2006.06.004; GUSTAFSSON MKS, 1976, Z PARASITENKD, V50, P323, DOI 10.1007/BF02462976; Hanselmann R, 2000, BIOL BULL, V199, P199, DOI 10.2307/1542896; Jimenez-Guri E, 2007, SCIENCE, V317, P116, DOI 10.1126/science.1142024; Jimenez-Guri E, 2006, INT J DEV BIOL, V50, P675, DOI 10.1387/ijdb.062167ej; Karling T.G., 1974, P1; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Ladurner P, 2000, DEV BIOL, V226, P231, DOI 10.1006/dbio.2000.9867; Larsson K, 2008, ORG DIVERS EVOL, V8, P378, DOI 10.1016/j.ode.2008.09.002; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; MACKINNON BM, 1981, HYDROBIOLOGIA, V84, P241, DOI 10.1007/BF00026186; Muller WA, 2004, DEV BIOL, V275, P215, DOI 10.1016/j.ydbio.2004.08.006; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645; O'Donnell KA, 2007, CELL, V129, P37, DOI 10.1016/j.cell.2007.03.028; OTT HN, 1892, J MORPHOL, V7, P263; Palakodeti D, 2008, RNA, V14, P1174, DOI 10.1261/rna.1085008; Paulus T, 2006, J MORPHOL, V267, P393, DOI 10.1002/jmor.10280; Pfister D, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-9; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Philippe H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000717; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; RIEGER R, 2006, SPEZIELLE ZOOLOGIE, V1, P209; Rossi L, 2006, DEV GENES EVOL, V216, P335, DOI 10.1007/s00427-006-0060-0; Ruiz-Trillo I, 2004, MOL PHYLOGENET EVOL, V33, P321, DOI 10.1016/j.ympev.2004.06.002; Ruiz-Trillo I, 2002, P NATL ACAD SCI USA, V99, P11246, DOI 10.1073/pnas.172390199; Ruiz-Trillo I, 1999, SCIENCE, V283, P1919, DOI 10.1126/science.283.5409.1919; Sempere LF, 2007, EVOL DEV, V9, P409, DOI 10.1111/j.1525-142X.2007.00180.x; SMITH JPS, 1986, HYDROBIOLOGIA, V132, P13, DOI 10.1007/BF00046223; SMITH JPS, 2009, NEOBLASTS NEMERTODER; Telford MJ, 2003, P ROY SOC B-BIOL SCI, V270, P1077, DOI 10.1098/rspb.2003.2342; Toledo A, 1997, J PARASITOL, V83, P189, DOI 10.2307/3284437; Tyler S, 2004, CAN J ZOOL, V82, P194, DOI [10.1139/z03-222, 10.1139/Z03-222]	45	79	82	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2009	4	5							e5502	10.1371/journal.pone.0005502	http://dx.doi.org/10.1371/journal.pone.0005502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VY	19430533	Green Published, gold			2022-12-25	WOS:000266009700007
J	Miksa, M; Das, P; Zhou, M; Wu, RQ; Dong, WF; Ji, YX; Goyert, SM; Ravikumar, TS; Wang, P				Miksa, Michael; Das, Padmalaya; Zhou, Mian; Wu, Rongqian; Dong, Weifeng; Ji, Youxin; Goyert, Sanna M.; Ravikumar, Thanjavur S.; Wang, Ping			Pivotal Role of the alpha(2A)-Adrenoceptor in Producing Inflammation and Organ Injury in a Rat Model of Sepsis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; HEPATOCELLULAR DYSFUNCTION; TNF-ALPHA; RECEPTORS; STIMULATION; EXPRESSION; MECHANISM; CYTOKINES; RELEASE; INNATE	Background: Norepinephrine (NE) modulates the responsiveness of macrophages to proinflammatory stimuli through the activation of adrenergic receptors (ARs). Being part of the stress response, early increases of NE in sepsis sustain adverse systemic inflammatory responses. The intestine is an important source of NE release in the early stage of cecal ligation and puncture (CLP)-induced sepsis in rats, which then stimulates TNF-alpha production in Kupffer cells (KCs) through the activation of the alpha(2)-AR. It is important to know which of the three alpha(2)-AR subtypes (i.e., alpha(2A), alpha(2B) or alpha(2C)) is responsible for the upregulation of TNF-alpha production. The aim of this study was to determine the contribution of alpha(2A)-AR in this process. Methodology/Principal Findings: Adult male rats underwent CLP and KCs were isolated 2 h later. Gene expression of alpha(2A)-AR was determined. In additional experiments, cultured KCs were incubated with NE with or without BRL-44408 maleate, a specific alpha(2A)-AR antagonist, and intraportal infusion of NE for 2 h with or without BRL-44408 maleate was carried out in normal animals. Finally, the impact of alpha(2A)-AR activation by NE was investigated under inflammatory conditions (i.e., endotoxemia and CLP). Gene expression of the alpha(2A)-AR subtype was significantly upregulated after CLP. NE increased the release of TNF-alpha in cultured KCs, which was specifically inhibited by the alpha(2A)-AR antagonist BRL-44408. Equally, intraportal NE infusion increased TNF-alpha gene expression in KCs and plasma TNF-alpha which was also abrogated by co-administration of BRL-44408. NE also potentiated LPS-induced TNF-alpha release via the alpha(2A)-AR in vitro and in vivo. This potentiation of TNF-alpha release by NE was mediated through the alpha(2A)-AR coupled G alpha i protein and the activation of the p38 MAP kinase. Treatment of septic animals with BRL-44408 suppressed TNF-alpha, prevented multiple organ injury and significantly improved survival from 45% to 75%. Conclusions/Significance: Our novel finding is that hyperresponsiveness to alpha(2)-AR stimulation observed in sepsis is primarily due to an increase in alpha(2A)-AR expression in KCs. This appears to be in part responsible for the increased proinflammatory response and ensuing organ injury in sepsis. These findings provide important feasibility information for further developing the alpha(2A)-AR antagonist as a new therapy for sepsis.			Miksa, M (corresponding author), N Shore Univ Hosp, Feinstein Inst Med Res, Ctr Immunol & Inflammat, Dept Surg, Manhasset, NY USA.	pwang@nshs.edu	Wu, Rongqian/I-3614-2012; ji, youxin/F-3802-2014; Goyert, Sanna/P-8351-2017; ji, youxin/F-3802-2014	Wu, Rongqian/0000-0003-0993-4531; ji, youxin/0000-0003-2895-4730; Wang, Ping/0000-0002-1557-0394; Goyert, Sanna/0000-0002-0994-7757; ji, youxin/0000-0003-2303-8784	NIA NIH HHS [R01 AG028352] Funding Source: Medline; NIGMS NIH HHS [R01 GM053008, R01 GM057468] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057468, R01GM053008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028352] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bergmann M, 2002, WIEN KLIN WOCHENSCHR, V114, P752; Beutler B, 2001, CRIT CARE MED, V29, pS2, DOI 10.1097/00003246-200107001-00002; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; BYLUND DB, 1994, PHARMACOL REV, V46, P121; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Flugge G, 2003, EUR J NEUROSCI, V17, P917, DOI 10.1046/j.1460-9568.2003.02510.x; HAHN PY, 1995, SHOCK, V4, P269, DOI 10.1097/00024382-199510000-00007; Handy DE, 1998, HYPERTENSION, V32, P311, DOI 10.1161/01.HYP.32.2.311; Hasko G, 1998, BIOCHEM PHARMACOL, V56, P1079, DOI 10.1016/S0006-2952(98)00153-1; Ihalainen JA, 2002, EUR J NEUROSCI, V15, P1789, DOI 10.1046/j.1460-9568.2002.02014.x; Koo DJ, 1999, J SURG RES, V83, P151, DOI 10.1006/jsre.1999.5584; Kotanidou A, 1996, J APPL PHYSIOL, V81, P2304, DOI 10.1152/jappl.1996.81.5.2304; KOVARIK MF, 1987, CIRC SHOCK, V22, P281; Oberholzer A, 2001, SHOCK, V16, P83, DOI 10.1097/00024382-200116020-00001; SPENGLER RN, 1990, J IMMUNOL, V145, P1430; Triantafilou M, 2004, BIOCHEM J, V381, P527, DOI 10.1042/BJ20040172; Vizi ES, 2000, PHARMACOL REV, V52, P63; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; WANG P, 1994, AM J PHYSIOL, V267, pG52, DOI 10.1152/ajpgi.1994.267.1.G52; WANG P, 1991, AM J PHYSIOL, V261, pR1507, DOI 10.1152/ajpregu.1991.261.6.R1507; WANG P, 1993, AM J PHYSIOL, V265, pG126, DOI 10.1152/ajpgi.1993.265.1.G126; Wang P, 1996, AM J PHYSIOL-REG I, V270, pR927, DOI 10.1152/ajpregu.1996.270.5.R927; Wang P, 1997, ARCH SURG-CHICAGO, V132, P364; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2; Willems EW, 2001, BRIT J PHARMACOL, V132, P1292, DOI 10.1038/sj.bjp.0703915; Wu RQ, 2003, REGUL PEPTIDES, V112, P19, DOI 10.1016/S0167-0115(03)00018-1; Yang SL, 2000, AM J PHYSIOL-GASTR L, V279, pG1274, DOI 10.1152/ajpgi.2000.279.6.G1274; Yang SL, 2001, AM J PHYSIOL-GASTR L, V281, pG1014, DOI 10.1152/ajpgi.2001.281.4.G1014; Yang SL, 1999, J TRAUMA, V47, P706, DOI 10.1097/00005373-199910000-00015; Zhou M, 2001, BBA-MOL BASIS DIS, V1537, P49, DOI 10.1016/S0925-4439(01)00055-2	32	58	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2009	4	5							e5504	10.1371/journal.pone.0005504	http://dx.doi.org/10.1371/journal.pone.0005504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VY	19430535	Green Published, gold			2022-12-25	WOS:000266009700009
J	Petit-Paitel, A; Brau, F; Cazareth, J; Chabry, J				Petit-Paitel, Agnes; Brau, Frederic; Cazareth, Julie; Chabry, Joelle			Involvment of Cytosolic and Mitochondrial GSK-3 beta in Mitochondrial Dysfunction and Neuronal Cell Death of MPTP/MPP+-Treated Neurons	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; PERMEABILITY TRANSITION PORE; COMPLEX-I DEFICIENCY; PARKINSONS-DISEASE; PROTECTS NEURONS; CHRONIC LITHIUM; APOPTOSIS; INHIBITION; GSK3-BETA; KINASE	Aberrant mitochondrial function appears to play a central role in dopaminergic neuronal loss in Parkinson's disease (PD). 1-methyl-4-phenylpyridinium iodide (MPP+), the active metabolite of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), is a selective inhibitor of mitochondrial complex I and is widely used in rodent and cell models to elicit neurochemical alterations associated with PD. Recent findings suggest that Glycogen Synthase Kinase-3 beta (GSK-3 beta), a critical activator of neuronal apoptosis, is involved in the dopaminergic cell death. In this study, the role of GSK-3 beta in modulating MPP+-induced mitochondrial dysfunction and neuronal death was examined in vivo, and in two neuronal cell models namely primary cultured and immortalized neurons. In both cell models, MPTP/MPP+ treatment caused cell death associated with time- and concentration-dependent activation of GSK-3b, evidenced by the increased level of the active form of the kinase, i.e. GSK-3 beta phosphorylated at tyrosine 216 residue. Using immunocytochemistry and subcellular fractionation techniques, we showed that GSK-3 beta partially localized within mitochondria in both neuronal cell models. Moreover, MPP+ treatment induced a significant decrease of the specific phospho-Tyr216-GSK-3 beta labeling in mitochondria concomitantly with an increase into the cytosol. Using two distinct fluorescent probes, we showed that MPP+ induced cell death through the depolarization of mitochondrial membrane potential. Inhibition of GSK-3 beta activity using well-characterized inhibitors, LiCl and kenpaullone, and RNA interference, prevented MPP+-induced cell death by blocking mitochondrial membrane potential changes and subsequent caspase-9 and -3 activation. These results indicate that GSK-3 beta is a critical mediator of MPTP/MPP+-induced neurotoxicity through its ability to regulate mitochondrial functions. Inhibition of GSK-3 beta activity might provide protection against mitochondrial stress-induced cell death.			Petit-Paitel, A (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, UMR 6097, 660 Route Lucioles, F-06560 Valbonne, France.	petit@ipmc.cnrs.fr	Chabry, Joelle/O-2101-2016	Petit-Paitel, Agnes/0000-0003-1138-9966				Alvarez AR, 2004, EXP CELL RES, V297, P186, DOI 10.1016/j.yexcr.2004.02.028; Avila Jesus, 2007, Expert Rev Neurother, V7, P1527, DOI 10.1586/14737175.7.11.1527; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Bijur GN, 2000, J BIOL CHEM, V275, P7583, DOI 10.1074/jbc.275.11.7583; Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; Bijur GN, 2001, J BIOL CHEM, V276, P37436, DOI 10.1074/jbc.M105725200; Chen G, 2004, FASEB J, V18, P1162, DOI 10.1096/fj.04-1551fje; Chen J, 1999, ECON BOT, V53, P2, DOI 10.1007/BF02860785; Chuang DM, 2002, BIPOLAR DISORD, V4, P129, DOI 10.1034/j.1399-5618.2002.01179.x; Das S, 2008, CIRC RES, V103, P983, DOI 10.1161/CIRCRESAHA.108.178970; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dirikoc S, 2007, J NEUROSCI, V27, P9537, DOI 10.1523/JNEUROSCI.1942-07.2007; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Feng JH, 2005, ANESTHESIOLOGY, V103, P987, DOI 10.1097/00000542-200511000-00013; Gomez L, 2008, CIRCULATION, V117, P2761, DOI 10.1161/CIRCULATIONAHA.107.755066; Gould TD, 2004, MOL PSYCHIATR, V9, P734, DOI 10.1038/sj.mp.4001518; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hetman M, 2000, J NEUROSCI, V20, P2567; HOSHI M, 1995, J BIOCHEM-TOKYO, V118, P683, DOI 10.1093/oxfordjournals.jbchem.a124965; Iqbal K, 2008, J CELL MOL MED, V12, P38, DOI 10.1111/j.1582-4934.2008.00225.x; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; King TD, 2001, BRAIN RES, V919, P106, DOI 10.1016/S0006-8993(01)03005-0; King TD, 2005, NEUROREPORT, V16, P597, DOI 10.1097/00001756-200504250-00016; Kunick C, 2004, BIOORG MED CHEM LETT, V14, P413, DOI 10.1016/j.bmcl.2003.10.062; Lai JS, 2006, EUR J PHARMACOL, V539, P18, DOI 10.1016/j.ejphar.2006.03.076; Lee KY, 2007, BRAIN RES, V1129, P89, DOI 10.1016/j.brainres.2006.10.055; Leng Y, 2008, J NEUROSCI, V28, P2576, DOI 10.1523/JNEUROSCI.5467-07.2008; Li XH, 2004, NEUROPSYCHOPHARMACOL, V29, P1426, DOI 10.1038/sj.npp.1300439; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Lizcano JM, 2002, CURR BIOL, V12, pR236, DOI 10.1016/S0960-9822(02)00777-7; Maiese K, 2007, CURR MED CHEM, V14, P1729; Manji HK, 1999, J CLIN PSYCHIAT, V60, P27; Manji HK, 2002, MOL PSYCHIATR, V7, pS46, DOI 10.1038/sj.mp.4001018; MANJI HK, 1999, J CLIN PSYCHIAT S2, V60, P113; Martinez A, 2002, MED RES REV, V22, P373, DOI 10.1002/med.10011; MAURER F, 1906, HDB VERGLEICHENDEN 1, V3, P1; Mishra R, 2007, J BIOL CHEM, V282, P30393, DOI 10.1074/jbc.M705895200; MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8; Muyllaert D, 2008, GENES BRAIN BEHAV, V7, P57, DOI 10.1111/j.1601-183X.2007.00376.x; Masahiro N, 2007, J MOL CELL CARDIOL, V43, P564, DOI 10.1016/j.yjmcc.2007.08.010; Nonaka S, 1998, P NATL ACAD SCI USA, V95, P2642, DOI 10.1073/pnas.95.5.2642; Nonaka S, 1998, J PHARMACOL EXP THER, V286, P539; Obame FN, 2008, J PHARMACOL EXP THER, V326, P252, DOI 10.1124/jpet.108.138008; Ohori K, 2008, AM J PHYSIOL-HEART C, V295, pH2079, DOI 10.1152/ajpheart.00092.2008; Orth M, 2003, MOVEMENT DISORD, V18, P729, DOI 10.1002/mds.10447; Park SS, 2006, J MOL CELL CARDIOL, V40, P708, DOI 10.1016/j.yjmcc.2006.01.024; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Perier C, 2005, P NATL ACAD SCI USA, V102, P19126, DOI 10.1073/pnas.0508215102; Przedborski S, 2004, J BIOENERG BIOMEMBR, V36, P375, DOI 10.1023/B:JOBB.0000041771.66775.d5; Przedborski S, 2001, J NEUROCHEM, V76, P1265, DOI 10.1046/j.1471-4159.2001.00183.x; Roucou X, 2001, CELL DEATH DIFFER, V8, P875, DOI 10.1038/sj.cdd.4400910; Rowe Michael K., 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008385; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Senatorov VV, 2004, MOL PSYCHIATR, V9, P371, DOI 10.1038/sj.mp.4001463; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417; Takadera T, 2004, EUR J PHARMACOL, V499, P239, DOI 10.1016/j.ejphar.2004.07.115; Takadera T, 2007, NEUROCHEM RES, V32, P1336, DOI 10.1007/s11064-007-9310-4; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Wang TE, 2007, ASIA-PAC J CLIN ONCO, V3, P52, DOI 10.1111/j.1743-7563.2006.00082.x; Watcharasit P, 2003, J BIOL CHEM, V278, P48872, DOI 10.1074/jbc.M305870200; Wu YM, 2007, BIOTECHNOL BIOPROC E, V12, P1, DOI 10.1007/BF02931796; Youdim MBH, 2004, NEUROPHARMACOLOGY, V46, P1130, DOI 10.1016/j.neuropharm.2004.02.005; Zhou KY, 2009, ALCOHOL ALCOHOLISM, V44, P20, DOI 10.1093/alcalc/agn098	71	94	96	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2009	4	5							e5491	10.1371/journal.pone.0005491	http://dx.doi.org/10.1371/journal.pone.0005491			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VY	19430525	Green Published, gold, Green Submitted			2022-12-25	WOS:000266009700001
J	Madjidian, JA; Lankinen, A				Madjidian, Josefin A.; Lankinen, Asa			Sexual Conflict and Sexually Antagonistic Coevolution in an Annual Plant	PLOS ONE			English	Article							COLLINSIA-HETEROPHYLLA PLANTAGINACEAE; MATING-SYSTEM; POPULATION CROSSES; POLLEN COMPETITION; STIGMA RECEPTIVITY; INBREEDING DEPRESSION; GENETIC-VARIABILITY; SELECTION; EVOLUTION; DIVERGENCE	Background: Sexual conflict theory predicts sexually antagonistic coevolution of reproductive traits driven by conflicting evolutionary interests of two reproducing individuals. Most studies of the evolutionary consequences of sexual conflicts have, however, to date collectively investigated only a few species. In this study we used the annual herb Collinsia heterophylla to experimentally test the existence and evolutionary consequences of a potential sexual conflict over onset of stigma receptivity. Methodology/Principal Findings: We conducted crosses within and between four greenhouse-grown populations originating from two regions. Our experimental setup allowed us to investigate male-female interactions at three levels of geographic distances between interacting individuals. Both recipient and pollen donor identity affected onset of stigma receptivity within populations, confirming previous results that some pollen donors can induce stigma receptivity. We also found that donors were generally better at inducing stigma receptivity following pollen deposition on stigmas of recipients from another population than their own, especially within a region. On the other hand, we found that donors did worse at inducing stigma receptivity in crosses between regions. Interestingly, recipient costs in terms of lowered seed number after early fertilisation followed the same pattern: the cost was apparent only if the pollen donor belonged to the same region as the recipient. Conclusion/Significance: Our results indicate that recipients are released from the cost of interacting with local pollen donors when crossed with donors from a more distant location, a pattern consistent with a history of sexually antagonistic coevolution within populations. Accordingly, sexual conflicts may have important evolutionary consequences also in plants.			Madjidian, JA (corresponding author), Lund Univ, Dept Plant Ecol & Systemat, Lund, Sweden.	josefin.madjidian@ekol.lu.se						Andersson Malte, 1994; Andres JA, 2001, P ROY SOC B-BIOL SCI, V268, P399, DOI 10.1098/rspb.2000.1392; Anthes N, 2007, BIOL LETTERS, V3, P121, DOI 10.1098/rsbl.2006.0596; Armbruster WS, 1996, J EVOLUTION BIOL, V9, P261, DOI 10.1046/j.1420-9101.1996.9030261.x; Armbruster WS, 2004, AM J BOT, V91, P1939, DOI 10.3732/ajb.91.11.1939; Armbruster WS, 2002, AM J BOT, V89, P37, DOI 10.3732/ajb.89.1.37; Arnqvist G, 2002, NATURE, V415, P787, DOI 10.1038/415787a; Arnqvist G, 2004, EVOLUTION, V58, P1383; ARNQVIST G, 2005, SEXUAL CONFLICT, P230; ASHMAN TL, 1994, NATURE, V371, P788, DOI 10.1038/371788a0; Attia FA, 2004, EVOL ECOL RES, V6, P927; Bernasconi G, 2004, SCIENCE, V303, P971, DOI 10.1126/science.1092180; Brandvain Y, 2005, AM NAT, V166, P330, DOI 10.1086/432036; Brody AK, 1997, ECOLOGY, V78, P1624, DOI 10.1890/0012-9658(1997)078[1624:EOPHAS]2.0.CO;2; Burdon JJ, 1999, EVOLUTION, V53, P704, DOI [10.1111/j.1558-5646.1999.tb05365.x, 10.2307/2640711]; Burke J, 2001, ENTERTAIN DES, V35, P52; Calsbeek R, 2003, MOL ECOL, V12, P1021, DOI 10.1046/j.1365-294X.2003.01794.x; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; CHARLESWORTH D, 1995, AM J BOT, V82, P112, DOI 10.2307/2445793; CHARNOV EL, 1979, P NATL ACAD SCI USA, V76, P2480, DOI 10.1073/pnas.76.5.2480; Clark AG, 1999, SCIENCE, V283, P217, DOI 10.1126/science.283.5399.217; ENDLER JA, 1995, TRENDS ECOL EVOL, V10, P22, DOI 10.1016/S0169-5347(00)88956-9; Fiebig A, 2004, P NATL ACAD SCI USA, V101, P3286, DOI 10.1073/pnas.0305448101; Fisher R.A., 1930, GENETICAL THEORY NAT; Fricke C, 2004, J EVOLUTION BIOL, V17, P1345, DOI 10.1111/j.1420-9101.2004.00757.x; GALEN C, 1986, AM NAT, V127, P462, DOI 10.1086/284495; Gavrilets S, 2001, P ROY SOC B-BIOL SCI, V268, P531, DOI 10.1098/rspb.2000.1382; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; Gavrilets S, 2002, P NATL ACAD SCI USA, V99, P10533, DOI 10.1073/pnas.152011499; Goodwillie C, 2005, ANNU REV ECOL EVOL S, V36, P47, DOI 10.1146/annurev.ecolsys.36.091704.175539; Hardling R, 1999, OIKOS, V84, P27, DOI 10.2307/3546863; Hiscock SJ, 2008, NEW PHYTOL, V179, P286, DOI 10.1111/j.1469-8137.2008.02457.x; HOEKSTRA FA, 1975, PHYSIOL PLANTARUM, V34, P221, DOI 10.1111/j.1399-3054.1975.tb03825.x; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Holland B, 1999, P NATL ACAD SCI USA, V96, P5083, DOI 10.1073/pnas.96.9.5083; Jolivet C, 2007, J EVOLUTION BIOL, V20, P1361, DOI 10.1111/j.1420-9101.2007.01344.x; Kearns C. A., 1993, TECHNIQUES POLLINATI; Knowles LL, 2001, P NATL ACAD SCI USA, V98, P8692, DOI 10.1073/pnas.151123998; Koene JM, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-25; LALONDE RG, 1989, AM J BOT, V76, P1107, DOI 10.2307/2444822; Lankinen A, 2007, J EVOLUTION BIOL, V20, P737, DOI 10.1111/j.1420-9101.2006.01233.x; LANKINEN A, 2007, EVOL ECOL IN PRESS; Lankinen A, 2007, AM NAT, V170, P854, DOI 10.1086/522839; Lankinen A, 2007, AM J BOT, V94, P1183, DOI 10.3732/ajb.94.7.1183; Lankinen A, 2006, EVOLUTION, V60, P2454, DOI 10.1111/j.0014-3820.2006.tb01881.x; Lankinen A, 2009, ANN BOT-LONDON, V103, P941, DOI 10.1093/aob/mcp014; Lapointe FJ, 2005, AM NAT, V166, P290, DOI 10.1086/431283; Li B, 1998, OECOLOGIA, V115, P293, DOI 10.1007/s004420050519; Long TAF, 2006, PHILOS T R SOC B, V361, P363, DOI 10.1098/rstb.2005.1786; LYNCH M, 1991, EVOLUTION, V45, P622, DOI [10.1111/j.1558-5646.1991.tb04333.x, 10.2307/2409915]; Marshall DL, 1996, EVOLUTION, V50, P1842, DOI 10.1111/j.1558-5646.1996.tb03570.x; MAZER SJ, 1987, BIOL J LINN SOC, V30, P115, DOI 10.1111/j.1095-8312.1987.tb00293.x; Michiels NK, 2006, INTEGR COMP BIOL, V46, P473, DOI 10.1093/icb/icj043; Michiels NK, 1998, NATURE, V391, P647, DOI 10.1038/35527; NEESE EC, 1993, JEPSON MANUAL HIGHER; Newsom VM, 1929, BOT GAZ, V87, P260, DOI 10.1086/333934; Nilsson T, 2002, EVOLUTION, V56, P111, DOI 10.1111/j.0014-3820.2002.tb00853.x; Olsson K, 2002, J EVOLUTION BIOL, V15, P983, DOI 10.1046/j.1420-9101.2002.00457.x; Parker G. A., 1979, SEXUAL SELECTION REP; Parker GA, 1998, PHILOS T R SOC B, V353, P261, DOI 10.1098/rstb.1998.0208; Pilson D, 2000, OECOLOGIA, V122, P72, DOI 10.1007/PL00008838; Pizzari T, 2004, EVOLUTION, V58, P1389; Pizzari T, 2003, EVOLUTION, V57, P1223, DOI 10.1111/j.0014-3820.2003.tb00331.x; Prasad NG, 2006, J GENET, V85, P161, DOI 10.1007/BF02935325; QUELLER DC, 1983, NATURE, V305, P706, DOI 10.1038/305706a0; QUELLER DC, 1984, EVOLUTION, V38, P1148, DOI 10.1111/j.1558-5646.1984.tb00383.x; Rhode JM, 2005, AM NAT, V166, pE124, DOI 10.1086/491798; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Rowe L, 2003, P ROY SOC B-BIOL SCI, V270, P2009, DOI 10.1098/rspb.2003.2453; Rowe L, 2002, EVOLUTION, V56, P754; SERVICE PM, 1993, GENETICA, V91, P111, DOI 10.1007/BF01435992; Shaanker RU, 1997, CURR SCI INDIA, V72, P932; Skogsmyr I, 2002, BIOL REV, V77, P537, DOI 10.1017/S1464793102005973; Sokal R. R, 1981, BIOMETRY; *SPSS INC, 2005, SPSS 14 0 SYNT REF G; Taylor LP, 1997, ANNU REV PLANT PHYS, V48, P461, DOI 10.1146/annurev.arplant.48.1.461; WEIL J, 1964, EVOLUTION, V18, P515, DOI 10.1111/j.1558-5646.1964.tb01668.x; Wright S, 1943, GENETICS, V28, P114; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	79	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2009	4	5							e5477	10.1371/journal.pone.0005477	http://dx.doi.org/10.1371/journal.pone.0005477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JH	19421402	Green Published, gold, Green Submitted			2022-12-25	WOS:000265837000011
J	Robert, F; Carrier, M; Rawe, S; Chen, S; Lowe, S; Pelletier, J				Robert, Francis; Carrier, Marilyn; Rawe, Svea; Chen, Samuel; Lowe, Scott; Pelletier, Jerry			Altering Chemosensitivity by Modulating Translation Elongation	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; C-MYC; CLINICAL-PHARMACOLOGY; MYELOID-LEUKEMIA; MESSENGER-RNAS; HUMAN BREAST; DIDEMNIN-B; CANCER; APOPTOSIS; INHIBITION	Background: The process of translation occurs at a nexus point downstream of a number of signal pathways and developmental processes. Modeling activation of the PTEN/AKT/mTOR pathway in the Em-Myc mouse is a valuable tool to study tumor genotype/chemosensitivity relationships in vivo. In this model, blocking translation initiation with silvestrol, an inhibitor of the ribosome recruitment step has been showed to modulate the sensitivity of the tumors to the effect of standard chemotherapy. However, inhibitors of translation elongation have been tested as potential anti-cancer therapeutic agents in vitro, but have not been extensively tested in genetically well-defined mouse tumor models or for potential synergy with standard of care agents. Methodology/Principal Findings: Here, we chose four structurally different chemical inhibitors of translation elongation: homoharringtonine, bruceantin, didemnin B and cycloheximide, and tested their ability to alter the chemoresistance of E mu-myc lymphomas harbouring lesions in Pten, Tsc2, Bcl-2, or elF4E. We show that in some genetic settings, translation elongation inhibitors are able to synergize with doxorubicin by reinstating an apoptotic program in tumor cells. We attribute this effect to a reduction in levels of pro-oncogenic or pro-survival proteins having short half-lives, like Mcl-1, cyclin D1 or c-Myc. Using lymphomas cells grown ex vivo we reproduced the synergy observed in mice between chemotherapy and elongation inhibition and show that this is reversed by blocking protein degradation with a proteasome inhibitor. Conclusion/Significance: Our results indicate that depleting short-lived pro-survival factors by inhibiting their synthesis could achieve a therapeutic response in tumors harboring PTEN/AKT/mTOR pathway mutations.			Robert, F (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	jerry.pelletier@mcgill.ca			NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams KW, 2007, J BIOL CHEM, V282, P6192, DOI 10.1074/jbc.M610643200; Alarcon-Vargas D, 2002, ONCOGENE, V21, P4384, DOI 10.1038/sj.onc.1205543; Bai JX, 2006, J PHARMACOL EXP THER, V319, P1435, DOI 10.1124/jpet.106.110007; Beasley VR, 2005, BIOPHARM DRUG DISPOS, V26, P341, DOI 10.1002/bdd.466; BENVENUTO JA, 1992, INVEST NEW DRUG, V10, P113, DOI 10.1007/BF00873128; Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753; Budihardjo II, 2000, MOL PHARMACOL, V57, P529, DOI 10.1124/mol.57.3.529; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cuendet M, 2004, J NAT PROD, V67, P269, DOI 10.1021/np030304+; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; DUNCAN R, 1987, J BIOL CHEM, V262, P380; FONG KLL, 1982, CANCER CHEMOTH PHARM, V9, P169, DOI 10.1007/BF00257747; Freemantle SJ, 2007, J CELL BIOCHEM, V102, P869, DOI 10.1002/jcb.21519; FRESNO M, 1977, EUR J BIOCHEM, V72, P323, DOI 10.1111/j.1432-1033.1977.tb11256.x; FURUSAWA E, 1981, CHEMOTHERAPY, V27, P277, DOI 10.1159/000237992; Furusawa S, 1996, RES COMMUN MOL PATH, V91, P245; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; HANN SR, 1984, MOL CELL BIOL, V4, P2486, DOI 10.1128/MCB.4.11.2486; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; HEYS SD, 1991, CLIN SCI, V80, P587, DOI 10.1042/cs0800587; HOFS HP, 1994, ANTI-CANCER DRUG, V5, P35, DOI 10.1097/00001813-199402000-00006; HROMAS R, 1983, CANCER RES, V43, P1135; HUANG MT, 1975, MOL PHARMACOL, V11, P511; KANO Y, 1991, LEUKEMIA RES, V15, P1059, DOI 10.1016/0145-2126(91)90112-7; Larsson O, 2006, NUCLEIC ACIDS RES, V34, P4375, DOI 10.1093/nar/gkl558; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Le Tourneau C, 2007, CURR PHARM DESIGN, V13, P3427; LIAO LL, 1976, MOL PHARMACOL, V12, P167; LU K, 1988, CANCER CHEMOTH PHARM, V21, P139; Mamane Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000242; MERINO R, 1994, EMBO J, V13, P683, DOI 10.1002/j.1460-2075.1994.tb06307.x; Mills JR, 2008, P NATL ACAD SCI USA, V105, P10853, DOI 10.1073/pnas.0804821105; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Novac O, 2004, NUCLEIC ACIDS RES, V32, P902, DOI 10.1093/nar/gkh235; PELLETIER J, 1985, CELL, V40, P515, DOI 10.1016/0092-8674(85)90200-4; Pelletier J, 2007, THERAPEUTIC OPPORTUN; Podar K, 2008, ONCOGENE, V27, P721, DOI 10.1038/sj.onc.1210679; Quintas-Cardama A, 2007, CANCER-AM CANCER SOC, V109, P248, DOI 10.1002/cncr.22398; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Raught B, 2000, COLD SPRING HARBOR M, V39, P245; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Sah NK, 2003, J BIOL CHEM, V278, P20593, DOI 10.1074/jbc.M211010200; SAKAI T, 1989, CANCER RES, V49, P1193; SAVARAJ N, 1986, CANCER TREAT REP, V70, P1403; Schmitt CA, 2002, J MOL MED-JMM, V80, P137, DOI 10.1007/s00109-001-0293-3; Schubert KM, 2001, BIOCHEM J, V356, P473, DOI 10.1042/0264-6021:3560473; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smukste I, 2006, CANCER CELL, V9, P133, DOI 10.1016/j.ccr.2006.01.012; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Tang RP, 2006, MOL CANCER THER, V5, P723, DOI 10.1158/1535-7163.MCT-05-0164; THAKKAR NS, 1992, BIOCHEM PHARMACOL, V43, P1683, DOI 10.1016/0006-2952(92)90697-H; TUJEBAJEVA RM, 1992, BIOCHIM BIOPHYS ACTA, V1129, P177, DOI 10.1016/0167-4781(92)90484-H; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wendel HG, 2006, CANCER RES, V66, P7639, DOI 10.1158/0008-5472.CAN-06-0419; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; WILLINGHAM W, 1981, BIOCHIM BIOPHYS ACTA, V654, P169, DOI 10.1016/0005-2787(81)90168-4; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wuilleme-Toumi S, 2005, LEUKEMIA, V19, P1248, DOI 10.1038/sj.leu.2403784; ZYLICZ Z, 1987, J NATL CANCER I, V78, P701	64	73	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5428	10.1371/journal.pone.0005428	http://dx.doi.org/10.1371/journal.pone.0005428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440GG	19412536	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000265688200014
J	Chen, Y; Qin, J; Cai, JY; Chen, ZW				Chen, Yong; Qin, Jie; Cai, Jiye; Chen, Zheng W.			Cold Induces Micro- and Nano-Scale Reorganization of Lipid Raft Markers at Mounds of T-Cell Membrane Fluctuations	PLOS ONE			English	Article								Whether and how cold causes changes in cell-membrane or lipid rafts remain poorly characterized. Using the NSOM/QD and confocal imaging systems, we found that cold caused microscale redistribution of lipid raft markers, GM1 for lipid and CD59 for protein, from the peripheral part of microdomains to the central part on Jurkat T cells, and that cold also induced the nanoscale size-enlargement (1/3- to 2/3-fold) of the nanoclusters of lipid raft markers and even the colocalization of GM1 and CD59 nanoclusters. These findings indicate cold-induced lateral rearrangement/coalescence of raft-related membrane heterogeneity. The cold-induced re-distribution of lipid raft markers under a nearly-natural condition provide clues for their alternations, and help to propose a model in which raft lipids associate themselves or interact with protein components to generate functional membrane heterogeneity in response to stimulus. The data also underscore the possible cold-induced artifacts in early-described cold-related experiments and the detergent-resistance-based analyses of lipid rafts at 4 degrees C, and provide a biophysical explanation for recently-reported cold-induced activation of signaling pathways in T cells. Importantly, our fluorescence-topographic NSOM imaging demonstrated that GM1/CD59 raft markers distributed and re-distributed at mounds but not depressions of T-cell membrane fluctuations. Such mound-top distribution of lipid raft markers or lipid rafts provides spatial advantage for lipid rafts or contact molecules interacting readily with neighboring cells or free molecules.			Chen, Y (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol, Ctr Primate Biomed Res, Chicago, IL 60612 USA.	zchen@uic.edu	Chen, Yong/A-8143-2008	Chen, Yong/0000-0003-1678-1537; Cai, Jiye/0000-0002-4791-3320	NCRR NIH HHS [R01 RR013601, R01 RR13601] Funding Source: Medline; NHLBI NIH HHS [R01 HL064560, R01 HL64560] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR013601] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064560] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Burgos P, 2003, LANGMUIR, V19, P8002, DOI 10.1021/la034551p; Chen Y, 2008, J LIPID RES, V49, P2268, DOI 10.1194/jlr.D800031-JLR200; Chen Y, 2008, BLOOD, V111, P4220, DOI 10.1182/blood-2007-07-101691; de Bakker BI, 2008, J CELL SCI, V121, P627, DOI 10.1242/jcs.019513; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; Hammond AT, 2005, P NATL ACAD SCI USA, V102, P6320, DOI 10.1073/pnas.0405654102; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Harder T, 2007, CURR OPIN IMMUNOL, V19, P470, DOI 10.1016/j.coi.2007.05.002; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Heerklotz H, 2003, J MOL BIOL, V329, P793, DOI 10.1016/S0022-2836(03)00504-7; Hwang J, 1998, BIOPHYS J, V74, P2184, DOI 10.1016/S0006-3495(98)77927-5; Koopman M, 2004, FEBS LETT, V573, P6, DOI 10.1016/j.febslet.2004.07.035; Kusumi A, 2004, TRAFFIC, V5, P213, DOI 10.1111/j.1600-0854.2004.0178.x; Lagerholm BC, 2005, ANNU REV PHYS CHEM, V56, P309, DOI 10.1146/annurev.physchem.56.092503.141211; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Magee AI, 2005, J CELL SCI, V118, P3141, DOI 10.1242/jcs.02442; Mitchell JS, 2002, J IMMUNOL, V168, P2737, DOI 10.4049/jimmunol.168.6.2737; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nagy P, 1999, J CELL SCI, V112, P1733; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Tokumasu F, 2004, LANGMUIR, V20, P614, DOI 10.1021/la0355388; Viola A, 2001, TRENDS IMMUNOL, V22, P322, DOI 10.1016/S1471-4906(01)01938-X; WINOKUR R, 1995, BLOOD, V85, P1796, DOI 10.1182/blood.V85.7.1796.bloodjournal8571796; ZUCKER MB, 1954, BLOOD, V9, P602, DOI 10.1182/blood.V9.6.602.602	31	41	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5386	10.1371/journal.pone.0005386	http://dx.doi.org/10.1371/journal.pone.0005386			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404395	Green Published, Green Submitted, gold			2022-12-25	WOS:000265614900005
J	Torosantucci, A; Chiani, P; Bromuro, C; De Bernardis, F; Palma, AS; Liu, Y; Mignogna, G; Maras, B; Colone, M; Stringaro, A; Zamboni, S; Feizi, T; Cassone, A				Torosantucci, Antonella; Chiani, Paola; Bromuro, Carla; De Bernardis, Flavia; Palma, Angelina S.; Liu, Yan; Mignogna, Giuseppina; Maras, Bruno; Colone, Marisa; Stringaro, Annarita; Zamboni, Silvia; Feizi, Ten; Cassone, Antonio			Protection by Anti-beta-Glucan Antibodies Is Associated with Restricted beta-1,3 Glucan Binding Specificity and Inhibition of Fungal Growth and Adherence	PLOS ONE			English	Article								Anti-beta-glucan antibodies elicited by a laminarin-conjugate vaccine confer cross-protection to mice challenged with major fungal pathogens such as Candida albicans, Aspergillus fumigatus and Cryptococcus neoformans. To gain insights into protective beta-glucan epitope(s) and protection mechanisms, we studied two anti-beta-glucan monoclonal antibodies (mAb) with identical complementarity-determining regions but different isotypes (mAb 2G8, IgG2b and mAb 1E12, IgM). C. albicans, the most relevant fungal pathogen for humans, was used as a model. Both mAbs bound to fungal cell surface and to the beta 1,3-beta 1,6 glucan of the fungal cell wall skeleton, as shown by immunofluorescence, electron-microscopy and ELISA. They were also equally unable to opsonize fungal cells in a J774 macrophage phagocytosis and killing assay. However, only the IgG2b conferred substantial protection against mucosal and systemic candidiasis in passive vaccination experiments in rodents. Competition ELISA and microarray analyses using sequence-defined glucan oligosaccharides showed that the protective IgG2b selectively bound to beta 1,3-linked (laminarin-like) glucose sequences whereas the nonprotective IgM bound to beta 1,6- and beta 1,4-linked glucose sequences in addition to beta 1,3-linked ones. Only the protective IgG2b recognized heterogeneous, polydisperse high molecular weight cell wall and secretory components of the fungus, two of which were identified as the GPI-anchored cell wall proteins Als3 and Hyr1. In addition, only the IgG2b inhibited in vitro two critical virulence attributes of the fungus, hyphal growth and adherence to human epithelial cells. Our study demonstrates that the isotype of anti-beta-glucan antibodies may affect details of the beta-glucan epitopes recognized, and this may be associated with a differing ability to inhibit virulence attributes of the fungus and confer protection in vivo. Our data also suggest that the anti-virulence properties of the IgG2b mAb may be linked to its capacity to recognize beta-glucan epitope(s) on some cell wall components that exert critical functions in fungal cell wall structure and adherence to host cells.			Torosantucci, A (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	antonio.cassone@iss.it	Maras, Bruno/A-2020-2010; Cassone, Antonio/J-4666-2019; BROMURO, CARLA/C-9591-2016; STRINGARO, ANNARITA/E-9092-2015; /AAQ-2983-2020; Liu, Yan/D-9117-2013; Palma, Angelina S/D-2052-2013; DE BERNARDIS, FLAVIA/C-9589-2016; COLONE, MARISA/E-9089-2015; Chiani, Paola/AAC-4436-2021; Mignogna, Giuseppina/A-2126-2010; TOROSANTUCCI, ANTONELLA/C-9594-2016	BROMURO, CARLA/0000-0002-5668-9009; STRINGARO, ANNARITA/0000-0002-0143-2978; Palma, Angelina S/0000-0001-5797-6555; DE BERNARDIS, FLAVIA/0000-0001-9440-8629; COLONE, MARISA/0000-0002-7522-7483; Chiani, Paola/0000-0001-9836-3579; TOROSANTUCCI, ANTONELLA/0000-0002-0074-4486; Mignogna, Giuseppina/0000-0001-9238-132X; Feizi, Ten/0000-0001-6495-0329	Engineering and Physical Sciences Research Council [GR/S79268/02] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Almeida RS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000217; Bailey DA, 1996, J BACTERIOL, V178, P5353, DOI 10.1128/jb.178.18.5353-5360.1996; Bodey GP, 2005, CLIN INFECT DIS, V40, pS239, DOI 10.1086/427328; Brena S, 2007, INFECT IMMUN, V75, P3680, DOI 10.1128/IAI.01840-06; Bromuro C, 2002, INFECT IMMUN, V70, P5462, DOI 10.1128/IAI.70.10.5462-5470.2002; Casadevall A, 2002, CURR OPIN MICROBIOL, V5, P386, DOI 10.1016/S1369-5274(02)00337-5; Cassone A, 1997, J LEUKOCYTE BIOL, V62, P60, DOI 10.1002/jlb.62.1.60; CASSONE A, 1988, J MED MICROBIOL, V27, P233, DOI 10.1099/00222615-27-4-233; Cassone A, 2005, CURR MOL MED, V5, P377, DOI 10.2174/1566524054022549; Cassone A, 2008, LANCET INFECT DIS, V8, P114, DOI 10.1016/S1473-3099(08)70016-1; Chaturvedi AK, 2005, CLIN DIAGN LAB IMMUN, V12, P1063, DOI 10.1128/CDLI.12.9.1063-1068.2005; COOPER LJN, 1993, J IMMUNOL, V150, P2231; Cutler JE, 2005, CURR MOL MED, V5, P383, DOI 10.2174/1566524054022576; Cutler JE, 2007, NAT REV MICROBIOL, V5, P13, DOI 10.1038/nrmicro1537; Datta K, 2008, CLIN VACCINE IMMUNOL, V15, P1176, DOI 10.1128/CVI.00130-08; De Bernardis F, 2002, INFECT IMMUN, V70, P2725, DOI 10.1128/IAI.70.5.2725-2729.2002; De Bernardis F, 2007, J INFECT DIS, V195, P149, DOI 10.1086/509891; De Groot PWJ, 2005, FUNGAL GENET BIOL, V42, P657, DOI 10.1016/j.fgb.2005.04.002; Deepe George S Jr, 2004, Expert Rev Vaccines, V3, P701, DOI 10.1586/14760584.3.6.701; DELACRUZ J, 1995, J BACTERIOL, V177, P1864, DOI 10.1128/jb.177.7.1864-1871.1995; Enoch DA, 2006, J MED MICROBIOL, V55, P809, DOI 10.1099/jmm.0.46548-0; Fernandez-Arenas E, 2007, MOL CELL PROTEOMICS, V6, P460, DOI 10.1074/mcp.M600210-MCP200; Fleuridor R, 2001, J IMMUNOL, V166, P1087, DOI 10.4049/jimmunol.166.2.1087; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Fu Y, 2008, EUKARYOT CELL, V7, P483, DOI 10.1128/EC.00445-07; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Garcia-Sanchez S, 2005, MOL BIOL CELL, V16, P2913, DOI 10.1091/mbc.E05-01-0071; Gomez MJ, 1996, INFECT IMMUN, V64, P2577, DOI 10.1128/IAI.64.7.2577-2584.1996; Gow NAR, 2007, J INFECT DIS, V196, P1565, DOI 10.1086/523110; Han Y, 1999, J INFECT DIS, V179, P1477, DOI 10.1086/314779; Han YM, 1998, INFECT IMMUN, V66, P5771, DOI 10.1128/IAI.66.12.5771-5776.1998; Heinsbroek SEM, 2005, TRENDS IMMUNOL, V26, P352, DOI 10.1016/j.it.2005.05.005; Herre J, 2004, CRIT REV IMMUNOL, V24, P193, DOI 10.1615/CritRevImmunol.v24.i3.30; Hoyer LL, 2001, GENETICS, V157, P1555; Hoyer LL, 2008, MED MYCOL, V46, P1, DOI 10.1080/13693780701435317; Iorio E, 2008, CARBOHYD RES, V343, P1050, DOI 10.1016/j.carres.2008.02.020; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; Kanafani ZA, 2008, CLIN INFECT DIS, V46, P120, DOI 10.1086/524071; Kapteyn JC, 2000, MOL MICROBIOL, V35, P601, DOI 10.1046/j.1365-2958.2000.01729.x; KAPTEYN JC, 1995, J BACTERIOL, V177, P3788, DOI 10.1128/jb.177.13.3788-3792.1995; Kapteyn JC, 1999, BBA-GEN SUBJECTS, V1426, P373, DOI 10.1016/S0304-4165(98)00137-8; Kedzierska A, 2007, EUR J CLIN MICROBIOL, V26, P755, DOI 10.1007/s10096-007-0373-6; Klis FM, 2001, MED MYCOL, V39, P1, DOI 10.1080/744118876; Lane S, 2001, J BIOL CHEM, V276, P48988, DOI 10.1074/jbc.M104484200; Larsen RA, 2005, ANTIMICROB AGENTS CH, V49, P952, DOI 10.1128/AAC.49.3.952-958.2005; Lavigne LM, 2006, J IMMUNOL, V177, P8667, DOI 10.4049/jimmunol.177.12.8667; Lee SA, 2003, YEAST, V20, P595, DOI 10.1002/yea.988; Liu Y, 2007, CHEM BIOL, V14, P847, DOI 10.1016/j.chembiol.2007.06.009; Magliani W, 2005, NEW MICROBIOL, V28, P299; Magliani W, 2005, CURR MOL MED, V5, P443, DOI 10.2174/1566524054022558; Martinez-Esparza M, 2006, J IMMUNOL METHODS, V314, P90, DOI 10.1016/j.jim.2006.06.004; Maschmeyer G, 2006, INT J ANTIMICROB AG, V27, pS3, DOI 10.1016/j.ijantimicag.2006.03.006; Matthews RC, 2004, VACCINE, V22, P865, DOI 10.1016/j.vaccine.2003.11.032; Matthews RC, 2003, ANTIMICROB AGENTS CH, V47, P2208, DOI 10.1128/AAC.47.7.2208-2216.2003; McCloskey N, 1996, IMMUNOLOGY, V88, P169, DOI 10.1111/j.1365-2567.1996.tb00001.x; McFadden DC, 2004, J IMMUNOL, V172, P3670, DOI 10.4049/jimmunol.172.6.3670; MUKHERJEE J, 1995, J EXP MED, V181, P405, DOI 10.1084/jem.181.1.405; MUKHERJEE J, 1992, INFECT IMMUN, V60, P4534, DOI 10.1128/IAI.60.11.4534-4541.1992; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Nett J, 2007, ANTIMICROB AGENTS CH, V51, P510, DOI 10.1128/AAC.01056-06; Nisini R, 2007, J LEUKOCYTE BIOL, V82, P1136, DOI 10.1189/jlb.0307160; Nobile CJ, 2008, CURR BIOL, V18, P1017, DOI 10.1016/j.cub.2008.06.034; Oh SH, 2005, MICROBIOL-SGM, V151, P673, DOI 10.1099/mic.0.27680-0; Pachl J, 2006, CLIN INFECT DIS, V42, P1404, DOI 10.1086/503428; Palma AS, 2006, J BIOL CHEM, V281, P5771, DOI 10.1074/jbc.M511461200; Pirofski LA, 2001, TRENDS MICROBIOL, V9, P445, DOI 10.1016/S0966-842X(01)02134-5; Rachini A, 2007, INFECT IMMUN, V75, P5085, DOI 10.1128/IAI.00278-07; Read SM, 1996, CARBOHYD RES, V281, P187, DOI 10.1016/0008-6215(95)00350-9; Richard ML, 2007, EUKARYOT CELL, V6, P119, DOI 10.1128/EC.00297-06; Richardson M, 2005, CANCER CHEMOTH PHARM, V56, P1, DOI 10.1007/s00280-004-0955-2; Rodrigues ML, 2007, CLIN VACCINE IMMUNOL, V14, P1372, DOI 10.1128/CVI.00202-07; Romagnoli G, 2004, J LEUKOCYTE BIOL, V75, P117, DOI 10.1189/jlb.0503226; Sevilla MJ, 2006, INFECT IMMUN, V74, P3042, DOI 10.1128/IAI.74.5.3042-3045.2006; Sheppard DC, 2004, J BIOL CHEM, V279, P30480, DOI 10.1074/jbc.M401929200; Shoham S, 2005, BRIT J HAEMATOL, V129, P569, DOI 10.1111/j.1365-2141.2005.05397.x; Spellberg BJ, 2006, J INFECT DIS, V194, P256, DOI 10.1086/504691; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Tarcha EJ, 2006, INFECT IMMUN, V74, P516, DOI 10.1128/IAI.74.1.516-527.2006; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; TOROSANTUCCI A, 1990, J GEN MICROBIOL, V136, P2155, DOI 10.1099/00221287-136-11-2155; Torosantucci A, 2005, J EXP MED, V202, P597, DOI 10.1084/jem.20050749; Torosantucci A, 2000, J LEUKOCYTE BIOL, V68, P923; Torres M, 2005, J IMMUNOL, V174, P2132, DOI 10.4049/jimmunol.174.4.2132; Torres M, 2008, TRENDS IMMUNOL, V29, P91, DOI 10.1016/j.it.2007.11.004; Vilanova M, 2004, IMMUNOLOGY, V111, P334, DOI 10.1111/j.1365-2567.2004.01819.x; Warnock DW, 2006, MED MYCOL, V44, P697, DOI 10.1080/13693780601009493; Wheeler RT, 2006, PLOS PATHOG, V2, P328, DOI 10.1371/journal.ppat.0020035; Wheeler RT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000227; Xin H, 2008, P NATL ACAD SCI USA, V105, P13526, DOI 10.1073/pnas.0803195105; Yuan RR, 1998, INFECT IMMUN, V66, P1057, DOI 10.1128/IAI.66.3.1057-1062.1998; Zhao XM, 2004, MICROBIOL-SGM, V150, P2415, DOI 10.1099/mic.0.26943-0	92	158	168	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5392	10.1371/journal.pone.0005392	http://dx.doi.org/10.1371/journal.pone.0005392			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399183	Green Submitted, gold, Green Published			2022-12-25	WOS:000265514900024
J	Richardson, JS; Yao, MK; Tran, KN; Croyle, MA; Strong, JE; Feldmann, H; Kobinger, GP				Richardson, Jason S.; Yao, Michel K.; Tran, Kaylie N.; Croyle, Maria A.; Strong, James E.; Feldmann, Heinz; Kobinger, Gary P.			Enhanced Protection against Ebola Virus Mediated by an Improved Adenovirus-Based Vaccine	PLOS ONE			English	Article								Background: The Ebola virus is transmitted by direct contact with bodily fluids of infected individuals, eliciting death rates as high as 90% among infected humans. Currently, replication defective adenovirus-based Ebola vaccine is being studied in a phase I clinical trial. Another Ebola vaccine, based on an attenuated vesicular stomatitis virus has shown efficacy in post-exposure treatment of nonhuman primates to Ebola infection. In this report, we modified the common recombinant adenovirus serotype 5-based Ebola vaccine expressing the wild-type ZEBOV glycoprotein sequence from a CMV promoter (Ad-CMVZGP). The immune response elicited by this improved expression cassette vector (Ad-CAGoptZGP) and its ability to afford protection against lethal ZEBOV challenge in mice was compared to the standard Ad-CMVZGP vector. Methodology/Principal Findings: Ad-CMVZGP was previously shown to protect mice, guinea pigs and nonhuman primates from an otherwise lethal challenge of Zaire ebolavirus. The antigenic expression cassette of this vector was improved through codon optimization, inclusion of a consensus Kozak sequence and reconfiguration of a CAG promoter (Ad-CAGoptZGP). Expression of GP from Ad-CAGoptZGP was substantially higher than from Ad-CMVZGP. Ad-CAGoptZGP significantly improved T and B cell responses at doses 10 to 100-fold lower than that needed with Ad-CMVZGP. Additionally, Ad-CAGoptZGP afforded full protections in mice against lethal challenge at a dose 100 times lower than the dose required for Ad-CMVZGP. Finally, Ad-CAGoptZGP induced full protection to mice when given 30 minutes post-challenge. Conclusions/Significance: We describe an improved adenovirus-based Ebola vaccine capable of affording post-exposure protection against lethal challenge in mice. The molecular modifications of the new improved vaccine also translated in the induction of significantly enhanced immune responses and complete protection at a dose 100 times lower than with the previous generation adenovirus-based Ebola vaccine. Understanding and improving the molecular components of adenovirus-based vaccines can produce potent, optimized product, useful for vaccination and post-exposure therapy.			Richardson, JS (corresponding author), Publ Hlth Agcy Canada, Special Pathogens Program, Natl Microbiol Lab, Winnipeg, MB, Canada.	gary_kobinger@phac-aspc.gc.ca	Croyle, Maria/L-4586-2019	Croyle, Maria/0000-0003-0809-901X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001089] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; Bray M, 1998, J INFECT DIS, V178, P651, DOI 10.1086/515386; Brunetti-Pierri N, 2004, HUM GENE THER, V15, P35, DOI 10.1089/10430340460732445; Daddario-DiCaprio KM, 2006, LANCET, V367, P1399, DOI 10.1016/S0140-6736(06)68546-2; Ebihara H, 2007, J INFECT DIS, V196, pS313, DOI 10.1086/520590; Feldmann H, 2003, NAT REV IMMUNOL, V3, P677, DOI 10.1038/nri1154; Fitzsimons HL, 2002, METHODS, V28, P227, DOI 10.1016/S1046-2023(02)00227-X; FURTH PA, 1991, NUCLEIC ACIDS RES, V19, P6205, DOI 10.1093/nar/19.22.6205; Hensley LE, 2005, CURR MOL MED, V5, P761, DOI 10.2174/156652405774962344; Hoenen T, 2006, J VIROL, V80, P7260, DOI 10.1128/JVI.00051-06; Kobinger GP, 2006, VIROLOGY, V346, P394, DOI 10.1016/j.virol.2005.10.042; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; McConnell MJ, 2004, HUM GENE THER, V15, P1022, DOI 10.1089/hum.2004.15.1022; Nazir SA, 2005, J INVEST MED, V53, P292, DOI 10.2310/6650.2005.53605; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Rao M, 1999, VACCINE, V17, P2991, DOI 10.1016/S0264-410X(99)00170-X; Reed DS, 2007, VACCINE, V25, P1923, DOI 10.1016/j.vaccine.2006.11.037; SANCHEZ A, 2007, MARBURG EBOLA VIRUSE, P1409; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Sullivan NJ, 2006, PLOS MED, V3, P865, DOI 10.1371/journal.pmed.0030177; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Wilson JA, 2001, CELL MOL LIFE SCI, V58, P1826, DOI 10.1007/PL00000821	26	65	80	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5308	10.1371/journal.pone.0005308	http://dx.doi.org/10.1371/journal.pone.0005308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390586	Green Published, gold, Green Submitted			2022-12-25	WOS:000265514200019
J	Vergni, D; Castiglione, F; Briani, M; Middei, S; Alberdi, E; Reymann, KG; Natalini, R; Volonte, C; Matute, C; Cavaliere, F				Vergni, Davide; Castiglione, Filippo; Briani, Maya; Middei, Silvia; Alberdi, Elena; Reymann, Klaus G.; Natalini, Roberto; Volonte, Cinzia; Matute, Carlos; Cavaliere, Fabio			A Model of Ischemia-Induced Neuroblast Activation in the Adult Subventricular Zone	PLOS ONE			English	Article							NEURAL STEM-CELLS; GLUCOSE DEPRIVATION; PROGENITOR CELLS; SLICE CULTURES; PROLIFERATION; HIPPOCAMPUS; ATP; NEUROGENESIS; MIGRATION; MICROGLIA	We have developed a rat brain organotypic culture model, in which tissue slices contain cortex-subventricular zone-striatum regions, to model neuroblast activity in response to in vitro ischemia. Neuroblast activation has been described in terms of two main parameters, proliferation and migration from the subventricular zone into the injured cortex. We observed distinct phases of neuroblast activation as is known to occur after in vivo ischemia. Thus, immediately after oxygen/glucose deprivation (6-24 hours), neuroblasts reduce their proliferative and migratory activity, whereas, at longer time points after the insult (2 to 5 days), they start to proliferate and migrate into the damaged cortex. Antagonism of ionotropic receptors for extracellular ATP during and after the insult unmasks an early activation of neuroblasts in the subventricular zone, which responded with a rapid and intense migration of neuroblasts into the damaged cortex (within 24 hours). The process is further enhanced by elevating the production of the chemoattractant SDf-1 alpha and may also be boosted by blocking the activation of microglia. This organotypic model which we have developed is an excellent in vitro system to study neurogenesis after ischemia and other neurodegenerative diseases. Its application has revealed a SOS response to oxygen/glucose deprivation, which is inhibited by unfavorable conditions due to the ischemic environment. Finally, experimental quantifications have allowed us to elaborate a mathematical model to describe neuroblast activation and to develop a computer simulation which should have promising applications for the screening of drug candidates for novel therapies of ischemia-related pathologies.			Vergni, D (corresponding author), CNR, IAC, Rome, Italy.	fabio.cavaliere@ciberned.es	cavaliere, fabio/L-2111-2014; Castiglione, Filippo/B-1366-2010; Briani, Maya/GZN-0556-2022; Reymann, Klaus G/J-8507-2013; Alberdi, Elena/D-6383-2017; Matute, Carlos/N-5559-2014; Alberdi, Elena/AAH-1757-2019; Natalini, Roberto/P-6189-2018; Cavaliere, Fabio/L-7247-2019; Volonté, Cinzia/N-6474-2013	cavaliere, fabio/0000-0003-2003-522X; Castiglione, Filippo/0000-0002-1442-3552; Alberdi, Elena/0000-0002-8000-142X; Matute, Carlos/0000-0001-8672-711X; Alberdi, Elena/0000-0002-8000-142X; Natalini, Roberto/0000-0002-5453-6383; Cavaliere, Fabio/0000-0003-2003-522X; Volonté, Cinzia/0000-0001-7362-8307; Vergni, Davide/0000-0003-3227-5765; middei, silvia/0000-0002-0488-323X				Agasse F, 2004, EUR J NEUROSCI, V19, P1459, DOI 10.1111/j.1460-9568.2004.03259.x; Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; AlvarezBuylla A, 1997, SEMIN CELL DEV BIOL, V8, P207, DOI 10.1006/scdb.1996.0134; Baker SA, 2004, EUR J NEUROSCI, V20, P575, DOI 10.1111/j.1460-9568.2004.03486.x; Brana C, 2002, BRAIN RES PROTOC, V10, P109, DOI 10.1016/S1385-299X(02)00201-5; Cavaliere F, 2005, NEUROSCIENCE, V136, P615, DOI 10.1016/j.neuroscience.2005.04.038; Cavaliere F, 2001, NEUROCHEM INT, V38, P189, DOI 10.1016/S0197-0186(00)00088-7; Cavaliere F, 2007, J PHARMACOL EXP THER, V323, P70, DOI 10.1124/jpet.106.119024; Cavaliere F, 2006, EXP NEUROL, V201, P66, DOI 10.1016/j.expneurol.2006.03.020; Chechneva O, 2005, NEUROSCIENCE, V136, P343, DOI 10.1016/j.neuroscience.2005.07.058; Chechneva O, 2006, NEUROBIOL DIS, V23, P247, DOI 10.1016/j.nbd.2006.02.015; Coppi E, 2007, STEM CELLS, V25, P1840, DOI 10.1634/stemcells.2006-0669; CORRADIN SB, 1993, GLIA, V7, P255, DOI 10.1002/glia.440070309; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Ernst C, 2006, J NEUROSCI RES, V83, P349, DOI 10.1002/jnr.20724; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; GIVAN AL, 1992, FLOW CYTOMETRY; Hammerle B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001169; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Kawauchi T, 2008, DEV NEUROSCI-BASEL, V30, P36, DOI 10.1159/000109850; Keener J., 1998, INTERD APPL, V8; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Kokaia Z, 2006, CEREB CORTEX, V16, pI162, DOI 10.1093/cercor/bhj174; Kristensen BW, 1999, BRAIN RES, V841, P143, DOI 10.1016/S0006-8993(99)01833-8; Lambrecht G, 2000, N-S ARCH PHARMACOL, V362, P340, DOI 10.1007/s002100000312; Langer D, 2007, NEUROSCIENCE, V150, P863, DOI 10.1016/j.neuroscience.2007.07.064; Laskowski A, 2007, NEUROSCI LETT, V415, P17, DOI 10.1016/j.neulet.2006.12.050; Lecca D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003579; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Lim DA, 2007, NEUROSURG CLIN N AM, V18, P81, DOI 10.1016/j.nec.2006.10.002; Liu XX, 2008, P NATL ACAD SCI USA, V105, P11802, DOI 10.1073/pnas.0805180105; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Matute C, 2007, J NEUROSCI, V27, P9525, DOI 10.1523/JNEUROSCI.0579-07.2007; Maysami S, 2008, J CEREBR BLOOD F MET, V28, P1104, DOI 10.1038/jcbfm.2008.4; MILLER LDP, 1994, NEUROSCIENCE, V63, P471, DOI 10.1016/0306-4522(94)90544-4; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; Nomura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001454; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Okano H, 2007, J NEUROCHEM, V102, P1459, DOI 10.1111/j.1471-4159.2007.04674.x; Pardal R, 2007, CELL, V131, P364, DOI 10.1016/j.cell.2007.07.043; Plenz D, 1996, NEUROSCI LETT, V209, P177, DOI 10.1016/0304-3940(96)12644-6; Rossi F, 2002, NAT REV NEUROSCI, V3, P401, DOI 10.1038/nrn809; Sacco RL, 2007, LANCET, V369, P331, DOI 10.1016/S0140-6736(07)60155-X; Schmidt W, 2002, NEUROSCI LETT, V334, P153, DOI 10.1016/S0304-3940(02)01072-8; Slusarski DC, 2007, DEV BIOL, V307, P1, DOI 10.1016/j.ydbio.2007.04.043; Stafford MR, 2007, MOL CELL NEUROSCI, V35, P535, DOI 10.1016/j.mcn.2007.04.013; Sundstrom L, 2005, DRUG DISCOV TODAY, V10, P993, DOI 10.1016/S1359-6446(05)03502-6; Takasawa K, 2002, J CEREBR BLOOD F MET, V22, P299, DOI 10.1097/00004647-200203000-00007; Taupin P, 2006, CURR OPIN MOL THER, V8, P225; Volonte C, 2003, CNS NEUROL DISORD-DR, V2, P403, DOI 10.2174/1568007033482643; Waldau B, 2008, CELL MOL LIFE SCI, V65, P2372, DOI 10.1007/s00018-008-8053-y; Zhang RL, 2007, J NEUROSCI, V27, P3157, DOI 10.1523/JNEUROSCI.4969-06.2007; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	53	17	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5278	10.1371/journal.pone.0005278	http://dx.doi.org/10.1371/journal.pone.0005278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390597	Green Published, Green Submitted, gold			2022-12-25	WOS:000265514200008
J	Zhou, XJ; Tang, W; Greenwood, TA; Guo, SZ; He, L; Geyer, MA; Kelsoe, JR				Zhou, Xianjin; Tang, Wei; Greenwood, Tiffany A.; Guo, Shengzhen; He, Lin; Geyer, Mark A.; Kelsoe, John R.			Transcription Factor SP4 Is a Susceptibility Gene for Bipolar Disorder	PLOS ONE			English	Article							SENSORIMOTOR GATING DEFICITS; PREPULSE INHIBITION; GENOME SCAN; DOPAMINE RELEASE; SCHIZOPHRENIA; PEDIGREES; FAMILIES; STARTLE; AUTISM; LOCUS	The Sp4 transcription factor plays a critical role for both development and function of mouse hippocampus. Reduced expression of the mouse Sp4 gene results in a variety of behavioral abnormalities relevant to human psychiatric disorders. The human SP4 gene is therefore examined for its association with both bipolar disorder and schizophrenia in European Caucasian and Chinese populations respectively. Out of ten SNPs selected from human SP4 genomic locus, four displayed significant association with bipolar disorder in European Caucasian families (rs12668354, p = 0.022; rs12673091, p = 0.0005; rs3735440, p = 0.019; rs11974306, p = 0.018). To replicate the genetic association, the same set of SNPs was examined in a Chinese bipolar case control sample. Four SNPs displayed significant association (rs40245, p = 0.009; rs12673091, p = 0.002; rs1018954, p = 0.001; rs3735440, p = 0.029), and two of them (rs12673091, rs3735440) were shared with positive SNPs from European Caucasian families. Considering the genetic overlap between bipolar disorder and schizophrenia, we extended our studies in Chinese trios families for schizophrenia. The SNP7 (rs12673091, p = 0.012) also displayed a significant association. The SNP7 (rs12673091) was therefore significantly associated in all three samples, and shared the same susceptibility allele (A) across all three samples. On the other hand, we found a gene dosage effect for mouse Sp4 gene in the modulation of sensorimotor gating, a putative endophenotype for both schizophrenia and bipolar disorder. The deficient sensorimotor gating in Sp4 hypomorphic mice was partially reversed by the administration of dopamine D2 antagonist or mood stabilizers. Both human genetic and mouse pharmacogenetic studies support Sp4 gene as a susceptibility gene for bipolar disorder or schizophrenia. The studies on the role of Sp4 gene in hippocampal development may provide novel insights for the contribution of hippocampal abnormalities in these psychiatric disorders.			Zhou, XJ (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	helin@nhgg.org; jkelsoe@ucsd.edu	Tang, Wei/H-7103-2013; Greenwood, Tiffany/F-6356-2012	Tang, Wei/0000-0002-7089-4391; Greenwood, Tiffany/0000-0002-6080-6503	Intramural NIH HHS [Z01 MH002810] Funding Source: Medline; NIMH NIH HHS [MH47612, R01 MH59533, MH073991, R01 MH059534, R01 MH59553, R01 MH59535, U01 MH46274, R01 MH059548, R01 MH059553, R01 MH059556, R01 MH60068, U01 MH46280, R01 MH059533, MH68503, R01 MH068503, U01 MH46282, R01 MH059545, MH59567, R01 MH59567, R01 MH059535, R01 MH060068, R01 MH59545, R01 MH059567, R01 MH073991] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH047612, R01MH059567, U01MH046274, R01MH068503, R01MH059545, R01MH059553, Z01MH002810, R01MH059535, R01MH060068, R01MH073991, R01MH059533, R01MH059534, R01MH059556, U01MH046280, U01MH046282, R01MH059548] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bakker SC, 2003, AM J HUM GENET, V72, P1251, DOI 10.1086/375143; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Ben-Shachar D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000817; Berrettini Wade, 2003, World Psychiatry, V2, P68; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Cannon TD, 2006, ANNU REV CLIN PSYCHO, V2, P267, DOI 10.1146/annurev.clinpsy.2.022305.095232; Crowe RR, 2001, AM J MED GENET, V105, P105, DOI 10.1002/1096-8628(20010108)105:1<105::AID-AJMG1072>3.0.CO;2-P; Curtis D, 2003, PSYCHIAT GENET, V13, P77, DOI 10.1097/01.ypg.0000056684.89558.d2; DeteraWadleigh SD, 1997, AM J MED GENET, V74, P254, DOI 10.1002/(SICI)1096-8628(19970531)74:3<254::AID-AJMG4>3.0.CO;2-Q; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Fallin MD, 2003, AM J HUM GENET, V73, P601, DOI 10.1086/378158; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; Geyer MA, 2002, MOL PSYCHIATR, V7, P1039, DOI 10.1038/sj.mp.4001159; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; GIAKOUMAKI SG, 2007, BIOL PSYCHIAT; Gogos JA, 2001, AM J MED GENET, V105, P50, DOI 10.1002/1096-8628(20010108)105:1<50::AID-AJMG1058>3.3.CO;2-X; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Halperin E, 2004, BIOINFORMATICS, V20, P1842, DOI 10.1093/bioinformatics/bth149; Heisler LE, 2005, NUCLEIC ACIDS RES, V33, P2952, DOI 10.1093/nar/gki582; Ingram JL, 2000, TERATOLOGY, V62, P393, DOI 10.1002/1096-9926(200012)62:6<393::AID-TERA6>3.3.CO;2-M; Kelsoe JR, 2001, P NATL ACAD SCI USA, V98, P585, DOI 10.1073/pnas.011358498; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kita JM, 2007, J NEUROCHEM, V102, P1115, DOI 10.1111/j.1471-4159.2007.04621.x; Knowles JA, 1998, AM J MED GENET, V81, P139, DOI 10.1002/(SICI)1096-8628(19980328)81:2<139::AID-AJMG4>3.0.CO;2-R; Le-Niculescu H, 2009, AM J MED GENET B, V150B, P155, DOI 10.1002/ajmg.b.30887; Lerer B, 2003, MOL PSYCHIATR, V8, P488, DOI 10.1038/sj.mp.4001322; Maier W, 2006, CURR OPIN PSYCHIATR, V19, P165, DOI 10.1097/01.yco.0000214342.52249.82; Meincke U, 2004, EUR ARCH PSY CLIN N, V254, P415, DOI 10.1007/S00406-004-0523-0; MESSIHA FS, 1986, ALCOHOL, V3, P131, DOI 10.1016/0741-8329(86)90022-4; Moskvina V, 2009, MOL PSYCHIATR, V14, P252, DOI 10.1038/mp.2008.133; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Nurnberger JI, 1997, AM J MED GENET, V74, P227, DOI 10.1002/(SICI)1096-8628(19970531)74:3<227::AID-AJMG1>3.0.CO;2-N; Perry W, 2001, BIOL PSYCHIAT, V50, P418, DOI 10.1016/S0006-3223(01)01184-2; Purcell S, 2005, AM J HUM GENET, V76, P249, DOI 10.1086/427886; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; STAMFORD JA, 1988, BRIT J PHARMACOL, V94, P924, DOI 10.1111/j.1476-5381.1988.tb11605.x; Supp DM, 1996, DEV BIOL, V176, P284, DOI 10.1006/dbio.1996.0134; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Swerdlow NR, 2006, ARCH GEN PSYCHIAT, V63, P1325, DOI 10.1001/archpsyc.63.12.1325; Wang N, 2002, AM J HUM GENET, V71, P1227, DOI 10.1086/344398; Wolpert CM, 2001, AM J MED GENET, V105, P222, DOI 10.1002/ajmg.1258; Zhou X, 2007, GENES BRAIN BEHAV, V6, P269, DOI 10.1111/j.1601-183X.2006.00256.x; Zhou X, 2005, MOL PSYCHIATR, V10, P393, DOI 10.1038/sj.mp.4001621	44	47	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2009	4	4							e5196	10.1371/journal.pone.0005196	http://dx.doi.org/10.1371/journal.pone.0005196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RZ	19401786	Green Submitted, gold, Green Published			2022-12-25	WOS:000265505900024
J	Pozzi, S; Zambelli, F; Merico, D; Pavesi, G; Robert, A; Maltere, P; Gidrol, X; Mantovani, R; Vigano, MA				Pozzi, Silvia; Zambelli, Federico; Merico, Daniele; Pavesi, Giulio; Robert, Amelie; Maltere, Peggy; Gidrol, Xavier; Mantovani, Roberto; Vigano, M. Alessandra			Transcriptional Network of p63 in Human Keratinocytes	PLOS ONE			English	Article								p63 is a transcription factor required for the development and maintenance of ectodermal tissues in general, and skin keratinocytes in particular. The identification of its target genes is fundamental for understanding the complex network of gene regulation governing the development of epithelia. We report a list of almost 1000 targets derived from ChIP on chip analysis on two platforms; all genes analyzed changed in expression during differentiation of human keratinocytes. Functional annotation highlighted unexpected GO terms enrichments and confirmed that genes involved in transcriptional regulation are the most significant. A detailed analysis of these transcriptional regulators in condition of perturbed p63 levels confirmed the role of p63 in the regulatory network. Rather than a rigid master-slave hierarchical model, our data indicate that p63 connects different hubs involved in the multiple specific functions of the skin.	[Pozzi, Silvia; Zambelli, Federico; Merico, Daniele; Pavesi, Giulio; Mantovani, Roberto; Vigano, M. Alessandra] Univ Milan, Dept Biomol Sci & Biotechnol, Milan, Italy; [Robert, Amelie; Maltere, Peggy; Gidrol, Xavier] CEA, Lab Explorat Fonctionnelle Genomes, Evry, France	University of Milan; CEA	Pozzi, S (corresponding author), Univ Milan, Dept Biomol Sci & Biotechnol, Milan, Italy.	mantor@unimi.it; alessandra.vigano@guest.unimi.it	Pavesi, Giulio/AAB-3230-2022; Zambelli, Federico/B-8198-2017; Zambelli, Federico/GRR-2570-2022	Zambelli, Federico/0000-0003-3487-4331; Zambelli, Federico/0000-0003-3487-4331; vigano, maria alessandra/0000-0003-2009-0384; Merico, Daniele/0000-0002-3728-4401; Gidrol, Xavier/0000-0002-4233-3749	EPISTEM [LSHB-CT-2005-019067]	EPISTEM	This work was supported by the EPISTEM LSHB-CT-2005-019067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberdam D, 2007, CR BIOL, V330, P479, DOI 10.1016/j.crvi.2007.03.007; Antonini D, 2006, MOL CELL BIOL, V26, P3308, DOI 10.1128/MCB.26.8.3308-3318.2006; Bakkers J, 2002, DEV CELL, V2, P617, DOI 10.1016/S1534-5807(02)00163-6; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Blais A, 2004, CURR OPIN GENET DEV, V14, P527, DOI 10.1016/j.gde.2004.07.003; Borrelli S, 2009, CELL DEATH DIFFER, V16, P253, DOI 10.1038/cdd.2008.147; Borrelli S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-85; Candi E, 2006, J CELL SCI, V119, P4617, DOI 10.1242/jcs.03265; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Della Gatta G, 2008, GENOME RES, V18, P939, DOI 10.1101/gr.073601.107; Flores ER, 2007, CELL CYCLE, V6, P300, DOI 10.4161/cc.6.3.3793; Gu XL, 2008, CANCER LETT, V263, P26, DOI 10.1016/j.canlet.2007.12.011; Han GW, 2006, DEV CELL, V11, P301, DOI 10.1016/j.devcel.2006.06.014; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Kennedy RE, 2006, BIOINFORMATICS, V22, P1272, DOI 10.1093/bioinformatics/btl108; Kim SI, 2007, ONCOGENE, V26, P6777, DOI 10.1038/sj.onc.1210761; King KE, 2008, CANCER RES, V68, P5122, DOI 10.1158/0008-5472.CAN-07-6123; Kohlhase J, 2002, HUM MOL GENET, V11, P2979, DOI 10.1093/hmg/11.23.2979; Kohlhase J, 2003, J MED GENET, V40, P473, DOI 10.1136/jmg.40.7.473; Koster MI, 2007, ANNU REV CELL DEV BI, V23, P93, DOI 10.1146/annurev.cellbio.23.090506.123357; Koster MI, 2007, CELL CYCLE, V6, P269, DOI 10.4161/cc.6.3.3792; Koster MI, 2007, P NATL ACAD SCI USA, V104, P3255, DOI 10.1073/pnas.0611376104; Lee H, 2002, DEV CELL, V2, P607, DOI 10.1016/S1534-5807(02)00166-1; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Man MQ, 2008, J INVEST DERMATOL, V128, P370, DOI 10.1038/sj.jid.5701026; Mathur D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r126; Mikkola ML, 2008, CYTOKINE GROWTH F R, V19, P219, DOI 10.1016/j.cytogfr.2008.04.008; Miller FD, 2007, CELL CYCLE, V6, P312, DOI 10.4161/cc.6.3.3795; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Ortt K, 2006, FEBS LETT, V580, P4544, DOI 10.1016/j.febslet.2006.07.004; Pavesi G, 2007, LECT NOTES ARTIF INT, V4578, P651; Perez CA, 2007, CELL CYCLE, V6, P246, DOI 10.4161/cc.6.3.3801; Reichrath J, 2007, HORM METAB RES, V39, P71, DOI 10.1055/s-2007-958715; Rinne T, 2007, CELL CYCLE, V6, P262, DOI 10.4161/cc.6.3.3796; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Sur I, 2008, INT REV IMMUNOL, V27, P205, DOI 10.1080/08830180802130319; Swiers G, 2006, DEV BIOL, V294, P525, DOI 10.1016/j.ydbio.2006.02.051; Testoni B, 2006, CELL CYCLE, V5, P2805, DOI 10.4161/cc.5.23.3525; Trink B, 2007, CELL CYCLE, V6, P240, DOI 10.4161/cc.6.3.3803; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Vigano MA, 2007, CELL CYCLE, V6, P233, DOI 10.4161/cc.6.3.3802; Vigano MA, 2006, EMBO J, V25, P5105, DOI 10.1038/sj.emboj.7601375; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zouboulis CC, 2007, HORM METAB RES, V39, P85, DOI 10.1055/s-2007-961807	56	38	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e5008	10.1371/journal.pone.0005008	http://dx.doi.org/10.1371/journal.pone.0005008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19390658	Green Published, Green Submitted, gold			2022-12-25	WOS:000265499200020
J	Kim, D; Kolch, W; Cho, KH				Kim, Dongsan; Kolch, Walter; Cho, Kwang-Hyun			Multiple roles of the NF-kappa B signaling pathway regulated by coupled negative feedback circuits	FASEB JOURNAL			English	Article						heterogeneity; oscillations; stochastic simulations; systems biology; mathematical model; design principle	GENE-EXPRESSION; PROTEIN EXPRESSION; TEMPORAL CONTROL; NOISE; OSCILLATIONS; CELLS; ACTIVATION; PHENOTYPES; EVOLUTION; NETWORKS	The NF-kappa B signaling pathway can perform multiple functional roles depending on specific cellular environments and cell types. Even in the same cell clones, the pathway can show different kinetic and phenotypic properties. It is believed that the complex networks controlling the NF-kappa B signaling pathway can generate these diverse and sometimes ambiguous phenomena. We noted, however, that the dynamics of NF-kappa B signaling pathway is highly stochastic and that the NF-kappa B signaling pathway contains multiple negative feedback circuits formed by I kappa B isoform proteins, I kappa B alpha and I kappa B epsilon in particular. Considering the topological similarity, their functional roles seem to be redundant, raising the question why different types of I kappa B isoforms need to exist. From extensive stochastic simulations of the NF-kappa B signaling pathway, we found that each I kappa B isoform actually conducts a different regulatory role through its own negative feedback. Specifically, our data suggest that I kappa B alpha controls the dynamic patterns of nuclear NF-kappa B, while I kappa B epsilon induces cellular heterogeneity of the NF-kappa B activities. These results may provide an answer to the question of how a single NF-kappa B signaling pathway can perform multiple biological functions even in the same clonal populations.-Kim, D., Kolch, W., Cho, K.-H. Multiple roles of the NF-kappa B signaling pathway regulated by coupled negative feedback circuits. FASEB J. 23, 2796-2802 (2009). www.fasebj.org	[Kim, Dongsan; Cho, Kwang-Hyun] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Kolch, Walter] Canc Res UK, Beatson Inst Canc Res, Glasgow, Lanark, Scotland; [Kolch, Walter] Univ Glasgow, Glasgow, Lanark, Scotland	Korea Advanced Institute of Science & Technology (KAIST); Beatson Institute; Cancer Research UK; University of Glasgow	Cho, KH (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, 335 Gwahangno, Taejon 305701, South Korea.	ckh@kaist.ac.kr	Kolch, Walter/ABF-2102-2021; Cho, Kwang-Hyun/C-1684-2011; Admin, SBI/HGB-2738-2022	Kolch, Walter/0000-0001-5777-5016	Korea Science and Engineering Foundation (KOSEF); Korea Ministry of Education, Science, and Technology [M10503010001-07N030100112]; Nuclear Research [M20708000001-07B0800-00110]; 21C Frontier Microbial Genomics and Application Center [MG08-0205-4-0]; World Class University (WCU) [R32-2008-000-10218-0]; Cancer Research UK	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Korea Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Nuclear Research; 21C Frontier Microbial Genomics and Application Center(Ministry of Education, Science & Technology (MEST), Republic of Korea); World Class University (WCU); Cancer Research UK(Cancer Research UK)	This work was supported by a Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea Ministry of Education, Science, and Technology through Systems Biology grant M10503010001-07N030100112, Nuclear Research grant M20708000001-07B0800-00110, 21C Frontier Microbial Genomics and Application Center Program grant MG08-0205-4-0, World Class University (WCU) grant R32-2008-000-10218-0, and Cancer Research UK.	Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Doerre S, 2005, J IMMUNOL, V174, P983, DOI 10.4049/jimmunol.174.2.983; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gillespie DT, 2003, J CHEM PHYS, V119, P8229, DOI 10.1063/1.1613254; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hayot F, 2006, J THEOR BIOL, V240, P583, DOI 10.1016/j.jtbi.2005.10.018; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Jang YJ, 2003, CANCER LETT, V194, P107, DOI 10.1016/S0304-3835(02)00680-8; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kaufmann BB, 2007, CURR OPIN GENET DEV, V17, P107, DOI 10.1016/j.gde.2007.02.007; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Krishna S, 2006, P NATL ACAD SCI USA, V103, P10840, DOI 10.1073/pnas.0604085103; Lin SC, 1996, MOL CELL BIOL, V16, P4591; Lipniacki T, 2006, BIOPHYS J, V90, P725, DOI 10.1529/biophysj.104.056754; Mercurio F, 1999, CURR OPIN CELL BIOL, V11, P226, DOI 10.1016/S0955-0674(99)80030-1; Neildez-Nguyen TMA, 2008, DIFFERENTIATION, V76, P33, DOI 10.1111/j.1432-0436.2007.00219.x; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Notarangelo LD, 2006, J ALLERGY CLIN IMMUN, V117, P855, DOI 10.1016/j.jaci.2006.01.043; Pasparakis M, 2006, CELL DEATH DIFFER, V13, P861, DOI 10.1038/sj.cdd.4401870; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Ramsey Stephen, 2005, Journal of Bioinformatics and Computational Biology, V3, P415, DOI 10.1142/S0219720005001132; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Sillitoe K, 2007, BIOCHEM SOC T, V35, P263, DOI 10.1042/BST0350263; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Subkhankulova T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-268; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Wagner A, 1996, BIOL CYBERN, V74, P557, DOI 10.1007/BF00209427; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Wilkinso D.J., 2006, STOCHASTIC MODELLING; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	43	17	18	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					2796	2802		10.1096/fj.09-130369	http://dx.doi.org/10.1096/fj.09-130369			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19417085				2022-12-25	WOS:000270241000002
J	Yu, Y; Cai, JP; Tu, B; Wu, LP; Zhao, Y; Liu, XY; Li, L; McNutt, MA; Feng, JN; He, QH; Yang, Y; Wang, HY; Sekiguchi, M; Zhu, WG				Yu, Yu; Cai, Jian-Ping; Tu, Bo; Wu, Lipeng; Zhao, Ying; Liu, Xiangyu; Li, Lian; McNutt, Michael A.; Feng, Jingnan; He, Qihua; Yang, Yang; Wang, Haiying; Sekiguchi, Mutsuo; Zhu, Wei-Guo			Proliferating Cell Nuclear Antigen Is Protected from Degradation by Forming a Complex with MutT Homolog2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-DELTA; MUTAGENIC SUBSTRATE; ESCHERICHIA-COLI; PCNA-BINDING; LUNG-CANCER; TYROSINE PHOSPHORYLATION; REPLICATION INVITRO; AUXILIARY PROTEIN; REPAIR; CYCLIN	Proliferating cell nuclear antigen ( PCNA) has been demonstrated to interact with multiple proteins involved in several metabolic pathways such as DNA replication and repair. However, there have been fewer reports about whether these PCNA-binding proteins influence stability of PCNA. Here, we observed a physical interaction between PCNA and MutT homolog2 (MTH2), a new member of the MutT-related proteins that hydrolyzes 8-oxo-7,8-dihydrodeoxyguanosine triphosphate (8-oxo-dGTP). In several unstressed human cancer cell lines and in normal human fibroblast cells, PCNA and MTH2 formed a complex and their mutual binding fragments were confirmed. It was intriguing that PCNA and MTH2 were dissociated dependent on acetylation of PCNA, which in turn induced degradation of PCNA in response to UV irradiation, but not in response to other forms of DNA-damaging stress. To further explore the link between dissociation of PCNA-MTH2 and degradation of PCNA, RNAi against MTH2 was performed to mimic the dissociated status of PCNA to evaluate changes in the half-life of PCNA. Knockdown of MTH2 significantly promoted degradation of PCNA, suggesting that the physiological interaction of PCNA-MTH2 may confer protection from degradation for PCNA, whereas UV irradiation accelerates PCNA degradation by inducing dissociation of PCNA-MTH2. Moreover, secondary to degradation of PCNA, UV-induced inhibition of DNA synthesis or cell cycle progression was enhanced. Collectively, our data demonstrate for the first time that PCNA is protected by this newly identified partner molecule MTH2, which is related to DNA synthesis and cell cycle progression.	[Yu, Yu; Tu, Bo; Wu, Lipeng; Zhao, Ying; Liu, Xiangyu; Li, Lian; Feng, Jingnan; Yang, Yang; Wang, Haiying; Zhu, Wei-Guo] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol, Key Lab Carcinogenesis & Translat Res,Educ Minist, Beijing 100191, Peoples R China; [McNutt, Michael A.] Peking Univ, Hlth Sci Ctr, Dept Pathol, Beijing 100191, Peoples R China; [He, Qihua] Peking Univ, Hlth Sci Ctr, Biomed Teaching Lab Ctr, Beijing 100191, Peoples R China; [Cai, Jian-Ping] Beijing Hosp, Natl Ctr Clin Lab, Beijing 100730, Peoples R China; [Sekiguchi, Mutsuo] Fukuoka Dent Coll, Frontier Res Ctr, Fukuoka 8140193, Japan; [Zhu, Wei-Guo] Peking Univ, Hlth Sci Ctr, Canc Res Ctr, Beijing 100191, Peoples R China	Peking University; Peking University; Peking University; Beijing Hospital; Fukuoka Dental College (FDC); Peking University	Zhu, WG (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol, Key Lab Carcinogenesis & Translat Res,Educ Minist, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	zhuweiguo@bjmu.edu	zhu, wei-guo/E-1334-2012; liu, xiangyu/D-8213-2014	Zhu, Wei-Guo/0000-0001-8385-6581; Yang, Yang/0000-0002-8737-590X	National Natural Science Foundation of China [90919030, 30425017, 30670417, 30621002]; Ministry of Science and Technology of China [2005CB522403, 2006CB910300, B07001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This study was supported by the National Natural Science Foundation of China ( No. 90919030, No. 30425017, 30670417, and 30621002) and Grants 2005CB522403, 2006CB910300, and B07001 from the Ministry of Science and Technology of China.	AKIYAMA M, 1989, P NATL ACAD SCI USA, V86, P3949, DOI 10.1073/pnas.86.11.3949; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; Cai JP, 2003, BIOCHEM BIOPH RES CO, V305, P1073, DOI 10.1016/S0006-291X(03)00864-7; Cai JP, 1997, NUCLEIC ACIDS RES, V25, P1170, DOI 10.1093/nar/25.6.1170; Cazzalini O, 2008, NUCLEIC ACIDS RES, V36, P1713, DOI 10.1093/nar/gkn014; Chodon D, 2007, MOL CELL BIOCHEM, V297, P73, DOI 10.1007/s11010-006-9324-2; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Clark AB, 2000, J BIOL CHEM, V275, P36498, DOI 10.1074/jbc.C000513200; COHEN B, 1990, P NATL ACAD SCI USA, V87, P4458, DOI 10.1073/pnas.87.12.4458; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Engel FB, 2003, MOL CELL BIOL, V23, P555, DOI 10.1128/MCB.23.2.555-565.2003; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Gary R, 1997, J BIOL CHEM, V272, P24522, DOI 10.1074/jbc.272.39.24522; Gniadecki R, 1997, J INVEST DERMATOL, V109, P163, DOI 10.1111/1523-1747.ep12319216; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Han LY, 2006, CANCER RES, V66, P8633, DOI 10.1158/0008-5472.CAN-06-1410; Haracska L, 2001, MOL CELL BIOL, V21, P7199, DOI 10.1128/MCB.21.21.7199-7206.2001; Hasan S, 2001, NATURE, V410, P387, DOI 10.1038/35066610; Hiyama H, 1999, CELL DEATH DIFFER, V6, P565, DOI 10.1038/sj.cdd.4400524; Hong R, 2003, J BIOL CHEM, V278, P44505, DOI 10.1074/jbc.M303138200; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; Huen MSY, 2008, J BIOL CHEM, V283, P11073, DOI 10.1074/jbc.C700242200; HUI Z, 1993, MOL BIOL CELL, V4, P897, DOI 10.1091/mbc.4.9.897; Indiani C, 2006, NAT REV MOL CELL BIO, V7, P751, DOI 10.1038/nrm2022; Ishibashi T, 2003, EMBO REP, V4, P479, DOI 10.1038/sj.embor.embor838; Izumi M, 2001, J BIOL CHEM, V276, P48526, DOI 10.1074/jbc.M107190200; JASKULSKI D, 1988, SCIENCE, V240, P1544, DOI 10.1126/science.2897717; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kamat AA, 2007, CANCER RES, V67, P281, DOI 10.1158/0008-5472.CAN-06-3282; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kedar PS, 2002, J BIOL CHEM, V277, P31115, DOI 10.1074/jbc.M201497200; Kobayashi M, 1998, J BIOL CHEM, V273, P26394, DOI 10.1074/jbc.273.41.26394; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Levin DS, 1997, P NATL ACAD SCI USA, V94, P12863, DOI 10.1073/pnas.94.24.12863; Liebermann DA, 2007, BLOOD CELL MOL DIS, V39, P329, DOI 10.1016/j.bcmd.2007.06.006; Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Maga G, 2002, J BIOL CHEM, V277, P48434, DOI 10.1074/jbc.M206889200; Magrini R, 2008, J CELL BIOCHEM, V104, P2363, DOI 10.1002/jcb.21794; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; MARTIN SJ, 1991, INT J RADIAT BIOL, V59, P1001, DOI 10.1080/09553009114550891; Masih PJ, 2008, NUCLEIC ACIDS RES, V36, P67, DOI 10.1093/nar/gkm943; MATSUOKA S, 1994, J BIOL CHEM, V269, P11030; Matunis MJ, 2002, MOL CELL, V10, P441, DOI 10.1016/S1097-2765(02)00653-6; Milutinovic S, 2002, J BIOL CHEM, V277, P20974, DOI 10.1074/jbc.M202504200; Naryzhny SN, 2003, PROTEOMICS, V3, P930, DOI 10.1002/pmic.200300400; Naryzhny SN, 2004, J BIOL CHEM, V279, P20194, DOI 10.1074/jbc.M312850200; Niimi A, 2008, P NATL ACAD SCI USA, V105, P16125, DOI 10.1073/pnas.0802727105; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; PRELICH G, 1987, NATURE, V326, P471, DOI 10.1038/326471a0; PRELICH G, 1988, CELL, V53, P117, DOI 10.1016/0092-8674(88)90493-X; SAKUMI K, 1993, J BIOL CHEM, V268, P23524; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; SCHWARZ A, 1995, J INVEST DERMATOL, V104, P922, DOI 10.1111/1523-1747.ep12606202; Scorah J, 2008, J BIOL CHEM, V283, P17250, DOI 10.1074/jbc.M800369200; Sekiguchi M, 2002, ONCOGENE, V21, P8895, DOI 10.1038/sj.onc.1206023; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; SHIVJI MKK, 1992, CELL, V69, P367, DOI 10.1016/0092-8674(92)90416-A; TAJIRI T, 1995, MUTAT RES-DNA REPAIR, V336, P257, DOI 10.1016/0921-8777(94)00062-B; Tsuzuki T, 2001, P NATL ACAD SCI USA, V98, P11456, DOI 10.1073/pnas.191086798; Vairapandi M, 2000, J BIOL CHEM, V275, P16810, DOI 10.1074/jbc.275.22.16810; Volm M, 2000, ANTICANCER RES, V20, P3449; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Wang H, 2008, J BIOL CHEM, V283, P2564, DOI 10.1074/jbc.M702454200; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Wu XT, 1996, NUCLEIC ACIDS RES, V24, P2036, DOI 10.1093/nar/24.11.2036; Xu H, 2001, BIOCHEMISTRY-US, V40, P4512, DOI 10.1021/bi010103+; ZENG XR, 1994, J BIOL CHEM, V269, P24027; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006; Zhu WG, 2004, J BIOL CHEM, V279, P15161, DOI 10.1074/jbc.M311703200; Zhu WG, 2001, CANCER RES, V61, P1327	76	40	43	3	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19310	19320		10.1074/jbc.M109.015289	http://dx.doi.org/10.1074/jbc.M109.015289			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19419956	Green Published, hybrid			2022-12-25	WOS:000267908300022
J	Brazier-Hicks, M; Evans, KM; Gershater, MC; Puschmann, H; Steel, PG; Edwards, R				Brazier-Hicks, Melissa; Evans, Kathryn M.; Gershater, Markus C.; Puschmann, Horst; Steel, Patrick G.; Edwards, Robert			The C-Glycosylation of Flavonoids in Cereals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS-THALIANA; IN-VITRO; IDENTIFICATION; BIOSYNTHESIS; GLYCOSYLTRANSFERASE; GLUCOSYLTRANSFERASE; METABOLISM; GLYCOSYLFLAVONES; ISOVITEXIN; GLYCOSIDES	Flavonoids normally accumulate in plants as O-glycosylated derivatives, but several species, including major cereal crops, predominantly synthesize flavone-C-glycosides, which are stable to hydrolysis and are biologically active both in planta and as dietary components. An enzyme (OsCGT) catalyzing the UDP-glucosedependent C-glucosylation of 2-hydroxyflavanone precursors of flavonoids has been identified and cloned from rice (Oryza sativa ssp. indica), with a similar protein characterized in wheat (Triticum aestivum L.). OsCGT is a 49-kDa family 1 glycosyltransferase related to known O-glucosyltransferases. The recombinant enzyme C-glucosylated 2-hydroxyflavanones but had negligible O-glucosyltransferase activity with flavonoid acceptors. Enzyme chemistry studies suggested that OsCGT preferentially C-glucosylated the dibenzoylmethane tautomers formed in equilibrium with 2-hydroxyflavanones. The resulting 2-hydroxyflavanone-C-glucosides were unstable and spontaneously dehydrated in vitro to yield a mixture of 6C-and 8C-glucosyl derivatives of the respective flavones. In contrast, in planta, only the respective 6C-glucosides accumulated. Consistent with this selectivity in glycosylation product, a dehydratase activity that preferentially converted 2-hydroxyflavanone-C-glucosides to the corresponding flavone-6C-glucosides was identified in both rice and wheat. Our results demonstrate that cereal crops synthesize C-glucosylated flavones through the concerted action of a CGT and dehydratase acting on activated 2-hydroxyflavanones, as an alternative means of generating flavonoid metabolites.	[Brazier-Hicks, Melissa; Evans, Kathryn M.; Gershater, Markus C.; Puschmann, Horst; Steel, Patrick G.; Edwards, Robert] Univ Durham, Ctr Bioact Chem, Durham DH1 3LE, England	Durham University	Edwards, R (corresponding author), Univ Durham, Ctr Bioact Chem, Durham DH1 3LE, England.	Robert.Edwards@durham.ac.uk	Steel, Patrick/G-3187-2012; Puschmann, Horst/L-3630-2018	Steel, Patrick/0000-0002-2493-5826; EVANS, KATE/0000-0002-2184-7433; Brazier-Hicks, Melissa/0000-0001-5993-1940; Edwards, Robert/0000-0003-0809-5991	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F01094X/1]; BBSRC [BB/F01094X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F01094X/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/F01094X/1).	Akashi T, 1998, FEBS LETT, V431, P287, DOI 10.1016/S0014-5793(98)00781-9; Akashi T, 2005, PLANT PHYSIOL, V137, P882, DOI 10.1104/pp.104.056747; Akiyama K, 2002, MOL PLANT MICROBE IN, V15, P334, DOI 10.1094/MPMI.2002.15.4.334; AMINO S, 1985, PHYSIOL PLANTARUM, V64, P197, DOI 10.1111/j.1399-3054.1985.tb02335.x; BESSON E, 1985, PHYTOCHEMISTRY, V24, P1061, DOI 10.1016/S0031-9422(00)83183-0; Bililign T, 2005, NAT PROD REP, V22, P742, DOI 10.1039/b407364a; Brazier M, 2002, PHYTOCHEMISTRY, V59, P149, DOI 10.1016/S0031-9422(01)00458-7; Brazier-Hicks M, 2008, J BIOL CHEM, V283, P21102, DOI 10.1074/jbc.M801998200; Brazier-Hicks M, 2007, P NATL ACAD SCI USA, V104, P20238, DOI 10.1073/pnas.0706421104; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cone K., 1989, Maize Genetics Cooperation News Letter, P68; Cummins I, 2006, PHYTOCHEMISTRY, V67, P1722, DOI 10.1016/j.phytochem.2006.01.012; Dinda B, 2006, CHEM PHARM BULL, V54, P679, DOI 10.1248/cpb.54.679; Dixon DP, 2009, J EXP BOT, V60, P1207, DOI 10.1093/jxb/ern365; Durr C, 2004, ANGEW CHEM INT EDIT, V43, P2962, DOI 10.1002/anie.200453758; ELIX JA, 1990, AUST J CHEM, V43, P1745, DOI 10.1071/CH9901745; Faust B, 2000, MICROBIOL-UK, V146, P147, DOI 10.1099/00221287-146-1-147; Fischbach MA, 2005, P NATL ACAD SCI USA, V102, P571, DOI 10.1073/pnas.0408463102; FRANZ G, 1983, PLANTA MED, V47, P131, DOI 10.1055/s-2007-969972; GAITAN E, 1995, J CLIN ENDOCR METAB, V80, P1144, DOI 10.1210/jc.80.4.1144; Harborne J. B., 1993, FLAVONOIDS ADV RES 1, P57; Hultin PG, 2005, CURR TOP MED CHEM, V5, P1299, DOI 10.2174/156802605774643015; Kazuno S, 2005, ANAL BIOCHEM, V347, P182, DOI 10.1016/j.ab.2005.09.020; KERSCHER F, 1988, J PLANT PHYSIOL, V132, P110, DOI 10.1016/S0176-1617(88)80193-7; KERSCHER F, 1987, Z NATURFORSCH C, V42, P519; Kim JH, 2008, J PLANT BIOL, V51, P97, DOI 10.1007/BF03030717; KIM M, 1985, J CHEM ECOL, V11, P441, DOI 10.1007/BF00989555; Kim YC, 2005, J FOOD SCI, V70, pS575; KITTA K, 1992, J AGR FOOD CHEM, V40, P1843, DOI 10.1021/jf00022a023; LES DH, 1990, AM J BOT, V77, P453, DOI [10.1002/j.1537-2197.1990.tb13576.x, 10.2307/2444379]; Lim EK, 2005, FEBS LETT, V579, P2802, DOI 10.1016/j.febslet.2005.04.016; Loutre C, 2003, PLANT J, V34, P485, DOI 10.1046/j.1365-313X.2003.01742.x; Manthey JA, 2001, CURR MED CHEM, V8, P135, DOI 10.2174/0929867013373723; Markham KR, 1998, PHYTOCHEMISTRY, V49, P1913, DOI 10.1016/S0031-9422(98)00438-5; Markham KR, FLAVONOIDS, DOI 10.1016/0022-2860(71)87109-0; Martens S, 2005, PHYTOCHEMISTRY, V66, P2399, DOI 10.1016/j.phytochem.2005.07.013; Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430; Mittler M, 2007, J MOL BIOL, V372, P67, DOI 10.1016/j.jmb.2007.06.005; Osmani SA, 2009, PHYTOCHEMISTRY, V70, P325, DOI 10.1016/j.phytochem.2008.12.009; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Ralston L, 2005, PLANT PHYSIOL, V137, P1375, DOI 10.1104/pp.104.054502; RAMARATHNAM N, 1989, J AGR FOOD CHEM, V37, P316, DOI 10.1021/jf00086a009; Rauter AP, 2005, J CHROMATOGR A, V1089, P59, DOI 10.1016/j.chroma.2005.06.046; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SHEN CC, 1993, PHYTOCHEMISTRY, V34, P843, DOI 10.1016/0031-9422(93)85370-7	46	208	220	10	94	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					17926	17934		10.1074/jbc.M109.009258	http://dx.doi.org/10.1074/jbc.M109.009258			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19411659	Green Published, hybrid			2022-12-25	WOS:000267712400004
J	Montalbano, J; Lui, K; Sheikh, MS; Huang, Y				Montalbano, JoAnne; Lui, Ki; Sheikh, M. Saeed; Huang, Ying			Identification and Characterization of RBEL1 Subfamily of GTPases in the Ras Superfamily Involved in Cell Growth Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEINS; GENE; TRANSPORT; CANCER; GAPS; ONCOGENES; NUCLEUS; CLONING; FAMILY; GEFS	Recently, we reported the identification of a novel gene named RBEL1 (Rab-like protein 1) and characterized its two encoded isoforms, RBEL1A and RBEL1B, that function as novel GTPases of Ras superfamily. Here we report the identification of two additional splice variants of RBEL1 that we have named RBEL1C and -D. All four RBEL1 isoforms (A, B, C, and D) have identical N termini harboring the Rab-like GTPase domains but contain variable C termini. Although all isoforms can be detected in both cytoplasm and nucleus, RBEL1A is predominantly cytoplasmic, whereas RBEL1B is mostly nuclear. RBEL1C and -D, by contrast, are evenly distributed between the cytoplasm and nucleus. Furthermore, all four RBEL1 proteins are also capable of associating with cellular membrane. The RBEL1 proteins also exhibit a unique nucleotide-binding potential and, whereas the larger A and B isoforms are mainly GTP-bound, the smaller C and D variants bind to both GTP and GDP. Furthermore, a regulatory region at amino acid position 236 - 302 immediately adjacent to the GTP-binding domain is important for GTP-binding potential of RBEL1A, because deletion of this region converts RBEL1A from predominantly GTP-bound to GDP-bound. RBEL1 knockdown via RNA interference results in marked cell growth suppression, which is associated with morphological and biochemical features of apoptosis as well as inhibition of extracellular signal-regulated kinase phosphorylation. Taken together, our results indicate that RBEL1 proteins are linked to cell growth and survival and possess unique biochemical, cellular, and functional characteristics and, therefore, appear to form a novel subfamily of GTPases within the Ras superfamily.	[Montalbano, JoAnne; Lui, Ki; Sheikh, M. Saeed; Huang, Ying] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Huang, Y (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, 750 E Adams St, Syracuse, NY 13210 USA.	huangy@upstate.edu		Lui, Ki/0000-0002-1690-4616	National Institutes of Health [CA113868, DK067271, ES014489]; NATIONAL CANCER INSTITUTE [R21CA113868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK067271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES014489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA113868 (to Y. H.), DK067271 (to Y. H.), and ES014489 (to M. S. S.).	Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; BOS JL, 1989, CANCER RES, V49, P4682; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Ciciarello M, 2007, CELL MOL LIFE SCI, V64, P1891, DOI 10.1007/s00018-007-6568-2; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Darchen F, 2000, BIOCHIMIE, V82, P375, DOI 10.1016/S0300-9084(00)00219-4; Deneka M, 2003, CRIT REV BIOCHEM MOL, V38, P121, DOI 10.1080/713609214; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Geyer M, 1997, CURR OPIN STRUC BIOL, V7, P786, DOI 10.1016/S0959-440X(97)80147-9; HUANG Y, 1995, ONCOGENE, V11, P1255; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Luo XQ, 2005, CANCER RES, V65, P10725, DOI 10.1158/0008-5472.CAN-05-1132; Luo XQ, 2003, ONCOGENE, V22, P7247, DOI 10.1038/sj.onc.1207010; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Mitra RS, 2003, ONCOGENE, V22, P6243, DOI 10.1038/sj.onc.1206534; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Montalbano J, 2007, J BIOL CHEM, V282, P37640, DOI 10.1074/jbc.M704760200; Pei L, 2002, CANCER RES, V62, P5420; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Quimby BB, 2003, CURR OPIN CELL BIOL, V15, P338, DOI 10.1016/S0955-0674(03)00046-2; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Rong R, 2004, ONCOGENE, V23, P8216, DOI 10.1038/sj.onc.1207901; Stenmark H, 2001, GENOME BIOL, V2; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Vetter IR, 1999, Q REV BIOPHYS, V32, P1, DOI 10.1017/S0033583599003480; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Yao RS, 2003, NEOPLASIA, V5, P41, DOI 10.1016/S1476-5586(03)80016-7; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	32	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18129	18142		10.1074/jbc.M109.009597	http://dx.doi.org/10.1074/jbc.M109.009597			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19433581	hybrid, Green Published			2022-12-25	WOS:000267712400024
J	Subramanya, AR; Liu, J; Ellison, DH; Wade, JB; Welling, PA				Subramanya, Arohan R.; Liu, Jie; Ellison, David H.; Wade, James B.; Welling, Paul A.			WNK4 Diverts the Thiazide-sensitive NaCl Cotransporter to the Lysosome and Stimulates AP-3 Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; CL COTRANSPORTER; MOLECULAR PATHOGENESIS; SURFACE EXPRESSION; MEMBRANE-PROTEINS; BLOOD-PRESSURE; KINASES; COMPLEX; KIDNEY; CELLS	With-no-lysine kinase 4 (WNK4) inhibits electroneutral sodium chloride reabsorption by attenuating the cell surface expression of the thiazide-sensitive NaCl cotransporter (NCC). The underlying mechanism for this effect remains poorly understood. Here, we explore how WNK4 affects the trafficking of NCC through its interactions with intracellular sorting machinery. An analysis of NCC cell surface lifetime showed that WNK4 did not alter the net rate of cotransporter internalization. In contrast, direct measurements of forward trafficking revealed that WNK4 attenuated the rate of NCC surface delivery, inhibiting the anterograde movement of cotransporters traveling to the plasma membrane from the trans-Golgi network. The response was paralleled by a dramatic reduction in NCC protein abundance, an effect that was sensitive to the lysosomal protease inhibitor leupeptin, insensitive to proteasome inhibition, and attenuated by endogenous WNK4 knockdown. Subcellular localization studies performed in the presence of leupeptin revealed that WNK4 enhanced the accumulation of NCC in lysosomes. Moreover, NCC immunoprecipitated with endogenous AP-3 complexes, and WNK4 increased the fraction of cotransporters that associate with this adaptor, which facilitates cargo transport to lysosomes. WNK4 expression also increased LAMP-2-positive lysosomal content, indicating that the kinase may act by a general AP-3-dependent mechanism to promote cargo delivery into the lysosomal pathway. Taken together, these findings indicate that WNK4 inhibits NCC activity by diverting the cotransporter to the lysosome for degradation by way of an AP-3 transport carrier.	[Subramanya, Arohan R.; Liu, Jie; Wade, James B.; Welling, Paul A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Subramanya, Arohan R.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Subramanya, Arohan R.] Dept Vet Affairs Med Ctr, Baltimore, MD 21201 USA; [Wade, James B.] Oregon Hlth & Sci Univ, Div Nephrol & Hypertens, Portland, OR 97239 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Oregon Health & Science University	Subramanya, AR (corresponding author), 660 W Redwood St,HH517, Baltimore, MD 21201 USA.	asubr001@umaryland.edu	Subramanya, Arohan R./AAN-5217-2020; , David/X-5730-2019	Subramanya, Arohan R./0000-0002-2609-7643; Ellison, David/0000-0003-2915-265X	National Institutes of Health [DK072865, DK063049, DK054231, DK051496]; American Heart Association [0755503U]; United States Department of Veterans Affairs Mid-Level Career Development Award; National Kidney Foundation of Maryland; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063049, F32DK072865, R01DK051496, R01DK054231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); United States Department of Veterans Affairs Mid-Level Career Development Award(US Department of Veterans Affairs); National Kidney Foundation of Maryland; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK072865 (to A. R. S.), DK063049 (to P. A. W.), DK054231 (to P. A. W.), and DK051496 (to D. H. E.). This work was also supported by American Heart Association Grant 0755503U (to J. B. W.), a United States Department of Veterans Affairs Mid-Level Career Development Award (to A. R. S.), and a Mini-Grant from the National Kidney Foundation of Maryland (to A. R. S.).	Boehm M, 2002, GENE, V286, P175, DOI 10.1016/S0378-1119(02)00422-5; Bostonjoglo M, 1998, J AM SOC NEPHROL, V9, P1347; Cai H, 2006, KIDNEY INT, V69, P2162, DOI 10.1038/sj.ki.5000333; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; Duffield A, 2003, P NATL ACAD SCI USA, V100, P15560, DOI 10.1073/pnas.2536699100; FANG L, 2008, FASEB J, V22; Golbang AP, 2006, AM J PHYSIOL-RENAL, V291, pF1369, DOI 10.1152/ajprenal.00468.2005; GRIFFITHS G, 1985, J CELL BIOL, V101, P949, DOI 10.1083/jcb.101.3.949; Halperin ML, 2000, CAN J PHYSIOL PHARM, V78, P587, DOI 10.1139/cjpp-78-8-587; He GC, 2007, J CLIN INVEST, V117, P1078, DOI 10.1172/JCI30087; Janvier K, 2003, J CELL BIOL, V163, P1281, DOI 10.1083/jcb.200307157; Kahle KT, 2008, ANNU REV PHYSIOL, V70, P329, DOI 10.1146/annurev.physiol.70.113006.100651; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P2064, DOI 10.1073/pnas.0308434100; Kahle KT, 2003, NAT GENET, V35, P372, DOI 10.1038/ng1271; Kunchaparty S, 1999, AM J PHYSIOL-RENAL, V277, pF643, DOI 10.1152/ajprenal.1999.277.4.F643; Ladinsky MS, 2002, MOL BIOL CELL, V13, P2810, DOI 10.1091/mbc.01-12-0593; Lalioti MD, 2006, NAT GENET, V38, P1124, DOI 10.1038/ng1877; Lazrak A, 2006, P NATL ACAD SCI USA, V103, P1615, DOI 10.1073/pnas.0510609103; Lee-Kwon W, 2003, J BIOL CHEM, V278, P16494, DOI 10.1074/jbc.M300580200; Ma DH, 2007, J BIOL CHEM, V282, P5781, DOI 10.1074/jbc.M608776200; Madrid R, 2001, EMBO J, V20, P7008, DOI 10.1093/emboj/20.24.7008; Mason AK, 2008, J BIOL CHEM, V283, P5973, DOI 10.1074/jbc.M709756200; McCormick JA, 2008, HYPERTENSION, V51, P588, DOI 10.1161/HYPERTENSIONAHA.107.103788; Newell-Litwa K, 2007, J CELL SCI, V120, P531, DOI 10.1242/jcs.03365; O'Reilly M, 2006, J AM SOC NEPHROL, V17, P2402, DOI 10.1681/ASN.2005111197; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; PELHAM HRB, 1991, CELL, V67, P449, DOI 10.1016/0092-8674(91)90517-3; Peng Y, 2001, AM J PHYSIOL-RENAL, V280, pF34, DOI 10.1152/ajprenal.2001.280.1.F34; PFEIFFER S, 1985, J CELL BIOL, V101, P470, DOI 10.1083/jcb.101.2.470; Schwake M, 2001, J BIOL CHEM, V276, P12049, DOI 10.1074/jbc.M010642200; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; Simpson F, 1997, J CELL BIOL, V137, P835, DOI 10.1083/jcb.137.4.835; Song J, 2006, AM J PHYSIOL-RENAL, V290, pF1055, DOI 10.1152/ajprenal.00108.2005; Subramanya AR, 2006, AM J PHYSIOL-RENAL, V290, pF619, DOI 10.1152/ajprenal.00280.2005; Wade JB, 2006, P NATL ACAD SCI USA, V103, P8558, DOI 10.1073/pnas.0603109103; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; Yang CL, 2007, J CLIN INVEST, V117, P3403, DOI 10.1172/JCI32033; Yang CL, 2005, J CLIN INVEST, V115, P1379, DOI 10.1172/JCI200522452; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443; Yang SS, 2005, BIOCHEM BIOPH RES CO, V330, P410, DOI 10.1016/j.bbrc.2005.02.172; Yang SS, 2007, CELL METAB, V5, P331, DOI 10.1016/j.cmet.2007.03.009; Yoo D, 2005, J BIOL CHEM, V280, P35281, DOI 10.1074/jbc.M504836200	43	85	88	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18471	18480		10.1074/jbc.M109.008185	http://dx.doi.org/10.1074/jbc.M109.008185			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19401467	Green Published, hybrid			2022-12-25	WOS:000267712400058
J	Gianni, T; Amasio, M; Campadelli-Fiume, G				Gianni, Tatiana; Amasio, Michele; Campadelli-Fiume, Gabriella			Herpes Simplex Virus gD Forms Distinct Complexes with Fusion Executors gB and gH/gL in Part through the C-terminal Profusion Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-D; RECEPTOR-BINDING; HERPES-SIMPLEX-VIRUS-1 GH; POLIOVIRUS RECEPTOR; CRYSTAL-STRUCTURE; HEPTAD-REPEAT; ALPHA-HELIX; TYPE-1; ENTRY; MEMBRANE	Herpes simplex virus entry into cells requires a multipartite fusion apparatus made of glycoprotein D (gD), gB, and heterodimer gH/gL. gD serves as a receptor-binding glycoprotein and trigger of fusion; its ectodomain is organized in an N-terminal domain carrying the receptor-binding sites and a C-terminal domain carrying the profusion domain, required for fusion but not receptor binding. gB and gH/gL execute fusion. To understand how the four glycoproteins cross-talk to each other, we searched for biochemical defined complexes in infected and transfected cells and in virions. Previously, interactions were detected in transfected whole cells by split green fluorescent protein complementation (Atanasiu, D., Whitbeck, J. C., Cairns, T. M., Reilly, B., Cohen, G. H., and Eisen-berg, R. J. (2007) Proc. Natl. Acad. Sci. U. S. A. 104, 18718-18723; Avitabile, E., Forghieri, C., and Campadelli-Fiume, G. (2007) J. Virol. 81, 11532-11537); it was not determined whether they led to biochemical complexes. Infected cells harbor a gD-gH complex (Perez-Romero, P., Perez, A., Capul, A., Montgomery, R., and Fuller, A. O. (2005) J. Virol. 79, 4540-4544). We report that gD formed complexes with gB in the absence of gH/gL and with gH/gL in the absence of gB. Complexes with similar composition were formed in infected and transfected cells. They were also present in virions prior to entry and did not increase at virus entry into the cell. A panel of gD mutants enabled the preliminary location of part of the binding site in gD to gB to the amino acids 240-260 portion and downstream with Thr(304)-Pro(305) as critical residues and of the binding site to gH/gL at the amino acids 260-310 portion with Pro(291)-Pro(292) as critical residues. The results indicate that gD carries composite-independent binding sites for gB and gH/gL, both of which are partly located in the profusion domain.	[Gianni, Tatiana; Amasio, Michele; Campadelli-Fiume, Gabriella] Univ Bologna, Dept Expt Pathol, Sect Microbiol & Virol, I-40126 Bologna, Italy	University of Bologna	Campadelli-Fiume, G (corresponding author), Univ Bologna, Dept Expt Pathol, Sect Microbiol & Virol, Via San Giacomo 12, I-40126 Bologna, Italy.	gabriella.campadelli@unibo.it		Campadelli-Fiume, Gabriella/0000-0002-6012-6081; GIANNI, TATIANA/0000-0003-1946-2064	TargetHerpes European Union Grant [LSHG-CT-2006-037517]; Fondi Pallotti; Progetti di Ricerca di Interesse Nazionale; Ministero dell'Istruzione Universita e Ricerca; University of Bologna Ricerca Fondamentale Orientata	TargetHerpes European Union Grant; Fondi Pallotti; Progetti di Ricerca di Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Ministero dell'Istruzione Universita e Ricerca(Ministry of Education, Universities and Research (MIUR)); University of Bologna Ricerca Fondamentale Orientata	This work was supported by TargetHerpes European Union Grant LSHG-CT-2006-037517 (we specifically acknowledge the contribution of IBA GmbH) and by our department through Fondi Pallotti, by Progetti di Ricerca di Interesse Nazionale, Ministero dell'Istruzione Universita e Ricerca, and by a University of Bologna Ricerca Fondamentale Orientata grant.	Atanasiu D, 2007, P NATL ACAD SCI USA, V104, P18718, DOI 10.1073/pnas.0707452104; Avitabile E, 2003, J VIROL, V77, P6836, DOI 10.1128/JVI.77.12.6836-6844.2003; Avitabile E, 2007, J VIROL, V81, P11532, DOI 10.1128/JVI.01343-07; BAINES JD, 1993, J VIROL, V67, P1441, DOI 10.1128/JVI.67.3.1441-1452.1993; BRANDIMARTI R, 1994, P NATL ACAD SCI USA, V91, P5406, DOI 10.1073/pnas.91.12.5406; Browne H, 2003, J GEN VIROL, V84, P1085, DOI 10.1099/vir.0.19039-0; CAI WH, 1987, J VIROL, V61, P714, DOI 10.1128/JVI.61.3.714-721.1987; Calistri A, 2007, J VIROL, V81, P11468, DOI 10.1128/JVI.01364-07; Campadelli-Fiume G, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P93; Campadelli-Fiume G, 2007, REV MED VIROL, V17, P313, DOI 10.1002/rmv.546; Carfi A, 2001, MOL CELL, V8, P169, DOI 10.1016/S1097-2765(01)00298-2; Cocchi F, 1998, J VIROL, V72, P9992, DOI 10.1128/JVI.72.12.9992-10002.1998; Cocchi F, 2004, P NATL ACAD SCI USA, V101, P7445, DOI 10.1073/pnas.0401883101; Cocchi F, 2004, J VIROL, V78, P4720, DOI 10.1128/JVI.78.9.4720-4729.2004; EJERCITO PM, 1968, J GEN VIROL, V2, P357, DOI 10.1099/0022-1317-2-3-357; Farnsworth A, 2007, P NATL ACAD SCI USA, V104, P10187, DOI 10.1073/pnas.0703790104; FORRESTER A, 1992, J VIROL, V66, P341, DOI 10.1128/JVI.66.1.341-348.1992; Fusco D, 2005, P NATL ACAD SCI USA, V102, P9323, DOI 10.1073/pnas.0503907102; Galdiero S, 2005, J BIOL CHEM, V280, P28632, DOI 10.1074/jbc.M505196200; Galdiero S, 2006, J GEN VIROL, V87, P1085, DOI 10.1099/vir.0.81794-0; Galdiero S, 2008, J BIOL CHEM, V283, P29993, DOI 10.1074/jbc.M803092200; Galdiero S, 2008, PEPTIDES, V29, P1461, DOI 10.1016/j.peptides.2008.04.022; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Gianni T, 2006, J VIROL, V80, P2216, DOI 10.1128/JVI.80.5.2216-2224.2006; Gianni T, 2005, J VIROL, V79, P7042, DOI 10.1128/JVI.79.11.7042-7049.2005; Gianni T, 2005, J VIROL, V79, P2931, DOI 10.1128/JVI.79.5.2931-2940.2005; Gianni T, 2006, J VIROL, V80, P8190, DOI 10.1128/JVI.00504-06; Gillet L, 2007, J VIROL, V81, P13082, DOI 10.1128/JVI.01141-07; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Kirschner AN, 2007, J VIROL, V81, P9216, DOI 10.1128/JVI.00575-07; Krummenacher C, 2005, EMBO J, V24, P4144, DOI 10.1038/sj.emboj.7600875; Lazear E, 2008, J VIROL, V82, P700, DOI 10.1128/JVI.02192-07; LIGAS MW, 1988, J VIROL, V62, P1486, DOI 10.1128/JVI.62.5.1486-1494.1988; Markert JM, 2000, REV MED VIROL, V10, P17, DOI 10.1002/(SICI)1099-1654(200001/02)10:1<17::AID-RMV258>3.0.CO;2-G; Menotti L, 2002, VIROLOGY, V301, P6, DOI 10.1006/viro.2002.1620; Menotti L, 2008, J VIROL, V82, P10153, DOI 10.1128/JVI.01133-08; Milne RSB, 2003, J VIROL, V77, P8962, DOI 10.1128/JVI.77.16.8962-8972.2003; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; PARA MF, 1980, J VIROL, V34, P512, DOI 10.1128/JVI.34.2.512-520.1980; Patrone M, 2007, J VIROL, V81, P11479, DOI 10.1128/JVI.00788-07; Perez-Romero P, 2005, J VIROL, V79, P4540, DOI 10.1128/JVI.79.7.4540-4544.2005; Pertel PE, 2001, VIROLOGY, V279, P313, DOI 10.1006/viro.2000.0713; Rey FA, 2006, EMBO REP, V7, P1000, DOI 10.1038/sj.embor.7400807; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; ROOP C, 1993, J VIROL, V67, P2285, DOI 10.1128/JVI.67.4.2285-2297.1993; Rovero S, 2000, J IMMUNOL, V165, P5133, DOI 10.4049/jimmunol.165.9.5133; Satoh T, 2008, CELL, V132, P935, DOI 10.1016/j.cell.2008.01.043; SHOWALTER SD, 1981, INFECT IMMUN, V34, P684, DOI 10.1128/IAI.34.3.684-692.1981; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Stefan A, 1997, J VIROL, V71, P5758, DOI 10.1128/JVI.71.8.5758-5763.1997; STETAN A, 1999, J CLIN MICROBIOL, V37, P3980; Subramanian RP, 2007, P NATL ACAD SCI USA, V104, P2903, DOI 10.1073/pnas.0608374104; TORRISI MR, 1992, J VIROL, V66, P554, DOI 10.1128/JVI.66.1.554-561.1992; Turner A, 1998, J VIROL, V72, P873, DOI 10.1128/JVI.72.1.873-875.1998; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Zhou GY, 2007, P NATL ACAD SCI USA, V104, P4142, DOI 10.1073/pnas.0611565104; Zhou GY, 2000, J VIROL, V74, P11782, DOI 10.1128/JVI.74.24.11782-11791.2000	58	81	88	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17370	17382		10.1074/jbc.M109.005728	http://dx.doi.org/10.1074/jbc.M109.005728			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19386594	Green Published, hybrid			2022-12-25	WOS:000267202500003
J	Sun, Q; Ming, L; Thomas, SM; Wang, Y; Chen, ZG; Ferris, RL; Grandis, JR; Zhang, L; Yu, J				Sun, Q.; Ming, L.; Thomas, S. M.; Wang, Y.; Chen, Z. G.; Ferris, R. L.; Grandis, J. R.; Zhang, L.; Yu, J.			PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells	ONCOGENE			English	Article						PUMA; EGFR-TKI; p73; apoptosis; PI3K/AKT; head and neck cancer	BH3-ONLY PROTEINS; CARCINOMA; GROWTH; EXPRESSION; P53; INDUCTION; P63; (-)-GOSSYPOL; GEFITINIB; DISCOVERY	Overexpression of epidermal growth factor receptor (EGFR) is found in over 80% of head and neck squamous cell carcinomas (HNSCC) and associated with poor clinical outcomes. EFGR selective tyrosine kinase inhibitors (TKIs) or antibodies have recently emerged as promising treatments for solid tumors, including HNSCC, though the response rate to these agents is low. p53 upregulated modulator of apoptosis (PUMA), a BH3-only Bcl-2 family protein, is required for apoptosis induced by p53 and various chemotherapeutic agents. In this study, we show that PUMA induction is correlated with EGFR-TKI sensitivity, and is mediated through the p53 family protein p73 beta and inhibition of the PI3K/AKT pathway. In some HNSCC cells, the gefitinib-induced degradation of oncogenic Delta Np63 seems to facilitate p73-mediated PUMA transcription. Inhibiting PUMA expression by small hairpin RNA (shRNA) impairs gefitinib-induced apoptosis. Furthermore, PUMA or BH3 mimetics sensitize HNSCC cells to gefitinib-induced apoptosis. Our results suggest that PUMA induction through p73 represents a new mechanism of EGFR inhibitor-induced apoptosis, and provide potential ways for enhancing and predicting the sensitivity to EGFR-targeted therapies in HNSCC. Oncogene (2009) 28, 2348-2357; doi:10.1038/onc.2009.108; published online 4 May 2009	[Sun, Q.; Ming, L.; Yu, J.] Univ Pittsburgh, Dept Pathol, Hillman Canc Ctr, Inst Canc, Pittsburgh, PA 15213 USA; [Thomas, S. M.; Ferris, R. L.; Grandis, J. R.] Univ Pittsburgh, Dept Otolaryngol, Hillman Canc Ctr, Inst Canc, Pittsburgh, PA 15213 USA; [Wang, Y.] Univ Pittsburgh, Dept Biostat, Hillman Canc Ctr, Inst Canc, Pittsburgh, PA 15213 USA; [Chen, Z. G.] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Grandis, J. R.; Zhang, L.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Hillman Canc Ctr, Inst Canc, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Emory University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yu, J (corresponding author), Univ Pittsburgh, Dept Pathol, Hillman Canc Ctr, Inst Canc, Suite 2-26H,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	yuj2@upmc.edu	Yu, Jian/A-8301-2009; Zhang, Lin/A-7389-2009; Thomas, Sufi Mary/AFR-1642-2022; Thomas, Sufi/O-1487-2018	Yu, Jian/0000-0002-4021-1000; Zhang, Lin/0000-0003-0018-3903; Thomas, Sufi Mary/0000-0001-5370-0842; Thomas, Sufi/0000-0001-5370-0842	NIH [CA129829, P50CA097190, CA106348, CA121105]; American Cancer Society [RSG-07-156-01-CNE]; NATIONAL CANCER INSTITUTE [R01CA121105, R01CA129829, P50CA097190, R01CA106348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085570] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank other members of our laboratories for helpful discussion and advice. We also thank Drs Cary Wu, Susanne M Gollin (University of Pittsburgh), Bert Vogelstein (HHMI and Sidney Kimmel Cancer Center at Johns Hopkins), David Sidransky (Sidney Kimmel Cancer Center at Johns Hopkins), and Carol Prives (Columbia University) for reagents. This work is supported in part by NIH grant CA129829, P50CA097190 (Head and Neck SPORE career development award) and those from ACGT and FAMRI (J Yu), and by NIH grants CA106348, CA121105, and American Cancer Society grant RSG-07-156-01-CNE (L Zhang).	Barbieri CE, 2006, EXP CELL RES, V312, P695, DOI 10.1016/j.yexcr.2005.11.028; Barbieri CE, 2003, J BIOL CHEM, V278, P51408, DOI 10.1074/jbc.M309943200; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Choong NW, 2006, CRIT REV ONCOL HEMAT, V57, P25, DOI 10.1016/j.critrevonc.2005.06.002; Chun PY, 2006, CANCER RES, V66, P981, DOI 10.1158/0008-5472.CAN-05-2665; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang CS, 1997, J BIOL CHEM, V272, P4187, DOI 10.1074/jbc.272.7.4187; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Karst AM, 2005, ONCOGENE, V24, P1111, DOI 10.1038/sj.onc.1208374; Kitada S, 2003, J MED CHEM, V46, P4259, DOI 10.1021/jm030190z; Labi V, 2006, CELL DEATH DIFFER, V13, P1325, DOI 10.1038/sj.cdd.4401940; Liu B, 2000, BRIT J CANCER, V82, P1991; Matheny KE, 2003, LARYNGOSCOPE, V113, P936, DOI 10.1097/00005537-200306000-00004; Ming LH, 2008, CARCINOGENESIS, V29, P1878, DOI 10.1093/carcin/bgn150; Muller S, 2008, CANCER-AM CANCER SOC, V113, P97, DOI 10.1002/cncr.23557; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oliver CL, 2004, CLIN CANCER RES, V10, P7757, DOI 10.1158/1078-0432.CCR-04-0551; PIETENPOL JA, 1994, CANCER RES, V54, P3714; Qiu W, 2008, CELL STEM CELL, V2, P576, DOI 10.1016/j.stem.2008.03.009; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Sun Q, 2007, MOL CANCER THER, V6, P3180, DOI 10.1158/1535-7163.MCT-07-0265; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wang GP, 2006, J MED CHEM, V49, P6139, DOI 10.1021/jm060460o; Wang HJ, 2006, CANCER BIOL THER, V5, P380, DOI 10.4161/cbt.5.4.2477; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; Wang P, 2007, P NATL ACAD SCI USA, V104, P4054, DOI 10.1073/pnas.0700020104; Wolter KG, 2006, NEOPLASIA, V8, P163, DOI 10.1593/neo.05691; Wu B, 2007, GUT, V56, P645, DOI 10.1136/gut.2006.101683; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Yu J, 2007, ONCOGENE, V26, P4189, DOI 10.1038/sj.onc.1210196; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu J, 2006, CLIN CANCER RES, V12, P2928, DOI 10.1158/1078-0432.CCR-05-2429; Yu J, 2004, CURR OPIN ONCOL, V16, P19, DOI 10.1097/00001622-200401000-00005; Yu J, 2003, CANCER CELL, V4, P248, DOI 10.1016/S1535-6108(03)00249-6; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zhang L, 2007, DRUG RESIST UPDATE, V10, P207, DOI 10.1016/j.drup.2007.08.002	45	55	64	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2009	28	24					2348	2357		10.1038/onc.2009.108	http://dx.doi.org/10.1038/onc.2009.108			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	459GJ	19421143	Green Accepted			2022-12-25	WOS:000267089100005
J	Pei, AN; Nossa, CW; Chokshi, P; Blaser, MJ; Yang, LY; Rosmarin, DM; Pei, ZH				Pei, Anna; Nossa, Carlos W.; Chokshi, Pooja; Blaser, Martin J.; Yang, Liying; Rosmarin, David M.; Pei, Zhiheng			Diversity of 23S rRNA Genes within Individual Prokaryotic Genomes	PLOS ONE			English	Article							SECONDARY-STRUCTURE; CONCERTED EVOLUTION; SEQUENCE; 16S; CONVERSION; BACTERIA; DATABASE; OPERONS; STRAIN; SPACER	Background: The concept of ribosomal constraints on rRNA genes is deduced primarily based on the comparison of consensus rRNA sequences between closely related species, but recent advances in whole-genome sequencing allow evaluation of this concept within organisms with multiple rRNA operons. Methodology/Principal Findings: Using the 23S rRNA gene as an example, we analyzed the diversity among individual rRNA genes within a genome. Of 184 prokaryotic species containing multiple 23S rRNA genes, diversity was observed in 113 (61.4%) genomes (mean 0.40%, range 0.01%- 4.04%). Significant (1.17%-4.04%) intragenomic variation was found in 8 species. In 5 of the 8 species, the diversity in the primary structure had only minimal effect on the secondary structure (stem versus loop transition). In the remaining 3 species, the diversity significantly altered local secondary structure, but the alteration appears minimized through complex rearrangement. Intervening sequences (IVS), ranging between 9 and 1471 nt in size, were found in 7 species. IVS in Deinococcus radiodurans and Nostoc sp. encode transposases. T. tengcongensis was the only species in which intragenomic diversity > 3% was observed among 4 paralogous 23S rRNA genes. Conclusions/Significance: These findings indicate tight ribosomal constraints on individual 23S rRNA genes within a genome. Although classification using primary 23S rRNA sequences could be erroneous, significant diversity among paralogous 23S rRNA genes was observed only once in the 184 species analyzed, indicating little overall impact on the mainstream of 23S rRNA gene-based prokaryotic taxonomy.			Pei, ZH (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10003 USA.	zhiheng.pei@nyumc.org		Yang, Liying/0000-0003-1442-4915; Pei, Zhiheng/0000-0001-8570-6747	NATIONAL CANCER INSTITUTE [R01CA097946, UH2CA140233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063477] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA097946, R01 CA97946, UH2 CA140233] Funding Source: Medline; NIAID NIH HHS [R01 AI063477] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Asai T, 1999, P NATL ACAD SCI USA, V96, P1971, DOI 10.1073/pnas.96.5.1971; Bao QY, 2002, GENOME RES, V12, P689, DOI 10.1101/gr.219302; BURGIN AB, 1990, CELL, V60, P405, DOI 10.1016/0092-8674(90)90592-3; CEDERGREN R, 1988, J MOL EVOL, V28, P98, DOI 10.1007/BF02143501; Coenye T, 2003, FEMS MICROBIOL LETT, V228, P45, DOI 10.1016/S0378-1097(03)00717-1; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; CURTISS WC, 1984, J MOL EVOL, V20, P351, DOI 10.1007/BF02104741; DeRijk P, 1997, NUCLEIC ACIDS RES, V25, P4679, DOI 10.1093/nar/25.22.4679; DERIJK P, 1995, J MOL EVOL, V41, P366, DOI 10.1007/BF01215184; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Evguenieva-Hackenberg E, 2005, MOL MICROBIOL, V57, P318, DOI 10.1111/j.1365-2958.2005.04662.x; Gurtler V, 1999, GENE, V238, P241, DOI 10.1016/S0378-1119(99)00224-3; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; Harrington CS, 1999, INT J SYST BACTERIOL, V49, P1171, DOI 10.1099/00207713-49-3-1171; Higgs PG, 1998, GENETICA, V102-3, P91, DOI 10.1023/A:1017059530664; HORI H, 1986, BIOSYSTEMS, V19, P163, DOI 10.1016/0303-2647(86)90037-7; Hunt DE, 2006, APPL ENVIRON MICROB, V72, P2221, DOI 10.1128/AEM.72.3.2221-2225.2006; Kaneko T, 2001, DNA RES, V8, P205, DOI 10.1093/dnares/8.5.205; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Liao DQ, 2000, J MOL EVOL, V51, P305, DOI 10.1007/s002390010093; LUDWIG W, 1994, FEMS MICROBIOL REV, V15, P155, DOI 10.1111/j.1574-6976.1994.tb00132.x; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mattatall NR, 1996, J BACTERIOL, V178, P2272, DOI 10.1128/jb.178.8.2272-2278.1996; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Oberreuter H, 2002, MICROBIOL-SGM, V148, P1523, DOI 10.1099/00221287-148-5-1523; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Relman DA, 1999, SCIENCE, V284, P1308, DOI 10.1126/science.284.5418.1308; Santoyo G, 2005, FEMS MICROBIOL REV, V29, P169, DOI 10.1016/j.femsre.2004.10.004; Schlunzen F, 2001, NATURE, V413, P814, DOI 10.1038/35101544; STACKEBRANDT E, 1994, TAXONOMIC NOTE PLACE, P846; Stewart FJ, 2007, J MOL EVOL, V65, P44, DOI 10.1007/s00239-006-0235-3; STIEGLER P, 1981, EUR J BIOCHEM, V120, P487, DOI 10.1111/j.1432-1033.1981.tb05727.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vandamme P, 2000, J CLIN MICROBIOL, V38, P2261; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804; Wuyts J, 2001, NUCLEIC ACIDS RES, V29, P5017, DOI 10.1093/nar/29.24.5017; Yokoyama T, 2008, NUCLEIC ACIDS RES, V36, P3539, DOI 10.1093/nar/gkn224; ZWIEB C, 1981, NUCLEIC ACIDS RES, V9, P3621, DOI 10.1093/nar/9.15.3621	47	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2009	4	5							e5437	10.1371/journal.pone.0005437	http://dx.doi.org/10.1371/journal.pone.0005437			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JE	19415112	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000265836700010
J	Kauer, M; Ban, J; Kofler, R; Walker, B; Davis, S; Meltzer, P; Kovar, H				Kauer, Maximilian; Ban, Jozef; Kofler, Reinhard; Walker, Bob; Davis, Sean; Meltzer, Paul; Kovar, Heinrich			A Molecular Function Map of Ewing's Sarcoma	PLOS ONE			English	Article								Background: EWS-FLI1 is a chimeric ETS transcription factor that is, due to a chromosomal rearrangement, specifically expressed in Ewing's sarcoma family tumors (ESFT) and is thought to initiate the development of the disease. Previous genomic profiling experiments have identified EWS-FLI1-regulated genes and genes that discriminate ESFT from other sarcomas, but so far a comprehensive analysis of EWS-FLI1-dependent molecular functions characterizing this aggressive cancer is lacking. Methodology/Principal Findings: In this study, a molecular function map of ESFT was constructed based on an integrative analysis of gene expression profiling experiments following EWS-FLI1 knockdown in a panel of five ESFT cell lines, and on gene expression data from the same platform of 59 primary ESFT. Out of 80 normal tissues tested, mesenchymal progenitor cells (MPC) were found to fit the hypothesis that EWS-FLI1 is the driving transcriptional force in ESFT best and were therefore used as the reference tissue for the construction of the molecular function map. The interrelations of molecular pathways were visualized by measuring the similarity among annotated gene functions by gene sharing. The molecular function map highlighted distinct clusters of activities for EWS-FLI1 regulated genes in ESFT and revealed a striking difference between EWS-FLI1 up-and down-regulated genes: EWS-FLI1 induced genes mainly belong to cell cycle regulation, proliferation, and response to DNA damage, while repressed genes were associated with differentiation and cell communication. Conclusions/Significance: This study revealed that EWS-FLI1 combines by distinct molecular mechanisms two important functions of cellular transformation in one protein, growth promotion and differentiation blockage. By taking MPC as a reference tissue, a significant EWS-FLI1 signature was discovered in ESFT that only partially overlapped with previously published EWS-FLI1-dependent gene expression patterns, identifying a series of novel targets for the chimeric protein in ESFT. Our results may guide target selection for future ESFT specific therapies.			Kauer, M (corresponding author), St Anna Childrens Hosp, Childrens Canc Res Inst, Kinderspitalgasse 6, A-1090 Vienna, Austria.	heinrich.kovar@ccri.at	Davis, Sean/AAD-1801-2021	Davis, Sean/0000-0002-8991-6458; Walker, Robert/0000-0001-8235-4686; Kovar, Heinrich/0000-0001-6873-9109	Austrian Science Fund FWF [P 18046] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010759] Funding Source: NIH RePORTER	Austrian Science Fund FWF(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abaan OD, 2005, ONCOGENE, V24, P2715, DOI 10.1038/sj.onc.1208247; BAILLY RA, 1994, MOL CELL BIOL, V14, P3230, DOI 10.1128/MCB.14.5.3230; Baird K, 2005, CANCER RES, V65, P9226, DOI 10.1158/0008-5472.CAN-05-1699; Ban J, 2008, CANCER RES, V68, P7100, DOI 10.1158/0008-5472.CAN-07-6145; Bernstein M, 2006, ONCOLOGIST, V11, P503, DOI 10.1634/theoncologist.11-5-503; Boquest AC, 2006, METH MOL B, V325, P35; Braunreiter CL, 2006, CELL CYCLE, V5, P2753, DOI 10.4161/cc.5.23.3505; Cherian MG, 2003, MUTAT RES-FUND MOL M, V533, P201, DOI 10.1016/j.mrfmmm.2003.07.013; Cheung IY, 2007, CLIN CANCER RES, V13, P6978, DOI 10.1158/1078-0432.CCR-07-1417; Cironi L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002634; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Deneen B, 2003, CANCER RES, V63, P4268; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dziegiel Piotr, 2004, Polish Journal of Pathology, V55, P3; Endo Y, 2008, MOL CELL BIOL, V28, P2368, DOI 10.1128/MCB.01780-07; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hahm KB, 1999, NAT GENET, V23, P222, DOI 10.1038/13854; Hancock JD, 2008, CELL CYCLE, V7, P250, DOI 10.4161/cc.7.2.5229; Hattinger CM, 2002, BRIT J CANCER, V86, P1763, DOI 10.1038/sj.bjc.6600332; Henderson SR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r76; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Hu-Lieskovan S, 2005, CANCER RES, V65, P4633, DOI 10.1158/0008-5472.CAN-04-2857; Kikuchi R, 2007, ONCOGENE, V26, P1802, DOI 10.1038/sj.onc.1209973; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Kovar H, 1997, ONCOGENE, V15, P2225, DOI 10.1038/sj.onc.1201397; Kovar H, 2005, SEMIN CANCER BIOL, V15, P189, DOI 10.1016/j.semcancer.2005.01.004; KOVAR H, 1993, ONCOGENE, V8, P2683; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; Mendiola M, 2006, INT J CANCER, V118, P1381, DOI 10.1002/ijc.21578; Miyagawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004634; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nishimori H, 2002, ONCOGENE, V21, P8302, DOI 10.1038/sj.onc.1206025; Potikyan G, 2008, LAB INVEST, V88, P1291, DOI 10.1038/labinvest.2008.99; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Schaefer KL, 2008, EUR J CANCER, V44, P699, DOI 10.1016/j.ejca.2008.01.020; Siligan C, 2005, ONCOGENE, V24, P2512, DOI 10.1038/sj.onc.1208455; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Staege MS, 2004, CANCER RES, V64, P8213, DOI 10.1158/0008-5472.CAN-03-4059; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi A, 2003, CANCER RES, V63, P8338; Tirado OM, 2006, CANCER RES, V66, P9937, DOI 10.1158/0008-5472.CAN-06-0927; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Uren Aykut, 2005, Future Oncol, V1, P521, DOI 10.2217/14796694.1.4.521; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yeny CT, 2005, CANCER RES, V65, P8698, DOI 10.1158/0008-5472.CAN-05-1704; Zilliox MJ, 2007, NAT METHODS, V4, P911, DOI 10.1038/NMETH1102; Zwerner JP, 2003, EXP CELL RES, V290, P414, DOI 10.1016/S0014-4827(03)00371-9; Zwerner JP, 2001, ONCOGENE, V20, P626, DOI 10.1038/sj.onc.1204133	53	118	127	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5415	10.1371/journal.pone.0005415	http://dx.doi.org/10.1371/journal.pone.0005415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404404	Green Submitted, Green Published, gold			2022-12-25	WOS:000265614900024
J	Koo, QY; Khan, AM; Jung, KO; Ramdas, S; Miotto, O; Tan, TW; Brusic, V; Salmon, J; August, JT				Koo, Qi Ying; Khan, Asif M.; Jung, Keun-Ok; Ramdas, Shweta; Miotto, Olivo; Tan, Tin Wee; Brusic, Vladimir; Salmon, Jerome; August, J. Thomas			Conservation and Variability of West Nile Virus Proteins	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MHC CLASS-I; COMPUTATIONAL SYSTEM; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; INFLUENZA-A; EPITOPE; BINDING; DENGUE; POLYMERASE	West Nile virus (WNV) has emerged globally as an increasingly important pathogen for humans and domestic animals. Studies of the evolutionary diversity of the virus over its known history will help to elucidate conserved sites, and characterize their correspondence to other pathogens and their relevance to the immune system. We describe a large-scale analysis of the entire WNV proteome, aimed at identifying and characterizing evolutionarily conserved amino acid sequences. This study, which used 2,746 WNV protein sequences collected from the NCBI GenPept database, focused on analysis of peptides of length 9 amino acids or more, which are immunologically relevant as potential T-cell epitopes. Entropy-based analysis of the diversity of WNV sequences, revealed the presence of numerous evolutionarily stable nonamer positions across the proteome (entropy value of <= 1). The representation (frequency) of nonamers variant to the predominant peptide at these stable positions was, generally, low (<= 10% of the WNV sequences analyzed). Eighty-eight fragments of length 9-29 amino acids, representing similar to 34% of the WNV polyprotein length, were identified to be identical and evolutionarily stable in all analyzed WNV sequences. Of the 88 completely conserved sequences, 67 are also present in other flaviviruses, and several have been associated with the functional and structural properties of viral proteins. Immunoinformatic analysis revealed that the majority (78/88) of conserved sequences are potentially immunogenic, while 44 contained experimentally confirmed human T-cell epitopes. This study identified a comprehensive catalogue of completely conserved WNV sequences, many of which are shared by other flaviviruses, and majority are potential epitopes. The complete conservation of these immunologically relevant sequences through the entire recorded WNV history suggests they will be valuable as components of peptide-specific vaccines or other therapeutic applications, for sequence-specific diagnosis of a wide-range of Flavivivirus infections, and for studies of homologous sequences among other flaviviruses.			Koo, QY (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	taugust@jhmi.edu	Khan, M. Asif/ABE-7839-2021; Brusic, Vladimir/B-1478-2008; Tan, Tin Wee/B-8963-2009; Ramdas, Shweta/J-7712-2019; Khan, Mohammad Asif/F-4663-2010; Miotto, Olivo/AAE-7124-2019	Khan, M. Asif/0000-0001-9202-279X; Brusic, Vladimir/0000-0003-0523-5266; Tan, Tin Wee/0000-0002-4062-2854; Ramdas, Shweta/0000-0001-8888-4661; Khan, Mohammad Asif/0000-0001-9202-279X; Miotto, Olivo/0000-0001-8060-6771; Jung, Keunok/0000-0003-2967-8432	PHS HHS [HHSN266200400085C] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bian HJ, 2004, METHODS, V34, P468, DOI 10.1016/j.ymeth.2004.06.002; Biswas T, 2005, NATURE, V435, P1059, DOI 10.1038/nature03657; Bondre VP, 2007, J GEN VIROL, V88, P875, DOI 10.1099/vir.0.82403-0; Brien JD, 2007, EUR J IMMUNOL, V37, P1855, DOI 10.1002/eji.200737196; Bui HH, 2005, IMMUNOGENETICS, V57, P304, DOI 10.1007/s00251-005-0798-y; Cheng Y, 2004, J INFECT DIS, V189, P658, DOI 10.1086/381501; Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; De Groot AS, 2001, EMERG INFECT DIS, V7, P706; Domingo E, 1997, BIOL TRACE ELEM RES, V56, P23, DOI 10.1007/BF02778981; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elena SF, 2006, EMBO REP, V7, P168, DOI 10.1038/sj.embor.7400636; Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073; Freeman S., 2003, BIOL SCI; Gottesman ME, 2004, MICROBIOL MOL BIOL R, V68, P796, DOI 10.1128/MMBR.68.4.796-813.2004; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Heiny AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001190; Horga MA, 2001, PEDIATR INFECT DIS J, V20, P801, DOI 10.1097/00006454-200108000-00016; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Feito MJ, 2008, VIRUS RES, V135, P166, DOI 10.1016/j.virusres.2008.03.008; Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06; Khan AM, 2006, CELL IMMUNOL, V244, P141, DOI 10.1016/j.cellimm.2007.02.005; Khan AM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000272; KURANE I, 1995, J GEN VIROL, V76, P2243, DOI 10.1099/0022-1317-76-9-2243; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Lanteri MC, 2008, J INFECT DIS, V197, P1296, DOI 10.1086/586898; Larsen MV, 2005, EUR J IMMUNOL, V35, P2295, DOI 10.1002/eji.200425811; Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999; Mackenzie JM, 2007, J GEN VIROL, V88, P1163, DOI 10.1099/vir.0.82552-0; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; Marfin AA, 2001, EMERG INFECT DIS, V7, P730; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Miotto O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S18; Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316; O'Donovan Claire, 2002, Brief Bioinform, V3, P275; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Petersen LR, 2001, EMERG INFECT DIS, V7, P611; Petersen LR, 2003, JAMA-J AM MED ASSOC, V290, P524, DOI 10.1001/jama.290.4.524; Purtha WE, 2007, EUR J IMMUNOL, V37, P1845, DOI 10.1002/eji.200737192; RAMMENSEE HG, 1995, CURR OPIN IMMUNOL, V7, P85, DOI 10.1016/0952-7915(95)80033-6; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shrestha B, 2006, J VIROL, V80, P5338, DOI 10.1128/JVI.00274-06; SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; Wang Y, 2003, J VIROL, V77, P13323, DOI [10.1128/JVI.77.24.13323-13334.2003, 10.1128/JVi.77.24.13323-13334.2003]; Wheeler DL, 2005, NUCLEIC ACIDS RES, V33, pD39, DOI 10.1093/nar/gki062; Zhang GL, 2005, NUCLEIC ACIDS RES, V33, pW172, DOI 10.1093/nar/gki452; Zhang GL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S19	52	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5352	10.1371/journal.pone.0005352	http://dx.doi.org/10.1371/journal.pone.0005352			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401763	Green Submitted, Green Published, gold			2022-12-25	WOS:000265601100008
J	Leotard, G; Debout, G; Dalecky, A; Guillot, S; Gaume, L; Mckey, D; Kjellberg, F				Leotard, Guillaume; Debout, Gabriel; Dalecky, Ambroise; Guillot, Sylvain; Gaume, Laurence; Mckey, Doyle; Kjellberg, Finn			Range Expansion Drives Dispersal Evolution In An Equatorial Three-Species Symbiosis	PLOS ONE			English	Article							ANT PETALOMYRMEX-PHYLAX; GENETIC CONSEQUENCES; LEONARDOXA-AFRICANA; F-STATISTICS; PLANT-ANTS; CLIMATE; PHYLOGEOGRAPHY; COLONIZATION; OSCILLATIONS; POLYMORPHISM	Background: Recurrent climatic oscillations have produced dramatic changes in species distributions. This process has been proposed to be a major evolutionary force, shaping many life history traits of species, and to govern global patterns of biodiversity at different scales. During range expansions selection may favor the evolution of higher dispersal, and symbiotic interactions may be affected. It has been argued that a weakness of climate fluctuation-driven range dynamics at equatorial latitudes has facilitated the persistence there of more specialized species and interactions. However, how much the biology and ecology of species is changed by range dynamics has seldom been investigated, particularly in equatorial regions. Methodology/Principal Findings: We studied a three-species symbiosis endemic to coastal equatorial rainforests in Cameroon, where the impact of range dynamics is supposed to be limited, comprised of two species-specific obligate mutualists - an ant-plant and its protective ant - and a species-specific ant parasite of this mutualism. We combined analyses of within-species genetic diversity and of phenotypic variation in a transect at the southern range limit of this ant-plant system. All three species present congruent genetic signatures of recent gradual southward expansion, a result compatible with available regional paleoclimatic data. As predicted, this expansion has been accompanied by the evolution of more dispersive traits in the two ant species. In contrast, we detected no evidence of change in lifetime reproductive strategy in the tree, nor in its investment in food resources provided to its symbiotic ants. Conclusions/Significance: Despite the decreasing investment in protective workers and the increasing investment in dispersing females by both the mutualistic and the parasitic ant species, there was no evidence of destabilization of the symbiosis at the colonization front. To our knowledge, we provide here the first evidence at equatorial latitudes that biological traits associated with dispersal are affected by the range expansion dynamics of a set of interacting species.			Leotard, G (corresponding author), CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34033 Montpellier, France.	ambroise.dalecky@ird.fr	Kjellberg, Finn/S-3281-2019; Dalecky, Ambroise/AAF-9578-2021	Kjellberg, Finn/0000-0001-6708-9538; Dalecky, Ambroise/0000-0002-5075-4121				Austerlitz F, 2000, GENETICS, V154, P1309; BERGER A, 1988, REV GEOPHYS, V26, P624, DOI 10.1029/RG026i004p00624; Bernasconi G, 1998, BEHAV ECOL, V9, P478, DOI 10.1093/beheco/9.5.478; BORN C, 2007, THESIS U MONTPELLIER; Bowie RCK, 2006, MOL PHYLOGENET EVOL, V38, P171, DOI 10.1016/j.ympev.2005.06.001; Brochmann C, 2003, TAXON, V52, P417, DOI 10.2307/3647444; Bush MB, 2004, SCIENCE, V303, P827, DOI 10.1126/science.1090795; Castric V, 2003, GENETICS, V163, P983; Cody ML, 1996, J ECOL, V84, P53, DOI 10.2307/2261699; Cruzan MB, 2000, TRENDS ECOL EVOL, V15, P491, DOI 10.1016/S0169-5347(00)01998-4; CWYNAR LC, 1987, AM NAT, V129, P463, DOI 10.1086/284651; Dalecky A, 2005, BIOL J LINN SOC, V86, P133, DOI 10.1111/j.1095-8312.2005.00524.x; Dalecky A, 2007, EVOLUTION, V61, P579, DOI 10.1111/j.1558-5646.2007.00044.x; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Debout G, 2005, INSECT SOC, V52, P205, DOI 10.1007/s00040-004-0795-4; DEBOUT G, 2003, THESIS U MONTPELLIER; DEBOUT GDG, 2009, OIKOS IN PRESS; Delegue MA, 2001, OECOLOGIA, V129, P106, DOI 10.1007/s004420100696; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Espadaler X, 2001, INSECT SOC, V48, P159, DOI 10.1007/PL00001760; Estoup A, 1998, NATO ADV SCI I A-LIF, V306, P55; Gaume L, 2005, EVOL ECOL RES, V7, P435; Gaume L, 1999, OIKOS, V84, P130, DOI 10.2307/3546873; Gaume L, 1997, OECOLOGIA, V112, P209, DOI 10.1007/s004420050302; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Hampe A, 2000, ECOGRAPHY, V23, P603, DOI 10.1034/j.1600-0587.2000.230511.x; Hardy OJ, 2003, GENETICS, V163, P1467; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hewitt Godfrey M., 2004, Frontiers in Zoology, V1, P1, DOI 10.1186/1742-9994-1-4; Holldobler B., 1990, pi; Holmgren M, 2007, J BIOGEOGR, V34, P1100, DOI 10.1111/j.1365-2699.2006.01683.x; IMBRIE J, 1993, PALEOCEANOGRAPHY, V8, P699, DOI 10.1029/93PA02751; Jablonski D, 2008, EVOLUTION, V62, P715, DOI 10.1111/j.1558-5646.2008.00317.x; Jansson R, 2002, ANNU REV ECOL SYST, V33, P741, DOI 10.1146/annurev.ecolsys.33.010802.150520; Johnson RA, 2002, OECOLOGIA, V132, P60, DOI 10.1007/s00442-002-0960-2; Kebede M, 2007, MOL ECOL, V16, P1233, DOI 10.1111/j.1365-294X.2007.03232.x; Kimmel M, 1998, GENETICS, V148, P1921; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Leger EA, 2003, ECOL LETT, V6, P257, DOI 10.1046/j.1461-0248.2003.00423.x; Leotard G, 2008, J EVOLUTION BIOL, V21, P1133, DOI 10.1111/j.1420-9101.2008.01521.x; Maley J, 2002, IDS BULL-I DEV STUD, V33, P13, DOI 10.1111/j.1759-5436.2002.tb00003.x; Maley J, 1998, REV PALAEOBOT PALYNO, V99, P157, DOI 10.1016/S0034-6667(97)00047-X; MCKEY D, 1984, BIOTROPICA, V16, P81, DOI 10.2307/2387840; McKey Doyle B., 2000, Adansonia (Paris), V22, P71; MINTZER AC, 1987, INSECT SOC, V34, P108, DOI 10.1007/BF02223829; Nei M., 1987, MOL EVOLUTIONARY GEN; Ngomanda A, 2005, HOLOCENE, V15, P1021, DOI 10.1191/0959683605hl875ra; Nieberding CM, 2007, TRENDS ECOL EVOL, V22, P156, DOI 10.1016/j.tree.2006.11.012; Niemela Jari, 1999, Diversity and Distributions, V5, P121, DOI 10.1046/j.1472-4642.1999.00048.x; Phillips BL, 2006, NATURE, V439, P803, DOI 10.1038/439803a; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Querouil S, 2003, MOL PHYLOGENET EVOL, V28, P24, DOI 10.1016/S1055-7903(03)00027-7; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reich DE, 1998, P NATL ACAD SCI USA, V95, P11026; Richardson DHS, 1999, MYCOL RES, V103, P641, DOI 10.1017/S0953756298008259; ROSS KG, 1995, ANNU REV ECOL SYST, V26, P631, DOI 10.1146/annurev.es.26.110195.003215; Rousset F, 1997, GENETICS, V145, P1219; Roy K, 1996, TRENDS ECOL EVOL, V11, P458, DOI 10.1016/0169-5347(96)10054-9; Ruppell O, 1999, INSECT SOC, V46, P6, DOI 10.1007/s000400050106; Simmons AD, 2004, AM NAT, V164, P378, DOI 10.1086/423430; Smith TB, 2000, MOL ECOL, V9, P1505, DOI 10.1046/j.1365-294x.2000.01032.x; *SPSS I, 1998, SYSTAT 9 STAT; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Telfer PT, 2003, MOL ECOL, V12, P2019, DOI 10.1046/j.1365-294X.2003.01877.x; Travis JMJ, 2002, EVOL ECOL RES, V4, P1119; Tschinkel Walter R., 2002, Journal of Insect Science (Tucson), V2, P1; Vincens A, 1999, J BIOGEOGR, V26, P879, DOI 10.1046/j.1365-2699.1999.00333.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239	74	45	45	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5377	10.1371/journal.pone.0005377	http://dx.doi.org/10.1371/journal.pone.0005377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401769	gold, Green Published, Green Submitted			2022-12-25	WOS:000265601100015
J	Zhong, BJ; Yonezawa, T; Zhong, Y; Hasegawa, M				Zhong, Bojian; Yonezawa, Takahiro; Zhong, Yang; Hasegawa, Masami			Episodic Evolution and Adaptation of Chloroplast Genomes in Ancestral Grasses	PLOS ONE			English	Article							NUCLEOTIDE SUBSTITUTION RATES; MONOCOT-DICOT DIVERGENCE; ORIGIN; TIMES; DIVERSIFICATION; PHYLOGENETICS; PATTERNS; SEQUENCE; SUPPORT; HISTORY	Background: It has been suggested that the chloroplast genomes of the grass family, Poaceae, have undergone an elevated evolutionary rate compared to most other angiosperms, yet the details of this phenomenon have remained obscure. To know how the rate change occurred during evolution, estimation of the time-scale with reliable calibrations is needed. The recent finding of 65 Ma grass phytoliths in Cretaceous dinosaur coprolites places the diversification of the grasses to the Cretaceous period, and provides a reliable calibration in studying the tempo and mode of grass chloroplast evolution. Methodology/Principal Findings: By using chloroplast genome data from angiosperms and by taking account of new paleontological evidence, we now show that episodic rate acceleration both in terms of non-synonymous and synonymous substitutions occurred in the common ancestral branch of the core Poaceae (a group formed by rice, wheat, maize, and their allies) accompanied by adaptive evolution in several chloroplast proteins, while the rate reverted to the slow rate typical of most monocot species in the terminal branches. Conclusions/Significance: Our finding of episodic rate acceleration in the ancestral grasses accompanied by adaptive molecular evolution has a profound bearing on the evolution of grasses, which form a highly successful group of plants. The widely used model for estimating divergence times was based on the assumption of correlated rates between ancestral and descendant lineages. However, the assumption is proved to be inadequate in approximating the episodic rate acceleration in the ancestral grasses, and the assumption of independent rates is more appropriate. This finding has implications for studies of molecular evolutionary rates and time-scale of evolution in other groups of organisms.			Zhong, BJ (corresponding author), Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China.	hasegawa@fudan.edu.cn	Zhong, Bojian/AAH-1236-2020	Zhong, Bojian/0000-0002-6496-7646; Yonezawa, Takahiro/0000-0002-0012-1887				Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Aris-Brosou S, 2003, MOL BIOL EVOL, V20, P1947, DOI 10.1093/molbev/msg226; BOUSQUET J, 1992, P NATL ACAD SCI USA, V89, P7844, DOI 10.1073/pnas.89.16.7844; Bremer K, 2002, EVOLUTION, V56, P1374, DOI 10.1111/j.0014-3820.2002.tb01451.x; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Erixon P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001386; GAUT BS, 1992, J MOL EVOL, V35, P292, DOI 10.1007/BF00161167; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Guisinger MM, 2008, P NATL ACAD SCI USA, V105, P18424, DOI 10.1073/pnas.0806759105; Hasegawa M, 2003, GENES GENET SYST, V78, P267, DOI 10.1266/ggs.78.267; Herendeen P.S., 1995, MONOCOTYLEDONS SYSTE, P1; Huelsenbeck JP, 2000, GENETICS, V154, P1879; Jacobs BF, 1999, ANN MO BOT GARD, V86, P590, DOI 10.2307/2666186; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Kitazoe Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000384; Leebens-Mack J, 2005, MOL BIOL EVOL, V22, P1948, DOI 10.1093/molbev/msi191; Lepage T, 2007, MOL BIOL EVOL, V24, P2669, DOI 10.1093/molbev/msm193; Linder HP, 2005, ANNU REV ECOL EVOL S, V36, P107, DOI 10.1146/annurev.ecolsys.36.102403.135635; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Martin W, 2005, TRENDS PLANT SCI, V10, P203, DOI 10.1016/j.tplants.2005.03.007; Matsuoka Y, 2002, MOL BIOL EVOL, V19, P2084, DOI 10.1093/oxfordjournals.molbev.a004033; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Muse SV, 1997, GENETICS, V146, P393; Nikaido M, 2001, P NATL ACAD SCI USA, V98, P7384, DOI 10.1073/pnas.121139198; Piperno DR, 2005, SCIENCE, V310, P1126, DOI 10.1126/science.1121020; Prasad V, 2005, SCIENCE, V310, P1177, DOI 10.1126/science.1118806; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; Renner SS, 2008, SYST BIOL, V57, P795, DOI 10.1080/10635150802422282; Sanderson MJ, 2004, AM J BOT, V91, P1656, DOI 10.3732/ajb.91.10.1656; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; YANG Z, 2006, COMPUTAIONAL MOL EVO; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoder AD, 2004, MOL ECOL, V13, P757, DOI 10.1046/j.1365-294X.2004.02106.x	45	40	41	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5297	10.1371/journal.pone.0005297	http://dx.doi.org/10.1371/journal.pone.0005297			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390686	Green Published, gold			2022-12-25	WOS:000265514400003
J	Dunshea, G				Dunshea, Glenn			DNA-Based Diet Analysis for Any Predator	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; GUT CONTENTS; PREY DNA; PCR; SOFTWARE; IDENTIFICATION; SEQUENCES; PRIMERS; RESTRICTION; PSEUDOGENES	Background: Prey DNA from diet samples can be used as a dietary marker; yet current methods for prey detection require a priori diet knowledge and/or are designed ad hoc, limiting their scope. I present a general approach to detect diverse prey in the feces or gut contents of predators. Methodology/Principal Findings: In the example outlined, I take advantage of the restriction site for the endonuclease Pac I which is present in 16S mtDNA of most Odontoceti mammals, but absent from most other relevant non-mammalian chordates and invertebrates. Thus in DNA extracted from feces of these mammalian predators Pac I will cleave and exclude predator DNA from a small region targeted by novel universal primers, while most prey DNA remain intact allowing prey selective PCR. The method was optimized using scat samples from captive bottlenose dolphins (Tursiops truncatus) fed a diet of 6-10 prey species from three phlya. Up to five prey from two phyla were detected in a single scat and all but one minor prey item (2% of the overall diet) were detected across all samples. The same method was applied to scat samples from free-ranging bottlenose dolphins; up to seven prey taxa were detected in a single scat and 13 prey taxa from eight teleost families were identified in total. Conclusions/Significance: Data and further examples are provided to facilitate rapid transfer of this approach to any predator. This methodology should prove useful to zoologists using DNA-based diet techniques in a wide variety of study systems.			Dunshea, G (corresponding author), Univ Tasmania, Antarctic Wildlife Res Unit, Sch Zool, Hobart, Tas, Australia.	glenn.dunshea@aad.gov.au		Dunshea, Glenn/0000-0002-8683-0181				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barros NB, 1998, J MAMMAL, V79, P1045, DOI 10.2307/1383114; BARROS NB, 1990, FOOD HABITS BOTTLENO, P309; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Blankenship LE, 2005, MOL ECOL, V14, P891, DOI 10.1111/j.1365-294X.2005.02448.x; CASPER RM, 2007, J EXPT MARINE BIOL A, DOI DOI 10.1016/J.JEMBE.2007.1004.1002; Casper RM, 2007, MAR BIOL, V152, P815, DOI 10.1007/s00227-007-0732-y; Deagle BE, 2005, J HERED, V96, P417, DOI 10.1093/jhered/esi036; Deagle BE, 2005, MOL ECOL, V14, P1831, DOI 10.1111/j.1365-294X.2005.02531.x; DEAGLE BE, 2006, CONSERV GENET, DOI DOI 10.1007/S10592-00609197-00609197; DEAGLE BE, 2009, MOL ECOLOGY IN PRESS; DEAGLE BE, 2006, FRONTIERS ZOOLOGY, V3; Deagle BE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000831; Dunshea G, 2008, B ENTOMOL RES, V98, P239, DOI 10.1017/S0007485308005993; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gonzalez JM, 2005, BIOINFORMATICS, V21, P333, DOI 10.1093/bioinformatics/bti008; Green SJ, 2005, APPL ENVIRON MICROB, V71, P4721, DOI 10.1128/AEM.71.8.4721-4727.2005; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Harper GL, 2005, MOL ECOL, V14, P819, DOI [10.1111/j.1365-294X.2005.02442.x, 10.1111/j.1365-294x.2005.02442.x]; Huber JA, 2002, APPL ENVIRON MICROB, V68, P1585, DOI 10.1128/AEM.68.4.1585-1594.2002; Iverson SJ, 2004, ECOL MONOGR, V74, P211, DOI 10.1890/02-4105; Jarman SN, 2006, BIOINFORMATICS, V22, P2160, DOI 10.1093/bioinformatics/btl330; Jarman SN, 2006, MOL ECOL NOTES, V6, P268, DOI 10.1111/j.1471-8286.2005.01172.x; Jarman SN, 2004, BIOINFORMATICS, V20, P1644, DOI 10.1093/bioinformatics/bth121; Jarman SN, 2004, MOL ECOL, V13, P1313, DOI 10.1111/j.1365-294X.2004.02109.x; Jarman SN, 2002, MOL ECOL, V11, P2679, DOI 10.1046/j.1365-294X.2002.01641.x; Juen A, 2005, OECOLOGIA, V142, P344, DOI 10.1007/s00442-004-1736-7; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; Kohn MH, 1997, TRENDS ECOL EVOL, V12, P223, DOI 10.1016/S0169-5347(97)01050-1; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kvitrud MA, 2005, MAR BIOL, V147, P1459, DOI 10.1007/s00227-005-0047-9; Martin DL, 2006, MAR ECOL PROG SER, V319, P155, DOI 10.3354/meps319155; Parsons KM, 2005, J ZOOL, V266, P275, DOI 10.1017/S0952836905006904; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sheppard SK, 2005, FUNCT ECOL, V19, P751, DOI 10.1111/j.1365-2435.2005.01041.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Steinke D, 2005, PHILOS T R SOC B, V360, P1975, DOI 10.1098/rstb.2005.1729; Sunnucks P, 2000, MOL ECOL, V9, P1699, DOI 10.1046/j.1365-294x.2000.01084.x; SUTHERLAND RM, 2000, THESIS U OXFORD OXFO; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Vences M, 2005, FRONTIERS ZOOLOGY, DOI [10. 1186/1742-9994-1182-1185, DOI 10.1186/1742-9994-1182-1185]; Venkatesh B, 2006, GENOMICS, V87, P307, DOI 10.1016/j.ygeno.2005.11.007; VESTHEIM H, 2008, FRONTIERS ZOOLOGY, V5, DOI DOI 10.1186/1742-9994-1185-1112; von Wintzingerode F, 2000, APPL ENVIRON MICROB, V66, P549, DOI 10.1128/AEM.66.2.549-557.2000; Wells R.S., 2004, ECOHEALTH, V1, P246, DOI [10.1007/s10393-004-0094-6, DOI 10.1007/S10393-004-0094-6]; Zaidi RH, 1999, MOL ECOL, V8, P2081, DOI 10.1046/j.1365-294x.1999.00823.x	46	47	49	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5252	10.1371/journal.pone.0005252	http://dx.doi.org/10.1371/journal.pone.0005252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390570	Green Published, Green Accepted, gold			2022-12-25	WOS:000265514200002
J	Luo, MJ; Cui, XF; Fredman, D; Brookes, AJ; Azaro, MA; Greenawalt, DM; Hu, GH; Wang, HY; Tereshchenko, IV; Lin, Y; Shentu, Y; Gao, RC; Shen, L; Li, HH				Luo, Minjie; Cui, Xiangfeng; Fredman, David; Brookes, Anthony J.; Azaro, Marco A.; Greenawalt, Danielle M.; Hu, Guohong; Wang, Hui-Yun; Tereshchenko, Irina V.; Lin, Yong; Shentu, Yue; Gao, Richeng; Shen, Li; Li, Honghua			Genetic Structures of Copy Number Variants Revealed by Genotyping Single Sperm	PLOS ONE			English	Article							SEGMENTAL DUPLICATIONS; NUCLEOTIDE POLYMORPHISMS; LINKAGE DISEQUILIBRIUM; GENOME; SEQUENCE; REGIONS; HAPLOTYPE; DELETIONS; SNPS	Background: Copy number variants (CNVs) occupy a significant portion of the human genome and may have important roles in meiotic recombination, human genome evolution and gene expression. Many genetic diseases may be underlain by CNVs. However, because of the presence of their multiple copies, variability in copy numbers and the diploidy of the human genome, detailed genetic structure of CNVs cannot be readily studied by available techniques. Methodology/Principal Findings: Single sperm samples were used as the primary subjects for the study so that CNV haplotypes in the sperm donors could be studied individually. Forty-eight CNVs characterized in a previous study were analyzed using a microarray-based high-throughput genotyping method after multiplex amplification. Seventeen single nucleotide polymorphisms (SNPs) were also included as controls. Two single-base variants, either allelic or paralogous, could be discriminated for all markers. Microarray data were used to resolve SNP alleles and CNV haplotypes, to quantitatively assess the numbers and compositions of the paralogous segments in each CNV haplotype. Conclusions/Significance: This is the first study of the genetic structure of CNVs on a large scale. Resulting information may help understand evolution of the human genome, gain insight into many genetic processes, and discriminate between CNVs and SNPs. The highly sensitive high-throughput experimental system with haploid sperm samples as subjects may be used to facilitate detailed large-scale CNV analysis.			Luo, MJ (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Microbiol Mol Genet & Immunol, Canc Inst New Jersey, Piscataway, NJ 08854 USA.	holi@umdnj.edu	Shen, Lishuang/B-3040-2013; Fredman, David J/H-3566-2013	Fredman, David J/0000-0003-3507-0554; Hu, Guohong/0000-0002-2980-5166	NCI NIH HHS [R33 CA096309, R01CA77363, R33 CA 96309] Funding Source: Medline; NHGRI NIH HHS [R01 HG002094, R01 HG02094] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R33CA096309, R01CA077363] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002094] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Buckland PR, 2003, ANN MED, V35, P308, DOI 10.1080/07853890310001276; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; CUI XF, 1989, P NATL ACAD SCI USA, V86, P9389, DOI 10.1073/pnas.86.23.9389; Estivill X, 2002, HUM MOL GENET, V11, P1987, DOI 10.1093/hmg/11.17.1987; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Greenawalt DM, 2006, GENOME RES, V16, P208, DOI 10.1101/gr.4641706; Gut IG, 2004, NAT GENET, V36, P789, DOI 10.1038/ng0804-789; Hasin Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000249; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hu GH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl601; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Jiang RH, 2003, PHARMACOGENOMICS, V4, P779; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Pastinen T, 1997, GENOME RES, V7, P606, DOI 10.1101/gr.7.6.606; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wang HY, 2005, GENOME RES, V15, P276, DOI 10.1101/gr.2885205; Warburton PE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-533; Yang TL, 2008, AM J HUM GENET, V83, P663, DOI 10.1016/j.ajhg.2008.10.006	38	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5236	10.1371/journal.pone.0005236	http://dx.doi.org/10.1371/journal.pone.0005236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384415	Green Published, gold			2022-12-25	WOS:000265513900007
J	Suied, C; Viaud-Delmon, I				Suied, Clara; Viaud-Delmon, Isabelle			Auditory-Visual Object Recognition Time Suggests Specific Processing for Animal Sounds	PLOS ONE			English	Article							NATURAL SOUNDS; DIVIDED ATTENTION; HUMAN BRAIN; CORTEX; DEFICITS; REPRESENTATION; INTEGRATION; KNOWLEDGE; RESPONSES; PATHWAYS	Background: Recognizing an object requires binding together several cues, which may be distributed across different sensory modalities, and ignoring competing information originating from other objects. In addition, knowledge of the semantic category of an object is fundamental to determine how we should react to it. Here we investigate the role of semantic categories in the processing of auditory-visual objects. Methodology/Findings: We used an auditory-visual object-recognition task (go/no-go paradigm). We compared recognition times for two categories: a biologically relevant one (animals) and a non-biologically relevant one (means of transport). Participants were asked to react as fast as possible to target objects, presented in the visual and/or the auditory modality, and to withhold their response for distractor objects. A first main finding was that, when participants were presented with unimodal or bimodal congruent stimuli (an image and a sound from the same object), similar reaction times were observed for all object categories. Thus, there was no advantage in the speed of recognition for biologically relevant compared to non-biologically relevant objects. A second finding was that, in the presence of a biologically relevant auditory distractor, the processing of a target object was slowed down, whether or not it was itself biologically relevant. It seems impossible to effectively ignore an animal sound, even when it is irrelevant to the task. Conclusions/Significance: These results suggest a specific and mandatory processing of animal sounds, possibly due to phylogenetic memory and consistent with the idea that hearing is particularly efficient as an alerting sense. They also highlight the importance of taking into account the auditory modality when investigating the way object concepts of biologically relevant categories are stored and retrieved.			Suied, C (corresponding author), IRCAM CNRS, UMR 9912, Paris, France.	clarasuied@gmail.com		Viaud-Delmon, Isabelle/0000-0002-8664-3941				Armony JL, 1997, CEREB CORTEX, V7, P157, DOI 10.1093/cercor/7.2.157; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Caramazza A, 2003, TRENDS COGN SCI, V7, P354, DOI 10.1016/S1364-6613(03)00159-1; Chi TS, 1999, J ACOUST SOC AM, V106, P2719, DOI 10.1121/1.428100; Chocholle R, 1940, ANN PSYCHOL, V41-42, P65; Clarke S, 2000, NEUROPSYCHOLOGIA, V38, P797, DOI 10.1016/S0028-3932(99)00141-4; Clarke S, 1996, NEUROPSYCHOLOGIA, V34, P587, DOI 10.1016/0028-3932(95)00142-5; Doehrmann O, 2008, BRAIN RES, V1242, P136, DOI 10.1016/j.brainres.2008.03.071; Humphreys GW, 2001, BEHAV BRAIN SCI, V24, P453, DOI 10.1017/S0140525X01004150; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Laurienti PJ, 2004, EXP BRAIN RES, V158, P405, DOI 10.1007/s00221-004-1913-2; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Lewis JW, 2005, J NEUROSCI, V25, P5148, DOI 10.1523/JNEUROSCI.0419-05.2005; Lewis JW, 2004, CEREB CORTEX, V14, P1008, DOI 10.1093/cercor/bhh061; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; MILLER J, 1986, PERCEPT PSYCHOPHYS, V40, P331, DOI 10.3758/BF03203025; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; Molholm S, 2004, CEREB CORTEX, V14, P452, DOI 10.1093/cercor/bhh007; Murray MM, 2006, J NEUROSCI, V26, P1293, DOI 10.1523/JNEUROSCI.4511-05.2006; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; Nelken I, 2004, CURR OPIN NEUROBIOL, V14, P474, DOI 10.1016/j.conb.2004.06.005; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Rousselet GA, 2003, J VISION, V3, P440, DOI 10.1167/3.6.5; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; Suied C, 2008, J EXP PSYCHOL-APPL, V14, P201, DOI 10.1037/1076-898X.14.3.201; Suied C, 2009, EXP BRAIN RES, V194, P91, DOI 10.1007/s00221-008-1672-6; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Ulrich R, 2007, BEHAV RES METHODS, V39, P291, DOI 10.3758/BF03193160; VanRullen R, 2001, PERCEPTION, V30, P655, DOI 10.1068/p3029; von Kriegstein K, 2006, PLOS BIOL, V4, P1809, DOI 10.1371/journal.pbio.0040326; WARRINGTON EK, 1984, BRAIN, V107, P829, DOI 10.1093/brain/107.3.829; WARRINGTON EK, 1983, BRAIN, V106, P859, DOI 10.1093/brain/106.4.859; YUVALGREENBERG S, 2009, EXP BRAIN R IN PRESS	33	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5256	10.1371/journal.pone.0005256	http://dx.doi.org/10.1371/journal.pone.0005256			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437VB	19384414	Green Published, gold, Green Submitted			2022-12-25	WOS:000265513900010
J	Cohen, AA; Kalisky, T; Mayo, A; Geva-Zatorsky, N; Danon, T; Issaeva, I; Kopito, RB; Perzov, N; Milo, R; Sigal, A; Alon, U				Cohen, Ariel Aharon; Kalisky, Tomer; Mayo, Avi; Geva-Zatorsky, Naama; Danon, Tamar; Issaeva, Irina; Kopito, Ronen Benjamine; Perzov, Natalie; Milo, Ron; Sigal, Alex; Alon, Uri			Protein Dynamics in Individual Human Cells: Experiment and Theory	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; RNA-POLYMERASE-II; TRANSCRIPTION; NOISE; CYCLE; PRC1; FLUCTUATIONS; DEPENDENCE; PROTEOMICS; STABILITY	A current challenge in biology is to understand the dynamics of protein circuits in living human cells. Can one define and test equations for the dynamics and variability of a protein over time? Here, we address this experimentally and theoretically, by means of accurate time-resolved measurements of endogenously tagged proteins in individual human cells. As a model system, we choose three stable proteins displaying cell-cycle-dependant dynamics. We find that protein accumulation with time per cell is quadratic for proteins with long mRNA life times and approximately linear for a protein with short mRNA lifetime. Both behaviors correspond to a classical model of transcription and translation. A stochastic model, in which genes slowly switch between ON and OFF states, captures measured cell-cell variability. The data suggests, in accordance with the model, that switching to the gene ON state is exponentially distributed and that the cell-cell distribution of protein levels can be approximated by a Gamma distribution throughout the cell cycle. These results suggest that relatively simple models may describe protein dynamics in individual human cells.			Cohen, AA (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	uri.alon@weizmann.ac.il	Milo, Hilla/C-8767-2016; MAYO, AVI E/K-1736-2012; Sigal, Alex/GWC-7488-2022; mayo, avi/N-3756-2019; Geva-Zatorsky, Naama/AAP-9176-2021	Sigal, Alex/0000-0001-8571-2004; mayo, avi/0000-0002-4479-3423; Geva-Zatorsky, Naama/0000-0002-7303-854X; Milo, Ron/0000-0003-1641-2299				Alon U, 2007, INTRO SYSTEMS BIOL D; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Beucher S., 1992, SCANNING MICROSCOPY, P28; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Chabot JR, 2007, NATURE, V450, P1249, DOI 10.1038/nature06395; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679; Jarvik JW, 1996, BIOTECHNIQUES, V20, P896; Jarvik JW, 2002, BIOTECHNIQUES, V33, P852, DOI 10.2144/02334rr02; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Jurchott K, 2003, J BIOL CHEM, V278, P27988, DOI 10.1074/jbc.M212966200; KO MSH, 1990, EMBO J, V9, P2835, DOI 10.1002/j.1460-2075.1990.tb07472.x; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Kopito RB, 2007, P NATL ACAD SCI USA, V104, P12743, DOI 10.1073/pnas.0702690104; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; MONOD J, 1952, BIOCHIM BIOPHYS ACTA, V9, P648, DOI 10.1016/0006-3002(52)90227-8; Nguyen VT, 1996, NUCLEIC ACIDS RES, V24, P2924, DOI 10.1093/nar/24.15.2924; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2000, PHYS REV LETT, V84, P5447, DOI 10.1103/PhysRevLett.84.5447; PRICE VE, 1962, J BIOL CHEM, V237, P3468; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rosenfeld N, 2003, J MOL BIOL, V329, P645, DOI 10.1016/S0022-2836(03)00506-0; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; ROSENFELD NY, 2005, GENE REGULATION SING, V307, P1962; ROSS IL, 1994, IMMUNOL CELL BIOL, V72, P177, DOI 10.1038/icb.1994.26; Sigal A, 2007, NAT PROTOC, V2, P1515, DOI 10.1038/nprot.2007.197; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Sigal A, 2006, NAT METHODS, V3, P525, DOI 10.1038/NMETH892; Straight AF, 2005, MOL BIOL CELL, V16, P193, DOI 10.1091/mbc.E04-08-0758; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Vincent L, 1993, IEEE T IMAGE PROCESS, V2, P176, DOI 10.1109/83.217222; WALTERS MC, 1995, P NATL ACAD SCI USA, V92, P7125, DOI 10.1073/pnas.92.15.7125; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Zhu CJ, 2006, P NATL ACAD SCI USA, V103, P6196, DOI 10.1073/pnas.0506926103	48	51	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e4901	10.1371/journal.pone.0004901	http://dx.doi.org/10.1371/journal.pone.0004901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381343	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000265510800001
J	Tikhonov, DB; Zhorov, BS				Tikhonov, Denis B.; Zhorov, Boris S.			Structural Model for Dihydropyridine Binding to L-type Calcium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMANENTLY CHARGED 1,4-DIHYDROPYRIDINES; CA2+ CHANNEL; SODIUM-CHANNEL; OPTICAL ISOMERS; DRUG-BINDING; K+ CHANNEL; MOLECULAR DETERMINANTS; SLOW INACTIVATION; POTASSIUM CHANNEL; LOCAL-ANESTHETICS	1,4-Dihydropyridines (DHPs) constitute a major class of ligands for L-type Ca2+ channels (LTCC). The DHPs have a boat-like, six-membered ring with an NH group at the stern, an aromatic moiety at the bow, and substituents at the port and starboard sides. Various DHPs exhibit antagonistic or agonistic activities, which were previously explained as stabilization or destabilization, respectively, of the closed activation gate by the portside substituents. Here we report a novel structural model in which agonist and antagonist activities are determined by different parts of the DHP molecule and have different mechanisms. In our model, which is based on Monte Carlo minimizations of DHP-LTCC complexes, the DHP moieties at the stern, bow, and starboard form H-bonds with side chains of the key DHP-sensing residues Tyr_IIIS6, Tyr_IVS6, and Gln_IIIS5, respectively. We propose that these H-bonds, which are common for agonists and antagonists, stabilize the LTCC conformation with the open activation gate. This explains why both agonists and antagonists increase probability of the long lasting channel openings and why even partial disruption of the contacts eliminates the agonistic action. In our model, the portside approaches the selectivity filter. Hydrophobic portside of antagonists may induce long lasting channel closings by destabilizing Ca2+ binding to the selectivity filter glutamates. Agonists have either hydrophilic substituents or a hydrogen atom at their portside, and thus lack this destabilizing effect. The predicted orientation of the DHP core allows accommodation of long substituents in the domain interface or in the inner pore. Our model may be useful for developing novel clinically relevant LTCC blockers.	[Tikhonov, Denis B.; Zhorov, Boris S.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Tikhonov, Denis B.] Russian Acad Sci, IM Sechenov Evolutionary Physiol & Biochem Inst, St Petersburg 194223, Russia	McMaster University; North-Western State Medical University named after I.I. Mechnikov; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Zhorov, BS (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.	zhorov@mcmaster.ca	Zhorov, Boris/T-9892-2019; Tikhonov, Denis/AAK-9148-2020; Zhorov, Boris S./V-8072-2019	Zhorov, Boris/0000-0002-3630-7114; Tikhonov, Denis/0000-0001-8523-4305	Canadian Institutes of Health	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research (to B. S.Z.).	ARROWSMITH JE, 1986, J MED CHEM, V29, P1696, DOI 10.1021/jm00159a022; BAINDUR N, 1993, J MED CHEM, V36, P3743, DOI 10.1021/jm00075a034; BANGALORE R, 1994, MOL PHARMACOL, V46, P660; Berjukow S, 2000, J BIOL CHEM, V275, P22114, DOI 10.1074/jbc.M908836199; Bodi I, 1997, J BIOL CHEM, V272, P24952, DOI 10.1074/jbc.272.40.24952; Bruhova I, 2008, MOL PHARMACOL, V74, P1033, DOI 10.1124/mol.108.049759; Bruhova I, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-5; Bruhova I, 2009, BIOPHYS J, V96, p183A, DOI 10.1016/j.bpj.2008.12.854; CAHALAN MD, 1979, BIOPHYS J, V27, P39, DOI 10.1016/S0006-3495(79)85201-7; CERBAI E, 1990, J CARDIOVASC PHARM, V15, P604, DOI 10.1097/00005344-199004000-00013; Chen YA, 2006, NEURON, V49, P409, DOI 10.1016/j.neuron.2006.01.009; Chen ZH, 2000, J PHYSIOL-LONDON, V524, P37, DOI 10.1111/j.1469-7793.2000.t01-1-00037.x; Cosconati S, 2007, J MED CHEM, V50, P1504, DOI 10.1021/jm061245a; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Faraldo-Gomez JD, 2007, J MOL BIOL, V365, P649, DOI 10.1016/j.jmb.2006.09.069; FRANCKOWIAK G, 1985, EUR J PHARMACOL, V114, P223, DOI 10.1016/0014-2999(85)90631-4; GOLDMANN S, 1991, ANGEW CHEM INT EDIT, V30, P1559, DOI 10.1002/anie.199115591; Grabner M, 1996, NEURON, V16, P207, DOI 10.1016/S0896-6273(00)80037-9; He M, 1997, J BIOL CHEM, V272, P2629, DOI 10.1074/jbc.272.5.2629; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; Hockerman GH, 1997, ANNU REV PHARMACOL, V37, P361, DOI 10.1146/annurev.pharmtox.37.1.361; Hockerman GH, 1997, P NATL ACAD SCI USA, V94, P14906, DOI 10.1073/pnas.94.26.14906; HOF RP, 1985, J CARDIOVASC PHARM, V7, P689, DOI 10.1097/00005344-198507000-00012; Huber I, 2000, BIOCHEM J, V347, P829, DOI 10.1042/0264-6021:3470829; Ito H, 1997, MOL PHARMACOL, V52, P735, DOI 10.1124/mol.52.4.735; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; KASS RS, 1987, CIRC RES, V61, P1; KASS RS, 1989, J GEN PHYSIOL, V93, P1109, DOI 10.1085/jgp.93.6.1109; KASS RS, 1991, J GEN PHYSIOL, V98, P63, DOI 10.1085/jgp.98.1.63; KOKUBUN S, 1984, P NATL ACAD SCI-BIOL, V81, P4824, DOI 10.1073/pnas.81.15.4824; KWAN YW, 1995, J MOL CELL CARDIOL, V27, P253, DOI 10.1016/S0022-2828(08)80024-7; Lacinova L, 2005, GEN PHYSIOL BIOPHYS, V24, P3; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611; Lipkind GM, 2003, MOL PHARMACOL, V63, P499, DOI 10.1124/mol.63.3.499; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MITTERDORFER J, 1995, BIOCHEMISTRY-US, V34, P9350, DOI 10.1021/bi00029a010; Mitterdorfer J, 1996, J BIOL CHEM, V271, P30330, DOI 10.1074/jbc.271.48.30330; MUTO K, 1988, ARZNEIMITTEL-FORSCH, V38-2, P1662; Peri R, 2000, J MED CHEM, V43, P2906, DOI 10.1021/jm000028l; Peterson BZ, 2006, MOL PHARMACOL, V70, P667, DOI 10.1124/mol.105.020644; Peterson BZ, 1997, J BIOL CHEM, V272, P18752, DOI 10.1074/jbc.272.30.18752; PETERSON BZ, 1995, J BIOL CHEM, V270, P18201, DOI 10.1074/jbc.270.31.18201; Peterson BZ, 1996, J BIOL CHEM, V271, P5293, DOI 10.1074/jbc.271.10.5293; Schuster A, 1996, EMBO J, V15, P2365, DOI 10.1002/j.1460-2075.1996.tb00592.x; Tikhonov DB, 2005, FEBS LETT, V579, P4207, DOI 10.1016/j.febslet.2005.07.017; Tikhonov DB, 2005, BIOPHYS J, V88, P184, DOI 10.1529/biophysj.104.048173; Tikhonov DB, 2008, J BIOL CHEM, V283, P17594, DOI 10.1074/jbc.M800141200; Tikhonov DB, 2007, BIOPHYS J, V93, P1557, DOI 10.1529/biophysj.106.100248; TOWART R, 1982, ARZNEIMITTEL-FORSCH, V32-1, P338; Wang SY, 2007, CHANNELS, V1, pE1, DOI 10.4161/chan.4437; Wang SY, 2007, PFLUG ARCH EUR J PHY, V454, P277, DOI 10.1007/s00424-006-0202-2; Wang SY, 2006, MOL PHARMACOL, V69, P788, DOI 10.1124/mol.105.018200; Wanner-Olsen H, 2000, CHIRALITY, V12, P660, DOI 10.1002/1520-636X(2000)12:9<660::AID-CHIR3>3.0.CO;2-1; Wappl E, 2001, J BIOL CHEM, V276, P12730, DOI 10.1074/jbc.M010164200; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; WILLIAMS JS, 1985, BIOCHEM BIOPH RES CO, V131, P13, DOI 10.1016/0006-291X(85)91763-2; Yamaguchi S, 2003, MOL PHARMACOL, V64, P235, DOI 10.1124/mol.64.2.235; Yamaguchi S, 2000, J BIOL CHEM, V275, P41504, DOI 10.1074/jbc.M007165200; Zhen XG, 2005, J GEN PHYSIOL, V126, P193, DOI 10.1085/jgp.200509292; Zhorov BS, 1996, BIOPHYS J, V70, P22, DOI 10.1016/S0006-3495(96)79561-9; Zhorov BS, 2001, ARCH BIOCHEM BIOPHYS, V393, P22, DOI 10.1006/abbi.2001.2484	65	61	65	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					19006	19017		10.1074/jbc.M109.011296	http://dx.doi.org/10.1074/jbc.M109.011296			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19416978	Green Published, hybrid			2022-12-25	WOS:000267711500050
J	Toustrup-Jensen, MS; Holm, R; Einholm, AP; Schack, VR; Morth, JP; Nissen, P; Andersen, JP; Vilsen, B				Toustrup-Jensen, Mads S.; Holm, Rikke; Einholm, Anja Pernille; Schack, Vivien Rodacker; Morth, J. Preben; Nissen, Poul; Andersen, Jens Peter; Vilsen, Bente			The C Terminus of Na+, K+-ATPase Controls Na+ Affinity on Both Sides of the Membrane through Arg(935)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4TH TRANSMEMBRANE SEGMENT; SODIUM-PUMP; FUNCTIONAL CONSEQUENCES; ADENOSINE-TRIPHOSPHATE; CATION-BINDING; ADP EXCHANGE; NA,K-ATPASE; NA+,K+-ATPASE; TRANSPORT; SITES	The Na+, K+-ATPase C terminus has a unique location between transmembrane segments, appearing to participate in a network of interactions. We have examined the functional consequences of amino acid substitutions in this region and deletions of the C terminus of varying lengths. Assays revealing separately the mutational effects on internally and externally facing Na+ sites, as well as E-1-E-2 conformational changes, have been applied. The results pinpoint the two terminal tyrosines, Tyr(1017) and Tyr(1018), as well as putative interaction partners, Arg(935) in the loop between transmembrane segments M8 and M9 and Lys(768) in transmembrane segment M5, as crucial to Na+ activation of phosphorylation of E-1, a partial reaction reflecting Na+ interaction on the cytoplasmic side of the membrane. Tyr1017, Tyr1018, and Arg935 are furthermore indispensable to Na+ interaction on the extracellular side of the membrane, as revealed by inability of high Na+ concentrations to drive the transition from E1P to E2P backwards toward E1P and inhibit Na+-ATPase activity in mutants. Lys768 is not important for Na+ binding from the external side of the membrane but is involved in stabilization of the E-2 form. These data demonstrate that the C terminus controls Na+ affinity on both sides of the membrane and suggest that Arg935 constitutes an important link between the C terminus and the third Na+ site, involving an arginine-pi stacking interaction between Arg935 and the C-terminal tyrosines. Lys768 may interact preferentially with the C terminus in E1 and E1P forms and with the loop between transmembrane segments M6 and M7 in E-2 and E2P forms.	[Toustrup-Jensen, Mads S.; Holm, Rikke; Einholm, Anja Pernille; Schack, Vivien Rodacker; Andersen, Jens Peter; Vilsen, Bente] Aarhus Univ, Dept Physiol & Biophys, DK-8000 Aarhus C, Denmark; [Toustrup-Jensen, Mads S.; Holm, Rikke; Einholm, Anja Pernille; Schack, Vivien Rodacker; Morth, J. Preben; Nissen, Poul; Andersen, Jens Peter; Vilsen, Bente] Aarhus Univ, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, DK-8000 Aarhus C, Denmark; [Morth, J. Preben; Nissen, Poul] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Danmarks Grundforskningsfond; Aarhus University	Vilsen, B (corresponding author), Aarhus Univ, Dept Physiol & Biophys, Ole Worms Alle 6,Blg 1180, DK-8000 Aarhus C, Denmark.	bv@fi.au.dk	Morth, Jens Preben/G-4450-2013; Morth, Jens Preben/AAP-7834-2021	Morth, Jens Preben/0000-0003-4077-0192; Morth, Jens Preben/0000-0003-4077-0192; Vilsen, Bente/0000-0002-4727-9382; Toustrup-Jensen, Mads Schak/0000-0003-2064-5861; Andersen, Jens Peter/0000-0003-0654-4300; Nissen, Poul/0000-0003-0948-6628; Schack, Vivien/0000-0002-1365-3938	Lundbeck Foundation, Denmark; Danish Medical Research Council; Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Legat), Denmark; Danish National Research Foundation (PUMPKIN Centre)	Lundbeck Foundation, Denmark(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Legat), Denmark(Novo Nordisk Foundation); Danish National Research Foundation (PUMPKIN Centre)(Danmarks Grundforskningsfond)	This study was funded in part by grants from the Lundbeck Foundation, Denmark, the Danish Medical Research Council, the Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Legat), Denmark, and the Danish National Research Foundation (PUMPKIN Centre).	BEAUGE LA, 1979, J PHYSIOL-LONDON, V289, P17, DOI 10.1113/jphysiol.1979.sp012722; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; ESMANN M, 1985, BIOCHEM BIOPH RES CO, V127, P857, DOI 10.1016/S0006-291X(85)80022-X; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; GARRAHAN PJ, 1967, J PHYSIOL-LONDON, V192, P159, DOI 10.1113/jphysiol.1967.sp008294; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; GLYNN IM, 1993, J PHYSIOL-LONDON, V462, P1; GLYNN IM, 1976, J PHYSIOL-LONDON, V256, P465, DOI 10.1113/jphysiol.1976.sp011333; Holmgren M, 2000, NATURE, V403, P898, DOI 10.1038/35002599; Imagawa T, 2005, J BIOL CHEM, V280, P18736, DOI 10.1074/jbc.M500137200; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; KAPLAN JH, 1982, J GEN PHYSIOL, V80, P915, DOI 10.1085/jgp.80.6.915; KAPLAN JH, 1980, NATURE, V288, P587, DOI 10.1038/288587a0; KAPLAN JH, 1985, J GEN PHYSIOL, V85, P123, DOI 10.1085/jgp.85.1.123; LAUGER P, 1991, ELECTROGENIC ION PUM, P27; Li CM, 2005, P NATL ACAD SCI USA, V102, P12706, DOI 10.1073/pnas.0505980102; LUTSENKO S, 1993, BIOCHEMISTRY-US, V32, P6737, DOI 10.1021/bi00077a029; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2009, PHILOS T R SOC B, V364, P217, DOI 10.1098/rstb.2008.0201; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; POST RL, 1972, J BIOL CHEM, V247, P6530; Riant F, 2005, HUM MUTAT, V26, DOI 10.1002/humu.9361; Rodacker V, 2006, J BIOL CHEM, V281, P18539, DOI 10.1074/jbc.M601780200; Schneeberger A, 1999, J MEMBRANE BIOL, V168, P221, DOI 10.1007/s002329900511; Skou J. C, 1991, SODIUM PUMP RECENT D, P317; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; TANIGUCHI K, 1975, J BIOL CHEM, V250, P3010; Therien AG, 1996, J BIOL CHEM, V271, P7104, DOI 10.1074/jbc.271.12.7104; Toustrup-Jensen M, 2001, BIOCHEMISTRY-US, V40, P5521, DOI 10.1021/bi002367m; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Vilsen B, 1998, BIOCHEMISTRY-US, V37, P10961, DOI 10.1021/bi9802925; VILSEN B, 1995, BIOCHEMISTRY-US, V34, P1455, DOI 10.1021/bi00004a041; VILSEN B, 1992, FEBS LETT, V314, P301, DOI 10.1016/0014-5793(92)81494-7; Vilsen B, 1997, BIOCHEMISTRY-US, V36, P13312, DOI 10.1021/bi971030q; Vilsen B, 1997, ANN NY ACAD SCI, V834, P297, DOI 10.1111/j.1749-6632.1997.tb52260.x; WUDDEL I, 1995, BIOPHYS J, V69, P909, DOI 10.1016/S0006-3495(95)79965-9; YODA S, 1986, J BIOL CHEM, V261, P1147	38	42	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18715	18725		10.1074/jbc.M109.015099	http://dx.doi.org/10.1074/jbc.M109.015099			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19416970	Green Published, hybrid			2022-12-25	WOS:000267711500021
J	Kabra, N; Li, ZY; Chen, LH; Li, BZ; Zhang, XH; Wang, CG; Yeatman, T; Coppola, D; Chen, JD				Kabra, Neha; Li, Zhenyu; Chen, Lihong; Li, Baozong; Zhang, Xiaohong; Wang, Chuangui; Yeatman, Timothy; Coppola, Domenico; Chen, Jiandong			SirT1 Is an Inhibitor of Proliferation and Tumor Formation in Colon Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE ACTIVATORS; PANCREATIC BETA-CELLS; DNA-DAMAGE; LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; INSULIN-SECRETION; INCREASED DOSAGE; REGULATES SIRT1; SURVIVAL	The NAD-dependent deacetylase SirT1 regulates factors involved in stress response and cell survival and is a potential drug target of activators and inhibitors. Determination of SirT1 function in tumor cells is important for its targeting in cancer therapy. We found that SirT1 knockdown by short hairpin RNA accelerates tumor xenograft formation by HCT116 cells, whereas SirT1 overexpression inhibits tumor formation. Furthermore, pharmacological inhibition of SirT1 stimulates cell proliferation under conditions of growth factor deprivation. Paradoxically, SirT1 inhibition also sensitizes cells to apoptosis by chemotherapy drugs. Immunohistochemical staining revealed high level SirT1 in normal colon mucosa and benign adenomas. SirT1 overexpression was observed in similar to 25% of stage I/II/III colorectal adenocarcinomas but rarely found in advanced stage IV tumors. Furthermore, similar to 30% of carcinomas showed lower than normal SirT1 expression. This pattern is consistent with SirT1 having pleiotropic effects during cancer development (anti-proliferation and anti-apoptotic). These results suggest a rationale for the use of SirT1 activators and inhibitors in the prevention and treatment of colon cancer.	[Kabra, Neha; Li, Zhenyu; Chen, Lihong; Li, Baozong; Zhang, Xiaohong; Chen, Jiandong] H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA; [Yeatman, Timothy] H Lee Moffitt Canc Ctr & Res Inst, Dept Surg, Tampa, FL 33612 USA; [Coppola, Domenico] H Lee Moffitt Canc Ctr & Res Inst, Div Anat Pathol, Tampa, FL 33612 USA; [Zhang, Xiaohong] Univ S Florida, Dept Pathol & Cell Biol, Tampa, FL 33612 USA; [Wang, Chuangui] E China Normal Univ, Inst Biomed Sci, Shanghai 200241, Peoples R China	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; East China Normal University	Chen, JD (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA.	Jiandong.chen@moffitt.org	li, baozong/K-4176-2012; Li, Baozong/ABD-4742-2020		National Institutes of Health [CA121291]; NATIONAL CANCER INSTITUTE [R01CA121291, R01CA112215] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA121291 ( to J. C.).	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; Guarante LP, 2005, ANN NY ACAD SCI, V1055, P222; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Hida Y, 2007, ARCH DERMATOL RES, V299, P103, DOI 10.1007/s00403-006-0725-6; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; LUONGO C, 1994, CANCER RES, V54, P5947; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Narala SR, 2008, MOL BIOL CELL, V19, P1210, DOI 10.1091/mbc.E07-09-0965; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wong S, 2007, BIOCHEM J, V407, P451, DOI 10.1042/BJ20070151; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029	37	144	151	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18210	18217		10.1074/jbc.M109.000034	http://dx.doi.org/10.1074/jbc.M109.000034			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19433578	Green Published, hybrid			2022-12-25	WOS:000267712400033
J	Schmidtchen, A; Pasupuleti, M; Morgelin, M; Davoudi, M; Alenfall, J; Chalupka, A; Malmsten, M				Schmidtchen, Artur; Pasupuleti, Mukesh; Morgelin, Matthias; Davoudi, Mina; Alenfall, Jan; Chalupka, Anna; Malmsten, Martin			Boosting Antimicrobial Peptides by Hydrophobic Oligopeptide End Tags	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN-BINDING PEPTIDES; ANTIBACTERIAL PEPTIDES; WATER-INTERFACE; LIPID-BILAYERS; MEMBRANE; TRYPTOPHAN; BACTERIA; LIPOPEPTIDES; SELECTIVITY; RESISTANCE	A novel approach for boosting antimicrobial peptides through end tagging with hydrophobic oligopeptide stretches is demonstrated. Focusing on two peptides derived from kininogen, GKHKNKGKKNGKHNGWK (GKH17) and HKHGHGHGKHKNKGKKN (HKH17), tagging resulted in enhanced killing of Gram-positive Staphylococcus aureus, Gram-negative Escherichia coli, and fungal Candida albicans. Microbicidal potency increased with tag length, also in plasma, and was larger for Trp and Phe stretches than for aliphatic ones. The enhanced microbicidal effects correlated to a higher degree of bacterial wall rupture. Analogously, tagging promoted peptide binding to model phospholipid membranes and liposome rupture, particularly for anionic and cholesterol-void membranes. Tagged peptides displayed low toxicity, particularly in the presence of serum, and resisted degradation by human leukocyte elastase and by staphylococcal aureolysin and V8 proteinase. The biological relevance of these findings was demonstrated ex vivo and in vivo in porcine S. aureus skin infection models. The generality of end tagging for facile boosting of antimicrobial peptides without the need for post-synthesis modification was also demonstrated.	[Malmsten, Martin] Uppsala Univ, Dept Pharm, SE-75123 Uppsala, Sweden; [Schmidtchen, Artur; Pasupuleti, Mukesh; Davoudi, Mina; Chalupka, Anna] Lund Univ, Dept Clin Sci, Div Dermatol & Venereol, SE-22184 Lund, Sweden; [Morgelin, Matthias; Alenfall, Jan] Lund Univ, Dept Clin Sci, Div Infect Med, SE-22184 Lund, Sweden; [Morgelin, Matthias; Alenfall, Jan] Dermagen AB, SE-22363 Lund, Sweden	Uppsala University; Lund University; Lund University	Malmsten, M (corresponding author), Uppsala Univ, Dept Pharm, SE-75123 Uppsala, Sweden.	martin.malmsten@farmaci.uu.se	Schmidtchen, Artur/F-9507-2015; Pasupuleti, Mukesh/AAF-4066-2020; Pasupuleti, Mukesh/H-7605-2013; Pasupuleti, Mukesh/AAD-9977-2020	Pasupuleti, Mukesh/0000-0001-6337-6257; Davoudi, Mina/0000-0002-4952-1099	Swedish Research Council [521-2006-2784, 621-2003-4022]; Royal Physiographic Society in Lund; Welander-Finsen; Soderberg; Schyberg; Crafoord; Alfred Osterlund; Kock Foundations; Swedish Government Funds for Clinical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Physiographic Society in Lund; Welander-Finsen; Soderberg; Schyberg; Crafoord; Alfred Osterlund; Kock Foundations; Swedish Government Funds for Clinical Research	This work was supported by Swedish Research Council Projects 521-2006-2784 and 621-2003-4022, the Royal Physiographic Society in Lund, the Welander-Finsen, Soderberg, Schyberg, Crafoord, Alfred Osterlund, and Kock Foundations, and the Swedish Government Funds for Clinical Research.	Andersson E, 2004, EUR J BIOCHEM, V271, P1219, DOI 10.1111/j.1432-1033.2004.04035.x; Avrahami D, 2004, J BIOL CHEM, V279, P12277, DOI 10.1074/jbc.M312260200; Avrahami D, 2002, BIOCHEMISTRY-US, V41, P2254, DOI 10.1021/bi011549t; Bechinger B, 1999, BBA-BIOMEMBRANES, V1462, P157, DOI 10.1016/S0005-2736(99)00205-9; Bhonsle JB, 2007, J MED CHEM, V50, P6545, DOI 10.1021/jm070884y; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chen FY, 2003, BIOPHYS J, V84, P3751, DOI 10.1016/S0006-3495(03)75103-0; de Planque MRR, 1999, J BIOL CHEM, V274, P20839, DOI 10.1074/jbc.274.30.20839; DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711; Deslouches B, 2005, ANTIMICROB AGENTS CH, V49, P316, DOI 10.1128/AAC.49.1.316-322.2005; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; EMBER JA, 1991, BIOCHEMISTRY-US, V30, P3603, DOI 10.1021/bi00229a003; Fimland G, 2002, BIOCHEMISTRY-US, V41, P9508, DOI 10.1021/bi025856q; French GL, 2005, ADV DRUG DELIVER REV, V57, P1514, DOI 10.1016/j.addr.2005.04.005; Glukhov E, 2005, J BIOL CHEM, V280, P33960, DOI 10.1074/jbc.M507042200; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Haney EF, 2007, BBA-BIOMEMBRANES, V1768, P2355, DOI 10.1016/j.bbamem.2007.04.018; Huang HW, 2006, BBA-BIOMEMBRANES, V1758, P1292, DOI 10.1016/j.bbamem.2006.02.001; Ishitsuka Y, 2006, BBA-BIOMEMBRANES, V1758, P1450, DOI 10.1016/j.bbamem.2006.08.001; Jenssen H, 2008, J PEPT SCI, V14, P110, DOI 10.1002/psc.908; Jerala R, 2007, EXPERT OPIN INV DRUG, V16, P1159, DOI 10.1517/13543784.16.8.1159; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Li X, 2006, BBA-BIOMEMBRANES, V1758, P1203, DOI 10.1016/j.bbamem.2006.03.032; Lotte K, 2004, PHOTOCH PHOTOBIO SCI, V3, P348, DOI 10.1039/b312436c; MALMSTEN M, 1994, J COLLOID INTERF SCI, V166, P333, DOI 10.1006/jcis.1994.1303; Malmsten M., 2003, SURFACTANTS POLYM DR; Malmsten M, 2007, GROWTH FACTORS, V25, P60, DOI 10.1080/08977190701344120; Malmsten M, 2006, MATRIX BIOL, V25, P294, DOI 10.1016/j.matbio.2006.04.003; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Masny A, 2001, BIOTECHNIQUES, V31, P930, DOI 10.2144/01314rr04; McDonnell G, 1999, J MICROBIOL METH, V35, P31, DOI 10.1016/S0167-7012(98)00094-3; McInturff JE, 2005, J INVEST DERMATOL, V125, P256, DOI 10.1111/j.0022-202X.2005.23805.x; Mouritsen OG, 2004, LIPIDS, V39, P1101, DOI 10.1007/s11745-004-1336-x; Nizet V, 2006, CURR ISSUES MOL BIOL, V8, P11; Nordahl EA, 2004, P NATL ACAD SCI USA, V101, P16879, DOI 10.1073/pnas.0406678101; Nordahl EA, 2005, J BIOL CHEM, V280, P34832, DOI 10.1074/jbc.M507249200; Pasupuleti M, 2008, BIOCHEMISTRY-US, V47, P9057, DOI 10.1021/bi800991e; Ramamoorthy A, 2006, BIOPHYS J, V91, P206, DOI 10.1529/biophysj.105.073890; Ringstad L, 2008, LANGMUIR, V24, P208, DOI 10.1021/la702538k; Ringstad L, 2007, BBA-BIOMEMBRANES, V1768, P715, DOI 10.1016/j.bbamem.2006.11.016; Ringstad L, 2006, LANGMUIR, V22, P5042, DOI 10.1021/la060317y; Ringstad L, 2007, BIOPHYS J, V92, P87, DOI 10.1529/biophysj.106.088161; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; Straus SK, 2006, BBA-BIOMEMBRANES, V1758, P1215, DOI 10.1016/j.bbamem.2006.02.009; Stromstedt AA, 2009, ANTIMICROB AGENTS CH, V53, P593, DOI 10.1128/AAC.00477-08; Stromstedt AA, 2007, J COLLOID INTERF SCI, V311, P59, DOI 10.1016/j.jcis.2007.02.070; Tiberg F, 2000, EUR BIOPHYS J BIOPHY, V29, P196, DOI 10.1007/PL00006646; Tossi A, 2000, BIOPOLYMERS, V55, P4; Tossi A, 2002, PEPTIDES 2002, P416; Wei SY, 2006, J BACTERIOL, V188, P328, DOI 10.1128/JB.188.1.328-334.2006; WILLIAMS.P, 1965, J INVEST DERMATOL, V45, P498, DOI 10.1038/jid.1965.164; Wu MH, 1999, J BIOL CHEM, V274, P29, DOI 10.1074/jbc.274.1.29; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zelezetsky I, 2006, BBA-BIOMEMBRANES, V1758, P1436, DOI 10.1016/j.bbamem.2006.03.021	55	108	112	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17584	17594		10.1074/jbc.M109.011650	http://dx.doi.org/10.1074/jbc.M109.011650			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19398550	hybrid, Green Published			2022-12-25	WOS:000267202500024
J	Xia, Y; Ongusaha, P; Lee, SW; Liou, YC				Xia, Yun; Ongusaha, Pat; Lee, Sam W.; Liou, Yih-Cherng			Loss of Wip1 Sensitizes Cells to Stress- and DNA Damage-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-JUN; SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTOR; PROTEIN PHOSPHATASE; KINASE; P53; ACTIVATION; PATHWAYS; PPM1D; PHOSPHORYLATION	In response to various environmental stresses, the stress-responsive MAPKs p38 and JNK are activated and phosphorylate ATF2 and c-Jun transcription factors, thereby affecting cell-fate decision. Targeted gene disruption studies have established that JNK-c-Jun signaling plays a vital role in stress-induced apoptosis. The oncogenic phosphatase Wip1 acts as an important regulator in DNA damage pathway by dephosphorylating a spectrum of proteins including p53, p38, Chk1, Chk2, and ATM. In this study we show that Wip1 negatively regulates the activation of MKK4-JNK-c-Jun signaling during stress-induced apoptosis. The loss of Wip1 function sensitizes mouse embryonic fibroblasts to stress-induced apoptosis via the activation of both p38-ATF2 and JNK-c-Jun signaling. Here we reveal that Wip1 has dual roles in alternatively regulating stress- and DNA damage-induced apoptosis through p38/JNK MAPKs and p38/p53-dependent pathways, respectively. Our results point to Wip1 as a general regulator of apoptosis, which further supports its role in tumorigenesis.	[Xia, Yun; Liou, Yih-Cherng] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117543, Singapore; [Ongusaha, Pat; Lee, Sam W.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Boston, MA 02129 USA; [Ongusaha, Pat; Lee, Sam W.] Harvard Univ, Sch Med, Boston, MA 02129 USA	National University of Singapore; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Liou, YC (corresponding author), 14 Sci Dr 4, Singapore 117543, Singapore.	dbslyc@nus.edu.sg	Xia, Yun/K-4128-2015	Xia, Yun/0000-0003-2184-4870	Biomedical Research Council [06/1/21/19/473]; Agency for Science, Research and Technology, Singapore	Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Agency for Science, Research and Technology, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported, in whole or in part, by Grant 06/1/21/19/473 from the Biomedical Research Council, the Agency for Science, Research and Technology, Singapore (to Y.C.L.).	Anderson SM, 1999, CELL DEATH DIFFER, V6, P454, DOI 10.1038/sj.cdd.4400507; Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Baldwin E. L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P363, DOI 10.2174/1568011054222364; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Choi J, 2002, MOL CELL BIOL, V22, P1094, DOI 10.1128/MCB.22.4.1094-1105.2002; Chresta CM, 1996, CANCER RES, V56, P1834; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Demidov ON, 2007, ONCOGENE, V26, P2502, DOI 10.1038/sj.onc.1210032; Demidov ON, 2007, CELL STEM CELL, V1, P180, DOI 10.1016/j.stem.2007.05.020; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Hanada M, 1998, FEBS LETT, V437, P172, DOI 10.1016/S0014-5793(98)01229-0; Harrison M, 2004, TRENDS MOL MED, V10, P359, DOI 10.1016/j.molmed.2004.06.010; Hazzalin CA, 1998, MOL CELL BIOL, V18, P1844, DOI 10.1128/MCB.18.4.1844; Hazzalin CA, 1996, CURR BIOL, V6, P1028, DOI 10.1016/S0960-9822(02)00649-8; Hershko T, 2006, J BIOL CHEM, V281, P31309, DOI 10.1074/jbc.M601758200; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; Hildesheim J, 2002, CANCER RES, V62, P7305; Hirasawa A, 2003, CLIN CANCER RES, V9, P1995; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kolbus A, 2000, MOL CELL BIOL, V20, P575, DOI 10.1128/MCB.20.2.575-582.2000; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lawler S, 1998, CURR BIOL, V8, P1387, DOI 10.1016/S0960-9822(98)00019-0; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Li J, 2002, NAT GENET, V31, P133, DOI 10.1038/ng888; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Liu G, 2006, J CELL BIOCHEM, V97, P448, DOI 10.1002/jcb.20700; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Lu XB, 2004, MOL CELL, V15, P621, DOI 10.1016/j.molcel.2004.08.007; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Manfredi JJ, 2003, MOL CELL, V11, P552, DOI 10.1016/S1097-2765(03)00106-0; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Morton S, 2004, FEBS LETT, V572, P177, DOI 10.1016/j.febslet.2004.07.031; Motoyama N, 2004, CURR OPIN GENET DEV, V14, P11, DOI 10.1016/j.gde.2003.12.003; Rossi R, 2006, CANCER RES, V66, P1675, DOI 10.1158/0008-5472.CAN-05-2741; Saito-Ohara F, 2003, CANCER RES, V63, P1876; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Shreeram S, 2006, J EXP MED, V203, P2793, DOI 10.1084/jem.20061563; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Wagner EF, 2001, ONCOGENE, V20, P2334, DOI 10.1038/sj.onc.1204416; Whitmarsh AJ, 2007, ONCOGENE, V26, P3172, DOI 10.1038/sj.onc.1210410; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899	49	32	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17428	17437		10.1074/jbc.M109.007823	http://dx.doi.org/10.1074/jbc.M109.007823			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19395378	hybrid, Green Published			2022-12-25	WOS:000267202500009
J	Li, CR; Fu, XP; Qi, X; Hu, XS; Chasteen, ND; Zhao, GH				Li, Chaorui; Fu, Xiaoping; Qi, Xin; Hu, Xiaosong; Chasteen, N. Dennis; Zhao, Guanghua			Protein Association and Dissociation Regulated by Ferric Ion A NOVEL PATHWAY FOR OXIDATIVE DEPOSITION OF IRON IN PEA SEED FERRITIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-CHAIN FERRITIN; HYDROGEN-PEROXIDE DETOXIFICATION; PISUM-SATIVUM FERRITIN; ESCHERICHIA-COLI; PLANT FERRITIN; STORAGE FUNCTION; CORE FORMATION; HORSE SPLEEN; BINDING; MECHANISM	Iron stored in phytoferritin plays an important role in the germination and early growth of seedlings. The protein is located in the amyloplast where it stores large amounts of iron as a hydrated ferric oxide mineral core within its shell-like structure. The present work was undertaken to study alternate mechanisms of core formation in pea seed ferritin (PSF). The data reveal a new mechanism for mineral core formation in PSF involving the binding and oxidation of iron at the extension peptide (EP) located on the outer surface of the protein shell. This binding induces aggregation of the protein into large assemblies of similar to 400 monomers. The bound iron is gradually translocated to the mineral core during which time the protein dissociates back into its monomeric state. Either the oxidative addition of Fe2+ to the apoprotein to form Fe3+ or the direct addition of Fe3+ to apoPSF causes protein aggregation once the binding capacity of the 24 ferroxidase centers (48 Fe3+ / shell) is exceeded. When the EP is enzymatically deleted from PSF, aggregation is not observed, and the rate of iron oxidation is significantly reduced, demonstrating that the EP is a critical structural component for iron binding, oxidation, and protein aggregation. These data point to a functional role for the extension peptide as an iron binding and ferroxidase center that contributes to mineralization of the iron core. As the iron core grows larger, the new pathway becomes less important, and Fe2+ oxidation and deposition occurs directly on the surface of the iron core.	[Li, Chaorui; Fu, Xiaoping; Hu, Xiaosong; Zhao, Guanghua] China Agr Univ, Coll Food Sci & Nutr Engn, Key Lab Fruits & Vegetables Proc, Minist Agr, Beijing 100083, Peoples R China; [Chasteen, N. Dennis] Univ New Hampshire, Dept Chem, Durham, NH 03824 USA; [Qi, Xin] Natl Inst Metrol, Beijing 100013, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; University System Of New Hampshire; University of New Hampshire; National Institute of Metrology China	Zhao, GH (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Key Lab Fruits & Vegetables Proc, Minist Agr, Beijing 100083, Peoples R China.	gzhao1000@yahoo.com	Zhao, Guanghua/GSE-4215-2022		China High-Tech [2007AA10Z333]; National Key Technology RD Program [2006BAD27B04]; National Institutes of Health [R01-GM20294]	China High-Tech; National Key Technology RD Program(National Key Technology R&D Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by China High-Tech (863) Project 2007AA10Z333 (to G.Z.) and National Key Technology R&D Program 2006BAD27B04 (to G.Z.). This project was also supported by National Institutes of Health Grant R01-GM20294 (NIGMS, to N.D.C.).	Aitken-Rogers H, 2004, J BIOL INORG CHEM, V9, P161, DOI 10.1007/s00775-003-0504-1; BAUMINGER ER, 1991, P ROY SOC B-BIOL SCI, V244, P211, DOI 10.1098/rspb.1991.0073; BAUMINGER ER, 1991, BIOCHIM BIOPHYS ACTA, V1118, P48, DOI 10.1016/0167-4838(91)90440-B; BI X, 1991, J BIOL CHEM, V266, P19965; Bou-Abdallah F, 2005, J AM CHEM SOC, V127, P3885, DOI 10.1021/ja044355k; Bou-Abdallah F, 2005, J MOL BIOL, V347, P543, DOI 10.1016/j.jmb.2005.01.007; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; Crichton RR, 1996, J BIOL INORG CHEM, V1, P567, DOI 10.1007/s007750050093; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hwang J, 2000, SCIENCE, V287, P122, DOI 10.1126/science.287.5450.122; Ivanova E, 2008, J MOL BIOL, V375, P229, DOI 10.1016/j.jmb.2007.10.037; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Kopp DA, 2002, CURR OPIN CHEM BIOL, V6, P568, DOI 10.1016/S1367-5931(02)00366-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAULHERE JP, 1989, J BIOL CHEM, V264, P3629; Lee J, 2002, J AM CHEM SOC, V124, P3042, DOI 10.1021/ja011447q; LESCURE AM, 1991, P NATL ACAD SCI USA, V88, P8222, DOI 10.1073/pnas.88.18.8222; Li CR, 2009, BIOCHIMIE, V91, P230, DOI 10.1016/j.biochi.2008.09.008; LOBREAUX S, 1992, BIOCHEM J, V288, P931, DOI 10.1042/bj2880931; Masuda T, 2001, J BIOL CHEM, V276, P19575, DOI 10.1074/jbc.M011399200; Masuda T, 2007, PROTEIN EXPRES PURIF, V56, P237, DOI 10.1016/j.pep.2007.07.011; NIITSU Y, 1973, BIOCHEMISTRY-US, V12, P4690, DOI 10.1021/bi00747a023; Pereira AS, 1998, BIOCHEMISTRY-US, V37, P9871, DOI 10.1021/bi980847w; Petsev DN, 2000, BIOPHYS J, V78, P2060, DOI 10.1016/S0006-3495(00)76753-1; RAGLAND M, 1990, J BIOL CHEM, V265, P18339; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; TONOMURA B, 1978, ANAL BIOCHEM, V84, P370, DOI 10.1016/0003-2697(78)90054-4; Treffry A, 1998, FEBS LETT, V432, P213, DOI 10.1016/S0014-5793(98)00867-9; Treffry A, 1997, BIOCHEMISTRY-US, V36, P432, DOI 10.1021/bi961830l; VANWUYTSWINKEL O, 1995, BIOCHEM J, V305, P253, DOI 10.1042/bj3050253; WALDO GS, 1995, PLANT PHYSIOL, V109, P797, DOI 10.1104/pp.109.3.797; Welch KD, 2001, FREE RADICAL BIO MED, V31, P999, DOI 10.1016/S0891-5849(01)00676-1; Yang XK, 1998, BIOCHEMISTRY-US, V37, P9743, DOI 10.1021/bi973128a; Yang XO, 2000, BIOCHEMISTRY-US, V39, P4915, DOI 10.1021/bi992631f; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200; Zhao GH, 2006, BIOCHEMISTRY-US, V45, P3429, DOI 10.1021/bi052443r; Zhao GH, 2005, J MOL BIOL, V352, P467, DOI 10.1016/j.jmb.2005.07.039; Zhao GH, 2003, BIOCHEMISTRY-US, V42, P3142, DOI 10.1021/bi027357v	38	47	55	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16743	16751		10.1074/jbc.M109.011528	http://dx.doi.org/10.1074/jbc.M109.011528			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19398557	Green Published, hybrid			2022-12-25	WOS:000266962400009
J	Thurman, JM; Renner, B; Kunchithapautham, K; Ferreira, VP; Pangburn, MK; Ablonczy, Z; Tomlinson, S; Holers, VM; Rohrer, B				Thurman, Joshua M.; Renner, Brandon; Kunchithapautham, Kannan; Ferreira, Viviana P.; Pangburn, Michael K.; Ablonczy, Zsolt; Tomlinson, Stephen; Holers, V. Michael; Rohrer, Baerbel			Oxidative Stress Renders Retinal Pigment Epithelial Cells Susceptible to Complement-mediated Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; CHOROIDAL NEOVASCULARIZATION; FUNDUS CHANGES; ACTIVATION; SECRETION; DRUSEN; RPE; RECEPTORS	Uncontrolled activation of the alternative pathway of complement is thought to be associated with age-related macular degeneration (AMD). The alternative pathway is continuously activated in the fluid phase, and tissue surfaces require continuous complement inhibition to prevent spontaneous autologous tissue injury. Here, we examined the effects of oxidative stress on the ability of immortalized human retinal pigment epithelial cells (ARPE-19) to regulate complement activation on their cell surface. Combined treatment with H2O2 (to induce oxidative stress) and complement-sufficient serum was found to disrupt the barrier function of stable ARPE-19 monolayers as determined by transepithelial resistance (TER) measurements. Neither treatment alone had any effect. TER reduction was correlated with increased cell surface deposition of C3, and could be prevented by using C7-depleted serum, an essential component of the terminal complement pathway. Treatment with H2O2 reduced surface expression of the complement inhibitors DAF, CD55, and CD59, and impaired regulation at the cell surface by factor H present within the serum. Combined treatment of the monolayers with H2O2 and serum elicited polarized secretion of vascular epidermal growth factor (VEGF). Both, secretion of VEGF and TER reduction could be attenuated using either an alternative pathway inhibitor or by blocking VEGF receptor-1/2 signaling. Regarded together, these studies demonstrate that oxidative stress reduces regulation of complement on the surface of ARPE-19 cells, increasing complement activation. This sublytic activation results in VEGF release, which mediates disruption of the cell monolayer. These findings link oxidative stress, complement activation, and apical VEGF release, which have all been associated with the pathogenesis of AMD.	[Holers, V. Michael] Univ Colorado Denver, Sch Med, Dept Med, Aurora, CO 80045 USA; [Kunchithapautham, Kannan; Ablonczy, Zsolt; Rohrer, Baerbel] Med Univ S Carolina, Dept Ophthalmol, Div Res, Charleston, SC 29425 USA; [Kunchithapautham, Kannan; Ablonczy, Zsolt; Rohrer, Baerbel] Med Univ S Carolina, Dept Neurosci, Div Res, Charleston, SC 29425 USA; [Tomlinson, Stephen] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Ferreira, Viviana P.; Pangburn, Michael K.] Univ Texas Hlth Ctr Tyler, Dept Biochem, Tyler, TX 75708 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Rohrer, B (corresponding author), 167 Ashley Ave,SEI 511, Charleston, SC 29425 USA.	rohrer@musc.edu		Thurman, Joshua Michael/0000-0002-3476-9956; Ferreira, Viviana/0000-0001-8923-5671	National Institutes of Health [DK077661, DK076690, DK035081, EY13520, EY017465, HL082485]; Vision Core [EY014793]; Foundation Fighting Blindness; American Heart Association [0735101N]; Medical University of South Carolina; NATIONAL EYE INSTITUTE [R01EY013520, R43EY017465, R24EY014793] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK035081, R01DK035081, R01DK076690, R03DK077661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vision Core; Foundation Fighting Blindness(European Commission); American Heart Association(American Heart Association); Medical University of South Carolina; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077661 and DK076690 (to J.M.T.), DK035081 (to M. K. P.), EY13520 and EY017465 (to B. R.), and HL082485 (to S. T.). This work was also supported by Vision Core Grant EY014793, the Foundation Fighting Blindness, American Heart Association Grant 0735101N (to V. P. F.), and an unrestricted grant to the Medical University of South Carolina from Research to Prevent Blindness, Inc., New York.	Ablonczy Z, 2007, EXP EYE RES, V85, P762, DOI 10.1016/j.exer.2007.08.010; Ancelin M, 2004, LAB INVEST, V84, P502, DOI 10.1038/labinvest.3700053; Atkinson JP, 2007, J EXP MED, V204, P1245, DOI 10.1084/jem.20070664; Bailey TA, 2004, INVEST OPHTH VIS SCI, V45, P675, DOI 10.1167/iovs.03-0351; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; Bora PS, 2005, J IMMUNOL, V174, P491, DOI 10.4049/jimmunol.174.1.491; Cai JY, 2000, PROG RETIN EYE RES, V19, P205, DOI 10.1016/S1350-9462(99)00009-9; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Dunn KC, 1998, INVEST OPHTH VIS SCI, V39, P2744; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; DUVALLYOUNG J, 1989, BRIT J OPHTHALMOL, V73, P297, DOI 10.1136/bjo.73.4.297; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Elward K, 2005, J BIOL CHEM, V280, P36342, DOI 10.1074/jbc.M506579200; Ferreira VP, 2006, J IMMUNOL, V177, P6308, DOI 10.4049/jimmunol.177.9.6308; Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HOGAN M J, 1972, Transactions of the American Academy of Ophthalmology and Oto-Laryngology, V76, P64; Huang YX, 2008, J IMMUNOL, V181, P8068, DOI 10.4049/jimmunol.181.11.8068; Kannan R, 2006, MOL VIS, V12, P1649; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kunchithapautham K, 2007, AUTOPHAGY, V3, P433, DOI 10.4161/auto.4294; LEYS A, 1991, GRAEF ARCH CLIN EXP, V229, P406, DOI 10.1007/BF00166300; Lopez PF, 1996, INVEST OPHTH VIS SCI, V37, P855; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Pratt JR, 2002, NAT MED, V8, P582, DOI 10.1038/nm0602-582; Prosser BE, 2007, J EXP MED, V204, P2277, DOI 10.1084/jem.20071069; Sohn JH, 2000, INVEST OPHTH VIS SCI, V41, P3492; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; Vogt SD, 2006, EXP EYE RES, V83, P834, DOI 10.1016/j.exer.2006.04.002; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	32	136	142	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16939	16947		10.1074/jbc.M808166200	http://dx.doi.org/10.1074/jbc.M808166200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19386604	Green Published, hybrid			2022-12-25	WOS:000266962400031
J	Xie, Y; Blanc, V; Kerr, TA; Kennedy, S; Luo, J; Newberry, EP; Davidson, NO				Xie, Yan; Blanc, Valerie; Kerr, Thomas A.; Kennedy, Susan; Luo, Jianyang; Newberry, Elizabeth P.; Davidson, Nicholas O.			Decreased Expression of Cholesterol 7 alpha-Hydroxylase and Altered Bile Acid Metabolism in Apobec-1(-/-) Mice Lead to Increased Gallstone Susceptibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; 7 ALPHA-HYDROXYLASE; MESSENGER-RNA LEVELS; APOLIPOPROTEIN-B; POSTTRANSCRIPTIONAL REGULATION; ENDOGENOUS TRIGLYCERIDE; CHENODEOXYCHOLIC ACID; HORMONAL-REGULATION; BINDING PROTEIN; MOUSE	Quantitative trait mapping in mice identified a susceptibility locus for gallstones (Lith6) spanning the Apobec-1 locus, the structural gene encoding the RNA-specific cytidine deaminase responsible for production of apolipoprotein B48 in mammalian small intestine and rodent liver. This observation prompted us to compare dietary gallstone susceptibility in Apobec-1(-/-) mice and congenic C57BL/6 wild type controls. When fed a lithogenic diet (LD) for 2 weeks, 90% Apobec-1(-/-) mice developed solid gallstones in comparison with 16% wild type controls. LD-fed Apobec-1(-/-) mice demonstrated increased biliary cholesterol secretion as well as increased cholesterol saturation and bile acid hydrophobicity indices. These changes occurred despite a relative decrease in cholesterol absorption in LD-fed Apobec-1(-/-) mice. Among the possible mechanisms to account for this phenotype, expression of Cyp7a1 mRNA and protein were significantly decreased in chow-fed Apobec-1(-/-) mice, decreasing further in LD-fed animals. Cyp7a1 transcription in hepatocyte nuclei, however, was unchanged in Apobec-1(-/-) mice, excluding transcriptional repression as a potential mechanism for decreased Cyp7a1 expression. We demonstrated that APOBEC-1 binds to AU-rich regions of the 3'-untranslated region of the Cyp7a1 transcript, containing the UUUN(A/U)U consensus motif, using both UV cross-linking to recombinant APOBEC-1 and in vivo RNA co-immunoprecipitation. In vivo Apobec-1-dependent modulation of Cyp7a1 expression was further confirmed following adenovirus-Apobec-1 administration to chow-fed Apobec-1(-/-) mice, which rescued Cyp7a1 gene expression. Taken together, the findings suggest that the AU-rich RNA binding-protein Apobec-1 mediates post-transcriptional regulation of murine Cyp7a1 expression and influences susceptibility to diet-induced gallstone formation.	[Xie, Yan; Blanc, Valerie; Kerr, Thomas A.; Kennedy, Susan; Luo, Jianyang; Newberry, Elizabeth P.; Davidson, Nicholas O.] Washington Univ, GI Div, Sch Med, Dept Med, St Louis, MO 63110 USA; [Davidson, Nicholas O.] Washington Univ, Sch Med, Dept Pharmacol & Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Davidson, NO (corresponding author), Washington Univ, GI Div, Sch Med, Dept Med, 660 S Euclid Ave, St Louis, MO 63110 USA.	nod@wustl.edu	Kerr, Thomas/C-2190-2011	Kerr, Thomas/0000-0002-7432-3289	National Institutes of Health [R01 DK056260, R37 HL038180, P30 DK052574]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL038180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R01DK056260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK056260 and R37 HL038180 (to N. O. D.) and P30 DK052574 (to N. O. D. and the Washington University Digestive Diseases Research Core Center, in particular the Morphology and Functional Genomics Cores).	Agellon LB, 1997, BIOCHEM J, V328, P393; Amigo L, 2006, GASTROENTEROLOGY, V131, P1870, DOI 10.1053/j.gastro.2006.08.029; Anant S, 2004, GASTROENTEROLOGY, V127, P1139, DOI 10.1053/j.gastro.2004.06.022; Anant S, 2000, MOL CELL BIOL, V20, P1982, DOI 10.1128/MCB.20.6.1982-1992.2000; ANGELIN B, 1978, J LIPID RES, V19, P1004; ANGELIN B, 1978, J LIPID RES, V19, P1017; Baker DM, 2000, J BIOL CHEM, V275, P19985, DOI 10.1074/jbc.M002351200; Blanc V, 2001, J BIOL CHEM, V276, P10272, DOI 10.1074/jbc.M006435200; Blanc V, 2007, CANCER RES, V67, P8565, DOI 10.1158/0008-5472.CAN-07-1593; CAREY MC, 1978, J LIPID RES, V19, P945; Castro J, 2007, HEPATOLOGY, V45, P1261, DOI 10.1002/hep.21616; Chen CYA, 2007, RNA, V13, P1775, DOI 10.1261/rna.663507; Davidson NO, 2000, ANNU REV NUTR, V20, P169, DOI 10.1146/annurev.nutr.20.1.169; Farese RV, 1996, P NATL ACAD SCI USA, V93, P6393, DOI 10.1073/pnas.93.13.6393; Feingold KR, 1996, J LIPID RES, V37, P223; HEUMAN DM, 1989, J LIPID RES, V30, P719; Hirano K, 1996, J BIOL CHEM, V271, P9887, DOI 10.1074/jbc.271.17.9887; Hirokane H, 2004, J BIOL CHEM, V279, P45685, DOI 10.1074/jbc.M404255200; HYLEMON PB, 1992, J BIOL CHEM, V267, P16866; Ishibashi S, 1996, J BIOL CHEM, V271, P18017, DOI 10.1074/jbc.271.30.18017; Kulinski A, 2002, J BIOL CHEM, V277, P31516, DOI 10.1074/jbc.M202015200; Lammert F, 2001, GASTROENTEROLOGY, V120, P221, DOI 10.1053/gast.2001.20878; LI YC, 1990, J BIOL CHEM, V265, P12012; Lyons MA, 2003, J LIPID RES, V44, P1763, DOI 10.1194/jlr.M300149-JLR200; Lyons MA, 2003, J LIPID RES, V44, P953, DOI 10.1194/jlr.M300002-JLR200; Lyons MA, 2006, GASTROENTEROLOGY, V131, P1943, DOI 10.1053/j.gastro.2006.10.024; MILLER NE, 1974, LANCET, V2, P929; Moschetta A, 2004, NAT MED, V10, P1352, DOI 10.1038/nm1138; NESS GC, 1990, BIOCHEM BIOPH RES CO, V172, P1150, DOI 10.1016/0006-291X(90)91568-D; NOSHIRO M, 1990, J BIOL CHEM, V265, P10036; Pandak WM, 1996, AM J PHYSIOL-GASTR L, V270, pG401, DOI 10.1152/ajpgi.1996.270.3.G401; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; ROSSI SS, 1987, J LIPID RES, V28, P589; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; Schwarz M, 1998, J LIPID RES, V39, P1833; Schwarz M, 1996, J BIOL CHEM, V271, P18024, DOI 10.1074/jbc.271.30.18017; SETCHELL KDR, 1983, J LIPID RES, V24, P1085; SHIELS BR, 1987, J BIOL CHEM, V262, P12826; Sowden MP, 2002, J CELL SCI, V115, P1027; STRAKA MS, 1990, J BIOL CHEM, V265, P7145; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Wang DQH, 2003, J LIPID RES, V44, P1042, DOI 10.1194/jlr.D200041-JLR200; Wang DQH, 2001, J LIPID RES, V42, P1820; Wang HH, 2005, HEPATOLOGY, V42, P894, DOI 10.1002/hep.20867; Wang YW, 1997, J BIOL CHEM, V272, P12272, DOI 10.1074/jbc.272.19.12272; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Xie Y, 2006, J BIOL CHEM, V281, P4075, DOI 10.1074/jbc.M510622200; Yamasaki S, 2007, J BIOL CHEM, V282, P30070, DOI 10.1074/jbc.M706273200; Zanlungo S, 2004, CURR OPIN LIPIDOL, V15, P279, DOI 10.1097/00041433-200406000-00007	49	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16860	16871		10.1074/jbc.M109.010173	http://dx.doi.org/10.1074/jbc.M109.010173			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19386592	Green Published, hybrid			2022-12-25	WOS:000266962400022
J	Choi, DY; Liu, M; Hunter, RL; Cass, WA; Pandya, JD; Sullivan, PG; Shin, EJ; Kim, HC; Gash, DM; Bing, GY				Choi, Dong-Young; Liu, Mei; Hunter, Randy L.; Cass, Wayne A.; Pandya, Jignesh D.; Sullivan, Patrick G.; Shin, Eun-Joo; Kim, Hyoung-Chun; Gash, Don M.; Bing, Guoying			Striatal Neuroinflammation Promotes Parkinsonism in Rats	PLOS ONE			English	Article								Background: Sporadic Parkinson's disease (PD) is a progressive neurodegenerative disorder with unknown cause, but it has been suggested that neuroinflammation may play a role in pathogenesis of the disease. Neuroinflammatory component in process of PD neurodegeneration was proposed by postmortem, epidemiological and animal model studies. However, it remains unclear how neuroinflammatory factors contribute to dopaminergic neuronal death in PD. Findings: In this study, we analyzed the relationship among inducible nitric oxide synthase (iNOS)-derived NO, mitochondrial dysfunction and dopaminergic neurodegeneration to examine the possibility that microglial neuroinflammation may induce dopaminergic neuronal loss in the substantia nigra. Unilateral injection of lipopolysaccharide (LPS) into the striatum of rat was followed by immunocytochemical, histological, neurochemical and biochemical analyses. In addition, behavioral assessments including cylinder test and amphetamine-induced rotational behavior test were employed to validate ipsilateral damage to the dopamine nigrostriatal pathway. LPS injection caused progressive degeneration of the dopamine nigrostriatal system, which was accompanied by motor impairments including asymmetric usage of forelimbs and amphetamine-induced turning behavior in animals. Interestingly, some of the remaining nigral dopaminergic neurons had intracytoplasmic accumulation of alpha-synuclein and ubiquitin. Furthermore, defect in the mitochondrial respiratory chain, and extensive S-nitrosylation/nitration of mitochondrial complex I were detected prior to the dopaminergic neuronal loss. The mitochondrial injury was prevented by treatment with L-N-6-(l-iminoethyl)-lysine, an iNOS inhibitor, suggesting that iNOS-derived NO is associated with the mitochondrial impairment. Conclusions: These results implicate neuroinflammation-induced S-nitrosylation/nitration of mitochondrial complex I in mitochondrial malfunction and subsequent degeneration of the nigral dopamine neurons.			Choi, DY (corresponding author), Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA.	gbing@uky.edu		Bing, Guoying/0000-0003-0609-8152	NINDS NIH HHS [R01 NS044157, NS39345, NS044157] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039345, R01NS044157] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antunes F, 2002, BBA-BIOENERGETICS, V1556, P233, DOI 10.1016/S0005-2728(02)00365-1; Ara J, 1998, P NATL ACAD SCI USA, V95, P7659, DOI 10.1073/pnas.95.13.7659; Arimoto T, 2003, NEUROBIOL DIS, V12, P35, DOI 10.1016/S0969-9961(02)00017-7; Arimoto T, 2007, NEUROBIOL AGING, V28, P894, DOI 10.1016/j.neurobiolaging.2006.04.011; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Banati RB, 1998, MOVEMENT DISORD, V13, P221, DOI 10.1002/mds.870130205; BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117; Barger SW, 2001, J NEUROCHEM, V76, P846, DOI 10.1046/j.1471-4159.2001.00075.x; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Brown GC, 2004, BBA-BIOENERGETICS, V1658, P44, DOI 10.1016/j.bbabio.2004.03.016; Brown MR, 2006, J BIOL CHEM, V281, P11658, DOI 10.1074/jbc.M510303200; Cass WA, 2003, BRAIN RES, V984, P133, DOI 10.1016/S0006-8993(03)03122-6; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chen HL, 2005, ANN NEUROL, V58, P963, DOI 10.1002/ana.20682; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631; Cohen G, 1999, J NEUROCHEM, V73, P2310, DOI 10.1046/j.1471-4159.1999.0732310.x; COSTALL B, 1985, BRIT J PHARMACOL, V85, P943, DOI 10.1111/j.1476-5381.1985.tb11095.x; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Duda JE, 2000, AM J PATHOL, V157, P1439, DOI 10.1016/S0002-9440(10)64781-5; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Fang JG, 2007, P NATL ACAD SCI USA, V104, P18742, DOI 10.1073/pnas.0705904104; Gash DM, 2008, ANN NEUROL, V63, P184, DOI 10.1002/ana.21288; GEHRMANN J, 1995, NEUROPATH APPL NEURO, V21, P277, DOI 10.1111/j.1365-2990.1995.tb01062.x; Georgievska B, 2004, EUR J NEUROSCI, V20, P3121, DOI 10.1111/j.1460-9568.2004.03770.x; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Herrera AJ, 2000, NEUROBIOL DIS, V7, P429, DOI 10.1006/nbdi.2000.0289; Hsieh PF, 2002, NEUROREPORT, V13, P277, DOI 10.1097/00001756-200203040-00006; Hunot S, 1996, NEUROSCIENCE, V72, P355, DOI 10.1016/0306-4522(95)00578-1; Hunter RL, 2007, J NEUROCHEM, V100, P1375, DOI 10.1111/j.1471-4159.2006.04327.x; HUNTER RL, 2009, J NEUROSCI RES; Knott C, 2000, MOL CELL NEUROSCI, V16, P724, DOI 10.1006/mcne.2000.0914; LANGSTON JW, 1984, ACTA NEUROL SCAND, V70, P49; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Langston JW, 1999, ANN NEUROL, V46, P598, DOI 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F; Liberatore GT, 1999, NAT MED, V5, P1403; Liu M, 2008, J NEUROSCI RES, V86, P2792, DOI 10.1002/jnr.21725; Lundblad M, 2002, EUR J NEUROSCI, V15, P120, DOI 10.1046/j.0953-816x.2001.01843.x; McGeer PL, 2003, ANN NEUROL, V54, P599, DOI 10.1002/ana.10728; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; McNaught KSP, 2001, NAT REV NEUROSCI, V2, P589, DOI 10.1038/35086067; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Schapira AHV, 2007, CELL DEATH DIFFER, V14, P1261, DOI 10.1038/sj.cdd.4402160; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Tangpong J, 2007, J NEUROCHEM, V100, P191, DOI 10.1111/j.1471-4159.2006.04179.x; Teismann P, 2003, P NATL ACAD SCI USA, V100, P5473, DOI 10.1073/pnas.0837397100; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Yagami T, 2004, NEUROBIOL DIS, V16, P481, DOI 10.1016/j.nbd.2004.04.013; Zhang J, 2005, NEUROSCIENCE, V135, P829, DOI 10.1016/j.neuroscience.2005.06.049; ZIGMOND MJ, 1990, TRENDS NEUROSCI, V13, P290, DOI 10.1016/0166-2236(90)90112-N	59	93	97	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5482	10.1371/journal.pone.0005482	http://dx.doi.org/10.1371/journal.pone.0005482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424495	Green Published, gold, Green Submitted			2022-12-25	WOS:000265933800014
J	Song, SQ; Huang, QL; Guo, JM; Li-Ling, J; Chen, XP; Ma, F				Song, Shiqin; Huang, Qianli; Guo, Jiaming; Li-Ling, Jesse; Chen, Xueping; Ma, Fei			Comparative Component Analysis of Exons with Different Splicing Frequencies	PLOS ONE			English	Article							SELECTION PRESSURE; INTRONIC SEQUENCES; MESSENGER-RNA; GC CONTENT; EVENTS; CONSERVATION; EVOLUTION; ELEMENTS; MOUSE; IDENTIFICATION	Transcriptional isoforms are not just random combinations of exons. What has caused exons to be differentially spliced and whether exons with different splicing frequencies are subjected to divergent regulation by potential elements or splicing signals? Beyond the conventional classification for alternatively spliced exons (ASEs) and constitutively spliced exons (CSEs), we have classified exons from alternatively spliced human genes and their mouse orthologs (12,314 and 5,464, respectively) into four types based on their splicing frequencies. Analysis has indicated that different groups of exons presented divergent compositional and regulatory properties. Interestingly, with the decrease of splicing frequency, exons tend to have greater lengths, higher GC content, and contain more splicing elements and repetitive elements, which seem to imply that the splicing frequency is influenced by such factors. Comparison of non-alternatively spliced (NAS) mouse genes with alternatively spliced human orthologs also suggested that exons with lower splicing frequencies may be newly evolved ones which gained functions with splicing frequencies altered through the evolution. Our findings have revealed for the first time that certain factors may have critical influence on the splicing frequency, suggesting that exons with lower splicing frequencies may originate from old repetitive sequences, with splicing sites altered by mutation, gaining novel functions and become more frequently spliced.			Song, SQ (corresponding author), Univ Sci & Technol China, Dept Chem, Hefei 230026, Peoples R China.	ustcchxp@sina.com; feima1968@gmail.com						Alekseyenko AV, 2007, RNA, V13, P661, DOI 10.1261/rna.325107; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Baek D, 2005, P NATL ACAD SCI USA, V102, P12813, DOI 10.1073/pnas.0506139102; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Boue S, 2003, BIOESSAYS, V25, P1031, DOI 10.1002/bies.10371; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Clark F, 2002, HUM MOL GENET, V11, P451, DOI 10.1093/hmg/11.4.451; Galante PAF, 2004, RNA, V10, P757, DOI 10.1261/rna.5123504; Garg K, 2007, GENOME RES, V17, P1015, DOI 10.1101/gr.6347907; Gotea V, 2006, TRENDS GENET, V22, P260, DOI 10.1016/j.tig.2006.03.006; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Hasler J, 2006, NUCLEIC ACIDS RES, V34, P5491, DOI 10.1093/nar/gkl706; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Imanishi T, 2004, PLOS BIOL, V2, P856, DOI 10.1371/journal.pbio.0020162; Itoh H, 2004, RNA, V10, P1005, DOI 10.1261/rna.5221604; Kan Z, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P42; Kim E, 2008, BIOESSAYS, V30, P38, DOI 10.1002/bies.20692; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Kondrashov FA, 2001, HUM MOL GENET, V10, P2661, DOI 10.1093/hmg/10.23.2661; Ladd AN, 2002, GENOME BIOL, V3; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lareau LF, 2004, CURR OPIN STRUC BIOL, V14, P273, DOI 10.1016/j.sbi.2004.05.002; Letunic I, 2002, HUM MOL GENET, V11, P1561, DOI 10.1093/hmg/11.13.1561; Lev-Maor G, 2003, SCIENCE, V300, P1288, DOI 10.1126/science.1082588; Lev-Maor G, 2007, PLOS GENET, V3, P2221, DOI 10.1371/journal.pgen.0030203; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; MAKALOWSKI W, 1994, TRENDS GENET, V10, P188, DOI 10.1016/0168-9525(94)90254-2; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Nurtdinov RN, 2003, HUM MOL GENET, V12, P1313, DOI 10.1093/hmg/ddg137; Oliver JL, 1996, J MOL EVOL, V43, P216, DOI 10.1007/PL00006080; Pozzoli U, 2005, CELL MOL LIFE SCI, V62, P1579, DOI 10.1007/s00018-005-5030-6; Sela N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r127; Sorek R, 2004, GENOME RES, V14, P1617, DOI 10.1101/gr.2572604; Sorek R, 2004, MOL CELL, V14, P221, DOI 10.1016/S1097-2765(04)00181-9; Sorek R, 2003, GENOME RES, V13, P1631, DOI 10.1101/gr.1208803; Sorek R, 2002, GENOME RES, V12, P1060, DOI 10.1101/gr.229302; Stamm S, 2000, DNA CELL BIOL, V19, P739, DOI 10.1089/104454900750058107; Su ZX, 2006, GENOME RES, V16, P182, DOI 10.1101/gr.4197006; Sugnet CW, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P66; Thanaraj T A, 2003, Prog Mol Subcell Biol, V31, P1; Thanaraj TA, 2003, NUCLEIC ACIDS RES, V31, P2544, DOI 10.1093/nar/gkg355; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang JH, 2005, NUCLEIC ACIDS RES, V33, P5053, DOI 10.1093/nar/gki810; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Xia XH, 2003, J MOL EVOL, V56, P362, DOI 10.1007/s00239-002-2406-1; Xing Y, 2005, P NATL ACAD SCI USA, V102, P13526, DOI 10.1073/pnas.0501213102; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zhang XHF, 2005, MOL CELL BIOL, V25, P7323, DOI 10.1128/MCB.25.16.7323-7332.2005; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zhang XHF, 2006, P NATL ACAD SCI USA, V103, P13427, DOI 10.1073/pnas.0603042103; Zheng CL, 2005, RNA, V11, P1777, DOI 10.1261/rna.2660805	60	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5387	10.1371/journal.pone.0005387	http://dx.doi.org/10.1371/journal.pone.0005387			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404386	gold, Green Published, Green Submitted			2022-12-25	WOS:000265614900006
J	Raman, B; Pan, C; Hurst, GB; Rodriguez, M; McKeown, CK; Lankford, PK; Samatova, NF; Mielenz, JR				Raman, Babu; Pan, Chongle; Hurst, Gregory B.; Rodriguez, Miguel, Jr.; McKeown, Catherine K.; Lankford, Patricia K.; Samatova, Nagiza F.; Mielenz, Jonathan R.			Impact of Pretreated Switchgrass and Biomass Carbohydrates on Clostridium thermocellum ATCC 27405 Cellulosome Composition: A Quantitative Proteomic Analysis	PLOS ONE			English	Article								Background: Economic feasibility and sustainability of lignocellulosic ethanol production requires the development of robust microorganisms that can efficiently degrade and convert plant biomass to ethanol. The anaerobic thermophilic bacterium Clostridium thermocellum is a candidate microorganism as it is capable of hydrolyzing cellulose and fermenting the hydrolysis products to ethanol and other metabolites. C. thermocellum achieves efficient cellulose hydrolysis using multiprotein extracellular enzymatic complexes, termed cellulosomes. Methodology/Principal Findings: In this study, we used quantitative proteomics (multidimensional LC-MS/MS and N-15-metabolic labeling) to measure relative changes in levels of cellulosomal subunit proteins (per CipA scaffoldin basis) when C. thermocellum ATCC 27405 was grown on a variety of carbon sources [dilute-acid pretreated switchgrass, cellobiose, amorphous cellulose, crystalline cellulose (Avicel) and combinations of crystalline cellulose with pectin or xylan or both]. Cellulosome samples isolated from cultures grown on these carbon sources were compared to N-15 labeled cellulosome samples isolated from crystalline cellulose-grown cultures. In total from all samples, proteomic analysis identified 59 dockerin-and 8 cohesin-module containing components, including 16 previously undetected cellulosomal subunits. Many cellulosomal components showed differential protein abundance in the presence of non-cellulose substrates in the growth medium. Cellulosome samples from amorphous cellulose, cellobiose and pretreated switchgrass-grown cultures displayed the most distinct differences in composition as compared to cellulosome samples from crystalline cellulose-grown cultures. While Glycoside Hydrolase Family 9 enzymes showed increased levels in the presence of crystalline cellulose, and pretreated switchgrass, in particular, GH5 enzymes showed increased levels in response to the presence of cellulose in general, amorphous or crystalline. Conclusions/Significance: Overall, the quantitative results suggest a coordinated substrate-specific regulation of cellulosomal subunit composition in C. thermocellum to better suit the organism's needs for growth under different conditions. To date, this study provides the most comprehensive comparison of cellulosomal compositional changes in C. thermocellum in response to different carbon sources. Such studies are vital to engineering a strain that is best suited to grow on specific substrates of interest and provide the building blocks for constructing designer cellulosomes with tailored enzyme composition for industrial ethanol production.			Raman, B (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA.	mielenzjr@ornl.gov	Pan, Chongle/C-6960-2008	Pan, Chongle/0000-0003-2860-0334; Hurst, Gregory/0000-0002-7650-8009				Arai T, 2001, APPL MICROBIOL BIOT, V57, P660, DOI 10.1007/s00253-001-0832-4; Barr BK, 1996, BIOCHEMISTRY-US, V35, P586, DOI 10.1021/bi9520388; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; BAYER EA, 1985, J BACTERIOL, V163, P552, DOI 10.1128/JB.163.2.552-559.1985; Bayer EA, 1998, J STRUCT BIOL, V124, P221, DOI 10.1006/jsbi.1998.4065; Bayer EA, 1998, CURR OPIN STRUC BIOL, V8, P548, DOI 10.1016/S0959-440X(98)80143-7; BAYER EA, 1986, J BACTERIOL, V167, P828, DOI 10.1128/jb.167.3.828-836.1986; Bayer EA, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P578, DOI 10.1007/0-387-30742-7_19; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Demain AL, 2005, MICROBIOL MOL BIOL R, V69, P124, DOI 10.1128/MMBR.69.1.124-154.2005; Dror TW, 2005, J BACTERIOL, V187, P2261, DOI 10.1128/JB.187.7.2261-2266.2005; Dror TW, 2003, J BACTERIOL, V185, P5109, DOI 10.1128/JB.185.17.5109-5116.2003; Dror TW, 2003, J BACTERIOL, V185, P3042, DOI 10.1128/JB.185.10.3042-3048.2003; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fuchs KP, 2003, MICROBIOL-SGM, V149, P1021, DOI 10.1099/mic.0.26153-0; GERWIG GJ, 1989, J BIOL CHEM, V264, P1027; Gold ND, 2007, J BACTERIOL, V189, P6787, DOI 10.1128/JB.00882-07; Halstead JR, 1999, MICROBIOL-SGM, V145, P3101, DOI 10.1099/00221287-145-11-3101; Hayashi H, 1997, J BACTERIOL, V179, P4246, DOI 10.1128/jb.179.13.4246-4253.1997; Hayashi H, 1999, APPL MICROBIOL BIOT, V51, P348, DOI 10.1007/s002530051401; JOLIFF G, 1986, NUCLEIC ACIDS RES, V14, P8605, DOI 10.1093/nar/14.21.8605; Kataeva I, 1999, J BACTERIOL, V181, P5288, DOI 10.1128/JB.181.17.5288-5295.1999; KRUUS K, 1995, J BACTERIOL, V177, P1641, DOI 10.1128/jb.177.6.1641-1644.1995; KRUUS K, 1995, P NATL ACAD SCI USA, V92, P9254, DOI 10.1073/pnas.92.20.9254; Kurokawa J, 2002, APPL MICROBIOL BIOT, V59, P455, DOI 10.1007/s00253-002-1048-y; Kurokawa J, 2001, BIOSCI BIOTECH BIOCH, V65, P548, DOI 10.1271/bbb.65.548; LAMED R, 1983, J BACTERIOL, V156, P828, DOI 10.1128/JB.156.2.828-836.1983; LEMAIRE M, 1993, J BACTERIOL, V175, P3353, DOI 10.1128/jb.175.11.3353-3360.1993; LEMAIRE M, 1995, J BACTERIOL, V177, P2451, DOI 10.1128/jb.177.9.2451-2459.1995; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; MISHRA S, 1991, J BACTERIOL, V173, P80, DOI 10.1128/jb.173.1.80-85.1991; MORAG E, 1990, J BACTERIOL, V172, P6098, DOI 10.1128/jb.172.10.6098-6105.1990; Newcomb M, 2007, P NATL ACAD SCI USA, V104, P3747, DOI 10.1073/pnas.0700087104; Pan CL, 2006, ANAL CHEM, V78, P7121, DOI 10.1021/ac060654b; Pan CL, 2006, ANAL CHEM, V78, P7110, DOI 10.1021/ac0606554; SALAMITOU S, 1994, J BACTERIOL, V176, P2822, DOI 10.1128/JB.176.10.2822-2827.1994; SALAMITOU S, 1994, J BACTERIOL, V176, P2828, DOI 10.1128/JB.176.10.2828-2834.1994; Schell DJ, 2003, APPL BIOCHEM BIOTECH, V105, P69, DOI 10.1385/ABAB:105:1-3:69; Schwarz WH, 2001, APPL MICROBIOL BIOT, V56, P634, DOI 10.1007/s002530100710; Stevenson DM, 2005, APPL ENVIRON MICROB, V71, P4672, DOI 10.1128/AEM.71.8.4672-4678.2005; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; WANG WK, 1993, J BACTERIOL, V175, P1293, DOI 10.1128/JB.175.5.1293-1302.1993; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Zhang YHP, 2006, BIOMACROMOLECULES, V7, P644, DOI 10.1021/bm050799c; Zhang YHP, 2005, J BACTERIOL, V187, P99, DOI 10.1128/JB.187.1.99-106.2005; Zverlov VV, 2008, ANN NY ACAD SCI, V1125, P298, DOI 10.1196/annals.1419.008; Zverlov VV, 2005, PROTEOMICS, V5, P3646, DOI 10.1002/pmic.200401199; Zverlov VV, 2005, MICROBIOL-SGM, V151, P3395, DOI 10.1099/mic.0.28206-0; Zverlov VV, 2005, FEMS MICROBIOL LETT, V249, P353, DOI 10.1016/j.femsle.2005.06.037; Zverlov VV, 2003, MICROBIOL-SGM, V149, P515, DOI 10.1099/mic.0.25959-0; Zverlov VV, 2002, APPL ENVIRON MICROB, V68, P3176, DOI 10.1128/AEM.68.6.3176-3179.2002; Zverlov VV, 2002, MICROBIOL-SGM, V148, P247, DOI 10.1099/00221287-148-1-247; Zverlov VV, 1999, APPL MICROBIOL BIOT, V51, P852, DOI 10.1007/s002530051473; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	58	195	201	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5271	10.1371/journal.pone.0005271	http://dx.doi.org/10.1371/journal.pone.0005271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384422	Green Published, gold			2022-12-25	WOS:000265513900014
J	Wu, ZH; Hansmann, B; Meyer-Hoffert, U; Glaser, R; Schroder, JM				Wu, Zhihong; Hansmann, Britta; Meyer-Hoffert, Ulf; Glaeser, Regine; Schroeder, Jens-Michael			Molecular Identification and Expression Analysis of Filaggrin-2, a Member of the S100 Fused-Type Protein Family	PLOS ONE			English	Article							EPIDERMAL DIFFERENTIATION COMPLEX; CALCIUM-BINDING PROTEINS; PROLINE-RICH PROTEINS; CORNIFIED ENVELOPE; STRUCTURAL PROTEINS; GENE FAMILY; PEPTIDYLARGININE DEIMINASE; HUMAN PROFILAGGRIN; SKIN-BARRIER; TRICHOHYALIN	Genes of the S100 fused-type protein (SFTP) family are clustered within the epidermal differentiation complex and encode essential components that maintain epithelial homeostasis and barrier functions. Recent genetic studies have shown that mutations within the gene encoding the SFTP filaggrin cause ichthyosis vulgaris and are major predisposing factors for atopic dermatitis. As a vital component of healthy skin, filaggrin is also a precursor of natural moisturizing factors. Here we present the discovery of a member of this family, designated as filaggrin-2 (FLG2) that is expressed in human skin. The FLG2 gene encodes a histidine-and glutamine-rich protein of approximately 248 kDa, which shares common structural features with other SFTP members, in particular filaggrin. We found that FLG2 transcripts are present in skin, thymus, tonsils, stomach, testis and placenta. In cultured primary keratinocytes, FLG2 mRNA expression displayed almost the same kinetics as that of filaggrin following Ca2+ stimulation, suggesting an important role in molecular regulation of epidermal terminal differentiation. We provide evidences that like filaggrin, FLG2 is initially expressed by upper granular cells, proteolytically processed and deposited in the stratum granulosum and stratum corneum (SC) layers of normal epidermis. Thus, FLG2 and filaggrin may have overlapping and perhaps synergistic roles in the formation of the epidermal barrier, protecting the skin from environmental insults and the escape of moisture by offering precursors of natural moisturizing factors.			Wu, ZH (corresponding author), Univ Hosp Schleswig Holstein, Dept Dermatol, Kiel, Germany.	jschroeder@dermatology.uni-kiel.de	Wu, Zhihong/AAK-3433-2020; Wu, Zhihong/G-3569-2011; Meyer-Hoffert, Ulf/F-4623-2012; Gläser, Regine/B-3168-2010	Meyer-Hoffert, Ulf/0000-0003-2305-1428; 				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BANKSSCHLEGEL S, 1981, J CELL BIOL, V90, P732, DOI 10.1083/jcb.90.3.732; BRIAND JP, 1985, J IMMUNOL METHODS, V78, P59, DOI 10.1016/0022-1759(85)90329-1; Cabral A, 2001, J BIOL CHEM, V276, P19231, DOI 10.1074/jbc.M100336200; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Contzler R, 2005, J INVEST DERMATOL, V124, P990, DOI 10.1111/j.0022-202X.2005.23694.x; Dale B. A., 1994, KERATINOCYTE HDB, P323; DALE BA, 1985, J CELL BIOL, V101, P1257, DOI 10.1083/jcb.101.4.1257; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; GAN SQ, 1990, BIOCHEMISTRY-US, V29, P9432, DOI 10.1021/bi00492a018; Gross Liza, 2008, PLoS Biol, V6, pe133, DOI 10.1371/journal.pbio.0060133; Heger A, 2000, PROTEINS, V41, P224, DOI 10.1002/1097-0134(20001101)41:2<224::AID-PROT70>3.0.CO;2-Z; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; HOHL D, 1991, J BIOL CHEM, V266, P6626; Huber M, 2005, J INVEST DERMATOL, V124, P998, DOI 10.1111/j.0022-202X.2005.23675.x; IshidaYamamoto A, 1997, BRIT J DERMATOL, V137, P9, DOI 10.1046/j.1365-2133.1997.17611855.x; Jackson B, 2005, J INVEST DERMATOL, V124, P1062, DOI 10.1111/j.0022-202X.2005.23699.x; Kahlem P, 1996, P NATL ACAD SCI USA, V93, P14580, DOI 10.1073/pnas.93.25.14580; Kalinin A, 2001, J CELL SCI, V114, P3069; Kanno T, 2000, J INVEST DERMATOL, V115, P813, DOI 10.1046/j.1523-1747.2000.00131.x; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Krieg P, 1997, GENOMICS, V43, P339, DOI 10.1006/geno.1997.4818; Lee JH, 1996, J BIOL CHEM, V271, P4561; LEE SC, 1993, J INVEST DERMATOL, V100, P65, DOI 10.1111/1523-1747.ep12354504; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Makino T, 2001, J BIOL CHEM, V276, P47445, DOI 10.1074/jbc.M107512200; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Marenholz I, 1996, GENOMICS, V37, P295, DOI 10.1006/geno.1996.0563; Matsuki M, 1998, P NATL ACAD SCI USA, V95, P1044, DOI 10.1073/pnas.95.3.1044; McGrath JA, 2008, TRENDS MOL MED, V14, P20, DOI 10.1016/j.molmed.2007.10.006; MCKINLEYGRANT LJ, 1989, P NATL ACAD SCI USA, V86, P4848, DOI 10.1073/pnas.86.13.4848; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; Moretti S, 2007, NUCLEIC ACIDS RES, V35, pW645, DOI 10.1093/nar/gkm333; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Pearton DJ, 2002, J INVEST DERMATOL, V119, P661, DOI 10.1046/j.1523-1747.2002.01831.x; Pendegrass CJ, 2006, J ANAT, V209, P59, DOI 10.1111/j.1469-7580.2006.00595.x; PILLAI S, 1990, J CELL PHYSIOL, V143, P294, DOI 10.1002/jcp.1041430213; Presland RB, 1997, J INVEST DERMATOL, V108, P170, DOI 10.1111/1523-1747.ep12333356; PRESLAND RB, 1992, J BIOL CHEM, V267, P23772; Presland RB, 2000, CRIT REV ORAL BIOL M, V11, P383, DOI 10.1177/10454411000110040101; Rawlings A.V., 2004, DERMATOL THER S1, V17, P43, DOI [10.1111/j.1396-0296.2004.04s1005.x, DOI 10.1111/J.1396-0296.2004.04S1005.X]; Rozen S, 2000, Methods Mol Biol, V132, P365; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandilands A, 2007, J INVEST DERMATOL, V127, P1282, DOI 10.1038/sj.jid.5700876; Sastry M, 1998, STRUCTURE, V6, P223, DOI 10.1016/S0969-2126(98)00023-9; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Segre JA, 2006, J INVEST DERMATOL, V126, P1202, DOI 10.1038/sj.jid.5700367; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Smith FJD, 1996, NAT GENET, V13, P450, DOI 10.1038/ng0896-450; Steinert PM, 1998, J STRUCT BIOL, V122, P76, DOI 10.1006/jsbi.1998.3957; STEINERT PM, 1981, P NATL ACAD SCI-BIOL, V78, P4097, DOI 10.1073/pnas.78.7.4097; Steinert PM, 2003, J BIOL CHEM, V278, P41409, DOI 10.1074/jbc.M302037200; Steinert PM, 1998, J BIOL CHEM, V273, P11758, DOI 10.1074/jbc.273.19.11758; TAKAHASHI M, 1994, FEBS LETT, V340, P173, DOI 10.1016/0014-5793(94)80131-2; Takaishi M, 2005, J BIOL CHEM, V280, P4696, DOI 10.1074/jbc.M409026200; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarcsa E, 1997, J BIOL CHEM, V272, P27893, DOI 10.1074/jbc.272.44.27893; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Toulza E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r107; VARADARAJ K, 1994, GENE, V140, P1, DOI 10.1016/0378-1119(94)90723-4; Wan H, 2003, J CELL SCI, V116, P4239, DOI 10.1242/jcs.00701; WATANABE S, 1991, Journal of Dermatology (Tokyo), V18, P143; Wiedow O, 1998, BIOCHEM BIOPH RES CO, V248, P904, DOI 10.1006/bbrc.1998.9069; WU Z, 2009, J INVEST DE IN PRESS; Xu ZX, 2000, GENOMICS, V69, P322, DOI 10.1006/geno.2000.6344; Zhao XP, 1997, GENOMICS, V45, P250, DOI 10.1006/geno.1997.4952; Zhao Y, 2007, J INVEST DERMATOL, V127, P1878, DOI 10.1038/sj.jid.5700817	69	83	87	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5227	10.1371/journal.pone.0005227	http://dx.doi.org/10.1371/journal.pone.0005227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384417	Green Submitted, gold, Green Published			2022-12-25	WOS:000265513900005
J	Bistulfi, G; Diegelman, P; Foster, BA; Kramer, DL; Porter, CW; Smiraglia, DJ				Bistulfi, G.; Diegelman, P.; Foster, B. A.; Kramer, D. L.; Porter, C. W.; Smiraglia, D. J.			Polyamine biosynthesis impacts cellular folate requirements necessary to maintain S-adenosylmethionine and nucleotide pools	FASEB JOURNAL			English	Article						one-carbon metabolism; prostate cancer	ORNITHINE-DECARBOXYLASE; MEMBRANE ANTIGEN; PROSTATE-CANCER; DIETARY-FOLATE; DNA METHYLATION; ANDROGEN-REGULATION; METABOLIC FLUX; FOLIC-ACID; DEFICIENCY; EXPRESSION	Folate (vitamin B9) is utilized for synthesis of both S-adenosylmethionine (AdoMet) and deoxythymidine monophosphate (dTMP), which are required for methylation reactions and DNA synthesis, respectively. Folate depletion leads to an imbalance in both AdoMet and nucleotide pools, causing epigenetic and genetic damage capable of initiating tumorigenesis. Polyamine biosynthesis also utilizes AdoMet, but polyamine pools are not reduced under a regimen of folate depletion. We hypothesized that high polyamine biosynthesis, due to the high demand on AdoMet pools, might be a factor in determining sensitivity to folate depletion. We found a significant correlation (P<0.001) between polyamine biosynthesis and the amount of folate required to sustain cell line proliferation. We manipulated polyamine biosynthesis by genetic and pharmacological intervention and mechanistically demonstrated that we could thereby alter AdoMet pools and increase or decrease demand on folate availability needed to sustain cellular proliferation. Furthermore, growing a panel of cell lines with 100 nM folate led to imbalanced nucleotide and AdoMet pools only in cells with endogenously high polyamine biosynthesis. These data demonstrate that polyamine biosynthesis is a critical factor in determining sensitivity to folate depletion and may be particularly important in the prostate, where biosynthesis of polyamines is characteristically high due to its secretory function.-Bistulfi, G., Diegelman, P., Foster, B. A., Kramer, D. L., Porter, C. W., Smiraglia, D. J. Polyamine biosynthesis impacts cellular folate requirements necessary to maintain S-adenosylmethionine and nucleotide pools. FASEB J. 23, 2888-2897 (2009). www.fasebj.org	[Bistulfi, G.; Smiraglia, D. J.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Smiraglia, DJ (corresponding author), Roswell Pk Canc Inst, Dept Canc Genet, Elm & Carlton St,BLSC L3-314, Buffalo, NY 14263 USA.	dominic.smiraglia@rosewellpark.org	Smiraglia, Dominic/R-2069-2019	Smiraglia, Dominic/0000-0001-8852-1510	American Institute for Cancer Research Fellowship; American-Italian Cancer Foundation Fellowship; National Cancer Institute (NCI) [NCI R21 CA121216, NCI CA022153, NCI CA076428]; NCI Cancer Center [CA016056]; NATIONAL CANCER INSTITUTE [R21CA121216, R01CA076428, R21CA131646, P30CA016056, R01CA022153] Funding Source: NIH RePORTER	American Institute for Cancer Research Fellowship; American-Italian Cancer Foundation Fellowship; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by an American Institute for Cancer Research Fellowship (G.B.); an American-Italian Cancer Foundation Fellowship (G.B.); National Cancer Institute (NCI) grants NCI R21 CA121216 (G.B. and D.J.S.), NCI CA022153 (C.W P.), and NCI CA076428 (C.W.P.); and the NCI Cancer Center Support grant to the Roswell Park Cancer Institute (CA016056). We thank Dr. Sufrin (Roswell Park Cancer Institute, Buffalo, NY, USA), who kindly gave us purified dcAdoMet to use as an HPLC standard.	BLACKSHEAR PJ, 1989, MOL ENDOCRINOL, V3, P68, DOI 10.1210/mend-3-1-68; Bronder JL, 2003, J BIOL CHEM, V278, P48861, DOI 10.1074/jbc.M304844200; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; CHANDAR N, 1988, CARCINOGENESIS, V9, P259, DOI 10.1093/carcin/9.2.259; Chen Y, 2001, CANCER RES, V61, P6437; Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; CROSS DR, 1993, CELL PROLIFERAT, V26, P327, DOI 10.1111/j.1365-2184.1993.tb00328.x; Crott JW, 2008, J NUTR BIOCHEM, V19, P328, DOI 10.1016/j.jnutbio.2007.05.003; Cyriac J, 2002, PROSTATE, V50, P252, DOI 10.1002/pros.10052; DANZIN C, 1990, BIOCHEM PHARMACOL, V40, P1499, DOI 10.1016/0006-2952(90)90446-R; Duthie SJ, 2000, NUTR CANCER, V37, P245, DOI 10.1207/S15327914NC372_18; Fair WR, 1997, PROSTATE, V32, P140; FJOSNE HE, 1992, PROSTATE, V21, P239, DOI 10.1002/pros.2990210307; FOGEL WA, 1980, ARCH IMMUNOL THER EX, V28, P907; Foster BA, 1997, CANCER RES, V57, P3325; Gangjee A, 2007, ANTI-CANCER AGENT ME, V7, P524, DOI 10.2174/187152007781668724; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Ghosh A, 2004, J CELL BIOCHEM, V91, P528, DOI 10.1002/jcb.10661; Harrison GA, 1931, BIOCHEM J, V25, P1885, DOI 10.1042/bj0251885; HESTON WDW, 1991, CANCER SURV, V11, P217; HORNE DW, 1988, CLIN CHEM, V34, P2357; Hultdin J, 2005, INT J CANCER, V113, P819, DOI 10.1002/ijc.20646; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; ISRAELI RS, 1993, CANCER RES, V53, P227; James SJ, 1997, CARCINOGENESIS, V18, P287, DOI 10.1093/carcin/18.2.287; James SJ, 2003, J NUTR, V133, p3740S, DOI 10.1093/jn/133.11.3740S; JANNE OA, 1991, J STEROID BIOCHEM, V40, P307, DOI 10.1016/0960-0760(91)90196-C; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; KABRA PM, 1986, J CHROMATOGR, V380, P19, DOI 10.1016/S0378-4347(00)83621-X; Kee K, 2004, J BIOL CHEM, V279, P40076, DOI 10.1074/jbc.M406002200; Kee K, 2004, J BIOL CHEM, V279, P27050, DOI 10.1074/jbc.M403323200; Kim YI, 2006, GUT, V55, P1387, DOI 10.1136/gut.2006.095463; Kim YI, 1997, AM J CLIN NUTR, V65, P46, DOI 10.1093/ajcn/65.1.46; Kim YI, 1996, GUT, V39, P732, DOI 10.1136/gut.39.5.732; Kim YI, 2005, J NUTR, V135, P2703, DOI 10.1093/jn/135.11.2703; Knock E, 2006, CANCER RES, V66, P10349, DOI 10.1158/0008-5472.CAN-06-2477; KRAMER D, 1995, BIOCHEM PHARMACOL, V50, P1433, DOI 10.1016/0006-2952(95)02037-3; KRAMER D, 1995, J BIOL CHEM, V270, P2124, DOI 10.1074/jbc.270.5.2124; Kramer DL, 2008, J BIOL CHEM, V283, P4241, DOI 10.1074/jbc.M706806200; Kramer DL, 2001, CANCER RES, V61, P7754; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; Liu H, 1997, CANCER RES, V57, P3629; Loenen WAM, 2006, BIOCHEM SOC T, V34, P330, DOI 10.1042/BST0340330; Mi Z, 1998, PROSTATE, V34, P51, DOI 10.1002/(SICI)1097-0045(19980101)34:1<51::AID-PROS7>3.0.CO;2-N; Mohan RR, 1999, CLIN CANCER RES, V5, P143; PEGG AE, 1970, BIOCHEM J, V117, P17, DOI 10.1042/bj1170017; Pelucchi C, 2005, CANCER EPIDEM BIOMAR, V14, P944, DOI 10.1158/1055-9965.EPI-04-0787; Pinto JT, 1996, CLIN CANCER RES, V2, P1445; Pogribny IP, 1997, CARCINOGENESIS, V18, P2071, DOI 10.1093/carcin/18.11.2071; Pogribny IP, 2004, MUTAT RES-FUND MOL M, V548, P53, DOI 10.1016/j.mrfmmm.2003.12.014; POGRIBNY IP, 1995, CANCER RES, V55, P1894; Rossi E, 2006, ANN EPIDEMIOL, V16, P206, DOI 10.1016/j.annepidem.2005.03.010; Silver DA, 1997, CLIN CANCER RES, V3, P81; Sohn KJ, 2003, CARCINOGENESIS, V24, P81, DOI 10.1093/carcin/24.1.81; Stempak JM, 2005, CARCINOGENESIS, V26, P981, DOI 10.1093/carcin/bgi037; Stevens VL, 2006, AM J EPIDEMIOL, V163, P989, DOI 10.1093/aje/kwj126; Sun DM, 2002, J NUTR, V132, P2632, DOI 10.1093/jn/132.9.2632; WILLIAMSASHMAN HG, 1979, PERSPECT BIOL MED, V22, P421; YARLETT N, 1988, MOL BIOCHEM PARASIT, V27, P1, DOI 10.1016/0166-6851(88)90019-9	59	46	49	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					2888	2897		10.1096/fj.09-130708	http://dx.doi.org/10.1096/fj.09-130708			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19417083	Green Published			2022-12-25	WOS:000270241000012
J	Ghosh, AK; Bhattacharyya, S; Wei, J; Kim, S; Barak, Y; Mori, Y; Varga, J				Ghosh, Asish K.; Bhattacharyya, Swati; Wei, Jun; Kim, Suyeon; Barak, Yaacov; Mori, Yasuji; Varga, John			Peroxisome proliferator-activated receptor-gamma abrogates Smad-dependent collagen stimulation by targeting the p300 transcriptional coactivator	FASEB JOURNAL			English	Article						fibrosis; 15d-PGJ(2); type I collagen; fibroblast; acetyltransferase	GROWTH-FACTOR-BETA; NORMAL SKIN FIBROBLASTS; CREB-BINDING PROTEIN; SMOOTH-MUSCLE-CELLS; PPAR-GAMMA; GENE-EXPRESSION; I COLLAGEN; TGF-BETA; PROFIBROTIC RESPONSES; INTERFERON-GAMMA	Ligands of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) abrogate the stimulation of collagen gene transcription induced by transforming growth factor-beta (TGF-beta). Here, we delineate the mechanisms underlying this important novel physiological function for PPAR-gamma in connective tissue homeostasis. First, we demonstrated that antagonistic regulation of TGF-beta activity by PPAR-gamma ligands involves cellular PPAR-gamma, since 15-deoxy-Delta 12,14-prostaglandin J(2) (15d-PGJ(2)) failed to block TGF-beta-induced responses in either primary cultures of PPAR-gamma-null murine embryonic fibroblasts, or in normal human skin fibroblasts with RNAi-mediated knockdown of PPAR-gamma. Next, we examined the molecular basis underlying the abrogation of TGF-beta signaling by PPAR-gamma in normal human fibroblasts in culture. The results demonstrated that Smad-dependent transcriptional responses were blocked by PPAR-gamma without preventing Smad2/3 activation. In contrast, the interaction between activated Smad2/3 and the transcriptional coactivator and histone acetyltransferase p300 induced by TGF-beta, and the accumulation of p300 on consensus Smad-binding DNA sequences and histone H4 hyperacetylation at the COL1A2 locus, were all prevented by PPAR-gamma. Wild-type p300, but not a mutant form of p300 lacking functional histone acetyltransferase, was able to restore TGF-beta-induced stimulation of COL1A2 in the presence of PPAR-gamma ligands. Collectively, these results indicate that PPAR-gamma blocked Smad-mediated transcriptional responses by preventing p300 recruitment and histone H4 hyperacetylation, resulting in the inhibition of TGF-beta-induced collagen gene expression. Pharmacological activation of PPAR-gamma thus may represent a novel therapeutic approach to target p300-dependent TGF-beta profibrotic responses such as stimulation of collagen gene expression.-Ghosh, A. K., Bhattacharyya, S., Wei, J., Kim, S., Barak, Y., Mori, Y., and Varga, J. Peroxisome proliferator-activated receptor-gamma abrogates Smad-dependent collagen stimulation by targeting the p300 transcriptional coactivator. FASEB J. 23, 2968-2977 (2009). www.fasebj.org	[Ghosh, Asish K.] Northwestern Univ, Feinberg Cardiovasc Res Inst, Feinberg Sch Med, Chicago, IL 60611 USA; [Bhattacharyya, Swati; Wei, Jun; Mori, Yasuji; Varga, John] Northwestern Univ, Div Rheumatol, Feinberg Sch Med, Chicago, IL 60611 USA; [Kim, Suyeon; Barak, Yaacov] Jackson Lab, Bar Harbor, ME 04609 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Jackson Laboratory	Ghosh, AK (corresponding author), Northwestern Univ, Feinberg Cardiovasc Res Inst, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.	a-ghosh2@northwestern.edu; j-varga@northwestern.edu	Bhattacharyya, Swati/W-8145-2019; Wei, Jun/G-3295-2012; Varga, John/AAK-6472-2021; Wei, Jun/G-5854-2012		Scleroderma Foundation; National Institutes of Health [AR-49025]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049025] Funding Source: NIH RePORTER	Scleroderma Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to Christopher K. Glass (University of California, San Diego, CA, USA) and Joan Boyes (Institute of Cancer Research, London, UK) for PPAR-gamma and p300 expression vectors. This work was supported by grants from the Scleroderma Foundation to A.K.G. and the National Institutes of Health (AR-49025) to J.V.	Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bhattacharyya S, 2005, ARTHRITIS RHEUM-US, V52, P1248, DOI 10.1002/art.20996; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Burgess HA, 2005, AM J PHYSIOL-LUNG C, V288, pL1146, DOI 10.1152/ajplung.00383.2004; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; Farrajota K, 2005, ARTHRITIS RHEUM-US, V52, P94, DOI 10.1002/art.20714; Galli A, 2002, GASTROENTEROLOGY, V122, P1924, DOI 10.1053/gast.2002.33666; Gao DF, 2007, BIOCHEM PHARMACOL, V73, P185, DOI 10.1016/j.bcp.2006.09.019; Gelman L, 1999, J BIOL CHEM, V274, P7681, DOI 10.1074/jbc.274.12.7681; Genovese T, 2005, EUR RESPIR J, V25, P225, DOI 10.1183/09031936.05.00049704; Ghosh AK, 2004, ARTHRITIS RHEUM-US, V50, P1305, DOI 10.1002/art.20104; Ghosh AK, 2006, J CELL PHYSIOL, V207, P251, DOI 10.1002/jcp.20559; Ghosh AK, 2004, J BIOL CHEM, V279, P47455, DOI 10.1074/jbc.M403477200; Ghosh AK, 2002, EXP BIOL MED, V227, P301, DOI 10.1177/153537020222700502; Ghosh AK, 2001, J BIOL CHEM, V276, P11041, DOI 10.1074/jbc.M004709200; Ghosh AK, 2000, ONCOGENE, V19, P3546, DOI 10.1038/sj.onc.1203693; Ghosh AK, 2008, BIOCHEM BIOPH RES CO, V374, P231, DOI 10.1016/j.bbrc.2008.07.014; Ghosh AK, 2007, J CELL PHYSIOL, V213, P663, DOI 10.1002/jcp.21162; Gressner OA, 2008, J HEPATOL, V49, P758, DOI 10.1016/j.jhep.2008.03.029; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Ihn H, 1996, J BIOL CHEM, V271, P26717, DOI 10.1074/jbc.271.43.26717; Ihn H, 2006, RHEUMATOLOGY, V45, P157, DOI 10.1093/rheumatology/kei124; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; Kodera Y, 2000, J BIOL CHEM, V275, P33201, DOI 10.1074/jbc.C000517200; Kon K, 2002, BIOCHEM BIOPH RES CO, V291, P55, DOI 10.1006/bbrc.2002.6385; Lakatos HF, 2007, PPAR RES, V2007, DOI 10.1155/2007/71323; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000; Li YJ, 2006, J AM SOC NEPHROL, V17, P54, DOI 10.1681/ASN.2005030257; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Ma LJ, 2001, KIDNEY INT, V59, P1899, DOI 10.1046/j.1523-1755.2001.0590051899.x; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; McCarthy KJ, 2000, KIDNEY INT, V58, P2341, DOI 10.1046/j.1523-1755.2000.00418.x; Mori Y, 2003, ARTHRITIS RHEUM-US, V48, P1964, DOI 10.1002/art.11157; Mori Y, 2000, EXP CELL RES, V258, P374, DOI 10.1006/excr.2000.4930; Panchapakesan U, 2005, AM J PHYSIOL-RENAL, V289, pF1153, DOI 10.1152/ajprenal.00097.2005; Ramirez F, 2006, MATRIX BIOL, V25, P365, DOI 10.1016/j.matbio.2006.05.002; Redondo S, 2005, DIABETES, V54, P811, DOI 10.2337/diabetes.54.3.811; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Ricote M, 2007, BBA-MOL CELL BIOL L, V1771, P926, DOI 10.1016/j.bbalip.2007.02.013; Ross S, 2006, EMBO J, V25, P4490, DOI 10.1038/sj.emboj.7601332; Ruiz E, 2007, J PHARMACOL EXP THER, V321, P431, DOI 10.1124/jpet.106.114934; Sertznig P, 2007, J CELL PHYSIOL, V212, P1, DOI 10.1002/jcp.20998; Straus DS, 2001, MED RES REV, V21, P185, DOI 10.1002/med.1006.abs; Takahashi N, 2002, J BIOL CHEM, V277, P16906, DOI 10.1074/jbc.M200585200; Teresi RE, 2006, INT J CANCER, V118, P2390, DOI 10.1002/ijc.21799; Varga J, 2008, CURR OPIN RHEUMATOL, V20, P720, DOI 10.1097/BOR.0b013e32830e48e8; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; White ES, 2006, AM J RESP CRIT CARE, V173, P112, DOI 10.1164/rccm.200507-1058OC; Wu MH, 2009, AM J PATHOL, V174, P519, DOI 10.2353/ajpath.2009.080574; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Xia H, 2008, J EXP MED, V205, P1659, DOI 10.1084/jem.20080001; Xu Y, 2007, J BIOL CHEM, V282, P26046, DOI 10.1074/jbc.M703652200; Yavrom S, 2005, J BIOL CHEM, V280, P40650, DOI 10.1074/jbc.M510094200; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhao CY, 2006, BIOCHEM BIOPH RES CO, V350, P385, DOI 10.1016/j.bbrc.2006.09.069; Zheng F, 2002, AM J PHYSIOL-RENAL, V282, pF639, DOI 10.1152/ajprenal.00189.2001	62	92	96	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					2968	2977		10.1096/fj.08-128736	http://dx.doi.org/10.1096/fj.08-128736			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19395477	Green Published			2022-12-25	WOS:000270241000019
J	Mauro, TM; McCormick, JA; Wang, J; Boini, KM; Ray, L; Monks, B; Birnbaum, MJ; Lang, F; Pearce, D				Mauro, Theodora M.; McCormick, James A.; Wang, Jian; Boini, Krishna M.; Ray, Leena; Monks, Bobby; Birnbaum, Morris J.; Lang, Florian; Pearce, David			Akt2 and SGK3 are both determinants of postnatal hair follicle development	FASEB JOURNAL			English	Article						phosphatidylinositol-3-kinase; beta-catenin; Lef1; proliferation; baldness	GLUCOCORTICOID-INDUCIBLE KINASE-1; FORKHEAD TRANSCRIPTION FACTOR; TARGETED MICE LACKING; VITAMIN-D-RECEPTOR; PROTEIN-KINASE; BETA-CATENIN; GLUCOSE-HOMEOSTASIS; SGK1-KNOCKOUT MOUSE; GENE-EXPRESSION; STEM-CELLS	SGK3, which previously has been shown to play a key role in hair follicle development in mice, is a member of the AGC family of serine-threonine kinases. Mice lacking SGK3 have abnormal follicle cycling, which begins shortly after birth and ameliorates substantially with age. However, this developmental abnormality is not recapitulated in mice lacking closely related kinases Akt1, Akt2, or Akt3. To examine whether Akt2 interacts with SGK3 in postnatal hair development, we have generated and characterized Akt2/SGK3 double knockouts (DKOs). We find that the DKO mice have a defect in hair growth that is markedly worse than that of SGK3(-/-) mice and does not ameliorate with age. Morphologically, this defect is characterized by accelerated entry into catagen and through anagen, irregular hair follicle orientation, and increased expression of sebaceous glands. The defect is preceded by a profound failure to increase follicle matrix cell nuclear beta-catenin accumulation and proliferation at the onset of morphogenesis. Furthermore, in cultured keratinocytes, transfected Akt2 and SGK3 both stimulate transcription of a beta-catenin-LEF1-dependent reporter gene. Thus, SGK3 and Akt2 both appear to play important roles in postnatal hair follicle morphogenesis, likely because of their redundant regulation of beta-catenin-dependent transcriptional processes, which control hair follicle cell proliferation.-Mauro, T. M., McCormick, J. A., Wang, J., Boini, K. M., Ray, L., Monks, B., Birnbaum, M. J., Lang, F., and Pearce, D. Akt2 and SGK3 are both determinants of postnatal hair follicle development. FASEB J. 23, 3193-3202 (2009). www.fasebj.org	[McCormick, James A.; Wang, Jian; Ray, Leena; Pearce, David] Univ Calif San Francisco, Dept Med, San Francisco, CA 94107 USA; [Mauro, Theodora M.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [McCormick, James A.; Wang, Jian; Ray, Leena; Pearce, David] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; [Mauro, Theodora M.] San Francisco Vet Hosp, Dept Dermatol, San Francisco, CA USA; [McCormick, James A.] Oregon Hlth & Sci Univ, Dept Med, Div Nephrol & Hypertens, Portland, OR 97201 USA; [McCormick, James A.; Boini, Krishna M.; Lang, Florian] Univ Tubingen, Dept Physiol, Tubingen, Germany; [Monks, Bobby; Birnbaum, Morris J.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Oregon Health & Science University; Eberhard Karls University of Tubingen; University of Pennsylvania	Pearce, D (corresponding author), Univ Calif San Francisco, Dept Med, Box 2140, San Francisco, CA 94107 USA.	dpearce@medsfgh.ucsf.edu	Boini, Krishna/H-3548-2011; McCormick, James A/A-9121-2010	McCormick, James/0000-0003-4000-6653; Birnbaum, Morris/0000-0001-9972-8680	U.S. National Institutes of Health (NIH) [T32DK007219, AR051930, DK-56886, DK56695]; Deutsche Forschungsgemeinschaft [La 315/4-6]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056695, R01DK056886, T32DK007219] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health (NIH) training grant T32DK007219 ( to J.A.M.), NIH grant AR051930 ( to T. M.), NIH grant DK-56886 ( to M. B.), Deutsche Forschungsgemeinschaft ( La 315/4-6) ( to F. L.), and NIH grant DK56695 ( to D. P.). We thank D. Kusewitt ( Ohio State University Mouse Phenotyping Service, Columbus, OH, USA) for multiple-tissue histological analysis, blood chemistry and cytokeratin immunostaining; Z. Huang and Melanie Hupe for technical assistance; L. Prentice for skin section preparation; and Louella Lee for assistance with preparation of the manuscript. We gratefully thank Rudy Grosschedl (Max Planck Institute of Immunobiology, Freiburg, Germany) for providing Lef1 reporter and expression vector.	Alonso L, 2005, J CELL BIOL, V170, P559, DOI 10.1083/jcb.200504131; Altomare DA, 1998, ONCOGENE, V16, P2407, DOI 10.1038/sj.onc.1201750; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Bikle DD, 2006, J CELL PHYSIOL, V207, P340, DOI 10.1002/jcp.20578; Boini KM, 2006, DIABETES, V55, P2059, DOI 10.2337/db05-1038; Botchkarev VA, 2000, FASEB J, V14, P1931, DOI 10.1096/fj.99-0930com; Botchkarev VA, 2001, AM J PATHOL, V158, P1913, DOI 10.1016/S0002-9440(10)64659-7; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; Chen SY, 1997, J BIOL CHEM, V272, P14087, DOI 10.1074/jbc.272.22.14087; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Chen XL, 2003, J CELL SCI, V116, P3511, DOI 10.1242/jcs.00675; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cianferotti L, 2007, P NATL ACAD SCI USA, V104, P9428, DOI 10.1073/pnas.0702884104; Dai FY, 1999, GENOMICS, V62, P95, DOI 10.1006/geno.1999.5969; Dai FY, 2002, BIOCHEM BIOPH RES CO, V293, P1191, DOI 10.1016/S0006-291X(02)00349-2; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Dummler B, 2006, MOL CELL BIOL, V26, P8042, DOI 10.1128/MCB.00722-06; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Edlund S, 2005, MOL CELL BIOL, V25, P1475, DOI 10.1128/MCB.25.4.1475-1488.2005; Fuchs E, 2001, DEV CELL, V1, P13, DOI 10.1016/S1534-5807(01)00022-3; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; GIESE K, 1993, EMBO J, V12, P4667, DOI 10.1002/j.1460-2075.1993.tb06155.x; Grahammer F, 2006, AM J PHYSIOL-REG I, V290, pR945, DOI 10.1152/ajpregu.00484.2005; Grahammer F, 2006, AM J PHYSIOL-GASTR L, V290, pG1114, DOI 10.1152/ajpgi.00231.2005; Guha U, 2004, AM J PATHOL, V165, P729, DOI 10.1016/S0002-9440(10)63336-6; Huang DY, 2004, J AM SOC NEPHROL, V15, P885, DOI 10.1097/01.ASN.0000120368.59693.A8; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Lang F, 2001, Sci STKE, V2001, pre17, DOI 10.1126/stke.2001.108.re17; Li X, 2004, GASTROENTEROLOGY, V126, P122, DOI 10.1053/j.gastro.2003.10.061; Liu D, 2000, CURR BIOL, V10, P1233, DOI 10.1016/S0960-9822(00)00733-8; Maupas-Schwalm F, 2005, CANCER RES, V65, P526; McCormick JA, 2004, MOL BIOL CELL, V15, P4278, DOI 10.1091/mbc.E04-01-0027; Muller D, 2007, DIABETOLOGIA, V50, P1239, DOI 10.1007/s00125-007-0671-7; Muller D, 2006, DIABETES, V55, P2835, DOI 10.2337/db06-0532; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; O'Shaughnessy RFL, 2007, CANCER RES, V67, P8207, DOI 10.1158/0008-5472.CAN-07-0755; Okada T, 2006, AM J PATHOL, V168, P1119, DOI 10.2353/ajpath.2006.050507; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Pao AC, 2007, AM J PHYSIOL-RENAL, V292, pF1741, DOI 10.1152/ajprenal.00027.2007; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Sandu C, 2005, PFLUG ARCH EUR J PHY, V451, P437, DOI 10.1007/s00424-005-1474-7; Sharov AA, 2005, P NATL ACAD SCI USA, V102, P93, DOI 10.1073/pnas.0408455102; Strutz-Seebohm N, 2005, J PHYSIOL-LONDON, V565, P381, DOI 10.1113/jphysiol.2004.079582; Tian Q, 2005, CELL CYCLE, V4, P215; Tian Q, 2004, P NATL ACAD SCI USA, V101, P15370, DOI 10.1073/pnas.0406499101; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Ullrich S, 2005, DIABETES, V54, P1090, DOI 10.2337/diabetes.54.4.1090; Virbasius JV, 2001, P NATL ACAD SCI USA, V98, P12908, DOI 10.1073/pnas.221352898; Wang J, 1999, J MOL BIOL, V286, P315, DOI 10.1006/jmbi.1998.2489; Wulff P, 2002, J CLIN INVEST, V110, P1263, DOI 10.1172/JCI200215696; Xu JS, 2001, J CELL BIOL, V154, P1069, DOI 10.1083/jcb.200103111; Yang ZZ, 2005, MOL CELL BIOL, V25, P10407, DOI 10.1128/MCB.25.23.10407-10418.2005; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200	63	16	18	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					3193	3202		10.1096/fj.08-123729	http://dx.doi.org/10.1096/fj.08-123729			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19433625	Green Published			2022-12-25	WOS:000270241000041
J	Rogers, SC; Said, A; Corcuera, D; McLaughlin, D; Kell, P; Doctor, A				Rogers, Stephen C.; Said, Ahmed; Corcuera, Daniella; McLaughlin, Dylan; Kell, Pamela; Doctor, Allan			Hypoxia limits antioxidant capacity in red blood cells by altering glycolytic pathway dominance	FASEB JOURNAL			English	Article						band 3 protein; hemoglobin; glucose metabolism; thiol; reactive oxygen species; glycolysis	REDUCED PYRIDINE-NUCLEOTIDES; HUMAN-ERYTHROCYTES; NITRIC-OXIDE; MEMBRANE-PROTEIN; GLUTATHIONE TURNOVER; SUPEROXIDE ANIONS; FREE-RADICALS; IN-VITRO; OXYGEN; HEMOGLOBIN	The erythrocyte membrane is a newly appreciated platform for thiol-based circulatory signaling, and it requires robust free thiol maintenance. We sought to define physiological constraints on erythrocyte antioxidant defense. Hemoglobin (Hb) conformation gates glycolytic flux through the hexose monophosphate pathway (HMP), the sole source of nicotinamide adenine dinucleotide phosphate ( NADPH) in erythrocytes. We hypothesized elevated intraerythrocytic deoxyHb would limit resilience to oxidative stress. Human erythrocytes were subjected to controlled oxidant ( superoxide) loading following independent manipulation of oxygen tension, Hb conformation, and glycolytic pathway dominance. Sufficiency of antioxidant defense was determined by serial quantification of GSH, NADPH, NADH redox couples. Hypoxic erythrocytes demonstrated greater loss of reduction potential [Delta GSH E-hc (mV): 123.4 +/- 9.7 vs. 57.2 +/- 11.1] and reduced membrane thiol (47.7 +/- 5.7 vs. 20.1 +/- 4.3%) ( hypoxia vs. normoxia, respectively; P<0.01), a finding mimicked in normoxic erythrocytes after HMP blockade. Rebalancing HMP flux during hypoxia restored resilience to oxidative stress at all stages of the system. Cell-free studies assured oxidative loading was not altered by oxygen tension, heme ligation, or the inhibitors employed. These data indicate that Hb conformation controls coupled glucose and thiol metabolism in erythrocytes, and implicate hypoxemia in the pathobiology of erythrocyte-based vascular signaling.-Rogers, S. C., Said, A., Corcuera, D., McLaughlin, D., Kell, P., Doctor, A. Hypoxia limits antioxidant capacity in red blood cells by altering glycolytic pathway dominance. FASEB J. 23, 3159-3170 ( 2009). www.fasebj.org	[Rogers, Stephen C.; Said, Ahmed; Corcuera, Daniella; McLaughlin, Dylan; Kell, Pamela; Doctor, Allan] Washington Univ, Dept Pediat, St Louis, MO 63110 USA; [Doctor, Allan] Washington Univ, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Doctor, A (corresponding author), Washington Univ, Dept Pediat, McDonnell Pediat Res Bldg,Campus Box 8116,1 Child, St Louis, MO 63110 USA.	doctor@wustl.edu	Said, Ahmed/AAA-1152-2022	Said, Ahmed/0000-0002-1215-2664; Rogers, Stephen/0000-0003-1139-4730; Doctor, Allan/0000-0002-6096-6400	U.S. National Institutes of Health [1K08GM069977]; Children's Discovery Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM069977] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Discovery Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We greatly appreciate the gift of KA from Dr. Keiji Hasumi, (Tokyo Noko University, Tokyo, Japan). We thank Dr. Alan Schwartz and Dr. Jonathan Gitlin for thoughtful comments. This work was supported by U.S. National Institutes of Health grant 1K08GM069977 and by an interdisciplinary research initiative from the Children's Discovery Institute ( both to A. D.).	Balagopalakrishna C, 1996, BIOCHEMISTRY-US, V35, P6393, DOI 10.1021/bi952875+; Barvitenko NN, 2005, CELL PHYSIOL BIOCHEM, V15, P1, DOI 10.1159/000083634; Baskurt OK, 1998, FREE RADICAL BIO MED, V24, P102, DOI 10.1016/S0891-5849(97)00169-X; Bennett-Guerrero E, 2007, P NATL ACAD SCI USA, V104, P17063, DOI 10.1073/pnas.0708160104; Bossi D, 1996, MOL ASPECTS MED, V17, P117, DOI 10.1016/0098-2997(96)88343-9; Buehler PW, 2005, ANTIOXID REDOX SIGN, V7, P1755, DOI 10.1089/ars.2005.7.1755; Buehler PW, 2004, ANTIOXID REDOX SIGN, V6, P1000, DOI 10.1089/ars.2004.6.1000; Campanella ME, 2008, BLOOD, V112, P3900, DOI 10.1182/blood-2008-03-146159; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Chang SH, 2001, J BIOL CHEM, V276, P22223, DOI 10.1074/jbc.M100604200; Chu HY, 2008, BLOOD, V111, P932, DOI 10.1182/blood-2007-07-100180; Cimen MYB, 2008, CLIN CHIM ACTA, V390, P1, DOI 10.1016/j.cca.2007.12.025; CORBISIER P, 1987, ANAL BIOCHEM, V164, P240, DOI 10.1016/0003-2697(87)90392-7; Crimi E, 2007, FREE RADICAL RES, V41, P1364, DOI 10.1080/10715760701732830; Dietrich HH, 2000, AM J PHYSIOL-HEART C, V278, pH1294, DOI 10.1152/ajpheart.2000.278.4.H1294; Doctor A, 2005, P NATL ACAD SCI USA, V102, P5709, DOI 10.1073/pnas.0407490102; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; ENDO A, 1985, J ANTIBIOT, V38, P920, DOI 10.7164/antibiotics.38.920; FEIG SA, 1972, J CLIN INVEST, V51, P1547, DOI 10.1172/JCI106951; Forman HJ, 2004, AM J PHYSIOL-CELL PH, V287, pC246, DOI 10.1152/ajpcell.00516.2003; FRIDOVICH I, 1970, J BIOL CHEM, V245, P4053; Gibson JS, 2000, J EXP BIOL, V203, P1395; Gonzalez C, 2002, RESP PHYSIOL NEUROBI, V132, P17, DOI 10.1016/S1569-9048(02)00047-2; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; GRIFFITH OW, 1981, J BIOL CHEM, V256, P4900; HAMASAKI N, 1970, J BIOCHEM-TOKYO, V68, P157, DOI 10.1093/oxfordjournals.jbchem.a129341; Kemp M, 2008, FREE RADICAL BIO MED, V44, P921, DOI 10.1016/j.freeradbiomed.2007.11.008; Kinoshita A, 2007, J BIOL CHEM, V282, P10731, DOI 10.1074/jbc.M610717200; KONDO T, 1989, METHOD ENZYMOL, V171, P217; Lang KS, 2005, CELL PHYSIOL BIOCHEM, V15, P195, DOI 10.1159/000086406; LOW PS, 1993, J BIOL CHEM, V268, P14627; LUNN G, 1979, BLOOD, V54, P238; LYNCH RE, 1978, J BIOL CHEM, V253, P4697; McMahon TJ, 2002, NAT MED, V8, P711, DOI 10.1038/nm718; Messana I, 1996, FEBS LETT, V390, P25, DOI 10.1016/0014-5793(96)00624-2; Messner KR, 2002, METHOD ENZYMOL, V349, P354, DOI 10.1016/S0076-6879(02)49351-2; Minetti M, 2007, CARDIOVASC RES, V75, P21, DOI 10.1016/j.cardiores.2007.03.007; Mingone CJ, 2006, AM J PHYSIOL-LUNG C, V290, pL549, DOI 10.1152/ajplung.00331.2005; MURPHY JR, 1960, J LAB CLIN MED, V55, P286; NIORT G, 1985, J STEROID BIOCHEM, V23, P657, DOI 10.1016/0022-4731(85)90018-4; Palmer LA, 2007, J CLIN INVEST, V117, P2592, DOI 10.1172/JCI29444; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; RAPOPORT I, 1976, BIOCHIM BIOPHYS ACTA, V428, P193, DOI 10.1016/0304-4165(76)90120-3; Richards RS, 1998, MED HYPOTHESES, V50, P363, DOI 10.1016/S0306-9877(98)90206-7; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Singel DJ, 2005, ANNU REV PHYSIOL, V67, P99, DOI 10.1146/annurev.physiol.67.060603.090918; Souza HP, 2002, AM J PHYSIOL-HEART C, V282, pH466, DOI 10.1152/ajpheart.00482.2001; Sun GY, 2008, J CHROMATOGR B, V867, P1, DOI 10.1016/j.jchromb.2008.02.014; UYESAKA N, 1992, BIORHEOLOGY, V29, P217; VALENTINE WN, 1985, ANN INTERN MED, V103, P245, DOI 10.7326/0003-4819-103-2-245; WAGNER TC, 1994, ANAL BIOCHEM, V222, P417, DOI 10.1006/abio.1994.1511; Wang X, 1999, CLIN HEMORHEOL MICRO, V21, P137; ZEREZ CR, 1987, ANAL BIOCHEM, V164, P367, DOI 10.1016/0003-2697(87)90506-9	53	65	69	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					3159	3170		10.1096/fj.09-130666	http://dx.doi.org/10.1096/fj.09-130666			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19417084	Green Published			2022-12-25	WOS:000270241000038
J	Zou, W; Reeve, JL; Zhao, H; Ross, FP; Teitelbaum, SL				Zou, Wei; Reeve, Jennifer L.; Zhao, Haibo; Ross, F. Patrick; Teitelbaum, Steven L.			Syk Tyrosine 317 Negatively Regulates Osteoclast Function via the Ubiquitin-Protein Isopeptide Ligase Activity of Cbl	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; LINKER REGION TYROSINES; C-CBL; MICE LACKING; KINASE SYK; IN-VITRO; SRC; ACTIVATION; PHOSPHORYLATION; INTEGRIN	Cytoskeletal organization of the osteoclast (OC), which is central to the capacity of the cell to resorb bone, is induced by occupancy of the alpha v beta 3 integrin or the macrophage colony-stimulating factor (M-CSF) receptor c-Fms. In both circumstances, the tyrosine kinase Syk is an essential signaling intermediary. We demonstrate that Cbl negatively regulates OC function by interacting with Syk(Y317). Expression of nonphosphorylatable Syk(Y317F) in primary Syk(-/-) OCs enhances M-CSF- and alpha v beta 3-induced phosphorylation of the cytoskeleton-organizing molecules, SLP76, Vav3, and PLC gamma 2, to levels greater than wild type, thereby accelerating the resorptive capacity of the cell. SykY317 suppresses cytoskeletal organization and function while binding the ubiquitin-protein isopeptide ligase Cbl. Consequently, SykY317F abolishes M-CSF- and integrin-stimulated Syk ubiquitination. Thus, Cbl/Syk(Y317) association negatively regulates OC function and therefore is essential for maintenance of skeletal homeostasis.	[Zou, Wei; Reeve, Jennifer L.; Zhao, Haibo; Ross, F. Patrick; Teitelbaum, Steven L.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Reeve, Jennifer L.] Washington Univ, Sch Med, Div Biol & Biomed Sci, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Teitelbaum, SL (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, Campus Box 8118,660 S Euclid Ave,4940 Parkview Pl, St Louis, MO 63110 USA.	teitelbs@wustl.edu	Zhao, Haibo/ABG-9729-2021	ZHAO, HAIBO/0000-0003-0836-7555; Zou, Wei/0000-0001-8081-268X; Teitelbaum, Steven/0000-0002-4054-6679	National Institutes of Health [AR046852, AR032788, AR046523, 1 F30 AG302802]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR032788, R37AR046523, R01AR046523, R01AR046852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG030280] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AR046852 (to F.P.R.), AR032788 and AR046523 ( to S.L.T.), and 1 F30 AG302802 (to J.L.R.).	Akiyama T, 2003, EMBO J, V22, P6653, DOI 10.1093/emboj/cdg635; Bradley EW, 2008, J BIOL CHEM, V283, P8055, DOI 10.1074/jbc.M709500200; Bruzzaniti A, 2005, MOL BIOL CELL, V16, P3301, DOI 10.1091/mbc.e04-12-1117; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; Epple H, 2008, MOL CELL BIOL, V28, P3610, DOI 10.1128/MCB.00259-08; Faccio R, 2003, J CLIN INVEST, V111, P749, DOI 10.1172/JCI200316924; Faccio R, 2003, J CELL BIOCHEM, V90, P871, DOI 10.1002/jcb.10694; Faccio R, 2005, NAT MED, V11, P284, DOI 10.1038/nm1194; Faccio R, 2007, J BIOL CHEM, V282, P18991, DOI 10.1074/jbc.M610937200; Hitomi T, 2001, GENES CELLS, V6, P475, DOI 10.1046/j.1365-2443.2001.00434.x; Hong JJ, 2002, J BIOL CHEM, V277, P31703, DOI 10.1074/jbc.M201362200; Insogna KL, 1997, J CLIN INVEST, V100, P2476, DOI 10.1172/JCI119790; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Keshvara LM, 1998, J IMMUNOL, V161, P5276; Kim HJ, 2009, P NATL ACAD SCI USA, V106, P2325, DOI 10.1073/pnas.0806963106; Kitaura Y, 2007, IMMUNITY, V26, P567, DOI 10.1016/j.immuni.2007.03.015; Kumar CC, 1998, ONCOGENE, V17, P1365, DOI 10.1038/sj.onc.1202172; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Moon KD, 2005, J BIOL CHEM, V280, P1543, DOI 10.1074/jbc.M407805200; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Paolini R, 2002, J BIOL CHEM, V277, P36940, DOI 10.1074/jbc.M204948200; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Rao N, 2001, EMBO J, V20, P7085, DOI 10.1093/emboj/20.24.7085; Reeve J, 2008, J BONE MINER RES, V23, pS4; Sada K, 2000, J IMMUNOL, V164, P338, DOI 10.4049/jimmunol.164.1.338; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Simon M, 2005, J BIOL CHEM, V280, P4510, DOI 10.1074/jbc.M410326200; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Takeshita S, 2007, J BIOL CHEM, V282, P18980, DOI 10.1074/jbc.M610938200; Tanaka S, 1996, NATURE, V383, P528, DOI 10.1038/383528a0; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Turner M, 2000, IMMUNOL TODAY, V21, P148, DOI 10.1016/S0167-5699(99)01574-1; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Wonerow P, 2003, J BIOL CHEM, V278, P37520, DOI 10.1074/jbc.M305077200; Yankee TM, 1999, J IMMUNOL, V163, P5827; Zhang J, 2002, MOL CELL BIOL, V22, P8144, DOI 10.1128/MCB.22.23.8144-8154.2002; Zhao HB, 2008, DEV CELL, V14, P914, DOI 10.1016/j.devcel.2008.03.022; Zou W, 2008, MOL CELL, V31, P422, DOI 10.1016/j.molcel.2008.06.023; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083	47	14	14	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18833	18839		10.1074/jbc.M109.012385	http://dx.doi.org/10.1074/jbc.M109.012385			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19419964	hybrid, Green Published			2022-12-25	WOS:000267711500033
J	Lian, M; Zheng, XF				Lian, Min; Zheng, Xiaofeng			HSCARG Regulates NF-kappa B Activation by Promoting the Ubiquitination of RelA or COMMD1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANINE COPPER TOXICOSIS; NITRIC-OXIDE; TUMOR-SUPPRESSOR; SENSOR PROTEIN; ALPHA; DEHYDROEPIANDROSTERONE; TRANSCRIPTION; MURR1; GENE; TERMINATION	The redox sensor protein HSCARG translocates from the cytoplasm to the nucleus in response to decreased cellular NADPH or increased nitric oxide, and is involved in protein regulation. However, the regulatory mechanism of HSCARG has remained elusive. In this report, through a yeast two-hybrid screen, HSCARG was found to associate with the copper metabolism gene MURR1 domain containing protein 1 (COMMD1), an inhibitor of NF-kappa B, and negatively regulate COMMD1 by accelerating its ubiquitination and proteasome-dependent degradation. Interestingly, we observed that HSCARG also blocked basal and stimulus-coupled NF-kappa B activation by promoting ubiquitination and degradation of the NF-kappa B subunit RelA. Further analyses showed that in cells under normal conditions, HSCARG localized mainly in the cytoplasm and acted as a negative regulator of COMMD1, and was distributed in the nucleus in small quantities to inhibit NF-kappa B. Although in response to intracellular redox changes by dehydroepiandrosterone or S-nitroso-N-acetylpenicillamine treatment, a large amount of HSCARG translocated to the nucleus, which terminated NF-kappa B activation. Meanwhile, COMMD1 was restored due to decreased cytoplasmic HSCARG levels and negatively regulated NF-kappa B as well. Thus, NF-kappa B activation was terminated efficiently. Our results indicate that HSCARG plays critical roles in regulation of NF-kappa B in response to cellular redox changes by promoting ubiquitination and proteolysis of RelA or COMMD1.	[Lian, Min; Zheng, Xiaofeng] Peking Univ, Dept Biochem & Mol Biol, Natl Lab Prot Engn & Plant Genet Engn, Coll Life Sci, Beijing 100871, Peoples R China	Peking University	Zheng, XF (corresponding author), Peking Univ, Dept Biochem & Mol Biol, Natl Lab Prot Engn & Plant Genet Engn, Coll Life Sci, Beijing 100871, Peoples R China.	xiaofengz@pku.edu.cn			National Science Foundation of China [30670416]; National High Technology and Development Program of China Program [863, 2006AA02A314, 973, 2007CB914303]; International Centre for Genetic Engineering and Biotechnology ( ICGEB) [CRP/CHN05-01]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology and Development Program of China Program(National High Technology Research and Development Program of China); International Centre for Genetic Engineering and Biotechnology ( ICGEB)	This work was supported by National Science Foundation of China Grant 30670416, the National High Technology and Development Program of China Program numbers 863, 2006AA02A314 and 973, 2007CB914303, and International Centre for Genetic Engineering and Biotechnology ( ICGEB) Project number CRP/CHN05-01.	Aragno M, 2002, ENDOCRINOLOGY, V143, P3250, DOI 10.1210/en.2002-220182; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; El Omari K, 2005, J BIOL CHEM, V280, P18229, DOI 10.1074/jbc.M501113200; Ganesh L, 2003, NATURE, V426, P853, DOI 10.1038/nature02171; Garcia-Nogales P, 1999, J NEUROCHEM, V72, P1750, DOI 10.1046/j.1471-4159.1999.721750.x; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Green DR, 2003, MOL CELL, V11, P551, DOI 10.1016/S1097-2765(03)00107-2; Greene WC, 2004, NAT IMMUNOL, V5, P18, DOI 10.1038/ni0104-18; Gutierrez G, 2007, ATHEROSCLEROSIS, V190, P90, DOI 10.1016/j.atherosclerosis.2006.02.031; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Huang Y, 2008, J BIOL CHEM, V283, P11453, DOI 10.1074/jbc.M708544200; Iwasaki Y, 2004, J CLIN ENDOCR METAB, V89, P3449, DOI 10.1210/jc.2003-031441; Janssen-Heininger YMW, 2000, FREE RADICAL BIO MED, V28, P1317, DOI 10.1016/S0891-5849(00)00218-5; Kaisho T, 2008, TRENDS IMMUNOL, V29, P329, DOI 10.1016/j.it.2008.03.005; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kim YM, 1997, J BIOL CHEM, V272, P1402, DOI 10.1074/jbc.272.2.1402; Krappmann D, 2005, EMBO REP, V6, P321, DOI 10.1038/sj.embor.7400380; Lamb HK, 2004, PROTEIN SCI, V13, P3127, DOI 10.1110/ps.04958904; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Maine GN, 2007, CELL MOL LIFE SCI, V64, P1997, DOI 10.1007/s00018-007-7078-y; Maine GN, 2007, CELL CYCLE, V6, P672, DOI 10.4161/cc.6.6.3989; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Malek S, 1998, J BIOL CHEM, V273, P25427, DOI 10.1074/jbc.273.39.25427; Marshall HE, 2000, FASEB J, V14, P1889, DOI 10.1096/fj.00.011rev; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mulherkar N, 2006, ONCOGENE, V25, P6252, DOI 10.1038/sj.onc.1209650; Muller T, 2003, J HEPATOL, V38, P164, DOI 10.1016/S0168-8278(02)00356-2; Perkins ND, 2000, TRENDS BIOCHEM SCI, V25, P434, DOI 10.1016/S0968-0004(00)01617-0; Reynaert NL, 2005, ANTIOXID REDOX SIGN, V7, P129, DOI 10.1089/ars.2005.7.129; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Schwartz AG, 2004, AGEING RES REV, V3, P171, DOI 10.1016/j.arr.2003.05.001; Stammers DK, 2001, EMBO J, V20, P6619, DOI 10.1093/emboj/20.23.6619; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; van de Sluis B, 2000, MAMM GENOME, V11, P455, DOI 10.1007/s003350010086; Wullaert A, 2006, TRENDS IMMUNOL, V27, P533, DOI 10.1016/j.it.2006.09.003; Yamamoto Yumi, 2001, Current Molecular Medicine (Hilversum), V1, P287; Zhang QH, 2006, P NATL ACAD SCI USA, V103, P9029, DOI 10.1073/pnas.0603269103; Zhao YM, 2008, J BIOL CHEM, V283, P11004, DOI 10.1074/jbc.M708697200; Zheng XF, 2007, P NATL ACAD SCI USA, V104, P8809, DOI 10.1073/pnas.0700480104	45	23	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					17998	18006		10.1074/jbc.M809752200	http://dx.doi.org/10.1074/jbc.M809752200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19433587	hybrid, Green Published			2022-12-25	WOS:000267712400011
J	Zhang, YW; Jones, TL; Martin, SE; Caplen, NJ; Pommier, Y				Zhang, Yong-Wei; Jones, Tamara L.; Martin, Scott E.; Caplen, Natasha J.; Pommier, Yves			Implication of Checkpoint Kinase-dependent Up-regulation of Ribonucleotide Reductase R2 in DNA Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-I INHIBITORS; DOUBLE-STRAND BREAKS; S-PHASE CHECKPOINT; CANCER-CELL-LINES; PROTEIN-KINASE; MULTIDRUG-RESISTANCE; CLEAVABLE COMPLEXES; REPLICATION STRESS; CARCINOMA CELLS; CAMPTOTHECIN	To investigate drug mechanisms of action and identify molecular targets for the development of rational drug combinations, we conducted synthetic small interfering RNA (siRNA)-based RNAi screens to identify genes whose silencing affects anti-cancer drug responses. Silencing of RRM1 and RRM2, which encode the large and small subunits of the human ribonucleotide reductase complex, respectively, markedly enhanced the cytotoxicity of the topoisomerase I inhibitor camptothecin (CPT). Silencing of RRM2 was also found to enhance DNA damage as measured by histone gamma-H2AX. Further studies showed that CPT up-regulates both RRM1 and RRM2 mRNA and protein levels and induces the nuclear translocation of RRM2. The checkpoint kinase 1 (Chk1) was up-regulated and activated in response to CPT, and CHEK1 down-regulation by siRNA and small molecule inhibitors of Chk1 blocked RRM2 induction by CPT. CHEK1 siRNA also suppressed E2F1 up-regulation by CPT, and silencing of E2F1 suppressed the up-regulation of RRM2. Silencing of ATR or ATM and inhibition of ATM activity by KU-55933 blocked Chk1 activation and RRM2 up-regulation. This study links the known components of CPT-induced DNA damage response with proteins required for the synthesis of dNTPs and DNA repair. Specifically, we propose that upon DNA damage, Chk1 activation, mediated by ATM and ATR, up-regulates RRM2 expression through the E2F1 transcription factor. Upregulation in RRM2 expression levels coupled with its nuclear recruitment suggests an active role for ribonucleotide reductase in the cellular response to CPT-mediated DNA damage that could potentially be exploited as a strategy for enhancing the efficacy of topoisomerase I inhibitors.	[Zhang, Yong-Wei; Pommier, Yves] NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA; [Jones, Tamara L.; Martin, Scott E.; Caplen, Natasha J.] NCI, Gene Silencing Sect, Genet Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pommier, Y (corresponding author), Bldg 37,Rm 5068,9000 Rockville Pike, Bethesda, MD 20892 USA.	pommier@nih.gov	ZHANG, YONGWEI/E-6252-2012; Caplen, Natasha J/H-2768-2016	Caplen, Natasha J/0000-0002-0001-9460; Zhang, Yongwei/0000-0003-2900-1149	National Institutes of Health Intramural Research Program; Center for Cancer Research, NCI; NATIONAL CANCER INSTITUTE [ZIABC006150, ZIABC006161, ZIABC010939, Z01BC006150, ZIABC010615, Z01BC010613, ZIABC010613, Z01BC006161, Z01BC010939] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, Center for Cancer Research, NCI.	ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; Antony S, 2007, CANCER RES, V67, P10397, DOI 10.1158/0008-5472.CAN-07-0938; Bailly C, 2003, CRIT REV ONCOL HEMAT, V45, P91, DOI 10.1016/S1040-8428(02)00090-2; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brangi M, 1999, CANCER RES, V59, P5938; Chabes AL, 2004, J BIOL CHEM, V279, P10796, DOI 10.1074/jbc.M312482200; Chen SH, 2007, J BIOL CHEM, V282, P986, DOI 10.1074/jbc.M609322200; CHENG MF, 1994, ONCOL RES, V6, P269; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Decrock E, 2009, CELL DEATH DIFFER, V16, P524, DOI 10.1038/cdd.2008.196; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Desai AA, 2005, ANN ONCOL, V16, P958, DOI 10.1093/annonc/mdi178; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Eaton JS, 2007, J CLIN INVEST, V117, P2723, DOI 10.1172/JCI31604; ELLEDGE SJ, 1993, BIOESSAYS, V15, P333, DOI 10.1002/bies.950150507; ENGSTROM Y, 1988, EMBO J, V7, P1615, DOI 10.1002/j.1460-2075.1988.tb02987.x; ENGSTROM Y, 1984, EMBO J, V3, P863, DOI 10.1002/j.1460-2075.1984.tb01897.x; Fedier A, 2003, INT J ONCOL, V22, P1169; Flatten K, 2005, J BIOL CHEM, V280, P14349, DOI 10.1074/jbc.M411890200; Furuta T, 2006, ONCOGENE, V25, P2839, DOI 10.1038/sj.onc.1209313; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Fusaro G, 2002, ONCOGENE, V21, P4539, DOI 10.1038/sj.onc.1205551; Goldwasser F, 1996, CANCER RES, V56, P4430; Heidel JD, 2007, CLIN CANCER RES, V13, P2207, DOI 10.1158/1078-0432.CCR-06-2218; Herrick J, 2007, MOL MICROBIOL, V63, P22, DOI 10.1111/j.1365-2958.2006.05493.x; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; HOLM C, 1989, CANCER RES, V49, P6365; HSIANG YH, 1989, CANCER RES, V49, P5077; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Klisovic RB, 2008, CLIN CANCER RES, V14, P3889, DOI 10.1158/1078-0432.CCR-08-0109; Koc A, 2007, BIOCHEM BIOPH RES CO, V353, P527, DOI 10.1016/j.bbrc.2006.12.049; Kuo ML, 2003, CANCER J, V9, P277, DOI 10.1097/00130404-200307000-00010; LASSMANN G, 1992, BIOCHEM BIOPH RES CO, V188, P879, DOI 10.1016/0006-291X(92)91138-G; Lee YD, 2006, GENE DEV, V20, P334, DOI 10.1101/gad.1380506; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Lin WC, 2001, GENE DEV, V15, P1833; Lin ZP, 2007, BIOCHEM PHARMACOL, V73, P760, DOI 10.1016/j.bcp.2006.11.014; Lin ZP, 2004, J BIOL CHEM, V279, P27030, DOI 10.1074/jbc.M402056200; Liu QH, 2000, GENE DEV, V14, P1448; Lubelsky Y, 2005, MOL CELL BIOL, V25, P10665, DOI 10.1128/MCB.25.23.10665-10673.2005; Martin SE, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm141; Naruyama H, 2008, BIOCHEM BIOPH RES CO, V374, P79, DOI 10.1016/j.bbrc.2008.06.112; Nieves-Neira W, 1999, INT J CANCER, V82, P396, DOI 10.1002/(SICI)1097-0215(19990730)82:3<396::AID-IJC13>3.0.CO;2-Z; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; O'Connor T, 2008, CANCER CHEMOTH PHARM, V61, P125, DOI 10.1007/s00280-007-0456-1; Pommier Y, 1996, ANN NY ACAD SCI, V803, P60, DOI 10.1111/j.1749-6632.1996.tb26377.x; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Seiler JA, 2007, MOL CELL BIOL, V27, P5806, DOI 10.1128/MCB.02278-06; Shao RG, 1997, CANCER RES, V57, P4029; Stadler WM, 2008, CANCER CHEMOTH PHARM, V61, P689, DOI 10.1007/s00280-007-0524-6; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Takemura H, 2006, J BIOL CHEM, V281, P30814, DOI 10.1074/jbc.M603747200; Teicher BA, 2008, BIOCHEM PHARMACOL, V75, P1262, DOI 10.1016/j.bcp.2007.10.016; TSAO YP, 1993, CANCER RES, V53, P5908; Tse AN, 2004, CANCER RES, V64, P6635, DOI 10.1158/0008-5472.CAN-04-0841; Uchiki T, 2004, J BIOL CHEM, V279, P11293, DOI 10.1074/jbc.M309751200; Wang JL, 2002, CELL CYCLE, V1, P267, DOI 10.4161/cc.1.4.137; Woolstencroft RN, 2006, J CELL SCI, V119, P5178, DOI 10.1242/jcs.03221; Yamaguchi T, 2001, CANCER RES, V61, P8256; Zhao XL, 2001, EMBO J, V20, P3544, DOI 10.1093/emboj/20.13.3544; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhao XL, 2002, P NATL ACAD SCI USA, V99, P3746, DOI 10.1073/pnas.062502299; Zhou BS, 2003, CANCER RES, V63, P6583; ZHOU Z, 1993, CELL, V75, P1119, DOI 10.1016/0092-8674(93)90321-G	66	100	102	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18085	18095		10.1074/jbc.M109.003020	http://dx.doi.org/10.1074/jbc.M109.003020			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19416980	hybrid, Green Published			2022-12-25	WOS:000267712400020
J	Nadolski, MJ; Linder, ME				Nadolski, Marissa J.; Linder, Maurine E.			Molecular Recognition of the Palmitoylation Substrate Vac8 by Its Palmitoyltransferase Pfa3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARMADILLO REPEAT PROTEIN; HUNTINGTIN-INTERACTING PROTEIN-14; CYSTEINE-RICH DOMAIN; SACCHAROMYCES-CEREVISIAE; MEMBRANE LOCALIZATION; MENTAL-RETARDATION; ESCHERICHIA-COLI; N-MYRISTOYLATION; PLASMA-MEMBRANE; GLOBAL ANALYSIS	Palmitoylation of the yeast vacuolar protein Vac8 is important for its role in membrane-mediated events such as vacuole fusion. It has been established both in vivo and in vitro that Vac8 is palmitoylated by the Asp-His-His-Cys (DHHC) protein Pfa3. However, the determinants of Vac8 critical for recognition by Pfa3 have yet to be elucidated. This is of particular importance because of the lack of a consensus sequence for palmitoylation. Here we show that Pfa3 was capable of palmitoylating each of the three N-terminal cysteines of Vac8 and that this reaction was most efficient when Vac8 is N-myristoylated. Additionally, when we analyzed the Src homology 4 (SH4) domain of Vac8 independent of the rest of the protein, palmitoylation by Pfa3 still occurred. However, the specificity of palmitoylation seen for the full-length protein was lost, and the SH4 domain was palmitoylated by all five of the yeast DHHC proteins tested. These data suggested that a region of the protein C-terminal to the SH4 domain was important for conferring specificity of palmitoylation. This was confirmed by use of a chimeric protein in which the SH4 domain of Vac8 was swapped for that of Meh1, another palmitoylated and N-myristoylated protein in yeast. In this case we saw specificity mimic that of wild type Vac8. Competition experiments revealed that the 11th armadillo repeat of Vac8 is an important element for recognition by Pfa3. This demonstrates that regions distant from the palmitoylated cysteines are important for recognition by DHHC proteins.	[Nadolski, Marissa J.; Linder, Maurine E.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Linder, ME (corresponding author), Washington Univ, Dept Cell Biol & Physiol, Campus Box 8228,660 S Euclid Ave, St Louis, MO 63110 USA.	mlinder@wustl.edu	Linder, Maurine/AAU-9999-2021	Linder, Maurine/0000-0003-2202-9712	National Institutes of Health [GM51466]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051466, T32GM007067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51466.	Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; BERTHIAUME L, 1995, J BIOL CHEM, V270, P22399, DOI 10.1074/jbc.270.38.22399; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Budde C, 2006, METHODS, V40, P143, DOI 10.1016/j.ymeth.2006.07.017; DEGTYAREV MY, 1994, J BIOL CHEM, V269, P30898; Draper JM, 2007, J LIPID RES, V48, P1873, DOI 10.1194/jlr.M700179-JLR200; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Duncan JA, 1996, J BIOL CHEM, V271, P23594, DOI 10.1074/jbc.271.38.23594; Dunphy JT, 1996, J BIOL CHEM, V271, P7154, DOI 10.1074/jbc.271.12.7154; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Fleckenstein D, 1998, J CELL SCI, V111, P3109; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Gao XD, 2005, FEBS J, V272, P2497, DOI 10.1111/j.1742-4658.2005.04670.x; Gonzalo S, 1999, J BIOL CHEM, V274, P21313, DOI 10.1074/jbc.274.30.21313; GRAZIANO MP, 1989, J BIOL CHEM, V264, P409; Greaves J, 2009, MOL BIOL CELL, V20, P1845, DOI 10.1091/mbc.E08-09-0944; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hou HT, 2005, P NATL ACAD SCI USA, V102, P17366, DOI 10.1073/pnas.0508885102; HUANG K, 2009, FASEB J IN PRESS; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; KOEGL M, 1994, BIOCHEM J, V303, P749, DOI 10.1042/bj3030749; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; MAGEE AI, 1985, EMBO J, V4, P1137, DOI 10.1002/j.1460-2075.1985.tb03751.x; Mansouri MR, 2005, EUR J HUM GENET, V13, P970, DOI 10.1038/sj.ejhg.5201445; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Ohyama T, 2007, J CELL BIOL, V179, P1481, DOI 10.1083/jcb.200710061; Pan XZ, 2000, MOL BIOL CELL, V11, P2445, DOI 10.1091/mbc.11.7.2445; Pan XZ, 1998, J CELL SCI, V111, P2137; Peng YT, 2006, TRAFFIC, V7, P1378, DOI 10.1111/j.1600-0854.2006.00472.x; Raymond FL, 2007, AM J HUM GENET, V80, P982, DOI 10.1086/513609; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Scott SV, 2000, J BIOL CHEM, V275, P25840, DOI 10.1074/jbc.M002813200; Sharma C, 2008, MOL BIOL CELL, V19, P3415, DOI 10.1091/mbc.E07-11-1164; SIGAL CT, 1994, P NATL ACAD SCI USA, V91, P12253, DOI 10.1073/pnas.91.25.12253; Smotrys JE, 2005, J CELL BIOL, V170, P1091, DOI 10.1083/jcb.200507048; Srinivasa SP, 1998, P NATL ACAD SCI USA, V95, P5584, DOI 10.1073/pnas.95.10.5584; Stowers RS, 2007, J NEUROSCI, V27, P12874, DOI 10.1523/JNEUROSCI.2464-07.2007; Subramanian K, 2006, J CELL SCI, V119, P2477, DOI 10.1242/jcs.02972; Tang FS, 2006, TRAFFIC, V7, P1368, DOI 10.1111/j.1600-0854.2006.00458.x; TOWLER DA, 1987, J BIOL CHEM, V262, P1030; Veit M, 2001, EMBO J, V20, P3145, DOI 10.1093/emboj/20.12.3145; Wang YX, 2001, J BIOL CHEM, V276, P35133, DOI 10.1074/jbc.M103937200; Wang YX, 1998, J CELL BIOL, V140, P1063, DOI 10.1083/jcb.140.5.1063; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702	54	41	43	4	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17720	17730		10.1074/jbc.M109.005447	http://dx.doi.org/10.1074/jbc.M109.005447			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19416974	hybrid, Green Published			2022-12-25	WOS:000267202500038
J	Lee, SH; Hatakeyama, S; Yu, SY; Bao, XF; Ohyama, C; Khoo, KH; Fukuda, MN; Fukuda, M				Lee, Seung Ho; Hatakeyama, Shingo; Yu, Shin-Yi; Bao, Xingfeng; Ohyama, Chikara; Khoo, Kai-Hooi; Fukuda, Michiko N.; Fukuda, Minoru			Core3 O-Glycan Synthase Suppresses Tumor Formation and Metastasis of Prostate Carcinoma PC3 and LNCaP Cells through Down-regulation of alpha 2 beta 1 Integrin Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINYLTRANSFERASE-V; HAMSTER-KIDNEY CELLS; MOLECULAR-CLONING; ALPHA-3-BETA-1 INTEGRIN; LUNG COLONIZATION; BRANCH FORMATION; GENE-TRANSFER; CANCER-CELLS; UDP-GLCNAC; EXPRESSION	Although there are numerous reports of carbohydrates enriched in cancer cells, very few studies have addressed the functions of carbohydrates present in normal cells that decrease in cancer cells. It has been reported that core3 O-glycans are synthesized in normal gastrointestinal cells but are down-regulated in cancer cells. To determine the roles of core3 O-glycans, we transfected PC3 and LNCaP prostate cancer cells with beta 3-N-acetylglucosaminyltransferase-6 ( core3 synthase) required to synthesize core3 O-glycans. Both engineered cell lines exhibited reduced migration and invasion through extracellular matrix components compared with mock-transfected cells. Moreover we found that alpha 2 beta 1 integrin acquired core3 O-glycans in cells expressing core3 synthase with decreased maturation of beta 1 integrin, leading to decreased levels of the alpha 2 beta 1 integrin complex, decreased activation of focal adhesion kinase, and reduced lamellipodia formation. Upon inoculation into the prostate of nude mice, PC3 cells expressing core3 O-glycans produced much smaller tumors without metastasis to the surrounding lymph nodes in contrast to robust tumor formation and metastasis seen in mock-transfected PC3 cells. Similarly LNCaP cells expressing core3 O-glycans barely produced subcutaneous tumors in contrast to robust tumor formation by mock-transfected LNCaP cells. These findings indicate that addition of core3 O-glycans to beta 1 and alpha 2 integrin subunits in prostate cancer cells suppresses tumor formation and tumor metastasis.	[Lee, Seung Ho; Hatakeyama, Shingo; Bao, Xingfeng; Fukuda, Michiko N.; Fukuda, Minoru] Burnham Inst Med Res, Ctr Canc, Glycobiol Unit, Tumor Microenvironm Program, La Jolla, CA 92037 USA; [Yu, Shin-Yi; Khoo, Kai-Hooi] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Ohyama, Chikara] Hirosaki Univ, Sch Med, Dept Urol, Hirosaki, Aomori 0362562, Japan	Sanford Burnham Prebys Medical Discovery Institute; Academia Sinica - Taiwan; Hirosaki University	Fukuda, M (corresponding author), Burnham Inst Med Res, Ctr Canc, Glycobiol Unit, Tumor Microenvironm Program, La Jolla, CA 92037 USA.	minoru@burnham.org	Khoo, Kay-Hooi/E-1989-2019; Hatakeyama, Shingo/AAQ-2583-2020; Hatakeyama, Shingo/E-9234-2013	Khoo, Kay-Hooi/0000-0003-2906-406X; Hatakeyama, Shingo/0000-0002-0026-4079; YU, Shin-Yi/0000-0003-0197-9575	National Institutes of Health [CA33000, CA48737, PO1CA71932]; Taiwan National Science Council; NATIONAL CANCER INSTITUTE [P01CA071932, R37CA033000, R01CA033000, R01CA048737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taiwan National Science Council(Ministry of Science and Technology, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants CA33000 and in part by CA48737 ( to M. F.) and PO1CA71932 ( to M. F. and M. N. F.) and by grants from Taiwan National Science Council ( to K. H. K.).	An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Bellis SL, 1999, J CELL PHYSIOL, V181, P33, DOI 10.1002/(SICI)1097-4652(199910)181:1<33::AID-JCP4>3.0.CO;2-#; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; Bonaccorsi L, 2000, ENDOCRINOLOGY, V141, P3172, DOI 10.1210/en.141.9.3172; Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; Chen SH, 2005, J EXP MED, V202, P1679, DOI 10.1084/jem.20051473; Clement M, 2004, J CELL SCI, V117, P5059, DOI 10.1242/jcs.01350; Dalziel M, 2001, J BIOL CHEM, V276, P11007, DOI 10.1074/jbc.M006523200; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Fukuda M, 1996, CANCER RES, V56, P2237; FUKUSHIMA K, 1984, CANCER RES, V44, P5279; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Guo HB, 2005, J BIOL CHEM, V280, P8332, DOI 10.1074/jbc.M413532200; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Hatakeyama S, 2009, P NATL ACAD SCI USA, V106, P3095, DOI 10.1073/pnas.0810110106; Huang MC, 2006, ONCOGENE, V25, P3267, DOI 10.1038/sj.onc.1209350; HUBBARD SC, 1987, J BIOL CHEM, V262, P16403; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Inaba Y, 2003, INT J CANCER, V107, P949, DOI 10.1002/ijc.11513; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Iwai T, 2005, P NATL ACAD SCI USA, V102, P4572, DOI 10.1073/pnas.0407983102; Iwai T, 2002, J BIOL CHEM, V277, P12802, DOI 10.1074/jbc.M112457200; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; LOTAN R, 1975, J BIOL CHEM, V250, P8518; Lyer P N, 1976, Arch Biochem Biophys, V177, P330; Machida E, 2001, CANCER RES, V61, P2226; MEROMSKY L, 1986, CANCER RES, V46, P5270; Mitoma J, 2003, J BIOL CHEM, V278, P9953, DOI 10.1074/jbc.M212756200; Mitoma J, 2007, NAT IMMUNOL, V8, P409, DOI 10.1038/ni1442; NAKAMORI S, 1993, CANCER RES, V53, P3632; OLSSON L, 1984, P NATL ACAD SCI-BIOL, V81, P3389, DOI 10.1073/pnas.81.11.3389; PIERCE M, 1986, J BIOL CHEM, V261, P772; PILLER F, 1988, J BIOL CHEM, V263, P15146; SCHACHTER H, 1992, BIOSYNTHESIS SERINE, P263; Schwientek T, 2000, J BIOL CHEM, V275, P11106, DOI 10.1074/jbc.275.15.11106; Schwientek T, 1999, J BIOL CHEM, V274, P4504, DOI 10.1074/jbc.274.8.4504; Sugihara K, 2007, P NATL ACAD SCI USA, V104, P3799, DOI 10.1073/pnas.0611516104; TAKADA Y, 1993, J BIOL CHEM, V268, P17597; VAVASSEUR F, 1995, GLYCOBIOLOGY, V5, P351, DOI 10.1093/glycob/5.3.351; VAVASSEUR F, 1994, EUR J BIOCHEM, V222, P415, DOI 10.1111/j.1432-1033.1994.tb18880.x; YAMASHITA K, 1984, J BIOL CHEM, V259, P834; Yeh JC, 1999, J BIOL CHEM, V274, P3215, DOI 10.1074/jbc.274.5.3215; Yu SY, 2006, GLYCOCONJUGATE J, V23, P355, DOI 10.1007/s10719-006-8492-3; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200	48	53	53	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17157	17169		10.1074/jbc.M109.010934	http://dx.doi.org/10.1074/jbc.M109.010934			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19395705	Green Published, hybrid			2022-12-25	WOS:000266962400054
J	Ala-Laurila, P; Cornwall, MC; Crouch, RK; Kono, M				Ala-Laurila, Petri; Cornwall, M. Carter; Crouch, Rosalie K.; Kono, Masahiro			The Action of 11-cis-Retinol on Cone Opsins and Intact Cone Photoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VISUAL-PIGMENT; ROD PHOTORECEPTORS; DARK-ADAPTATION; 9-METHYL GROUP; SALAMANDER; ACTIVATION; RETINA; CYCLE; REGENERATION; PHOTOTRANSDUCTION	11-cis-Retinol has previously been shown in physiological experiments to promote dark adaptation and recovery of photo-responsiveness of bleached salamander red cones but not of bleached salamander red rods. The purpose of this study was to evaluate the direct interaction of 11-cis-retinol with expressed human and salamander cone opsins, and to determine by microspectrophotometry pigment formation in isolated salamander photoreceptors. We show here in a cell-free system using incorporation of radioactive guanosine 5'-3-O-( thio) triphosphate into transducin as an index of activity, that 11-cis-retinol inactivates expressed salamander cone opsins, acting an inverse agonist. Similar results were obtained with expressed human red and green opsins. 11-cis-Retinol had no significant effect on the activity of human blue cone opsin. In contrast, 11-cis-retinol activates the expressed salamander and human red rod opsins, acting as an agonist. Using microspectrophotometry of salamander cone photoreceptors before and after bleaching and following subsequent treatment with 11-cis-retinol, we show that 11-cis-retinol promotes pigment formation. Pigment was not formed in salamander red rods or green rods ( containing the same opsin as blue cones) treated under the same conditions. These results demonstrate that 11-cis-retinol is not a useful substrate for rod photoreceptors although it is for cone photoreceptors. These data support the premise that rods and cones have mechanisms for handling retinoids and regenerating visual pigment that are specific to photoreceptor type. These mechanisms are critical to providing regenerated pigments in a time scale required for the function of these two types of photoreceptors.	[Crouch, Rosalie K.; Kono, Masahiro] Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; [Ala-Laurila, Petri; Cornwall, M. Carter] Boston Univ, Dept Physiol & Biophys, Sch Med, Boston, MA 02118 USA; [Ala-Laurila, Petri] Univ Helsinki, Dept Biol & Environm Sci, FI-00014 Helsinki, Finland	Medical University of South Carolina; Boston University; University of Helsinki	Kono, M (corresponding author), Med Univ S Carolina, Dept Ophthalmol, Box 250676,167 Ashley Ave, Charleston, SC 29425 USA.	konom@musc.edu	Ala-Laurila, Petri/AAE-1203-2019; Kono, Masahiro/AAT-2265-2021	Ala-Laurila, Petri/0000-0002-6139-6825; Kono, Masahiro/0000-0001-7377-1664; Cornwall, M./0000-0002-0847-939X	National Institutes of Health [EY01157, EY04939, EY14793]; Academy of Finland [123231]; Foundation Fighting Blindness, Inc.; Owings Mills, MD; Research to Prevent Blindness, New York; NATIONAL EYE INSTITUTE [R01EY001157, R01EY004939, R24EY014793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); Foundation Fighting Blindness, Inc.; Owings Mills, MD; Research to Prevent Blindness, New York(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY01157 (to M. C. C.), EY04939 (to R. K. C.), and EY14793 (vision core at the Medical University of South Carolina). This work was also supported by Academy of Finland Grant 123231 (to P. A.- L.), a grant from the Foundation Fighting Blindness, Inc., Owings Mills, MD (to R. K. C.), and an unrestricted grant to the Department of Ophthalmology at the Medical University of South Carolina from Research to Prevent Blindness, New York.	Ala-Laurila P, 2007, J PHYSIOL-LONDON, V585, P57, DOI 10.1113/jphysiol.2007.142935; Ala-Laurila P, 2006, J GEN PHYSIOL, V128, P153, DOI 10.1085/jgp.200609557; Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; CORNWALL MC, 1984, VISION RES, V24, P1651, DOI 10.1016/0042-6989(84)90323-7; Cornwall MC, 2000, METHOD ENZYMOL, V316, P224; Crouch RK, 2002, METHOD ENZYMOL, V343, P29; DAEMEN FJM, 1978, NATURE, V276, P847, DOI 10.1038/276847a0; Das J, 2004, BIOCHEMISTRY-US, V43, P5532, DOI 10.1021/bi036097u; DAS SR, 1992, BIOCHEM J, V285, P907, DOI 10.1042/bj2850907; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; Estevez ME, 2006, J GEN PHYSIOL, V128, P671, DOI 10.1085/jgp.200609630; Fan J, 2008, INVEST OPHTH VIS SCI, V49, P2384, DOI 10.1167/iovs.08-1727; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Haeseleer F, 1998, J BIOL CHEM, V273, P21790, DOI 10.1074/jbc.273.34.21790; HAROSI FI, 1975, J GEN PHYSIOL, V66, P357, DOI 10.1085/jgp.66.3.357; Isayama T, 2006, VISUAL NEUROSCI, V23, P899, DOI 10.1017/S0952523806230256; JIN J, 1994, VISUAL NEUROSCI, V11, P389, DOI 10.1017/S0952523800001735; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; JONES GJ, 1993, J GEN PHYSIOL, V102, P483, DOI 10.1085/jgp.102.3.483; Kefalov VJ, 2001, NEURON, V29, P749, DOI 10.1016/S0896-6273(01)00249-5; Kono M, 2006, FEBS LETT, V580, P229, DOI 10.1016/j.febslet.2005.12.002; Kono M, 2008, BIOCHEMISTRY-US, V47, P7567, DOI 10.1021/bi800357b; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Ma JX, 2001, NEURON, V32, P451, DOI 10.1016/S0896-6273(01)00482-2; MacNichol E. F.  Jr., 1978, Frontiers in Visual Science, P194; Makino CL, 1999, BIOPHYS J, V77, P1024, DOI 10.1016/S0006-3495(99)76953-5; Makino CL, 1996, J GEN PHYSIOL, V108, P27, DOI 10.1085/jgp.108.1.27; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Melia TJ, 1997, BIOPHYS J, V73, P3182, DOI 10.1016/S0006-3495(97)78344-9; Miyazono S, 2008, P NATL ACAD SCI USA, V105, P16051, DOI 10.1073/pnas.0806593105; Moiseyev G, 2003, BIOCHEMISTRY-US, V42, P2229, DOI 10.1021/bi026911y; Muniz A, 2007, EXP EYE RES, V85, P175, DOI 10.1016/j.exer.2007.05.003; OPRIAN DD, 1993, METH NEUROSCI, V15, P301; Robinson PR, 2000, METHOD ENZYMOL, V315, P207; RUSHTON WAH, 1968, J PHYSIOL-LONDON, V198, P219, DOI 10.1113/jphysiol.1968.sp008603; RUSHTON WAH, 1968, VISION RES, V8, P617, DOI 10.1016/0042-6989(68)90040-0; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1; YU HB, 1995, BIOCHEMISTRY-US, V34, P14963, DOI 10.1021/bi00046a002; Zhang HB, 2008, J NEUROSCI, V28, P4008, DOI 10.1523/JNEUROSCI.0317-08.2008	42	31	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16492	16500		10.1074/jbc.M109.004697	http://dx.doi.org/10.1074/jbc.M109.004697			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19386593	Green Published, hybrid			2022-12-25	WOS:000266730900046
J	Zhang, X; Zhu, Y; Geng, L; Wang, H; Legerski, RJ				Zhang, X.; Zhu, Y.; Geng, L.; Wang, H.; Legerski, R. J.			Artemis is a negative regulator of p53 in response to oxidative stress	ONCOGENE			English	Article						Artemis; p53; DNA-PKcs; oxidative stress	DEPENDENT PROTEIN-KINASE; STRAND BREAK REPAIR; DNA-DAMAGE; V(D)J RECOMBINATION; TUMOR-SUPPRESSOR; CELL-DEATH; PHOSPHORYLATION; ACTIVATION; APOPTOSIS; MITOCHONDRIA	Artemis is a multifunctional phospho-protein with roles in V(D)J recombination, repair of double-strand breaks by nonhomologous end-joining and regulation of cell-cycle checkpoints after DNA damage. Here, we describe a new function of Artemis as a negative regulator of p53 in response to oxidative stress in both primary cells and cancer cell lines. We show that depletion of Artemis under typical culture conditions (21% oxygen) leads to a spontaneous phosphorylation and stabilization of p53, and resulting cellular G1 arrest and apoptosis. These effects are suppressed by co-depletion of DNA-PKcs, but not ATM, indicating that Artemis is an inhibitor of DNA-PKcs-mediated stabilization of p53. Culturing of cellsat 3% oxygen or treatment with an antioxidant abrogated p53 stabilization, indicating that oxidative stress is the responsible cellular stimulus. Treatment with ionizing radiation or hydrogen peroxide did not cause activation of this signaling pathway, whereas inhibitors of mitochondrial electron transport were effective in reducing its activation. In addition, we show that p53-inducible genes involved in reducing reactive oxygen species are upregulated by Artemis depletion. These findings indicate that Artemis and DNA-PKcs participate in a new, signaling pathway to modulate p53 function in response to oxidative stress produced by mitochondrial respiration. Oncogene (2009) 28, 2196-2204; doi: 10.1038/onc.2009.100; published online 27 April 2009	[Zhang, X.; Zhu, Y.; Geng, L.; Wang, H.; Legerski, R. J.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Legerski, RJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, 1515 Holcombe Blvd, Houston, TX 77030 USA.	rlegersk@mdanderson.org			National Cancer Institute [CA096574]; NATIONAL CANCER INSTITUTE [R01CA096574, P01CA097175] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G Lozano for helpful discussions of the paper. This work was supported by National Cancer Institute grant CA096574 (RJL).	Anwar A, 2003, J BIOL CHEM, V278, P10368, DOI 10.1074/jbc.M211981200; Asher G, 2002, P NATL ACAD SCI USA, V99, P3099, DOI 10.1073/pnas.052706799; Asher G, 2001, P NATL ACAD SCI USA, V98, P1188, DOI 10.1073/pnas.021558898; Bensaad K, 2007, TRENDS CELL BIOL, V17, P286, DOI 10.1016/j.tcb.2007.04.004; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Chang NS, 2003, BIOCHEM PHARMACOL, V66, P1347, DOI 10.1016/S0006-2952(03)00484-2; Chen L, 2005, CANCER SCI, V96, P134, DOI 10.1111/j.1349-7006.2005.00019.x; Geng LY, 2007, MOL CELL BIOL, V27, P2625, DOI 10.1128/MCB.02072-06; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Karawajew L, 2005, BLOOD, V105, P4767, DOI 10.1182/blood-2004-09-3428; Kondoh H, 2005, CANCER RES, V65, P177; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Ma YM, 2005, J BIOL CHEM, V280, P33839, DOI 10.1074/jbc.M507113200; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; MAYER M, 1994, P NATL ACAD SCI USA, V91, P7496, DOI 10.1073/pnas.91.16.7496; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; MONTES DOL, 1995, NATURE, V378, P203; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Moshous D, 2000, HUM MOL GENET, V9, P583, DOI 10.1093/hmg/9.4.583; Poinsignon C, 2004, EUR J IMMUNOL, V34, P3146, DOI 10.1002/eji.200425455; Punj V, 2003, CELL MICROBIOL, V5, P225, DOI 10.1046/j.1462-5822.2003.00269.x; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rooney S, 2004, P NATL ACAD SCI USA, V101, P2410, DOI 10.1073/pnas.0308757101; Rooney S, 2002, MOL CELL, V10, P1379, DOI 10.1016/S1097-2765(02)00755-4; Sarkaria JN, 1998, CANCER RES, V58, P4375; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SEEDORF K, 1987, EMBO J, V6, P139, DOI 10.1002/j.1460-2075.1987.tb04731.x; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Sohn D, 2006, CANCER RES, V66, P11254, DOI 10.1158/0008-5472.CAN-06-1569; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Tian H, 2000, CANCER RES, V60, P679; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang JH, 2005, DNA REPAIR, V4, P556, DOI 10.1016/j.dnarep.2005.02.001; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhang XS, 2004, MOL CELL BIOL, V24, P9207, DOI 10.1128/MCB.24.20.9207-9220.2004	39	18	20	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2009	28	22					2196	2204		10.1038/onc.2009.100	http://dx.doi.org/10.1038/onc.2009.100			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	453VF	19398950	Green Accepted			2022-12-25	WOS:000266640300002
J	Tanaka, K; Okamoto, S; Ishikawa, Y; Tamura, H; Hara, T				Tanaka, K.; Okamoto, S.; Ishikawa, Y.; Tamura, H.; Hara, T.			DDX1 is required for testicular tumorigenesis, partially through the transcriptional activation of 12p stem cell genes	ONCOGENE			English	Article						DDX1; germ cell tumor; testis; cyclin-D2	MESSENGER-RNA EXPRESSION; DEAD-BOX PROTEINS; CD9 EXPRESSION; CYCLIN D2; TUMORS; PROLIFERATION; NEUROBLASTOMA; TESTIS; MOUSE; DIFFERENTIATION	Cytogenetic analysis has identified 12p gain as the most frequent abnormality in human testicular germ cell tumors (TGCTs). It has been suggested that amplification and overexpression of stem cell-associated genes, including cyclin-D2, on the human chromosome 12p region are involved in germ cell tumorigenesis. By subtractive cDNA analysis, we identified Ddx1, a member of the DEAD-box protein family, as a gene predominantly expressed in the primordial germ cells of mouse embryos. Knockdown of Ddx1 in a mouse spermatogonia-derived cell line, GC-1spg, by short interference RNA repressed the expression of cyclin-D2, CD9 and GDF3 genes. In the mouse cyclin-D2 gene, a genomic DNA region between -348 and -329 was responsible for transcriptional activation by DDX1 based on reporter and gel shift assays. Similarly, DDX1 knockdown in the human TGCT cell line NEC8 repressed the expression of stem cell-associated genes localized on chromosome 12p13.3, including cyclin-D2, CD9 and NANOG. DDX1-knocked-down TGCT cells could not form solid tumors in nude mice. Furthermore, in situ hybridization revealed that DDX1 mRNA was produced in both seminoma and nonseminoma types of human TGCT samples. We conclude that DDX1 is a critical factor for testicular tumorigenesis. Oncogene (2009) 28, 2142-2151; doi: 10.1038/onc.2009.89; published online 27 April 2009	[Hara, T.] Tokyo Metropolitan Org Med Res, Stem Cell Project Grp, Tokyo Metropolitan Inst Med Sci, Setagaya Ku, Tokyo 1568506, Japan; [Ishikawa, Y.] Tokyo Metropolitan Org Med Res, Core Technol & Res Ctr, Tokyo Metropolitan Inst Med Sci, Tokyo 1568506, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science	Hara, T (corresponding author), Tokyo Metropolitan Org Med Res, Stem Cell Project Grp, Tokyo Metropolitan Inst Med Sci, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	tanaka-ky@igakuken.or.jp; hara-tk@igakuken.or.jp	Okamoto, Shiki/X-7274-2018	Okamoto, Shiki/0000-0002-2802-0527	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Y Futamata (Nippon Becton Dickinson) for help in the cell sorting experiments. We extend our thanks to all laboratory members for their technical assistance and valuable advice. The anti-SSEA-1 antibody (MC-480) developed by Dr D Solter and Dr BB Knowles was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and was maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA 52242. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	ATKIN NB, 1982, LANCET, V2, P1349; Beumer TL, 2000, BIOL REPROD, V63, P1893, DOI 10.1095/biolreprod63.6.1893; Biermann Katharina, 2007, Cancer Genomics & Proteomics, V4, P359; Bosl GJ, 1997, NEW ENGL J MED, V337, P242, DOI 10.1056/NEJM199707243370406; Chaganti RSK, 2000, CANCER RES, V60, P1475; Chaganti RSK, 1998, APMIS, V106, P80, DOI 10.1111/j.1699-0463.1998.tb01322.x; De Rooij DG, 1998, INT J EXP PATHOL, V79, P67, DOI 10.1046/j.1365-2613.1998.00057.x; DEVALOIR T, 1991, P NATL ACAD SCI USA, V88, P2113, DOI 10.1073/pnas.88.6.2113; Fujino RS, 2006, MOL ENDOCRINOL, V20, P904, DOI 10.1210/me.2005-0423; Godbout R, 1998, J BIOL CHEM, V273, P21161, DOI 10.1074/jbc.273.33.21161; GODBOUT R, 1993, P NATL ACAD SCI USA, V90, P7578, DOI 10.1073/pnas.90.16.7578; Hori H, 2004, J SURG RES, V117, P208, DOI 10.1016/j.jss.2004.01.014; Houldsworth J, 1997, CELL GROWTH DIFFER, V8, P293; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; Javed A, 2001, MOL CELL BIOL, V21, P2891, DOI 10.1128/MCB.21.8.2891-2905.2001; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; Kawashima M, 2002, J HISTOCHEM CYTOCHEM, V50, P1195, DOI 10.1177/002215540205000906; Korkola JE, 2006, CANCER RES, V66, P820, DOI 10.1158/0008-5472.CAN-05-2445; Kubota H, 2003, P NATL ACAD SCI USA, V100, P6487, DOI 10.1073/pnas.0631767100; Kubota H, 2004, BIOL REPROD, V71, P722, DOI 10.1095/biolreprod.104.029207; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; MOTOYAMA T, 1987, ACTA PATHOL JAPON, V37, P431; Nakayama H, 1996, DEV GROWTH DIFFER, V38, P141, DOI 10.1046/j.1440-169X.1996.t01-1-00003.x; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; RODRIGUEZ E, 1992, GENE CHROMOSOME CANC, V5, P21, DOI 10.1002/gcc.2870050104; Rosenberg C, 2000, ONCOGENE, V19, P5858, DOI 10.1038/sj.onc.1203950; SHUIN T, 1994, CANCER, V73, P1721, DOI 10.1002/1097-0142(19940315)73:6<1721::AID-CNCR2820730628>3.0.CO;2-W; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; SQUIRE JA, 1995, ONCOGENE, V10, P1417; Summersgill B, 2001, BRIT J CANCER, V85, P213, DOI 10.1054/bjoc.2001.1889; Sunden Y, 2007, MICROBIOL IMMUNOL, V51, P339, DOI 10.1111/j.1348-0421.2007.tb03907.x; Tanaka K, 2002, DEV BIOL, V246, P466, DOI 10.1006/dbio.2002.0671; Watsuji T, 1997, BIOCHEM BIOPH RES CO, V234, P769, DOI 10.1006/bbrc.1997.6705; Weber A, 2004, J CLIN ONCOL, V22, P2681, DOI 10.1200/JCO.2004.07.192	37	38	41	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 28	2009	28	21					2142	2151		10.1038/onc.2009.89	http://dx.doi.org/10.1038/onc.2009.89			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	451DQ	19398953				2022-12-25	WOS:000266451300003
J	Li, L; Oropeza, CE; Sainz, B; Uprichard, SL; Gonzalez, FJ; McLachlan, A				Li, Lie; Oropeza, Claudia E.; Sainz, Bruno, Jr.; Uprichard, Susan L.; Gonzalez, Frank J.; McLachlan, Alan			Developmental Regulation of Hepatitis B Virus Biosynthesis by Hepatocyte Nuclear Factor 4 alpha	PLOS ONE			English	Article								The host cellular factors that promote persistent viral infections in vivo are, in general, poorly understood. Utilizing the hepatitis B virus (HBV) transgenic mouse model of chronic infection, we demonstrate that the nuclear receptor, hepatocyte nuclear factor 4 alpha (HNF4 alpha, NR2A1), is essential for viral biosynthesis in the liver. The dependency of HBV transcription on HNF4 alpha links viral biosynthesis and persistence to a developmentally regulated transcription factor essential for host viability.			Li, L (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA.	mclach@uic.edu	Anding, Bruno Sainz/ABH-5365-2020; McLachlan, Alan/AAR-9194-2020	Anding, Bruno Sainz/0000-0003-4829-7651; McLachlan, Alan/0000-0002-4168-2365	NATIONAL CANCER INSTITUTE [ZIABC005561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI30070, R01AI030070, N01AI030070] Funding Source: NIH RePORTER; NIAID NIH HHS [N01AI30070, R01 AI030070] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson AL, 2005, J VIROL, V79, P11045, DOI 10.1128/JVI.79.17.11045-11052.2005; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; DELCANHO R, 1994, VACCINE, V12, P1323, DOI 10.1016/S0264-410X(94)80059-9; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; FENECH FF, 1967, BMJ-BRIT MED J, V3, P155, DOI 10.1136/bmj.3.5558.155; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; GALIBERT F, 1979, NATURE, V281, P646, DOI 10.1038/281646a0; Geeraert L, 2008, ANNU REV MED, V59, P487, DOI 10.1146/annurev.med.59.062806.123001; GUIDOTTI LG, 1995, J VIROL, V69, P6158, DOI 10.1128/JVI.69.10.6158-6169.1995; Guidotti LG, 1999, J VIROL, V73, P10377, DOI 10.1128/JVI.73.12.10377-10386.1999; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Knipe DM, 2008, NAT REV MICROBIOL, V6, P211, DOI 10.1038/nrmicro1794; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lok AS, 2001, GASTROENTEROLOGY, V120, P1828, DOI 10.1053/gast.2001.24839; MILICH DR, 1990, P NATL ACAD SCI USA, V87, P6599, DOI 10.1073/pnas.87.17.6599; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; SABATH DE, 1990, GENE, V91, P185, DOI 10.1016/0378-1119(90)90087-8; Sambrook J., 2002, MOL CLONING LAB MANU; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shih DQ, 2000, DIABETES, V49, P832, DOI 10.2337/diabetes.49.5.832; Shlomai A, 2006, P NATL ACAD SCI USA, V103, P16003, DOI 10.1073/pnas.0607837103; Stanley M, 2008, GYNECOL ONCOL, V109, pS15, DOI 10.1016/j.ygyno.2008.02.003; Tang H, 2001, P NATL ACAD SCI USA, V98, P1841, DOI 10.1073/pnas.041479698; Tang H, 2001, DRUG NEWS PERSPECT, V14, P325; WILL H, 1987, J VIROL, V61, P904, DOI 10.1128/JVI.61.3.904-911.1987; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0	30	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5489	10.1371/journal.pone.0005489	http://dx.doi.org/10.1371/journal.pone.0005489			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424486	Green Published, gold, Green Submitted			2022-12-25	WOS:000265933800019
J	Schmidt, J; Kirsch, S; Rappold, GA; Schempp, W				Schmidt, Julia; Kirsch, Stefan; Rappold, Gudrun A.; Schempp, Werner			Complex Evolution of a Y-Chromosomal Double Homeobox 4 (DUX4)-Related Gene Family in Hominoids	PLOS ONE			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; PRIMATE SEGMENTAL DUPLICATIONS; DNA-SEQUENCES; HUMAN GENOME; GREAT-APE; LONG ARM; REPEAT; RECOMBINATION; ORIGIN; REGION	The human Y chromosome carries four human Y-chromosomal euchromatin/heterochromatin transition regions, all of which are characterized by the presence of interchromosomal segmental duplications. The Yq11.1/Yq11.21 transition region harbours a peculiar segment composed of an imperfectly organized tandem-repeat structure encoding four members of the double homeobox ( DUX) gene family. By comparative fluorescence in situ hybridization ( FISH) analysis we have documented the primary appearance of Y-chromosomal DUX genes (DUXY) on the gibbon Y chromosome. The major amplification and dispersal of DUXY paralogs occurred after the gibbon and hominid lineages had diverged. Orthologous DUXY loci of human and chimpanzee show a highly similar structural organization. Sequence alignment survey, phylogenetic reconstruction and recombination detection analyses of human and chimpanzee DUXY genes revealed the existence of all copies in a common ancestor. Comparative analysis of the circumjacent beta-satellites indicated that DUXY genes and beta-satellites evolved in concert. However, evolutionary forces acting on DUXY genes may have induced amino acid sequence differences in the orthologous chimpanzee and human DUXY open reading frames (ORFs). The acquisition of complete ORFs in human copies might relate to evolutionary advantageous functions indicating neo-functionalization. We propose an evolutionary scenario in which an ancestral tandem array DUX gene cassette transposed to the hominoid Y chromosome followed by lineage-specific chromosomal rearrangements paved the way for a species-specific evolution of the Y-chromosomal members of a large highly diverged homeobox gene family.			Schmidt, J (corresponding author), Univ Freiburg, Inst Human Genet, Freiburg, Germany.	werner.schempp@uniklinik-freiburg.de						AGRESTI A, 1989, J MOL BIOL, V205, P625, DOI 10.1016/0022-2836(89)90308-2; ASHLEY E, 2004, HEATMAP BUILDER 1 0; AVARELLO R, 1992, HUM GENET, V89, P247; Bailey JA, 2003, COLD SPRING HARB SYM, V68, P115, DOI 10.1101/sqb.2003.68.115; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; BAILEY TL, 2006, NUCLEIC ACIDS RES, V34, pW39; Beckers MC, 2001, GENE, V264, P51, DOI 10.1016/S0378-1119(00)00602-8; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Bullaughey K, 2008, GENOME RES, V18, P544, DOI 10.1101/gr.071548.107; Calendini F., 2005, PAUPUP FREE GRAPHICA; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Clapp J, 2007, AM J HUM GENET, V81, P264, DOI 10.1086/519311; Clark LN, 1996, CHROMOSOMA, V105, P180, DOI 10.1007/BF02509499; COOPER KF, 1992, J MOL BIOL, V228, P421, DOI 10.1016/0022-2836(92)90831-4; Deidda G, 1996, J MED GENET, V33, P361, DOI 10.1136/jmg.33.5.361; Ding H, 1998, HUM MOL GENET, V7, P1681, DOI 10.1093/hmg/7.11.1681; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Eichler EE, 1998, GENOME RES, V8, P791, DOI 10.1101/gr.8.8.791; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Force A, 1999, GENETICS, V151, P1531; Gerrard DT, 2005, MOL BIOL EVOL, V22, P1423, DOI 10.1093/molbev/msi128; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Goidts V, 2005, GENOME RES, V15, P1232, DOI 10.1101/gr.3732505; GRUMMT I, 1979, NUCLEIC ACIDS RES, V6, P1351, DOI 10.1093/nar/6.4.1351; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; Horvath JE, 2005, GENOME RES, V15, P914, DOI 10.1101/gr.3916405; Horvath JE, 2003, MOL BIOL EVOL, V20, P1463, DOI 10.1093/molbev/msg158; Hughes JF, 2005, NATURE, V437, P101, DOI 10.1038/nature04101; HUGHES JF, 2004, ALRY MAJOR PT MAJOR; IJDO JW, 1991, P NATL ACAD SCI USA, V88, P9051, DOI 10.1073/pnas.88.20.9051; Jiang Z, 2007, NAT GENET, V39, P1361, DOI 10.1038/ng.2007.9; Kehrer-Sawatzki H, 2005, GENOMICS, V85, P542, DOI 10.1016/j.ygeno.2005.01.012; Kirsch S, 2005, GENOME RES, V15, P195, DOI 10.1101/gr.3302705; Kirsch S, 2008, GENOME RES, V18, P1030, DOI 10.1101/gr.076711.108; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Kuroki Y, 2006, NAT GENET, V38, P158, DOI 10.1038/ng1729; LAURSEN HB, 1992, EMBO J, V11, P2367, DOI 10.1002/j.1460-2075.1992.tb05300.x; Lemmers RJLF, 2002, NAT GENET, V32, P235, DOI 10.1038/ng999; Lernmers RJLF, 2001, ANN NEUROL, V50, P816, DOI 10.1002/ana.10057; Linardopoulou EV, 2005, NATURE, V437, P94, DOI 10.1038/nature04029; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; McConkey EH, 2004, CYTOGENET GENOME RES, V105, P157, DOI 10.1159/000078022; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; MILATOVICH A, 1993, AM J HUM GENET, V53, P1146; Montefalcone G, 1999, GENOME RES, V9, P1184, DOI 10.1101/gr.9.12.1184; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nguyen DQ, 2008, GENOME RES, V18, P1711, DOI 10.1101/gr.077289.108; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; RIED T, 1992, P NATL ACAD SCI USA, V89, P1388, DOI 10.1073/pnas.89.4.1388; Roberto R, 2007, GENOME RES, V17, P249, DOI 10.1101/gr.6052507; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rudd MK, 2006, GENOME RES, V16, P88, DOI 10.1101/gr.3810906; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; SCHEMPP W, 1995, CHROMOSOME RES, V3, P227, DOI 10.1007/BF00713047; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; She XW, 2006, GENOME RES, V16, P576, DOI 10.1101/gr.4949406; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Shiels C, 1997, GENOMICS, V44, P35, DOI 10.1006/geno.1997.4817; SINGH L, 1984, NUCLEIC ACIDS RES, V12, P5627, DOI 10.1093/nar/12.14.5627; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; SMITH JM, 1992, J MOL EVOL, V34, P126; SWOFFORD D.L., 2000, PHYLOGENETIC ANAL US; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tawil R, 1998, ANN NEUROL, V43, P279, DOI 10.1002/ana.410430303; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TYLERSMITH C, 1987, J MOL BIOL, V195, P457, DOI 10.1016/0022-2836(87)90175-6; VOGT P, 1990, HUM GENET, V84, P301; WEBER B, 1986, CYTOGENET CELL GENET, V43, P72, DOI 10.1159/000132300; Weiller GF, 1998, MOL BIOL EVOL, V15, P326, DOI 10.1093/oxfordjournals.molbev.a025929; Wienberg J, 1994, CHROMOSOME RES, V2, P405, DOI 10.1007/BF01552800; WILLARD HF, 1990, TRENDS GENET, V6, P410, DOI 10.1016/0168-9525(90)90302-M; Winokur ST, 1994, CHROMOSOME RES, V2, P225, DOI 10.1007/BF01553323; Winokur ST, 1996, HUM MOL GENET, V5, P1567, DOI 10.1093/hmg/5.10.1567; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861	82	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5288	10.1371/journal.pone.0005288	http://dx.doi.org/10.1371/journal.pone.0005288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404400	Green Submitted, Green Published, gold			2022-12-25	WOS:000265614900002
J	Diederich, K; Schabitz, WR; Kuhnert, K; Hellstrom, N; Sachser, N; Schneider, A; Kuhn, HG; Knecht, S				Diederich, Kai; Schaebitz, Wolf-Ruediger; Kuhnert, Katharina; Hellstrom, Nina; Sachser, Norbert; Schneider, Armin; Kuhn, Hans-Georg; Knecht, Stefan			Synergetic Effects of Granulocyte-Colony Stimulating Factor and Cognitive Training on Spatial Learning and Survival of Newborn Hippocampal Neurons	PLOS ONE			English	Article								Granulocyte-Colony Stimulating Factor (G-CSF) is an endogenous hematopoietic growth factor known for its role in the proliferation and differentiation of cells of the myeloic lineage. Only recently its significance in the CNS has been uncovered. G-CSF attenuates apoptosis and controls proliferation and differentiation of neural stem cells. G-CSF activates upstream kinases of the cAMP response element binding protein (CREB), which is thought to facilitate the survival of neuronal precursors and to recruit new neurons into the dentate gyrus. CREB is also essential for spatial long-term memory formation. To assess the role and the potential of this factor on learning and memory-formation we systemically administered G-CSF in rats engaged in spatial learning in an eight-arm radial maze. G-CSF significantly improved spatial learning and increased in combination with cognitive training the survival of newborn neurons in the hippocampus as measured by bromodeoxyuridine and doublecortin immunohistochemistry. Additionally, G-CSF improved re-acquisition of spatial information after 26 days. These findings support the hypothesis that G-CSF can enhance learning and memory formation. Due to its easy applicability and its history as a well-tolerated hematological drug, the use of G-CSF opens up new neurological treatment opportunities in conditions where learning and memory-formation deficits occur.			Diederich, K (corresponding author), Univ Munster, Dept Neurol, D-4400 Munster, Germany.	kai.diederich@uni-muenster.de	Kuhn, Hans-Georg/L-8127-2014	Kuhn, Hans-Georg/0000-0003-4247-5613; Hellstrom Erkenstam, Nina/0000-0002-4336-5419; Diederich, Kai/0000-0002-6550-9460; Schneider, Armin/0000-0003-0296-0059; Knecht, Stefan/0000-0003-1056-9228				Ambrogini P, 2004, NEUROSCI LETT, V359, P13, DOI 10.1016/j.neulet.2003.12.123; Cao XQ, 2006, J NEUROCHEM, V99, P861, DOI 10.1111/j.1471-4159.2006.04125.x; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717; Ding Q, 2006, NEUROSCIENCE, V140, P823, DOI 10.1016/j.neuroscience.2006.02.084; Dobrossy MD, 2003, MOL PSYCHIATR, V8, P974, DOI 10.1038/sj.mp.4001419; Drapeau E, 2007, J NEUROSCI, V27, P6037, DOI 10.1523/JNEUROSCI.1031-07.2007; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Epp JR, 2007, NEUROSCIENCE, V149, P273, DOI 10.1016/j.neuroscience.2007.07.046; Florian C, 2006, LEARN MEMORY, V13, P465, DOI 10.1101/lm.249306; Gibson CL, 2005, J CEREBR BLOOD F MET, V25, P431, DOI 10.1038/sj.jcbfm.9600033; Gilman CP, 2003, J NEUROCHEM, V87, P1137, DOI 10.1046/j.1471-4159.2003.02073.x; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Greenough WT, 1999, NAT NEUROSCI, V2, P203, DOI 10.1038/6300; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2002, EUR J NEUROSCI, V16, P129, DOI 10.1046/j.1460-9568.2002.02042.x; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Komine-Kobayashi M, 2006, J CEREBR BLOOD F MET, V26, P402, DOI 10.1038/sj.jcbfm.9600195; Leuner B, 2004, J NEUROSCI, V24, P7477, DOI 10.1523/JNEUROSCI.0204-04.2004; Maher P, 2006, P NATL ACAD SCI USA, V103, P16568, DOI 10.1073/pnas.0607822103; Meuer K, 2006, J NEUROCHEM, V97, P675, DOI 10.1111/j.1471-4159.2006.03727.x; Minnerup J, 2008, STROKE, V39, P1855, DOI 10.1161/STROKEAHA.107.506816; Mizuno K, 2005, J PHARMACOL SCI, V98, P191, DOI 10.1254/jphs.CRJ05005X; Mizuno M, 2002, BEHAV BRAIN RES, V133, P135, DOI 10.1016/S0166-4328(01)00470-3; Nottebohm F, 2002, BRAIN RES BULL, V57, P737, DOI 10.1016/S0361-9230(02)00750-5; Peters M, 2003, J NEUROSCI, V23, P9752; Pitzer C, 2008, BRAIN, V131, P3335, DOI 10.1093/brain/awn243; Schabitz WR, 2003, STROKE, V34, P745, DOI 10.1161/01.STR.0000057814.70180.17; Schabitz WR, 2007, TRENDS PHARMACOL SCI, V28, P157, DOI 10.1016/j.tips.2007.02.007; Schneider A, 2005, CELL CYCLE, V4, P1753, DOI 10.4161/cc.4.12.2213; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Solaroglu I, 2006, NEUROSCIENCE, V143, P965, DOI 10.1016/j.neuroscience.2006.09.014; Solaroglu I, 2007, FRONT BIOSCI-LANDMRK, V12, P712, DOI 10.2741/2095; Sosa L, 2006, NAT NEUROSCI, V9, P993, DOI 10.1038/nn1742; Sweatt JD, 2004, PSYCHOPHARMACOLOGY, V174, P99, DOI 10.1007/s00213-004-1795-9; Tsai KJ, 2007, J EXP MED, V204, P1273, DOI 10.1084/jem.20062481; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; WILLIAMS RW, 1988, J COMP NEUROL, V278, P344, DOI 10.1002/cne.902780305; Zhu DY, 2004, P NATL ACAD SCI USA, V101, P9453, DOI 10.1073/pnas.0401063101	42	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5303	10.1371/journal.pone.0005303	http://dx.doi.org/10.1371/journal.pone.0005303			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390691	Green Published, Green Submitted, gold			2022-12-25	WOS:000265514400004
J	Young, RP; Hopkins, RJ; Hay, BA; Epton, MJ; Mills, GD; Black, PN; Gardner, HD; Sullivan, R; Gamble, GD				Young, Robert P.; Hopkins, Raewyn J.; Hay, Bryan A.; Epton, Michael J.; Mills, Graham D.; Black, Peter N.; Gardner, Heather D.; Sullivan, Richard; Gamble, Gregory D.			Lung Cancer Susceptibility Model Based on Age, Family History and Genetic Variants	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; RISK; POLYMORPHISMS; ASSOCIATION; INFLAMMATION; EMPHYSEMA; INTEGRIN; PATHWAY; DEATH; COPD	Background: Epidemiological and pedigree studies suggest that lung cancer results from the combined effects of age, smoking, impaired lung function and genetic factors. In a case control association study of healthy smokers and lung cancer cases, we identified genetic markers associated with either susceptibility or protection to lung cancer. Methodology/Principal Findings: We screened 157 candidate single nucleotide polymorphisms (SNP) in a discovery cohort of 439 subjects (200 controls and 239 lung cancer cases) and identified 30 SNPs associated with either the healthy smokers (protective) or lung cancer (susceptibility) phenotype. After genotyping this 30 SNP panel in a validation cohort of 491 subjects (248 controls and 207 lung cancers) and, using the same protective and susceptibility genotypes from our discovery cohort, a 20 SNP panel was selected based on replication of SNP associations in the validation cohort. Following multivariate logistic regression analyses, including the selected SNPs from runs 1 and 2, we found age and family history of lung cancer to be significantly and independently associated with lung cancer. Numeric scores were assigned to both the SNP and demographic data, and combined to form a simple algorithm of risk. Conclusions/Significance: Significant differences in the distribution of the lung cancer susceptibility score was found between normal controls and lung cancer cases, which remained after accounting for differences in lung function. Validation in other case-control and prospective cohorts are underway to further define the potential clinical utility of this model.			Young, RP (corresponding author), Auckland Hosp, Dept Med, Auckland, New Zealand.	roberty@adhb.govt.nz	Wang, Weili/D-1546-2011	Gamble, Greg/0000-0003-0412-3203; Epton, Michael/0000-0003-4644-366X; Hopkins, Raewyn/0000-0003-2168-6235				ALBERG AJ, 2003, CHEST S1, V123, P21; AMOS CI, 2008, NAT GENETICS    0402, P1; ANTHONISEN NR, 1989, AM REV RESPIR DIS, V140, pS95, DOI 10.1164/ajrccm/140.3_Pt_2.S95; Brody Jerome S, 2006, Proc Am Thorac Soc, V3, P535, DOI 10.1513/pats.200603-089MS; Campa D, 2004, CARCINOGENESIS, V25, P229, DOI 10.1093/carcin/bgh008; Campa D, 2007, LUNG CANCER, V56, P17, DOI 10.1016/j.lungcan.2006.11.007; Chong IW, 2006, ONCOL REP, V16, P981; Droemann D, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-1; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Engels EA, 2007, CANCER RES, V67, P6520, DOI 10.1158/0008-5472.CAN-07-0370; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gwilt CR, 2007, PHARMACOL THERAPEUT, V115, P208, DOI 10.1016/j.pharmthera.2007.05.007; Hoshino T, 2007, AM J RESP CRIT CARE, V176, P49, DOI 10.1164/rccm.200603-316OC; Hu Z, 2004, LUNG CANCER, V46, P1, DOI 10.1016/j.lungcan.2004.03.016; Ishii T, 2000, EUR J CLIN INVEST, V30, P543; Jain M, 2007, CANCER DETECT PREV, V31, P225, DOI 10.1016/j.cdp.2007.04.005; Jakubowska A, 2007, J MED GENET, V44, P408, DOI 10.1136/jmg.2006.047498; Lee KI, 1997, COMMUN STAT-SIMUL C, V26, P559, DOI 10.1080/03610919708813397; Lerman C, 1997, HEALTH PSYCHOL, V16, P87, DOI 10.1037/0278-6133.16.1.87; Li GJ, 2004, CANCER RES, V64, P6863, DOI 10.1158/0008-5472.CAN-04-1804; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lokke A, 2006, THORAX, V61, P935, DOI 10.1136/thx.2006.062802; MATTSON ME, 1987, AM J PUBLIC HEALTH, V77, P425, DOI 10.2105/AJPH.77.4.425; McBride CM, 2002, CANCER EPIDEM BIOMAR, V11, P521; Moskvina V, 2005, ANN HUM GENET, V69, P566, DOI 10.1111/j.1529-8817.2005.00175.x; Neugut AI, 2006, JAMA-J AM MED ASSOC, V296, P218, DOI 10.1001/jama.296.2.218; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; RUDD MF, 2007, GENOME RES       AUG, P693; Sata M, 2007, RESPIROLOGY, V12, P34, DOI 10.1111/j.1440-1843.2006.00959.x; Schwartz AG, 2007, CARCINOGENESIS, V28, P507, DOI 10.1093/carcin/bgl253; Shields PG, 2000, J CLIN ONCOL, V18, P2309, DOI 10.1200/JCO.2000.18.11.2309; Spitz MR, 2007, JNCI-J NATL CANCER I, V99, P715, DOI 10.1093/jnci/djk153; Strange C, 2004, GENET MED, V6, P204, DOI 10.1097/01.GIM.0000132669.09819.79; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; Wikman H, 2001, PHARMACOGENETICS, V11, P157, DOI 10.1097/00008571-200103000-00006; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P738, DOI 10.1164/rccm.200803-435OC; Wu XF, 2000, CANCER EPIDEM BIOMAR, V9, P1021; Wu XF, 1998, CANCER EPIDEM BIOMAR, V7, P13; Xu HY, 2005, HUM GENET, V116, P121, DOI 10.1007/s00439-004-1212-9; Yang P, 2005, CHEST, V128, P452, DOI 10.1378/chest.128.1.452; Young RP, 2008, EUR RESPIR J, V32, P1158, DOI 10.1183/09031936.00093908; Young RP, 2007, EUR RESPIR J, V30, P616, DOI 10.1183/09031936.00021707; YOUNG RP, 2006, THORAX, V30, P1; Zhang X, 2005, J MED GENET, V42, P479, DOI 10.1136/jmg.2004.030106; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819; Zhou W, 2005, CANCER EPIDEM BIOMAR, V14, P491, DOI 10.1158/1055-9965.EPI-04-0612; Zhu CQ, 2007, P NATL ACAD SCI USA, V104, P11754, DOI 10.1073/pnas.0703040104	48	38	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5302	10.1371/journal.pone.0005302	http://dx.doi.org/10.1371/journal.pone.0005302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390575	Green Submitted, Green Published, gold			2022-12-25	WOS:000265514200015
J	Deng, YR; Almsherqi, ZA; Shui, GH; Wenk, MR; Kohlwein, SD				Deng, Yuru; Almsherqi, Zakaria A.; Shui, Guanghou; Wenk, Markus R.; Kohlwein, Sepp D.			Docosapentaenoic acid (DPA) is a critical determinant of cubic membrane formation in amoeba Chaos mitochondria	FASEB JOURNAL			English	Article						very long-chain polyunsaturated fatty acid; omega-3 DPA; omega-6 DPA; lipid mass spectrometry	CORONARY SYNDROME PATIENTS; DOCOSAHEXAENOIC ACID; FATTY-ACIDS; CAROLINENSIS; BILAYERS; LIPIDS; DHA	Very long-chain polyunsaturated fatty acids (VLC-PUFAs), such as docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA), have recently made it to the realm of "magical molecules" based on their multiple presumably beneficial effects in biological systems, making these PUFAs particularly interesting in biomedicine. Their specific biological functions, however, remain enigmatic. Here we provide evidence derived from studies in the amoeba Chaos that indicates a structural role for omega-6 DPA in cell membrane organization, which may help to explain the multiple diverse effects of VLC-PUFA in healthy and diseased states. Amoeba Chaos mitochondria undergo a remarkable and reversible morphological transition into cubic morphology on starvation. This morphological transition is reflected in major changes in fatty acid and lipid composition, as determined by gas liquid chromatography and mass spectrometry, in particular by a drastic increase in C22:5 modified phosphatidylcholine plasmalogen, phosphatidylethanolamine plasmalogen, and phosphatidylinositol species. Liposomes produced in vitro from lipids of starved amoeba cells show a high propensity to form hexagonal tubular and cubic morphologies. Addition of omega-6 DPA, but not of omega-3 DPA, to the cell culture also induced mitochondrial membrane transformation into cubic morphology in fed cells, demonstrating for the first time an important structural role of omega-6 DPA-containing lipids in cell membrane organization.-Deng, Y., Almsherqi, Z. A., Shui, G., Wenk, M. R., Kohlwein, S. D. Docosapentaenoic acid (DPA) is a critical determinant of cubic membrane formation in amoeba Chaos mitochondria. FASEB J. 23, 2866-2871 (2009). www.fasebj.org	[Deng, Yuru] Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Singapore 117597, Singapore; [Shui, Guanghou; Wenk, Markus R.] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore; [Wenk, Markus R.] Natl Univ Singapore, Dept Biol Sci, Singapore 117597, Singapore; [Kohlwein, Sepp D.] Graz Univ, Inst Mol Biosci, Graz, Austria	National University of Singapore; National University of Singapore; National University of Singapore; University of Graz	Deng, YR (corresponding author), Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Singapore 117597, Singapore.	phsdy@nus.edu.sg	Wenk, Markus Rene/D-1441-2014	Shui, Guanghou/0000-0002-1621-9643; Kohlwein, Sepp Dieter/0000-0002-1030-0598	Austrian Science Fund FWF [Lipotox F3005]; National Research Foundation [2007-04]; Academic Research Fund [R-183-000-160-112]; Biomedical Research Council of Singapore [R-183-000211-305, R-185-000-065-305]; National Medical Research Council [R-183000-224-213, R-185-000-058-213]; Biomedical Research Council of Singapore; Austrian Science Fund (FWF) [F 3005] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); National Research Foundation; Academic Research Fund(Ministry of Education, Singapore); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank Chwee Wah Low, Li Ling Olivia Tan, and Mei Yin Shoon for help with electron microscopy, liposome preparation, and amoeba cell culture. Support was provided by the Austrian Science Fund FWF (SFB project Lipotox F3005) to S. D. K.; the National Research Foundation under CRP award 2007-04, the Academic Research Fund (R-183-000-160-112), the Biomedical Research Council of Singapore (R-183-000211-305), and the National Medical Research Council (R-183000-224-213) to M. R. W; and the National Medical Research Council (R-185-000-058-213) and Biomedical Research Council of Singapore (R-185-000-065-305) to Y.D.	Almsherqi ZA, 2006, J CELL BIOL, V173, P839, DOI 10.1083/jcb.200603055; BIRCH EE, 1992, INVEST OPHTH VIS SCI, V33, P3242; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Block RC, 2008, ATHEROSCLEROSIS, V197, P821, DOI 10.1016/j.atherosclerosis.2007.07.042; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; DAS UN, 1994, PROSTAG LEUKOTR ESS, V51, P207, DOI 10.1016/0952-3278(94)90136-8; Deng YR, 1999, J STRUCT BIOL, V127, P231, DOI 10.1006/jsbi.1999.4147; Deng YR, 1998, PROTOPLASMA, V203, P16, DOI 10.1007/BF01280583; Eldho NV, 2003, J AM CHEM SOC, V125, P6409, DOI 10.1021/ja029029o; Epand RM, 1997, BIOCHEM SOC T, V25, P1073; Feller SE, 2008, CHEM PHYS LIPIDS, V153, P76, DOI 10.1016/j.chemphyslip.2008.02.013; Gawrisch K, 2008, CHEM PHYS LIPIDS, V153, P64, DOI 10.1016/j.chemphyslip.2008.02.016; Guan XL, 2006, FASEB J, V20, P1152, DOI 10.1096/fj.05-5362com; Harris WS, 2007, AM J CARDIOL, V99, P154, DOI 10.1016/j.amjcard.2006.08.013; Jump DB, 2008, CHEM PHYS LIPIDS, V153, P3, DOI 10.1016/j.chemphyslip.2008.02.007; KREMER JM, 1990, GERIATRICS, V45, P43; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; Shui GH, 2007, J LIPID RES, V48, P1976, DOI 10.1194/jlr.M700060-JLR200; Siddiqui RA, 2008, CHEM PHYS LIPIDS, V153, P47, DOI 10.1016/j.chemphyslip.2008.02.009; Stillwell W, 2008, CHEM PHYS LIPIDS, V153, P1, DOI 10.1016/j.chemphyslip.2008.02.012; Tan Olivia Li Ling, 2005, Protistology, V4, P185; Tarahovsky YS, 2000, BIOPHYS J, V79, P3193, DOI 10.1016/S0006-3495(00)76552-0; Wassall SR, 2008, CHEM PHYS LIPIDS, V153, P57, DOI 10.1016/j.chemphyslip.2008.02.010; Wenk MR, 2003, METHOD ENZYMOL, V372, P248; Yokoyama A, 2000, INT ARCH ALLERGY IMM, V123, P327, DOI 10.1159/000053645	25	32	32	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					2866	2871		10.1096/fj.09-130435	http://dx.doi.org/10.1096/fj.09-130435			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19406841				2022-12-25	WOS:000270241000009
J	Kiely, PA; Baillie, GS; Barrett, R; Buckley, DA; Adams, DR; Houslay, MD; O'Connor, R				Kiely, Patrick A.; Baillie, George S.; Barrett, Robert; Buckley, Deirdre A.; Adams, David R.; Houslay, Miles D.; O'Connor, Rosemary			Phosphorylation of RACK1 on Tyrosine 52 by c-Abl Is Required for Insulin-like Growth Factor I-mediated Regulation of Focal Adhesion Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-SPECIFIC PHOSPHODIESTERASE; ANCHORAGE-INDEPENDENT GROWTH; RECEPTOR-INTERACTING PROTEIN; PROMOTE CELL-MIGRATION; BREAST-CANCER CELLS; EXTRACELLULAR-MATRIX; MEMBRANE SUPPORTS; MAPK ACTIVATION; AKT ACTIVATION; PEPTIDE ARRAYS	Focal Adhesion Kinase (FAK) activity is controlled by growth factors and adhesion signals in tumor cells. The scaffolding protein RACK1 (receptor for activated C kinases) integrates insulin-like growth factor I (IGF-I) and integrin signaling, but whether RACK1 is required for FAK function is unknown. Here we show that association of FAK with RACK1 is required for both FAK phosphorylation and dephosphorylation in response to IGF-I. Suppression of RACK1 by small interfering RNA ablates FAK phosphorylation and reduces cell adhesion, cell spreading, and clonogenic growth. Peptide array and mutagenesis studies localize the FAK binding interface to blades I-III of the RACK1 beta-propeller and specifically identify a set of basic and hydrophobic amino acids (Arg-47, Tyr-52, Arg-57, Arg-60, Phe-65, Lys-127, and Lys-130) as key determinants for association with FAK. Mutation of tyrosine 52 alone is sufficient to disrupt interaction of RACK1 with FAK in cells where endogenous RACK1 is suppressed by small interfering RNA. Cells expressing a Y52F mutant RACK1 are impaired in adhesion, growth, and foci formation. Comparative analyses of homology models and crystal structures for RACK1 orthologues suggest a role for Tyr-52 as a site for phosphorylation that induces conformational change in RACK1, switching the protein into a FAK binding state. Tyrosine 52 is further shown to be phosphorylated by c-Abl kinase, and the c-Abl inhibitor STI571 disrupts FAK interaction with RACK1. We conclude that FAK association with RACK1 is regulated by phosphorylation of Tyr-52. Our data reveal a novel mechanism whereby IGF-I and c-Abl control RACK1 association with FAK to facilitate adhesion signaling.	[Kiely, Patrick A.; Barrett, Robert; Buckley, Deirdre A.; O'Connor, Rosemary] Natl Univ Ireland Univ Coll Cork, Dept Biochem, BioSci Inst, Cell Biol Lab, Cork, Ireland; [Baillie, George S.; Houslay, Miles D.] Univ Glasgow, Mol Pharmacol Grp, Div Biochem & Mol Biol, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Adams, David R.] Heriot Watt Univ, Dept Chem, Edinburgh EH1 4AS, Midlothian, Scotland	University College Cork; University of Glasgow; Heriot Watt University	O'Connor, R (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Biochem, BioSci Inst, Cell Biol Lab, Cork, Ireland.	r.oconnor@ucc.ie	Houslay, Miles/AAM-5281-2020; O'Connor, Rosemary/B-7902-2014; Houslay, Miles D/A-6825-2011; Adams, David R/E-3916-2010	O'Connor, Rosemary/0000-0002-0687-3422; Adams, David R/0000-0002-7154-7332; Houslay, Miles/0000-0002-3826-8091	Health Research Board of Ireland; Cancer Research Ireland; Science Foundation Ireland; Medical Research Council (UK) [G0600765, G0400053]; European Union [037189]; Fondation Leducq (Paris) [06VD02]; Medical Research Council [G0400053, G0600765] Funding Source: researchfish; MRC [G0600765, G0400053] Funding Source: UKRI	Health Research Board of Ireland; Cancer Research Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Fondation Leducq (Paris)(Leducq Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Health Research Board of Ireland, Cancer Research Ireland, and Science Foundation Ireland as well as Medical Research Council (UK) Grants G0600765 and G0400053, European Union Grant 037189, and Fondation Leducq (Paris) Grant 06VD02 (to M. D. H. and G. S. B.).	Baillie GS, 2007, BIOCHEM J, V404, P71, DOI 10.1042/BJ20070005; Bolger GB, 2006, BIOCHEM J, V398, P23, DOI 10.1042/BJ20060423; Buensuceso CS, 2001, J CELL SCI, V114, P1691; Cox EA, 2003, MOL BIOL CELL, V14, P658, DOI 10.1091/mbc.E02-03-0142; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; Doan AT, 2007, EXP CELL RES, V313, P2667, DOI 10.1016/j.yexcr.2007.05.013; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; DRUKER BJ, 2001, NEW ENGL J MED, V344, P1037; Frank R, 1996, Methods Mol Biol, V66, P149; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Goel HL, 2005, CANCER RES, V65, P6692, DOI 10.1158/0008-5472.CAN-04-4315; Guan JL, 1997, MATRIX BIOL, V16, P195, DOI 10.1016/S0945-053X(97)90008-1; Guvakova MA, 1999, EXP CELL RES, V251, P244, DOI 10.1006/excr.1999.4566; Hermanto U, 2002, MOL CELL BIOL, V22, P2345, DOI 10.1128/MCB.22.7.2345-2365.2002; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Huang CC, 2008, INT J BIOCHEM CELL B, V40, P423, DOI 10.1016/j.biocel.2007.08.002; Kiely PA, 2005, J BIOL CHEM, V280, P7624, DOI 10.1074/jbc.M412889200; Kiely PA, 2002, J BIOL CHEM, V277, P22581, DOI 10.1074/jbc.M201758200; Kiely PA, 2008, J BIOL CHEM, V283, P22952, DOI 10.1074/jbc.M800802200; Kiely PA, 2006, MOL CELL BIOL, V26, P4041, DOI 10.1128/MCB.01868-05; Kramer A, 1998, METH MOL B, V87, P25; Kraus S, 2006, CANCER RES, V66, P11047, DOI 10.1158/0008-5472.CAN-06-0596; Leahy M, 2004, J BIOL CHEM, V279, P18306, DOI 10.1074/jbc.M309234200; Li W, 2001, AM J PHYSIOL-GASTR L, V280, pG75, DOI 10.1152/ajpgi.2001.280.1.G75; Lynch L, 2005, MOL BIOL CELL, V16, P51, DOI 10.1091/mbc.E04-05-0399; Mamidipudi V, 2007, ONCOGENE, V26, P2914, DOI 10.1038/sj.onc.1210091; Mamidipudi V, 2004, FEBS LETT, V567, P321, DOI 10.1016/j.febslet.2004.03.125; Manes S, 1999, MOL CELL BIOL, V19, P3125; Mauro L, 1999, EXP CELL RES, V252, P439, DOI 10.1006/excr.1999.4639; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitsushima M, 2006, FEBS LETT, V580, P4288, DOI 10.1016/j.febslet.2006.06.072; Mon NN, 2006, ANN NY ACAD SCI, V1086, P199, DOI 10.1196/annals.1377.019; OConnor R, 1997, MOL CELL BIOL, V17, P427, DOI 10.1128/MCB.17.1.427; Onishi I, 2007, CELL SIGNAL, V19, P194, DOI 10.1016/j.cellsig.2006.06.011; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Renshaw MW, 2000, ONCOGENE, V19, P3216, DOI 10.1038/sj.onc.1203667; Ron D, 1999, J BIOL CHEM, V274, P27039, DOI 10.1074/jbc.274.38.27039; Schlaepfer DD, 2007, J BIOL CHEM, V282, P17450, DOI 10.1074/jbc.M610672200; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Sechler JL, 1998, ANN NY ACAD SCI, V857, P143, DOI 10.1111/j.1749-6632.1998.tb10114.x; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; Sieg DJ, 1999, J CELL SCI, V112, P2677; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; Sottile J, 1998, J CELL SCI, V111, P2933; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Steele MR, 2001, CELL SIGNAL, V13, P507, DOI 10.1016/S0898-6568(01)00167-X; Ullah H, 2008, PROTEIN SCI, V17, P1771, DOI 10.1110/ps.035121.108; Vomastek T, 2007, MOL CELL BIOL, V27, P8296, DOI 10.1128/MCB.00598-07; Wang JG, 2005, LIFE SCI, V76, P2817, DOI 10.1016/j.lfs.2004.10.050; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Zhang WZ, 2006, MOL CELL BIOL, V26, P413, DOI 10.1128/MCB.26.2.413-424.2006; Zvara A, 2001, ONCOGENE, V20, P951, DOI 10.1038/sj.onc.1204173	57	76	79	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20263	20274		10.1074/jbc.M109.017640	http://dx.doi.org/10.1074/jbc.M109.017640			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19423701	Green Published, hybrid			2022-12-25	WOS:000268097400053
J	Hislop, JN; Henry, AG; Marchese, A; von Zastrow, M				Hislop, James N.; Henry, Anastasia G.; Marchese, Adriano; von Zastrow, Mark			Ubiquitination Regulates Proteolytic Processing of G Protein-coupled Receptors after Their Sorting to Lysosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-OPIOID RECEPTOR; ENDOCYTIC MEMBRANE TRAFFICKING; MULTIVESICULAR BODY PATHWAY; INDUCED DOWN-REGULATION; BETA(2)-ADRENERGIC RECEPTOR; MEDIATES UBIQUITINATION; ENDOPLASMIC-RETICULUM; MOLECULAR-MECHANISMS; PROTEASOME; CXCR4	Ubiquitination is essential for the endocytic sorting of various G protein-coupled receptors to lysosomes. Here we identify a distinct function of this covalent modification in controlling the later proteolytic processing of receptors. Mutation of all cytoplasmic lysine residues in the murine delta-opioid receptor blocked receptor ubiquitination without preventing ligand-induced endocytosis of receptors or their subsequent delivery to lysosomes, as verified by proteolysis of extramembrane epitope tags and down-regulation of radioligand binding to the transmembrane helices. Surprisingly, a functional screen revealed that the E3 ubiquitin ligase AIP4 specifically controls down-regulation of wild type receptors measured by radioligand binding without detectably affecting receptor delivery to lysosomes defined both immunochemically and biochemically. This specific AIP4-dependent regulation required direct ubiquitination of receptors and was also regulated by two deubiquitinating enzymes, AMSH and UBPY, which localized to late endosome/lysosome membranes containing internalized delta-opioid receptor. These results identify a distinct function of AIP4-dependent ubiquitination in controlling the later proteolytic processing of G protein-coupled receptors, without detectably affecting their endocytic sorting to lysosomes. We propose that ubiquitination or ubiquitination/deubiquitination cycling specifically regulates later proteolytic processing events required for destruction of the receptor's hydrophobic core.	[Hislop, James N.; von Zastrow, Mark] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Hislop, James N.; von Zastrow, Mark] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Henry, Anastasia G.; von Zastrow, Mark] Univ Calif San Francisco, Cell Biol Program, San Francisco, CA 94158 USA; [Marchese, Adriano] Loyola Univ Chicago, Dept Pharmacol & Expt Therapeut, Stritch Sch Med, Maywood, IL 60153 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Loyola University Chicago	Hislop, JN (corresponding author), MC 2140,Rm GH N216P,600 16th St, San Francisco, CA 94158 USA.	james.hislop@ucsf.edu			National Institutes of Health, NIDA [DA012864, DA010711]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026040, R29DA010711, R01DA010711, R01DA012864, R37DA010711] Funding Source: NIH RePORTER	National Institutes of Health, NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health, NIDA, Grants DA012864 and DA010711 ( to M. Z.).	Befort K, 1996, J BIOL CHEM, V271, P10161, DOI 10.1074/jbc.271.17.10161; Befort K, 1996, MOL PHARMACOL, V49, P216; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5; Chaturvedi K, 2001, J BIOL CHEM, V276, P12345, DOI 10.1074/jbc.M008054200; Chen LY, 2002, TRAFFIC, V3, P110, DOI 10.1034/j.1600-0854.2002.030204.x; Chung HY, 2008, J VIROL, V82, P4884, DOI 10.1128/JVI.02667-07; Duan L, 2003, J BIOL CHEM, V278, P28950, DOI 10.1074/jbc.M304474200; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Hislop JN, 2004, J BIOL CHEM, V279, P22522, DOI 10.1074/jbc.M311062200; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; LAW PY, 1984, J BIOL CHEM, V259, P4096; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Martin-Serrano J, 2004, J VIROL, V78, P5554, DOI 10.1128/JVI.78.11.5554-5563.2004; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; McNatt MW, 2007, MOL BIOL CELL, V18, P697, DOI 10.1091/mbc.E06-08-0663; Medina G, 2008, VIROLOGY, V377, P30, DOI 10.1016/j.virol.2008.04.024; Mosberg HI, 2002, J PEPT RES, V60, P329, DOI 10.1034/j.1399-3011.2002.21061.x; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Russell MRG, 2006, CURR OPIN CELL BIOL, V18, P422, DOI 10.1016/j.ceb.2006.06.002; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Scherrer G, 2006, P NATL ACAD SCI USA, V103, P9691, DOI 10.1073/pnas.0603359103; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Simonin F, 2004, J NEUROCHEM, V89, P766, DOI 10.1111/j.1471-4159.2004.02411.x; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Tanowitz M, 2003, J BIOL CHEM, V278, P45978, DOI 10.1074/jbc.M304504200; Tanowitz M, 2002, J BIOL CHEM, V277, P50219, DOI 10.1074/jbc.C200536200; Tsao P, 2000, CURR OPIN NEUROBIOL, V10, P365, DOI 10.1016/S0959-4388(00)00096-9; Tsao PI, 2001, PHARMACOL THERAPEUT, V89, P139, DOI 10.1016/S0163-7258(00)00107-8; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; Urbe S, 2005, ESSAYS BIOCHEM, V41, P81, DOI 10.1042/EB0410081; Vickery RG, 1999, J CELL BIOL, V144, P31, DOI 10.1083/jcb.144.1.31; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Yadav PN, 2007, J PHARMACOL EXP THER, V320, P1186, DOI 10.1124/jpet.106.113621	50	68	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19361	19370		10.1074/jbc.M109.001644	http://dx.doi.org/10.1074/jbc.M109.001644			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19433584	Green Published, hybrid			2022-12-25	WOS:000267908300027
J	Corre, S; Primot, A; Baron, Y; Le Seyec, J; Goding, C; Galibert, MD				Corre, Sebastien; Primot, Aline; Baron, Yorann; Le Seyec, Jacques; Goding, Colin; Galibert, Marie-Dominique			Target Gene Specificity of USF-1 Is Directed via p38-mediated Phosphorylation-dependent Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UPSTREAM STIMULATORY FACTOR; TRANSCRIPTION FACTOR USF; HELIX-LOOP-HELIX; ACTIVATES TRANSCRIPTION; HUMAN MELANOCYTES; IN-VIVO; C-MYC; EXPRESSION; PROMOTER; PROTEINS	How transcription factors interpret the output from signal transduction pathways to drive distinct programs of gene expression is a key issue that underpins development and disease. The ubiquitously expressed basic-helix-loop-helix leucine zipper upstream stimulating factor-1 binds E-box regulatory elements (CANNTG) to regulate a wide number of gene networks. In particular, USF-1 is a key component of the tanning process. Following UV irradiation, USF-1 is phosphorylated by the p38 stress-activated kinase on threonine 153 and directly up-regulates expression of the POMC, MC1R, TYR, TYRP-1 and DCT genes. However, how phosphorylation on Thr-153 might affect the activity of USF-1 is unclear. Here we show that, in response to DNA damage, oxidative stress and cellular infection USF-1 is acetylated in a phospho-Thr-153-dependent fashion. Phospho-acetylated USF-1 is nuclear and interacts with DNA but displays altered gene regulatory properties. Phospho-acetylated USF-1 is thus proposed to be associated with loss of transcriptional activation properties toward several target genes implicated in pigmentation process and cell cycle regulation. The identification of this critical stress-dependent USF-1 modification gives new insights into understanding USF-1 gene expression modulation associated with cancer development.	[Corre, Sebastien; Primot, Aline; Baron, Yorann; Galibert, Marie-Dominique] Univ Rennes 1, CNRS, Inst Genet & Dev Rennes,Regulat Transcript & Onco, Fac Med,UMR 6061,CS 34317,IFR GFAS 140, F-35043 Rennes, France; [Corre, Sebastien; Goding, Colin] Marie Curie Res Inst, Signaling & Dev Lab, Oxted RH8 0TL, England; [Le Seyec, Jacques] Hop Pontchaillou, INSERM, U522, IFR GFAS 140, F-35033 Rennes, France; [Goding, Colin] Univ Oxford, Ludwig Inst Canc Res, Oxford OX3 7DQ, England	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Ludwig Institute for Cancer Research; University of Oxford	Galibert, MD (corresponding author), Univ Rennes 1, CNRS, Inst Genet & Dev Rennes,Regulat Transcript & Onco, Fac Med,UMR 6061,CS 34317,IFR GFAS 140, 2 Av Pr Leon Bernard, F-35043 Rennes, France.	mgaliber@univ-rennes1.fr	CORRE, Sebastien/B-7069-2018; Le Seyec, Jacques/GLU-3933-2022; Le Seyec, Jacques/J-5680-2015	CORRE, Sebastien/0000-0003-1532-5660; Le Seyec, Jacques/0000-0002-1118-3311; Goding, Colin/0000-0002-1614-3909	Ligue National contre le Cancer-Comites Departementaux du Grand Ouest; Marie Curie Cancer Care,; Association pour la Recherche contre le Cancer Foundations.; Rennes University and the Intra-European Fellowship	Ligue National contre le Cancer-Comites Departementaux du Grand Ouest; Marie Curie Cancer Care,; Association pour la Recherche contre le Cancer Foundations.; Rennes University and the Intra-European Fellowship	This work was supported in part by the Ligue National contre le Cancer-Comites Departementaux du Grand Ouest, the Marie Curie Cancer Care, and the Association pour la Recherche contre le Cancer Foundations.; Supported by the Rennes University and the Intra-European Fellowship (6 Framework Programme).	Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; BAXEVANIS AD, 1993, CURR OPIN GENET DEV, V3, P278, DOI 10.1016/0959-437X(93)90035-N; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Carreira S, 2000, J BIOL CHEM, V275, P21920, DOI 10.1074/jbc.M000035200; Casado M, 1999, J BIOL CHEM, V274, P2009, DOI 10.1074/jbc.274.4.2009; Cheung E, 1999, BIOCHEM J, V344, P145, DOI 10.1042/0264-6021:3440145; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; COGSWELL JP, 1995, MOL CELL BIOL, V15, P2782; Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x; Corre S, 2004, J BIOL CHEM, V279, P51226, DOI 10.1074/jbc.M409768200; Davis PL, 1999, ONCOGENE, V18, P6000, DOI 10.1038/sj.onc.1202990; Deininger MH, 2000, BRAIN RES, V882, P1, DOI 10.1016/S0006-8993(00)02594-4; FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; Galibert MD, 1997, J IMMUNOL, V159, P6176; Goueli BS, 2003, ONCOGENE, V22, P8042, DOI 10.1038/sj.onc.1206847; Hock TD, 2004, BIOCHEM J, V383, P209, DOI 10.1042/BJ20040794; Huang S, 2007, MOL CELL BIOL, V27, P7991, DOI 10.1128/MCB.01326-07; Ismail PM, 1999, ONCOGENE, V18, P5582, DOI 10.1038/sj.onc.1202932; Kawaguchi Y, 2006, J BIOL CHEM, V281, P1394, DOI 10.1074/jbc.M505772200; Kingsley-Kallesen ML, 1999, J BIOL CHEM, V274, P34020, DOI 10.1074/jbc.274.48.34020; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Liu MJ, 2004, BIOCHEM J, V383, P249, DOI 10.1042/BJ20040414; MAEKAWA T, 1991, NUCLEIC ACIDS RES, V19, P4689, DOI 10.1093/nar/19.17.4689; Meyskens FL, 2001, PIGM CELL RES, V14, P148, DOI 10.1034/j.1600-0749.2001.140303.x; North S, 1999, ONCOGENE, V18, P1945, DOI 10.1038/sj.onc.1202506; Nowak M, 2005, MOL CELL BIOL, V25, P1537, DOI 10.1128/MCB.25.4.1537-1548.2005; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Pawar SA, 2004, ONCOGENE, V23, P6125, DOI 10.1038/sj.onc.1207806; POGO BGT, 1966, P NATL ACAD SCI USA, V55, P805, DOI 10.1073/pnas.55.4.805; Polesskaya A, 2000, J BIOL CHEM, V275, P34359, DOI 10.1074/jbc.M003815200; Qyang YB, 1999, MOL CELL BIOL, V19, P1508; Rahaus M, 2003, J GEN VIROL, V84, P2957, DOI 10.1099/vir.0.19335-0; REISMAN D, 1993, NUCLEIC ACIDS RES, V21, P345, DOI 10.1093/nar/21.2.345; Roth U, 2004, BIOL CHEM, V385, P239, DOI 10.1515/BC.2004.018; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Schwahn DJ, 2001, PIGM CELL RES, V14, P32, DOI 10.1034/j.1600-0749.2001.140106.x; Sirito M, 1998, P NATL ACAD SCI USA, V95, P3758, DOI 10.1073/pnas.95.7.3758; SIRITO M, 1994, NUCLEIC ACIDS RES, V22, P427, DOI 10.1093/nar/22.3.427; Sirito Mario, 1992, Gene Expression, V2, P231; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Takahashi K, 1999, J NEUROCHEM, V72, P2356, DOI 10.1046/j.1471-4159.1999.0722356.x; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005; Wu YL, 2002, BIOL REPROD, V66, P1505, DOI 10.1095/biolreprod66.5.1505; Xiao QX, 2002, AM J PHYSIOL-HEART C, V283, pH213, DOI 10.1152/ajpheart.01085.2001; Zachos G, 1999, J BIOL CHEM, V274, P5097, DOI 10.1074/jbc.274.8.5097	48	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18851	18862		10.1074/jbc.M808605200	http://dx.doi.org/10.1074/jbc.M808605200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19389701	Green Published, hybrid			2022-12-25	WOS:000267711500035
J	Modder, UI; Monroe, DG; Fraser, DG; Spelsberg, TC; Rosen, CJ; Gehin, M; Chambon, P; O'Malley, BW; Khosla, S				Modder, Ulrike I.; Monroe, David G.; Fraser, Daniel G.; Spelsberg, Thomas C.; Rosen, Clifford J.; Gehin, Martine; Chambon, Pierre; O'Malley, Bert W.; Khosla, Sundeep			Skeletal Consequences of Deletion of Steroid Receptor Coactivator-2/Transcription Intermediary Factor-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; POSTMENOPAUSAL WOMEN; TISSUE-SPECIFICITY; GENE-EXPRESSION; DRUG-THERAPY; STEM-CELLS; BONE; ESTROGEN; MARROW; MICE	Both estrogen receptor (ER) and peroxisome proliferator-activated receptor gamma (PPAR gamma) regulate bone metabolism, and because steroid receptor coactivator (SRC)-2 (TIF-2) enhances ER and PPAR gamma activity, we examined the consequences of deletion of SRC-2 on bone using SRC-2 knock out (KO) mice. Loss of SRC-2 resulted in increased bone mass, with SRC-2 KO mice having 80% higher trabecular bone volume as compared with wild type mice. SRC-2 KO mice also had a marked decrease (by 50%) in bone marrow adipocytes. These data suggested that marrow precursor cells in the SRC-2 KO mice may be resistant to the inhibitory effects of endogenous PPAR gamma ligands on bone formation. Consistent with this, compared with cultures from wild type mice, marrow stromal cultures from SRC-2 KO mice formed significantly more mineralized nodules (by 3-fold) in the presence of the PPAR gamma agonist, rosiglitazone. Using chromatin immunoprecipitation analysis, we demonstrated that in bone marrow stromal cells, loss of SRC-2 leads to destabilization of the transcription complex at the peroxisome proliferator response elements of a number of PPAR gamma target genes, resulting in an overall decrease in the expression of adipocyte-related genes and a marked decrease in adipocyte development. Using ovariectomy with or without estrogen replacement, we also demonstrated that SRC-2 KO mice were partially resistant to the skeletal actions of estrogen. Collectively, these findings indicate that loss of SRC-2 leads to partial skeletal resistance to the ER and PPAR gamma, but resistance to PPAR gamma is dominant, leading to increased bone mass. Modulating SRC-2 action may, thus, represent a novel therapeutic target for osteoporosis.	[Modder, Ulrike I.; Monroe, David G.; Fraser, Daniel G.; Khosla, Sundeep] Mayo Clin, Coll Med, Endocrine Res Unit, Rochester, MN 55905 USA; [Spelsberg, Thomas C.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Rosen, Clifford J.] Maine Med Ctr, Res Inst, Scarborough, ME 04074 USA; [Gehin, Martine; Chambon, Pierre] Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [O'Malley, Bert W.] Baylor Coll Med, Houston, TX 77030 USA	Mayo Clinic; Mayo Clinic; Maine Medical Center; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Baylor College of Medicine	Khosla, S (corresponding author), Mayo Clin, Coll Med, Endocrine Res Unit, 200 1st St SW,Guggenheim 7, Rochester, MN 55905 USA.	khosla.sundeep@mayo.edu	Khosla, Sundeep/AAE-6170-2020	Khosla, Sundeep/0000-0002-2936-4372	National Institutes of Health [AG004875, AG028936, HD07857, DK59820]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD007857] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD007857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK059820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028936, P01AG004875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG004875 and AG028936 (to S. K.) and HD07857 and DK59820 (to B. W. O.).	Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Aubin Jane E., 1996, P51; BENNETT JH, 1991, J CELL SCI, V99, P131; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; DUNNILL MS, 1967, J PATHOL BACTERIOL, V94, P275, DOI 10.1002/path.1700940205; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fu MG, 2001, J BIOL CHEM, V276, P45888, DOI 10.1074/jbc.M105490200; Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002; Gimble JM, 1996, MOL PHARMACOL, V50, P1087; Gori F, 1999, J BONE MINER RES, V14, P1522, DOI 10.1359/jbmr.1999.14.9.1522; Grey A, 2007, J CLIN ENDOCR METAB, V92, P1305, DOI 10.1210/jc.2006-2646; Jilka RL, 1996, J CLIN INVEST, V97, P1732, DOI 10.1172/JCI118600; Khastgir G, 2001, J CLIN ENDOCR METAB, V86, P289, DOI 10.1210/jc.86.1.289; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; Meier C, 2008, ARCH INTERN MED, V168, P820, DOI 10.1001/archinte.168.8.820; MEUNIER P, 1971, CLIN ORTHOP RELAT R, V80, P147, DOI DOI 10.1097/00003086-197110000-00021; Modder UIL, 2004, EUR J ENDOCRINOL, V151, P503, DOI 10.1530/eje.0.1510503; Modder UIL, 2004, ENDOCRINOLOGY, V145, P913, DOI 10.1210/en.2003-1089; Modder UI, 2008, BONE, V42, P414, DOI 10.1016/j.bone.2007.10.017; Monroe DG, 2003, J ENDOCRINOL, V176, P349, DOI 10.1677/joe.0.1760349; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Oda Y, 2003, MOL ENDOCRINOL, V17, P2329, DOI 10.1210/me.2003-0063; ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Syed FA, 2008, OSTEOPOROSIS INT, V19, P1323, DOI 10.1007/s00198-008-0574-6; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Xu Jianming, 2002, Rev Endocr Metab Disord, V3, P185, DOI 10.1023/A:1020016208071; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; Yamada T, 2004, J BONE MINER RES, V19, P1452, DOI 10.1359/JBMR.040515; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001	42	19	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18767	18777		10.1074/jbc.M109.000836	http://dx.doi.org/10.1074/jbc.M109.000836			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19423703	hybrid, Green Published			2022-12-25	WOS:000267711500026
J	Scarpellini, A; Germack, R; Lortat-Jacob, H; Muramatsu, T; Billett, E; Johnson, T; Verderio, EAM				Scarpellini, Alessandra; Germack, Renee; Lortat-Jacob, Hugues; Muramatsu, Takashi; Billett, Ellen; Johnson, Timothy; Verderio, Elisabetta A. M.			Heparan Sulfate Proteoglycans Are Receptors for the Cell-surface Trafficking and Biological Activity of Transglutaminase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	19th International Symposium on Glycoconjugates	JUL 15-20, 2007	Cairns, AUSTRALIA				HUMAN-ERYTHROCYTE TRANSGLUTAMINASE; UNCONVENTIONAL EXPORT MACHINERY; SWISS 3T3 FIBROBLASTS; TISSUE TRANSGLUTAMINASE; CROSS-LINKING; EXTRACELLULAR-MATRIX; ESSENTIAL COMPONENTS; BINDING SITE; FIBRONECTIN; ADHESION	Transglutaminase type 2 (TG2) is both a protein cross-linking enzyme and a cell adhesion molecule with an elusive unconventional secretion pathway. In normal conditions, TG2-mediated modification of the extracellular matrix modulates cell motility, proliferation and tissue repair, but under continuous cell insult, higher expression and elevated extracellular trafficking of TG2 contribute to the pathogenesis of tissue scarring. In search of TG2 ligands that could contribute to its regulation, we characterized the affinity of TG2 for heparan sulfate (HS) and heparin, an analogue of the chains of HS proteoglycans (HSPGs). By using heparin/HS solid-binding assays and surface plasmon resonance we showed that purified TG2 has high affinity for heparin/HS, comparable to that for fibronectin, and that cell-surface TG2 interacts with heparin/HS. We demonstrated that cell-surface TG2 directly associates with the HS chains of syndecan-4 without the mediation of fibronectin, which has affinity for both syndecan-4 and TG2. Functional inhibition of the cell-surface HS chains of wild-type and syndecan-4-null fibroblasts revealed that the extracellular cross-linking activity of TG2 depends on the HS of HSPG and that syndecan-4 plays a major but not exclusive role. We found that heparin binding did not alter TG2 activity per se. Conversely, fibroblasts deprived of syndecan-4 were unable to effectively externalize TG2, resulting in its cytosolic accumulation. We propose that the membrane trafficking of TG2, and hence its extracellular activity, is linked to TG2 binding to cell-surface HSPG.	[Scarpellini, Alessandra; Germack, Renee; Billett, Ellen; Verderio, Elisabetta A. M.] Nottingham Trent Univ, Sch Sci & Technol, Nottingham NG11 8NS, England; [Lortat-Jacob, Hugues] UJF, CEA, CNRS, Inst Biol Struct, F-380272 Grenoble, France; [Muramatsu, Takashi] Aichi Gakuin Univ, Fac Psychol & Phys Sci, Dept Hlth Sci, Aichi 47001953, Japan; [Johnson, Timothy] Univ Sheffield, Sch Med, Acad Nephrol Unit, Sheffield S10 2RZ, S Yorkshire, England	Nottingham Trent University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Aichi Gakuin University; University of Sheffield	Verderio, EAM (corresponding author), Nottingham Trent Univ, Sch Sci & Technol, Clifton Lane, Nottingham NG11 8NS, England.	elisabetta.verderio-edwards@ntu.ac.uk	Verderio, Elisabetta/H-2789-2016	Verderio, Elisabetta/0000-0001-9153-8997; Billett, Ellen/0000-0001-8245-6519				Aeschlimann D, 2000, CONNECT TISSUE RES, V41, P1, DOI 10.3109/03008200009005638; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; BACIU PC, 1995, MOL BIOL CELL, V6, P1503, DOI 10.1091/mbc.6.11.1503; Backhaus R, 2004, J CELL SCI, V117, P1727, DOI 10.1242/jcs.01027; Balklava Z, 2002, J BIOL CHEM, V277, P16567, DOI 10.1074/jbc.M109836200; Begg GE, 2006, J BIOL CHEM, V281, P12603, DOI 10.1074/jbc.M600146200; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Chau DYS, 2005, BIOMATERIALS, V26, P6518, DOI 10.1016/j.biomaterials.2005.04.017; De Laurenzi V, 2001, MOL CELL BIOL, V21, P148, DOI 10.1128/MCB.21.1.148-155.2001; Echtermeyer F, 1999, J CELL SCI, V112, P3433; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Feng JF, 1996, J BIOL CHEM, V271, P16451, DOI 10.1074/jbc.271.28.16451; Gambetti S, 2005, BIOCHIMIE, V87, P551, DOI 10.1016/j.biochi.2005.01.012; Gaudry CA, 1999, J BIOL CHEM, V274, P30707, DOI 10.1074/jbc.274.43.30707; Germack R, 2006, J PHARMACOL EXP THER, V316, P392, DOI 10.1124/jpet.105.090597; Greene DK, 2003, J BIOL CHEM, V278, P7617, DOI 10.1074/jbc.M207123200; Grenard P, 2001, J HEPATOL, V35, P367, DOI 10.1016/S0168-8278(01)00135-0; GRIFFIN M, 1979, BRIT J EXP PATHOL, V60, P653; Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189; Hang J, 2005, J BIOL CHEM, V280, P23675, DOI 10.1074/jbc.M503323200; Haroon ZA, 1999, FASEB J, V13, P1787, DOI 10.1096/fasebj.13.13.1787; Heath DJ, 2001, J BONE MINER RES, V16, P1477, DOI 10.1359/jbmr.2001.16.8.1477; IKURA K, 1989, BIOCHEMISTRY-US, V28, P2344, DOI 10.1021/bi00431a054; Ishiguro K, 2000, J BIOL CHEM, V275, P5249, DOI 10.1074/jbc.275.8.5249; Johnson TS, 2003, J AM SOC NEPHROL, V14, P2052, DOI 10.1097/01.ASN.0000079614.63463.DD; Johnson TS, 1999, J AM SOC NEPHROL, V10, P2146; Jones RA, 1997, J CELL SCI, V110, P2461; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Longley RL, 1999, J CELL SCI, V112, P3421; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; Mahley RW, 1999, J LIPID RES, V40, P1; Mahoney DJ, 2004, ANAL BIOCHEM, V330, P123, DOI 10.1016/j.ab.2004.03.055; MARTINEZ J, 1994, BIOCHEMISTRY-US, V33, P2538, DOI 10.1021/bi00175a024; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; MUESCH A, 1990, TRENDS BIOCHEM SCI, V15, P86, DOI 10.1016/0968-0004(90)90186-F; NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253; Nicholas B, 2003, BIOCHEM J, V371, P413, DOI 10.1042/BJ20021949; Nickel W, 2007, J CELL SCI, V120, P2295, DOI 10.1242/jcs.011080; Ott VL, 1998, J BIOL CHEM, V273, P35291, DOI 10.1074/jbc.273.52.35291; RADEK JT, 1993, P NATL ACAD SCI USA, V90, P3152, DOI 10.1073/pnas.90.8.3152; RICHARDS RJ, 1991, TOXICOL PATHOL, V19, P526; Rock MJ, 2004, J BIOL CHEM, V279, P23748, DOI 10.1074/jbc.M400212200; Rudd TR, 2007, GLYCOBIOLOGY, V17, P983, DOI 10.1093/glycob/cwm062; Schuksz M, 2008, P NATL ACAD SCI USA, V105, P13075, DOI 10.1073/pnas.0805862105; Scotchford CA, 1998, BIOMATERIALS, V19, P1, DOI 10.1016/S0142-9612(97)00236-6; Seelenmeyer C, 2005, J CELL BIOL, V171, P373, DOI 10.1083/jcb.200506026; SIGNORINI M, 1988, BIOL CHEM H-S, V369, P275, DOI 10.1515/bchm3.1988.369.1.275; Skill NJ, 2004, J BIOL CHEM, V279, P47754, DOI 10.1074/jbc.M402698200; Smethurst PA, 1996, BIOCHEM J, V313, P803, DOI 10.1042/bj3130803; Stephens P, 2004, J CELL SCI, V117, P3389, DOI 10.1242/jcs.01188; Telci D, 2008, J BIOL CHEM, V283, P20937, DOI 10.1074/jbc.M801763200; THOMAZY V, 1989, CELL TISSUE RES, V255, P215; Verderio E, 1998, EXP CELL RES, V239, P119, DOI 10.1006/excr.1997.3874; Verderio E, 2001, J BIOMED MATER RES, V54, P294, DOI 10.1002/1097-4636(200102)54:2<294::AID-JBM17>3.0.CO;2-Q; Verderio EAM, 2009, AMINO ACIDS, V36, P671, DOI 10.1007/s00726-008-0134-6; Verderio EAM, 2004, AMINO ACIDS, V26, P387, DOI 10.1007/s00726-004-0094-4; Verderio EAM, 2003, J BIOL CHEM, V278, P42604, DOI 10.1074/jbc.M303303200; Zamir E, 2001, J CELL SCI, V114, P3577; Zehe C, 2006, P NATL ACAD SCI USA, V103, P15479, DOI 10.1073/pnas.0605997103; Zemskov EA, 2007, J CELL SCI, V120, P3188, DOI 10.1242/jcs.010397	61	72	73	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18411	18423		10.1074/jbc.M109.012948	http://dx.doi.org/10.1074/jbc.M109.012948			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	467BW	19398782	Green Published, hybrid			2022-12-25	WOS:000267712400053
J	Hobeika, M; Brockmann, C; Gruessing, F; Neuhaus, D; Divita, G; Stewart, M; Dargemont, C				Hobeika, Maria; Brockmann, Christoph; Gruessing, Florian; Neuhaus, David; Divita, Gilles; Stewart, Murray; Dargemont, Catherine			Structural Requirements for the Ubiquitin-associated Domain of the mRNA Export Factor Mex67 to Bind Its Specific Targets, the Transcription Elongation THO Complex Component Hpr1 and Nucleoporin FXFG Repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYS48-LINKED POLYUBIQUITIN CHAIN; PROTEIN-PROTEIN INTERACTIONS; UBA DOMAIN; NUCLEAR EXPORT; DNA-REPAIR; QUALITY-CONTROL; LIGASE RSP5P; HIV-1 VPR; RECOGNITION; INTERACTS	The ubiquitin-associated (UBA) domain of the principal Saccharomyces cerevisiae mRNA nuclear export factor, Mex67, can bind both nuclear pore protein (nucleoporin) FG repeats and Hpr1, a component of the TREX center dot THO complex that functions to link transcription and export. Using fluorescence resonance energy transfer-based assays, we show here that Hpr1 and the FG repeats interact with overlapping binding sites on the Mex67 UBA domain. We present the solution structure of the Mex67 UBA domain (UBA-Mex67) complexed with a FXFG nucleoporin peptide and define residues engaged in the interaction and those involved in the FXFG-induced conformational change. We show by NMR titration that the binding of Hpr1 produces analogous changes in chemical shifts in similar regions of the UBA domain. Together the data presented here indicate that both Hpr1 and FXFG nucleoporins may bind in a similar way to the UBA-Mex67 domain. However, whereas binding of Hpr1 allows UBA-Mex67 to interact with tetra-ubiquitin, the complex between UBA-Mex67 and FXFG is unable to bind mono- or tetra-ubiquitin, suggesting that both substrate binding and also the nature of the substrate may influence the affinity of the UBA-Mex67 domain for ubiquitin.	[Hobeika, Maria; Dargemont, Catherine] Univ Paris 07, Inst Jacques Monod, CNRS, F-75251 Paris 05, France; [Brockmann, Christoph; Gruessing, Florian; Neuhaus, David; Stewart, Murray] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Divita, Gilles] Univ Montpellier 1, CNRS, CRBM, UMR 2593, F-34293 Montpellier 5, France; [Divita, Gilles] Univ Montpellier 2, F-34293 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; MRC Laboratory Molecular Biology; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier	Dargemont, C (corresponding author), Univ Paris 07, Inst Jacques Monod, CNRS, 2 Pl Jussieu,Tour 43, F-75251 Paris 05, France.	dargemont@ijm.jussieu.fr	DIVITA, GILLES/AAV-9214-2021		Wellcome Trust; Agence Nationale pour la Recherche [BLAN06-1_134099]; Ligue contre le Cancer; Medical Research Council [MC_U105178934, MC_U105178939] Funding Source: researchfish; MRC [MC_U105178934, MC_U105178939] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Ligue contre le Cancer(Ligue nationale contre le cancer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by a Program Grant from the Wellcome Trust (to M. S.), by Agence Nationale pour la Recherche Grant BLAN06-1_134099 (to C. D. and G. D.), and the Ligue contre le Cancer.	Agopian A, 2009, J BIOL CHEM, V284, P254, DOI 10.1074/jbc.M802199200; Aguilera A, 2005, CURR OPIN CELL BIOL, V17, P242, DOI 10.1016/j.ceb.2005.03.001; Bertolaet BL, 2001, J MOL BIOL, V313, P955, DOI 10.1006/jmbi.2001.5105; Clarkson WD, 1996, J MOL BIOL, V263, P517, DOI 10.1006/jmbi.1996.0594; CLORE GM, 1992, J MOL BIOL, V223, P853, DOI 10.1016/0022-2836(92)90247-H; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dieckmann T, 1998, NAT STRUCT BIOL, V5, P1042, DOI 10.1038/4220; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Duncan K, 2000, CURR BIOL, V10, P687, DOI 10.1016/S0960-9822(00)00527-3; Fasken MB, 2005, NAT STRUCT MOL BIOL, V12, P482, DOI 10.1038/nsmb945; Grant RP, 2003, J MOL BIOL, V326, P849, DOI 10.1016/S0022-2836(02)01474-2; Grant RP, 2002, NAT STRUCT BIOL, V9, P247, DOI 10.1038/nsb773; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; GRZESIEK S, 1992, J AM CHEM SOC, V115, P11620; Gwizdek C, 2005, J BIOL CHEM, V280, P13401, DOI 10.1074/jbc.C500040200; Gwizdek C, 2006, P NATL ACAD SCI USA, V103, P16376, DOI 10.1073/pnas.0607941103; Heitz F, 1997, BIOCHEMISTRY-US, V36, P4995, DOI 10.1021/bi962349y; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hobeika M, 2007, MOL BIOL CELL, V18, P2561, DOI 10.1091/mbc.E07-02-0153; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Iglesias N, 2008, FEBS LETT, V582, P1987, DOI 10.1016/j.febslet.2008.03.038; KAY LE, 1990, J AM CHEM SOC, V112, P888, DOI 10.1021/ja00158a070; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Miao F, 2000, J BIOL CHEM, V275, P28433, DOI 10.1074/jbc.M001064200; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Neumann S, 2003, EMBO REP, V4, P1156, DOI 10.1038/sj.embor.7400026; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Rodriguez MS, 2004, BIOL CELL, V96, P639, DOI 10.1016/j.biolcel.2004.04.014; Rodriguez MS, 2003, TRAFFIC, V4, P566, DOI 10.1034/j.1600-0854.2003.00115.x; Saguez C, 2008, MOL CELL, V31, P91, DOI 10.1016/j.molcel.2008.04.030; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Strasser K, 2000, J CELL BIOL, V150, P695, DOI 10.1083/jcb.150.4.695; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Suzuki T, 2001, J BIOL CHEM, V276, P21601, DOI 10.1074/jbc.M100826200; Swanson KA, 2006, J MOL BIOL, V358, P713, DOI 10.1016/j.jmb.2006.02.059; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Trempe JF, 2005, EMBO J, V24, P3178, DOI 10.1038/sj.emboj.7600797; Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang QH, 2003, BIOCHEMISTRY-US, V42, P13529, DOI 10.1021/bi035391j; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Withers-Ward ES, 2000, BIOCHEMISTRY-US, V39, P14103, DOI 10.1021/bi0017071; WithersWard ES, 1997, J VIROL, V71, P9732, DOI 10.1128/JVI.71.12.9732-9742.1997; Zenklusen D, 2001, FEBS LETT, V498, P150, DOI 10.1016/S0014-5793(01)02482-6; Zhu QZ, 2001, CANCER RES, V61, P64	53	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17575	17583		10.1074/jbc.M109.004374	http://dx.doi.org/10.1074/jbc.M109.004374			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19401465	Green Published, hybrid			2022-12-25	WOS:000267202500023
J	Price, PA; Toroian, D; Lim, JE				Price, Paul A.; Toroian, Damon; Lim, Joo Eun			Mineralization by Inhibitor Exclusion THE CALCIFICATION OF COLLAGEN WITH FETUIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-MICROSCOPIC TOMOGRAPHY; ACID-CONTAINING PROTEIN; DEMINERALIZED BONE; ORGANIC MATRIX; CORTICAL BONE; SERUM FACTOR; GLYCOPROTEIN; PARTICLES; CRYSTALS; TENDON	One of our goals is to understand the mechanisms that deposit mineral within collagen fibrils, and as a first step we recently determined the size exclusion characteristics of the fibril. This study revealed that apatite crystals up to 12 unit cells in size can access the water within the fibril, whereas molecules larger than a 40-kDa protein are excluded. Based on these observations, we proposed a novel mechanism for fibril mineralization: that macromolecular inhibitors of apatite growth favor fibril mineralization by selectively inhibiting crystal growth in the solution outside of the fibril. To test this mechanism, we developed a system in which crystal formation is driven by homogeneous nucleation at high calcium phosphate concentration and the only macromolecule in solution is fetuin, a 48-kDa inhibitor of apatite growth. Our experiments with this system demonstrated that fetuin determines the location of mineral growth; in the presence of fetuin mineral grows exclusively within the fibril, whereas in its absence mineral grows in solution outside the fibril. Additional experiments showed that fetuin is also able to localize calcification to the interior of synthetic matrices that have size exclusion characteristics similar to those of collagen and that it does so by selectively inhibiting mineral growth outside of these matrices. We termed this new calcification mechanism "mineralization by inhibitor exclusion," the selective mineralization of a matrix using a macromolecular inhibitor of mineral growth that is excluded from that matrix. Future studies will be needed to evaluate the possible role of this mechanism in bone mineralization.	[Price, Paul A.; Toroian, Damon; Lim, Joo Eun] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Price, PA (corresponding author), Univ Calif San Diego, Div Biol Sci, Mail Code 0368, La Jolla, CA 92093 USA.	pprice@ucsd.edu						ASHTON BA, 1976, CALC TISS RES, V22, P27; ASHTON BA, 1974, EUR J BIOCHEM, V45, P525, DOI 10.1111/j.1432-1033.1974.tb03577.x; Boivin G, 2002, CALCIFIED TISSUE INT, V70, P503, DOI 10.1007/s00223-001-2048-0; BROWN WM, 1992, BIOESSAYS, V14, P749, DOI 10.1002/bies.950141105; CHEN PS, 1956, ANAL CHEM, V28, P1758; DICKSON IR, 1975, NATURE, V256, P430, DOI 10.1038/256430a0; Fuchs RK, 2008, MATRIX BIOL, V27, P34, DOI 10.1016/j.matbio.2007.07.006; HALE JE, 1991, J BIOL CHEM, V266, P21145; Hamlin NJ, 2006, CALCIFIED TISSUE INT, V78, P326, DOI 10.1007/s00223-005-0205-6; Hamlin NJ, 2004, CALCIFIED TISSUE INT, V75, P231, DOI 10.1007/s00223-004-0190-1; Heiss A, 2008, J BIOL CHEM, V283, P14815, DOI 10.1074/jbc.M709938200; Ix JH, 2009, J BONE MINER RES, V24, P514, DOI 10.1359/JBMR.081017; Jager I, 2000, BIOPHYS J, V79, P1737, DOI 10.1016/S0006-3495(00)76426-5; JahnenDechent W, 1997, J BIOL CHEM, V272, P31496, DOI 10.1074/jbc.272.50.31496; KATZ EP, 1973, J MOL BIOL, P1; LANDIS WJ, 1993, J STRUCT BIOL, V110, P39, DOI 10.1006/jsbi.1993.1003; Landis WJ, 1996, MICROSC RES TECHNIQ, V33, P192; MAROTTI G, 1972, CALC TISS RES, V10, P67, DOI 10.1007/BF02012537; MIZUNO M, 1991, BONE MINER, V13, P1, DOI 10.1016/0169-6009(91)90046-3; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Nikolov S, 2008, BIOPHYS J, V94, P4220, DOI 10.1529/biophysj.107.125567; OHNISHI T, 1991, J BIOL CHEM, V266, P14636; Olivier E, 2000, BIOCHEM J, V350, P589, DOI 10.1042/0264-6021:3500589; Pedersen KO, 1944, NATURE, V154, P575, DOI 10.1038/154575a0; Price PA, 2006, KIDNEY INT, V70, P1577, DOI 10.1038/sj.ki.5001841; Price PA, 2004, J BIOL CHEM, V279, P19169, DOI 10.1074/jbc.M307880200; Price PA, 2003, J BIOL CHEM, V278, P22144, DOI 10.1074/jbc.M300744200; PRICE PA, 1976, P NATL ACAD SCI USA, V73, P1447, DOI 10.1073/pnas.73.5.1447; QUELCH KJ, 1984, CALCIFIED TISSUE INT, V36, P545, DOI 10.1007/BF02405363; ROBINSON RA, 1957, J BONE JOINT SURG AM, V39, P167, DOI 10.2106/00004623-195739010-00015; Rubin MA, 2003, BONE, V33, P270, DOI 10.1016/S8756-3282(03)00194-7; Sasaki N, 1997, CALCIFIED TISSUE INT, V60, P361, DOI 10.1007/s002239900244; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; Siperko LM, 2001, J STRUCT BIOL, V135, P313, DOI 10.1006/jsbi.2001.4414; Tong W, 2003, CALCIFIED TISSUE INT, V72, P592, DOI 10.1007/s00223-002-1077-7; Toroian D, 2008, CALCIFIED TISSUE INT, V82, P116, DOI 10.1007/s00223-007-9085-2; Toroian D, 2007, J BIOL CHEM, V282, P22437, DOI 10.1074/jbc.M700591200; WENDEL M, 1993, MATRIX, V13, P331, DOI 10.1016/S0934-8832(11)80029-6	38	122	128	3	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17092	17101		10.1074/jbc.M109.007013	http://dx.doi.org/10.1074/jbc.M109.007013			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19414589	hybrid, Green Published			2022-12-25	WOS:000266962400047
J	Okumura, N; Koh, T; Hasebe, Y; Seki, T; Ariga, T				Okumura, Nobuaki; Koh, Tomohiko; Hasebe, Yuichi; Seki, Taiichiro; Ariga, Toyohiko			A Novel Function of Thrombin-activatable Fibrinolysis Inhibitor during Rat Liver Regeneration and in Growth-promoted Hepatocytes in Primary Culture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA PROCARBOXYPEPTIDASE-B; EXTRACELLULAR-MATRIX; PLASMINOGEN ACTIVATORS; PARTIAL-HEPATECTOMY; CARBOXYPEPTIDASE-N; SIGNALING PATHWAY; GENE-EXPRESSION; TOXIC INJURY; CLOT LYSIS; TAFI	Thrombin-activatable fibrinolysis inhibitor (TAFI) exhibits anti-fibrinolytic activity by removing C-terminal lysine residues from fibrin or plasminogen receptor proteins on the cellular surface, and plays an important role in the regulation of fibrinolysis. In this study, we examined the regulation of TAFI in hepatocytes during liver regeneration, and revealed its pivotal role in hepatocyte proliferation. In rat models, partial hepatectomy or carbon tetrachloride (CCl4)-induced acute liver injury suppressed the levels of plasma TAFI activity and hepatic TAFI mRNA, whereas this operation markedly increased both the hepatic plasmin activity and the level of proliferating cell nuclear antigen. In primary cultures of rat hepatocytes, the TAFI mRNA level was decreased under growth-promoting culture conditions. Treatment of the hepatocytes with TAFI siRNA increased the amount of plasmin on the hepatocytes and promoted hepatocyte proliferation. We concluded that TAFI regulates plasmin activity through its enzymatic activity whereby it reduces the plasminogen-binding capacity of the hepatocytes. The TAFI gene expression is down-regulated in hepatocyte proliferation for producing a fibrinolytic microenvironment suitable for cell growth. This is the first report on the role of TAFI in the pericellular fibrinolysis necessary for cellular proliferation.	[Seki, Taiichiro] Nihon Univ, Coll Bioresource Sci, Dept Chem & Life Sci, Kanagawa 2528510, Japan; Nihon Univ, Grad Sch Bioresource Sci, Dept Appl Life Sci, Kanagawa 2528510, Japan	Nihon University; Nihon University	Seki, T (corresponding author), Nihon Univ, Coll Bioresource Sci, Dept Chem & Life Sci, Kanagawa 2528510, Japan.	tseki@brs.nihon-u.ac.jp	Hasebe, Yuichi/C-5350-2016	Okumura, Nobuaki/0000-0002-2997-7291	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science (JSPS); Nihon University; COE Program	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nihon University; COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Academic Frontier Project (to T. S.), the Japan Society for the Promotion of Science (JSPS), grant-in aid for scientific research (C) (to T. S.), and a Nihon University individual research grant (to T. S.).; Supported by a Fellowship from the Academic Frontier Project from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and from the COE Program in the 21st Century in Japan.	Akao M, 2002, THROMB RES, V107, P169, DOI 10.1016/S0049-3848(02)00258-X; Bajzar L, 1996, J BIOL CHEM, V271, P16603, DOI 10.1074/jbc.271.28.16603; BAJZAR L, 1995, J BIOL CHEM, V270, P14477, DOI 10.1074/jbc.270.24.14477; Bajzar L, 2000, ARTERIOSCL THROM VAS, V20, P2511, DOI 10.1161/01.ATV.20.12.2511; BENZEEV A, 1988, P NATL ACAD SCI USA, V85, P2161, DOI 10.1073/pnas.85.7.2161; Bezerra JA, 1999, P NATL ACAD SCI USA, V96, P15143, DOI 10.1073/pnas.96.26.15143; Bezerra JA, 2001, AM J PATHOL, V158, P921, DOI 10.1016/S0002-9440(10)64039-4; Boffa MB, 2003, J BIOL CHEM, V278, P9250, DOI 10.1074/jbc.M209588200; Bouma BN, 2003, J THROMB HAEMOST, V1, P1566, DOI 10.1046/j.1538-7836.2003.00329.x; Campbell WD, 2002, MICROBIOL IMMUNOL, V46, P131, DOI 10.1111/j.1348-0421.2002.tb02669.x; Colucci M, 2003, HEPATOLOGY, V38, P230, DOI 10.1053/jhep.2003.50277; Daveau M, 2004, J IMMUNOL, V173, P3418, DOI 10.4049/jimmunol.173.5.3418; Drixler TA, 2003, BRIT J SURG, V90, P1384, DOI 10.1002/bjs.4275; Grunnet N, 1999, J HEPATOL, V31, P117, DOI 10.1016/S0168-8278(99)80171-8; HAJJAR KA, 1995, THROMB HAEMOSTASIS, V74, P294; Hasebe Y, 2003, BIOCHEM BIOPH RES CO, V308, P852, DOI 10.1016/S0006-291X(03)01468-2; HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3; Hosaka Y, 1998, THROMB HAEMOSTASIS, V79, P371, DOI 10.1055/s-0037-1614994; HUBBARD AL, 1983, J CELL BIOL, V96, P217, DOI 10.1083/jcb.96.1.217; Ichihara A, 1980, Ann N Y Acad Sci, V349, P77, DOI 10.1111/j.1749-6632.1980.tb29517.x; Kawao N, 2007, BBA-MOL CELL RES, V1773, P718, DOI 10.1016/j.bbamcr.2007.03.019; Kim TH, 1997, HEPATOLOGY, V26, P896, DOI 10.1002/hep.510260415; Mandal SK, 2005, J THROMB HAEMOST, V3, P163, DOI 10.1111/j.1538-7836.2004.01054.x; Mao SS, 1999, J BIOL CHEM, V274, P35046, DOI 10.1074/jbc.274.49.35046; Markiewski MM, 2004, J IMMUNOL, V173, P747, DOI 10.4049/jimmunol.173.2.747; MARTINEZHERNANDEZ A, 1991, LAB INVEST, V64, P157; MIZUNO K, 1993, J BIOCHEM-TOKYO, V114, P96, DOI 10.1093/oxfordjournals.jbchem.a124147; MOROI M, 1976, J BIOL CHEM, V251, P5956; Mosnier LO, 1998, THROMB HAEMOSTASIS, V80, P829; Nagaki M, 2000, J HEPATOL, V32, P488, DOI 10.1016/S0168-8278(00)80401-8; Nagashima M, 2002, J CLIN INVEST, V109, P101, DOI 10.1172/JCI12119; NAKAMURA T, 1983, J BIOCHEM-TOKYO, V94, P1029, DOI 10.1093/oxfordjournals.jbchem.a134444; Natarajan A, 2007, P NATL ACAD SCI USA, V104, P17081, DOI 10.1073/pnas.0704126104; Nicholl SM, 2005, J SURG RES, V127, P39, DOI 10.1016/j.jss.2005.03.004; Noguchi T, 2001, THROMB RES, V104, P283, DOI 10.1016/S0049-3848(01)00370-X; ODA H, 1995, BIOCHEM BIOPH RES CO, V212, P800, DOI 10.1006/bbrc.1995.2039; Okada K, 2004, J HEPATOL, V40, P110, DOI 10.1016/j.jhep.2003.09.016; Okumura N, 2007, BIOSCI BIOTECH BIOCH, V71, P1542, DOI 10.1271/bbb.70126; Olaso E, 1998, J HEPATOL, V29, P836, DOI 10.1016/S0168-8278(98)80269-9; REDLITZ A, 1995, J CLIN INVEST, V96, P2534, DOI 10.1172/JCI118315; Renckens R, 2005, J IMMUNOL, V175, P6764, DOI 10.4049/jimmunol.175.10.6764; Sato T, 2000, J IMMUNOL, V165, P1053, DOI 10.4049/jimmunol.165.2.1053; Sun ZY, 2002, BBA-PROTEIN STRUCT M, V1596, P182, DOI 10.1016/S0167-4838(02)00233-9; Swaisgood CM, 2002, J CLIN INVEST, V110, P1275, DOI 10.1172/JCI200215082; Syrovets T, 2001, BLOOD, V97, P3941, DOI 10.1182/blood.V97.12.3941; Tanaka M, 2001, FIBRINOLYSIS PROTEOL, V15, P2, DOI 10.1054/fipr.2001.0097; Tarui T, 2002, J BIOL CHEM, V277, P33564, DOI 10.1074/jbc.M205514200; Van Thiel DH, 2001, THROMB HAEMOSTASIS, V85, P667; Velde EAT, 2003, J THROMB HAEMOST, V1, P2087, DOI 10.1046/j.1538-7836.2003.00404.x	49	6	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16553	16561		10.1074/jbc.M109.011452	http://dx.doi.org/10.1074/jbc.M109.011452			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19386599	hybrid, Green Published			2022-12-25	WOS:000266730900052
J	Wu, D; Asiedu, M; Wei, Q				Wu, D.; Asiedu, M.; Wei, Q.			Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoC	ONCOGENE			English	Article						MyoGEF; RhoA; RhoC; MDA-MB-231; cell motility; nonmuscle myosin II	BINDING PROTEIN RHO; MIGRATING CELLS; LIVING CELLS; MEMBRANE PROTRUSIONS; ADHESION DYNAMICS; CENTRAL SPINDLE; DISTINCT ROLES; HELA-CELLS; ANTI-RHOA; IN-VIVO	The small guanine triphosphatase (GTPase) proteins RhoA and RhoC are essential for tumor invasion and/or metastasis in breast carcinomas. However, it is poorly understood how RhoA and RhoC are activated in breast cancer cells. Here we describe the role of myosin-interacting guanine nucleotide exchange factor (MyoGEF) in regulating RhoA and RhoC activation as well as cell polarity and invasion in an invasive breast cancer cell line MDA-MB-231. RNA-interference (RNAi)-mediated depletion of MyoGEF in MDA-MB-231 cells not only suppresses the activation of RhoA and RhoC, but also decreases cell polarity and invasion activity. The dominant-negative mutants of RhoA and RhoC, but not Rac1 and Cdc42, dramatically decrease actin polymerization induced by MyoGEF. In addition, MyoGEF colocalizes with nonmuscle myosin IIA (NMIIA) to the front of migrating cells, and depletion of NMIIA by RNAi disrupts the polarized localization of MyoGEF at the cell leading edge, suggesting a role for NMIIA in regulating MyoGEF localization and function. Moreover, MyoGEF protein levels significantly increase in infiltrating ductal carcinomas as well as in invasive breast cancer cell lines. Taken together, our results suggest that MyoGEF cooperates with NMIIA to regulate the polarity and invasion activity of breast cancer cells through activation of RhoA and RhoC. Oncogene (2009) 28, 2219-2230; doi: 10.1038/onc.2009.96; published online 4 May 2009	[Wu, D.; Asiedu, M.; Wei, Q.] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA	Kansas State University	Wei, Q (corresponding author), Kansas State Univ, Dept Biochem, 141 Chalmers Hall, Manhattan, KS 66506 USA.	weiq@ksu.edu			National Institutes of Health (NIH) [P20 RR015563, k22 HL071542]; National Center for Research Resources; Kansas Agricultural Experiment Station, Manhattan, KS, USA [09-136-J]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015563] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K22HL071542] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Kansas Agricultural Experiment Station, Manhattan, KS, USA; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Dr Robert S Adelstein and Dr Mary Anne Conti for their criticalreading and comments on the manuscript. We thank Dr Keith Burridge (University of North Carolina at Chapel Hill, Chapel Hill, NC, USA) and Dr Rick Cerione (Cornell University, Ithaca, NY, USA) for providing GSTRBD and GST- PBD plasmids. This publication was made possible by National Institutes of Health (NIH) Grant no. P20 RR015563 from the NationalCenter for Research Resources. This work was also supported by NIH Grant k22 HL071542 (to QW), as well as a fund from Terry C. Johnson Center for Basic Cancer Research (to QW). This is contribution 09-136-J from the Kansas Agricultural Experiment Station, Manhattan, KS, USA.	Abe K, 2000, J BIOL CHEM, V275, P10141, DOI 10.1074/jbc.275.14.10141; Ahram M, 2000, EXP CELL RES, V260, P292, DOI 10.1006/excr.2000.5031; Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Asiedu M, 2008, J BIOL CHEM, V283, P28392, DOI 10.1074/jbc.M801801200; Asiedu M, 2009, MOL BIOL CELL, V20, P1428, DOI 10.1091/mbc.E08-01-0001; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chang F, 2002, SCIENCE, V297, P531, DOI 10.1126/science.1074649; Cheng L, 2004, J BIOL CHEM, V279, P12786, DOI 10.1074/jbc.M313099200; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Demou ZN, 2005, CANCER RES, V65, P5674, DOI 10.1158/0008-5472.CAN-04-1682; Wu D, 2006, CELL CYCLE, V5, P1234, DOI 10.4161/cc.5.11.2815; Glaven JA, 1999, J BIOL CHEM, V274, P2279, DOI 10.1074/jbc.274.4.2279; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kleer CG, 2002, AM J PATHOL, V160, P579, DOI 10.1016/S0002-9440(10)64877-8; Kleer CG, 2005, BREAST CANCER RES TR, V93, P101, DOI 10.1007/s10549-005-4170-6; Kleer CG, 2004, BREAST CANCER RES, V6, pR110, DOI 10.1186/bcr755; Kolega J, 2006, MOL BIOL CELL, V17, P4435, DOI 10.1091/mbc.E06-05-0431; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Kurokawa K, 2005, BIOCHEM SOC T, V33, P631, DOI 10.1042/BST0330631; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Kusama T, 2006, INT J ONCOL, V29, P217; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Liu BP, 2000, MOL CELL BIOL, V20, P7160, DOI 10.1128/MCB.20.19.7160-7169.2000; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pille JY, 2006, HUM GENE THER, V17, P1019, DOI 10.1089/hum.2006.17.1019; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2001, J CELL SCI, V114, P2713; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; Sastry SK, 2006, J BIOL CHEM, V281, P11627, DOI 10.1074/jbc.M600897200; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Simpson KJ, 2004, CANCER RES, V64, P8694, DOI 10.1158/0008-5472.CAN-04-2247; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; van Golen KL, 1999, CLIN CANCER RES, V5, P2511; van Golen KL, 2000, CANCER RES, V60, P5832; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Wei QZ, 2005, J BIOL CHEM, V280, P37790, DOI 10.1074/jbc.M502974200; Wells CM, 2004, J CELL SCI, V117, P1259, DOI 10.1242/jcs.00997; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	67	46	47	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2009	28	22					2219	2230		10.1038/onc.2009.96	http://dx.doi.org/10.1038/onc.2009.96			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	453VF	19421144	Green Accepted			2022-12-25	WOS:000266640300004
J	Parcellier, A; Tintignac, LA; Zhuravleva, E; Dummler, B; Brazil, DP; Hynx, D; Cron, P; Schenk, S; Olivieri, V; Hemmings, BA				Parcellier, Arnaud; Tintignac, Lionel A.; Zhuravleva, Elena; Dummler, Bettina; Brazil, Derek P.; Hynx, Debby; Cron, Peter; Schenk, Susanne; Olivieri, Vesna; Hemmings, Brian A.			The Carboxy-Terminal Modulator Protein (CTMP) Regulates Mitochondrial Dynamics	PLOS ONE			English	Article								Background: Mitochondria are central to the metabolism of cells and participate in many regulatory and signaling events. They are looked upon as dynamic tubular networks. We showed recently that the Carboxy-Terminal Modulator Protein (CTMP) is a mitochondrial protein that may be released into the cytosol under apoptotic conditions. Methodology/Principal Findings: Here we report an unexpected function of CTMP in mitochondrial homeostasis. In this study, both full length CTMP, and a CTMP mutant refractory to N-terminal cleavage and leading to an immature protein promote clustering of spherical mitochondria, suggesting a role for CTMP in the fission process. Indeed, cellular depletion of CTMP led to accumulation of swollen and interconnected mitochondria, without affecting the mitochondrial fusion process. Importantly, in vivo results support the relevance of these findings, as mitochondria from livers of adult CTMP knockout mice had a similar phenotype to cells depleted of CTMP. Conclusions/Significance: Together, these results lead us to propose that CTMP has a major function in mitochondrial dynamics and could be involved in the regulation of mitochondrial functions.			Parcellier, A (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	brian.hemmings@fmi.ch		Tintignac, Lionel/0000-0001-5902-1138; Brazil, Derek/0000-0003-1375-1076				Ahmad N, 2006, AM J PHYSIOL-HEART C, V290, pH2402, DOI 10.1152/ajpheart.00737.2005; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bergemann AD, 2005, TRENDS GENET, V21, P188, DOI 10.1016/j.tig.2005.01.008; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Cereghetti GM, 2006, ONCOGENE, V25, P4717, DOI 10.1038/sj.onc.1209605; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Delivani P, 2006, MOL CELL, V21, P761, DOI 10.1016/j.molcel.2006.01.034; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Dimmer KS, 2008, HUM MOL GENET, V17, P201, DOI 10.1093/hmg/ddm297; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hergovich A, 2007, MOL CELL, V25, P625, DOI 10.1016/j.molcel.2007.01.020; Ishihara N, 2003, BIOCHEM BIOPH RES CO, V301, P891, DOI 10.1016/S0006-291X(03)00050-0; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Knobbe CB, 2004, J NATL CANCER I, V96, P483, DOI 10.1093/jnci/djh064; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Maira SM, 2001, SCIENCE, V294, P374, DOI 10.1126/science.1062030; Mattenberger Y, 2003, FEBS LETT, V538, P53, DOI 10.1016/S0014-5793(03)00124-8; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; McWhirter SM, 2005, CELL, V122, P645, DOI 10.1016/j.cell.2005.08.026; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; PARCELLIER A, 2009, CELL SIGNAL; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; PIAO L, 2009, CELL SIGNAL; Rojo M, 2002, J CELL SCI, V115, P1663; Sasaki K, 2003, J BIOL CHEM, V278, P30945, DOI 10.1074/jbc.M212167200; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Tamai S, 2008, J CELL SCI, V121, P2588, DOI 10.1242/jcs.026625; Taylor AB, 2001, STRUCTURE, V9, P615, DOI 10.1016/S0969-2126(01)00621-9; Tintignac LAJ, 2004, MOL CELL BIOL, V24, P1809, DOI 10.1128/MCB.24.4.1809-1821.2004; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Wright GL, 2008, FASEB J, V22, P3264, DOI 10.1096/fj.08-106468; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Youle RJ, 2005, DEV CELL, V8, P298, DOI 10.1016/j.devcel.2005.02.003; Zollino M, 2003, AM J HUM GENET, V72, P590, DOI 10.1086/367925	45	13	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2009	4	5							e5471	10.1371/journal.pone.0005471	http://dx.doi.org/10.1371/journal.pone.0005471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JH	19421406	Green Submitted, gold, Green Published			2022-12-25	WOS:000265837000007
J	Defourny, I; Minetti, A; Harczi, G; Doyon, S; Shepherd, S; Tectonidis, M; Bradol, JH; Golden, M				Defourny, Isabelle; Minetti, Andrea; Harczi, Geza; Doyon, Stephane; Shepherd, Susan; Tectonidis, Milton; Bradol, Jean-Herve; Golden, Michael			A Large-Scale Distribution of Milk-Based Fortified Spreads: Evidence for a New Approach in Regions with High Burden of Acute Malnutrition	PLOS ONE			English	Article								Background: There are 146 million underweight children in the developing world, which contribute to up to half of the world's child deaths. In high burden regions for malnutrition, the treatment of individual children is limited by available resources. Here, we evaluate a large-scale distribution of a nutritional supplement on the prevention of wasting. Methods and Findings: A new ready-to-use food (RUF) was developed as a diet supplement for children under three. The intervention consisted of six monthly distributions of RUF during the 2007 hunger gap in a district of Maradi region, Niger, for approximately 60,000 children (length: 60-85 cm). At each distribution, all children over 65 cm had their Mid-Upper Arm Circumference (MUAC) recorded. Admission trends for severe wasting (WFH, 70% NCHS) in Maradi, 2002-2005 show an increase every year during the hunger gap. In contrast, in 2007, throughout the period of the distribution, the incidence of severe acute malnutrition (MUAC, 110 mm) remained at extremely low levels. Comparison of year-over-year admissions to the therapeutic feeding program shows that the 2007 blanket distribution had essentially the same flattening effect on the seasonal rise in admissions as the 2006 individualized treatment of almost 60,000 children moderately wasted. Conclusions: These results demonstrate the potential for distribution of fortified spreads to reduce the incidence of severe wasting in large population of children 6-36 months of age. Although further information is needed on the cost-effectiveness of such distributions, these results highlight the importance of re-evaluating current nutritional strategies and international recommendations for high burden areas of childhood malnutrition.			Defourny, I (corresponding author), Med Sans Frontieres, Paris, France.	andrea.minetti@epicentre.msf.org	Golden, Michael/AAB-8989-2020	Golden, Michael/0000-0002-4039-7538				Adu-Afarwuah S, 2007, AM J CLIN NUTR, V86, P412, DOI 10.1093/ajcn/86.2.412; Attama S, 1998, ENQUETE DEMOGRAPHIQU; Beaton G., 1993, EFFECTIVENESS VITAMI; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Ciliberto MA, 2005, AM J CLIN NUTR, V81, P864, DOI 10.1093/ajcn/81.4.864; Dale NM, 2009, ARCH PEDIAT ADOL MED, V163, P126, DOI 10.1001/archpediatrics.2008.540; Defourny I, 2006, FIELD EXCHANGE, V28, P2; Defourny I, 2007, FIELD EXCHANGE, V31, P2; Delpeuch F., 2006, EVALUATION DISPOSITI; Diop EHI, 2003, AM J CLIN NUTR, V78, P302, DOI 10.1093/ajcn/78.2.302; *FEWS, 2008, FEWS NET W AFR FOOD; Flax VL, 2008, MATERN CHILD NUTR, V4, P65, DOI 10.1111/j.1740-8709.2007.00098.x; Galpin L, 2007, J NUTR, V137, P1828, DOI 10.1093/jn/137.7.1828; GOLDEN MHN, 1991, ACTA PAEDIATR SCAND, P95; *INS NIG MACR INT, 2007, DEM HLTH SURV MULT I; Isanaka S, 2009, PEDIATRICS, V123, pE54, DOI 10.1542/peds.2008-1375; KOURGUENI IA, 1992, ENQUETE DEMOGRAPHIQU; Kuusipalo H, 2006, J PEDIATR GASTR NUTR, V43, P525, DOI 10.1097/01.mpg.0000235981.26700.d3; Lapidus N, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000039; Lopriore C, 2004, AM J CLIN NUTR, V80, P973, DOI 10.1093/ajcn/80.4.973; Maleta T, 2004, J PEDIATR GASTR NUTR, V38, P152; NAVARROCOLORADO C, 2007, RETROSPECTIVE STUDY; Ndekha MJ, 2005, ACTA PAEDIATR, V94, P222, DOI 10.1080/08035250410022503; Patel MP, 2005, J HEALTH POPUL NUTR, V23, P351; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; Phuka JC, 2008, ARCH PEDIAT ADOL MED, V162, P619, DOI 10.1001/archpedi.162.7.619; Phuka JC, 2009, AM J CLIN NUTR, V89, P382, DOI 10.3945/ajcn.2008.26483; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Ruel MT, 2008, LANCET, V371, P588, DOI 10.1016/S0140-6736(08)60271-8; Sadler K, 2007, PUBLIC HEALTH NUTR, V10, P907, DOI 10.1017/S1368980007711035; Tectonidis M, 2006, NEW ENGL J MED, V354, P224, DOI 10.1056/NEJMp058240; *UN CHILDR FUND, 2006, 4 UN CHILDR FUND; UN Millennium Project, 2005, HALV HUNG IT CAN BE; United Nations Children's Fund, STAT WORLDS CHILDR 2; YIP R, 1994, J NUTR, V124, pS2043	35	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5455	10.1371/journal.pone.0005455	http://dx.doi.org/10.1371/journal.pone.0005455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421316	gold, Green Published, Green Submitted			2022-12-25	WOS:000265836900011
J	Singh, S; Soe, S; Weisman, S; Barnwell, JW; Perignon, JL; Druilhe, P				Singh, Subhash; Soe, Soe; Weisman, Simon; Barnwell, John W.; Perignon, Jean Louis; Druilhe, Pierre			A Conserved Multi-Gene Family Induces Cross-Reactive Antibodies Effective in Defense against Plasmodium falciparum	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-3; MALARIA VACCINE; GAMMA-GLOBULIN; COOPERATION; IMMUNITY; DISRUPTION; PROTECTION; MONOCYTES; INVASION; ELICITS	Background: Two related merozoite surface proteins, MSP3 and MSP6, have previously been identified as targets of antibody-dependent cellular inhibition (ADCI), a protective mechanism against Plasmodium falciparum malaria. Both MSP3 and MSP6 share a common characteristic small N-terminal signature amino-acid stretch (NLRNA/G), a feature similar to MSP3-like orthologs identified in other human and primate malaria parasites. Methods/Results: This signature amino-acid sequence led to the identification of eight ORFs contiguously located on P. falciparum chromosome 10. Our subsequent investigations on their expression, localization, sequence conservation, epitope sharing, immunogenicity and the functional role of antibodies in defense are reported here. Six members of P. falciparum MSP3-multigene family share similar sequence organization within their C-terminal regions, are simultaneously expressed as merozoite surface proteins and are highly conserved among parasite isolates. Each of these proteins is a target of naturally occurring antibodies effective at parasite killing in ADCI assays. Moreover, both naturally occurring antibodies and those generated by immunization display cross-reactivity with other members of the family and exhibit varied binding avidities. Conclusions/Significance: The unusual characteristics of the MSP3 multi-gene family lead us to hypothesize that the simultaneous expression of targets eliciting cross-reactive antibody responses capable of controlling parasite densities could represent an immune process selected through evolution to maintain homeostasis between P. falciparum and human hosts; a process that allows the continuous transmission of the parasite without killing the host. Our observations also have practical consequences for vaccine development by suggesting MSP3 vaccine efficacy might be improved when combined with the various C-terminus regions of the MSP3 family members to generate a wider range of antibodies acting and to increase vaccine immunogenicity in varied human genetic backgrounds.			Singh, S (corresponding author), Gennova Biopharmaceut Ltd, Div Res & Dev, Pune, Maharashtra, India.	subhash.singh@gennova.co.in; druilhe@pasteur.fr						Audran R, 2005, INFECT IMMUN, V73, P8017, DOI 10.1128/IAI.73.12.8017-8026.2005; Black CG, 2003, MOL BIOCHEM PARASIT, V127, P59, DOI 10.1016/S0166-6851(02)00308-0; Bornberg-Bauer E, 1998, NUCLEIC ACIDS RES, V26, P2740, DOI 10.1093/nar/26.11.2740; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; BOUHAROUNTAYOUN H, 1992, INFECT IMMUN, V60, P1473, DOI 10.1128/IAI.60.4.1473-1481.1992; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Chattopadhyay R, 2003, INFECT IMMUN, V71, P597, DOI 10.1128/IAI.71.2.597-604.2003; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Cowman AF, 2002, SCIENCE, V298, P126, DOI 10.1126/science.1078169; DAVID PH, 1985, J IMMUNOL, V134, P4146; Druilhe P, 2005, PLOS MED, V2, P1135, DOI 10.1371/journal.pmed.0020344; Druilhe Pierre, 2002, Methods Mol Med, V72, P457, DOI 10.1385/1-59259-271-6:457; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; EDOZIEN JC, 1962, LANCET, V2, P951; Galinski MR, 2001, MOL BIOCHEM PARASIT, V115, P41, DOI 10.1016/S0166-6851(01)00267-5; Hisaeda H, 2002, J INFECT DIS, V185, P657, DOI 10.1086/339187; Jafarshad A, 2007, J IMMUNOL, V178, P3099, DOI 10.4049/jimmunol.178.5.3099; Kaneko O, 2000, MOL BIOCHEM PARASIT, V110, P135, DOI 10.1016/S0166-6851(00)00263-2; KHUSMITH S, 1983, INFECT IMMUN, V41, P219, DOI 10.1128/IAI.41.1.219-223.1983; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lusingu JP, 2008, AM J TROP MED HYG, V79, P7; MCCOLL DJ, 1994, MOL BIOCHEM PARASIT, V68, P53, DOI 10.1016/0166-6851(94)00149-9; McGREGOR I. A., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P170, DOI 10.1016/0035-9203(63)90058-0; MCGREGOR IA, 1988, PRINCIPLES PRACTICE, P559; Mills KE, 2002, MOL MICROBIOL, V43, P1401, DOI 10.1046/j.1365-2958.2002.02834.x; OEUVRAY C, 1994, BLOOD, V84, P1594; Osier FHA, 2007, PARASITE IMMUNOL, V29, P387, DOI 10.1111/j.1365-3024.2007.00951.x; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Pearce JA, 2005, MOL BIOCHEM PARASIT, V139, P141, DOI 10.1016/j.molbiopara.2004.09.012; Polley SD, 2007, J INFECT DIS, V195, P279, DOI 10.1086/509806; Rayner JC, 2002, PARASITOLOGY, V125, P393, DOI 10.1017/S0031182002002317; Rayner JC, 2004, INFECT GENET EVOL, V4, P309, DOI 10.1016/j.meegid.2004.03.003; Reed MB, 2000, P NATL ACAD SCI USA, V97, P7509, DOI 10.1073/pnas.97.13.7509; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; SERGENT ED, 1935, IMMUNITE PREMUNITION, P279; Singh S, 2005, INFECT IMMUN, V73, P1235, DOI 10.1128/IAI.73.2.1235-1238.2005; Singh S, 2004, J INFECT DIS, V190, P1010, DOI 10.1086/423208; Soe S, 2004, INFECT IMMUN, V72, P247, DOI 10.1128/IAI.72.1.247-252.2004; Stepniewska K, 2008, AM J TROP MED HYG, V79, P253; Trucco C, 2001, MOL BIOCHEM PARASIT, V112, P91, DOI 10.1016/S0166-6851(00)00350-9; Wang L, 1999, INFECT IMMUN, V67, P2193, DOI 10.1128/IAI.67.5.2193-2200.1999; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606	43	52	53	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5410	10.1371/journal.pone.0005410	http://dx.doi.org/10.1371/journal.pone.0005410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404387	Green Published, Green Submitted, gold			2022-12-25	WOS:000265614900021
J	Cencic, R; Carrier, M; Galicia-Vazquez, G; Bordeleau, ME; Sukarieh, R; Bourdeau, A; Brem, B; Teodoro, JG; Greger, H; Tremblay, ML; Porco, JA; Pelletier, J				Cencic, Regina; Carrier, Marilyn; Galicia-Vazquez, Gabriela; Bordeleau, Marie-Eve; Sukarieh, Rami; Bourdeau, Annie; Brem, Brigitte; Teodoro, Jose G.; Greger, Harald; Tremblay, Michel L.; Porco, John A., Jr.; Pelletier, Jerry			Antitumor Activity and Mechanism of Action of the Cyclopenta[b]benzofuran, Silvestrol	PLOS ONE			English	Article								Background: Flavaglines are a family of natural products from the genus Aglaia that exhibit anti-cancer activity in vitro and in vivo and inhibit translation initiation. They have been shown to modulate the activity of eIF4A, the DEAD-box RNA helicase subunit of the eukaryotic initiation factor (eIF) 4F complex, a complex that stimulates ribosome recruitment during translation initiation. One flavagline, silvestrol, is capable of modulating chemosensitivity in a mechanism-based mouse model. Methodology/Principal Findings: Among a number of flavagline family members tested herein, we find that silvestrol is the more potent translation inhibitor among these. We find that silvestrol impairs the ribosome recruitment step of translation initiation by affecting the composition of the eukaryotic initiation factor (eIF) 4F complex. We show that silvestrol exhibits significant anticancer activity in human breast and prostate cancer xenograft models, and that this is associated with increased apoptosis, decreased proliferation, and inhibition of angiogenesis. We demonstrate that targeting translation by silvestrol results in preferential inhibition of weakly initiating mRNAs. Conclusions/Significance: Our results indicate that silvestrol is a potent anti-cancer compound in vivo that exerts its activity by affecting survival pathways as well as angiogenesis. We propose that silvestrol mediates its effects by preferentially inhibiting translation of malignancy-related mRNAs. Silvestrol appears to be well tolerated in animals.			Pelletier, J (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	jerry.pelletier@mcgill.ca	Teodoro, Joe/AFT-2440-2022	Teodoro, Joe/0000-0002-3713-6839; GALICIA VAZQUEZ, GABRIELA/0000-0001-6706-7742; Sukarieh, Rami/0000-0002-4890-3079	NIGMS NIH HHS [R01 GM073855] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073855] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anthony TG, 2001, J NUTR, V131, P1171, DOI 10.1093/jn/131.4.1171; Avdulov S, 2004, CANCER CELL, V5, P553, DOI 10.1016/j.ccr.2004.05.024; Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753; Bordeleau ME, 2006, CHEM BIOL, V13, P1287, DOI 10.1016/j.chembiol.2006.10.005; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; EDERY I, 1983, J BIOL CHEM, V258, P1398; Gerard B, 2007, ANGEW CHEM INT EDIT, V46, P7831, DOI 10.1002/anie.200702707; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; Graff JR, 2000, J BIOL CHEM, V275, P24500, DOI 10.1074/jbc.M003145200; Graff JR, 2003, CLIN EXP METASTAS, V20, P265, DOI 10.1023/A:1022943419011; GREENBERG JR, 1981, P NATL ACAD SCI-BIOL, V78, P2923, DOI 10.1073/pnas.78.5.2923; GRIFO JA, 1982, J BIOL CHEM, V257, P5246; Hwang BY, 2004, J ORG CHEM, V69, P3350, DOI 10.1021/jo040120f; Jiang LC, 1997, CHEM BIOL, V4, P35, DOI 10.1016/S1074-5521(97)90235-0; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kim Soyoung, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P319, DOI 10.2174/187152006777698123; Kimball SR, 2003, AM J PHYSIOL-CELL PH, V284, pC273, DOI 10.1152/ajpcell.00314.2002; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Lee SK, 1998, CHEM-BIOL INTERACT, V115, P215, DOI 10.1016/S0009-2797(98)00073-8; Lin CJ, 2008, CANCER RES, V68, P5326, DOI 10.1158/0008-5472.CAN-07-5876; Lindqvist L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001583; Maeshima Y, 2002, SCIENCE, V295, P140, DOI 10.1126/science.1065298; Majumder PK, 2005, ONCOGENE, V24, P7465, DOI 10.1038/sj.onc.1209096; Mamane Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000242; Mavrakis KJ, 2008, GENE DEV, V22, P2178, DOI 10.1101/gad.1690808; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; Merrick WC, 1997, METHODS, V11, P333, DOI 10.1006/meth.1996.0431; MEURERGRIMES BM, 2004, THERAPEUTIC COMPOUND; Mi QW, 2006, ANTICANCER RES, V26, P947; Mills JR, 2008, P NATL ACAD SCI USA, V105, P10853, DOI 10.1073/pnas.0804821105; Morley SJ, 1997, J BIOL CHEM, V272, P17887, DOI 10.1074/jbc.272.28.17887; Mungamuri SK, 2006, CANCER RES, V66, P4715, DOI 10.1158/0008-5472.CAN-05-3830; Novac O, 2004, NUCLEIC ACIDS RES, V32, P902, DOI 10.1093/nar/gkh235; Ohse T, 1996, J NAT PROD, V59, P650, DOI 10.1021/np960346g; PARKIN NT, 1988, EMBO J, V7, P2831, DOI 10.1002/j.1460-2075.1988.tb03139.x; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Polunovsky VA, 1996, MOL CELL BIOL, V16, P6573; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; RAUGHT B, 2000, REGULATION RIBOSOME, P245; Rogers GW, 2002, PROG NUCLEIC ACID RE, V72, P307, DOI 10.1016/S0079-6603(02)72073-4; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; SONENBERG N, 1981, NUCLEIC ACIDS RES, V9, P1643, DOI 10.1093/nar/9.7.1643; Svitkin YV, 2001, RNA, V7, P1743; Tee AR, 2000, ONCOGENE, V19, P3021, DOI 10.1038/sj.onc.1203622; Wendel HG, 2006, CANCER RES, V66, P7639, DOI 10.1158/0008-5472.CAN-06-0419; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369	53	219	229	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5223	10.1371/journal.pone.0005223	http://dx.doi.org/10.1371/journal.pone.0005223			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401772	Green Published, gold			2022-12-25	WOS:000265601100002
J	Janzi, M; Sjoberg, R; Wan, JH; Fischler, B; von Dobeln, U; Isaac, L; Nilsson, P; Hammarstrom, L				Janzi, Magdalena; Sjoberg, Ronald; Wan, Jinghong; Fischler, Bjorn; von Dobeln, Ulrika; Isaac, Lourdes; Nilsson, Peter; Hammarstrom, Lennart			Screening for C3 Deficiency in Newborns Using Microarrays	PLOS ONE			English	Article								Background: Dried blood spot samples (DBSS) from newborns are widely used in neonatal screening for selected metabolic diseases and diagnostic possibilities for additional disorders are continuously being evaluated. Primary immunodeficiency disorders comprise a group of more than one hundred diseases, several of which are fatal early in life. Yet, a majority of the patients are not diagnosed due to lack of high-throughput screening methods. Methodology/Principal Findings: We have previously developed a system using reverse phase protein microarrays for analysis of IgA levels in serum samples. In this study, we extended the applicability of the method to include determination of complement component C3 levels in eluates from DBSS collected at birth. Normal levels of C3 were readily detected in 269 DBSS from healthy newborns, while no C3 was detected in sera and DBSS from C3 deficient patients. Conclusions/Significance: The findings suggest that patients with deficiencies of specific serum proteins can be identified by analysis of DBSS using reverse phase protein microarrays.			Janzi, M (corresponding author), KUS Huddinge, Karolinska Inst, Div Clin Immunol, Stockholm, Sweden.	nipe@kth.se; lennart.hammarstrom@ki.se	Nilsson, Peter/E-4547-2010; Isaac, Lourdes/I-7186-2012	Nilsson, Peter/0000-0002-4657-8532; Isaac, Lourdes/0000-0002-7746-8942; Venkatasubramanian, Siddharth/0000-0002-5860-0768				[Anonymous], 1999, CLIN EXP IMMUNOL, V118, P1; BOTTO M, 1990, J CLIN INVEST, V86, P1158, DOI 10.1172/JCI114821; BOTTO M, 1992, P NATL ACAD SCI USA, V89, P4957, DOI 10.1073/pnas.89.11.4957; Chan K, 2005, J ALLERGY CLIN IMMUN, V115, P391, DOI 10.1016/j.jaci.2004.10.012; Fujioka H, 2005, AM J MED GENET A, V138A, P399, DOI 10.1002/ajmg.a.30964; Ghannam A, 2008, J IMMUNOL, V181, P5158, DOI 10.4049/jimmunol.181.7.5158; HUANG JL, 1994, CLIN IMMUNOL IMMUNOP, V73, P267, DOI 10.1006/clin.1994.1197; Ingvarsson J, 2007, J PROTEOME RES, V6, P3527, DOI 10.1021/pr070204f; Janzi M, 2005, MOL CELL PROTEOMICS, V4, P1942, DOI 10.1074/mcp.M500213-MCP200; *JEFFR MOD FDN, 2009, JEFFR MOD FDN BREAK; Kida M, 2008, BLOOD CELL MOL DIS, V40, P410, DOI 10.1016/j.bcmd.2007.11.002; Lannergard A, 2001, SCAND J MED SCI SPOR, V11, P274, DOI 10.1034/j.1600-0838.2001.110504.x; Matsuyama W, 2001, HUM MUTAT, V17, DOI 10.1002/1098-1004(2001)17:1<79::AID-HUMU22>3.3.CO;2-X; Mcdade TW, 2007, DEMOGRAPHY, V44, P899, DOI 10.1353/dem.2007.0038; Reis ED, 2002, J CLIN IMMUNOL, V22, P321, DOI 10.1023/A:1020665614139; Reis ES, 2006, SCAND J IMMUNOL, V63, P155, DOI 10.1111/j.1365-3083.2006.01729.x; Reis ES, 2004, IMMUNOGENETICS, V55, P667, DOI 10.1007/s00251-003-0624-3; SINGER L, 1994, J BIOL CHEM, V269, P28494; SINGER L, 1994, PATHOBIOLOGY, V62, P14, DOI 10.1159/000163873; Sjoholm AG, 2006, MOL IMMUNOL, V43, P78, DOI 10.1016/j.molimm.2005.06.025; Skogstrand K, 2005, CLIN CHEM, V51, P1854, DOI 10.1373/clinchem.2005.052241; Tsukamoto H, 2005, BIOCHEM BIOPH RES CO, V330, P298, DOI 10.1016/j.bbrc.2005.02.159; Ulbrich AG, 2001, SCAND J IMMUNOL, V53, P622, DOI 10.1046/j.1365-3083.2001.00934.x	23	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5321	10.1371/journal.pone.0005321	http://dx.doi.org/10.1371/journal.pone.0005321			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390687	Green Published, gold			2022-12-25	WOS:000265514400009
J	Matukumalli, LK; Lawley, CT; Schnabel, RD; Taylor, JF; Allan, MF; Heaton, MP; O'Connell, J; Moore, SS; Smith, TPL; Sonstegard, TS; Van Tassell, CP				Matukumalli, Lakshmi K.; Lawley, Cynthia T.; Schnabel, Robert D.; Taylor, Jeremy F.; Allan, Mark F.; Heaton, Michael P.; O'Connell, Jeff; Moore, Stephen S.; Smith, Timothy P. L.; Sonstegard, Tad S.; Van Tassell, Curtis P.			Development and Characterization of a High Density SNP Genotyping Assay for Cattle	PLOS ONE			English	Article								The success of genome-wide association (GWA) studies for the detection of sequence variation affecting complex traits in human has spurred interest in the use of large-scale high-density single nucleotide polymorphism (SNP) genotyping for the identification of quantitative trait loci (QTL) and for marker-assisted selection in model and agricultural species. A cost-effective and efficient approach for the development of a custom genotyping assay interrogating 54,001 SNP loci to support GWA applications in cattle is described. A novel algorithm for achieving a compressed inter-marker interval distribution proved remarkably successful, with median interval of 37 kb and maximum predicted gap of,350 kb. The assay was tested on a panel of 576 animals from 21 cattle breeds and six outgroup species and revealed that from 39,765 to 46,492 SNP are polymorphic within individual breeds (average minor allele frequency (MAF) ranging from 0.24 to 0.27). The assay also identified 79 putative copy number variants in cattle. Utility for GWA was demonstrated by localizing known variation for coat color and the presence/absence of horns to their correct genomic locations. The combination of SNP selection and the novel spacing algorithm allows an efficient approach for the development of high-density genotyping platforms in species having full or even moderate quality draft sequence. Aspects of the approach can be exploited in species which lack an available genome sequence. The BovineSNP50 assay described here is commercially available from Illumina and provides a robust platform for mapping disease genes and QTL in cattle.			Matukumalli, LK (corresponding author), George Mason Univ, Dept Bioinformat & Computat Biol, Manassas, VA USA.	curtvt@ars.usda.gov	Moore, Stephen S/F-5285-2013; Van Tassell, Curtis P./O-4247-2019	Van Tassell, Curtis P./0000-0002-8416-2087; Moore, Stephen/0000-0002-9758-166X; Schnabel, Robert/0000-0001-5018-7641; Heaton, Michael/0000-0003-1386-1208				Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Banos G, 2001, J DAIRY SCI, V84, P2523, DOI 10.3168/jds.S0022-0302(01)74703-0; Brenneman RA, 1996, J HERED, V87, P156, DOI 10.1093/oxfordjournals.jhered.a022975; CHRISTENSEN LG, 2008, INFLUENCE INCORRECT, P200; GELDERMANN H, 1986, J ANIM SCI, V63, P1759, DOI 10.2527/jas1986.6361759x; Harmegnies N, 2006, ANIM GENET, V37, P225, DOI 10.1111/j.1365-2052.2006.01438.x; Hassanin A, 2004, MOL PHYLOGENET EVOL, V33, P896, DOI 10.1016/j.ympev.2004.08.009; Heaton MP, 2005, JAVMA-J AM VET MED A, V226, P1311, DOI 10.2460/javma.2005.226.1311; Heaton MP, 2002, MAMM GENOME, V13, P272, DOI 10.1007/s00335-001-2146-3; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Israel C, 2000, J DAIRY SCI, V83, P181, DOI 10.3168/jds.S0022-0302(00)74869-7; Klein RJ, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-58; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; Massey DCO, 2007, AUTOPHAGY, V3, P649, DOI 10.4161/auto.5075; McKay SD, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-74; Meuwissen THE, 2001, GENETICS, V157, P1819; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ron M, 1996, J DAIRY SCI, V79, P676, DOI 10.3168/jds.S0022-0302(96)76413-5; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Warren W, 2000, MAMM GENOME, V11, P662, DOI 10.1007/s003350010126; Werth LA, 1996, J ANIM SCI, V74, P262; Wilk JB, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S8; SCIENCE IN PRESS	25	665	691	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5350	10.1371/journal.pone.0005350	http://dx.doi.org/10.1371/journal.pone.0005350			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390634	Green Published, gold			2022-12-25	WOS:000265514400020
J	Margarit, I; Bonacci, S; Pietrocola, G; Rindi, S; Ghezzo, C; Bombaci, M; Nardi-Dei, V; Grifantini, R; Speziale, P; Grandi, G				Margarit, Immaculada; Bonacci, Stefano; Pietrocola, Giampiero; Rindi, Simonetta; Ghezzo, Claudia; Bombaci, Mauro; Nardi-Dei, Vincenzo; Grifantini, Renata; Speziale, Pietro; Grandi, Guido			Capturing host-pathogen interactions by protein microarrays: identification of novel streptococcal proteins binding to human fibronectin, fibrinogen, and C4BP	FASEB JOURNAL			English	Article						GBS; GAS; virulence factors	GROUP-B STREPTOCOCCUS; COMPLETE GENOME SEQUENCE; PILUS-LIKE STRUCTURES; COMPLEMENT REGULATORS; SURFACE-PROTEINS; C5A PEPTIDASE; PYOGENES; VACCINE; ADHERENCE; PURIFICATION	Microbial pathogen entry and survival in the host is mediated by a network of molecular interactions between the two partners, which has been the subject of many research efforts. A complex picture is emerging in which host-pathogen crosstalk involves a high number of proteins, often with redundant functions. In the present study, we investigated the potential of protein microarrays to simultaneously scan interactions between surface proteins from two main human streptococcal pathogens, Streptococcus pyogenes and Streptococcus agalactiae, and three human ligands, fibronectin, fibrinogen, and C4 binding protein, known to play an important role in streptococcal pathogenesis. By using this technology, we confirmed interactions described in the literature and detected a novel set of streptococcal proteins with binding capacities for the human ligands. The observations were validated by Western blot and ELISA techniques. Three of the newly identified proteins were isoforms of a group B streptococcus-secreted component named Fib and displayed differential binding capacities for fibronectin, fibrinogen, and C4BP. The protein regions involved in the interaction with each ligand were identified by constructing fragments of one of the Fib variants. The approach proved valuable for the acquisition of novel insights into the complex network of protein-protein interactions occurring during microbial infection.-Margarit, I., Bonacci, S., Pietrocola, G., Rindi, S., Ghezzo, C., Bombaci, M., Nardi-Dei, V., Grifantini, R., Speziale, P., Grandi, G. Capturing host-pathogen interactions by protein microarrays: identification of novel streptococcal proteins binding to human fibronectin, fibrinogen and C4BP. FASEB J. 23, 3100-3112 ( 2009). www.fasebj.org	[Margarit, Immaculada; Bonacci, Stefano; Ghezzo, Claudia; Nardi-Dei, Vincenzo; Grandi, Guido] Novartis Vaccines & Diagnost, Siena, Italy; [Pietrocola, Giampiero; Rindi, Simonetta; Speziale, Pietro] Univ Pavia, Dept Biochem, I-27100 Pavia, Italy; [Bombaci, Mauro] Ist Nazl Genet Mol, Milan, Italy; [Grifantini, Renata] Externautics, Siena, Italy	Novartis; University of Pavia	Margarit, I (corresponding author), Novartis Vaccines, Res Ctr, Via Fiorentina 1, I-53100 Siena, Italy.	margarit_y_ros@novartis.com	Bombaci, Mauro/K-6106-2016; Renata, Grifantini/AAB-9969-2022; Bonacci, Stefano/ABI-5676-2020	Bombaci, Mauro/0000-0002-9887-4165; Renata, Grifantini/0000-0003-0024-3355; Grandi, Guido/0000-0001-9724-2185; PIETROCOLA, GIAMPIERO/0000-0002-7069-8155				AKESSON P, 1994, BIOCHEM J, V300, P877, DOI 10.1042/bj3000877; Bacarese-Hamilton T, 2004, J APPL MICROBIOL, V96, P10, DOI 10.1046/j.1365-2672.2003.02111.x; Beckmann C, 2002, INFECT IMMUN, V70, P2869, DOI 10.1128/IAI.70.6.2869-2876.2002; Berggard K, 2001, MOL MICROBIOL, V42, P539, DOI 10.1046/j.1365-2958.2001.02664.x; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; BORSI L, 1986, ANAL BIOCHEM, V155, P335, DOI 10.1016/0003-2697(86)90443-4; Brochet M, 2006, MICROBES INFECT, V8, P1227, DOI 10.1016/j.micinf.2005.11.010; Cai HY, 2005, J CLIN MICROBIOL, V43, P3427, DOI 10.1128/JCM.43.7.3427-3430.2005; Carlsson F, 2005, MOL MICROBIOL, V56, P28, DOI 10.1111/j.1365-2958.2005.04527.x; Chavakis T, 2005, THROMB HAEMOSTASIS, V94, P278, DOI 10.1160/TH05-05-0306; Chen CS, 2008, NAT METHODS, V5, P69, DOI 10.1038/NMETH1148; Cheng Q, 2002, INFECT IMMUN, V70, P2408, DOI 10.1128/IAI.70.5.2408-2413.2002; Courtney HS, 1999, MOL MICROBIOL, V32, P89, DOI 10.1046/j.1365-2958.1999.01328.x; COURTNEY HS, 1994, INFECT IMMUN, V62, P3937, DOI 10.1128/IAI.62.9.3937-3946.1994; Cue D, 2001, MICROB PATHOGENESIS, V31, P231, DOI 10.1006/mpat.2001.0467; Cue D, 1998, INFECT IMMUN, V66, P4593, DOI 10.1128/IAI.66.10.4593-4601.1998; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dale JB, 2008, ADV EXP MED BIOL, V609, P53, DOI 10.1007/978-0-387-73960-1_5; Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102; Doran KS, 2004, MOL MICROBIOL, V54, P23, DOI 10.1111/j.1365-2958.2004.04266.x; Edwards RJ, 2005, J INFECT DIS, V192, P783, DOI 10.1086/432485; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Gutekunst H, 2004, INFECT IMMUN, V72, P3495, DOI 10.1128/IAI.72.6.3495-3504.2004; HANSKI E, 1992, P NATL ACAD SCI USA, V89, P6172, DOI 10.1073/pnas.89.13.6172; Hanski E, 1996, ADV EXP MED BIOL, V408, P141; Harris JW, 1998, HDB MATH COMPUTATION, P824; Joh D, 1999, MATRIX BIOL, V18, P211, DOI 10.1016/S0945-053X(99)00025-6; Johri AK, 2007, INFECT IMMUN, V75, P1473, DOI 10.1128/IAI.00638-06; Johri AK, 2006, NAT REV MICROBIOL, V4, P932, DOI 10.1038/nrmicro1552; Katerov V, 1998, MICROBIOL-UK, V144, P119, DOI 10.1099/00221287-144-1-119; Korf U, 2005, EXPERT REV PROTEOMIC, V2, P13, DOI 10.1586/14789450.2.1.13; Kwinn LA, 2007, FUTURE MICROBIOL, V2, P75, DOI 10.2217/17460913.2.1.75; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; Lee LYL, 2004, J BIOL CHEM, V279, P50710, DOI 10.1074/jbc.M408570200; Li B, 2005, INFECT IMMUN, V73, P3734, DOI 10.1128/IAI.73.6.3734-3739.2005; Liden A, 2008, J BIOL CHEM, V283, P1234, DOI 10.1074/jbc.M704827200; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Lindahl G, 2000, CURR OPIN IMMUNOL, V12, P44, DOI 10.1016/S0952-7915(99)00049-7; MacBeath G, 2000, SCIENCE, V289, P1760; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; NOEL GJ, 1991, PEDIATR RES, V30, P118, DOI 10.1203/00006450-199107000-00023; Panizzi P, 2006, J BIOL CHEM, V281, P1179, DOI 10.1074/jbc.M507956200; Perez-Caballero D, 2004, J IMMUNOL, V173, P6899, DOI 10.4049/jimmunol.173.11.6899; Persson Jenny, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020047; Rivera J, 2007, THROMB HAEMOSTASIS, V98, P503, DOI 10.1160/TH07-03-0233; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; RUBENS CE, 1992, INFECT IMMUN, V60, P5157, DOI 10.1128/IAI.60.12.5157-5163.1992; Sandin C, 2006, MOL MICROBIOL, V59, P20, DOI 10.1111/j.1365-2958.2005.04913.x; Santi I, 2007, MOL MICROBIOL, V63, P754, DOI 10.1111/j.1365-2958.2006.05555.x; SCHMIDT KH, 1993, FEMS IMMUNOL MED MIC, V7, P135; Schubert A, 2002, MOL MICROBIOL, V46, P557, DOI 10.1046/j.1365-2958.2002.03177.x; Schuchat A, 1999, LANCET, V353, P51, DOI 10.1016/S0140-6736(98)07128-1; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; SKORSTENGAARD K, 1986, EUR J BIOCHEM, V154, P15, DOI 10.1111/j.1432-1033.1986.tb09353.x; Sobke ACS, 2006, FASEB J, V20, P2621, DOI 10.1096/fj.06-5764fje; Speziale P, 2008, NAT PROTOC, V3, P525, DOI 10.1038/nprot.2008.12; Steller S, 2005, PROTEOMICS, V5, P2048, DOI 10.1002/pmic.200401097; TALAY SR, 1992, INFECT IMMUN, V60, P3837, DOI 10.1128/IAI.60.9.3837-3844.1992; Terao Y, 2002, J BIOL CHEM, V277, P47428, DOI 10.1074/jbc.M209133200; Terao Y, 2001, MOL MICROBIOL, V42, P75, DOI 10.1046/j.1365-2958.2001.02579.x; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; WESTERLUND B, 1993, MOL MICROBIOL, V9, P687, DOI 10.1111/j.1365-2958.1993.tb01729.x; WILLIAMS MJ, 1994, J MOL BIOL, V235, P1302, DOI 10.1006/jmbi.1994.1083; Zhu H, 2006, P NATL ACAD SCI USA, V103, P4011, DOI 10.1073/pnas.0510921103; Zhu H, 2003, ANNU REV BIOCHEM, V72, P783, DOI 10.1146/annurev.biochem.72.121801.161511	71	43	43	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					3100	3112		10.1096/fj.09-131458	http://dx.doi.org/10.1096/fj.09-131458			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19417080				2022-12-25	WOS:000270241000032
J	Stamatovic, SM; Keep, RF; Wang, MM; Jankovic, I; Andjelkovic, AV				Stamatovic, Svetlana M.; Keep, Richard F.; Wang, Michael M.; Jankovic, Ivana; Andjelkovic, Anuska V.			Caveolae-mediated Internalization of Occludin and Claudin-5 during CCL2-induced Tight Junction Remodeling in Brain Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS; DEPENDENT ENDOCYTOSIS; BARRIER FUNCTION; KNOCKOUT MICE; VE-CADHERIN; RHO-KINASE; IN-VITRO; PERMEABILITY; PROTEINS; EXPRESSION	Disturbance of the tight junction (TJ) complexes between brain endothelial cells leads to increased paracellular permeability, allowing leukocyte entry into inflamed brain tissue and also contributing to edema formation. The current study dissects the mechanisms by which a chemokine, CCL2, induces TJ disassembly. It investigates the potential role of selective internalization of TJ transmembrane proteins (occludin and claudin-5) in increased permeability of the brain endothelial barrier in vitro. To map the internalization and intracellular fate of occludin and claudin-5, green fluorescent protein fusion proteins of these TJ proteins were generated and imaged by fluorescent microscopy with simultaneous measurement of transendothelial electrical resistance. During CCL2-induced reductions in transendothelial electrical resistance, claudin-5 and occludin became internalized via caveolae and further processed to early (EEA1+) and recycling (Rab4+) endosomes but not to late endosomes. Western blot analysis of fractions collected from a sucrose gradient showed the presence of claudin-5 and occludin in the same fractions that contained caveolin-1. For the first time, these results suggest an underlying molecular mechanism by which the pro-inflammatory chemokine CCL2 mediates brain endothelial barrier disruption during CNS inflammation.	[Stamatovic, Svetlana M.; Jankovic, Ivana; Andjelkovic, Anuska V.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Keep, Richard F.; Andjelkovic, Anuska V.] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Keep, Richard F.; Wang, Michael M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Wang, Michael M.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Andjelkovic, AV (corresponding author), Univ Michigan, Dept Pathol, 7520A MSRB I,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	anuskaa@umich.edu		Keep, Richard/0000-0001-6441-5334	National Institutes of Health [NS 044907]; Office of the Vice President for Research Faculty Grants and Awards Program, University of Michigan; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044907] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Vice President for Research Faculty Grants and Awards Program, University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant (AVA) NS 044907. This work was also supported by the Office of the Vice President for Research Faculty Grants and Awards Program, University of Michigan.	Abedinpour P, 2003, ANAL BIOCHEM, V313, P1, DOI 10.1016/S0003-2697(02)00561-4; Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Bamforth SD, 1999, J CELL SCI, V112, P1879; Bazzoni G, 2006, THROMB HAEMOSTASIS, V95, P36, DOI 10.1160/TH05-07-0488; Blasig IE, 2006, CELL MOL LIFE SCI, V63, P505, DOI 10.1007/s00018-005-5472-x; Bruewer M, 2005, FASEB J, V19, P923, DOI 10.1096/fj.04-3260com; Chen JJ, 2007, ARTERIOSCL THROM VAS, V27, P2005, DOI 10.1161/ATVBAHA.107.145961; D'Alessio A, 2005, AM J PATHOL, V166, P1273, DOI 10.1016/S0002-9440(10)62346-2; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; DeMaio L, 2006, AM J PHYSIOL-HEART C, V290, pH674, DOI 10.1152/ajpheart.00554.2005; Diacovo TG, 1996, BLOOD, V88, P146; Echarri A, 2007, SEMIN CELL DEV BIOL, V18, P627, DOI 10.1016/j.semcdb.2007.08.004; Fanning AS, 2007, MOL BIOL CELL, V18, P721, DOI 10.1091/mbc.E06-08-0764; Farshori P, 1999, J MEMBRANE BIOL, V170, P147, DOI 10.1007/s002329900544; Frank PG, 2003, ARTERIOSCL THROM VAS, V23, P1161, DOI 10.1161/01.ATV.0000070546.16946.3A; GARCIA JGN, 1995, J INVEST MED, V43, P117; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Haorah J, 2007, J NEUROCHEM, V101, P566, DOI 10.1111/j.1471-4159.2006.04393.x; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Hartmann C, 2007, EXP CELL RES, V313, P1318, DOI 10.1016/j.yexcr.2007.01.024; Hommelgaard AM, 2005, TRAFFIC, V6, P720, DOI 10.1111/j.1600-0854.2005.00314.x; Hopkins AM, 2003, J CELL SCI, V116, P725, DOI 10.1242/jcs.00300; Ivanov AI, 2004, MOL BIOL CELL, V15, P2639, DOI 10.1091/mbc.E04-02-0163; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Jasmin JF, 2007, CIRC RES, V100, P721, DOI 10.1161/01.RES.0000260180.42709.29; Kirkham M, 2005, BBA-MOL CELL RES, V1745, P273, DOI 10.1016/j.bbamcr.2005.06.002; Lambert D, 2007, CELL PHYSIOL BIOCHEM, V20, P495, DOI 10.1159/000107533; Lee HS, 2004, MICROVASC RES, V68, P231, DOI 10.1016/j.mvr.2004.07.005; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lin MI, 2007, CANCER RES, V67, P2849, DOI 10.1158/0008-5472.CAN-06-4082; Liu LB, 2008, J NEUROSCI RES, V86, P1153, DOI 10.1002/jnr.21558; Martineau M, 2008, GLIA, V56, P1271, DOI 10.1002/glia.20696; Matsuda M, 2004, J CELL SCI, V117, P1247, DOI 10.1242/jcs.00972; Medina R, 2000, J MEMBRANE BIOL, V178, P235, DOI 10.1007/s002320010031; Miakotina OL, 2002, AM J PHYSIOL-LUNG C, V283, pL418, DOI 10.1152/ajplung.00470.2001; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Mul FPJ, 2000, J LEUKOCYTE BIOL, V68, P529; Murata T, 2007, J EXP MED, V204, P2373, DOI 10.1084/jem.20062340; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Nag S, 2007, ACTA NEUROPATHOL, V114, P459, DOI 10.1007/s00401-007-0274-x; NAKAJIMA S, 1994, AM J PHYSIOL-LUNG C, V267, pL422, DOI 10.1152/ajplung.1994.267.4.L422; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Nusrat A, 2000, J CELL SCI, V113, P1771; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Panicker AK, 2006, EXP CELL RES, V312, P299, DOI 10.1016/j.yexcr.2005.10.031; Park DS, 2002, AM J PATHOL, V160, P2207, DOI 10.1016/S0002-9440(10)61168-6; Paterson AD, 2003, J BIOL CHEM, V278, P21050, DOI 10.1074/jbc.M300082200; Persidsky Y, 2006, BLOOD, V107, P4770, DOI 10.1182/blood-2005-11-4721; Poritz LS, 2004, J SURG RES, V116, P14, DOI 10.1016/S0022-4804(03)00311-1; Ruffer C, 2004, EUR J CELL BIOL, V83, P135, DOI 10.1078/0171-9335-00366; Schreibelt G, 2007, FASEB J, V21, P3666, DOI 10.1096/fj.07-8329com; Schwarz BT, 2007, GASTROENTEROLOGY, V132, P2383, DOI 10.1053/j.gastro.2007.02.052; Shakirova Y, 2006, AM J PHYSIOL-CELL PH, V291, pC1326, DOI 10.1152/ajpcell.00046.2006; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; Song L, 2007, BLOOD, V109, P1515, DOI 10.1182/blood-2006-07-034009; Stamatovic SM, 2006, J BIOL CHEM, V281, P8379, DOI 10.1074/jbc.M513122200; Stamatovic SM, 2003, J CELL SCI, V116, P4615, DOI 10.1242/jcs.00755; Terai T, 2006, MOL BIOL CELL, V17, P2465, DOI 10.1091/mbc.E05-09-0826; Tsukamoto T, 1999, AM J PHYSIOL-RENAL, V276, pF737, DOI 10.1152/ajprenal.1999.276.5.F737; Utech M, 2005, MOL BIOL CELL, V16, P5040, DOI 10.1091/mbc.E05-03-0193; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Wilhelm I, 2007, PHYS MED BIOL, V52, P6261, DOI 10.1088/0031-9155/52/20/012; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440; Yamamoto M, 2008, AM J PATHOL, V172, P521, DOI 10.2353/ajpath.2008.070076; Yu J, 2006, J CLIN INVEST, V116, P1284, DOI 10.1172/JCI27100; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	66	141	151	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					19053	19066		10.1074/jbc.M109.000521	http://dx.doi.org/10.1074/jbc.M109.000521			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19423710	Green Published, hybrid			2022-12-25	WOS:000267711500054
J	Antonyak, MA; Li, B; Regan, AD; Feng, QY; Dusaban, SS; Cerione, RA				Antonyak, Marc A.; Li, Bo; Regan, Andrew D.; Feng, Qiyu; Dusaban, Stephanie S.; Cerione, Richard A.			Tissue Transglutaminase Is an Essential Participant in the Epidermal Growth Factor-stimulated Signaling Pathway Leading to Cancer Cell Migration and Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; DRUG-RESISTANCE; CARCINOMA-CELLS; FACTOR RECEPTOR; HUMAN BREAST; EXPRESSION; ACTIVATION; TARGET; TUMORS; RAS	Epidermal growth factor (EGF) exerts pleiotropic effects during oncogenesis, including the stimulation of cell migration and invasiveness. Although a number of traditional signaling proteins (e. g. Ras and Rho GTPases) have been implicated in EGF-stimulated cancer cell migration, less is known about the identity of those proteins functioning further downstream in this growth factor pathway. Here we have used HeLa carcinoma cells as a model system for investigating the role of tissue transglutaminase (TGase), a protein that has been linked to oncogenesis, in EGF-stimulated cancer cell migration and invasion. Treatment of HeLa cells with EGF resulted in TGase activation and its accumulation at their leading edges, whereas knocking down TGase expression, or treating cells with a TGase inhibitor, blocked EGF-stimulated cell migration and invasion. We show that EGF signaling through Ras and c-Jun N-terminal kinase is responsible for targeting TGase to the leading edges of cells and activating it. The requirement for EGF to properly localize and activate TGase can be circumvented by the expression of oncogenic Ras (G12V), whose ability to stimulate migration is also dependent on TGase. We further show that, in the highly aggressive breast cancer cell line MDAMB231, where EGF stimulation is unnecessary for migration and invasive activity, TGase is already at the leading edge and activated. These findings demonstrate that TGase plays a key role in cancer cell motility and invasiveness and represents a previously unappreciated participant in the EGF pathway that stimulates these processes in cancer cells.	[Antonyak, Marc A.; Regan, Andrew D.; Feng, Qiyu; Dusaban, Stephanie S.; Cerione, Richard A.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Li, Bo; Cerione, Richard A.] Cornell Univ, Baker Lab, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu	Li, Bo/O-7127-2019; Li, Bo/M-2192-2013; Li, Bo/M-2192-2013	Li, Bo/0000-0002-7979-8339; Li, Bo/0000-0001-8256-5045				Antonyak MA, 2004, J BIOL CHEM, V279, P41461, DOI 10.1074/jbc.M404976200; Antonyak MA, 2003, J BIOL CHEM, V278, P15859, DOI 10.1074/jbc.M300037200; Antonyak MA, 2002, J BIOL CHEM, V277, P14712, DOI 10.1074/jbc.M112259200; Antonyak MA, 2002, ONCOGENE, V21, P5038, DOI 10.1038/sj.onc.1205593; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Chen HY, 2004, MOL CELL BIOL, V24, P10558, DOI 10.1128/MCB.24.24.10558-10572.2004; CHIOCCA EA, 1988, J BIOL CHEM, V263, P11584; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cui XJ, 2006, CANCER RES, V66, P5304, DOI 10.1158/0008-5472.CAN-05-2858; Datta S, 2007, BIOCHEMISTRY-US, V46, P14819, DOI 10.1021/bi701422h; Hauck CR, 2001, CANCER RES, V61, P7079; Henson ES, 2006, CELL SIGNAL, V18, P2089, DOI 10.1016/j.cellsig.2006.05.015; Hill K, 2000, J BIOL CHEM, V275, P3741, DOI 10.1074/jbc.275.6.3741; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang C, 2004, CELL CYCLE, V3, P4, DOI 10.4161/cc.3.1.601; Hwang JY, 2008, CANCER RES, V68, P5849, DOI 10.1158/0008-5472.CAN-07-6130; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Kim DS, 2006, CANCER RES, V66, P10936, DOI 10.1158/0008-5472.CAN-06-1521; Laskin JJ, 2004, CANCER TREAT REV, V30, P1, DOI 10.1016/j.ctrv.2003.10.002; Li G, 2008, EXPERT REV VACCINES, V7, P977, DOI 10.1586/14760584.7.7.977; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mangala LS, 2007, ONCOGENE, V26, P2459, DOI 10.1038/sj.onc.1210035; Mann AP, 2006, CANCER RES, V66, P8788, DOI 10.1158/0008-5472.CAN-06-1457; Moscatello DK, 1997, CANCER RES, V57, P1419; PIACENTINI M, 1988, BIOCHEM J, V253, P33, DOI 10.1042/bj2530033; Piccolo E, 2002, ONCOGENE, V21, P6520, DOI 10.1038/sj.onc.1205821; Pouliot N, 2001, EXP CELL RES, V266, P1, DOI 10.1006/excr.2001.5197; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Singer CF, 2006, CLIN EXP METASTAS, V23, P33, DOI 10.1007/s10585-006-9015-0; SPORN MB, 1983, CANCER RES, V43, P3034; Verma A, 2006, CANCER RES, V66, P10525, DOI 10.1158/0008-5472.CAN-06-2387; Verma A, 2008, CLIN CANCER RES, V14, P2476, DOI 10.1158/1078-0432.CCR-07-4529; Yip SC, 2007, J CELL SCI, V120, P3138, DOI 10.1242/jcs.005298; Yuan L, 2007, ONCOGENE, V26, P2563, DOI 10.1038/sj.onc.1210048; Zandi R, 2007, CELL SIGNAL, V19, P2013, DOI 10.1016/j.cellsig.2007.06.023; Zuo XF, 2006, NAT CELL BIOL, V8, P1383, DOI 10.1038/ncb1505	38	59	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					17914	17925		10.1074/jbc.M109.013037	http://dx.doi.org/10.1074/jbc.M109.013037			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19403524	Green Published, hybrid			2022-12-25	WOS:000267712400003
J	Chiang, MH; Liang, FY; Chen, CP; Chang, CW; Cheong, ML; Wang, LJ; Liang, CY; Lin, FY; Chou, CC; Chen, HW				Chiang, Meng-Hsiu; Liang, Feng-Yu; Chen, Chie-Pein; Chang, Ching-Wen; Cheong, Mei-Leng; Wang, Liang-Jie; Liang, Ching-Yeu; Lin, Fang-Yu; Chou, Chih-Chine; Chen, Hungwen			Mechanism of Hypoxia-induced GCM1 Degradation IMPLICATIONS FOR THE PATHOGENESIS OF PREECLAMPSIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLACENTAL GROWTH-FACTOR; BREAST-CANCER CELLS; INDUCIBLE FACTOR-1-ALPHA; TRANSCRIPTIONAL ACTIVITY; 3-KINASE/AKT PATHWAY; ESTROGEN-RECEPTOR; SOLUBLE ENDOGLIN; TROPHOBLAST; SYNCYTIN; PROTEIN	Preeclampsia is a major pregnancy-specific disorder affecting 5-7% of pregnancies worldwide. Although hypoxia caused by incomplete trophoblast invasion and impaired spiral arterial remodeling is thought to be a major cause of preeclampsia, how hypoxia affects placental development remains uncertain. GCM1 (glial cells missing homolog 1) is a transcription factor critical for placental development. In preeclampsia, GCM1 and its target genes syncytin 1 and placental growth factor, important for syncytiotrophoblast formation and placental vasculogenesis, are all decreased. Here we present evidence that GCM1 is a major target of hypoxia associated with preeclampsia. We show that hypoxia triggers GCM1 degradation by suppressing the phosphatidylinositol 3-kinase-Akt signaling pathway, leading to GSK-3 beta activation. Activated GSK-3 beta phosphorylates GCM1 on Ser(322), which in turn recruits the F-box protein FBW2, leading to GCM1 ubiquitination and degradation. Importantly, the GSK-3 beta inhibitor LiCl prevented hypoxia-induced GCM1 degradation. Our study identifies a molecular basis for the disrupted GCM1 transcription network in preeclampsia and provides a potential avenue for therapeutic intervention.	[Liang, Ching-Yeu; Chou, Chih-Chine; Chen, Hungwen] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Chiang, Meng-Hsiu; Liang, Feng-Yu; Chang, Ching-Wen; Wang, Liang-Jie; Lin, Fang-Yu; Chen, Hungwen] Natl Taiwan Univ, Grad Inst Biochem Sci, Taipei 106, Taiwan; [Chen, Chie-Pein] Mackay Mem Hosp, Div High Risk Pregnancy, Taipei 104, Taiwan; [Cheong, Mei-Leng] Cathay Gen Hosp, Dept Obstet & Gynecol, Taipei 106, Taiwan	Academia Sinica - Taiwan; National Taiwan University; Mackay Memorial Hospital; Cathay General Hospital	Chen, HW (corresponding author), Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan.	hwchen@gate.sinica.edu.tw	Chang, Ching-Wen/N-7867-2018; CHEN, CHEN/HDM-6657-2022	Chang, Ching-Wen/0000-0002-5693-3809; 	National Science Council [96-2311-B-001-034]; Academia Sinica, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This work was supported by National Science Council Grant 96-2311-B-001-034 (to H. C.) and a grant from Academia Sinica, Taiwan (to H. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adelman DM, 2000, GENE DEV, V14, P3191, DOI 10.1101/gad.853700; Alvarez-Tejado M, 2002, J BIOL CHEM, V277, P13508, DOI 10.1074/jbc.M200017200; Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; Beitner-Johnson D, 2001, CELL SIGNAL, V13, P23, DOI 10.1016/S0898-6568(00)00128-5; BENIRSCHKE K, 2001, PATHOLOGY HUMAN PLAC, P134; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Chang CW, 2005, MOL CELL BIOL, V25, P8401, DOI 10.1128/MCB.25.19.8401-8414.2005; Chang M, 2008, BIOL REPROD, V78, P841, DOI 10.1095/biolreprod.107.065599; Chen CP, 2008, BIOL REPROD, V79, P815, DOI 10.1095/biolreprod.108.069765; Chen CP, 2006, BJOG-INT J OBSTET GY, V113, P152, DOI 10.1111/j.1471-0528.2005.00843.x; Chen CP, 2004, PLACENTA, V25, P413, DOI 10.1016/j.placenta.2003.10.014; Chen EY, 2001, CANCER RES, V61, P2429; Chiang MH, 2008, BIOL REPROD, V79, P914, DOI 10.1095/biolreprod.108.071407; Cho JY, 2005, MOL ENDOCRINOL, V19, P1191, DOI 10.1210/me.2004-0162; Dahl KDC, 2005, MOL CELL BIOL, V25, P10479, DOI 10.1128/MCB.25.23.10479-10491.2005; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Ilekis JV, 2007, REPROD SCI, V14, P508, DOI 10.1177/1933719107306232; Kanasaki K, 2008, NATURE, V453, P1117, DOI 10.1038/nature06951; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Knerr I, 2005, FEBS LETT, V579, P3991, DOI 10.1016/j.febslet.2005.06.029; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Li H, 2005, PLACENTA, V26, P210, DOI 10.1016/j.placenta.2004.05.004; Maltepe E, 2005, DEVELOPMENT, V132, P3393, DOI 10.1242/dev.01923; Mangeney M, 2007, P NATL ACAD SCI USA, V104, P20534, DOI 10.1073/pnas.0707873105; Maynard S, 2008, ANNU REV MED, V59, P61, DOI 10.1146/annurev.med.59.110106.214058; MOORE STA, 2007, AM J OBSTET GYNECOL, V197; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Munaut C, 2008, HUM REPROD, V23, P1407, DOI 10.1093/humrep/den114; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Schreiber J, 2000, MOL CELL BIOL, V20, P2466, DOI 10.1128/MCB.20.7.2466-2474.2000; Soleymanlou N, 2005, J CLIN ENDOCR METAB, V90, P4299, DOI 10.1210/jc.2005-0078; Stoner M, 2002, MOL ENDOCRINOL, V16, P2231, DOI 10.1210/me.2001-0347; Torry DS, 1998, AM J OBSTET GYNECOL, V179, P1539, DOI 10.1016/S0002-9378(98)70021-3; Wikstom AK, 2007, OBSTET GYNECOL, V109, P1368, DOI 10.1097/01.AOG.0000264552.85436.a1; Wulff C, 2003, REPRODUCTION, V126, P569, DOI 10.1530/rep.0.1260569; Yamada K, 1999, J BIOL CHEM, V274, P32279, DOI 10.1074/jbc.274.45.32279; Yang CS, 2005, J BIOL CHEM, V280, P10083, DOI 10.1074/jbc.M413986200; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200; Yung HW, 2008, AM J PATHOL, V173, P451, DOI 10.2353/ajpath.2008.071193; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856; Zhou Y, 2003, DEV BIOL, V263, P114, DOI 10.1016/S0012-1606(03)00449-4; Zhou Y, 2002, AM J PATHOL, V160, P1405, DOI 10.1016/S0002-9440(10)62567-9	43	49	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17411	17419		10.1074/jbc.M109.016170	http://dx.doi.org/10.1074/jbc.M109.016170			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19416964	Green Published, hybrid			2022-12-25	WOS:000267202500007
J	Iino, R; Hasegawa, R; Tabata, KV; Noji, H				Iino, Ryota; Hasegawa, Rie; Tabata, Kazuhito V.; Noji, Hiroyuki			Mechanism of Inhibition by C-terminal alpha-Helices of the epsilon Subunit of Escherichia coli FoF1-ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED ATP SYNTHESIS; ROTARY MOTOR; THERMOPHILIC F-1-ATPASE; CONFORMATIONAL-CHANGES; ENDOGENOUS INHIBITOR; CATALYTIC SUBUNITS; MOLECULAR MACHINE; F1F0-ATP SYNTHASE; CRYSTAL-STRUCTURE; H+/ATP RATIO	The epsilon subunit of bacterial FoF1-ATP synthase (FoF1), a rotary motor protein, is known to inhibit the ATP hydrolysis reaction of this enzyme. The inhibitory effect is modulated by the conformation of the C-terminal alpha-helices of epsilon, and the "extended" but not "hairpin-folded" state is responsible for inhibition. Although the inhibition of ATP hydrolysis by the C-terminal domain of epsilon has been extensively studied, the effect on ATP synthesis is not fully understood. In this study, we generated an Escherichia coli FoF1 (EFoF1) mutant in which the epsilon subunit lacked the C-terminal domain (FoF1 epsilon Delta C), and ATP synthesis driven by acid-base transition (Delta pH) and the K+-valinomycin diffusion potential (Delta Psi) was compared in detail with that of the wild-type enzyme (FoF1 epsilon WT). The turnover numbers (k(cat)) of FoF1 epsilon WT were severalfold lower than those of FoF1 epsilon Delta C.FoF1 epsilon WT showed higher Michaelis constants (K-m). The dependence of the activities of FoF1 epsilon WT and FoF1 epsilon Delta C on various combinations of Delta pH and Delta Psi was similar, suggesting that the rate-limiting step in ATP synthesis was unaltered by the C-terminal domain of epsilon. Solubilized FoF1 epsilon WT also showed lower k(cat) and higher K-m values for ATP hydrolysis than the corresponding values of FoF1 epsilon Delta C. These results suggest that the C-terminal domain of the epsilon subunit of EFoF1 slows multiple elementary steps in both the ATP synthesis/hydrolysis reactions by restricting the rotation of the gamma subunit.	[Iino, Ryota; Hasegawa, Rie; Tabata, Kazuhito V.; Noji, Hiroyuki] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	Osaka University	Iino, R (corresponding author), Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan.	iino@sanken.osaka-u.ac.jp; hnoji@sanken.osaka-u.ac.jp	Iino, Ryota/B-7746-2011; 田端, 和仁/GON-3471-2022	Iino, Ryota/0000-0003-0110-5704; 田端, 和仁/0000-0002-0463-1374	Ministry of Education, Culture, Sports, Science and Technology, Japan [18770134, 18074005]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research 18770134 and 18074005 (to R. I. and H. N., respectively) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Aggeler R, 1997, J BIOL CHEM, V272, P19621, DOI 10.1074/jbc.272.31.19621; AGGELER R, 1992, BIOCHEMISTRY-US, V31, P2956, DOI 10.1021/bi00126a016; Ariga T, 2007, NAT STRUCT MOL BIOL, V14, P841, DOI 10.1038/nsmb1296; BOYER PD, 1973, P NATL ACAD SCI USA, V70, P2837, DOI 10.1073/pnas.70.10.2837; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Bulygin VV, 2004, J BIOL CHEM, V279, P35616, DOI 10.1074/jbc.M405012200; Capaldi RA, 2000, BBA-BIOENERGETICS, V1458, P263, DOI 10.1016/S0005-2728(00)00078-5; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Cipriano DJ, 2006, J BIOL CHEM, V281, P501, DOI 10.1074/jbc.M509986200; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; DUNN SD, 1987, BIOCHEMISTRY-US, V26, P4488, DOI 10.1021/bi00388a047; Feniouk BA, 2006, BBA-BIOENERGETICS, V1757, P326, DOI 10.1016/j.bbabio.2006.03.022; Fischer S, 1999, FEBS LETT, V457, P327, DOI 10.1016/S0014-5793(99)01060-1; FISCHER S, 1994, EUR J BIOCHEM, V225, P167, DOI 10.1111/j.1432-1033.1994.00167.x; Ganti S, 2007, J BIOENERG BIOMEMBR, V39, P99, DOI 10.1007/s10863-006-9066-6; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Hausrath AC, 2001, J BIOL CHEM, V276, P47227, DOI 10.1074/jbc.M107536200; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Iino R, 2005, J BIOENERG BIOMEMBR, V37, P451, DOI 10.1007/s10863-005-9489-5; Iino R, 2005, J BIOL CHEM, V280, P40130, DOI 10.1074/jbc.M506160200; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; Kaim G, 1998, FEBS LETT, V434, P57, DOI 10.1016/S0014-5793(98)00969-7; Kato Y, 1997, J BIOL CHEM, V272, P24906, DOI 10.1074/jbc.272.40.24906; Kato-Yamada Y, 1999, J BIOL CHEM, V274, P33991, DOI 10.1074/jbc.274.48.33991; Kato-Yamada Y, 2000, J BIOL CHEM, V275, P35746, DOI 10.1074/jbc.M006575200; Kinosita K, 2004, ANNU REV BIOPH BIOM, V33, P245, DOI 10.1146/annurev.biophys.33.110502.132716; Masaike T, 2006, BIOCHEM BIOPH RES CO, V342, P800, DOI 10.1016/j.bbrc.2006.02.017; Masaike T, 2008, NAT STRUCT MOL BIOL, V15, P1326, DOI 10.1038/nsmb.1510; MENDELHARTVIG J, 1991, BIOCHEMISTRY-US, V30, P10987, DOI 10.1021/bi00109a025; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Nakanishi-Matsui M, 2006, J BIOL CHEM, V281, P4126, DOI 10.1074/jbc.M510090200; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Okuno D, 2008, P NATL ACAD SCI USA, V105, P20722, DOI 10.1073/pnas.0805828106; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; Schulenberg B, 1999, J BIOL CHEM, V274, P28351, DOI 10.1074/jbc.274.40.28351; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; STERNWEIS PC, 1980, BIOCHEMISTRY-US, V19, P526, DOI 10.1021/bi00544a021; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Toei M, 2007, P NATL ACAD SCI USA, V104, P20256, DOI 10.1073/pnas.0706914105; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; Turina P, 2003, EMBO J, V22, P418, DOI 10.1093/emboj/cdg073; Uhlin U, 1997, STRUCTURE, V5, P1219, DOI 10.1016/S0969-2126(97)00272-4; Vik SB, 2000, J BIOENERG BIOMEMBR, V32, P485, DOI 10.1023/A:1005664908066; Watanabe R, 2008, EMBO REP, V9, P84, DOI 10.1038/sj.embor.7401135; Weber J, 1999, J BIOL CHEM, V274, P19124, DOI 10.1074/jbc.274.27.19124; WILKENS S, 1995, NAT STRUCT BIOL, V2, P961, DOI 10.1038/nsb1195-961; Wilkens S, 1998, J BIOL CHEM, V273, P26645, DOI 10.1074/jbc.273.41.26645; Xiong H, 1998, BIOCHEMISTRY-US, V37, P16423, DOI 10.1021/bi981522i; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Zimmermann B, 2005, EMBO J, V24, P2053, DOI 10.1038/sj.emboj.7600682	55	65	65	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17457	17464		10.1074/jbc.M109.003798	http://dx.doi.org/10.1074/jbc.M109.003798			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19411254	Green Published, hybrid			2022-12-25	WOS:000267202500012
J	Li, HZ; Liu, GD; Yu, JK; Cao, WG; Lobo, VG; Xie, JY				Li, Hongzhao; Liu, Guodong; Yu, Jiankun; Cao, Wenguang; Lobo, Vincent G.; Xie, Jiuyong			In Vivo Selection of Kinase-responsive RNA Elements Controlling Alternative Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; TRACT-BINDING PROTEIN; CATALYTIC SUBUNIT; SEQUENCE MOTIFS; PHOSPHORYLATION; IDENTIFICATION; EXPRESSION; ENHANCERS; CASCADE; EXON	Alternative pre-mRNA splicing is often controlled by cell signals, for example, those activating the cAMP-dependent protein kinase (PKA) or the Ca2+/calmodulin-dependent protein kinase IV (CaMKIV). We have shown that CaMKIV regulates alternative splicing through short CA repeats and hnRNP L. Here we use a splicing reporter that shows PKA/CaMKIV promotion of exon inclusion to select from exons containing random 13-nt sequences for RNA elements responsive to the kinases in cultured cells. This selection not only identified both PKA- and CaMKIV-responsive elements that are similar to the CaMKIV-responsive RNA element 1 (CaRRE1) or CA repeats, but also A-rich elements not previously known to respond to these kinases. Consistently, hnRNP L is identified as a factor binding the CA-rich elements. Analyses of the motifs in the highly responsive elements indicate that they are indeed critical for the kinase effect and are enriched in alternative exons. Interestingly, a CAAAAAA motif is sufficient for the PKA/CaMKIV-regulated splicing of the exon 16 of the CaMK kinase beta 1 (CaMKK2) transcripts, implying a role of this motif in signaling cross-talk or feedback regulation between these kinases through alternative splicing. Therefore, these experiments identified a group of RNA elements responsive to PKA and CaMKIV from in vivo selection. This also provides an approach for selecting RNA elements similarly responsive to other cell signals controlling alternative splicing.	[Li, Hongzhao; Liu, Guodong; Yu, Jiankun; Cao, Wenguang; Lobo, Vincent G.; Xie, Jiuyong] Univ Manitoba, Fac Med, Dept Physiol, Winnipeg, MB R3E 0J9, Canada	University of Manitoba	Xie, JY (corresponding author), 439 BMSB,745 Bannatyne Ave, Winnipeg, MB R3E 0J9, Canada.	xiej@cc.umanitoba.ca	Xie, Jiuyong/D-2899-2013	Xie, Jiuyong/0000-0003-2909-1033; Yu, Jiankun/0000-0001-9916-1012	Canadian Institutes of Health Research (CIHR) [MOP 68919]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (CIHR, MOP 68919) (to J. X.).	An P, 2007, PLOS BIOL, V5, P263, DOI 10.1371/journal.pbio.0050036; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Berke JD, 2001, NEURON, V32, P277, DOI 10.1016/S0896-6273(01)00465-2; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BORTFELDT R, 2007, MATH MODELING BIOL S, V1, P337; Chatila T, 1996, J BIOL CHEM, V271, P21542, DOI 10.1074/jbc.271.35.21542; Coulter LR, 1997, MOL CELL BIOL, V17, P2143, DOI 10.1128/MCB.17.4.2143; Davare MA, 2004, J BIOL CHEM, V279, P52191, DOI 10.1074/jbc.M409873200; DOMINSKI Z, 1991, MOL CELL BIOL, V11, P6075, DOI 10.1128/MCB.11.12.6075; Dunster K, 2005, CLIN EXP IMMUNOL, V140, P556, DOI 10.1111/j.1365-2249.2005.02774.x; Feng Y, 2008, NAT STRUCT MOL BIOL, V15, P1040, DOI 10.1038/nsmb.1485; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Hai Y, 2008, NUCLEIC ACIDS RES, V36, P3320, DOI 10.1093/nar/gkn207; Holste D, 2006, NUCLEIC ACIDS RES, V34, pD56, DOI 10.1093/nar/gkj048; Hsu LS, 2001, J BIOL CHEM, V276, P31113, DOI 10.1074/jbc.M011720200; Kataoka Naoyuki, 2008, V488, P357, DOI 10.1007/978-1-60327-475-3_23; Kim N, 2007, NUCLEIC ACIDS RES, V35, pD93, DOI 10.1093/nar/gkl884; Kitani T, 2001, J BIOCHEM, V130, P515, DOI 10.1093/oxfordjournals.jbchem.a003014; Konig H, 1998, EMBO J, V17, P2904, DOI 10.1093/emboj/17.10.2904; Kuppers E, 2000, MOL BRAIN RES, V81, P19, DOI 10.1016/S0169-328X(00)00156-X; Kvissel AK, 2007, EXP CELL RES, V313, P2795, DOI 10.1016/j.yexcr.2007.05.014; Lee JA, 2007, PLOS BIOL, V5, P281, DOI 10.1371/journal.pbio.0050040; Ma SM, 2007, BBA-MOL CELL RES, V1773, P912, DOI 10.1016/j.bbamcr.2007.02.006; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Matsushita M, 1999, J BIOL CHEM, V274, P10086, DOI 10.1074/jbc.274.15.10086; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Mckee AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r159; Modafferi EF, 1997, MOL CELL BIOL, V17, P6537, DOI 10.1128/MCB.17.11.6537; Okuno S, 2001, J BIOCHEM, V130, P503, DOI 10.1093/oxfordjournals.jbchem.a003013; PINOLROMA S, 1989, J CELL BIOL, V109, P2575, DOI 10.1083/jcb.109.6.2575; Rothrock C, 2003, MOL CELL, V12, P1317, DOI 10.1016/S1097-2765(03)00434-9; Sgambato V, 2003, J NEUROCHEM, V86, P153, DOI 10.1046/j.1471-4159.2003.01816.x; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Stickeler E, 2001, EMBO J, V20, P3821, DOI 10.1093/emboj/20.14.3821; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Wayman GA, 1997, J BIOL CHEM, V272, P16073, DOI 10.1074/jbc.272.26.16073; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Xie JY, 2008, BBA-GENE REGUL MECH, V1779, P438, DOI 10.1016/j.bbagrm.2008.01.003; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Xie JY, 2005, RNA, V11, P1825, DOI 10.1261/rna.2171205; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Yu JK, 2009, J BIOL CHEM, V284, P1505, DOI 10.1074/jbc.M805113200; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005	50	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16191	16201		10.1074/jbc.M900393200	http://dx.doi.org/10.1074/jbc.M900393200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19386606	Green Published, hybrid			2022-12-25	WOS:000266730900016
J	Guidicelli, G; Chaigne-Delalande, B; Dilhuydy, MS; Pinson, B; Mahfouf, W; Pasquet, JM; Mahon, FX; Pourquier, P; Moreau, JF; Legembre, P				Guidicelli, Gwendaline; Chaigne-Delalande, Benjamin; Dilhuydy, Marie-Sarah; Pinson, Benoit; Mahfouf, Walid; Pasquet, Jean-Max; Mahon, Francois-Xavier; Pourquier, Philippe; Moreau, Jean-Francois; Legembre, Patrick			The Necrotic Signal Induced by Mycophenolic Acid Overcomes Apoptosis-Resistance in Tumor Cells	PLOS ONE			English	Article								Background: The amount of inosine monophosphate dehydrogenase (IMPDH), a pivotal enzyme for the biosynthesis of the guanosine tri-phosphate (GTP), is frequently increased in tumor cells. The anti-viral agent ribavirin and the immunosuppressant mycophenolic acid (MPA) are potent inhibitors of IMPDH. We recently showed that IMPDH inhibition led to a necrotic signal requiring the activation of Cdc42. Methodology/Principal Findings: Herein, we strengthened the essential role played by this small GTPase in the necrotic signal by silencing Cdc42 and by the ectopic expression of a constitutive active mutant of Cdc42. Since resistance to apoptosis is an essential step for the tumorigenesis process, we next examined the effect of the MPA-mediated necrotic signal on different tumor cells demonstrating various mechanisms of resistance to apoptosis (Bcl2-, HSP70-, Lyn-, BCR-ABL-overexpressing cells). All tested cells remained sensitive to MPA-mediated necrotic signal. Furthermore, inhibition of IMPDH activity in Chronic Lymphocytic Leukemia cells was significantly more efficient at eliminating malignant cells than apoptotic inducers. Conclusions/Significance: These findings indicate that necrosis and apoptosis are split signals that share few if any common hub of signaling. In addition, the necrotic signaling pathway induced by depletion of the cellular amount of GTP/GDP would be of great interest to eliminate apoptotic-resistant tumor cells.			Guidicelli, G (corresponding author), CNRS, UMR 5164, Bordeaux, France.	patrick.legembre@inserm.fr	PASQUET, JEAN-MAX/I-9702-2014; PASQUET, JEAN-MAX/T-4906-2019; Pourquier, Philippe/O-8030-2018; Legembre, Patrick/U-1882-2019; legembre, patrick/L-3475-2016	PASQUET, JEAN-MAX/0000-0002-1345-3776; Pourquier, Philippe/0000-0001-5326-3005; Legembre, Patrick/0000-0001-6649-8049; legembre, patrick/0000-0001-6649-8049; Pinson, Benoit/0000-0003-2936-9058				Ahn JH, 1999, MOL CELLS, V9, P200; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Beneteau M, 2008, MOL CANCER RES, V6, P604, DOI 10.1158/1541-7786.MCR-07-0331; Beneteau M, 2007, CANCER RES, V67, P108, DOI 10.1158/0008-5472.CAN-06-1415; Buell JF, 2005, TRANSPLANTATION, V80, pS254, DOI 10.1097/01.tp.0000186382.81130.ba; BUGG BY, 1991, P NATL ACAD SCI USA, V88, P7654, DOI 10.1073/pnas.88.17.7654; Chaigne-Delalande B, 2008, J IMMUNOL, V181, P7630, DOI 10.4049/jimmunol.181.11.7630; Chen LQ, 2007, CURR OPIN DRUG DISC, V10, P403; DANCKER P, 1975, BIOCHIM BIOPHYS ACTA, V400, P407, DOI 10.1016/0005-2795(75)90196-8; Danilov AV, 2006, CURR MOL MED, V6, P665, DOI 10.2174/156652406778195008; Dyer MJS, 2007, J CLIN ONCOL, V25, P4505, DOI 10.1200/JCO.2007.13.1011; Friesen C, 1996, NAT MED, V2, P574, DOI 10.1038/nm0596-574; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Haessler J, 2007, CLIN CANCER RES, V13, P7073, DOI 10.1158/1078-0432.CCR-07-0527; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; Henson ES, 2008, LEUKEMIA LYMPHOMA, V49, P27, DOI 10.1080/10428190701713655; Holland GN, 2000, OCUL IMMUNOL INFLAMM, V8, P1, DOI 10.1076/0927-3948(200003)8:1;1-S;FT001; Inoue S, 2004, CELL DEATH DIFFER, V11, pS193, DOI 10.1038/sj.cdd.4401535; Koehl GE, 2007, TRANSPLANTATION, V83, P607, DOI 10.1097/01.tp.0000253756.69243.65; Legembre P, 2005, MOL CELL BIOL, V25, P6811, DOI 10.1128/MCB.25.15.6811-6820.2005; Legembre P, 2002, CELL DEATH DIFFER, V9, P329, DOI 10.1038/sj.cdd.4400960; Luciano F, 2003, FASEB J, V17, P711, DOI 10.1096/fj.02-0716fje; Mahon FX, 2008, CANCER RES, V68, P9809, DOI 10.1158/0008-5472.CAN-08-1008; Mateo W, 2002, BLOOD, V100, P2882, DOI 10.1182/blood-2001-12-0217; MCGAHON A, 1994, BLOOD, V83, P1179, DOI 10.1182/blood.V83.5.1179.bloodjournal8351179; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; NAGAI M, 1991, CANCER RES, V51, P3886; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; Pedersen IM, 2004, LEUKEMIA LYMPHOMA, V45, P2365, DOI 10.1080/10428190412331272703; Pelish HE, 2006, NAT CHEM BIOL, V2, P221, DOI 10.1038/nchembio0406-221b; Pocaly M, 2007, LEUKEMIA, V21, P93, DOI 10.1038/sj.leu.2404463; Robson R, 2005, AM J TRANSPLANT, V5, P2954, DOI 10.1111/j.1600-6143.2005.01125.x; Sperandio S, 2004, CELL DEATH DIFFER, V11, P1066, DOI 10.1038/sj.cdd.4401465; Thompson JE, 2004, J CLIN ONCOL, V22, P4217, DOI 10.1200/jco.2004.01.103; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; VELASQUEZ WS, 1994, J CLIN ONCOL, V12, P1169, DOI 10.1200/JCO.1994.12.6.1169	40	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2009	4	5							e5493	10.1371/journal.pone.0005493	http://dx.doi.org/10.1371/journal.pone.0005493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VY	19430526	Green Published, gold, Green Submitted			2022-12-25	WOS:000266009700002
J	Shim, E; Galvani, AP				Shim, Eunha; Galvani, Alison P.			Evolutionary Repercussions of Avian Culling on Host Resistance and Influenza Virulence	PLOS ONE			English	Article							A H5N1; HUMAN-DISEASE; GENETICS; MALARIA; VIRUS; EMERGENCE; MORTALITY; THAILAND; PROTEIN; MX	Background: Keeping pandemic influenza at bay is a global health priority. Of particular concern is the continued spread ofthe influenza subtype H5N1 in avian populations and the increasing frequency of transmission to humans. To decrease this threat, mass culling is the principal strategy for eradicating influenza in avian populations. Although culling has a crucial short-term epidemiological benefit, evolutionary repercussions on reservoir hosts and on the viral population have not been considered. Methods and Findings: To explore the epidemiological and evolutionary repercussions of mass avian culling, we combine population genetics and epidemiological influenza dynamics in a mathematical model parameterized by clinical, epidemiological, and poultry data. We model the virulence level of influenza and the selection on a dominant allele that confers resistance against influenza [ 1,2] in a poultry population. Our findings indicate that culling impedes the evolution of avian host resistance against influenza. On the pathogen side of the coevolutionary race between pathogen and host, culling selects for heightened virulence and transmissibility of influenza. Conclusions: Mass culling achieves a short-term benefit at the expense of long-term detriments: a more genetically susceptible host population, ultimately greater mortality, and elevated influenza virulence.			Shim, E (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA.	eunha.shim@yale.edu						Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; ANDERSON R M, 1991; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Bacon PA, 2005, NEW ENGL J MED, V352, P330, DOI 10.1056/NEJMp048338; BARD CW, 1998, AVIAN INFLUENZA FORE, P73; BEAN WJ, 1985, J VIROL, V54, P151, DOI 10.1128/JVI.54.1.151-160.1985; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; BULL JJ, 1994, EVOLUTION, V48, P1423, DOI 10.1111/j.1558-5646.1994.tb02185.x; Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; *CHICK FARM NOV SO, 2002, IS CHICK RAIS; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; DOLAN RB, 1987, PARASITOL TODAY, V3, P137, DOI 10.1016/0169-4758(87)90197-9; DWYER G, 1990, ECOL MONOGR, V60, P423, DOI 10.2307/1943014; Ellis TM, 2004, AVIAN PATHOL, V33, P492, DOI 10.1080/03079450400003601; *FAO, 2004, FAO WORKSH SOC EC IM; *FAO, 2005, AV INFL DIS CARD; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Frodsham AJ, 2004, HUM MOL GENET, V13, pR187, DOI 10.1093/hmg/ddh225; Galvani AP, 2003, TRENDS ECOL EVOL, V18, P132, DOI 10.1016/S0169-5347(02)00050-2; Galvani AP, 2003, P NATL ACAD SCI USA, V100, P15276, DOI 10.1073/pnas.2435085100; Gandon S, 2001, NATURE, V414, P751, DOI 10.1038/414751a; GARBER EA, 1991, VIROLOGY, V180, P754, DOI 10.1016/0042-6822(91)90088-S; Garcia M, 1996, J GEN VIROL, V77, P1493, DOI 10.1099/0022-1317-77-7-1493; GILCHRIST MA, 2005, THEORETICAL POPULATI, V69, P145; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; HORIMOTO T, 1994, J VIROL, V68, P3120, DOI 10.1128/JVI.68.5.3120-3128.1994; Ito T, 2001, J VIROL, V75, P4439, DOI 10.1128/JVI.75.9.4439-4443.2001; Ko JH, 2004, ANIM GENET, V35, P119, DOI 10.1111/j.1365-2052.2004.01096.x; Landes M., 2004, INDIAS POULTRY SECTO; LEVIN S, 1981, AM NAT, V117, P308, DOI 10.1086/283708; Lipsitch M, 1997, TRENDS MICROBIOL, V5, P31, DOI 10.1016/S0966-842X(97)81772-6; Mackinnon MJ, 2004, PHILOS T R SOC B, V359, P965, DOI 10.1098/rstb.2003.1414; Mackinnon MJ, 1999, EVOLUTION, V53, P689, DOI [10.2307/2640710, 10.1111/j.1558-5646.1999.tb05364.x]; MARSHALL I. D., 1958, JOUR HYGIENE, V56, P288; Matthews L, 1999, P ROY SOC B-BIOL SCI, V266, P1085, DOI 10.1098/rspb.1999.0747; MATTHEWS L, 2003, P ROY SOC LOND B BIO, V270, P1679; Novembre J, 2005, PLOS BIOL, V3, P1954, DOI 10.1371/journal.pbio.0030339; *OFF INT EP, 2005, DIS INF PUBL 18 MONT; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Porco TC, 2005, J THEOR BIOL, V233, P91, DOI 10.1016/j.jtbi.2004.09.009; Qiao CL, 2009, ANTIVIR RES, V81, P234, DOI 10.1016/j.antiviral.2008.12.002; *SASK AGR FOOD, 2005, EGG PROD CHICK; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; STAEHELI P, 1986, J VIROL, V58, P967, DOI 10.1128/JVI.58.3.967-969.1986; Tiensin T, 2005, EMERG INFECT DIS, V11, P1664, DOI 10.3201/eid1111.050608; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; Webster RG, 2004, REV SCI TECH OIE, V23, P453, DOI 10.20506/rst.23.2.1493; *WHO, 2007, CUM NUMB CONF HUM CA; Williams PD, 2001, P ROY SOC B-BIOL SCI, V268, P2331, DOI 10.1098/rspb.2001.1795; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zeitlin Gary Adam, 2005, Curr Infect Dis Rep, V7, P193, DOI 10.1007/s11908-005-0034-9	54	27	27	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2009	4	5							e5503	10.1371/journal.pone.0005503	http://dx.doi.org/10.1371/journal.pone.0005503			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VY	19430529	Green Published, gold, Green Submitted			2022-12-25	WOS:000266009700008
J	Sheth, BR; Nguyen, N; Janvelyan, D				Sheth, Bhavin R.; Nguyen, Ngan; Janvelyan, Davit			Does Sleep Really Influence Face Recognition Memory?	PLOS ONE			English	Article							DECLARATIVE MEMORY; CONSOLIDATION; AREA	Mounting evidence implicates sleep in the consolidation of various kinds of memories. We investigated the effect of sleep on memory for face identity, a declarative form of memory that is indispensable for nearly all social interaction. In the acquisition phase, observers viewed faces that they were required to remember over a variable retention period (0-36 hours). In the test phase, observers viewed intermixed old and new faces and judged seeing each before. Participants were classified according to acquisition and test times into seven groups. Memory strength (d') and response bias (c) were evaluated. Substantial time spent awake (12 hours or more) during the retention period impaired face recognition memory evaluated at test, whereas sleep per se during the retention period did little to enhance the memory. Wakefulness during retention also led to a tightening of the decision criterion. Our findings suggest that sleep passively and transiently shelters face recognition memory from waking interference (exposure) but does not actively aid in its long-term consolidation.			Sheth, BR (corresponding author), Univ Houston, Dept Elect & Comp Engn, Houston, TX 77004 USA.	brsheth@uh.edu						CRICK F, 1983, NATURE, V304, P111, DOI 10.1038/304111a0; Ellenbogen JM, 2006, CURR BIOL, V16, P1290, DOI 10.1016/j.cub.2006.05.024; Ellenbogen JM, 2006, CURR OPIN NEUROBIOL, V16, P716, DOI 10.1016/j.conb.2006.10.006; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Gais S, 2004, LEARN MEMORY, V11, P679, DOI 10.1101/lm.80504; Hancock PJB, 2000, TRENDS COGN SCI, V4, P330, DOI 10.1016/S1364-6613(00)01519-9; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; HODDES E, 1972, PSYCHOPHYSIOLOGY, V9, P150; Jenkins JG, 1924, AM J PSYCHOL, V35, P605, DOI 10.2307/1414040; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Kuriyama K, 2004, LEARN MEMORY, V11, P705, DOI 10.1101/lm.76304; Mednick S, 2003, NAT NEUROSCI, V6, P697, DOI 10.1038/nn1078; Sheth BR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003190; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 1998, J COGNITIVE NEUROSCI, V10, P77; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Wagner U, 2007, NEUROBIOL LEARN MEM, V87, P679, DOI 10.1016/j.nlm.2007.01.004; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Walker MP, 2004, SLEEP, V27, P406; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2003, SLEEP, V26, pA441; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555	28	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5496	10.1371/journal.pone.0005496	http://dx.doi.org/10.1371/journal.pone.0005496			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	443TN	19424440	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000265933800023
J	Kaur, D; Pham, H; Larrouy-Maumus, G; Riviere, M; Vissa, V; Guerin, ME; Puzo, G; Brennan, PJ; Jackson, M				Kaur, Devinder; Pham, Ha; Larrouy-Maumus, Gerald; Riviere, Michel; Vissa, Varalakshmi; Guerin, Marcelo E.; Puzo, Germain; Brennan, Patrick J.; Jackson, Mary			Initiation of Methylglucose Lipopolysaccharide Biosynthesis in Mycobacteria	PLOS ONE			English	Article							TUBERCULOSIS; POLYSACCHARIDE; GROWTH	Background: Mycobacteria produce two unique families of cytoplasmic polymethylated polysaccharides - the methylglucose lipopolysaccharides ( MGLPs) and the methylmannose polysaccharides ( MMPs) - the physiological functions of which are still poorly defined. Towards defining the roles of these polysaccharides in mycobacterial physiology, we generated knock-out mutations of genes in their putative biosynthetic pathways. Methodology/Principal Findings: We report here on the characterization of the Rv1208 protein of Mycobacterium tuberculosis and its ortholog in Mycobacterium smegmatis (MSMEG_5084) as the enzymes responsible for the transfer of the first glucose residue of MGLPs. Disruption of MSMEG_5084 in M. smegmatis resulted in a dramatic decrease in MGLP synthesis directly attributable to the almost complete abolition of glucosyl-3-phosphoglycerate synthase activity in this strain. Synthesis of MGLPs in the mutant was restored upon complementation with wild-type copies of the Rv1208 gene from M. tuberculosis or MSMEG_5084 from M. smegmatis. Conclusions/Significance: This is the first evidence linking Rv1208 to MGLP biosynthesis. Thus, the first step in the initiation of MGLP biosynthesis in mycobacteria has been defined, and subsequent steps can be inferred.			Kaur, D (corresponding author), Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Mary.Jackson@colostate.edu	Guerin, Marcelo M/N-7245-2016; Jackson, Mary/D-5345-2017	Guerin, Marcelo M/0000-0001-9524-3184; Jackson, Mary/0000-0002-9212-0258; Larrouy-Maumus, Gerald/0000-0001-6614-8698	NIAID NIH HHS [R01 AI064798] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064798] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Pereira PJB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003748; BLOCH K, 1977, ADV ENZYMOLOGY, P1; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Empadinhas N, 2008, FEMS MICROBIOL LETT, V280, P195, DOI 10.1111/j.1574-6968.2007.01064.x; FORSBERG LS, 1982, J BIOL CHEM, V257, P3555; Fulton Z, 2008, J BIOL CHEM, V283, P27881, DOI 10.1074/jbc.M801853200; Gest P, 2008, ACTA CRYSTALLOGR F, V64, P1121, DOI 10.1107/S1744309108032892; GRAY GR, 1971, J BIOL CHEM, V246, P6835; Jackson M, 2001, Methods Mol Med, V54, P59, DOI 10.1385/1-59259-147-7:059; Jackson M, 2009, J BIOL CHEM, V284, P1949, DOI 10.1074/jbc.R800047200; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; LEE YC, 1966, J BIOL CHEM, V241, P1899; LEE YC, 1964, J BIOL CHEM, V239; MAITRA SK, 1977, J BIOL CHEM, V252, P2459; MALONEY DH, 1980, J BACTERIOL, V141, P1217, DOI 10.1128/JB.141.3.1217-1221.1980; Sambou T, 2008, MOL MICROBIOL, V70, P762, DOI 10.1111/j.1365-2958.2008.06445.x; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Stadthagen G, 2007, J BIOL CHEM, V282, P27270, DOI 10.1074/jbc.M702676200; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; YABUSAKI KK, 1979, J BIOL CHEM, V254, P2314	20	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2009	4	5							e5447	10.1371/journal.pone.0005447	http://dx.doi.org/10.1371/journal.pone.0005447			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JH	19421329	Green Submitted, Green Published, gold			2022-12-25	WOS:000265837000001
J	Wang, ZH; Fan, ZC; Williamson, SM; Qin, HM				Wang, Zhaohui; Fan, Zhen-Chuan; Williamson, Shana M.; Qin, Hongmin			Intraflagellar Transport (IFT) Protein IFT25 Is a Phosphoprotein Component of IFT Complex B and Physically Interacts with IFT27 in Chlamydomonas	PLOS ONE			English	Article								Background: Intraflagellar transport (IFT) is the bidirectional movement of IFT particles between the cell body and the distal tip of a flagellum. Organized into complexes A and B, IFT particles are composed of at least 18 proteins. The function of IFT proteins in flagellar assembly has been extensively investigated. However, much less is known about the molecular mechanism of how IFT is regulated. Methodology/Principal Findings: We herein report the identification of a novel IFT particle protein, IFT25, in Chlamydomonas. Dephosphorylation assay revealed that IFT25 is a phosphoprotein. Biochemical analysis of temperature sensitive IFT mutants indicated that IFT25 is an IFT complex B subunit. In vitro binding assay confirmed that IFT25 binds to IFT27, a Rab-like small GTPase component of the IFT complex B. Immunofluorescence staining showed that IFT25 has a punctuate flagellar distribution as expected for an IFT protein, but displays a unique distribution pattern at the flagellar base. IFT25 co-localizes with IFT27 at the distal-most portion of basal bodies, probably the transition zones, and concentrates in the basal body region by partially overlapping with other IFT complex B subunits, such as IFT46. Sucrose density gradient centrifugation analysis demonstrated that, in flagella, the majority of IFT27 and IFT25 including both phosphorylated and non-phosphorylated forms are cosedimented with other complex B subunits in the 16S fractions. In contrast, in cell body, only a fraction of IFT25 and IFT27 is integrated into the preassembled complex B, and IFT25 detected in complex B is preferentially phosphorylated. Conclusion/Significance: IFT25 is a phosphoprotein component of IFT particle complex B. IFT25 directly interacts with IFT27, and these two proteins likely form a subcomplex in vivo. We postulate that the association and disassociation between the subcomplex of IFT25 and IFT27 and complex B might be involved in the regulation of IFT.			Wang, ZH (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	hqin@bio.mail.tamu.edu		Fan, Zhen-Chuan/0000-0003-1712-3413				Ahmed NT, 2008, J CELL BIOL, V183, P313, DOI 10.1083/jcb.200802025; Cole DG, 2003, TRAFFIC, V4, P435, DOI 10.1034/j.1600-0854.2003.t01-1-00103.x; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Dutcher SK, 2002, MOL BIOL CELL, V13, P3859, DOI 10.1091/mbc.E02-04-0205; FOLLIT J, 2009, CELL MOTIL CYTOSKELE; Hou YQ, 2004, MOL BIOL CELL, V15, P4382, DOI 10.1091/mbc.E04-05-0377; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Huang K, 2007, J CELL BIOL, V179, P501, DOI 10.1083/jcb.200704069; Iomini C, 2001, J CELL BIOL, V153, P13, DOI 10.1083/jcb.153.1.13; JOHNSON KA, 1992, J CELL BIOL, V119, P1605, DOI 10.1083/jcb.119.6.1605; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Lucker BF, 2005, J BIOL CHEM, V280, P27688, DOI 10.1074/jbc.M505062200; Marshall WF, 2006, CURR BIOL, V16, pR604, DOI 10.1016/j.cub.2006.07.012; Marshall WF, 2001, J CELL BIOL, V155, P405, DOI 10.1083/jcb.200106141; Miller MS, 2005, MOL BIOL CELL, V16, P3810, DOI 10.1091/mbc.E05-05-0404; Mueller J, 2005, MOL BIOL CELL, V16, P1341, DOI 10.1091/mbc.E04-10-0931; Pan JM, 2005, LAB INVEST, V85, P452, DOI 10.1038/labinvest.3700253; Pan JM, 2005, DEV CELL, V9, P431, DOI 10.1016/j.devcel.2005.07.010; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Pazour GJ, 1998, J CELL BIOL, V141, P979, DOI 10.1083/jcb.141.4.979; Pedersen LB, 2005, CURR BIOL, V15, P262, DOI 10.1016/j.cub.2005.01.037; Perrone CA, 2003, MOL BIOL CELL, V14, P2041, DOI 10.1091/mbc.e02-10-0682; Piperno G, 1998, J CELL BIOL, V143, P1591, DOI 10.1083/jcb.143.6.1591; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; Porter ME, 1999, MOL BIOL CELL, V10, P693, DOI 10.1091/mbc.10.3.693; Qin HM, 2005, CURR BIOL, V15, P1695, DOI 10.1016/j.cub.2005.08.047; Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132; Qin HM, 2001, CURR BIOL, V11, P457, DOI 10.1016/S0960-9822(01)00122-1; Qin HM, 2007, CURR BIOL, V17, P193, DOI 10.1016/j.cub.2006.12.040; Quarmby LM, 2004, INT REV CYTOL, V233, P47, DOI 10.1016/S0074-7696(04)33002-0; Robert A, 2007, J CELL SCI, V120, P628, DOI 10.1242/jcs.03366; Rompolas P, 2007, J CELL SCI, V120, P3653, DOI 10.1242/jcs.012773; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; Scholey JM, 2008, J CELL BIOL, V180, P23, DOI 10.1083/jcb.200709133; Tam LW, 2007, J CELL BIOL, V176, P819, DOI 10.1083/jcb.200610022; Tsao CC, 2008, MOL BIOL CELL, V19, P1450, DOI 10.1091/mbc.E07-05-0403; Tsao CC, 2008, J CELL SCI, V121, P428, DOI 10.1242/jcs.015826; WALTHER Z, 1994, J CELL BIOL, V126, P175, DOI 10.1083/jcb.126.1.175; Wang Q, 2006, CELL, V125, P549, DOI 10.1016/j.cell.2006.02.044; WITMAN GB, 1975, ANN NY ACAD SCI, V253, P178, DOI 10.1111/j.1749-6632.1975.tb19199.x	44	75	82	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5384	10.1371/journal.pone.0005384	http://dx.doi.org/10.1371/journal.pone.0005384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440GG	19412537	Green Published, Green Submitted, gold			2022-12-25	WOS:000265688200003
J	Wang, AL; Lukas, TJ; Yuan, M; Du, N; Handa, JT; Neufeld, AH				Wang, Ai Ling; Lukas, Thomas J.; Yuan, Ming; Du, Nga; Handa, James T.; Neufeld, Arthur H.			Changes in Retinal Pigment Epithelium Related to Cigarette Smoke: Possible Relevance to Smoking as a Risk Factor for Age-Related Macular Degeneration	PLOS ONE			English	Article								Age-related Macular Degeneration (AMD) is a major cause of central vision loss in the elderly and smoking is a primary risk factor associated with the prevalence and incidence of AMD. To better understand the cellular and molecular bases for the association between smoking and AMD, we determined the effects of Benzo(a) Pyrene (B(a) P), a toxic element in cigarette smoke, on cultured retinal pigment epithelia (RPE) and we examined the RPE/choroid from mice exposed to chronic cigarette smoke. We measured: mitochondrial DNA (mtDNA) damage, phagocytic activity, lysosomal enzymes, exosome markers and selected complement pathway components. In the presence of a non-cytotoxic dose of B(a) P, there was extensive mtDNA damage but no nuclear DNA damage. RPE phagocytic activity was not altered but there were increased lysosomal activity, exocytotic activity and complement pathway components. Retinas from mice exposed to cigarette smoke contained markers for mtDNA damage, exosomes and complement pathway components surrounding Bruch's membrane. Markers for these processes are found in drusen from AMD patients. Thus, smoking may cause damage to mtDNA and increased degradative processes in the RPE. These altered cell biological processes in the RPE may contribute to the formation of drusen in individuals who are cigarette smokers and underlie susceptibility to genetic mutations associated with AMD.			Wang, AL (corresponding author), Northwestern Univ, Sch Med, Dept Ophthalmol, Forsythe Lab Invest Aging Retina, Chicago, IL 60611 USA.	a-wang@northwestern.edu			NATIONAL EYE INSTITUTE [R01EY014005, R01EY019904] Funding Source: NIH RePORTER; NEI NIH HHS [EY14005, R01 EY014005, R01 EY019904, R01 EY014005-06A2] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BACKER JM, 1980, SCIENCE, V209, P297, DOI 10.1126/science.6770466; BOULTON M, 1994, BRIT J OPHTHALMOL, V78, P125, DOI 10.1136/bjo.78.2.125; Canter JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002091; Chang YG, 2007, J CELL SCI, V120, P3053, DOI 10.1242/jcs.006361; CHEN H, 2009, INVEST OPHTHALMOL VI; Chen HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002339; Cingle KA, 1996, CURR EYE RES, V15, P433, DOI 10.3109/02713689608995834; CONNEY AH, 1982, CANCER RES, V42, P4875; DING X, 2008, PROG RETIN EYE RES; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Evans JR, 2005, BRIT J OPHTHALMOL, V89, P550, DOI 10.1136/bjo.2004.049726; Finnemann SC, 1999, J EXP MED, V190, P861, DOI 10.1084/jem.190.6.861; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; Fujihara M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003119; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; Kimura K, 2000, AM J OPHTHALMOL, V130, P769, DOI 10.1016/S0002-9394(00)00552-3; Klein R, 2008, ARCH OPHTHALMOL-CHIC, V126, P115, DOI 10.1001/archopht.126.1.115; Milton RC, 2005, OPHTHALMOLOGY, V112, P533, DOI 10.1016/j.ophtha.2004.10.047; Mitchell P, 2002, ARCH OPHTHALMOL-CHIC, V120, P1357, DOI 10.1001/archopht.120.10.1357; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; Patton WP, 2002, EXP EYE RES, V74, P513, DOI 10.1006/exer.2001.1160; Rakoczy PE, 1999, EXP EYE RES, V69, P367, DOI 10.1006/exer.1999.0700; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Verdugo ME, 1997, EXP EYE RES, V65, P231, DOI 10.1006/exer.1997.0325; Wang A.L., 2008, NEUROBIOL AGING; Wang AL, 2008, MOL VIS, V14, P644; WANG AL, 2008, PLOS ONE; Yamada Y, 2008, J NEUROCHEM, V105, P1187, DOI 10.1111/j.1471-4159.2008.05211.x	36	58	61	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5304	10.1371/journal.pone.0005304	http://dx.doi.org/10.1371/journal.pone.0005304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390692	gold, Green Submitted, Green Published			2022-12-25	WOS:000265514400005
J	Bartels, ED; Nielsen, JM; Hellgren, LI; Ploug, T; Nielsen, LB				Bartels, Emil D.; Nielsen, Jan M.; Hellgren, Lars I.; Ploug, Thorkil; Nielsen, Lars B.			Cardiac Expression of Microsomal Triglyceride Transfer Protein Is Increased in Obesity and Serves to Attenuate Cardiac Triglyceride Accumulation	PLOS ONE			English	Article								Obesity causes lipid accumulation in the heart and may lead to lipotoxic heart disease. Traditionally, the size of the cardiac triglyceride pool is thought to reflect the balance between uptake and beta-oxidation of fatty acids. However, triglycerides can also be exported from cardiomyocytes via secretion of apolipoproteinB-containing (apoB) lipoproteins. Lipoprotein formation depends on expression of microsomal triglyceride transfer protein (MTP); the mouse expresses two isoforms of MTP, A and B. Since many aspects of the link between obesity-induced cardiac disease and cardiac lipid metabolism remain unknown, we investigated how cardiac lipoprotein synthesis affects cardiac expression of triglyceride metabolism-controlling genes, insulin sensitivity, and function in obese mice. Heart-specific ablation of MTP-A in mice using Cre-loxP technology impaired upregulation of MTP expression in response to increased fatty acid availability during fasting and fat feeding. This resulted in cardiac triglyceride accumulation but unaffected cardiac insulin-stimulated glucose uptake. Longterm fat-feeding of male C57Bl/6 mice increased cardiac triglycerides, induced cardiac expression of triglyceride metabolism-controlling genes and attenuated heart function. Abolishing cardiac triglyceride accumulation in fat-fed mice by overexpression of an apoB transgene in the heart prevented the induction of triglyceride metabolism-controlling genes and improved heart function. The results suggest that in obesity, the physiological increase of cardiac MTP expression serves to attenuate cardiac triglyceride accumulation albeit without major effects on cardiac insulin sensitivity. Nevertheless, the data suggest that genetically increased lipoprotein secretion prevents development of obesity-induced lipotoxic heart disease.			Bartels, ED (corresponding author), Univ Copenhagen, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark.	larsbo@rh.dk	Bartels, Emil/AAY-3268-2020; Hellgren, Lars/B-5137-2010	Hellgren, Lars/0000-0001-9215-4880; Ploug, Thorkil/0000-0002-5375-6595				Adiels M, 2005, ARTERIOSCL THROM VAS, V25, P1697, DOI 10.1161/01.ATV.0000172689.53992.25; Bamba V, 2007, GASTROENTEROLOGY, V132, P2181, DOI 10.1053/j.gastro.2007.03.056; Bang CA, 2007, AM J PHYSIOL-RENAL, V293, pF1325, DOI 10.1152/ajprenal.00039.2007; Bartels ED, 2009, EUR J CLIN INVEST, V39, P190, DOI 10.1111/j.1365-2362.2009.02086.x; Bartels ED, 2002, DIABETES, V51, P1233, DOI 10.2337/diabetes.51.4.1233; Bjorkegren J, 2001, J BIOL CHEM, V276, P38511, DOI 10.1074/jbc.M106839200; Boren J, 1998, J CLIN INVEST, V101, P1197, DOI 10.1172/JCI1785; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Buchanan J, 2005, ENDOCRINOLOGY, V146, P5341, DOI 10.1210/en.2005-0938; Chess DJ, 2008, CARDIOVASC RES, V79, P269, DOI 10.1093/cvr/cvn074; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Chiu HC, 2005, CIRC RES, V96, P225, DOI 10.1161/01.RES.0000154079.20681.B9; Christoffersen C, 2003, ENDOCRINOLOGY, V144, P3483, DOI 10.1210/en.2003-0242; Dougan SK, 2007, J EXP MED, V204, P533, DOI 10.1084/jem.20062006; Finck BN, 2003, P NATL ACAD SCI USA, V100, P1226, DOI 10.1073/pnas.0336724100; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Georgakopoulos D, 1998, AM J PHYSIOL-HEART C, V274, pH1416, DOI 10.1152/ajpheart.1998.274.4.H1416; GORDON DA, 1994, P NATL ACAD SCI USA, V91, P7628, DOI 10.1073/pnas.91.16.7628; Hammer S, 2008, J CLIN ENDOCR METAB, V93, P497, DOI 10.1210/jc.2007-2015; Hollander MC, 2001, INT J CANCER, V96, P22, DOI 10.1002/1097-0215(20010220)96:1<22::AID-IJC3>3.0.CO;2-K; Jacob S, 1999, DIABETES, V48, P1113, DOI 10.2337/diabetes.48.5.1113; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Koutsari C, 2006, J LIPID RES, V47, P1643, DOI 10.1194/jlr.R600011-JLR200; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kurtz DM, 1998, P NATL ACAD SCI USA, V95, P15592, DOI 10.1073/pnas.95.26.15592; Ledmyr H, 2004, CIRCULATION, V109, P2279, DOI 10.1161/01.CIR.0000130070.96758.7b; Lee Y, 2004, P NATL ACAD SCI USA, V101, P13624, DOI 10.1073/pnas.0405499101; Lindegaard MLS, 2008, METABOLISM, V57, P766, DOI 10.1016/j.metabol.2008.01.016; Lopaschuk GD, 2007, CIRC RES, V101, P335, DOI 10.1161/CIRCRESAHA.107.150417; Mazumder PK, 2004, DIABETES, V53, P2366, DOI 10.2337/diabetes.53.9.2366; McGavock JM, 2007, CIRCULATION, V116, P1170, DOI 10.1161/CIRCULATIONAHA.106.645614; Mohler PJ, 2007, J BIOL CHEM, V282, P26981, DOI 10.1074/jbc.M700500200; Nielsen JM, 2007, AM J PHYSIOL-HEART C, V293, pH534, DOI 10.1152/ajpheart.01268.2006; Nielsen LB, 2002, J BIOL CHEM, V277, P27014, DOI 10.1074/jbc.M203458200; Nielsen LB, 1998, CIRCULATION, V98, P13, DOI 10.1161/01.CIR.98.1.13; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530; Park TS, 2008, J LIPID RES, V49, P2101, DOI 10.1194/jlr.M800147-JLR200; Pedersen TX, 2009, ATHEROSCLEROSIS, V202, P372, DOI 10.1016/j.atherosclerosis.2008.04.041; PETERSEN S, 1991, FEBS LETT, V286, P1, DOI 10.1016/0014-5793(91)80927-U; Peterson LR, 2004, CIRCULATION, V109, P2191, DOI 10.1161/01.CIR.0000127959.28627.F8; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Raabe M, 1998, P NATL ACAD SCI USA, V95, P8686, DOI 10.1073/pnas.95.15.8686; SADDIK M, 1991, J BIOL CHEM, V266, P8162; Somoza B, 2007, ENDOCRINOLOGY, V148, P924, DOI 10.1210/en.2006-0914; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Stanley William C, 2002, Heart Fail Rev, V7, P115, DOI 10.1023/A:1015320423577; Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003; Szczepaniak LS, 2007, CIRC RES, V101, P759, DOI 10.1161/CIRCRESAHA.107.160457; Szczepaniak LS, 2003, MAGN RESON MED, V49, P417, DOI 10.1002/mrm.10372; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Unger RH, 2003, ENDOCRINOLOGY, V144, P5159, DOI 10.1210/en.2003-0870; Wilson CR, 2007, BIOCHEM J, V406, P457, DOI 10.1042/BJ20070392; WISNESKI JA, 1987, J CLIN INVEST, V79, P359, DOI 10.1172/JCI112820; Yagyu H, 2003, J CLIN INVEST, V111, P419, DOI [10.1172/JCI200316751, 10.1172/JCI16751]; Yang J, 2007, CIRC RES, V100, P1208, DOI 10.1161/01.RES.0000264104.25265.b6; Ye G, 2003, DIABETES, V52, P777, DOI 10.2337/diabetes.52.3.777; Yokoyama M, 2004, J BIOL CHEM, V279, P4204, DOI 10.1074/jbc.M311995200; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	61	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5300	10.1371/journal.pone.0005300	http://dx.doi.org/10.1371/journal.pone.0005300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390571	Green Submitted, Green Published, gold			2022-12-25	WOS:000265514200013
J	Diaz-Pulido, G; McCook, LJ; Dove, S; Berkelmans, R; Roff, G; Kline, DI; Weeks, S; Evans, RD; Williamson, DH; Hoegh-Guldberg, O				Diaz-Pulido, Guillermo; McCook, Laurence J.; Dove, Sophie; Berkelmans, Ray; Roff, George; Kline, David I.; Weeks, Scarla; Evans, Richard D.; Williamson, David H.; Hoegh-Guldberg, Ove			Doom and Boom on a Resilient Reef: Climate Change, Algal Overgrowth and Coral Recovery	PLOS ONE			English	Article							GREAT-BARRIER-REEF; PHASE-SHIFTS; COMMUNITY STRUCTURE; HARD CORAL; BROWN ALGA; HERBIVORY; COMPETITION; NUTRIENTS; DYNAMICS; RECRUITMENT	Background: Coral reefs around the world are experiencing large-scale degradation, largely due to global climate change, overfishing, diseases and eutrophication. Climate change models suggest increasing frequency and severity of warming-induced coral bleaching events, with consequent increases in coral mortality and algal overgrowth. Critically, the recovery of damaged reefs will depend on the reversibility of seaweed blooms, generally considered to depend on grazing of the seaweed, and replenishment of corals by larvae that successfully recruit to damaged reefs. These processes usually take years to decades to bring a reef back to coral dominance. Methodology/Principal Findings: In 2006, mass bleaching of corals on inshore reefs of the Great Barrier Reef caused high coral mortality. Here we show that this coral mortality was followed by an unprecedented bloom of a single species of unpalatable seaweed (Lobophora variegata), colonizing dead coral skeletons, but that corals on these reefs recovered dramatically, in less than a year. Unexpectedly, this rapid reversal did not involve reestablishment of corals by recruitment of coral larvae, as often assumed, but depended on several ecological mechanisms previously underestimated. Conclusions/Significance: These mechanisms of ecological recovery included rapid regeneration rates of remnant coral tissue, very high competitive ability of the corals allowing them to out-compete the seaweed, a natural seasonal decline in the particular species of dominant seaweed, and an effective marine protected area system. Our study provides a key example of the doom and boom of a highly resilient reef, and new insights into the variability and mechanisms of reef resilience under rapid climate change.			Diaz-Pulido, G (corresponding author), Univ Queensland, Ctr Marine Studies, Brisbane, Qld, Australia.	g.diazpulido@uq.edu.au	Hoegh-Guldberg, Ove/ABA-5420-2020; Evans, Richard D./O-3559-2019; Roff, George/C-8766-2015; Roff, George/ABB-4406-2021; Hoegh-Guldberg, Ove/H-6169-2011; Diaz-Pulido, Guillermo/B-3648-2013; Evans, Richard D/K-5779-2013; Weeks, Scarla J/E-8632-2013; Dove, Sophie/I-7873-2013	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Evans, Richard D./0000-0003-4364-4810; Roff, George/0000-0002-2823-0575; Roff, George/0000-0002-2823-0575; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Weeks, Scarla J/0000-0002-0579-7069; Dove, Sophie/0000-0003-1823-8634; Kline, David/0000-0001-5128-9439; Diaz-Pulido, Guillermo/0000-0002-0901-3727; Williamson, David/0000-0001-8447-039X				Anthony KRN, 2006, MAR ECOL PROG SER, V319, P111, DOI 10.3354/meps319111; Banks SA, 1995, MAR FRESHWATER RES, V46, P1137, DOI 10.1071/MF9951137; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Brown Barbara E., 1994, P279; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; CARPENTER RC, 1990, MAR BIOL, V104, P67, DOI 10.1007/BF01313159; COLGAN MW, 1987, ECOLOGY, V68, P1592, DOI 10.2307/1939851; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Crabbe MJC, 2005, CORAL REEFS, V24, P437, DOI 10.1007/s00338-005-0004-6; Davey M, 2008, CORAL REEFS, V27, P227, DOI 10.1007/s00338-007-0316-9; Diaz-Pulido G, 2003, ECOLOGY, V84, P2026, DOI 10.1890/01-3127; Diaz-Pulido G, 2002, MAR ECOL PROG SER, V232, P115, DOI 10.3354/meps232115; Diaz-Pulido G., 2007, CLIMATE CHANGE GREAT, P153; DIAZPULIDO G, 1997, P 8 INT COR REEF S P, V1, P827; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Endean R., 1973, Atoll Res Bull, VNo. 168, P1; FISHELSON L, 1973, MAR BIOL, V19, P183, DOI 10.1007/BF02097137; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Golbuu Y, 2007, CORAL REEFS, V26, P319, DOI 10.1007/s00338-007-0200-7; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; HATCHER BG, 1984, CORAL REEFS, V3, P199, DOI 10.1007/BF00288255; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1987, J EXP MAR BIOL ECOL, V113, P39, DOI 10.1016/0022-0981(87)90081-5; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1989, ECOLOGY, V70, P275, DOI 10.2307/1938434; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hunter Cynthia L., 1994, P339; Idjadi JA, 2006, CORAL REEFS, V25, P209, DOI 10.1007/s00338-006-0088-7; Jokiel P., 1978, CORAL REEFS RES METH, P529; JOKIEL PL, 1993, CORAL REEFS, V12, P177, DOI 10.1007/BF00334477; Jompa J, 2002, J EXP MAR BIOL ECOL, V271, P25, DOI 10.1016/S0022-0981(02)00040-0; Jompa J, 2002, LIMNOL OCEANOGR, V47, P527, DOI 10.4319/lo.2002.47.2.0527; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Krupp D.A., 1992, P 7 INT COR REEF S, VVol. 1, P527; Ledlie MH, 2007, CORAL REEFS, V26, P641, DOI 10.1007/s00338-007-0230-1; LOYA Y, 1976, NATURE, V261, P490, DOI 10.1038/261490a0; McClanahan TR, 1999, CORAL REEFS, V18, P61, DOI 10.1007/s003380050155; McCook L.J., 2007, CLIMATE CHANGE GREAT, P75; McCook LJ, 1996, MAR ECOL PROG SER, V139, P179, DOI 10.3354/meps139179; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Nugues MM, 2006, MAR ECOL PROG SER, V315, P75, DOI 10.3354/meps315075; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; PEARSON RG, 1981, MAR ECOL PROG SER, V4, P105, DOI 10.3354/meps004105; Riegl B, 2001, CORAL REEFS, V20, P67; RUSS G, 1984, MAR ECOL PROG SER, V20, P23, DOI 10.3354/meps020023; Russ GR, 2008, CURR BIOL, V18, pR514, DOI 10.1016/j.cub.2008.04.016; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Smith JE, 2001, CORAL REEFS, V19, P332, DOI 10.1007/s003380000124; Steneck R.S., 1988, P 6 INT COR REEF S A, P37; Steneck Robert S., 1994, P220; vanWoesik R, 1997, CORAL REEFS, V16, P103, DOI 10.1007/s003380050064; VanWoesik R, 1995, MAR ECOL PROG SER, V128, P261, DOI 10.3354/meps128261; Weeks SJ, 2008, LIMNOL OCEANOGR, V53, P1369, DOI 10.4319/lo.2008.53.4.1369	62	227	234	4	162	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5239	10.1371/journal.pone.0005239	http://dx.doi.org/10.1371/journal.pone.0005239			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384423	Green Accepted, gold, Green Published			2022-12-25	WOS:000265513900008
J	Kilman, VL; Zhang, LY; Meissner, RA; Burg, E; Allada, R				Kilman, Valerie L.; Zhang, Luoying; Meissner, Rose-Anne; Burg, Elyssa; Allada, Ravi			Perturbing Dynamin Reveals Potent Effects on the Drosophila Circadian Clock	PLOS ONE			English	Article							TEMPERATURE-SENSITIVE MUTANT; PROTEIN-COUPLED RECEPTOR; PACEMAKER NEURONS; GENE-PRODUCT; TRANSCRIPTIONAL REPRESSOR; REVERSIBLE BLOCKAGE; INTRACELLULAR CA2+; NERVOUS-SYSTEM; BETA-ARRESTINS; TIMELESS GENES	Background: Transcriptional feedback loops are central to circadian clock function. However, the role of neural activity and membrane events in molecular rhythms in the fruit fly Drosophila is unclear. To address this question, we expressed a temperature-sensitive, dominant negative allele of the fly homolog of dynamin called shibire(ts1) (shi(ts1)), an active component in membrane vesicle scission. Principal Findings: Broad expression in clock cells resulted in unexpectedly long, robust periods (. 28 hours) comparable to perturbation of core clock components, suggesting an unappreciated role of membrane dynamics in setting period. Expression in the pacemaker lateral ventral neurons (LNv) was necessary and sufficient for this effect. Manipulation of other endocytic components exacerbated shi(ts1)'s behavioral effects, suggesting its mechanism is specific to endocytic regulation. PKA overexpression rescued period effects suggesting shi(ts1) may downregulate PKA pathways. Levels of the clock component PERIOD were reduced in the shi(ts1)-expressing pacemaker small LNv of flies held at a fully restrictive temperature (29 degrees C). Less restrictive conditions (25 degrees C) delayed cycling proportional to observed behavioral changes. Levels of the neuropeptide PIGMENT-DISPERSING FACTOR (PDF), the only known LNv neurotransmitter, were also reduced, but PERIOD cycling was still delayed in flies lacking PDF, implicating a PDF-independent process. Further, shi(ts1) expression in the eye also results in reduced PER protein and per and vri transcript levels, suggesting that shibire-dependent signaling extends to peripheral clocks. The level of nuclear CLK, transcriptional activator of many core clock genes, is also reduced in shi(ts1) flies, and Clk overexpression suppresses the period-altering effects of shi(ts1). Conclusions: We propose that membrane protein turnover through endocytic regulation of PKA pathways modulates the core clock by altering CLK levels and/or activity. These results suggest an important role for membrane scission in setting circadian period.			Kilman, VL (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	r-allada@northwestern.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067870, K01MH070456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052903] Funding Source: NIH RePORTER; NIMH NIH HHS [K01 MH070456, R01MH067870, R01 MH067870, K01MH070456] Funding Source: Medline; NINDS NIH HHS [R01 NS052903, R01NS052903] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agosto J, 2008, NAT NEUROSCI, V11, P354, DOI 10.1038/nn2046; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Benito J, 2007, J NEUROSCI, V27, P2539, DOI 10.1523/JNEUROSCI.4870-06.2007; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; BRODSKY FM, 1987, NATURE, V326, P203, DOI 10.1038/326203a0; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Chang HC, 2002, J CELL BIOL, V159, P477, DOI 10.1083/jcb.200205086; CHUNG BY, 2009, CURR BIOL IN PRESS; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; DARGENT B, 1995, J NEUROCHEM, V65, P407; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; EWER J, 1992, J NEUROSCI, V12, P3321; Fache MP, 2004, J CELL BIOL, V166, P571, DOI 10.1083/jcb.200312155; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Guha A, 2003, J CELL SCI, V116, P3373, DOI 10.1242/jcs.00637; Hamasaka Y, 2006, J COMP NEUROL, V494, P314, DOI 10.1002/cne.20807; HAMASAKA Y, 2005, J NEUROBIOL; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Harrisingh MC, 2007, J NEUROSCI, V27, P12489, DOI 10.1523/JNEUROSCI.3680-07.2007; Hastings MH, 2008, CURR BIOL, V18, pR805, DOI 10.1016/j.cub.2008.07.021; Helfrich-Forster C, 2005, GENES BRAIN BEHAV, V4, P65, DOI 10.1111/j.1601-183X.2004.00092.X; Helfrich-Forster C, 1998, J COMP PHYSIOL A, V182, P435, DOI 10.1007/s003590050192; HELFRICHFORSTER C, 1993, J COMP NEUROL, V337, P177, DOI 10.1002/cne.903370202; Hodge JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002274; Houl JH, 2006, J BIOL RHYTHM, V21, P93, DOI 10.1177/0748730405283697; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Kadener S, 2007, GENE DEV, V21, P1675, DOI 10.1101/gad.1552607; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kaneko M, 1997, J NEUROSCI, V17, P6745; Kaneko M, 2000, J NEUROBIOL, V43, P207, DOI 10.1002/(SICI)1097-4695(20000605)43:3<207::AID-NEU1>3.0.CO;2-0; Kim EY, 2006, P NATL ACAD SCI USA, V103, P6178, DOI 10.1073/pnas.0511215103; Kim EY, 2002, NEURON, V34, P69, DOI 10.1016/S0896-6273(02)00639-6; KIM YT, 1987, J NEUROSCI, V7, P3245; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; KOSAKA T, 1983, J CELL BIOL, V97, P499, DOI 10.1083/jcb.97.2.499; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Kula E, 2006, J BIOL RHYTHM, V21, P104, DOI 10.1177/0748730405285715; Lear BC, 2005, NEURON, V48, P965, DOI 10.1016/j.neuron.2005.10.030; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; LEVINE JD, 1994, NEURON, V13, P967, DOI 10.1016/0896-6273(94)90262-3; Lim C, 2007, CURR BIOL, V17, P1082, DOI 10.1016/j.cub.2007.05.039; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luttrell LM, 2002, J CELL SCI, V115, P455; Majercak J, 1997, MOL CELL BIOL, V17, P5915, DOI 10.1128/MCB.17.10.5915; MASUR SK, 1990, J NEUROGENET, V6, P191, DOI 10.3109/01677069009107110; Matsumoto A, 2007, GENE DEV, V21, P1687, DOI 10.1101/gad.1552207; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; O'Neill JS, 2008, J BIOL RHYTHM, V23, P483, DOI 10.1177/0748730408326682; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Shafer OT, 2006, J COMP NEUROL, V498, P180, DOI 10.1002/cne.21021; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; Staples RR, 1999, J NEUROGENET, V13, P119, DOI 10.3109/01677069909083470; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Suri V, 1999, EMBO J, V18, P675, DOI 10.1093/emboj/18.3.675; Tong YH, 2001, J GEN PHYSIOL, V117, P103, DOI 10.1085/jgp.117.2.103; Tsai LTY, 2004, PLOS BIOL, V2, P2122, DOI 10.1371/journal.pbio.0020408; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Weber F, 2006, J NEUROCHEM, V98, P248, DOI 10.1111/j.1471-4159.2006.03865.x; Wegener C, 2004, J NEUROPHYSIOL, V91, P912, DOI 10.1152/jn.00678.2003; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Wu Y, 2008, J BIOL RHYTHM, V23, P117, DOI 10.1177/0748730407312984; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Yu WJ, 2006, GENE DEV, V20, P723, DOI 10.1101/gad.1404406; ZENG HK, 1994, EMBO J, V13, P3590, DOI 10.1002/j.1460-2075.1994.tb06666.x; Zhao J, 2003, CELL, V113, P755, DOI 10.1016/S0092-8674(03)00400-8	80	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5235	10.1371/journal.pone.0005235	http://dx.doi.org/10.1371/journal.pone.0005235			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384421	gold, Green Published, Green Submitted			2022-12-25	WOS:000265513900006
J	Moreau, A; Hill, M; Thebault, P; Deschamps, JY; Chiffoleau, E; Chauveau, C; Moullier, P; Anegon, I; Alliot-Licht, B; Cuturi, MC				Moreau, A.; Hill, M.; Thebault, P.; Deschamps, J. Y.; Chiffoleau, E.; Chauveau, C.; Moullier, P.; Anegon, I.; Alliot-Licht, B.; Cuturi, M. C.			Tolerogenic dendritic cells actively inhibit T cells through heme oxygenase-1 in rodents and in nonhuman primates	FASEB JOURNAL			English	Article						immune tolerance; cell therapy; macaque	ANTIGEN-PRESENTING CELLS; ALLOGRAFT SURVIVAL; TOLERANCE; MONOXIDE; MATURATION; IMMATURE; PROLIFERATION; EXPRESSION; TRANSPLANTATION; SUPPRESSION	Clinical translation of dendritic cell (DC)-based cell therapy requires preclinical studies in nonhuman primates (NHPs). The aim of this work was to establish the in vitro conditions for generation of NHP tolerogenic DCs (Tol-DCs), as well as to analyze the molecular mechanisms by which these cells could control an immune response. Two populations of NHP bone marrow-derived DCs (BMDCs) were obtained: adherent and nonadherent. Although both populations displayed a quite similar phenotype, they were very different functionally. We characterized the adherent BMDCs as Tol-DCs that were poor stimulators of T cells and actively inhibited T-cell proliferation, whereas the nonadherent population displayed immunogenic properties in vitro. Interestingly, the anti-inflammatory and immunosuppressive enzyme heme oxygenase-1 (HO-1) was up-regulated in Tol-DCs, compared to the immunogenic BMDCs. We demonstrated that HO-1 mediates the immunosuppressive properties of Tol-DCs in vitro ( in NHPs and rats) and that HO-1 is involved in the in vivo tolerogenic effect of Tol-DCs in a rat model of allotransplantation. In conclusion, here we characterized the in vitro generation of NHP Tol-DCs. Furthermore, we showed for the first time that HO-1 plays a role in the active inhibition of T-cell responses by rat and NHP Tol-DCs.-Moreau, A., Hill, M., Thebault, P., Deschamps, J. Y., Chiffoleau, E., Chauveau, C., Moullier, P., Anegon, I., Alliot-Licht, B., Cuturi M. C. Tolerogenic dendritic cells actively inhibit T cells through heme oxygenase-1 in rodents and in nonhuman primates. FASEB J. 23, 3070-3077 ( 2009). www.fasebj.org	[Hill, M.; Thebault, P.; Chiffoleau, E.; Chauveau, C.; Anegon, I.; Alliot-Licht, B.; Cuturi, M. C.] CHU Hotel Dieu, INSERM, U643, F-44093 Nantes 01, France; [Moreau, A.; Moullier, P.] CHU Hotel Dieu, INSERM, U649, F-44093 Nantes 01, France; [Hill, M.; Thebault, P.; Chiffoleau, E.; Chauveau, C.; Anegon, I.; Alliot-Licht, B.; Cuturi, M. C.] CHU Nantes, Inst Transplantat & Rech Transplantat, F-44035 Nantes 01, France; [Hill, M.; Thebault, P.; Chiffoleau, E.; Chauveau, C.; Anegon, I.; Alliot-Licht, B.; Cuturi, M. C.] Univ Nantes, Fac Med, Nantes, France; [Deschamps, J. Y.] Ecole Natl Vet Nantes, Serv Urgence, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique	Cuturi, MC (corresponding author), CHU Hotel Dieu, INSERM, U643, 30 Bd Jean Monnet, F-44093 Nantes 01, France.	maria-cristina.cuturi@univ-nantes.fr	Moreau, Aurelie/J-4139-2017; Anegon, Ignacio/I-7498-2018; Chiffoleau, Elise/N-2982-2018; Anegon, Ignacio/I-7760-2018	Moreau, Aurelie/0000-0002-8519-2632; Chiffoleau, Elise/0000-0001-6167-682X; Hill, Marcelo/0000-0002-1589-0320				Akamatsu Y, 2004, FASEB J, V18, P771, DOI 10.1096/fj.03-0921fje; Beriou G, 2005, TRANSPLANTATION, V79, P969, DOI 10.1097/01.TP.0000158277.50073.35; Braudeau C, 2004, GENE THER, V11, P701, DOI 10.1038/sj.gt.3302208; Chabannes D, 2007, BLOOD, V110, P3691, DOI 10.1182/blood-2007-02-075481; Chauveau C, 2005, BLOOD, V106, P1694, DOI 10.1182/blood-2005-02-0494; Chitta S, 2008, IMMUNOL LETT, V116, P41, DOI 10.1016/j.imlet.2007.11.013; Choi BM, 2005, BIOCHEM BIOPH RES CO, V327, P1066, DOI 10.1016/j.bbrc.2004.12.106; Chora AA, 2007, J CLIN INVEST, V117, P438, DOI 10.1172/JCI28844; George JF, 2008, AM J PATHOL, V173, P154, DOI 10.2353/ajpath.2008.070963; Griffith LM, 2005, BIOL BLOOD MARROW TR, V11, P862, DOI 10.1016/j.bbmt.2005.07.009; Haga Y, 1996, BBA-MOL BASIS DIS, V1317, P65, DOI 10.1016/0925-4439(96)00039-7; Hill M, 2005, FASEB J, V19, P1957, DOI 10.1096/fj.05-3875com; Kapturczak MH, 2004, AM J PATHOL, V165, P1045, DOI 10.1016/S0002-9440(10)63365-2; Kotsch K, 2007, ANTIOXID REDOX SIGN, V9, P2049, DOI 10.1089/ars.2007.1801; Lee DY, 2006, AM J TRANSPLANT, V6, P1820, DOI 10.1111/j.1600-6143.2006.01414.x; Listopad J, 2007, EXP DERMATOL, V16, P661, DOI 10.1111/j.1600-0625.2007.00581.x; Lutz MB, 2000, EUR J IMMUNOL, V30, P1813, DOI 10.1002/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Mashreghi MF, 2008, J IMMUNOL, V180, P7919, DOI 10.4049/jimmunol.180.12.7919; Moreau A, 2008, TRANSPLANTATION, V85, P1351, DOI 10.1097/TP.0b013e31816f22d6; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Pae HO, 2004, J IMMUNOL, V172, P4744, DOI 10.4049/jimmunol.172.8.4744; Peche H, 2005, AM J TRANSPLANT, V5, P255, DOI 10.1111/j.1600-6143.2004.00683.x; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; ROSENBERG DW, 1989, PHARMACOLOGY, V39, P224, DOI 10.1159/000138601; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Song RP, 2004, J IMMUNOL, V172, P1220, DOI 10.4049/jimmunol.172.2.1220; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Taille C, 2004, J BIOL CHEM, V279, P28681, DOI 10.1074/jbc.M310661200; Yamashita K, 2004, FASEB J, V18, P765, DOI 10.1096/fj.03-0839fje; Yamashita K, 2006, FASEB J, V20, P776, DOI 10.1096/fj.05-4791fje; Zelenay S, 2007, INT IMMUNOL, V19, P11, DOI 10.1093/intimm/dxl116	32	74	77	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2009	23	9					3070	3077		10.1096/fj.08-128173	http://dx.doi.org/10.1096/fj.08-128173			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19420134				2022-12-25	WOS:000270241000029
J	Wolf, SA; Steiner, B; Wengner, A; Lipp, M; Kammertoens, T; Kempermann, G				Wolf, Susanne A.; Steiner, Barbara; Wengner, Antje; Lipp, Martin; Kammertoens, Thomas; Kempermann, Gerd			Adaptive peripheral immune response increases proliferation of neural precursor cells in the adult hippocampus	FASEB JOURNAL			English	Article						CD4; glucocorticoids; rheumatoid arthritis	ADJUVANT-INDUCED ARTHRITIS; PITUITARY-ADRENAL AXIS; DENTATE GYRUS; ENVIRONMENTAL ENRICHMENT; PURKINJE NEURONS; RAT HIPPOCAMPUS; CHRONIC INFLAMMATION; NERVOUS-SYSTEM; NEUROGENESIS; STRESS	To understand the link between peripheral immune activation and neuronal precursor biology, we investigated the effect of T-cell activation on adult hippocampal neurogenesis in female C57B1/6 mice. A peripheral adaptive immune response triggered by adjuvant-induced rheumatoid arthritis (2 mu g/mu l methylated BSA) or staphylococcus enterotoxin B (EC50 of 0.25 mu g/ml per 20 g body weight) was associated with a transient increase in hippocampal precursor cell proliferation and neurogenesis as assessed by immunohistochemistry and confocal microscopy. Both treatments were paralleled by an increase in corticosterone levels in the hippocampus 1- to 2-fold over the physiological amount measured by quantitative radioimmunoassay. In contrast, intraperitoneal administration of the innate immune response activator lipopolysaccaride (EC50 of 0.5 mu g/ml per 20 g body weight) led to a chronic 5-fold increase of hippocampal glucocorticoid levels and a decrease of adult neurogenesis. In vitro exposure of murine neuronal progenitor cells to corticosterone triggered either cell death at high (1.5 nM) or proliferation at low ( 0.25 nM) concentrations. This effect could be blocked using a viral vector system expressing a transdomain of the glucocorticoid receptor. We suggest an evolutionary relevant communication route for the brain to respond to environmental stressors like inflammation mediated by glucocorticoid levels in the hippocampus.-Wolf, S. A., Steiner, B., Wengner, A., Lipp, M., Kammertoens, T., Kempermann, G. Adaptive peripheral immune response increases proliferation of neural precursor cells in the adult hippocampus. FASEB J. 23, 3121-3128 (2009). www.fasebj.org	[Wolf, Susanne A.; Steiner, Barbara; Kempermann, Gerd] Max Delbruck Ctr Mol Med, Neuronal Stem Cells Res Grp, Berlin, Germany; [Wengner, Antje; Lipp, Martin] Max Delbruck Ctr Mol Med, Mol Tumor Genet Res Grp, Berlin, Germany; [Kammertoens, Thomas] Max Delbruck Ctr Mol Med, Mol Immunol & Genetherapy Res Grp, Berlin, Germany; [Wolf, Susanne A.] Stanford Univ, Inst Biol Sci, Inst Neurosurg, Stanford, CA 94305 USA; [Steiner, Barbara; Kempermann, Gerd] Charite, Volkswagenstiftung Res Grp, Dept Expt Neurol, Berlin, Germany; [Kammertoens, Thomas] Charite, Inst Immunol, Berlin, Germany; [Steiner, Barbara] Charite, Dept Neurol, D-13353 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Stanford University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Volkswagen; Volkswagen Germany; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kempermann, G (corresponding author), CRTD DFG, Ctr Regenerat Therapies Dresden, Tatzberg 47-49, D-01307 Dresden, Germany.	gerd.kempermann@crt-dresden.de	Wolf, Susanne/A-1907-2011; Kempermann, Gerd/F-5416-2010; Wolf, Susanne/AAA-6598-2022	Kempermann, Gerd/0000-0002-5304-4061; Lipp, Martin/0000-0002-0087-2672; Steiner, Barbara/0000-0003-2106-4532; Wolf, Susanne/0000-0003-0922-8418; Kammertoens, Thomas/0000-0003-3309-5141	VolkswagenStiftung	VolkswagenStiftung(Volkswagen)	thank Ruth Zarmstorff for excellent technical assistance. We thank Ariel Achtmann for help in getting the AIA experiments started and Josef Kohrle for the corticosterone measurements. Many thanks to Robert Sapolsky ( Stanford University, Stanford, CA, USA), for providing us with the vector and essential information on glucocorticoid biology, and to Polly Matzinger, for reading and commenting on the manuscript. This work was supported by VolkswagenStiftung. B. S. is a Rahel Hirsch fellow of the Charite, University Medicine Berlin.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388; Brunson KL, 2005, HIPPOCAMPUS, V15, P491, DOI 10.1002/hipo.20074; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Cameron H, 1996, J COMP NEUROL, V369, P56, DOI 10.1002/(SICI)1096-9861(19960520)369:1<56::AID-CNE4>3.0.CO;2-J; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; COOKE TD, 1972, ARTHRITIS RHEUM, V15, P327, DOI 10.1002/art.1780150402; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; de Kloet ER, 2008, NEUROCHEM RES, V33, P637, DOI 10.1007/s11064-007-9520-9; DEKLOET ER, 1993, J STEROID BIOCHEM, V47, P183; DEKLOET ER, 1988, PROG BRAIN RES, V73, P101; Droste SK, 2003, ENDOCRINOLOGY, V144, P3012, DOI 10.1210/en.2003-0097; Duric V, 2006, J PAIN, V7, P544, DOI 10.1016/j.jpain.2006.01.458; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Ekstrand J, 2008, NEUROSCI LETT, V442, P203, DOI 10.1016/j.neulet.2008.06.085; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fediuc S, 2006, J APPL PHYSIOL, V100, P1867, DOI 10.1152/japplphysiol.01416.2005; Ferguson D, 2008, HIPPOCAMPUS, V18, P1103, DOI 10.1002/hipo.20467; FLEISCHER B, 1994, APMIS, V102, P3, DOI 10.1111/j.1699-0463.1994.tb04839.x; Garcia A, 2004, AGING CELL, V3, P363, DOI 10.1111/j.1474-9728.2004.00130.x; Gass P, 2000, EMBO REP, V1, P447, DOI 10.1093/embo-reports/kvd088; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; Heine VM, 2004, NEUROBIOL AGING, V25, P361, DOI 10.1016/S0197-4580(03)00090-3; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Ho DY, 1997, SCI AM, V276, P116, DOI 10.1038/scientificamerican0697-116; Johansson CB, 2008, NAT CELL BIOL, V10, P575, DOI 10.1038/ncb1720; Kaufer D, 2004, NAT NEUROSCI, V7, P947, DOI 10.1038/nn1296; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Kempermann G, 2008, CURR OPIN PSYCHIATR, V21, P290, DOI 10.1097/YCO.0b013e3282fad375; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kusnecov AW, 2005, CURR PHARM DESIGN, V11, P1039, DOI 10.2174/1381612053381602; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; Moncek F, 2004, J NEUROENDOCRINOL, V16, P423, DOI 10.1111/j.1365-2826.2004.01173.x; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Reagan LP, 1997, J CHEM NEUROANAT, V13, P149, DOI 10.1016/S0891-0618(97)00031-8; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; SARLIS NJ, 1992, ENDOCRINOLOGY, V130, P1775, DOI 10.1210/en.130.4.1775; SHORS TJ, 1989, SCIENCE, V244, P224, DOI 10.1126/science.2704997; Shurin G, 1997, NEUROENDOCRINOLOGY, V65, P18, DOI 10.1159/000127161; Simon J, 2001, J AUTOIMMUN, V17, P127, DOI 10.1006/jaut.2001.0534; SLOVITER RS, 1989, SCIENCE, V243, P535, DOI 10.1126/science.2911756; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; VAHER P, 1994, ANN NY ACAD SCI, V746, P405; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; VANBEUSEKOM HJ, 1981, SCAND J RHEUMATOL, P37; VANEEKELEN JAM, 1988, J NEUROSCI RES, V21, P88, DOI 10.1002/jnr.490210113; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; Windle RJ, 2001, J NEUROENDOCRINOL, V13, P905, DOI 10.1046/j.1365-2826.2001.00715.x; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629; Ziv Y, 2008, BRAIN BEHAV IMMUN, V22, P167, DOI 10.1016/j.bbi.2007.08.006	58	61	63	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					3121	3128		10.1096/fj.08-113944	http://dx.doi.org/10.1096/fj.08-113944			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19433626				2022-12-25	WOS:000270241000034
J	Yan, J; Menendez, D; Yang, XP; Resnick, MA; Jetten, AM				Yan, Jun; Menendez, Daniel; Yang, Xiao-Ping; Resnick, Michael A.; Jetten, Anton M.			A Regulatory Loop Composed of RAP80-HDM2-p53 Provides RAP80-enhanced p53 Degradation by HDM2 in Response to DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL MODIFICATIONS; DEPENDENT PHOSPHORYLATION; TRANSCRIPTION-FACTOR; BINDING-SITES; RAP80; REPAIR; BRCA1; RNF8; CHECKPOINTS; GENOME	The ubiquitin interaction motif-containing protein RAP80 plays a key role in DNA damage response signaling. Using genomic and functional analysis, we established that the expression of the RAP80 gene is regulated in a DNA damage-responsive manner by the master regulator p53. This regulation occurs at the transcriptional level through a noncanonical p53 response element in the RAP80 promoter. Although it is inducible by p53, RAP80 is also able to regulate p53 through an association with both p53 and the E3 ubiquitin ligase HDM2, providing HDM2-dependent enhancement of p53 poly-ubiquitination. Depletion of RAP80 by small interfering RNA stabilizes p53, which, following DNA damage, results in an increased transactivation of several p53 target genes as well as greater apoptosis. Consistent with these observations, exogenous expression of RAP80 selectively inhibits p53-dependent transactivation of target genes in an mdm2-dependent manner in MEF cells. Thus, we identify a new DNA damage-associated role for RAP80. It can function in an autoregulatory loop consisting of RAP80, HDM2, and the p53 master regulatory network, implying an important role for this loop in genome stability and oncogenesis.	[Menendez, Daniel; Resnick, Michael A.] NIEHS, Chromosome Stabil Grp, Mol Genet Lab, Div Intramural Res,NIH, Res Triangle Pk, NC 27709 USA; [Yan, Jun; Yang, Xiao-Ping; Jetten, Anton M.] NIEHS, Cell Biol Sect, Lab Resp Biol, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Resnick, MA (corresponding author), NIEHS, Chromosome Stabil Grp, Mol Genet Lab, Div Intramural Res,NIH, Res Triangle Pk, NC 27709 USA.	resnick@niehs.nih.gov; jetten@niehs.nih.gov	Jetten, Anton/C-3736-2019; resnick, Michael/F-1668-2019	Jetten, Anton/0000-0003-0954-4445; resnick, Michael/0000-0002-8473-7506	National Institutes of Health [Z01 ES101586, Z01 ES065079]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES065079, ZIAES101586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants Z01 ES101586 ( to A. M. J.) and Z01 ES065079 ( to M. A. R.).	Akbari MR, 2009, BREAST CANCER RES TR, V113, P377, DOI 10.1007/s10549-008-9938-z; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Foray N, 2003, EMBO J, V22, P2860, DOI 10.1093/emboj/cdg274; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Higashitsuji H, 2005, CANCER CELL, V8, P75, DOI 10.1016/j.ccr.2005.06.006; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109; Inga A, 2002, MOL CELL BIOL, V22, P8612, DOI 10.1128/MCB.22.24.8612-8625.2002; Jegga AG, 2008, P NATL ACAD SCI USA, V105, P944, DOI 10.1073/pnas.0704694105; Jordan JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000104; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; Menendez D, 2007, ONCOGENE, V26, P2191, DOI 10.1038/sj.onc.1210277; Menendez D, 2006, MOL CELL BIOL, V26, P2297, DOI 10.1128/MCB.26.6.2297-2308.2006; Menendez D, 2007, MOL CELL BIOL, V27, P2590, DOI 10.1128/MCB.01742-06; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Osorio A, 2009, BREAST CANCER RES TR, V113, P371, DOI 10.1007/s10549-008-9933-4; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rodier F, 2007, NUCLEIC ACIDS RES, V35, P7475, DOI 10.1093/nar/gkm744; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Shebzukhov YV, 2007, CANCER LETT, V255, P255, DOI 10.1016/j.canlet.2007.04.013; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Tomso DJ, 2005, P NATL ACAD SCI USA, V102, P6431, DOI 10.1073/pnas.0501721102; Veprintsev DB, 2008, NUCLEIC ACIDS RES, V36, P1589, DOI 10.1093/nar/gkm1040; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yan J, 2008, CANCER LETT, V271, P179, DOI 10.1016/j.canlet.2008.04.046; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Yan J, 2007, NUCLEIC ACIDS RES, V35, P1673, DOI 10.1093/nar/gkl1112; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	49	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19280	19289		10.1074/jbc.M109.013102	http://dx.doi.org/10.1074/jbc.M109.013102			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19433585	hybrid, Green Published			2022-12-25	WOS:000267908300019
J	Gangopadhyay, SS; Kengni, E; Appel, S; Gallant, C; Kim, HR; Leavis, P; DeGnore, J; Morgan, KG				Gangopadhyay, Samudra S.; Kengni, Edouard; Appel, Sarah; Gallant, Cynthia; Kim, Hak Rim; Leavis, Paul; DeGnore, Jon; Morgan, Kathleen G.			Smooth Muscle Archvillin Is an ERK Scaffolding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-II; ACTIVATION; CALPONIN; PEPTIDE	ERK influences a number of pathways in all cells, but how ERK activities are segregated between different pathways has not been entirely clear. Using immunoprecipitation and pulldown experiments with domain-specific recombinant fragments, we show that smooth muscle archvillin (SmAV) binds ERK and members of the ERK signaling cascade in a domain-specific, stimulus-dependent, and pathway-specific manner. MEK binds specifically to the first 445 residues of SmAV. B-Raf, an upstream regulator of MEK, constitutively interacts with residues 1-445 and 446-1250. Both ERK and 14-3-3 bind to both fragments, but in a stimulus-specific manner. Phosphorylated ERK is associated only with residues 1-445. An ERK phosphorylation site was determined by mass spectrometry to reside at Ser(132). Aphospho-antibody raised to this site shows that the site is phosphorylated during alpha-agonist-mediated ERK activation in smooth muscle tissue. Phosphorylation of SmAV by ERK decreases the association of phospho-ERK with SmAV. These results, combined with previous observations, indicate that SmAV serves as a new ERK scaffolding protein and provide a mechanism for regulation of ERK binding, activation, and release from the signaling complex.	[Gangopadhyay, Samudra S.; Kengni, Edouard; Appel, Sarah; Gallant, Cynthia; Kim, Hak Rim; Morgan, Kathleen G.] Boston Univ, Boston, MA 02215 USA; [Gangopadhyay, Samudra S.; Gallant, Cynthia; Leavis, Paul; Morgan, Kathleen G.] Boston Biomed Res Inst, Watertown, MA 02472 USA; [Leavis, Paul; DeGnore, Jon] Tufts Univ, Sch Med, Boston, MA 02111 USA	Boston University; Boston Biomedical Research Institute; Tufts University	Morgan, KG (corresponding author), Boston Univ, 635 Commonwealth Ave, Boston, MA 02215 USA.	kmorgan@bu.edu		Morgan, Kathleen/0000-0003-3300-3630; Appel, Sarah/0000-0003-0315-6513	National Institutes of Health [HL31704, HL80003, HL86655, HD43054, HL074470]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043054] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL074470, P01HL086655, R01HL031704, R01HL080003] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL31704, HL80003, HL86655, and HD43054 (to K. G. M.) and HL074470 (to S. S. G.).	Abraham ST, 1997, CIRC RES, V81, P575, DOI 10.1161/01.RES.81.4.575; ADAM LP, 1995, CIRC RES, V76, P183, DOI 10.1161/01.RES.76.2.183; Chuderland D, 2005, MOL BIOTECHNOL, V29, P57, DOI 10.1385/MB:29:1:57; Dhillon AS, 2002, ARCH BIOCHEM BIOPHYS, V404, P3, DOI 10.1016/S0003-9861(02)00244-8; Gangopadhyay SS, 2004, J CELL SCI, V117, P5043, DOI 10.1242/jcs.01378; Gerthoffer WT, 1996, J PHYSIOL-LONDON, V495, P597, DOI 10.1113/jphysiol.1996.sp021619; GONZALEZ FA, 1993, J CELL BIOL, V122, P1089, DOI 10.1083/jcb.122.5.1089; KHALIL RA, 1993, AM J PHYSIOL, V265, pC406, DOI 10.1152/ajpcell.1993.265.2.C406; KHALIL RA, 1995, CIRC RES, V76, P1101, DOI 10.1161/01.RES.76.6.1101; Leinweber BD, 1999, BIOCHEM J, V344, P117, DOI 10.1042/0264-6021:3440117; Marganski WA, 2005, CIRC RES, V97, P541, DOI 10.1161/01.RES.0000182630.29093.0d; Menice CB, 1997, J BIOL CHEM, V272, P25157, DOI 10.1074/jbc.272.40.25157; MICHAUD NR, 1995, MOL CELL BIOL, V15, P3390; Morgan KG, 2001, J APPL PHYSIOL, V91, P953, DOI 10.1152/jappl.2001.91.2.953; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Pouyssegur J, 2003, EUR J BIOCHEM, V270, P3291, DOI 10.1046/j.1432-1033.2003.03707.x; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Taggart MJ, 2007, SEMIN CELL DEV BIOL, V18, P296, DOI 10.1016/j.semcdb.2007.05.006; Veprek P, 1999, J PEPT SCI, V5, P203, DOI 10.1002/(SICI)1099-1387(199905)5:5<203::AID-PSC181>3.0.CO;2-N; Wier WG, 2004, REV PHYSIOL BIOCH P, V150, P91, DOI 10.1007/s10254-003-0019-8; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	23	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17607	17615		10.1074/jbc.M109.002386	http://dx.doi.org/10.1074/jbc.M109.002386			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19406750	Green Published, hybrid			2022-12-25	WOS:000267202500026
J	Smith, NJ; Stoddart, LA; Devine, NM; Jenkins, L; Milligan, G				Smith, Nicola J.; Stoddart, Leigh A.; Devine, Nicola M.; Jenkins, Laura; Milligan, Graeme			The Action and Mode of Binding of Thiazolidinedione Ligands at Free Fatty Acid Receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; STIMULATED INSULIN-SECRETION; BETA-CELLS; IN-VIVO; GPR40; ACTIVATION; AGONISTS; DISCOVERY; GENE; MICE	The endogenous ligands for free fatty acid receptor 1 (FFA1) are medium and longer chain free fatty acids. However, a range of selective, small molecule ligands have recently been developed as tool compounds to explore the therapeutic potential of this receptor, whereas clinically employed thiazolidinedione "glitazone" drugs are also agonists at FFA1. Each of these classes of agonist was able to promote phosphorylation of the ERK1/2 mitogen-activated protein (MAP) kinases in cells able to express human FFA1 on demand. However, although both lauric acid and the synthetic agonist GW9508X produced rapid and transient ERK1/2 MAP kinase phosphorylation, the thiazolidinedione rosiglitazone produced responses that were sustained for a substantially longer period. Despite this difference, the effects of each ligand required FFA1 and were transduced in each case predominantly via G proteins of the G alpha(q)/G alpha(11) family. Different glitazone drugs also displayed markedly different efficacy and kinetics of sustainability of ERK1/2 MAP kinase phosphorylation. A number of orthosteric binding site mutants of FFA1 were generated, and despite variations in the changes of potency and efficacy of the three ligand classes in different functional end point assays, these were consistent with rosiglitazone also binding at the orthosteric site. Four distinct polymorphic variants of human FFA1 have been described. Despite previous indications that these display differences in function and pharmacology, they all responded in entirely equivalent ways to lauric acid, rosiglitazone, and GW9508X in measures of ERK1/2 MAP kinase phosphorylation, enhancement of binding of [S-35]GTP gamma S (guanosine 5'-O-(3-[S-35] thio) triphosphate) to G alpha(q), and elevation of intracellular [Ca2+], suggesting that individuals expressing each variant are likely to respond equivalently to orthosteric agonists of FFA1.	[Smith, Nicola J.; Stoddart, Leigh A.; Devine, Nicola M.; Jenkins, Laura; Milligan, Graeme] Univ Glasgow, Mol Pharmacol Grp, Fac Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Milligan, G (corresponding author), Univ Glasgow, Mol Pharmacol Grp, Fac Biomed & Life Sci, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	g.milligan@bio.gla.ac.uk	Milligan, Graeme/F-9426-2011	Milligan, Graeme/0000-0002-6946-3519; Smith, Nicola J/0000-0002-7247-9562; Stoddart, Leigh/0000-0002-4469-0600	Biotechnology and Biosciences Research Council [BB/E019455/1]; Biotechnology and Biological Sciences Research Council [BB/E019455/1] Funding Source: researchfish; BBSRC [BB/E019455/1] Funding Source: UKRI	Biotechnology and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Biotechnology and Biosciences Research Council Grant BB/E019455/1.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bharate SB, 2008, BIOORG MED CHEM LETT, V18, P6357, DOI 10.1016/j.bmcl.2008.10.085; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Brownlie R, 2008, BIOCHEM SOC T, V36, P950, DOI 10.1042/BST0360950; Canals M, 2008, J BIOL CHEM, V283, P11424, DOI 10.1074/jbc.M710300200; Canals M, 2006, J BIOL CHEM, V281, P16757, DOI 10.1074/jbc.M601121200; Christiansen E, 2008, J MED CHEM, V51, P7061, DOI 10.1021/jm8010178; Costanzi S, 2008, J BIOL CHEM, V283, P16269, DOI 10.1074/jbc.R800014200; Crespo Piero, 2004, Methods Mol Biol, V250, P203; Ellis J, 2006, J BIOL CHEM, V281, P38812, DOI 10.1074/jbc.M602494200; Gardner OS, 2005, MOL PHARMACOL, V68, P933, DOI 10.1124/mol.105.012260; Garrido DM, 2006, BIOORG MED CHEM LETT, V16, P1840, DOI 10.1016/j.bmcl.2006.01.007; Hamid YH, 2005, DIABETIC MED, V22, P74, DOI 10.1111/j.1464-5491.2005.01505.x; Insel PA, 2007, BBA-BIOMEMBRANES, V1768, P994, DOI 10.1016/j.bbamem.2006.09.029; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jha RJ, 1999, CLIN EXP HYPERTENS, V21, P157, DOI 10.3109/10641969909068658; Kazius J, 2008, HUM MUTAT, V29, P39, DOI 10.1002/humu.20638; Kebede M, 2008, DIABETES, V57, P2432, DOI 10.2337/db08-0553; Kotarsky K, 2003, BIOCHEM BIOPH RES CO, V301, P406, DOI 10.1016/S0006-291X(02)03064-4; Lan H, 2008, DIABETES, V57, P2999, DOI 10.2337/db08-0596; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Luttrell LM, 2008, MOL BIOTECHNOL, V39, P239, DOI 10.1007/s12033-008-9031-1; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Milasta S, 2006, MOL PHARMACOL, V69, P479, DOI 10.1124/mol.105.018788; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Milligan G, 2006, CELL SIGNAL, V18, P1360, DOI 10.1016/j.cellsig.2006.03.011; MITCHELL FM, 1993, BIOCHEM J, V293, P495, DOI 10.1042/bj2930495; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Ogawa T, 2005, METABOLISM, V54, P296, DOI 10.1016/j.metabol.2004.09.008; Salehi A, 2005, CELL TISSUE RES, V322, P207, DOI 10.1007/s00441-005-0017-z; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; Sawzdargo M, 1997, BIOCHEM BIOPH RES CO, V239, P543, DOI 10.1006/bbrc.1997.7513; Schnell S, 2007, MOL CELL ENDOCRINOL, V263, P173, DOI 10.1016/j.mce.2006.09.013; Shapiro H, 2005, BIOCHEM BIOPH RES CO, V335, P97, DOI 10.1016/j.bbrc.2005.07.042; Smith NJ, 2006, HYPERTENSION, V48, P173, DOI 10.1161/01.HYP.0000232641.84521.92; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Stoddart LA, 2008, J BIOL CHEM, V283, P32913, DOI 10.1074/jbc.M805601200; Stoddart LA, 2007, MOL PHARMACOL, V71, P994, DOI 10.1124/mol.106.031534; Stoddart LA, 2008, PHARMACOL REV, V60, P405, DOI 10.1124/pr.108.00802; Sum CS, 2007, J BIOL CHEM, V282, P29248, DOI 10.1074/jbc.M705077200; Sum CS, 2009, J BIOL CHEM, V284, P3529, DOI 10.1074/jbc.M806987200; Sundriyal S, 2008, J PHYS ORG CHEM, V21, P30, DOI 10.1002/poc.1273; Swaminath G, 2008, ARCH PHARM, V341, P755, DOI 10.1002/ardp.200800096; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tan CP, 2008, DIABETES, V57, P2211, DOI 10.2337/db08-0130; Telvekar VN, 2008, CURR DRUG TARGETS, V9, P899, DOI 10.2174/138945008785909301; Thompson Miles D., 2008, V448, P139, DOI 10.1007/978-1-59745-205-2_8; Tikhonova IG, 2008, J MED CHEM, V51, P625, DOI 10.1021/jm7012425; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Vettor R, 2008, J CLIN ENDOCR METAB, V93, P3541, DOI 10.1210/jc.2007-2680	56	70	72	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17527	17539		10.1074/jbc.M109.012849	http://dx.doi.org/10.1074/jbc.M109.012849			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19398560	hybrid, Green Published			2022-12-25	WOS:000267202500019
J	Thein, MC; Winter, AD; Stepek, G; McCormack, G; Stapleton, G; Johnstone, IL; Page, AP				Thein, Melanie C.; Winter, Alan D.; Stepek, Gillian; McCormack, Gillian; Stapleton, Genevieve; Johnstone, Iain L.; Page, Antony P.			Combined Extracellular Matrix Cross-linking Activity of the Peroxidase MLT-7 and the Dual Oxidase BLI-3 Is Critical for Post-embryonic Viability in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR EVOLUTION; DISULFIDE-ISOMERASE; CUTICLE COLLAGEN; BRUGIA-MALAYI; PROTEIN; NEMATODE; IDENTIFICATION; PROCOLLAGEN; TRANSGLUTAMINASE; BIOSYNTHESIS	The nematode cuticle is a protective collagenous extracellular matrix that is modified, cross-linked, and processed by a number of key enzymes. This Ecdysozoan-specific structure is synthesized repeatedly and allows growth and development in a linked degradative and biosynthetic process known as molting. A targeted RNA interference screen using a cuticle collagen marker has been employed to identify components of the cuticle biosynthetic pathway. We have characterized an essential peroxidase, MoLT-7 (MLT-7), that is responsible for proper cuticle molting and re-synthesis. MLT-7 is an active, inhibitable peroxidase that is expressed in the cuticle-synthesizing hypodermis coincident with each larval molt. mlt-7 mutants show a range of body morphology defects, most notably molt, dumpy, and early larval stage arrest phenotypes that can all be complemented with a wild type copy of mlt-7. The cuticles of these mutants lacks di-tyrosine cross-links, becomes permeable to dye and accessible to tyrosine iodination, and have aberrant collagen protein expression patterns. Overexpression of MLT-7 causes mutant phenotypes further supporting its proposed enzymatic role. In combination with BLI-3, an H2O2-generating NADPH dual oxidase, MLT-7 is essential for post-embryonic development. Disruption of mlt-7, and particularly bli-3, via RNA interference also causes dramatic changes to the in vivo cross-linking patterns of the cuticle collagens DPY-13 and COL-12. This points toward a functionally cooperative relationship for these two hypodermally expressed proteins that is essential for collagen cross-linking and proper extracellular matrix formation.	[Thein, Melanie C.; Winter, Alan D.; Stepek, Gillian; McCormack, Gillian; Page, Antony P.] Univ Glasgow, Fac Vet, Inst Comparat Med, Glasgow G61 1QH, Lanark, Scotland; [Stapleton, Genevieve; Johnstone, Iain L.] Univ Glasgow, Inst Biomed & Life Sci, Glasgow G61 1QH, Lanark, Scotland	University of Glasgow; University of Glasgow	Page, AP (corresponding author), Univ Glasgow, Fac Vet, Inst Comparat Med, Bearsden Rd, Glasgow G61 1QH, Lanark, Scotland.	a.page@vet.gla.ac.uk			Medical Research and the Biotechnology and Biological Sciences Research Councils of the United Kingdom; Biotechnology and Biological Sciences Research Council [BB/D000661/1] Funding Source: researchfish; Medical Research Council [G0401202, G117/476] Funding Source: researchfish; BBSRC [BB/D000661/1] Funding Source: UKRI; MRC [G117/476, G0401202] Funding Source: UKRI	Medical Research and the Biotechnology and Biological Sciences Research Councils of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research and the Biotechnology and Biological Sciences Research Councils of the United Kingdom.	Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Blaxter M, 1998, SCIENCE, V282, P2041, DOI 10.1126/science.282.5396.2041; COX GN, 1981, DEV BIOL, V86, P456, DOI 10.1016/0012-1606(81)90204-9; COX GN, 1981, J CELL BIOL, V90, P7, DOI 10.1083/jcb.90.1.7; Daiyasu H, 2000, J MOL EVOL, V51, P433, DOI 10.1007/s002390010106; Donko A, 2005, PHILOS T R SOC B, V360, P2301, DOI 10.1098/rstb.2005.1767; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Eschenlauer SCP, 2003, J BIOL CHEM, V278, P4227, DOI 10.1074/jbc.M210510200; FETTERER RH, 1993, J PARASITOL, V79, P160, DOI 10.2307/3283502; FRANCIS GR, 1985, J CELL BIOL, V101, P1532, DOI 10.1083/jcb.101.4.1532; FUJIMOTO D, 1981, BIOCHEM BIOPH RES CO, V99, P637, DOI 10.1016/0006-291X(81)91792-7; Johnstone IL, 2000, TRENDS GENET, V16, P21, DOI 10.1016/S0168-9525(99)01857-0; Johnstone IL, 1996, EMBO J, V15, P3633, DOI 10.1002/j.1460-2075.1996.tb00732.x; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; McMahon L, 2003, MOL BIOL CELL, V14, P1366, DOI 10.1091/mbc.E02-08-0479; MEHTA K, 1992, MOL BIOCHEM PARASIT, V53, P1, DOI 10.1016/0166-6851(92)90002-2; Moribe H, 2004, J CELL SCI, V117, P5209, DOI 10.1242/jcs.01403; MORRISON M, 1976, ANNU REV BIOCHEM, V45, P861, DOI 10.1146/annurev.bi.45.070176.004241; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nomura K, 1999, ARCH BIOCHEM BIOPHYS, V367, P173, DOI 10.1006/abbi.1999.1219; Norman KR, 2000, DEV BIOL, V227, P690, DOI 10.1006/dbio.2000.9897; Page AP, 2006, INT J PARASITOL, V36, P681, DOI 10.1016/j.ijpara.2006.01.004; Page AP, 2003, ADV PARASIT, V53, P85, DOI 10.1016/S0065-308X(03)53003-2; Page AP, 2007, WORMBOOK, P1, DOI DOI 10.1895/WORMBOOK.1.138.1; SAKURA S, 1984, PHOTOCHEM PHOTOBIOL, V40, P731, DOI 10.1111/j.1751-1097.1984.tb04644.x; SCHOFIELD JD, 1974, BIOCHEMISTRY-US, V13, P1801, DOI 10.1021/bi00706a004; SELKIRK ME, 1989, MOL BIOCHEM PARASIT, V32, P229, DOI 10.1016/0166-6851(89)90073-X; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Taurog A, 1999, BIOCHIMIE, V81, P557, DOI 10.1016/S0300-9084(99)80110-2; Thein MC, 2003, DEV DYNAM, V226, P523, DOI 10.1002/dvdy.10259; Tsang SW, 2007, DEV BIOL, V312, P353, DOI 10.1016/j.ydbio.2007.09.037; Winter AD, 2000, MOL CELL BIOL, V20, P4084, DOI 10.1128/MCB.20.11.4084-4093.2000; Winter AD, 2007, DEV BIOL, V308, P449, DOI 10.1016/j.ydbio.2007.05.041	35	60	68	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17549	17563		10.1074/jbc.M900831200	http://dx.doi.org/10.1074/jbc.M900831200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19406744	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000267202500021
J	Amundsen, SK; Fero, J; Salama, NR; Smith, GR				Amundsen, Susan K.; Fero, Jutta; Salama, Nina R.; Smith, Gerald R.			Dual Nuclease and Helicase Activities of Helicobacter pylori AddAB Are Required for DNA Repair, Recombination, and Mouse Infectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; COMPLETE NUCLEOTIDE-SEQUENCE; BINDING CONSENSUS SEQUENCE; COGNATE CHI SEQUENCE; ATP-DEPENDENT DNASE; RECBCD ENZYME; BACILLUS-SUBTILIS; RECD SUBUNIT; HOMOLOGOUS RECOMBINATION; DEFICIENT MUTANTS	Helicobacter pylori infection of the human stomach is associated with disease-causing inflammation that elicits DNA damage in both bacterial and host cells. Bacteria must repair their DNA to persist. The H. pylori AddAB helicase-exonuclease is required for DNA repair and efficient stomach colonization. To dissect the role of each activity in DNA repair and infectivity, we altered the AddA and AddB nuclease (NUC) domains and the AddA helicase (HEL) domain by site-directed mutagenesis. Extracts of Escherichia coli expressing H. pylori addA(NUC)B or addAB(NUC) mutants unwound DNA but had approximately half of the exonuclease activity of wild-type AddAB; the addA(NUC)B(NUC) double mutant lacked detectable nuclease activity but retained helicase activity. Extracts with AddA(HEL)B lacked detectable helicase and nuclease activity. H. pylori with the single nuclease domain mutations were somewhat less sensitive to the DNA-damaging agent ciprofloxacin than the corresponding deletion mutant, suggesting that residual nuclease activity promotes limited DNA repair. The addA(NUC) and addA(HEL) mutants colonized the stomach less efficiently than the wild type; addB(NUC) showed partial attenuation. E. coli Delta recBCD expressing H. pylori addAB was recombination-deficient unless H. pylori recA was also expressed, suggesting a species-specific interaction between AddAB and RecA and also that H. pylori AddAB participates in both DNA repair and recombination. These results support a role for both the AddAB nuclease and helicase in DNA repair and promoting infectivity.	[Amundsen, Susan K.; Smith, Gerald R.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Fero, Jutta; Salama, Nina R.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Smith, GR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N,A1-162, Seattle, WA 98109 USA.	gsmith@fhcrc.org	Salama, Nina Reda/AAG-2437-2019	Salama, Nina Reda/0000-0003-2762-1424; Smith, Gerald/0000-0002-8747-1352	National Institutes of Health [GM031693, AI054423]; Fred Hutchinson Cancer Research Center Synergy Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054423] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM031693, R01GM031693] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fred Hutchinson Cancer Research Center Synergy Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by National Institutes of Health Grants GM031693 (to G. R. S.) and AI054423 (to N. R. S.). This work was also supported by the Fred Hutchinson Cancer Research Center Synergy Fund (to G. R. S. and N. R. S.).	Allen LAH, 2005, J IMMUNOL, V174, P3658, DOI 10.4049/jimmunol.174.6.3658; Amundsen SK, 2000, P NATL ACAD SCI USA, V97, P7399, DOI 10.1073/pnas.130192397; AMUNDSEN SK, 1990, GENETICS, V126, P25; Amundsen SK, 2003, CELL, V112, P741, DOI 10.1016/S0092-8674(03)00197-1; Amundsen SK, 2002, GENETICS, V161, P483; AMUNDSEN SK, 1986, P NATL ACAD SCI USA, V83, P5558, DOI 10.1073/pnas.83.15.5558; Amundsen SK, 2008, MOL MICROBIOL, V69, P994, DOI 10.1111/j.1365-2958.2008.06336.x; Amundsen SK, 2007, GENE DEV, V21, P3296, DOI 10.1101/gad.1605807; Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Aravind L, 2000, NUCLEIC ACIDS RES, V28, P3417, DOI 10.1093/nar/28.18.3417; Chaturvedi R, 2004, J BIOL CHEM, V279, P40161, DOI 10.1074/jbc.M401370200; CHAUDHURY AM, 1985, MOL GEN GENET, V201, P525, DOI 10.1007/BF00331350; Chedin F, 2000, J MOL BIOL, V298, P7, DOI 10.1006/jmbi.2000.3556; Chedin F, 2006, J BIOL CHEM, V281, P18610, DOI 10.1074/jbc.M600882200; Chen HW, 1997, J BIOL CHEM, V272, P10072; Chen HW, 1998, J MOL BIOL, V278, P89, DOI 10.1006/jmbi.1998.1694; Churchill JJ, 1999, GENE DEV, V13, P901, DOI 10.1101/gad.13.7.901; Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176; CLARK AJ, 1965, P NATL ACAD SCI USA, V53, P451, DOI 10.1073/pnas.53.2.451; DEVRIES J, 1992, J GEN MICROBIOL, V138, P31, DOI 10.1099/00221287-138-1-31; DIXON DA, 1991, CELL, V66, P361, DOI 10.1016/0092-8674(91)90625-9; EICHLER DC, 1977, J BIOL CHEM, V252, P499; FINCH PW, 1986, NUCLEIC ACIDS RES, V14, P8583, DOI 10.1093/nar/14.21.8583; FINCH PW, 1986, NUCLEIC ACIDS RES, V14, P4437, DOI 10.1093/nar/14.11.4437; FINCH PW, 1986, NUCLEIC ACIDS RES, V14, P8573, DOI 10.1093/nar/14.21.8573; Fischer W, 2004, J BACTERIOL, V186, P777, DOI 10.1128/JB.186.3.777-784.2004; FRY DC, 1986, P NATL ACAD SCI USA, V83, P907, DOI 10.1073/pnas.83.4.907; GOLDMARK PJ, 1972, J BIOL CHEM, V247, P1849; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Haijema BJ, 1996, J BACTERIOL, V178, P5086, DOI 10.1128/jb.178.17.5086-5091.1996; Haijema BJ, 1996, J BACTERIOL, V178, P5130, DOI 10.1128/jb.178.17.5130-5137.1996; Haijema BJ, 1996, MOL MICROBIOL, V21, P989, DOI 10.1046/j.1365-2958.1996.601424.x; HOWARDFLANDERS P, 1966, GENETICS, V53, P1137; IYER VN, 1963, P NATL ACAD SCI USA, V50, P355, DOI 10.1073/pnas.50.2.355; KARU AE, 1973, J BIOL CHEM, V248, P4874; KARU AE, 1972, P NATL ACAD SCI USA, V69, P2855, DOI 10.1073/pnas.69.10.2855; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kooistra J, 1997, MOL MICROBIOL, V23, P137, DOI 10.1046/j.1365-2958.1997.1991570.x; KOOISTRA J, 1991, J BACTERIOL, V173, P3644, DOI 10.1128/JB.173.12.3644-3655.1991; KOOISTRA J, 1988, J BACTERIOL, V170, P4791, DOI 10.1128/jb.170.10.4791-4797.1988; KOOISTRA J, 1993, MOL MICROBIOL, V7, P915, DOI 10.1111/j.1365-2958.1993.tb01182.x; KORANGY F, 1992, J BIOL CHEM, V267, P3088; KORANGY F, 1994, BIOCHEMISTRY-US, V33, P9552, DOI 10.1021/bi00198a022; KORANGY F, 1992, J BIOL CHEM, V267, P1733; KORANGY F, 1992, J BIOL CHEM, V267, P1727; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; LIPINSKA B, 1989, J BACTERIOL, V171, P488, DOI 10.1128/jb.171.1.488-497.1989; MACKAY V, 1974, J BIOL CHEM, V249, P4286; Marsin S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000146; MASTERSON C, 1992, J BIOL CHEM, V267, P13564; MCPARTLAND A, 1980, CELL, V20, P731, DOI 10.1016/0092-8674(80)90319-0; Meddows TR, 2005, MOL MICROBIOL, V57, P97, DOI 10.1111/j.1365-2958.2005.04677.x; Montecucco C, 2001, NAT REV MOL CELL BIO, V2, P457, DOI 10.1038/35073084; O'Rourke EJ, 2003, P NATL ACAD SCI USA, V100, P2789, DOI 10.1073/pnas.0337641100; OLIVER DB, 1977, J MOL BIOL, V116, P877, DOI 10.1016/0022-2836(77)90276-5; PONTICELLI AS, 1985, CELL, V41, P145, DOI 10.1016/0092-8674(85)90069-8; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; SCHMITT W, 1995, MOL GEN GENET, V248, P563, DOI 10.1007/BF02423452; SCHULTZ DW, 1983, J BACTERIOL, V155, P664, DOI 10.1128/JB.155.2.664-680.1983; SIOUD M, 1989, BIOCHEMISTRY-US, V28, P3638, DOI 10.1021/bi00435a002; Smeets LC, 2000, J BACTERIOL, V182, P3948, DOI 10.1128/JB.182.14.3948-3954.2000; Smith GR, 2001, ANNU REV GENET, V35, P243, DOI 10.1146/annurev.genet.35.102401.090509; Solnick JV, 2004, P NATL ACAD SCI USA, V101, P2106, DOI 10.1073/pnas.0308573100; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; TAYLOR A, 1980, CELL, V22, P447, DOI 10.1016/0092-8674(80)90355-4; TAYLOR AF, 1995, J BIOL CHEM, V270, P24451, DOI 10.1074/jbc.270.41.24451; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; Teshima S, 1999, FEBS LETT, V452, P243, DOI 10.1016/S0014-5793(99)00636-5; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang G, 2008, INFECT IMMUN, V76, P153, DOI 10.1128/IAI.00791-07; WANG Y, 1993, J GEN MICROBIOL, V139, P2485, DOI 10.1099/00221287-139-10-2485; WILLETTS NS, 1969, J BACTERIOL, V100, P923, DOI 10.1128/JB.100.2.923-934.1969; WILLETTS NS, 1969, J BACTERIOL, V97, P244, DOI 10.1128/JB.97.1.244-249.1969; WILLETTS NS, 1969, J BACTERIOL, V100, P231, DOI 10.1128/JB.100.1.231-239.1969; WOLFSON JS, 1985, ANTIMICROB AGENTS CH, V28, P581, DOI 10.1128/AAC.28.4.581; Xu HX, 2004, CANCER RES, V64, P8521, DOI 10.1158/0008-5472.CAN-04-3511; Yeeles JTP, 2007, J MOL BIOL, V371, P66, DOI 10.1016/j.jmb.2007.05.053; Yu M, 1998, J MOL BIOL, V283, P797, DOI 10.1006/jmbi.1998.2127; Yu M, 1998, P NATL ACAD SCI USA, V95, P981, DOI 10.1073/pnas.95.3.981	80	27	27	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16759	16766		10.1074/jbc.M109.005587	http://dx.doi.org/10.1074/jbc.M109.005587			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19395381	hybrid, Green Published			2022-12-25	WOS:000266962400011
J	Yotsumoto, K; Saito, T; Asada, A; Oikawa, T; Kimura, T; Uchida, C; Ishiguro, K; Uchida, T; Hasegawa, M; Hisanaga, S				Yotsumoto, Kensuke; Saito, Taro; Asada, Akiko; Oikawa, Takayuki; Kimura, Taeko; Uchida, Chiyoko; Ishiguro, Koichi; Uchida, Takafumi; Hasegawa, Masato; Hisanaga, Shin-ichi			Effect of Pin1 or Microtubule Binding on Dephosphorylation of FTDP-17 Mutant Tau	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; ABNORMALLY PHOSPHORYLATED-TAU; FRONTOTEMPORAL DEMENTIA; WILD-TYPE; ALZHEIMER-DISEASE; PROLYL ISOMERASE; P301L TAU; MUTATIONS; BRAIN; SITE	Neurodegenerative tauopathies, including Alzheimer disease, are characterized by abnormal hyperphosphorylation of the microtubule-associated protein Tau. One group of tauopathies, known as frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17), is directly associated with mutations of the gene tau. However, it is unknown why mutant Tau is highly phosphorylated in the patient brain. In contrast to in vivo high phosphorylation, FTDP-17 Tau is phosphorylated less than wild-type Tau in vitro. Because phosphorylation is a balance between kinase and phosphatase activities, we investigated dephosphorylation of mutant Tau proteins, P301L and R406W. Tau phosphorylated by Cdk5-p25 was dephosphorylated by protein phosphatases in rat brain extracts. Compared with wildtype Tau, R406W was dephosphorylated faster and P301L slower. The two-dimensional phosphopeptide map analysis suggested that faster dephosphorylation of R406W was due to a lack of phosphorylation at Ser-404, which is relatively resistant to dephosphorylation. We studied the effect of the peptidylprolyl isomerase Pin1 or microtubule binding on dephosphorylation of wild-type Tau, P301L, and R406W in vitro. Pin1 catalyzes the cis/trans isomerization of phospho-Ser/Thr-Pro sequences in a subset of proteins. Dephosphorylation of wildtype Tau was reduced in brain extracts of Pin1-knockout mice, and this reduction was not observed with P301L and R406W. On the other hand, binding to microtubules almost abolished dephosphorylation of wild-type and mutant Tau proteins. These results demonstrate that mutation of Tau and its association with microtubules may change the conformation of Tau, thereby suppressing dephosphorylation and potentially contributing to the etiology of tauopathies.	[Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Fac Sci & Engn, Dept Biol Sci, Tokyo 1920397, Japan; [Oikawa, Takayuki; Hasegawa, Masato] Tokyo Metropolitan Inst Psychiat, Mol Neurobiol Lab, Tokyo 1568585, Japan; [Uchida, Chiyoko] Ibaraki Univ, Univ Hlth Ctr, Ibaraki 3108512, Japan; [Ishiguro, Koichi] Mitsubishi Kagaku Inst Life Sci, Tokyo 1948511, Japan; [Uchida, Takafumi] Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Biol, Sendai, Miyagi 9818555, Japan	Tokyo Metropolitan University; Ibaraki University; Mitsubishi Kagaku Institute of Life Sciences (MITILS); Tohoku University	Hisanaga, S (corresponding author), Tokyo Metropolitan Univ, Fac Sci & Engn, Dept Biol Sci, 1-1 Minami Osawa, Tokyo 1920397, Japan.	hisanaga-shinichi@tmu.ac.jp		yotsumoto, Kensuke/0000-0003-2258-6324; Uchida, Takafumi/0000-0003-3665-4906	MEXT of Japan	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research on Priority Area from MEXT of Japan (to S. H.).	Akiyama H, 2005, BIOCHEM BIOPH RES CO, V336, P521, DOI 10.1016/j.bbrc.2005.08.130; Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; Amos LA, 2005, ADV PROTEIN CHEM, V71, P257, DOI 10.1016/S0065-3233(04)71007-4; Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; Avila J, 2006, FEBS LETT, V580, P2922, DOI 10.1016/j.febslet.2006.02.067; Bird TD, 1999, BRAIN, V122, P741, DOI 10.1093/brain/122.4.741; Bunker JM, 2006, J BIOL CHEM, V281, P11856, DOI 10.1074/jbc.M509420200; Cole AR, 2008, J BIOL CHEM, V283, P18227, DOI 10.1074/jbc.M801645200; Connell JW, 2001, FEBS LETT, V493, P40, DOI 10.1016/S0014-5793(01)02267-0; Dayanandan R, 1999, FEBS LETT, V446, P228, DOI 10.1016/S0014-5793(99)00222-7; Fanghanel J, 2006, FEBS LETT, V580, P3237, DOI 10.1016/j.febslet.2006.04.087; Fischer D, 2007, BIOCHEMISTRY-US, V46, P2574, DOI 10.1021/bi061318s; Galas MC, 2006, J BIOL CHEM, V281, P19296, DOI 10.1074/jbc.M601849200; GOEDERT M, 1995, J NEUROCHEM, V65, P2804; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; GONG CX, 1994, NEUROSCIENCE, V61, P765, DOI 10.1016/0306-4522(94)90400-6; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; Han D, 2009, NEUROCHEM INT, V54, P14, DOI 10.1016/j.neuint.2008.09.014; Hanger DP, 1998, J NEUROCHEM, V71, P2465; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Hasegawa M, 2006, NEUROPATHOLOGY, V26, P484, DOI 10.1111/j.1440-1789.2006.00666.x; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Horowitz PM, 2006, BIOCHEMISTRY-US, V45, P12859, DOI 10.1021/bi061325g; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Imahori K, 1997, J BIOCHEM, V121, P179; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Kins S, 2001, J BIOL CHEM, V276, P38193; Krishnamurthy PK, 2004, J BIOL CHEM, V279, P7893, DOI 10.1074/jbc.M311203200; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 1999, NATURE, V399, P784; Mack TGA, 2001, NEUROSCIENCE, V108, P701, DOI 10.1016/S0306-4522(01)00434-1; MANDELKOW EM, 1995, NEUROBIOL AGING, V16, P355, DOI 10.1016/0197-4580(95)00025-A; Matsumura N, 1999, AM J PATHOL, V154, P1649, DOI 10.1016/S0002-9440(10)65420-X; Miyasaka T, 2001, AM J PATHOL, V158, P373, DOI 10.1016/S0002-9440(10)63979-X; Morfini G, 2007, J NEUROSCI RES, V85, P2620, DOI 10.1002/jnr.21154; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Perez M, 2000, J NEUROCHEM, V74, P2583, DOI 10.1046/j.1471-4159.2000.0742583.x; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Reed LA, 1997, ANN NEUROL, V42, P564, DOI 10.1002/ana.410420406; Rizzu P, 2000, HUM MOL GENET, V9, P3075, DOI 10.1093/hmg/9.20.3075; Sahara N, 2000, J NEUROSCI RES, V60, P380, DOI 10.1002/(SICI)1097-4547(20000501)60:3<380::AID-JNR13>3.0.CO;2-5; Saito T, 2003, J NEUROSCI, V23, P1189, DOI 10.1523/JNEUROSCI.23-04-01189.2003; Sakaue F, 2005, J BIOL CHEM, V280, P31522, DOI 10.1074/jbc.M504792200; Sasaki T, 2002, J BIOL CHEM, V277, P36032, DOI 10.1074/jbc.M206674200; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Smet C, 2004, BIOCHEMISTRY-US, V43, P2032, DOI 10.1021/bi035479x; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P1080, DOI 10.1093/jnen/63.10.1080; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Takahashi K, 2008, CELL MOL LIFE SCI, V65, P359, DOI 10.1007/s00018-007-7270-0; Tatebayashi Y, 2002, P NATL ACAD SCI USA, V99, P13896, DOI 10.1073/pnas.202205599; Tatebayashi Y, 2006, FASEB J, V20, P762, DOI 10.1096/fj.05-4362fje; van Swieten JC, 1999, ANN NEUROL, V46, P617, DOI 10.1002/1531-8249(199910)46:4<617::AID-ANA10>3.0.CO;2-I; Wada Y, 1998, J BIOCHEM-TOKYO, V124, P738, DOI 10.1093/oxfordjournals.jbchem.a022174; Wintjens R, 2001, J BIOL CHEM, V276, P25150, DOI 10.1074/jbc.M010327200; YAMAMOTO H, 1995, J BIOCHEM-TOKYO, V118, P1224, DOI 10.1093/oxfordjournals.jbchem.a125011; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	63	21	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16840	16847		10.1074/jbc.M109.003277	http://dx.doi.org/10.1074/jbc.M109.003277			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19401603	hybrid, Green Published			2022-12-25	WOS:000266962400020
J	Flahaut, M; Meier, R; Coulon, A; Nardou, KA; Niggli, FK; Martinet, D; Beckmann, JS; Joseph, JM; Muhlethaler-Mottet, A; Gross, N				Flahaut, M.; Meier, R.; Coulon, A.; Nardou, K. A.; Niggli, F. K.; Martinet, D.; Beckmann, J. S.; Joseph, J-M; Muehlethaler-Mottet, A.; Gross, N.			The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway	ONCOGENE			English	Article						neuroblastoma; chemoresistance; FZD1; MDR1; Wnt signalling	MULTIDRUG-RESISTANCE; GENE-EXPRESSION; BETA-CATENIN; CELL-LINES; INDUCED APOPTOSIS; CYCLIN D1; CANCER; CARCINOMA; TARGET; AMPLIFICATION	The development of chemoresistance represents a major obstacle in the successful treatment of cancers such as neuroblastoma (NB), a particularly aggressive childhood solid tumour. The mechanisms underlying the chemoresistant phenotype in NB were addressed by gene expression profiling of two doxorubicin (DoxR)-resistant vs sensitive parental cell lines. Not surprisingly, the MDR1 gene was included in the identified upregulated genes, although the highest overexpressed transcript in both cell lines was the frizzled-1 Wnt receptor (FZD1) gene, an essential component of the Wnt/beta-catenin pathway. FZD1 upregulation in resistant variants was shown to mediate sustained activation of the Wnt/b-catenin pathway as revealed by nuclear beta-catenin translocation and target genes transactivation. Interestingly, specific micro-adapted short hairpin RNA (shRNAmir)-mediated FZD1 silencing induced parallel strong decrease in the expression of MDR1, another beta-catenin target gene, revealing a complex, Wnt/beta-catenin-mediated implication of FZD1 in chemoresistance. The significant restoration of drug sensitivity in FZD1-silenced cells confirmed the FZD1-associated chemoresistance. RNA samples from 21 patient tumours (diagnosis and postchemotherapy), showed a highly significant FZD1 and/or MDR1 overexpression after treatment, underlining a role for FZD1-mediated Wnt/beta-catenin pathway in clinical chemoresistance. Our data represent the first implication of the Wnt/beta-catenin pathway in NB chemoresistance and identify potential new targets to treat aggressive and resistant NB. Oncogene (2009) 28, 2245-2256; doi:10.1038/onc.2009.80; published online 4 May 2009	[Flahaut, M.; Coulon, A.; Nardou, K. A.; Joseph, J-M; Muehlethaler-Mottet, A.; Gross, N.] Univ Hosp CHUV, Dept Paediat, CH-1011 Lausanne, Switzerland; [Meier, R.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Niggli, F. K.] Univ Children Hosp, Dept Paediat, Zurich, Switzerland; [Martinet, D.; Beckmann, J. S.] Univ Hosp CHUV, Med Genet Serv, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University Children's Hospital Zurich; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Flahaut, M (corresponding author), Univ Hosp CHUV, Dept Paediat, CH-1011 Lausanne, Switzerland.	Marjorie.Flahaut@chuv.ch	Mühlethaler-Mottet, Annick/H-2848-2019; Beckmann, Jacques S/A-9772-2008; Niggli, Felix/L-6547-2017	Mühlethaler-Mottet, Annick/0000-0001-8274-0907; Beckmann, Jacques S/0000-0002-9741-1900; Niggli, Felix/0000-0002-7553-3712	Schweizer Forschungsstiftung Kind und Krebs; Swiss National Science foundation; FORCE foundation	Schweizer Forschungsstiftung Kind und Krebs; Swiss National Science foundation(Swiss National Science Foundation (SNSF)European Commission); FORCE foundation	We thank M Wicht and N Besuchet Schmutz ( Medical Genetic Service, CHUV) for their skillful help. This study was supported by the Schweizer Forschungsstiftung Kind und Krebs, the Swiss National Science foundation and the FORCE foundation.	Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Bedrnicek J, 2005, NEOPLASMA, V52, P415; Blanc E, 2003, AM J PATHOL, V163, P321, DOI 10.1016/S0002-9440(10)63656-5; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Duhem, 1996, Oncologist, V1, P151; Eisenmann David M, 2005, WormBook, P1, DOI 10.1895/wormbook.1.7.1; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Flahaut M, 2006, GENE CHROMOSOME CANC, V45, P495, DOI 10.1002/gcc.20312; Gillet JP, 2007, BBA-REV CANCER, V1775, P237, DOI 10.1016/j.bbcan.2007.05.002; GOLDSTEIN LJ, 1990, J CLIN ONCOL, V8, P128, DOI 10.1200/JCO.1990.8.1.128; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Haber M, 1997, EUR J CANCER, V33, P2031, DOI 10.1016/S0959-8049(97)00229-3; Holcombe RF, 2002, J CLIN PATHOL-MOL PA, V55, P220, DOI 10.1136/mp.55.4.220; Hopkins-Donaldson S, 2002, ONCOGENE, V21, P6132, DOI 10.1038/sj.onc.1205879; Hopkins-Donaldson S, 2000, CANCER RES, V60, P4315; Johnsson A, 2005, ANTICANCER RES, V25, P2661; Kolligs FT, 2002, CANCER CELL, V1, P145, DOI 10.1016/S1535-6108(02)00035-1; Lastowska M, 2001, J CLIN ONCOL, V19, P3080; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; Liu X, 2008, ONCOGENE, V27, P1478, DOI 10.1038/sj.onc.1210769; Longo KA, 2002, J BIOL CHEM, V277, P38239, DOI 10.1074/jbc.M206402200; Ludwig JA, 2006, CANCER RES, V66, P4808, DOI 10.1158/0008-5472.CAN-05-3322; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Merle P, 2005, J HEPATOL, V43, P854, DOI 10.1016/j.jhep.2005.05.018; Milovanovic T, 2004, INT J ONCOL, V25, P1337; Modok S, 2006, CURR OPIN PHARMACOL, V6, P350, DOI 10.1016/j.coph.2006.01.009; Muhlethaler-Mottet A, 2004, ONCOGENE, V23, P5415, DOI 10.1038/sj.onc.1207704; Munoz M, 2007, IUBMB LIFE, V59, P752, DOI 10.1080/15216540701736285; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Norris MD, 1997, EUR J CANCER, V33, P1911, DOI 10.1016/S0959-8049(97)00284-0; Polakis P, 2000, GENE DEV, V14, P1837; Psarros M, 2005, NUCLEIC ACIDS RES, V33, pW638, DOI 10.1093/nar/gki490; SEEGER RC, 1977, CANCER RES, V37, P1364; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Sinner D, 2004, DEVELOPMENT, V131, P3069, DOI 10.1242/dev.01176; SMITH KJ, 1993, P NATL ACAD SCI USA, V90, P2846, DOI 10.1073/pnas.90.7.2846; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Ueno K, 2008, NEOPLASIA, V10, P697, DOI 10.1593/neo.08320; Valent A, 1999, CANCER GENET CYTOGEN, V112, P124, DOI 10.1016/S0165-4608(98)00264-7; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; Yamada T, 2000, CANCER RES, V60, P4761	44	138	146	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 11	2009	28	23					2245	2256		10.1038/onc.2009.80	http://dx.doi.org/10.1038/onc.2009.80			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	456XM	19421142				2022-12-25	WOS:000266886300001
J	Kadzhaev, K; Zingmark, C; Golovliov, I; Bolanowski, M; Shen, H; Conlan, W; Sjostedt, A				Kadzhaev, Konstantin; Zingmark, Carl; Golovliov, Igor; Bolanowski, Mark; Shen, Hua; Conlan, Wayne; Sjostedt, Anders			Identification of Genes Contributing to the Virulence of Francisella tularensis SCHU S4 in a Mouse Intradermal Infection Model	PLOS ONE			English	Article							LIVE VACCINE STRAIN; MOLECULAR-CLONING; O-ANTIGEN; PROTECTIVE IMMUNITY; SEQUENCE-ANALYSIS; ESCHERICHIA-COLI; ACID TRANSFERASE; MUTANT; DELETION; PROTEIN	Background: Francisella tularensis is a highly virulent human pathogen. The most virulent strains belong to subspecies tularensis and these strains cause a sometimes fatal disease. Despite an intense recent research effort, there is very limited information available that explains the unique features of subspecies tularensis strains that distinguish them from other F. tularensis strains and that explain their high virulence. Here we report the use of targeted mutagenesis to investigate the roles of various genes or pathways for the virulence of strain SCHU S4, the type strain of subspecies tularensis. Methodology/Principal Findings: The virulence of SCHU S4 mutants was assessed by following the outcome of infection after intradermal administration of graded doses of bacteria. By this route, the LD50 of the SCHU S4 strain is one CFU. The virulence of 20 in-frame deletion mutants and 37 transposon mutants was assessed. A majority of the mutants did not show increased prolonged time to death, among them notably Delta pyrB and Delta recA. Of the remaining, mutations in six unique targets, tolC, rep, FTT0609, FTT1149c, ahpC, and hfq resulted in significantly prolonged time to death and mutations in nine targets, rplA, wbtI, iglB, iglD, purL, purF, ggt, kdtA, and glpX, led to marked attenuation with an LD50 of >10(3) CFU. In fact, the latter seven mutants showed very marked attenuation with an LD50 of >= 10(7) CFU. Conclusions/Significance: The results demonstrate that the characterization of targeted mutants yielded important information about essential virulence determinants that will help to identify the so far little understood extreme virulence of F. tularensis subspecies tularensis.			Kadzhaev, K (corresponding author), Umea Univ, Dept Clin Microbiol, Umea, Sweden.	anders.sjostedt@climi.umu.se	Sjöstedt, Anders/AAC-6575-2020	Sjöstedt, Anders/0000-0002-0768-8405	NIAID NIH HHS [AI60689, R01 AI060689] Funding Source: Medline; PHS HHS [HHSN26620050041C] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060689] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alcantara RB, 2004, INFECT IMMUN, V72, P4911, DOI 10.1128/IAI.72.8.4911-4917.2004; Alkhuder K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000284; Ancuta P, 1996, INFECT IMMUN, V64, P2041, DOI 10.1128/IAI.64.6.2041-2046.1996; BERG JM, 1992, INFECT IMMUN, V60, P690, DOI 10.1128/IAI.60.2.690-693.1992; Bonquist L, 2008, INFECT IMMUN, V76, P3502, DOI 10.1128/IAI.00226-08; Broekhuijsen M, 2003, J CLIN MICROBIOL, V41, P2924, DOI 10.1128/JCM.41.7.2924-2931.2003; Broms JE, 2009, J BACTERIOL, V191, P2431, DOI 10.1128/JB.01759-08; Cole LE, 2008, J IMMUNOL, V180, P6885, DOI 10.4049/jimmunol.180.10.6885; Conlan JW, 2007, ANN NY ACAD SCI, V1105, P325, DOI 10.1196/annals.1409.012; Conlan JW, 2002, MICROB PATHOGENESIS, V32, P127, DOI 10.1006/mpat.2001.0489; Conlan JW, 2002, VACCINE, V20, P3465, DOI 10.1016/S0264-410X(02)00345-6; Crawford RM, 1996, INFECT IMMUN, V64, P2188, DOI 10.1128/IAI.64.6.2188-2192.1996; de Bruin OM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-1; Deng K, 2006, INFECT IMMUN, V74, P4224, DOI 10.1128/IAI.01975-05; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; Forslund AL, 2006, MOL MICROBIOL, V59, P1818, DOI 10.1111/j.1365-2958.2006.05061.x; FRIESEN JD, 1974, P NATL ACAD SCI USA, V71, P3465, DOI 10.1073/pnas.71.9.3465; Fuller JR, 2008, INFECT IMMUN, V76, P4934, DOI 10.1128/IAI.00475-08; Galperin MY, 1997, PROTEIN SCI, V6, P2639; Gil H, 2004, INFECT IMMUN, V72, P3042, DOI 10.1128/IAI.72.5.3042-3047.2004; Gil H, 2006, P NATL ACAD SCI USA, V103, P12897, DOI 10.1073/pnas.0602582103; Golovliov I, 2003, FEMS MICROBIOL LETT, V222, P273, DOI 10.1016/S0378-1097(03)00313-6; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; Hager AJ, 2006, MOL MICROBIOL, V62, P227, DOI 10.1111/j.1365-2958.2006.05365.x; KANG WK, 1989, MOL GEN GENET, V217, P281, DOI 10.1007/BF02464894; Kawula TH, 2004, APPL ENVIRON MICROB, V70, P6901, DOI 10.1128/AEM.70.11.6901-6904.2004; Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011; KISS K, 2008, FEMS MICROBIOL LETT; Kosuge T, 1997, FEMS MICROBIOL LETT, V157, P73, DOI 10.1016/S0378-1097(97)00456-4; Kotloff KL, 2004, J INFECT DIS, V190, P1745, DOI 10.1086/424680; Kraemer PS, 2009, INFECT IMMUN, V77, P232, DOI 10.1128/IAI.00978-08; Kulesus RR, 2008, INFECT IMMUN, V76, P3019, DOI 10.1128/IAI.00022-08; Lai XH, 2004, MICROB PATHOGENESIS, V37, P225, DOI 10.1016/j.micpath.2004.07.002; Langer RC, 2001, TRENDS PARASITOL, V17, P269, DOI 10.1016/S1471-4922(01)01918-3; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Li J, 2007, MICROBIOL-SGM, V153, P3141, DOI 10.1099/mic.0.2007/006460-0; Lindgren H, 2004, J MED MICROBIOL, V53, P953, DOI 10.1099/jmm.0.45685-0; Lindgren H, 2007, INFECT IMMUN, V75, P1303, DOI 10.1128/IAI.01717-06; Liu KY, 2003, MICROBIOL-SGM, V149, P1829, DOI 10.1099/mic.0.26234-0; LOBAU S, 1995, MOL MICROBIOL, V18, P391, DOI 10.1111/j.1365-2958.1995.mmi_18030391.x; McGovern KJ, 2001, INFECT IMMUN, V69, P4168, DOI 10.1128/IAI.69.6.4168-4173.2001; MEDINA V, 1990, J BACTERIOL, V172, P7151, DOI 10.1128/jb.172.12.7151-7156.1990; MEIBOM KL, 2009, HFQ NOVEL PLEIOTROPI; Morel F, 1999, MICROBIOL-UK, V145, P437, DOI 10.1099/13500872-145-2-437; Nano FE, 2007, ANN NY ACAD SCI, V1105, P122, DOI 10.1196/annals.1409.000; NORTH RJ, 1981, J IMMUNOL, V127, P342; OLSUFJEV NG, 1970, J HYG EPID MICROB IM, V14, P67; Pechous RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002487; Peng DX, 2005, INFECT IMMUN, V73, P4222, DOI 10.1128/IAI.73.7.4222-4230.2005; Qin AP, 2008, INFECT IMMUN, V76, P3086, DOI 10.1128/IAI.00363-08; Qin AP, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-69; Qin AP, 2009, INFECT IMMUN, V77, P152, DOI 10.1128/IAI.01113-08; Quarry JE, 2007, VACCINE, V25, P2011, DOI 10.1016/j.vaccine.2006.11.054; Raynaud C, 2007, INFECT IMMUN, V75, P536, DOI 10.1128/IAI.01429-06; Rohmer L, 2006, INFECT IMMUN, V74, P6895, DOI 10.1128/IAI.01006-06; Sander P, 2001, INFECT IMMUN, V69, P3562, DOI 10.1128/IAI.69.6.3562-3568.2001; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; Santic M, 2007, CELL MICROBIOL, V9, P2391, DOI 10.1111/j.1462-5822.2007.00968.x; Shen H, 2004, VACCINE, V22, P2116, DOI 10.1016/j.vaccine.2003.12.003; Sjostedt A, 2006, MICROBES INFECT, V8, P561, DOI 10.1016/j.micinf.2005.08.001; SJOSTEDT AB, 2005, PROTEOBACTERIA B, V2, P200; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Staples JE, 2006, EMERG INFECT DIS, V12, P1113; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; Tarnvik A, 2003, EUR RESPIR J, V21, P361, DOI 10.1183/09031936.03.00088903; Tarnvik A, 2007, ANN NY ACAD SCI, V1105, P378, DOI 10.1196/annals.1409.017; Tempel R, 2006, INFECT IMMUN, V74, P5095, DOI 10.1128/IAI.00598-06; Thomas RM, 2007, INFECT IMMUN, V75, P371, DOI 10.1128/IAI.01241-06; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Wang JY, 2001, INFECT IMMUN, V69, P4734, DOI 10.1128/IAI.69.8.4734-4741.2001; Wehmeier L, 2001, MICROBIOL-UK, V147, P691, DOI 10.1099/00221287-147-3-691; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; WOOD WB, 1980, MICROBIOLOGY, P551; Yimga MT, 2006, INFECT IMMUN, V74, P1130, DOI 10.1128/IAI.74.2.1130-1140.2006; Zogaj X, 2008, MICROBIOL-SGM, V154, P2139, DOI 10.1099/mic.0.2008/018077-0	78	87	90	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5463	10.1371/journal.pone.0005463	http://dx.doi.org/10.1371/journal.pone.0005463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424499	Green Published, gold, Green Submitted			2022-12-25	WOS:000265933800002
J	Ralser, M; Zeidler, U; Lehrach, H				Ralser, Markus; Zeidler, Ute; Lehrach, Hans			Interfering with Glycolysis Causes Sir2-Dependent Hyper-Recombination of Saccharomyces cerevisiae Plasmids	PLOS ONE			English	Article								Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a key metabolic regulator implicated in a variety of cellular processes. It functions as a glycolytic enzyme, a protein kinase, and a metabolic switch under oxidative stress. Its enzymatic inactivation causes a major shift in the primary carbohydrate flux. Furthermore, the protein is implicated in regulating transcription, ER-to-Golgi transport, and apoptosis. We found that Saccharomyces cerevisiae cells null for all GAPDH paralogues (Tdh1, Tdh2, and Tdh3) survived the counter-selection of a GAPDH-encoding plasmid when the NAD+ metabolizing deacetylase Sir2 was overexpressed. This phenotype required a fully functional copy of SIR2 and resulted from hyper-recombination between S. cerevisiae plasmids. In the wild-type background, GAPDH overexpression increased the plasmid recombination rate in a growth-condition dependent manner. We conclude that GAPDH influences yeast episome stability via Sir2 and propose a model for the interplay of Sir2, GAPDH, and the glycolytic flux.			Ralser, M (corresponding author), Max Planck Inst Mol Genet, Berlin, Germany.	ralser@molgen.mpg.de		Ralser, Markus/0000-0001-9535-7413				Abdullah MFF, 2001, P NATL ACAD SCI USA, V98, P14524, DOI 10.1073/pnas.201529598; BOLES E, 1993, EUR J BIOCHEM, V217, P469, DOI 10.1111/j.1432-1033.1993.tb18266.x; Brachmann CB, 1998, YEAST, V14, P115; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Chiani F, 2006, NUCLEIC ACIDS RES, V34, P5426, DOI 10.1093/nar/gkl678; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902; Colussi C, 2000, FASEB J, V14, P2266, DOI 10.1096/fj.00-0074com; Cubizolles F, 2006, MOL CELL, V21, P825, DOI 10.1016/j.molcel.2006.02.006; Cumming RC, 2005, FASEB J, V19, P2060, DOI 10.1096/fj.05-4195fje; Dastoor Z, 2001, J CELL SCI, V114, P1643; Duclos-Vallee JC, 1998, J GEN VIROL, V79, P1665, DOI 10.1099/0022-1317-79-7-1665; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Grant Chris M, 2008, J Biol, V7, P1, DOI 10.1186/jbiol63; Grunweller A, 2002, GENETICS, V162, P59; Hadany L, 2003, GENETICS, V165, P2167; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Holtgrefe S, 2008, PHYSIOL PLANTARUM, V133, P211, DOI 10.1111/j.1399-3054.2008.01066.x; Ishii T, 1999, BIOCHEM PHARMACOL, V58, P133, DOI 10.1016/S0006-2952(99)00060-X; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2007, AGEING RES REV, V6, P128, DOI 10.1016/j.arr.2007.04.001; Laschet JJ, 2004, J NEUROSCI, V24, P7614, DOI 10.1523/JNEUROSCI.0868-04.2004; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Masri FA, 2005, AM J RESP CRIT CARE, V172, P597, DOI 10.1164/rccm.200411-1523OC; Matecic M, 2002, GENETICS, V162, P973; MCALISTER L, 1985, J BIOL CHEM, V260, P5019; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; NEWMAN SF, 2007, J NEUROSCI RES; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Ralser M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000030; RAVICHANDRAN V, 1994, J BIOL CHEM, V269, P25010; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Shenton D, 2003, BIOCHEM J, V374, P513, DOI 10.1042/BJ20030414; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Tisdale EJ, 2007, TRAFFIC, V8, P733, DOI 10.1111/j.1600-0854.2007.00569.x; Verho R, 2003, APPL ENVIRON MICROB, V69, P5892, DOI 10.1128/AEM.69.10.5892-5897.2003; Verho R, 2002, BIOCHEMISTRY-US, V41, P13833, DOI 10.1021/bi0265325; Voss P, 2007, BIOL CHEM, V388, P583, DOI 10.1515/BC.2007.068; Warburg O, 1939, BIOCHEM Z, V303, P40; Wentzel P, 2003, DIABETES, V52, P1222, DOI 10.2337/diabetes.52.5.1222; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	48	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5376	10.1371/journal.pone.0005376	http://dx.doi.org/10.1371/journal.pone.0005376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390637	Green Published, Green Submitted, gold			2022-12-25	WOS:000265514400023
J	Yao, J; Bajjalieh, SM				Yao, Jia; Bajjalieh, Sandra M.			SVOP Is a Nucleotide Binding Protein	PLOS ONE			English	Article							SYNAPTIC VESICLE PROTEIN; SUGAR-TRANSPORT REGULATION; MEMBRANE-PROTEINS; LEVETIRACETAM; SV2; BRAIN; IDENTIFICATION; DETERMINANTS	Background: Synaptic Vesicle Protein 2 (SV2) and SV2-related protein (SVOP) are transporter-like proteins that localize to neurotransmitter-containing vesicles. Both proteins share structural similarity with the major facilitator (MF) family of small molecule transporters. We recently reported that SV2 binds nucleotides, a feature that has also been reported for another MF family member, the human glucose transporter 1 (Glut1). In the case of Glut1, nucleotide binding affects transport activity. In this study, we determined if SVOP also binds nucleotides and assessed its nucleotide binding properties. Methodology/Principal Findings: We performed in vitro photoaffinity labeling experiments with the photoreactive ATP analogue, 8-azido-ATP[gamma] biotin and purified recombinant SVOP-FLAG fusion protein. We found that SVOP is a nucleotide-binding protein, although both its substrate specificity and binding site differ from that of SV2. Within the nucleotides tested, ATP, GTP and NAD show same level of inhibition on SVOP-FLAG labeling. Dose dependent studies indicated that SVOP demonstrates the highest affinity for NAD, in contrast to SV2, which binds both NAD and ATP with equal affinity. Mapping of the binding site revealed a single region spanning transmembrane domains 9-12, which contrasts to the two binding sites in the large cytoplasmic domains in SV2A. Conclusions/Significance: SVOP is the third MF family member to be found to bind nucleotides. Given that the binding sites are unique in SVOP, SV2 and Glut1, this feature appears to have arisen separately.			Yao, J (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	bajjalie@u.washington.edu	Yao, Jia/D-3484-2009; Yao, Jia/E-8711-2011	Yao, Jia/0000-0003-3235-5351	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059842] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH059842, R01MH059842] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ardid D, 2003, EUR J PHARMACOL, V473, P27, DOI 10.1016/S0014-2999(03)01933-2; BAJJALIEH SM, 1992, SCIENCE, V257, P1271, DOI 10.1126/science.1519064; BAJJALIEH SM, 1993, P NATL ACAD SCI USA, V90, P2150, DOI 10.1073/pnas.90.6.2150; Bornstein P, 1977, Methods Enzymol, V47, P132; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; Carreno M, 2007, DRUG TODAY, V43, P769, DOI 10.1358/dot.2007.43.11.1136902; CARRUTHERS A, 1989, BIOCHEMISTRY-US, V28, P8337, DOI 10.1021/bi00447a011; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; Enggaard TP, 2006, EUR J PAIN, V10, P193, DOI 10.1016/j.ejpain.2005.03.011; FEANY MB, 1992, CELL, V70, P861, DOI 10.1016/0092-8674(92)90319-8; FLOOR E, 1989, J NEUROCHEM, V52, P1433, DOI 10.1111/j.1471-4159.1989.tb09190.x; Gillard M, 2006, EUR J PHARMACOL, V536, P102, DOI 10.1016/j.ejphar.2006.02.022; Henderson PJF, 1993, CURR OPIN CELL BIOL, V5, P708, DOI 10.1016/0955-0674(93)90144-F; Jacobsson JA, 2007, GENOMICS, V90, P595, DOI 10.1016/j.ygeno.2007.03.017; Janz R, 1999, NEUROSCIENCE, V94, P1279, DOI 10.1016/S0306-4522(99)00370-X; Janz R, 1998, J NEUROSCI, V18, P9269; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Lazzell DR, 2004, J BIOL CHEM, V279, P52124, DOI 10.1074/jbc.M407502200; Levine KB, 2002, BIOCHEMISTRY-US, V41, P12629, DOI 10.1021/bi0258997; Levine KB, 1998, BIOCHEMISTRY-US, V37, P12221, DOI 10.1021/bi980585y; Logan MA, 2005, DEV DYNAM, V234, P802, DOI 10.1002/dvdy.20618; LOWE AW, 1988, J CELL BIOL, V106, P51, DOI 10.1083/jcb.106.1.51; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Matagne A, 2008, BRIT J PHARMACOL, V154, P1662, DOI 10.1038/bjp.2008.198; Meco G, 2006, CLIN NEUROPHARMACOL, V29, P265, DOI 10.1097/01.WNF.0000228807.49044.7D; Schivell AE, 2005, MOL CELL NEUROSCI, V29, P56, DOI 10.1016/j.mcn.2004.12.011; Schivell AE, 1996, J BIOL CHEM, V271, P27770, DOI 10.1074/jbc.271.44.27770; Woods SW, 2008, J CLIN PSYCHIAT, V69, P546, DOI 10.4088/JCP.v69n0405; Xu T, 2001, NAT CELL BIOL, V3, P691, DOI 10.1038/35087000; Yao J, 2008, J BIOL CHEM, V283, P20628, DOI 10.1074/jbc.M800738200	32	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5315	10.1371/journal.pone.0005315	http://dx.doi.org/10.1371/journal.pone.0005315			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390693	Green Published, Green Submitted, gold			2022-12-25	WOS:000265514400007
J	Kleene, SJ				Kleene, Steven J.			Limits of Calcium Clearance by Plasma Membrane Calcium ATPase in Olfactory Cilia	PLOS ONE			English	Article							ULTRASTRUCTURAL-LOCALIZATION; SODIUM/CALCIUM EXCHANGER; RECEPTOR NEURONS; CA2+ EXTRUSION; FROG; RAT; CHANNELS; CELLS; AMPLIFICATION; CONDUCTANCE	Background: In any fine sensory organelle, a small influx of Ca2+ can quickly elevate cytoplasmic Ca2+. Mechanisms must exist to clear the ciliary Ca2+ before it reaches toxic levels. One such organelle has been well studied: the vertebrate olfactory cilium. Recent studies have suggested that clearance from the olfactory cilium is mediated in part by plasma membrane Ca2+-ATPase (PMCA). Principal Findings: In the present study, electrophysiological assays were devised to monitor cytoplasmic free Ca2+ in single frog olfactory cilia. Ca2+ was allowed to enter isolated cilia, either through the detached end or through membrane channels. Intraciliary Ca2+ was monitored via the activity of ciliary Ca2+-gated Cl- channels, which are sensitive to free Ca2+ from about 2 to 10 mu M. No significant effect of MgATP on intraciliary free Ca2+ could be found. Carboxyeosin, which has been used to inhibit PMCA, was found to substantially increase a ciliary transduction current activated by cyclic AMP. This increase was ATP-independent. Conclusions: Alternative explanations are suggested for two previous experiments taken to support a role for PMCA in ciliary Ca2+ clearance. It is concluded that PMCA in the cilium plays a very limited role in clearing the micromolar levels of intraciliary Ca2+ produced during the odor response.			Kleene, SJ (corresponding author), Univ Cincinnati, Dept Canc & Cell Biol, Cincinnati, OH 45221 USA.	steve@syrano.acb.uc.edu						Antolin S, 2007, J PHYSIOL-LONDON, V581, P495, DOI 10.1113/jphysiol.2007.131094; Badamdorj D, 2008, MATH METHOD APPL SCI, V31, P1860, DOI 10.1002/mma.1007; BERS DM, 1982, AM J PHYSIOL, V242, pC404, DOI 10.1152/ajpcell.1982.242.5.C404; Brini M, 2000, CELL MOL LIFE SCI, V57, P354, DOI 10.1007/PL00000698; Castillo K, 2007, EUR J NEUROSCI, V26, P2524, DOI 10.1111/j.1460-9568.2007.05863.x; CHA YN, 1971, J GEN PHYSIOL, V57, P202, DOI 10.1085/jgp.57.2.202; Delgado R, 2004, EUR J NEUROSCI, V20, P2975, DOI 10.1111/j.1460-9568.2004.03778.x; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; FARBMAN AI, 1992, CELL BIOL OLFACTION; GRAF E, 1982, BIOCHEMISTRY-US, V21, P4511, DOI 10.1021/bi00261a049; JUNG A, 1994, NEUROREPORT, V5, P1741, DOI 10.1097/00001756-199409080-00013; KERN RC, 1991, BRAIN RES, V546, P8, DOI 10.1016/0006-8993(91)91153-R; KLEENE SJ, 1991, J MEMBRANE BIOL, V120, P75, DOI 10.1007/BF01868593; KLEENE SJ, 1993, NEURON, V11, P123, DOI 10.1016/0896-6273(93)90276-W; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; Kleene SJ, 2008, CHEM SENSES, V33, P839, DOI 10.1093/chemse/bjn048; Klimmeck D, 2008, NEUROSCIENCE, V151, P901, DOI 10.1016/j.neuroscience.2007.11.023; Kreitzer MA, 2007, J GEN PHYSIOL, V130, P169, DOI 10.1085/jgp.200709737; KURAHASHI T, 1993, NATURE, V363, P71, DOI 10.1038/363071a0; Kwon HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004260; Leinders-Zufall T, 1998, J NEUROSCI, V18, P5630; Lindemann B, 2001, BIOPHYS J, V80, P1712, DOI 10.1016/S0006-3495(01)76142-5; LO YH, 1994, BBA-BIOMEMBRANES, V1192, P153, DOI 10.1016/0005-2736(94)90113-9; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; Mackiewicz U, 2009, CARDIOVASC RES, V81, P546, DOI 10.1093/cvr/cvn285; Mayer U, 2009, PROTEOMICS, V9, P322, DOI 10.1002/pmic.200800149; Menco BPM, 1997, CHEM SENSES, V22, P295, DOI 10.1093/chemse/22.3.295; MENCO BPM, 1980, CELL TISSUE RES, V207, P183; Menco BPM, 1998, CHEM SENSES, V23, P137, DOI 10.1093/chemse/23.2.137; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Noe J, 1997, NEUROCHEM INT, V30, P523, DOI 10.1016/S0197-0186(96)00090-3; Pifferi S, 2006, P NATL ACAD SCI USA, V103, P12929, DOI 10.1073/pnas.0604505103; REESE TS, 1965, J CELL BIOL, V25, P209, DOI 10.1083/jcb.25.2.209; REGA AF, 1973, BIOCHEM J, V136, P185, DOI 10.1042/bj1360185; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Reisert J, 1998, J GEN PHYSIOL, V112, P529, DOI 10.1085/jgp.112.5.529; Schuh K, 2004, J BIOL CHEM, V279, P28220, DOI 10.1074/jbc.M312599200; Shmigol A, 1998, PFLUG ARCH EUR J PHY, V437, P158, DOI 10.1007/s004240050761; SZEWCZYK M, 2007, PFLUGERS ARCH, V456, P255; Takeuchi H, 2008, J NEUROSCI, V28, P766, DOI 10.1523/JNEUROSCI.3531-07.2008; Tian J, 2008, PHYSIOLOGY, V23, P205, DOI 10.1152/physiol.00008.2008; Wanaverbecq N, 2003, J PHYSIOL-LONDON, V550, P83, DOI 10.1113/jphysiol.2002.035782; Weeraratne SD, 2006, CHEM SENSES, V31, P725, DOI 10.1093/chemse/bjl014	43	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5266	10.1371/journal.pone.0005266	http://dx.doi.org/10.1371/journal.pone.0005266			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390572	Green Published, Green Submitted, gold			2022-12-25	WOS:000265514200005
J	Breneman, KD; Brownell, WE; Rabbitt, RD				Breneman, Kathryn D.; Brownell, William E.; Rabbitt, Richard D.			Hair Cell Bundles: Flexoelectric Motors of the Inner Ear	PLOS ONE			English	Article								Microvilli (stereocilia) projecting from the apex of hair cells in the inner ear are actively motile structures that feed energy into the vibration of the inner ear and enhance sensitivity to sound. The biophysical mechanism underlying the hair bundle motor is unknown. In this study, we examined a membrane flexoelectric origin for active movements in stereocilia and conclude that it is likely to be an important contributor to mechanical power output by hair bundles. We formulated a realistic biophysical model of stereocilia incorporating stereocilia dimensions, the known flexoelectric coefficient of lipid membranes, mechanical compliance, and fluid drag. Electrical power enters the stereocilia through displacement sensitive ion channels and, due to the small diameter of stereocilia, is converted to useful mechanical power output by flexoelectricity. This motor augments molecular motors associated with the mechanosensitive apparatus itself that have been described previously. The model reveals stereocilia to be highly efficient and fast flexoelectric motors that capture the energy in the extracellular electro-chemical potential of the inner ear to generate mechanical power output. The power analysis provides an explanation for the correlation between stereocilia height and the tonotopic organization of hearing organs. Further, results suggest that flexoelectricity may be essential to the exquisite sensitivity and frequency selectivity of non-mammalian hearing organs at high auditory frequencies, and may contribute to the "cochlear amplifier'' in mammals.			Breneman, KD (corresponding author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.	r.rabbitt@utah.edu		Rabbitt, Richard/0000-0002-2959-7248	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002775, R01DC000354, F32DC000384, R01DC006685, R01DC004928] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC002775, R01 DC004928, R01 DC000354-23, R01 DC002775-12, R01 DC00384, R01 DC000354, R01 DC04928, R01 DC006685, R01 DC06685, F32 DC000384, R01 DC002775-13, R01 DC000354-22] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abnet CC, 2000, HEARING RES, V144, P29, DOI 10.1016/S0378-5955(00)00041-1; ANVARI B, 2007, C P IEEE ENG MED BIO, V1, P5384; Benser ME, 1996, J NEUROSCI, V16, P5629; BRENEMAN KD, 2008, BIOPHYS J; BRENEMAN KD, 2008, SCIENCE UNPUB; Cotton J, 2004, HEARING RES, V197, P105, DOI 10.1016/j.heares.2004.06.005; Cotton JR, 2000, J BIOMECH ENG-T ASME, V122, P44, DOI 10.1115/1.429626; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; Eguiluz VM, 2000, PHYS REV LETT, V84, P5232, DOI 10.1103/PhysRevLett.84.5232; FLOCK A, 1976, J PHYSIOL-LONDON, V257, P45, DOI 10.1113/jphysiol.1976.sp011355; FRISHKOPF LS, 1983, HEARING RES, V12, P393, DOI 10.1016/0378-5955(83)90008-4; FUCHS PA, 1992, J NEUROSCI, V12, P800; FUNG YC, 1979, 1 COURSE CONTINUUM M; GARFINKLE TJ, 1983, OTOLARYNG HEAD NECK, V91, P421, DOI 10.1177/019459988309100415; GEISLER CD, 1974, J ACOUST SOC AM, V56, P1910, DOI 10.1121/1.1903533; Glassinger E, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041926; GUINAN JJ, 1997, J ACOUST SOC AM, V100, P1980; HACKNEY CM, 1993, HEARING RES, V69, P163, DOI 10.1016/0378-5955(93)90104-9; Halter JA, 1997, NEUROREPORT, V8, P2517, DOI 10.1097/00001756-199707280-00020; Happel, 2012, LOW REYNOLDS NUMBER; HARASZTOSI C, 2009, LOCATING MET CHANNEL; HOCHMUTH RM, 1982, BIOPHYS J, V39, P71, DOI 10.1016/S0006-3495(82)84492-5; HOCHMUTH RM, 1982, BIOPHYS J, V39, P83, DOI 10.1016/S0006-3495(82)84493-7; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; HOLTON T, 1983, SCIENCE, V222, P508, DOI 10.1126/science.6623089; Hudspeth A, 2005, CR BIOL, V328, P155, DOI 10.1016/j.crvi.2004.12.003; Hudspeth AJ, 2008, NEURON, V59, P530, DOI 10.1016/j.neuron.2008.07.012; HUDSPETH AJ, 1985, SCIENCE, V230, P745, DOI 10.1126/science.2414845; HUDSPETH AJ, 1982, J NEUROSCI, V2, P1; HUXLEY AF, 1974, J PHYSIOL-LONDON, V243, P1; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; LIBERMAN MC, 1980, HEARING RES, V3, P189, DOI 10.1016/0378-5955(80)90046-5; Lin HW, 2005, CURR OPIN CELL BIOL, V17, P55, DOI 10.1016/j.ceb.2004.12.005; Martin P, 1999, P NATL ACAD SCI USA, V96, P14306, DOI 10.1073/pnas.96.25.14306; Meirovitch L., 1967, ANAL METHODS VIBRATI; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; MULROY MJ, 1987, HEARING RES, V25, P11, DOI 10.1016/0378-5955(87)90075-X; Murugasu E, 1996, J NEUROSCI, V16, P325; Nam JH, 2006, BIOPHYS J, V90, P2786, DOI 10.1529/biophysj.105.066027; Nam JH, 2007, BIOPHYS J, V92, P1918, DOI 10.1529/biophysj.106.085076; Petrov AG, 2002, BBA-BIOMEMBRANES, V1561, P1, DOI 10.1016/S0304-4157(01)00007-7; PETROV AG, 1994, EUR BIOPHYS J BIOPHY, V23, P1, DOI 10.1007/BF00192201; PETROV AG, 1975, FLEXOELECTRIC MODEL, P111; RABBITT RD, 2008, POWER EFFICIEN UNPUB; Raphael RM, 2000, BIOPHYS J, V78, P2844, DOI 10.1016/S0006-3495(00)76827-5; Rattay F, 1998, J ACOUST SOC AM, V103, P1558, DOI 10.1121/1.421291; Ricci AJ, 2000, J NEUROSCI, V20, P7131; Stepanyan R, 2006, J PHYSIOL-LONDON, V576, P801, DOI 10.1113/jphysiol.2006.118547; TENKATE JH, 1970, J EXP BIOL, V53, P495; Tiersten H.F., 1969, LINEAR PIEZOELECTRIC, DOI [10.1007/978-1-4899-6453-3, DOI 10.1007/978-1-4899-6453-3]; TILNEY LG, 1983, J CELL BIOL, V96, P822, DOI 10.1083/jcb.96.3.822; Vater M, 1996, HEARING RES, V94, P63, DOI 10.1016/0378-5955(96)00005-6; Verpy E, 2008, NATURE, V456, P255, DOI 10.1038/nature07380; Weiss T., 1996, CELLULAR BIOPHYSICS, VII; WEISS TF, 1976, BRAIN RES, V115, P71, DOI 10.1016/0006-8993(76)90823-4; WRIGHT A, 1984, HEARING RES, V13, P89, DOI 10.1016/0378-5955(84)90099-6; Zetes DE, 1997, J ACOUST SOC AM, V101, P3593, DOI 10.1121/1.418320	57	57	59	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5201	10.1371/journal.pone.0005201	http://dx.doi.org/10.1371/journal.pone.0005201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384413	Green Published, Green Submitted, gold			2022-12-25	WOS:000265513900002
J	Gentili, RJ; Papaxanthis, C; Ebadzadeh, M; Eskiizmirliler, S; Ouanezar, S; Darlot, C				Gentili, Rodolphe J.; Papaxanthis, Charalambos; Ebadzadeh, Mehdi; Eskiizmirliler, Selim; Ouanezar, Sofiane; Darlot, Christian			Integration of Gravitational Torques in Cerebellar Pathways Allows for the Dynamic Inverse Computation of Vertical Pointing Movements of a Robot Arm	PLOS ONE			English	Article							BASAL GANGLIA; MOTOR CONTROL; REACHING MOVEMENTS; NEURONAL-ACTIVITY; INTERNAL-MODELS; SENSORIMOTOR; CORTEX; PREDICTION; DIRECTION; MUSCLES	Background: Several authors suggested that gravitational forces are centrally represented in the brain for planning, control and sensorimotor predictions of movements. Furthermore, some studies proposed that the cerebellum computes the inverse dynamics (internal inverse model) whereas others suggested that it computes sensorimotor predictions (internal forward model). Methodology/Principal Findings: This study proposes a model of cerebellar pathways deduced from both biological and physical constraints. The model learns the dynamic inverse computation of the effect of gravitational torques from its sensorimotor predictions without calculating an explicit inverse computation. By using supervised learning, this model learns to control an anthropomorphic robot arm actuated by two antagonists McKibben artificial muscles. This was achieved by using internal parallel feedback loops containing neural networks which anticipate the sensorimotor consequences of the neural commands. The artificial neural networks architecture was similar to the large-scale connectivity of the cerebellar cortex. Movements in the sagittal plane were performed during three sessions combining different initial positions, amplitudes and directions of movements to vary the effects of the gravitational torques applied to the robotic arm. The results show that this model acquired an internal representation of the gravitational effects during vertical arm pointing movements. Conclusions/Significance: This is consistent with the proposal that the cerebellar cortex contains an internal representation of gravitational torques which is encoded through a learning process. Furthermore, this model suggests that the cerebellum performs the inverse dynamics computation based on sensorimotor predictions. This highlights the importance of sensorimotor predictions of gravitational torques acting on upper limb movements performed in the gravitational field.			Gentili, RJ (corresponding author), Univ Paris 05, CNRS, UMR 7060, Paris, France.	charalambos.papaxanthis@u-bourgogne.fr	Ebadzadeh, Mohammad Mehdi/F-7542-2013; Ebadzadeh, Mohammad Mehdi/AAA-1476-2020	Ebadzadeh, Mohammad Mehdi/0000-0001-6466-5229				Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 2003, EXP BRAIN RES, V153, P239, DOI 10.1007/s00221-003-1597-z; Blakemore SJ, 2001, NEUROREPORT, V12, P1879, DOI 10.1097/00001756-200107030-00023; BULLOCK D, 1993, J COGNITIVE NEUROSCI, V5, P408, DOI 10.1162/jocn.1993.5.4.408; Cheron G, 1997, ELECTROMYOGR MOTOR C, V105, P58, DOI 10.1016/S0924-980X(96)96544-3; Clower DM, 2001, J NEUROSCI, V21, P6283, DOI 10.1523/JNEUROSCI.21-16-06283.2001; Darlot C, 1996, BIOL CYBERN, V75, P173, DOI 10.1007/s004220050285; DATTA A, 1998, ADAPTIVE INTERNAL MO, P50; Diedrichsen J, 2005, J NEUROSCI, V25, P9919, DOI 10.1523/JNEUROSCI.1874-05.2005; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Ebadzadeh M, 2005, NEUROSCIENCE, V133, P29, DOI 10.1016/j.neuroscience.2004.09.048; Ebadzadeh M, 2003, NEUROSCIENCE, V122, P941, DOI 10.1016/S0306-4522(03)00569-4; Eccles JC, 1967, CEREBELLUM NEURONAL; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Eskiizmirliler S, 2002, BIOL CYBERN, V86, P379, DOI 10.1007/s00422-001-0302-1; Flanagan JR, 2001, J NEUROSCI, V21, P1361; Flanagan JR, 2003, CURR BIOL, V13, P146, DOI 10.1016/S0960-9822(03)00007-1; Gentili R, 2007, NEUROSCIENCE, V145, P20, DOI 10.1016/j.neuroscience.2006.11.035; Gentili R, 2006, NEUROSCIENCE, V137, P761, DOI 10.1016/j.neuroscience.2005.10.013; Gentili R, 2004, BEHAV BRAIN RES, V155, P231, DOI 10.1016/j.bbr.2004.04.027; Glickstein M, 2000, TRENDS NEUROSCI, V23, P613, DOI 10.1016/S0166-2236(00)01681-7; Grosse-Wentrup M, 2007, BIOL CYBERN, V96, P377, DOI 10.1007/s00422-007-0142-8; Haruno M, 2001, NEURAL COMPUT, V13, P2201, DOI 10.1162/089976601750541778; Holscher C, 2003, BEHAV BRAIN RES, V142, P181, DOI 10.1016/S0166-4328(02)00422-9; Imamizu H, 2004, J NEUROSCI, V24, P1173, DOI 10.1523/JNEUROSCI.4011-03.2004; Indovina I, 2005, SCIENCE, V308, P416, DOI 10.1126/science.1107961; Ito M, 1984, CEREBELLUM NEURAL CO; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Jordan M., 1999, COGNITIVE NEUROSCIEN, P601; Jordan M. I., 1986, PROC C COGNITIVE SCI, P531; JORDAN MI, 1992, COGNITIVE SCI, V16, P307, DOI 10.1207/s15516709cog1603_1; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; KAWATO M, 1992, TRENDS NEUROSCI, V15, P445, DOI 10.1016/0166-2236(92)90008-V; Kawato M, 2007, CURR OPIN NEUROBIOL, V17, P205, DOI 10.1016/j.conb.2007.03.004; Manzoni D, 2007, CEREBELLUM, V6, P24, DOI 10.1080/14734220601132135; Manzoni D, 2005, CEREBELLUM, V4, P178, DOI 10.1080/14734220500193493; Maschke M, 2004, J NEUROPHYSIOL, V91, P230, DOI 10.1152/jn.00557.2003; McIntyre J, 2000, NEURAL COMPUT, V12, P2823, DOI 10.1162/089976600300014746; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Middleton FA, 1998, TRENDS COGN SCI, V2, P348, DOI 10.1016/S1364-6613(98)01220-0; Mitsuo K, 2003, PROG BRAIN RES, V142, P171; Okatan M, 2009, HIPPOCAMPUS, V19, P487, DOI 10.1002/hipo.20535; Papaxanthis C, 2002, EXP BRAIN RES, V143, P447, DOI 10.1007/s00221-002-1012-1; Papaxanthis C, 1998, NEUROSCI LETT, V253, P103, DOI 10.1016/S0304-3940(98)00604-1; Pigeon P, 2003, J NEUROPHYSIOL, V89, P276, DOI 10.1152/jn.00159.2001; Pozzo T, 1998, BRAIN RES REV, V28, P92, DOI 10.1016/S0165-0173(98)00030-7; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Rost K, 2005, CLIN NEUROPHYSIOL, V116, P1405, DOI 10.1016/j.clinph.2005.02.015; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schweighofer N, 1998, EUR J NEUROSCI, V10, P86, DOI 10.1046/j.1460-9568.1998.00006.x; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P595, DOI 10.1152/jn.1989.62.2.595; Spoelstra J, 2000, BIOL CYBERN, V82, P321, DOI 10.1007/s004220050586; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Tani J, 1999, NEURAL NETWORKS, V12, P1131, DOI 10.1016/S0893-6080(99)00060-X; Tani J, 2003, IEEE T SYST MAN CY A, V33, P481, DOI 10.1109/TSMCA.2003.809171; TANI J, 2007, FRONT NEUROROBOTICS, V1, P1; Tondu B, 2000, IEEE CONTR SYST MAG, V20, P15, DOI 10.1109/37.833638; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Yamashita Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000220; Zago M, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S04	65	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5176	10.1371/journal.pone.0005176	http://dx.doi.org/10.1371/journal.pone.0005176			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437VB	19384420	gold, Green Published			2022-12-25	WOS:000265513900001
J	Kim, SM; Power, A; Brown, TM; Constance, CM; Coon, SL; Nishimura, T; Hirai, H; Cai, T; Eisner, C; Weaver, DR; Piggins, HD; Klein, DC; Schnermann, J; Notkins, AL				Kim, Soo Mi; Power, Andrea; Brown, Timothy M.; Constance, Cara M.; Coon, Steven L.; Nishimura, Takuya; Hirai, Hiroki; Cai, Tao; Eisner, Christoph; Weaver, David R.; Piggins, Hugh D.; Klein, David C.; Schnermann, Juergen; Notkins, Abner L.			Deletion of the secretory vesicle proteins IA-2 and IA-2 beta disrupts circadian rhythms of cardiovascular and physical activity	FASEB JOURNAL			English	Article						blood pressure; heart rate; temperature; diabetes; behavior	TYROSINE-PHOSPHATASE; SUPRACHIASMATIC NUCLEI; TRANSMEMBRANE PROTEIN; TARGETED DISRUPTION; CLOCK; MAINTENANCE; AUTOANTIGEN; PACEMAKER; GENES; ROLES	Targeted deletion of IA-2 and IA-2 beta, major autoantigens in type 1 diabetes and transmembrane secretory vesicle proteins, results in impaired secretion of hormones and neurotransmitters. In the present study, we evaluated the effect of these deletions on daily rhythms in blood pressure, heart rate, core body temperature, and spontaneous physical and neuronal activity. We found that deletion of both IA-2 and IA-2 beta profoundly disrupts the usual diurnal variation of each of these parameters, whereas the deletion of either IA-2 or IA-2 beta alone did not produce a major change. In situ hybridization revealed that IA-2 and IA-2 beta transcripts are highly but nonrhythmically expressed in the suprachiasmatic nuclei, the site of the brain's master circadian oscillator. Electrophysiological studies on tissue slices from the suprachiasmatic nuclei showed that disruption of both IA-2 and IA-2 beta results in significant alterations in neuronal firing. From these studies, we concluded that deletion of IA-2 and IA-2 beta, structural proteins of secretory vesicles and modulators of neuroendocrine secretion, has a profound effect on the circadian system.-Kim, S. M., Power, A., Brown, T. M., Constance, C. M., Coon, S. L., Nishimura, T., Hirai, H., Cai, T., Eisner, C., Weaver, D. R., Piggins, H. D., Klein, D. C., Schnermann, J., Notkins, A. L. Deletion of the secretory vesicle proteins IA-2 and IA-2 beta disrupts circadian rhythms of cardiovascular and physical activity. FASEB J. 23, 3226-3232 ( 2009). www.fasebj.org	[Nishimura, Takuya; Hirai, Hiroki; Cai, Tao; Notkins, Abner L.] Natl Inst Dent & Craniofacial Res, Expt Med Sect, NIH, Bethesda, MD 20892 USA; [Kim, Soo Mi; Eisner, Christoph; Schnermann, Juergen] NIDDK, Kidney Dis Branch, Bethesda, MD USA; [Coon, Steven L.; Klein, David C.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Neuroendocrinol, Program Dev Endocrinol & Genet, Bethesda, MD USA; [Power, Andrea; Brown, Timothy M.; Piggins, Hugh D.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Constance, Cara M.] Coll Holy Cross, Dept Biol, Worcester, MA 01610 USA; [Weaver, David R.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Manchester; College of the Holy Cross; University of Massachusetts System; University of Massachusetts Worcester	Notkins, AL (corresponding author), Natl Inst Dent & Craniofacial Res, Expt Med Sect, NIH, 30 Convent Dr, Bethesda, MD 20892 USA.	anotkins@mail.nih.gov	cai, tao/C-5060-2011; Brown, Timothy/A-3018-2011	Piggins, Hugh/0000-0003-2555-9858; Cai, Tao/0000-0002-2877-8637; Brown, Timothy/0000-0002-5625-4750; Weaver, David/0000-0001-7941-6719; Klein, David/0000-0002-1792-5806	National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Dental and Craniofacial Research; Eunice Kennedy Shriver National Institute of Child Health and Human Development; NIH [NS056125]; Biotechnology and Biological Sciences Research Council (UK); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008836, ZIAHD008838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000423] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056125] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the intramural research programs of the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Dental and Craniofacial Research, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, and by project grants from the Biotechnology and Biological Sciences Research Council (UK) to H. D. P. and NIH grant NS056125 to D. R. W. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare no conflicts of interest.	Albus H, 2002, CURR BIOL, V12, P1130, DOI 10.1016/S0960-9822(02)00923-5; [Anonymous], 1991, SUPRACHIASMATIC NUCL; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Bae K, 2007, J BIOL RHYTHM, V22, P85, DOI 10.1177/0748730406296718; Brown TM, 2007, J NEUROPHYSIOL, V97, P2553, DOI 10.1152/jn.01206.2006; Brown TM, 2007, PROG NEUROBIOL, V82, P229, DOI 10.1016/j.pneurobio.2007.05.002; Brown TM, 2006, J NEUROSCI METH, V156, P173, DOI 10.1016/j.jneumeth.2006.02.024; Brown TM, 2005, J NEUROSCI, V25, P11155, DOI 10.1523/JNEUROSCI.3821-05.2005; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Harashima S, 2005, P NATL ACAD SCI USA, V102, P8704, DOI 10.1073/pnas.0408887102; Hughes AT, 2004, J NEUROSCI, V24, P3522, DOI 10.1523/JNEUROSCI.5345-03.2004; Kim SM, 2006, AM J PHYSIOL-RENAL, V290, pF1016, DOI 10.1152/ajprenal.00367.2005; Kubosaki A, 2006, ENDOCRINOLOGY, V147, P811, DOI 10.1210/en.2005-0638; Kubosaki A, 2005, DIABETES, V54, pS46, DOI 10.2337/diabetes.54.suppl_2.S46; Kubosaki A, 2004, DIABETES, V53, P1684, DOI 10.2337/diabetes.53.7.1684; Lan MS, 1996, P NATL ACAD SCI USA, V93, P6367, DOI 10.1073/pnas.93.13.6367; Lu J, 1996, P NATL ACAD SCI USA, V93, P2307, DOI 10.1073/pnas.93.6.2307; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; Nishimura T, 2009, NEUROSCIENCE, V159, P427, DOI 10.1016/j.neuroscience.2009.01.022; Notkins AL, 2001, J CLIN INVEST, V108, P1247, DOI 10.1172/JCI200114257; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Saeki K, 2002, DIABETES, V51, P1842, DOI 10.2337/diabetes.51.6.1842; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	30	21	23	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					3226	3232		10.1096/fj.09-132019	http://dx.doi.org/10.1096/fj.09-132019			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19433624	Green Published			2022-12-25	WOS:000270241000044
J	Paulhe, F; Wehrle-Haller, M; Jacquier, MC; Imhof, BA; Tabone-Eglinger, S; Wehrle-Haller, B				Paulhe, Frederique; Wehrle-Haller, Monique; Jacquier, Marie-Claude; Imhof, Beat A.; Tabone-Eglinger, Severine; Wehrle-Haller, Bernhard			Dimerization of Kit-ligand and efficient cell-surface presentation requires a conserved Ser-Gly-Gly-Tyr motif in its transmembrane domain	FASEB JOURNAL			English	Article						bimolecular fluorescence complementation; growth factors; intracellular transport; c-Kit; evolution; Flt3-L	C-KIT; STEEL FACTOR; FLUORESCENCE COMPLEMENTATION; INFLUENZA HEMAGGLUTININ; MELANOCYTE DEVELOPMENT; ENDOPLASMIC-RETICULUM; PROTEIN INTERACTIONS; CYTOPLASMIC DOMAIN; STRUCTURAL BASIS; POINT MUTATIONS	Kit-ligand (Kitl), also known as stem cell factor, is a membrane-anchored, noncovalently bound dimer signaling via the c-kit receptor tyrosine kinase, required for migration, survival, and proliferation of hematopoietic stem and germ cells, melanocytes, and mastocytes. Despite its fundamental role in morphogenesis and stem cell biology, the mechanisms that regulate Kitl dimerization are not well understood. By employing cell-permeable cross-linker and quantitative bimolecular fluorescence complementation of wildtype and truncated forms of Kitl, we determined that Kitl dimerization is initiated in the endoplasmic reticulum and mediated to similar levels by the transmembrane and the extracellular growth factor domain. Further biochemical and mutational analysis revealed a conserved Ser-Gly-Gly-Tyr-containing motif that is required for transmembrane domain dimerization and efficient cell-surface expression of Kitl. A novel intracellular capture assay with the Kitl transmembrane domain as bait revealed specific interactions with Kitl, but not with unrelated transmembrane proteins. During evolution, the transmembrane dimerization motif appeared in Kitl at the transition from teleosts to tetrapods, which correlates with the emergence of Kitl as a supporter of stem cell populations. Thus, transmembrane-mediated association of membrane-anchored growth factors consists of a novel mechanism to improve paracrine signaling and morphogenesis.-Paulhe, F., Wehrle-Haller, M., Jacquier, M.-C., Imhof, B. A., Tabone-Eglinger, S., Wehrle-Haller, B. Dimerization of Kit-ligand and efficient cell-surface presentation requires a conserved Ser-Gly-Gly-Tyr motif in its transmembrane domain. FASEB J. 23, 3037-3048 ( 2009). www.fasebj.org	[Paulhe, Frederique; Wehrle-Haller, Monique; Jacquier, Marie-Claude; Tabone-Eglinger, Severine; Wehrle-Haller, Bernhard] Univ Geneva, Dept Cellular Physiol & Metab, Ctr Med Univ Geneva, Geneva, Switzerland; [Imhof, Beat A.] Univ Geneva, Dept Pathol & Immunol, Ctr Med Univ Geneva, Geneva, Switzerland; [Tabone-Eglinger, Severine] Univ Lyon 1, Ctr Leon Berard, INSERM, Cytokine & Canc Grp,U590, F-69365 Lyon, France	University of Geneva; University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard	Wehrle-Haller, B (corresponding author), Ctr Med Univ Geneva, Dept Cellular Physiol, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	bernhard.wehrle-haller@unige.ch		TABONE-eglinger, Severine/0000-0003-4247-1321	Swiss National Science Foundation [3100A0-103805]; Nevus Outreach; CONTICANET of the University of Lyon (Lyon, France)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Nevus Outreach; CONTICANET of the University of Lyon (Lyon, France)	We thank Drs. Pierre Cosson ( Centre Medical Universitaire, Geneva, Switzerland) and Roger Tsien ( University of California, San Diego, CA, USA) for reagents, and Drs. Jim Weston, Benoit Gauthier, and Jean-Yves Blay for helpful discussions and critical reading of the manuscript. We are grateful to the support by the Swiss National Science Foundation (3100A0-103805) and Nevus Outreach. S.T.-E. is the recipient of a fellowship from the CONTICANET of the University of Lyon ( Lyon, France).	Aridor M, 2007, ADV DRUG DELIVER REV, V59, P759, DOI 10.1016/j.addr.2007.06.002; BRANNAN CI, 1991, P NATL ACAD SCI USA, V88, P4671, DOI 10.1073/pnas.88.11.4671; BRANNAN CI, 1992, GENE DEV, V6, P1832, DOI 10.1101/gad.6.10.1832; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CHENG HJ, 1994, MOL BIOL CELL, V5, P943, DOI 10.1091/mbc.5.9.943; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; FLANAGAN JG, 1991, CELL, V64, P1025, DOI 10.1016/0092-8674(91)90326-T; Goldman DC, 2006, BLOOD, V107, P3114, DOI 10.1182/blood-2005-09-3930; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hsu YR, 1997, J BIOL CHEM, V272, P6406, DOI 10.1074/jbc.272.10.6406; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; HUANG EJ, 1992, MOL BIOL CELL, V3, P349, DOI 10.1091/mbc.3.3.349; Hultman KA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030017; Jiang XL, 2000, EMBO J, V19, P3192, DOI 10.1093/emboj/19.13.3192; JOHNSON KF, 1992, J BIOL CHEM, V267, P17110; Kunisada T, 1998, J EXP MED, V187, P1565, DOI 10.1084/jem.187.10.1565; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Liu HL, 2007, EMBO J, V26, P891, DOI 10.1038/sj.emboj.7601545; LU HS, 1995, BIOCHEM J, V305, P563, DOI 10.1042/bj3050563; Nyfeler B, 2007, BIOCHEM SOC T, V35, P970, DOI 10.1042/BST0350970; PANDIT J, 1992, SCIENCE, V258, P1358, DOI 10.1126/science.1455231; Parichy DM, 1999, DEVELOPMENT, V126, P3425; Paulhe F, 2004, J BIOL CHEM, V279, P55545, DOI 10.1074/jbc.M407813200; Rajaraman S, 2002, GENETICS, V162, P331; Rajaraman S, 2002, GENETICS, V162, P341; Rickert M, 2005, SCIENCE, V308, P1477, DOI 10.1126/science.1109745; RODEWALD HR, 1995, IMMUNITY, V3, P313, DOI 10.1016/1074-7613(95)90116-7; RUBIN LA, 1985, HYBRIDOMA, V4, P91, DOI 10.1089/hyb.1985.4.91; Savvides SN, 2000, NAT STRUCT BIOL, V7, P486; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Schneider D, 2004, J MOL BIOL, V343, P799, DOI 10.1016/j.jmb.2004.08.083; SINGH I, 1990, EMBO J, V9, P631, DOI 10.1002/j.1460-2075.1990.tb08155.x; Tajima Y, 1998, J EXP MED, V187, P1451, DOI 10.1084/jem.187.9.1451; Tajima Y, 1998, P NATL ACAD SCI USA, V95, P11903, DOI 10.1073/pnas.95.20.11903; TATU U, 1995, EMBO J, V14, P1340, DOI 10.1002/j.1460-2075.1995.tb07120.x; Unterreitmeier S, 2007, J MOL BIOL, V374, P705, DOI 10.1016/j.jmb.2007.09.056; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Waskow C, 2007, BLOOD, V109, P5363, DOI 10.1182/blood-2006-08-039131; Wehrle-Haller B, 1999, DEV BIOL, V210, P71, DOI 10.1006/dbio.1999.9260; Wehrle-Haller B, 2003, PIGM CELL RES, V16, P287, DOI 10.1034/j.1600-0749.2003.00055.x; Wehrle-Haller B, 2001, DEV BIOL, V232, P471, DOI 10.1006/dbio.2001.0167; Wehrle-Haller B, 2001, J BIOL CHEM, V276, P12667, DOI 10.1074/jbc.M008357200; WEHRLEHALLER B, 1995, DEVELOPMENT, V121, P731; WILLIAMS DE, 1992, DEV BIOL, V151, P368, DOI 10.1016/0012-1606(92)90176-H; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Yin H, 2007, SCIENCE, V315, P1817, DOI 10.1126/science.1136782; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055; Zama AM, 2005, BIOL REPROD, V73, P639, DOI 10.1095/biolreprod.105.042846; Zhang ZT, 2000, P NATL ACAD SCI USA, V97, P7732, DOI 10.1073/pnas.97.14.7732	53	13	13	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					3037	3048		10.1096/fj.09-129577	http://dx.doi.org/10.1096/fj.09-129577			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19386768				2022-12-25	WOS:000270241000026
J	van der Veen, JN; van Dijk, TH; Vrins, CLJ; van Meer, H; Havinga, R; Bijsterveld, K; Tietge, UJF; Groen, AK; Kuipers, F				van der Veen, Jelske N.; van Dijk, Theo H.; Vrins, Carlos L. J.; van Meer, Hester; Havinga, Rick; Bijsterveld, Klaas; Tietge, Uwe J. F.; Groen, Albert K.; Kuipers, Folkert			Activation of the Liver X Receptor Stimulates Trans-intestinal Excretion of Plasma Cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOTOPOMER DISTRIBUTION ANALYSIS; HIGH-DENSITY-LIPOPROTEIN; NEUTRAL STEROL LOSS; SCAVENGER RECEPTOR; MICE LACKING; RATIO METHOD; ABSORPTION; SECRETION; METABOLISM; SITOSTEROLEMIA	Recent studies have indicated that direct intestinal secretion of plasma cholesterol significantly contributes to fecal neutral sterol loss in mice. The physiological relevance of this novel route, which represents a part of the reverse cholesterol transport pathway, has not been directly established in vivo as yet. We have developed a method to quantify the fractional and absolute contributions of several cholesterol fluxes to total fecal neutral sterol loss in vivo in mice, by assessing the kinetics of orally and intravenously administered stable isotopically labeled cholesterol combined with an isotopic approach to assess the fate of de novo synthesized cholesterol. Our results show that trans-intestinal cholesterol excretion significantly contributes to removal of blood-derived free cholesterol in C57B16/J mice (33% of 231 mu mol/kg/day) and that pharmacological activation of LXR with T0901317 strongly stimulates this pathway (63% of 706 mu mol/kg/day). Trans-intestinal cholesterol excretion is impaired in mice lacking Abcg5 (-4%), suggesting that the cholesterol transporting Abcg5/Abcg8 heterodimer is involved in this pathway. Our data demonstrate that intestinal excretion represents a quantitatively important route for fecal removal of neutral sterols independent of biliary secretion in mice. This pathway is sensitive to pharmacological activation of the LXR system. These data support the concept that the intestine substantially contributes to reverse cholesterol transport.	[Kuipers, Folkert] Univ Groningen, Univ Med Ctr Groningen, Pediat Lab, Ctr Liver Digest & Metab Dis, Dept Pediat, NL-9713 GZ Groningen, Netherlands; [Vrins, Carlos L. J.] Univ Amsterdam, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands	University of Groningen; University of Amsterdam	Kuipers, F (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Pediat Lab, Ctr Liver Digest & Metab Dis, Dept Pediat, Rm Y2145,CMC 4,Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	f.kuipers@med.umcg.nl		Kuipers, Folkert/0000-0003-2518-737X	Netherlands Organization for Scientific Research [912-02-063]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by Grant 912-02-063 from the Netherlands Organization for Scientific Research.	ARCA M, 1983, J LIPID RES, V24, P332; Bandsma RHJ, 1998, BIOCHEM J, V329, P699, DOI 10.1042/bj3290699; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BORGSTROM B, 1968, J LIPID RES, V9, P473; Bosner MS, 1999, J LIPID RES, V40, P302; Brown JM, 2008, J BIOL CHEM, V283, P10522, DOI 10.1074/jbc.M707659200; Cai SF, 2001, J LIPID RES, V42, P902; Davies JP, 2005, J BIOL CHEM, V280, P12710, DOI 10.1074/jbc.M409110200; DIETSCHY JM, 1993, J LIPID RES, V34, P1637; FEREZOU J, 1981, DIGESTION, V21, P232, DOI 10.1159/000198568; FIELDING CJ, 1995, J LIPID RES, V36, P211; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Groen AK, 2001, J CLIN INVEST, V108, P843, DOI 10.1172/JCI12473; HELLERSTEIN MK, 1992, AM J PHYSIOL, V263, pE988; HERNELL O, 1990, BIOCHEMISTRY-US, V29, P2041, DOI 10.1021/bi00460a012; HERZ J, 1995, P NATL ACAD SCI USA, V92, P4611, DOI 10.1073/pnas.92.10.4611; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Jolley CD, 1998, J LIPID RES, V39, P2143; Kruit JK, 2005, GASTROENTEROLOGY, V128, P147, DOI 10.1053/j.gastro.2004.10.006; KUIPERS F, 1985, GASTROENTEROLOGY, V88, P403, DOI 10.1016/0016-5085(85)90499-8; KUKSIS A, 1986, J CHROMATOGR, V381, P1, DOI 10.1016/S0378-4347(00)83559-8; Narita K, 2005, FASEB J, V19, P1558, DOI 10.1096/fj.04-2714fje; NEESE RA, 1993, AM J PHYSIOL, V264, pE136, DOI 10.1152/ajpendo.1993.264.1.E136; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Plosch T, 2004, GASTROENTEROLOGY, V126, P290, DOI 10.1053/j.gastro.2003.10.074; Plosch T, 2002, J BIOL CHEM, V277, P33870, DOI 10.1074/jbc.M206522200; Rader DJ, 2007, NAT CLIN PRACT CARD, V4, P102, DOI 10.1038/ncpcardio0768; REDGRAVE TG, 1987, BIOCHIM BIOPHYS ACTA, V921, P154, DOI 10.1016/0005-2760(87)90182-2; REDGRAVE TG, 1985, BIOCHIM BIOPHYS ACTA, V835, P104, DOI 10.1016/0005-2760(85)90036-0; RENSEN PCN, 1995, NAT MED, V1, P221, DOI 10.1038/nm0395-221; Rensen PCN, 1997, J LIPID RES, V38, P1070; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; TURLEY SD, 1994, J LIPID RES, V35, P328; van der Velde AE, 2008, AM J PHYSIOL-GASTR L, V295, pG203, DOI 10.1152/ajpgi.90231.2008; Van der Velde AE, 2007, GASTROENTEROLOGY, V133, P967, DOI 10.1053/j.gastro.2007.06.019; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399; Yu LQ, 2003, J BIOL CHEM, V278, P15565, DOI 10.1074/jbc.M301311200; ZILVERSMIT DB, 1974, J LIPID RES, V15, P465	41	162	164	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19211	19219		10.1074/jbc.M109.014860	http://dx.doi.org/10.1074/jbc.M109.014860			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19416968	hybrid, Green Published			2022-12-25	WOS:000267908300011
J	Cha-Molstad, H; Saxena, G; Chen, JQ; Shalev, A				Cha-Molstad, Hyunjoo; Saxena, Geetu; Chen, Junqin; Shalev, Anath			Glucose-stimulated Expression of Txnip Is Mediated by Carbohydrate Response Element-binding Protein, p300, and Histone H4 Acetylation in Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOREDOXIN-INTERACTING PROTEIN; TRANSCRIPTION FACTOR; ORDERED RECRUITMENT; MICROARRAY ANALYSIS; GENE-TRANSCRIPTION; APOPTOSIS; MLX; CHREBP; MONDOA; COACTIVATOR	Recently, we identified Txnip (thioredoxin-interacting protein) as a mediator of glucotoxic beta cell death and discovered that lack of Txnip protects against streptozotocin- and obesity-induced diabetes by preventing beta cell apoptosis and preserving endogenous beta cell mass. Txnip has therefore become an attractive target for diabetes therapy, but although we have found that txnip transcription is highly induced by glucose through a unique carbohydrate response element, the factors controlling this effect have remained unknown. Using transient transfection experiments, we now show that overexpression of the carbohydrate response element-binding protein (ChREBP) transactivates the txnip promoter, whereas ChREBP knockdown by small interfering RNA completely blunts glucose-induced txnip transcription. Moreover, chromatin immunoprecipitation demonstrated that glucose leads to a dose- and time-dependent recruitment of ChREBP to the txnip promoter in vivo in INS-1 beta cells as well as human islets. Furthermore, we found that the co-activator and histone acetyltransferase p300 co-immunoprecipitates with ChREBP and also binds to the txnip promoter in response to glucose. Interestingly, this is associated with specific acetylation of histone H4 and recruitment of RNA polymerase II as measured by chromatin immunoprecipitation. Thus, with this study we have identified ChREBP as the transcription factor that mediates glucose-induced txnip expression in human islets and INS-1 beta cells and have characterized the chromatin modification associated with glucose-induced txnip transcription. In addition, the results reveal for the first time that ChREBP interacts with p300. This may explain how ChREBP induces H4 acetylation and sheds new light on glucose-mediated regulation of chromatin structure and transcription.	[Cha-Molstad, Hyunjoo; Saxena, Geetu; Chen, Junqin; Shalev, Anath] Univ Wisconsin, Dept Med, Madison, WI 53792 USA; [Cha-Molstad, Hyunjoo; Saxena, Geetu; Chen, Junqin; Shalev, Anath] William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Shalev, A (corresponding author), Univ Wisconsin, Dept Med, H4-526 Clin Sci Ctr,600 Highland Ave, Madison, WI 53792 USA.	as7@medicine.wisc.edu			National Institutes of Health [R01DK-078752, R21HL-089205]; American Diabetes Association [7-07-CD-22]; Juvenile Diabetes Research Foundation [1-2007-790]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grant R01DK-078752 and National Institutes of Health, NHLBI, Grant R21HL-089205. This work was also supported by American Diabetes Association Grant 7-07-CD-22 and Juvenile Diabetes Research Foundation Grant 1-2007-790.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; Billin AN, 2000, MOL CELL BIOL, V20, P8845, DOI 10.1128/MCB.20.23.8845-8854.2000; Breen GAM, 1999, BBA-GEN SUBJECTS, V1428, P169, DOI 10.1016/S0304-4165(99)00061-6; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Cosma MP, 2002, MOL CELL, V10, P227, DOI 10.1016/S1097-2765(02)00604-4; Davies MN, 2008, J BIOL CHEM, V283, P24029, DOI 10.1074/jbc.M801539200; Deato MDE, 2008, MOL CELL, V32, P96, DOI 10.1016/j.molcel.2008.09.009; Deato MDE, 2007, GENE DEV, V21, P2137, DOI 10.1101/gad.1583407; Eckert DT, 2008, BIOCHEM BIOPH RES CO, V372, P131, DOI 10.1016/j.bbrc.2008.05.002; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; Eizirik DL, 2003, ANN NY ACAD SCI, V1005, P55, DOI 10.1196/annals.1288.007; Espinoza CR, 2005, J IMMUNOL, V175, P6668, DOI 10.4049/jimmunol.175.10.6668; Faiola F, 2005, MOL CELL BIOL, V25, P10220, DOI 10.1128/MCB.25.23.10220-10234.2005; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kaur H, 2006, DIABETES, V55, P3104, DOI 10.2337/db06-0519; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Kee BL, 1996, J BIOL CHEM, V271, P2373, DOI 10.1074/jbc.271.5.2373; Kim MY, 2001, EMBO J, V20, P6084, DOI 10.1093/emboj/20.21.6084; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Lan H, 2003, DIABETES, V52, P688, DOI 10.2337/diabetes.52.3.688; Ma L, 2005, J BIOL CHEM, V280, P12019, DOI 10.1074/jbc.M413063200; Ma L, 2007, NUCLEIC ACIDS RES, V35, P35, DOI 10.1093/nar/gkl987; Meroni G, 2000, ONCOGENE, V19, P3266, DOI 10.1038/sj.onc.1203634; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Mosley AL, 2004, MOL ENDOCRINOL, V18, P2279, DOI 10.1210/me.2003-0463; Nishiyama A, 2001, IUBMB LIFE, V52, P29, DOI 10.1080/15216540252774739; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Qiu Y, 2002, MOL CELL BIOL, V22, P412, DOI 10.1128/MCB.22.2.412-420.2002; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Rufo C, 2001, J BIOL CHEM, V276, P21969, DOI 10.1074/jbc.M100461200; Saitoh T, 2001, J NEUROCHEM, V78, P1267, DOI 10.1046/j.1471-4159.2001.00505.x; Sans CL, 2006, MOL CELL BIOL, V26, P4863, DOI 10.1128/MCB.00657-05; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; Wang HY, 2002, J BIOL CHEM, V277, P32746, DOI 10.1074/jbc.M201635200; Wang YL, 2002, J BIOL CHEM, V277, P26496, DOI 10.1074/jbc.M202133200; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942	45	162	168	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16898	16905		10.1074/jbc.M109.010504	http://dx.doi.org/10.1074/jbc.M109.010504			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19411249	hybrid, Green Published			2022-12-25	WOS:000266962400026
J	Charbonneau, ME; Janvore, J; Mourez, M				Charbonneau, Marie-Eve; Janvore, Julie; Mourez, Michael			Autoprocessing of the Escherichia coli AIDA-I Autotransporter A NEW MECHANISM INVOLVING ACIDIC RESIDUES IN THE JUNCTION REGION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZAE HAP AUTOTRANSPORTER; DIFFUSE ADHERENCE; SERINE-PROTEASE; NEISSERIA-MENINGITIDIS; BACTERIAL AUTOTRANSPORTER; BARTONELLA-HENSELAE; CRYSTAL-STRUCTURE; PASSENGER DOMAIN; BETA-HELIX; ADHESIN	The cleavage of the autotransporter adhesin involved in diffuse adherence (AIDA-I) of Escherichia coli yields a membrane-embedded fragment, AIDAc, and an extracellular fragment, the mature AIDA-I adhesin. The latter remains noncovalently associated with AIDAc but can be released by heat treatment. In this study we determined the mechanism of AIDA-I cleavage. We showed that AIDA-I processing is an autocatalytic event by monitoring the in vitro cleavage of an uncleaved mutant protein isolated from inclusion bodies. Furthermore, by following changes in circular dichroism spectra and protease resistance of the renaturated protein, we showed that the cleavage of the protein is correlated with folding. With site-directed deletions, we showed that the catalytic activity of the protein lies in a region encompassing amino acids between Ala-667 and Thr-953, which includes the conserved junction domain of some auto-transporters. With site-directed point mutations, we also found that Asp-878 and Glu-897 are involved in the processing of AIDA-I and that a mutation preserving the acidic side chain of Asp-878 was tolerated, giving evidence that this carboxylic acid group is directly involved in catalysis. Last, we confirmed that cleavage of AIDA-I is intramolecular. Our results unveil a new mechanism of auto-processing in the autotransporter family.	[Charbonneau, Marie-Eve; Janvore, Julie; Mourez, Michael] Univ Montreal, Canada Res Chair Bacterial Anim Dis, Fac Med Vet, St Hyacinthe, PQ J2S 7C6, Canada	Universite de Montreal	Mourez, M (corresponding author), Univ Montreal, Canada Res Chair Bacterial Anim Dis, Fac Med Vet, 3200 Sicotte, St Hyacinthe, PQ J2S 7C6, Canada.	m.mourez@umontreal.ca			Groupe de Recherche et dEtudes sur les Maladies Infectieuses du Porc (GREMIP); Canadian Institutes of Health Research [84578]; Canada Research Chair program and the Canada Foundation for Innovation [201414]; Natural Sciences and and Engineering Research Council of Canada [85297596]	Groupe de Recherche et dEtudes sur les Maladies Infectieuses du Porc (GREMIP); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair program and the Canada Foundation for Innovation; Natural Sciences and and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by financial contributions from the Groupe de Recherche et dEtudes sur les Maladies Infectieuses du Porc (GREMIP), Canadian Institutes of Health Research Grant 84578, Canada Research Chair program and the Canada Foundation for Innovation Grant 201414, and a graduate fellowship from the Natural Sciences and and Engineering Research Council of Canada (Grant 85297596, to M.-E.C.).	Barnard TJ, 2007, NAT STRUCT MOL BIOL, V14, P1214, DOI 10.1038/nsmb1322; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Benz I, 2001, MOL MICROBIOL, V40, P1403, DOI 10.1046/j.1365-2958.2001.02487.x; BENZ I, 1989, INFECT IMMUN, V57, P1506, DOI 10.1128/IAI.57.5.1506-1511.1989; BENZ I, 1992, MOL MICROBIOL, V6, P1539, DOI 10.1111/j.1365-2958.1992.tb00875.x; Chapman TA, 2006, APPL ENVIRON MICROB, V72, P4782, DOI 10.1128/AEM.02885-05; Charbonneau ME, 2008, RES MICROBIOL, V159, P537, DOI 10.1016/j.resmic.2008.06.009; Charbonneau ME, 2007, J BACTERIOL, V189, P9020, DOI 10.1128/JB.01238-07; Charbonneau ME, 2007, J BACTERIOL, V189, P8880, DOI 10.1128/JB.00969-07; Charbonneau ME, 2006, J BACTERIOL, V188, P8504, DOI 10.1128/JB.00864-06; Coutte L, 2003, MOL MICROBIOL, V49, P529, DOI 10.1046/j.1365-2958.2003.03573.x; Dautin N, 2007, EMBO J, V26, P1942, DOI 10.1038/sj.emboj.7601638; dHauteville H, 1996, INFECT IMMUN, V64, P511, DOI 10.1128/IAI.64.2.511-517.1996; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; Fink DL, 2003, J BACTERIOL, V185, P1608, DOI 10.1128/JB.185.5.1608-1615.2003; Fink DL, 2001, J BIOL CHEM, V276, P39492, DOI 10.1074/jbc.M106913200; Girard V, 2006, RES MICROBIOL, V157, P407, DOI 10.1016/j.resmic.2006.02.001; Henderson IR, 1999, J BACTERIOL, V181, P2132, DOI 10.1128/JB.181.7.2132-2141.1999; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Henderson IR, 2001, INFECT IMMUN, V69, P1231, DOI 10.1128/IAI.69.3.1231-1243.2001; Hritonenko V, 2007, MOL MEMBR BIOL, V24, P395, DOI 10.1080/09687680701443822; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Klemm P, 2004, MOL MICROBIOL, V51, P283, DOI 10.1046/j.1365-2958.2003.03833.x; Klemm P, 2006, INT J MED MICROBIOL, V296, P187, DOI 10.1016/j.ijmm.2005.10.002; Litwin CM, 2007, INFECT IMMUN, V75, P5255, DOI 10.1128/IAI.00533-07; Litwin CM, 2005, INFECT IMMUN, V73, P4205, DOI 10.1128/IAI.73.7.4205-4213.2005; Mogensen JE, 2005, BIOCHEMISTRY-US, V44, P4533, DOI 10.1021/bi0475121; Navarro-Garcia F, 2001, INFECT IMMUN, V69, P1053, DOI 10.1128/IAI.69.2.1053-1060.2001; Nguyen VQ, 2001, INFECT IMMUN, V69, P543, DOI 10.1128/IAI.69.1.543-546.2001; Niewerth U, 2001, CLIN DIAGN LAB IMMUN, V8, P143, DOI 10.1128/CDLI.8.1.143-149.2001; Ohnishi Y, 1997, J BIOCHEM, V121, P902; Oliver DC, 2003, MOL MICROBIOL, V47, P1367, DOI 10.1046/j.1365-2958.2003.03377.x; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Otto BR, 2005, J BIOL CHEM, V280, P17339, DOI 10.1074/jbc.M412885200; Peterson JH, 2006, J BIOL CHEM, V281, P9038, DOI 10.1074/jbc.M508681200; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; Renn JP, 2008, BIOPOLYMERS, V89, P420, DOI 10.1002/bip.20924; Serruto D, 2003, MOL MICROBIOL, V48, P323, DOI 10.1046/j.1365-2958.2003.03420.x; Shere KD, 1997, MOL MICROBIOL, V25, P451, DOI 10.1046/j.1365-2958.1997.4681827.x; Sherlock O, 2004, J BACTERIOL, V186, P8058, DOI 10.1128/JB.186.23.8058-8065.2004; Suhr M, 1996, MOL MICROBIOL, V22, P31, DOI 10.1111/j.1365-2958.1996.tb02653.x; Turner DPJ, 2006, INFECT IMMUN, V74, P2957, DOI 10.1128/IAI.74.5.2957-2964.2006; van Ulsen P, 2003, MOL MICROBIOL, V50, P1017, DOI 10.1046/j.1365-2958.2003.03773.x; van Ulsen P, 2006, MICROBES INFECT, V8, P2088, DOI 10.1016/j.micinf.2006.03.007; Vandahl BB, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-36; Vandeputte-Rutten L, 2001, EMBO J, V20, P5033, DOI 10.1093/emboj/20.18.5033; Zarivach R, 2008, NATURE, V453, P124, DOI 10.1038/nature06832; Zhang WP, 2007, VET MICROBIOL, V123, P145, DOI 10.1016/j.vetmic.2007.02.018	48	30	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17340	17351		10.1074/jbc.M109.010108	http://dx.doi.org/10.1074/jbc.M109.010108			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19398552	hybrid, Green Published			2022-12-25	WOS:000266962400069
J	Lu, SP; Kato, M; Lin, SJ				Lu, Shu-Ping; Kato, Michiko; Lin, Su-Ju			Assimilation of Endogenous Nicotinamide Riboside Is Essential for Calorie Restriction-mediated Life Span Extension in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE; NMN ADENYLYLTRANSFERASE; INSULIN-SECRETION; NAD(+) METABOLISM; GENE DISRUPTION; LONGEVITY; MONONUCLEOTIDE; IDENTIFICATION; SALVAGE; SIR2	NAD(+) (nicotinamide adenine dinucleotide) is an essential cofactor involved in various biological processes including calorie restriction-mediated life span extension. Administration of nicotinamide riboside (NmR) has been shown to ameliorate deficiencies related to aberrant NAD(+) metabolism in both yeast and mammalian cells. However, the biological role of endogenous NmR remains unclear. Here we demonstrate that salvaging endogenous NmR is an integral part of NAD(+) metabolism. A balanced NmR salvage cycle is essential for calorie restriction-induced life span extension and stress resistance in yeast. Our results also suggest that partitioning of the pyridine nucleotide flux between the classical salvage cycle and the NmR salvage branch might be modulated by the NAD(+)-dependent Sir2 deacetylase. Furthermore, two novel deamidation steps leading to nicotinic acid mononucleotide and nicotinic acid riboside production are also uncovered that further underscore the complexity and flexibility of NAD(+) metabolism. In addition, utilization of extracellular nicotinamide mononucleotide requires prior conversion to NmR mediated by a periplasmic phosphatase Pho5. Conversion to NmR may thus represent a strategy for the transport and assimilation of large nonpermeable NAD(+) precursors. Together, our studies provide a molecular basis for how NAD(+) homeostasis factors confer metabolic flexibility.	[Lu, Shu-Ping; Kato, Michiko; Lin, Su-Ju] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA	University of California System; University of California Davis	Lin, SJ (corresponding author), Univ Calif Davis, Dept Microbiol, 323 Briggs Hall,1 Shields Ave, Davis, CA 95616 USA.	slin@ucdavis.edu			National Institute on Aging; Ellison Medical Foundation; NATIONAL INSTITUTE ON AGING [R01AG024351] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging and the Ellison Medical Foundation.	Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Belenky P, 2009, J BIOL CHEM, V284, P158, DOI 10.1074/jbc.M807976200; Belenky PA, 2008, J BIOL CHEM, V283, P8075, DOI 10.1074/jbc.C800021200; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Brachmann CB, 1998, YEAST, V14, P115; Burke D., 2000, METHODS YEAST GENETI, P171; Chen P, 2007, ANAL BIOANAL CHEM, V387, P2441, DOI 10.1007/s00216-006-0615-y; CHENG WL, 1995, J BACTERIOL, V177, P6711, DOI 10.1128/jb.177.23.6711-6717.1995; Dilova I, 2007, CELL MOL LIFE SCI, V64, P752, DOI 10.1007/s00018-007-6381-y; Easlon E, 2008, GENE DEV, V22, P931, DOI 10.1101/gad.1648308; Easlon E, 2007, J BIOL CHEM, V282, P6161, DOI 10.1074/jbc.M607661200; Emanuelli M, 1999, FEBS LETT, V455, P13, DOI 10.1016/S0014-5793(99)00852-2; Emanuelli M, 2003, PROTEIN EXPRES PURIF, V27, P357, DOI 10.1016/S1046-5928(02)00645-9; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; Grose JH, 2005, J BACTERIOL, V187, P4521, DOI 10.1128/JB.187.13.4521-4530.2005; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Kemmer G, 2001, J BACTERIOL, V183, P3974, DOI 10.1128/JB.183.13.3974-3981.2001; Kennedy EJ, 2005, EUKARYOT CELL, V4, P1892, DOI 10.1128/EC.4.11.1892-1901.2005; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Ma B, 2007, MOL MICROBIOL, V66, P14, DOI 10.1111/j.1365-2958.2007.05886.x; McClure JM, 2008, GENETICS, V180, P797, DOI 10.1534/genetics.108.091090; Oshima Y, 1997, GENES GENET SYST, V72, P323, DOI 10.1266/ggs.72.323; Panozzo C, 2002, FEBS LETT, V517, P97, DOI 10.1016/S0014-5793(02)02585-1; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Ramsey KM, 2008, AGING CELL, V7, P78, DOI 10.1111/j.1474-9726.2007.00355.x; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Roth GS, 2001, ANN NY ACAD SCI, V928, P305; Sandmeier JJ, 2002, GENETICS, V160, P877; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schmidt-Brauns J, 2001, INT J MED MICROBIOL, V291, P219, DOI 10.1078/1438-4221-00122; Sporty JL, 2008, J SEP SCI, V31, P3202, DOI 10.1002/jssc.200800238; Spronck JC, 2007, NUTR CANCER, V57, P88, DOI 10.1080/01635580701268337; Svaren J, 1997, TRENDS BIOCHEM SCI, V22, P93, DOI 10.1016/S0968-0004(97)01001-3; Tempel W, 2007, PLOS BIOL, V5, P2220, DOI 10.1371/journal.pbio.0050263; WEINDRUCH W, 1998, RETARDATION AGING DI; Yang T, 2007, J MED CHEM, V50, P6458, DOI 10.1021/jm701001c	50	52	60	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17110	17119		10.1074/jbc.M109.004010	http://dx.doi.org/10.1074/jbc.M109.004010			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19416965	Green Published, hybrid			2022-12-25	WOS:000266962400049
J	Monastyrskaya, K; Babiychuk, EB; Hostettler, A; Wood, P; Grewal, T; Draeger, A				Monastyrskaya, Katia; Babiychuk, Eduard B.; Hostettler, Andrea; Wood, Peta; Grewal, Thomas; Draeger, Annette			Plasma Membrane-associated Annexin A6 Reduces Ca2+ Entry by Stabilizing the Cortical Actin Cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATIVE CALCIUM-ENTRY; LIPID RAFTS; H-RAS; STORE; VI; ACTIVATION; STIM1; INHIBITION; DYNAMICS; BINDING	The annexins are a family of Ca2+- and phospholipid-binding proteins, which interact with membranes upon increase of [Ca2+](i) or during cytoplasmic acidification. The transient nature of the membrane binding of annexins complicates the study of their influence on intracellular processes. To address the function of annexins at the plasma membrane ( PM), we fused fluorescent protein-tagged annexins A6, A1, and A2 with H- and K-Ras membrane anchors. Stable PM localization of membrane-anchored annexin A6 significantly decreased the store-operated Ca2+ entry (SOCE), but did not influence the rates of Ca2+ extrusion. This attenuation was specific for annexin A6 because PM-anchored annexins A1 and A2 did not alter SOCE. Membrane association of annexin A6 was necessary for a measurable decrease of SOCE, because cytoplasmic annexin A6 had no effect on Ca2+ entry as long as [Ca2+](i) was below the threshold of annexin A6-membrane translocation. However, when[Ca2+](i) reached the levels necessary for the Ca2+-dependent PM association of ectopically expressed wild-type annexin A6, SOCE was also inhibited. Conversely, knockdown of the endogenous annexin A6 in HEK293 cells resulted in an elevated Ca2+ entry. Constitutive PM localization of annexin A6 caused a rearrangement and accumulation of F-actin at the PM, indicating a stabilized cortical cytoskeleton. Consistent with these findings, disruption of the actin cytoskeleton using latrunculin A abolished the inhibitory effect of PM-anchored annexin A6 on SOCE. In agreement with the inhibitory effect of annexin A6 on SOCE, constitutive PM localization of annexin A6 inhibited cell proliferation. Taken together, our results implicate annexin A6 in the actin-dependent regulation of Ca2+ entry, with consequences for the rates of cell proliferation.	[Monastyrskaya, Katia; Draeger, Annette] Univ Bern, Inst Anat, Dept Cell Biol, CH-3000 Bern 9, Switzerland; [Wood, Peta; Grewal, Thomas] Univ Sydney, Dept Pharmaceut Chem, Fac Pharm, Sydney, NSW 2006, Australia	University of Bern; University of Sydney	Monastyrskaya, K (corresponding author), Univ Bern, Inst Anat, Dept Cell Biol, CH-3000 Bern 9, Switzerland.	monastyk@ana.unibe.ch	Babiychuk, Eduard/AAV-7223-2021	Grewal, Thomas/0000-0002-7937-8887; Monastyrskaya, Katia/0000-0003-2042-1139; Babiychuk, Eduard/0000-0003-1786-0085	Swiss National Science Foundation [320000-111778, 3100A0-121980/1]; National Research Programme NRP 53 [405340-104679/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Research Programme NRP 53	This work was supported in part by the Swiss National Science Foundation (SNF Grants 320000-111778 to K. M. and 3100A0-121980/1 to E. B.) and the National Research Programme NRP 53 "Musculoskeletal Health-Chronic Pain" (Grant 405340-104679/1 to A. D.).	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Babiychuk EB, 1999, J BIOL CHEM, V274, P35191, DOI 10.1074/jbc.274.49.35191; Babiychuk EB, 2000, J CELL BIOL, V150, P1113, DOI 10.1083/jcb.150.5.1113; Babiychuk EB, 2002, BBA-PROTEINS PROTEOM, V1600, P154, DOI 10.1016/S1570-9639(02)00456-9; Babiychuk EB, 2008, TRAFFIC, V9, P1757, DOI 10.1111/j.1600-0854.2008.00800.x; Babiychuk EB, 2006, BIOCHEM J, V397, P407, DOI 10.1042/BJ20060056; Camors E, 2006, J MOL CELL CARDIOL, V40, P47, DOI 10.1016/j.yjmcc.2005.08.009; Cubells L, 2008, J BIOL CHEM, V283, P10174, DOI 10.1074/jbc.M706618200; Cubells L, 2007, TRAFFIC, V8, P1568, DOI 10.1111/j.1600-0854.2007.00640.x; Darbellay B, 2009, J BIOL CHEM, V284, P5370, DOI 10.1074/jbc.M806726200; de Diego I, 2002, J BIOL CHEM, V277, P32187, DOI 10.1074/jbc.M205499200; DIAZMUNOZ M, 1990, J BIOL CHEM, V265, P15894; Draeger A, 2005, BIOCHEM J, V387, P309, DOI 10.1042/BJ20041363; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Filipenko NR, 2001, J BIOL CHEM, V276, P5310, DOI 10.1074/jbc.M009710200; Fleet A, 1999, BIOCHEM BIOPH RES CO, V260, P540, DOI 10.1006/bbrc.1999.0915; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Golczak M, 2001, FEBS LETT, V496, P49, DOI 10.1016/S0014-5793(01)02402-4; Grewal T, 2000, J BIOL CHEM, V275, P33806, DOI 10.1074/jbc.M002662200; Grewal T, 2005, ONCOGENE, V24, P5809, DOI 10.1038/sj.onc.1208743; Grewal T, 2006, BIOESSAYS, V28, P1211, DOI 10.1002/bies.20503; Grewal T, 2009, CELL SIGNAL, V21, P847, DOI 10.1016/j.cellsig.2009.01.031; HAMBLIN AMG, 1996, AM J PHYSIOL, V270, pH1091; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; Harder T, 1997, MOL BIOL CELL, V8, P533, DOI 10.1091/mbc.8.3.533; Hawkins TE, 2000, CELL BIOCHEM BIOPHYS, V33, P275, DOI 10.1385/CBB:33:3:275; Hayes MJ, 2006, EMBO J, V25, P1816, DOI 10.1038/sj.emboj.7601078; Hayes MJ, 2004, BIOCHEM BIOPH RES CO, V322, P1166, DOI 10.1016/j.bbrc.2004.07.124; Hayes MJ, 2004, TRAFFIC, V5, P571, DOI 10.1111/j.1600-0854.2004.00210.x; Jardin I, 2008, J BIOL CHEM, V283, P25296, DOI 10.1074/jbc.M802904200; Jardin I, 2008, CHANNELS, V2, P401, DOI 10.4161/chan.2.6.7055; KAETZEL MA, 1994, J BIOL CHEM, V269, P5297; Kim YE, 2005, J BIOL CHEM, V280, P32398, DOI 10.1074/jbc.M505017200; Kohler G, 1997, BIOCHEMISTRY-US, V36, P8189, DOI 10.1021/bi9703960; Locate S, 2008, CELL BIOL INT, V32, P1388, DOI 10.1016/j.cellbi.2008.08.009; Monastyrskaya K, 2005, J BIOL CHEM, V280, P7135, DOI 10.1074/jbc.M405806200; Monastyrskaya K, 2008, BIOCHEM J, V409, P65, DOI 10.1042/BJ20071116; Monastyrskaya K, 2007, CELL CALCIUM, V41, P207, DOI 10.1016/j.ceca.2006.06.008; Morales S, 2005, CELL SIGNAL, V17, P635, DOI 10.1016/j.cellsig.2004.10.002; Mussunoor S, 2008, J PATHOL, V216, P131, DOI 10.1002/path.2400; Naciff JM, 1996, AM J PHYSIOL-CELL PH, V271, pC2004; Ong HL, 2007, J BIOL CHEM, V282, P12176, DOI 10.1074/jbc.M609435200; Parekh AB, 2006, PFLUG ARCH EUR J PHY, V453, P303, DOI 10.1007/s00424-006-0089-y; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Prior IA, 2001, J CELL SCI, V114, P1603; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Putney JW, 2005, J CELL BIOL, V169, P381, DOI 10.1083/jcb.200503161; Rosado JA, 2000, J PHYSIOL-LONDON, V526, P221, DOI 10.1111/j.1469-7793.2000.t01-2-00221.x; Soboloff J, 2006, BBA-MOL CELL RES, V1763, P1161, DOI 10.1016/j.bbamcr.2006.09.023; Song GJ, 2002, FASEB J, V16, P622, DOI 10.1096/fj.01-0892fje; Tamarina NA, 2008, CELL CALCIUM, V44, P533, DOI 10.1016/j.ceca.2008.03.007; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; de Muga SV, 2009, ONCOGENE, V28, P363, DOI 10.1038/onc.2008.386; Zaidi A, 1998, NEUROBIOL AGING, V19, P487, DOI 10.1016/S0197-4580(98)00078-5; Zhu H, 2008, J PHARMACOL SCI, V106, P287, DOI 10.1254/jphs.FP0071192; Zylinska L, 2000, ACTA BIOCHIM POL, V47, P529	58	54	56	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17227	17242		10.1074/jbc.M109.004457	http://dx.doi.org/10.1074/jbc.M109.004457			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19386597	Green Published, hybrid			2022-12-25	WOS:000266962400060
J	Wang, XJ; Zhang, DD				Wang, Xiao-Jun; Zhang, Donna D.			Ectodermal-Neural Cortex 1 Down-Regulates Nrf2 at the Translational Level	PLOS ONE			English	Article								The transcription factor Nrf2 is the master regulator of a cellular defense mechanism against environmental insults. The Nrf2-mediated antioxidant response is accomplished by the transcription of a battery of genes that encode phase II detoxifying enzymes, xenobiotic transporters, and antioxidants. Coordinated expression of these genes is critical in protecting cells from toxic and carcinogenic insults and in maintaining cellular redox homeostasis. Activation of the Nrf2 pathway is primarily controlled by Kelch-like ECH-associated protein 1 (Keap1), which is a molecular switch that turns on or off the Nrf2 signaling pathway according to intracellular redox conditions. Here we report our finding of a novel Nrf2 suppressor ectodermal-neural cortex 1 (ENC1), which is a BTB-Kelch protein and belongs to the same family as Keap1. Transient expression of ENC1 reduced steady-state levels of Nrf2 and its downstream gene expression. Although ENC1 interacted with Keap1 indirectly, the ENC1-mediated down-regulation of Nrf2 was independent of Keap1. The negative effect of ENC1 on Nrf2 was not due to a change in the stability of Nrf2 because neither proteasomal nor lysosomal inhibitors had any effects. Overexpression of ENC1 did not result in a change in the level of Nrf2 mRNA, rather, it caused a decrease in the rate of Nrf2 protein synthesis. These results demonstrate that ENC1 functions as a negative regulator of Nrf2 through suppressing Nrf2 protein translation, which adds another level of complexity in controlling the Nrf2 signaling pathway.			Wang, XJ (corresponding author), Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA.	dzhang@pharmacy.arizona.edu	Zhang, Donna/B-1015-2012		NIEHS NIH HHS [ES015010, R01 ES015010, ES006694, P30 ES006694] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015010, P30ES006694] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Andreassi MG, 2003, MUTAT RES-REV MUTAT, V543, P67, DOI 10.1016/S1383-5742(02)00089-3; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Du Y, 2008, ENVIRON HEALTH PERSP, V116, P1154, DOI 10.1289/ehp.11464; Frohlich DA, 2008, ONCOGENE, V27, P4353, DOI 10.1038/onc.2008.79; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Hammarsund M, 2004, HUM MOL GENET, V13, P2925, DOI 10.1093/hmg/ddh315; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hernandez MC, 1998, EXP CELL RES, V242, P470, DOI 10.1006/excr.1998.4109; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; Katoh Y, 2005, ARCH BIOCHEM BIOPHYS, V433, P342, DOI 10.1016/j.abb.2004.10.012; Kim TA, 2000, GENE, V255, P105, DOI 10.1016/S0378-1119(00)00297-3; Kim TA, 1998, J CELL BIOL, V141, P553, DOI 10.1083/jcb.141.3.553; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Laezza F, 2008, NEUROPHARMACOLOGY, V55, P1131, DOI 10.1016/j.neuropharm.2008.07.021; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Lee JM, 2001, J BIOL CHEM, V276, P20011, DOI 10.1074/jbc.M100734200; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Lefebvre S, 1998, HUM MOL GENET, V7, P1531, DOI 10.1093/hmg/7.10.1531; Li LY, 2009, BBA-MOL CELL RES, V1793, P346, DOI 10.1016/j.bbamcr.2008.09.013; Liang XQ, 2004, ONCOGENE, V23, P5890, DOI 10.1038/sj.onc.1207776; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; MEIJERMAN I, 2008, CANC TREAT REV; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; Purdom-Dickinson SE, 2007, MOL PHARMACOL, V72, P1074, DOI 10.1124/mol.107.035360; Rondou P, 2008, J BIOL CHEM, V283, P11083, DOI 10.1074/jbc.M708473200; Salazar M, 2006, J BIOL CHEM, V281, P14841, DOI 10.1074/jbc.M513737200; Salinas GD, 2006, J BIOL CHEM, V281, P40164, DOI 10.1074/jbc.M608194200; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Seng S, 2009, ONCOGENE, V28, P378, DOI 10.1038/onc.2008.396; Seng S, 2007, CANCER RES, V67, P8596, DOI 10.1158/0008-5472.CAN-06-3785; Shen GX, 2004, J BIOL CHEM, V279, P23052, DOI 10.1074/jbc.M401368200; Singh A, 2009, FREE RADICAL BIO MED, V46, P376, DOI 10.1016/j.freeradbiomed.2008.10.026; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; SUN Z, 2009, MOL CELL BIOL; Sun Z, 2007, MOL CELL BIOL, V27, P6334, DOI 10.1128/MCB.00630-07; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Wang XJ, 2007, TOXICOL APPL PHARM, V225, P206, DOI 10.1016/j.taap.2007.07.016; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; Zhao L, 2000, J BIOL CHEM, V275, P16845, DOI 10.1074/jbc.275.22.16845; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200	53	21	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5492	10.1371/journal.pone.0005492	http://dx.doi.org/10.1371/journal.pone.0005492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424503	Green Submitted, gold, Green Published			2022-12-25	WOS:000265933800020
J	Gatti, G; Maresca, G; Natoli, M; Florenzano, F; Nicolin, A; Felsani, A; D'Agnano, I				Gatti, Giuliana; Maresca, Giovanna; Natoli, Manuela; Florenzano, Fulvio; Nicolin, Angelo; Felsani, Armando; D'Agnano, Igea			Myc Prevents Apoptosis and Enhances Endoreduplication Induced by Paclitaxel	PLOS ONE			English	Article								Background: The role of the MYC oncogene in the apoptotic pathways is not fully understood. MYC has been reported to protect cells from apoptosis activation but also to sensitize cells to apoptotic stimuli. We have previously demonstrated that the down-regulation of Myc protein activates apoptosis in melanoma cells and increases the susceptibility of cells to various antitumoral treatments. Beyond the well-known role in the G1 -> S transition, MYC is also involved in the G2-M cell cycle phases regulation. Methodology/Principal Findings: In this study we have investigated how MYC could influence cell survival signalling during G2 and M phases. We used the microtubules damaging agent paclitaxel (PTX), to arrest the cells in the M phase, in a p53 mutated melanoma cell line with modulated Myc level and activity. An overexpression of Myc protein is able to increase endoreduplication favoring the survival of cells exposed to antimitotic poisoning. The PTX-induced endoreduplication is associated in Myc overexpressing cells with a reduced expression of MAD2, essential component of the molecular core of the spindle assembly checkpoint (SAC), indicating an impairment of this checkpoint. In addition, for the first time we have localized Myc protein at the spindle poles (centrosomes) during pro-metaphase in different cell lines. Conclusions: The presence of Myc at the poles during the prometaphase could be necessary for the Myc-mediated attenuation of the SAC and the subsequent induction of endoreduplication. In addition, our data strongly suggest that the use of taxane in antitumor therapeutic strategies should be rationally based on the molecular profile of the individual tumor by specifically analyzing Myc expression levels.			Gatti, G (corresponding author), Univ Milan, Dept Pharmacol, Milan, Italy.	armando.felsani@inmm.cnr.it; igea.dagnano@inmm.cnr.it	D'Agnano, Igea/AAR-7282-2020; Felsani, Armando/D-1784-2010	Felsani, Armando/0000-0001-8851-6295; D'Agnano, Igea/0000-0002-2646-9224; Gatti, Giuliana/0000-0001-8844-4543				Abal M, 2003, CURR CANCER DRUG TAR, V3, P193, DOI 10.2174/1568009033481967; Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; ALEXANDROVA N, 1995, MOL CELL BIOL, V15, P5188; Amati Bruno, 1998, Frontiers in Bioscience, V3, pD250; Asnaghi L, 2004, ONCOGENE, V23, P5781, DOI 10.1038/sj.onc.1207698; Ayala-Torres S, 1999, EXP CELL RES, V246, P193, DOI 10.1006/excr.1998.4308; Baudino TA, 2003, MOL CELL, V11, P905, DOI 10.1016/S1097-2765(03)00102-3; Beckman RA, 2005, SEMIN CANCER BIOL, V15, P423, DOI 10.1016/j.semcancer.2005.06.007; Biroccio A, 2001, MOL PHARMACOL, V60, P174, DOI 10.1124/mol.60.1.174; Bucci B, 2005, CLIN CANCER RES, V11, P2756, DOI 10.1158/1078-0432.CCR-04-1582; Chow JM, 2008, EXP HEMATOL, V36, P140, DOI 10.1016/j.exphem.2007.10.004; Citro G, 1998, CANCER RES, V58, P283; Cowling VH, 2006, MOL CELL BIOL, V26, P4226, DOI 10.1128/MCB.01959-05; CRESCENZI M, 1994, J CELL BIOL, V125, P1137, DOI 10.1083/jcb.125.5.1137; D'Agnano I, 2001, ONCOGENE, V20, P2814, DOI 10.1038/sj.onc.1204392; D'Agnano I, 2007, J CELL PHYSIOL, V210, P72, DOI 10.1002/jcp.20810; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Felsher DW, 2000, P NATL ACAD SCI USA, V97, P10544, DOI 10.1073/pnas.190327097; Greco C, 2006, INT J IMMUNOPATH PH, V19, P67; HANSON KD, 1994, MOL CELL BIOL, V14, P5748, DOI 10.1128/MCB.14.9.5748; Job D, 2003, CURR OPIN CELL BIOL, V15, P111, DOI 10.1016/S0955-0674(02)00003-0; Juin P, 1999, GENE DEV, V13, P1367, DOI 10.1101/gad.13.11.1367; Juin P, 2002, MOL CELL BIOL, V22, P6158, DOI 10.1128/MCB.22.17.6158-6169.2002; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; LEVY N, 1993, MOL CELL BIOL, V13, P7942, DOI 10.1128/MCB.13.12.7942; Li Q, 1999, MOL CELL BIOL, V19, P5339; Menssen A, 2007, CELL CYCLE, V6, P339, DOI 10.4161/cc.6.3.3808; Michor F, 2004, NAT REV CANCER, V4, P197, DOI 10.1038/nrc1295; Mullan PB, 2001, ONCOGENE, V20, P6123, DOI 10.1038/sj.onc.1204712; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nesbit CE, 2000, ONCOGENE, V19, P3200, DOI 10.1038/sj.onc.1203636; Niklinski J, 2000, MOL CELL BIOL, V20, P5276, DOI 10.1128/MCB.20.14.5276-5284.2000; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Prochownik EV, 2007, CELL CYCLE, V6, P1024, DOI 10.4161/cc.6.9.4161; Ryan KM, 1996, BIOCHEM J, V314, P713, DOI 10.1042/bj3140713; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Sheen JH, 2003, BRIT J CANCER, V89, P1479, DOI 10.1038/sj.bjc.6601307; Taylor SS, 2004, CHROMOSOME RES, V12, P599, DOI 10.1023/B:CHRO.0000036610.78380.51; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Wade M, 2006, CURR TOP MICROBIOL, V302, P169; Wang YH, 2005, BREAST CANCER RES, V7, pR220, DOI 10.1186/bcr975; Wassmann K, 2003, EMBO J, V22, P797, DOI 10.1093/emboj/cdg071; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Zanet J, 2005, J CELL SCI, V118, P1693, DOI 10.1242/jcs.02298; Zhang P, 2006, J NEURO-ONCOL, V80, P123, DOI 10.1007/s11060-006-9172-7; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	52	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5442	10.1371/journal.pone.0005442	http://dx.doi.org/10.1371/journal.pone.0005442			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421315	Green Published, Green Submitted, gold			2022-12-25	WOS:000265836900004
J	Haskell, DG; Adhikari, A				Haskell, David G.; Adhikari, Anupam			Darwin's Manufactory Hypothesis Is Confirmed and Predicts the Extinction Risk of Extant Birds	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; SPECIES RICHNESS; HIGHER TAXA; EVOLUTIONARY; DIVERSITY; AVES; DIVERGENCE; SURROGATES; PATTERNS; NUCLEAR	In the Origin of Species Darwin hypothesized that the "manufactory'' of species operates at different rates in different lineages and that the richness of taxonomic units is autocorrelated across levels of the taxonomic hierarchy. We confirm the manufactory hypothesis using a database of all the world's extant avian subspecies, species and genera. The hypothesis is confirmed both in correlations across all genera and in paired comparisons controlling for phylogeny. We also find that the modern risk of extinction, as measured by "Red List'' classifications, differs across the different categories of genera identified by Darwin. Specifically, species in "manufactory'' genera are less likely to be threatened, endangered or recently extinct than are "weak manufactory'' genera. Therefore, although Darwin used his hypothesis to investigate past evolutionary processes, we find that the hypothesis also foreshadows future changes to the evolutionary tree.			Haskell, DG (corresponding author), Univ South, Dept Biol, Sewanee, TN 37375 USA.	dhaskell@sewanee.edu		Haskell, David G./0000-0003-1580-9438				Baillie J.E.M., 2004, IUCN RED LIST THREAT; Baker AJ, 2007, BIOL LETTERS, V3, P205, DOI 10.1098/rsbl.2006.0606; Baldi A, 2003, BASIC APPL ECOL, V4, P589, DOI 10.1078/1439-1791-00193; Benz BW, 2006, MOL PHYLOGENET EVOL, V40, P389, DOI 10.1016/j.ympev.2006.02.021; Cade B.S., 2005, USER MANUAL BLOSSOM; Cardillo M, 2003, ANIM CONSERV, V6, P63, DOI 10.1017/S1367943003003093; Darwin C., 1859, ORIGIN SPECIES MEANS; Dickinson EC., 2003, HOWARD MOORE COMPLET; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; ERWIN TL, 1991, SCIENCE, V253, P750, DOI 10.1126/science.253.5021.750; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Griffiths CS, 2007, J AVIAN BIOL, V38, P587, DOI 10.1111/j.2007.0908-8857.03971.x; Heino J, 2007, BIOL CONSERV, V137, P78, DOI 10.1016/j.biocon.2007.01.017; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Jablonski D, 2005, PALEOBIOLOGY, V31, P192, DOI 10.1666/0094-8373(2005)031[0192:MEAM]2.0.CO;2; Keller RA, 2003, BOT REV, V69, P93, DOI 10.1663/0006-8101(2003)069[0093:TIBOPN]2.0.CO;2; Kotiaho JS, 2005, P NATL ACAD SCI USA, V102, P1963, DOI 10.1073/pnas.0406718102; Lerner HRL, 2008, AUK, V125, P304, DOI 10.1525/auk.2008.06161; Lerner HRL, 2005, MOL PHYLOGENET EVOL, V37, P327, DOI 10.1016/j.ympev.2005.04.010; Lovette IJ, 2002, AUK, V119, P695, DOI 10.1642/0004-8038(2002)119[0695:WIAWWM]2.0.CO;2; Lovette IJ, 2007, MOL PHYLOGENET EVOL, V44, P1031, DOI 10.1016/j.ympev.2007.03.017; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Mielke P. W., 2001, PERMUTATION METHODS; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Mooers AO, 1997, Q REV BIOL, V72, P31, DOI 10.1086/419657; Nee S, 2005, CONSERV BIOL SER, V8, P387; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; Ohlson JI, 2007, MOL PHYLOGENET EVOL, V42, P25, DOI 10.1016/j.ympev.2006.05.041; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Phillimore AB, 2006, P R SOC B, V273, P1049, DOI 10.1098/rspb.2005.3425; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Phillimore AB, 2007, EVOLUTION, V61, P942, DOI 10.1111/j.1558-5646.2007.00068.x; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Rabosky DL, 2008, EVOLUTION, V62, P1866, DOI 10.1111/j.1558-5646.2008.00409.x; Rodrigues ASL, 2005, CONSERV BIOL SER, V8, P101; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Schuh RT, 2003, BOT REV, V69, P59, DOI 10.1663/0006-8101(2003)069[0059:TLSAIY]2.0.CO;2; SEPKOSKI JJ, 1978, PALEOBIOLOGY, V4, P223, DOI 10.1017/S0094837300005972; Sol D, 2005, EVOLUTION, V59, P2669, DOI 10.1111/j.0014-3820.2005.tb00978.x; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Weir JT, 2006, EVOLUTION, V60, P842; Wlodarska-Kowalczuk M, 2007, MAR ECOL PROG SER, V351, P53, DOI 10.3354/meps07127; Zink RM, 2004, P ROY SOC B-BIOL SCI, V271, P561, DOI 10.1098/rspb.2003.2617	43	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5460	10.1371/journal.pone.0005460	http://dx.doi.org/10.1371/journal.pone.0005460			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421332	gold, Green Submitted, Green Published			2022-12-25	WOS:000265836900015
J	Bais, M; McLean, J; Sebastiani, P; Young, M; Wigner, N; Smith, T; Kotton, DN; Einhorn, TA; Gerstenfeld, LC				Bais, Manish; McLean, Jody; Sebastiani, Paola; Young, Megan; Wigner, Nathan; Smith, Temple; Kotton, Darrell N.; Einhorn, Thomas A.; Gerstenfeld, Louis C.			Transcriptional Analysis of Fracture Healing and the Induction of Embryonic Stem Cell-Related Genes	PLOS ONE			English	Article							SINGLE PERCUTANEOUS INJECTION; BONE MORPHOGENETIC PROTEIN-2; FIBROBLAST-GROWTH-FACTOR; TEMPORAL EXPRESSION; TNF-ALPHA; MARROW; DIFFERENTIATION; ADULT; CHONDROGENESIS; SPECIFICATION	Fractures are among the most common human traumas. Fracture healing represents a unique temporarily definable postnatal process in which to study the complex interactions of multiple molecular events that regulate endochondral skeletal tissue formation. Because of the regenerative nature of fracture healing, it is hypothesized that large numbers of post-natal stem cells are recruited and contribute to formation of the multiple cell lineages that contribute to this process. Bayesian modeling was used to generate the temporal profiles of the transcriptome during fracture healing. The temporal relationships between ontologies that are associated with various biologic, metabolic, and regulatory pathways were identified and related to developmental processes associated with skeletogenesis, vasculogenesis, and neurogenesis. The complement of all the expressed BMPs, Wnts, FGFs, and their receptors were related to the subsets of transcription factors that were concurrently expressed during fracture healing. We further defined during fracture healing the temporal patterns of expression for 174 of the 193 genes known to be associated with human genetic skeletal disorders. In order to identify the common regulatory features that might be present in stem cells that are recruited during fracture healing to other types of stem cells, we queried the transcriptome of fracture healing against that seen in embryonic stem cells ( ESCs) and mesenchymal stem cells ( MSCs). Approximately 300 known genes that are preferentially expressed in ESCs and,350 of the known genes that are preferentially expressed in MSCs showed induction during fracture healing. Nanog, one of the central epigenetic regulators associated with ESC stem cell maintenance, was shown to be associated in multiple forms or bone repair as well as MSC differentiation. In summary, these data present the first temporal analysis of the transcriptome of an endochondral bone formation process that takes place during fracture healing. They show that neurogenesis as well as vasculogenesis are predominant components of skeletal tissue formation and suggest common pathways are shared between post-natal stem cells and those seen in ESCs.			Gerstenfeld, LC (corresponding author), Boston Univ, Sch Med, Orthopaed Res Lab, Boston, MA 02118 USA.	lgersten@bu.edu		/0000-0002-0477-1211; Kotton, Darrell/0000-0002-9604-8476; sebastiani, paola/0000-0001-6419-1545; Einhorn, Thomas/0000-0002-5075-4885; Bais, Manish/0000-0003-4198-7377	NIAMS NIH HHS [P01 AR049920, R01 AR044927, R29 AR044927, R56 AR044927, AR044927] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR044927, P01AR049920, R01AR044927, R29AR044927] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Baldock PA, 2002, J CLIN INVEST, V109, P915, DOI 10.1172/JCI14588; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Buckwalter JA., 2001, ROCKWOOD GREENS FRAC, P245; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; CALVO W, 1969, AM J ANAT, V126, P355, DOI 10.1002/aja.1001260308; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Chang WY, 2006, BIOCHEM CELL BIOL, V84, P257, DOI 10.1139/O06-036; Chen Y, 2009, J CELL BIOCHEM, V106, P353, DOI 10.1002/jcb.22020; Chen YM, 2006, J BIOL CHEM, V281, P5726, DOI 10.1074/jbc.M510945200; Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513; Denes A, 2005, NEUROSCIENCE, V134, P947, DOI 10.1016/j.neuroscience.2005.03.060; Desai BJ, 2003, J ORTHOP TRAUMA, V17, P689, DOI 10.1097/00005131-200311000-00005; Edgar CM, 2007, BONE, V40, P1389, DOI 10.1016/j.bone.2007.01.001; Einhorn TA, 2003, J BONE JOINT SURG AM, V85A, P1425, DOI 10.2106/00004623-200308000-00002; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Ferguson C, 1999, MECH DEVELOP, V87, P57, DOI 10.1016/S0925-4773(99)00142-2; Gadue P, 2005, EXP HEMATOL, V33, P955, DOI 10.1016/j.exphem.2005.06.009; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584; Gerstenfeld LC, 2001, CELLS TISSUES ORGANS, V169, P285, DOI 10.1159/000047893; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Hadjiargyrou M, 2002, J BIOL CHEM, V277, P30177, DOI 10.1074/jbc.M203171200; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Iversen PO, 2000, BLOOD, V96, P2081; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jepsen KJ, 2008, J BONE MINER RES, V23, P1204, DOI 10.1359/JBMR.080317; Kakar S, 2007, J BONE MINER RES, V22, P1903, DOI 10.1359/JBMR.070724; Kochupurakkal BS, 2008, BIOCHEM BIOPH RES CO, V365, P846, DOI 10.1016/j.bbrc.2007.11.073; Kon T, 2001, J BONE MINER RES, V16, P1004, DOI 10.1359/jbmr.2001.16.6.1004; Krampera M, 2007, STEM CELLS DEV, V16, P797, DOI 10.1089/scd.2007.0024; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lehmann W, 2005, BONE, V36, P300, DOI 10.1016/j.bone.2004.10.010; Mach DB, 2002, NEUROSCIENCE, V113, P155, DOI 10.1016/S0306-4522(02)00165-3; Maestroni GJM, 2000, ANN NY ACAD SCI, V917, P29; Meyer MH, 2007, J ORTHOP RES, V25, P488, DOI 10.1002/jor.20334; MICHALSKA AE, 2007, CURRENT PROTOCOLS ST; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakajima A, 2001, BONE, V29, P458, DOI 10.1016/S8756-3282(01)00604-4; Nakajima F, 2007, CALCIFIED TISSUE INT, V81, P132, DOI 10.1007/s00223-007-9048-7; NORK SE, 2006, ROCKWOOD GREENS FRAC, P1845; Office of the Surgeon General (US), 2004, BON HLTH OST REP SUR; Ota S, 2007, DEVELOPMENT, V134, P1583, DOI 10.1242/dev.000703; Pala D, 2008, J BIOL CHEM, V283, P9239, DOI 10.1074/jbc.M705175200; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Phillips AM, 2005, INJURY, V36, P5, DOI 10.1016/j.injury.2005.07.027; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Ramoni MF, 2002, P NATL ACAD SCI USA, V99, P9121, DOI 10.1073/pnas.132656399; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Roubelakis MG, 2007, STEM CELLS DEV, V16, P931, DOI 10.1089/scd.2007.0036; Rundle CH, 2006, BONE, V38, P521, DOI 10.1016/j.bone.2005.09.015; Spater D, 2006, DEVELOPMENT, V133, P3039, DOI 10.1242/dev.02471; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Superti-Furga A, 2007, AM J MED GENET A, V143A, P1, DOI 10.1002/ajmg.a.31483; SUVA LJ, 1993, J BONE MINER RES, V8, P379; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Tabarowski Z, 1996, ACTA HISTOCHEM, V98, P453, DOI 10.1016/S0065-1281(96)80013-4; Takeda S, 2008, J NEUROENDOCRINOL, V20, P802, DOI 10.1111/j.1365-2826.2008.01732.x; Takeda S, 2008, BONE, V42, P837, DOI 10.1016/j.bone.2008.01.005; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Vortkamp A, 1998, MECH DEVELOP, V71, P65, DOI 10.1016/S0925-4773(97)00203-7; Wang K, 2006, MATRIX BIOL, V25, P271, DOI 10.1016/j.matbio.2006.02.001; Wang L, 2006, LECT NOTES COMPUT SC, V3909, P60; Wang L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-147; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; YAMAZAKI K, 1990, AM J ANAT, V187, P261, DOI 10.1002/aja.1001870306; Yoon BS, 2006, DEVELOPMENT, V133, P4667, DOI 10.1242/dev.02680	74	74	77	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2009	4	5							e5393	10.1371/journal.pone.0005393	http://dx.doi.org/10.1371/journal.pone.0005393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JE	19415118	gold, Green Published, Green Submitted			2022-12-25	WOS:000265836700004
J	Long, MA; Rossi, FMV				Long, Michael A.; Rossi, Fabio M. V.			Silencing Inhibits Cre-Mediated Recombination of the Z/AP and Z/EG Reporters in Adult Cells	PLOS ONE			English	Article								Background: The Cre-loxP system has been used to enable tissue specific activation, inactivation and mutation of many genes in vivo and has thereby greatly facilitated the genetic dissection of several cellular and developmental processes. In such studies, Cre-reporter strains, which carry a Cre-activated marker gene, are frequently utilized to validate the expression profile of Cre transgenes, to act as a surrogate marker for excision of a second allele, and to irreversibly label cells for lineage tracing experiments. Principal Findings: We have studied three commonly used Cre-reporter strains, Z/AP, Z/EG and R26R-EYFP and have demonstrated that although each reporter can be reliably activated by Cre during early development, exposure to Cre in adult hematopoietic cells results in a much lower frequency of marker-positive cells in the Z/AP or Z/EG strains than in the R26R-EYFP strain. In marker negative cells derived from the Z/AP and Z/EG strains, the transgenic promoter is methylated and Cre-mediated recombination of the locus is inhibited. Conclusions: These results show that the efficiency of Cre-mediated recombination is not only dependent on the genomic context of a given loxP-flanked sequence, but also on stochastic epigenetic mechanisms underlying transgene variegation. Furthermore, our data highlights the potential shortcomings of utilizing the Z/AP and Z/EG reporters as surrogate markers of excision or in lineage tracing experiments.			Rossi, FMV (corresponding author), Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada.	fabio@brc.ubc.ca	Rossi, Fabio MV/B-5587-2013	Rossi, Fabio MV/0000-0002-0368-2620				Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; AUSTIN S, 1981, CELL, V25, P729, DOI 10.1016/0092-8674(81)90180-X; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cohen-Tannoudji M, 2000, TRANSGENIC RES, V9, P233, DOI 10.1023/A:1008916910392; Ferron M, 2005, GENESIS, V41, P138, DOI 10.1002/gene.20108; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; Harris RG, 2004, SCIENCE, V305, P90, DOI 10.1126/science.1098925; IWAMA A, 1993, BIOCHEM BIOPH RES CO, V195, P301, DOI 10.1006/bbrc.1993.2045; JAHNER D, 1982, NATURE, V298, P623, DOI 10.1038/298623a0; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Jullien N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001355; Kidder BL, 2008, CLONING STEM CELLS, V10, P231, DOI 10.1089/clo.2007.0039; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Rotolo T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004099; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STERNBERG N, 1986, J MOL BIOL, V187, P197, DOI 10.1016/0022-2836(86)90228-7; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Yano M, 1997, BLOOD, V89, P4317, DOI 10.1182/blood.V89.12.4317; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhang XM, 2005, INVEST OPHTH VIS SCI, V46, P3515, DOI 10.1167/iovs.04-1201; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895	29	50	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2009	4	5							e5435	10.1371/journal.pone.0005435	http://dx.doi.org/10.1371/journal.pone.0005435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JE	19415111	Green Published, gold, Green Submitted			2022-12-25	WOS:000265836700008
J	Sakamoto, KQ; Sato, K; Ishizuka, M; Watanuki, Y; Takahashi, A; Daunt, F; Wanless, S				Sakamoto, Kentaro Q.; Sato, Katsufumi; Ishizuka, Mayumi; Watanuki, Yutaka; Takahashi, Akinori; Daunt, Francis; Wanless, Sarah			Can Ethograms Be Automatically Generated Using Body Acceleration Data from Free-Ranging Birds?	PLOS ONE			English	Article							SHAGS PHALACROCORAX-ARISTOTELIS; BREEDING SUCCESS; DIVING BEHAVIOR; TIME BUDGET; CAMERAS; QUANTIFY; INSIGHTS; SEABIRD; STROKE; DEPTH	An ethogram is a catalogue of discrete behaviors typically employed by a species. Traditionally animal behavior has been recorded by observing study individuals directly. However, this approach is difficult, often impossible, in the case of behaviors which occur in remote areas and/or at great depth or altitude. The recent development of increasingly sophisticated, animal-borne data loggers, has started to overcome this problem. Accelerometers are particularly useful in this respect because they can record the dynamic motion of a body in e. g. flight, walking, or swimming. However, classifying behavior using body acceleration characteristics typically requires prior knowledge of the behavior of free-ranging animals. Here, we demonstrate an automated procedure to categorize behavior from body acceleration, together with the release of a user-friendly computer application, "Ethographer''. We evaluated its performance using longitudinal acceleration data collected from a foot-propelled diving seabird, the European shag, Phalacrocorax aristotelis. The time series data were converted into a spectrum by continuous wavelet transformation. Then, each second of the spectrum was categorized into one of 20 behavior groups by unsupervised cluster analysis, using k-means methods. The typical behaviors extracted were characterized by the periodicities of body acceleration. Each categorized behavior was assumed to correspond to when the bird was on land, in flight, on the sea surface, diving and so on. The behaviors classified by the procedures accorded well with those independently defined from depth profiles. Because our approach is performed by unsupervised computation of the data, it has the potential to detect previously unknown types of behavior and unknown sequences of some behaviors.	[Sakamoto, Kentaro Q.; Ishizuka, Mayumi] Hokkaido Univ, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Sato, Katsufumi] Univ Tokyo, Ocean Res Inst, Int Coastal Res Ctr, Otsuchi, Iwate, Japan; [Watanuki, Yutaka] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido, Japan; [Takahashi, Akinori] Natl Inst Polar Res, Tokyo, Tokyo, Japan; [Daunt, Francis; Wanless, Sarah] Bush Estate, Ctr Ecol & Hydrol, Penicuik, Midlothian, Scotland	Hokkaido University; University of Tokyo; Hokkaido University; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; UK Centre for Ecology & Hydrology (UKCEH)	Sakamoto, KQ (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Sapporo, Hokkaido, Japan.	sakamoto@vetmed.hokudai.ac.jp	Wanless, Sarah/K-2338-2012; Ishizuka, Mayumi/F-9548-2012; Sakamoto, Kentaro/N-7424-2019; Daunt, Francis/K-6688-2012; Sakamoto, Kentaro/A-4843-2012	Wanless, Sarah/0000-0002-2788-4606; Sakamoto, Kentaro/0000-0002-8499-799X; Daunt, Francis/0000-0003-4638-3388; Sakamoto, Kentaro/0000-0002-8499-799X	Natural Environment Research Council [CEH010021] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Boyd Ian L., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P1; Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Daunt F, 2007, FUNCT ECOL, V21, P561, DOI 10.1111/j.1365-2435.2007.01260.x; Gentry R.L., 1986, P28; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Hooker SK, 2007, DEEP-SEA RES PT II, V54, P177, DOI 10.1016/j.dsr2.2007.01.001; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jenouvrier S, 2005, P ROY SOC B-BIOL SCI, V272, P887, DOI 10.1098/rspb.2004.2978; Karlsson S, 2000, IEEE T BIO-MED ENG, V47, P228, DOI 10.1109/10.821766; Lagarde F, 2008, ANIM BEHAV, V75, P319, DOI 10.1016/j.anbehav.2007.01.010; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; PERCIVAL DP, 1995, BIOMETRIKA, V82, P619, DOI 10.2307/2337538; Ropert-Coudert Y, 2004, ANIM BEHAV, V67, P985, DOI 10.1016/j.anbehav.2003.09.010; Rutz C, 2007, SCIENCE, V318, P765, DOI 10.1126/science.1146788; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Sato K, 2008, J EXP BIOL, V211, P58, DOI 10.1242/jeb.009811; Takahashi A, 2004, P ROY SOC B-BIOL SCI, V271, pS281, DOI 10.1098/rsbl.2004.0182; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Tremblay Y, 2003, J EXP BIOL, V206, P1929, DOI 10.1242/jeb.00363; WANLESS S, 1993, IBIS, V135, P19, DOI 10.1111/j.1474-919X.1993.tb02805.x; WANLESS S, 1991, IBIS, V133, P37, DOI 10.1111/j.1474-919X.1991.tb04807.x; Wanless S., 1992, P591; WANLESS S, 1993, J ZOOL, V231, P11, DOI 10.1111/j.1469-7998.1993.tb05349.x; Watanabe S, 2005, APPL ANIM BEHAV SCI, V94, P117, DOI 10.1016/j.applanim.2005.01.010; Watanuki Y, 2005, J EXP BIOL, V208, P2207, DOI 10.1242/jeb.01639; Watanuki Y, 2008, MAR ECOL PROG SER, V356, P283, DOI 10.3354/meps07266; Watanuki Yutaka, 2007, British Birds, V100, P466; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2008, ENDANGER SPECIES RES, V10, P29, DOI [10.3354/esr00091, DOI 10.3354/ESR00091]; Yoda K, 2001, J EXP BIOL, V204, P685; Young SS., 2001, COMPUTERIZED DATA AC, DOI 10.1017/CBO9780511609558	34	239	247	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5379	10.1371/journal.pone.0005379	http://dx.doi.org/10.1371/journal.pone.0005379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404389	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000265614900004
J	Cuesta, AM; Sanchez-Martin, D; Sanz, L; Bonet, J; Compte, M; Kremer, L; Blanco, FJ; Oliva, B; Alvarez-Vallina, L				Cuesta, Angel M.; Sanchez-Martin, David; Sanz, Laura; Bonet, Jaume; Compte, Marta; Kremer, Leonor; Blanco, Francisco J.; Oliva, Baldomero; Alvarez-Vallina, Luis			In Vivo Tumor Targeting and Imaging with Engineered Trivalent Antibody Fragments Containing Collagen-Derived Sequences	PLOS ONE			English	Article							SINGLE-CHAIN FV; BINDING-AFFINITY; GENE-THERAPY; PROTEIN; DOMAIN; GENERATION; INHIBITION; SELECTION; DIVALENT; DIABODY	There is an urgent need to develop new and effective agents for cancer targeting. In this work, a multivalent antibody is characterized in vivo in living animals. The antibody, termed "trimerbody", comprises a single-chain antibody (scFv) fragment connected to the N-terminal trimerization subdomain of collagen XVIII NC1 by a flexible linker. As indicated by computer graphic modeling, the trimerbody has a tripod-shaped structure with three highly flexible scFv heads radially outward oriented. Trimerbodies are trimeric in solution and exhibited multivalent binding, which provides them with at least a 100-fold increase in functional affinity than the monovalent scFv. Our results also demonstrate the feasibility of producing functional bispecific trimerbodies, which concurrently bind two different ligands. A trimerbody specific for the carcinoembryonic antigen (CEA), a classic tumor-associated antigen, showed efficient tumor targeting after systemic administration in mice bearing CEA-positive tumors. Importantly, a trimerbody that recognizes an angiogenesis-associated laminin epitope, showed excellent tumor localization in several cancer types, including fibrosarcomas and carcinomas. These results illustrate the potential of this new antibody format for imaging and therapeutic applications, and suggest that some laminin epitopes might be universal targets for cancer targeting.	[Cuesta, Angel M.; Sanchez-Martin, David; Sanz, Laura; Compte, Marta; Alvarez-Vallina, Luis] Hosp Univ Puerta de Hierro, Mol Immunol Unit, Madrid, Spain; [Bonet, Jaume; Oliva, Baldomero] Parc Recerca Biomed Barcelona, Biomed Informat Res Unit, Struct Bioinformat Lab, Barcelona, Spain; [Kremer, Leonor] CSIC, Ctr Nacl Biotecnol, Prot Tools Unit, Madrid, Spain; [Blanco, Francisco J.] Parque Tecnol Bizkaia, Struct Biol Unit, CIC bioGUNE, Bizkaia, Spain	Hospital Puerta de Hierro-Majadahonda; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); CIC bioGUNE	Cuesta, AM (corresponding author), Hosp Univ Puerta de Hierro, Mol Immunol Unit, Madrid, Spain.	lalvarezv.hpth@salud.madrid.org	Sánchez-Martín, David/C-9927-2013; Bonet, Jaume/C-5551-2011; Blanco, Francisco J/D-4401-2009; Cuesta, Angel/F-1668-2011; AM, Cuesta/AAA-9356-2020; Sanz, Laura/F-8542-2010; Alvarez-Vallina, Luis/ABD-2431-2020; Kremer, Leonor/L-5445-2015; cancer, biogune/H-7276-2012; Gasull, Martina/J-4076-2019; Álvarez-Vallina, Luis/A-2032-2010; Oliva, Baldomero/A-2690-2009; Alvarez-Vallina, Luis/A-2033-2010	Sánchez-Martín, David/0000-0002-2712-4762; Bonet, Jaume/0000-0001-5210-4387; Blanco, Francisco J/0000-0003-2545-4319; Cuesta, Angel/0000-0002-6596-9600; AM, Cuesta/0000-0002-6596-9600; Sanz, Laura/0000-0002-3119-3218; Alvarez-Vallina, Luis/0000-0003-3053-6757; Kremer, Leonor/0000-0002-2235-2010; Oliva, Baldomero/0000-0003-0702-0250; Compte Grau, Marta/0000-0002-7138-9266				Adams GP, 1998, BRIT J CANCER, V77, P1405, DOI 10.1038/bjc.1998.233; ADAMS GP, 1995, CANCER IMMUNOL IMMUN, V40, P299, DOI 10.1007/BF01519629; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Beresford GW, 1999, INT J CANCER, V81, P911, DOI 10.1002/(SICI)1097-0215(19990611)81:6<911::AID-IJC12>3.0.CO;2-O; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Birchler M, 1999, J IMMUNOL METHODS, V231, P239, DOI 10.1016/S0022-1759(99)00160-X; Blanco B, 2003, J IMMUNOL, V171, P1070, DOI 10.4049/jimmunol.171.2.1070; CHESTER KA, 1994, LANCET, V343, P455, DOI 10.1016/S0140-6736(94)92695-6; Chester KA, 2000, CANCER CHEMOTH PHARM, V46, pS8, DOI 10.1007/PL00014055; Compte M, 2007, CANCER GENE THER, V14, P380, DOI 10.1038/sj.cgt.7701021; Ebbinghaus C, 2005, INT J CANCER, V116, P304, DOI 10.1002/ijc.20952; Fan CY, 2008, FASEB J, V22, P3795, DOI 10.1096/fj.08-111484; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; HOLLIGER P, 1993, P NATL ACAD SCI USA, V90, P6444, DOI 10.1073/pnas.90.14.6444; Hu SZ, 1996, CANCER RES, V56, P3055; Huang BC, 2006, J IMMUNOL METHODS, V313, P149, DOI 10.1016/j.jim.2006.04.006; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Lawrence LJ, 1998, FEBS LETT, V425, P479, DOI 10.1016/S0014-5793(98)00292-0; PACK P, 1995, J MOL BIOL, V246, P28, DOI 10.1006/jmbi.1994.0062; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pieper U, 2004, NUCLEIC ACIDS RES, V32, pD217, DOI 10.1093/nar/gkh095; Pluckthun A, 1997, IMMUNOTECHNOLOGY, V3, P83, DOI 10.1016/S1380-2933(97)00067-5; Lobo VJSA, 2006, INT J CANCER, V119, P455, DOI 10.1002/ijc.21851; Sanz L, 2004, TRENDS IMMUNOL, V25, P85, DOI 10.1016/j.it.2003.12.001; Sanz L, 2003, TRENDS MOL MED, V9, P256, DOI 10.1016/S1471-4914(03)00070-4; Sanz L, 2003, EMBO J, V22, P1508, DOI 10.1093/emboj/cdg150; Sanz L, 2002, GENE THER, V9, P1049, DOI 10.1038/sj.gt.3301725; Sanz L, 2001, CANCER IMMUNOL IMMUN, V50, P557, DOI 10.1007/s00262-001-0235-5; Sasaki T, 2004, J CELL BIOL, V164, P959, DOI 10.1083/jcb.200401058; Sasaki T, 1998, EMBO J, V17, P4249, DOI 10.1093/emboj/17.15.4249; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Viti F, 1999, CANCER RES, V59, P347; WHITLOW M, 1993, PROTEIN ENG, V6, P989, DOI 10.1093/protein/6.8.989; Williams LE, 2001, CANCER BIOTHER RADIO, V16, P25, DOI 10.1089/108497801750095989; Willuda J, 2001, J BIOL CHEM, V276, P14385, DOI 10.1074/jbc.M011669200; Wong JYC, 2004, CLIN CANCER RES, V10, P5014, DOI 10.1158/1078-0432.CCR-03-0576; Wu AM, 1996, IMMUNOTECHNOLOGY, V2, P21, DOI 10.1016/1380-2933(95)00027-5; Yazaki Paul J, 2003, Methods Mol Biol, V207, P351; YOKOTA T, 1993, CANCER RES, V53, P3776; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	42	48	59	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5381	10.1371/journal.pone.0005381	http://dx.doi.org/10.1371/journal.pone.0005381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401768	Green Published, gold			2022-12-25	WOS:000265601100018
J	Gerard, E; Moreira, D; Philippot, P; Van Kranendonk, MJ; Lopez-Garcia, P				Gerard, Emmanuelle; Moreira, David; Philippot, Pascal; Van Kranendonk, Martin J.; Lopez-Garcia, Purificacion			Modern Subsurface Bacteria in Pristine 2.7 Ga-Old Fossil Stromatolite Drillcore Samples from the Fortescue Group, Western Australia	PLOS ONE			English	Article							ANCIENT DNA; SP-NOV.; DIVERSITY; COMMUNITY; BIOMASS; ICE	Background: Several abiotic processes leading to the formation of life-like signatures or later contamination with actual biogenic traces can blur the interpretation of the earliest fossil record. In recent years, a large body of evidence showing the occurrence of diverse and active microbial communities in the terrestrial subsurface has accumulated. Considering the time elapsed since Archaean sedimentation, the contribution of subsurface microbial communities postdating the rock formation to the fossil biomarker pool and other biogenic remains in Archaean rocks may be far from negligible. Methodology/Principal Findings: In order to evaluate the degree of potential contamination of Archean rocks by modern microorganisms, we looked for the presence of living indigenous bacteria in fresh diamond drillcores through 2,724 Myr-old stromatolites (Tumbiana Formation, Fortescue Group, Western Australia) using molecular methods based on the amplification of small subunit ribosomal RNA genes (SSU rDNAs). We analyzed drillcore samples from 4.3 m and 66.2 m depth, showing signs of meteoritic alteration, and also from deeper "fresh'' samples showing no apparent evidence for late stage alteration (68 m, 78.8 m, and 99.3 m). We also analyzed control samples from drilling and sawing fluids and a series of laboratory controls to establish a list of potential contaminants introduced during sample manipulation and PCR experiments. We identified in this way the presence of indigenous bacteria belonging to Firmicutes, Actinobacteria, and Alpha-, Beta-, and Gammaproteobacteria in aseptically-sawed inner parts of drillcores down to at least 78.8 m depth. Conclusions/Significance: The presence of modern bacterial communities in subsurface fossil stromatolite layers opens the possibility that a continuous microbial colonization had existed in the past and contributed to the accumulation of biogenic traces over geological timescales. This finding casts shadow on bulk analyses of early life remains and makes claims for morphological, chemical, isotopic, and biomarker traces syngenetic with the rock unreliable in the absence of detailed contextual analyses at microscale.			Gerard, E (corresponding author), Univ Paris 07, IPGP IMPMC, Paris, France.	puri.lopez@u-psud.fr	Moreira, David/F-7445-2012; Philippot, Pascal/AAD-4313-2020; Van Kranendonk, Martin J/J-8755-2012; GERARD, Emmanuelle/A-3828-2013; Lopez-Garcia, Purificacion/B-6775-2012	Moreira, David/0000-0002-2064-5354; Van Kranendonk, Martin J/0000-0002-0611-2703; GERARD, Emmanuelle/0000-0002-4910-747X; Lopez-Garcia, Purificacion/0000-0002-0927-0651				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barton HA, 2006, J MICROBIOL METH, V66, P21, DOI 10.1016/j.mimet.2005.10.005; Baxter NJ, 2002, APPL ENVIRON MICROB, V68, P289, DOI 10.1128/AEM.68.1.289-296.2002; Brasier M, 2006, PHILOS T R SOC B, V361, P887, DOI 10.1098/rstb.2006.1835; Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a; Brocks JJ, 2005, TREATISE ON GEOCHEMISTRY, VOL 8: BIOGEOCHEMISTRY, P63; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; CANO RJ, 1995, SCIENCE, V268, P1060, DOI 10.1126/science.7538699; Cox TL, 1997, INT J SYST BACTERIOL, V47, P377, DOI 10.1099/00207713-47-2-377; DORN RI, 1981, SCIENCE, V213, P1245, DOI 10.1126/science.213.4513.1245; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ercole C, 1997, FUEL PROCESS TECHNOL, V52, P191, DOI 10.1016/S0378-3820(97)00028-3; Fish SA, 2002, NATURE, V417, P432, DOI 10.1038/417432a; FREDRICKSON JK, 1995, APPL ENVIRON MICROB, V61, P1917, DOI 10.1128/AEM.61.5.1917-1922.1995; Hayes J.M., 1994, EARLY LIFE EARTH, V84, P220; Hebsgaard MB, 2005, TRENDS MICROBIOL, V13, P212, DOI 10.1016/j.tim.2005.03.010; Inagaki F, 2005, ASTROBIOLOGY, V5, P141, DOI 10.1089/ast.2005.5.141; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kanso S, 2003, INT J SYST EVOL MICR, V53, P401, DOI 10.1099/ijs.0.02348-0; Kanso S, 2002, INT J SYST EVOL MICR, V52, P869, DOI 10.1099/00207713-52-3-869; Kimura H, 2005, EXTREMOPHILES, V9, P407, DOI 10.1007/s00792-005-0454-3; Lambert DM, 2002, SCIENCE, V295, P2270, DOI 10.1126/science.1068105; Lavire C, 2006, ENVIRON MICROBIOL, V8, P2106, DOI 10.1111/j.1462-2920.2006.01087.x; Lepot K, 2008, NAT GEOSCI, V1, P118, DOI 10.1038/ngeo107; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Miyake D, 2007, ARCH MICROBIOL, V188, P199, DOI 10.1007/s00203-007-0244-7; Moissl C, 2007, FEMS MICROBIOL ECOL, V61, P509, DOI 10.1111/j.1574-6941.2007.00360.x; Newman DK, 2002, SCIENCE, V296, P1071, DOI 10.1126/science.1010716; North NN, 2004, APPL ENVIRON MICROB, V70, P4911, DOI 10.1128/aem.70.8.4911-4920.2004; Onstott TC, 2003, ENVIRON MICROBIOL, V5, P1168, DOI 10.1046/j.1462-2920.2003.00512.x; Parkes RJ, 2005, NATURE, V436, P390, DOI 10.1038/nature03796; Pedersen K, 2000, FEMS MICROBIOL LETT, V185, P9, DOI 10.1016/S0378-1097(00)00061-6; Pedersen K, 2008, ISME J, V2, P760, DOI 10.1038/ismej.2008.43; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Rasmussen B, 2008, NATURE, V455, P1101, DOI 10.1038/nature07381; Rogers SO, 2004, APPL ENVIRON MICROB, V70, P2540, DOI 10.1128/AEM.70.4.2540-2544.2004; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schopf JW, 2006, PHILOS T R SOC B, V361, P869, DOI 10.1098/rstb.2006.1834; Shi T, 2001, J IND MICROBIOL BIOT, V26, P283, DOI 10.1038/sj.jim.7000130; Damste JSS, 2006, ASTROBIOLOGY, V6, P299, DOI 10.1089/ast.2006.6.299; Stapleton RD, 2000, MICROB ECOL, V39, P211; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; Takeuchi M, 2001, INT J SYST EVOL MICR, V51, P1405, DOI 10.1099/00207713-51-4-1405; Teske AP, 2005, TRENDS MICROBIOL, V13, P402, DOI 10.1016/j.tim.2005.07.004; van Zuilen MA, 2002, NATURE, V418, P627, DOI 10.1038/nature00934; VANKRANENDONK MJ, 2006, 200614 W AUSTR GEOL; Vreeland RH, 2000, NATURE, V407, P897, DOI 10.1038/35038060; Zhang GX, 2005, APPL ENVIRON MICROB, V71, P3213, DOI 10.1128/AEM.71.6.3213-3227.2005	48	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2009	4	4							e5298	10.1371/journal.pone.0005298	http://dx.doi.org/10.1371/journal.pone.0005298			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VI	19396360	Green Published, Green Submitted, gold			2022-12-25	WOS:000265514600002
J	Camoletto, PG; Vara, H; Morando, L; Connell, E; Marletto, FP; Giustetto, M; Sassoe-Pognetto, M; Van Veldhoven, PP; Ledesma, MD				Camoletto, Paola G.; Vara, Hugo; Morando, Laura; Connell, Emma; Marletto, Fabio P.; Giustetto, Maurizio; Sassoe-Pognetto, Marco; Van Veldhoven, Paul P.; Ledesma, Maria Dolores			Synaptic Vesicle Docking: Sphingosine Regulates Syntaxin1 Interaction with Munc18	PLOS ONE			English	Article							SPHINGOMYELINASE-DEFICIENT MICE; CONFORMATIONAL SWITCH; SNARE COMPLEX; ACID; EXOCYTOSIS; METABOLISM; SUBSTRATE; MODEL	Consensus exists that lipids must play key functions in synaptic activity but precise mechanistic information is limited. Acid sphingomyelinase knockout mice (ASMko) are a suitable model to address the role of sphingolipids in synaptic regulation as they recapitulate a mental retardation syndrome, Niemann Pick disease type A (NPA), and their neurons have altered levels of sphingomyelin (SM) and its derivatives. Electrophysiological recordings showed that ASMko hippocampi have increased paired-pulse facilitation and post-tetanic potentiation. Consistently, electron microscopy revealed reduced number of docked vesicles. Biochemical analysis of ASMko synaptic membranes unveiled higher amounts of SM and sphingosine (Se) and enhanced interaction of the docking molecules Munc18 and syntaxin1. In vitro reconstitution assays demonstrated that Se changes syntaxin1 conformation enhancing its interaction with Munc18. Moreover, Se reduces vesicle docking in primary neurons and increases paired-pulse facilitation when added to wt hippocampal slices. These data provide with a novel mechanism for synaptic vesicle control by sphingolipids and could explain cognitive deficits of NPA patients.	[Camoletto, Paola G.; Ledesma, Maria Dolores] VIB, Dept Mol & Dev Genet, Louvain, Belgium; [Camoletto, Paola G.; Ledesma, Maria Dolores] Katholieke Univ Leuven, Ctr Human Genet, Leuven, Belgium; [Camoletto, Paola G.; Ledesma, Maria Dolores] CSIC UAM, Dept Mol Neurobiol, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Vara, Hugo; Morando, Laura; Marletto, Fabio P.; Giustetto, Maurizio; Sassoe-Pognetto, Marco] Dept Anat Pharmacol & Forens Med, Turin, Italy; [Vara, Hugo; Morando, Laura; Marletto, Fabio P.; Giustetto, Maurizio; Sassoe-Pognetto, Marco] Natl Inst Neurosci Italy, Turin, Italy; [Connell, Emma] Med Res Council Lab Mol Biol, Cambridge, England; [Van Veldhoven, Paul P.] Katholieke Univ Leuven, LIPIT, Dept Mol Cell Biol, Leuven, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); KU Leuven	Ledesma, MD (corresponding author), VIB, Dept Mol & Dev Genet, Louvain, Belgium.	dledesma@cbm.uam.es	Vara Rivera, Hugo/L-4480-2018; giustetto, maurizio/D-6606-2011; Ledesma, Maria Dolores/I-5619-2015; Sassoe-Pognetto, Marco/AAE-3536-2022; , Van Veldhoven Paul/U-6359-2019	Vara Rivera, Hugo/0000-0002-7287-815X; giustetto, maurizio/0000-0003-1323-4060; Ledesma, Maria Dolores/0000-0002-5679-6891; , Van Veldhoven Paul/0000-0002-4478-2564; Sassoe-Pognetto, Marco/0000-0001-8906-0613	Medical Research Council [MC_U105178791] Funding Source: Medline; Telethon [GGP05236] Funding Source: Medline; MRC [MC_U105178791] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Telethon(Fondazione Telethon); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Banker G., 1991, CULTURING NERVE CELL; BRADY RO, 1966, P NATL ACAD SCI USA, V55, P366, DOI 10.1073/pnas.55.2.366; Connell E, 2007, EMBO REP, V8, P414, DOI 10.1038/sj.embor.7400935; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Galvan C, 2008, MOL BIOL CELL, V19, P509, DOI 10.1091/mbc.E07-05-0439; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Gijsbers S, 2002, BBA-MOL CELL BIOL L, V1580, P1, DOI 10.1016/S1388-1981(01)00166-4; Graham ME, 2008, BIOCHEM J, V409, P407, DOI 10.1042/BJ20071094; Hering H, 2003, J NEUROSCI, V23, P3262; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; Kuemmel TA, 1997, J NEUROPATH EXP NEUR, V56, P171, DOI 10.1097/00005072-199702000-00008; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Latham CF, 2007, J NEUROCHEM, V100, P1543, DOI 10.1111/j.1471-4159.2006.04286.x; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; NAGY A, 1984, J NEUROCHEM, V43, P1114, DOI 10.1111/j.1471-4159.1984.tb12851.x; OTTERBACH B, 1995, CELL, V81, P1053, DOI 10.1016/S0092-8674(05)80010-8; Raghavachari S, 2004, J NEUROPHYSIOL, V92, P2456, DOI 10.1152/jn.00258.2004; Rickman C, 2005, CHEM BIOL, V12, P545, DOI 10.1016/j.chembiol.2005.03.004; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Sarna J, 2001, EUR J NEUROSCI, V13, P1873, DOI 10.1046/j.0953-816x.2001.01564.x; Silva AJ, 1996, CURR BIOL, V6, P1509, DOI 10.1016/S0960-9822(96)00756-7; Stoffel W, 1999, CHEM PHYS LIPIDS, V102, P107, DOI 10.1016/S0009-3084(99)00079-1; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; Toonen RF, 2006, EMBO J, V25, P3725, DOI 10.1038/sj.emboj.7601256; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; Toonen RFG, 2006, P NATL ACAD SCI USA, V103, P18332, DOI 10.1073/pnas.0608507103; Van Overloop H, 2006, J LIPID RES, V47, P268, DOI 10.1194/jlr.M500321-JLR200; Van Veldhoven PP, 1998, ANAL BIOCHEM, V258, P152, DOI 10.1006/abio.1998.2584; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Xu-Friedman MA, 2004, PHYSIOL REV, V84, P69, DOI 10.1152/physrev.00016.2003	32	45	46	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5310	10.1371/journal.pone.0005310	http://dx.doi.org/10.1371/journal.pone.0005310			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390577	gold, Green Published, Green Submitted			2022-12-25	WOS:000265514200021
J	Denisova, G; Denisov, D; Evelegh, C; Weissgram, M; Beck, J; Foley, SR; Bramson, JL				Denisova, Galina; Denisov, Dimitri; Evelegh, Carole; Weissgram, Michaela; Beck, Jochen; Foley, Stephen Ronan; Bramson, Jonathan Lorne			Characterizing Complex Polysera Produced by Antigen-Specific Immunization through the Use of Affinity-Selected Mimotopes	PLOS ONE			English	Article								Background: Antigen-based (as opposed to whole organism) vaccines are actively being pursued for numerous indications. Even though different formulations may produce similar levels of total antigen-specific antibody, the composition of the antibody response can be quite distinct resulting in different levels of therapeutic activity. Methodology/Principal Findings: Using plasmid-based immunization against the proto-oncogene HER-2 as a model, we have demonstrated that affinity-selected epitope mimetics (mimotopes) can provide a defined signature of a polyclonal antibody response. Further, using novel computer algorithms that we have developed, these mimotopes can be used to predict epitope targets. Conclusions/Significance: By combining our novel strategy with existing methods of epitope prediction based on physical properties of an individual protein, we believe that this method offers a robust method for characterizing the breadth of epitope-specificity within a specific polyserum. This strategy is useful as a tool for monitoring immunity following vaccination and can also be used to define relevant epitopes for the creation of novel vaccines.			Denisova, G (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	bramsonj@mcmaster.ca		Bramson, Jonathan/0000-0003-2874-6886				Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; Batori V, 2006, J MOL RECOGNIT, V19, P21, DOI 10.1002/jmr.752; Boggio K, 1998, J EXP MED, V188, P589, DOI 10.1084/jem.188.3.589; Bonnycastle LLC, 1996, J MOL BIOL, V258, P747, DOI 10.1006/jmbi.1996.0284; Bramson JL, 2003, VACCINE, V21, P1363, DOI 10.1016/S0264-410X(02)00694-1; Chen Y, 2001, GENE THER, V8, P316, DOI 10.1038/sj.gt.3301396; Dayball K, 2003, J IMMUNOL, V171, P3379, DOI 10.4049/jimmunol.171.7.3379; Denisov DA, 2009, MOL IMMUNOL, V46, P429, DOI 10.1016/j.molimm.2008.10.013; DENISOVA G, 1995, FASEB J, V9, P127, DOI 10.1096/fasebj.9.1.7529735; Denisova G, 1996, AIDS RES HUM RETROV, V12, P901, DOI 10.1089/aid.1996.12.901; Denisova G, 2003, MOL IMMUNOL, V40, P231, DOI 10.1016/s0161-5890(03)00147-0; Denisova GF, 2008, MOL IMMUNOL, V46, P125, DOI 10.1016/j.molimm.2008.07.020; Denisova GF, 2000, MOL IMMUNOL, V37, P53, DOI 10.1016/S0161-5890(00)00022-5; Enshell-Seijffers D, 2003, J MOL BIOL, V334, P87, DOI 10.1016/j.jmb.2003.09.002; ENSHELLSEIJFFER.D, 2002, CURR PROTOC IMMUNOL, pCH9; FELICI F, 1993, GENE, V128, P21, DOI 10.1016/0378-1119(93)90148-V; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; GERSHONI JM, 1993, FASEB J, V7, P1185, DOI 10.1096/fasebj.7.12.7690724; Gershoni JM, 1997, IMMUNOL TODAY, V18, P108, DOI 10.1016/S0167-5699(97)01024-4; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; IKEDA Y, 1987, BIOCHEM BIOPH RES CO, V144, P191, DOI 10.1016/S0006-291X(87)80494-1; Kianizad K, 2007, CANCER RES, V67, P6459, DOI 10.1158/0008-5472.CAN-06-4336; Lane C, 2004, CANCER RES, V64, P1509, DOI 10.1158/0008-5472.CAN-03-3227; LUZZAGO A, 1993, GENE, V128, P51, DOI 10.1016/0378-1119(93)90152-S; NOVOTNY J, 1986, J MOL BIOL, V189, P715, DOI 10.1016/0022-2836(86)90502-4; Paley EL, 2007, MOL IMMUNOL, V44, P541, DOI 10.1016/j.molimm.2006.02.006; Pupa SM, 2005, CANCER RES, V65, P1071; Quaglino E, 2004, CANCER RES, V64, P2858, DOI 10.1158/0008-5472.CAN-03-2962; Rovero S, 2000, J IMMUNOL, V165, P5133, DOI 10.4049/jimmunol.165.9.5133; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; Shak S, 1999, SEMIN ONCOL, V26, P71; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SMITH GP, PHAGE DISPLAY VECTOR; Stern B, 1997, FASEB J, V11, P147, DOI 10.1096/fasebj.11.2.9039957; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; THORNTON JM, 1986, EMBO J, V5, P409, DOI 10.1002/j.1460-2075.1986.tb04226.x; Van Regenmortal Marc H. V., 1996, Methods (Orlando), V9, P465, DOI 10.1006/meth.1996.0054; WESTHOF E, 1984, NATURE, V311, P123, DOI 10.1038/311123a0; Yip YL, 2001, J IMMUNOL, V166, P5271, DOI 10.4049/jimmunol.166.8.5271; ZACHER AN, 1980, GENE, V9, P127, DOI 10.1016/0378-1119(80)90171-7	41	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5309	10.1371/journal.pone.0005309	http://dx.doi.org/10.1371/journal.pone.0005309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390580	Green Published, gold, Green Submitted			2022-12-25	WOS:000265514200020
J	Yih, WK; Teates, KS; Abrams, A; Kleinman, K; Kulldorff, M; Pinner, R; Harmon, R; Wang, S; Platt, R				Yih, W. Katherine; Teates, Kathryn S.; Abrams, Allyson; Kleinman, Ken; Kulldorff, Martin; Pinner, Robert; Harmon, Robert; Wang, Stanley; Platt, Richard			Telephone Triage Service Data for Detection of Influenza-Like Illness	PLOS ONE			English	Article							SYNDROMIC SURVEILLANCE; PANDEMIC INFLUENZA; ONTARIO	Background: Surveillance for influenza and influenza-like illness (ILI) is important for guiding public health prevention programs to mitigate the morbidity and mortality caused by influenza, including pandemic influenza. Nontraditional sources of data for influenza and ILI surveillance are of interest to public health authorities if their validity can be established. Methods/Principal Findings: National telephone triage call data were collected through automated means for purposes of syndromic surveillance. For the 17 states with at least 500,000 inhabitants eligible to use the telephone triage services, call volume for respiratory syndrome was compared to CDC weekly number of influenza isolates and percentage of visits to sentinel providers for ILI. The degree to which the call data were correlated with either CDC viral isolates or sentinel provider percentage ILI data was highly variable among states. Conclusions: Telephone triage data in the U. S. are patchy in coverage and therefore not a reliable source of ILI surveillance data on a national scale. However, in states displaying a higher correlation between the call data and the CDC data, call data may be useful as an adjunct to state-level surveillance data, for example at times when sentinel surveillance is not in operation or in areas where sentinel provider coverage is considered insufficient. Sufficient population coverage, a specific ILI syndrome definition, and the use of a threshold of percentage of calls that are for ILI would likely improve the utility of such data for ILI surveillance purposes.			Yih, WK (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02115 USA.	katherine_yih@hphc.org	Kulldorff, Martin/H-4282-2011	CLAYPOOL, KATHRYN/0000-0003-0557-8330; Kulldorff, Martin/0000-0002-5284-2993; Kleinman, Ken/0000-0002-5600-5834	PHS HHS [UR8/CCU115079] Funding Source: Medline; PHPPO CDC HHS [R01 PH000032, R501 PH000032] Funding Source: Medline; PUBLIC HEALTH PRACTICE PROGRAM OFFICE [R01PH000032] Funding Source: NIH RePORTER	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); PHPPO CDC HHS; PUBLIC HEALTH PRACTICE PROGRAM OFFICE(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)		Brownstein JS, 2005, AM J EPIDEMIOL, V162, P686, DOI 10.1093/aje/kwi257; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P631; Clothier HJ, 2006, COMMUN DIS INTELL, V30, P345; Cooper DL, 2007, J INFECTION, V55, P240, DOI 10.1016/j.jinf.2007.04.353; Cooper D L, 2002, Commun Dis Public Health, V5, P127; Dailey L, 2007, J AM MED INFORM ASSN, V14, P626, DOI 10.1197/jamia.M2328; Doroshenko Alexander, 2005, MMWR Suppl, V54, P117; Espino Jeremy U, 2003, AMIA Annu Symp Proc, P215; Harcourt S E, 2001, Commun Dis Public Health, V4, P178; Heffernan R, 2004, EMERG INFECT DIS, V10, P858, DOI 10.3201/eid1005.030646; Henry Jade Vu, 2004, MMWR Suppl, V53, P112; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Lazarus R, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-9; Lewis MD, 2002, AM J PREV MED, V23, P180, DOI 10.1016/S0749-3797(02)00490-7; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; Miller B, 2004, EMERG INFECT DIS, V10, P1806, DOI 10.3201/eid1010.030789; Moore K, 2004, EUR J EMERG MED, V11, P3, DOI 10.1097/00063110-200402000-00002; Paget J, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-141; Platt R, 2003, J URBAN HEALTH, V80, pI25; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Ritzwoller Debra P, 2005, MMWR Suppl, V54, P151; Smith G E, 2006, Euro Surveill, V11, P220; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; van Dijk A, 2008, CAN J EMERG MED, V10, P18; Yih W Katherine, 2004, MMWR Suppl, V53, P43; Zheng W, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-250	26	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5260	10.1371/journal.pone.0005260	http://dx.doi.org/10.1371/journal.pone.0005260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381342	Green Submitted, Green Published, gold			2022-12-25	WOS:000265510800011
J	Reddy, A; Suri, S; Sargent, IL; Redman, CWG; Muttukrishna, S				Reddy, Aparna; Suri, Sangeeta; Sargent, Ian L.; Redman, Christopher W. G.; Muttukrishna, Shanthi			Maternal Circulating Levels of Activin A, Inhibin A, sFlt-1 and Endoglin at Parturition in Normal Pregnancy and Pre-Eclampsia	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-1; BLOOD MONONUCLEAR-CELLS; ELEVATED LIVER-ENZYMES; OXIDATIVE STRESS; TYROSINE KINASE-1; SOLUBLE ENDOGLIN; ANGIOGENIC FACTORS; SERUM-LEVELS; UTERINE; LABOR	Background: Maternal circulating levels of anti-angiogenic factors such as soluble fms-like tyrosine kinase-1 (sFlt-1), endoglin (sEng) and placental proteins like activin A and inhibin A are increased before the onset of pre-eclampsia. There is evidence for oxidative stress in pre eclampsia. Recently it was shown that placental oxygen concentration is related to sFlt-1 and inhibin A. In addition it is reported that oxidative stress markers are increased in placental tissue delivered after labour. Therefore, the objective of this study is to investigate if these proteins are altered in maternal circulation of labouring pre-eclampsia and normal pregnancies. Methodology: To assess the effects of labour, samples were taken from 10 normal pregnant (NP) and 10 pre-eclamptic (PE) women pre-labour, full dilation, placental delivery and 24 h. To assess the effects of placental delivery, plasma samples were taken from 10NP and 10PE women undergoing elective Caesarean section, pre-delivery, placental delivery and 10 min, 60 min and 24 h post delivery. SFlt-1 and sEng and activin A and inhibin A were measured using commercial and in house ELISA's respectively. Results: The levels of sFlt- 1 and sEng were significantly higher in PE compared to NP women in both groups. In labour, sFlt-1 levels increased significantly at full dilatation in PE women, before declining by 24 hr. However there was no significant rise in sEng levels in labour. Activin A and inhibin A levels declined rapidly with placental delivery in NP and PE pregnancies. There was a significant rise in activin A levels during labour in PE compared to pre labour, but inhibin levels did not increase. Conclusion: Labour in pre-eclamptic women increases the levels of sFlt-1 and activin A. This pilot data suggests that increase in the maternal levels of these factors in labour could predict and/or contribute to the maternal syndrome postpartum.	Univ Coll London Hosp, Elizabeth Gareth Anderson Hosp, Fetal Med Unit, London, England; [Suri, Sangeeta; Muttukrishna, Shanthi] Elizabeth Gareth Anderson UCL Inst Womens Hlth, London, England; [Sargent, Ian L.; Redman, Christopher W. G.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX1 2JD, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of Oxford	Reddy, A (corresponding author), Univ Coll London Hosp, Elizabeth Gareth Anderson Hosp, Fetal Med Unit, London, England.	s.muttukrishna@ucl.ac.uk			Silver Star Society, Oxford	Silver Star Society, Oxford	Supported by Silver Star Society, Oxford. The funding body did not have any input into the study.	BRAR HS, 1988, AM J OBSTET GYNECOL, V158, P952, DOI 10.1016/0002-9378(88)90100-7; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Buhimschi CS, 2006, OBSTET GYNECOL, V107, P1103, DOI 10.1097/01.AOG.0000207698.74104.4f; Bujold E, 2005, J MATERN-FETAL NEO M, V18, P9, DOI 10.1080/14767050500202493; Cindrova-Davies T, 2007, AM J PATHOL, V171, P1168, DOI 10.2353/ajpath.2007.070528; Donner MW., 1980, PLACENTAL VASCULATUR; DOUGLAS KA, 1994, BMJ-BRIT MED J, V309, P1395, DOI 10.1136/bmj.309.6966.1395; Fainaru O, 2002, BJOG-INT J OBSTET GY, V109, P938, DOI 10.1111/j.1471-0528.2002.01494.x; FLEISCHER A, 1987, AM J OBSTET GYNECOL, V157, P40, DOI 10.1016/S0002-9378(87)80342-3; Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669; Gu Y, 2008, J CLIN ENDOCR METAB, V93, P260, DOI 10.1210/jc.2007-1550; Hirshfeld-Cytron J, 2006, OBSTET GYNECOL SURV, V61, P471, DOI 10.1097/01.ogx.0000219564.65999.0d; Jauniaux E, 2003, AM J PATHOL, V162, P115, DOI 10.1016/S0002-9440(10)63803-5; Karumanchi SA, 2004, ENDOCRINOLOGY, V145, P4835, DOI 10.1210/en.2004-1028; Koga K, 2003, J CLIN ENDOCR METAB, V88, P2348, DOI 10.1210/jc.2002-021942; Leszczynska-Gorzelak B, 2002, GYNECOL OBSTET INVES, V54, P159, DOI 10.1159/000067884; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Li H, 2005, PLACENTA, V26, P210, DOI 10.1016/j.placenta.2004.05.004; Madazli R, 2000, BRIT J OBSTET GYNAEC, V107, P514, DOI 10.1111/j.1471-0528.2000.tb13271.x; Makris A, 2007, KIDNEY INT, V71, P977, DOI 10.1038/sj.ki.5002175; Mandang S, 2007, J ENDOCRINOL, V192, P485, DOI 10.1677/JOE-06-0061; Manuelpillai U, 2003, PLACENTA, V24, P77, DOI 10.1053/plac.2002.0870; Many A, 1997, PLACENTA, V18, P725, DOI 10.1016/S0143-4004(97)90015-1; Matthys LA, 2004, AM J OBSTET GYNECOL, V190, P1464, DOI 10.1016/j.ajog.2004.02.037; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Maynard S, 2008, ANNU REV MED, V59, P61, DOI 10.1146/annurev.med.59.110106.214058; Mohan A, 2001, EUR J ENDOCRINOL, V145, P505, DOI 10.1530/eje.0.1450505; Muttukrishna S, 1996, J CLIN ENDOCR METAB, V81, P3328, DOI 10.1210/jc.81.9.3328; Muttukrishna S, 2000, HUM REPROD, V15, P1640, DOI 10.1093/humrep/15.7.1640; MUTTUKRISHNA S, 1995, CLIN ENDOCRINOL, V42, P391, DOI 10.1111/j.1365-2265.1995.tb02648.x; Muttukrishna S, 1997, LANCET, V349, P1285, DOI 10.1016/S0140-6736(96)09264-1; Nagamatsu T, 2004, ENDOCRINOLOGY, V145, P4838, DOI 10.1210/en.2004-0533; Nevo O, 2006, AM J PHYSIOL-REG I, V291, pR1085, DOI 10.1152/ajpregu.00794.2005; PETRAGLIA F, 1994, OBSTET GYNECOL, V84, P278; Pijnenborg R, 2006, PLACENTA, V27, P939, DOI 10.1016/j.placenta.2005.12.006; PIJNENBORG R, 1994, REPRODUCTIVE MED REV, V3, P53; Powers RW, 2005, AM J OBSTET GYNECOL, V193, P185, DOI 10.1016/j.ajog.2004.11.038; Rajakumar A, 2005, PLACENTA, V26, P563, DOI 10.1016/j.placenta.2004.09.001; Reddy A, 2008, PLACENTA, V29, P942, DOI 10.1016/j.placenta.2008.08.018; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Redman CWG, 2000, PLACENTA, V21, P597, DOI 10.1053/plac.2000.0560; Roberts JM, 1999, LANCET, V354, P788, DOI 10.1016/S0140-6736(99)80002-6; Schneider-Kolsky M, 2000, BRIT J OBSTET GYNAEC, V107, P995, DOI 10.1111/j.1471-0528.2000.tb10402.x; Sela S, 2008, CIRC RES, V102, P1566, DOI 10.1161/CIRCRESAHA.108.171504; SIBAI BM, 1993, AM J OBSTET GYNECOL, V169, P1000, DOI 10.1016/0002-9378(93)90043-I; Silver HM, 2002, J SOC GYNECOL INVEST, V9, P308, DOI 10.1016/S1071-5576(02)00165-X; Siristatidis Charalambos, 2005, Archives of Gynecology and Obstetrics, V272, P191, DOI 10.1007/s00404-004-0722-y; Stepan H, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.052; Sugimoto H, 2003, J BIOL CHEM, V278, P12605, DOI 10.1074/jbc.C300012200; Tannetta DS, 2003, J CLIN ENDOCR METAB, V88, P5995, DOI 10.1210/jc.2002-021924; Unal ER, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.05.022; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Wikstom AK, 2007, OBSTET GYNECOL, V109, P1368, DOI 10.1097/01.AOG.0000264552.85436.a1; Yaacobi N, 1999, ARCH GYNECOL OBSTET, V263, P23, DOI 10.1007/s004040050255; Zhou Y, 2002, AM J PATHOL, V160, P1405, DOI 10.1016/S0002-9440(10)62567-9	56	73	77	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4453	10.1371/journal.pone.0004453	http://dx.doi.org/10.1371/journal.pone.0004453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19412349	Green Published, Green Submitted, gold			2022-12-25	WOS:000265484100012
J	Nagatoshi, Y; Nakamura, T				Nagatoshi, Yukari; Nakamura, Tatsuo			Arabidopsis HARMLESS TO OZONE LAYER Protein Methylates a Glucosinolate Breakdown Product and Functions in Resistance to Pseudomonas syringae pv. maculicola	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORINE EMISSIONS INVENTORY; BRASSICA-OLERACEA; BIOSYNTHESIS; METHYLTRANSFERASE; METHANETHIOL; TRANSFERASE; METABOLISM; INDOLE-3-ACETONITRILE; PURIFICATION; HALOMETHANES	Almost all of the chlorine-containing gas emitted from natural sources is methyl chloride (CH3Cl), which contributes to the destruction of the stratospheric ozone layer. Tropical and subtropical plants emit substantial amounts of CH3Cl. A gene involved in CH3Cl emission from Arabidopsis was previously identified and designated HARMLESS TO OZONE LAYER (hereafter AtHOL1) based on the mutant phenotype. Our previous studies demonstrated that AtHOL1 and its homologs, AtHOL2 and AtHOL3, have S-adenosyl-L-methionine-dependent methyltransferase activities. However, the physiological functions of AtHOLs have yet to be elucidated. In the present study, our comparative kinetic analyses with possible physiological substrates indicated that all of the AtHOLs have low activities toward chloride. AtHOL1 was highly reactive to thiocyanate (NCS-), a pseudohalide, synthesizing methylthiocyanate (CH3SCN) with a very high k(cat)/K-m value. We demonstrated in vivo that substantial amounts of NCS- were synthesized upon tissue damage in Arabidopsis and that NCS- was largely derived from myrosinase-mediated hydrolysis of glucosinolates. Analyses with the T-DNA insertion Arabidopsis mutants (hol1, hol2, and hol3) revealed that only hol1 showed increased sensitivity to NCS- in medium and a concomitant lack of CH3SCN synthesis upon tissue damage. Bacterial growth assays indicated that the conversion of NCS- into CH3SCN dramatically increased antibacterial activities against Arabidopsis pathogens that normally invade the wound site. Furthermore, hol1 seedlings showed an increased susceptibility toward an Arabidopsis pathogen, Pseudomonas syringae pv. maculicola. Here we propose that AtHOL1 is involved in glucosinolate metabolism and defense against phytopathogens. Moreover, CH3Cl synthesized by AtHOL1 could be considered a byproduct of NCS- metabolism.	[Nagatoshi, Yukari; Nakamura, Tatsuo] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Kanagawa 2408501, Japan	Yokohama National University	Nakamura, T (corresponding author), 79-7 Tokiwadai,Hodogaya Ku, Kanagawa 2408501, Japan.	t-nakamu@ynu.ac.jp	Nakamura, Tatsuo/AAI-9172-2020; Nakamura, Tatsuo/C-2826-2013	Nakamura, Tatsuo/0000-0002-8761-0498; Nakamura, Tatsuo/0000-0002-8761-0498; Nagatoshi, Yukari/0000-0002-9029-7826	Ministry of Education, Science, Sports, and Culture of Japan [19780249]; Sasagawa Scientific Research Grant from the Japan Science Society; ESPEC Foundation for Global Environmental Research and Technology	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sasagawa Scientific Research Grant from the Japan Science Society; ESPEC Foundation for Global Environmental Research and Technology	This work was supported by Grant-in-aid for Scientific Research 19780249 from the Ministry of Education, Science, Sports, and Culture of Japan ( to T. N.), a Sasagawa Scientific Research Grant from the Japan Science Society ( to Y. N.), and a research grant from the ESPEC Foundation for Global Environmental Research and Technology ( to T. N.).	Agerbirk N, 1998, J AGR FOOD CHEM, V46, P1563, DOI 10.1021/jf9708498; Agerbirk N, 2009, PHYTOCHEM REV, V8, P101, DOI 10.1007/s11101-008-9098-0; Attieh J, 2000, PLANT CELL ENVIRON, V23, P165, DOI 10.1046/j.1365-3040.2000.00541.x; Attieh J, 2002, PLANT MOL BIOL, V50, P511, DOI 10.1023/A:1019865829534; ATTIEH JM, 1995, J BIOL CHEM, V270, P9250, DOI 10.1074/jbc.270.16.9250; BATES TS, 1992, J ATMOS CHEM, V14, P315, DOI 10.1007/BF00115242; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bentley R, 2004, CHEMOSPHERE, V55, P291, DOI 10.1016/j.chemosphere.2003.12.017; Bones AM, 2006, PHYTOCHEMISTRY, V67, P1053, DOI 10.1016/j.phytochem.2006.02.024; Brader G, 2001, PLANT PHYSIOL, V126, P849, DOI 10.1104/pp.126.2.849; Brown J., 2005, GLUCOSINOLATE CONTAI; CAMMUE BPA, 1992, J BIOL CHEM, V267, P2228; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Vos M, 2008, PLANT PHYSIOL, V146, P916, DOI 10.1104/pp.107.112185; DOUGHTY KJ, 1991, ANN APPL BIOL, V118, P469, DOI 10.1111/j.1744-7348.1991.tb05648.x; Feder R, 2000, J BIOL CHEM, V275, P4230, DOI 10.1074/jbc.275.6.4230; Goyer A, 2007, PLANT CELL PHYSIOL, V48, P232, DOI 10.1093/pcp/pcl055; Grubb CD, 2006, TRENDS PLANT SCI, V11, P89, DOI 10.1016/j.tplants.2005.12.006; Harper DB, 2003, CHEMOSPHERE, V52, P433, DOI 10.1016/S0045-6535(03)00206-6; Hirai MY, 2004, P NATL ACAD SCI USA, V101, P10205, DOI 10.1073/pnas.0403218101; JU HY, 1983, J CHEM ECOL, V9, P1255, DOI 10.1007/BF00982227; Kabisch U, 2005, MICROBIOL-SGM, V151, P269, DOI 10.1099/mic.0.27491-0; Khalil MAK, 1999, J GEOPHYS RES-ATMOS, V104, P8333, DOI 10.1029/1998JD100079; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; Lobert JM, 1999, J GEOPHYS RES-ATMOS, V104, P8373, DOI 10.1029/1998JD100077; MASDUKI A, 1995, J BACTERIOL, V177, P948, DOI 10.1128/jb.177.4.948-952.1995; MIDORIKAWA K, 2009, PLANT BIOTE IN PRESS, V26; Nagatoshi Y, 2007, PLANT BIOTECHNOL-NAR, V24, P503, DOI 10.5511/plantbiotechnology.24.503; Ni XH, 1998, P NATL ACAD SCI USA, V95, P12866, DOI 10.1073/pnas.95.22.12866; Ni XH, 1999, P NATL ACAD SCI USA, V96, P3611, DOI 10.1073/pnas.96.7.3611; OHGA T, 1993, FEMS MICROBIOL LETT, V113, P63; Pedras MSC, 2002, PHYTOCHEMISTRY, V59, P611, DOI 10.1016/S0031-9422(02)00026-2; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Petersen BL, 2002, PLANTA, V214, P562, DOI 10.1007/s004250100659; Rhew RC, 2003, CURR BIOL, V13, P1809, DOI 10.1016/j.cub.2003.09.055; Rhew RC, 2002, BIOGEOCHEMISTRY, V60, P141, DOI 10.1023/A:1019812006560; Rostas M, 2002, J CHEM ECOL, V28, P2449, DOI 10.1023/A:1021427917603; SAINI HS, 1995, PLANT CELL ENVIRON, V18, P1027, DOI 10.1111/j.1365-3040.1995.tb00613.x; Saito T, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000127; SAITO T, 2008, GEOPHYS RES IN PRESS, V35; Saito T, 2006, ATMOS ENVIRON, V40, P2806, DOI 10.1016/j.atmosenv.2006.01.016; Sasaki-Sekimoto Y, 2005, PLANT J, V44, P653, DOI 10.1111/j.1365-313X.2005.02560.x; STIEHL B, 1989, HORTSCIENCE, V24, P99; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wittstock U, 2002, TRENDS PLANT SCI, V7, P263, DOI 10.1016/S1360-1385(02)02273-2; *WORLD MET ORG, 2007, 50 WORLD MET ORG; WUOSMAA AM, 1990, SCIENCE, V249, P160, DOI 10.1126/science.2371563; Yokouchi Y, 2002, NATURE, V416, P163, DOI 10.1038/416163a	48	31	34	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19301	19309		10.1074/jbc.M109.001032	http://dx.doi.org/10.1074/jbc.M109.001032			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19419967	Green Published, hybrid			2022-12-25	WOS:000267908300021
J	Kiessling, A; Hogrefe, C; Erb, S; Bobach, C; Fuessel, S; Wessjohann, L; Seliger, B				Kiessling, A.; Hogrefe, C.; Erb, S.; Bobach, C.; Fuessel, S.; Wessjohann, L.; Seliger, B.			Expression, regulation and function of the ISGylation system in prostate cancer	ONCOGENE			English	Article						ISG15; prostate cancer; androgen receptor; androgen-regulated genes	UBIQUITIN-LIKE PROTEIN; ANDROGEN RECEPTOR EXPRESSION; RESPONSIVE FINGER PROTEIN; RAT VENTRAL PROSTATE; HUMAN BREAST-CANCER; ISG15 E3 LIGASE; NEGATIVE REGULATION; EPITHELIAL-CELLS; GENE-EXPRESSION; LUNG-CANCER	The androgen receptor (AR) plays a crucial role in the modulation of prostate cell proliferation and is involved in the development and progression of prostate cancer (PCa). An understanding of the complex regulation of AR provides novel treatment options for PCa. Here, we show (i) that the ubiquitin-like modifier, interferon-stimulated gene 15 (ISG15), and most enzymes involved in ISG15 conjugation were upregulated in tumor samples versus in non-malignant tissues of PCa patients and (ii) that the expression of these components significantly differed between tumors in patients treated with and without androgen ablation. Using PCa cell lines as in vitro models, the specific androgen-mediated, AR-dependent regulation of the ISGylation components was confirmed. In addition, the ISGylation system controls AR mRNA and protein expressions, as overexpression of Ube1L as a limiting ISGylation factor in the AR(+) androgen-sensitive PCa cell line, LNCaP, results in significant AR upregulation, accompanied by an increased proliferation even under androgen deprivation. Accordingly, Ube1L knockdown decreased the AR expression. Thus, this study describes for the. first time the modulation of AR expression by ISGylation components, which affects the proliferation of PCa cells, thereby providing evidence for a novel function of the ISGylation system in malignant transformation. Oncogene (2009) 28, 2606-2620; doi: 10.1038/onc.2009.115; published online 11 May 2009	[Kiessling, A.; Hogrefe, C.; Erb, S.; Seliger, B.] Univ Halle Wittenberg, Inst Med Immunol, Fac Med, D-06112 Halle, Germany; [Bobach, C.; Wessjohann, L.] Leibniz Inst Plant Biochem, Dept Bioorgan Chem, Halle, Germany; [Fuessel, S.] Tech Univ Dresden, Dept Urol, Med Fac Carl Gustav Carus, Dresden, Germany	Martin Luther University Halle Wittenberg; Leibniz Institut fur Pflanzenbiochemie; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Seliger, B (corresponding author), Univ Halle Wittenberg, Inst Med Immunol, Fac Med, Magdeburger Str 2, D-06112 Halle, Germany.	Andrea.Kiessling@novartis.com; Barbara.Seliger@medizin.uni-halle.de	Wessjohann, Ludger/AAZ-3838-2021	Wessjohann, Ludger A./0000-0003-2060-8235; Seliger, Barbara/0000-0002-5544-4958				Andersen JB, 2006, BRIT J CANCER, V94, P1465, DOI 10.1038/sj.bjc.6603099; Andersen JB, 2006, CYTOKINE GROWTH F R, V17, P411, DOI 10.1016/j.cytogfr.2006.10.001; Asirvatham AJ, 2006, ENDOCRINOLOGY, V147, P257, DOI 10.1210/en.2005-0942; Basrawala Z, 2006, ONCOGENE, V25, P2812, DOI 10.1038/sj.onc.1209304; Bektas N, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2117; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Borden EC, 2000, SEMIN CANCER BIOL, V10, P125, DOI 10.1006/scbi.2000.0315; Callewaert L, 2004, MOL ENDOCRINOL, V18, P1438, DOI 10.1210/me.2003-0313; Chen L, 2004, NEW ASTRON, V10, P39, DOI 10.1016/j.newast.2004.04.008; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; Culig Z, 1998, BRIT J CANCER, V78, P1004, DOI 10.1038/bjc.1998.619; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; Desai KV, 2004, MOL ENDOCRINOL, V18, P2895, DOI 10.1210/me.2004-0033; Desai SD, 2006, CANCER RES, V66, P921, DOI 10.1158/0008-5472.CAN-05-1123; Desai SD, 2008, MOL CANCER THER, V7, P1430, DOI 10.1158/1535-7163.MCT-07-2345; Edwards J, 2003, BRIT J CANCER, V89, P552, DOI 10.1038/sj.bjc.6601127; Feng Q, 2008, MOL CANCER THER, V7, P3780, DOI 10.1158/1535-7163.MCT-08-0753; Giannakopoulos NV, 2005, BIOCHEM BIOPH RES CO, V336, P496, DOI 10.1016/j.bbrc.2005.08.132; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; GONG YW, 1995, ENDOCRINOLOGY, V136, P2172, DOI 10.1210/en.136.5.2172; Gregory CW, 2001, CANCER RES, V61, P2892; Gregory CW, 2001, CANCER RES, V61, P4315; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Iacobuzio-Donahue CA, 2003, AM J PATHOL, V162, P1151, DOI 10.1016/S0002-9440(10)63911-9; Ikeda K, 2000, FEBS LETT, V472, P9, DOI 10.1016/S0014-5793(00)01421-6; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jung D, 1999, SCAND J IMMUNOL, V50, P242; Kalvakolanu DV, 2000, HISTOL HISTOPATHOL, V15, P523, DOI 10.14670/HH-15.523; Khodarev NN, 2007, CANCER RES, V67, P9214, DOI 10.1158/0008-5472.CAN-07-1019; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; Ko S, 2008, MOL ENDOCRINOL, V22, P273, DOI 10.1210/me.2007-0332; KORANT BD, 1984, J BIOL CHEM, V259, P4835; Li R, 2004, AM J SURG PATHOL, V28, P928, DOI 10.1097/00000478-200407000-00013; Lin DL, 2001, CLIN CANCER RES, V7, P1773; Linja MJ, 2001, CANCER RES, V61, P3550; Liu MJ, 2004, J INTERF CYTOK RES, V24, P647, DOI 10.1089/jir.2004.24.647; Maggiolini M, 2004, J MOL ENDOCRINOL, V32, P777, DOI 10.1677/jme.0.0320777; Malakhov MP, 2003, J BIOL CHEM, V278, P16608, DOI 10.1074/jbc.M208435200; Malakhova OA, 2008, J BIOL CHEM, V283, P8783, DOI 10.1074/jbc.C800030200; Mitsui K, 1999, BIOCHEM BIOPH RES CO, V266, P115, DOI 10.1006/bbrc.1999.1777; Nakajima A, 2007, BIOCHEM BIOPH RES CO, V357, P245, DOI 10.1016/j.bbrc.2007.03.134; Nantermet PV, 2004, J BIOL CHEM, V279, P1310, DOI 10.1074/jbc.M310206200; Okumura F, 2007, GENE DEV, V21, P255, DOI 10.1101/gad.1521607; Olshavsky NA, 2008, ONCOGENE, V27, P3111, DOI 10.1038/sj.onc.1210981; Pitterle DM, 1998, IN VIVO, V12, P643; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Reddy GPV, 2006, J CELL BIOCHEM, V98, P1408, DOI 10.1002/jcb.20927; Rokhlin OW, 2005, ONCOGENE, V24, P6773, DOI 10.1038/sj.onc.1208833; Sakuma M, 2005, GYNECOL ONCOL, V99, P664, DOI 10.1016/j.ygyno.2005.07.103; SICA G, 1994, UROL RES, V22, P33, DOI 10.1007/BF00431546; Stanbrough M, 2001, P NATL ACAD SCI USA, V98, P10823, DOI 10.1073/pnas.191235898; Suzuki T, 2005, CLIN CANCER RES, V11, P6148, DOI 10.1158/1078-0432.CCR-05-0040; Takahashi Y, 2007, MOL CARCINOGEN, V46, P117, DOI 10.1002/mc.20254; Takeuchi T, 2005, J BIOCHEM, V138, P711, DOI 10.1093/jb/mvi172; Takeuchi T, 2005, BIOCHEM BIOPH RES CO, V336, P9, DOI 10.1016/j.bbrc.2005.08.034; Takeuchi T, 2006, FEBS LETT, V580, P4521, DOI 10.1016/j.febslet.2006.07.032; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105; Yeap BB, 1999, ENDOCRINOLOGY, V140, P3282, DOI 10.1210/en.140.7.3282; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zhao C, 2004, P NATL ACAD SCI USA, V101, P7578, DOI 10.1073/pnas.0402528101; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102; Zou WG, 2007, BIOCHEM BIOPH RES CO, V354, P321, DOI 10.1016/j.bbrc.2006.12.210; Zou WG, 2006, J BIOL CHEM, V281, P3989, DOI 10.1074/jbc.M510787200	65	45	47	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 16	2009	28	28					2606	2620		10.1038/onc.2009.115	http://dx.doi.org/10.1038/onc.2009.115			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	471LJ	19430494				2022-12-25	WOS:000268058900006
J	Hayes, D; Napoli, V; Mazurkie, A; Stafford, WF; Graceffa, P				Hayes, David; Napoli, Vanessa; Mazurkie, Andrew; Stafford, Walter F.; Graceffa, Philip			Phosphorylation Dependence of Hsp27 Multimeric Size and Molecular Chaperone Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; ALPHA-CRYSTALLIN DOMAIN; SELF-ASSOCIATION; SEDIMENTATION-VELOCITY; THERMAL-DENATURATION; SUBUNIT INTERACTIONS; PROTECTIVE ACTIVITY; NONNATIVE PROTEIN; STRESS-PROTEIN; MAPKAP KINASE	The molecular chaperone Hsp27 exists as a distribution of large oligomers that are disassembled by phosphorylation at Ser-15, -78, and -82. It is controversial whether the unphosphorylated Hsp27 or the widely used triple Ser-to-Asp phosphomimic mutant is the more active molecular chaperone in vitro. This question was investigated here by correlating chaperone activity, as measured by the aggregation of reduced insulin or alpha-lactalbumin, with Hsp27 self-association as monitored by analytical ultracentrifugation. Furthermore, because the phosphomimic is generally assumed to reproduce the phosphorylated molecule, the size and chaperone activity of phosphorylated Hsp27 were compared with that of the phospho-mimic. Hsp27 was triply phosphorylated by MAPKAP-2 kinase, and phosphorylation was tracked by urea-PAGE. An increasing degree of suppression of insulin or alpha-lactalbumin aggregation correlated with a decreasing Hsp27 self-association, which was the least for phosphorylated Hsp27 followed by the mimic followed by the unphosphorylated protein. It was also found that Hsp27 added to pre-aggregated insulin did not reverse aggregation but did inhibit these aggregates from assembling into even larger aggregates. This chaperone activity appears to be independent of Hsp27 phosphorylation. In conclusion, the most active chaperone of insulin and alpha-lactalbumin was the Hsp27 ( elongated) dimer, the smallest Hsp27 subunit observed under physiological conditions. Next, the Hsp27 phospho-mimic is only a partial mimic of phosphorylated Hsp27, both in self-association and in chaperone function. Finally, the efficient inhibition of insulin aggregation by Hsp27 dimer led to the proposal of two models for this chaperone activity.	[Hayes, David; Napoli, Vanessa; Mazurkie, Andrew; Stafford, Walter F.; Graceffa, Philip] Boston Biomed Res Inst, Watertown, MA 02472 USA	Boston Biomedical Research Institute	Graceffa, P (corresponding author), Boston Biomed Res Inst, 64 Grove St, Watertown, MA 02472 USA.	Graceffa@bbri.org	Stafford, Walter/ABC-6553-2020; Hayes, David B/CAH-1880-2022	Hayes, David B/0000-0002-1133-3471	National Institutes of Health [HL66219, AR41637]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR041637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL66219 and AR41637. This work was also supported by an American Heart Association post-doctoral fellowship (to A. M.) and a Boston Biomedical Research Institute pilot grant.	AGRAWAL HC, 1982, BIOCHEM J, V201, P39, DOI 10.1042/bj2010039; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; Berengian AR, 1999, J BIOL CHEM, V274, P6305, DOI 10.1074/jbc.274.10.6305; Chernik IS, 2004, BIOCHEM BIOPH RES CO, V324, P1199, DOI 10.1016/j.bbrc.2004.09.176; Chiou YW, 2008, BBA-MOL BASIS DIS, V1782, P169, DOI 10.1016/j.bbadis.2007.12.010; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; Diaz-Latoud C, 2005, ANTIOXID REDOX SIGN, V7, P436, DOI 10.1089/ars.2005.7.436; Dillmann WH, 1999, ANN NY ACAD SCI, V874, P66, DOI 10.1111/j.1749-6632.1999.tb09225.x; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P509, DOI 10.1021/bi00002a015; GAESTEL M, 1991, J BIOL CHEM, V266, P14721; Geum D, 2002, J BIOL CHEM, V277, P19913, DOI 10.1074/jbc.M104396200; Gusev NB, 2002, BIOCHEMISTRY-MOSCOW+, V67, P511, DOI 10.1023/A:1015549725819; Haley DA, 2000, J MOL BIOL, V298, P261, DOI 10.1006/jmbi.2000.3657; HARISANOVA NT, 1986, MOL BIOL REP, V11, P199, DOI 10.1007/BF00419597; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hayley M, 2008, J MUSCLE RES CELL M, V29, P101, DOI 10.1007/s10974-008-9143-z; KATO K, 1994, J BIOL CHEM, V269, P11274; KNAUF U, 1994, EMBO J, V13, P54, DOI 10.1002/j.1460-2075.1994.tb06234.x; Kuwajima K, 1996, FASEB J, V10, P102, DOI 10.1096/fasebj.10.1.8566530; Lambert H, 1999, J BIOL CHEM, V274, P9378, DOI 10.1074/jbc.274.14.9378; LANDRY J, 1992, J BIOL CHEM, V267, P794; Larsen JK, 1997, AM J PHYSIOL-LUNG C, V273, pL930, DOI 10.1152/ajplung.1997.273.5.L930; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; Lelj-Garolla B, 2006, J BIOL CHEM, V281, P8169, DOI 10.1074/jbc.M512553200; Lelj-Garolla B, 2005, J MOL BIOL, V345, P631, DOI 10.1016/j.jmb.2004.10.056; MacRae TH, 2000, CELL MOL LIFE SCI, V57, P899, DOI 10.1007/PL00000733; Markov DI, 2008, FEBS LETT, V582, P1407, DOI 10.1016/j.febslet.2008.03.035; Mchaourab HS, 1997, BIOCHEMISTRY-US, V36, P14627, DOI 10.1021/bi971700s; MIRON T, 1988, EUR J BIOCHEM, V178, P543, DOI 10.1111/j.1432-1033.1988.tb14481.x; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Mounier N, 2002, CELL STRESS CHAPERON, V7, P167, DOI 10.1379/1466-1268(2002)007<0167:ACASHS>2.0.CO;2; PAL BK, 1975, J VIROL, V16, P123, DOI 10.1128/JVI.16.1.123-131.1975; Panasenko OO, 2002, BBA-PROTEINS PROTEOM, V1601, P64, DOI 10.1016/S1570-9639(02)00430-2; PERRIE WT, 1970, BIOCHEM J, V119, P31, DOI 10.1042/bj1190031; Pivovarova AV, 2005, BIOCHEM BIOPH RES CO, V331, P1548, DOI 10.1016/j.bbrc.2005.04.077; Roberts CJ, 2007, BIOTECHNOL BIOENG, V98, P927, DOI 10.1002/bit.21627; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; SANGER F, 1949, BIOCHEM J, V44, P126, DOI 10.1042/bj0440126; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Shashidharamurthy R, 2005, J BIOL CHEM, V280, P5281, DOI 10.1074/jbc.M407236200; Stafford WF, 2004, BIOPHYS CHEM, V108, P231, DOI 10.1016/j.bpc.2003.10.028; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; Theriault JR, 2004, J BIOL CHEM, V279, P23463, DOI 10.1074/jbc.M402325200; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; Van Montfort RLM, 2003, PROTEIN SCI, V12, P2606, DOI 10.1110/ps.03265903; Welsh MJ, 1998, ANN NY ACAD SCI, V851, P28, DOI 10.1111/j.1749-6632.1998.tb08973.x; Zavialov A, 1998, INT J BIOL MACROMOL, V22, P163, DOI 10.1016/S0141-8130(98)00014-2; Zavialov AV, 1998, BBA-PROTEIN STRUCT M, V1388, P123, DOI 10.1016/S0167-4838(98)00172-1	50	100	104	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18801	18807		10.1074/jbc.M109.011353	http://dx.doi.org/10.1074/jbc.M109.011353			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19411251	hybrid, Green Published			2022-12-25	WOS:000267711500029
J	Hoshino, T; Namba, T; Takehara, M; Nakaya, T; Sugimoto, Y; Araki, W; Narumiya, S; Suzuki, T; Mizushima, T				Hoshino, Tatsuya; Namba, Takushi; Takehara, Masaya; Nakaya, Tadashi; Sugimoto, Yukihiko; Araki, Wataru; Narumiya, Shuh; Suzuki, Toshiharu; Mizushima, Tohru			Prostaglandin E-2 Stimulates the Production of Amyloid-beta Peptides through Internalization of the EP4 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE ACTIVITY; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; AGONIST-INDUCED INTERNALIZATION; PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; A-BETA; ENDOCYTIC PATHWAY; NEURODEGENERATIVE DISEASES; CARBOXYL-TERMINUS; TRANSGENIC MICE	Amyloid-beta (A beta) peptides, generated by the proteolysis of beta-amyloid precursor protein by beta- and gamma-secretases, play an important role in the pathogenesis of Alzheimer disease. Inflammation is also important. We recently reported that prostaglandin E-2 (PGE(2)), a strong inducer of inflammation, stimulates the production of A beta through EP2 and EP4 receptors, and here we have examined the molecular mechanism. Activation of EP2 and EP4 receptors is coupled to an increase in cellular cAMP levels and activation of protein kinase A (PKA). We found that inhibitors of adenylate cyclase and PKA suppress EP2, but not EP4, receptor-mediated stimulation of the A beta production. In contrast, inhibitors of endocytosis suppressed EP4, but not EP2, receptor-mediated stimulation. Activation of gamma-secretase was observed with the activation of EP4 receptors but not EP2 receptors. PGE(2)-dependent internalization of the EP4 receptor was observed, and cells expressing a mutant EP4 receptor lacking the internalization activity did not exhibit PGE(2)-stimulated production of A beta. A physical interaction between the EP4 receptor and PS-1, a catalytic subunit of gamma-secretases, was revealed by immunoprecipitation assays. PGE(2)-induced internalization of PS-1 and co-localization of EP4, PS-1, and Rab7 (a marker of late endosomes and lysosomes) was observed. Co-localization of PS-1 and Rab7 was also observed in the brain of wild-type mice but not of EP4 receptor null mice. These results suggest that PGE(2)-stimulated production of A beta involves EP4 receptor-mediated endocytosis of PS-1 followed by activation of the gamma-secretase, as well as EP2 receptor-dependent activation of adenylate cyclase and PKA, both of which are important in the inflammation-mediated progression of Alzheimer disease.	[Hoshino, Tatsuya; Namba, Takushi; Takehara, Masaya; Mizushima, Tohru] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto 8620973, Japan; [Nakaya, Tadashi; Suzuki, Toshiharu] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan; [Sugimoto, Yukihiko] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Araki, Wataru] Natl Inst Neurosci, Kodaira, Tokyo 1878502, Japan; [Narumiya, Shuh] Kyoto Univ, Fac Med, Kyoto 6068501, Japan	Kumamoto University; Hokkaido University; Kyoto University; National Center for Neurology & Psychiatry - Japan; Kyoto University	Mizushima, T (corresponding author), Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	mizu@gpo.kumamoto-u.ac.jp	Suzuki, Toshiharu/B-5342-2013; Araki, Wataru/G-7913-2014; Sugimoto, Yukihiko/AAV-6470-2021	Araki, Wataru/0000-0001-8467-6937; Sugimoto, Yukihiko/0000-0001-6973-932X	Ministry of Health, Labor, and Welfare, Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Science and Technology Agency	Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by grants-in-aid for scientific research from the Ministry of Health, Labor, and Welfare, Japan and the Ministry of Education, Culture, Sports, Science, and Technology, Japan and by the Japan Science and Technology Agency.	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Andreasson KI, 2001, J NEUROSCI, V21, P8198; Bastepe M, 1997, MOL PHARMACOL, V51, P343, DOI 10.1124/mol.51.2.343; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; COLEMAN RA, 1994, PHARMACOL REV, V46, P205; De Strooper B, 2000, J CELL SCI, V113, P1857; Desai S, 2000, MOL PHARMACOL, V58, P1279, DOI 10.1124/mol.58.6.1279; Desai S, 2001, FEBS LETT, V501, P156, DOI 10.1016/S0014-5793(01)02640-0; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Gardner LA, 2004, J BIOL CHEM, V279, P21135, DOI 10.1074/jbc.M313652200; Gonzalez-Gaitan Marcos, 2003, Cell, V115, P513, DOI 10.1016/S0092-8674(03)00932-2; Grbovic OM, 2003, J BIOL CHEM, V278, P31261, DOI 10.1074/jbc.M304122200; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Guo DF, 2001, CELL RES, V11, P165, DOI 10.1038/sj.cr.7290083; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He XY, 2007, J NEUROSCI, V27, P4052, DOI 10.1523/JNEUROSCI.3993-06.2007; Ho L, 2001, ARCH NEUROL-CHICAGO, V58, P487, DOI 10.1001/archneur.58.3.487; Hoshino T, 2003, J BIOL CHEM, V278, P12752, DOI 10.1074/jbc.M212097200; Hoshino T, 2007, J BIOL CHEM, V282, P32676, DOI 10.1074/jbc.M703087200; Hoshino T, 2007, BIOCHEM J, V402, P581, DOI 10.1042/BJ20061318; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Kitamura Y, 1999, BIOCHEM BIOPH RES CO, V254, P582, DOI 10.1006/bbrc.1998.9981; KOO EH, 1994, J BIOL CHEM, V269, P17386; Langui D, 2004, AM J PATHOL, V165, P1465, DOI 10.1016/S0002-9440(10)63405-0; Lee RKK, 1999, J NEUROSCI, V19, P940; Liang XB, 2005, J NEUROSCI, V25, P10180, DOI 10.1523/JNEUROSCI.3591-05.2005; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Montine TJ, 1999, NEUROLOGY, V53, P1495, DOI 10.1212/WNL.53.7.1495; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Pooler AM, 2004, NEUROSCI LETT, V362, P127, DOI 10.1016/j.neulet.2004.03.013; Price DL, 1998, SCIENCE, V282, P1079, DOI 10.1126/science.282.5391.1079; Qin WP, 2003, J BIOL CHEM, V278, P50970, DOI 10.1074/jbc.M307699200; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Sang N, 2005, J NEUROSCI, V25, P9858, DOI 10.1523/JNEUROSCI.2392-05.2005; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Shie FS, 2005, AM J PATHOL, V166, P1163, DOI 10.1016/S0002-9440(10)62336-X; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Smith CJ, 1998, P NATL ACAD SCI USA, V95, P13313, DOI 10.1073/pnas.95.22.13313; Srinivasan B D, 1989, Prog Clin Biol Res, V312, P229; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Tomita S, 1998, J BIOL CHEM, V273, P19304, DOI 10.1074/jbc.273.30.19304; Townsend KP, 2005, FASEB J, V19, P1592, DOI 10.1096/fj.04-3620rev; VANE J, 1994, NATURE, V367, P215, DOI 10.1038/367215a0; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yasojima K, 1999, BRAIN RES, V830, P226, DOI 10.1016/S0006-8993(99)01389-X	60	46	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18493	18502		10.1074/jbc.M109.003269	http://dx.doi.org/10.1074/jbc.M109.003269			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19407341	hybrid, Green Published			2022-12-25	WOS:000267712400060
J	Hsieh, JY; Chen, SH; Hung, HC				Hsieh, Ju-Yi; Chen, Shao-Hung; Hung, Hui-Chih			Functional Roles of the Tetramer Organization of Malic Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VELOCITY ANALYTICAL ULTRACENTRIFUGATION; SIZE-DISTRIBUTION ANALYSIS; OXIDATIVE DECARBOXYLASES; STRUCTURAL STABILITY; SUBUNIT INTERACTIONS; CATALYTIC MECHANISM; CRYSTAL-STRUCTURE; ADRENAL-CORTEX; CDNA CLONING; RAT-LIVER	Malic enzyme has a dimer of dimers quaternary structure in which the dimer interface associates more tightly than the tetramer interface. In addition, the enzyme has distinct active sites within each subunit. The mitochondrial NAD(P)(+)-dependent malic enzyme (m-NAD(P)-ME) isoform behaves cooperatively and allosterically and exhibits a quaternary structure in dimertetramer equilibrium. The cytosolic NADP(+)-dependent malic enzyme (c-NADP-ME) isoform is noncooperative and nonallosteric and exists as a stable tetramer. In this study, we analyze the essential factors governing the quaternary structure stability for human c-NADP-ME and m-NAD(P)-ME. Site-directed mutagenesis at the dimer and tetramer interfaces was employed to generate a series of dimers of c-NADP-ME and m-NAD(P)ME. Size distribution analysis demonstrated that human c-NADP-ME exists mainly as a tetramer, whereas human m-NAD(P)-ME exists as a mixture of dimers and tetramers. Kinetic data indicated that the enzyme activity of c-NADP-ME is not affected by disruption of the interface. There are no significant differences in the kinetic properties between AB and AD dimers, and the dimeric form of c-NADP-ME is as active as tetramers. In contrast, disrupting the interface of m-NAD(P)-ME causes the enzyme to be less active than wild type and to become less cooperative for malate binding; the k(cat) values of mutants decreased with increasing K-d,K-24 values, indicating that the dissociation of subunits at the dimer or tetramer interfaces significantly affects the enzyme activity. The above results suggest that the tetramer is required for a fully functional m-NAD(P)-ME. Taken together, the analytical ultracentrifugation data and the kinetic analysis of these interface mutants demonstrate the differential role of tetramer organization for the c-NADP-ME and m-NAD(P)-ME isoforms. The regulatory mechanism of m-NAD(P)-ME is closely related to the tetramer formation of this isoform.	[Hsieh, Ju-Yi; Chen, Shao-Hung; Hung, Hui-Chih] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Hung, Hui-Chih] Natl Chung Hsing Univ, Inst Bioinformat, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University	Hung, HC (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, 250 Kuo Kuang Rd, Taichung 40227, Taiwan.	hchung@dragon.nchu.edu.tw	Hung, Hui-Chih/L-8061-2019; Hung, Hui-Chih/G-4485-2013	Hung, Hui-Chih/0000-0003-0180-1822; Hung, Hui-Chih/0000-0003-0180-1822	National Science Council [NSC-96-2311B-005-005]; Ministry of Education, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported by National Science Council Grant NSC-96-2311B-005-005 (to H.-C. H.) and in part by the Ministry of Education, Taiwan, under the Aiming for Top University plan.	BAGGETTO LG, 1992, BIOCHIMIE, V74, P959, DOI 10.1016/0300-9084(92)90016-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; CHANG GG, 1991, EUR J BIOCHEM, V202, P681, DOI 10.1111/j.1432-1033.1991.tb16423.x; Chang GG, 2003, BIOCHEMISTRY-US, V42, P12721, DOI 10.1021/bi035251+; Chang HC, 2003, J BIOL CHEM, V278, P23996, DOI 10.1074/jbc.M213242200; Chang HC, 2002, J BIOL CHEM, V277, P4663, DOI 10.1074/jbc.M111156200; Chang HC, 2007, BIOPHYS J, V93, P3977, DOI 10.1529/biophysj.107.111385; Chou WY, 1996, BIOCHEMISTRY-US, V35, P9873, DOI 10.1021/bi960200g; Chou WY, 1997, PROTEIN ENG, V10, P1205, DOI 10.1093/protein/10.10.1205; Coleman DE, 2002, BIOCHEMISTRY-US, V41, P6928, DOI 10.1021/bi0255120; Edens WA, 1997, BIOCHEMISTRY-US, V36, P1141, DOI 10.1021/bi962128s; FAHIEN LA, 1992, J BIOL CHEM, V267, P10411; Frenkel R, 1975, Curr Top Cell Regul, V9, P157; Hsieh JY, 2008, FEBS J, V275, P5383, DOI 10.1111/j.1742-4658.2008.06668.x; Hsieh JY, 2006, J BIOL CHEM, V281, P23237, DOI 10.1074/jbc.M603451200; HSU RY, 1982, MOL CELL BIOCHEM, V43, P3; Hsu WC, 2004, BIOCHEMISTRY-US, V43, P7382, DOI 10.1021/bi049600r; Hung HC, 2005, BIOCHEM J, V392, P39, DOI 10.1042/BJ20050641; Hung HC, 2005, BIOCHEMISTRY-US, V44, P12737, DOI 10.1021/bi050510b; Karsten WE, 2003, BIOCHEMISTRY-US, V42, P9712, DOI 10.1021/bi034101w; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; LOEBER G, 1994, BIOCHEM J, V304, P687, DOI 10.1042/bj3040687; LOEBER G, 1994, FEBS LETT, V344, P181, DOI 10.1016/0014-5793(94)00386-6; LOEBER G, 1991, J BIOL CHEM, V266, P3016; MANDELLA RD, 1975, J BIOL CHEM, V250, P5877; MCKEEHAN WL, 1982, CELL BIOL INT REP, V6, P635, DOI 10.1016/0309-1651(82)90125-4; MOREADITH RW, 1984, J BIOL CHEM, V259, P6215; MOREADITH RW, 1984, J BIOL CHEM, V259, P6222; Rao GSJ, 2003, J BIOL CHEM, V278, P38051, DOI 10.1074/jbc.M305145200; Sanz N, 1997, BRIT J CANCER, V75, P487, DOI 10.1038/bjc.1997.85; SAUER LA, 1973, BIOCHEM BIOPH RES CO, V50, P524, DOI 10.1016/0006-291X(73)90871-1; SAUER LA, 1980, J BIOL CHEM, V255, P3844; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Tao X, 2003, STRUCTURE, V11, P1141, DOI 10.1016/S0969-2126(03)00168-0; TELLER JK, 1992, J BIOL CHEM, V267, P10423; Xu YW, 1999, STRUCT FOLD DES, V7, P877, DOI 10.1016/S0969-2126(99)80115-4; Yang ZR, 2000, NAT STRUCT BIOL, V7, P251; Yang ZR, 2002, PROTEIN SCI, V11, P332, DOI 10.1110/ps.38002; Yang ZR, 2002, STRUCTURE, V10, P951, DOI 10.1016/S0969-2126(02)00788-8; ZOLNIEROWICZ S, 1988, BIOCHEM MED METAB B, V39, P208, DOI 10.1016/0885-4505(88)90078-3	44	25	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18096	18105		10.1074/jbc.M109.005082	http://dx.doi.org/10.1074/jbc.M109.005082			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19416979	Green Published, hybrid			2022-12-25	WOS:000267712400021
J	Zhou, JM; Zhong, Q; Li, GL; Greenberg, ML				Zhou, Jingming; Zhong, Quan; Li, Guiling; Greenberg, Miriam L.			Loss of Cardiolipin Leads to Longevity Defects That Are Alleviated by Alterations in Stress Response Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CELL INTEGRITY PATHWAY; LIFE-SPAN EXTENSION; SUPPRESSES TEMPERATURE SENSITIVITY; YEAST SACCHAROMYCES-CEREVISIAE; RAT-LIVER MITOCHONDRIA; HIGH-OSMOLARITY; CALORIE RESTRICTION; LIPID-COMPOSITION; OUTER-MEMBRANE	Perturbation of cardiolipin (CL) synthesis in yeast cells leads to defective respiratory chain function and mitochondrial DNA loss, both of which have been implicated in aging in mammals. The availability of yeast CL mutants enabled us to directly investigate the role of CL synthesis in aging. In this report, we show that the replicative life span of pgs1 Delta, which lacks both CL and the precursor phosphatidylglycerol (PG), was significantly decreased at 30 degrees C. The life span of crd1 Delta, which has PG but not CL, was unaffected at 30 degrees C but reduced at 37 degrees C. Life span extension induced by calorie restriction was not affected by the loss of CL. However, mild heat and osmotic stress, which extend life span in wild type cells, did not increase longevity in CL mutants, suggesting that the stress response is perturbed in these mutants. Consistent with this, longevity defects in pgs1 Delta were alleviated by down-regulation of the high osmolarity glycerol stress response pathway, as well as by promoting cell integrity with the osmotic stabilizer sorbitol or via genetic suppression with the kre5(W1166X) mutant. These findings show for the first time that perturbation of CL synthesis leads to decreased longevity in yeast, which is restored by altering signaling through stress response pathways.	[Zhou, Jingming; Zhong, Quan; Li, Guiling; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	MLGREEN@sun.science.wayne.edu	zhong, quan/AAE-8893-2021	Zhong, Quan/0000-0003-2910-5597; He, Quan/0000-0001-7706-9960	National Institutes of Health [HL62263]; Barth Syndrome Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barth Syndrome Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL62263. This work was also supported by a grant from the Barth Syndrome Foundation.	Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Bonawitz ND, 2007, CELL CYCLE, V6, P1574, DOI 10.4161/cc.6.13.4457; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Clotet J, 2006, EMBO J, V25, P2338, DOI 10.1038/sj.emboj.7601095; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; DAVENPORT KR, 1995, J BIOL CHEM, V270, P30157; deKroon AIPM, 1997, BBA-BIOMEMBRANES, V1325, P108, DOI 10.1016/S0005-2736(96)00240-4; Fabrizio P, 2004, FEBS LETT, V557, P136, DOI 10.1016/S0014-5793(03)01462-5; Ferreira FM, 2003, BBA-MOL BASIS DIS, V1639, P113, DOI 10.1016/j.bbadis.2003.08.001; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Garcia-Rodriguez LJ, 2005, FEBS LETT, V579, P6186, DOI 10.1016/j.febslet.2005.10.001; Grethe S, 2004, EXP CELL RES, V298, P632, DOI 10.1016/j.yexcr.2004.05.007; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Hahn JS, 2002, J BIOL CHEM, V277, P21278, DOI 10.1074/jbc.M202557200; Harris N, 2003, FREE RADICAL BIO MED, V34, P1599, DOI 10.1016/S0891-5849(03)00210-7; Hayashi M, 2006, J BIOCHEM, V139, P797, DOI 10.1093/jb/mvj089; Heinisch JJ, 2005, BBA-PROTEINS PROTEOM, V1754, P171, DOI 10.1016/j.bbapap.2005.07.032; Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N; JANITOR M, 1993, CURR GENET, V24, P307, DOI 10.1007/BF00336781; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; Jiang F, 1999, MOL MICROBIOL, V31, P373, DOI 10.1046/j.1365-2958.1999.01181.x; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Kaeberlein M, 2004, GENETICS, V166, P1661, DOI 10.1534/genetics.166.4.1661; Kaeberlein M, 2002, GENETICS, V160, P83; Kaeberlein M, 2002, MOL CELL BIOL, V22, P8056, DOI 10.1128/MCB.22.22.8056-8066.2002; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Kirchman PA, 1999, GENETICS, V152, P179; Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1111/j.1574-6976.2002.tb00613.x; Kojima K, 2006, MICROBIOL-SGM, V152, P591, DOI 10.1099/mic.0.28571-0; Korolyev E, 2005, FEMS MICROBIOL LETT, V244, P379, DOI 10.1016/j.femsle.2005.02.009; Koshkin V, 2002, BIOCHEM J, V364, P317, DOI 10.1042/bj3640317; Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687; Krantz M, 2004, EUKARYOT CELL, V3, P1381, DOI 10.1128/EC.3.6.1381-1390.2004; Laun P, 2007, NUCLEIC ACIDS RES, V35, P7514, DOI 10.1093/nar/gkm919; Lee JR, 2002, BIOCHEM J, V362, P395, DOI 10.1042/bj3620395; Lesnefsky EJ, 2001, AM J PHYSIOL-HEART C, V280, pH2770; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lussier M, 1997, GENETICS, V147, P435; MAFTAH A, 1994, MECH AGEING DEV, V77, P83, DOI 10.1016/0047-6374(94)90017-5; McMillin JB, 2002, BBA-MOL CELL BIOL L, V1585, P97, DOI 10.1016/S1388-1981(02)00329-3; McVey M, 2001, GENETICS, V157, P1531; Ostrander DB, 2001, J BIOL CHEM, V276, P25262, DOI 10.1074/jbc.M103689200; PARADIES G, 1990, BIOCHIM BIOPHYS ACTA, V1016, P207, DOI 10.1016/0005-2728(90)90060-H; Peter PS, 2007, J CLIN INVEST, V117, P1335, DOI 10.1172/JCI29576; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Popolo L, 2001, MED MYCOL, V39, P111, DOI 10.1080/744118881; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; ROBINSON NC, 1993, J BIOENERG BIOMEMBR, V25, P153, DOI 10.1007/BF00762857; Sato H, 2007, SHOCK, V28, P291, DOI 10.1097/SHK.0b013e3180326e3d; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 1999, J LIPID RES, V40, P1585; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Shama S, 1998, EXP CELL RES, V245, P379, DOI 10.1006/excr.1998.4279; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Struchkov VA, 2002, BIOELECTROCHEMISTRY, V56, P195, DOI 10.1016/S1567-5394(02)00052-X; Swiecilo A, 2000, ACTA BIOCHIM POL, V47, P355; Tamas MJ, 2000, FEBS LETT, V472, P159, DOI 10.1016/S0014-5793(00)01445-9; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Winkler A, 2002, EUKARYOT CELL, V1, P163, DOI 10.1128/EC.1.2.163-173.2002; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yaakov G, 2003, MOL CELL BIOL, V23, P4826, DOI 10.1128/MCB.23.14.4826-4840.2003; Zhong Q, 2005, BIOCHEM SOC T, V33, P1158, DOI 10.1042/BST0331158; Zhong Q, 2005, MOL BIOL CELL, V16, P665, DOI 10.1091/mbc.E04-09-0808; Zhong Q, 2004, J BIOL CHEM, V279, P32294, DOI 10.1074/jbc.M403275200; Zhong Q, 2007, J BIOL CHEM, V282, P15946, DOI 10.1074/jbc.M701055200	72	22	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18106	18114		10.1074/jbc.M109.003236	http://dx.doi.org/10.1074/jbc.M109.003236			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19401462	hybrid, Green Published			2022-12-25	WOS:000267712400022
J	Horie, Y; Ito, H; Kusaba, M; Tanaka, R; Tanaka, A				Horie, Yukiko; Ito, Hisashi; Kusaba, Makoto; Tanaka, Ryouichi; Tanaka, Ayumi			Participation of Chlorophyll b Reductase in the Initial Step of the Degradation of Light-harvesting Chlorophyll a/b-Protein Complexes in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-II; ACCLIMATIVE PROTEOLYSIS; THYLAKOID MEMBRANES; DUNALIELLA-SALINA; ANTENNA SYSTEMS; OXYGENASE CAO; CONVERSION; SENESCENCE; PHOTOSYNTHESIS; BIOSYNTHESIS	The light-harvesting chlorophyll a/b-protein complex of photosystem II (LHCII) is the most abundant membrane protein in green plants, and its degradation is a crucial process for the acclimation to high light conditions and for the recovery of nitrogen (N) and carbon (C) during senescence. However, the molecular mechanism of LHCII degradation is largely unknown. Here, we report that chlorophyll b reductase, which catalyzes the first step of chlorophyll b degradation, plays a central role in LHCII degradation. When the genes for chlorophyll b reductases NOL and NYC1 were disrupted in Arabidopsis thaliana, chlorophyll b and LHCII were not degraded during senescence, whereas other pigment complexes completely disappeared. When purified trimeric LHCII was incubated with recombinant chlorophyll b reductase (NOL), expressed in Escherichia coli, the chlorophyll b in LHCII was converted to 7-hydroxymethyl chlorophyll a. Accompanying this conversion, chlorophylls were released from LHCII apoproteins until all the chlorophyll molecules in LHCII dissociated from the complexes. Chlorophyll-depleted LHCII apoproteins did not dissociate into monomeric forms but remained in the trimeric form. Based on these results, we propose the novel hypothesis that chlorophyll b reductase catalyzes the initial step of LHCII degradation, and that trimeric LHCII is a substrate of LHCII degradation.	[Horie, Yukiko; Ito, Hisashi; Tanaka, Ryouichi; Tanaka, Ayumi] Hokkaido Univ, Inst Low Temp Sci, Kita Ku, Sapporo, Hokkaido 0600819, Japan; [Kusaba, Makoto] Hiroshima Univ, Grad Sch Sci, Higashihiroshima 7398526, Japan	Hokkaido University; Hiroshima University	Tanaka, A (corresponding author), N19 W8,Kita Ku, Sapporo, Hokkaido 0600819, Japan.	ayumi@lowtem.hokudai.ac.jp	Tanaka, Ryouichi/A-4030-2012; Ito, Hisashi/A-4211-2012; Tanaka, Ayumi/D-9003-2012; Kusaba, Makoto/AAQ-4469-2021	Tanaka, Ryouichi/0000-0002-5858-5326; Ito, Hisashi/0000-0002-2482-5870; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [17GS0314, 68700307]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid for creative scientific research (17GS0314 to A. T.) and a Grant-in-aid for Scientific Research (68700307 to R. T.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ANDERSON JM, 1988, TRENDS BIOCHEM SCI, V13, P351, DOI 10.1016/0968-0004(88)90106-5; Andersson J, 2003, PLANT J, V35, P350, DOI 10.1046/j.1365-313X.2003.01811.x; Barber J, 2000, BBA-BIOENERGETICS, V1459, P239, DOI 10.1016/S0005-2728(00)00158-4; BENNETT J, 1981, EUR J BIOCHEM, V118, P61, DOI 10.1111/j.1432-1033.1981.tb05486.x; CHITNIS PR, 1988, PHOTOSYNTH RES, V16, P41, DOI 10.1007/BF00039485; Consoli E, 2005, EMBO REP, V6, P782, DOI 10.1038/sj.embor.7400464; Elrad D, 2002, PLANT CELL, V14, P1801, DOI 10.1105/tpc.002154; Folly P, 1999, J BIOL CHEM, V274, P21811, DOI 10.1074/jbc.274.31.21811; Fromme P, 2003, FEBS LETT, V555, P40, DOI 10.1016/S0014-5793(03)01124-4; GandulRojas B, 1996, J SCI FOOD AGR, V72, P291, DOI 10.1002/(SICI)1097-0010(199611)72:3&lt;291::AID-JSFA654&gt;3.0.CO;2-O; Georgakopoulos JH, 2002, BBA-BIOENERGETICS, V1556, P53, DOI 10.1016/S0005-2728(02)00306-7; Green BR, 1996, ANNU REV PLANT PHYS, V47, P685, DOI 10.1146/annurev.arplant.47.1.685; Haussuhl K, 2001, EMBO J, V20, P713, DOI 10.1093/emboj/20.4.713; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; Hirashima M, 2006, J BIOL CHEM, V281, P15385, DOI 10.1074/jbc.M602903200; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; HONDA H, 1991, REGULATION CHLOROPLA, P329; Horn R, 2004, J BIOL CHEM, V279, P44400, DOI 10.1074/jbc.M407188200; Ito H, 1996, J BIOL CHEM, V271, P1475, DOI 10.1074/jbc.271.3.1475; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Kusaba M, 2007, PLANT CELL, V19, P1362, DOI 10.1105/tpc.106.042911; Lensch M, 2001, J BIOL CHEM, V276, P33645, DOI 10.1074/jbc.M100506200; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Masuda T, 2003, PLANT MOL BIOL, V51, P757, DOI 10.1023/A:1022545118212; Mimuro M, 2004, PHOTOSYNTH RES, V81, P129, DOI 10.1023/B:PRES.0000035047.50742.bf; Morosinotto T, 2003, J BIOL CHEM, V278, P49223, DOI 10.1074/jbc.M309203200; Nagata N, 2007, PLANT CELL PHYSIOL, V48, P1803, DOI 10.1093/pcp/pcm153; Ohtsuka T, 1997, PLANT PHYSIOL, V113, P137, DOI 10.1104/pp.113.1.137; Park SY, 2007, PLANT CELL, V19, P1649, DOI 10.1105/tpc.106.044891; Reinsberg D, 2001, J MOL BIOL, V308, P59, DOI 10.1006/jmbi.2001.4573; Rudiger W, 2002, PHOTOSYNTH RES, V74, P187, DOI 10.1023/A:1020959610952; Sato Y, 2009, PLANT J, V57, P120, DOI 10.1111/j.1365-313X.2008.03670.x; Shioi Y, 1996, PLANT PHYSIOL BIOCH, V34, P41; Smith CK, 1999, P NATL ACAD SCI USA, V96, P6678, DOI 10.1073/pnas.96.12.6678; Tanaka A, 1997, PLANT CELL PHYSIOL, V38, P17, DOI 10.1093/oxfordjournals.pcp.a029080; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; TANAKA A, 1991, PLANT CELL PHYSIOL, V32, P195, DOI 10.1093/oxfordjournals.pcp.a078064; TANAKA A, 1987, PLANT CELL PHYSIOL, V28, P1537; Tanaka Ayumi, 1993, Planta (Heidelberg), V192, P92; Tanaka R, 2005, PHOTOSYNTH RES, V85, P327, DOI 10.1007/s11120-005-6807-z; Tsuchiya T, 1999, P NATL ACAD SCI USA, V96, P15362, DOI 10.1073/pnas.96.26.15362; Tziveleka LA, 1998, PLANT PHYSIOL, V117, P961, DOI 10.1104/pp.117.3.961; Yang CH, 2006, BBA-BIOENERGETICS, V1757, P1642, DOI 10.1016/j.bbabio.2006.08.010; Yang DH, 2000, FEBS LETT, V466, P385, DOI 10.1016/S0014-5793(00)01107-8; Yang DH, 1998, PLANT PHYSIOL, V118, P827, DOI 10.1104/pp.118.3.827; Yang DH, 2001, PHOTOSYNTH RES, V68, P163, DOI 10.1023/A:1011849919438; Zaltsman A, 2005, PLANT CELL, V17, P2782, DOI 10.1105/tpc.105.035071; Zelisko A, 2005, P NATL ACAD SCI USA, V102, P13699, DOI 10.1073/pnas.0503472102	48	171	184	4	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17449	17456		10.1074/jbc.M109.008912	http://dx.doi.org/10.1074/jbc.M109.008912			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19403948	hybrid, Green Published			2022-12-25	WOS:000267202500011
J	Brunert, D; Kurtenbach, S; Isik, S; Benecke, H; Gisselmann, G; Schuhmann, W; Hatt, H; Wetzel, CH				Brunert, Daniela; Kurtenbach, Stefan; Isik, Sonnur; Benecke, Heike; Gisselmann, Guenter; Schuhmann, Wolfgang; Hatt, Hanns; Wetzel, Christian H.			Odorant-Dependent Generation of Nitric Oxide in Mammalian Olfactory Sensory Neurons	PLOS ONE			English	Article								The gaseous signalling molecule nitric oxide (NO) is involved in various physiological processes including regulation of blood pressure, immunocytotoxicity and neurotransmission. In the mammalian olfactory bulb (OB), NO plays a role in the formation of olfactory memory evoked by pheromones as well as conventional odorants. While NO generated by the neuronal isoform of NO synthase (nNOS) regulates neurogenesis in the olfactory epithelium, NO has not been implicated in olfactory signal transduction. We now show the expression and function of the endothelial isoform of NO synthase (eNOS) in mature olfactory sensory neurons (OSNs) of adult mice. Using NO-sensitive micro electrodes, we show that stimulation liberates NO from isolated wild-type OSNs, but not from OSNs of eNOS deficient mice. Integrated electrophysiological recordings (electro-olfactograms or EOGs) from the olfactory epithelium of these mice show that NO plays a significant role in modulating adaptation. Evidence for the presence of eNOS in mature mammalian OSNs and its involvement in odorant adaptation implicates NO as an important new element involved in olfactory signal transduction. As a diffusible messenger, NO could also have additional functions related to cross adaptation, regeneration, and maintenance of MOE homeostasis.			Brunert, D (corresponding author), Ruhr Univ Bochum, Lehrstuhl Zellphysiol, Bochum, Germany.	christian.wetzel@rub.de	Wetzel, Christian/F-1366-2018; Schuhmann, Wolfgang/S-2626-2016; Kurtenbach, Stefan/H-3786-2019; Wetzel, Christian H/N-9880-2017; Wetzel, Christian/C-2501-2009	Schuhmann, Wolfgang/0000-0003-2916-5223; Kurtenbach, Stefan/0000-0002-7445-596X; Wetzel, Christian H/0000-0002-5762-0003; Wetzel, Christian/0000-0002-5762-0003				Arnhold S, 1997, NEUROSCI LETT, V229, P165, DOI 10.1016/S0304-3940(97)00457-6; BARTSCH S, 1992, J NEUROSCI, V12, P736; Bedioui F, 1997, BIOSENS BIOELECTRON, V12, P205, DOI 10.1016/S0956-5663(97)85338-9; BREER H, 1992, NEUROREPORT, V3, P1030, DOI 10.1097/00001756-199211000-00022; Broillet MC, 1997, NEURON, V18, P951, DOI 10.1016/S0896-6273(00)80334-7; Broillet MC, 1996, NEURON, V16, P377, DOI 10.1016/S0896-6273(00)80055-0; Chang SC, 2005, BIOSENS BIOELECTRON, V21, P917, DOI 10.1016/j.bios.2005.02.015; Cometto-Muniz JE, 1998, PHARMACOL BIOCHEM BE, V60, P765, DOI 10.1016/S0091-3057(98)00054-9; DAWSON TM, 1994, J NEUROSCI, V14, P5147; DINERMAN JL, 1994, P NATL ACAD SCI USA, V91, P4214, DOI 10.1073/pnas.91.10.4214; Godecke A, 1998, CIRC RES, V82, P186; Govers R, 2001, AM J PHYSIOL-RENAL, V280, pF193, DOI 10.1152/ajprenal.2001.280.2.F193; Ingi T, 1995, J NEUROSCI, V15, P8214; Isik S, 2006, ANGEW CHEM INT EDIT, V45, P7451, DOI 10.1002/anie.200601708; Kosaka T, 2007, NEUROSCI RES, V57, P165, DOI 10.1016/j.neures.2006.10.005; LAMAS S, 1992, P NATL ACAD SCI USA, V89, P6348, DOI 10.1073/pnas.89.14.6348; LEIBOWITZ MD, 1986, J GEN PHYSIOL, V87, P25, DOI 10.1085/jgp.87.1.25; Lucero MT, 1998, BRAIN RES, V807, P234, DOI 10.1016/S0006-8993(98)00825-7; Lynch JW, 1998, J MEMBRANE BIOL, V165, P227, DOI 10.1007/s002329900436; Monti-Graziadei G A, 1977, J Histochem Cytochem, V25, P1311; Moon C, 2005, J NEUROCHEM, V95, P200, DOI 10.1111/j.1471-4159.2005.03356.x; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; ROSKAMS AJ, 1994, NEURON, V13, P289; Schmachtenberg O, 2003, BRAIN RES, V980, P146, DOI 10.1016/S0006-8993(03)02990-1; Spehr M, 2002, NEURON, V33, P731, DOI 10.1016/S0896-6273(02)00610-4; Torroglosa A, 2007, STEM CELLS, V25, P88, DOI 10.1634/stemcells.2006-0131; Weiler E, 1997, J NEUROSCI, V17, P3610; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; Zufall F, 1998, ANN NY ACAD SCI, V855, P199, DOI 10.1111/j.1749-6632.1998.tb10566.x	29	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2009	4	5							e5499	10.1371/journal.pone.0005499	http://dx.doi.org/10.1371/journal.pone.0005499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VY	19430528	Green Submitted, gold, Green Published			2022-12-25	WOS:000266009700005
J	Cagigi, A; Du, LK; Dang, LVP; Grutzmeier, S; Atlas, A; Chiodi, F; Pan-Hammarstrom, Q; Nilsson, A				Cagigi, Alberto; Du, Likun; Dang, Linh Vu Phuong; Grutzmeier, Sven; Atlas, Ann; Chiodi, Francesca; Pan-Hammarstrom, Qiang; Nilsson, Anna			CD27(-) B-Cells Produce Class Switched and Somatically Hyper-Mutated Antibodies during Chronic HIV-1 Infection	PLOS ONE			English	Article							INDUCED CYTIDINE DEAMINASE; ANTIRETROVIRAL THERAPY; IMMUNE ACTIVATION; SOLUBLE CD27; MEMORY; RECOMBINATION; EXPRESSION; HYPERGAMMAGLOBULINEMIA; IMMUNODEFICIENCY; DIFFERENTIATION	Class switch recombination and somatic hypermutation occur in mature B-cells in response to antigen stimulation. These processes are crucial for the generation of functional antibodies. During HIV-1 infection, loss of memory B-cells, together with an altered differentiation of naive B-cells result in production of low quality antibodies, which may be due to impaired immunoglobulin affinity maturation. In the current study, we evaluated the effect of HIV-1 infection on class switch recombination and somatic hypermutation by studying the expression of activation-induced cytidine deaminase (AID) in peripheral B-cells from a cohort of chronically HIV-1 infected patients as compared to a group of healthy controls. In parallel, we also characterized the phenotype of B-cells and their ability to produce immunoglobulins in vitro. Cells from HIV-1 infected patients showed higher baseline levels of AID expression and increased IgA production measured ex-vivo and upon CD40 and TLR9 stimulation in vitro. Moreover, the percentage of CD27(-) IgA(+) and CD27(-) IgG(+) B-cells in blood was significantly increased in HIV-1 infected patients as compared to controls. Interestingly, our results showed a significantly increased number of somatic hypermutations in the VH genes in CD27(-) cells from patients. Taken together, these results show that during HIV-1 infection, CD27(-) B-cells can also produce class switched and somatically hypermutated antibodies. Our data add important information for the understanding of the mechanisms underlying the loss of specific antibody production observed during HIV-1 infection.			Cagigi, A (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	Alberto.Cagigi@ki.se	hammarstrom, qiang pan/ABA-4589-2021; Cagigi, Alberto/K-4824-2016	Cagigi, Alberto/0000-0002-3567-9514; Du, Likun/0000-0002-8448-2187; Nilsson, Anna/0000-0001-5885-7101; Chiodi, Francesca/0000-0002-1385-8343; pan-hammarstrom, qiang/0000-0003-1990-8804				Agematsu K, 2000, HISTOL HISTOPATHOL, V15, P573, DOI 10.14670/HH-15.573; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Cagigi A, 2008, BLOOD, V112, P4401, DOI 10.1182/blood-2008-02-140426; Carsetti R, 2004, IMMUNOL REV, V197, P179, DOI 10.1111/j.0105-2896.2004.0109.x; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; De Milito A, 2004, CURR HIV RES, V2, P11, DOI 10.2174/1570162043485068; De Milito A, 2002, CLIN EXP IMMUNOL, V127, P486, DOI 10.1046/j.1365-2249.2002.01786.x; De Milito A, 2001, AIDS, V15, P957, DOI 10.1097/00002030-200105250-00003; Epeldegui M, 2007, AIDS, V21, P2265, DOI 10.1097/QAD.0b013e3282ef9f59; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Fecteau JF, 2006, J IMMUNOL, V177, P3728, DOI 10.4049/jimmunol.177.6.3728; Fondere JM, 2004, JAIDS-J ACQ IMM DEF, V35, P114, DOI 10.1097/00126334-200402010-00002; Frasca D, 2007, EXP GERONTOL, V42, P192, DOI 10.1016/j.exger.2006.09.003; He B, 2004, J IMMUNOL, V173, P4479, DOI 10.4049/jimmunol.173.7.4479; He B, 2006, J IMMUNOL, V176, P3931, DOI 10.4049/jimmunol.176.7.3931; Hsu HC, 2007, J IMMUNOL, V178, P5357, DOI 10.4049/jimmunol.178.8.5357; Huggins J, 2007, BLOOD, V109, P1611, DOI 10.1182/blood-2006-03-008441; ISLAM KB, 1991, INT IMMUNOL, V3, P1099, DOI 10.1093/intimm/3.11.1099; Kato K, 2007, EXP HEMATOL, V35, P434, DOI 10.1016/j.exphem.2006.10.018; KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0; Laurence Jeffrey, 2005, AIDS Read, V15, P330; Malisan F, 1996, J EXP MED, V183, P937, DOI 10.1084/jem.183.3.937; Manzardo C, 2005, J NEUROVIROL, V11, P72, DOI 10.1080/13550280500513846; Meyer-Bahlburg A, 2008, AUTOIMMUN REV, V7, P313, DOI 10.1016/j.autrev.2007.11.027; Moir S, 2001, P NATL ACAD SCI USA, V98, P10362, DOI 10.1073/pnas.181347898; MOIR S, 2008, J INFECT DIS; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nannini Esteban C, 2002, Curr Gastroenterol Rep, V4, P392, DOI 10.1007/s11894-002-0009-z; Onlamoon N, 2005, ANN NY ACAD SCI, V1050, P397, DOI 10.1196/annals.1313.091; Pan-Hammarstrom Q, 2007, ADV IMMUNOL, V93, P1, DOI 10.1016/S0065-2776(06)93001-6; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Redgrave BE, 2005, HIV MED, V6, P307, DOI 10.1111/j.1468-1293.2005.00312.x; Revy P, 2005, ADV IMMUNOL, V87, P237, DOI 10.1016/S0065-2776(05)87007-5; Sgadari C, 2003, LANCET ONCOL, V4, P537, DOI 10.1016/S1470-2045(03)01192-6; Stavnezer J, 1996, CURR OPIN IMMUNOL, V8, P199, DOI 10.1016/S0952-7915(96)80058-6; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Titanji K, 2005, AIDS, V19, P1947, DOI 10.1097/01.aids.0000191231.54170.89; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; Wei C, 2007, J IMMUNOL, V178, P6624, DOI 10.4049/jimmunol.178.10.6624; Wen SC, 2004, J IMMUNOL, V172, P2595, DOI 10.4049/jimmunol.172.4.2595; Xu W, 2008, J IMMUNOL, V181, P276, DOI 10.4049/jimmunol.181.1.276; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zinkernagel RM, 2000, PHILOS T R SOC B, V355, P369, DOI 10.1098/rstb.2000.0576	47	43	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5427	10.1371/journal.pone.0005427	http://dx.doi.org/10.1371/journal.pone.0005427			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440GG	19412542	Green Published, Green Submitted, gold			2022-12-25	WOS:000265688200013
J	Vigne, P; Tauc, M; Frelin, C				Vigne, Paul; Tauc, Michel; Frelin, Christian			Strong Dietary Restrictions Protect Drosophila against Anoxia/Reoxygenation Injuries	PLOS ONE			English	Article							LIFE-SPAN; STRESS RESISTANCE; INSULIN-RECEPTOR; HYPOXIA TOLERANCE; HOMOLOG; OVEREXPRESSION; STARVATION; MUTANT; MODEL; GENE	Background: Reoxygenation of ischemic tissues is a major factor that determines the severity of cardiovascular diseases. This paper describes the consequences of anoxia/reoxygenation (A/R) stresses on Drosophila, a useful, anoxia tolerant, model organism. Methodology/Principal Findings: Newly emerged adult male flies were exposed to anoxic conditions (<1% O-2) for 1 to 6 hours, reoxygenated and their survival was monitored. Results: A/R stresses induced a transient increase in mortality which peaked at the time of reoxygenation. Then flies recovered low mortality rates similar to those of control flies. A/R induced mortality was strongly dependent on dietary conditions during the 48 h that preceded anoxia. Well fed flies were anoxia sensitive. Strong dietary restrictions and starvation conditions protected flies against A/R injuries. The tolerance to anoxia was associated to large decreases in glycogen, protein, and ATP contents. During anoxia, anoxia tolerant flies produced more lactate, less phosphate and they maintained more stable ATP levels than anoxia sensitive flies. Moderate dietary restrictions, which increased the longevity of normoxic flies, did not promote resistance to A/R stresses. Diet dependent A/R injuries were still observed in sima loss of function mutants and they were insensitive to dietary rapamycin or resveratrol. AICAR (5-aminoimidazole-4-carboxamide-1-beta-D-ribosefuranoside), an activator AMP kinase decreased A/R injuries. Mutants in the insulin signalling pathway were more anoxia tolerant in a fed state. Conclusion/Significance: Long A/R stresses induce a transient increase in mortality in Drosophila. This mortality is highly dependent on dietary conditions prior to the stress. Strong dietary restrictions and starvation conditions protect flies against A/R injuries, probably by inducing a major remodelling of energy metabolism. The results also indicate that mechanistically different responses develop in response to dietary restrictions of different strengths. AMP kinase and the insulin signalling pathway are possible mediators of diet dependent anoxic tolerance in Drosophila.			Vigne, P (corresponding author), Univ Nice Sophia Antipolis, CNRS, IBDC, UMR 6543, Nice, France.	cfrelin@unice.fr	Tauc, Michel/F-1530-2013	Tauc, Michel/0000-0002-8383-9818				[Anonymous], 2005, FUNCTIONAL METABOLIS; Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Arquier N, 2006, BIOCHEM J, V393, P471, DOI 10.1042/BJ20050675; Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; Becker LB, 1999, AM J PHYSIOL-HEART C, V277, pH2240, DOI 10.1152/ajpheart.1999.277.6.H2240; Bickler PE, 2007, ANNU REV PHYSIOL, V69, P145, DOI 10.1146/annurev.physiol.69.031905.162529; Bier E, 2004, GENE, V342, P1, DOI 10.1016/j.gene.2004.07.018; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Centanin L, 2005, EMBO REP, V6, P1070, DOI 10.1038/sj.embor.7400528; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; Chen ZY, 1998, J MOL CELL CARDIOL, V30, P2281, DOI 10.1006/jmcc.1998.0789; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Djawdan M, 1997, ECOLOGY, V78, P828, DOI 10.1890/0012-9658(1997)078[0828:DSFSRL]2.0.CO;2; Feala JD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100139; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Giannakou ME, 2007, TRENDS BIOCHEM SCI, V32, P180, DOI 10.1016/j.tibs.2007.02.007; Good TP, 2001, J INSECT PHYSIOL, V47, P1467, DOI 10.1016/S0022-1910(01)00138-X; Haddad GG, 2006, EXP PHYSIOL, V91, P277, DOI 10.1113/expphysiol.2005.030767; Haddad GG, 2000, J APPL PHYSIOL, V88, P1481, DOI 10.1152/jappl.2000.88.4.1481; Harbison ST, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r36; Harbison ST, 2004, GENETICS, V166, P1807, DOI 10.1534/genetics.166.4.1807; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Knoppien P, 2000, J INSECT BEHAV, V13, P27, DOI 10.1023/A:1007759424777; Krishnan SN, 1997, J INSECT PHYSIOL, V43, P203, DOI 10.1016/S0022-1910(96)00084-4; Lavista-Llanos S, 2002, MOL CELL BIOL, V22, P6842, DOI 10.1128/MCB.22.19.6842-6853.2002; LAZDUNSKI M, 1985, J MOL CELL CARDIOL, V17, P1029, DOI 10.1016/S0022-2828(85)80119-X; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Lighton JRB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001267; Magwere T, 2006, MECH AGEING DEV, V127, P356, DOI 10.1016/j.mad.2005.12.009; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Murakami K, 1997, STROKE, V28, P1797, DOI 10.1161/01.STR.28.9.1797; Partridge L, 2005, MECH AGEING DEV, V126, P938, DOI 10.1016/j.mad.2005.03.023; Pletcher SD, 2005, AGEING RES REV, V4, P451, DOI 10.1016/j.arr.2005.06.007; Ramirez JM, 2007, ANNU REV PHYSIOL, V69, P113, DOI 10.1146/annurev.physiol.69.031905.163111; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tu MP, 2002, AGING CELL, V1, P75, DOI 10.1046/j.1474-9728.2002.00010.x; Vigne P, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000056; Vigne P, 2007, MECH AGEING DEV, V128, P401, DOI 10.1016/j.mad.2007.05.008; Vigne Paul, 2008, BMC Physiology, V8, P22, DOI 10.1186/1472-6793-8-22; Wang PH, 1998, P NATL ACAD SCI USA, V95, P4556, DOI 10.1073/pnas.95.8.4556; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yoshida T, 2000, CIRC RES, V86, P264, DOI 10.1161/01.RES.86.3.264; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	50	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5422	10.1371/journal.pone.0005422	http://dx.doi.org/10.1371/journal.pone.0005422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440GG	19412543	Green Published, Green Submitted, gold			2022-12-25	WOS:000265688200009
J	Naddafi, R; Eklov, P; Pettersson, K				Naddafi, Rahmat; Eklov, Peter; Pettersson, Kurt			Stoichiometric Constraints Do Not Limit Successful Invaders: Zebra Mussels in Swedish Lakes	PLOS ONE			English	Article							DREISSENA-POLYMORPHA; FOOD QUALITY; ECOLOGICAL STOICHIOMETRY; SESTON STOICHIOMETRY; GROWTH; POPULATION; INVASION; ZOOPLANKTON; ENERGY; NITROGEN	Background: Elemental imbalances of carbon (C): nitrogen (N): phosphorus (P) ratios in food resources can constrain the growth of grazers owning to tight coupling between growth rate, RNA allocation and biomass P content in animals. Testing for stoichiometric constraints among invasive species is a novel challenge in invasion ecology to unravel how a successful invader tackles ecological barriers in novel ecosystems. Methodology/Principal Findings: We examined the C:P and N:P ratios and the condition factor of a successful invader in lakes, the zebra mussel (Dreissena polymorpha), collected from two Swedish lakes. Concurrently, we analyzed the elemental composition of the food (seston) and tissue of the mussels in which nutrient composition of food and mussels varied over time. Zebra mussel condition factor was weakly related to the their own tissue N:P and C:P ratios, although the relation with the later ratio was not significant. Smaller mussels had relatively lower tissue N:P ratio and higher condition factor. There was no difference in C:P and N:P ratios between seston and mussels' tissues. Our results indicated that the variation in nutrient stoichiometry of zebra mussels can be explained by food quality and quantity. Conclusions/Significance: Our study suggests that fitness of invasive zebra mussels is not constrained by nutrient stoichiometry which is likely to be important for their proliferation in novel ecosystems. The lack of imbalance in C:P and N:P ratios between seston and mussels along with high tissue C:P ratio of the mussel allow them to tolerate potential P limitation and maintain high growth rate. Moreover, zebra mussels are able to change their tissue C:P and N:P ratios in response to the variation in elemental composition of their food. This can also help them to bypass potential nutrient stoichiometric constraints. Our finding is an important step towards understanding the mechanisms contributing to the success of exotic species from stoichiometric principles.			Naddafi, R (corresponding author), Uppsala Univ, Dept Ecol & Evolut Erken Lab, Evolutionary Biol Ctr, Norrtalje, Sweden.	rahmat.naddafi@ebc.uu.se						Acharya K, 2006, ARCH HYDROBIOL, V165, P433, DOI 10.1127/0003-9136/2006/0165-0433; Andersen T, 2004, ECOL LETT, V7, P884, DOI 10.1111/j.1461-0248.2004.00646.x; Arnott DL, 1996, CAN J FISH AQUAT SCI, V53, P646, DOI 10.1139/cjfas-53-3-646; Baker SM, 1998, J SHELLFISH RES, V17, P1207; Cote IM, 2002, SCIENCE, V298, P1181; Cotner JB, 1995, J GREAT LAKES RES, V21, P517, DOI 10.1016/S0380-1330(95)71063-2; Cox GW, 2004, ALIEN SPECIES EVOLUT; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x; Frost PC, 2002, ECOL LETT, V5, P232, DOI 10.1046/j.1461-0248.2002.00307.x; Grasshoff K., 1999, METHODS SEAWATER ANA; Hessen DO, 2005, J PLANKTON RES, V27, P449, DOI 10.1093/plankt/fbi018; Hessen DO, 2002, ECOLOGY, V83, P1886, DOI 10.2307/3071772; HICKMAN RW, 1980, MAR BIOL, V60, P27, DOI 10.1007/BF00395603; Hillebrand H, 2001, LIMNOL OCEANOGR, V46, P1881, DOI 10.4319/lo.2001.46.8.1881; Holway DA, 1998, SCIENCE, V282, P949, DOI 10.1126/science.282.5390.949; Jantz B, 1998, OECOLOGIA, V114, P213, DOI 10.1007/s004420050439; Josefsson M, 2001, AMBIO, V30, P514, DOI 10.1639/0044-7447(2001)030[0514:TECOAS]2.0.CO;2; Kahlert M, 2002, FRESHWATER BIOL, V47, P1191, DOI 10.1046/j.1365-2427.2002.00844.x; Karatayev AY, 1997, J SHELLFISH RES, V16, P187; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Lennon JT, 2003, OIKOS, V103, P191, DOI 10.1034/j.1600-0706.2003.12260.x; Liess A, 2005, J N AM BENTHOL SOC, V24, P256, DOI 10.1899/04-015.1; MACISAAC HJ, 1991, CAN J FISH AQUAT SCI, V48, P2051, DOI 10.1139/f91-244; MacIsaac HJ, 1996, AM ZOOL, V36, P287; Malmaeus JM, 2006, ECOL MODEL, V190, P1, DOI 10.1016/j.ecolmodel.2005.03.017; Miller TE, 2005, AM NAT, V165, P439, DOI 10.1086/428681; Mitra A, 2007, AM NAT, V169, P632, DOI 10.1086/513187; Moe SJ, 2005, OIKOS, V109, P29, DOI 10.1111/j.0030-1299.2005.14056.x; Naddafi R, 2008, LIMNOL OCEANOGR, V53, P1973, DOI 10.4319/lo.2008.53.5.1973; Naddafi R, 2007, OIKOS, V116, P1289, DOI 10.1111/j.2007.0030-1299.15695.x; Naddafi R, 2007, FRESHWATER BIOL, V52, P823, DOI 10.1111/j.1365-2427.2007.01732.x; NALEPA TF, 1991, HYDROBIOLOGIA, V219, P239, DOI 10.1007/BF00024758; NIX ER, 1995, MAR BIOL, V122, P605, DOI 10.1007/BF00350682; Peacor SD, 2006, PLOS BIOL, V4, P2112, DOI 10.1371/journal.pbio.0040372; Ptacnik R, 2005, OIKOS, V109, P52, DOI 10.1111/j.0030-1299.2005.14051.x; QIN P, 2007, LIMNOL OCEANOGR, V42, P1436; Roditi HA, 2000, NATURE, V407, P78, DOI 10.1038/35024069; Savage VM, 2004, AM NAT, V163, P429, DOI 10.1086/381872; Seabloom EW, 2003, P NATL ACAD SCI USA, V100, P13384, DOI 10.1073/pnas.1835728100; SEIMANN E, 2007, J ECOL, V95, P689; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; SMAAL AC, 1990, HYDROBIOLOGIA, V195, P179, DOI 10.1007/BF00026822; Smolders R, 2004, ENVIRON POLLUT, V129, P99, DOI 10.1016/j.envpol.2003.09.027; Soto M, 2000, SCI TOTAL ENVIRON, V247, P175, DOI 10.1016/S0048-9697(99)00489-1; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Sterner RW, 2008, LIMNOL OCEANOGR, V53, P1169, DOI 10.4319/lo.2008.53.3.1169; Sterner RW, 1997, AM NAT, V150, P663, DOI 10.1086/286088; STERNER RW, 1994, ANNU REV ECOL SYST, V25, P1, DOI 10.1146/annurev.es.25.110194.000245; Stoeckmann A, 2003, CAN J FISH AQUAT SCI, V60, P126, DOI 10.1139/F03-005; Stoeckmann A. M., 1994, American Zoologist, V34, p47A; Stoeckmann AM, 1997, CAN J FISH AQUAT SCI, V54, P2743, DOI 10.1139/cjfas-54-12-2743; THEBAULT H, 2005, RADIOPROTECTION, V140, pS47; Tilman D., 1982, Monographs in Population Biology, pi; Urabe J, 1997, LIMNOL OCEANOGR, V42, P1436, DOI 10.4319/lo.1997.42.6.1436; Vanderploeg HA, 2002, CAN J FISH AQUAT SCI, V59, P1209, DOI 10.1139/F02-087; Villar-Argaiz M, 2002, ECOLOGY, V83, P1899, DOI 10.2307/3071773; Voets J, 2006, AQUAT TOXICOL, V79, P213, DOI 10.1016/j.aquatox.2006.06.001; Vrede T, 2004, ECOLOGY, V85, P1217, DOI 10.1890/02-0249; Wacker A, 2003, OECOLOGIA, V135, P332, DOI 10.1007/s00442-003-1208-5; WALZ N, 1978, Archiv fuer Hydrobiologie Supplement, V55, P83; White T. C. R., 1993, INADEQUATE ENV NITRO; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; Wu RSS, 1998, AQUACULTURE, V163, P47, DOI 10.1016/S0044-8486(98)00218-X	65	30	33	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5345	10.1371/journal.pone.0005345	http://dx.doi.org/10.1371/journal.pone.0005345			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401773	Green Published, Green Submitted, gold			2022-12-25	WOS:000265601100006
J	Flowers, M; Thompson, PA				Flowers, Margaret; Thompson, Patricia A.			t10c12 Conjugated Linoleic Acid Suppresses HER2 Protein and Enhances Apoptosis in SKBr3 Breast Cancer Cells: Possible Role of COX2	PLOS ONE			English	Article								Background: HER2-targeted therapy with the monoclonal antibody trastuzumab (Herceptin (R)) has improved disease-free survival for women diagnosed with HER2-positive breast cancers; however, treatment resistance and disease progression are not uncommon. Current data suggest that resistance to treatment in HER2 cancers may be a consequence of NF-kappa B overexpression and increased COX2-derived prostaglandin E2 (PGE(2)). Conjugated linoleic acid (CLA) has been shown to have anti-tumor properties and to inhibit NF-kappa B activity and COX2. Methods: In this study, HER2-overexpressing SKBr3 breast cancer cells were treated with t10c12 CLA. Protein expression of the HER2 receptor, nuclear NF-kappa B p65, and total and phosphorylated I kappa B were examined by western blot and immunofluorescence. PGE2 levels were determined by ELISA. Proliferation was measured by metabolism of 3-(4, 5-Dimethylthiazol- 2-yl)-2, 5-diphenyltetrazolium bromide (MTT), and apoptosis was measured by FITC-conjugated Annexin V staining and flow cytometry. Results/Conclusions: We observed a significant decrease in HER2 protein expression on western blot following treatment with 40 and 80 mu M t10c12 CLA (p < 0.01 and 0.001, respectively) and loss of HER2 protein in cells using immunoflourescence that was most pronounced at 80 mM. Protein levels of nuclear NF-kappa B p65 were also significantly reduced at the 80 mM dose. This was accompanied by a significant decrease in PGE2 levels (p = 0.05). Pretreatment with t10c12 CLA significantly enhanced TNF alpha-induced apoptosis and the anti-proliferative action of trastuzumab (p = 0.05 and 0.001, respectively). These data add to previous reports of an anti-tumor effect of t10c12 CLA and suggest an effect on the HER2 oncogene that may be through CLA mediated downregulation of COX2-derived PGE(2).			Flowers, M (corresponding author), Univ Arizona, Dept Nutr Sci, Tucson, AZ 85721 USA.	mflowers@email.arizona.edu						Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Ahmed KM, 2006, ANTICANCER RES, V26, P4235; Basu A, 2001, BIOCHEM BIOPH RES CO, V280, P883, DOI 10.1006/bbrc.2000.4209; Benoit V, 2004, ONCOGENE, V23, P1631, DOI 10.1038/sj.onc.1207295; Biswas DK, 2006, J CELL PHYSIOL, V209, P645, DOI 10.1002/jcp.20785; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Biswas DK, 2001, P NATL ACAD SCI USA, V98, P10386, DOI 10.1073/pnas.151257998; Biswas DK, 2003, CANCER RES, V63, P290; Cao YX, 2007, P NATL ACAD SCI USA, V104, P15852, DOI 10.1073/pnas.0706728104; Chapkin RS, 2008, BRIT J NUTR, V100, P1152, DOI 10.1017/S0007114508992576; Cheng WL, 2004, J AGR FOOD CHEM, V52, P71, DOI 10.1021/jf0348626; Cho HJ, 2005, WORLD J GASTROENTERO, V11, P5142; Cho HJ, 2003, AM J PHYSIOL-GASTR L, V284, pG996, DOI 10.1152/ajpgi.00347.2002; Citri A, 2004, CELL CYCLE, V3, P51; DANG CT, 2004, PHASE 2 STUDY CELECO, P4062; Degner SC, 2006, J NUTR, V136, P421, DOI 10.1093/jn/136.2.421; ESPARISOGANDO A, 2008, ANN ONCOL; Furstenberger G, 2006, INT J CANCER, V119, P2247, DOI 10.1002/ijc.22153; Griffin JD, 2001, BLOOD, V98, P2291, DOI 10.1182/blood.V98.8.2291a; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hardy DB, 2008, MOL ENDOCRINOL, V22, P1812, DOI 10.1210/me.2007-0443; Howe LR, 2002, CANCER RES, V62, P5405; HOWE LR, 2005, HER2 NEUINDUCED MAMM, P10113; Hwang DM, 2007, CARCINOGENESIS, V28, P363, DOI 10.1093/carcin/bgl151; Ip MM, 2007, CARCINOGENESIS, V28, P1269, DOI 10.1093/carcin/bgm018; Ip MM, 1999, EXP CELL RES, V250, P22, DOI 10.1006/excr.1999.4499; Iwakiri Y, 2002, PROSTAG LEUKOTR ESS, V67, P435, DOI 10.1054/plef.2002.0454; Kao J, 2006, GENE CHROMOSOME CANC, V45, P761, DOI 10.1002/gcc.20339; Kelley NS, 2007, J NUTR, V137, P2599, DOI 10.1093/jn/137.12.2599; Kemp MQ, 2003, J NUTR, V133, P3670; Kim BY, 2002, ONCOGENE, V21, P4490, DOI 10.1038/sj.onc.1205547; Kim DW, 2000, ONCOGENE, V19, P5498, DOI 10.1038/sj.onc.1203945; Kim JM, 2008, LAB INVEST, V88, P541, DOI 10.1038/labinvest.2008.16; Kordes U, 2000, LEUKEMIA, V14, P399, DOI 10.1038/sj.leu.2401705; Lee S, 2002, CANCER RES, V62, P5703; Li GM, 2005, J LIPID RES, V46, P2134, DOI 10.1194/jlr.M500064-JLR200; Lim DY, 2005, J CELL PHYSIOL, V205, P107, DOI 10.1002/jcp.20380; Ma DWL, 2002, NUTR CANCER, V44, P202, DOI 10.1207/S15327914NC4402_13; Majumder B, 2002, FASEB J, V16, P1447, DOI 10.1096/fj.01-0720fje; Mann M, 2001, GASTROENTEROLOGY, V120, P1713, DOI 10.1053/gast.2001.24844; Masso-Welch PA, 2002, CANCER RES, V62, P4383; Menendez JA, 2005, ANN ONCOL, V16, P359, DOI 10.1093/annonc/mdi090; MENG X, 2008, T10 C12 CONJUGATED L, P1013; Miller A, 2001, LIPIDS, V36, P1161, DOI 10.1007/s11745-001-0827-0; Moulder S, 2008, CLIN PHARMACOL THER, V83, P26, DOI 10.1038/sj.clpt.6100449; Myers RB, 1996, INT J CANCER, V69, P398, DOI 10.1002/(SICI)1097-0215(19961021)69:5<398::AID-IJC8>3.0.CO;2-0; Nahta R, 2007, ONCOGENE, V26, P3637, DOI 10.1038/sj.onc.1210379; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Ohtsu H, 2005, NUTR RES, V25, P655, DOI 10.1016/j.nutres.2005.05.008; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Palayoor ST, 1999, ONCOGENE, V18, P7389, DOI 10.1038/sj.onc.1203160; Pianetti S, 2001, ONCOGENE, V20, P1287, DOI 10.1038/sj.onc.1204257; Ross JS, 1998, STEM CELLS, V16, P413, DOI 10.1002/stem.160413; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Sethi G, 2008, EXP BIOL MED, V233, P21, DOI 10.3181/0707-MR-196; Song HJ, 2006, PROSTATE, V66, P839, DOI 10.1002/pros.20351; Sroka IC, 2007, NEOPLASIA, V9, P406, DOI 10.1593/neo.07193; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; Subbaramaiah K, 2002, CANCER RES, V62, P2522; Valabrega G, 2007, ANN ONCOL, V18, P977, DOI 10.1093/annonc/mdl475; VAN AD, 1996, SCIENCE, V274, P787; Van Laere SJ, 2007, BRIT J CANCER, V97, P659, DOI 10.1038/sj.bjc.6603906; Wahle KWJ, 2004, PROG LIPID RES, V43, P553, DOI 10.1016/j.plipres.2004.08.002; Weisz L, 2007, CANCER RES, V67, P2396, DOI 10.1158/0008-5472.CAN-06-2425; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Zhou BP, 2000, J BIOL CHEM, V275, P8027, DOI 10.1074/jbc.275.11.8027; Zhou F, 2007, IET RADAR SONAR NAV, V1, P59, DOI 10.1049/iet-rsn:20060040	68	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5342	10.1371/journal.pone.0005342	http://dx.doi.org/10.1371/journal.pone.0005342			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399184	Green Published, gold, Green Submitted			2022-12-25	WOS:000265514900007
J	Mullauer, FB; Kessler, JH; Medema, JP				Mullauer, Franziska B.; Kessler, Jan H.; Medema, Jan Paul			Betulin Is a Potent Anti-Tumor Agent that Is Enhanced by Cholesterol	PLOS ONE			English	Article								Betulinic Acid (BetA) and its derivatives have been extensively studied in the past for their anti-tumor effects, but relatively little is known about its precursor Betulin ( BE). We found that BE induces apoptosis utilizing a similar mechanism as BetA and is prevented by cyclosporin A (CsA). BE induces cell death more rapidly as compared to BetA, but to achieve similar amounts of cell death a considerably higher concentration of BE is needed. Interestingly, we observed that cholesterol sensitized cells to BE-induced apoptosis, while there was no effect of cholesterol when combined with BetA. Despite the significantly enhanced cytotoxicity, the mode of cell death was not changed as CsA completely abrogated cell death. These results indicate that BE has potent anti-tumor activity especially in combination with cholesterol.			Mullauer, FB (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, LEXOR, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	J.P.Medema@amc.nl	Kessler, Jan/C-5559-2009	Medema, Jan Paul/0000-0003-3045-2924				Abe K, 1999, NEUROSCI RES, V35, P165, DOI 10.1016/S0168-0102(99)00048-6; Abe K, 1998, NEUROSCI RES, V31, P295, DOI 10.1016/S0168-0102(98)00055-8; Ahmad S, 2006, INT J TOXICOL, V25, P17, DOI 10.1080/10915810500488361; Alakurtti S, 2006, EUR J PHARM SCI, V29, P1, DOI 10.1016/j.ejps.2006.04.006; Bi Y, 2007, BIOORG MED CHEM LETT, V17, P1475, DOI 10.1016/j.bmcl.2006.09.096; Cichewicz RH, 2004, MED RES REV, V24, P90, DOI 10.1002/med.10053; Colell A, 2003, J BIOL CHEM, V278, P33928, DOI 10.1074/jbc.M210943200; de Souza MT, 2007, Z NATURFORSCH C, V62, P550; Fulda S, 1997, CANCER RES, V57, P4956; Fulda S, 1998, CANCER RES, V58, P4453; Fulda S, 1998, J BIOL CHEM, V273, P33942, DOI 10.1074/jbc.273.51.33942; Fulda S, 2000, MED PEDIATR ONCOL, V35, P616, DOI 10.1002/1096-911X(20001201)35:6<616::AID-MPO27>3.0.CO;2-N; Gao HY, 2003, CHEM PHARM BULL, V51, P1318, DOI 10.1248/cpb.51.1318; Gauthier C, 2009, J NAT PROD, V72, P72, DOI 10.1021/np800579x; Gniadecki R, 2004, BIOCHEM BIOPH RES CO, V320, P165, DOI 10.1016/j.bbrc.2004.05.145; Grimm S, 2007, APOPTOSIS, V12, P841, DOI 10.1007/s10495-007-0747-3; Hata K, 2003, TOXICOL LETT, V143, P1, DOI 10.1016/S0378-4274(03)00092-4; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; Jager S, 2008, MOLECULES, V13, P3224, DOI 10.3390/molecules13123224; Jeong HJ, 1999, BIOORG MED CHEM LETT, V9, P1201, DOI 10.1016/S0960-894X(99)00165-1; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kessler JH, 2007, CANCER LETT, V251, P132, DOI 10.1016/j.canlet.2006.11.003; Kim DSHL, 1998, BIOORG MED CHEM LETT, V8, P1707, DOI 10.1016/S0960-894X(98)00295-9; Kvasnica M, 2005, BIOORGAN MED CHEM, V13, P3447, DOI 10.1016/j.bmc.2005.03.006; Malorni W, 2007, APOPTOSIS, V12, P941, DOI 10.1007/s10495-007-0757-1; Mollinedo F, 2006, DRUG RESIST UPDATE, V9, P51, DOI 10.1016/j.drup.2006.04.002; Mouritsen OG, 2004, LIPIDS, V39, P1101, DOI 10.1007/s11745-004-1336-x; Muceniece R, 2008, PHARMACOL BIOCHEM BE, V90, P712, DOI 10.1016/j.pbb.2008.05.015; Mukherjee Rama, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P271, DOI 10.2174/187152006776930846; Mullauer FB, 2009, APOPTOSIS, V14, P191, DOI 10.1007/s10495-008-0290-x; Pyo JS, 2009, PLANTA MED, V75, P127, DOI 10.1055/s-0028-1088366; Rajendran P, 2008, INVEST NEW DRUG, V26, P25, DOI 10.1007/s10637-007-9081-4; Sarek J, 2005, BIOORG MED CHEM LETT, V15, P4196, DOI 10.1016/j.bmcl.2005.06.087; SLATER TF, 1963, BIOCHIM BIOPHYS ACTA, V77, P383, DOI 10.1016/0006-3002(63)90513-4; Tan YM, 2003, CLIN CANCER RES, V9, P2866; Waterhouse NJ, 2003, CELL DEATH DIFFER, V10, P853, DOI 10.1038/sj.cdd.4401263; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wick W, 1999, J PHARMACOL EXP THER, V289, P1306; Yamashita K, 2002, CLIN CHIM ACTA, V325, P91, DOI 10.1016/S0009-8981(02)00252-8	39	55	55	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e1	10.1371/journal.pone.0005361	http://dx.doi.org/10.1371/journal.pone.0005361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399186	Green Published, gold, Green Submitted			2022-12-25	WOS:000265514900017
J	Diezmann, S; Dietrich, FS				Diezmann, Stephanie; Dietrich, Fred S.			Saccharomyces cerevisiae: Population Divergence and Resistance to Oxidative Stress in Clinical, Domesticated and Wild Isolates	PLOS ONE			English	Article								Background: Saccharomyces cerevisiae has been associated with human life for millennia in the brewery and bakery. Recently it has been recognized as an emerging opportunistic pathogen. To study the evolutionary history of S. cerevisiae, the origin of clinical isolates and the importance of a virulence-associated trait, population genetics and phenotypic assays have been applied to an ecologically diverse set of 103 strains isolated from clinics, breweries, vineyards, fruits, soil, commercial supplements and insect guts. Methodology/Principal Findings: DNA sequence data from five nuclear DNA loci were analyzed for population structure and haplotype distribution. Additionally, all strains were tested for survival of oxidative stress, a trait associated with microbial pathogenicity. DNA sequence analyses identified three genetic subgroups within the recombining S. cerevisiae strains that are associated with ecology, geography and virulence. Shared alleles suggest that the clinical isolates contain genetic contribution from the fruit isolates. Clinical and fruit isolates exhibit high levels of recombination, unlike the genetically homogenous soil isolates in which no recombination was detected. However, clinical and soil isolates were more resistant to oxidative stress than any other population, suggesting a correlation between survival in oxidative stress and yeast pathogenicity. Conclusions/Significance: Population genetic analyses of S. cerevisiae delineated three distinct groups, comprising primarily the (i) human-associated brewery and vineyard strains, (ii) clinical and fruit isolates (iii) and wild soil isolates from eastern U.S. The interactions between S. cerevisiae and humans potentiate yeast evolution and the development of genetically, ecologically and geographically divergent groups.			Diezmann, S (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27706 USA.	sd21@duke.edu		Diezmann, Stephanie/0000-0002-9528-1495				Aa E, 2006, FEMS YEAST RES, V6, P702, DOI 10.1111/j.1567-1364.2006.00059.x; ABSHIRE KZ, 1993, J BACTERIOL, V175, P3734, DOI 10.1128/JB.175.12.3734-3743.1993; Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aref H, 1934, J BACTERIOL, V27, P443, DOI 10.1128/JB.27.5.443-452.1934; AUCOTT JN, 1990, REV INFECT DIS, V12, P406; Bassetti S, 1998, AM J MED, V105, P71, DOI 10.1016/S0002-9343(98)00133-8; Bougnoux ME, 2003, J CLIN MICROBIOL, V41, P5265, DOI 10.1128/JCM.41.11.5265-5266.2003; Bulmer GS, 1999, MYCOPATHOLOGIA, V146, P117, DOI 10.1023/A:1007025212469; BURKE D, 2000, TECHNIQUES PROTOCOLS, V18, P205; CAPRIOTTI A, 1967, ARCH MIKROBIOL, V57, P406, DOI 10.1007/BF00416939; CAPRIOTTI A, 1954, ANTON LEEUW INT J G, V21, P145; Cavalieri D, 2003, J MOL EVOL, V57, pS226, DOI 10.1007/s00239-003-0031-2; Cesaro S, 2000, SUPPORT CARE CANCER, V8, P504, DOI 10.1007/s005200000123; CHERTOW GM, 1991, CHEST, V99, P1518, DOI 10.1378/chest.99.6.1518; CHIA JKS, 1995, CLIN INFECT DIS, V20, P1581, DOI 10.1093/clinids/20.6.1581; CIMOLAI N, 1987, DIAGN MICR INFEC DIS, V8, P113, DOI 10.1016/0732-8893(87)90158-1; CLEMONS KV, 1994, J INFECT DIS, V169, P859, DOI 10.1093/infdis/169.4.859; Clemons KV, 1996, J MED VET MYCOL, V34, P259; Diezmann S, 2004, J CLIN MICROBIOL, V42, P5624, DOI 10.1128/JCM.42.12.5624-5635.2004; Enache-Angoulvant A, 2005, CLIN INFECT DIS, V41, P1559, DOI 10.1086/497832; Esseiva P, 2005, TALANTA, V67, P360, DOI 10.1016/j.talanta.2005.03.041; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; GARZA S, 1994, INT J FOOD MICROBIOL, V23, P209, DOI 10.1016/0168-1605(94)90053-1; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; HAZEN KC, 1995, CLIN MICROBIOL REV, V8, P462, DOI 10.1128/CMR.8.4.462; IYER GY, 1961, NATURE, V192, P535, DOI 10.1038/192535a0; Konecny P, 1999, INT J STD AIDS, V10, P821, DOI 10.1258/0956462991913475; Kvitek DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000223; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Maddison W, 1997, MACCLADE ANAL PHYLOG; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; McCullough MJ, 1998, J CLIN MICROBIOL, V36, P557, DOI 10.1128/JCM.36.2.557-562.1998; McCullough MJ, 1998, J CLIN MICROBIOL, V36, P2613, DOI 10.1128/JCM.36.9.2613-2617.1998; MCCUSKER JH, 1994, INFECT IMMUN, V62, P5447, DOI 10.1128/IAI.62.12.5447-5455.1994; MCCUSKER JH, 1994, GENETICS, V136, P1261; McCusker JH, 2006, MOLECULAR PRINCIPLES OF FUNGAL PATHOGENESIS, P245; McFarland LV, 1996, CLIN INFECT DIS, V22, P200, DOI 10.1093/clinids/22.1.200; McGovern PE, 2004, P NATL ACAD SCI USA, V101, P17593, DOI 10.1073/pnas.0407921102; McNeil MM, 2001, CLIN INFECT DIS, V33, P641, DOI 10.1086/322606; MORTIMER RK, 1986, GENETICS, V113, P35; MORTIMER RK, 1994, YEAST, V10, P1543, DOI 10.1002/yea.320101203; NAUMOV G, 1992, ANTON LEEUW INT J G, V61, P237, DOI 10.1007/BF00584230; Naumov GI, 1998, CAN J MICROBIOL, V44, P1045, DOI 10.1139/cjm-44-11-1045; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perlstein EO, 2006, CHEM BIOL, V13, P319, DOI 10.1016/j.chembiol.2006.01.010; Rea RB, 2004, INFECT IMMUN, V72, P717, DOI 10.1128/IAI.72.2.717-727.2004; Replansky T, 2008, TRENDS ECOL EVOL, V23, P494, DOI 10.1016/j.tree.2008.05.005; Riboulet E, 2007, J MOL MICROB BIOTECH, V13, P140, DOI 10.1159/000103605; ROUSE AL, 2007, EVOLUTION YEAST TRAN; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SBARRA AJ, 1959, J BIOL CHEM, V234, P1355; Skovgaard N, 2007, INT J FOOD MICROBIOL, V120, P217, DOI 10.1016/j.ijfoodmicro.2007.07.046; Smith D, 2002, J CLIN MICROBIOL, V40, P2691, DOI 10.1128/JCM.40.7.2691-2692.2002; Sniegowski Paul D., 2002, FEMS Yeast Research, V1, P299, DOI 10.1016/S1567-1356(01)00043-5; SOBEL JD, 1993, CLIN INFECT DIS, V16, P93, DOI 10.1093/clinids/16.1.93; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Suh SO, 2005, MYCOL RES, V109, P261, DOI 10.1017/S0953756205002388; TAWFIK OW, 1989, J CLIN MICROBIOL, V27, P1689, DOI 10.1128/JCM.27.7.1689-1691.1989; TEMPLETON AR, 1992, GENETICS, V132, P619; TORASKAR MV, 1989, ACTA HORTIC, V231, P697; VAUGHANMARTINI A, 1995, J IND MICROBIOL, V14, P514, DOI 10.1007/BF01573967; Weger SD, 2002, MED MYCOL, V40, P161, DOI 10.1080/mmy.40.2.161.168; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Williams JS, 2007, CLIN EXP DERMATOL, V32, P395, DOI 10.1111/j.1365-2230.2007.02375.x; Zaoutis TE, 2005, CLIN INFECT DIS, V41, P1232, DOI 10.1086/496922	72	71	72	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5317	10.1371/journal.pone.0005317	http://dx.doi.org/10.1371/journal.pone.0005317			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390633	Green Submitted, Green Published, gold			2022-12-25	WOS:000265514400008
J	Cabrol, C; Huzarska, MA; Dinolfo, C; Rodriguez, MC; Reinstatler, L; Ni, J; Yeh, LA; Cuny, GD; Stein, RL; Selkoe, DJ; Leissring, MA				Cabrol, Christelle; Huzarska, Malwina A.; Dinolfo, Christopher; Rodriguez, Maria C.; Reinstatler, Lael; Ni, Jake; Yeh, Li-An; Cuny, Gregory D.; Stein, Ross L.; Selkoe, Dennis J.; Leissring, Malcolm A.			Small-Molecule Activators of Insulin-Degrading Enzyme Discovered through High-Throughput Compound Screening	PLOS ONE			English	Article								Background: Hypocatabolism of the amyloid beta-protein (A beta) by insulin-degrading enzyme (IDE) is implicated in the pathogenesis of Alzheimer disease (AD), making pharmacological activation of IDE an attractive therapeutic strategy. However, it has not been established whether the proteolytic activity of IDE can be enhanced by drug-like compounds. Methodology/Principal Findings: Based on the finding that ATP and other nucleotide polyphosphates modulate IDE activity at physiological concentrations, we conducted parallel high-throughput screening campaigns in the absence or presence of ATP and identified two compounds -designated Ia1 and Ia2 -that significantly stimulate IDE proteolytic activity. Both compounds were found to interfere with the crosslinking of a photoaffinity ATP analogue to IDE, suggesting that they interact with a bona fide ATP-binding domain within IDE. Unexpectedly, we observed highly synergistic activation effects when the activity of Ia1 or Ia2 was tested in the presence of ATP, a finding that has implications for the mechanisms underlying ATP-mediated activation of IDE. Notably, Ia1 and Ia2 activated the degradation of A beta by similar to 700% and similar to 400%, respectively, albeit only when A beta was presented in a mixture also containing shorter substrates. Conclusions/Significance: This study describes the first examples of synthetic small-molecule activators of IDE, showing that pharmacological activation of this important protease with drug-like compounds is achievable. These novel activators help to establish the putative ATP-binding domain as a key modulator of IDE proteolytic activity and offer new insights into the modulatory action of ATP. Several larger lessons abstracted from this screen will help inform the design of future screening campaigns and facilitate the eventual development of IDE activators with therapeutic utility.			Cabrol, C (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	Leissring@mayo.edu	LEISSRING, MALCOLM/AAW-5361-2021	LEISSRING, MALCOLM/0000-0001-7185-4255; Cuny, Gregory/0000-0002-3188-4748; Rodriguez Benavente, Maria/0000-0001-8484-251X	NATIONAL INSTITUTE ON AGING [R21AG030718, R01AG012749] Funding Source: NIH RePORTER; NIA NIH HHS [R21 AG030718, AG030718, R01 AG012749, AG012749] Funding Source: Medline; NIDA NIH HHS [R03 DA024888] Funding Source: Medline; PHS HHS [A024888] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Camberos MC, 2001, EXP BIOL MED, V226, P334, DOI 10.1177/153537020122600411; El-Amouri SS, 2008, AM J PATHOL, V172, P1342, DOI 10.2353/ajpath.2008.070620; Ertekin-Taner N, 2000, SCIENCE, V290, P2303, DOI 10.1126/science.290.5500.2303; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Hamel FG, 2003, ENDOCRINOLOGY, V144, P2404, DOI 10.1210/en.2002-0007; Im H, 2007, J BIOL CHEM, V282, P25453, DOI 10.1074/jbc.M701590200; Jacobsen JS, 2008, P NATL ACAD SCI USA, V105, P8754, DOI 10.1073/pnas.0710823105; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Leissring MA, 2003, J BIOL CHEM, V278, P37314, DOI 10.1074/jbc.M305627200; Leissring MA, 2007, ADV GENETICS MOL CEL, P157; Leissring MA, 2008, J BIOL CHEM, V283, P29645, DOI 10.1074/jbc.R800022200; Leissring MA, 2006, NATURE, V443, P761, DOI 10.1038/nature05210; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Neant-Fery M, 2008, P NATL ACAD SCI USA, V105, P9582, DOI 10.1073/pnas.0801261105; Prince JA, 2003, HUM MUTAT, V22, P363, DOI 10.1002/humu.10282; Qiu WQ, 2006, NEUROBIOL AGING, V27, P190, DOI 10.1016/j.neurobiolaging.2005.01.004; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Roth R.A., 2004, HDB PROTEOLYTIC ENZY, V2nd ed., P871; ROYCHAUDHURI R, 2008, J BIOL CHEM; Saric T, 2003, MOL CELL ENDOCRINOL, V204, P11, DOI 10.1016/S0303-7207(03)00154-0; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Song ES, 2005, J MOL NEUROSCI, V25, P201, DOI 10.1385/JMN:25:3:201; Song ES, 2004, J BIOL CHEM, V279, P54216, DOI 10.1074/jbc.M411177200; Song ES, 2003, J BIOL CHEM, V278, P49789, DOI 10.1074/jbc.M308983200; Song ES, 2001, J BIOL CHEM, V276, P1152, DOI 10.1074/jbc.M008702200; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Walker LC, 2005, BIOCHEM PHARMACOL, V69, P1001, DOI 10.1016/j.bcp.2004.12.015; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Zhao J, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-4	35	56	58	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5274	10.1371/journal.pone.0005274	http://dx.doi.org/10.1371/journal.pone.0005274			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384407	Green Published, Green Submitted, gold			2022-12-25	WOS:000265513900015
J	Bansal, PK; Mishra, A; High, AA; Abdulle, R; Kitagawa, K				Bansal, Parmil K.; Mishra, Ashutosh; High, Anthony A.; Abdulle, Rashid; Kitagawa, Katsumi			Sgt1 Dimerization Is Negatively Regulated by Protein Kinase CK2-mediated Phosphorylation at Ser361	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE KINETOCHORE; CENTROMERE-BINDING PROTEIN; BUDDING YEAST KINETOCHORE; CHROMOSOME SEGREGATION; ESSENTIAL COMPONENT; CASEIN KINASE-2; IN-VIVO; HSP90; GENE; DNA	The kinetochore, which consists of centromere DNA and structural proteins, is essential for proper chromosome segregation in eukaryotes. In budding yeast, Sgt1 and Hsp90 are required for the binding of Skp1 to Ctf13 ( a component of the core kinetochore complex CBF3) and therefore for the assembly of CBF3. We have previously shown that Sgt1 dimerization is important for this kinetochore assembly mechanism. In this study, we report that protein kinase CK2 phosphorylates Ser(361) on Sgt1, and this phosphorylation inhibits Sgt1 dimerization.	[Bansal, Parmil K.; Abdulle, Rashid; Kitagawa, Katsumi] St Jude Childrens Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA; [Mishra, Ashutosh; High, Anthony A.] St Jude Childrens Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Kitagawa, K (corresponding author), St Jude Childrens Hosp, Dept Mol Pharmacol, MS 230,262 Danny Thomas Pl, Memphis, TN 38105 USA.	katsumi.kitagawa@stjude.org			National Institutes of Health [GM68418]; NCI; Cancer Center [CA21765]; American Lebanese Syrian Association Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center; American Lebanese Syrian Association Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Cancer Center Support Grant CA21765 and National Institutes of Health Grant GM68418. This work was also supported by the American Lebanese Syrian Association Charities.	Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; BAKER RE, 1990, MOL CELL BIOL, V10, P2458, DOI 10.1128/MCB.10.6.2458; Bansal PK, 2009, J BIOL CHEM, V284, P3586, DOI 10.1074/jbc.M806281200; Bansal PK, 2004, MOL CELL BIOL, V24, P8069, DOI 10.1128/MCB.24.18.8069-8079.2004; CAI MJ, 1989, MOL CELL BIOL, V9, P2544, DOI 10.1128/MCB.9.6.2544; CAI MJ, 1990, CELL, V61, P437, DOI 10.1016/0092-8674(90)90525-J; CARMICHAEL DF, 1982, J BIOL CHEM, V257, P440; Catlett MG, 2006, J BIOL CHEM, V281, P33739, DOI 10.1074/jbc.M603847200; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Connelly C, 1996, CELL, V86, P275, DOI 10.1016/S0092-8674(00)80099-9; DOHENY KF, 1993, CELL, V73, P761, DOI 10.1016/0092-8674(93)90255-O; Domanska K, 2005, ACTA BIOCHIM POL, V52, P947; Dubacq C, 2002, EUKARYOT CELL, V1, P568, DOI 10.1128/EC.1.4.568-582.2002; FITZGERALDHAYES M, 1982, CELL, V29, P235, DOI 10.1016/0092-8674(82)90108-8; Fritz G, 1999, ONCOGENE, V18, P1033, DOI 10.1038/sj.onc.1202394; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; HEGEMANN JH, 1988, MOL CELL BIOL, V8, P2523, DOI 10.1128/MCB.8.6.2523; HIETER P, 1985, CELL, V42, P913, DOI 10.1016/0092-8674(85)90287-9; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JIANG WD, 1993, J CELL BIOL, V121, P513, DOI 10.1083/jcb.121.3.513; Kaplan KB, 1997, CELL, V91, P491, DOI 10.1016/S0092-8674(00)80435-3; Kitagawa K, 2003, MOL CELL, V11, P1201, DOI 10.1016/S1097-2765(03)00145-X; Kitagawa K, 2002, BIOTECHNIQUES, V33, P288, DOI 10.2144/02332bm07; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Kreegipuu A, 1999, NUCLEIC ACIDS RES, V27, P237, DOI 10.1093/nar/27.1.237; LECHNER J, 1991, CELL, V64, P717, DOI 10.1016/0092-8674(91)90501-O; LECHNER J, 1994, EMBO J, V13, P5203, DOI 10.1002/j.1460-2075.1994.tb06851.x; Lee YT, 2004, J BIOL CHEM, V279, P16511, DOI 10.1074/jbc.M400215200; Lingelbach LB, 2004, MOL CELL BIOL, V24, P8938, DOI 10.1128/MCB.24.20.8938-8950.2004; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mckenzie JA, 2003, ANAL BIOCHEM, V313, P9; Niikura Y, 2006, ONCOGENE, V25, P4133, DOI 10.1038/sj.onc.1209461; Nowotny M, 2003, J BIOL CHEM, V278, P26923, DOI 10.1074/jbc.M211518200; Nyarko A, 2007, BIOCHEMISTRY-US, V46, P11331, DOI 10.1021/bi700735t; PADMANABHA R, 1990, MOL CELL BIOL, V10, P4089, DOI 10.1128/MCB.10.8.4089; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; Poole A, 2005, MOL CELL BIOCHEM, V274, P163, DOI 10.1007/s11010-005-2945-z; Rose MD., 1990, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; Sorger PK, 1995, P NATL ACAD SCI USA, V92, P12026, DOI 10.1073/pnas.92.26.12026; Steensgaard P, 2004, EMBO REP, V5, P626, DOI 10.1038/sj.embor.7400154; Stemmann O, 1996, EMBO J, V15, P3611, DOI 10.1002/j.1460-2075.1996.tb00730.x; Stemmann O, 2002, P NATL ACAD SCI USA, V99, P8585, DOI 10.1073/pnas.082223899; STRUNNIKOV AV, 1995, J CELL BIOL, V128, P749, DOI 10.1083/jcb.128.5.749; Sudakin V, 2007, BIODRUGS, V21, P225, DOI 10.2165/00063030-200721040-00003; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607	49	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18692	18698		10.1074/jbc.M109.012732	http://dx.doi.org/10.1074/jbc.M109.012732			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19398558	hybrid, Green Published			2022-12-25	WOS:000267711500018
J	Brooks, YS; Wang, G; Yang, Z; Smith, KK; Bieberich, E; Ko, L				Brooks, Yang S.; Wang, Guanghu; Yang, Zheqiong; Smith, Kimberly K.; Bieberich, Erhard; Ko, Lan			Functional Pre-mRNA trans-Splicing of Coactivator CoAA and Corepressor RBM4 during Stem/Progenitor Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLICED LEADER SEQUENCE; BINDING PROTEIN; NONCODING RNA; STEM-CELLS; DROSOPHILA; TRANSCRIPTION; CEREBELLUM; EXPRESSION; MUTATIONS; DIVERSITY	Alternative splicing yields functionally distinctive gene products, and their balance plays critical roles in cell differentiation and development. We have previously shown that tumor-associated enhancer loss in coactivator gene CoAA leads to its altered alternative splicing. Here we identified two intergenic splicing variants, a zinc finger-containing coactivator CoAZ and a non-coding transcript ncCoAZ, between CoAA and its downstream corepressor gene RBM4. During stem/progenitor cell neural differentiation, we found that the switched alternative splicing and trans-splicing between CoAA and RBM4 transcripts result in lineage-specific expression of wild type CoAA, RBM4, and their variants. Stable expression of CoAA, RBM4, or their variants prevents the switch and disrupts the embryoid body formation. In addition, CoAA and RBM4 counter-regulate the target gene Tau at exon 10, and their splicing activities are subjected to the control by each splice variant. Further phylogenetic analysis showed that mammalian CoAA and RBM4 genes share common ancestry with the Drosophila melanogaster gene Lark, which is known to regulate early development and circadian rhythms. Thus, the trans-splicing between CoAA and RBM4 transcripts may represent a required regulation preserved during evolution. Our results demonstrate that a linked splicing control of transcriptional coactivator and corepressor is involved in stem/progenitor cell differentiation. The alternative splicing imbalance of CoAA and RBM4, because of loss of their common enhancer in cancer, may deregulate stem/progenitor cell differentiation.	[Brooks, Yang S.; Wang, Guanghu; Yang, Zheqiong; Bieberich, Erhard; Ko, Lan] Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Smith, Kimberly K.; Ko, Lan] Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Ko, L (corresponding author), Med Coll Georgia, Inst Mol Med & Genet, 1120 15th St,CB2803, Augusta, GA 30912 USA.	lko@mcg.edu		Ko, Lan/0000-0002-0089-9090	Georgia Cancer Coalition Distinguished Cancer Scholar Award	Georgia Cancer Coalition Distinguished Cancer Scholar Award	This work was supported by a Georgia Cancer Coalition Distinguished Cancer Scholar Award (to L. K.).	Adamia S, 2005, BLOOD, V105, P4836, DOI 10.1182/blood-2004-10-3825; Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; Auboeuf D, 2004, MOL CELL BIOL, V24, P442, DOI 10.1128/MCB.24.1.442-453.2004; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; Bieberich E, 2003, J CELL BIOL, V162, P469, DOI 10.1083/jcb.200212067; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Brose MS, 2004, GENET TEST, V8, P133, DOI 10.1089/1090657041797347; Cavaleri F, 2003, CELL, V113, P551, DOI 10.1016/S0092-8674(03)00394-5; CHOW LT, 1977, CELL, V12, P1, DOI 10.1016/0092-8674(77)90180-5; D'Souza I, 2005, BBA-MOL BASIS DIS, V1739, P104, DOI 10.1016/j.bbadis.2004.08.009; Dehmelt L, 2005, GENOME BIOL, V6; Dorn R, 2001, P NATL ACAD SCI USA, V98, P9724, DOI 10.1073/pnas.151268698; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; EUL J, 1995, EMBO J, V14, P3226, DOI 10.1002/j.1460-2075.1995.tb07325.x; Finta C, 2002, J BIOL CHEM, V277, P5882, DOI 10.1074/jbc.M109175200; Goedert M, 2005, MOVEMENT DISORD, V20, pS45, DOI 10.1002/mds.20539; Iwasaki T, 2001, J BIOL CHEM, V276, P33375, DOI 10.1074/jbc.M101517200; Jackson FB, 1997, GENOMICS, V41, P444, DOI 10.1006/geno.1997.4704; Kalnina Z, 2005, GENE CHROMOSOME CANC, V42, P342, DOI 10.1002/gcc.20156; Kang YK, 2008, CANCER RES, V68, P7887, DOI 10.1158/0008-5472.CAN-08-1734; Kar A, 2006, J BIOL CHEM, V281, P24479, DOI 10.1074/jbc.M603971200; Kornblihtt AR, 2005, CURR OPIN CELL BIOL, V17, P262, DOI 10.1016/j.ceb.2005.04.014; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; Lai MC, 2003, EMBO J, V22, P1359, DOI 10.1093/emboj/cdg126; Lin JC, 2005, MOL CELL BIOL, V25, P10111, DOI 10.1128/MCB.25.22.10111-10121.2005; Liu F, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-8; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Mayer MG, 2005, MEM I OSWALDO CRUZ, V100, P501, DOI 10.1590/S0074-02762005000500010; McNeil GP, 1998, NEURON, V20, P297, DOI 10.1016/S0896-6273(00)80457-2; McNeil GP, 2001, GENETICS, V159, P229; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Neklason Deborah W, 2004, Fam Cancer, V3, P35; Ozcelik H, 1999, HUM MUTAT, V14, P540, DOI 10.1002/(SICI)1098-1004(199912)14:6<540::AID-HUMU13>3.3.CO;2-3; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; PARSONS M, 1984, CELL, V38, P309, DOI 10.1016/0092-8674(84)90552-X; Pfuhl T, 2008, NEUROSCI LETT, V444, P11, DOI 10.1016/j.neulet.2008.08.017; Pittman AM, 2006, HUM MOL GENET, V15, pR188, DOI 10.1093/hmg/ddl190; RAJKOVIC A, 1990, P NATL ACAD SCI USA, V87, P8879, DOI 10.1073/pnas.87.22.8879; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; SCHWARTZ JP, 1992, GLIA, V5, P75, DOI 10.1002/glia.440050111; SMITH CWJ, 1989, ANNU REV GENET, V23, P527, DOI 10.1146/annurev.genet.23.1.527; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Stetefeld J, 2005, TRENDS BIOCHEM SCI, V30, P515, DOI 10.1016/j.tibs.2005.07.001; Sui Y, 2007, ONCOGENE, V26, P822, DOI 10.1038/sj.onc.1209847; TESSIER LH, 1991, EMBO J, V10, P2621, DOI 10.1002/j.1460-2075.1991.tb07804.x; van der Heyden MAG, 2003, CARDIOVASC RES, V58, P292, DOI 10.1016/S0008-6363(02)00771-X; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GH, 2005, J BIOL CHEM, V280, P26415, DOI 10.1074/jbc.M501492200; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Yang ZQ, 2007, NUCLEIC ACIDS RES, V35, P1919, DOI 10.1093/nar/gkl1092; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196	52	28	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18033	18046		10.1074/jbc.M109.006999	http://dx.doi.org/10.1074/jbc.M109.006999			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19416963	Green Published, hybrid			2022-12-25	WOS:000267712400015
J	Khozoie, C; Pleass, RJ; Avery, SV				Khozoie, Combiz; Pleass, Richard J.; Avery, Simon V.			The Antimalarial Drug Quinine Disrupts Tat2p-mediated Tryptophan Transport and Causes Tryptophan Starvation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-TRANSPORT; SACCHAROMYCES-CEREVISIAE; PLASMODIUM-FALCIPARUM; GENE-EXPRESSION; YEAST; TOXICITY; MALARIA; PERMEASES; PROTEINS; SYSTEM	Quinine is a major drug of choice for the treatment of malaria. However, the primary mode of quinine action is unclear, and its efficacy is marred by adverse reactions among patients. To help address these issues, a genome-wide screen for quinine sensitivity was carried out using the yeast deletion strain collection. Quinine-sensitive mutants identified in the screen included several that were defective for tryptophan biosynthesis (trp strains). This sensitivity was confirmed in independent assays and was suppressible with exogenous Trp, suggesting that quinine caused Trp starvation. Accordingly, quinine was found to inhibit [H-3] Trp uptake by cells, and the quinine sensitivity of a trp1 Delta mutant could be rescued by overexpression of Trp permeases, encoded by TAT1 and TAT2. The site of quinine action was identified specifically as the high affinity Trp/Tyr permease, Tat2p, with which quinine associated in a Trp-suppressible manner. A resultant action also on Tyr levels was reflected by the Tyr-suppressible quinine hypersensitivity of an aro7 Delta deletion strain, which is auxotrophic for Tyr (and Phe). The present genome-wide dataset provides an important resource for discovering modes of quinine toxicity. That potential was validated with our demonstration that Trp and Tyr uptake via Tat2p is a major target of cellular quinine toxicity. The results also suggest that dietary tryptophan supplements could help to avert the toxic effects of quinine.	[Khozoie, Combiz; Pleass, Richard J.; Avery, Simon V.] Univ Nottingham, Sch Biol, Inst Genet, Nottingham NG7 2RD, England	University of Nottingham	Pleass, RJ (corresponding author), Univ Nottingham, Sch Biol, Inst Genet, Univ Pk, Nottingham NG7 2RD, England.	Richard.Pleass@nottingham.ac.uk; Simon.Avery@nottingham.ac.uk	Avery, Simon/U-5816-2019; Pleass, Richard/N-7831-2019; Avery, Simon/AAS-5291-2021; Pleass, Richard J/L-4148-2015	Pleass, Richard/0000-0001-7438-8296; Avery, Simon/0000-0002-2102-2255; Pleass, Richard J/0000-0001-7438-8296	Sir Halley Stewart Trust	Sir Halley Stewart Trust	This work was supported by a grant from the Sir Halley Stewart Trust (to S.V.A. and R.J.P.).	Abe F, 2003, MOL CELL BIOL, V23, P7566, DOI 10.1128/MCB.23.21.7566-7584.2003; ABE F, 2007, INT C TRYPT REL SUBS, P75; Alkadi HO, 2007, CHEMOTHERAPY, V53, P385, DOI 10.1159/000109767; ALVAN G, 1991, BRIT J CLIN PHARMACO, V31, P409, DOI 10.1111/j.1365-2125.1991.tb05554.x; AUSUBEL FM, 2007, CURRENT PROTOCOLS MO; Avery SV, 2000, J BACTERIOL, V182, P76, DOI 10.1128/JB.182.1.76-80.2000; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Bell DJ, 2007, EXPERT REV ANTI-INFE, V5, P141, DOI 10.1586/14787210.5.1.141; Bishop AL, 2007, MOL MICROBIOL, V63, P507, DOI 10.1111/j.1365-2958.2006.05504.x; Bisswanger H., 2008, ENZYME KINETICS PRIN; Blackburn AS, 2003, ANTIMICROB AGENTS CH, V47, P676, DOI 10.1128/AAC.47.2.676-681.2003; Booij L, 2006, BIOL PSYCHIAT, V60, P507, DOI 10.1016/j.biopsych.2006.02.010; Craig CL, 1998, MOL BIOL EVOL, V15, P774, DOI 10.1093/oxfordjournals.molbev.a025981; Daily JP, 2007, NATURE, V450, P1091, DOI 10.1038/nature06311; Dobson PD, 2009, CURR TOP MED CHEM, V9, P163, DOI 10.2174/156802609787521616; Ericson E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000151; Eriksson T, 1997, PSYCHOL MED, V27, P477, DOI 10.1017/S0033291796003935; Ferreira PE, 2008, PERS MED, V5, P627, DOI 10.2217/17410541.5.6.627; Foury F, 1997, GENE, V195, P1, DOI 10.1016/S0378-1119(97)00140-6; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GREASHAM RL, 1973, J BACTERIOL, V115, P975, DOI 10.1128/JB.115.3.975-981.1973; Hall AP, 1997, BRIT J OPHTHALMOL, V81, P1029, DOI 10.1136/bjo.81.12.1029; Holland S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r268; Huston M, 2006, J EMERG MED, V31, P395, DOI 10.1016/j.jemermed.2006.07.018; Kakkar T, 1999, DRUG METAB DISPOS, V27, P756; KROGSTAD DJ, 1985, J CELL BIOL, V101, P2302, DOI 10.1083/jcb.101.6.2302; LEETE E, 1969, ACCOUNTS CHEM RES, V2, P59, DOI 10.1021/ar50014a005; Li W, 2005, PLOS GENET, V1, P329, DOI 10.1371/journal.pgen.0010036; Liu J, 2006, P NATL ACAD SCI USA, V103, P8840, DOI 10.1073/pnas.0601876103; Lovegrove FE, 2008, TRENDS PARASITOL, V24, P288, DOI 10.1016/j.pt.2008.04.004; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Morales FJ, 2007, J AGR FOOD CHEM, V55, P6793, DOI 10.1021/jf071036e; Morton CO, 2007, ANTIMICROB AGENTS CH, V51, P3948, DOI 10.1128/AAC.01007-07; O'Connor SE, 2006, NAT PROD REP, V23, P532, DOI 10.1039/b512615k; PEET M, 1976, BRIT J PSYCHIAT, V128, P255, DOI 10.1192/bjp.128.3.255; Porter RJ, 2008, J AFFECT DISORDERS, V109, P209, DOI 10.1016/j.jad.2007.11.010; Raiford DW, 2008, J MOL EVOL, V67, P621, DOI 10.1007/s00239-008-9162-9; Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506; Rojas M, 2008, ANTIMICROB AGENTS CH, V52, P3844, DOI 10.1128/AAC.00532-08; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Ruotolo R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r67; SCHMIDT A, 1994, MOL CELL BIOL, V14, P6597, DOI 10.1128/MCB.14.10.6597; Seymour RL, 2006, J LEUKOCYTE BIOL, V80, P1320, DOI 10.1189/jlb.1205727; Simpson JJ, 2000, HEARING RES, V145, P1, DOI 10.1016/S0378-5955(00)00093-9; Smith MCA, 2007, MOL MICROBIOL, V66, P699, DOI 10.1111/j.1365-2958.2007.05951.x; Sullivan DJ, 2002, INT J PARASITOL, V32, P1645, DOI 10.1016/S0020-7519(02)00193-5; Suthram S, 2005, NATURE, V438, P108, DOI 10.1038/nature04135; Taylor WRJ, 2004, DRUG SAFETY, V27, P25, DOI 10.2165/00002018-200427010-00003; Tetsutani K, 2007, PARASITOLOGY, V134, P923, DOI 10.1017/S0031182007002326; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; Tucker CL, 2004, COMP FUNCT GENOM, V5, P216, DOI 10.1002/cfg.391; van der Veen FM, 2008, PSYCHOPHARMACOLOGY, V199, P255, DOI 10.1007/s00213-008-1176-x; Welsch CA, 2003, J BIOL CHEM, V278, P26976, DOI 10.1074/jbc.M213144200; WOLF L R, 1992, Journal of Emergency Medicine, V10, P295, DOI 10.1016/0736-4679(92)90336-R; Zhang NS, 2003, GENE, V303, P121, DOI 10.1016/S0378-1119(02)01142-3	57	34	35	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					17968	17974		10.1074/jbc.M109.005843	http://dx.doi.org/10.1074/jbc.M109.005843			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19416971	Green Published, hybrid			2022-12-25	WOS:000267712400008
J	Sy, SMH; Huen, MSY; Zhu, YY; Chen, JJ				Sy, Shirley M. -H.; Huen, Michael S. Y.; Zhu, Yongyou; Chen, Junjie			PALB2 Regulates Recombinational Repair through Chromatin Association and Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; STRAND BREAK REPAIR; TUMOR-SUPPRESSOR GENES; S-PHASE CHECKPOINT; HOMOLOGOUS RECOMBINATION; GENOMIC STABILITY; FANCONI-ANEMIA; SACCHAROMYCES-CEREVISIAE; HUMAN CTIP; PROTEIN	Maintenance of genomic stability ensures faithful transmission of genetic information and helps suppress neoplastic transformation and tumorigenesis. Although recent progress has advanced our understanding of DNA damage checkpoint regulations, little is known as to how DNA repair, especially the RAD51-dependent homologous recombination repair pathway, is executed in vivo. Here, we reveal novel properties of the BRCA2-associated protein PALB2 in the assembly of the recombinational DNA repair machinery at DNA damage sites. Although the chromatin association of PALB2 is a prerequisite for subsequent BRCA2 and RAD51 loading, the focal accumulation of the PALB2.BRCA2.RAD51 complex at DSBs occurs independently of known DNA damage checkpoint and repair proteins. We provide evidence to support that PALB2 exists as homo-oligomers and that PALB2 oligomerization is essential for its focal accumulation at DNA breaks in vivo. We propose that both PALB2 chromatin association and its oligomerization serve to secure the BRCA2.RAD51 repair machinery at the sites of DNA damage. These attributes of PALB2 are likely instrumental for proficient homologous recombination DNA repair in the cell.	[Sy, Shirley M. -H.; Huen, Michael S. Y.; Zhu, Yongyou; Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA	Yale University	Chen, JJ (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, Hunter Bldg Rm 213C,333 Cedar St,POB 208040, New Haven, CT 06520 USA.	Junjie.Chen@yale.edu	Zhu, Yongyou/H-3791-2013; Huen, Michael Shing Yan/E-9862-2010	Sy, Ming Hui/0000-0002-2731-6692	National Institutes of Health [CA089239]; NATIONAL CANCER INSTITUTE [R01CA089239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA089239 ( to J. C.).	Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Foulkes WD, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1828; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Huen MSY, 2008, MOL CELL BIOL, V28, P6104, DOI 10.1128/MCB.00987-08; Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109; Kennedy RD, 2006, J CLIN ONCOL, V24, P3799, DOI 10.1200/JCO.2005.05.4171; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Lord CJ, 2007, NAT STRUCT MOL BIOL, V14, P461, DOI 10.1038/nsmb0607-461; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Motoyama N, 2004, CURR OPIN GENET DEV, V14, P11, DOI 10.1016/j.gde.2003.12.003; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Pellegrini L, 2004, TRENDS BIOCHEM SCI, V29, P310, DOI 10.1016/j.tibs.2004.04.009; Penkner A, 2007, EMBO J, V26, P5071, DOI 10.1038/sj.emboj.7601916; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Shin DS, 2004, DNA REPAIR, V3, P863, DOI 10.1016/j.dnarep.2004.03.022; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Takeda S, 2007, MOL CELL, V28, P351, DOI 10.1016/j.molcel.2007.10.016; Thorslund T, 2007, ONCOGENE, V26, P7720, DOI 10.1038/sj.onc.1210870; Tischkowitz M, 2007, P NATL ACAD SCI USA, V104, P6788, DOI 10.1073/pnas.0701724104; Uanschou C, 2007, EMBO J, V26, P5061, DOI 10.1038/sj.emboj.7601913; Usui T, 2009, MOL CELL, V33, P147, DOI 10.1016/j.molcel.2008.12.022; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018; Zhang HB, 1998, CELL, V92, P433, DOI 10.1016/S0092-8674(00)80936-8; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	44	75	77	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18302	18310		10.1074/jbc.M109.016717	http://dx.doi.org/10.1074/jbc.M109.016717			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19423707	hybrid, Green Published			2022-12-25	WOS:000267712400043
J	Qadri, YJ; Berdiev, BK; Song, YH; Lippton, HL; Fuller, CM; Benos, DJ				Qadri, Yawar J.; Berdiev, Bakhrom K.; Song, Yuhua; Lippton, Howard L.; Fuller, Catherine M.; Benos, Dale J.			Psalmotoxin-1 Docking to Human Acid-sensing Ion Channel-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARANTULA TOXIN PSALMOTOXIN-1; POISSON-BOLTZMANN EQUATION; PROTEIN-DOCKING; MOLECULAR-DYNAMICS; PEPTIDE INHIBITOR; PK(A) VALUES; NA+ CHANNEL; ASIC1A; PH; RATIONALIZATION	Acid- sensing ion channel-1 (ASIC-1) is a proton-gated ion channel implicated in nociception and neuronal death during ischemia. Recently the first crystal structure of a chicken ASIC was obtained. Expanding upon this work, homology models of the human ASICs were constructed and evaluated. Energy-minimized structures were tested for validity by in silico docking of the models to psalmotoxin-1, which potently inhibits ASIC-1 and not other members of the family. The data are consistent with prior radioligand binding and functional assays while also explaining the selectivity of PcTX-1 for homomeric hASIC-1a. Binding energy calculations suggest that the toxin and channel create a complex that is more stable than the channel alone. The binding is dominated by the coulombic contributions, which account for why the toxin-channel interaction is not observed at low pH. The computational data were experimentally verified with single channel and whole-cell electrophysiological studies. These validated models should allow for the rational design of specific and potent peptidomimetic compounds that may be useful for the treatment of pain or ischemic stroke.	[Benos, Dale J.] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Berdiev, Bakhrom K.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Song, Yuhua] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA; [Lippton, Howard L.] Pneumosite LLC, Shreveport, LA 71103 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Benos, DJ (corresponding author), Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA.	benos@uab.edu	Fuller, Cathy/B-4046-2011	Qadri, Yawar/0000-0003-2138-4018	National Institutes of Health [DK37206]; American Medical Association Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK037206, R01DK037206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Medical Association Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK37206. This work was also supported by the American Medical Association Foundation.	Alexander SPH, 2008, BRIT J PHARMACOL, V153, pS1, DOI 10.1038/sj.bjp.0707746; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Berdiev BK, 2002, J BIOL CHEM, V277, P45734, DOI 10.1074/jbc.M208995200; Berdiev BK, 2001, J BIOL CHEM, V276, P38755, DOI 10.1074/jbc.M107266200; Chagot B, 2005, PROTEIN SCI, V14, P2003, DOI 10.1110/ps.051378905; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen R, 2003, PROTEINS, V51, P397, DOI 10.1002/prot.10334; Chen XM, 2006, J GEN PHYSIOL, V127, P267, DOI 10.1085/jgp.200509409; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dube GR, 2005, PAIN, V117, P88, DOI 10.1016/j.pain.2005.05.021; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Escoubas P, 2003, PROTEIN SCI, V12, P1332, DOI 10.1110/ps.0307003; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Harris M, 2008, J BIOL CHEM, V283, P7455, DOI 10.1074/jbc.M707399200; HOLST M, 1993, J COMPUT CHEM, V14, P105, DOI 10.1002/jcc.540140114; Holst M, 2001, ADV COMPUT MATH, V15, P139, DOI 10.1023/A:1014246117321; Holst M, 2001, J COMPUT CHEM, V22, P475, DOI 10.1002/1096-987X(200103)22:4<475::AID-JCC1018>3.0.CO;2-7; HOLST MJ, 1995, J COMPUT CHEM, V16, P337, DOI 10.1002/jcc.540160308; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ismailov II, 1996, J BIOL CHEM, V271, P807, DOI 10.1074/jbc.271.2.807; Ismailov II, 1997, J PHYSIOL-LONDON, V504, P287, DOI 10.1111/j.1469-7793.1997.287be.x; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jensen JE, 2009, TOXICON, V54, P56, DOI 10.1016/j.toxicon.2009.03.014; Kedem K, 1999, PROTEINS, V37, P554, DOI 10.1002/(SICI)1097-0134(19991201)37:4<554::AID-PROT6>3.0.CO;2-1; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lupyan D, 2005, BIOINFORMATICS, V21, P3255, DOI 10.1093/bioinformatics/bti527; Meltzer RH, 2007, J BIOL CHEM, V282, P25548, DOI 10.1074/jbc.M703825200; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Pietra F, 2009, J CHEM INF MODEL, V49, P972, DOI 10.1021/ci800463h; Pignataro G, 2007, BRAIN, V130, P151, DOI 10.1093/brain/awl325; Reddy SLC, 2006, EUR J CARDIO-THORAC, V30, P126, DOI 10.1016/j.ejcts.2006.03.045; Salinas M, 2006, J PHYSIOL-LONDON, V570, P339, DOI 10.1113/jphysiol.2005.095810; Samways DSK, 2009, CELL CALCIUM, V45, P319, DOI 10.1016/j.ceca.2008.12.002; Sherwood TW, 2008, J BIOL CHEM, V283, P1818, DOI 10.1074/jbc.M705118200; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Voilley N, 2001, J NEUROSCI, V21, P8026, DOI 10.1523/JNEUROSCI.21-20-08026.2001; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang WZ, 2006, J BIOL CHEM, V281, P29369, DOI 10.1074/jbc.M605122200; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2007, FRONT BIOSCI-LANDMRK, V12, P1376, DOI 10.2741/2154; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100	49	35	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17625	17633		10.1074/jbc.M109.003913	http://dx.doi.org/10.1074/jbc.M109.003913			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19395383	hybrid, Green Published			2022-12-25	WOS:000267202500028
J	Datta, K; Johnson, NP; LiCata, VJ; von Hippel, PH				Datta, Kausiki; Johnson, Neil P.; LiCata, Vince J.; von Hippel, Peter H.			Local Conformations and Competitive Binding Affinities of Single- and Double-stranded Primer-Template DNA at the Polymerization and Editing Active Sites of DNA Polymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I KLENOW FRAGMENT; SEDIMENTATION-VELOCITY ANALYSIS; COEFFICIENT DISTRIBUTIONS C(S); PROTEIN-PROTEIN INTERACTIONS; NUCLEIC-ACID FRAMEWORK; LOW-ENERGY CD; ESCHERICHIA-COLI; THERMUS-AQUATICUS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS	In addition to their capacity for template-directed 5' -> 3' DNA synthesis at the polymerase (pol) site, DNA polymerases have a separate 3' -> 5' exonuclease (exo) editing activity that is involved in assuring the fidelity of DNA replication. Upon mis-incorporation of an incorrect nucleotide residue, the 3' terminus of the primer strand at the primer-template (P/T) junction is preferentially transferred to the exo site, where the faulty residue is excised, allowing the shortened primer to rebind to the template strand at the pol site and incorporate the correct dNTP. Here we describe the conformational changes that occur in the primer strand as it shuttles between the pol and exo sites of replication-competent Klenow and Klentaq DNA polymerase complexes in solution and use these conformational changes to measure the equilibrium distribution of the primer between these sites for P/TDNA constructs carrying both matched and mismatched primer termini. To this end, we have measured the fluorescence and circular dichroism spectra at wavelengths of >300 nm for conformational probes comprising pairs of 2-aminopurine bases site-specifically replacing adenine bases at various positions in the primer strand of P/T DNA constructs bound to DNA polymerases. Control experiments that compare primer conformations with available x-ray structures confirm the validity of this approach. These distributions and the conformational changes in the P/T DNA that occur during template-directed DNA synthesis in solution illuminate some of the mechanisms used by DNA polymerases to assure the fidelity of DNA synthesis.	[Datta, Kausiki; von Hippel, Peter H.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Datta, Kausiki; von Hippel, Peter H.] Univ Oregon, Dept Chem, Eugene, OR 97403 USA; [Johnson, Neil P.] CNRS, Inst Pharmacol & Biol Struct, UMR 5089, F-31077 Toulouse, France; [LiCata, Vince J.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	University of Oregon; University of Oregon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Louisiana State University System; Louisiana State University	von Hippel, PH (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	petevh@molbio.uoregon.edu		von Hippel, Peter H./0000-0003-2512-8097	National Institutes of Health [GM-15792]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015792, R37GM015792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-15792 ( to P. H. v. H.).	Allen WJ, 2008, PROTEIN SCI, V17, P401, DOI 10.1110/ps.073309208; ASTATKE M, 1995, J BIOL CHEM, V270, P1945, DOI 10.1074/jbc.270.4.1945; Bailey MF, 2001, METHODS, V25, P62, DOI 10.1006/meth.2001.1216; Bailey MF, 2007, BIOCHEMISTRY-US, V46, P8085, DOI 10.1021/bi6024148; Beechem JM, 1998, BIOCHEMISTRY-US, V37, P10144, DOI 10.1021/bi980074b; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; BRUTLAG D, 1972, J BIOL CHEM, V247, P241; CARVER TE, 1994, P NATL ACAD SCI USA, V91, P10670, DOI 10.1073/pnas.91.22.10670; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Dam J, 2005, BIOPHYS J, V89, P651, DOI 10.1529/biophysj.105.059584; Datta K, 2003, J BIOL CHEM, V278, P5694, DOI 10.1074/jbc.M208133200; Datta K, 2008, J BIOL CHEM, V283, P3537, DOI 10.1074/jbc.M707998200; Datta K, 2006, J MOL BIOL, V360, P800, DOI 10.1016/j.jmb.2006.05.053; DELUCIA P, 1969, NATURE, V224, P1164, DOI 10.1038/2241164a0; DERBYSHIRE V, 1988, SCIENCE, V240, P199, DOI 10.1126/science.2832946; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; FREEMONT PS, 1988, P NATL ACAD SCI USA, V85, P8924, DOI 10.1073/pnas.85.23.8924; Gangurde R, 2002, BIOCHEMISTRY-US, V41, P14552, DOI 10.1021/bi0264216; Hariharan C, 2005, BIOCHEMISTRY-US, V44, P15674, DOI 10.1021/bi051462y; HUANG MM, 1992, NUCLEIC ACIDS RES, V20, P4567, DOI 10.1093/nar/20.17.4567; Johnson NP, 2005, J BIOL CHEM, V280, P32177, DOI 10.1074/jbc.M504619200; Johnson NP, 2004, P NATL ACAD SCI USA, V101, P3426, DOI 10.1073/pnas.0400591101; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Jose D, 2009, P NATL ACAD SCI USA, V106, P4231, DOI 10.1073/pnas.0900803106; Joyce CM, 2008, BIOCHEMISTRY-US, V47, P6103, DOI 10.1021/bi7021848; Joyce CM, 1995, METHOD ENZYMOL, V262, P3; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; KIM Y, 1995, NATURE, V376, P612, DOI 10.1038/376612a0; KOROLEV S, 1995, P NATL ACAD SCI USA, V92, P9264, DOI 10.1073/pnas.92.20.9264; KUCHTA RD, 1988, BIOCHEMISTRY-US, V27, P6716, DOI 10.1021/bi00418a012; Kukreti P, 2008, J BIOL CHEM, V283, P17979, DOI 10.1074/jbc.M801053200; KUNKEL TA, 1988, CELL, V53, P837, DOI 10.1016/S0092-8674(88)90189-4; Lam WC, 1998, BIOCHEMISTRY-US, V37, P1513, DOI 10.1021/bi9720181; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; MULLEN GP, 1990, J BIOL CHEM, V265, P14327; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; POLESKY AH, 1992, J BIOL CHEM, V267, P8417; POLESKY AH, 1990, J BIOL CHEM, V265, P14579; SETLOW P, 1972, J BIOL CHEM, V247, P224; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Thompson EHZ, 2002, BIOCHEMISTRY-US, V41, P713, DOI 10.1021/bi0114271; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; Tleugabulova D, 2007, BIOCHEMISTRY-US, V46, P6559, DOI 10.1021/bi700380a; Turner RM, 2003, BIOCHEMISTRY-US, V42, P2373, DOI 10.1021/bi026566c	48	19	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17180	17193		10.1074/jbc.M109.007641	http://dx.doi.org/10.1074/jbc.M109.007641			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19411253	Green Published, hybrid			2022-12-25	WOS:000266962400056
J	Frey, T; De Maio, A				Frey, Tiffany; De Maio, Antonio			The Antifungal Agent Itraconazole Induces the Accumulation of High Mannose Glycoproteins in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED GLYCOSYLATION; SECRETORY PATHWAY; INHIBITION; CD14; LYMPHOCYTE; ACTIVATION; BACTERIA; CALCIUM; LPS	Bacterial lipopolysaccharide (LPS) is a key mediator in the development of Gram-negative septic shock, which is a major health problem. The effect of LPS on myeloid cells is mediated by a multicomplex receptor system in which CD14, a glycosylphosphatidylinositol-anchored glycoprotein, and Toll-like receptor 4 are the major players. We have found that incubation of macrophages with itraconazole (ICZ), an azole antifungal commonly used in humans, altered both the expression and glycosylation of CD14. This glycoprotein, which is endo H-resistant in untreated cells, becomes endo H-sensitive following ICZ treatment. The effect of ICZ on glycan processing was observed in all newly synthesized glycoproteins as indicated by incorporation of [2-H-3] mannose. In addition, cells treated with ICZ increased surface concanavalin A (ConA) binding, corroborating an increase in high mannose surface glycoproteins. Although the glycosylation pattern of CD14 was altered, this glycoprotein was delivered to the cell surface or was secreted. Moreover, it appeared functional as demonstrated by the release of LPS-induced tumor necrosis factor-alpha under conditions specific for a CD14-mediated activation process. The effect of ICZ on glycosylation was not dependent on inhibition of the cholesterol biosynthetic pathway and was specific for this drug because other azole antifungals, such as ketoconazole and econazole, did not alter glycan processing. These results suggest a possible secondary effect of ICZ that impacts the processing of glyconjugates and may alter cellular function and homeostasis.	[De Maio, Antonio] Univ Calif San Diego, Sch Med, Dept Surg, La Jolla, CA 92093 USA; [De Maio, Antonio] Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21205 USA; [De Maio, Antonio] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	University of California System; University of California San Diego; Johns Hopkins University; Johns Hopkins University	De Maio, A (corresponding author), 9500 Gilman Dr 0739, La Jolla, CA 92093 USA.	ademaio@ucsd.edu			National Institutes of Health Grant NIGMS [GM 073825, GM05078]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073825] Funding Source: NIH RePORTER	National Institutes of Health Grant NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant NIGMS Grants GM 073825 and GM05078.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; BRUMMER E, 1992, ANTIMICROB AGENTS CH, V36, P2487, DOI 10.1128/AAC.36.11.2487; Chong CR, 2007, ACS CHEM BIOL, V2, P263, DOI 10.1021/cb600362d; Chui D, 2001, P NATL ACAD SCI USA, V98, P1142, DOI 10.1073/pnas.98.3.1142; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; DEMAIO A, 1986, CELL IMMUNOL, V99, P345, DOI 10.1016/0008-8749(86)90243-1; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; Frey T, 2007, MOL MED, V13, P592, DOI 10.2119/2007-00054.Frey; Green RS, 2007, IMMUNITY, V27, P308, DOI 10.1016/j.immuni.2007.06.008; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Kageyama S., 1999, J Infect Chemother, V5, P213, DOI 10.1007/s101560050038; KAUFMAN RJ, 1994, BIOCHEMISTRY-US, V33, P9813, DOI 10.1021/bi00199a001; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; KUZNETSOV G, 1993, J BIOL CHEM, V268, P2001; Lowe JB, 2001, CELL, V104, P809, DOI 10.1016/S0092-8674(01)00277-X; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Marques SA, 2008, MED MYCOL, V46, P725, DOI 10.1080/13693780802247736; Meng J, 2008, J BIOL CHEM, V283, P3376, DOI 10.1074/jbc.M707640200; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; Ochi H, 1998, FEMS IMMUNOL MED MIC, V20, P181, DOI 10.1111/j.1574-695X.1998.tb01126.x; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Steel HC, 2007, CLIN EXP IMMUNOL, V150, P144, DOI 10.1111/j.1365-2249.2007.03470.x; Togayachi A, 2007, P NATL ACAD SCI USA, V104, P15829, DOI 10.1073/pnas.0707426104; VARKI A, 1994, METHOD ENZYMOL, V230, P16; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Zonios DI, 2008, SEMIN RESP CRIT CARE, V29, P198, DOI 10.1055/s-2008-1063858	30	11	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16882	16890		10.1074/jbc.M109.007609	http://dx.doi.org/10.1074/jbc.M109.007609			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19414590	Green Published, hybrid			2022-12-25	WOS:000266962400024
J	Quaye, O; Cowins, S; Gadda, G				Quaye, Osbourne; Cowins, Sharonda; Gadda, Giovanni			Contribution of Flavin Covalent Linkage with Histidine 99 to the Reaction Catalyzed by Choline Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPTOPHAN 7-HALOGENASE PRNA; ACCUMULATE GLYCINE BETAINE; HYDRIDE TRANSFER-REACTION; GLUCOSE-OXIDASE; DIHYDROOROTATE DEHYDROGENASE; CHOLESTEROL OXIDASE; LACTOCOCCUS-LACTIS; CRYSTAL-STRUCTURE; ABIOTIC-STRESS; GLUCOOLIGOSACCHARIDE OXIDASE	The FAD-dependent choline oxidase has a flavin cofactor covalently attached to the protein via histidine 99 through an 8 alpha-N(3)-histidyl linkage. The enzyme catalyzes the four-electron oxidation of choline to glycine betaine, forming betaine aldehyde as an enzyme-bound intermediate. The variant form of choline oxidase in which the histidine residue has been replaced with asparagine was used to investigate the contribution of the 8 alpha-N(3)-histidyl linkage of FAD to the protein toward the reaction catalyzed by the enzyme. Decreases of 10-fold and 30-fold in the k(cat)/K-m and k(cat) values were observed as compared with wild-type choline oxidase at pH 10 and 25 degrees C, with no significant effect on k(cat)/K-O using choline as substrate. Both the k(cat)/K-m and kcat values increased with increasing pH to limiting values at high pH consistent with the participation of an unprotonated group in the reductive half-reaction and the overall turnover of the enzyme. The pH independence of both (D)(k(cat)/K-m) and (D)k(cat), with average values of 9.2 +/- 3.3 and 7.4 +/- 0.5, respectively, is consistent with absence of external forward and reverse commitments to catalysis, and the chemical step of CH bond cleavage being rate-limiting for both the reductive half-reaction and the overall enzyme turnover. The temperature dependence of the (D)k(red) values suggests disruption of the preorganization in the asparagine variant enzyme. Altogether, the data presented in this study are consistent with the FAD-histidyl covalent linkage being important for the optimal positioning of the hydride ion donor and acceptor in the tunneling reaction catalyzed by choline oxidase.	[Gadda, Giovanni] Georgia State Univ, Dept Chem, Atlanta, GA 30302 USA; [Gadda, Giovanni] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA; [Gadda, Giovanni] Georgia State Univ, Ctr Biotechnol & Drug Design, Atlanta, GA 30302 USA; [Cowins, Sharonda] Albany State Univ, Dept Chem, Albany, GA 31705 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Albany State University	Gadda, G (corresponding author), Georgia State Univ, Dept Chem, POB 4098, Atlanta, GA 30302 USA.	ggadda@gsu.edu	Gadda, Giovanni/M-2354-2016	Gadda, Giovanni/0000-0002-7508-4195; Quaye, Osbourne/0000-0002-0621-876X	National Science Foundation [MCB-0545712]	National Science Foundation(National Science Foundation (NSF))	This work was supported in part by a National Science Foundation Career Award (Grant MCB-0545712 to G. G.).	Ballou DP, 2005, BIOCHEM BIOPH RES CO, V338, P590, DOI 10.1016/j.bbrc.2005.09.081; Basran J, 2003, J BIOL CHEM, V278, P43973, DOI 10.1074/jbc.M305983200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caldinelli L, 2005, J BIOL CHEM, V280, P22572, DOI 10.1074/jbc.M500549200; Caldinelli L, 2008, PROTEIN SCI, V17, P409, DOI 10.1110/ps.073137708; Chen THH, 2002, CURR OPIN PLANT BIOL, V5, P250, DOI 10.1016/S1369-5266(02)00255-8; Chen XP, 2008, ACTA BIOCH BIOPH SIN, V40, P183, DOI 10.1111/j.1745-7270.2008.00390.x; CLELAND WW, 1982, METHOD ENZYMOL, V87, P390; COOK PF, 1980, BIOCHEMISTRY-US, V19, P4853, DOI 10.1021/bi00562a023; Cui Q, 2002, J AM CHEM SOC, V124, P3093, DOI 10.1021/ja0118439; Dong CJ, 2005, SCIENCE, V309, P2216, DOI 10.1126/science.1116510; EMANUELE JJ, 1995, BIOCHEMISTRY-US, V34, P3710, DOI 10.1021/bi00011a028; Fagan RL, 2006, BIOCHEMISTRY-US, V45, P14926, DOI 10.1021/bi060919g; Fan F, 2005, J AM CHEM SOC, V127, P17954, DOI 10.1021/ja0560377; Fan F, 2005, J AM CHEM SOC, V127, P2067, DOI 10.1021/ja044541q; Fan F, 2004, ARCH BIOCHEM BIOPHYS, V421, P149, DOI 10.1016/j.abb.2003.10.003; Fan F, 2006, BIOCHEMISTRY-US, V45, P1979, DOI 10.1021/bi0517537; Fan F, 2007, BIOCHEMISTRY-US, V46, P6402, DOI 10.1021/bi700255v; Finnegan S, 2008, BIOCHEMISTRY-US, V47, P13850, DOI 10.1021/bi801424p; Fraaije MW, 1999, J BIOL CHEM, V274, P35514, DOI 10.1074/jbc.274.50.35514; Gadda G, 2004, ARCH BIOCHEM BIOPHYS, V430, P264, DOI 10.1016/j.abb.2004.07.011; Gadda G, 2003, BBA-PROTEINS PROTEOM, V1650, P4, DOI 10.1016/S1570-9639(03)00188-2; Gadda G, 2008, BIOCHEMISTRY-US, V47, P13745, DOI 10.1021/bi801994c; Ghanem M, 2005, BIOCHEMISTRY-US, V44, P893, DOI 10.1021/bi048056j; Ghanem M, 2006, BIOCHEMISTRY-US, V45, P3437, DOI 10.1021/bi052514m; Ghanem M, 2003, BIOCHEMISTRY-US, V42, P15179, DOI 10.1021/bi035435o; Hassan-Abdallah A, 2006, BIOCHEMISTRY-US, V45, P9454, DOI 10.1021/bi0607352; Heuts DPHM, 2008, BIOCHEM J, V413, P175, DOI 10.1042/BJ20071591; Huang CH, 2005, J BIOL CHEM, V280, P38831, DOI 10.1074/jbc.M506078200; HUANG CH, 2008, J BIOL CHEM, V0283; Joosten V, 2007, CURR OPIN CHEM BIOL, V11, P195, DOI 10.1016/j.cbpa.2007.01.010; Keller S, 2000, ANGEW CHEM INT EDIT, V39, P2300, DOI 10.1002/1521-3773(20000703)39:13<2300::AID-ANIE2300>3.0.CO;2-I; Kim J, 1995, J BIOL CHEM, V270, P31202, DOI 10.1074/jbc.270.52.31202; Kohen A, 1997, BIOCHEMISTRY-US, V36, P2603, DOI 10.1021/bi962492r; Lee MH, 2005, APPL ENVIRON MICROB, V71, P8881, DOI 10.1128/AEM.71.12.8881-8887.2005; Malmquist NA, 2008, BIOCHEMISTRY-US, V47, P2466, DOI 10.1021/bi702218c; Marcus RA, 2006, PHILOS T R SOC B, V361, P1445, DOI 10.1098/rstb.2006.1873; Mewies M, 1998, PROTEIN SCI, V7, P7, DOI 10.1002/pro.5560070102; Motteran L, 2001, J BIOL CHEM, V276, P18024, DOI 10.1074/jbc.M010953200; Nagel ZD, 2006, CHEM REV, V106, P3095, DOI 10.1021/cr050301x; O'Callaghan J, 2000, INT J FOOD MICROBIOL, V55, P127, DOI 10.1016/S0168-1605(00)00168-9; Orville AM, 2009, BIOCHEMISTRY-US, V48, P720, DOI 10.1021/bi801918u; Pang JY, 2008, J AM CHEM SOC, V130, P7092, DOI 10.1021/ja800471f; Peddie BA, 1996, J LAB CLIN MED, V128, P417, DOI 10.1016/S0022-2143(96)80014-X; Quan RD, 2004, PLANT BIOTECHNOL J, V2, P477, DOI 10.1111/j.1467-7652.2004.00093.x; Quaye O, 2008, BIOCHEMISTRY-US, V47, P243, DOI 10.1021/bi7017943; Rand T, 2006, FEBS J, V273, P2693, DOI 10.1111/j.1742-4658.2006.05285.x; Rontein D, 2002, METAB ENG, V4, P49, DOI 10.1006/mben.2001.0208; Roth JP, 2003, P NATL ACAD SCI USA, V100, P62, DOI 10.1073/pnas.252644599; Rowland P, 1997, STRUCTURE, V5, P239, DOI 10.1016/S0969-2126(97)00182-2; Rowland P, 1998, PROTEIN SCI, V7, P1269, DOI 10.1002/pro.5560070601; Rungsrisuriyachai K, 2008, BIOCHEMISTRY-US, V47, P6762, DOI 10.1021/bi800650w; Sanchez-Aguayo I, 2004, PLANTA, V220, P278, DOI 10.1007/s00425-004-1350-2; Seymour SL, 2002, BIOCHEMISTRY-US, V41, P8747, DOI 10.1021/bi020054g; Sharma SC, 2008, J AM CHEM SOC, V130, P17632, DOI 10.1021/ja806354w; Shirasawa K, 2006, ANN BOT-LONDON, V98, P565, DOI 10.1093/aob/mcl126; Su QJ, 1999, BIOCHEMISTRY-US, V38, P8572, DOI 10.1021/bi990044o; Sygmund C, 2008, J BIOTECHNOL, V133, P334, DOI 10.1016/j.jbiotec.2007.10.013; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; van Pee KH, 2006, APPL MICROBIOL BIOT, V70, P631, DOI 10.1007/s00253-005-0232-2; Velasco-Garcia R, 2003, CHEM-BIOL INTERACT, V143, P149, DOI 10.1016/S0009-2797(02)00199-0; Waditee R, 2005, P NATL ACAD SCI USA, V102, P1318, DOI 10.1073/pnas.0409017102; Waditee R, 2007, J BIOL CHEM, V282, P34185, DOI 10.1074/jbc.M704939200; WINKKLER A, 2008, NAT CHEM BIOL; Winkler A, 2007, J BIOL CHEM, V282, P24437, DOI 10.1074/jbc.M703642200; Winkler A, 2006, J BIOL CHEM, V281, P21276, DOI 10.1074/jbc.M603267200; Wong CM, 2008, APPL MICROBIOL BIOT, V78, P927, DOI 10.1007/s00253-008-1407-4; Zamocky M, 2006, CURR PROTEIN PEPT SC, V7, P255, DOI 10.2174/138920306777452367; Ziegler DM, 2002, DRUG METAB REV, V34, P503, DOI 10.1081/DMR-120005650	69	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16990	16997		10.1074/jbc.M109.003715	http://dx.doi.org/10.1074/jbc.M109.003715			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19398559	Green Published, hybrid			2022-12-25	WOS:000266962400036
J	Morrison, BH; Haney, R; Lamarre, E; Drazba, J; Prestwich, GD; Lindner, DJ				Morrison, B. H.; Haney, R.; Lamarre, E.; Drazba, J.; Prestwich, G. D.; Lindner, D. J.			Gene deletion of inositol hexakisphosphate kinase 2 predisposes to aerodigestive tract carcinoma	ONCOGENE			English	Article						inositol hexakisphosphate kinase 2; chemical carcinogenesis; ionizing radiation; proliferation; inositol polyphosphates; apoptosis	DNA-PK; PYROPHOSPHATES; PHOSPHATE; HEAD; 3P; 12P12-13; GROWTH; ASSAY; BETA; KU	Inositol hexakisphosphate kinase 2 (IP6K2), a member of the inositol hexakisphosphate kinase family, functions as a growth suppressive and apoptosis-enhancing kinase during cell stress. We created mice with a targeted deletion of IP6K2; these mice display normal embryogenesis, development, growth and fertility. Chronic exposure to the carcinogen 4-nitroquinoline 1-oxide (4-NQO, a UV-mimetic compound) in drinking water resulted in fourfold increased incidence of invasive squamous cell carcinoma (SCC) formation in the oral cavity and esophagus of the knockout (KO) mice compared to the wild-type (WT) littermates. Paradoxically, KO mice displayed relative resistance to ionizing radiation and exhibit enhanced survival following 8-10 Gy total body irradiation. Primary KO fibroblasts displayed resistance to antiproliferative effects of interferon-beta and increased colony forming units following ionizing radiation. Radioresistance of KO fibroblasts was associated with accelerated DNA repair measured by comet assay. Direct microinjection of 5-PP-Ins(1,2,3,4,6) P-5 (the enzymatic product of IP6K2), but not InsP(6) (the substrate of IP6K2) induced cell death in SCC22A squamous carcinoma cells. Oncogene (2009) 28, 2383-2392; doi:10.1038/onc.2009.113; published online 11 May 2009	[Lindner, D. J.] Cleveland Clin, Ctr Hematol & Oncol Mol Therapeut, Dept Translat Hematol & Oncol Res, Taussig Canc Inst, Cleveland, OH 44195 USA; [Lamarre, E.] Cleveland Clin, Head & Neck Inst, Cleveland, OH 44195 USA; [Drazba, J.] Cleveland Clin, Res Core Adm, Cleveland, OH 44195 USA; [Prestwich, G. D.] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA; [Lindner, D. J.] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Utah System of Higher Education; University of Utah; Cleveland Clinic Foundation	Lindner, DJ (corresponding author), Cleveland Clin, Ctr Hematol & Oncol Mol Therapeut, Dept Translat Hematol & Oncol Res, Taussig Canc Inst, 9500 Euclid Ave,R40, Cleveland, OH 44195 USA.	lindned@ccf.org	Lindner, Daniel/ABB-5440-2020		NIH/NCI [CA095020]; NIH [NS29632]; NATIONAL CANCER INSTITUTE [R01CA095020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029632] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Philip Sanford, University of Cincinnati, for design of targeting vector and creation of IHPK2 knockout mice. Donna Kusewitt, Ohio State University, Director, Mouse Phenotyping Shared Resource, kusewitt. 1@osu.edu, conducted the phenotyping studies. Judy Drazba, Cleveland Clinic Imaging Core, performed the time-lapse photography of microinjected cells. Dr Yong Xu, Dr Honglu Zhang and Dr Jianxing Zhang performed the synthesis of 5-PP-Ins( 1,2,3,4,6)P<INF>5</INF>. These studies were supported by grants from NIH/NCI (CA095020) to DJL and from NIH (NS29632) to GDP.	Bhandari R, 2008, P NATL ACAD SCI USA, V105, P2349, DOI 10.1073/pnas.0712227105; Bhandari R, 2007, P NATL ACAD SCI USA, V104, P15305, DOI 10.1073/pnas.0707338104; Byrum J, 2004, NUCLEIC ACIDS RES, V32, P2776, DOI 10.1093/nar/gkh592; Chakraborty SB, 2003, CANCER GENET CYTOGEN, V146, P130, DOI 10.1016/S0165-4608(03)00127-4; Cheung JCY, 2008, NUCLEIC ACIDS RES, V36, P5713, DOI 10.1093/nar/gkn572; Fridy PC, 2007, J BIOL CHEM, V282, P30754, DOI 10.1074/jbc.M704656200; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; HAWKINS BL, 1994, HEAD NECK-J SCI SPEC, V16, P424, DOI 10.1002/hed.2880160506; HECHT JT, 1995, AM J HUM GENET, V56, P1125; Hoornaert I, 2003, ONCOGENE, V22, P7728, DOI 10.1038/sj.onc.1207089; Illies C, 2007, SCIENCE, V318, P1299, DOI 10.1126/science.1146824; Kawata T, 2005, RADIAT RES, V164, P509, DOI 10.1667/RR3382.1; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kibel AS, 2004, INT J CANCER, V109, P668, DOI 10.1002/ijc.20060; KOK K, 1987, NATURE, V330, P578, DOI 10.1038/330578a0; LI XH, 1994, J NATL CANCER I, V86, P1524, DOI 10.1093/jnci/86.20.1524; Lu BJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-40; Luo HBR, 2003, CELL, V114, P559, DOI 10.1016/S0092-8674(03)00640-8; MA Y, 2002, J BIOL CHEM, V30, P30; MAESTRO R, 1993, CANCER RES, V53, P5775; Magnusdottir E, 2007, P NATL ACAD SCI USA, V104, P14988, DOI 10.1073/pnas.0707323104; Morrison BH, 2002, ONCOGENE, V21, P1882, DOI 10.1038/sj.onc.1205265; Morrison BH, 2001, J BIOL CHEM, V276, P24965, DOI 10.1074/jbc.M101161200; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Nagata E, 2005, J BIOL CHEM, V280, P1634, DOI 10.1074/jbc.M409416200; PANIGRAHI GB, 1990, BIOCHEMISTRY-US, V29, P2122, DOI 10.1021/bi00460a023; Pogach MS, 2007, J CELL BIOCHEM, V100, P1415, DOI 10.1002/jcb.21142; RASKIND WH, 1995, AM J HUM GENET, V56, P1132; Saiardi A, 2005, P NATL ACAD SCI USA, V102, P1911, DOI 10.1073/pnas.0409322102; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Shears SB, 2004, BIOCHEM J, V377, P265, DOI 10.1042/BJ20031428; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Teng CH, 2007, J BIOL CHEM, V282, P28395, DOI 10.1074/jbc.M705142200; Wojewodzka M, 2002, MUTAT RES-GEN TOX EN, V518, P9, DOI 10.1016/S1383-5718(02)00070-0; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200; Zhang HL, 2009, ORG LETT, V11, P1551, DOI 10.1021/ol900149x	37	56	56	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2009	28	25					2383	2392		10.1038/onc.2009.113	http://dx.doi.org/10.1038/onc.2009.113			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	462HS	19430495	Green Accepted			2022-12-25	WOS:000267342400003
J	Velazquez-Perez, L; Diaz, R; Perez-Gonzalez, R; Canales, N; Rodriguez-Labrada, R; Medrano, J; Sanchez, G; Almaguer-Mederos, L; Torres, C; Fernandez-Ruiz, J				Velazquez-Perez, Luis; Diaz, Rosalinda; Perez-Gonzalez, Ruth; Canales, Nalia; Rodriguez-Labrada, Roberto; Medrano, Jacquelin; Sanchez, Gilberto; Almaguer-Mederos, Luis; Torres, Cira; Fernandez-Ruiz, Juan			Motor Decline in Clinically Presymptomatic Spinocerebellar Ataxia Type 2 Gene Carriers	PLOS ONE			English	Article								Background: Motor deficits are a critical component of the clinical characteristics of patients with spinocerebellar ataxia type 2. However, there is no current information on the preclinical manifestation of those motor deficits in presymptomatic gene carriers. To further understand and characterize the onset of the clinical manifestation in this disease, we tested presymptomatic spinocerebellar ataxia type 2 gene carriers, and volunteers, in a task that evaluates their motor performance and their motor learning capabilities. Methods and Findings: 28 presymptomatic spinocerebellar ataxia type 2 gene carriers and an equal number of control volunteers matched for age and gender participated in the study. Both groups were tested in a prism adaptation task known to be sensible to both motor performance and visuomotor learning deficits. Our results clearly show that although motor learning capabilities are intact, motor performance deficits are present even years before the clinical manifestation of the disease start. Conclusions: The results show a clear deficit in motor performance that can be detected years before the clinical onset of the disease. This motor performance deficit appears before any motor learning or clinical manifestations of the disease. These observations identify the performance coefficient as an objective and quantitative physiological biomarker that could be useful to assess the efficiency of different therapeutic agents.			Velazquez-Perez, L (corresponding author), Ctr Invest & Rehabil Ataxias Hereditarias, Holguin, Cuba.	jfr@servidor.unam.mx	Mederos, Luis Almaguer/G-8625-2016; Velázquez-Pérez, Luis/AAM-4460-2020; RodrÃguez-Labrada, Roberto/AAM-1692-2020; Fernandez-Ruiz, Juan/B-6154-2012	Mederos, Luis Almaguer/0000-0003-0887-2359; Fernandez-Ruiz, Juan/0000-0002-4038-0904; Rodriguez-Labrada, Roberto/0000-0003-3193-7683				Blekher TM, 2004, VISION RES, V44, P2729, DOI 10.1016/j.visres.2004.06.006; Christova P, 2008, ARCH NEUROL-CHICAGO, V65, P530, DOI 10.1001/archneur.65.4.530; deBoo GM, 1997, ARCH NEUROL-CHICAGO, V54, P1353, DOI 10.1001/archneur.1997.00550230030012; Denny-Brown D., 1982, HDB NEUROLOGICAL EXA; Durr A, 1995, BRAIN, V118, P1573, DOI 10.1093/brain/118.6.1573; Farrow M, 2006, COGN BEHAV NEUROL, V19, P208, DOI 10.1097/01.wnn.0000213914.64772.b6; Feigin A, 2006, ANN NEUROL, V59, P53, DOI 10.1002/ana.20684; Fernandez-Ruiz J, 1999, LEARN MEMORY, V6, P47; Fernandez-Ruiz J, 2003, NEUROREPORT, V14, P1339, DOI 10.1097/01.wnr.0000077551.91466.d3; Fernandez-Ruiz J, 2007, NEUROPSYCHOLOGIA, V45, P2692, DOI 10.1016/j.neuropsychologia.2007.04.006; Fox NC, 1998, BRAIN, V121, P1631, DOI 10.1093/brain/121.9.1631; Geschwind DH, 1997, AM J HUM GENET, V60, P842; Globas C, 2008, MOVEMENT DISORD, V23, P2232, DOI 10.1002/mds.22288; Inagaki A, 2005, EUR J NEUROL, V12, P725, DOI 10.1111/j.1468-1331.2005.01011.x; Larsson M, 2006, J CLIN EXP NEUROPSYC, V28, P1373, DOI 10.1080/13803390500473746; Martin TA, 1996, BRAIN, V119, P1183, DOI 10.1093/brain/119.4.1183; OROZCO G, 1989, J NEUROL SCI, V93, P37, DOI 10.1016/0022-510X(89)90159-7; Pang JT, 2002, BRAIN, V125, P656, DOI 10.1093/brain/awf060; Perez LV, 2007, J NEUROL SCI, V263, P158, DOI 10.1016/j.jns.2007.07.013; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Rosa AL, 2006, MOVEMENT DISORD, V21, P66, DOI 10.1002/mds.20636; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Schols L, 2004, LANCET NEUROL, V3, P291, DOI 10.1016/S1474-4422(04)00737-9; Siemers E, 1996, ARCH NEUROL-CHICAGO, V53, P487, DOI 10.1001/archneur.1996.00550060029011; Smith MA, 2000, NATURE, V403, P544, DOI 10.1038/35000576; Velazquez-Perez L, 2004, ANN NEUROL, V56, P444, DOI 10.1002/ana.20220; Velazquez-Perez L, 2006, J NEUROL, V253, P1165, DOI 10.1007/s00415-006-0183-2; Verny C, 2007, EUR J NEUROL, V14, P1344, DOI 10.1111/j.1468-1331.2007.01975.x; Wahlin TBR, 2007, NEUROPSYCHOLOGY, V21, P31, DOI 10.1037/0894-4105.21.1.31; Wolf RC, 2007, BRAIN, V130, P2845, DOI 10.1093/brain/awm210	30	18	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5398	10.1371/journal.pone.0005398	http://dx.doi.org/10.1371/journal.pone.0005398			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401771	gold, Green Published, Green Submitted			2022-12-25	WOS:000265601100025
J	Romanowska, M; Evans, A; Kellock, D; Bray, SE; McLean, K; Donandt, S; Foerster, J				Romanowska, Malgorzata; Evans, Alan; Kellock, David; Bray, Susan E.; McLean, Kathleen; Donandt, Susanne; Foerster, John			Wnt5a Exhibits Layer-Specific Expression in Adult Skin, Is Upregulated in Psoriasis, and Synergizes with Type 1 Interferon	PLOS ONE			English	Article								Background: Wnt5a is a member of the wingless-type patterning regulators important in pre-natal development. The expression and distribution of Wnt5a and its receptors frizzled (fzd) 3 and fzd 5 in adult human skin have not been comprehensively studied to date. Methodology/Principal Findings: We here show that Wnt5a, fzd3, fzd5, as well as fzd6 are restricted to specific layers in normal epidermis, analogous to their zonal distribution in hair follicles, suggesting a role in adult skin differentiation. In line, Wnt5a and fzd5 are both overexpressed and re-distributed in the epidermis of psoriasis which involves disturbed keratinocyte differentiation. Functionally, Wnt5a lowers the concentration of IFN required to induce target genes, and increases the magnitude of IFN target gene induction, suggesting a molecular mechanism underlying IFN hypersensitivity in psoriasis. Finally, we identify nedd8 and the amyloid precursor APP, previously shown to be upregulated in psoriasis, as targets of synergistic IFN alpha/Wnt5a induction. Conclusions/Significance: The present data (i) suggest that Wnt5a regulates epidermal differentiation even in adult skin and (ii) identify synergistic induction of type 1 IFN target genes as a novel mode of Wnt5a action. Targeting Wnt5a in the skin may reduce IFN hypersensitivity and be of therapeutical value.			Romanowska, M (corresponding author), Univ Dundee, Div Expt Med, Dundee, Scotland.	j.foerster@dundee.ac.uk			Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Al Yacoub N, 2007, J GENE MED, V9, P579, DOI 10.1002/jgm.1052; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Boyman O, 2004, J EXP MED, V199, P731, DOI 10.1084/jem.20031482; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Cheng CW, 2008, BIOCHEM BIOPH RES CO, V365, P285, DOI 10.1016/j.bbrc.2007.10.166; Downs AMR, 2000, CLIN EXP DERMATOL, V25, P351, DOI 10.1046/j.1365-2230.2000.00655-4.x; Eriksen KW, 2005, J INVEST DERMATOL, V125, P936, DOI 10.1111/j.0022-202X.2005.23864.x; Fathke C, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-4; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Haider AS, 2006, J INVEST DERMATOL, V126, P869, DOI 10.1038/sj.jid.5700157; Hampton PJ, 2007, BRIT J DERMATOL, V157, P1168, DOI 10.1111/j.1365-2133.2007.08195.x; Herzog V, 2004, EUR J CELL BIOL, V83, P613, DOI 10.1078/0171-9335-00401; Hida S, 2000, IMMUNITY, V13, P643, DOI 10.1016/S1074-7613(00)00064-9; Hung BS, 2001, J INVEST DERMATOL, V116, P940, DOI 10.1046/j.1523-1747.2001.01336.x; Ito M, 2004, J DERMATOL SCI, V36, P157, DOI 10.1016/j.jdermsci.2004.08.012; Katoh M, 2007, INT J MOL MED, V19, P273; KAWASAKI A, 2007, CELL SIGNAL; Kowalzick L, 1997, J AM ACAD DERMATOL, V36, P501, DOI 10.1016/S0190-9622(97)80248-4; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Murphy LLS, 2002, J IMMUNOL, V169, P3717, DOI 10.4049/jimmunol.169.7.3717; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Reddy ST, 2004, J INVEST DERMATOL, V123, P275, DOI 10.1111/j.0022-202X.2004.23215.x; Reischl J, 2007, J INVEST DERMATOL, V127, P163, DOI 10.1038/sj.jid.5700488; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Romanowska M, 2008, J INVEST DERMATOL, V128, P110, DOI 10.1038/sj.jid.5700943; Safholm A, 2006, J BIOL CHEM, V281, P2740, DOI 10.1074/jbc.M508386200; Safholm A, 2008, CLIN CANCER RES, V14, P6556, DOI 10.1158/1078-0432.CCR-08-0711; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Sen M, 2001, ARTHRITIS RHEUM, V44, P772, DOI 10.1002/1529-0131(200104)44:4<772::AID-ANR133>3.3.CO;2-C; Siemes C, 2004, J INVEST DERMATOL, V123, P556, DOI 10.1111/j.0022-202X.2004.23320.x; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Wang S, 2004, FOREST POLICY ECON, V6, P205, DOI 10.1016/j.forpol.2004.03.004; Wolf R, 1999, ADV EXP MED BIOL, V455, P221; YU JM, 2007, CANC LETT	38	49	53	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5354	10.1371/journal.pone.0005354	http://dx.doi.org/10.1371/journal.pone.0005354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399181	gold, Green Submitted, Green Published			2022-12-25	WOS:000265514900014
J	MacKenzie, S; Ribas, L; Pilarczyk, M; Capdevila, DM; Kadri, S; Huntingford, FA				MacKenzie, Simon; Ribas, Laia; Pilarczyk, Maciej; Capdevila, Davinia Morera; Kadri, Sunil; Huntingford, Felicity A.			Screening for Coping Style Increases the Power of Gene Expression Studies	PLOS ONE			English	Article							BEHAVIORAL SYNDROMES; FISH; TEMPERAMENT; STRESS	Background: Individuals of many vertebrate species show different stress coping styles and these have a striking influence on how gene expression shifts in response to a variety of challenges. Principal Findings: This is clearly illustrated by a study in which common carp displaying behavioural predictors of different coping styles (characterised by a proactive, adrenaline-based or a reactive, cortisol-based response) were subjected to inflammatory challenge and specific gene transcripts measured in individual brains. Proactive and reactive fish differed in baseline gene expression and also showed diametrically opposite responses to the challenge for 80% of the genes investigated. Significance: Incorporating coping style as an explanatory variable can account for some the unexplained variation that is common in gene expression studies, can uncover important effects that would otherwise have passed unnoticed and greatly enhances the interpretive value of gene expression data.			MacKenzie, S (corresponding author), Univ Autonoma Barcelona, Unitat Fisiol Anim, Dept Biol Cellular Fisiol & Immunol, Fac Biociencies, E-08193 Barcelona, Spain.	Simon.MacKenzie@uab.es	MacKenzie, Simon/Q-2362-2019; Ribas, Laia/E-1466-2013	MacKenzie, Simon/0000-0003-1845-6826; Ribas, Laia/0000-0001-5538-6236				Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; BENUS RF, 1991, EXPERIENTIA, V47, P1008, DOI 10.1007/BF01923336; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; Cossins AR, 2005, NAT REV GENET, V6, P324, DOI 10.1038/nrg1590; Crawford DL, 2007, J EXP BIOL, V210, P1613, DOI 10.1242/jeb.005454; Cubitt K.F., 2008, PHYSL BEHAV; Garcia-Castillo J, 2002, IMMUNOGENETICS, V54, P200, DOI 10.1007/s00251-002-0451-y; Goetz FW, 2008, FISH FISH, V9, P378, DOI 10.1111/j.1467-2979.2008.00301.x; HESSING MJC, 1993, APPL ANIM BEHAV SCI, V37, P285, DOI 10.1016/0168-1591(93)90118-9; Iliev DB, 2005, FEBS LETT, V579, P6519, DOI 10.1016/j.febslet.2005.10.061; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Larsen PF, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-12; Larsen PF, 2007, MOL ECOL, V16, P4674, DOI 10.1111/j.1365-294X.2007.03530.x; MacKenzie S, 2004, IMMUNOGENETICS, V56, P611, DOI 10.1007/s00251-004-0698-6; Malmkvist J, 2002, ANIM BEHAV, V64, P487, DOI 10.1006/anbe.2002.3058; Martin JGA, 2008, ANIM BEHAV, V75, P309, DOI 10.1016/j.anbehav.2007.05.026; Oleksiak MF, 2005, NAT GENET, V37, P67, DOI 10.1038/ng1483; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Overli O, 2006, PHYSIOL BEHAV, V87, P506, DOI 10.1016/j.physbeh.2005.11.012; Overli O, 2007, NEUROSCI BIOBEHAV R, V31, P396, DOI 10.1016/j.neubiorev.2006.10.006; Reale D, 2000, ANIM BEHAV, V60, P589, DOI 10.1006/anbe.2000.1530; Reale D, 2003, ANIM BEHAV, V65, P463, DOI 10.1006/anbe.2003.2100; Saeij JPJ, 2003, DEV COMP IMMUNOL, V27, P29, DOI 10.1016/S0145-305X(02)00064-2; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; van Hierden YM, 2002, APPL ANIM BEHAV SCI, V77, P183, DOI 10.1016/S0168-1591(02)00046-1; Whitehead A, 2006, P NATL ACAD SCI USA, V103, P5425, DOI 10.1073/pnas.0507648103; Whitehead A, 2006, MOL ECOL, V15, P1197, DOI 10.1111/j.1365-294X.2006.02868.x; Whitehead A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r13	29	56	57	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5314	10.1371/journal.pone.0005314	http://dx.doi.org/10.1371/journal.pone.0005314			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390591	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000265514200024
J	Aubry, S; Burlina, F; Dupont, E; Delaroche, D; Joliot, A; Lavielle, S; Chassaing, G; Sagan, S				Aubry, Soline; Burlina, Fabienne; Dupont, Edmond; Delaroche, Diane; Joliot, Alain; Lavielle, Solange; Chassaing, Gerard; Sagan, Sandrine			Cell-surface thiols affect cell entry of disulfide-conjugated peptides	FASEB JOURNAL			English	Article						CPP; redox potential; MALDI-TOF MS	TOF MASS-SPECTROMETRY; PENETRATING PEPTIDES; DEPENDENT TRANSLOCATION; DRUG-DELIVERY; IN-VIVO; INHIBITION; PROTEIN; MEMBRANE; BONDS; QUANTIFICATION	Cell-penetrating peptides (CPPs) can cross the cell membrane and are widely used to deliver bioactive cargoes inside cells. The cargo and the CPP are often conjugated through a disulfide bridge with the common acceptation that this linker is stable in the extracellular biological medium and should not perturb the internalization process. However, with the use of thiol-specific reagents combined with mass spectrometry (as a quantitative method to measure intracellular concentrations of peptides) and confocal microscopy (as a qualitative method to visualize internalized peptides) analyses, we could show that, depending on the peptide sequence, thiol/disulfide exchange reactions could happen at the cell surface. These exchange reactions lead to the reduction of disulfide conjugates. In addition, it was observed that not only disulfide-but also thiol-containing peptides could cross-react with cell-surface thiols. The peptides cross-linked by thiol-containing membrane proteins were either trapped in the membrane or further internalized. Therefore, a new route of cellular uptake was unveiled that is not restricted to CPPs: a protein kinase C peptide inhibitor that is not cell permeant could cross cell membranes when an activated cysteine (with a 3-nitro-2-pyridinesulfenyl moiety) was introduced in its sequence.-Aubry, S., Burlina, F., Dupont, E., Delaroche, D., Joliot, A., Lavielle, S., Chassaing, G., Sagan, S. Cell-surface thiols affect cell entry of disulfide-conjugated peptides. FASEB J. 23, 2956-2967 (2009). www.fasebj.org	[Aubry, Soline; Burlina, Fabienne; Delaroche, Diane; Lavielle, Solange; Chassaing, Gerard; Sagan, Sandrine] Univ Paris 06, UMR 7613, F-75005 Paris, France; [Dupont, Edmond; Joliot, Alain] Ecole Normale Super, CNRS, UMR 8542, Paris, France; [Aubry, Soline; Burlina, Fabienne; Delaroche, Diane; Lavielle, Solange; Chassaing, Gerard; Sagan, Sandrine] CNRS, UMR 7613, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS)	Sagan, S (corresponding author), Univ Paris 06, UMR 7613, Case Courier 182,4 Pl Jussieu, F-75005 Paris, France.	sandrine.sagan@upmc.fr	S, SAGAN/I-8132-2013; s, s/HIK-1178-2022; s, s/GYR-2278-2022; s, s/GVS-3323-2022; s, s/HHD-0404-2022; QI, DANDAN/GVR-9324-2022; SAGAN, Sandrine/AAA-8537-2022	S, SAGAN/0000-0003-0083-4411; Burlina, Fabienne/0000-0002-6042-680X	Agence Nationale pour la Recherche [ANR-06-PCVI-9187]; FRM	Agence Nationale pour la Recherche(French National Research Agency (ANR)); FRM(Fondation pour la Recherche Medicale)	We are grateful to Dr. Gerard Bolbach, Gilles Clodic, and Thierry Blasco from the Mass Spectrometry and Proteomic Plateform, Universite Pierre et Marie Curie, for fruitful discussion. We also thank Dr. Yves Jacquot and Vanessa Point for their assistance in peptide synthesis. This study was supported by Agence Nationale pour la Recherche (project ANR-06-PCVI-9187, ProbDom) and a grant from FRM (S.A.).	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Astriab-Fisher A, 2000, BIOCHEM PHARMACOL, V60, P83, DOI 10.1016/S0006-2952(00)00310-5; Boon JM, 2003, J AM CHEM SOC, V125, P8195, DOI 10.1021/ja029670q; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Boutorine AS, 1990, BIOCONJUGATE CHEM, V1, P350, DOI 10.1021/bc00005a009; BOUTORINE AS, 1993, BIOCHIMIE, V75, P35, DOI 10.1016/0300-9084(93)90022-K; Burlina F, 2005, ANGEW CHEM INT EDIT, V44, P4244, DOI 10.1002/anie.200500477; Burlina F, 2006, NAT PROTOC, V1, P200, DOI 10.1038/nprot.2006.30; BUTTERS TD, 1980, J CELL SCI, V44, P33; CAPOZZI G, 1980, J CHEM SOC PERK T 2, P68, DOI 10.1039/p29800000068; Chaloin L, 1998, BIOCHEM BIOPH RES CO, V243, P601, DOI 10.1006/bbrc.1997.8050; Chen YNP, 1999, P NATL ACAD SCI USA, V96, P4325, DOI 10.1073/pnas.96.8.4325; Cline DJ, 2004, ANAL BIOCHEM, V335, P168, DOI 10.1016/j.ab.2004.07.015; COLLINS DS, 1991, J IMMUNOL, V147, P4054; Delaroche D, 2007, ANAL CHEM, V79, P1932, DOI 10.1021/ac061108l; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; Dom G, 2003, NUCLEIC ACIDS RES, V31, P556, DOI 10.1093/nar/gkg160; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Dupont E, 2007, J BIOL CHEM, V282, P8994, DOI 10.1074/jbc.M609246200; FEENER EP, 1990, J BIOL CHEM, V265, P18780; Fischer R, 2002, BBA-BIOMEMBRANES, V1564, P365, DOI 10.1016/S0005-2736(02)00471-6; Fretz MM, 2007, BIOCHEM J, V403, P335, DOI 10.1042/BJ20061808; Fujimoto K, 2000, CANCER LETT, V159, P151, DOI 10.1016/S0304-3835(00)00536-X; GRINNEL F, 1979, ARCH BIOCHEM BIOPHYS, V153, P193; Hallbrink M, 2001, BBA-BIOMEMBRANES, V1515, P101, DOI 10.1016/S0005-2736(01)00398-4; Henriques ST, 2008, J PEPT SCI, V14, P482, DOI 10.1002/psc.1003; Jiang XM, 1999, J BIOL CHEM, V274, P2416, DOI 10.1074/jbc.274.4.2416; Jones AT, 2008, INT J PHARMACEUT, V354, P34, DOI 10.1016/j.ijpharm.2007.10.046; Kamp D, 2001, BIOCHEMISTRY-US, V40, P9438, DOI 10.1021/bi0107492; KICHLER A, 1995, BIOCHEM BIOPH RES CO, V209, P444, DOI 10.1006/bbrc.1995.1522; LAURIAULT VVM, 1991, MOL PHARMACOL, V40, P125; Loretz B, 2007, BIOCONJUGATE CHEM, V18, P1028, DOI 10.1021/bc0603079; MANDEL R, 1993, P NATL ACAD SCI USA, V90, P4112, DOI 10.1073/pnas.90.9.4112; MAY JM, 1985, J BIOL CHEM, V260, P462; MCABEE DD, 1982, BIOCHEM J, V208, P473, DOI 10.1042/bj2080473; OBERHAUSER B, 1992, NUCLEIC ACIDS RES, V20, P533, DOI 10.1093/nar/20.3.533; Oehlke J, 1998, BBA-BIOMEMBRANES, V1414, P127, DOI 10.1016/S0005-2736(98)00161-8; Plummer JS, 1999, BIOORG MED CHEM LETT, V9, P835, DOI 10.1016/S0960-894X(99)00096-7; Pooga M, 1998, NAT BIOTECHNOL, V16, P857, DOI 10.1038/nbt0998-857; RAVENSCROFT M, 1982, J CHEM SOC PERK T 2, P1569, DOI 10.1039/p29820001569; RYSER HJP, 1994, P NATL ACAD SCI USA, V91, P4559, DOI 10.1073/pnas.91.10.4559; RYSER HJP, 1991, J BIOL CHEM, V266, P18439; Sahaf B, 2005, ARCH BIOCHEM BIOPHYS, V434, P26, DOI 10.1016/j.abb.2004.11.015; Saito G, 2003, ADV DRUG DELIVER REV, V55, P199, DOI 10.1016/S0169-409X(02)00179-5; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Snyder EL, 2004, PLOS BIOL, V2, P186, DOI 10.1371/journal.pbio.0020036; THEODORE L, 1995, J NEUROSCI, V15, P7158; Thoren PEG, 2003, BIOCHEM BIOPH RES CO, V307, P100, DOI 10.1016/S0006-291X(03)01135-5; TURNER JJ, 2006, HDB CELL PENETRATING, P313; Vocero-Akbani AM, 1999, NAT MED, V5, P29, DOI 10.1038/4710; Weller K, 2005, BIOCHEMISTRY-US, V44, P15799, DOI 10.1021/bi051535d; Yang J, 2006, P NATL ACAD SCI USA, V103, P13872, DOI 10.1073/pnas.0601455103	53	118	121	0	37	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					2956	2967		10.1096/fj.08-127563	http://dx.doi.org/10.1096/fj.08-127563			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19403512				2022-12-25	WOS:000270241000018
J	Gordon, JW; Pagiatakis, C; Salma, J; Du, M; Andreucci, JJ; Zhao, JZ; Hou, GP; Perry, RL; Dan, QH; Courtman, D; Bendeck, MP; McDermott, JC				Gordon, Joseph W.; Pagiatakis, Christina; Salma, Jahan; Du, Min; Andreucci, John J.; Zhao, Jianzhong; Hou, Guangpei; Perry, Robert L.; Dan, Qinghong; Courtman, David; Bendeck, Michelle P.; McDermott, John C.			Protein Kinase A-regulated Assembly of a MEF2.HDAC4 Repressor Complex Controls c-Jun Expression in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECT TRANSCRIPTIONAL TARGET; SERUM RESPONSE FACTOR; GROWTH-FACTOR; GENE-EXPRESSION; NEOINTIMAL HYPERPLASIA; HISTONE DEACETYLASE-5; MOUSE EMBRYOGENESIS; CARDIAC-HYPERTROPHY; SIGNALING PATHWAYS; NUCLEAR EXPORT	Vascular smooth muscle cells (VSMCs) maintain the ability to modulate their phenotype in response to changing environmental stimuli. This phenotype modulation plays a critical role in the development of most vascular disease states. In these studies, stimulation of cultured vascular smooth muscle cells with platelet-derived growth factor resulted in marked induction of c-jun expression, which was attenuated by protein kinase C delta and calcium/calmodulin-dependent protein kinase inhibition. Given that these signaling pathways have been shown to relieve the repressive effects of class II histone deacetylases (HDACs) on myocyte enhancer factor (MEF) 2 proteins, we ectopically expressed HDAC4 and observed repression of c-jun expression. Congruently, suppression of HDAC4 by RNA interference resulted in enhanced c-jun expression. Consistent with these findings, mutation of the MEF2 cis-element in the c-jun promoter resulted in promoter activation during quiescent conditions, suggesting that the MEF2 cis-element functions as a repressor in this context. Furthermore, we demonstrate that protein kinase A attenuates c-Jun expression by promoting the formation of a MEF2.HDAC4 repressor complex by inhibiting salt-inducible kinase 1. Finally, we document a physical interaction between c-Jun and myocardin, and we document that forced expression of c-Jun represses the ability of myocardin to activate smooth muscle gene expression. Thus, MEF2 and HDAC4 act to repress c-Jun expression in quiescent VSMCs, protein kinase A enhances this repression, and platelet-derived growth factor derepresses c-Jun expression through calcium/calmodulin-dependent protein kinases and novel protein kinase Cs. Regulation of this molecular "switch" on the c-jun promoter may thus prove critical for toggling between the activated and quiescent VSMC phenotypes.	[Gordon, Joseph W.; Pagiatakis, Christina; Salma, Jahan; Du, Min; Andreucci, John J.; Zhao, Jianzhong; Perry, Robert L.; McDermott, John C.] York Univ, Dept Biol, N York, ON M3J 1P3, Canada; [Hou, Guangpei; Bendeck, Michelle P.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Dan, Qinghong; Courtman, David] Univ Toronto, St Michaels Hosp, Terrence Donnelly Cardiovasc Labs, Toronto, ON M5S 1A8, Canada	York University - Canada; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	McDermott, JC (corresponding author), 4700 Keele St, Toronto, ON MJ3 1P3, Canada.	jmcderm@yorku.ca	Pagiatakis, Christina/AAB-3844-2019	Pagiatakis, Christina/0000-0002-9315-9648; Gordon, Joseph/0000-0002-0061-2168	Muscular Dystrophy Association of Canada and Canadian Institute of Health Research; Canadian Institute of Health Research	Muscular Dystrophy Association of Canada and Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by a postdoctoral fellowship from the Muscular Dystrophy Association of Canada and Canadian Institute of Health Research (to R. L. P.) and by a grant from the Canadian Institute of Health Research (to J. C. M.).	Aizawa T, 2003, CIRC RES, V93, P406, DOI 10.1161/01.RES.0000091074.33584.F0; Anderson JP, 2004, MOL CELL BIOL, V24, P3757, DOI 10.1128/MCB.24.9.3757-3768.2004; Andreucci JJ, 2002, J BIOL CHEM, V277, P16426, DOI 10.1074/jbc.M110891200; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Antos CL, 2001, CIRC RES, V89, P997, DOI 10.1161/hh2301.100003; Assadnia S, 1999, CIRC RES, V84, P1252, DOI 10.1161/01.RES.84.11.1252; Bendeck MP, 2002, AM J PATHOL, V160, P1089, DOI 10.1016/S0002-9440(10)64929-2; BENGAL E, 1992, CELL, V68, P507, DOI 10.1016/0092-8674(92)90187-H; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; BILATO C, 1995, J CLIN INVEST, V96, P1905, DOI 10.1172/JCI118236; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Bornfeldt KE, 1999, CELL SIGNAL, V11, P465, DOI 10.1016/S0898-6568(99)00020-0; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Courtman DW, 2004, J VASC RES, V41, P157, DOI 10.1159/000077145; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; de Angelis L, 2005, DEV BIOL, V283, P171, DOI 10.1016/j.ydbio.2005.04.009; Du M, 2008, MOL CELL BIOL, V28, P2952, DOI 10.1128/MCB.00248-08; Fetalvero KM, 2006, AM J PHYSIOL-HEART C, V290, pH1337, DOI 10.1152/ajpheart.00936.2005; Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588; Firulli AB, 1996, CIRC RES, V78, P196, DOI 10.1161/01.RES.78.2.196; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Gum R, 1996, J BIOL CHEM, V271, P10672, DOI 10.1074/jbc.271.18.10672; HAN TH, 1995, MOL CELL BIOL, V15, P2907; Ho B, 2008, AM J PATHOL, V173, P278, DOI 10.2353/ajpath.2008.071046; Hou GP, 2001, J CLIN INVEST, V107, P727, DOI 10.1172/JCI10720; House SJ, 2008, ARTERIOSCL THROM VAS, V28, P441, DOI 10.1161/ATVBAHA.107.156810; Ioroi T, 2003, J PHARMACOL SCI, V91, P145; Kollias HD, 2006, MOL CELL BIOL, V26, P6248, DOI 10.1128/MCB.00384-06; Kuhel DG, 2002, ARTERIOSCL THROM VAS, V22, P955, DOI 10.1161/01.ATV.0000017994.77066.75; Laaksamo E, 2008, STROKE, V39, P886, DOI 10.1161/STROKEAHA.107.497875; Lee JS, 1996, MOL CELL BIOL, V16, P4312; LI L, 1992, GENE DEV, V6, P676, DOI 10.1101/gad.6.4.676; Lin Q, 1998, DEVELOPMENT, V125, P4565; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Markou T, 2006, J BIOL CHEM, V281, P8321, DOI 10.1074/jbc.M508398200; Maurice DH, 2003, MOL PHARMACOL, V64, P533, DOI 10.1124/mol.64.3.533; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; Meier KE, 1998, CELL SIGNAL, V10, P415, DOI 10.1016/S0898-6568(97)00140-X; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; MIANO JM, 1994, CIRC RES, V75, P803, DOI 10.1161/01.RES.75.5.803; Najwer I, 2005, AM J PHYSIOL-CELL PH, V289, pC785, DOI 10.1152/ajpcell.00098.2005; Naya FJ, 1999, DEVELOPMENT, V126, P2045; Ornatsky OI, 1999, NUCLEIC ACIDS RES, V27, P2646, DOI 10.1093/nar/27.13.2646; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Perry RLS, 2001, MOL CELL, V8, P291, DOI 10.1016/S1097-2765(01)00302-1; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Rao GN, 1996, J BIOL CHEM, V271, P20805, DOI 10.1074/jbc.271.34.20805; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; SCHUNKERT H, 1991, P NATL ACAD SCI USA, V88, P11480, DOI 10.1073/pnas.88.24.11480; Suzuki E, 2004, CIRC RES, V95, P42, DOI 10.1161/01.RES.0000134631.75684.4A; Takemori H, 2002, J BIOL CHEM, V277, P42334, DOI 10.1074/jbc.M204602200; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang DZ, 2004, CURR OPIN GENET DEV, V14, P558, DOI 10.1016/j.gde.2004.08.003; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e; Xu XB, 2007, ARTERIOSCL THROM VAS, V27, P2355, DOI 10.1161/ATVBAHA.107.151704; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335; Zhan YM, 2002, ARTERIOSCL THROM VAS, V22, P82, DOI 10.1161/hq0102.101821; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	60	55	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					19027	19042		10.1074/jbc.M109.000539	http://dx.doi.org/10.1074/jbc.M109.000539			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19389706	Green Published, hybrid			2022-12-25	WOS:000267711500052
J	Guzman-Hernandez, ML; Vazquez-Macias, A; Carretero-Ortega, J; Hernandez-Garcia, R; Garcia-Regalado, A; Hernandez-Negrete, I; Reyes-Cruz, G; Gutkind, JS; Vazquez-Prado, J				Luisa Guzman-Hernandez, Maria; Vazquez-Macias, Aleida; Carretero-Ortega, Jorge; Hernandez-Garcia, Ricardo; Garcia-Regalado, Alejandro; Hernandez-Negrete, Ivette; Reyes-Cruz, Guadalupe; Silvio Gutkind, J.; Vazquez-Prado, Jose			Differential Inhibitor of G beta gamma Signaling to AKT and ERK Derived from Phosducin-like Protein EFFECT ON SPHINGOSINE 1-PHOSPHATE-INDUCED ENDOTHELIAL CELL MIGRATION AND IN VITRO ANGIOGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; ENDOTHELIAL-CELL CHEMOTAXIS; HEPATOCYTE GROWTH-FACTOR; NITRIC-OXIDE SYNTHASE; SPHINGOSINE 1-PHOSPHATE; DICTYOSTELIUM-DISCOIDEUM; COUPLED RECEPTORS; ACTIVATION; COMPLEX; TRANSDUCIN	Differential inhibitors of G beta gamma-effector regions are required to dissect the biological contribution of specific G beta gamma-initiated signaling pathways. Here, we characterize PhLP-M1-G149, a G beta gamma-interacting construct derived from phosducin-like protein 1 (PhLP) as a differential inhibitor of G beta gamma, which, in endothelial cells, prevented sphingosine 1-phosphate- induced phosphorylation of AKT, glycogen synthase kinase 3 beta, cell migration, and tubulogenesis, while having no effect on ERK phosphorylation or hepatocyte growth factor-dependent responses. This construct attenuated the recruitment of phosphoinositide 3-kinase gamma (PI3K gamma) to the plasma membrane and the signaling to AKT in response to G beta gamma overexpression. In coimmunoprecipitation experiments, PhLP-M1-G149 interfered with the interaction between PI3K gamma and G beta gamma. Other PhLP- derived constructs interacted with G beta gamma but were not effective inhibitors of G beta gamma signaling to AKT or ERK. Our results indicate that PhLP-M1-G149 is a suitable tool to differentially modulate the G beta gamma-initiated pathway linking this heterodimer to AKT, endothelial cell migration, and in vitro angiogenesis. It can be also useful to further characterize the molecular determinants of the G beta gamma-PI3K gamma interaction.	[Vazquez-Prado, Jose] Natl Polytech Inst, CINVESTAV IPN, Dept Pharmacol, Ctr Res & Adv Studies, Mexico City 14740, DF, Mexico; [Luisa Guzman-Hernandez, Maria; Vazquez-Macias, Aleida; Carretero-Ortega, Jorge; Hernandez-Garcia, Ricardo; Hernandez-Negrete, Ivette; Vazquez-Prado, Jose] Inst Politecn Nacl, Ctr Res & Adv Studies, Dept Pharmacol, Mexico City 07000, DF, Mexico; [Luisa Guzman-Hernandez, Maria; Vazquez-Macias, Aleida; Carretero-Ortega, Jorge; Hernandez-Garcia, Ricardo; Hernandez-Negrete, Ivette; Vazquez-Prado, Jose] Inst Politecn Nacl, Ctr Res & Adv Studies, Dept Cell Biol, Mexico City 07000, DF, Mexico; [Silvio Gutkind, J.] NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Vazquez-Prado, J (corresponding author), Natl Polytech Inst, CINVESTAV IPN, Dept Pharmacol, Ctr Res & Adv Studies, Av Inst Politcn Nacl 2508,Col San Pedro Zacatenco, Mexico City 14740, DF, Mexico.	jvazquez@cinvestav.mx	Gutkind, J. Silvio/J-1201-2016; Guzman-Hernandez, Maria Luisa/AAN-2347-2021; VAZQUEZ-PRADO, JOSE/C-1630-2017; Garcia-Regalado, Alejandro/ABA-2604-2021; Gutkind, J. Silvio/A-1053-2009	Gutkind, J. Silvio/0000-0002-5150-4482; Guzman-Hernandez, Maria Luisa/0000-0003-3366-6813; VAZQUEZ-PRADO, JOSE/0000-0001-5797-6643; Hernandez Negrete, Ivette/0000-0003-1097-0038; Garcia-Regalado, Alejandro/0000-0002-4201-8423; Carretero-Ortega, Jorge/0000-0003-1295-9596	National Institutes of Health [R01TW006664]; Fogarty International Center; the Consejo Nacional de Ciencia y Tecnologia [61127, 45957]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); the Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01TW006664 ( to J. V. P.) from the Fogarty International Center. This work was also supported by the Consejo Nacional de Ciencia y Tecnologia ( CONACyT, Grant 61127 to J. V. P. and Grant 45957 to G. R. C.).	BAUER PH, 1992, NATURE, V358, P73, DOI 10.1038/358073a0; Blaauw M, 2003, EMBO J, V22, P5047, DOI 10.1093/emboj/cdg508; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; CHEN JQ, 1995, SCIENCE, V268, P1166, DOI 10.1126/science.7761832; Chen SH, 2005, J BIOL CHEM, V280, P33445, DOI 10.1074/jbc.M505422200; Chen SH, 2004, J MOL CELL CARDIOL, V37, P399, DOI 10.1016/j.yjmcc.2004.04.019; Chen SH, 2004, J BIOL CHEM, V279, P17861, DOI 10.1074/jbc.M313727200; Chen SH, 2008, MOL BIOL CELL, V19, P3909, DOI 10.1091/mbc.E08-04-0433; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Craft CM, 1998, BIOCHEMISTRY-US, V37, P15758, DOI 10.1021/bi980921a; Donald S, 2004, FEBS LETT, V572, P172, DOI 10.1016/j.febslet.2004.06.096; English D, 2002, BBA-MOL CELL BIOL L, V1582, P228, DOI 10.1016/S1388-1981(02)00176-2; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Garcia-Regalado A, 2008, MOL BIOL CELL, V19, P4188, DOI 10.1091/mbc.E07-10-1089; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Gaudet R, 1999, MOL CELL, V3, P649, DOI 10.1016/S1097-2765(00)80358-5; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRANT DS, 1993, P NATL ACAD SCI USA, V90, P1937, DOI 10.1073/pnas.90.5.1937; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Harwood AJ, 2001, CELL, V105, P821, DOI 10.1016/S0092-8674(01)00412-3; Hla T, 2003, PHARMACOL RES, V47, P401, DOI 10.1016/S1043-6618(03)00046-X; Humrich J, 2005, J BIOL CHEM, V280, P20042, DOI 10.1074/jbc.M409233200; Igarashi J, 2001, J BIOL CHEM, V276, P12420, DOI 10.1074/jbc.M008375200; Igarashi J, 2001, J BIOL CHEM, V276, P36281, DOI 10.1074/jbc.M105628200; Kasahara S, 2000, P NATL ACAD SCI USA, V97, P412, DOI 10.1073/pnas.97.1.412; Kerchner KR, 2004, J BIOL CHEM, V279, P44554, DOI 10.1074/jbc.M406071200; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Knol JC, 2005, MOL CELL BIOL, V25, P8393, DOI 10.1128/MCB.25.18.8393-8400.2005; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; KUO CH, 1989, BIOCHEM BIOPH RES CO, V162, P1063, DOI 10.1016/0006-291X(89)90781-X; Lee MJ, 2001, MOL CELL, V8, P693, DOI 10.1016/S1097-2765(01)00324-0; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; LEE RH, 1987, BIOCHEMISTRY-US, V26, P3983, DOI 10.1021/bi00387a036; Li Z, 2005, PROSTAG OTH LIPID M, V76, P95, DOI 10.1016/j.prostaglandins.2005.02.002; Liu F, 2001, AM J RESP CELL MOL, V24, P711, DOI 10.1165/ajrcmb.24.6.4323; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Loew A, 1998, STRUCT FOLD DES, V6, P1007, DOI 10.1016/S0969-2126(98)00102-6; Lukov GL, 2006, J BIOL CHEM, V281, P22261, DOI 10.1074/jbc.M601590200; MILES MF, 1993, P NATL ACAD SCI USA, V90, P10831, DOI 10.1073/pnas.90.22.10831; Morales-Ruiz M, 2001, J BIOL CHEM, V276, P19672, DOI 10.1074/jbc.M009993200; Murga C, 2000, J BIOL CHEM, V275, P12069, DOI 10.1074/jbc.275.16.12069; Nakagami H, 2001, HYPERTENSION, V37, P581, DOI 10.1161/01.HYP.37.2.581; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rosenfeldt H, 2004, FEBS LETT, V572, P167, DOI 10.1016/j.febslet.2004.06.097; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Schulz R, 2001, PHARMACOL RES, V43, P1, DOI 10.1006/phrs.2000.0757; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; Watterson K, 2003, PROG LIPID RES, V42, P344, DOI 10.1016/S0163-7827(03)00015-8; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Willardson BM, 2007, CELL SIGNAL, V19, P2417, DOI 10.1016/j.cellsig.2007.06.013; Yang M, 2009, BIOCHEM J, V417, P287, DOI 10.1042/BJ20081561; YOSHIDA T, 1994, J BIOL CHEM, V269, P24050	55	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18334	18346		10.1074/jbc.M109.008839	http://dx.doi.org/10.1074/jbc.M109.008839			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19403526	hybrid, Green Published			2022-12-25	WOS:000267712400046
J	Silverman, WR; Vaccari, JPDR; Locovei, S; Qiu, F; Carlsson, SK; Scemes, E; Keane, RW; Dahl, G				Silverman, William R.; Vaccari, Juan Pablo de Rivero; Locovei, Silviu; Qiu, Feng; Carlsson, Steven K.; Scemes, Eliana; Keane, Robert W.; Dahl, Gerhard			The Pannexin 1 Channel Activates the Inflammasome in Neurons and Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL-CORD-INJURY; P2X(7) RECEPTOR; CASPASE-1 ACTIVATION; MOLECULAR PLATFORM; ATP; RELEASE; CELL; GAP; INTERLEUKIN-1-BETA; INHIBITION	The inflammasome is a multiprotein complex involved in innate immunity. Activation of the inflammasome causes the processing and release of the cytokines interleukins 1 beta and 18. In primary macrophages, potassium ion flux and the membrane channel pannexin 1 have been suggested to play roles in inflammasome activation. However, the molecular mechanism(s) governing inflammasome signaling remains poorly defined, and it is undetermined whether these mechanisms apply to the central nervous system. Here we show that high extracellular potassium opens pannexin channels leading to caspase-1 activation in primary neurons and astrocytes. The effect of K+ on pannexin 1 channels was independent of membrane potential, suggesting that stimulation of inflammasome signaling was mediated by an allosteric effect. The activation of the inflammasome by K+ was inhibited by the pannexin 1 channel blocker probenecid, supporting a role of pannexin 1 in inflammasome activation. Co-immunoprecipitation of neuronal lysates indicates that pannexin 1 associates with components of the multiprotein inflammasome complex, including the P2X7 receptor and caspase-1. Moreover antibody neutralization of the adaptor protein ASC (apoptosis-associated speck-like protein containing a CARD) blocked ATP-induced cell death in oocytes co-expressing P2X7 receptor and pannexin 1. Thus, in contrast to macrophages and monocytes in which low intracellular K+ has been suggested to trigger inflammasome activation, in neural cells, high extracellular K+ activates caspase-1 probably through pannexin 1.	[Silverman, William R.; Locovei, Silviu; Qiu, Feng; Carlsson, Steven K.; Keane, Robert W.; Dahl, Gerhard] Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA; [Vaccari, Juan Pablo de Rivero] Univ Miami, Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Scemes, Eliana] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	University of Miami; University of Miami; Yeshiva University; Albert Einstein College of Medicine	Dahl, G (corresponding author), Univ Miami, Sch Med, Dept Physiol & Biophys, 1600 NW 10th Ave,RSMB 5135, Miami, FL 33136 USA.	gdahl@miami.edu	Silverman, William/AAE-4799-2019; Qiu, Feng/D-8223-2011; de Rivero Vaccari, Juan Pablo/ABE-3248-2020; de Rivero Vaccari, Juan Pablo/H-5718-2019; Scemes, Eliana/K-6257-2019	de Rivero Vaccari, Juan Pablo/0000-0002-5460-8834; Scemes, Eliana/0000-0002-6650-3976	National Institutes of Health [GM48610, NS052245]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052245] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM48610 (to G. D.) and NS052245 (to E. S.) and a training grant (to W. S.).	Abulafia DP, 2009, J CEREBR BLOOD F MET, V29, P534, DOI 10.1038/jcbfm.2008.143; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Bodin P, 1996, J CARDIOVASC PHARM, V27, P872, DOI 10.1097/00005344-199606000-00015; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Carneiro LAM, 2008, J PATHOL, V214, P136, DOI 10.1002/path.2271; Carta S, 2006, BLOOD, V108, P1618, DOI 10.1182/blood-2006-03-014126; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Colomar A, 2003, J BIOL CHEM, V278, P30732, DOI 10.1074/jbc.M304534200; Dahl G, 2006, IUBMB LIFE, V58, P409, DOI 10.1080/15216540600794526; DEUTICKE B, 1970, NATURWISSENSCHAFTEN, V57, P172, DOI 10.1007/BF00592968; DOUCET JP, 1992, J BIOL CHEM, V267, P16503; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; GUTMAN AB, 1951, B NEW YORK ACAD MED, V27, P144; Huang Y, 2007, GLIA, V55, P46, DOI 10.1002/glia.20435; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Ji HL, 2004, J BIOL CHEM, V279, P26939, DOI 10.1074/jbc.M401143200; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; KAWAMOTO JC, 1986, BRAIN RES, V384, P84, DOI 10.1016/0006-8993(86)91222-9; Keane RW, 1997, J NEUROSCI RES, V48, P168, DOI 10.1002/(SICI)1097-4547(19970415)48:2<168::AID-JNR9>3.0.CO;2-A; KEANE RW, 1992, TRANSPLANTATION, V54, P520, DOI 10.1097/00007890-199209000-00025; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Matzinger P, 2002, ANN NY ACAD SCI, V961, P341, DOI 10.1111/j.1749-6632.2002.tb03118.x; Matzinger P, 2007, NAT IMMUNOL, V8, P11, DOI 10.1038/ni0107-11; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Scemes E, 2007, NEURON GLIA BIOL, V3, P199, DOI 10.1017/S1740925X08000069; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Taniguchi S, 2007, SEMIN IMMUNOPATHOL, V29, P231, DOI 10.1007/s00281-007-0082-3; TEDESCHI B, 1986, J CELL BIOL, V102, P2244, DOI 10.1083/jcb.102.6.2244; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; WALEV I, 1995, EMBO J, V14, P1607, DOI 10.1002/j.1460-2075.1995.tb07149.x; [No title captured]	47	401	409	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18143	18151		10.1074/jbc.M109.004804	http://dx.doi.org/10.1074/jbc.M109.004804			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19416975	hybrid, Green Published			2022-12-25	WOS:000267712400025
J	Kaye, NM; Emmett, KJ; Merrick, WC; Jankowsky, E				Kaye, Nicholas M.; Emmett, Kelly J.; Merrick, William C.; Jankowsky, Eckhard			Intrinsic RNA Binding by the Eukaryotic Initiation Factor 4F Depends on a Minimal RNA Length but Not on the m(7)G Cap	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOBIN MESSENGER-RNA; BOX PROTEIN EIF4A; FACTOR 4E; TRANSLATIONAL EFFICIENCY; DECAPPING ENZYME; PURIFICATION; RECOGNITION; COMPLEX; KINASE; NUCLEOTIDE	The eukaryotic initiation factor 4F (eIF4F) is thought to be the first factor to bind mRNA during 7-methylguanosine (m(7)G) cap-dependent translation initiation. The multipartite eIF4F contains the cap-binding protein eIF4E, and it is assumed that eIF4F binds mRNAs primarily at the 5' m(7)G cap structure. We have analyzed equilibrium binding of rabbit eIF4F to a series of diverse RNAs and found no impact of the 5'-cap on the stability of eIF4F-RNA complexes. However, eIF4F preferentially and cooperatively binds to RNAs with a minimum length of similar to 60 nucleotides in vitro. Furthermore, translation activity in rabbit reticulocyte lysate is strongly inhibited by RNAs exceeding this length, but not by shorter ones, consistent with the notion that eIF4F in its physiological environment preferentially binds longer RNAs, too. Collectively, our results indicate that intrinsic RNA binding by eIF4F depends on a minimal RNA length, rather than on cap recognition. The nonetheless essential m(7)G cap may either function at steps subsequent to eIF4F-RNA binding, or other factors facilitate preferential binding of eIF4F to the m(7)G cap.	Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Jankowsky, Eckhard] Case Western Reserve Univ, Sch Med, Ctr RNA Mol Biol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Jankowsky, E (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	exj13@case.edu		Jankowsky, Eckhard/0000-0001-7677-7412	National Institutes of Health [GM067700, GM0026796]; Damon Runyon Cancer Research Foundation [DRS042]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067700, R01GM026796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM067700 (to E. J.) and GM0026796 (to W. C. M.). This work was also supported by Damon Runyon Cancer Research Foundation Grant DRS042 (to E. J.).	ABRAMSON RD, 1987, J BIOL CHEM, V262, P3826; Amrani N, 2008, NATURE, V453, P1276, DOI 10.1038/nature06974; Berset C, 2003, RNA, V9, P871, DOI 10.1261/rna.5380903; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; GODEFROYCOLBURN T, 1981, J BIOL CHEM, V256, P1762; Gollnick P, 2005, ANNU REV GENET, V39, P47, DOI 10.1146/annurev.genet.39.073003.093745; GOYER C, 1993, MOL CELL BIOL, V13, P4860, DOI 10.1128/MCB.13.8.4860; GRIFO JA, 1982, J BIOL CHEM, V257, P5246; GRIFO JA, 1983, J BIOL CHEM, V258, P5804; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Grudzien E, 2004, RNA, V10, P1479, DOI 10.1261/rna.7380904; Hagedorn CH, 1997, PROTEIN EXPRES PURIF, V9, P53, DOI 10.1006/prep.1996.0661; Haghighat A, 1997, J BIOL CHEM, V272, P21677, DOI 10.1074/jbc.272.35.21677; HARTZ D, 1988, METHOD ENZYMOL, V164, P419; HARTZ D, 1991, J MOL BIOL, V218, P99, DOI 10.1016/0022-2836(91)90876-8; Jankowsky Eckhard, 2008, V488, P343, DOI 10.1007/978-1-60327-475-3_22; JARAMILLO M, 1991, MOL CELL BIOL, V11, P5992, DOI 10.1128/MCB.11.12.5992; Jemielity J, 2003, NUCLEOS NUCLEOT NUCL, V22, P691, DOI 10.1081/NCN-120022611; Kahvejian A, 2001, COLD SPRING HARB SYM, V66, P293, DOI 10.1101/sqb.2001.66.293; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Kaye NM, 2002, J MOL BIOL, V324, P429, DOI 10.1016/S0022-2836(02)01094-X; KELLY RC, 1976, J BIOL CHEM, V251, P7240; LaGrandeur TE, 1998, EMBO J, V17, P1487, DOI 10.1093/emboj/17.5.1487; LAWSON TG, 1986, J BIOL CHEM, V261, P13979; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2180, DOI 10.1021/bi972430g; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2194, DOI 10.1021/bi9724319; Marcotrigiano J, 2001, MOL CELL, V7, P193, DOI 10.1016/S1097-2765(01)00167-8; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; MINICH WB, 1994, P NATL ACAD SCI USA, V91, P7668, DOI 10.1073/pnas.91.16.7668; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859; Pisarev AV, 2007, METHOD ENZYMOL, V430, P147, DOI 10.1016/S0076-6879(07)30007-4; Pyle AM, 2000, METHOD ENZYMOL, V317, P140; Richter-Cook NJ, 1998, J BIOL CHEM, V273, P7579, DOI 10.1074/jbc.273.13.7579; SAFER B, 1976, P NATL ACAD SCI USA, V73, P2584, DOI 10.1073/pnas.73.8.2584; SHA M, 1995, J BIOL CHEM, V270, P29904; Steiger M, 2003, RNA, V9, P231, DOI 10.1261/rna.2151403; Tomoo K, 2003, J MOL BIOL, V328, P365, DOI 10.1016/S0022-2836(03)00314-0; Tomoo K, 2002, BIOCHEM J, V362, P539, DOI 10.1042/0264-6021:3620539; Volpon L, 2006, EMBO J, V25, P5138, DOI 10.1038/sj.emboj.7601380; von der Haar T, 2000, J BIOL CHEM, V275, P30551, DOI 10.1074/jbc.M004565200; von der Haar T, 2006, J MOL BIOL, V356, P982, DOI 10.1016/j.jmb.2005.12.034; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Yang QS, 2005, BIOCHEMISTRY-US, V44, P13591, DOI 10.1021/bi0508946	46	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17742	17750		10.1074/jbc.M109.009001	http://dx.doi.org/10.1074/jbc.M109.009001			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19414591	Green Published, hybrid			2022-12-25	WOS:000267202500040
J	Morley, TJ; Willis, LM; Whitfield, C; Wakarchuk, WW; Withers, SG				Morley, Thomas J.; Willis, Lisa M.; Whitfield, Chris; Wakarchuk, Warren W.; Withers, Stephen G.			A New Sialidase Mechanism BACTERIOPHAGE K1F ENDO-SIALIDASE IS AN INVERTING GLYCOSIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION-MOLECULE; COMPLETE NUCLEOTIDE-SEQUENCE; INVERTING MUTANT SIALIDASE; ENDO-N-ACETYLNEURAMINIDASE; POLYSIALIC ACID; ESCHERICHIA-COLI; NEISSERIA-MENINGITIDIS; GROUP-B; ACTIVE-SITE; POLYSACCHARIDE ANTIGENS	Bacteriophages specific for Escherichia coli K1 express a tailspike protein that degrades the polysialic acid coat of E. coli K1 that is essential for bacteriophage infection. This enzyme is specific for polysialic acid and is a member of a family of endo-sialidases. This family is unusual because all other previously reported sialidases outside of this family are exo- or trans-sialidases. The recently determined structure of an endo-sialidase derived from bacteriophage K1F (endoNF) revealed an active site that lacks a number of the residues that are conserved in other sialidases, implying a new, endo-sialidase-specific catalytic mechanism. Using synthetic trifluoromethylumbelliferyl oligosialoside substrates, kinetic parameters for hydrolysis at a single cleavage site were determined. Measurement of k(cat)/K-m at a series of pH values revealed a dependence on a single protonated group of pK(a) 5. Mutation of a putative active site acidic residue, E581A, resulted in complete loss of sialidase activity. Direct H-1 NMR analysis of the hydrolysis of trifluoromethylumbelliferyl sialotrioside revealed that endoNF is an inverting sialidase. All other wild type sialidases previously reported are retaining glycosidases, implying a new mechanism of sialidase action specific to this family of endo-sialidases.	[Morley, Thomas J.; Withers, Stephen G.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Willis, Lisa M.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Wakarchuk, Warren W.] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of British Columbia; University of Guelph; National Research Council Canada	Withers, SG (corresponding author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.	withers@chem.ubc.ca	Morley, Thomas/A-5224-2013; Wakarchuk, Warren/AAO-2774-2020; Wakarchuk, Warren/Q-9514-2017	Wakarchuk, Warren/0000-0002-1539-1679; Wakarchuk, Warren/0000-0002-1539-1679; Willis, Lisa/0000-0001-6204-033X	Leverhulme Trust; Natural Sciences and Engineering Research Council; Canada Research Chairs; Canadian Institute of Health Research	Leverhulme Trust(Leverhulme Trust); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs(Canada Research ChairsCGIAR); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	Supported by the Leverhulme Trust. Supported by the Natural Sciences and Engineering Research Council. Recipients of Canada Research Chairs. Supported by the Canadian Institute of Health Research.	ACHESON A, 1991, J CELL BIOL, V114, P143, DOI 10.1083/jcb.114.1.143; ADLAM C, 1987, FEMS MICROBIOL LETT, V42, P23, DOI 10.1111/j.1574-6968.1987.tb02293.x; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; ASHWELL M, 1992, J AM CHEM SOC, V114, P10158, DOI 10.1021/ja00052a011; BHATTACHARJEE AK, 1975, J BIOL CHEM, V250, P1926; Brayer GD, 2000, BIOCHEMISTRY-US, V39, P4778, DOI 10.1021/bi9921182; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; BRISSON JR, 1992, BIOCHEMISTRY-US, V31, P4996, DOI 10.1021/bi00136a012; Chiu CPC, 2004, NAT STRUCT MOL BIOL, V11, P163, DOI 10.1038/nsmb720; CIPPOLA L, 2008, CURR MED CHEM ANTICA, V8, P92; Damager I, 2008, BIOCHEMISTRY-US, V47, P3507, DOI 10.1021/bi7024832; Damude HG, 1996, BIOCHEM J, V315, P467, DOI 10.1042/bj3150467; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DEVI SJN, 1991, INFECT IMMUN, V59, P732, DOI 10.1128/IAI.59.2.732-736.1991; Drake PM, 2008, J IMMUNOL, V181, P6850, DOI 10.4049/jimmunol.181.10.6850; Engstler M, 1997, ANAL BIOCHEM, V250, P176, DOI 10.1006/abio.1997.2205; EVANS SV, 1995, BIOCHEMISTRY-US, V34, P6737, DOI 10.1021/bi00020a019; FIGARELLABRANGER DF, 1990, CANCER RES, V50, P6364; FINNE J, 1985, J BIOL CHEM, V260, P1265; FINNE J, 1982, J BIOL CHEM, V257, P1966; FINNE J, 1983, LANCET, V2, P355; Franz CK, 2005, J NEUROSCI, V25, P2081, DOI 10.1523/JNEUROSCI.4880-04.2005; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Galuska SP, 2008, J BIOL CHEM, V283, P17, DOI 10.1074/jbc.M707024200; GOTSCHLICH EC, 1981, J BIOL CHEM, V256, P8915; GROSS RJ, 1977, J CLIN MICROBIOL, V6, P548; HALLENBECK PC, 1987, J BIOL CHEM, V262, P3553; Haselhorst T, 2006, CHEMBIOCHEM, V7, P1875, DOI 10.1002/cbic.200600252; HENKEL E, 1983, CLIN CHEM, V29, P1182; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; HOFFMAN S, 1982, J BIOL CHEM, V257, P7720; Horstkorte R, 2004, EXP CELL RES, V298, P268, DOI 10.1016/j.yexcr.2004.04.014; Jakobsson E, 2007, BIOCHEM J, V405, P465, DOI 10.1042/BJ20070177; JANN K, 1983, PROG ALLERGY, V33, P53; JENNINGS HJ, 1985, J IMMUNOL, V134, P2651; JENNINGS HJ, 1984, PURE APPL CHEM, V56, P893, DOI 10.1351/pac198456070893; JENNINGS HJ, 1993, GLYCOCONJUGATE J, V10, P328, DOI 10.1007/BF01210139; JOLLEY ME, 1974, CARBOHYD RES, V33, P377, DOI 10.1016/S0008-6215(00)82819-0; Joshi MD, 2000, J MOL BIOL, V299, P255, DOI 10.1006/jmbi.2000.3722; Kao YH, 1997, GLYCOBIOLOGY, V7, P559, DOI 10.1093/glycob/7.4.559; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kataoka Y, 2006, J BIOSCI BIOENG, V101, P198, DOI 10.1263/jbb.101.198; KEY B, 1990, J CELL BIOL, V110, P1729, DOI 10.1083/jcb.110.5.1729; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; Kobayashi T, 2000, J BIOCHEM-TOKYO, V127, P569, DOI 10.1093/oxfordjournals.jbchem.a022642; Leiman PG, 2007, J MOL BIOL, V371, P836, DOI 10.1016/j.jmb.2007.05.083; LONG GS, 1995, BIOCHEM J, V309, P543, DOI 10.1042/bj3090543; Machida Y, 2000, J BIOSCI BIOENG, V90, P62, DOI 10.1016/S1389-1723(00)80035-3; Machida Y, 2000, FEMS MICROBIOL LETT, V182, P333, DOI 10.1111/j.1574-6968.2000.tb08917.x; MANZI AE, 1994, J BIOL CHEM, V269, P23617; Manzoni M, 2007, BIOCHEM J, V408, P395, DOI 10.1042/BJ20070627; MICHON F, 1987, BIOCHEMISTRY-US, V26, P8399, DOI 10.1021/bi00399a055; Miyake K, 1997, J FERMENT BIOENG, V84, P90, DOI 10.1016/S0922-338X(97)82793-6; MOOLENAAR CECK, 1990, CANCER RES, V50, P1102; Muhlenhoff M, 1998, CURR OPIN STRUC BIOL, V8, P558, DOI 10.1016/S0959-440X(98)80144-9; Muller D, 2000, P NATL ACAD SCI USA, V97, P4315, DOI 10.1073/pnas.070022697; Namchuk MN, 2000, J AM CHEM SOC, V122, P1270, DOI 10.1021/ja992044h; Newstead S, 2005, BIOCHEMISTRY-US, V44, P9117, DOI 10.1021/bi050517t; Newstead SL, 2008, J BIOL CHEM, V283, P9080, DOI 10.1074/jbc.M710247200; OGURA H, 1986, CARBOHYD RES, V158, P37, DOI 10.1016/0008-6215(86)84004-6; ORSKOV I, 1977, BACTERIOL REV, V41, P667, DOI 10.1128/MMBR.41.3.667-710.1977; PELKONEN S, 1989, J VIROL, V63, P4409, DOI 10.1128/JVI.63.10.4409-4416.1989; PETTER JG, 1993, J BACTERIOL, V175, P4354, DOI 10.1128/JB.175.14.4354-4363.1993; Rockle I, 2008, DEV NEUROBIOL, V68, P1170, DOI 10.1002/dneu.20649; ROTH J, 1988, AM J PATHOL, V133, P227; ROTH J, 1988, P NATL ACAD SCI USA, V85, P2999, DOI 10.1073/pnas.85.9.2999; Rutishauser U, 1998, J CELL BIOCHEM, V70, P304, DOI 10.1002/(SICI)1097-4644(19980901)70:3<304::AID-JCB3>3.0.CO;2-R; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; Schauer R, 2000, GLYCOCONJUGATE J, V17, P485, DOI 10.1023/A:1011062223612; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; SCHAUER R, 1997, GLYCOPROTEINS 2, V19, P243; Scholl D, 2001, J VIROL, V75, P2509, DOI 10.1128/JVI.75.6.2509-2515.2001; Schwarzer D, 2009, J BIOL CHEM, V284, P9465, DOI 10.1074/jbc.M808475200; Seidenfaden R, 2003, MOL CELL BIOL, V23, P5908, DOI 10.1128/MCB.23.16.5908-5918.2003; Seidenfaden R, 2003, EUR J CELL BIOL, V82, P48; Severi E, 2008, J BIOL CHEM, V283, P4841, DOI 10.1074/jbc.M707822200; SILVER RP, 1984, J BACTERIOL, V157, P568, DOI 10.1128/JB.157.2.568-575.1984; Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874; Taylor G, 1996, CURR OPIN STRUC BIOL, V6, P830, DOI 10.1016/S0959-440X(96)80014-5; TROY FA, 1992, GLYCOBIOLOGY, V2, P5, DOI 10.1093/glycob/2.1.5; TROY FA, 1979, J BIOL CHEM, V254, P7377; TULL D, 1994, BIOCHEMISTRY-US, V33, P6363, DOI 10.1021/bi00186a041; Vimr E, 2002, TRENDS MICROBIOL, V10, P254, DOI 10.1016/S0966-842X(02)02361-2; WANG Q, 1995, BIOCHEMISTRY-US, V34, P14554, DOI 10.1021/bi00044a034; Watson JN, 2006, BIOCHEMISTRY-US, V45, P13264, DOI 10.1021/bi061489x; Watson JN, 2003, BIOCHEMISTRY-US, V42, P12682, DOI 10.1021/bi035396g; Willis LM, 2008, GLYCOBIOLOGY, V18, P177, DOI 10.1093/glycob/cwm126; YAMASAKI R, 1991, BIOCHEMISTRY-US, V30, P851, DOI 10.1021/bi00217a039	88	31	32	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17404	17410		10.1074/jbc.M109.003970	http://dx.doi.org/10.1074/jbc.M109.003970			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19411257	Green Published, hybrid			2022-12-25	WOS:000267202500006
J	Anandatheerthavarada, HK; Sepuri, NBV; Avadhani, NG				Anandatheerthavarada, Hindupur K.; Sepuri, Naresh Babu V.; Avadhani, Narayan G.			Mitochondrial Targeting of Cytochrome P450 Proteins Containing NH2-terminal Chimeric Signals Involves an Unusual TOM20/TOM22 Bypass Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPORT RECEPTORS TOM20; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONES; OUTER-MEMBRANE; SACCHAROMYCES-CEREVISIAE; TRANSLOCATION; BIOGENESIS; ACTIVATION; PATHWAY; PREPROTEINS	Previously we showed that xenobiotic inducible cytochrome P450 (CYP) proteins are bimodally targeted to the endoplasmic reticulum and mitochondria. In this study, we investigated the mechanism of delivery of chimeric signal containing CYP proteins to the peripheral and channel-forming mitochondrial outer membrane translocases (TOMs). CYP+33/1A1 and CYP2B1 did not require peripheral TOM70, TOM20, or TOM22 for translocation through the channel-forming TOM40 protein. In contrast, CYP+5/1A1 and CYP2E1 were able to bypass TOM20 and TOM22 but required TOM70. CYP27, which contains a canonical cleavable mitochondrial signal, required all of the peripheral TOMs for its mitochondrial translocation. We investigated the underlying mechanisms of bypass of peripheral TOMs by CYPs with chimeric signals. The results suggested that interaction of CYPs with Hsp70, a cytosolic chaperone involved in the mitochondrial import, alone was sufficient for the recognition of chimeric signals by peripheral TOMs. However, sequential interaction of chimeric signal containing CYPs with Hsp70 and Hsp90 resulted in the bypass of peripheral TOMs, whereas CYP27A1 interacted only with Hsp70 and was not able to bypass peripheral TOMs. Our results also show that delivery of a chimeric signal containing client protein by Hsp90 required the cytosol-exposed NH2-terminal 143 amino acids of TOM40. TOM40 devoid of this domain was unable to import CYP proteins. These results suggest that compared with the unimodal mitochondrial targeting signals, the chimeric mitochondrial targeting signals are highly evolved and dynamic in nature.	[Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Avadhani, NG (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, 3800 Spruce St, Philadelphia, PA 19104 USA.	narayan@vet.upenn.edu	Sepuri, Naresh/AAF-2704-2020		National Institutes of Health [GM-34883]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-34883.	Addya S, 1997, J CELL BIOL, V139, P589, DOI 10.1083/jcb.139.3.589; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030; Anandatheerthavarada HK, 1997, ARCH BIOCHEM BIOPHYS, V339, P136, DOI 10.1006/abbi.1996.9855; BARNUN S, 1980, P NATL ACAD SCI-BIOL, V77, P965, DOI 10.1073/pnas.77.2.965; Beddoe T, 2002, BBA-MOL CELL RES, V1592, P35, DOI 10.1016/S0167-4889(02)00262-8; Bhagwat SV, 1999, J BIOL CHEM, V274, P24014, DOI 10.1074/jbc.274.34.24014; Boopathi E, 2008, MOL CELL, V32, P32, DOI 10.1016/j.molcel.2008.09.008; Brix J, 1997, J BIOL CHEM, V272, P20730, DOI 10.1074/jbc.272.33.20730; Brix J, 1999, J BIOL CHEM, V274, P16522, DOI 10.1074/jbc.274.23.16522; Brunner M, 1995, COLD SPRING HARB SYM, V60, P619, DOI 10.1101/SQB.1995.060.01.066; Chacinska A, 2002, TRENDS CELL BIOL, V12, P299, DOI 10.1016/S0962-8924(02)02310-3; DESHAIES RJ, 1988, TRENDS BIOCHEM SCI, V13, P384, DOI 10.1016/0968-0004(88)90180-6; Diekert K, 2001, EMBO J, V20, P5626, DOI 10.1093/emboj/20.20.5626; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Ellis RJ, 2003, NATURE, V421, P801, DOI 10.1038/421801a; Fan ACY, 2006, J BIOL CHEM, V281, P33313, DOI 10.1074/jbc.M605250200; Folsch H, 1996, EMBO J, V15, P479, DOI 10.1002/j.1460-2075.1996.tb00380.x; Gabaldon T, 2004, BBA-BIOENERGETICS, V1659, P212, DOI 10.1016/j.bbabio.2004.07.011; GILMORE R, 1982, J CELL BIOL, V95, P470, DOI 10.1083/jcb.95.2.470; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Isenmann S, 1998, MOL BIOL CELL, V9, P1649, DOI 10.1091/mbc.9.7.1649; JAUSSI R, 1995, EUR J BIOCHEM, V228, P551, DOI 10.1111/j.1432-1033.1995.tb20294.x; Karniely S, 2005, EMBO REP, V6, P420, DOI 10.1038/sj.embor.7400394; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Knox C, 1998, J BIOL CHEM, V273, P25587, DOI 10.1074/jbc.273.40.25587; Kurz M, 1999, MOL BIOL CELL, V10, P2461, DOI 10.1091/mbc.10.7.2461; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LITHGOW T, 1994, J BIOL CHEM, V269, P15325; Ma YL, 2008, J BIOL CHEM, V283, P11743, DOI 10.1074/jbc.M710494200; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MURAKAMI H, 1988, J CELL BIOL, V107, P2051, DOI 10.1083/jcb.107.6.2051; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; NIRANJAN BG, 1984, J BIOL CHEM, V259, P2495; NOTHWEHR SF, 1990, BIOESSAYS, V12, P479, DOI 10.1002/bies.950121005; Otera H, 2007, J CELL BIOL, V179, P1355, DOI 10.1083/jcb.200702143; PFALLER R, 1989, J BIOL CHEM, V264, P34; PFANNER N, 1994, TRENDS BIOCHEM SCI, V19, P368, DOI 10.1016/0968-0004(94)90113-9; Ren J, 2006, ONCOGENE, V25, P20, DOI 10.1038/sj.onc.1209012; Robin MA, 2003, J BIOL CHEM, V278, P18960, DOI 10.1074/jbc.M301807200; Robin MA, 2002, J BIOL CHEM, V277, P40583, DOI 10.1074/jbc.M203292200; ROSE MD, 1987, METHOD ENZYMOL, V152, P481; RYAN KR, 1995, CELL, V83, P517, DOI 10.1016/0092-8674(95)90089-6; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; Sepuri NBV, 2007, FEBS J, V274, P4615, DOI 10.1111/j.1742-4658.2007.05990.x; Sepuri NBV, 1998, J BIOL CHEM, V273, P1420, DOI 10.1074/jbc.273.3.1420; Stan T, 2003, MOL CELL BIOL, V23, P2239, DOI 10.1128/MCB.23.7.2239-2250.2003; STEGER HF, 1990, J CELL BIOL, V111, P2353, DOI 10.1083/jcb.111.6.2353; SU P, 1990, DNA CELL BIOL, V9, P657, DOI 10.1089/dna.1990.9.657; Subramani S, 1998, PHYSIOL REV, V78, P171, DOI 10.1152/physrev.1998.78.1.171; Suzuki H, 2004, J BIOL CHEM, V279, P50619, DOI 10.1074/jbc.M408604200; SZCZESNASKORUPA E, 1995, J BIOL CHEM, V270, P24327, DOI 10.1074/jbc.270.41.24327; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Van Ael E, 2006, BBA-MOL CELL RES, V1763, P1629, DOI 10.1016/j.bbamcr.2006.08.020; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; WICKNER WT, 1985, SCIENCE, V230, P400, DOI 10.1126/science.4048938; Wilkinson BM, 1997, J MEMBRANE BIOL, V155, P189, DOI 10.1007/s002329900171; Yamano K, 2008, J BIOL CHEM, V283, P3799, DOI 10.1074/jbc.M708339200; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; ZALMAN LS, 1980, J BIOL CHEM, V255, P1771	68	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17352	17363		10.1074/jbc.M109.007492	http://dx.doi.org/10.1074/jbc.M109.007492			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19401463	hybrid, Green Published			2022-12-25	WOS:000266962400070
J	Ludlam, A; Brunzelle, J; Pribyl, T; Xu, XJ; Gatti, DL; Ackerman, SH				Ludlam, Anthony; Brunzelle, Joseph; Pribyl, Thomas; Xu, Xingjue; Gatti, Domenico L.; Ackerman, Sharon H.			Chaperones of F-1-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL F-1-ATPASE; ALPHA-SUBUNIT; BETA-SUBUNIT; YEAST; PROTEIN; IDENTIFICATION; ATP11; ACCUMULATION; F1-ATPASE; FEATURES	Mitochondrial F-1-ATPase contains a hexamer of alternating alpha and beta subunits. The assembly of this structure requires two specialized chaperones, Atp11p and Atp12p, that bind transiently to beta and alpha. In the absence of Atp11p and Atp12p, the hexamer is not formed, and alpha and beta precipitate as large insoluble aggregates. An early model for the mechanism of chaperone-mediated F-1 assembly (Wang, Z. G., Sheluho, D., Gatti, D. L., and Ackerman, S. H. (2000) EMBO J. 19, 1486-1493) hypothesized that the chaperones themselves look very much like the alpha and beta subunits, and proposed an exchange of Atp11p for alpha and of Atp12p for beta; the driving force for the exchange was expected to be a higher affinity of alpha and beta for each other than for the respective chaperone partners. One important feature of this model was the prediction that as long as Atp11p is bound to beta and Atp12p is bound to alpha, the two F-1 subunits cannot interact at either the catalytic site or the noncatalytic site interface. Here we present the structures of Atp11p from Candida glabrata and Atp12p from Paracoccus denitrificans, and we show that some features of the Wang model are correct, namely that binding of the chaperones to alpha and beta prevents further interactions between these F-1 subunits. However, Atp11p and Atp12p do not resemble alpha or beta, and it is instead the F-1 gamma subunit that initiates the release of the chaperones from alpha and beta and their further assembly into the mature complex.	[Ludlam, Anthony; Pribyl, Thomas; Xu, Xingjue; Gatti, Domenico L.; Ackerman, Sharon H.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; [Brunzelle, Joseph] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Life Sci Collaborat Access Team, Chicago, IL 60611 USA	Wayne State University; Northwestern University; Feinberg School of Medicine	Gatti, DL (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA.	dgatti@med.wayne.edu; sackerm@med.wayne.edu			National Institutes of Health [GM41857, GM69840]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM41857 ( to S. H. A.) and GM69840 ( to D. L. G.) from USPHS. Author's Choice-Final version full access.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ACKERMAN SH, 1992, J BIOL CHEM, V267, P7386; ACKERMAN SH, 1990, P NATL ACAD SCI USA, V87, P4986, DOI 10.1073/pnas.87.13.4986; Ackerman Sharon H, 2007, Methods Mol Biol, V372, P363, DOI 10.1007/978-1-59745-365-3_26; Alouf JE, 2003, FOLIA MICROBIOL, V48, P5, DOI 10.1007/BF02931271; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bianchet MA, 1998, P NATL ACAD SCI USA, V95, P11065, DOI 10.1073/pnas.95.19.11065; BOWMAN S, 1991, J BIOL CHEM, V266, P7517; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047; DeLano W. L., 2007, PYMOL MOL GRAPHICS S; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Hinton A, 2004, J BIOL CHEM, V279, P9016, DOI 10.1074/jbc.M312631200; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Kallhoff V, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-6; Kanekiyo T, 2007, P NATL ACAD SCI USA, V104, P6412, DOI 10.1073/pnas.0701585104; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Lazo ND, 2005, PROTEIN SCI, V14, P1581, DOI 10.1110/ps.041292205; Lefebvre-Legendre L, 2005, J BIOL CHEM, V280, P18386, DOI 10.1074/jbc.M410789200; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; Mueller DM, 2004, PROTEIN EXPRES PURIF, V37, P479, DOI 10.1016/j.pep.2004.06.035; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAUL MF, 1994, J BIOL CHEM, V269, P26158; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wang ZG, 1998, J BIOL CHEM, V273, P2993, DOI 10.1074/jbc.273.5.2993; Wang ZG, 2000, EMBO J, V19, P1486, DOI 10.1093/emboj/19.7.1486; Wang ZG, 1996, J BIOL CHEM, V271, P4887; Wang ZG, 2000, J BIOL CHEM, V275, P5767, DOI 10.1074/jbc.275.8.5767; WHITE M, 1995, ARCH BIOCHEM BIOPHYS, V319, P299, DOI 10.1006/abbi.1995.1296	42	23	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17138	17146		10.1074/jbc.M109.002568	http://dx.doi.org/10.1074/jbc.M109.002568			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19383603	hybrid, Green Published			2022-12-25	WOS:000266962400052
J	Attema, JL; Pronk, CJH; Norddahl, GL; Nygren, JM; Bryder, D				Attema, J. L.; Pronk, C. J. H.; Norddahl, G. L.; Nygren, J. M.; Bryder, D.			Hematopoietic stem cell ageing is uncoupled from p16(INK4A)-mediated senescence	ONCOGENE			English	Article						stem cells; hematopoiesis; ageing; senescence	TUMOR-SUPPRESSOR; BONE-MARROW; PROTEINS; GENE; AGE; PROLIFERATION; METHYLATION; PROGENITORS; POPULATION; EXPRESSION	Somatic stem cells are ultimately responsible for mediating appropriate organ homeostasis and have therefore been proposed to represent a cellular origin of the ageing process-a state often characterized by inappropriate homeostasis. Specifically, it has been suggested that ageing stem cells might succumb to replicative senescence by a mechanism involving the cyclin-dependent kinase inhibitor p16(INK4A). Here, we tested multiple functional and molecular parameters indicative of p16(INK4A) activity in primary aged murine hematopoietic stem cells (HSCs). We found no evidence that replicative senescence accompanies stem cell ageing in vivo, and in line with p16(INK4A) being a critical determinant of such processes, most aged HSCs (>99%) failed to express p16(INK4A) at the mRNA level. Moreover, whereas loss of epigenetically guided repression of the INK4A/ARF locus accompanied replicative senescent murine embryonic fibroblasts, such repression was maintained in aged stem cells. Taken together, these studies indicate that increased senescence as mediated by the p16(INK4A) tumor suppressor has only a minor function as an intrinsic regulator of steady-state HSC ageing in vivo. Oncogene (2009) 28, 2238-2243; doi: 10.1038/onc.2009.94; published online 27 April 2009	[Attema, J. L.; Pronk, C. J. H.; Norddahl, G. L.; Nygren, J. M.; Bryder, D.] Lund Univ, Immunol Unit, Expt Med Res Inst, S-22184 Lund, Sweden	Lund University	Bryder, D (corresponding author), Lund Univ, Immunol Unit, Expt Med Res Inst, BMC D14, S-22184 Lund, Sweden.	David.Bryder@med.lu.se	Bryder, David/Q-6292-2019	Bryder, David/0000-0002-8761-4237; Nygren, Jens M/0000-0002-3576-2393	Swedish Medical Research Council; Swedish Strategic Research Foundation; Swedish Cancer Society; Crafoord foundation and the Medical Faculty at Lund University	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Strategic Research Foundation(Swedish Foundation for Strategic Research); Swedish Cancer Society(Swedish Cancer Society); Crafoord foundation and the Medical Faculty at Lund University	We thank William Agace for critical review of the paper. The expert technical support from Gerd Sten is greatly appreciated. These studies were generously supported by grants to DB from the Swedish Medical Research Council, the Swedish Strategic Research Foundation, The Swedish Cancer Society, The Crafoord foundation and the Medical Faculty at Lund University.	Attema JL, 2007, P NATL ACAD SCI USA, V104, P12371, DOI 10.1073/pnas.0704468104; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Nygren JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003710; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Patel AC, 2000, CARCINOGENESIS, V21, P1691, DOI 10.1093/carcin/21.9.1691; Pearce DJ, 2007, STEM CELLS, V25, P828, DOI 10.1634/stemcells.2006-0405; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Randall TD, 1998, STEM CELLS, V16, P38, DOI 10.1002/stem.160038; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Signer RAJ, 2008, GENE DEV, V22, P3115, DOI 10.1101/gad.1715808; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	26	56	64	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2009	28	22					2238	2243		10.1038/onc.2009.94	http://dx.doi.org/10.1038/onc.2009.94			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	453VF	19398954				2022-12-25	WOS:000266640300006
J	Albergotti, LC; Hamlin, HJ; Mccoy, MW; Guillette, LJ				Albergotti, Lori C.; Hamlin, Heather J.; McCoy, Michael W.; Guillette, Louis J., Jr.			Endocrine Activity of Extraembryonic Membranes Extends beyond Placental Amniotes	PLOS ONE			English	Article							PROGESTERONE-RECEPTOR ISOFORMS; EMBRYONIC-DEVELOPMENT; POSSIBLE MECHANISM; STEROID-HORMONES; FETAL MEMBRANES; ESTROGEN; CHICKEN; EXPRESSION; WITHDRAWAL; PREGNANCY	Background: During development, all amniotes (mammals, reptiles, and birds) form extraembryonic membranes, which regulate gas and water exchange, remove metabolic wastes, provide shock absorption, and transfer maternally derived nutrients. In viviparous (live-bearing) amniotes, both extraembryonic membranes and maternal uterine tissues contribute to the placenta, an endocrine organ that synthesizes, transports, and metabolizes hormones essential for development. Historically, endocrine properties of the placenta have been viewed as an innovation of placental amniotes. However, an endocrine role of extraembryonic membranes has not been investigated in oviparous (egg-laying) amniotes despite similarities in their basic structure, function, and shared evolutionary ancestry. In this study, we ask whether the oviparous chorioallantoic membrane (CAM) of chicken (Gallus gallus) has the capability to synthesize and receive signaling of progesterone, a major placental steroid hormone. Methodology/Principal Findings: We quantified mRNA expression of key steroidogenic enzymes involved in progesterone synthesis and found that 3 beta-hydroxysteroid dehydrogenase, which converts pregnenolone to progesterone exhibited a 464 fold increase in the CAM from day 8 to day 18 of embryonic development (F-5,F- 68 = 89.282, p<0.0001). To further investigate progesterone synthesis, we performed explant culture and found that the CAM synthesizes progesterone in vitro in the presence of a steroid precursor. Finally, we quantified mRNA expression and performed protein immunolocalization of the progesterone receptor in the CAM. Conclusions/Significance: Collectively, our data indicate that the chick CAM is steroidogenic and has the capability to both synthesize progesterone and receive progesterone signaling. These findings represent a paradigm shift in evolutionary reproductive biology by suggesting that endocrine activity of extraembryonic membranes is not a novel characteristic of placental amniotes. Rather, we hypothesize that these membranes may share an additional unifying characteristic, steroidogenesis, across amniotes at large.			Albergotti, LC (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.	ljg@zoology.ufl.edu	Hamlin, Heather/K-6235-2019	Hamlin, Heather/0000-0002-9042-5509; McCoy, Michael/0000-0002-7993-6236	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Blackburn DG, 1999, HERPETOLOGICA, V55, P556; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; CROSS JC, 2003, GENES DEV EVOLUTION, P123; Cudeville C, 2000, BIOL REPROD, V62, P759, DOI 10.1095/biolreprod62.3.759; Elf PK, 2002, J EXP ZOOL, V293, P594, DOI 10.1002/jez.10169; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Giannoulias D, 2005, PLACENTA, V26, P289, DOI 10.1016/j.placenta.2004.07.005; Girling JE, 2007, ENDOCRINOLOGY, V148, P5433, DOI 10.1210/en.2007-0856; Girling JE, 2003, GEN COMP ENDOCR, V133, P100, DOI 10.1016/S0016-6480(03)00147-3; Goldman S, 2005, MOL HUM REPROD, V11, P269, DOI 10.1093/molehr/gah161; Gonzalez-Moran G, 2003, LIFE SCI, V73, P871, DOI 10.1016/S0024-3205(03)00353-9; Gonzalez-Moran G, 2002, COMP BIOCHEM PHYS A, V132, P519, DOI 10.1016/S1095-6433(02)00096-X; Graham JD, 1997, ENDOCR REV, V18, P502, DOI 10.1210/er.18.4.502; Griffin C, 1999, MOL ENDOCRINOL, V13, P1571, DOI 10.1210/me.13.9.1571; Guarino FM, 1998, GEN COMP ENDOCR, V111, P261, DOI 10.1006/gcen.1998.7098; GUILLETTE LJ, 1993, BIOSCIENCE, V43, P742, DOI 10.2307/1312318; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Henson MC, 1998, HUM REPROD UPDATE, V4, P389, DOI 10.1093/humupd/4.4.389; Jojovic M, 1998, ANAT EMBRYOL, V198, P133, DOI 10.1007/s004290050171; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; King SR, 2004, J MOL ENDOCRINOL, V32, P507, DOI 10.1677/jme.0.0320507; Kluge A. G., 1977, CHORDATE STRUCTURE F, V2nd; Mark PJ, 2006, PLACENTA, V27, P208, DOI 10.1016/j.placenta.2005.01.004; MCCOY KA, 2008, ENV HLTH PERSPECT, V7, P116; MCEWEN RS, 1957, VERTEBRATE EMBRYOLOG; Mesiano S, 2002, J CLIN ENDOCR METAB, V87, P2924, DOI 10.1210/jc.87.6.2924; Norris D. O., 1997, VERTEBRATE ENDOCRINO; OGLE TF, 1990, BIOL REPROD, V43, P276, DOI 10.1095/biolreprod43.2.276; OMAR HA, 1995, J CLIN ENDOCR METAB, V80, P370, DOI 10.1210/jc.80.2.370; Painter DL, 2005, PHYSIOL BIOCHEM ZOOL, V78, P364, DOI 10.1086/430222; Pasanen S, 1997, MOL CELL ENDOCRINOL, V135, P79, DOI 10.1016/S0303-7207(97)00192-5; Pasqualini JR, 2005, J STEROID BIOCHEM, V97, P401, DOI 10.1016/j.jsbmb.2005.08.004; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Penning TM, 1997, ENDOCR REV, V18, P281, DOI 10.1210/er.18.3.281; Petraglia F, 1996, ENDOCR REV, V17, P156, DOI 10.1210/er.17.2.156; Pinheiro J, 2001, MIXED EFFECTS MODELS; ROSEN S, 2000, PRIMER3 WWW GEN USER, P365; Team RDC, 2019, R LANG ENV STAT COMP; TORA L, 1988, NATURE, V333, P185, DOI 10.1038/333185a0; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walter LM, 2005, REPRODUCTION, V129, P765, DOI 10.1530/rep.1.00625	42	29	29	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5452	10.1371/journal.pone.0005452	http://dx.doi.org/10.1371/journal.pone.0005452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424488	Green Published, gold, Green Submitted			2022-12-25	WOS:000265933800001
J	Garber, DA; O'Mara, LA; Zhao, J; Gangadhara, S; An, I; Feinberg, MB				Garber, David A.; O'Mara, Leigh A.; Zhao, Jun; Gangadhara, Sailaja; An, InChul; Feinberg, Mark B.			Expanding the Repertoire of Modified Vaccinia Ankara-Based Vaccine Vectors via Genetic Complementation Strategies	PLOS ONE			English	Article							URACIL-DNA GLYCOSYLASE; SIMIAN IMMUNODEFICIENCY VIRUS; ATTENUATED MVA STRAIN; CD8(+) T-CELLS; HOST-RANGE; PROTECTIVE IMMUNITY; DOMINANT SELECTION; SELECTABLE MARKER; REPLICATION; IMMUNOGENICITY	Background: Modified Vaccinia virus Ankara (MVA) is a safe, highly attenuated orthopoxvirus that is being developed as a recombinant vaccine vector for immunization against a number of infectious diseases and cancers. However, the expression by MVA vectors of large numbers of poxvirus antigens, which display immunodominance over vectored antigens-of-interest for the priming of T cell responses, and the induction of vector-neutralizing antibodies, which curtail the efficacy of subsequent booster immunizations, remain as significant impediments to the overall utility of such vaccines. Thus, genetic approaches that enable the derivation of MVA vectors that are antigenically less complex may allow for rational improvement of MVA-based vaccines. Principal Findings: We have developed a genetic complementation system that enables the deletion of essential viral genes from the MVA genome, thereby allowing us to generate MVA vaccine vectors that are antigenically less complex. Using this system, we deleted the essential uracil-DNA-glycosylase (udg) gene from MVA and propagated this otherwise replication-defective variant on a complementing cell line that constitutively expresses the poxvirus udg gene and that was derived from a newly identified continuous cell line that is permissive for growth of wild type MVA. The resulting virus, MVA Delta udg, does not replicate its DNA genome or express late viral gene products during infection of non-complementing cells in culture. As proof-of-concept for immunological 'focusing', we demonstrate that immunization of mice with MVA Delta udg elicits CD8+ T cell responses that are directed against a restricted repertoire of vector antigens, as compared to immunization with parental MVA. Immunization of rhesus macaques with MVA Delta udg-gag, a udg 2 recombinant virus that expresses an HIV subtype-B consensus gag transgene, elicited significantly higher frequencies of Gag-specific CD8 and CD4 T cells following both primary (2-4-fold) and booster (2-fold) immunizations as compared to the udg(+) control virus MVA-gag, as determined by intracellular cytokine assay. In contrast, levels of HIV Gag-specific antibodies were elicited similarly in macaques following immunization with MVA Delta udg-gag and MVA-gag. Furthermore, both udg 2 and udg+ MVA vectors induced comparatively similar titers of MVA-specific neutralizing antibody responses following immunization of mice (over a 4-log range: 10(4)-10(8) PFU) and rhesus macaques. These results suggest that the generation of MVA-specific neutralizing antibody responses are largely driven by input MVA antigens, rather than those that are synthesized de novo during infection, and that the processes governing the generation of antiviral antibody responses are more readily saturated by viral antigen than are those that elicit CD8+ T cell responses. Significance: Our identification of a spontaneously-immortalized (but not transformed) chicken embryo fibroblast cell line (DF-1) that is fully permissive for MVA growth and that can be engineered to stably express MVA genes provides the basis for a genetic system for MVA. DF-1 cells (and derivatives thereof) constitute viable alternatives, for the manufacture of MVA-based vaccines, to primary CEFs-the conventional cell substrate for MVA vaccines that is not amenable to genetic complementation strategies due to these cells' finite lifespan in culture. The establishment of a genetic system for MVA, as illustrated here to allow udg deletion, enables the generation of novel replication-defective MVA mutants and expands the repertoire of genetic viral variants that can now be explored as improved vaccine vectors.			Garber, DA (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	david.garber@emory.edu			NIAID NIH HHS [P01 AI046007, U19 AI061728] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Ausubel F., 1999, CURRENT PROTOCOLS MO; Basta S, 2002, J IMMUNOL, V168, P5403, DOI 10.4049/jimmunol.168.11.5403; BERDY J, 1980, AMINO ACID PEPTIDE A, P459; Blanchard TJ, 1998, J GEN VIROL, V79, P1159, DOI 10.1099/0022-1317-79-5-1159; BORY JPL, 2006, PHASE 2 STUDY HPV16; Brockman MA, 2002, J VIROL, V76, P3678, DOI 10.1128/JVI.76.8.3678-3687.2002; CALMELS T, 1991, CURR GENET, V20, P309, DOI 10.1007/BF00318520; Carroll MW, 1997, VIROLOGY, V238, P198, DOI 10.1006/viro.1997.8845; CARROLL MW, 1995, BIOTECHNIQUES, V19, P352; Casimiro DR, 2004, J VIROL, V78, P11434, DOI 10.1128/JVI.78.20.11434-11438.2004; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Coulibaly S, 2005, VIROLOGY, V341, P91, DOI 10.1016/j.virol.2005.06.043; Da Costa XJ, 2001, VIROLOGY, V288, P256, DOI 10.1006/viro.2001.1094; Davies DH, 2008, J VIROL, V82, P652, DOI 10.1128/JVI.01706-07; De Silva FS, 2003, J VIROL, V77, P159, DOI 10.1128/JVI.77.1.159-166.2003; Drexler I, 1998, J GEN VIROL, V79, P347, DOI 10.1099/0022-1317-79-2-347; Earl PL, 2003, J VIROL, V77, P10684, DOI 10.1128/JVI.77.19.10684-10688.2003; Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261; Ellison KS, 1996, J VIROL, V70, P7965, DOI 10.1128/JVI.70.11.7965-7973.1996; ENGRAM J, VACCINE INDUCE UNPUB; FALKNER FG, 1988, J VIROL, V62, P1849, DOI 10.1128/JVI.62.6.1849-1854.1988; FALKNER FG, 1990, J VIROL, V64, P3108, DOI 10.1128/JVI.64.6.3108-3111.1990; FARRELL HE, 1994, J VIROL, V68, P927, DOI 10.1128/JVI.68.2.927-932.1994; Fischer MA, 2007, J GEN VIROL, V88, P2378, DOI 10.1099/vir.0.83107-0; FRANKE CA, 1985, MOL CELL BIOL, V5, P1918, DOI 10.1128/MCB.5.8.1918; Garg S, 2004, J IMMUNOL, V173, P550, DOI 10.4049/jimmunol.173.1.550; Gasteiger G, 2007, J VIROL, V81, P11925, DOI 10.1128/JVI.00903-07; GOEPFERT PHC, 2007, HIV 1 DNA PRIME FOLL; GUIMARAESWALKER A, 2004, PRIMING CANDIDATE HI; Gutierrez CMC, 2004, HUM GENE THER, V15, P421, DOI 10.1089/10430340460745757; Hansen SG, 2002, BIOTECHNIQUES, V32, P1178, DOI 10.2144/02325dd08; HARRER THJ, 2007, THERAPEUTIC VACCINAT; Himly M, 1998, VIROLOGY, V248, P295, DOI 10.1006/viro.1998.9290; Hirsch VM, 1996, J VIROL, V70, P3741, DOI 10.1128/JVI.70.6.3741-3752.1996; Holzer GW, 1998, VIROLOGY, V249, P160, DOI 10.1006/viro.1998.9307; Holzer GW, 1999, J VIROL, V73, P4536, DOI 10.1128/JVI.73.6.4536-4542.1999; Holzer GW, 1997, J VIROL, V71, P4997, DOI 10.1128/JVI.71.7.4997-5002.1997; JAOKO W, 2004, SAFETY IMMUNOGENICIT; Kastenmuller W, 2007, J EXP MED, V204, P2187, DOI 10.1084/jem.20070489; KEEFER MCE, 2007, SAFETY IMMUNOGENICIT; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Lauvau G, 2004, EUR J IMMUNOL, V34, P913, DOI 10.1002/eji.200424944; Manischewitz J, 2003, J INFECT DIS, V188, P440, DOI 10.1086/376557; MAYR A, 1978, ZBL BAKT MIK HYG B, V167, P375; Mayr A., 1975, INFECTION, V3, P6, DOI [10.1007/BF01641272, DOI 10.1007/BF01641272]; McShane H, 2005, TUBERCULOSIS, V85, P47, DOI 10.1016/j.tube.2004.09.015; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; MEYER H, 1991, J GEN VIROL, V72, P1031, DOI 10.1099/0022-1317-72-5-1031; MILLNS AK, 1994, VIROLOGY, V198, P504, DOI 10.1006/viro.1994.1061; Moorthy VS, 2004, PLOS MED, V1, P128, DOI 10.1371/journal.pmed.0010033; Moorthy VS, 2004, J INFECT DIS, V189, P2213, DOI 10.1086/421118; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Murphy CG, 2000, J VIROL, V74, P7745, DOI 10.1128/JVI.74.17.7745-7754.2000; Mwau M, 2004, J GEN VIROL, V85, P911, DOI 10.1099/vir.0.19701-0; NGUYEN LH, 1992, J VIROL, V66, P7067, DOI 10.1128/JVI.66.12.7067-7072.1992; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Ober BT, 2002, J VIROL, V76, P7713, DOI 10.1128/JVI.76.15.7713-7723.2002; Parrino J, 2007, VACCINE, V25, P1513, DOI 10.1016/j.vaccine.2006.10.047; Sanchez-Puig JM, 2000, GENE, V257, P57, DOI 10.1016/S0378-1119(00)00398-X; SANDSTROM EWB, 2007, IMPROVED MODES DELIV; Schaefer-Klein J, 1998, VIROLOGY, V248, P305, DOI 10.1006/viro.1998.9291; Shen XF, 2002, J IMMUNOL, V169, P4222, DOI 10.4049/jimmunol.169.8.4222; Shiver JW, 2004, ANNU REV MED, V55, P355, DOI 10.1146/annurev.med.55.091902.104344; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Smith CL, 2005, J IMMUNOL, V175, P8431, DOI 10.4049/jimmunol.175.12.8431; Smith CL, 2005, INT J CANCER, V113, P259, DOI 10.1002/ijc.20569; SNAITH MR, 1995, GENE, V166, P173, DOI 10.1016/0378-1119(95)00579-8; Stittelaar KJ, 2001, VACCINE, V19, P3700, DOI 10.1016/S0264-410X(01)00075-5; STUART DT, 1993, J VIROL, V67, P2503, DOI 10.1128/JVI.67.5.2503-2512.1993; SUTTER G, 1994, VACCINE, V12, P1032, DOI 10.1016/0264-410X(94)90341-7; SUTTER G, 1992, P NATL ACAD SCI USA, V89, P10847, DOI 10.1073/pnas.89.22.10847; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; VASAN S, 2007, CELLULAR HUMORAL IMM; Wyatt LS, 2004, P NATL ACAD SCI USA, V101, P4590, DOI 10.1073/pnas.0401165101; YUEN L, 1987, P NATL ACAD SCI USA, V84, P6417, DOI 10.1073/pnas.84.18.6417	76	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5445	10.1371/journal.pone.0005445	http://dx.doi.org/10.1371/journal.pone.0005445			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421328	Green Submitted, Green Published, gold			2022-12-25	WOS:000265836900006
J	Williams, DC; Novick, PJ				Williams, Daniel C.; Novick, Peter J.			Analysis of SEC9 Suppression Reveals a Relationship of SNARE Function to Cell Physiology	PLOS ONE			English	Article								Background: Growth and division of Saccharomyces cerevisiae is dependent on the action of SNARE proteins that are required for membrane fusion. SNAREs are regulated, through a poorly understood mechanism, to ensure membrane fusion at the correct time and place within a cell. Although fusion of secretory vesicles with the plasma membrane is important for yeast cell growth, the relationship between exocytic SNAREs and cell physiology has not been established. Methodology/Principal Findings: Using genetic analysis, we identified several influences on the function of exocytic SNAREs. Genetic disruption of the V-ATPase, but not vacuolar proteolysis, can suppress two different temperature-sensitive mutations in SEC9. Suppression is unlikely due to increased SNARE complex formation because increasing SNARE complex formation, through overexpression of SRO7, does not result in suppression. We also observed suppression of sec9 mutations by growth on alkaline media or on a non-fermentable carbon source, conditions associated with a reduced growth rate of wild-type cells and decreased SNARE complex formation. Conclusions/Significance: Three main conclusions arise from our results. First, there is a genetic interaction between SEC9 and the V-ATPase, although it is unlikely that this interaction has functional significance with respect to membrane fusion or SNAREs. Second, Sro7p acts to promote SNARE complex formation. Finally, Sec9p function and SNARE complex formation are tightly coupled to the physiological state of the cell.			Williams, DC (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.	pnovick@ucsd.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035370, R01GM082861, R01GM035370] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM035370, GM082861, R01 GM082861, GM35370, R37 GM035370] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; Bayer MJ, 2003, J CELL BIOL, V162, P211, DOI 10.1083/jcb.200212004; BRENNWALD P, 1994, CELL, V79, P245, DOI 10.1016/0092-8674(94)90194-5; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Cheviet S, 2006, J CELL SCI, V119, P2912, DOI 10.1242/jcs.03037; FIELD C, 1980, J CELL BIOL, V86, P123, DOI 10.1083/jcb.86.1.123; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Galli T, 1996, J BIOL CHEM, V271, P2193, DOI 10.1074/jbc.271.4.2193; Gangar A, 2005, CURR BIOL, V15, P1136, DOI 10.1016/j.cub.2005.05.046; Gerst JE, 1999, CELL MOL LIFE SCI, V55, P707, DOI 10.1007/s000180050328; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Grosshans BL, 2006, J CELL BIOL, V172, P55, DOI 10.1083/jcb.200510016; Grote E, 1999, MOL BIOL CELL, V10, P4149, DOI 10.1091/mbc.10.12.4149; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; HIRATA R, 1990, J BIOL CHEM, V265, P6726; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kagami M, 1998, GENETICS, V149, P1717; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; MATSUI Y, 1992, MOL CELL BIOL, V12, P5690, DOI 10.1128/MCB.12.12.5690; Munson M, 2002, J BIOL CHEM, V277, P9375, DOI 10.1074/jbc.M111729200; Munson M, 2000, NAT STRUCT BIOL, V7, P894; NEBES VL, 1991, J BIOL CHEM, V266, P22851; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Prelich G, 1999, TRENDS GENET, V15, P261, DOI 10.1016/S0168-9525(99)01749-7; PROTOPOPOV V, 1993, CELL, V74, P855, DOI 10.1016/0092-8674(93)90465-3; Rossi G, 1997, J BIOL CHEM, V272, P16610, DOI 10.1074/jbc.272.26.16610; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SORENSEN SO, 1994, EUR J BIOCHEM, V220, P19, DOI 10.1111/j.1432-1033.1994.tb18594.x; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; ZUBENKO GS, 1983, P NATL ACAD SCI-BIOL, V80, P510, DOI 10.1073/pnas.80.2.510	42	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5449	10.1371/journal.pone.0005449	http://dx.doi.org/10.1371/journal.pone.0005449			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421331	Green Published, Green Submitted, gold			2022-12-25	WOS:000265836900008
J	Forero, MG; Pennack, JA; Learte, AR; Hidalgo, A				Forero, Manuel G.; Pennack, Jenny A.; Learte, Anabel R.; Hidalgo, Alicia			DeadEasy Caspase: Automatic Counting of Apoptotic Cells in Drosophila	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; NERVOUS-SYSTEM; NUCLEI; COMPENSATION; SEGMENTATION; ATTENUATION; INTENSITY; SURVIVAL; DEATH	Development, cancer, neurodegenerative and demyelinating diseases, injury, and stem cell manipulations are characterised by alterations in cell number. Research into development, disease, and the effects of drugs require cell number counts. These are generally indirect estimates, because counting cells in an animal or organ is paradoxically difficult, as well as being tedious and unmanageable. Drosophila is a powerful model organism used to investigate the genetic bases of development and disease. There are Drosophila models for multiple neurodegenerative diseases, characterised by an increase in cell death. However, a fast, reliable, and accurate way to count the number of dying cells in vivo is not available. Here, we present a method based on image filtering and mathematical morphology techniques, to count automatically the number of dying cells in intact fruit-fly embryos. We call the resulting programme DeadEasy Caspase. It has been validated for Drosophila and we present examples of its power to address biological questions. Quantification is automatic, accurate, objective, and very fast. DeadEasy Caspase will be freely available as an ImageJ plug-in, and it can be modified for use in other sample types. It is of interest to the Drosophila and wider biomedical communities. DeadEasy Caspase is a powerful tool for the analysis of cell survival and cell death in development and in disease, such as neurodegenerative diseases and ageing. Combined with the power of Drosophila genetics, DeadEasy expands the tools that enable the use of Drosophila to analyse gene function, model disease and test drugs in the intact nervous system and whole animal.			Hidalgo, A (corresponding author), Univ Birmingham, Sch Biosci, NeuroDev Grp, Birmingham, W Midlands, England.	a.hidalgo@bham.ac.uk	Hidalgo, Alicia/F-5930-2015	Hidalgo, Alicia/0000-0001-8041-5764; Forero, Manuel/0000-0001-9972-8621	MRC [G0200140] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council Funding Source: Medline; Medical Research Council [G0200140] Funding Source: Medline; Wellcome Trust [073228] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Adiga PSU, 2001, MICRON, V32, P363, DOI 10.1016/S0968-4328(00)00046-9; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Booth GE, 2000, DEVELOPMENT, V127, P237; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Burne JF, 1996, J NEUROSCI, V16, P2064; Can A, 2003, J MICROSC-OXFORD, V211, P67, DOI 10.1046/j.1365-2818.2003.01195.x; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Colombani J, 2006, CURR BIOL, V16, P1453, DOI 10.1016/j.cub.2006.05.059; CONCHELLO JA, 1995, P 1995 IS T SPIE S E, P138; CONOVER JC, 1995, NATURE, V375, P235, DOI 10.1038/375235a0; Forero MG, 2006, J MICROSC-OXFORD, V223, P120, DOI 10.1111/j.1365-2818.2006.01610.x; Griffiths RL, 2004, EMBO J, V23, P2440, DOI 10.1038/sj.emboj.7600258; Guan YQ, 2008, MICROSC RES TECHNIQ, V71, P146, DOI 10.1002/jemt.20536; Gue M, 2005, CYTOM PART A, V67A, P18, DOI 10.1002/cyto.a.20170; Kervrann C, 2004, J MICROSC-OXFORD, V214, P297, DOI 10.1111/j.0022-2720.2004.01333.x; Learte AR, 2008, GLIA, V56, P164, DOI 10.1002/glia.20601; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lin G, 2003, CYTOM PART A, V56A, P23, DOI 10.1002/cyto.a.10079; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; Ragone G, 2003, DEV BIOL, V255, P138, DOI 10.1016/S0012-1606(02)00081-7; ROERDINK JBT, 1993, J MICROSCOPY, V169, P233; Rogulja-Ortmann A, 2007, DEVELOPMENT, V134, P105, DOI 10.1242/dev.02707; Shimada T, 2005, PHYSICA A, V350, P144, DOI 10.1016/j.physa.2004.11.033; Soustelle L, 2007, DEVELOPMENT, V134, P625, DOI 10.1242/dev.02750; Wahlby C, 2004, J MICROSC-OXFORD, V215, P67, DOI 10.1111/j.0022-2720.2004.01338.x; Wahlby C., 2003, ALGORITHMS APPL DIGI; Wu HX, 2005, J MICROSC-OXFORD, V220, P9, DOI 10.1111/j.1365-2818.2005.01508.x; Zhu BF, 2008, PLOS BIOL, V6, P2476, DOI 10.1371/journal.pbio.0060284	29	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2009	4	5							e5441	10.1371/journal.pone.0005441	http://dx.doi.org/10.1371/journal.pone.0005441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JE	19415123	Green Published, gold, Green Submitted			2022-12-25	WOS:000265836700013
J	Thye, T; Browne, EN; Chinbuah, MA; Gyapong, J; Osei, I; Owusu-Dabo, E; Brattig, NW; Niemann, S; Rusch-Gerdes, S; Horstmann, RD; Meyer, CG				Thye, Thorsten; Browne, Edmund N.; Chinbuah, Margaret A.; Gyapong, John; Osei, Ivy; Owusu-Dabo, Ellis; Brattig, Norbert W.; Niemann, Stefan; Ruesch-Gerdes, Sabine; Horstmann, Rolf D.; Meyer, Christian G.			IL 10 Haplotype Associated with Tuberculin Skin Test Response but Not with Pulmonary TB	PLOS ONE			English	Article							INTERLEUKIN-10 PROMOTER POLYMORPHISM; SINGLE-NUCLEOTIDE POLYMORPHISMS; MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; CYTOKINE PRODUCTION; SUSCEPTIBILITY; GENE; FERTILITY; INFECTION; ANERGY	Evidence from genetic association and twin studies indicates that susceptibility to tuberculosis (TB) is under genetic control. One gene implicated in susceptibility to TB is that encoding interleukin-10 (IL10). In a group of 2010 Ghanaian patients with pulmonary TB and 2346 healthy controls exposed to Mycobacterium tuberculosis, among them 129 individuals lacking a tuberculin skin test (PPD) response, we genotyped four IL10 promoter variants at positions 22849, 21082, 2819, and 2592 and reconstructed the haplotypes. The IL10 low-producer haplotype 22849A/21082A/2819C/2592C, compared to the high-producer haplotype -2849G/-1082G/-819C/-592C, occurred less frequent among PPD-negative controls than among cases (OR 2.15, CI 1.3-3.6) and PPD-positive controls (OR 2.09, CI 1.2-3.5). Lower IL-10 plasma levels in homozygous -2849A/-1082A/-819C/-592C carriers, compared to homozygous -2849G/-1082G/-819C/-592C carriers, were confirmed by a IL-10 ELISA (p=0.016). Although we did not observe differences between the TB patients and all controls, our results provide evidence that a group of individuals exposed to M. tuberculosis transmission is genetically distinct from healthy PPD positives and TB cases. In these PPD-negative individuals, higher IL-10 production appears to reflect IL-10-dependent suppression of adaptive immune responses and sustained long-term specific anergy.			Thye, T (corresponding author), Bernhard Nocht Inst Trop Med, Dept Mol Med, Hamburg, Germany.	thye@bni-hamburg.de	Niemann, Stefan/C-9327-2011	Niemann, Stefan/0000-0002-6604-0684; Gyapong, John/0000-0002-8415-1468				ATES O, 2007, J CLIN IMMUNOL; BARNES PF, 1993, INFECT IMMUN, V61, P197, DOI 10.1128/IAI.61.1.197-203.1993; Bellamy R, 2005, CLIN CHEST MED, V26, P233, DOI 10.1016/j.ccm.2005.02.006; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Crawley E, 1999, ARTHRITIS RHEUM-US, V42, P1101, DOI 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y; CROWLE AJ, 1990, INFECT IMMUN, V58, P632, DOI 10.1128/IAI.58.3.632-638.1990; de Groot CJM, 2004, GENES IMMUN, V5, P313, DOI 10.1038/sj.gene.6364092; de Jong BA, 2002, HUM IMMUNOL, V63, P281, DOI 10.1016/S0198-8859(02)00369-5; Delgado JC, 2002, J INFECT DIS, V186, P1463, DOI 10.1086/344891; Delgado JC, 2002, P NATL ACAD SCI USA, V99, P7576, DOI 10.1073/pnas.062056099; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; DUBOS R, 1952, WHITE PLAGUE TUBERCU, P1; El Baghdadi J, 2006, J EXP MED, V203, P1679, DOI 10.1084/jem.20060269; Fitness J, 2004, AM J TROP MED HYG, V71, P341, DOI 10.4269/ajtmh.2004.71.341; Gerosa F, 1999, CLIN IMMUNOL, V92, P224, DOI 10.1006/clim.1999.4752; Gibson AW, 2001, J IMMUNOL, V166, P3915, DOI 10.4049/jimmunol.166.6.3915; Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19; Herb F, 2008, HUM MOL GENET, V17, P1052, DOI 10.1093/hmg/ddm378; HOUK VN, 1968, ARCH ENVIRON HEALTH, V16, P26, DOI 10.1080/00039896.1968.10665011; Hudson LL, 2005, GENES IMMUN, V6, P274, DOI 10.1038/sj.gene.6364180; Jamieson SE, 2004, GENES IMMUN, V5, P46, DOI 10.1038/sj.gene.6364029; KALLMANN F. J., 1943, American Review of Tuberculosis and Pulmonary Diseases, V47, P549; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lard LR, 2003, ARTHRITIS RHEUM-US, V48, P1841, DOI 10.1002/art.11160; Lopez-Maderuelo D, 2003, AM J RESP CRIT CARE, V167, P970, DOI 10.1164/rccm.200205-438BC; Meyer CG, 2008, TUBERCULOSIS, V88, P482, DOI 10.1016/j.tube.2008.05.004; Mocellin S, 2003, TRENDS IMMUNOL, V24, P36, DOI 10.1016/S1471-4906(02)00009-1; Moraes MO, 2004, GENES IMMUN, V5, P592, DOI 10.1038/sj.gene.6364122; Netsawang Janjuree, 2004, Journal of the Medical Association of Thailand, V87, pS117; Owusu-Dabo E, 2006, EMERG INFECT DIS, V12, P1170, DOI 10.3201/eid1207.051028; Shaw TC, 2000, CYTOKINE, V12, P483, DOI 10.1006/cyto.1999.0586; Shin HD, 2005, EXP MOL MED, V37, P128, DOI 10.1038/emm.2005.17; Simonds B., 1963, TUBERCULOSIS TWINS; Sousa AO, 1997, P NATL ACAD SCI USA, V94, P13227, DOI 10.1073/pnas.94.24.13227; STEAD WW, 1990, NEW ENGL J MED, V322, P422, DOI 10.1056/NEJM199002153220702; Suarez A, 2003, TRANSPLANTATION, V75, P711, DOI 10.1097/01.TP.0000055216.19866.9A; Takiff HE, 2007, TUBERCULOSIS 2007 BA, P207; Thye T, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037960; Timmann C, 2004, GENES IMMUN, V5, P256, DOI 10.1038/sj.gene.6364094; Tso HW, 2005, GENES IMMUN, V6, P358, DOI 10.1038/sj.gene.6364189; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; van Dunne FM, 2006, GENES IMMUN, V7, P688, DOI 10.1038/sj.gene.6364347; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Vankayalapati R, 2003, CLIN INFECT DIS, V36, P24, DOI 10.1086/344903; Verbon A, 1999, CLIN EXP IMMUNOL, V115, P110; Westendorp RGJ, 2001, NAT MED, V7, P873, DOI 10.1038/90868	47	48	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5420	10.1371/journal.pone.0005420	http://dx.doi.org/10.1371/journal.pone.0005420			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440GG	19412539	Green Submitted, gold, Green Published			2022-12-25	WOS:000265688200007
J	Exner, V; Aichinger, E; Shu, H; Wildhaber, T; Alfarano, P; Caflisch, A; Gruissem, W; Kohler, C; Hennig, L				Exner, Vivien; Aichinger, Ernst; Shu, Huan; Wildhaber, Thomas; Alfarano, Pietro; Caflisch, Amedeo; Gruissem, Wilhelm; Koehler, Claudia; Hennig, Lars			The Chromodomain of LIKE HETEROCHROMATIN PROTEIN 1 Is Essential for H3K27me3 Binding and Function during Arabidopsis Development	PLOS ONE			English	Article							HISTONE H3; FLOWERING TIME; GENE-EXPRESSION; LHP1 PROTEIN; PLANT; HP1; METHYLATION; HOMOLOG; ARCHITECTURE; THALIANA	Polycomb group (PcG) proteins are essential to maintain gene expression patterns during development. Transcriptional repression by PcG proteins involves trimethylation of H3K27 (H3K27me3) by Polycomb Repressive Complex 2 (PRC2) in animals and plants. PRC1 binds to H3K27me3 and is required for transcriptional repression in animals, but in plants PRC1-like activities have remained elusive. One candidate protein that could be involved in PRC1-like functions in plants is LIKE HETEROCHROMATIN PROTEIN 1 (LHP1), because LHP1 associates with genes marked by H3K27me3 in vivo and has a chromodomain that binds H3K27me3 in vitro. Here, we show that disruption of the chromodomain of Arabidopsis thaliana LHP1 abolishes H3K27me3 recognition, releases gene silencing and causes similar phenotypic alterations as transcriptional lhp1 null mutants. Therefore, binding to H3K27me3 is essential for LHP1 protein function.			Exner, V (corresponding author), Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland.	lhennig@ethz.ch	Caflisch, Amedeo/I-3459-2012; Gruissem, Wilhelm/H-1752-2013; Köhler, Claudia/G-9668-2011; Hennig, Lars/G-2081-2011	Köhler, Claudia/0000-0002-2619-4857; Hennig, Lars/0000-0002-6645-1862; Gruissem, Wilhelm/0000-0002-1872-2998				Aubert D, 2001, PLANT CELL, V13, P1865, DOI 10.1105/tpc.13.8.1865; Bouveret R, 2006, DEVELOPMENT, V133, P1693, DOI 10.1242/dev.02340; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Calonje M, 2008, PLANT CELL, V20, P277, DOI 10.1105/tpc.106.049957; Cowell IG, 2002, CHROMOSOMA, V111, P22, DOI 10.1007/s00412-002-0182-8; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dialynas GK, 2006, J BIOL CHEM, V281, P14350, DOI 10.1074/jbc.M600558200; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Gaudin V, 2001, DEVELOPMENT, V128, P4847; Germann S, 2006, PLANT J, V48, P153, DOI 10.1111/j.1365-313X.2006.02859.x; HAUGHN GW, 1991, PLANT PHYSIOL, V97, P217, DOI 10.1104/pp.97.1.217; Hennig L, 2003, DEVELOPMENT, V130, P2555, DOI 10.1242/dev.00470; Hennig L, 2005, TRENDS CELL BIOL, V15, P295, DOI 10.1016/j.tcb.2005.04.004; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Katz A, 2004, PLANT J, V37, P707, DOI 10.1111/j.1365-313X.2003.01996.x; Kim JH, 2004, PLANT MOL BIOL, V54, P671, DOI 10.1023/B:PLAN.0000040897.49151.98; Kohler C, 2008, TRENDS CELL BIOL, V18, P236, DOI 10.1016/j.tcb.2008.02.005; Kotake T, 2003, PLANT CELL PHYSIOL, V44, P555, DOI 10.1093/pcp/pcg091; Larsson AS, 1998, GENETICS, V149, P597; Libault M, 2005, PLANTA, V222, P910, DOI 10.1007/s00425-005-0129-4; Meehan RR, 2003, EMBO J, V22, P3164, DOI 10.1093/emboj/cdg306; Mimida N, 2007, MOL GENET GENOMICS, V278, P295, DOI 10.1007/s00438-007-0250-0; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; MOMANY FA, 1992, J COMPUT CHEM, V13, P888, DOI 10.1002/jcc.540130714; Mylne JS, 2006, P NATL ACAD SCI USA, V103, P5012, DOI 10.1073/pnas.0507427103; Nakahigashi K, 2005, PLANT CELL PHYSIOL, V46, P1747, DOI 10.1093/pcp/pci195; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Sanchez-Pulido L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-308; Schonrock N, 2006, GENE DEV, V20, P1667, DOI 10.1101/gad.377206; Schonrock N, 2006, J BIOL CHEM, V281, P9560, DOI 10.1074/jbc.M513426200; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Telfer A, 1997, DEVELOPMENT, V124, P645; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Xu L, 2008, CURR BIOL, V18, P1966, DOI 10.1016/j.cub.2008.11.019; Zemach A, 2006, PLANT CELL, V18, P133, DOI 10.1105/tpc.105.036855; Zhang X, 2007, NAT STRUCT MOL BIOL, V14, P869, DOI 10.1038/nsmb1283	43	102	109	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5335	10.1371/journal.pone.0005335	http://dx.doi.org/10.1371/journal.pone.0005335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399177	Green Published, gold, Green Submitted			2022-12-25	WOS:000265514900003
J	Chang, YC; Kao, WC; Wang, WY; Wang, WY; Yang, RB; Peck, K				Chang, Yi-Chung; Kao, Wei-Chen; Wang, Wei-Ya; Wang, Wan-Yi; Yang, Ruey-Bing; Peck, Konan			Identification and characterization of oligonucleotides that inhibit Toll-like receptor 2-associated immune responses	FASEB JOURNAL			English	Article						aptamer microarray; microbial infection; IP-SELEX	GINGIVALIS LIPOPOLYSACCHARIDE; PORPHYROMONAS-GINGIVALIS; CELL MATURATION; KAPPA-B; RNA; ACTIVATION; PROTEIN; APTAMERS; LIGANDS; MICE	Toll-like receptors (TLRs) play important roles in the immune responses against invading microorganisms. Development of TLR antagonists is recognized as a promising direction in suppressing the associated inflammatory reactions of the TLRs. Aptamers are single-stranded RNA or DNA molecules isolated through an in vitro selection process. Using a novel molecular evolution strategy that combines immuno-precipitation (IP) with systematic evolution of ligands by exponential enrichment (SELEX), we developed an IP-SELEX selection method to facilitate the screening of high-affinity aptamers for the Toll-like receptor 2 (TLR2). Also, human TLR2 functional aptamers were identified and characterized using NF-kappa B reporter assays. Among the functional aptamers, the most effective, AP177, with a dissociation constant of 73 pM, was characterized with TLR2-expressing cells challenged with bacterial cells and purified ligands. The aptamer could effectively antagonize TLR2, significantly inhibit NF-kappa B activity, and suppress the secretion of the cytokines by >80%. In addition, the precise region within the functional aptamer that specifically bound TLR2 was resolved using aptamer microarray analysis. The results of functional assays showed that AP177 acted as a TLR2 antagonist and may hold therapeutic potential in the treatment of diseases related to dysregulated TLR2 immune responses.-Chang, Y.-C., Kao, W.-C., Wang, W.-Y., Wang, W.-Y., Yang, R.-B., Peck, K. Identification and characterization of oligonucleotides that inhibit Toll-like receptor 2-associated immune responses. FASEB J. 23, 3078-3088 ( 2009). www.fasebj.org	[Chang, Yi-Chung; Kao, Wei-Chen; Wang, Wei-Ya; Wang, Wan-Yi; Yang, Ruey-Bing; Peck, Konan] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Chang, Yi-Chung; Peck, Konan] Natl Taiwan Univ, Dept Microbiol, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Peck, K (corresponding author), Acad Sinica, Inst Biomed Sci, 128,Sec 2,Acad Rd, Taipei 115, Taiwan.	konan@ibms.sinica.edu.tw	Yang, Ruey-Bing/O-1494-2018; Wang, Pa-Chun/AAD-4094-2019	Yang, Ruey-Bing/0000-0003-3017-3714; 	National Science Council [NSC-96-2628-B-001-024-MY3]; Department of Health, and Academia Sinica, Taipei, Taiwan, ROC	National Science Council(Ministry of Science and Technology, Taiwan); Department of Health, and Academia Sinica, Taipei, Taiwan, ROC	This work was supported by the National Science Council (NSC-96-2628-B-001-024-MY3), the NRPGM grant from the Department of Health, and Academia Sinica, Taipei, Taiwan, ROC. The authors declare no competing financial interests.	Abrahams VM, 2004, J IMMUNOL, V173, P4286, DOI 10.4049/jimmunol.173.7.4286; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Bourquin C, 2008, J IMMUNOL, V181, P2990, DOI 10.4049/jimmunol.181.5.2990; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Cerchia L, 2005, PLOS BIOL, V3, P697, DOI 10.1371/journal.pbio.0030123; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Hamdy S, 2008, VACCINE, V26, P5046, DOI 10.1016/j.vaccine.2008.07.035; Hayashi EA, 2005, J IMMUNOL, V174, P6639, DOI 10.4049/jimmunol.174.11.6639; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; HAYLETT DG, 2003, TXB RECEPTOR PHARM, P153; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hertz CJ, 2001, J IMMUNOL, V166, P2444, DOI 10.4049/jimmunol.166.4.2444; Huang YH, 2006, ENDOCRINOLOGY, V147, P4792, DOI 10.1210/en.2005-1476; Johnson GB, 2003, CRIT REV IMMUNOL, V23, P15, DOI 10.1615/CritRevImmunol.v23.i12.20; Katilius E, 2007, NUCLEIC ACIDS RES, V35, P7626, DOI 10.1093/nar/gkm922; Kido J, 2003, J PERIODONTAL RES, V38, P557, DOI 10.1034/j.1600-0765.2003.00691.x; Koch TH, 2004, J MOL BIOL, V336, P1159, DOI 10.1016/j.jmb.2004.01.001; Lee JH, 2005, P NATL ACAD SCI USA, V102, P18902, DOI 10.1073/pnas.0509069102; Liu X, 2008, ATHEROSCLEROSIS, V196, P146, DOI 10.1016/j.atherosclerosis.2007.03.025; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; McNamara JO, 2008, J CLIN INVEST, V118, P376, DOI 10.1172/JCI33365; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Meng GX, 2004, J CLIN INVEST, V113, P1473, DOI 10.1172/JCI200420762; Mi J, 2006, NUCLEIC ACIDS RES, V34, P3577, DOI 10.1093/nar/gkl482; Mullick AE, 2005, J CLIN INVEST, V115, P3149, DOI 10.1172/JCI25482; Nemoto E, 2006, J DENT RES, V85, P733, DOI 10.1177/154405910608500809; Nishikawa F, 2003, NUCLEIC ACIDS RES, V31, P1935, DOI 10.1093/nar/gkg291; Okusawa T, 2004, INFECT IMMUN, V72, P1657, DOI 10.1128/IAI.72.3.1657-1665.2004; Quesniaux VJ, 2004, J IMMUNOL, V172, P4425, DOI 10.4049/jimmunol.172.7.4425; Rodriguez D, 2003, J IMMUNOL, V171, P1001, DOI 10.4049/jimmunol.171.2.1001; Rusconi CP, 2004, NAT BIOTECHNOL, V22, P1423, DOI 10.1038/nbt1023; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wyllie DH, 2000, J IMMUNOL, V165, P7125, DOI 10.4049/jimmunol.165.12.7125; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yadav M, 2006, BLOOD, V108, P3168, DOI 10.1182/blood-2006-05-024406; Zhang D, 2008, INNATE IMMUN-LONDON, V14, P99, DOI 10.1177/1753425907088244; Zhou QD, 2007, J IMMUNOL, V179, P7777, DOI 10.4049/jimmunol.179.11.7777	49	49	53	3	31	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					3078	3088		10.1096/fj.09-129312	http://dx.doi.org/10.1096/fj.09-129312			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19406842				2022-12-25	WOS:000270241000030
J	Davies, MJ; Miranda, E; Roussel, BD; Kaufman, RJ; Marciniak, SJ; Lomas, DA				Davies, Mark J.; Miranda, Elena; Roussel, Benoit D.; Kaufman, Randal J.; Marciniak, Stefan J.; Lomas, David A.			Neuroserpin Polymers Activate NF-kappa B by a Calcium Signaling Pathway That Is Independent of the Unfolded Protein Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-OVERLOAD RESPONSE; ENDOPLASMIC-RETICULUM; CONFORMATIONAL DISEASE; INCLUSION-BODIES; REACTIVE LOOP; DEMENTIA; PHOSPHORYLATION; ACCUMULATION; TRANSDUCTION; TRANSLATION	The autosomal dominant dementia familial encephalopathy with neuroserpin inclusion bodies is characterized by the accumulation of ordered polymers of mutant neuroserpin within the endoplasmic reticulum of neurones. We show here that intracellular neuroserpin polymers activate NF-kappa B by a pathway that is independent of the IRE1, ATF6, and PERK limbs of the canonical unfolded protein response but is dependent on intracellular calcium. This pathway provides a mechanism for cells to sense and react to the accumulation of folded structures of mutant serpins within the endoplasmic reticulum. Our results provide strong support for the endoplasmic reticulum overload response being independent of the unfolded protein response.	[Davies, Mark J.; Miranda, Elena; Roussel, Benoit D.; Marciniak, Stefan J.; Lomas, David A.] Univ Cambridge, Cambridge Inst Med Res, Dept Med, Cambridge CB2 0XY, England; [Kaufman, Randal J.] Univ Michigan, Med Ctr, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Kaufman, Randal J.] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Kaufman, Randal J.] Univ Michigan, Med Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Cambridge; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lomas, DA (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Med, Wellcome Trust Med Res Council Bldg,Hills Rd, Cambridge CB2 0XY, England.	dal16@cam.ac.uk	Roussel, Benoit/L-9520-2018; Marciniak, Stefan J/F-1855-2010; Roussel, Benoit/P-9309-2019; Miranda, Elena/J-4999-2012; Longo, Kenneth A/A-5631-2010	Roussel, Benoit/0000-0003-0575-8112; Miranda, Elena/0000-0002-0586-8795; Marciniak, Stefan/0000-0001-8472-7183	National Institutes of Health [RO1-DK042394, RO1-HL052173, PO1-HL057346]; Medical Research Council; Papworth National Health Service Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057346, R01HL052173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042394, R01DK042394] Funding Source: NIH RePORTER; Medical Research Council [G0500306, G0601840] Funding Source: researchfish; MRC [G0601840, G0500306] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Papworth National Health Service Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK042394, RO1-HL052173, and PO1-HL057346 ( to R. J. K.). This work was also supported by the Medical Research Council ( MRC, UK) and Papworth National Health Service Trust.	Bartz SR, 1997, METHODS, V12, P337, DOI 10.1006/meth.1997.0487; Belorgey D, 2002, J BIOL CHEM, V277, P17367, DOI 10.1074/jbc.M200680200; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Davis RL, 1999, AM J PATHOL, V155, P1901, DOI 10.1016/S0002-9440(10)65510-1; Davis RL, 1999, NATURE, V401, P376, DOI 10.1038/43897; Davis RL, 2002, LANCET, V359, P2242, DOI 10.1016/S0140-6736(02)09293-0; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Gooptu B, 2000, P NATL ACAD SCI USA, V97, P67, DOI 10.1073/pnas.97.1.67; GRAHAM KS, 1990, J BIOL CHEM, V265, P20463; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hidvegi T, 2005, J BIOL CHEM, V280, P39002, DOI 10.1074/jbc.M508652200; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Knorre A, 2002, BIOL CHEM, V383, P271, DOI 10.1515/BC.2002.029; Kuang E, 2005, J CELL PHYSIOL, V204, P549, DOI 10.1002/jcp.20340; Lawless MW, 2004, J IMMUNOL, V172, P5722, DOI 10.4049/jimmunol.172.9.5722; LIBBY P, 1978, SCIENCE, V199, P534, DOI 10.1126/science.622552; Lilienbaum A, 2003, MOL CELL BIOL, V23, P2680, DOI 10.1128/MCB.23.8.2680-2698.2003; Lomas DA, 2002, NAT REV GENET, V3, P759, DOI 10.1038/nrg907; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; Miranda E, 2004, J BIOL CHEM, V279, P28283, DOI 10.1074/jbc.M313166200; Miranda E, 2008, HUM MOL GENET, V17, P1527, DOI 10.1093/hmg/ddn041; Molinari M, 2000, SCIENCE, V288, P331, DOI 10.1126/science.288.5464.331; Pahl HL, 1996, FEBS LETT, V392, P129, DOI 10.1016/0014-5793(96)00800-9; Pahl HL, 1999, PHYSIOL REV, V79, P683, DOI 10.1152/physrev.1999.79.3.683; PAHL HL, 1995, EMBO J, V14, P2580, DOI 10.1002/j.1460-2075.1995.tb07256.x; Pahl HL, 1996, J CELL BIOL, V132, P511, DOI 10.1083/jcb.132.4.511; Pahl HL, 1997, TRENDS BIOCHEM SCI, V22, P63, DOI 10.1016/S0968-0004(96)10073-6; Palmer EA, 2003, J CELL SCI, V116, P2361, DOI 10.1242/jcs.00439; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; SEGLEN PO, 1983, METHOD ENZYMOL, V96, P737; Shen JS, 2005, METHODS, V35, P382, DOI 10.1016/j.ymeth.2004.10.011; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Sivasothy P, 2000, J BIOL CHEM, V275, P33663, DOI 10.1074/jbc.M004054200; STEFFAN NM, 1995, J IMMUNOL, V155, P4685; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V279, pG961, DOI 10.1152/ajpgi.2000.279.5.G961; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923	46	61	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18202	18209		10.1074/jbc.M109.010744	http://dx.doi.org/10.1074/jbc.M109.010744			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19423713	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000267712400032
J	Chen, RQ; Yang, QK; Chen, YL; Oliveira, VA; Dalton, WS; Fearns, C; Lee, JD				Chen, Run-Qiang; Yang, Qing-Kai; Chen, Yan-Ling; Oliveira, Vasco A.; Dalton, William S.; Fearns, Colleen; Lee, Jiing-Dwan			Kinome Sirna Screen Identifies SMG-1 as a Negative Regulator of Hypoxia-inducible Factor-1 alpha in Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA SURVEILLANCE PROTEIN; OXIDATIVE STRESS; LIFE-SPAN; CANCER; KINASE; HIF-1; MTOR; PATHWAYS; COMPLEX; HSMG-1	Hypoxia-inducible factor-1 (HIF-1) plays a central role in tumor progression by regulating genes involved in proliferation, glycolysis, angiogenesis, and metastasis. To improve our understanding of HIF-1 regulation by kinome, we screened a kinase-specific small interference RNA library using a hypoxia-response element (HRE) luciferase reporter assay under hypoxic conditions. This screen determined that depletion of cellular SMG-1 kinase most significantly modified cellular HIF-1 activity in hypoxia. SMG-1 is the newest and least studied member of the phosphoinositide 3-kinase-related kinase family, which consists of ATM, ATR, DNA-PKcs, mTOR, and SMG-1. We individually depleted members of the phosphoinositide 3-kinase-related kinase family, and only SMG-1 deficiency significantly augmented HIF-1 activity in hypoxia. We subsequently discovered that SMG-1 kinase activity was activated by hypoxia, and depletion of SMG-1 up-regulated MAPK activity under low oxygen. Suppressing cellular MAPK by silencing ERK1/2 or by treatment with U0126, a MAPK inhibitor, partially blocked the escalation of HIF-1 activity resulting from SMG-1 deficiency in hypoxic cells. Increased expression of SMG-1 but not kinase-dead SMG-1 effectively inhibited the activity of HIF-1 alpha. In addition, cellular SMG-1 deficiency increased secretion of the HIF-1 alpha-regulated angiogenic factor, vascular epidermal growth factor, and survival factor, carbonic anhydrase IX (CA9), as well as promoted the hypoxic cell motility. Taken together, we discovered that SMG-1 negatively regulated HIF-1 alpha activity in hypoxia, in part through blocking MAPK activation.	[Lee, Jiing-Dwan] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Fearns, Colleen] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Oliveira, Vasco A.; Dalton, William S.] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Expt Therapeut & Interdisciplinary Oncol, Tampa, FL 33612 USA	Scripps Research Institute; Scripps Research Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Lee, JD (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, IMM 12,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jdlee@scripps.edu	chen, yanling/GRE-8287-2022; Yang, Qingkai/AAK-5111-2021	Yang, Qingkai/0000-0001-6628-5393	National Institutes of Health [CA079871, CA114059]; Tobacco-Related Disease, Research Program of the University of California [15RT-0104]; NATIONAL CANCER INSTITUTE [R01CA079871, R01CA114059] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco-Related Disease, Research Program of the University of California(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA079871 and CA114059 (to J.-D.L.). This work was also supported by funds from the Tobacco-Related Disease, Research Program of the University of California (Grant 15RT-0104 to J.-D.L.).	Abraham RT, 2004, DNA REPAIR, V3, P919, DOI 10.1016/j.dnarep.2004.04.003; Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bell EL, 2007, MOL CELL BIOL, V27, P5737, DOI 10.1128/MCB.02265-06; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Blanco S, 2007, MOL CELL BIOL, V27, P7273, DOI 10.1128/MCB.00025-07; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Denning G, 2001, J BIOL CHEM, V276, P22709, DOI 10.1074/jbc.C100144200; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Gehen SC, 2008, ONCOGENE, V27, P4065, DOI 10.1038/onc.2008.48; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Liu CJ, 2005, EXP CELL RES, V309, P410, DOI 10.1016/j.yexcr.2005.06.022; Masse I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003354; Minet E, 2000, FEBS LETT, V468, P53, DOI 10.1016/S0014-5793(00)01181-9; Morita T, 2007, J BIOL CHEM, V282, P7799, DOI 10.1074/jbc.M610159200; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Oliveira V, 2008, J BIOL CHEM, V283, P13174, DOI 10.1074/jbc.M708008200; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Sang NL, 2003, J BIOL CHEM, V278, P14013, DOI 10.1074/jbc.M209702200; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sodhi A, 2001, BIOCHEM BIOPH RES CO, V287, P292, DOI 10.1006/bbrc.2001.5532; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Sutton KM, 2007, ONCOGENE, V26, P3920, DOI 10.1038/sj.onc.1210168; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001	38	20	22	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16752	16758		10.1074/jbc.M109.014316	http://dx.doi.org/10.1074/jbc.M109.014316			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19406746	hybrid, Green Published			2022-12-25	WOS:000266962400010
J	Wei, XL; Guo, W; Wu, SH; Wang, L; Lu, YL; Xu, B; Liu, JS; Fang, BL				Wei, Xiaoli; Guo, Wei; Wu, Shuhong; Wang, Li; Lu, Yiling; Xu, Bo; Liu, Jinsong; Fang, Bingliang			Inhibiting JNK Dephosphorylation and Induction of Apoptosis by Novel Anticancer Agent NSC-741909 in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUN NH2-TERMINAL KINASE; ALPHA-INDUCED APOPTOSIS; N-TERMINAL KINASE; PROTEIN-KINASE; SYNTHETIC LETHALITY; SIGNAL-TRANSDUCTION; ACTIVATION DOMAIN; MAP KINASES; HA-RAS; C-IOTA	NSC-741909 is a recently identified novel anticancer agent that suppresses the growth of several NCI-60 cancer cell lines with a unique anticancer spectrum. However, its molecular mechanisms remain unknown. To determine the molecular mechanisms of NSC-741909- induced antitumor activity, we analyzed the changes of 77 protein biomarkers in a sensitive lung cancer cell line after treatment with this compound by using reverse-phase protein microarray. The results showed that phosphorylation of mitogen-activated protein (MAP) kinases (P38 MAPK, ERK, and JNK) were persistently elevated by the treatment with NSC-741909. However, only the JNK-specific inhibitor SP600125 effectively blocked the apoptosis induced by NSC-741909. Moreover, NSC-741909-mediated apoptosis was also blocked by a dominant-negative JNK construct, suggesting that sustained activation of JNK is critical for the apoptosis induction. Further studies revealed that treatment with NSC-741909 suppressed dephosphorylation of JNK and the expression of MAPK phosphatase-1. Thus, NSC-741909 mediated inhibition of JNK dephosphorylation results in sustained JNK activation, which leads to apoptosis in cancer cells.	[Wei, Xiaoli; Guo, Wei; Wu, Shuhong; Wang, Li; Fang, Bingliang] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Lu, Yiling] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Liu, Jinsong] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Xu, Bo] Univ Texas Med Branch, Prot Biosynth & Biomarker Core Lab, Galveston, TX 77555 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Medical Branch Galveston	Fang, BL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA.	bfang@mdanderson.org			National Institutes of Health [R01 CA 092487]; Cancer Center [CA 3P30CA016672]; Lockton; NATIONAL CANCER INSTITUTE [R01CA131183, R01CA124951, P30CA016672, R01CA092487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; Lockton; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA 092487 (to B. F.) through the NCI. This work was also supported by Lockton Grant matching funds and by Cancer Center Support Grant CA 3P30CA016672 (J. Mendelsohn).	ADLER V, 1995, P NATL ACAD SCI USA, V92, P10585, DOI 10.1073/pnas.92.23.10585; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DOBZHANSKY T, 1946, GENETICS, V31, P269; Guo W, 2008, CANCER RES, V68, P7403, DOI 10.1158/0008-5472.CAN-08-1449; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Joneson T, 1997, J MOL MED-JMM, V75, P587, DOI 10.1007/s001090050143; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kang HJ, 2003, INT J CANCER, V103, P475, DOI 10.1002/ijc.10855; Kennedy NJ, 2003, GENE DEV, V17, P629, DOI 10.1101/gad.1062903; Kennedy NJ, 2003, CELL CYCLE, V2, P199, DOI 10.4161/cc.2.3.388; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Liu JS, 2004, CANCER RES, V64, P1655, DOI 10.1158/0008-5472.CAN-03-3380; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Murray NR, 2004, J CELL BIOL, V164, P797, DOI 10.1083/jcb.200311011; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; RUBINSTEIN LV, 1990, J NATL CANCER I, V82, P1113, DOI 10.1093/jnci/82.13.1113; Santibanez JF, 2005, FEBS LETT, V579, P6459, DOI 10.1016/j.febslet.2005.10.025; Tang FM, 2002, MOL CELL BIOL, V22, P8571, DOI 10.1128/MCB.22.24.8571-8579.2002; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Wojtaszek PA, 1998, J BIOL CHEM, V273, P800, DOI 10.1074/jbc.273.2.800; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Zhang L, 2002, GENE THER, V9, P1262, DOI 10.1038/sj.gt.3301797	32	20	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16948	16955		10.1074/jbc.M109.010256	http://dx.doi.org/10.1074/jbc.M109.010256			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19414586	hybrid, Green Published			2022-12-25	WOS:000266962400032
J	Charriere, F; O'Donoghue, P; Helgadottir, S; Marechal-Drouard, L; Cristodero, M; Horn, EK; Soll, D; Schneider, A				Charriere, Fabien; O'Donoghue, Patrick; Helgadottir, Sunna; Marechal-Drouard, Laurence; Cristodero, Marina; Horn, Elke K.; Soell, Dieter; Schneider, Andre			Dual Targeting of a tRNA(Asp) Requires Two Different Aspartyl-tRNA Synthetases in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOACYL-TRANSFER-RNA; SACCHAROMYCES-CEREVISIAE; LEISHMANIA-TARENTOLAE; EVOLUTIONARY HISTORY; GENETIC-CODE; MITOCHONDRIAL; ANTICODON; IMPORT; SYSTEM; BIOGENESIS	The mitochondrion of the parasitic protozoon Trypanosoma brucei does not encode any tRNAs. This deficiency is compensated for by partial import of nearly all of its cytosolic tRNAs. Most trypanosomal aminoacyl-tRNA synthetases are encoded by single copy genes, suggesting the use of the same enzyme in the cytosol and in the mitochondrion. However, the T. brucei genome encodes two distinct genes for eukaryotic aspartyl-tRNA synthetase (AspRS), although the cell has a single tRNA(Asp) isoacceptor only. Phylogenetic analysis showed that the two T. brucei AspRSs evolved from a duplication early in kinetoplastid evolution and also revealed that eight other major duplications of AspRS occurred in the eukaryotic domain. RNA interference analysis established that both Tb-AspRS1 and Tb-AspRS2 are essential for growth and required for cytosolic and mitochondrial Asp-tRNA(Asp) formation, respectively. In vitro charging assays demonstrated that the mitochondrial Tb-AspRS2 aminoacylates both cytosolic and mitochondrial tRNA(Asp), whereas the cytosolic Tb-AspRS1 selectively recognizes cytosolic but not mitochondrial tRNA(Asp). This indicates that cytosolic and mitochondrial tRNA(Asp), although derived from the same nuclear gene, are physically different, most likely due to a mitochondria-specific nucleotide modification. Mitochondrial Tb-AspRS2 defines a novel group of eukaryotic AspRSs with an expanded substrate specificity that are restricted to trypanosomatids and therefore may be exploited as a novel drug target.	[Charriere, Fabien; Cristodero, Marina; Horn, Elke K.; Schneider, Andre] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; [O'Donoghue, Patrick; Helgadottir, Sunna; Soell, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [O'Donoghue, Patrick; Helgadottir, Sunna; Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Marechal-Drouard, Laurence] Univ Strasbourg, Unite Propre Rech 2357, Inst Biol Mol Plantes, F-67084 Strasbourg, France; [Marechal-Drouard, Laurence] Univ Strasbourg, CNRS, F-67084 Strasbourg, France	University of Bern; Yale University; Yale University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Schneider, A (corresponding author), Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland.	andre.schneider@ibc.unibe.ch	Drouard, Laurence/D-2385-2010; Cristodero, Marina/AAK-5703-2021; Cristodero, Marina/AAC-8824-2022	Drouard, Laurence/0000-0001-6537-524X; O'Donoghue, Patrick/0000-0002-9500-8640	Swiss National Foundation [3100A0_121937]; VELUX Foundation	Swiss National Foundation(Swiss National Science Foundation (SNSF)); VELUX Foundation(Velux Fonden)	This work was supported by Swiss National Foundation Grant 3100A0_121937 (to A. S.) and by a grant from the VELUX Foundation (to F.C.).	Alfonzo JD, 1999, EMBO J, V18, P7056, DOI 10.1093/emboj/18.24.7056; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Besteiro S, 2005, TRENDS PARASITOL, V21, P185, DOI 10.1016/j.pt.2005.02.008; Bhattacharyya Suvendra Nath, 2004, RNA Biol, V1, P84, DOI 10.4161/rna.1.2.1180; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Charriere F, 2006, P NATL ACAD SCI USA, V103, P6847, DOI 10.1073/pnas.0602362103; CHATTON B, 1988, J BIOL CHEM, V263, P52; Crain PF, 2002, RNA, V8, P752, DOI 10.1017/S1355838202022045; Dorner M, 2001, MOL BIOL CELL, V12, P2688, DOI 10.1091/mbc.12.9.2688; Duchene AM, 2005, P NATL ACAD SCI USA, V102, P16484, DOI 10.1073/pnas.0504682102; Dutta Shuchismita, 2008, V426, P81, DOI 10.1007/978-1-60327-058-8_5; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Feagin JE, 2000, INT J PARASITOL, V30, P371, DOI 10.1016/S0020-7519(99)00190-3; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Horvath A, 2002, J BIOL CHEM, V277, P7222, DOI 10.1074/jbc.M109715200; Luscher A, 2007, CURR PHARM DESIGN, V13, P555, DOI 10.2174/138161207780162809; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD528, DOI 10.1093/nar/gkm846; McCulloch Richard, 2004, Methods Mol Biol, V262, P53; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; O'Donoghue P, 2005, P NATL ACAD SCI USA, V102, P19003, DOI 10.1073/pnas.0509617102; O'Donoghue P, 2003, MICROBIOL MOL BIOL R, V67, P550, DOI 10.1128/MMBR.67.4.550-573.2003; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Rinehart J, 2005, GENE DEV, V19, P583, DOI 10.1101/gad.1269305; Rinehart J, 2004, J BIOL CHEM, V279, P1161, DOI 10.1074/jbc.M310100200; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; Salinas T, 2008, TRENDS BIOCHEM SCI, V33, P320, DOI 10.1016/j.tibs.2008.04.010; Sauter C, 2000, J MOL BIOL, V299, P1313, DOI 10.1006/jmbi.2000.3791; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; Schneider A, 2001, INT J PARASITOL, V31, P1403, DOI 10.1016/S0020-7519(01)00296-X; Schneider A, 2000, TRENDS CELL BIOL, V10, P509, DOI 10.1016/S0962-8924(00)01854-7; SCHNEIDER A, 1994, NUCLEIC ACIDS RES, V22, P3699, DOI 10.1093/nar/22.18.3699; Schneider A, 2001, TRENDS GENET, V17, P557, DOI 10.1016/S0168-9525(01)02439-8; Schneider Andre, 2007, Methods Mol Biol, V372, P67, DOI 10.1007/978-1-59745-365-3_5; Schneider Andre, 2007, Methods Mol Biol, V372, P379, DOI 10.1007/978-1-59745-365-3_27; Shen N, 2006, NUCLEIC ACIDS RES, V34, P3246, DOI 10.1093/nar/gkl441; Sheppard K, 2008, J MOL BIOL, V377, P831, DOI 10.1016/j.jmb.2008.01.016; Small I, 1998, PLANT MOL BIOL, V38, P265, DOI 10.1023/A:1006081903354; van der Giezen M, 2005, INT REV CYTOL, V244, P175, DOI 10.1016/S0074-7696(05)44005-X; VASSELLA E, 1994, NUCLEIC ACIDS RES, V22, P1359, DOI 10.1093/nar/22.8.1359; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Yang XL, 2003, P NATL ACAD SCI USA, V100, P15376, DOI 10.1073/pnas.2136794100	45	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16210	16217		10.1074/jbc.M109.005348	http://dx.doi.org/10.1074/jbc.M109.005348			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19386587	hybrid, Green Published			2022-12-25	WOS:000266730900018
J	Lopez-Soto, A; Folgueras, AR; Seto, E; Gonzalez, S				Lopez-Soto, A.; Folgueras, A. R.; Seto, E.; Gonzalez, S.			HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer	ONCOGENE			English	Article						ULBPs; NKG2D; HDAC3; tumour immunosurveillance	HISTONE DEACETYLASE INHIBITORS; I-RELATED CHAIN; NK CELLS; T-CELLS; RECEPTOR; SP3; CYTOTOXICITY; ACTIVATION; PROMOTER; SUSCEPTIBILITY	The expression of the NKG2D ligands on cancer cells leads to their recognition and elimination by host immune responses mediated by natural killer and T cells. UL160-binding proteins (ULBPs) are NKG2D ligands, which are scarcely expressed in epithelial tumours, favouring their evasion from the immune system. Herein, we investigated the epigenetic mechanisms underlying the repression of ULBPs in epithelial cancer cells. We show that ULBP1-3 expression is increased in tumour cells after exposure to the inhibitor of histone deacetylases (HDACs) trichostatin A (TSA), which enhances the natural killer cell-mediated cytotoxicity of HeLa cells. Our experiments showed that the transcription factor Sp3 is crucial in the activation of the ULBP1 promoter by TSA. Furthermore, by small interfering RNA-mediated knockdown and overexpression of HDAC1-3, we showed that HDAC3 is a repressor of ULBPs expression in epithelial cancer cells. Remarkably, TSA treatment caused the complete release of HDAC3 from the ULBP1-3 promoters. HDAC3 is recruited to the ULBP1 promoter through its interaction with Sp3 and TSA treatment interfered with this association. Together, we describe a new mechanism by which cancer cells may evade the immune response through the epigenetic modulation of the ULBPs expression and provide a model in which HDAC inhibitors may favour the elimination of transformed cells by increasing the immunogenicity of epithelial tumours. Oncogene (2009) 28, 2370-2382; doi:10.1038/onc.2009.117; published online 11 May 2009	[Gonzalez, S.] Univ Oviedo, Dept Biol Func, IUOPA, Fac Med, E-33006 Oviedo, Spain; [Folgueras, A. R.] Univ Oviedo, Dept Bioquim & Biol Mol, IUOPA, E-33006 Oviedo, Spain; [Seto, E.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Oviedo; Instituto Universitario de Oncologia de Asturias; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Gonzalez, S (corresponding author), Univ Oviedo, Dept Biol Func, IUOPA, Fac Med, Julian Claveria S-N, E-33006 Oviedo, Spain.	segundog@uniovi.es	Folgueras, Alicia/B-3281-2017; López-Soto, Alejandro/A-9779-2018; Gonzalez, Segundo/AAK-8719-2021	Folgueras, Alicia/0000-0003-3426-9502; López-Soto, Alejandro/0000-0002-6360-5205; Gonzalez, Segundo/0000-0003-4631-9255	Spanish grants of Fondo de Investigaciones Sanitarias [PI-06/0841]; FICYT of Asturias [BP06-99]	Spanish grants of Fondo de Investigaciones Sanitarias; FICYT of Asturias	We thank Dr Spies and Amgen for kindly providing ULBP antibodies, Dr Garcia de Herreros for providing HT-29 M6 cells, Banco de Tumores del Hospital Universitario Central de Asturias for providing human tumour samples, Dr G Gill for providing the pBS/U6-Scrambled plasmid, Dr A Astudillo for histopathological evaluation, Dr C Lopez-Otin for helpful comments and A Vallina and MS Pitiot for technical assistance. This work was supported by the Spanish grants of Fondo de Investigaciones Sanitarias PI-06/0841. ALS holds a predoctoral fellowship from FICYT of Asturias (BP06-99).	Ammanamanchi S, 2003, J BIOL CHEM, V278, P35775, DOI 10.1074/jbc.M305961200; Andresen L, 2007, J IMMUNOL, V179, P8235, DOI 10.4049/jimmunol.179.12.8235; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Armeanu S, 2005, CANCER RES, V65, P6321, DOI 10.1158/0008-5472.CAN-04-4252; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Braun H, 2001, NUCLEIC ACIDS RES, V29, P4994, DOI 10.1093/nar/29.24.4994; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(09)00098-3; Diermayr S, 2008, BLOOD, V111, P1428, DOI 10.1182/blood-2007-07-101311; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Gonzalez S, 2008, TRENDS IMMUNOL, V29, P397, DOI 10.1016/j.it.2008.04.007; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Kaiser BK, 2007, NATURE, V447, P482, DOI 10.1038/nature05768; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Kato N, 2007, LEUKEMIA, V21, P2103, DOI 10.1038/sj.leu.2404862; Knutson SK, 2008, EMBO J, V27, P1017, DOI 10.1038/emboj.2008.51; Kottilil S, 2006, J IMMUNOL, V176, P1107, DOI 10.4049/jimmunol.176.2.1107; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lopez-Larrea C, 2008, TRENDS MOL MED, V14, P179, DOI 10.1016/j.molmed.2008.02.004; Lopez-Soto A, 2006, J BIOL CHEM, V281, P30419, DOI 10.1074/jbc.M604868200; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Maio M, 2003, ONCOGENE, V22, P6484, DOI 10.1038/sj.onc.1206956; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Nausch N, 2008, ONCOGENE, V27, P5944, DOI 10.1038/onc.2008.272; Pende D, 2002, CANCER RES, V62, P6178; Ropero S, 2008, ONCOGENE, V27, P4008, DOI 10.1038/onc.2008.31; Salih HR, 2003, BLOOD, V102, P1389, DOI 10.1182/blood-2003-01-0019; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Skov S, 2005, CANCER RES, V65, P11136, DOI 10.1158/0008-5472.CAN-05-0599; Smyth MJ, 2005, J EXP MED, V202, P583, DOI 10.1084/jem.20050994; Sowa Y, 1999, CANCER RES, V59, P4266; Sun JM, 2002, J BIOL CHEM, V277, P35783, DOI 10.1074/jbc.C200378200; Sutherland CL, 2006, BLOOD, V108, P1313, DOI 10.1182/blood-2005-11-011320; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Waldhauer I, 2008, ONCOGENE, V27, P5932, DOI 10.1038/onc.2008.267; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Wooten-Blanks LG, 2007, FASEB J, V21, P3386, DOI 10.1096/fj.07-8621com; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Yokota T, 2004, ONCOGENE, V23, P5340, DOI 10.1038/sj.onc.1207689	45	85	89	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2009	28	25					2370	2382		10.1038/onc.2009.117	http://dx.doi.org/10.1038/onc.2009.117			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	462HS	19430493				2022-12-25	WOS:000267342400002
J	Piao, C; Jin, M; Kim, HB; Lee, SM; Amatya, PN; Hyun, JW; Chang, IY; You, HJ				Piao, C.; Jin, M.; Kim, H. B.; Lee, S. M.; Amatya, P. N.; Hyun, J-W; Chang, I-Y; You, H. J.			Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2	ONCOGENE			English	Article						p53R2; MEK2; ERK1/2; invasion; transformation	CELL-CYCLE CHECKPOINT; HUMAN CANCER-CELLS; DNA-SYNTHESIS; THYMIDYLATE SYNTHASE; RENAL-FAILURE; R2 COMPONENT; MAP KINASE; DNTP POOLS; PROTEIN; REPAIR	The p53-dependent RR small subunit (p53R2) protein, a newly identified member of the ribonucleotide reductase family, plays a key role in the p53-dependent cellular response to DNA. Several recent studies have suggested that p53R2 also plays an important role in suppressing the invasive potential of human cancer cells. However, the cellular mechanism that regulates invasiveness remains largely unknown. In this study, we show that p53R2 interacts with MEK2 (extracellular signal-regulated kinase (ERK) kinase 2-mitogen-activated protein kinase (MAPK) kinase 2), the molecule immediately upstream of ERK in the Ras-Raf-MAPK signaling cascade. In co-immunoprecipitation and immunofluorescence analyses, we found that p53R2 and MEK2 interact physically in cultured mammalian cells, and that the p53R2 segment comprising amino acids 161-206 is critical for this interaction. Moreover, serum-induced phosphorylation of MEK1/2 and ERK1/2 was greatly augmented in human cancer cells expressing small-interfering RNA against p53R2. On the other hand, phosphorylation of MEK1/2 and ERK1/2 in human cancer cells was markedly attenuated by overexpression of p53R2. Furthermore, MEK2 was required for p53R2 knockdown-induced enhancement of the invasive ability and anchorage-independent growth of human lung cancer H1299 cells. Taken together, these findings show that p53R2 negatively modulates serum-induced MEK-ERK activity and inhibits the MEK-ERK-mediated malignancy potential of human cancer cells. Oncogene (2009) 28, 2173-2184; doi: 10.1038/onc.2009.84; published online 27 April 2009	[Piao, C.; Jin, M.; Kim, H. B.; Lee, S. M.; Amatya, P. N.; Chang, I-Y; You, H. J.] Chosun Univ, DNA Repair Res Ctr, Kwangju 501759, South Korea; [Piao, C.; Kim, H. B.; You, H. J.] Chosun Univ, Dept Pharmacol, Kwangju 501759, South Korea; [Jin, M.] Yanbian Univ, Sch Med, Dept Biochem, Yanji, Jilin, Peoples R China; [Hyun, J-W] Jeju Natl Univ, Coll Med, Dept Biochem, Cheju, Jeju Do, South Korea; [Chang, I-Y] Chosun Univ, Dept Anat, Kwangju 501759, South Korea	Chosun University; Chosun University; Yanbian University; Jeju National University; Chosun University	You, HJ (corresponding author), 2F Chosun Univ, Sch Med, DNA Repair Res Ctr, 375 Seosuk Dong, Kwangju 501759, South Korea.	hjyou@chosun.ac.kr		, Chunmei/0000-0002-2975-7336; You, Ho Jin/0000-0002-0530-4017	Ministry of Science and Technology, the Korean Government [M 1063901, M 20706000032]; Chosun University	Ministry of Science and Technology, the Korean Government(Ministry of Science & Technology (MOST), Republic of Korea); Chosun University	This research was supported by a Grant [ M 1063901] [ M 20706000032] from the Ministry of Science and Technology, the Korean Government and funds from the Chosun University, 2002.	Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Cao MY, 2003, CLIN CANCER RES, V9, P4553; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Chen M, 2007, ONCOGENE, V26, P4817, DOI 10.1038/sj.onc.1210273; Devlin HL, 2008, MOL CANCER RES, V6, P808, DOI 10.1158/1541-7786.MCR-07-2027; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Enslen H, 2001, BIOL CELL, V93, P5, DOI 10.1016/S0248-4900(01)01156-X; Fan HZ, 1998, CANCER RES, V58, P1650; Fan HZ, 1996, P NATL ACAD SCI USA, V93, P14036, DOI 10.1073/pnas.93.24.14036; Fan HZ, 1997, P NATL ACAD SCI USA, V94, P13181, DOI 10.1073/pnas.94.24.13181; Gautam A, 2003, ONCOGENE, V22, P2135, DOI 10.1038/sj.onc.1206232; Gautam A, 2006, CANCER RES, V66, P6497, DOI 10.1158/0008-5472.CAN-05-4462; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212; Liu XY, 2007, CLIN COLORECTAL CANC, V6, P374, DOI 10.3816/CCC.2007.n.007; Liu XY, 2006, CLIN CANCER RES, V12, P6337, DOI 10.1158/1078-0432.CCR-06-0799; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Nakano K, 2000, ONCOGENE, V19, P4283, DOI 10.1038/sj.onc.1203774; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Powell DR, 2005, PEDIATR NEPHROL, V20, P432, DOI 10.1007/s00467-004-1696-5; Rahman L, 2004, CANCER CELL, V5, P341, DOI 10.1016/S1535-6108(04)00080-7; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Tsai MH, 2006, ONCOGENE, V25, P622, DOI 10.1038/sj.onc.1209082; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Xu X, 2008, CANCER RES, V68, P2652, DOI 10.1158/0008-5472.CAN-07-5873; Xue LJ, 2007, CANCER RES, V67, P16, DOI 10.1158/0008-5472.CAN-06-3200; Xue LJ, 2006, CANCER RES, V66, P1900, DOI 10.1158/0008-5472.CAN-05-2656; Xue LJ, 2003, CANCER RES, V63, P980; Yamaguchi T, 2001, CANCER RES, V61, P8256; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Yoshida T, 2006, INT J CANCER, V118, P1395, DOI 10.1002/ijc.21538; Zheng Z, 2007, NEW ENGL J MED, V356, P800, DOI 10.1056/NEJMoa065411; Zhou BS, 1998, CLIN EXP METASTAS, V16, P43	37	28	29	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 28	2009	28	21					2173	2184		10.1038/onc.2009.84	http://dx.doi.org/10.1038/onc.2009.84			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	451DQ	19398949				2022-12-25	WOS:000266451300006
J	Jafa, K; McElroy, P; Fitzpatrick, L; Borkowf, CB; MacGowan, R; Margolis, A; Robbins, K; Youngpairoj, AS; Stratford, D; Greenberg, A; Taussig, J; Shouse, RL; LaMarre, M; McLellan-Lemal, E; Heneine, W; Sullivan, PS				Jafa, Krishna; McElroy, Peter; Fitzpatrick, Lisa; Borkowf, Craig B.; MacGowan, Robin; Margolis, Andrew; Robbins, Ken; Youngpairoj, Ae Saekhou; Stratford, Dale; Greenberg, Alan; Taussig, Jennifer; Shouse, R. Luke; LaMarre, Madeleine; McLellan-Lemal, Eleanor; Heneine, Walid; Sullivan, Patrick S.			HIV Transmission in a State Prison System, 1988-2005	PLOS ONE			English	Article							DRUG-RESISTANCE; HEALTH	Introduction: HIV prevalence among state prison inmates in the United States is more than five times higher than among nonincarcerated persons, but HIV transmission within U.S. prisons is sparsely documented. We investigated 88 HIV seroconversions reported from 1988-2005 among male Georgia prison inmates. Methods: We analyzed medical and administrative data to describe seroconverters' HIV testing histories and performed a case-crossover analysis of their risks before and after HIV diagnosis. We sequenced the gag, env, and pol genes of seroconverters' HIV strains to identify genetically-related HIV transmission clusters and antiretroviral resistance. We combined risk, genetic, and administrative data to describe prison HIV transmission networks. Results: Forty-one (47%) seroconverters were diagnosed with HIV from July 2003-June 2005 when voluntary annual testing was offered. Seroconverters were less likely to report sex (OR [odds ratio] = 0.02, 95% CI [confidence interval]: 0-0.10) and tattooing (OR = 0.03, 95% CI: <0.01-0.20) in prison after their HIV diagnosis than before. Of 67 seroconverters' specimens tested, 33 (49%) fell into one of 10 genetically-related clusters; of these, 25 (76%) reported sex in prison before their HIV diagnosis. The HIV strains of 8 (61%) of 13 antiretroviral-naive and 21 (40%) of 52 antiretroviral-treated seroconverters were antiretroviral-resistant. Discussion: Half of all HIV seroconversions were identified when routine voluntary testing was offered, and seroconverters reduced their risks following their diagnosis. Most genetically-related seroconverters reported sex in prison, suggesting HIV transmission through sexual networks. Resistance testing before initiating antiretroviral therapy is important for newly-diagnosed inmates.			Jafa, K (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	kjafa@psi.org	McLellan-Lemal, Eleanor/J-9720-2012	McLellan-Lemal, Eleanor/0000-0002-1884-9315; MacGowan, Robin/0000-0002-8712-2849; Sullivan, Patrick Sean/0000-0002-7728-0587				Alatrakchi N, 2005, AIDS, V19, P25, DOI 10.1097/00002030-200501030-00003; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P421; [Anonymous], 2006, CRIMINOL PUBLIC POL, DOI DOI 10.1111/J.1745-9133.2006.00101.X; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P512; Hammett TM, 2006, AM J PUBLIC HEALTH, V96, P974, DOI 10.2105/AJPH.2005.066993; Johnson JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000638; Macher A, 2006, EMERG INFECT DIS, V12, P669, DOI 10.3201/eid1204.050484; MARUSCHAK L, 2006, BUREAU JUSTICE STAT; May JP, 2002, AIDS EDUC PREV, V14, P85, DOI 10.1521/aeap.14.7.85.23863; McQuillan GM, 2006, JAIDS-J ACQ IMM DEF, V41, P651, DOI 10.1097/01.qai.0000194235.31078.f6; Stephenson BL, 2005, PUBLIC HEALTH REP, V120, P84, DOI 10.1177/003335490512000114; Weinstock HS, 2004, J INFECT DIS, V189, P2174, DOI 10.1086/420789; Wolfe MI, 2001, AM J PUBLIC HEALTH, V91, P1220, DOI 10.2105/AJPH.91.8.1220	13	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5416	10.1371/journal.pone.0005416	http://dx.doi.org/10.1371/journal.pone.0005416			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	440GG	19412547	gold, Green Submitted, Green Published			2022-12-25	WOS:000265688200005
J	Majava, V; Kursula, P				Majava, Viivi; Kursula, Petri			Domain Swapping and Different Oligomeric States for the Complex Between Calmodulin and the Calmodulin-Binding Domain of Calcineurin A	PLOS ONE			English	Article								Background: Calmodulin (CaM) is a ubiquitously expressed calcium sensor that engages in regulatory interactions with a large number of cellular proteins. Previously, a unique mode of CaM target recognition has been observed in the crystal structure of a complex between CaM and the CaM-binding domain of calcineurin A. Methodology/Principal Findings: We have solved a high-resolution crystal structure of a complex between CaM and the CaM-binding domain of calcineurin A in a novel crystal form, which shows a dimeric assembly of calmodulin, as observed before in the crystal state. We note that the conformation of CaM in this complex is very similar to that of unliganded CaM, and a detailed analysis revels that the CaM-binding motif in calcineurin A is of a novel '1-11' type. However, using small-angle X-ray scattering (SAXS), we show that the complex is fully monomeric in solution, and a structure of a canonically collapsed CaM-peptide complex can easily be fitted into the SAXS data. This result is also supported by size exclusion chromatography, where the addition of the ligand peptide decreases the apparent size of CaM. In addition, we studied the energetics of binding by isothermal titration calorimetry and found them to closely resemble those observed previously for ligand peptides from CaM-dependent kinases. Conclusions/Significance: Our results implicate that CaM can also form a complex with the CaM-binding domain of calcineurin in a 1: 1 stoichiometry, in addition to the previously observed 2: 2 arrangement in the crystal state. At the structural level, going from 2: 2 association to two 1: 1 complexes will require domain swapping in CaM, accompanied by the characteristic bending of the central linker helix between the two lobes of CaM.			Majava, V (corresponding author), Univ Oulu, Dept Biochem, Oulu, Finland.	petri.kursula@oulu.fi	Kursula, Petri/AAF-4563-2020; Kursula, Petri/K-1058-2012	Kursula, Petri/0000-0001-8529-3751; Kursula, Petri/0000-0001-8529-3751				Aoyagi M, 2003, EMBO J, V22, P766, DOI 10.1093/emboj/cdg078; Brokx RD, 2001, J BIOL CHEM, V276, P14083, DOI 10.1074/jbc.M011026200; Carruthers NJ, 2008, BIOCHEMISTRY-US, V47, P3085, DOI 10.1021/bi702044x; Clapperton JA, 2002, BIOCHEMISTRY-US, V41, P14669, DOI 10.1021/bi026660t; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hayashi N, 2000, PROTEIN SCI, V9, P1905, DOI 10.1110/ps.9.10.1905; Hayashi N, 1998, PROTEIN EXPRES PURIF, V12, P25, DOI 10.1006/prep.1997.0807; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; HEIDORN DB, 1989, BIOCHEMISTRY-US, V28, P6757, DOI 10.1021/bi00442a032; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Izumi Y, 2008, BIOCHEMISTRY-US, V47, P7158, DOI 10.1021/bi702416b; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kursula P., 2004, J APPL CRYSTALLOGR, V37, P347; Kursula P, 2007, ACTA CRYSTALLOGR F, V63, P653, DOI 10.1107/S1744309107034525; Majava V, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-10; Majava V, 2008, FEBS J, V275, P4583, DOI 10.1111/j.1742-4658.2008.06601.x; Matsubara M, 2004, EMBO J, V23, P712, DOI 10.1038/sj.emboj.7600093; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noguchi M, 2004, FEBS LETT, V573, P121, DOI 10.1016/j.febslet.2004.07.079; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Ursby T, 2004, AIP CONF PROC, V705, P1241, DOI 10.1063/1.1758025; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Ye QL, 2008, PROTEINS, V73, P19, DOI 10.1002/prot.22032; Ye QL, 2006, BIOCHEMISTRY-US, V45, P738, DOI 10.1021/bi0521801; Zhang Y, 2008, J MOL RECOGNIT, V21, P267, DOI 10.1002/jmr.895	37	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5402	10.1371/journal.pone.0005402	http://dx.doi.org/10.1371/journal.pone.0005402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404396	Green Published, Green Submitted, gold			2022-12-25	WOS:000265614900013
J	Zakharian, E; Thyagarajan, B; French, RJ; Pavlov, E; Rohacs, T				Zakharian, Eleonora; Thyagarajan, Baskaran; French, Robert J.; Pavlov, Evgeny; Rohacs, Tibor			Inorganic Polyphosphate Modulates TRPM8 Channels	PLOS ONE			English	Article								Polyphosphate (polyP) is an inorganic polymer built of tens to hundreds of phosphates, linked by high-energy phosphoanhydride bonds. PolyP forms complexes and modulates activities of many proteins including ion channels. Here we investigated the role of polyP in the function of the transient receptor potential melastatin 8 (TRPM8) channel. Using whole-cell patch-clamp and fluorescent calcium measurements we demonstrate that enzymatic breakdown of polyP by exopolyphosphatase (scPPX1) inhibits channel activity in human embryonic kidney and F-11 neuronal cells expressing TRPM8. We demonstrate that the TRPM8 channel protein is associated with polyP. Furthermore, addition of scPPX1 altered the voltage-dependence and blocked the activity of the purified TRPM8 channels reconstituted into planar lipid bilayers, where the activity of the channel was initiated by cold and menthol in the presence of phosphatidylinositol 4,5-biphosphate (PtdIns(4,5) P-2). The biochemical analysis of the TRPM8 protein also uncovered the presence of poly-(R)-3-hydroxybutyrate (PHB), which is frequently associated with polyP. We conclude that the TRPM8 protein forms a stable complex with polyP and its presence is essential for normal channel activity.			Zakharian, E (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, 185 S Orange Ave, Newark, NJ 07103 USA.	zakharel@umdnj.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055159] Funding Source: NIH RePORTER; NINDS NIH HHS [NS055159, R01 NS055159] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abeele FV, 2006, J BIOL CHEM, V281, P40174, DOI 10.1074/jbc.M605779200; Abramov AY, 2007, P NATL ACAD SCI USA, V104, P18091, DOI 10.1073/pnas.0708959104; Andersson DA, 2004, J NEUROSCI, V24, P5364, DOI 10.1523/JNEUROSCI.0890-04.2004; Andersson DA, 2007, J NEUROSCI, V27, P3347, DOI 10.1523/JNEUROSCI.4846-06.2007; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; BRAUCHI S, 2004, CLUES UNDERSTANDING, P15494; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Das S, 1997, P NATL ACAD SCI USA, V94, P9075, DOI 10.1073/pnas.94.17.9075; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Gamper N, 2004, J NEUROSCI, V24, P10980, DOI 10.1523/JNEUROSCI.3869-04.2004; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; GRIFFIN JB, 1965, STUDIES PHOSPHORUS M, V7, P4427; Hardie RC, 2007, J PHYSIOL-LONDON, V578, P9, DOI 10.1113/jphysiol.2006.118372; HEGERMANN J, 2008, POLYPHOSPHATE STREPT, P174; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; HUANG R, 1996, POLY 3 HYDROXYBUTYRA, P22196; HUANG RP, 1995, J BACTERIOL, V177, P486, DOI 10.1128/jb.177.2.486-490.1995; Kim D, 2007, J NEUROSCI, V27, P6500, DOI 10.1523/JNEUROSCI.0623-07.2007; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; KORNBERG A, 1995, INORGANIC POLYPHOSPH, P491; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; Kumble KD, 1996, J BIOL CHEM, V271, P27146, DOI 10.1074/jbc.271.43.27146; Li Q, 2004, FEBS LETT, V576, P231, DOI 10.1016/j.febslet.2004.09.017; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P1, DOI 10.1007/s00424-007-0311-6; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Negoda A, 2007, P NATL ACAD SCI USA, V104, P4342, DOI 10.1073/pnas.0700495104; Negoda A, 2009, BBA-BIOMEMBRANES, V1788, P608, DOI 10.1016/j.bbamem.2008.12.017; Pavlov E, 2005, BIOPHYS J, V88, P2614, DOI 10.1529/biophysj.104.057281; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; REUSCH RN, 1995, BIOPHYS J, V69, P754, DOI 10.1016/S0006-3495(95)79958-1; REUSCH RN, 1988, P NATL ACAD SCI USA, V85, P4176, DOI 10.1073/pnas.85.12.4176; Reusch RN, 1997, FEBS LETT, V412, P592, DOI 10.1016/S0014-5793(97)00863-6; REUSCH RN, 1999, STREPTOMYCES LIVIDAN, P15666; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rohacs T, 2007, PFLUG ARCH EUR J PHY, V455, P157, DOI 10.1007/s00424-007-0275-6; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; TAMMENKOSKI M, 2007, KINETIC MUTATIONAL A, P9302; Tammenkoski M, 2008, BIOCHEMISTRY-US, V47, P9707, DOI 10.1021/bi8010847; Thebault S, 2005, J BIOL CHEM, V280, P39423, DOI 10.1074/jbc.M503544200; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, J PHYSIOL-LONDON, V582, P939, DOI 10.1113/jphysiol.2007.132522; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Wang LH, 2003, P NATL ACAD SCI USA, V100, P11249, DOI 10.1073/pnas.1534805100; WURST H, 1994, J BIOL CHEM, V269, P10996; Xian M, 2007, BBA-BIOMEMBRANES, V1768, P2660, DOI 10.1016/j.bbamem.2007.06.019; Zakharian E, 2007, BIOPHYS J, V92, P588, DOI 10.1529/biophysj.106.095273; Zakharian E, 2004, BIOCHEM BIOPH RES CO, V322, P1059, DOI 10.1016/j.bbrc.2004.08.027; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	53	96	101	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5404	10.1371/journal.pone.0005404	http://dx.doi.org/10.1371/journal.pone.0005404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404398	Green Published, Green Submitted, gold			2022-12-25	WOS:000265614900015
J	Vambutas, A; DeVoti, J; Goldofsky, E; Gordon, M; Lesser, M; Bonagura, V				Vambutas, Andrea; DeVoti, James; Goldofsky, Elliot; Gordon, Michael; Lesser, Martin; Bonagura, Vincent			Alternate Splicing of Interleukin-1 Receptor Type II (IL1R2) In Vitro Correlates with Clinical Glucocorticoid Responsiveness in Patients with AIED	PLOS ONE			English	Article							INNER-EAR DISEASE; MUCKLE-WELLS-SYNDROME; IL-1 DECOY RECEPTOR; HEARING-LOSS; T-CELLS; INNATE IMMUNITY; EXPRESSION; INDUCTION; HEAT-SHOCK-PROTEIN-70; DEXAMETHASONE	Autoimmune Inner Ear Disease (AIED) is poorly characterized clinically, with no definitive laboratory test. All patients suspected of having AIED are given glucocorticoids during periods of acute hearing loss, however, only half initially respond, and still fewer respond over time. We hypothesized that AIED is a systemic autoimmune disease characterized by dysfunctional peripheral blood mononuclear cells (PBMC) responses to a unique cochlear antigen(s). To test this hypothesis, we examined end-stage AIED patients undergoing cochlear implant surgery and compared autologous perilymph stimulated PBMC from AIED patients to controls. We determined that autologous perilymph from AIED patients was unable to induce expression of a long membrane-bound Interleukin-1 Receptor Type II (mIL1R2) transcript in PBMC as compared with controls, despite similar expression of the short soluble IL1R2 (sIL1R2) transcript ( p < 0.05). IL1R2 is a molecular decoy that traps interleukin-1 beta (IL-1 beta) and does not initiate subsequent signaling events, thereby suppressing an inflammatory response. IL1R2 transcript length is regulated by alternate splicing, and the major inhibitory function is attributed to the full-length mIL1R2. In addition, IL1R2 expression is induced by dexamethasone. Separately, we prospectively examined patients with newer onset glucocorticoid-responsive AIED. Immediately prior to clinical treatment for acute deterioration of hearing thresholds, their PBMC demonstrated a robust induction of mIL1R2 in PBMC in response to dexamethasone in vitro that correlated with a clinical response to prednisone in vivo (p < 0.0001) as measured by hearing restoration. In contrast, clinically steroid unresponsive patients demonstrated high basal levels of mIL1R2 in their PBMC and only minimally augmented expression in response to dexamethasone. Thus, induced expression of mIL1R2 appears to be a protective mechanism in hearing homeostasis and warrants further investigation in a large prospective clinical trial to determine if IL1R2 can be used as a specific biomarker for AIED.			Vambutas, A (corresponding author), N Shore LU Hlth Syst, Dept Otolaryngol, Apelian Cochlear Implant Ctr, Clinical Teaching Campus Albert Einstein Coll Med, New Hyde Pk, NY USA.	vambutas@lij.edu		Bonagura, Vincent/0000-0002-0681-2099				Agrup C, 2006, CURR OPIN NEUROL, V19, P26, DOI 10.1097/01.wco.0000194143.02171.46; Alsaeid K, 2006, JOINT BONE SPINE, V73, P62, DOI 10.1016/j.jbspin.2004.12.006; Amor-Dorado JC, 2005, ACTA OTO-LARYNGOL, V125, P1277, DOI 10.1080/00016480510012228; Attur MG, 2002, J IMMUNOL, V168, P2001, DOI 10.4049/jimmunol.168.4.2001; Auboeuf D, 2002, SCIENCE, V298, P416, DOI 10.1126/science.1073734; Berrocal JRG, 2002, ANN OTO RHINOL LARYN, V111, P989, DOI 10.1177/000348940211101107; Bessis N, 2000, EUR J IMMUNOL, V30, P867, DOI 10.1002/1521-4141(200003)30:3<867::AID-IMMU867>3.0.CO;2-M; Broughton SS, 2004, SEMIN ARTHRITIS RHEU, V34, P544, DOI 10.1016/j.semarthrit.2004.07.001; Brown EA, 1996, CYTOKINE, V8, P828; Cohen S, 2005, OTOL NEUROTOL, V26, P903, DOI 10.1097/01.mao.0000185082.28598.87; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; Colotta F, 1996, J IMMUNOL, V156, P2534; Cui XL, 2003, J IMMUNOL, V171, P6814, DOI 10.4049/jimmunol.171.12.6814; Dickensheets HL, 1997, J IMMUNOL, V159, P6226; Docagne F, 2005, EUR J NEUROSCI, V21, P1205, DOI 10.1111/j.1460-9568.2005.03965.x; Fujioka M, 2006, J NEUROSCI RES, V83, P575, DOI 10.1002/jnr.20764; Gloddek B, 2002, ACTA OTO-LARYNGOL, V122, P10, DOI 10.1080/00016480260094901; Harris JP, 2003, JAMA-J AM MED ASSOC, V290, P1875, DOI 10.1001/jama.290.14.1875; Hashimoto S, 2005, AUDIOL NEURO-OTOL, V10, P35, DOI 10.1159/000082306; Hirose K, 2005, J COMP NEUROL, V489, P180, DOI 10.1002/cne.20619; Iwai H, 1999, ANN OTO RHINOL LARYN, V108, P1146, DOI 10.1177/000348949910801209; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Liu CL, 1996, J BIOL CHEM, V271, P20965, DOI 10.1074/jbc.271.34.20965; Lorenz RR, 2002, J NEUROIMMUNOL, V130, P173, DOI 10.1016/S0165-5728(02)00190-X; Mantovani A, 2003, INT ARCH ALLERGY IMM, V132, P109, DOI 10.1159/000073711; Mantovani A, 1998, ANN NY ACAD SCI, V840, P338, DOI 10.1111/j.1749-6632.1998.tb09573.x; Matsuki T, 2006, INT IMMUNOL, V18, P399, DOI 10.1093/intimm/dxh379; MCCABE BF, 1979, ANN OTO RHINOL LARYN, V88, P585, DOI 10.1177/000348947908800501; Mirault T, 2006, ARTHRITIS RHEUM-US, V54, P1697, DOI 10.1002/art.21807; MOSCICKI RA, 1994, JAMA-J AM MED ASSOC, V272, P611, DOI 10.1001/jama.272.8.611; Neumann D, 2000, J IMMUNOL, V165, P3350, DOI 10.4049/jimmunol.165.6.3350; Niparko JK, 2005, OTOL NEUROTOL, V26, P908, DOI 10.1097/01.mao.0000185081.28598.5c; Orlando S, 1997, J BIOL CHEM, V272, P31764, DOI 10.1074/jbc.272.50.31764; Park SN, 2006, LARYNGOSCOPE, V116, P121, DOI 10.1097/01.mlg.0000187401.75156.b2; Penton-Rol G, 1999, J IMMUNOL, V162, P2931; RE F, 1994, J EXP MED, V179, P739, DOI 10.1084/jem.179.2.739; Reefhuis J, 2003, NEW ENGL J MED, V349, P435, DOI 10.1056/NEJMoa031101; Ruckenstein Michael J, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P426, DOI 10.1097/01.moo.0000136101.95662.aa; Ryan AF, 2002, ACTA OTO-LARYNGOL, V122, P38, DOI 10.1080/00016480260094965; Solares CA, 2004, J CLIN INVEST, V113, P1210, DOI 10.1172/JCI200418195; Trune DR, 1998, HEARING RES, V116, P65, DOI 10.1016/S0378-5955(97)00198-6; Wuorimaa T, 2001, SCAND J IMMUNOL, V53, P422, DOI 10.1046/j.1365-3083.2001.00882.x; Yamazaki T, 2008, ARTHRITIS RHEUM, V58, P864, DOI 10.1002/art.23261; Yeom K, 2003, LARYNGOSCOPE, V113, P1770, DOI 10.1097/00005537-200310000-00020; Zantut-Wittmann DE, 2004, HORM METAB RES, V36, P492, DOI 10.1055/s-2004-825732; Zeitoun H, 2005, ARCH OTOLARYNGOL, V131, P665, DOI 10.1001/archotol.131.8.665	46	44	46	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5293	10.1371/journal.pone.0005293	http://dx.doi.org/10.1371/journal.pone.0005293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401759	gold, Green Submitted, Green Published			2022-12-25	WOS:000265601100003
J	Li, H; Kristensen, DM; Coleman, MK; Mushegian, A				Li, Hua; Kristensen, David M.; Coleman, Michael K.; Mushegian, Arcady			Detection of Biochemical Pathways by Probabilistic Matching of Phyletic Vectors	PLOS ONE			English	Article							CELLULAR PATHWAYS; REVERSE GYRASE; VI SECRETION; PROTEIN; GENE; EVOLUTION; ARCHAEAL; GENOMES; TRAITS	A phyletic vector, also known as a phyletic (or phylogenetic) pattern, is a binary representation of the presences and absences of orthologous genes in different genomes. Joint occurrence of two or more genes in many genomes results in closely similar binary vectors representing these genes, and this similarity between gene vectors may be used as a measure of functional association between genes. Better understanding of quantitative properties of gene co-occurrences is needed for systematic studies of gene function and evolution. We used the probabilistic iterative algorithm Psi-square to find groups of similar phyletic vectors. An extended Psi-square algorithm, in which pseudocounts are implemented, shows better sensitivity in identifying proteins with known functional links than our earlier hierarchical clustering approach. At the same time, the specificity of inferring functional associations between genes in prokaryotic genomes is strongly dependent on the pathway: phyletic vectors of the genes involved in energy metabolism and in de novo biosynthesis of the essential precursors tend to be lumped together, whereas cellular modules involved in secretion, motility, assembly of cell surfaces, biosynthesis of some coenzymes, and utilization of secondary carbon sources tend to be identified with much greater specificity. It appears that the network of gene coinheritance in prokaryotes contains a giant connected component that encompasses most biosynthetic subsystems, along with a series of more independent modules involved in cell interaction with the environment.			Li, H (corresponding author), Stowers Inst Med Res, Kansas City, MO USA.	hul@stowers.org	Mushegian, Arcady/ABF-5387-2021	Mushegian, Arcady/0000-0002-6809-9225				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bardy SL, 2003, MICROBIOL-SGM, V149, P295, DOI 10.1099/mic.0.25948-0; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brochier-Armanet Celine, 2007, Archaea, V2, P83; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Forterre P, 2002, TRENDS GENET, V18, P236, DOI 10.1016/S0168-9525(02)02650-1; Glazko G, 2005, BIOINFORMATICS, V21, P2, DOI 10.1093/bioinformatics/bti1201; Glazko G, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-13; Glazko GV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r32; Goh CS, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-257; Jim K, 2004, GENOME RES, V14, P109; Jothi R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-173; Kensche PR, 2008, J R SOC INTERFACE, V5, P151, DOI 10.1098/rsif.2007.1047; Koonin EV, 1996, TRENDS GENET, V12, P334, DOI 10.1016/0168-9525(96)20010-1; Korbel JO, 2005, PLOS BIOL, V3, P815, DOI 10.1371/journal.pbio.0030134; Levesque M, 2003, CURR BIOL, V13, P129, DOI 10.1016/S0960-9822(03)00009-5; Liolios K, 2006, NUCLEIC ACIDS RES, V34, pD332, DOI 10.1093/nar/gkj145; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Romero H, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r66; Sadreyev R, 2003, J MOL BIOL, V326, P317, DOI 10.1016/S0022-2836(02)01371-2; Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; VONMERING C, 2007, NUCL ACIDS RES, V35; Wu J, 2003, BIOINFORMATICS, V19, P1524, DOI 10.1093/bioinformatics/btg187; Wu Jie, 2005, Genome Inform, V16, P142	29	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5326	10.1371/journal.pone.0005326	http://dx.doi.org/10.1371/journal.pone.0005326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390636	Green Published, Green Submitted, gold			2022-12-25	WOS:000265514400012
J	Houmani, JL; Ruf, IK				Houmani, Jennifer L.; Ruf, Ingrid K.			Clusters of Basic Amino Acids Contribute to RNA Binding and Nucleolar Localization of Ribosomal Protein L22	PLOS ONE			English	Article								The ribosomal protein L22 is a component of the 60S eukaryotic ribosomal subunit. As an RNA-binding protein, it has been shown to interact with both cellular and viral RNAs including 28S rRNA and the Epstein-Barr virus encoded RNA, EBER-1. L22 is localized to the cell nucleus where it accumulates in nucleoli. Although previous studies demonstrated that a specific amino acid sequence is required for nucleolar localization, the RNA-binding domain has not been identified. Here, we investigated the hypothesis that the nucleolar accumulation of L22 is linked to its ability to bind RNA. To address this hypothesis, mutated L22 proteins were generated to assess the contribution of specific amino acids to RNA binding and protein localization. Using RNA-protein binding assays, we demonstrate that basic amino acids 80-93 are required for high affinity binding of 28S rRNA and EBER-1 by L22. Fluorescence localization studies using GFP-tagged mutated L22 proteins further reveal that basic amino acids 80-93 are critical for nucleolar accumulation and for incorporation into ribosomes. Our data support the growing consensus that the nucleolar accumulation of ribosomal proteins may not be mediated by a defined localization signal, but rather by specific interaction with established nucleolar components such as rRNA.			Houmani, JL (corresponding author), Shriners Hosp Children, Div Res, Portland, OR 97201 USA.	iruf@uci.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007319] Funding Source: NIH RePORTER; NIAID NIH HHS [T32-AI007319, T32 AI007319] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson SJ, 2007, IMMUNITY, V26, P759, DOI 10.1016/j.immuni.2007.04.012; Annilo T, 1998, BIOCHEM BIOPH RES CO, V249, P759, DOI 10.1006/bbrc.1998.9187; Arava Yoav, 2003, Methods Mol Biol, V224, P79; Carmo-Fonseca M, 2000, NAT CELL BIOL, V2, pE107, DOI 10.1038/35014078; Chang SN, 2000, FEBS LETT, V484, P22, DOI 10.1016/S0014-5793(00)02118-9; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; CLARKE PA, 1991, NUCLEIC ACIDS RES, V19, P243, DOI 10.1093/nar/19.2.243; Da Costa L, 2003, BLOOD, V101, P5039, DOI 10.1182/blood-2002-12-3878; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; DOBBELSTEIN M, 1995, J VIROL, V69, P8027, DOI 10.1128/JVI.69.12.8027-8034.1995; Fok V, 2006, J CELL BIOL, V173, P319, DOI 10.1083/jcb.200601026; Fok V, 2006, RNA, V12, P872, DOI 10.1261/rna.2339606; Fujiwara T, 2006, EXP CELL RES, V312, P1703, DOI 10.1016/j.yexcr.2006.02.002; Gustafson WC, 1998, BIOCHEM J, V331, P387, DOI 10.1042/bj3310387; HATANAKA M, 1990, BIOESSAYS, V12, P143, DOI 10.1002/bies.950120310; Kubota S, 1999, ONCOGENE, V18, P1503, DOI 10.1038/sj.onc.1202429; Kundu-Michalik S, 2008, MOL BIOL EVOL, V25, P580, DOI 10.1093/molbev/msn002; LAVERGNE JP, 1987, FEBS LETT, V216, P83, DOI 10.1016/0014-5793(87)80761-5; Le SY, 2000, MOL BIOL CELL, V11, P999, DOI 10.1091/mbc.11.3.999; Leopardi R, 1996, P NATL ACAD SCI USA, V93, P4572, DOI 10.1073/pnas.93.10.4572; Leopardi R, 1997, J VIROL, V71, P1133, DOI 10.1128/JVI.71.2.1133-1139.1997; LERNER MR, 1981, P NATL ACAD SCI-BIOL, V78, P805, DOI 10.1073/pnas.78.2.805; Lipsius E, 2005, BIOCHEM BIOPH RES CO, V333, P1353, DOI 10.1016/j.bbrc.2005.06.043; Matsson H, 2004, MOL CELL BIOL, V24, P4032, DOI 10.1128/MCB.24.9.4032-4037.2004; MELESE T, 1995, CURR OPIN CELL BIOL, V7, P319, DOI 10.1016/0955-0674(95)80085-9; Michael WM, 1996, J BIOL CHEM, V271, P11571, DOI 10.1074/jbc.271.19.11571; MICHOT B, 1984, NUCLEIC ACIDS RES, V12, P4259, DOI 10.1093/nar/12.10.4259; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; Narayanan A, 1999, EMBO J, V18, P5120, DOI 10.1093/emboj/18.18.5120; Olson MOJ, 2005, HISTOCHEM CELL BIOL, V123, P203, DOI 10.1007/s00418-005-0754-9; Quaye IKE, 1996, EUR J CELL BIOL, V69, P151; Rosorius O, 2000, J BIOL CHEM, V275, P12061, DOI 10.1074/jbc.275.16.12061; Russo G, 2005, BIOCHEM J, V385, P289, DOI 10.1042/BJ20040371; SCHMIDT C, 1995, MOL BIOL CELL, V6, P1875, DOI 10.1091/mbc.6.12.1875; SCHMIDTZACHMANN MS, 1993, J CELL SCI, V105, P799; Shaw PJ, 1995, ANNU REV CELL DEV BI, V11, P93, DOI 10.1146/annurev.cb.11.110195.000521; Stuger R, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P205; Timmers ACJ, 1999, FEBS LETT, V452, P335, DOI 10.1016/S0014-5793(99)00669-9; TOCZYSKI DP, 1993, MOL CELL BIOL, V13, P703, DOI 10.1128/MCB.13.1.703; TOCZYSKI DP, 1994, P NATL ACAD SCI USA, V91, P3463, DOI 10.1073/pnas.91.8.3463; TOCZYSKI DPW, 1991, EMBO J, V10, P459, DOI 10.1002/j.1460-2075.1991.tb07968.x; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Wood J, 2001, J VIROL, V75, P1348, DOI 10.1128/JVI.75.3.1348-1358.2001; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8	44	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5306	10.1371/journal.pone.0005306	http://dx.doi.org/10.1371/journal.pone.0005306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390581	Green Published, Green Submitted, gold			2022-12-25	WOS:000265514200017
J	Wyman, SK; Parkin, RK; Mitchell, PS; Fritz, BR; O'Briant, K; Godwin, AK; Urban, N; Drescher, CW; Knudsen, BS; Tewari, M				Wyman, Stacia K.; Parkin, Rachael K.; Mitchell, Patrick S.; Fritz, Brian R.; O'Briant, Kathy; Godwin, Andrew K.; Urban, Nicole; Drescher, Charles W.; Knudsen, Beatrice S.; Tewari, Muneesh			Repertoire of microRNAs in Epithelial Ovarian Cancer as Determined by Next Generation Sequencing of Small RNA cDNA Libraries	PLOS ONE			English	Article							MIR-200 FAMILY; E-CADHERIN; MESENCHYMAL TRANSITION; TRANSCRIPTIONAL REPRESSOR; EXPRESSION PROFILES; SURFACE EPITHELIUM; ZEB1; IDENTIFICATION; SIGNATURES; CELLS	Background: MicroRNAs (miRNAs) are small regulatory RNAs that are implicated in cancer pathogenesis and have recently shown promise as blood-based biomarkers for cancer detection. Epithelial ovarian cancer is a deadly disease for which improved outcomes could be achieved by successful early detection and enhanced understanding of molecular pathogenesis that leads to improved therapies. A critical step toward these goals is to establish a comprehensive view of miRNAs expressed in epithelial ovarian cancer tissues as well as in normal ovarian surface epithelial cells. Methodology: We used massively parallel pyrosequencing (i.e., "454 sequencing'') to discover and characterize novel and known miRNAs expressed in primary cultures of normal human ovarian surface epithelium (HOSE) and in tissue from three of the most common histotypes of ovarian cancer. Deep sequencing of small RNA cDNA libraries derived from normal HOSE and ovarian cancer samples yielded a total of 738,710 high-quality sequence reads, generating comprehensive digital profiles of miRNA expression. Expression profiles for 498 previously annotated miRNAs were delineated and we discovered six novel miRNAs and 39 candidate miRNAs. A set of 124 miRNAs was differentially expressed in normal versus cancer samples and 38 miRNAs were differentially expressed across histologic subtypes of ovarian cancer. Taqman qRT-PCR performed on a subset of miRNAs confirmed results of the sequencing-based study. Conclusions: This report expands the body of miRNAs known to be expressed in epithelial ovarian cancer and provides a useful resource for future studies of the role of miRNAs in the pathogenesis and early detection of ovarian cancer.			Wyman, SK (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA.	mtewari@fhcrc.org		Mitchell, Patrick/0000-0001-8375-9060	NCI NIH HHS [T32 CA009657, P50 CA083638, 5 T32 CA09657-16, P50 CA083636, P50 CA83636] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA083638] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; BAR M, 2008, STEM CELLS; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Berkenblit A, 2005, J REPROD MED, V50, P426; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Christoffersen NR, 2007, RNA, V13, P1172, DOI 10.1261/rna.586807; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Cummins JM, 2006, ONCOGENE, V25, P6220, DOI 10.1038/sj.onc.1209914; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Dyck HG, 1996, INT J CANCER, V69, P429, DOI 10.1002/(SICI)1097-0215(19961220)69:6<429::AID-IJC1>3.0.CO;2-6; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Gregoire L, 1998, IN VITRO CELL DEV-AN, V34, P636; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Li NFF, 2004, LAB INVEST, V84, P923, DOI 10.1038/labinvest.3700093; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Steffen P, 2006, BIOINFORMATICS, V22, P500, DOI 10.1093/bioinformatics/btk010; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zou XH, 2008, CELL RES, V18, DOI 10.1038/cr.2008.171	52	198	218	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5311	10.1371/journal.pone.0005311	http://dx.doi.org/10.1371/journal.pone.0005311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390579	Green Published, Green Submitted, gold			2022-12-25	WOS:000265514200022
J	Buddenhagen, CE; Chimera, C; Clifford, P				Buddenhagen, Christopher Evan; Chimera, Charles; Clifford, Patti			Assessing Biofuel Crop Invasiveness: A Case Study	PLOS ONE			English	Article							RISK-ASSESSMENT SYSTEM; PROPAGULE PRESSURE; PLANTS; INVASIONS; PATTERN; MODEL	Background: There is widespread interest in biofuel crops as a solution to the world's energy needs, particularly in light of concerns over greenhouse-gas emissions. Despite reservations about their adverse environmental impacts, no attempt has been made to quantify actual, relative or potential invasiveness of terrestrial biofuel crops at an appropriate regional or international scale, and their planting continues to be largely unregulated. Methodology/Principal Findings: Using a widely accepted weed risk assessment system, we analyzed a comprehensive list of regionally suitable biofuel crops to show that seventy percent have a high risk of becoming invasive versus one-quarter of non-biofuel plant species and are two to four times more likely to establish wild populations locally or be invasive in Hawaii or in other locations with a similar climate. Conclusions/Significance: Because of climatic and ecological similarities, predictions of biofuel crop invasiveness in Hawaii are applicable to other vulnerable island and subtropical ecosystems worldwide. We demonstrate the utility of an accessible and scientifically proven risk assessment protocol that allows users to predict if introduced species will become invasive in their region of interest. Other evidence supports the contention that propagule pressure created by extensive plantings will exacerbate invasions, a scenario expected with large-scale biofuel crop cultivation. Proactive measures, such as risk assessments, should be employed to predict invasion risks, which could then be mitigated via implementation of appropriate planting policies and adoption of the "polluter-pays'' principle.			Buddenhagen, CE (corresponding author), Univ Hawaii Manoa, Pacific Cooperat Studies Unit, Honolulu, HI 96822 USA.	cbuddenhagen@gmail.com	Buddenhagen, Christopher/J-3942-2019	Buddenhagen, Christopher/0000-0002-3016-1054				Barney JN, 2008, BIOSCIENCE, V58, P64, DOI 10.1641/B580111; Caley P, 2006, BIOL INVASIONS, V8, P1595, DOI 10.1007/s10530-004-0010-6; Chow J, 2003, SCIENCE, V302, P1528, DOI 10.1126/science.1091939; Daehler CC, 2004, CONSERV BIOL, V18, P360, DOI 10.1111/j.1523-1739.2004.00066.x; Daehler CC, 1998, BIOL CONSERV, V84, P167, DOI 10.1016/S0006-3207(97)00096-7; Daehler CC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004462; Denslow JS, 2003, ANN MO BOT GARD, V90, P119, DOI 10.2307/3298531; Diez JM, 2008, ECOL LETT, V11, P674, DOI 10.1111/j.1461-0248.2008.01178.x; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Gordon DR, 2008, DIVERS DISTRIB, V14, P234, DOI 10.1111/j.1472-4642.2007.00460.x; Keller RP, 2007, P NATL ACAD SCI USA, V104, P203, DOI 10.1073/pnas.0605787104; Kinoshita CM., 1999, SITING EVALUATION BI; Knowler D, 2005, ECOL ECON, V52, P341, DOI 10.1016/j.ecolecon.2004.06.019; Kumar JV, 1996, THERMOCHIM ACTA, V279, P111; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; LONSDALE WM, 1994, AUST J ECOL, V19, P345, DOI 10.1111/j.1442-9993.1994.tb00498.x; Low T., 2007, WEEDY TRUTH BIOFUELS; Parker C, 2007, WEED SCI, V55, P386, DOI 10.1614/WS-06-168; Paynter Q, 2003, AUST SYST BOT, V16, P81, DOI 10.1071/SB01025; Perrings C, 2005, TRENDS ECOL EVOL, V20, P212, DOI 10.1016/j.tree.2005.02.011; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pimentel D., 2005, NAT RESOUR RES, V14, P65, DOI [DOI 10.1007/S11053-005-4679-8, 10.1007/s11053-005-4679-8]; Poteet MD., 2006, BIODIESEL CROP IMPLE; Pysek P, 1998, OIKOS, V82, P282, DOI 10.2307/3546968; R Core Team, 2022, R LANG ENV STAT COMP; Raghu S, 2006, SCIENCE, V313, P1742, DOI 10.1126/science.1129313; Raghu S, 2007, ILL NAT STEWARD, V16, P30; REJMANEK M, 2002, INVASIVE ALIEN SPECI; Rouget M, 2003, AM NAT, V162, P713, DOI 10.1086/379204; Scharlemann JPW, 2008, SCIENCE, V319, P43, DOI 10.1126/science.1153103; Staples GW., 2005, TROPICAL GARDEN FLOR; Turn S.Q., 2005, PHYSICOCHEMICAL ANAL; Turn SQ, 2002, ANAL HAWAII BIOMASS; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Weber J, 2009, J ENVIRON MANAGE, V90, P798, DOI 10.1016/j.jenvman.2008.01.012; [No title captured]	37	83	85	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5261	10.1371/journal.pone.0005261	http://dx.doi.org/10.1371/journal.pone.0005261			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384412	gold, Green Published			2022-12-25	WOS:000265513900011
J	Jia, Y; Warin, R; Yu, XB; Epstein, R; Noguchi, CT				Jia, Yi; Warin, Renaud; Yu, Xiaobing; Epstein, Reed; Noguchi, Constance Tom			Erythropoietin signaling promotes transplanted progenitor cell survival	FASEB JOURNAL			English	Article						myoblast; dystrophin; transplantation; receptor; EpoR	DUCHENNE MUSCULAR-DYSTROPHY; HEMATOPOIETIC STEM-CELLS; RECEPTOR GENE; PROLIFERATION; ACTIVATION; DIFFERENTIATION; ENGRAFTMENT; TRANSGENES; EXPRESSION; EXPANSION	We examine the potential for erythropoietin signaling to promote donor cell survival in a model of myoblast transplantation. Expression of a truncated erythropoietin receptor in hematopoietic stem cells has been shown to promote selective engraftment in mice. We previously demonstrated expression of endogenous erythropoietin receptor on murine myoblasts, and erythropoietin treatment can stimulate myoblast proliferation and delay differentiation. Here, we report that enhanced erythropoietin receptor expression, as well as exogenous erythropoietin treatment in myoblasts, provided a survival advantage and protection against apoptosis under serum-starvation conditions. When cultured in differentiation medium, expression of the myogenic regulatory proteins shifted toward early differentiation with increased erythropoietin receptor. Expression of early myogenic differentiation proteins Myf-5 and MyoD increased, while later stage protein myogenin decreased. Transplantation of C2C12 myoblasts overexpressing truncated erythropoietin receptor showed more transplanted cell incorporation into muscle fibers in muscular dystrophy mdx mice. These cells also restored dystrophin protein expression in mdx mice at 6 wk after cell treatment that was further increased with exogenous erythropoietin administration. In summary, enhanced erythropoietin receptor expression promotes transplanted cell survival in a mouse model for myoblast transplantation and provides dystrophin expression in mice with muscular dystrophy.-Jia, Y., Warin, R., Yu, X., Epstein, R., Noguchi, C. T. Erythropoietin signaling promotes transplanted progenitor cell survival. FASEB J. 23, 3089-3099 ( 2009). www.fasebj.org	[Jia, Yi; Warin, Renaud; Yu, Xiaobing; Epstein, Reed; Noguchi, Constance Tom] NIDDK, Mol Med Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Noguchi, CT (corresponding author), NIDDK, Mol Med Branch, NIH, Bldg 10,Rm 9N319,MSC-1822,10 Ctr Dr, Bethesda, MD 20892 USA.	cnoguchi@helix.nih.gov			National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025103, ZIADK025021, Z01DK025103] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Mingfeng Zhao for technical assistance in vector construction and Brenda Klaunberg for her expertise in animal imaging. Funding was provided by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases.	Arcasoy MO, 1999, EXP HEMATOL, V27, P63, DOI 10.1016/S0301-472X(98)00003-4; Arcasoy MO, 2008, BRIT J HAEMATOL, V141, P14, DOI 10.1111/j.1365-2141.2008.07014.x; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Chen J, 2008, J CLIN INVEST, V118, P526, DOI [10.1172/JC133813, 10.1172/JCI33813]; CHIN K, 1995, NUCLEIC ACIDS RES, V23, P3041, DOI 10.1093/nar/23.15.3041; Cossu G, 2007, TRENDS MOL MED, V13, P520, DOI 10.1016/j.molmed.2007.10.003; DANDREA AD, 1991, MOL CELL BIOL, V11, P1980, DOI 10.1128/MCB.11.4.1980; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Gensch N, 2008, DEVELOPMENT, V135, P1597, DOI 10.1242/dev.019331; Iwahori A, 2004, DEV BIOL, V270, P525, DOI 10.1016/j.ydbio.2004.03.012; Judge LM, 2006, J CELL SCI, V119, P1537, DOI 10.1242/jcs.02857; Kirby S, 2000, BLOOD, V95, P3710; Kirby SL, 1996, P NATL ACAD SCI USA, V93, P9402, DOI 10.1073/pnas.93.18.9402; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Meyer L, 2007, BLOOD, V109, P5215, DOI 10.1182/blood-2006-10-055350; Miller RG, 1997, MUSCLE NERVE, V20, P469, DOI 10.1002/(SICI)1097-4598(199704)20:4<469::AID-MUS10>3.3.CO;2-1; Nagashima T, 2004, J GENE MED, V6, P22, DOI 10.1002/jgm.467; Ogilvie M, 2000, J BIOL CHEM, V275, P39754, DOI 10.1074/jbc.M004999200; Partridge T, 2002, NEUROMUSCULAR DISORD, V12, pS3, DOI 10.1016/S0960-8966(02)00076-7; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Pelletier S, 2006, MOL CELL BIOL, V26, P8527, DOI 10.1128/MCB.01035-06; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sasaki R, 2003, INTERNAL MED, V42, P142, DOI 10.2169/internalmedicine.42.142; Shimizu R, 1999, EXP HEMATOL, V27, P229, DOI 10.1016/S0301-472X(98)00048-4; Urao N, 2006, CIRC RES, V98, P1405, DOI 10.1161/01.RES.0000224117.59417.f3; Urbinati F, 2005, HUM GENE THER, V16, P594, DOI 10.1089/hum.2005.16.594; Westenbrink BD, 2007, EUR HEART J, V28, P2018, DOI 10.1093/eurheartj/ehm177; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Yasuda Y, 1998, J BIOL CHEM, V273, P25381, DOI 10.1074/jbc.273.39.25381; Yu XB, 2003, MOL THER, V7, P827, DOI 10.1016/S1525-0016(03)00104-7; Yu XB, 2001, BLOOD, V98, P475, DOI 10.1182/blood.V98.2.475; Zhao W, 2006, BLOOD, V107, P907, DOI 10.1182/blood-2005-06-2516	33	21	23	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					3089	3099		10.1096/fj.09-130237	http://dx.doi.org/10.1096/fj.09-130237			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19417086	Green Published			2022-12-25	WOS:000270241000031
J	Klover, P; Chen, WP; Zhu, BM; Hennighausen, L				Klover, Peter; Chen, Weiping; Zhu, Bing-Mei; Hennighausen, Lothar			Skeletal muscle growth and fiber composition in mice are regulated through the transcription factors STAT5a/b: linking growth hormone to the androgen receptor	FASEB JOURNAL			English	Article						chromatin immunoprecipitation; microarray	FACTOR-I; GENE-EXPRESSION; EXERCISE; SPECIFICATION; METABOLISM; RESISTANCE; PATHWAY; ALPHA; IGF-1; MASS	In skeletal muscle, STAT5a/b transcription factors are critical for normal postnatal growth, whole-animal glucose homeostasis, and local IGF-1 production. These observations have led us to hypothesize that STAT5a/b are critical for maintenance of normal muscle mass and function. To investigate this, mice with a skeletal muscle-specific deletion of the Stat5a/b genes (Stat5MKO) were used. Stat5MKO mice displayed reduced muscle mass, altered fiber-type distribution and reduced activity. On a molecular level, gene expression in skeletal muscle of Stat5MKO and control mice was analyzed by microarrays and real-time PCR, both in the presence and absence of growth hormone (GH) stimulation. Expression of several genes involved in muscle growth and fiber type were significantly changed. Specifically, in the quadriceps, a muscle almost exclusively composed of type II fibers, the absence of STAT5a/b led to increased expression of several genes associated with type I fibers and the de novo appearance of type I fibers. In addition, it is shown here that expression of the androgen receptor gene (Ar) is controlled by GH through STAT5a/b. The link between STAT5a/b and Ar gene is likely through direct transcriptional regulation, as chromatin immunoprecipitaion of the Ar promoter region in C2C12 myoblasts was accomplished by antibodies against STAT5a. These experiments demonstrate an important role for STAT5a/b in skeletal muscle physiology, and they provide a direct link to androgen signaling.-Klover, P., Chen, W., Zhu, B.-M., Hennighausen, L. Skeletal muscle growth and fiber composition in mice are regulated through the transcription factors STAT5a/b: linking growth hormone to the androgen receptor. FASEB J. 23, 3140-3148 (2009). www.fasebj.org	[Klover, Peter; Chen, Weiping; Zhu, Bing-Mei; Hennighausen, Lothar] NIDDK, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Klover, P (corresponding author), NIDDK, NIH, 9000 Rockville Pike,Bldg 8,Rm 107, Bethesda, MD 20892 USA.	kloverp@niddk.nih.gov	Chen, Weiping/C-9550-2011	Hennighausen, Lothar/0000-0001-8319-9841	NIH; NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK061000, ZIADK061005, Z01DK061005, Z01DK061000] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank George Poy (NIDDK Genomics Core Laboratory, Bethesda, MD, USA) for assistance with the microarrays. We also thank Dr. Oksana Gavrilova and William Jou ( NIDDK Mouse Metabolism Core Laboratory) for conducting the locomotor activity and respiration experiments. Thanks to Dr. Richard Moriggl ( Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria) for providing the construct for the constitutively active STAT5a mutant. Finally, thanks to Alexandra Dr. McPherron and Dr. Kathleen Savage for technical expertise in muscle-fiber staining. This work was funded by the intramural program of NIH, NIDDK.	Auernhammer CJ, 1999, P NATL ACAD SCI USA, V96, P6964, DOI 10.1073/pnas.96.12.6964; Baker PE, 2006, NEUROGENETICS, V7, P81, DOI 10.1007/s10048-006-0031-7; Ben-Dov I, 2003, CLIN ENDOCRINOL, V59, P763, DOI 10.1046/j.1365-2265.2003.01920.x; Clark RP, 2006, HORM RES, V66, P26, DOI 10.1159/000096620; Consitt LA, 2008, MED SCI SPORT EXER, V40, P1031, DOI 10.1249/MSS.0b013e3181690760; Davey HW, 2001, ENDOCRINOLOGY, V142, P3836, DOI 10.1210/en.142.9.3836; DRENTH JPH, 1995, J APPL PHYSIOL, V79, P1497, DOI 10.1152/jappl.1995.79.5.1497; Fernandez AM, 2002, J CLIN INVEST, V109, P347, DOI 10.1172/JCI200213503; Garcia-Fernandez M, 2008, ENDOCRINOLOGY, V149, P2433, DOI 10.1210/en.2007-1190; Gotherstrom G, 2005, CLIN ENDOCRINOL, V62, P105, DOI 10.1111/j.1365-2265.2004.02181.x; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Herbst KL, 2004, CURR OPIN CLIN NUTR, V7, P271, DOI 10.1097/00075197-200405000-00006; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Klover P, 2007, ENDOCRINOLOGY, V148, P1489, DOI 10.1210/en.2006-1431; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; MacLean HE, 2008, FASEB J, V22, P2676, DOI 10.1096/fj.08-105726; Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; Tan SH, 2008, CANCER RES, V68, P236, DOI 10.1158/0008-5472.CAN-07-2972; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	26	45	46	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2009	23	9					3140	3148		10.1096/fj.08-128215	http://dx.doi.org/10.1096/fj.08-128215			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19417088	Green Published			2022-12-25	WOS:000270241000036
J	Lenoir, G; Williamson, P; Puts, CF; Holthuis, JCM				Lenoir, Guillaume; Williamson, Patrick; Puts, Catheleyne F.; Holthuis, Joost C. M.			Cdc50p Plays a Vital Role in the ATPase Reaction Cycle of the Putative Aminophospholipid Transporter Drs2p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; P-TYPE ATPASES; NA,K-ATPASE BETA-SUBUNIT; PLASMA-MEMBRANE; PHOSPHOLIPID TRANSLOCATION; ADENOSINE-TRIPHOSPHATASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PROTEIN; YEAST	Members of the P-4 subfamily of P-type ATPases are believed to catalyze transport of phospholipids across cellular bilayers. However, most P-type ATPases pump small cations or metal ions, and atomic structures revealed a transport mechanism that is conserved throughout the family. Hence, a challenging problem is to understand how this mechanism is adapted in P-4-ATPases to flip phospholipids. P-4-ATPases form heteromeric complexes with Cdc50 proteins. The primary role of these additional polypeptides is unknown. Here, we show that the affinity of yeast P-4-ATPase Drs2p for its Cdc50-binding partner fluctuates during the transport cycle, with the strongest interaction occurring at a point where the enzyme is loaded with phospholipid ligand. We also find that specific interactions with Cdc50p are required to render the ATPase competent for phosphorylation at the catalytically important aspartate residue. Our data indicate that Cdc50 proteins are integral components of the P-4-ATPase transport machinery. Thus, acquisition of these subunits may have been a crucial step in the evolution of flippases from a family of cation pumps.	[Lenoir, Guillaume; Puts, Catheleyne F.; Holthuis, Joost C. M.] Univ Utrecht, Dept Membrane Enzymol, Bijvoet Ctr, NL-3584 CH Utrecht, Netherlands; [Lenoir, Guillaume; Puts, Catheleyne F.; Holthuis, Joost C. M.] Univ Utrecht, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands; [Williamson, Patrick] Amherst Coll, Dept Biol, Amherst, MA 01002 USA	Utrecht University; Utrecht University; Amherst College	Holthuis, JCM (corresponding author), Univ Utrecht, Dept Membrane Enzymol, Bijvoet Ctr, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	j.c.holthuis@uu.nl	Lenoir, Guillaume/I-4002-2019; Holthuis, Joost/AAL-9157-2020	Lenoir, Guillaume/0000-0002-8759-5179; Holthuis, Joost/0000-0001-8912-1586	Fondation Recherge Medicale; Dutch Organization of Sciences; National Science Foundation	Fondation Recherge Medicale; Dutch Organization of Sciences; National Science Foundation(National Science Foundation (NSF))	This work was supported by grants from the Fondation Recherge Medicale (to G. L.), the Dutch Organization of Sciences (NWO-CW), the Utrecht High Potential Program (to J. H.), and the National Science Foundation (to P. W.).	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; ALLEN G, 1976, FEBS LETT, V63, P188, DOI 10.1016/0014-5793(76)80223-2; Anthonisen AN, 2006, J BIOL CHEM, V281, P31572, DOI 10.1074/jbc.M605194200; AULAND ME, 1994, P NATL ACAD SCI USA, V91, P10938, DOI 10.1073/pnas.91.23.10938; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; CHAMPEIL P, 1985, BIOCHEMISTRY-US, V24, P69, DOI 10.1021/bi00322a012; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Darland-Ransom M, 2008, SCIENCE, V320, P528, DOI 10.1126/science.1155847; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; Dempski RE, 2005, J GEN PHYSIOL, V125, P505, DOI 10.1085/jgp.200409186; Durr KL, 2009, J BIOL CHEM, V284, P3842, DOI 10.1074/jbc.M808101200; EBASHI F, 1962, NATURE, V194, P378, DOI 10.1038/194378a0; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; GOTTARDI CJ, 1993, SCIENCE, V260, P552, DOI 10.1126/science.8386395; GREFEN C, 2007, CURRENT PROTOCOLS NE; Hasler U, 2001, J BIOL CHEM, V276, P16356, DOI 10.1074/jbc.M008778200; Holthuis JCM, 1998, EMBO J, V17, P113, DOI 10.1093/emboj/17.1.113; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Kato U, 2002, J BIOL CHEM, V277, P37855, DOI 10.1074/jbc.M205564200; KAWAMURA M, 1985, BIOCHIM BIOPHYS ACTA, V821, P115, DOI 10.1016/0005-2736(85)90161-0; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Lenoir G, 2004, J BIOL CHEM, V279, P32125, DOI 10.1074/jbc.M402934200; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; Lenoir G, 2007, CURR OPIN CHEM BIOL, V11, P654, DOI 10.1016/j.cbpa.2007.09.008; LUTSENKO S, 1993, BIOCHEMISTRY-US, V32, P6737, DOI 10.1021/bi00077a029; LUTSENKO S, 1994, J BIOL CHEM, V269, P4555; Moller JV, 2005, CURR OPIN STRUC BIOL, V15, P387, DOI 10.1016/j.sbi.2005.06.005; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Nakano K, 2008, MOL BIOL CELL, V19, P1783, DOI 10.1091/mbc.E07-07-0646; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; ORRWEAVER TL, 1983, METHOD ENZYMOL, V101, P228; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Paulusma CC, 2006, HEPATOLOGY, V44, P195, DOI 10.1002/hep.21212; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Perez-Victoria FJ, 2006, J BIOL CHEM, V281, P23766, DOI 10.1074/jbc.M605214200; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Poulsen LR, 2008, CELL MOL LIFE SCI, V65, P3119, DOI 10.1007/s00018-008-8341-6; Poulsen LR, 2008, PLANT CELL, V20, P658, DOI 10.1105/tpc.107.054767; Puts CF, 2009, BBA-MOL CELL BIOL L, V1791, P603, DOI 10.1016/j.bbalip.2009.02.005; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; VILSEN B, 1986, BIOCHIM BIOPHYS ACTA, V855, P429, DOI 10.1016/0005-2736(86)90089-1; VILSEN B, 1989, J BIOL CHEM, V264, P21024; Wicky S, 2004, MOL CELL BIOL, V24, P7402, DOI 10.1128/MCB.24.17.7402-7418.2004	53	95	100	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					17956	17967		10.1074/jbc.M109.013722	http://dx.doi.org/10.1074/jbc.M109.013722			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19411703	Green Published, hybrid			2022-12-25	WOS:000267712400007
J	Goetz, R; Dover, K; Laezza, F; Shtraizent, N; Huang, X; Tchetchik, D; Eliseenkova, AV; Xu, CF; Neubert, TA; Ornitz, DM; Goldfarb, M; Mohammadi, M				Goetz, Regina; Dover, Katarzyna; Laezza, Fernanda; Shtraizent, Nataly; Huang, Xiao; Tchetchik, Dafna; Eliseenkova, Anna V.; Xu, Chong-Feng; Neubert, Thomas A.; Ornitz, David M.; Goldfarb, Mitchell; Mohammadi, Moosa			Crystal Structure of a Fibroblast Growth Factor Homologous Factor (FHF) Defines a Conserved Surface on FHFs for Binding and Modulation of Voltage-gated Sodium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR-14 GENE; INACTIVATION GATE; NERVOUS-SYSTEM; MUTATION; FGF; EXPRESSION; EXCITABILITY; EVOLUTION; NA(V)1.6; MEMBERS	Voltage-gated sodium channels (Na-v) produce sodium currents that underlie the initiation and propagation of action potentials in nerve and muscle cells. Fibroblast growth factor homologous factors (FHFs) bind to the intracellular C-terminal region of the Na-v alpha subunit to modulate fast inactivation of the channel. In this study we solved the crystal structure of a 149-residue-long fragment of human FHF2A which unveils the structural features of the homology core domain of all 10 human FHF isoforms. Through analysis of crystal packing contacts and site-directed mutagenesis experiments we identified a conserved surface on the FHF core domain that mediates channel binding in vitro and in vivo. Mutations at this channel binding surface impaired the ability of FHFs to co-localize with Na(v)s at the axon initial segment of hippocampal neurons. The mutations also disabled FHF modulation of voltage-dependent fast inactivation of sodium channels in neuronal cells. Based on our data, we propose that FHFs constitute auxiliary subunits for Na(v)s.	[Dover, Katarzyna; Shtraizent, Nataly; Huang, Xiao; Tchetchik, Dafna; Goldfarb, Mitchell] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; [Goetz, Regina; Eliseenkova, Anna V.; Neubert, Thomas A.; Mohammadi, Moosa] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; [Xu, Chong-Feng; Neubert, Thomas A.] NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; [Dover, Katarzyna] CUNY, Grad Program Biol, New York, NY 10021 USA; [Huang, Xiao] CUNY, Grad Program Biochem, New York, NY 10021 USA; [Laezza, Fernanda; Ornitz, David M.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	City University of New York (CUNY) System; Hunter College (CUNY); New York University; New York University; City University of New York (CUNY) System; City University of New York (CUNY) System; Washington University (WUSTL)	Goldfarb, M (corresponding author), 695 Pk Ave,Rm HN834, New York, NY 10021 USA.	goldfarb@genectr.hunter.cuny.edu; Moosa.Mohammadi@nyumc.org	Goetz, Regina/M-2411-2019; Laezza, Fernanda/L-6019-2016; Laezza, Fernanda/X-4076-2019; kasaei, fahime/T-7197-2018; Mohammadi, Moosa/ABA-6745-2020	Goetz, Regina/0000-0003-3681-4703; Laezza, Fernanda/0000-0003-1141-1852; Laezza, Fernanda/0000-0003-1141-1852; Mohammadi, Moosa/0000-0003-2434-9437; Ornitz, David/0000-0003-1592-7629	National Institutes of Health [DE13686, NS39906, R03 NS62431, S10 RR017990, P30 NS050276]; Washington University Hope Center for Neurological Disorders; National Ataxia Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039906, P30NS050276, R03NS062431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Hope Center for Neurological Disorders; National Ataxia Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DE13686 (to M. M.), NS39906 (to M. G.), R03 NS62431 (to D. M. O.), and S10 RR017990 and P30 NS050276 (to T. A. N.). This work was also supported by the Washington University Hope Center for Neurological Disorders (to D. M. O.) and the National Ataxia Foundation (to D. M. O.).	Abriel H, 2005, TRENDS CARDIOVAS MED, V15, P35, DOI 10.1016/j.tcm.2005.01.001; Boehm MK, 2000, BIOCHEM J, V346, P519, DOI 10.1042/0264-6021:3460519; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brusse E, 2006, MOVEMENT DISORD, V21, P396, DOI 10.1002/mds.20708; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Dalski A, 2005, EUR J HUM GENET, V13, P118, DOI 10.1038/sj.ejhg.5201286; DILL KA, 1985, BIOCHEMISTRY-US, V24, P1501, DOI 10.1021/bi00327a032; Ferrero GB, 1997, AM J HUM GENET, V61, P395, DOI 10.1086/514857; Gecz J, 1999, HUM GENET, V104, P56, DOI 10.1007/s004390050910; Gedeon AK, 1996, AM J MED GENET, V64, P121, DOI 10.1002/(SICI)1096-8628(19960712)64:1<121::AID-AJMG20>3.0.CO;2-O; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; Goldfarb M, 2005, CYTOKINE GROWTH F R, V16, P215, DOI 10.1016/j.cytogfr.2005.02.002; Goldfarb M, 2007, NEURON, V55, P449, DOI 10.1016/j.neuron.2007.07.006; Hartung H, 1997, MECH DEVELOP, V64, P31, DOI 10.1016/S0925-4773(97)00042-7; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Itoh N, 2008, DEV DYNAM, V237, P18, DOI 10.1002/dvdy.21388; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Laezza F, 2007, J NEUROSCI, V27, P12033, DOI 10.1523/JNEUROSCI.2282-07.2007; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Liu CJ, 2003, J BIOL CHEM, V278, P1029, DOI 10.1074/jbc.M207074200; Liu CJ, 2001, J BIOL CHEM, V276, P18925, DOI 10.1074/jbc.M101606200; Loll PJ, 2008, ACTA CRYSTALLOGR F, V64, P243, DOI 10.1107/S1744309108007574; Lou JY, 2005, J PHYSIOL-LONDON, V569, P179, DOI 10.1113/jphysiol.2005.097220; MALMGREN H, 1993, AM J HUM GENET, V52, P1046; Motoike HK, 2004, J GEN PHYSIOL, V123, P155, DOI 10.1085/jgp.200308929; Munoz-Sanjuan I, 2000, MECH DEVELOP, V95, P101, DOI 10.1016/S0925-4773(00)00336-1; Munoz-Sanjuan I, 2000, J BIOL CHEM, V275, P2589, DOI 10.1074/jbc.275.4.2589; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Nishimoto S, 2007, J BIOL CHEM, V282, P24255, DOI 10.1074/jbc.M704277200; Olsen SK, 2003, J BIOL CHEM, V278, P34226, DOI 10.1074/jbc.M303183200; Ornitz DM, 2001, GENOME BIOL, V2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; PATTON DE, 1993, NEURON, V11, P967; Rush AM, 2006, EUR J NEUROSCI, V23, P2551, DOI 10.1111/j.1460-9568.2006.04789.x; Shakkottai VG, 2009, NEUROBIOL DIS, V33, P81, DOI 10.1016/j.nbd.2008.09.019; SHILOH Y, 1990, AM J HUM GENET, V47, P20; Smallwood PM, 1996, P NATL ACAD SCI USA, V93, P9850, DOI 10.1073/pnas.93.18.9850; van Swieten JC, 2003, AM J HUM GENET, V72, P191, DOI 10.1086/345488; Wang Q, 2002, NEURON, V35, P25, DOI 10.1016/S0896-6273(02)00744-4; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Wittmack EK, 2004, J NEUROSCI, V24, P6765, DOI 10.1523/JNEUROSCI.1628-04.2004; Wozniak DF, 2007, NEUROBIOL DIS, V26, P14, DOI 10.1016/j.nbd.2006.11.014; Xiao ML, 2007, MOL CELL NEUROSCI, V34, P366, DOI 10.1016/j.mcn.2006.11.020	45	95	100	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17883	17896		10.1074/jbc.M109.001842	http://dx.doi.org/10.1074/jbc.M109.001842			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19406745	Green Published, hybrid			2022-12-25	WOS:000267202500054
J	Liu, R; Zheng, HQ; Zhou, ZM; Dong, JT; Chen, CS				Liu, Rong; Zheng, Han-Qiu; Zhou, Zhongmei; Dong, Jin-Tang; Chen, Ceshi			KLF5 Promotes Breast Cell Survival Partially through Fibroblast Growth Factor-binding Protein 1-pERK-mediated Dual Specificity MKP-1 Protein Phosphorylation and Stabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR-5; KINASE PHOSPHATASE-1; TRANSCRIPTION FACTOR; EXPRESSION; CANCER; ACTIVATION; APOPTOSIS; ERK; PROLIFERATION; DEGRADATION	Krupple-like transcription factor 5 (KLF5) is a zinc-finger transcription factor promoting cell survival and tumorigenesis in multiple cancers. A high expression level of KLF5 has been shown to be associated with shorter breast cancer patient survival. However, the role of KLF5 and mechanism of KLF5 actions in breast cancer remain unclear. In this study, we found that KLF5 knockdown by small interfering RNA in two breast cell lines, MCF10A and BT20, induces apoptosis. Interestingly, a pro-survival phosphatase, dual specificity mitogen-activated protein kinase phosphatase 1 (MKP-1), is down-regulated by KLF5 ablation. Consistently, KLF5 overexpression increases the MKP-1 protein expression in Hs578T and MCF7. We further found that MKP-1 is essential and sufficient for KLF5 to promote breast cell survival. However, MKP-1 is not a KLF5 direct transcription target because the MKP-1 mRNA level is not regulated by KLF5. By cycloheximide chase assays, we found that KLF5 decreases MKP-1 protein degradation via activating the ERK signaling. Inhibition of pERK by the pharmacological inhibitor U0126 specifically blocks KLF5-induced MKP-1 phosphorylation and stabilization. Additionally, constitutive activation of ERK by constitutively activated MEK1 rescues the KLF5 depletion-induced MKP-1 down-regulation. Consistently, the phosphorylation-deficient MKP-1 mutant cannot be stabilized by KLF5. Finally, the activation of ERK by KLF5 is very likely through the KLF5 direct target gene FGF-BP in breast cells. These findings suggest that KLF5 is a pro-survival factor that promotes breast cell survival partially through pERK-mediated MKP-1 phosphorylation and stabilization. The KLF5-FGF-BP-pERK-MKP-1 signaling axis may provide new therapeutic targets for invasive breast cancer.	[Liu, Rong; Zheng, Han-Qiu; Zhou, Zhongmei; Chen, Ceshi] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; [Dong, Jin-Tang] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA; [Dong, Jin-Tang] Emory Univ, Sch Med, Dept Hematol & Oncol, Atlanta, GA 30322 USA	Albany Medical College; Emory University; Emory University	Chen, CS (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA.	chenc@mail.amc.edu		Chen, Ceshi/0000-0001-6398-3516; Dong, Jin-Tang/0000-0003-2349-5782; Zheng, Hanqiu/0000-0002-8062-1215	Komen for the Cure [BCTR0503705]; American Cancer Society [RSG-08-199-01]; Department of Defense [W81XWH-07-1-0191]	Komen for the Cure(Susan G. Komen Breast Cancer Foundation); American Cancer Society(American Cancer Society); Department of Defense(United States Department of Defense)	This work was supported by Grant BCTR0503705 from Komen for the Cure, Grant RSG-08-199-01 from the American Cancer Society, and Grant W81XWH-07-1-0191 from the Department of Defense.	Aizawa K, 2004, J BIOL CHEM, V279, P70, DOI 10.1074/jbc.M306621200; Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; Beckers J, 2005, INT J CANCER, V114, P590, DOI 10.1002/ijc.20798; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Chanchevalap S, 2006, NUCLEIC ACIDS RES, V34, P1216, DOI 10.1093/nar/gkl014; Chen C, 2002, ONCOGENE, V21, P6567, DOI 10.1038/sj.onc.1205817; Chen CS, 2007, INT J CANCER, V121, P80, DOI 10.1002/ijc.22653; Chen CH, 2006, INT J CANCER, V118, P1346, DOI 10.1002/ijc.21533; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; Franklin CC, 1998, P NATL ACAD SCI USA, V95, P3014, DOI 10.1073/pnas.95.6.3014; Goldstein BG, 2007, AM J PHYSIOL-GASTR L, V292, pG1784, DOI 10.1152/ajpgi.00541.2006; Hamdi M, 2005, ONCOGENE, V24, P7135, DOI 10.1038/sj.onc.1208875; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Li J, 2001, MOL CELL BIOL, V21, P8213, DOI 10.1128/MCB.21.23.8213-8224.2001; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; Loda M, 1996, AM J PATHOL, V149, P1553; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Sanchez-Perez I, 2000, ONCOGENE, V19, P5142, DOI 10.1038/sj.onc.1203887; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; Sun RG, 2001, J BIOL CHEM, V276, P6897, DOI 10.1074/jbc.C000870200; Suzuki T, 2007, J BIOL CHEM, V282, P9895, DOI 10.1074/jbc.M608098200; Taneyhill Lisa, 2004, BMC Developmental Biology, V4; Tassi E, 2001, J BIOL CHEM, V276, P40247, DOI 10.1074/jbc.M104933200; Tong D, 2006, CLIN CANCER RES, V12, P2442, DOI 10.1158/1078-0432.CCR-05-0964; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wan HJ, 2008, DEVELOPMENT, V135, P2563, DOI 10.1242/dev.021964; Wang J, 2007, CANCER RES, V67, P11933, DOI 10.1158/0008-5472.CAN-07-5185; Wang ZQ, 2006, CANCER RES, V66, P8870, DOI 10.1158/0008-5472.CAN-06-1280; Wu W, 2005, J BIOL CHEM, V280, P4117, DOI 10.1074/jbc.M411200200; Yang YZ, 2008, J BIOL CHEM, V283, P18812, DOI 10.1074/jbc.M801384200; Yang YZ, 2007, FASEB J, V21, P543, DOI 10.1096/fj.06-6694com; Zhao Y, 2008, ONCOGENE, V27, P1, DOI 10.1038/sj.onc.1210625; Zhou JY, 2006, CANCER RES, V66, P4888, DOI 10.1158/0008-5472.CAN-05-4229; Zhu NX, 2006, J BIOL CHEM, V281, P14711, DOI 10.1074/jbc.M513810200	35	68	72	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16791	16798		10.1074/jbc.M808919200	http://dx.doi.org/10.1074/jbc.M808919200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19411256	Green Published, hybrid			2022-12-25	WOS:000266962400015
J	Selevsek, N; Rival, S; Tholey, A; Heinzle, E; Heinz, U; Hemmingsen, L; Adolph, HW				Selevsek, Nathalie; Rival, Sandrine; Tholey, Andreas; Heinzle, Elmar; Heinz, Uwe; Hemmingsen, Lars; Adolph, Hans W.			Zinc Ion-induced Domain Organization in Metallo-beta-lactamases A FLEXIBLE "ZINC ARM" FOR RAPID METAL ION TRANSFER?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERTURBED-ANGULAR-CORRELATION; IONIZATION MASS-SPECTROMETRY; BACILLUS-CEREUS; BINDING-SITES; CONFORMATIONAL-CHANGES; COORDINATION GEOMETRY; CATALYZED-HYDROLYSIS; INHIBITOR COMPLEXES; PAC SPECTROSCOPY; GLYOXALASE II	The reversible unfolding of metallo-beta-lactamase from Chryseobacterium meningosepticum (BlaB) by guanidinium hydrochloride is best described by a three-state model including folded, intermediate, and unfolded states. The transformation of the folded apoenzyme into the intermediate state requires only very low denaturant concentrations, in contrast to the Zn-2-enzyme. Similarly, circular dichroism spectra of both BlaB and metallo-beta-lactamase from Bacillus cereus 569/H/9 (BcII) display distinct differences between metal-free and Zn-2-enzymes, indicating that the zinc ions affect the folding of the proteins, giving a larger alpha-helix content. To identify the regions of the protein involved in this zinc ion-induced change, a hydrogen deuterium exchange study with matrix-assisted laser desorption ionization tandem time of flight mass spectrometry on metal-free and Zn-1- and Zn-2-BcII was carried out. The region spanning the metal binding metallo-beta-lactamases (MBL) superfamily consensus sequence His-X-His-X-Asp motif and the loop connecting the N- and C-terminal domains of the protein undergoes a zinc ion-dependent structural change between intrinsically disordered and ordered states. The inherent flexibility even appears to allow for the formation of metal ion-bridged protein-protein complexes which may account for both electrospray ionization-mass spectroscopy results obtained upon variation of the zinc/protein ratio and stoichiometry-dependent variations of Hg-199m-perturbed angular correlation of gamma-rays spectroscopic data. We suggest that this flexible "zinc arm" motif, present in all the MBL subclasses, is disordered in metal-free MBLs and may be involved in metal ion acquisition from zinc-carrying molecules different from MBL in an "activation on demand" regulation of enzyme activity.	[Heinz, Uwe; Hemmingsen, Lars; Adolph, Hans W.] Univ Copenhagen, Dept Basic Sci & Environm, Fac Life Sci, DK-1871 Frederiksberg C, Denmark; [Selevsek, Nathalie; Tholey, Andreas; Heinzle, Elmar] Univ Saarland, Dept Biochem & Engn, D-66041 Saarbrucken, Germany; [Rival, Sandrine] Univ Saarland, Dept Biochem, D-66041 Saarbrucken, Germany; [Tholey, Andreas] Univ Kiel, Inst Expt Med Syst Proteome Res & Bioanalyt, D-24105 Kiel, Germany	University of Copenhagen; Saarland University; Saarland University; University of Kiel	Adolph, HW (corresponding author), Univ Copenhagen, Dept Basic Sci & Environm, Fac Life Sci, DK-1871 Frederiksberg C, Denmark.	hwa@life.ku.dk	Hemmingsen, Lars/AAD-1318-2020; Hemmingsen, Lars/A-6780-2015; Tholey, Andreas/B-3407-2010	Hemmingsen, Lars/0000-0002-1823-3035; Hemmingsen, Lars/0000-0002-1823-3035; Tholey, Andreas/0000-0002-8687-6817	European Union [CT 98-0232, HPRN-CT-2002-00,264]; Villum Kann Rasmussen Foundation; Danish Instrument Centre for Cern; Danish Natural Science Research Council; European Union via EURONS	European Union(European Commission); Villum Kann Rasmussen Foundation(Villum Fonden); Danish Instrument Centre for Cern; Danish Natural Science Research Council(Danish Natural Science Research Council); European Union via EURONS	This work was supported by European Union Contracts CT 98-0232 and HPRN-CT-2002-00,264), the Villum Kann Rasmussen Foundation, the Danish Instrument Centre for Cern, The Danish Natural Science Research Council, and the European Union via EURONS.	Aravind L, 1999, In Silico Biol, V1, P69; Badarau A, 2008, J BIOL INORG CHEM, V13, P919, DOI 10.1007/s00775-008-0379-2; Badarau A, 2006, BIOCHEMISTRY-US, V45, P11012, DOI 10.1021/bi0610146; BUTZ T, 1991, CHEM PHYS, V149, P437, DOI 10.1016/0301-0104(91)90043-S; Carfi A, 1998, ACTA CRYSTALLOGR D, V54, P313, DOI 10.1107/S0907444997010627; Costello AL, 2006, BIOCHEMISTRY-US, V45, P13650, DOI 10.1021/bi061547e; de Peredo AG, 2001, J MOL BIOL, V310, P83, DOI 10.1006/jmbi.2001.4769; de Seny D, 2002, BIOCHEM J, V363, P687, DOI 10.1042/0264-6021:3630687; de Seny D, 2001, J BIOL CHEM, V276, P45065, DOI 10.1074/jbc.M106447200; Dragani B, 1999, J MOL BIOL, V291, P481, DOI 10.1006/jmbi.1999.2965; Faller P, 2000, J BIOL INORG CHEM, V5, P393, DOI 10.1007/PL00010668; FRERE JM, 1995, MOL MICROBIOL, V16, P385, DOI 10.1111/j.1365-2958.1995.tb02404.x; Galleni M, 2001, ANTIMICROB AGENTS CH, V45, P660, DOI 10.1128/AAC.45.3.660-663.2001; Garcia-Saez I, 2003, J BIOL CHEM, V278, P23868, DOI 10.1074/jbc.M301062200; Heinz U, 2005, J BIOL CHEM, V280, P3197, DOI 10.1074/jbc.M409425200; Heinz U, 2004, CELL MOL LIFE SCI, V61, P2827, DOI 10.1007/s00018-004-4214-9; Heinz U, 2003, J BIOL CHEM, V278, P20659, DOI 10.1074/jbc.M212581200; Hemmingsen L, 2004, CHEM REV, V104, P4027, DOI 10.1021/cr030030v; Hemmingsen L, 1996, EUR J BIOCHEM, V241, P546, DOI 10.1111/j.1432-1033.1996.00546.x; Hemmingsen L, 2001, J AM CHEM SOC, V123, P10329, DOI 10.1021/ja0112240; Hu ZX, 2008, BIOCHEMISTRY-US, V47, P7947, DOI 10.1021/bi8004768; Iranzo O, 2007, CHEM-EUR J, V13, P9178, DOI 10.1002/chem.200701208; Krezel A, 2007, J AM CHEM SOC, V129, P10911; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Llarrull LI, 2008, J AM CHEM SOC, V130, P15842, DOI 10.1021/ja801168r; Melino S, 1998, TRENDS BIOCHEM SCI, V23, P381, DOI 10.1016/S0968-0004(98)01264-X; NATH U, 1995, BIOCHEMISTRY-US, V34, P1702, DOI 10.1021/bi00005a027; Nemirovskiy O, 1999, J AM SOC MASS SPECTR, V10, P711, DOI 10.1016/S1044-0305(99)00036-7; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Pace C N, 1986, Methods Enzymol, V131, P266; Paul-Soto R, 1999, BIOCHEMISTRY-US, V38, P16500, DOI 10.1021/bi9911381; Paul-Soto R, 1998, FEBS LETT, V438, P137, DOI 10.1016/S0014-5793(98)01289-7; Paul-Soto R, 1999, J BIOL CHEM, V274, P13242, DOI 10.1074/jbc.274.19.13242; PAYNE DJ, 1994, BIOL MASS SPECTROM, V23, P159, DOI 10.1002/bms.1200230307; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Periyannan G, 2004, PROTEIN SCI, V13, P2236, DOI 10.1110/ps.04742704; Rossolini GM, 1998, BIOCHEM J, V332, P145, DOI 10.1042/bj3320145; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SCHELLMAN JA, 1978, BIOPOLYMERS, V17, P1305, DOI 10.1002/bip.1978.360170515; Selevsek N, 2006, J AM SOC MASS SPECTR, V17, P1000, DOI 10.1016/j.jasms.2006.03.010; Siemann S, 2002, BBA-GEN SUBJECTS, V1571, P190, DOI 10.1016/S0304-4165(02)00258-1; Troger W, 2000, HYPERFINE INTERACT, V129, P511, DOI 10.1023/A:1012646808055; Valladares MH, 1997, BIOCHEMISTRY-US, V36, P11534, DOI 10.1021/bi971056h; van den Bremer ETJ, 2002, PROTEIN SCI, V11, P1738, DOI 10.1110/ps.0200502; Vessillier S, 2002, ANTIMICROB AGENTS CH, V46, P1921, DOI 10.1128/AAC.46.6.1921-1927.2002; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wang F, 1999, J AM SOC MASS SPECTR, V10, P703, DOI 10.1016/S1044-0305(99)00039-2; Wommer S, 2002, J BIOL CHEM, V277, P24142, DOI 10.1074/jbc.M202467200; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	51	28	29	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16419	16431		10.1074/jbc.M109.001305	http://dx.doi.org/10.1074/jbc.M109.001305			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19395380	hybrid, Green Published			2022-12-25	WOS:000266730900039
J	Taniguchi, K; Sasaki, K; Watari, K; Yasukawa, H; Imaizumi, T; Ayada, T; Okamoto, F; Ishizaki, T; Kato, R; Kohno, RI; Kimura, H; Sato, Y; Ono, M; Yonemitsu, Y; Yoshimura, A				Taniguchi, Koji; Sasaki, Ken-ichiro; Watari, Kousuke; Yasukawa, Hideo; Imaizumi, Tsutomu; Ayada, Toranoshin; Okamoto, Fuyuki; Ishizaki, Takuma; Kato, Reiko; Kohno, Ri-ichiro; Kimura, Hiroshi; Sato, Yasufumi; Ono, Mayumi; Yonemitsu, Yoshikazu; Yoshimura, Akihiko			Suppression of Sproutys Has a Therapeutic Effect for a Mouse Model of Ischemia by Enhancing Angiogenesis	PLOS ONE			English	Article								Sprouty proteins (Sproutys) inhibit receptor tyrosine kinase signaling and control various aspects of branching morphogenesis. In this study, we examined the physiological function of Sproutys in angiogenesis, using gene targeting and short-hairpin RNA (shRNA) knockdown strategies. Sprouty2 and Sprouty4 double knockout (KO) (DKO) mice were embryonic-lethal around E12.5 due to cardiovascular defects. The number of peripheral blood vessels, but not that of lymphatic vessels, was increased in Sprouty4 KO mice compared with wild-type (WT) mice. Sprouty4 KO mice were more resistant to hind limb ischemia and soft tissue ischemia than WT mice were, because Sprouty4 deficiency causes accelerated neovascularization. Moreover, suppression of Sprouty2 and Sprouty4 expression in vivo by shRNA targeting accelerated angiogenesis and has a therapeutic effect in a mouse model of hind limb ischemia. These data suggest that Sproutys are physiologically important negative regulators of angiogenesis in vivo and novel therapeutic targets for treating peripheral ischemic diseases.			Taniguchi, K (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Fukuoka 812, Japan.	yoshimura@a6.keio.jp	Kimura, Hiroshi/B-9524-2015; Sato, Yasufumi/AAF-3367-2019; Yoshimura, Akihiko/K-5515-2013	Kimura, Hiroshi/0000-0003-0854-083X; Watari, Kosuke/0000-0003-0260-2323				Antoine M, 2005, GROWTH FACTORS, V23, P87, DOI 10.1080/08977190500096004; Ayada T, 2009, ONCOGENE, V28, P1076, DOI 10.1038/onc.2008.464; Brems H, 2007, NAT GENET, V39, P1120, DOI 10.1038/ng2113; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Chavakis E, 2005, J EXP MED, V201, P63, DOI 10.1084/jem.20041402; DAMATO R, 1993, MICROVASC RES, V46, P135, DOI 10.1006/mvre.1993.1042; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Flamme I, 1997, J CELL PHYSIOL, V173, P206, DOI 10.1002/(SICI)1097-4652(199711)173:2<206::AID-JCP22>3.0.CO;2-C; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Kato R, 2003, BIOCHEM BIOPH RES CO, V302, P767, DOI 10.1016/S0006-291X(03)00259-6; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; KIMURA H, 2009, BLOOD IN PRESS; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Masaki I, 2002, CIRC RES, V90, P966, DOI 10.1161/01.RES.0000019540.41697.60; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Moriyama T, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-3; Nakao S, 2005, J CLIN INVEST, V115, P2979, DOI 10.1172/JCI23298; Nishinakamura H, 2007, INT IMMUNOL, V19, P609, DOI 10.1093/intimm/dxm026; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Sasaki K, 2006, P NATL ACAD SCI USA, V103, P14537, DOI 10.1073/pnas.0604144103; Schalch P, 2004, J THORAC CARDIOV SUR, V128, P595, DOI 10.1016/j.jtcvs.2004.02.036; Shibuya M, 2008, BMB REP, V41, P278, DOI 10.5483/BMBRep.2008.41.4.278; Sivak JM, 2005, DEV CELL, V8, P689, DOI 10.1016/j.devcel.2005.02.011; Sugano M, 2007, ATHEROSCLEROSIS, V191, P33, DOI 10.1016/j.atherosclerosis.2006.04.021; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Takeshita S, 1996, LAB INVEST, V74, P1061; Taketomi T, 2005, NAT NEUROSCI, V8, P855, DOI 10.1038/nn1485; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Taniguchi K, 2007, MOL CELL BIOL, V27, P4541, DOI 10.1128/MCB.01600-06; Taniguchi K, 2007, BIOCHEM BIOPH RES CO, V352, P896, DOI 10.1016/j.bbrc.2006.11.107; Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002	40	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5467	10.1371/journal.pone.0005467	http://dx.doi.org/10.1371/journal.pone.0005467			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424491	Green Published, gold, Green Submitted			2022-12-25	WOS:000265933800004
J	Proverbio, AM; Riva, F; Zani, A				Proverbio, Alice Mado; Riva, Federica; Zani, Alberto			Observation of Static Pictures of Dynamic Actions Enhances the Activity of Movement-Related Brain Areas	PLOS ONE			English	Article								Background: Physiological studies of perfectly still observers have shown interesting correlations between increasing effortfulness of observed actions and increases in heart and respiration rates. Not much is known about the cortical response induced by observing effortful actions. The aim of this study was to investigate the time course and neural correlates of perception of implied motion, by presenting 260 pictures of human actions differing in degrees of dynamism and muscular exertion. ERPs were recorded from 128 sites in young male and female adults engaged in a secondary perceptual task. Principal Findings: Our results indicate that even when the stimulus shows no explicit motion, observation of static photographs of human actions with implied motion produces a clear increase in cortical activation, manifest in a long-lasting positivity (LP) between 350-600 ms that is much greater to dynamic than less dynamic actions, especially in men. A swLORETA linear inverse solution computed on the dynamic-minus-static difference wave in the time window 380-430 ms showed that a series of regions was activated, including the right V5/MT, left EBA, left STS (BA38), left premotor (BA6) and motor (BA4) areas, cingulate and IF cortex. Conclusions and Significance: Overall, the data suggest that corresponding mirror neurons respond more strongly to implied dynamic than to less dynamic actions. The sex difference might be partially cultural and reflect a preference of young adult males for highly dynamic actions depicting intense muscular activity, or a sporty context.			Proverbio, AM (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.	mado.proverbio@unimib.it	Zani, Alberto/ABG-8894-2020; Zani, Alberto/ABI-3498-2020	Zani, Alberto/0000-0002-3906-7988; Proverbio, Alice Mado/0000-0002-5138-1523				Arbib MA, 2005, BEHAV BRAIN SCI, V28, P105, DOI 10.1017/S0140525X05000038; Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Beauchamp MS, 2002, NEURON, V34, P149, DOI 10.1016/S0896-6273(02)00642-6; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Chong TTJ, 2008, CURR BIOL, V18, P1576, DOI 10.1016/j.cub.2008.08.068; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; DECETY J, 1993, J PHYSIOL-LONDON, V461, P549, DOI 10.1113/jphysiol.1993.sp019528; DECETY J, 1991, BEHAV BRAIN RES, V51, P1; DECETY J, 1994, MAPPING MOTOR REPRES, P600; Dinstein I, 2008, CURR BIOL, V18, pR13, DOI 10.1016/j.cub.2007.11.004; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; GAZZOLA V, 2008, CEREB CORTEX; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Grossman ED, 2002, NEURON, V35, P1167, DOI 10.1016/S0896-6273(02)00897-8; Hautzel H, 2001, BRAIN RES, V892, P281, DOI 10.1016/S0006-8993(00)03224-8; Holz EM, 2008, BRAIN TOPOGR, V21, P93, DOI 10.1007/s10548-008-0066-1; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; Paccalin C, 2000, BRAIN RES, V862, P194, DOI 10.1016/S0006-8993(00)02145-4; Palmero-Soler E, 2007, PHYS MED BIOL, V52, P1783, DOI 10.1088/0031-9155/52/7/002; Proverbio AM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-56; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; Senior C, 2000, CURR BIOL, V10, P16, DOI 10.1016/S0960-9822(99)00259-6; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; Urgesi C, 2006, J NEUROSCI, V26, P7942, DOI 10.1523/JNEUROSCI.1289-06.2006; Uusitalo MA, 1997, NEUROIMAGE, V5, P241, DOI 10.1006/nimg.1997.0266	31	71	73	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5389	10.1371/journal.pone.0005389	http://dx.doi.org/10.1371/journal.pone.0005389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421311	Green Submitted, gold, Green Published			2022-12-25	WOS:000265836900003
J	Miyagawa, T; Honda, M; Kawashima, M; Shimada, M; Tanaka, S; Honda, Y; Tokunaga, K				Miyagawa, Taku; Honda, Makoto; Kawashima, Minae; Shimada, Mihoko; Tanaka, Susumu; Honda, Yutaka; Tokunaga, Katsushi			Polymorphism Located between CPT1B and CHKB, and HLA-DRB1*1501-DQB1*0602 Haplotype Confer Susceptibility to CNS Hypersomnias (Essential Hypersomnia)	PLOS ONE			English	Article								Background: SNP rs5770917 located between CPT1B and CHKB, and HLA-DRB1*1501-DQB1* 0602 haplotype were previously identified as susceptibility loci for narcolepsy with cataplexy. This study was conducted in order to investigate whether these genetic markers are associated with Japanese CNS hypersomnias (essential hypersomnia: EHS) other than narcolepsy with cataplexy. Principal Findings: EHS was significantly associated with SNP rs5770917 (P(allele) = 3.6x10(-3); OR = 1.56; 95% c. i.: 1.12 - 2.15) and HLA-DRB1*1501-DQB1* 0602 haplotype (P(positivity) = 9.2x10(-11); OR = 3.97; 95% c. i.: 2.55-6.19). No interaction between the two markers (SNP rs5770917 and HLA-DRB1*1501-DQB1* 0602 haplotype) was observed in EHS. Conclusion: CPT1B, CHKB and HLA are candidates for susceptibility to CNS hypersomnias (EHS), as well as narcolepsy with cataplexy.			Miyagawa, T (corresponding author), Univ Tokyo, Dept Human Genet, Grad Sch Med, Tokyo, Japan.	miyagawa-taku@umin.ac.jp	Tanaka, Susumu/AAC-4739-2019	Tanaka, Susumu/0000-0003-4804-7839				Anderson KN, 2007, SLEEP, V30, P1274, DOI 10.1093/sleep/30.10.1274; Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; Fioravanti M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000269.pub3; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; HONDA Y, 1986, SLEEP, V9, P133, DOI 10.1093/sleep/9.1.133; HONDA Y, 1998, GENETIC ASPECTS NARC, P341; Hong SC, 2006, SLEEP, V29, P1429, DOI 10.1093/sleep/29.11.1429; JUJI T, 1984, TISSUE ANTIGENS, V24, P316, DOI 10.1111/j.1399-0039.1984.tb02144.x; Kent C, 1997, BBA-LIPID LIPID MET, V1348, P79, DOI 10.1016/S0005-2760(97)00112-4; Komada Y, 2005, PSYCHIAT CLIN NEUROS, V59, P194, DOI 10.1111/j.1440-1819.2005.01357.x; Kuwajima M, 2007, ENDOCR J; LANGDON N, 1984, LANCET, V2, P1178; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Miyagawa T, 2008, NAT GENET, V40, P1324, DOI 10.1038/ng.231; Nishino S, 1997, PROG NEUROBIOL, V52, P27, DOI 10.1016/S0301-0082(96)00070-6; Tafti M, 2003, NAT GENET, V34, P320, DOI 10.1038/ng1174; Yoshida G, 2006, NEUROSCI RES, V55, P78, DOI 10.1016/j.neures.2006.02.003; Zweigner J, 2004, J EXP MED, V200, P99, DOI 10.1084/jem.20032100	22	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5394	10.1371/journal.pone.0005394	http://dx.doi.org/10.1371/journal.pone.0005394			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404393	Green Published, Green Submitted, gold			2022-12-25	WOS:000265614900008
J	Guo, J; Jou, W; Gavrilova, O; Hall, KD				Guo, Juen; Jou, William; Gavrilova, Oksana; Hall, Kevin D.			Persistent Diet-Induced Obesity in Male C57BL/6 Mice Resulting from Temporary Obesigenic Diets	PLOS ONE			English	Article							ADIPOSE-TISSUE; LEPTIN RESISTANCE; RISK-FACTORS; INSULIN; RATS; REVERSAL; DEFENSE; FAT; INSIGHTS	Background: Does diet-induced obesity persist after an obesigenic diet is removed? We investigated this question by providing male C57BL/6 mice with free access to two different obesigenic diets followed by a switch to chow to determine if obesity was reversible. Methodology/Principal Findings: Male C57BL/6 mice were randomly assigned to five weight-matched groups: 1) C group that continuously received a chow diet; 2) HF group on a 60% high fat diet; 3) EN group on the high fat diet plus liquid Ensure (R); 4) HF-C group switched from high fat to chow after 7 weeks; 5) EN-C group switched from high fat plus Ensure (R) to chow after 7 weeks. All food intake was ad libitum. Body weight was increased after 7 weeks on both obesigenic diets (44.6 +/- 0.65, 39.8 +/- 0.63, and 28.6 +/- 0.63 g for EN, HF, and C groups, respectively) and resulted in elevated concentrations of serum insulin, glucose, and leptin and lower serum triglycerides. Development of obesity in HF and EN mice was caused by increased energy intake and a relative decrease of average energy output along with decreased ambulatory activity. After the switch to chow, the HF-C and EN-C groups lost weight but subsequently maintained a state of persistent obesity in comparison to the C group (34.8 +/- 1.2, 34.1 +/- 1.2 vs. 30.8 +/- 0.8 g respectively; P < 0.05) with a 40-50% increase of body fat. All serum hormones and metabolites returned to control levels with the exception of a trend for increased leptin. The HF-C and EN-C groups had an average energy output in line with the C group and the persistent obesity was maintained despite a non-significant increase of energy intake of less than 1 kcal/d at the end of the study. Conclusion: Our results illustrate the importance of considering the history of energy imbalance in determining body weight and that a persistent elevation of body weight after removal of obesigenic diets can result from very small increases of energy intake.			Guo, J (corresponding author), NIDDK, Lab Biol Modeling, NIH, Bethesda, MD 20892 USA.	kevinh@niddk.nih.gov	Hall, Kevin/F-2383-2010	Hall, Kevin/0000-0003-4062-3133; Guo, Juen/0000-0003-2876-5884	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK070002, ZICDK070002, Z01DK013038, ZIADK013038] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		BARTNESS TJ, 1992, AM J PHYSIOL, V263, pR790, DOI 10.1152/ajpregu.1992.263.4.R790; Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314; BJORNTORP P, 1990, ARTERIOSCLEROSIS, V10, P493, DOI 10.1161/01.ATV.10.4.493; Bjursell M, 2008, AM J PHYSIOL-ENDOC M, V294, pE251, DOI 10.1152/ajpendo.00401.2007; Chen M, 2004, ENDOCRINOLOGY, V145, P4094, DOI 10.1210/en.2004-0038; Corp N, 1997, PHYSIOL ZOOL, V70, P610, DOI 10.1086/515876; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dina C, 2008, CURR OPIN CLIN NUTR, V11, P378, DOI 10.1097/MCO.0b013e328303e5e6; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Flatt JP, 1997, OBES RES, V5, P632, DOI 10.1002/j.1550-8528.1997.tb00585.x; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Ginsberg HN, 2005, ARCH MED RES, V36, P232, DOI 10.1016/j.arcmed.2005.01.005; Hall K, 2002, DIABETES, V51, pA607; Hall KD, 2008, INT J OBESITY, V32, P573, DOI 10.1038/sj.ijo.0803720; HARRINGTON ME, 1983, PHYSIOL BEHAV, V30, P763, DOI 10.1016/0031-9384(83)90175-0; HARRIS RBS, 1989, P SOC EXP BIOL MED, V191, P82; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; HILL JO, 1989, INT J OBESITY, V13, P711; HimmsHagen J, 1997, SCIENCE, V276, P1132, DOI 10.1126/science.276.5315.1132; James WPT, 2008, J INTERN MED, V263, P336, DOI 10.1111/j.1365-2796.2008.01922.x; James WPT, 2008, OBES REV, V9, P6, DOI 10.1111/j.1467-789X.2007.00432.x; KESSLER JI, 1963, J CLIN INVEST, V42, P362, DOI 10.1172/JCI104722; Levin BE, 1998, AM J PHYSIOL-REG I, V274, pR412, DOI 10.1152/ajpregu.1998.274.2.R412; Levin BE, 2002, AM J PHYSIOL-REG I, V282, pR46, DOI 10.1152/ajpregu.2002.282.1.R46; LEWIS GF, 1995, J CLIN INVEST, V95, P158, DOI 10.1172/JCI117633; LLADO I, 1991, INT J OBESITY, V15, P415; Meugnier E, 2007, OBESITY, V15, P2583, DOI 10.1038/oby.2007.310; Parekh PI, 1998, METABOLISM, V47, P1089, DOI 10.1016/S0026-0495(98)90283-9; PECKHAM SC, 1962, RES DEV TECH REP, V546; ROGERS PJ, 1985, PHYSIOL BEHAV, V35, P493, DOI 10.1016/0031-9384(85)90129-5; ROLLS BJ, 1980, J PHYSIOL-LONDON, V298, P415, DOI 10.1113/jphysiol.1980.sp013091; SCLAFANI A, 1976, PHYSIOL BEHAV, V17, P461, DOI 10.1016/0031-9384(76)90109-8; Speakman JR, 2004, J NUTR, V134, p2090S, DOI 10.1093/jn/134.8.2090S; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Tam J, 2009, CELL METAB, V9, P52, DOI 10.1016/j.cmet.2008.11.005; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697	37	82	83	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5370	10.1371/journal.pone.0005370	http://dx.doi.org/10.1371/journal.pone.0005370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401758	gold, Green Published, Green Submitted			2022-12-25	WOS:000265601100012
J	Lei, Y; Moore, CB; Liesman, RM; O'Connor, BP; Bergstralh, DT; Chen, ZJJ; Pickles, RJ; Ting, JPY				Lei, Yu; Moore, Chris B.; Liesman, Rachael M.; O'Connor, Brian P.; Bergstralh, Daniel T.; Chen, Zhijian J.; Pickles, Raymond J.; Ting, Jenny P. -Y.			MAVS-Mediated Apoptosis and Its Inhibition by Viral Proteins	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; ANTIVIRAL SIGNALING PROTEIN; NF-KAPPA-B; ACTIVATION; IDENTIFICATION; MITOCHONDRIA; INFECTION; PATHWAYS; IPAF	Background: Host responses to viral infection include both immune activation and programmed cell death. The mitochondrial antiviral signaling adaptor, MAVS (IPS-1, VISA or Cardif) is critical for host defenses to viral infection by inducing type-1 interferons (IFN-I), however its role in virus-induced apoptotic responses has not been elucidated. Principal Findings: We show that MAVS causes apoptosis independent of its function in initiating IFN-I production. MAVS-induced cell death requires mitochondrial localization, is caspase dependent, and displays hallmarks of apoptosis. Furthermore, MAVS(-/-) fibroblasts are resistant to Sendai virus-induced apoptosis. A functional screen identifies the hepatitis C virus NS3/4A and the Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) nonstructural protein (NSP15) as inhibitors of MAVS-induced apoptosis, possibly as a method of immune evasion. Significance:This study describes a novel role for MAVS in controlling viral infections through the induction of apoptosis, and identifies viral proteins which inhibit this host response.	[Lei, Yu; Moore, Chris B.; O'Connor, Brian P.; Bergstralh, Daniel T.; Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Lei, Yu] Univ N Carolina, Dept Oral Biol, Chapel Hill, NC 27599 USA; [Moore, Chris B.] Univ N Carolina, Dept Surg, Chapel Hill, NC 27599 USA; [Liesman, Rachael M.; O'Connor, Brian P.; Pickles, Raymond J.; Ting, Jenny P. -Y.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Mol Biol, Dallas, TX 75390 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lei, Y (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	Jenny_Ting@med.unc.edu	Lei, Yu Leo/ABF-1293-2020; Ariel, Pablo/AGJ-4118-2022; Chen, Zhijian/C-6039-2012	Lei, Yu Leo/0000-0002-9868-9824; Chen, Zhijian/0000-0002-8475-8251; Bergstralh, Dan/0000-0003-1689-3715	NIAID	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from NIAID for SERCEB and Human Immunology to J.P.-Y.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2001, TRENDS BIOCHEM SCI, V26, P390, DOI 10.1016/S0968-0004(01)01844-8; Bouchier-Hayes L, 2002, EMBO REP, V3, P616, DOI 10.1093/embo-reports/kvf139; Chan-Yeung M, 2003, RESPIROLOGY, V8, P131, DOI 10.1046/j.1440-1843.2003.00453.x; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Chen CY, 2007, J INFECT DIS, V196, P405, DOI 10.1086/519166; Cuconati A, 2002, GENE DEV, V16, P2465, DOI 10.1101/gad.1012702; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; FREIMAN M, 2003, J VIROL, V133, P101; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Griffin DE, 1997, ANNU REV MICROBIOL, V51, P565, DOI 10.1146/annurev.micro.51.1.565; Hacker G, 2000, CELL TISSUE RES, V301, P5, DOI 10.1007/s004410000193; Heylbroeck C, 2000, J VIROL, V74, P3781, DOI 10.1128/JVI.74.8.3781-3792.2000; Holm GH, 2007, J BIOL CHEM, V282, P21953, DOI 10.1074/jbc.M702112200; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Iseni F, 2002, EMBO J, V21, P5141, DOI 10.1093/emboj/cdf513; Ivanov KA, 2004, P NATL ACAD SCI USA, V101, P12694, DOI 10.1073/pnas.0403127101; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; LAN YL, 2005, CURR OPIN IMMUNOL, V17, P404; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Miagkov AV, 1998, P NATL ACAD SCI USA, V95, P13859, DOI 10.1073/pnas.95.23.13859; MOORE CB, 2006, NATURE, V151, P573; Moore CB, 2008, IMMUNITY, V28, P735, DOI 10.1016/j.immuni.2008.05.005; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; PEIRIS JS, 2001, LANCET BIOL, V361, P1767; Peters K, 2008, J VIROL, V82, P3500, DOI 10.1128/JVI.02536-07; Potter JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-11; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Reeves MB, 2007, SCIENCE, V316, P1345, DOI 10.1126/science.1142984; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Sadasivam S, 2005, ONCOGENE, V24, P627, DOI 10.1038/sj.onc.1208201; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Tan YX, 2007, J VIROL, V81, P6346, DOI 10.1128/JVI.00090-07; TING JP, 2000, IMMUNITY, V20, P285; van Deventer HW, 2008, AM J PATHOL, V173, P253, DOI 10.2353/ajpath.2008.070732; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yang Y, 2007, P NATL ACAD SCI USA, V104, P7253, DOI 10.1073/pnas.0611506104; YE Z, 2008, ASARS CON PROTEIN OR; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; YONEYAMA M, 2005, J IMMUNOL, V173, P2581; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	50	151	156	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2009	4	5							e5466	10.1371/journal.pone.0005466	http://dx.doi.org/10.1371/journal.pone.0005466			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NK	19404494	gold, Green Published, Green Submitted			2022-12-25	WOS:000278066700001
J	Geng, L; Rachakonda, G; Morre, DJ; Morre, DM; Crooks, PA; Sonar, VN; Roti, JLR; Rogers, BE; Greco, S; Ye, F; Salleng, KJ; Sasi, S; Freeman, ML; Sekhar, KR				Geng, Ling; Rachakonda, Girish; Morre, D. James; Morre, Dorothy M.; Crooks, Peter A.; Sonar, Vijayakumar N.; Roti, Joseph L. Roti; Rogers, Buck E.; Greco, Suellen; Ye, Fei; Salleng, Kenneth J.; Sasi, Soumya; Freeman, Michael L.; Sekhar, Konjeti R.			Indolyl-quinuclidinols inhibit ENOX activity and endothelial cell morphogenesis while enhancing radiation-mediated control of tumor vasculature	FASEB JOURNAL			English	Article						angiogenesis; (Z)-(+/-)-2-(1-benzylindol-3-ylmethylene)-1-azabicyclo[2.2.2]octan-3-ol	MICROVESSEL DENSITY; IONIZING-RADIATION; PLASMA-MEMBRANE; S6 KINASE; ANGIOGENESIS; GROWTH; CANCER; THERAPY; OXIDASE; PROTEIN	There is a need for novel strategies that target tumor vasculature, specifically those that synergize with cytotoxic therapy, in order to overcome resistance that can develop with current therapeutics. A chemistry-driven drug discovery screen was employed to identify novel compounds that inhibit endothelial cell tubule formation. Cell-based phenotypic screening revealed that noncytotoxic concentrations of (Z)-(+/-)-2-(1-benzenesulfonylindol-3-ylmethylene)-1-azabicyclo[2. 2.2]octan-3-ol (analog I) and (Z)-(+/-)- 2-(1-benzylindol-3-ylmethylene)-1-azabicyclo[2.2.2]octan-3-ol (analog II) inhibited endothelial cell migration and the ability to form capillary-like structures in Matrigel by >= 70%. The ability to undergo neoangiogenesis, as measured in a window-chamber model, was also inhibited by 70%. Screening of biochemical pathways revealed that analog II inhibited the enzyme ENOX1 (EC50 = 10 mu M). Retroviral-mediated shRNA suppression of endothelial ENOX1 expression inhibited cell migration and tubule formation, recapitulating the effects observed with the small-molecule analogs. Genetic or chemical suppression of ENOX1 significantly increased radiation-mediated Caspase3-activated apoptosis, coincident with suppression of p70S6K1 phosphorylation. Administration of analog II prior to fractionated X-irradiation significantly diminished the number and density of tumor microvessels, as well as delayed syngeneic and xenograft tumor growth compared to results obtained with radiation alone. Analysis of necropsies suggests that the analog was well tolerated. These results suggest that targeting ENOX1 activity represents a novel therapeutic strategy for enhancing the radiation response of tumors.-Geng, L., Rachakonda, G., Morre, D. J., Morre, D. M., Crooks, P. A., Sonar, V. N., Roti Roti, J. L., Rogers, B. E., Greco, S., Ye, F., Salleng, K. J., Sasi, S., Freeman, M. L., Sekhar, K. R. Indolyl-quinuclidinols inhibit ENOX activity and endothelial cell morphogenesis while enhancing radiation-mediated control of tumor vasculature. FASEB J. 23, 2986-2995 (2009). www.fasebj.org	[Freeman, Michael L.] Vanderbilt Univ, Sch Med, TVC Radiat Oncol B902, Dept Radiat Oncol,Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Ye, Fei] Vanderbilt Univ, Sch Med, Dept Biostat, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Morre, D. James] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Morre, Dorothy M.] Purdue Univ, Dept Foods & Nutr, W Lafayette, IN 47907 USA; [Crooks, Peter A.; Sonar, Vijayakumar N.] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY USA; [Roti, Joseph L. Roti; Rogers, Buck E.] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO USA; [Greco, Suellen] Washington Univ, Sch Med, Div Comparat Med, St Louis, MO USA	Vanderbilt University; Vanderbilt University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Kentucky; Washington University (WUSTL); Washington University (WUSTL)	Freeman, ML (corresponding author), Vanderbilt Univ, Sch Med, TVC Radiat Oncol B902, Dept Radiat Oncol,Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA.	michael.freeman@vanderbilt.edu; raja.konjeti@vanderbilt.edu		Freeman, Michael/0000-0003-1881-366X; Konjeti, Sekhar/0000-0003-2930-0739	U.S. National Institutes of Health/National Cancer Institute [PO1 CA104457]; Vanderbilt-Ingram Cancer Center [P30 CA68485]; NATIONAL CANCER INSTITUTE [P30CA068485, P01CA104457, R01CA140409] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vanderbilt-Ingram Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by U.S. National Institutes of Health/National Cancer Institute grant PO1 CA104457 and Vanderbilt-Ingram Cancer Center grant P30 CA68485.	Al-Ghananeem AM, 2007, CANCER CHEMOTH PHARM, V60, P915, DOI 10.1007/s00280-007-0425-8; BRIGHTMAN AO, 1992, BIOCHIM BIOPHYS ACTA, V1105, P109, DOI 10.1016/0005-2736(92)90168-L; Brown M, 2003, CANCER BIOL THER, V2, P477, DOI 10.4161/cbt.2.5.450; Buck E, 2006, MOL CANCER THER, V5, P2676, DOI 10.1158/1535-7163.MCT-06-0166; Duda DG, 2007, J CLIN ONCOL, V25, P4033, DOI 10.1200/JCO.2007.11.3985; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Edwards E, 2002, CANCER RES, V62, P4671; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Folkman J, 2006, EXP CELL RES, V312, P594, DOI 10.1016/j.yexcr.2005.11.015; Gangadhar NM, 2007, CURR OPIN CHEM BIOL, V11, P83, DOI 10.1016/j.cbpa.2006.11.033; Geng L, 2001, CANCER RES, V61, P2413; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Hull MA, 2003, CANCER TREAT REV, V29, P309, DOI 10.1016/S0305-7372(03)00014-8; Jones MK, 1999, NAT MED, V5, P1418; Lee S, 2009, J LIPID RES, V50, P265, DOI 10.1194/jlr.M800317-JLR200; Li CY, 2000, JNCI-J NATL CANCER I, V92, P143, DOI 10.1093/jnci/92.2.143; Liu SC, 2008, BIOCHEM BIOPH RES CO, V365, P672, DOI 10.1016/j.bbrc.2007.11.025; Mauceri HJ, 1998, NATURE, V394, P287, DOI 10.1038/28412; Mobius C, 2007, EJSO-EUR J SURG ONC, V33, P1025, DOI 10.1016/j.ejso.2007.02.020; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Morre DJ, 2004, METHOD ENZYMOL, V378, P179; MORRE DJ, 1999, PLASMA MEMBRANE REDO, P121; Morre DM, 2000, J EXP BIOL, V203, P1513; Ogawa K, 2007, CANCER RES, V67, P4016, DOI 10.1158/0008-5472.CAN-06-4498; Osusky Katherine L., 2004, Angiogenesis, V7, P225, DOI 10.1007/s10456-004-3149-y; Pearce HR, 2003, J GASTROEN HEPATOL, V18, P1180, DOI 10.1046/j.1440-1746.2003.03152.x; Poon RTP, 2002, J CLIN ONCOL, V20, P1775, DOI 10.1200/JCO.2002.07.089; Rozic JG, 2001, INT J CANCER, V93, P497, DOI 10.1002/ijc.1376; Scarlett DJG, 2005, BBA-BIOENERGETICS, V1708, P108, DOI 10.1016/j.bbabio.2005.03.006; Sekhar KR, 2007, CANCER RES, V67, P695, DOI 10.1158/0008-5472.CAN-06-3212; Sekhar KR, 2003, CANCER RES, V63, P5636; Sessa C, 2008, NAT CLIN PRACT ONCOL, V5, P378, DOI 10.1038/ncponc1150; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Shinohara ET, 2005, ONCOGENE, V24, P5414, DOI 10.1038/sj.onc.1208715; Shinohara ET, 2005, CANCER RES, V65, P4987, DOI 10.1158/0008-5472.CAN-04-4250; Sonar VN, 2007, BIOORG MED CHEM LETT, V17, P6821, DOI 10.1016/j.bmcl.2007.10.035; Wang HM, 2005, WORLD J GASTROENTERO, V11, P340, DOI 10.3748/wjg.v11.i3.340; Wild R, 2000, MICROVASC RES, V59, P368, DOI 10.1006/mvre.1999.2233; Yagiz K, 2006, J NUTR BIOCHEM, V17, P750, DOI 10.1016/j.jnutbio.2005.12.006; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yazlovitskaya EM, 2008, CELL DEATH DIFFER, V15, P1641, DOI 10.1038/cdd.2008.93; Zhang P, 2006, ONCOGENE, V25, P7758, DOI 10.1038/sj.onc.1209744	42	14	15	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					2986	2995		10.1096/fj.09-130005	http://dx.doi.org/10.1096/fj.09-130005			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19395476	Green Published			2022-12-25	WOS:000270241000021
J	Glover, DJ; Ng, SM; Mechler, A; Martin, LL; Jans, DA				Glover, Dominic J.; Ng, Su May; Mechler, Adam; Martin, Lisandra L.; Jans, David A.			Multifunctional protein nanocarriers for targeted nuclear gene delivery in nondividing cells	FASEB JOURNAL			English	Article						atomic force microscopy; nanoparticles; nonviral vector; nuclear import; subcellular transport	DNA UPTAKE; MECHANISM; PROTAMINE; TRANSCRIPTION; RECOGNITION; EXPRESSION; IMPORTIN; BINDING; DOMAIN	Compartmentalization within eukaryotic cells hinders the efficient delivery of therapeutic agents to the cell nucleus. Here we describe novel multifunctional DNA carriers (MDCs) that self-assemble with DNA to form structured nanoparticles that possess virus-like functions for cellular trafficking. MDCs contain, in fusion, the DNA-compacting sperm chromatin component protamine, alpha-melanocyte-stimulating hormone for cell-targeted internalization, the endosome-translocation domain of diphtheria toxin, and an optimized nuclear localization sequence to confer recognition by the nuclear import machinery. The structure of the MDC-DNA particles was examined using atomic force microscopy, and the functionality of each domain assessed using in vitro techniques, including a reconstituted nuclear transport assay in semi-intact cells relying on the use of quantitative confocal laser scanning microscopy. The nanoparticles were internalized in cell-specific fashion and subsequently exited the endosome into the cytoplasm. Notably, the nanoparticles interact with cellular nuclear transport proteins as shown in direct binding assays and are actively trafficked into the cell nucleus of nondividing cells, resulting in 3- to 4-fold higher reporter gene expression in growth-arrested human embryonic kidney cells, as well as lower cytotoxicity, than lipid and polyethyleneimine vectors. The importance of each functional domain was examined by comparing MDCs with different domain compositions as controls, as well as using antibodies to block particular pathways. MDCs that utilize cellular signaling pathways have enormous potential to safely and efficiently deliver therapeutic transgenes into the nucleus of nondividing cells.-Glover, D. J., Ng, S. M., Mechler, A., Martin, L. L., Jans, D. A. Multifunctional protein nanocarriers for targeted nuclear gene delivery in nondividing cells. FASEB J. 23, 2996-3006 (2009). www.fasebj.org	[Glover, Dominic J.; Jans, David A.] Monash Univ, Nucl Signaling Lab, Dept Biochem & Mol Biol, Monash, Vic 3800, Australia; [Ng, Su May; Mechler, Adam; Martin, Lisandra L.] Monash Univ, Dept Chem, Monash, Vic 3800, Australia; [Jans, David A.] ARC Ctr Excellence Biotechnol & Dev, Canberra, ACT, Australia	Monash University; Monash University	Jans, DA (corresponding author), Monash Univ, Nucl Signaling Lab, Dept Biochem & Mol Biol, POB 13D, Monash, Vic 3800, Australia.	david.jans@med.monash.edu.au	Martin, Lisandra L/E-4482-2010; Mechler, Adam/C-5777-2009; Glover, Dominic/C-3333-2018	Martin, Lisandra L/0000-0003-0486-5813; Mechler, Adam/0000-0002-6428-6760; Glover, Dominic/0000-0002-6819-4089; Jans, David/0000-0001-5115-4745	National Health and Medical Research Council [384109, 284205]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The authors thank Ian McKinnon, School of Chemistry, Monash University, for assistance with zeta-potential and dynamic light-scattering experiments. The authors acknowledge the support of the National Health and Medical Research Council (fellowship no. 384109 and project grant no. 284205). The authors declare no competing financial interests.	Akhlynina TV, 1997, J BIOL CHEM, V272, P20328, DOI 10.1074/jbc.272.33.20328; Allen MJ, 1997, NUCLEIC ACIDS RES, V25, P2221, DOI 10.1093/nar/25.11.2221; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brewer LR, 1999, SCIENCE, V286, P120, DOI 10.1126/science.286.5437.120; Chan CK, 2000, GENE THER, V7, P1690, DOI 10.1038/sj.gt.3301275; Chan CK, 1998, GENE THER, V5, P1204, DOI 10.1038/sj.gt.3300708; Fasbender A, 1997, GENE THER, V4, P1173, DOI 10.1038/sj.gt.3300524; Glover DJ, 2005, NAT REV GENET, V6, P299, DOI 10.1038/nrg1577; Goncalves E, 2005, BIOCHEMISTRY-US, V44, P2692, DOI 10.1021/bi048046i; Grosse S, 2006, J GENE MED, V8, P845, DOI 10.1002/jgm.915; Hearps AC, 2006, BIOCHEM J, V398, P475, DOI 10.1042/BJ20060466; Hou X, 2007, FEBS J, V274, P1637, DOI 10.1111/j.1742-4658.2007.05712.x; Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191; Mastrobattista E, 2006, NAT REV DRUG DISCOV, V5, P115, DOI 10.1038/nrd1960; Masuda T, 2005, FEBS LETT, V579, P2143, DOI 10.1016/j.febslet.2005.02.071; McNulty DE, 2003, PROTEIN EXPRES PURIF, V27, P365, DOI 10.1016/S1046-5928(02)00610-1; Montagner C, 2007, BIOCHEMISTRY-US, V46, P1878, DOI 10.1021/bi602381z; Mudrak O, 2005, J CELL SCI, V118, P4541, DOI 10.1242/jcs.02581; Newton RA, 2005, PEPTIDES, V26, P1818, DOI 10.1016/j.peptides.2004.11.031; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Rosenkranz AA, 2003, FASEB J, V17, P1121, DOI 10.1096/fj.02-0888fje; Salazar-Onfray F, 2002, BRIT J CANCER, V87, P414, DOI 10.1038/sj.bjc.6600441; Salem AK, 2003, NAT MATER, V2, P668, DOI 10.1038/nmat974; Salman H, 2001, P NATL ACAD SCI USA, V98, P7247, DOI 10.1073/pnas.121067698; Vilfan ID, 2004, J BIOL CHEM, V279, P20088, DOI 10.1074/jbc.M312777200; Wagstaff KM, 2005, J FLUORESC, V15, P469, DOI 10.1007/s10895-005-2819-5; Wagstaff KM, 2007, MOL THER, V15, P721, DOI 10.1038/sj.mt.6300093; Wolff C, 2004, BBA-BIOMEMBRANES, V1661, P166, DOI 10.1016/j.bbamem.2004.01.001	29	18	21	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					2996	3006		10.1096/fj.09-131425	http://dx.doi.org/10.1096/fj.09-131425			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19395475				2022-12-25	WOS:000270241000022
J	Spruill, LS; McDermott, PJ				Spruill, Laura S.; McDermott, Paul J.			Role of the 5 '-untranslated region in regulating translational efficiency of specific mRNAs in adult cardiocytes	FASEB JOURNAL			English	Article						cardiac hypertrophy; protein biosynthesis; polyribosomes; peptide chain initiation	ELECTRICALLY STIMULATED CONTRACTION; GLYCOGEN-SYNTHASE KINASE-3-BETA; PROTEIN-SYNTHESIS; CARDIAC-HYPERTROPHY; FELINE CARDIOCYTES; SYNTHESIS RATES; IN-VITRO; INITIATION; EXPRESSION; GROWTH	It has been hypothesized that translational efficiency is determined by the amount of secondary structure in the 5'-untranslated region (5'-UTR) of mRNA. Here, we examined whether specific 5'-UTRs with excessive secondary structure selectively regulate translational efficiency in adult cardiocytes. Recombinant adenoviruses were generated to express reporter mRNAs consisting of the 5'-UTR derived from c-jun or ornithine decarboxylase (ODC) fused to beta-galactosidase (beta Gal) coding sequence. Each adenovirus expressed GFP mRNA as a control for 5'-UTRs with minimal secondary structure. Subsequently, cardiocytes were electrically stimulated to contract at 1 Hz to accelerate protein synthesis as compared to quiescent controls. Translational efficiency was calculated by measuring protein expression as a function of mRNA levels. Translational efficiency of c-jun/beta Gal mRNA increased significantly by 3.7-fold in contracting vs. quiescent cardiocytes, but ODC/beta Gal mRNA was unchanged. Contraction increased c-jun/beta Gal mRNA levels in polyribosomes by 2.3-fold, which indicates that translational efficiency was enhanced by mobilization. A short, unstructured 5'-UTR was sufficient for efficient translation of beta Gal mRNA in quiescent and contracting cardiocytes. GFP mRNA produced similar results. These studies demonstrate that the 5'-UTR functions as a determinant of translational efficiency of specific mRNAs, such as c-jun, that regulate growth of the adult cardiocyte.-Spruill, L. S., McDermott, P. J. Role of the 5'-untranslated region in regulating translational efficiency of specific mRNAs in adult cardiocytes. FASEB J. 23, 2879-2887 (2009). www.fasebj.org	[Spruill, Laura S.; McDermott, Paul J.] Med Univ S Carolina, Gazes Cardiac Res Inst, Dept Med, Charleston, SC 29403 USA; [McDermott, Paul J.] Vet Affairs Med Ctr, Ralph H Johnson Dept, Charleston, SC 29403 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	McDermott, PJ (corresponding author), Med Univ S Carolina, Gazes Cardiac Res Inst, Dept Med, Rm 303,Strom Thurmond Biomed Res Bldg,114 Doughty, Charleston, SC 29403 USA.	mcdermp@musc.edu			National Institutes of Health [PO1 HL-48788]; Research and Development Service, Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048788] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research and Development Service, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Daisy Dominick, Shaun Wahl, Harinath Kasiganesan, and Gina Keller for their excellent technical assistance. This work was supported by the National Institutes of Health (grant PO1 HL-48788) and by the Research and Development Service, Department of Veterans Affairs (Merit Review Award).	Cheng GM, 1999, J BIOL CHEM, V274, P12819, DOI 10.1074/jbc.274.18.12819; Colomer JM, 2003, MOL ENDOCRINOL, V17, P183, DOI 10.1210/me.2002-0350; Davuluri RV, 2000, GENOME RES, V10, P1807, DOI 10.1101/gr.GR-1460R; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; Hannan RD, 2003, CLIN EXP PHARMACOL P, V30, P517, DOI 10.1046/j.1440-1681.2003.03873.x; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hirotani S, 2007, CIRC RES, V101, P1164, DOI 10.1161/CIRCRESAHA.107.160614; IVESTER CT, 1995, J BIOL CHEM, V270, P21950, DOI 10.1074/jbc.270.37.21950; IVESTER CT, 1993, AM J PHYSIOL, V265, pH666; KATO S, 1995, AM J PHYSIOL-HEART C, V268, pH2495; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Lindsey ML, 2006, PROTEOMICS, V6, P2225, DOI 10.1002/pmic.200500013; LODISH HF, 1976, ANNU REV BIOCHEM, V45, P39, DOI 10.1146/annurev.bi.45.070176.000351; Makhlouf AA, 1998, AM J PHYSIOL-HEART C, V274, pH2133, DOI 10.1152/ajpheart.1998.274.6.H2133; Mamane Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000242; Mathews MB, 2000, COLD SPRING HARBOR M, V39, P1; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Michael A, 2004, J BIOL CHEM, V279, P21383, DOI 10.1074/jbc.M401413200; Misquitta CM, 2001, MOL CELL BIOCHEM, V224, P53, DOI 10.1023/A:1011982932645; Morgan HE, 1997, MOL CELL BIOCHEM, V176, P145, DOI 10.1023/A:1006855818855; Nagatomo Y, 1999, AM J PHYSIOL-HEART C, V277, pH2176; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Pesole G, 2001, GENE, V276, P73, DOI 10.1016/S0378-1119(01)00674-6; Pyronnet S, 2005, CELL MOL LIFE SCI, V62, P1267, DOI 10.1007/s00018-005-5020-8; Qin XL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r63; Ruggero D, 2005, ONCOGENE, V24, P7426, DOI 10.1038/sj.onc.1209098; Saghir AN, 2001, BIOCHEM J, V356, P557, DOI 10.1042/0264-6021:3560557; Schluter KD, 1998, J MOL CELL CARDIOL, V30, P763, DOI 10.1006/jmcc.1998.0640; Spruill LS, 2006, FASEB J, V20, P2133, DOI 10.1096/fj.06-6245fje; Standart N, 2007, GENE DEV, V21, P1975, DOI 10.1101/gad.1591507; Swynghedauw B, 2006, J EXP BIOL, V209, P2320, DOI 10.1242/jeb.02084; Tuxworth WJ, 2004, BIOCHEM J, V378, P73, DOI 10.1042/BJ20031027; Tuxworth WJ, 1999, AM J PHYSIOL-HEART C, V277, pH1273, DOI 10.1152/ajpheart.1999.277.4.H1273; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Wada H, 1996, AM J PHYSIOL-HEART C, V271, pH29, DOI 10.1152/ajpheart.1996.271.1.H29; Wada H, 1996, J BIOL CHEM, V271, P8359, DOI 10.1074/jbc.271.14.8359; Wiesner RJ, 1997, CIRCULATION, V95, P1253; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	43	7	7	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					2879	2887		10.1096/fj.08-128447	http://dx.doi.org/10.1096/fj.08-128447			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19417087	Green Published			2022-12-25	WOS:000270241000011
J	Pan, YJ; Cho, CC; Kao, YY; Sun, CH				Pan, Yu-Jiao; Cho, Chao-Cheng; Kao, Yu-Yun; Sun, Chin-Hung			A Novel WRKY-like Protein Involved in Transcriptional Activation of Cyst Wall Protein Genes in Giardia lamblia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY-DIVERGING EUKARYOTE; DNA-BINDING PROTEINS; PRIMITIVE EUKARYOTE; ARABIDOPSIS; PROMOTER; IDENTIFICATION; ENCYSTATION; PATHOGEN; EXPRESSION; ELEMENTS	Synthesis of a protective cyst wall is required for survival outside of the host and for infection of Giardia lamblia. Little is known of gene regulation of the cyst wall proteins (CWPs) during differentiation into dormant cysts. WRKY homologues constitute a large family of DNA-binding proteins in plants that are involved in several key cellular functions, including disease resistance, stress response, dormancy, and development. A putative wrky gene has been identified in the G. lamblia genome. We found that wrky expression levels increased significantly during encystation. The epitope-tagged WRKY was translocated into the nuclei during encystation. Recombinant WRKY specifically bound to its own promoter and the encystation-induced cwp1 and cwp2 promoters. WRKY contains several key residues for DNA binding, and mutation analysis revealed that its binding sequences are similar to those of the known plant WRKY proteins and that two of them are positive cis-acting elements of the wrky and cwp2 promoters. Overexpression of WRKY increased the cwp1-2 and myb2 mRNA levels, and these gene promoters were bound by WRKY in vivo. Interestingly, the wrky and cwp1-2 genes were up-regulated by ERK1 (extracellular signal-related kinase 1) overexpression, suggesting that WRKY may be a downstream component of the ERK1 pathway. In addition, a WRKY mutant that cannot enter nuclei and an ERK1 mutant lacking the predicted kinase domain showed decreased cwp1-2 gene expression. Our results suggest that the WRKY family has been conserved during evolution and that WRKY is an important transactivator of the cwp1-2 genes during G. lamblia differentiation into dormant cysts.	[Pan, Yu-Jiao; Cho, Chao-Cheng; Kao, Yu-Yun; Sun, Chin-Hung] Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei 100, Taiwan	National Taiwan University	Sun, CH (corresponding author), Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei 100, Taiwan.	chinhsun@ntu.edu.tw	Shin, Jerry/AAO-2515-2021	SUN, CHIN-HUNG/0000-0002-8604-8085	National Science Council [NSC 94-2320B-002-093, NSC 96-2320-B-002-040-MY3]; National Health Research Institutes [NHRI-EX96-9510NC, \NHRI-EX97-9510NC, NHRI-EX989510NC]; Department of Medical Research of National Taiwan University Hospital	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan); Department of Medical Research of National Taiwan University Hospital	This work was supported by National Science Council Grants NSC 94-2320B- 002-093 and NSC 96-2320-B-002-040-MY3 and National Health Research Institutes Grants NHRI-EX96-9510NC, NHRI-EX97-9510NC, and NHRI-EX989510NC in Taiwan and was also supported in part by the Department of Medical Research of National Taiwan University Hospital.	Abel ES, 2001, J BIOL CHEM, V276, P10320, DOI 10.1074/jbc.M006589200; Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; Best AA, 2004, GENOME RES, V14, P1537, DOI 10.1101/gr.2256604; Celiksoz A, 2005, PEDIATR INT, V47, P567, DOI 10.1111/j.1442-200x.2005.02110.x; Chen YH, 2008, INT J PARASITOL, V38, P1305, DOI 10.1016/j.ijpara.2008.02.006; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; COLL M, 1987, P NATL ACAD SCI USA, V84, P8385, DOI 10.1073/pnas.84.23.8385; Davis-Hayman SR, 2003, INT J PARASITOL, V33, P1005, DOI 10.1016/S0020-7519(03)00177-2; Dong JX, 2003, PLANT MOL BIOL, V51, P21, DOI 10.1023/A:1020780022549; Du LQ, 2000, PLANT J, V24, P837, DOI 10.1046/j.1365-313x.2000.00923.x; Eichinger D, 2001, CURR OPIN MICROBIOL, V4, P421, DOI 10.1016/S1369-5274(00)00229-0; Ellis JG, 2003, J BIOL CHEM, V278, P1936, DOI 10.1074/jbc.M209274200; Elmendorf HG, 2001, MOL BIOCHEM PARASIT, V113, P157, DOI 10.1016/S0166-6851(01)00211-0; Eulgem T, 1999, EMBO J, V18, P4689, DOI 10.1093/emboj/18.17.4689; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Gillin FD, 1996, ANNU REV MICROBIOL, V50, P679, DOI 10.1146/annurev.micro.50.1.679; HOLBERTON DV, 1995, NUCLEIC ACIDS RES, V23, P2945, DOI 10.1093/nar/23.15.2945; Huang YC, 2008, J BIOL CHEM, V283, P31021, DOI 10.1074/jbc.M805023200; Johnson CS, 2002, PLANT CELL, V14, P1359, DOI 10.1105/tpc.001404; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Knodler LA, 1999, MOL MICROBIOL, V34, P327, DOI 10.1046/j.1365-2958.1999.01602.x; LUJAN HD, 1995, J BIOL CHEM, V270, P29307, DOI 10.1074/jbc.270.49.29307; Lujan HD, 1997, MICROBIOL MOL BIOL R, V61, P294; Maeo K, 2001, BIOSCI BIOTECH BIOCH, V65, P2428, DOI 10.1271/bbb.65.2428; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; McArthur AG, 2000, FEMS MICROBIOL LETT, V189, P271, DOI 10.1111/j.1574-6968.2000.tb09242.x; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; MOWATT MR, 1995, MOL MICROBIOL, V15, P955, DOI 10.1111/j.1365-2958.1995.tb02364.x; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; NICOLAIDES NC, 1991, MOL CELL BIOL, V11, P6166, DOI 10.1128/MCB.11.12.6166; Pnueli L, 2002, PLANT J, V31, P319, DOI 10.1046/j.1365-313X.2002.01364.x; Robatzek S, 2002, GENE DEV, V16, P1139, DOI 10.1101/gad.222702; Rushton PJ, 1996, EMBO J, V15, P5690, DOI 10.1002/j.1460-2075.1996.tb00953.x; Seshadri V, 2003, J BIOL CHEM, V278, P27804, DOI 10.1074/jbc.M303316200; Singer SM, 1998, MOL BIOCHEM PARASIT, V92, P59, DOI 10.1016/S0166-6851(97)00225-9; SOGIN ML, 1989, SCIENCE, V243, P75, DOI 10.1126/science.2911720; Su LH, 2007, MOL BIOCHEM PARASIT, V156, P124, DOI 10.1016/j.molbiopara.2007.07.015; Sun CH, 2003, J BIOL CHEM, V278, P21701, DOI 10.1074/jbc.M302023200; Sun CH, 2006, MOL BIOCHEM PARASIT, V146, P45, DOI 10.1016/j.molbiopara.2005.10.017; Sun CH, 1999, J BIOL CHEM, V274, P19699, DOI 10.1074/jbc.274.28.19699; Sun CH, 2002, MOL MICROBIOL, V46, P971, DOI 10.1046/j.1365-2958.2002.03233.x; Sun CX, 2003, PLANT CELL, V15, P2076, DOI 10.1105/tpc.014597; Svard SG, 1999, MOL BIOCHEM PARASIT, V98, P253, DOI 10.1016/S0166-6851(98)00174-1; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; Van Keulen H, 1998, J EUKARYOT MICROBIOL, V45, P637, DOI 10.1111/j.1550-7408.1998.tb04560.x; Wan JR, 2004, MOL PLANT PATHOL, V5, P125, DOI [10.1111/j.1364-3703.2004.00215.x, 10.1111/J.1364-3703.2004.00215.X]; Wang CH, 2007, J BIOL CHEM, V282, P8905, DOI 10.1074/jbc.M611170200; WOLFE MS, 1992, CLIN MICROBIOL REV, V5, P93, DOI 10.1128/CMR.5.1.93-100.1992; Worgall TS, 2004, J LIPID RES, V45, P981, DOI 10.1194/jlr.M400024-JLR200; Xu XP, 2006, PLANT CELL, V18, P1310, DOI 10.1105/tpc.105.037523; Yamasaki K, 2005, PLANT CELL, V17, P944, DOI 10.1105/tpc.104.026435; Yang PZ, 1999, PLANT J, V18, P141, DOI 10.1046/j.1365-313X.1999.00437.x; Yee J, 2000, J BIOL CHEM, V275, P11432, DOI 10.1074/jbc.275.15.11432; Yoda H, 2002, MOL GENET GENOMICS, V267, P154, DOI 10.1007/s00438-002-0651-z; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1	59	52	61	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					17975	17988		10.1074/jbc.M109.012047	http://dx.doi.org/10.1074/jbc.M109.012047			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19423705	Green Published, hybrid			2022-12-25	WOS:000267712400009
J	Grandy, D; Shan, JF; Zhang, XX; Rao, S; Akunuru, S; Li, HY; Zhang, YH; Alpatov, I; Zhang, XA; Lang, RA; Shi, DL; Zheng, JJ				Grandy, David; Shan, Jufang; Zhang, Xinxin; Rao, Sujata; Akunuru, Shailaja; Li, Hongyan; Zhang, Yanhui; Alpatov, Ivan; Zhang, Xin A.; Lang, Richard A.; Shi, De-Li; Zheng, Jie J.			Discovery and Characterization of a Small Molecule Inhibitor of the PDZ Domain of Dishevelled	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-LIGAND INTERACTIONS; EMPIRICAL SCORING FUNCTION; PROGRAMMED CELL-DEATH; WNT PATHWAY; HUMAN COUNTERPART; UP-REGULATION; BINDING; EXPRESSION; PROSTATE; POLARITY	Dishevelled (Dvl) is an essential protein in the Wnt signaling pathways; it uses its PDZ domain to transduce the Wnt signals from the membrane receptor Frizzled to downstream components. Here, we report identifying a drug-like small molecule compound through structure-based ligand screening and NMR spectroscopy and show the compound to interact at low micromolar affinity with the PDZ domain of Dvl. In a Xenopus testing system, the compound could permeate the cell membrane and block the Wnt signaling pathways. In addition, the compound inhibited Wnt signaling and reduced the levels of apoptosis in the hyaloid vessels of eye. Moreover, this compound also suppressed the growth of prostate cancer PC-3 cells. These biological effects suggest that by blocking the PDZ domain of Dvl, the compound identified in our studies effectively inhibits the Wnt signaling and thus provides a useful tool for studies dissecting the Wnt signaling pathways.	[Grandy, David; Shan, Jufang; Zhang, Xinxin; Zheng, Jie J.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Zhang, Yanhui; Alpatov, Ivan; Zhang, Xin A.] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38163 USA; [Zheng, Jie J.] Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN 38163 USA; [Shan, Jufang] Univ Tennessee, Hlth Sci Ctr, Interdisciplinary Grad Program, Memphis, TN 38163 USA; [Rao, Sujata; Akunuru, Shailaja; Lang, Richard A.] Childrens Hosp Res Fdn, Dept Ophthalmol, Cincinnati, OH 45229 USA; [Rao, Sujata; Akunuru, Shailaja; Lang, Richard A.] Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA; [Li, Hongyan; Shi, De-Li] Univ Paris 06, Dev Biol Lab, CNRS, UMR 7622, F-75005 Paris, France	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Zheng, JJ (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA.	jie.zheng@stjude.org	Shi, De-Li/AAG-1807-2021; Li, HY/G-3987-2010; Lang, Richard/E-5578-2011; zhang, xinxin/E-8629-2012	Lang, Richard/0000-0002-5212-254X; Zhang, Yanhui/0000-0001-8277-8008; Zheng, Jie/0000-0001-6524-6800	National Institutes of Health [R01GM081492]; American Lebanese Syrian Associated Charities; Ligue National Contre le Cancer; Association pour la Recherche sur le Cancer; NATIONAL CANCER INSTITUTE [R25CA023944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081492] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Ligue National Contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM081492. This work was also supported, in whole or in part, by the American Lebanese Syrian Associated Charities and grants from the Ligue National Contre le Cancer and the Association pour la Recherche sur le Cancer.	Axelrod JD, 2001, GENE DEV, V15, P1182; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; BOHM HJ, 1992, J COMPUT AID MOL DES, V6, P61, DOI 10.1007/bf00124387; BOHM HJ, 1994, J COMPUT AID MOL DES, V8, P243, DOI 10.1007/BF00126743; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Bui TD, 1997, BIOCHEM BIOPH RES CO, V239, P510, DOI 10.1006/bbrc.1997.7500; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; GODDARD TD, 1998, SPARKY 3 0; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; KLEBE G, 1994, J COMPUT AID MOL DES, V8, P583, DOI 10.1007/BF00123667; Kramer B, 1999, PROTEINS, V37, P228, DOI 10.1002/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Leach AR, 2006, J MED CHEM, V49, P5851, DOI 10.1021/jm060999m; Lee HJ, 2009, BIOORGAN MED CHEM, V17, P1701, DOI 10.1016/j.bmc.2008.12.060; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; London TBC, 2004, BIOCHEM BIOPH RES CO, V322, P326, DOI 10.1016/j.bbrc.2004.07.113; Mizutani K, 2005, TUMORI J, V91, P546, DOI 10.1177/030089160509100616; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Muegge I, 1999, J MED CHEM, V42, P791, DOI 10.1021/jm980536j; Nagahata T, 2003, CANCER SCI, V94, P515, DOI 10.1111/j.1349-7006.2003.tb01475.x; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Shan JF, 2005, BIOCHEMISTRY-US, V44, P15495, DOI 10.1021/bi0512602; Shan JF, 2009, J COMPUT AID MOL DES, V23, P37, DOI 10.1007/s10822-008-9236-1; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; Uematsu K, 2003, CANCER RES, V63, P4547; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wong HC, 2000, NAT STRUCT BIOL, V7, P1178; Wuthrich K, 2000, NAT STRUCT BIOL, V7, P188, DOI 10.1038/73278; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Zhang XA, 2001, MOL BIOL CELL, V12, P351, DOI 10.1091/mbc.12.2.351; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103	45	151	155	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16256	16263		10.1074/jbc.M109.009647	http://dx.doi.org/10.1074/jbc.M109.009647			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19383605	Green Published, hybrid			2022-12-25	WOS:000266730900023
J	Toyoda, Y; Sakurai, A; Mitani, Y; Nakashima, M; Yoshiura, K; Nakagawa, H; Sakai, Y; Ota, I; Lezhava, A; Hayashizaki, Y; Niikawa, N; Ishikawa, T				Toyoda, Yu; Sakurai, Aki; Mitani, Yasumasa; Nakashima, Masahiro; Yoshiura, Koh-ichiro; Nakagawa, Hiroshi; Sakai, Yasuo; Ota, Ikuko; Lezhava, Alexander; Hayashizaki, Yoshihide; Niikawa, Norio; Ishikawa, Toshihisa			Earwax, osmidrosis, and breast cancer: why does one SNP (538G > A) in the human ABC transporter ABCC11 gene determine earwax type?	FASEB JOURNAL			English	Article						endoplasmic reticulum-associated degradation; genetic polymorphism; N-linked glycosylation; protein instability	BINDING CASSETTE TRANSPORTER; TRANSMEMBRANE CONDUCTANCE REGULATOR; SMART AMPLIFICATION PROCESS; ER-ASSOCIATED DEGRADATION; N-LINKED GLYCANS; QUALITY-CONTROL; ENDOPLASMIC-RETICULUM; CYSTIC-FIBROSIS; COMPETITIVE PROBE; EFFLUX PUMP	One single-nucleotide polymorphism (SNP), 538G>A (Gly180Arg), in the ABCC11 gene determines the type of earwax. The G/G and G/A genotypes correspond to the wet type of earwax, whereas A/A corresponds to the dry type. Wide ethnic differences exist in the frequencies of those alleles, reflecting global migratory waves of the ancestors of humankind. We herein provide the evidence that this genetic polymorphism has an effect on the N-linked glycosylation of ABCC11, intracellular sorting, and proteasomal degradation of the variant protein. Immunohistochemical studies with cerumen gland-containing tissue specimens revealed that the ABCC11 WT protein was localized in intracellular granules and large vacuoles, as well as at the luminal membrane of secretory cells in the cerumen gland, whereas granular or vacuolar localization was not detected for the SNP (Arg180) variant. This SNP variant lacking N-linked glycosylation is recognized as a misfolded protein in the endoplasmic reticulum and readily undergoes ubiquitination and proteasomal degradation, which determines the dry type of earwax as a mendelian trait with a recessive phenotype. For rapid genetic diagnosis of axillary osmidrosis and potential risk of breast cancer, we developed specific primers for the SmartAmp method that enabled us to clinically genotype the ABCC11 gene within 30 min.-Toyoda, Y., Sakurai, A., Mitani, Y., Nakashima, M., Yoshiura, K., Nakagawa, H., Sakai, Y., Ota, I., Lezhava, A., Hayashizaki, Y., Niikawa, N., Ishikawa, T. Earwax, osmidrosis, and breast cancer: why does one SNP (538G>A) in the human ABC transporter ABCC11 gene determine earwax type? FASEB J. 23, 2001-2013 (2009)	[Toyoda, Yu; Sakurai, Aki; Nakagawa, Hiroshi; Ishikawa, Toshihisa] Tokyo Inst Technol, Dept Biomol Engn, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Sakurai, Aki; Mitani, Yasumasa; Ota, Ikuko; Lezhava, Alexander; Hayashizaki, Yoshihide; Ishikawa, Toshihisa] RIKEN Yokohama Inst, OSC, Yokohama, Kanagawa, Japan; [Mitani, Yasumasa] KK DNAFORM, Yokohama, Kanagawa, Japan; [Nakashima, Masahiro] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Tissue & Histopathol Sect, Nagasaki 852, Japan; [Yoshiura, Koh-ichiro; Niikawa, Norio] Nagasaki Univ, Grad Sch Biomed Sci, Dept Human Genet, Nagasaki 852, Japan; [Sakai, Yasuo] Fujita Hlth Univ, Dept Plast & Reconstruct Surg, Toyoake, Aichi, Japan; [Ota, Ikuko] Yokohama City Univ, Grad Sch Med, Dept Surg Gastroenterol, Yokohama, Kanagawa 232, Japan; [Niikawa, Norio] Hlth Sci Univ Hokkaido, Res Inst Personalized Hlth Sci, Sapporo, Hokkaido, Japan	Tokyo Institute of Technology; RIKEN; Nagasaki University; Nagasaki University; Fujita Health University; Yokohama City University; Health Sciences University of Hokkaido	Ishikawa, T (corresponding author), Tokyo Inst Technol, Dept Biomol Engn, Grad Sch Biosci & Biotechnol, Midori Ku, 4259-B-60 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	tishikaw@bio.titech.ac.jp	Toyoda, Yu/S-9802-2019; Hayashizaki, Yoshihide/N-6590-2015	Toyoda, Yu/0000-0002-7411-0531; 	JST Solution Oriented Research for Science and Technology (SORST); Scientific Research on Priority [18059027]; Ministry of Education, Culture, Sports, Science and Technology (MEXT)	JST Solution Oriented Research for Science and Technology (SORST); Scientific Research on Priority; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Japan Science and Technology Agency (JST) research project, " Development of the world's fastest SNP detection system," to T. I.; by Grant-in-Aid for Scientific Research (A) 18201041 to T.I.; in part by a JST Solution Oriented Research for Science and Technology (SORST) grant to N. N.; by Japanese Society for the Promotion of Science (JSPS) Grant-in-Aid for Exploratory Research 19659136 to T. I.; by Grant-in-Aid for Young Scientists (B) 19791361 to H. N.; by Grant-in-Aid for Scientific Research on Priority Areas 18059027 to K. Y.; and by a Ministry of Education, Culture, Sports, Science and Technology (MEXT) research grant	Bera TK, 2001, MOL MED, V7, P509, DOI 10.1007/BF03401856; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Bortfeld M, 2006, NEUROSCIENCE, V137, P1247, DOI 10.1016/j.neuroscience.2005.10.025; BROOKSBANK BW, 1970, EXPERIENTIA, V26, P1012, DOI 10.1007/BF02114166; Chen ZS, 2005, MOL PHARMACOL, V67, P545, DOI 10.1124/mol.104.007138; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Ellgaard L, 2001, CURR OPIN CELL BIOL, V13, P431, DOI 10.1016/S0955-0674(00)00233-7; Furukawa T, 2009, PHARM RES-DORDR, V26, P469, DOI 10.1007/s11095-008-9752-7; Gesase AP, 2003, HISTOL HISTOPATHOL, V18, P597, DOI 10.14670/HH-18.597; Guo YP, 2003, J BIOL CHEM, V278, P29509, DOI 10.1074/jbc.M304059200; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; ING R, 1973, LANCET, V1, P41; Ishikawa T., 2003, NATURE ENCY HUMAN GE, V4, P154; JULESZ M, 1968, ACTA MED HUNG, V25, P273; Kawai Y, 2008, BIOLOGICALS, V36, P234, DOI 10.1016/j.biologicals.2008.01.003; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Kruh GD, 2007, PFLUG ARCH EUR J PHY, V453, P675, DOI 10.1007/s00424-006-0114-1; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LABOWS JN, 1979, STEROIDS, V34, P249, DOI 10.1016/0039-128X(79)90077-1; Mitani Y, 2007, NAT METHODS, V4, P257, DOI 10.1038/NMETH1007; Miura K, 2007, HUM GENET, V121, P631, DOI 10.1007/s00439-007-0356-9; Mochizuki K, 2007, AM J PHYSIOL-GASTR L, V292, pG818, DOI 10.1152/ajpgi.00415.2006; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Nakagawa H, 2008, BIOCHEM J, V411, P623, DOI 10.1042/BJ20071229; Nakashima M, 2002, PATHOL RES PRACT, V198, P717, DOI 10.1078/0344-0338-00326; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Ono N, 2007, BIOCHEM J, V406, P31, DOI 10.1042/BJ20070292; PETRAKIS NL, 1971, SCIENCE, V173, P347, DOI 10.1126/science.173.3994.347; PETRAKIS NL, 1983, AM J PHYS ANTHROPOL, V62, P115, DOI 10.1002/ajpa.1330620115; Qu BH, 1997, J BIOL CHEM, V272, P15739, DOI 10.1074/jbc.272.25.15739; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; SHEHADEH NH, 1963, J INVEST DERMATOL, V40, P61, DOI 10.1038/jid.1963.10; Shimizu H, 2003, GENE, V310, P17, DOI 10.1016/S0378-1119(03)00504-3; SHUGYO Y, 1988, AM J ANAT, V181, P377, DOI 10.1002/aja.1001810405; Skach WR, 2006, CELL, V127, P673, DOI 10.1016/j.cell.2006.11.002; Tammur J, 2001, GENE, V273, P89, DOI 10.1016/S0378-1119(01)00572-8; Tamura Ai, 2006, J Exp Ther Oncol, V6, P1; Tamura A, 2007, CANCER SCI, V98, P231, DOI 10.1111/j.1349-7006.2006.00371.x; Toyoda Y, 2008, XENOBIOTICA, V38, P833, DOI [10.1080/00498250701883514, 10.1080/00498250701883514 ]; Wakabayashi K, 2007, J BIOL CHEM, V282, P27841, DOI 10.1074/jbc.C700133200; Wakabayashi K, 2006, J EXP THER ONCOL, V5, P205; Wakabayashi-Nakao K, 2009, ADV DRUG DELIVER REV, V61, P66, DOI 10.1016/j.addr.2008.08.008; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Watanabe J, 2007, BIOTECHNIQUES, V43, P479, DOI 10.2144/000112563; Yabuuchi H, 2001, BIOCHEM BIOPH RES CO, V288, P933, DOI 10.1006/bbrc.2001.5865; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Yoo WM, 2006, J PLAST RECONSTR AES, V59, P978, DOI 10.1016/j.bjps.2005.12.046; Yoshiura K, 2006, NAT GENET, V38, P324, DOI 10.1038/ng1733; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	50	67	75	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					2001	2013		10.1096/fj.09-129098	http://dx.doi.org/10.1096/fj.09-129098			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19383836				2022-12-25	WOS:000266652400038
J	Sun, YR; Kong, WQ; Falk, A; Hu, J; Zhou, LF; Pollard, S; Smith, A				Sun, Yirui; Kong, Weiqing; Falk, Anna; Hu, Jin; Zhou, Liangfu; Pollard, Steve; Smith, Austin			CD133 (Prominin) Negative Human Neural Stem Cells Are Clonogenic and Tripotent	PLOS ONE			English	Article								Background: CD133 (Prominin) is widely used as a marker for the identification and isolation of neural precursor cells from normal brain or tumor tissue. However, the assumption that CD133 is expressed constitutively in neural precursor cells has not been examined. Methodology/Principal Findings: In this study, we demonstrate that CD133 and a second marker CD15 are expressed heterogeneously in uniformly undifferentiated human neural stem (NS) cell cultures. After fractionation by flow cytometry, clonogenic tripotent cells are found in populations negative or positive for either marker. We further show that CD133 is down-regulated at the mRNA level in cells lacking CD133 immunoreactivity. Cell cycle profiling reveals that CD133 negative cells largely reside in G1/G0, while CD133 positive cells are predominantly in S, G2, or M phase. A similar pattern is apparent in mouse NS cell lines. Compared to mouse NS cells, however, human NS cell cultures harbour an increased proportion of CD133 negative cells and display a longer doubling time. This may in part reflect a sub-population of slow- or non-cycling cells amongst human NS cells because we find that around 5% of cells do not take up BrdU over a 14-day labelling period. Non-proliferating NS cells remain undifferentiated and at least some of them are capable of re-entry into the cell cycle and subsequent continuous expansion. Conclusions: The finding that a significant fraction of clonogenic neural stem cells lack the established markers CD133 and CD15, and that some of these cells may be dormant or slow- cycling, has implications for approaches to identify and isolate neural stem cells and brain cancer stem cells. Our data also suggest the possibility that CD133 may be specifically down-regulated during G0/G1, and this should be considered when this marker is used to identify and isolate other tissue and cancer stem cells.			Sun, YR (corresponding author), Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge, England.	austin.smith@cscr.cam.ac.uk	Falk, Anna/GWV-1616-2022; Pollard, Steven/B-7966-2010	Smith, Austin/0000-0002-3029-4682; Pollard, Steven/0000-0001-6428-0492; Falk, Anna/0000-0003-1634-8610	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Medical Research Council [G0800784, G9806702] Funding Source: Medline; MRC [G0800784, G9806702] Funding Source: UKRI; Medical Research Council [G0800784B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; ARNDTJOVIN DJ, 1989, METHOD CELL BIOL, V30, P417; Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Azuma A, 2001, MOL PHARMACOL, V59, P725, DOI 10.1124/mol.59.4.725; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Cameron HA, 1998, CURR OPIN NEUROBIOL, V8, P677, DOI 10.1016/S0959-4388(98)80099-8; Capela A, 2006, DEV BIOL, V291, P300, DOI 10.1016/j.ydbio.2005.12.030; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; COROTTO FS, 1993, NEUROSCI LETT, V149, P111, DOI 10.1016/0304-3940(93)90748-A; Corti S, 2007, EXP NEUROL, V205, P547, DOI 10.1016/j.expneurol.2007.03.021; D'Amour KA, 2003, P NATL ACAD SCI USA, V100, P11866, DOI 10.1073/pnas.1834200100; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137; Frey D, 2008, CANCER BIOTHER RADIO, V23, P65, DOI 10.1089/cbr.2007.0407; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Jaksch M, 2008, CANCER RES, V68, P7882, DOI 10.1158/0008-5472.CAN-08-0723; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Ladd AC, 1997, BLOOD, V90, P658, DOI 10.1182/blood.V90.2.658.658_658_668; LATT SA, 1976, J HISTOCHEM CYTOCHEM, V24, P24, DOI 10.1177/24.1.943439; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Ligon KL, 2004, J NEUROPATH EXP NEUR, V63, P499, DOI 10.1093/jnen/63.5.499; Ostenfeld T, 2000, EXP NEUROL, V164, P215, DOI 10.1006/exnr.2000.7427; Pfenninger CV, 2007, CANCER RES, V67, P5727, DOI 10.1158/0008-5472.CAN-07-0183; POLLARD SM, 2009, CELL STEM C IN PRESS; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Roy NS, 2000, NAT MED, V6, P271; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; SHAPIRO HM, 1981, CYTOMETRY, V2, P143, DOI 10.1002/cyto.990020302; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; WARING MJ, 1965, J MOL BIOL, V13, P269, DOI 10.1016/S0022-2836(65)80096-1; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Zappone MV, 2000, DEVELOPMENT, V127, P2367	44	97	101	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2009	4	5							e5498	10.1371/journal.pone.0005498	http://dx.doi.org/10.1371/journal.pone.0005498			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VY	19430532	Green Submitted, Green Published, gold			2022-12-25	WOS:000266009700004
J	Sun, LN; Lu, XH; Li, C; Wang, M; Liu, QZ; Li, Z; Hu, XF; Li, JD; Liu, F; Li, Q; Belser, JA; Hancock, K; Shu, YL; Katz, JM; Liang, MF; Li, DX				Sun, Lina; Lu, Xiuhua; Li, Chuan; Wang, Min; Liu, Qinzhi; Li, Zi; Hu, Xiaofen; Li, Jiandong; Liu, Feng; Li, Qun; Belser, Jessica A.; Hancock, Kathy; Shu, Yuelong; Katz, Jacqueline M.; Liang, Mifang; Li, Dexin			Generation, Characterization and Epitope Mapping of Two Neutralizing and Protective Human Recombinant Antibodies against Influenza A H5N1 Viruses	PLOS ONE			English	Article								Background: The development of new therapeutic targets and strategies to control highly pathogenic avian influenza (HPAI) H5N1 virus infection in humans is urgently needed. Broadly cross-neutralizing recombinant human antibodies obtained from the survivors of H5N1 avian influenza provide an important role in immunotherapy for human H5N1 virus infection and definition of the critical epitopes for vaccine development. Methodology/Principal Findings: We have characterized two recombinant baculovirus-expressed human antibodies (rhAbs), AVFluIgG01 and AVFluIgG03, generated by screening a Fab antibody phage library derived from a patient recovered from infection with a highly pathogenic avian influenza A H5N1 clade 2.3 virus. AVFluIgG01 cross-neutralized the most of clade 0, clade 1, and clade 2 viruses tested, in contrast, AVFluIgG03 only neutralized clade 2 viruses. Passive immunization of mice with either AVFluIgG01 or AVFluIgG03 antibody resulted in protection from a lethal H5N1 clade 2.3 virus infection. Furthermore, through epitope mapping, we identify two distinct epitopes on H5 HA molecule recognized by these rhAbs and demonstrate their potential to protect against a lethal H5N1 virus infection in a mouse model. Conclusions/Significance: Importantly, localization of the epitopes recognized by these two neutralizing and protective antibodies has provided, for the first time, insight into the human antibody responses to H5N1 viruses which contribute to the H5 immunity in the recovered patient. These results highlight the potential of a rhAbs treatment strategy for human H5N1 virus infection and provide new insight for the development of effective H5N1 pandemic vaccines.			Sun, LN (corresponding author), China CDC, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Control & Prevent, Beijing, Peoples R China.	mifangl@vip.sina.com; lidx@chinacdc.cn						Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; ASSAAD FA, 1980, B WORLD HEALTH ORGAN, V58, P585; Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Barbas CF, 1996, TRENDS BIOTECHNOL, V14, P230, DOI 10.1016/0167-7799(96)10029-9; BARBAS CF, 1991, P NATL ACAD SCI USA, V88, P7978, DOI 10.1073/pnas.88.18.7978; Bayry J, 2004, TRENDS PHARMACOL SCI, V25, P306, DOI 10.1016/j.tips.2004.04.002; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; COX NJ, 1996, OPTIONS CONTROL INFL, V3, P591; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Eisen MB, 1997, VIROLOGY, V232, P19, DOI 10.1006/viro.1997.8526; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Hanson BJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-126; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; Keller MA, 2000, CLIN MICROBIOL REV, V13, P602, DOI 10.1128/CMR.13.4.602-614.2000; Kendal AP, 1982, CONCEPTS PROCEDURES; Kong L K, 2006, Hong Kong Med J, V12, P489; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Liang MF, 2001, J IMMUNOL METHODS, V247, P119, DOI 10.1016/S0022-1759(00)00322-7; Lu JH, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-43; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Mozdzanowska K, 2003, J VIROL, V77, P8322, DOI 10.1128/JVI.77.15.8322-8328.2003; Nguyen TD, 2008, EMERG INFECT DIS, V14, P632, DOI 10.3201/eid1404.071343; Nwe N, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-16; PHILPOTT M, 1990, J VIROL, V64, P2941, DOI 10.1128/JVI.64.6.2941-2947.1990; REED LJ, 1938, AM J HYG, V27; Rohm C, 1996, VIROLOGY, V217, P508, DOI 10.1006/viro.1996.0145; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Sawyer LA, 2000, ANTIVIR RES, V47, P57, DOI 10.1016/S0166-3542(00)00111-X; Simmons CP, 2007, PLOS MED, V4, P928, DOI 10.1371/journal.pmed.0040178; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stephenson I, 2003, J MED VIROL, V70, P391, DOI 10.1002/jmv.10408; Stephenson I, 2004, LANCET INFECT DIS, V4, P499, DOI 10.1016/S1473-3099(04)01105-3; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Tsuchiya E, 2001, J GEN VIROL, V82, P2475, DOI 10.1099/0022-1317-82-10-2475; Wang K, 2006, VACCINE, V24, P2176, DOI 10.1016/j.vaccine.2005.11.005; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; *WHO, 2008, WHO CUM NUMB CONF HU; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Wood JM, 2004, NAT REV MICROBIOL, V2, P842, DOI 10.1038/nrmicro979; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Zhou BP, 2007, NEW ENGL J MED, V357, P1450, DOI 10.1056/NEJMc070359	46	69	74	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2009	4	5							e5476	10.1371/journal.pone.0005476	http://dx.doi.org/10.1371/journal.pone.0005476			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JH	19421326	gold, Green Published			2022-12-25	WOS:000265837000010
J	Kind, T; Scholz, M; Fiehn, O				Kind, Tobias; Scholz, Martin; Fiehn, Oliver			How Large Is the Metabolome? A Critical Analysis of Data Exchange Practices in Chemistry	PLOS ONE			English	Article							IDENTIFICATION; WEB; ANNOTATION; EXTRACTION; TOOLS	Background: Calculating the metabolome size of species by genome-guided reconstruction of metabolic pathways misses all products from orphan genes and from enzymes lacking annotated genes. Hence, metabolomes need to be determined experimentally. Annotations by mass spectrometry would greatly benefit if peer-reviewed public databases could be queried to compile target lists of structures that already have been reported for a given species. We detail current obstacles to compile such a knowledge base of metabolites. Results: As an example, results are presented for rice. Two rice (oryza sativa) subspecies have been fully sequenced, oryza japonica and oryza indica. Several major small molecule databases were compared for listing known rice metabolites comprising PubChem, Chemical Abstracts, Beilstein, Patent databases, Dictionary of Natural Products, SetupX/BinBase, KNApSAcK DB, and finally those databases which were obtained by computational approaches, i.e. RiceCyc, KEGG, and Reactome. More than 5,000 small molecules were retrieved when searching these databases. Unfortunately, most often, genuine rice metabolites were retrieved together with non-metabolite database entries such as pesticides. Overlaps from database compound lists were very difficult to compare because structures were either not encoded in machine-readable format or because compound identifiers were not cross-referenced between databases. Conclusions: We conclude that present databases are not capable of comprehensively retrieving all known metabolites. Metabolome lists are yet mostly restricted to genome-reconstructed pathways. We suggest that providers of (bio) chemical databases enrich their database identifiers to PubChem IDs and InChIKeys to enable cross-database queries. In addition, peer-reviewed journal repositories need to mandate submission of structures and spectra in machine readable format to allow automated semantic annotation of articles containing chemical structures. Such changes in publication standards and database architectures will enable researchers to compile current knowledge about the metabolome of species, which may extend to derived information such as spectral libraries, organ-specific metabolites, and cross-study comparisons.			Fiehn, O (corresponding author), Univ Calif Davis, Genome Ctr Metabol, Davis, CA 95616 USA.	ofiehn@ucdavis.edu	Kind, Tobias/A-7553-2010	Kind, Tobias/0000-0002-1908-4916	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013932] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ES13932] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; [Anonymous], DICT NATURAL PRODUCT; APODACA R, IMAGE METADATA CHEMI; Arita M, 2003, GENOME RES, V13, P2455, DOI 10.1101/gr.1212003; AUSTIN R, 2001, PIUG N E WORKSH; BAKER DB, 1980, J CHEM INF COMP SCI, V20, P193, DOI 10.1021/ci60024a001; Casher O, 2006, J CHEM INF MODEL, V46, P2396, DOI 10.1021/ci060139c; CASPI R, 2008, GENOME DATABASES NUC, V36, pD623; ChEBI, CHEM ENT BIOL INT; *CHEM ABSTR DAT, CAS SCIFINDER AC PRO; *CHEM4WORLD, 2007, SEMRICH CHEM INF; *CHEMAXON, 2008, INSTANT J CHEM; *CROSSFIRE BEILST, CROSSFIRE BEILSTEIN; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; DESILVA LB, 1995, TETRAHEDRON LETT, V36, P1997, DOI 10.1016/0040-4039(95)00211-T; Downing J, 2008, J CHEM INF MODEL, V48, P1571, DOI 10.1021/ci7004737; *ED HUM DEV, ED HUM DEV AN ONT; Fiehn O, 2005, LECT NOTES COMPUT SC, V3615, P224; FIEHN O, 2007, CELLULAR METABOLOMIC; FILIPPOV IV, 2009, J CHEM INFORM MODELI; FLAXBART D, CHEM ABSTRACTS CENTE; Guha R, 2006, J CHEM INF MODEL, V46, P991, DOI 10.1021/ci050400b; HELLER SR, 2005, INCHI OPEN ACCESS OP; HELLER SR, IUPAC INT CHEM IDENT; Hill DW, 2008, ANAL CHEM, V80, P5574, DOI 10.1021/ac800548g; IBISON P, 1993, J CHEM INF COMP SCI, V33, P338, DOI 10.1021/ci00013a010; *IBM, IBM CHEM SEARCH ENG; Jaiswal P, 2006, NUCLEIC ACIDS RES, V34, pD717, DOI 10.1093/nar/gkj154; *KEGG DAT, KYOT ENC GEN GEN; Kidd R, 2009, INTEGR BIOL, V1, P293, DOI 10.1039/b905032a; KIND T, 2008, LCGC, V26, P176; KIND T, RICEORYZA SATIVA MET; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; Kind T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-234; *KNAPSACK, COMPR SPEC MET REL; Kuhn S, 2007, J CHEM INF MODEL, V47, P2015, DOI 10.1021/ci600531a; *LIPID MAPS, LIPID MET PATHW; MCDANIEL JR, 1992, J CHEM INF COMP SCI, V32, P373, DOI 10.1021/ci00008a018; Mu FP, 2007, BIOINFORMATICS, V23, P3193, DOI 10.1093/bioinformatics/btm498; Murray-Rust P, 2008, NATURE, V451, P648, DOI 10.1038/451648a; *NCBI ENTR, NCBI ENTR LIF SCI SE; *NCHI RES SERV, INCHI RES SERV CHEMS; Oikawa A, 2006, PLANT PHYSIOL, V142, P398, DOI 10.1104/pp.106.080317; *ORYZ, INT RIC SCI DAT; Ott MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-517; Paley SM, 2006, NUCLEIC ACIDS RES, V34, P3771, DOI 10.1093/nar/gkl334; Park J, 2009, CHEM CENT J, V3, DOI 10.1186/1752-153X-3-4; *PUBMED CENTR, PUBMED CENTR DIG ARC; *REACT, REACT CURAT KNOWLEDG; RHODES J, 2007, PAC S BIOC, P15; *RICECYE, RIC MET PATHW; *RSC, RSC PROJ PROSP; Schymanski EL, 2008, ANAL CHIM ACTA, V615, P136, DOI 10.1016/j.aca.2008.03.060; *SETUPX, STUD DES DAT MET PRO; *SMILES, SIMPL MOL INNP LIN; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; STEIN SE, OPEN STANDARD CHEM S; Steinbeck C, 2004, PHYTOCHEMISTRY, V65, P2711, DOI 10.1016/j.phytochem.2004.08.027; Strasser BJ, 2008, SCIENCE, V322, P537, DOI 10.1126/science.1163399; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; *SURECHEM, SURECHEM CHEM PAT SE; Taylor CF, 2008, NAT BIOTECHNOL, V26, P889, DOI 10.1038/nbt.1411; Wheeler DL, 2007, NUCL ACIDS RES; Williams AJ, 2008, DRUG DISCOV TODAY, V13, P502, DOI 10.1016/j.drudis.2008.03.015; Willighagen EL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-487; WISHART DS, 2007, HUMAN METABOLOME DAT, V35, pD521; Zhou YY, 2007, J CHEM INF MODEL, V47, P1386, DOI 10.1021/ci700092v; DUKES PHYTOCHEMICAL	68	88	89	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2009	4	5							e5440	10.1371/journal.pone.0005440	http://dx.doi.org/10.1371/journal.pone.0005440			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JE	19415114	Green Published, gold, Green Submitted			2022-12-25	WOS:000265836700012
J	Li, G; Peskind, ER; Millard, SP; Chi, P; Sokal, I; Yu, CE; Bekris, LM; Raskind, MA; Galasko, DR; Montine, TJ				Li, Ge; Peskind, Elaine R.; Millard, Steven P.; Chi, Peter; Sokal, Izabela; Yu, Chang-En; Bekris, Lynn M.; Raskind, Murray A.; Galasko, Douglas R.; Montine, Thomas J.			Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor and Cognitive Function in Non-Demented Subjects	PLOS ONE			English	Article								Background: Brain-derived neurotrophic factor (BDNF) is an activity-dependent secreted protein that is critical to organization of neuronal networks and synaptic plasticity, especially in the hippocampus. We tested hypothesis that reduced CSF BDNF is associated with age-related cognitive decline. Methodology/Principal Findings, and Conclusions/Significance: CSF concentration of BDNF, A beta(42) and total tau were measured in 128 cognitively normal adults (Normals), 21 patients with Alzheimer's disease (AD), and nine patients with Mild Cognitive Impairment. Apolipoprotein E and BDNF SNP rs6265 genotype were determined. Neuropsychological tests were performed at baseline for all subjects and at follow-up visits in 50 Normals. CSF BDNF level was lower in AD patients compared to age-matched Normals (p = 0.02). CSF BDNF concentration decreased with age among Normals and was higher in women than men (both p<0.001). After adjusting for age, gender, education, CSF A beta(42) and total tau, and APOE and BDNF genotypes, lower CSF BDNF concentration was associated poorer immediate and delayed recall at baseline (both p<0.05) and in follow up of approximately 3 years duration (both p<0.01). Conclusions/Significance: Reduced CSF BDNF was associated with age-related cognitive decline, suggesting a potential mechanism that may contribute in part to cognitive decline in older individuals.			Li, G (corresponding author), Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	gli@u.washington.edu			NATIONAL INSTITUTE ON AGING [R01AG023185, P50AG005136, U01AG016976] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG023185, AG05136, P50-AG005136, P50 AG005136, AG023185, U01 AG016976, P50 AG005136-26] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bekris LM, 2008, J ALZHEIMERS DIS, V13, P255; Blasko I, 2006, DEMENT GERIATR COGN, V21, P9, DOI 10.1159/000089137; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; CRAFT S, 1993, BEHAV NEUROSCI, V107, P926; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Gomez RG, 2006, ARCH CLIN NEUROPSYCH, V21, P771, DOI 10.1016/j.acn.2006.06.012; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; HIXSON JE, 1990, J LIPID RES, V31, P545; *INS CORP, 2008, CORP I S PLUS; Laske C, 2006, J NEURAL TRANSM, V113, P1217, DOI 10.1007/s00702-005-0397-y; Laske C, 2007, J PSYCHIATR RES, V41, P387, DOI 10.1016/j.jpsychires.2006.01.014; Li G, 2007, NEUROLOGY, V69, P631, DOI 10.1212/01.wnl.0000267428.62582.aa; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Milliken JK, 2000, STAT MED, V19, P1617, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1617::AID-SIM450>3.0.CO;2-C; Miyajima F, 2008, GENES BRAIN BEHAV, V7, P411, DOI 10.1111/j.1601-183X.2007.00363.x; Nagatsu T, 2000, ADV RES NEURODEGENER, V8, P277; Newcomer JW, 1998, ARCH GEN PSYCHIAT, V55, P995, DOI 10.1001/archpsyc.55.11.995; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Reitan RM, 1985, HALSTEAD REITAN NEUR; Sohrabji F, 2006, FRONT NEUROENDOCRIN, V27, P404, DOI 10.1016/j.yfrne.2006.09.003; *TEAM R D C, 2008, LANG ENV STAT COMP; Wechsler D, 1983, MANUAL WECHSLER MEMO; Zhang J, 2005, J ALZHEIMERS DIS, V7, P125; Zhang J, 2008, AM J CLIN PATHOL, V129, P526, DOI 10.1309/W01Y0B808EMEH12L	25	104	106	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5424	10.1371/journal.pone.0005424	http://dx.doi.org/10.1371/journal.pone.0005424			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440GG	19412541	gold, Green Published, Green Submitted			2022-12-25	WOS:000265688200011
J	Vallabhajosyula, RR; Chakravarti, D; Lutfeali, S; Ray, A; Raval, A				Vallabhajosyula, Ravishankar R.; Chakravarti, Deboki; Lutfeali, Samina; Ray, Animesh; Raval, Alpan			Identifying Hubs in Protein Interaction Networks	PLOS ONE			English	Article								Background: In spite of the scale-free degree distribution that characterizes most protein interaction networks (PINs), it is common to define an ad hoc degree scale that defines "hub'' proteins having special topological and functional significance. This raises the concern that some conclusions on the functional significance of proteins based on network properties may not be robust. Methodology: In this paper we present three objective methods to define hub proteins in PINs: one is a purely topological method and two others are based on gene expression and function. By applying these methods to four distinct PINs, we examine the extent of agreement among these methods and implications of these results on network construction. Conclusions: We find that the methods agree well for networks that contain a balance between error-free and unbiased interactions, indicating that the hub concept is meaningful for such networks.			Vallabhajosyula, RR (corresponding author), Keck Grad Inst Appl Life Sci, Claremont, CA USA.	alpan.raval@cgu.edu		Ray, Animesh/0000-0002-0120-5820; Raval, Alpan/0000-0002-2689-3594				Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Aragues R, 2007, PLOS COMPUT BIOL, V3, P1761, DOI 10.1371/journal.pcbi.0030178; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batada NN, 2007, PLOS BIOL, V5, P1202, DOI 10.1371/journal.pbio.0050154; Batada NN, 2006, PLOS BIOL, V4, P1720, DOI 10.1371/journal.pbio.0040317; Bertin N, 2007, PLOS BIOL, V5, P1206, DOI 10.1371/journal.pbio.0050153; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Grosse I, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041905; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jin GX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001207; Kemmeren P, 2002, MOL CELL, V9, P1133, DOI 10.1016/S1097-2765(02)00531-2; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Maslov S, 2002, FEBS LETT, V530, P255, DOI 10.1016/S0014-5793(02)03428-2; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Reguly T, 2006, J BIOL, V5, P10; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; SERRANO MA, 2005, PHYS REV E, V72; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Soffer SN, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.057101; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vazquez A, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.056104; VOSS RF, 1992, PHYS REV LETT, V68, P3805, DOI 10.1103/PhysRevLett.68.3805; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WONG AKC, 1985, IEEE T PATTERN ANAL, V7, P599, DOI 10.1109/TPAMI.1985.4767707; Wuchty S, 2005, PROTEOMICS, V5, P444, DOI 10.1002/pmic.200400962; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636	44	130	133	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5344	10.1371/journal.pone.0005344	http://dx.doi.org/10.1371/journal.pone.0005344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399170	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000265514900009
J	Johansson, LE; Johansson, LM; Danielsson, P; Norgren, S; Johansson, S; Marcus, C; Ridderstrale, M				Johansson, Lovisa E.; Johansson, Lina M.; Danielsson, Pernilla; Norgren, Svante; Johansson, Stina; Marcus, Claude; Ridderstrale, Martin			Genetic Variance in the Adiponutrin Gene Family and Childhood Obesity	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; BODY-MASS INDEX; INSULIN SENSITIVITY; ADIPOSE-TISSUE; MINIMAL-MODEL; FTO GENE; ASSOCIATION; EXPRESSION; CHILDREN; GLUCOSE	Aim: The adiponutrin gene family consists of five genes (PNPLA1-5) coding for proteins with both lipolytic and lipogenic properties. PNPLA3 has previously been associated with adult obesity. Here we investigated the possible association between genetic variants in these genes and childhood and adolescent obesity. Methods/Results: Polymorphisms in the five genes of the adiponutrin gene family were selected and genotyped using the Sequenom platform in a childhood and adolescent obesity case-control study. Six variants in PNPLA1 showed association with obesity (rs9380559, rs12212459, rs1467912, rs4713951, rs10947600, and rs12199580, p<0.05 after adjustment for age and gender). Three variants in PNPLA3 showed association with obesity before, but not after, adjustment for age and gender (rs139051, rs12483959, and rs2072907, p>0.05). When analyzing these SNPs in relation to phenotypes, two SNPs in the PNPLA3 gene showed association with insulin sensitivity (rs12483959: beta = -0.053, p = 0.016, and rs2072907: beta = -0.049, p = 0.024). No associations were seen for PNPLA2, PNPLA4, and PNPLA5. Conclusions: Genetic variation in the adiponutrin gene family does not seem to contribute strongly to obesity in children and adolescents. PNPLA1 exhibited a modest effect on obesity and PNPLA3 on insulin sensitivity. These data, however, require confirmation in other cohorts and ethnic groups.			Johansson, LE (corresponding author), Lund Univ, Dept Clin Sci Malmo, Lund, Sweden.	lovisa.johansson@med.lu.se	Marcus, Claude/ABE-1177-2020; Ridderstråle, Martin/F-7678-2012; Danielsson, Pernilla/ABD-9660-2020; Reinius, Lovisa/C-4555-2014	Marcus, Claude/0000-0003-0890-2650; Danielsson, Pernilla/0000-0002-4674-2638; Reinius, Lovisa/0000-0001-5029-0120				Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baulande S, 2001, J BIOL CHEM, V276, P33336, DOI 10.1074/jbc.M105193200; Bergman RN, 2005, HORM RES, V64, P8, DOI 10.1159/000089312; BERGMAN RN, 1989, DIABETES, V38, P1512, DOI 10.2337/diabetes.38.12.1512; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frayn KN, 2002, DIABETOLOGIA, V45, P1201, DOI 10.1007/s00125-002-0873-y; Garenc C, 2002, INT J OBESITY, V26, P220, DOI 10.1038/sj.ijo.0801872; Hoffstedt J, 2001, DIABETES, V50, P2410, DOI 10.2337/diabetes.50.10.2410; *INT HAPMAP PROJ, NATURE, V426, P789; Jacobsson JA, 2008, BIOCHEM BIOPH RES CO, V368, P476, DOI 10.1016/j.bbrc.2008.01.087; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Johansson LE, 2006, DIABETES, V55, P826, DOI 10.2337/diabetes.55.03.06.db05-1075; Johansson LE, 2008, EUR J ENDOCRINOL, V159, P577, DOI 10.1530/EJE-08-0426; Klannemark M, 1998, DIABETOLOGIA, V41, P1516, DOI 10.1007/s001250051099; Lake AC, 2005, J LIPID RES, V46, P2477, DOI 10.1194/jlr.M500290-JLR200; Lavebratt C, 2002, EUR J CLIN INVEST, V32, P938, DOI 10.1046/j.1365-2362.2002.01075.x; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Magre J, 1998, DIABETES, V47, P284, DOI 10.2337/diab.47.2.284; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Morinder G, 2009, ACTA PAEDIATR, V98, P132, DOI 10.1111/j.1651-2227.2008.01030.x; MOSSBERG HO, 1989, LANCET, V2, P491; Mulder H, 2003, J BIOL CHEM, V278, P36380, DOI 10.1074/jbc.M213032200; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi L, 2004, CLIN GENET, V65, P93, DOI 10.1111/j.0009-9163.2004.00196.x; ROLLANDCACHERA MF, 1982, AM J CLIN NUTR, V36, P178, DOI 10.1093/ajcn/36.1.178; Rossner SM, 2008, DIABETES CARE, V31, P802, DOI 10.2337/dc07-1655; Schoenborn V, 2006, DIABETES, V55, P1270, DOI 10.2337/db05-1498; Wang SP, 2001, OBES RES, V9, P119, DOI 10.1038/oby.2001.15; Wilson PA, 2006, J LIPID RES, V47, P1940, DOI 10.1194/jlr.M600185-JLR200; Wolf G, 2005, NUTR REV, V63, P166, DOI 10.1301/nr.2005.may.166-170	37	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5327	10.1371/journal.pone.0005327	http://dx.doi.org/10.1371/journal.pone.0005327			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390624	Green Published, Green Submitted, gold			2022-12-25	WOS:000265514400013
J	Woyke, T; Xie, G; Copeland, A; Gonzalez, JM; Han, C; Kiss, H; Saw, JH; Senin, P; Yang, C; Chatterji, S; Cheng, JF; Eisen, JA; Sieracki, ME; Stepanauskas, R				Woyke, Tanja; Xie, Gary; Copeland, Alex; Gonzalez, Jose M.; Han, Cliff; Kiss, Hajnalka; Saw, Jimmy H.; Senin, Pavel; Yang, Chi; Chatterji, Sourav; Cheng, Jan-Fang; Eisen, Jonathan A.; Sieracki, Michael E.; Stepanauskas, Ramunas			Assembling the Marine Metagenome, One Cell at a Time	PLOS ONE			English	Article								The difficulty associated with the cultivation of most microorganisms and the complexity of natural microbial assemblages, such as marine plankton or human microbiome, hinder genome reconstruction of representative taxa using cultivation or metagenomic approaches. Here we used an alternative, single cell sequencing approach to obtain high-quality genome assemblies of two uncultured, numerically significant marine microorganisms. We employed fluorescence-activated cell sorting and multiple displacement amplification to obtain hundreds of micrograms of genomic DNA from individual, uncultured cells of two marine flavobacteria from the Gulf of Maine that were phylogenetically distant from existing cultured strains. Shotgun sequencing and genome finishing yielded 1.9 Mbp in 17 contigs and 1.5 Mbp in 21 contigs for the two flavobacteria, with estimated genome recoveries of about 91% and 78%, respectively. Only 0.24% of the assembling sequences were contaminants and were removed from further analysis using rigorous quality control. In contrast to all cultured strains of marine flavobacteria, the two single cell genomes were excellent Global Ocean Sampling (GOS) metagenome fragment recruiters, demonstrating their numerical significance in the ocean. The geographic distribution of GOS recruits along the Northwest Atlantic coast coincided with ocean surface currents. Metabolic reconstruction indicated diverse potential energy sources, including biopolymer degradation, proteorhodopsin photometabolism, and hydrogen oxidation. Compared to cultured relatives, the two uncultured flavobacteria have small genome sizes, few non-coding nucleotides, and few paralogous genes, suggesting adaptations to narrow ecological niches. These features may have contributed to the abundance of the two taxa in specific regions of the ocean, and may have hindered their cultivation. We demonstrate the power of single cell DNA sequencing to generate reference genomes of uncultured taxa from a complex microbial community of marine bacterioplankton. A combination of single cell genomics and metagenomics enabled us to analyze the genome content, metabolic adaptations, and biogeography of these taxa.			Woyke, T (corresponding author), US DOE, Joint Genome Inst, Walnut Creek, CA USA.	rstepanauskas@bigelow.org	Gonzalez, Jose M./C-3333-2013; Saw, Jimmy HW/A-9972-2009; Eisen, Jonathan A./H-2706-2019; Saw, Jimmy/J-1360-2019	Gonzalez, Jose M./0000-0002-9926-3323; Saw, Jimmy HW/0000-0001-8353-3854; Eisen, Jonathan A./0000-0002-0159-2197; Saw, Jimmy/0000-0001-8353-3854; Senin, Pavel/0000-0001-5517-7768; Stepanauskas, Ramunas/0000-0003-4458-3108; Cheng, Jan-Fang/0000-0001-7315-7613; Yang, Chi/0000-0002-1676-5185; Sieracki, Michael/0000-0001-7959-1832; Han, Cliff/0000-0003-1972-0692				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Atamna-Ismaeel N, 2008, ISME J, V2, P656, DOI 10.1038/ismej.2008.27; Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Braun ST, 1999, FEMS MICROBIOL ECOL, V28, P273, DOI 10.1016/S0168-6496(98)00132-9; Caspi R, 2006, NUCLEIC ACIDS RES, V34, pD511, DOI 10.1093/nar/gkj128; Chatterji S, 2008, LECT N BIOINFORMAT, V4955, P17; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Eddy SR, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-18; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Gomez-Consarnau L, 2007, NATURE, V445, P210, DOI 10.1038/nature05381; Gonzalez JM, 2008, P NATL ACAD SCI USA, V105, P8724, DOI 10.1073/pnas.0712027105; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Haefner B, 2003, DRUG DISCOV TODAY, V8, P536, DOI 10.1016/S1359-6446(03)02713-2; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Han CS, 2006, J BACTERIOL, V188, P3382, DOI 10.1128/JB.188.9.3382-3390.2006; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jolliffe, 2002, PRINCIPAL COMPONENT; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lane D.J., 1991, NUCL ACID TECHNIQUES, DOI [10.1099/ijs.0.060731-0, DOI 10.1099/ijs.0.060731-0]; LASKEN RS, 2007, BMC BIOTECHNOLOGY, V7; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marcy Y, 2007, PLOS GENET, V3, P1702, DOI 10.1371/journal.pgen.0030155; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Moran MA, 2007, NAT REV MICROBIOL, V5, P792, DOI 10.1038/nrmicro1746; PACE NR, 1986, ADV MICROB ECOL, V9, P1; Petersohn A, 2001, J BACTERIOL, V183, P5617, DOI 10.1128/JB.183.19.5617-5631.2001; Punshon S, 2008, MAR CHEM, V108, P215, DOI 10.1016/j.marchem.2007.11.010; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Rogers YC, 2005, BIOTECHNIQUES, V39, P31, DOI 10.2144/05391BM01; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Stingl U, 2007, ISME J, V1, P361, DOI 10.1038/ismej.2007.49; Stingl U, 2007, APPL ENVIRON MICROB, V73, P2290, DOI 10.1128/AEM.02559-06; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vila M, 2004, APPL ENVIRON MICROB, V70, P4648, DOI 10.1128/AEM.70.8.4648-4657.2004; Woyke T, 2006, NATURE, V443, P950, DOI 10.1038/nature05192; Zengler K, 2002, P NATL ACAD SCI USA, V99, P15681, DOI 10.1073/pnas.252630999; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214	55	246	256	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5299	10.1371/journal.pone.0005299	http://dx.doi.org/10.1371/journal.pone.0005299			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390573	Green Submitted, gold, Green Published			2022-12-25	WOS:000265514200012
J	Chen, XF; Ding, BJ; LeJeune, D; Ruggiero, C; Li, SS				Chen, Xuefeng; Ding, Baojin; LeJeune, Danielle; Ruggiero, Christine; Li, Shisheng			Rpb1 Sumoylation in Response to UV Radiation or Transcriptional Impairment in Yeast	PLOS ONE			English	Article								Covalent modifications of proteins by ubiquitin and the Small Ubiquitin-like MOdifier (SUMO) have been revealed to be involved in a plethora of cellular processes, including transcription, DNA repair and DNA damage responses. It has been well known that in response to DNA damage that blocks transcription elongation, Rpb1, the largest subunit of RNA polymerase II (Pol II), is ubiquitylated and subsequently degraded in mammalian and yeast cells. However, it is still an enigma regarding how Pol II responds to damaged DNA and conveys signal(s) for DNA damage-related cellular processes. We found that Rpb1 is also sumoylated in yeast cells upon UV radiation or impairment of transcription elongation, and this modification is independent of DNA damage checkpoint activation. Ubc9, an E2 SUMO conjugase, and Siz1, an E3 SUMO ligase, play important roles in Rpb1 sumoylation. K1487, which is located in the acidic linker region between the C-terminal domain and the globular domain of Rpb1, is the major sumoylation site. Rpb1 sumoylation is not affected by its ubiquitylation, and vice versa, indicating that the two processes do not crosstalk. Abolishment of Rpb1 sumoylation at K1487 does not affect transcription elongation or transcription coupled repair (TCR) of UV-induced DNA damage. However, deficiency in TCR enhances UV-induced Rpb1 sumoylation, presumably due to the persistence of transcription-blocking DNA lesions in the transcribed strand of a gene. Remarkably, abolishment of Rpb1 sumoylation at K1487 causes enhanced and prolonged UV-induced phosphorylation of Rad53, especially in TCR-deficient cells, suggesting that the sumoylation plays a role in restraining the DNA damage checkpoint response caused by transcription-blocking lesions. Our results demonstrate a novel covalent modification of Rpb1 in response to UV induced DNA damage or transcriptional impairment, and unravel an important link between the modification and the DNA damage checkpoint response.			Chen, XF (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA.	shli@vetmed.lsu.edu	Li, Shisheng/H-9126-2012; Chen, Xuefeng/C-3410-2013; Ding, Baojin/J-5479-2015	Tatum, Danielle/0000-0002-3281-3853; Ding, Baojin/0000-0002-2149-2599	NIEHS NIH HHS [ES012718, R01 ES012718] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012718] Funding Source: NIH RePORTER; Direct For Biological Sciences [0745229] Funding Source: National Science Foundation	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; CHEN JZ, 1993, J THERM SPRAY TECHN, V2, P357; Chen XF, 2007, MOL CELL BIOL, V27, P4617, DOI 10.1128/MCB.00404-07; Cheng CH, 2006, GENE DEV, V20, P2067, DOI 10.1101/gad.1430406; Derheimer FA, 2007, P NATL ACAD SCI USA, V104, P12778, DOI 10.1073/pnas.0705317104; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Dohmen RJ, 2005, METHOD ENZYMOL, V399, P799, DOI 10.1016/S0076-6879(05)99052-6; Dotiwala F, 2007, P NATL ACAD SCI USA, V104, P11358, DOI 10.1073/pnas.0609636104; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Giannattasio M, 2004, EMBO J, V23, P429, DOI 10.1038/sj.emboj.7600051; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hyle JW, 2003, J BIOL CHEM, V278, P28470, DOI 10.1074/jbc.M303736200; Ii T, 2007, CELL CYCLE, V6, P2800, DOI 10.4161/cc.6.22.4882; Jansen LET, 2000, EMBO J, V19, P6498, DOI 10.1093/emboj/19.23.6498; Jiang GC, 2006, MOL CELL BIOL, V26, P39, DOI 10.1128/MCB.26.1.39-49.2006; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnston J.R., 1994, MOL GENETICS YEAST P; JONES EW, 1991, METHOD ENZYMOL, V194, P428; Laine JP, 2006, TRENDS GENET, V22, P430, DOI 10.1016/j.tig.2006.06.006; LEJEUNE D, 2008, DNA REPAIR AMST; Li SS, 2006, MOL CELL BIOL, V26, P9430, DOI 10.1128/MCB.01656-06; Li SS, 1996, CARCINOGENESIS, V17, P1549, DOI 10.1093/carcin/17.8.1549; Li SS, 2000, METHODS, V22, P170, DOI 10.1006/meth.2000.1058; Li SS, 2004, J BIOL CHEM, V279, P14418, DOI 10.1074/jbc.M312004200; Li SS, 2002, EMBO J, V21, P5921, DOI 10.1093/emboj/cdf589; Li T, 2007, DNA REPAIR, V6, P1679, DOI 10.1016/j.dnarep.2007.06.004; Lindsey-Boltz LA, 2007, P NATL ACAD SCI USA, V104, P13213, DOI 10.1073/pnas.0706316104; Lindstrom DL, 2001, GENETICS, V159, P487; Ljungman M, 1996, ONCOGENE, V13, P823; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; Lloyd RS, 2005, MUTAT RES-FUND MOL M, V577, P77, DOI 10.1016/j.mrfmmm.2005.04.003; Lommel L, 2000, P NATL ACAD SCI USA, V97, P9088, DOI 10.1073/pnas.150130197; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; MULLEN JR, 2008, ACTIVATION SLX5 SLX8; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Prakash S, 2000, MUTAT RES-FUND MOL M, V451, P13, DOI 10.1016/S0027-5107(00)00037-3; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Ribar B, 2006, MOL CELL BIOL, V26, P3999, DOI 10.1128/MCB.00293-06; Sambrook J, 2001, MOL CLONING LAB MANU; SANCHEZDIAZ A, 2004, SCI STKE, pPL8, DOI DOI 10.1126/STKE.2232004PL8; SIKORSKI RS, 1989, GENETICS, V122, P19; Somesh BP, 2007, CELL, V129, P57, DOI 10.1016/j.cell.2007.01.046; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Takahashi Y, 2001, J BIOL CHEM, V276, P48973, DOI 10.1074/jbc.M109295200; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; THOMPSON NE, 1989, J BIOL CHEM, V264, P11511; TIPPER DJ, 1973, J BACTERIOL, V116, P245, DOI 10.1128/JB.116.1.245-256.1973; Tornaletti S, 1999, J BIOL CHEM, V274, P24124, DOI 10.1074/jbc.274.34.24124; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; VANGOOL AJ, 1994, EMBO J, V13, P5361, DOI 10.1002/j.1460-2075.1994.tb06871.x; VANHOFFEN A, 1993, NUCLEIC ACIDS RES, V21, P5890, DOI 10.1093/nar/21.25.5890; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; VENEMA J, 1991, MOL CELL BIOL, V11, P4128, DOI 10.1128/MCB.11.8.4128; VERHAGE R, 1994, MOL CELL BIOL, V14, P6135, DOI 10.1128/MCB.14.9.6135; Verhage RA, 1996, MOL CELL BIOL, V16, P496; Wang Z, 2006, GENETICS, V172, P1499, DOI 10.1534/genetics.105.052811; WOOD JL, 2007, DNA REPAIR GENETIC I, P1; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Zhang H, 2003, J BIOL CHEM, V278, P9382, DOI 10.1074/jbc.M300061200; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zhao XL, 2002, P NATL ACAD SCI USA, V99, P3746, DOI 10.1073/pnas.062502299	75	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5267	10.1371/journal.pone.0005267	http://dx.doi.org/10.1371/journal.pone.0005267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384408	Green Published, gold			2022-12-25	WOS:000265513900012
J	Quintanilla, RA; Matthews-Roberson, TA; Dolan, PJ; Johnson, GVW				Quintanilla, Rodrigo A.; Matthews-Roberson, Tori A.; Dolan, Philip J.; Johnson, Gail V. W.			Caspase-cleaved Tau Expression Induces Mitochondrial Dysfunction in Immortalized Cortical Neurons IMPLICATIONS FOR THE PATHOGENESIS OF ALZHEIMER DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION; PROTEIN-TAU; HIPPOCAMPAL-NEURONS; OXIDATIVE STRESS; MOUSE MODEL; CELL-DEATH; IN-VITRO; APOPTOSIS; MORPHOLOGY; ABNORMALITIES	In Alzheimer disease (AD) mitochondrial abnormalities occur early in the pathogenic process and likely play a significant role in disease progression. Tau is a microtubule-associated protein that is abnormally processed in AD, and a connection between tau pathology and mitochondrial impairment has been proposed. However, few studies have examined the relationship between pathological forms of tau and mitochondrial dysfunction. We recently demonstrated that inducible expression of tau truncated at Asp-421 to mimic caspase cleavage (T4C3) was toxic to immortalized cortical neurons compared with a full-length tau isoform (T4). In this study we investigated the effects of T4C3 on mitochondrial function. Expression of T4C3 induced mitochondrial fragmentation and elevated oxidative stress levels in comparison with T4-expressing cells. Thapsigargin treatment of T4 or T4C3 cells, which causes an increase in intracellular calcium levels, resulted in a significant decrease in mitochondrial potential and loss of mitochondrial membrane integrity in T4C3 cells when compared with cells expressing T4. The mitochondrial fragmentation and mitochondrial membrane damage were ameliorated in T4C3 cells by pretreatment with cyclosporine A or FK506, implicating the calcium-dependent phosphatase calcineurin in these pathogenic events. Increased calcineurin activity has been reported in AD brain, and thus, inhibition of this phosphatase may provide a therapeutic target for the treatment of AD.	[Johnson, Gail V. W.] Univ Rochester, Med Ctr, Dept Anesthesiol, Rochester, NY 14642 USA; [Matthews-Roberson, Tori A.; Dolan, Philip J.; Johnson, Gail V. W.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Matthews-Roberson, Tori A.; Dolan, Philip J.; Johnson, Gail V. W.] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester; University of Alabama System; University of Alabama Birmingham; University of Rochester	Johnson, GVW (corresponding author), Univ Rochester, Med Ctr, Dept Anesthesiol, 601 Elmwood Ave,Box 604,Rm 4-6314, Rochester, NY 14642 USA.	gail_johnsonvoll@urmc.rochester.edu	Zhu, Longjun/C-2938-2012; Johnson, Gail V.W./K-4723-2012; QUINTANILLA, RODRIGO/ABG-8829-2021	Johnson, Gail V.W./0000-0003-3464-0404; 	National Institutes of Health [NS051279]; Alzheimer Disease Association; Merck Graduate Dissertation Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051279] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Disease Association; Merck Graduate Dissertation Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS051279 ( to G. V. W. J.). This work also supported by a grant from the Alzheimer Disease Association ( to G. V. W. J.) and a Merck Graduate Dissertation Fellowship ( to T. M.- R.).	AMCHENKOVA AA, 1988, J CELL BIOL, V107, P481, DOI 10.1083/jcb.107.2.481; Beutner G, 2001, J BIOL CHEM, V276, P21482, DOI 10.1074/jbc.M101486200; Blass JP, 2002, J ALZHEIMERS DIS, V4, P225, DOI 10.3233/JAD-2002-4312; Bongarzone ER, 1998, J NEUROSCI RES, V54, P309, DOI 10.1002/(SICI)1097-4547(19981101)54:3<309::AID-JNR2>3.0.CO;2-5; BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826; Cassina P, 2008, J NEUROSCI, V28, P4115, DOI 10.1523/JNEUROSCI.5308-07.2008; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chang DTW, 2006, PROG NEUROBIOL, V80, P241, DOI 10.1016/j.pneurobio.2006.09.003; Chung CW, 2001, NEUROBIOL DIS, V8, P162, DOI 10.1006/nbdi.2000.0335; Collins TJ, 2001, J BIOL CHEM, V276, P26411, DOI 10.1074/jbc.M101101200; Ding HP, 2008, J ALZHEIMERS DIS, V14, P441; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Dubinsky JM, 1998, J NEUROSCI RES, V53, P728, DOI 10.1002/(SICI)1097-4547(19980915)53:6<728::AID-JNR10>3.0.CO;2-U; Fasulo L, 2005, J ALZHEIMERS DIS, V7, P3; Fasulo L, 2000, J NEUROCHEM, V75, P624, DOI 10.1046/j.1471-4159.2000.0750624.x; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Garcia-Sierra F, 2008, J ALZHEIMERS DIS, V14, P401; Gibson GE, 1998, J NEURAL TRANSM, V105, P855, DOI 10.1007/s007020050099; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Han XJ, 2008, NEUROSCI RES, V60, P114, DOI 10.1016/j.neures.2007.09.012; Hansson MJ, 2003, BRAIN RES, V960, P99, DOI 10.1016/S0006-8993(02)03798-8; HAUPTMANN S, 2008, NEUROBIOL A IN PRESS; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Kim GJ, 2006, CANCER RES, V66, P10377, DOI 10.1158/0008-5472.CAN-05-3036; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Krishnamurthy PK, 2004, J BIOL CHEM, V279, P7893, DOI 10.1074/jbc.M311203200; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Matthews-Roberson TA, 2008, BRAIN RES, V1234, P206, DOI 10.1016/j.brainres.2008.07.111; Milakovic T, 2006, J BIOL CHEM, V281, P34785, DOI 10.1074/jbc.M603845200; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Quintanilla RA, 2005, J BIOL CHEM, V280, P11615, DOI 10.1074/jbc.M411936200; Quintanilla RA, 2008, J BIOL CHEM, V283, P25628, DOI 10.1074/jbc.M804291200; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Shelton SB, 2004, J NEUROSCI RES, V76, P110, DOI 10.1002/jnr.20051; Spires-Jones TL, 2008, J NEUROSCI, V28, P862, DOI 10.1523/JNEUROSCI.3072-08.2008; Stutzmann GE, 2007, NEUROSCIENTIST, V13, P546, DOI 10.1177/1073858407299730; Szydlowska K, 2006, J NEUROCHEM, V99, P965, DOI 10.1111/j.1471-4159.2006.04136.x; Wang XL, 2008, AM J PATHOL, V173, P470, DOI 10.2353/ajpath.2008.071208; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; WERTH JL, 1994, J NEUROSCI, V14, P348; Yu DY, 2008, BBA-MOL CELL RES, V1783, P2255, DOI 10.1016/j.bbamcr.2008.06.015; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zhu LP, 2000, CELL CALCIUM, V28, P107, DOI 10.1054/ceca.2000.0138	50	120	126	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18754	18766		10.1074/jbc.M808908200	http://dx.doi.org/10.1074/jbc.M808908200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19389700	Green Published, hybrid			2022-12-25	WOS:000267711500025
J	Vollmar, M; Schlieper, D; Winn, M; Buchner, C; Groth, G				Vollmar, Melanie; Schlieper, Daniel; Winn, Martyn; Buechner, Claudia; Groth, Georg			Structure of the c(14) Rotor Ring of the Proton Translocating Chloroplast ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-SUBUNIT OLIGOMER; F-ATPASE; BOVINE F-1-ATPASE; AQUEOUS ACCESS; CROSS-LINKING; ROTARY MOTOR; NA+-ATPASE; ROTATION; MODEL; RESOLUTION	The structure of the membrane integral rotor ring of the proton translocating F1F0 ATP synthase from spinach chloroplasts was determined to 3.8 angstrom resolution by x-ray crystallography. The rotor ring consists of 14 identical protomers that are symmetrically arranged around a central pore. Comparisons with the c(11) rotor ring of the sodium translocating ATPase from Ilyobacter tartaricus show that the conserved carboxylates involved in proton or sodium transport, respectively, are 10.6-10.8 angstrom apart in both c ring rotors. This finding suggests that both ATPases have the same gear distance despite their different stoichiometries. The putative proton-binding site at the conserved carboxylate Glu(61) in the chloroplast ATP synthase differs from the sodium-binding site in Ilyobacter. Residues adjacent to the conserved carboxylate show increased hydrophobicity and reduced hydrogen bonding. The crystal structure reflects the protonated form of the chloroplast c ring rotor. We propose that upon deprotonation, the conformation of Glu(61) is changed to another rotamer and becomes fully exposed to the periphery of the ring. Reprotonation of Glu(61) by a conserved arginine in the adjacent a subunit returns the carboxylate to its initial conformation.	[Vollmar, Melanie; Schlieper, Daniel; Buechner, Claudia; Groth, Georg] Univ Dusseldorf, Inst Biochem Pflanzen, D-40225 Dusseldorf, Germany; [Winn, Martyn] SERC, Daresbury Lab, Sci & Technol Facil Council, Computat Sci & Engn Dept, Warrington WA4 4AD, Cheshire, England	Heinrich Heine University Dusseldorf; STFC Daresbury Laboratory; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC)	Groth, G (corresponding author), Univ Dusseldorf, Inst Biochem Pflanzen, Univ Str 1, D-40225 Dusseldorf, Germany.	georg.groth@uni-duesseldorf.de		Vollmar, Melanie/0000-0002-9162-9159	German Research Foundation [GR1616/5-3]	German Research Foundation(German Research Foundation (DFG))	This work was supported by German Research Foundation Grant GR1616/5-3 ( to G. G.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Abrahams JP, 1996, P NATL ACAD SCI USA, V93, P9420, DOI 10.1073/pnas.93.18.9420; Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; BIRKENHAGER R, 1995, EUR J BIOCHEM, V230, P58, DOI 10.1111/j.1432-1033.1995.tb20534.x; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Bowler MW, 2006, P NATL ACAD SCI USA, V103, P8646, DOI 10.1073/pnas.0602915103; BUCHNER C, 2004, THESIS U DUSSELDORF; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; Dimroth P, 1999, P NATL ACAD SCI USA, V96, P4924, DOI 10.1073/pnas.96.9.4924; Dmitriev O, 1999, J BIOL CHEM, V274, P15598, DOI 10.1074/jbc.274.22.15598; Dmitriev OY, 2004, FEBS LETT, V556, P35, DOI 10.1016/S0014-5793(03)01360-7; Dmitriev OY, 1999, P NATL ACAD SCI USA, V96, P7785, DOI 10.1073/pnas.96.14.7785; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Girvin ME, 1998, BIOCHEMISTRY-US, V37, P8817, DOI 10.1021/bi980511m; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Groth G, 2002, P NATL ACAD SCI USA, V99, P3464, DOI 10.1073/pnas.052546099; Groth G, 1999, EUR J BIOCHEM, V260, P15, DOI 10.1046/j.1432-1327.1999.00101.x; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106; HOPPE J, 1984, BIOCHIM BIOPHYS ACTA, V768, P1, DOI 10.1016/0304-4173(84)90005-3; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; Jones PC, 2000, J BIOL CHEM, V275, P31340, DOI 10.1074/jbc.M003687200; Jones PC, 1998, J BIOL CHEM, V273, P17178, DOI 10.1074/jbc.273.27.17178; Junge W, 1996, BER BUNSEN PHYS CHEM, V100, P2014, DOI 10.1002/bbpc.19961001215; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Luo PZ, 1999, P NATL ACAD SCI USA, V96, P4930, DOI 10.1073/pnas.96.9.4930; Masaike T, 2008, NAT STRUCT MOL BIOL, V15, P1326, DOI 10.1038/nsmb.1510; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2003, J MOL BIOL, V325, P389, DOI 10.1016/S0022-2836(02)01204-4; Meier T, 2007, MOL MICROBIOL, V65, P1181, DOI 10.1111/j.1365-2958.2007.05857.x; Meier T, 2006, J BACTERIOL, V188, P7759, DOI 10.1128/JB.00934-06; Meiss E, 2008, J BIOL CHEM, V283, P24594, DOI 10.1074/jbc.M802574200; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishio K, 2002, P NATL ACAD SCI USA, V99, P13448, DOI 10.1073/pnas.202149599; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; PALLSDOTTIR H, 2004, BIOCHIM BIOPHYS ACTA, V1666, P2; Panke O, 2000, FEBS LETT, V472, P34, DOI 10.1016/S0014-5793(00)01436-8; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; Seelert H, 2000, NATURE, V405, P418, DOI 10.1038/35013148; Singh S, 1996, FEBS LETT, V397, P30, DOI 10.1016/S0014-5793(96)01127-1; Stahlberg H, 2001, EMBO REP, V2, P229, DOI 10.1093/embo-reports/kve047; Steed PR, 2008, J BIOL CHEM, V283, P12365, DOI 10.1074/jbc.M800901200; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; STROTMANN H, 1973, BIOCHIM BIOPHYS ACTA, V314, P202, DOI 10.1016/0005-2728(73)90135-7; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P898, DOI 10.1073/pnas.031564198; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Valiyaveetil FI, 1997, J BIOL CHEM, V272, P32635, DOI 10.1074/jbc.272.51.32635; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; Varco-Merth B, 2008, BBA-BIOENERGETICS, V1777, P605, DOI 10.1016/j.bbabio.2008.05.009; von Ballmoos C, 2007, BIOCHEMISTRY-US, V46, P11800, DOI 10.1021/bi701083v; Wada T, 1999, J BIOL CHEM, V274, P17353, DOI 10.1074/jbc.274.24.17353; Watts SD, 1996, J BIOL CHEM, V271, P28341, DOI 10.1074/jbc.271.45.28341	71	99	102	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18228	18235		10.1074/jbc.M109.006916	http://dx.doi.org/10.1074/jbc.M109.006916			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19423706	hybrid, Green Published			2022-12-25	WOS:000267712400035
J	Walcott, S; Fagnant, PM; Trybus, KM; Warshaw, DM				Walcott, Sam; Fagnant, Patricia M.; Trybus, Kathleen M.; Warshaw, David M.			Smooth Muscle Heavy Meromyosin Phosphorylated on One of Its Two Heads Supports Force and Motion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN PHOSPHORYLATION; MYOSIN MOLECULES; LASER TRAP; IN-VITRO; DEPENDENT REGULATION; IONIC-STRENGTH; BINDING LOOP; SINGLE HEAD; STEP-SIZE; ACTIN	Smooth muscle myosin is activated by regulatory light chain (RLC) phosphorylation. In the unphosphorylated state the activity of both heads is suppressed due to an asymmetric, intramolecular interaction between the heads. The properties of myosin with only one of its two RLCs phosphorylated, a state likely to be present both during the activation and the relaxation phase of smooth muscle, is less certain despite much investigation. Here we further characterize the mechanical properties of an expressed heavy meromyosin (HMM) construct with only one of its RLCs phosphorylated (HMM-1P). This construct was previously shown to have more than 50% of the ATPase activity of fully phosphorylated myosin (HMM-2P) and to move actin at the same speed in a motility assay as HMM-2P (Rovner, A. S., Fagnant, P. M., and Trybus, K. M. (2006) Biochemistry 45, 5280-5289). Here we show that the unitary step size and attachment time to actin of HMM-1P is indistinguishable from that of HMM-2P. Force-velocity measurements on small ensembles show that HMM-1P can generate approximately half the force of HMM-2P, which may relate to the observed duty ratio of HMM-1P being approximately half that of HMM-2P. Therefore, single-phosphorylated smooth muscle HMM molecules are active species, and the head associated with the unphosphorylated RLC is mechanically competent, allowing it to make a substantial contribution to both motion and force generation during smooth muscle contraction.	[Walcott, Sam; Fagnant, Patricia M.; Trybus, Kathleen M.; Warshaw, David M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA	University of Vermont	Warshaw, DM (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA.	david.warshaw@uvm.edu		Walcott, Sam/0000-0002-8871-6964	National Institutes of Health [HL085489, HL38113, HL007944]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038113, R01HL085489, T32HL007944, R29HL038113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL085489 ( to D. W.), HL38113 ( to K. T.), and HL007944 ( to S. W.).	Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; Berger CEM, 2001, J BIOL CHEM, V276, P23240, DOI 10.1074/jbc.M100524200; Burgess SA, 2007, J MOL BIOL, V372, P1165, DOI 10.1016/j.jmb.2007.07.014; CHACKO S, 1982, P NATL ACAD SCI-BIOL, V79, P292, DOI 10.1073/pnas.79.2.292; CRAIG R, 1983, NATURE, V302, P436, DOI 10.1038/302436a0; CREMO CR, 1995, J BIOL CHEM, V270, P2171, DOI 10.1074/jbc.270.5.2171; Debold EP, 2005, BIOPHYS J, V89, pL34, DOI 10.1529/biophysj.105.072967; DILLON PF, 1981, SCIENCE, V211, P495, DOI 10.1126/science.6893872; Ellison PA, 2000, J BIOL CHEM, V275, P15142, DOI 10.1074/jbc.275.20.15142; FUGLSANG A, 1993, J MUSCLE RES CELL M, V14, P666, DOI 10.1007/BF00141563; Gollub J, 1999, BIOCHEMISTRY-US, V38, P10107, DOI 10.1021/bi990267e; Guilford WH, 1997, BIOPHYS J, V72, P1006, DOI 10.1016/S0006-3495(97)78753-8; HARRIS DE, 1995, AM J PHYSIOL-CELL PH, V269, pC1160, DOI 10.1152/ajpcell.1995.269.5.C1160; HARRIS DE, 1993, J BIOL CHEM, V268, P14764; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Hodges AR, 2007, J BIOL CHEM, V282, P27192, DOI 10.1074/jbc.M703968200; IKEBE M, 1982, J BIOCHEM-TOKYO, V91, P1809, DOI 10.1093/oxfordjournals.jbchem.a133874; Jung HS, 2008, MOL BIOL CELL, V19, P3234, DOI 10.1091/mbc.E08-02-0206; Kad NM, 2003, J CELL BIOL, V162, P481, DOI 10.1083/jcb.200304023; Konishi K, 2001, J BIOCHEM-TOKYO, V129, P365, DOI 10.1093/oxfordjournals.jbchem.a002866; Lauzon AM, 1998, J MUSCLE RES CELL M, V19, P825, DOI 10.1023/A:1005489501357; Li XD, 2000, BIOCHEMISTRY-US, V39, P2254, DOI 10.1021/bi9924617; ONISHI H, 1982, J BIOCHEM-TOKYO, V92, P871, DOI 10.1093/oxfordjournals.jbchem.a134001; PATLAK JB, 1993, BIOPHYS J, V65, P29, DOI 10.1016/S0006-3495(93)81041-5; PERSECHINI A, 1981, SCIENCE, V213, P1383, DOI 10.1126/science.6455737; PERSECHINI A, 1986, J BIOL CHEM, V261, P6293; Rovner AS, 2006, BIOCHEMISTRY-US, V45, P5280, DOI 10.1021/bi060154c; Rovner AS, 1998, J BIOL CHEM, V273, P27939, DOI 10.1074/jbc.273.43.27939; Sellers JR, 2007, J MUSCLE RES CELL M, V28, P363, DOI 10.1007/s10974-008-9134-0; SELLERS JR, 1982, J BIOL CHEM, V257, P3880; SELLERS JR, 1983, J BIOL CHEM, V258, P4181; Sherwood JJ, 2004, P NATL ACAD SCI USA, V101, P10973, DOI 10.1073/pnas.0401699101; Sweeney HL, 2000, J BIOL CHEM, V275, P41273, DOI 10.1074/jbc.M008310200; Tanaka H, 2008, J BIOL CHEM, V283, P15611, DOI 10.1074/jbc.M710597200; TRYBUS KM, 1984, J BIOL CHEM, V259, P8564; Trybus KM, 1997, P NATL ACAD SCI USA, V94, P48, DOI 10.1073/pnas.94.1.48; TRYBUS KM, 1985, J BIOL CHEM, V260, P5988; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; VYAS TB, 1992, AM J PHYSIOL, V263, pC210, DOI 10.1152/ajpcell.1992.263.1.C210; WARSHAW DM, 1990, J CELL BIOL, V111, P453, DOI 10.1083/jcb.111.2.453; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098; Woodhead JL, 2005, NATURE, V436, P1195, DOI 10.1038/nature03920; Wu XD, 1999, J BIOL CHEM, V274, P20328, DOI 10.1074/jbc.274.29.20328	44	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18244	18251		10.1074/jbc.M109.003293	http://dx.doi.org/10.1074/jbc.M109.003293			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19419961	Green Published, hybrid			2022-12-25	WOS:000267712400037
J	Grote, M; Polyhach, Y; Jeschke, G; Steinhoff, HJ; Schneider, E; Bordignon, E				Grote, Mathias; Polyhach, Yevhen; Jeschke, Gunnar; Steinhoff, Heinz-Juergen; Schneider, Erwin; Bordignon, Enrica			Transmembrane Signaling in the Maltose ABC Transporter MalFGK(2)-E PERIPLASMIC MalF-P2 LOOP COMMUNICATES SUBSTRATE AVAILABILITY TO THE ATP-BOUND MalK DIMER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTER; ELECTRON-PARAMAGNETIC-RESONANCE; ESCHERICHIA-COLI; PROTEIN MALE; CATALYTIC CYCLE; SALMONELLA; P2; TYPHIMURIUM; INTERACTS; COMPLEX	ABC transporters are ubiquitous membrane proteins that translocate solutes across biological membranes at the expense of ATP. In prokaryotic ABC importers, the extracytoplasmic anchoring of the substrate-binding protein (receptor) is emerging as a key determinant for the structural rearrangements in the cytoplasmically exposed ATP-binding cassette domains and in the transmembrane gates during the nucleotide cycle. Here the molecular mechanism of such signaling events was addressed by electron paramagnetic resonance spectroscopy of spin-labeled ATP-binding cassette maltose transporter variants (MalFGK(2)-E). A series of doubly spin-labeled mutants in the MalF-P2 domain involving positions 92, 205, 239, 252, and 273 and one triple mutant labeled at positions 205/252 in P2 and 83 in the Q-loop of MalK were assayed. The EPR data revealed that the substrate-binding protein MalE is bound to the transporter throughout the transport cycle. Concomitantly with the three conformations of the ATP-binding cassette MalK(2), three functionally relevant conformations are found also in the periplasmic MalF-P2 loop, strictly dependent on cytoplasmic nucleotide binding and periplasmic docking of liganded MalE to MalFG. The reciprocal communication across the membrane unveiled here gives first insights into the stimulatory effect of MalE on the ATPase activity, and it is suggested to be an important mechanistic feature of receptor-coupled ABC transporters.	[Grote, Mathias; Schneider, Erwin] Humboldt Univ, Inst Biol Bakterienphysiol, D-10115 Berlin, Germany; [Polyhach, Yevhen; Jeschke, Gunnar; Bordignon, Enrica] ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland; [Steinhoff, Heinz-Juergen] Univ Osnabruck, Fachbereich Phys, D-49076 Osnabruck, Germany	Humboldt University of Berlin; Swiss Federal Institutes of Technology Domain; ETH Zurich; University Osnabruck	Schneider, E (corresponding author), Humboldt Univ, Inst Biol Bakterienphysiol, Chausseestr 117, D-10115 Berlin, Germany.	erwin.schneider@rz.hu-berlin.de; enrica.bordignon@phys.chem.ethz.ch	Steinhoff, Heinz-Juergen/H-3791-2014	Steinhoff, Heinz-Juergen/0000-0002-5888-0157; Bordignon, Enrica/0000-0003-2450-5161; Jeschke, Gunnar/0000-0001-6853-8585	Deutsche Forschungsgemeinschaft [SCHN 274/9-3, STE 640/7]; German National Academic Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German National Academic Foundation	This work was supported by Deutsche Forschungsgemeinschaft Grants SCHN 274/9-3 (to E. S.) and STE 640/7 (to H.- J. S.) and by a fellowship from the German National Academic Foundation (to M. G.).	Beier C, 2006, BIOPHYS J, V91, P2647, DOI 10.1529/biophysj.105.080051; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; Crosa JH., 2004, IRON TRANSPORT BACTE; Daus ML, 2007, MOL MICROBIOL, V66, P1107, DOI 10.1111/j.1365-2958.2007.05982.x; Daus ML, 2009, J BACTERIOL, V191, P754, DOI 10.1128/JB.01439-08; Daus ML, 2006, J BIOL CHEM, V281, P3856, DOI 10.1074/jbc.M511953200; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Goetz BA, 2009, FEBS LETT, V583, P266, DOI 10.1016/j.febslet.2008.12.020; Grote M, 2008, BIOPHYS J, V95, P2924, DOI 10.1529/biophysj.108.132456; Holland I. B., 2003, ABC PROTEINS BACTERI; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Jacso T, 2009, BIOCHEMISTRY-US, V48, P2216, DOI 10.1021/bi801376m; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Landmesser H, 2002, BBA-BIOMEMBRANES, V1565, P64, DOI 10.1016/S0005-2736(02)00506-0; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Steinhoff HJ, 1997, BIOPHYS J, V73, P3287, DOI 10.1016/S0006-3495(97)78353-X; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Tapia MI, 1999, J BACTERIOL, V181, P2267, DOI 10.1128/JB.181.7.2267-2272.1999; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001	24	62	62	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17521	17526		10.1074/jbc.M109.006270	http://dx.doi.org/10.1074/jbc.M109.006270			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19395376	Green Published, hybrid			2022-12-25	WOS:000267202500018
J	Ishikawa, Y; Wirz, J; Vranka, JA; Nagata, K; Bachinger, HP				Ishikawa, Yoshihiro; Wirz, Jackie; Vranka, Janice A.; Nagata, Kazuhiro; Baechinger, Hans Peter			Biochemical Characterization of the Prolyl 3-Hydroxylase 1(.)Cartilage-associated Protein(.)Cyclophilin B Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECESSIVE OSTEOGENESIS IMPERFECTA; PROTEIN DISULFIDE-ISOMERASE; FK506-BINDING PROTEIN; MOLECULAR CHAPERONE; IN-VITRO; MUTATIONS; COLLAGEN; ENZYME; DEFICIENCY; CATALYSIS	The rough endoplasmic reticulum-resident protein complex consisting of prolyl 3-hydroxylase 1 (P3H1), cartilage-associated protein (CRTAP), and cyclophilin B (CypB) can be isolated from chick embryos on a gelatin-Sepharose column, indicating some involvement in the biosynthesis of procollagens. Prolyl 3-hydroxylase 1 modifies a single proline residue in the alpha chains of type I, II, and III collagens to (3S)-hydroxyproline. The peptidyl-prolyl cis-trans isomerase activity of cyclophilin B was shown previously to catalyze the rate of triple helix formation. Here we show that cyclophilin B in the complex shows peptidyl-prolyl cis-trans isomerase activity and that the P3H1(.)CRTAP(.)CypB complex has another important function: it acts as a chaperone molecule when tested with two classical chaperone assays. The P3H1(.)CRTAP(.)CypB complex inhibited the thermal aggregation of citrate synthase and was active in the denatured rhodanese refolding and aggregation assay. The chaperone activity of the complex was higher than that of protein-disulfide isomerase, a well characterized chaperone. The P3H1(.)CRTAP(.)CypB complex also delayed the in vitro fibril formation of type I collagen, indicating that this complex is also able to interact with triple helical collagen and acts as a collagen chaperone.	[Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA; [Wirz, Jackie; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Ishikawa, Yoshihiro; Nagata, Kazuhiro] Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Kyoto 6068507, Japan	Oregon Health & Science University; Kyoto University	Bachinger, HP (corresponding author), Shriners Hosp Children, Res Dept, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	hpb@shcc.org		Ishikawa, Yoshihiro/0000-0003-2013-0518; Wirz, Jacqueline/0000-0003-2046-610X	Shriners Hospitals for Children; Osteogenesis Imperfecta Foundation	Shriners Hospitals for Children; Osteogenesis Imperfecta Foundation	This work was supported by a grant from the Shriners Hospitals for Children (to H. P. B.) and in part by a Michael Geisman Research Fellowship from the Osteogenesis Imperfecta Foundation (to J.A.V.).	Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; CHESSLER SD, 1993, J BIOL CHEM, V268, P18226; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P1684, DOI 10.1021/bi00459a003; Horibe T, 2002, J BIOCHEM, V132, P401, DOI 10.1093/oxfordjournals.jbchem.a003236; Ishikawa Y, 2008, J BIOL CHEM, V283, P31584, DOI 10.1074/jbc.M802535200; Knappe TA, 2007, J MOL BIOL, V368, P1458, DOI 10.1016/j.jmb.2007.02.097; Makareeva E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001029; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MENDOZA JA, 1991, J BIOL CHEM, V266, P13044; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; NATSUME T, 1994, J BIOL CHEM, V269, P31224; OGLE JD, 1962, J BIOL CHEM, V237, P3667; RISTELI J, 1978, ANAL BIOCHEM, V84, P423, DOI 10.1016/0003-2697(78)90060-X; RISTELI J, 1977, EUR J BIOCHEM, V73, P485, DOI 10.1111/j.1432-1033.1977.tb11341.x; Shao F, 2000, J BIOL CHEM, V275, P13349, DOI 10.1074/jbc.275.18.13349; Tiainen P, 2008, J BIOL CHEM, V283, P19432, DOI 10.1074/jbc.M802973200; TRYGGVASON K, 1979, BIOCHEM J, V183, P303, DOI 10.1042/bj1830303; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Zeng BF, 1998, BIOCHEM J, V330, P109, DOI 10.1042/bj3300109	27	86	88	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17641	17647		10.1074/jbc.M109.007070	http://dx.doi.org/10.1074/jbc.M109.007070			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19419969	Green Published, hybrid			2022-12-25	WOS:000267202500030
J	Zhang, F; Tsai, S; Kato, K; Yamanouchi, D; Wang, CJ; Rafii, S; Liu, B; Kent, KC				Zhang, Fan; Tsai, Shirling; Kato, Kaori; Yamanouchi, Dai; Wang, Chunjie; Rafii, Shahin; Liu, Bo; Kent, K. Craig			Transforming Growth Factor-beta Promotes Recruitment of Bone Marrow Cells and Bone Marrow-derived Mesenchymal Stem Cells through Stimulation of MCP-1 Production in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; INTIMAL HYPERPLASIA; PROGENITOR CELLS; NEOINTIMAL HYPERPLASIA; ARTERIAL INJURY; PKC-DELTA; IN-VIVO; MIGRATION; EXPRESSION; MECHANISMS	Bone marrow-derived progenitor cells have recently been shown to be involved in the development of intimal hyperplasia after vascular injury. Transforming growth factor-beta (TGF-beta) has profound stimulatory effects on intimal hyperplasia, but it is unknown whether these effects involve progenitor cell recruitment. In this study we found that although TGF-beta had no direct effect on progenitor cell recruitment, conditioned media derived from vascular smooth muscle cells (VSMC) stimulated with TGF-beta induced migration of both total bone marrow (BM) cells and BM-mesenchymal stem cells (MSC) and also induced MSC differentiation into smooth muscle like cells. Furthermore, overexpression of the signaling molecule Smad3 in VSMC via adenovirus-mediated gene transfer (AdSmad3) enhanced the TGF-beta's chemotactic effect. Microarray analysis of VSMC stimulated by TGF-beta/AdSmad3 revealed monocyte chemoattractant protein-1 (MCP-1) as a likely factor responsible for progenitor cell recruitment. We then demonstrated that TGF-beta through Smad3 phosphorylation induced a robust expression of MCP-1 in VSMC. Recombinant MCP-1 mimicked the stimulatory effect of conditioned media on BM and MSC migration. In the rat carotid injury model, Smad3 overexpression significantly increased MCP-1 expression after vascular injury, consistent with our in vitro results. Interestingly, TGF-beta/Smad3-induced MCP-1 was completely blocked by both Ro-32-0432 and rotterlin, suggesting protein kinase C-delta (PKC delta) may play a role in TGF-beta/Smad3-induced MCP-1 expression. In summary, our data demonstrate that TGF-beta, through Smad3 and PKC delta, stimulates VSMC production of MCP-1, which is a chemoattractant for bone marrow-derived cells, specifically MSC. Manipulation of this signaling system may provide a novel approach to inhibition of intimal hyperplasia.	[Zhang, Fan; Kato, Kaori; Yamanouchi, Dai; Liu, Bo; Kent, K. Craig] Univ Wisconsin, Dept Surg, Sch Med, Madison, WI 53705 USA; [Tsai, Shirling; Wang, Chunjie] Cornell Univ, Weill Med Coll, Div Vasc Surg, Dept Surg, New York, NY 10065 USA; [Rafii, Shahin] Weill Cornell Med Coll, Howard Hughes Med Inst, New York, NY 10065 USA	University of Wisconsin System; University of Wisconsin Madison; Cornell University; Cornell University; Howard Hughes Medical Institute	Liu, B (corresponding author), Univ Wisconsin, Dept Surg, Sch Med, WIMR 5137,1111 Highland Ave, Madison, WI 53705 USA.	liub@surgery.wisc.edu			National Institutes of Health [F32 HL088818-01]; Public Health Service [R01 HL-68673]; American Heart Association [0455859T]; Society of University Surgeons-Ethicon Scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL088818, R01HL068673] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); American Heart Association(American Heart Association); Society of University Surgeons-Ethicon Scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant F32 HL088818-01 (to S. T.) and Public Health Service Grant R01 HL-68673 (NHLBI, to K. K. and B. L.). The work was also supported by American Heart Association Grant-in-aid 0455859T (to B. L.) and a Society of University Surgeons-Ethicon Scholarship Grant Award (to S. T.).	Abedin M, 2004, CIRC RES, V95, P671, DOI 10.1161/01.RES.0000143421.27684.12; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Belmadani A, 2006, J NEUROSCI, V26, P3182, DOI 10.1523/JNEUROSCI.0156-06.2006; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; CLOWES AW, 1989, J CARDIOVASC PHARM, V14, pS12, DOI 10.1097/00005344-198906146-00005; CLOWES AW, 1983, LAB INVEST, V49, P208; CLOWES MM, 1994, J CLIN INVEST, V93, P644, DOI 10.1172/JCI117016; COMBADIERE C, 1995, J BIOL CHEM, V270, P29671; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Devine SM, 2001, EXP HEMATOL, V29, P244, DOI 10.1016/S0301-472X(00)00635-4; Dwyer RM, 2007, CLIN CANCER RES, V13, P5020, DOI 10.1158/1078-0432.CCR-07-0731; Egashira K, 2002, CIRC RES, V90, P1167, DOI 10.1161/01.RES.0000020561.03244.7E; Feinberg MW, 2004, CIRC RES, V94, P601, DOI 10.1161/01.RES.0000119170.70818.4F; Furukawa Y, 1999, CIRC RES, V84, P306, DOI 10.1161/01.RES.84.3.306; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Hollenbeck ST, 2004, J SURG RES, V120, P288, DOI 10.1016/j.jss.2004.01.005; Iwata H, 2007, FRONT BIOSCI, V12, P4157, DOI 10.2741/2377; Kamiya K, 2007, J SURG RES, V141, P91, DOI 10.1016/j.jss.2007.02.025; KANZAKI T, 1995, ARTERIOSCL THROM VAS, V15, P1951, DOI 10.1161/01.ATV.15.11.1951; Kashiwakura Y, 2003, CIRCULATION, V107, P2078, DOI 10.1161/01.CIR.0000070082.64414.B5; Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400; Massberg S, 2006, J EXP MED, V203, P1221, DOI 10.1084/jem.20051772; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; NIKOL S, 1992, J CLIN INVEST, V90, P1582, DOI 10.1172/JCI116027; REIDY MA, 1992, CIRCULATION, V86, P43; Ringe J, 2007, J CELL BIOCHEM, V101, P135, DOI 10.1002/jcb.21172; Roque M, 2002, ARTERIOSCL THROM VAS, V22, P554, DOI 10.1161/hq0402.105720; Runyan CE, 2003, AM J PHYSIOL-RENAL, V285, pF413, DOI 10.1152/ajprenal.00082.2003; Ryan ST, 2003, J VASC RES, V40, P37, DOI 10.1159/000068937; Ryer EJ, 2006, ARTERIOSCL THROM VAS, V26, P780, DOI 10.1161/01.ATV.0000209517.00220.cd; Ryer EJ, 2005, J BIOL CHEM, V280, P35310, DOI 10.1074/jbc.M507187200; Sahara M, 2005, STEM CELLS, V23, P874, DOI 10.1634/stemcells.2005-0012; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; Schenk S, 2007, STEM CELLS, V25, P245, DOI 10.1634/stemcells.2006-0293; Simper D, 2002, CIRCULATION, V106, P1199, DOI 10.1161/01.CIR.0000031525.61826.A8; Tanaka K, 2003, CIRC RES, V93, P783, DOI 10.1161/01.RES.0000096651.13001.B4; TEN DP, 2004, TRENDS BIOCHEM SCI, V29, P265; Tsai S, 2009, J VASC SURG, V49, P502, DOI 10.1016/j.jvs.2008.07.060; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wang CH, 2008, ARTERIOSCL THROM VAS, V28, P54, DOI 10.1161/ATVBAHA.107.147256; Wang CH, 2006, CIRC RES, V99, P617, DOI 10.1161/01.RES.0000243210.79654.fd; Wang L, 2002, EXP HEMATOL, V30, P831, DOI 10.1016/S0301-472X(02)00829-9; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; WOLF YG, 1994, J CLIN INVEST, V93, P1172, DOI 10.1172/JCI117070; Yakmovych I, 2001, FASEB J, V15, P553; Zernecke A, 2005, CIRC RES, V96, P784, DOI 10.1161/01.RES.0000162100.52009.38; Zhang L, 2004, J BIOL CHEM, V279, P28315, DOI 10.1074/jbc.C400115200; Zhao Y, 2003, P NATL ACAD SCI USA, V100, P2426, DOI 10.1073/pnas.0536882100	48	101	109	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17564	17574		10.1074/jbc.M109.013987	http://dx.doi.org/10.1074/jbc.M109.013987			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19406748	Green Published, hybrid			2022-12-25	WOS:000267202500022
J	Yang, L; Zhao, TJ; Shi, XL; Nakhaei, P; Wang, YL; Sun, Q; Hiscott, J; Lin, RT				Yang, Long; Zhao, Tiejun; Shi, Xiaoliu; Nakhaei, Peyman; Wang, Yunling; Sun, Qiang; Hiscott, John; Lin, Rongtuan			Functional Analysis of a Dominant Negative Mutation of Interferon Regulatory Factor 5	PLOS ONE			English	Article								Background: Interferon regulatory factor (IRF) family members have been implicated as critical transcription factors that function in immune response, hematopoietic differentiation and cell growth regulation. Activation of IRF-5 results in the production of pro-inflammatory cytokines such as TNF alpha, IL6 and IL12p40, as well as type I interferons. Methodology/Principal Findings: In this study, we identify a G202C (position relative to translation start codon) missense-mutation transcript of IRF-5 in transformed B and T cell lines, which were either infected or non-infected by viruses, and peripheral blood from ATL or CLL patients. The mutated transcript encodes a novel protein in which the sixty-eighth amino acid, Alanine, is substituted by Proline (IRF-5P68) in the DNA binding domain of IRF-5. IRF-5P68 phenotype results in a complete loss of its DNA-binding activity and functions as a dominant negative molecule through interacting with wild type IRF-5. Co-expression of IRF-5P68 inhibits MyD88-mediated IRF-5 transactivation. Moreover, Toll-like receptor (TLR)-dependent IL6 and IL12P40 production induced by lipopolysaccharide (LPS), R837 or CpG ODN 1826 was reduced in IRF-5 (P68) expressing cells as compared to the control cells. Conclusion: IRF-5P68 acts as a dominant negative regulator that interferes with IRF-5-mediated production of proinflammatory cytokines. The functional characterization of the novel IRF-5 mutant in transformed B and T cell lines and in ATL and CLL patients may lead to a better understanding of the role of these transcriptional regulators in hematopoietic malignancies.			Yang, L (corresponding author), Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Terry Fox Mol Oncol Grp, Montreal, PQ H3T 1E2, Canada.	rongtuan.lin@mcgill.ca	Lin, Rongtuan/A-1442-2008	Lin, Rongtuan/0000-0002-2238-3503; Shi, Xiaoliu/0000-0002-9759-2254				Abbott BL, 2006, CANCER INVEST, V24, P302, DOI 10.1080/07357900600620525; BALKHI MY, 2008, MOL CELL BIOL; Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200; Barnes BJ, 2003, CANCER RES, V63, P6424; Barnes BJ, 2003, J BIOL CHEM, V278, P16630, DOI 10.1074/jbc.M212609200; Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Couzinet A, 2008, P NATL ACAD SCI USA, V105, P2556, DOI 10.1073/pnas.0712295105; Decker T, 2000, BLOOD, V95, P999, DOI 10.1182/blood.V95.3.999.003k10_999_1006; Escalante CR, 1998, NATURE, V391, P103, DOI 10.1038/34224; Fujii Y, 1999, EMBO J, V18, P5028, DOI 10.1093/emboj/18.18.5028; Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hu GD, 2005, CANCER RES, V65, P7403, DOI 10.1158/0008-5472.CAN-05-0583; Lin RT, 2005, J BIOL CHEM, V280, P3088, DOI 10.1074/jbc.M408452200; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Martin HJ, 2007, J VIROL, V81, P9748, DOI 10.1128/JVI.01122-07; Mattick JS, 2008, TRENDS NEUROSCI, V31, P227, DOI 10.1016/j.tins.2008.02.003; Mori T, 2002, ONCOGENE, V21, P2914, DOI 10.1038/sj.onc.1205459; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Ochsenbein AF, 2001, NATURE, V411, P1058, DOI 10.1038/35082583; Paun A, 2008, J BIOL CHEM, V283, P14295, DOI 10.1074/jbc.M800501200; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; SCOTT J, 1995, CELL, V81, P833, DOI 10.1016/0092-8674(95)90002-0; SHARMA PM, 1994, GENE DEV, V8, P720, DOI 10.1101/gad.8.6.720; Spaner DE, 2006, LEUKEMIA, V20, P286, DOI 10.1038/sj.leu.2404061; Spaner DE, 2004, BRIT J HAEMATOL, V127, P531, DOI 10.1111/j.1365-2141.2004.05240.x; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	34	24	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2009	4	5							e5500	10.1371/journal.pone.0005500	http://dx.doi.org/10.1371/journal.pone.0005500			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VY	19430534	Green Submitted, gold, Green Published			2022-12-25	WOS:000266009700006
J	Grip, O; Janciauskiene, S				Grip, Olof; Janciauskiene, Sabina			Atorvastatin Reduces Plasma Levels of Chemokine (CXCL10) in Patients with Crohn's Disease	PLOS ONE			English	Article								Background: In Crohn's disease high tissue expression and serum levels of chemokines and their receptors are known to correlate with disease activity. Because statins can reduce chemokine expression in patients with coronary diseases, we wanted to test whether this can be achieved in patients with Crohn's disease. Methodology/Principal Findings: We investigated plasma levels of chemokines (CCL2, CCL4, CCL11, CCL13, CCL17, CCL22, CCL26, CXCL8, CXCL10) and endothelial cytokines (sP-selectin, sE-selectin, sICAM-3, thrombomodulin) in ten Crohn's disease patients before and after thirteen weeks' daily treatment with 80 mg atorvastatin. Of the 13 substances investigated, only CXCL10 was found to be significantly reduced (by 34%, p = 0.026) in all of the treated patients. Levels of CXCL10 correlated with C-reactive protein (r = 0.82, p<0.01). Conclusions/Significance: CXCL10 is a ligand for the CXCR3 receptor, the activation of which results in the recruitment of T lymphocytes and the perpetuation of mucosal inflammation. Hence the reduction of plasma CXCL10 levels by atorvastatin may represent a candidate for an approach to the treatment of Crohns disease in the future.			Grip, O (corresponding author), Lund Univ, Div Gastroenterol & Hepatol, Dept Clin Sci Malmo, Univ Hosp MAS, Malmo, Sweden.	olof.grip@med.lu.se						Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Andoh A, 2005, AM J GASTROENTEROL, V100, P2042, DOI 10.1111/j.1572-0241.2005.50381.x; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Banks C, 2003, J PATHOL, V199, P28, DOI 10.1002/path.1245; Barnes PJ, 1997, INT J BIOCHEM CELL B, V29, P867, DOI 10.1016/S1357-2725(96)00159-8; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Blanco-Colio LM, 2007, AM HEART J, V153, P881, DOI 10.1016/j.ahj.2007.02.029; Bolewski A, 2008, CARDIOLOGY, V111, P140, DOI 10.1159/000119702; Cammarano MS, 2001, J BIOL CHEM, V276, P25876, DOI 10.1074/jbc.M011345200; Chen W, 2001, SCAND J GASTROENTERO, V36, P515, DOI 10.1080/003655201750153377; D'Ambrosio D, 1998, J IMMUNOL, V161, P5111; Dwinell MB, 2001, GASTROENTEROLOGY, V120, P49, DOI 10.1053/gast.2001.20914; Garcia-Lopez MA, 2001, LAB INVEST, V81, P409, DOI 10.1038/labinvest.3780248; Gasperini S, 1999, J IMMUNOL, V162, P4928; Goke M, 1997, J GASTROENTEROL, V32, P480, DOI 10.1007/BF02934086; Grip O, 2004, INFLAMM BOWEL DIS, V10, P193, DOI 10.1097/00054725-200405000-00003; Grip O, 2008, BRIT J PHARMACOL, V155, P1085, DOI 10.1038/bjp.2008.369; Heystek HC, 2003, INT IMMUNOL, V15, P827, DOI 10.1093/intimm/dxg079; Hyun JG, 2005, INFLAMM BOWEL DIS, V11, P799, DOI 10.1097/01.MIB.0000178263.34099.89; Iqbal N, 2002, J EXP MED, V195, P71, DOI 10.1084/jem.2001889; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Jugde F, 2001, EUR CYTOKINE NETW, V12, P468; KOBAYASHI T, 2008, GUT; Kushiya F, 2005, AM J HEMATOL, V78, P1, DOI 10.1002/ajh.20191; Liao JK, 2002, J CLIN INVEST, V110, P285, DOI 10.1172/JCI200216421; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Luster AD, 2002, CURR OPIN IMMUNOL, V14, P129, DOI 10.1016/S0952-7915(01)00308-9; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Moser B, 2004, ANN RHEUM DIS, V63, P84, DOI 10.1136/ard.2004.028316; Ortego M, 1999, ATHEROSCLEROSIS, V147, P253, DOI 10.1016/S0021-9150(99)00193-8; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Rauch U, 2000, ATHEROSCLEROSIS, V153, P181, DOI 10.1016/S0021-9150(00)00397-X; Rosenson RS, 1999, LANCET, V353, P983, DOI 10.1016/S0140-6736(98)05917-0; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Sanders DSA, 2005, J CLIN PATHOL, V58, P568, DOI 10.1136/jcp.2004.021840; Scaldaferri F, 2007, J CLIN INVEST, V117, P1951, DOI 10.1172/JCI31027; Schmidt C, 2005, INFLAMM BOWEL DIS, V11, P16, DOI 10.1097/00054725-200501000-00003; Singh Udai P., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P111, DOI 10.2174/187153007780832109; Singh UP, 2003, J IMMUNOL, V171, P1401, DOI 10.4049/jimmunol.171.3.1401; Solem CA, 2005, INFLAMM BOWEL DIS, V11, P707, DOI 10.1097/01.MIB.0000173271.18319.53; Takahashi HK, 2005, J LEUKOCYTE BIOL, V77, P400, DOI 10.1189/jlb.0904510; Uguccioni M, 1999, AM J PATHOL, V155, P331, DOI 10.1016/S0002-9440(10)65128-0; Waehre T, 2003, J AM COLL CARDIOL, V41, P1460, DOI 10.1016/S0735-1097(03)00263-8; Wagner AH, 2002, BRIT J PHARMACOL, V136, P143, DOI 10.1038/sj.bjp.0704678; Wong CK, 2007, IMMUNOL LETT, V112, P82, DOI 10.1016/j.imlet.2007.07.002; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zhong W, 2008, FRONT BIOSCI-LANDMRK, V13, P1654, DOI 10.2741/2789	52	47	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5263	10.1371/journal.pone.0005263	http://dx.doi.org/10.1371/journal.pone.0005263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421322	gold, Green Published, Green Submitted			2022-12-25	WOS:000265836900001
J	Ozawa, A; Speaker, RB; Lindberg, I				Ozawa, Akihiko; Speaker, Richard B., III; Lindberg, Iris			Enzymatic Characterization of a Human Acyltransferase Activity	PLOS ONE			English	Article								Background: Non-histone protein acylation is increasingly recognized as an important posttranslational modification, but little is known as to the biochemical properties of protein serine acylating enzymes. Methodology/Principal Findings: We here report that we have identified a metal-stimulated serine octanoyltransferase activity in microsomes from human erythroleukemic (HEL) cells. The HEL acylating enzyme was linear with respect to time and protein, exhibited a neutral pH optimum (stimulated by cobalt and zinc), and inhibited by chelating reagents. Hydroxylamine treatment removed most, but not all, of the attached radioactivity. A salt extract of microsomal membranes contained the major portion of enzyme activity, indicating that this acyltransferase is not an integral membrane protein. Sucrose density fractionation showed that the acyltransferase activity is concentrated in the endoplasmic reticulum. In competition experiments, the acyltransferase was well inhibited by activated forms of fatty acids containing at least eight to fourteen carbons, but not by acetyl CoA. The zinc-stimulated HEL acyltransferase did not octanoylate proenkephalin, proopiomelanocortin, His-tagged proghrelin, or proghrelin lacking the amino-terminal His-tag stub of Gly-Ala-Met. The peptides des-acyl ghrelin and ACTH were also not acylated; however, des-acyl ghrelin containing the N-terminal tripeptide Gly-Ala-Met was acylated. Mutagenesis studies indicated a requirement for serine five residues from the amino terminus, reminiscent of myristoyl transferase, but not of ghrelin acylation. However, recombinant myristoyl transferase could not recapitulate the hydroxylamine sensitivity, zinc-stimulation, nor EDTA inhibition obtained with HEL acyltransferase, properties preserved in the HEL cell enzyme purified through four sequential chromatographic steps. Conclusions/Significance: In conclusion, our data demonstrate the presence of a zinc-stimulated acyltransferase activity concentrated in the endoplasmic reticulum in HEL cells which is likely to contribute to medium-chain protein lipidation.			Ozawa, A (corresponding author), Univ Maryland, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	ilind001@umaryland.edu	Ozawa, Akihiko/U-4426-2019; Lindberg, Iris/Q-3825-2019		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA005084] Funding Source: NIH RePORTER; NIDA NIH HHS [DA05084, R56 DA005084, R01 DA005084] Funding Source: Medline; NIDDK NIH HHS [R01 DK049703] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; De Vriese C, 2005, ENDOCRINOLOGY, V146, P1514, DOI 10.1210/en.2004-0964; EBERWINE JH, 1987, P NATL ACAD SCI USA, V84, P1449, DOI 10.1073/pnas.84.5.1449; GLEMBOTSKI CC, 1982, J BIOL CHEM, V257, P501; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; HIGGINS JA, 1966, BIOCHEM J, V99, P631, DOI 10.1042/bj0990631; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Hosoda H, 2000, BIOCHEM BIOPH RES CO, V279, P909, DOI 10.1006/bbrc.2000.4039; KO MH, 2008, J BIOL CHEM; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; LINDBERG I, 1991, ENDOCRINOLOGY, V128, P1849, DOI 10.1210/endo-128-4-1849; Liu L, 1996, J BIOL CHEM, V271, P23269, DOI 10.1074/jbc.271.38.23269; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Ozawa A, 2007, ANAL BIOCHEM, V366, P182, DOI 10.1016/j.ab.2007.04.020; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Wilkinson CW, 2006, PEPTIDES, V27, P453, DOI 10.1016/j.peptides.2005.05.029; WOODFORD TA, 1979, J BIOL CHEM, V254, P4993; Yang J, 2008, P NATL ACAD SCI USA, V105, P10750, DOI 10.1073/pnas.0805353105; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200	22	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2009	4	5							e5426	10.1371/journal.pone.0005426	http://dx.doi.org/10.1371/journal.pone.0005426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440RC	19412546	Green Published, gold, Green Submitted			2022-12-25	WOS:000265716400002
J	Bastonero, S; Le Priol, Y; Armand, M; Bernard, CS; Reynaud-Gaubert, M; Olive, D; Parzy, D; de Bentzmann, S; Capo, C; Mege, JL				Bastonero, Sonia; Le Priol, Yannick; Armand, Martine; Bernard, Christophe S.; Reynaud-Gaubert, Martine; Olive, Daniel; Parzy, Daniel; de Bentzmann, Sophie; Capo, Christian; Mege, Jean-Louis			New Microbicidal Functions of Tracheal Glands: Defective Anti-Infectious Response to Pseudomonas aeruginosa in Cystic Fibrosis	PLOS ONE			English	Article								Tracheal glands (TG) may play a specific role in the pathogenesis of cystic fibrosis (CF), a disease due to mutations in the cftr gene and characterized by airway inflammation and Pseudomonas aeruginosa infection. We compared the gene expression of wild-type TG cells and TG cells with the cftr Delta F508 mutation (CF-TG cells) using microarrays covering the whole human genome. In the absence of infection, CF-TG cells constitutively exhibited an inflammatory signature, including genes that encode molecules such as IL-1 alpha, IL-beta, IL-32, TNFSF14, LIF, CXCL1 and PLAU. In response to P. aeruginosa, genes associated with IFN-gamma response to infection (CXCL10, IL-24, IFN gamma R2) and other mediators of anti-infectious responses (CSF2, MMP1, MMP3, TLR2, S100 calcium-binding proteins A) were markedly up-regulated in wild-type TG cells. This microbicidal signature was silent in CF-TG cells. The deficiency of genes associated with IFN-gamma response was accompanied by the defective membrane expression of IFN gamma R2 and altered response of CF-TG cells to exogenous IFN-gamma. In addition, CF-TG cells were unable to secrete CXCL10, IL-24 and S100A8/S100A9 in response to P. aeruginosa. The differences between wild-type TG and CF-TG cells were due to the cftr mutation since gene expression was similar in wild-type TG cells and CF-TG cells transfected with a plasmid containing a functional cftr gene. Finally, we reported an altered sphingolipid metabolism in CF-TG cells, which may account for their inflammatory signature. This first comprehensive analysis of gene expression in TG cells proposes a protective role of wild- type TG against airborne pathogens and reveals an original program in which antiinfectious response was deficient in TG cells with a cftr mutation. This defective response may explain why host response does not contribute to protection against P. aeruginosa in CF.			Bastonero, S (corresponding author), Fac Med Marseille, CNRS, UMR 6236, Unite Rech Malad Infectieuses Trop & Emergentes, F-13385 Marseille, France.	Jean-Louis.Mege@univmed.fr	Reynaud-Gaubert, Martine LM/P-6958-2016; ARMAND, Martine/O-5780-2016; MEGE, JEAN-LOUIS/O-6063-2016	ARMAND, Martine/0000-0002-8712-6620; Bernard, Christophe/0000-0003-0582-3471; Le Priol, Yannick/0000-0002-5176-0857				Abul-Milh M, 2001, GLYCOCONJUGATE J, V18, P253, DOI 10.1023/A:1012460824913; Al-Aloul M, 2004, THORAX, V59, P334, DOI 10.1136/thx.2003.014258; Armand M, 1996, AM J PHYSIOL-GASTR L, V271, pG172, DOI 10.1152/ajpgi.1996.271.1.G172; Auge N, 1996, J BIOL CHEM, V271, P19251, DOI 10.1074/jbc.271.32.19251; Backhed F, 2002, J BIOL CHEM, V277, P18198, DOI 10.1074/jbc.M111640200; Ballard ST, 2007, RESP PHYSIOL NEUROBI, V159, P271, DOI 10.1016/j.resp.2007.06.017; BASBAUM CB, 1990, ANNU REV PHYSIOL, V52, P97; Bastonero S, 2005, J GENE MED, V7, P1439, DOI 10.1002/jgm.789; Beck DC, 2000, J BIOL CHEM, V275, P3365, DOI 10.1074/jbc.275.5.3365; Bonfield TL, 1999, J ALLERGY CLIN IMMUN, V104, P72, DOI 10.1016/S0091-6749(99)70116-8; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brown GR, 2005, J IMMUNOL, V174, P4688, DOI 10.4049/jimmunol.174.8.4688; Caudell EG, 2002, J IMMUNOL, V168, P6041, DOI 10.4049/jimmunol.168.12.6041; CHOW CW, 1982, EUR J PEDIATR, V139, P240, DOI 10.1007/BF00442171; Chun J, 2006, J IMMUNOL, V177, P1330, DOI 10.4049/jimmunol.177.2.1330; Coraux C, 2004, AM J RESP CELL MOL, V30, P605, DOI 10.1165/rcmb.2003-0056OC; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Dinarello CA, 2004, CURR OPIN PHARMACOL, V4, P378, DOI 10.1016/j.coph.2004.03.010; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Dorman SE, 1998, J CLIN INVEST, V101, P2364, DOI 10.1172/JCI2901; Elson G, 2007, BLOOD, V109, P1574, DOI 10.1182/blood-2006-06-032961; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; Escotte S, 2006, AM J RESP CELL MOL, V34, P348, DOI 10.1165/rcmb.2005-0191OC; Filali M, 2002, NOVART FDN SYMP, V248, P38; Ghigo E, 2002, INFECT IMMUN, V70, P1501, DOI 10.1128/IAI.70.3.1501-1506.2002; Hart CA, 2002, BRIT MED BULL, V61, P81, DOI 10.1093/bmb/61.1.81; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; Inglis SK, 2005, PEDIATR PULM, V40, P279, DOI 10.1002/ppul.20183; Inoue D, 2006, RESP PHYSIOL NEUROBI, V154, P484, DOI 10.1016/j.resp.2005.11.006; Jayaraman S, 2001, P NATL ACAD SCI USA, V98, P8119, DOI 10.1073/pnas.131087598; Kammouni W, 1999, AM J RESP CELL MOL, V20, P684, DOI 10.1165/ajrcmb.20.4.3341; Kammouni W, 1997, INFECT IMMUN, V65, P5176, DOI 10.1128/IAI.65.12.5176-5183.1997; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Knight D, 2001, PULM PHARMACOL THER, V14, P169, DOI 10.1006/pupt.2001.0282; Kreda SM, 2005, MOL BIOL CELL, V16, P2154, DOI 10.1091/mbc.E04-11-1010; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; Leduc D, 2007, INFECT IMMUN, V75, P3848, DOI 10.1128/IAI.00015-07; LUSTER AD, 1987, MOL CELL BIOL, V7, P3723, DOI 10.1128/MCB.7.10.3723; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; MERTEN M, 1996, HUMAN CELL CULTURE P, P201; Merten MD, 1996, AM J RESP CELL MOL, V15, P520, DOI 10.1165/ajrcmb.15.4.8879186; MERTEN MD, 1993, AM J PHYSIOL, V264, pL93, DOI 10.1152/ajplung.1993.264.2.L93; Moreilhon C, 2005, PHYSIOL GENOMICS, V20, P244, DOI 10.1152/physiolgenomics.00135.2004; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; MUSSO T, 1995, BLOOD, V86, P1961, DOI 10.1182/blood.V86.5.1961.bloodjournal8651961; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; Netea MG, 2005, P NATL ACAD SCI USA, V102, P16309, DOI 10.1073/pnas.0508237102; Pollara G, 2005, J CELL PHYSIOL, V205, P161, DOI 10.1002/jcp.20473; Schneider K, 2004, IMMUNOL REV, V202, P49, DOI 10.1111/j.0105-2896.2004.00206.x; SEO J, 2008, J BACTERIOL IN PRESS; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Tirouvanziam R, 2000, AM J RESP CELL MOL, V23, P121, DOI 10.1165/ajrcmb.23.2.4214; Ulrich M, 1998, AM J RESP CELL MOL, V19, P83, DOI 10.1165/ajrcmb.19.1.3137; Venkatakrishnan A, 2000, AM J RESP CELL MOL, V23, P396, DOI 10.1165/ajrcmb.23.3.3949; Verhaeghe C, 2007, J CYST FIBROS, V6, P304, DOI 10.1016/j.jcf.2006.12.001; Verhaeghe C, 2007, BIOCHEM PHARMACOL, V73, P1982, DOI 10.1016/j.bcp.2007.03.019; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Vos JB, 2005, PHYSIOL GENOMICS, V21, P324, DOI 10.1152/physiolgenomics.00289.2004; Wagener JS, 1997, PEDIATR PULM, P267; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Xu GL, 2007, J IMMUNOL, V179, P6901, DOI 10.4049/jimmunol.179.10.6901; Zabner J, 2005, AM J PHYSIOL-LUNG C, V289, pL545, DOI 10.1152/ajplung.00065.2005; Zaborina O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040043	66	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5357	10.1371/journal.pone.0005357	http://dx.doi.org/10.1371/journal.pone.0005357			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399182	Green Published, gold, Green Submitted			2022-12-25	WOS:000265514900016
J	Wang, SS; Purdue, MP; Cerhan, JR; Zheng, TZ; Menashe, I; Armstrong, BK; Lan, Q; Hartge, P; Kricker, A; Zhang, YW; Morton, LM; Vajdic, CM; Holford, TR; Severson, RK; Grulich, A; Leaderer, BP; Davis, S; Cozen, W; Yeager, M; Chanock, SJ; Chatterjee, N; Rothman, N				Wang, Sophia S.; Purdue, Mark P.; Cerhan, James R.; Zheng, Tongzhang; Menashe, Idan; Armstrong, Bruce K.; Lan, Qing; Hartge, Patricia; Kricker, Anne; Zhang, Yawei; Morton, Lindsay M.; Vajdic, Claire M.; Holford, Theodore R.; Severson, Richard K.; Grulich, Andrew; Leaderer, Brian P.; Davis, Scott; Cozen, Wendy; Yeager, Meredith; Chanock, Stephen J.; Chatterjee, Nilanjan; Rothman, Nathaniel			Common Gene Variants in the Tumor Necrosis Factor (TNF) and TNF Receptor Superfamilies and NF-kappa B Transcription Factors and Non-Hodgkin Lymphoma Risk	PLOS ONE			English	Article								Background: A promoter polymorphism in the pro-inflammatory cytokine tumor necrosis factor (TNF) (TNF G-308A) is associated with increased non-Hodgkin lymphoma (NHL) risk. The protein product, TNF-alpha, activates the nuclear factor kappa beta (NF-kappa B) transcription factor, and is critical for inflammatory and apoptotic responses in cancer progression. We hypothesized that the TNF and NF-kappa B pathways are important for NHL and that gene variations across the pathways may alter NHL risk. Methodology/Principal Findings: We genotyped 500 tag single nucleotide polymorphisms (SNPs) from 48 candidate gene regions (defined as 20 kb 5', 10 kb 3') in the TNF and TNF receptor superfamilies and the NF-kappa B and related transcription factors, in 1946 NHL cases and 1808 controls pooled from three independent population-based case-control studies. We obtaineded a gene region-level summary of association by computing the minimum p-value ("minP test''). We used logistic regression to compute odds ratios and 95% confidence intervals for NHL and four major NHL subtypes in relation to SNP genotypes and haplotypes. For NHL, the tail strength statistic supported an overall relationship between the TNF/NF-kappa B pathway and NHL (p = 0.02). We confirmed the association between TNF/LTA on chromosome 6p21.3 with NHL and found the LTA rs2844484 SNP most significantly and specifically associated with the major subtype, diffuse large B-cell lymphoma (DLBCL) (p-trend = 0.001). We also implicated for the first time, variants in NFKBIL1 on chromosome 6p21.3, associated with NHL. Other gene regions identified as statistically significantly associated with NHL included FAS, IRF4, TNFSF13B, TANK, TNFSF7 and TNFRSF13C. Accordingly, the single most significant SNPs associated with NHL were FAS rs4934436 (p-trend = 0.0024), IRF4 rs12211228 (p-trend = 0.0026), TNFSF13B rs2582869 (p-trend = 0.0055), TANK rs1921310 (p-trend = 0.0025), TNFSF7 rs16994592 (p-trend = 0.0024), and TNFRSF13C rs6002551 (p-trend = 0.0074). All associations were consistent in each study with no apparent specificity for NHL subtype. Conclusions/Significance: Our results provide consistent evidence that variation in the TNF superfamily of genes and specifically within chromosome 6p21.3 impacts lymphomagenesis. Further characterization of these susceptibility loci and identification of functional variants are warranted.			Wang, SS (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Rockville, MD USA.	wangso@mail.nih.gov	Morton, Lindsay/AAE-7495-2022; Morton, Lindsay M/B-5234-2015; Menashe, Idan/W-6214-2019; Yeager, Meredith/AAA-5322-2020; Vajdic, Claire/AAP-5940-2020; Purdue, Mark P/C-9228-2016; Menashe, Idan/AAC-8670-2020	Morton, Lindsay/0000-0001-9767-2310; Morton, Lindsay M/0000-0001-9767-2310; Purdue, Mark P/0000-0003-1177-3108; Menashe, Idan/0000-0003-1961-1461; WANG, SOPHIA/0000-0003-2597-9393; Cerhan, James/0000-0002-7482-178X; Vajdic, Claire/0000-0002-3612-8298	DIVISION OF CANCER CONTROL &POPULATION SCIENCE [N01PC067008, N01PC067010, N01PC065064, N01PC067009] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIACP010124, ZIACP010206, R01CA062006] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [N02-PC-71105, N01 PC065064, R01 CA062006, N01-PC-67009, N01 PC067008, N01 PC067010, N01 PC067009] Funding Source: Medline	DIVISION OF CANCER CONTROL &POPULATION SCIENCE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Altemeier WA, 2007, J LEUKOCYTE BIOL, V82, P721, DOI 10.1189/jlb.1006652; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; AUPHAN N, 1997, ARCH TOXICOL S, P87; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhatti P, 2005, CANCER EPIDEM BIOMAR, V14, P2449, DOI 10.1158/1055-9965.EPI-05-0463; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Cerhan JR, 2008, CANCER EPIDEM BIOMAR, V17, P3161, DOI 10.1158/1055-9965.EPI-08-0536; Cerhan JR, 2007, BLOOD, V110, P4455, DOI 10.1182/blood-2007-05-088682; Chatterjee N, 2004, CANCER EPIDEM BIOMAR, V13, P1415; Chen BSE, 2006, GENET EPIDEMIOL, V30, P495, DOI 10.1002/gepi.20162; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; DIDONATO JA, 1995, MOL CELL BIOL, V15, P1302; Fillatreau S, 2006, NAT IMMUNOL, V7, P704, DOI 10.1038/ni0706-704; Garcia-Closas M, 2001, CANCER EPIDEM BIOMAR, V10, P687; He B, 2004, J IMMUNOL, V172, P3268, DOI 10.4049/jimmunol.172.5.3268; Ho L, 2005, BLOOD, V105, P2891, DOI 10.1182/blood-2004-06-2297; Hughes AM, 2004, INT J CANCER, V110, P429, DOI 10.1002/ijc.20128; Jardin F, 2007, PATHOL BIOL, V55, P73, DOI 10.1016/j.patbio.2006.04.001; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; Keller SA, 2000, BLOOD, V96, P2537; KLEIHUES P, 2001, PATHOLOGY GENETICS T; Lan Q, 2006, BLOOD, V107, P4101, DOI 10.1182/blood-2005-10-4160; Lossos IS, 2007, CANCER CELL, V12, P189, DOI 10.1016/j.ccr.2007.08.012; Lyu MA, 2007, MOL CANCER THER, V6, P460, DOI 10.1158/1535-7163.MCT-06-0254; Mackay F, 2004, CURR OPIN PHARMACOL, V4, P347, DOI 10.1016/j.coph.2004.02.009; Mackay F, 2006, SEMIN IMMUNOL, V18, P261, DOI 10.1016/j.smim.2006.07.003; Morton LM, 2007, BLOOD, V110, P695, DOI 10.1182/blood-2006-11-051672; Novak AJ, 2006, J CLIN ONCOL, V24, P983, DOI 10.1200/JCO.2005.02.7938; Okamoto K, 2003, AM J HUM GENET, V72, P303, DOI 10.1086/346067; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Ponzoni M, 2007, ADV ANAT PATHOL, V14, P25, DOI 10.1097/PAP.0b013e31802f0495; Purdue MP, 2007, CARCINOGENESIS, V28, P704, DOI 10.1093/carcin/bgl200; Rao VK, 2006, HEMATOLOGY, V11, P15, DOI 10.1080/10245330500329094; Rosenwald A, 2003, LEUKEMIA LYMPHOMA, V44, pS41, DOI 10.1080/10428190310001623775; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Roth W.-M., 2006, ED RES REV, V1, P27, DOI DOI 10.1016/J.EDUREV.2006.01.002; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Schmidt M, 2000, J CLIN ONCOL, V18, P3331, DOI 10.1200/JCO.2000.18.19.3331; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Skibola CF, 2008, BLOOD, V111, P4348, DOI 10.1182/blood-2007-09-112144; Taylor J, 2006, BIOSTATISTICS, V7, P167, DOI 10.1093/biostatistics/kxj009; Wang SS, 2006, CANCER RES, V66, P9771, DOI 10.1158/0008-5472.CAN-06-0324; Westfall Peter H, 2002, Methods Mol Biol, V184, P143; Whiteside TL, 2007, IMMUNOL INVEST, V36, P25, DOI 10.1080/08820130600991893; Yaccoby S, 2008, LEUKEMIA, V22, P406, DOI 10.1038/sj.leu.2405048; Zhang YW, 2004, AM J EPIDEMIOL, V159, P148, DOI 10.1093/aje/kwh033	51	81	82	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5360	10.1371/journal.pone.0005360	http://dx.doi.org/10.1371/journal.pone.0005360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390683	Green Published, gold, Green Submitted			2022-12-25	WOS:000265514400022
J	Wray, J; Williamson, EA; Royce, M; Shaheen, M; Beck, BD; Lee, SH; Nickoloff, JA; Hromas, R				Wray, Justin; Williamson, Elizabeth A.; Royce, Melanie; Shaheen, Montaser; Beck, Brian D.; Lee, Suk-Hee; Nickoloff, Jac A.; Hromas, Robert			Metnase Mediates Resistance to Topoisomerase II Inhibitors in Breast Cancer Cells	PLOS ONE			English	Article								DNA replication produces tangled, or catenated, chromatids, that must be decatenated prior to mitosis or catastrophic genomic damage will occur. Topoisomerase II alpha (Topo II alpha) is the primary decatenating enzyme. Cells monitor catenation status and activate decatenation checkpoints when decatenation is incomplete, which occurs when Topo II alpha is inhibited by chemotherapy agents such as the anthracyclines and epididophyllotoxins. We recently demonstrated that the DNA repair component Metnase (also called SETMAR) enhances Topo II alpha-mediated decatenation, and hypothesized that Metnase could mediate resistance to Topo II alpha inhibitors. Here we show that Metnase interacts with Topo II alpha in breast cancer cells, and that reducing Metnase expression significantly increases metaphase decatenation checkpoint arrest. Repression of Metnase sensitizes breast cancer cells to Topo II alpha inhibitors, and directly blocks the inhibitory effect of the anthracycline adriamycin on Topo II alpha-mediated decatenation in vitro. Thus, Metnase may mediate resistance to Topo II alpha inhibitors, and could be a biomarker for clinical sensitivity to anthracyclines. Metnase could also become an important target for combination chemotherapy with current Topo II alpha inhibitors, specifically in anthracycline-resistant breast cancer.			Wray, J (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Med, Canc Res & Treatment Ctr,Div Hematol Oncol, Albuquerque, NM 87131 USA.	rhromas@salud.unm.edu			NCI NIH HHS [R01 CA100862, R01 CA092111, P30 CA118100, CA100862, CA92111] Funding Source: Medline; NCRR NIH HHS [S10 RR019287, P20 RR11830, S10 RR19287, 1 S10 RR14668, S10 RR016918] Funding Source: Medline; NHLBI NIH HHS [R01 HL093606, HL093606] Funding Source: Medline; NIDDK NIH HHS [T32 DK0075-20] Funding Source: Medline; NIGMS NIH HHS [R01 GM084020] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA092111, P30CA118100, R01CA100862] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR014668, P20RR011830, S10RR016918, S10RR019287] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084020] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baldwin E. L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P363, DOI 10.2174/1568011054222364; Beck BD, 2008, J BIOL CHEM, V283, P9023, DOI 10.1074/jbc.M800150200; Binaschi M., 2001, Current Medicinal Chemistry - Anti-Cancer Agents, V1, P113, DOI 10.2174/1568011013354723; Clarke DJ, 2000, BIOESSAYS, V22, P351, DOI 10.1002/(SICI)1521-1878(200004)22:4<351::AID-BIES5>3.0.CO;2-W; Clarke DJ, 2006, CELL CYCLE, V5, P1925, DOI 10.4161/cc.5.17.3200; Damelin M, 2007, BRIT J CANCER, V96, P201, DOI 10.1038/sj.bjc.6603537; Deming PB, 2002, J BIOL CHEM, V277, P36832, DOI 10.1074/jbc.M206109200; Deming PB, 2001, P NATL ACAD SCI USA, V98, P12044, DOI 10.1073/pnas.221430898; Doherty SC, 2003, J NATL CANCER I, V95, P1859, DOI 10.1093/jnci/djg120; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Felix CA, 2001, MED PEDIATR ONCOL, V36, P525, DOI 10.1002/mpo.1125; Garces CA, 2004, AM SURGEON, V70, P565; Hromas R, 2008, DNA REPAIR, V7, P1927, DOI 10.1016/j.dnarep.2008.08.002; ISHIDA R, 1991, CANCER RES, V51, P4909; Lee SH, 2005, P NATL ACAD SCI USA, V102, P18075, DOI 10.1073/pnas.0503676102; Mikhailov A, 2004, J CELL BIOL, V166, P517, DOI 10.1083/jcb.200405167; Nakagawa T, 2004, CANCER RES, V64, P4826, DOI 10.1158/0008-5472.CAN-04-0871; Richardson DS, 1997, BLOOD REV, V11, P201, DOI 10.1016/S0268-960X(97)90020-5; Roman Y, 2007, BIOCHEMISTRY-US, V46, P11369, DOI 10.1021/bi7005477; Skoufias DA, 2004, MOL CELL, V15, P977, DOI 10.1016/j.molcel.2004.08.018; Toyoda Y, 2006, MOL BIOL CELL, V17, P2287, DOI 10.1091/mbc.E05-11-1089; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Williamson EA, 2008, NUCLEIC ACIDS RES, V36, P5822, DOI 10.1093/nar/gkn560; Williamson EA, 2008, BIOCHIMIE, V90, P1422, DOI 10.1016/j.biochi.2008.05.010	24	39	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5323	10.1371/journal.pone.0005323	http://dx.doi.org/10.1371/journal.pone.0005323			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390626	Green Submitted, Green Published, gold			2022-12-25	WOS:000265514400011
J	Brea-Calvo, G; Siendones, E; Sanchez-Alcazar, JA; de Cabo, R; Navas, P				Brea-Calvo, Gloria; Siendones, Emilio; Sanchez-Alcazar, Jose A.; de Cabo, Rafael; Navas, Placido			Cell Survival from Chemotherapy Depends on NF-kappa B Transcriptional Up-Regulation of Coenzyme Q Biosynthesis	PLOS ONE			English	Article							ANTIOXIDANT SYSTEM; INDUCED APOPTOSIS; OXIDATIVE STRESS; RECEPTOR-ALPHA; CANCER-CELLS; GENE; EXPRESSION; CAMPTOTHECIN; DETOXIFICATION; ACTIVATION	Background: Coenzyme Q (CoQ) is a lipophilic antioxidant that is synthesized by a mitochondrial complex integrated by at least ten nuclear encoded COQ gene products. CoQ increases cell survival under different stress conditions, including mitochondrial DNA (mtDNA) depletion and treatment with cancer drugs such as camptothecin (CPT). We have previously demonstrated that CPT induces CoQ biosynthesis in mammal cells. Methodology/Principal Findings: CPT activates NF-kappa B that binds specifically to two kappa B binding sites present in the 5'-flanking region of the COQ7 gene. This binding is functional and induces both the COQ7 expression and CoQ biosynthesis. The inhibition of NF-kappa B activation increases cell death and decreases both, CoQ levels and COQ7 expression induced by CPT. In addition, using a cell line expressing very low of NF-kappa B, we demonstrate that CPT was incapable of enhancing enhance both CoQ biosynthesis and COQ7 expression in these cells. Conclusions/Significance: We demonstrate here, for the first time, that a transcriptional mechanism mediated by NF-kappa B regulates CoQ biosynthesis. This finding contributes new data for the understanding of the regulation of the CoQ biosynthesis pathway.			Brea-Calvo, G (corresponding author), Univ Pablo Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville, Spain.	pnavas@upo.es	de Cabo, Rafael/E-7996-2010; Brea-Calvo, Gloria/N-4728-2014; Sanchéz-Alcázar, José A. A/L-4925-2014; NAVAS, PLACIDO/R-5943-2019; de Cabo, Rafael Carlos/J-5230-2016; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael/0000-0003-2830-5693; Brea-Calvo, Gloria/0000-0001-5536-6868; Sanchéz-Alcázar, José A. A/0000-0001-9705-1469; NAVAS, PLACIDO/0000-0002-4115-7966; de Cabo, Rafael Carlos/0000-0003-2830-5693; de Cabo, Rafael/0000-0002-3354-2442; Siendones Castillo, Emilio/0000-0001-6006-563X	NATIONAL INSTITUTE ON AGING [ZIAAG000362, ZIAAG000368] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arroyo A, 2004, METHOD ENZYMOL, V378, P207; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Barroso MP, 1997, J BIOENERG BIOMEMBR, V29, P259, DOI 10.1023/A:1022462111175; Bentinger M, 2003, J MOL BIOL, V326, P795, DOI 10.1016/S0022-2836(02)01447-X; Brea-Calvo G, 2006, FREE RADICAL BIO MED, V40, P1293, DOI 10.1016/j.freeradbiomed.2005.11.014; De Cabo R, 2004, EXP GERONTOL, V39, P297, DOI 10.1016/j.exger.2003.12.003; Echtay KS, 2000, NATURE, V408, P609, DOI 10.1038/35046114; GomezDiaz C, 1997, BIOCHEM BIOPH RES CO, V234, P79, DOI 10.1006/bbrc.1997.6582; Gorman A, 1997, FEBS LETT, V404, P27, DOI 10.1016/S0014-5793(97)00069-0; Haddad JJ, 2004, BIOCHEM BIOPH RES CO, V316, P969, DOI 10.1016/j.bbrc.2004.02.162; Hiraoka W, 1998, J CLIN INVEST, V102, P1961, DOI 10.1172/JCI3437; HSIANG YH, 1988, CANCER RES, V48, P1722; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Huang TT, 2000, J BIOL CHEM, V275, P9501, DOI 10.1074/jbc.275.13.9501; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kawamukai M, 2002, J BIOSCI BIOENG, V94, P511, DOI 10.1016/S1389-1723(02)80188-8; Lopez-Martin JM, 2007, HUM MOL GENET, V16, P1091, DOI 10.1093/hmg/ddm058; Mates JM, 2000, INT J BIOCHEM CELL B, V32, P157, DOI 10.1016/S1357-2725(99)00088-6; Nakai D, 2001, BIOCHEM BIOPH RES CO, V289, P463, DOI 10.1006/bbrc.2001.5977; Navarro F, 1998, FASEB J, V12, P1665, DOI 10.1096/fasebj.12.15.1665; Navas P, 2007, MITOCHONDRION, V7, pS34, DOI 10.1016/j.mito.2007.02.010; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Ozben T, 2007, J PHARM SCI-US, V96, P2181, DOI 10.1002/jps.20874; PERKINS ND, 1994, MOL CELL BIOL, V14, P6570, DOI 10.1128/MCB.14.10.6570; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Piret B, 1996, NUCLEIC ACIDS RES, V24, P4242, DOI 10.1093/nar/24.21.4242; POMMIER Y, 2006, NATURE REV, V6, P802; Quinzii CM, 2007, NEUROCHEM RES, V32, P723, DOI 10.1007/s11064-006-9190-z; Reinhold WC, 2003, CANCER RES, V63, P1000; Sancho P, 2003, MOL PHARMACOL, V63, P581, DOI 10.1124/mol.63.3.581; Schoonbroodt S, 2000, J IMMUNOL, V164, P4292, DOI 10.4049/jimmunol.164.8.4292; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SCHUG J, 1997, COMPUTATIONAL BIOL I; Simizu S, 1998, J BIOL CHEM, V273, P26900, DOI 10.1074/jbc.273.41.26900; Somasundaram S, 2002, CANCER RES, V62, P3868; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Storz P, 2007, TRENDS CELL BIOL, V17, P13, DOI 10.1016/j.tcb.2006.11.003; Storz P, 2003, CELL CYCLE, V2, pA8, DOI 10.4161/cc.2.1.234; Teferedegne B, 2006, MOL CELL BIOL, V26, P5759, DOI 10.1128/MCB.00271-06; Timur M, 2005, ACTA BIOCHIM POL, V52, P897; Tomasetti M, 2001, FASEB J, V15, P1425, DOI 10.1096/fj.00-0694fje; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Turunen M, 2000, J MOL BIOL, V297, P607, DOI 10.1006/jmbi.2000.3596; TURUNEN M, 2004, BIOCHIM BIOPHYS ACTA, V1660, P177; Villalba JM, 2000, ANTIOXID REDOX SIGN, V2, P213, DOI 10.1089/ars.2000.2.2-213; Wenzel U, 2004, CARCINOGENESIS, V25, P703, DOI 10.1093/carcin/bgh079; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999; Xu Y, 2007, J BIOL CHEM, V282, P15981, DOI 10.1074/jbc.M608979200	50	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5301	10.1371/journal.pone.0005301	http://dx.doi.org/10.1371/journal.pone.0005301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390650	Green Published, Green Submitted, gold			2022-12-25	WOS:000265514200014
J	Ruggiero, T; Trabucchi, M; De Santa, F; Zupo, S; Harfe, BD; McManus, MT; Rosenfeld, MG; Briata, P; Gherzi, R				Ruggiero, Tina; Trabucchi, Michele; De Santa, Francesca; Zupo, Simona; Harfe, Brian D.; McManus, Michael T.; Rosenfeld, M. Geoff; Briata, Paola; Gherzi, Roberto			LPS induces KH-type splicing regulatory protein-dependent processing of microRNA-155 precursors in macrophages	FASEB JOURNAL			English	Article						RNA-binding protein; post-transcriptional regulation of gene expression; inflammation	AU-RICH ELEMENT; POSTTRANSCRIPTIONAL REGULATION; SIGNALING PATHWAYS; INNATE IMMUNITY; RNA; EXPRESSION; KSRP; INFLAMMATION; MECHANISMS; STABILITY	The importance of post-transcriptional mechanisms for the regulation of the homoeostasis of the immune system and the response to challenge by microorganisms is becoming increasingly appreciated. We investigated the contribution of microRNAs (miRNAs) to macrophage activation induced by lipopolysaccharide (LPS). We first observed that Dicer knockout in bone marrow-derived macrophages (BMDMs) increases the LPS-induced expression of some inflammation mediators. miRNA microarray analysis in BMDMs revealed that LPS significantly induces the expression of a single miRNA, miR-155, and this induction depends on enhanced miR-155 maturation from its precursors. The single-strand RNA-binding protein KH-type splicing regulatory protein (KSRP) binds to the terminal loop of miR-155 precursors and promotes their maturation. Both inhibition of miR-155 and KSRP knockdown enhance the LPS-induced expression of select inflammation mediators, and the effect of KSRP knockdown is reverted by mature miR-155. Our studies unveil the existence of an LPS-dependent post-transcriptional regulation of miR-155 biogenesis. Once induced, miR-155 finely tunes the expression of select inflammation mediators in response to LPS.-Ruggiero, T., Trabucchi, M., De Santa, F., Zupo, S., Harfe, B. D., McManus, M. T., Rosenfeld, M. G., Briata, P., Gherzi, R. LPS induces KH- type splicing regulatory protein-dependent processing of microRNA-155 precursors in macrophages. FASEB J. 23, 2898-2908 (2009). www.fasebj.org	[Ruggiero, Tina] Ctr Biotecnol Avanzate, RNA Technol Lab, Genoa, Italy; [Trabucchi, Michele; Rosenfeld, M. Geoff] Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92093 USA; [De Santa, Francesca] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Zupo, Simona; Briata, Paola; Gherzi, Roberto] Ist Nazl Ric Canc, I-16132 Genoa, Italy; [Harfe, Brian D.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [McManus, Michael T.] Univ Calif San Francisco, Dept Microbiol & Immunol, UCSF Diabet Ctr, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; IRCCS European Institute of Oncology (IEO); University of Genoa; IRCCS AOU San Martino IST; State University System of Florida; University of Florida; University of California System; University of California San Francisco	Briata, P (corresponding author), Natl Canc Inst IST, Gene Express Regulat Lab, Largo R Benzi 10, I-16132 Genoa, Italy.	paola.briata@istge.it; rgherzi@ucsd.edu	mcmanus, michael/AAB-1239-2020; De Santa, Francesca/A-2954-2014; Zupo, Simona/AAC-2757-2020; Trabucchi, Michele/O-1755-2018; Briata, Paola/AAC-6039-2020; DE SANTA, FRANCESCA/AAX-5810-2020; Gherzi, Roberto/AAA-7256-2020	mcmanus, michael/0000-0003-3013-6569; De Santa, Francesca/0000-0002-0034-5450; Zupo, Simona/0000-0001-6837-5763; Briata, Paola/0000-0003-3470-0454; DE SANTA, FRANCESCA/0000-0002-0034-5450; Gherzi, Roberto/0000-0001-8654-0611; Trabucchi, Michele/0000-0001-6885-5628	Centro Biotecnologie Avanzate fellowship; Italian Telethon Foundation fellowship; CIPE; Associazione Italiana per la Ricerca sul Cancro; Italian Istituto Superiore di Sanita (ISS) [527B/2B/6]; ISS [526D/39]	Centro Biotecnologie Avanzate fellowship; Italian Telethon Foundation fellowship(Fondazione Telethon); CIPE; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Istituto Superiore di Sanita (ISS); ISS	We are indebted to Dr. Gioacchino Natoli [European Institute of Oncology/FIRC Institute of Molecular Oncology Foundation (IEO/IFOM), Milan, Italy] and Dr. Antonio De Flora (University of Genova, Genoa, Italy) for helpful discussions and comments; Dr. G. Corte [Istituto Nazionale per la Ricerca sul Cancro (IST), Milan, Italy] for helpful discussions and for sharing lab facilities; and Dr. D. Shaffer (Bar Harbor BioTechnology, Trenton, ME, USA) for GPR analysis. T. R. is the recipient of a Centro Biotecnologie Avanzate fellowship [Interministerial Committee for Economic Planning (CIPE) 2007]. M. T. is the recipient of an Italian Telethon Foundation fellowship. The work of R. G. has been supported, in part, by CIPE 2007 (Regione Liguria), Associazione Italiana per la Ricerca sul Cancro, and the Italian Istituto Superiore di Sanita (ISS) (527B/2B/6). The work of P.B. has been supported, in part, by a grant from ISS (526D/39).	Akilesh S, 2003, GENOME RES, V13, P1719, DOI 10.1101/gr.533003; Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Allam R, 2008, CURR OPIN RHEUMATOL, V20, P538, DOI 10.1097/BOR.0b013e3283025ed4; Anderson P, 2004, J LEUKOCYTE BIOL, V76, P42, DOI 10.1189/jlb.1103536; Banerjee A, 2007, IMMUNOL CELL BIOL, V85, P420, DOI 10.1038/sj.icb.7100098; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Briata P, 2005, MOL CELL, V20, P891, DOI 10.1016/j.molcel.2005.10.021; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chen CY, 2000, GENE DEV, V14, P1236; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Frevel MAE, 2003, MOL CELL BIOL, V23, P425, DOI 10.1128/MCB.23.2.425-436.2003; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Gherzi R, 2007, PLOS BIOL, V5, P82, DOI 10.1371/journal.pbio.0050005; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harris J, 2006, J IMMUNOL, V177, P2527, DOI 10.4049/jimmunol.177.4.2527; Hong JA, 2004, J IMMUNOL, V172, P5870, DOI 10.4049/jimmunol.172.10.5870; Hume David A, 2007, Novartis Found Symp, V281, P2; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kluiver J, 2007, ONCOGENE, V26, P3769, DOI 10.1038/sj.onc.1210147; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Lu F, 2008, J VIROL, V82, P10436, DOI 10.1128/JVI.00752-08; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Papadimitraki ED, 2007, J AUTOIMMUN, V29, P310, DOI 10.1016/j.jaut.2007.09.001; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07	41	169	181	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					2898	2908		10.1096/fj.09-131342	http://dx.doi.org/10.1096/fj.09-131342			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19423639				2022-12-25	WOS:000270241000013
J	Fu, QS; Zhou, CJ; Gao, HC; Jiang, YJ; Zhou, ZR; Hong, J; Yao, WM; Song, AX; Lin, DH; Hu, HY				Fu, Qing-Shan; Zhou, Chen-Jie; Gao, Hong-Chang; Jiang, Ya-Jun; Zhou, Zi-Ren; Hong, Jing; Yao, Wen-Ming; Song, Ai-Xin; Lin, Dong-Hai; Hu, Hong-Yu			Structural Basis for Ubiquitin Recognition by a Novel Domain from Human Phospholipase A(2)-activating Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERACTING MOTIF; CHEMICAL-SHIFT; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; BINDING DOMAINS; COMPLEX REVEALS; PROTEASOME; ERAD; NMR; S5A	Ubiquitin (Ub) is an essential modifier conserved in all eukaryotes from yeast to human. Phospholipase A(2)-activating protein (PLAA), a mammalian homolog of yeast DOA1/UFD3, has been proposed to be able to bind with Ub, which plays important roles in endoplasmic reticulum-associated degradation, vesicle formation, and DNA damage response. We have identified a core domain from the PLAA family ubiquitin-binding region of human PLAA (residues 386-465, namely PFUC) that can bind Ub and elucidated its solution structure and Ub-binding mode by NMR approaches. The PFUC domain possesses equal population of two conformers in solution by cis/trans-isomerization, whereas the two isomers exhibit almost equivalent Ub binding abilities. This domain structure takes a novel fold consisting of four beta-strands and two alpha-helices, and the Ub-binding site on PFUC locates in the surface of alpha 2-helix, which is to some extent analogous to those of UBA, CUE, and UIM domains. This study provides structural basis and biochemical information for Ub recognition of the novel PFU domain from a PLAA family protein that may connect ubiquitination and degradation in endoplasmic reticulum-associated degradation.	[Gao, Hong-Chang; Hong, Jing; Yao, Wen-Ming; Lin, Dong-Hai] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, Shanghai 201203, Peoples R China; [Fu, Qing-Shan; Zhou, Chen-Jie; Jiang, Ya-Jun; Zhou, Zi-Ren; Song, Ai-Xin; Hu, Hong-Yu] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Fu, Qing-Shan; Jiang, Ya-Jun; Zhou, Zi-Ren] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Lin, DH (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, Shanghai 201203, Peoples R China.	dhlin@mail.shcnc.ac.cn; hyhu@sibs.ac.cn	Jiang, Yajun/AAE-7853-2020; Chou, Steven Ziren/M-1995-2014; Fu, Qingshan/E-8083-2015; Hu, Hong-Yu/AAQ-2633-2020; Fu, Qingshan/E-1405-2015	Fu, Qingshan/0000-0002-7445-2355; Jiang, Yajun/0000-0002-0886-292X	National Basic Research Program of China [2006CB910305, 2006CB806508, 2007CB914304]; National Natural Science Foundation of China [30600103, 30670431]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2006CB910305, 2006CB806508, and 2007CB914304 and National Natural Science Foundation of China Grants 30600103 and 30670431.	Alam SL, 2006, NAT STRUCT MOL BIOL, V13, P1029, DOI 10.1038/nsmb1160; Bao WJ, 2006, PROTEIN EXPRES PURIF, V47, P599, DOI 10.1016/j.pep.2005.11.021; Berke SJS, 2005, J BIOL CHEM, V280, P32026, DOI 10.1074/jbc.M506084200; Chang YG, 2006, PROTEIN SCI, V15, P1248, DOI 10.1110/ps.051995006; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Decottignies A, 2004, YEAST, V21, P127, DOI 10.1002/yea.1071; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; Fujiwara K, 2004, J BIOL CHEM, V279, P4760, DOI 10.1074/jbc.M309448200; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P272, DOI 10.1038/nsmb1051; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Hu HY, 2004, J BIOL CHEM, V279, P39736, DOI 10.1074/jbc.M402842200; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; Lis ET, 2006, MOL CELL BIOL, V26, P4122, DOI 10.1128/MCB.01640-05; Lord JM, 2005, CURR BIOL, V15, pR963, DOI 10.1016/j.cub.2005.11.013; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mullally JE, 2006, MOL CELL BIOL, V26, P822, DOI 10.1128/MCB.26.3.822-830.2006; Osipiuk J, 2001, ACTA CRYSTALLOGR D, V57, P1747, DOI 10.1107/S0907444901014019; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Ren JH, 2008, J BIOL CHEM, V283, P21599, DOI 10.1074/jbc.M802982200; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Romisch K, 2005, TRAFFIC, V6, P706, DOI 10.1111/j.1600-0854.2005.00310.x; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Russell NS, 2004, BIOCHEMISTRY-US, V43, P4844, DOI 10.1021/bi035626r; Ryu KS, 2003, J BIOL CHEM, V278, P36621, DOI 10.1074/jbc.M304628200; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Shen LN, 2005, EMBO J, V24, P1341, DOI 10.1038/sj.emboj.7600628; Souphron J, 2008, BIOCHEMISTRY-US, V47, P8961, DOI 10.1021/bi800604c; Swanson KA, 2003, EMBO J, V22, P4597, DOI 10.1093/emboj/cdg471; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Whitby FG, 1998, J BIOL CHEM, V273, P34983, DOI 10.1074/jbc.273.52.34983	41	17	18	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					19043	19052		10.1074/jbc.M109.009126	http://dx.doi.org/10.1074/jbc.M109.009126			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19423704	Green Published, hybrid			2022-12-25	WOS:000267711500053
J	Johnsen, IB; Nguyen, TT; Bergstroem, B; Fitzgerald, KA; Anthonsen, MW				Johnsen, Ingvild B.; Nguyen, Thuy Thanh; Bergstroem, Bjarte; Fitzgerald, Katherine A.; Anthonsen, Marit W.			The Tyrosine Kinase c-Src Enhances RIG-I (Retinoic Acid-inducible Gene I)-elicited Antiviral Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; FAMILY KINASES; RECEPTOR; PHOSPHORYLATION; TRAF3; RESPONSES; PROTEIN; VIRUS; DNA; UBIQUITINATION	Antiviral immune responses are initiated through Toll-like receptors (TLRs) and RIG-I (retinoic acid-inducible gene-I)-like RNA helicases that recognize nucleic acids from distinct viruses. In this study, we show that the tyrosine kinase c-Src participates in antiviral responses induced by the cytoplasmic RNA helicase RIG-I. Sendai virus (SV), which is recognized by RIG-I, induced c-Src phosphorylation. Functional impairment of c-Src through chemical inhibition or transient expression of a c-Src kinase-inactive mutant attenuated production of endogenous antiviral proteins after SV infection or after expression of RIG-I or its adapter protein MAVS. Importantly, SV-stimulated synthesis of antiviral proteins was significantly impaired in cells treated with c-Src small interfering RNA and in cells from c-Src-deficient mice. In addition, we found that c-Src interacted with components of the RIG-I pathway: RIG-I, MAVS, and TRAF3 (tumor necrosis factor receptor-associated factor-3). The interaction between c-Src and TRAF3 was found to occur within the RING domain of TRAF3. Taken together, our results suggest that c-Src enhances RIG-I-mediated signaling, acting at the level of TRAF3.	[Johnsen, Ingvild B.; Nguyen, Thuy Thanh; Bergstroem, Bjarte; Anthonsen, Marit W.] Norwegian Univ Sci & Technol, Fac Med, Childrens & Womens Hlth, Dept Lab Med, N-7006 Trondheim, Norway; [Bergstroem, Bjarte] Sor Trondelag Univ Coll, Fac Med Technol & Food Sci, N-7004 Trondheim, Norway; [Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Massachusetts System; University of Massachusetts Worcester	Anthonsen, MW (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Childrens & Womens Hlth, Dept Lab Med, N-7006 Trondheim, Norway.	Marit.W.Anthonsen@ntnu.no	Bergstrøm, Bjarte/H-8159-2016; Fitzgerald, Katherine/ABE-6317-2020	Bergstrøm, Bjarte/0000-0002-5042-6697; Fitzgerald, Kate/0000-0003-3175-609X; Bjellmo Johnsen, Ingvild/0000-0002-3520-6776	National Programme for Research in Functional Genomics in Norway (FUGE); FUGE Mid-Norway; Research Council of Norway; Faculty of Medicine, Norwegian University of Science and Technology; Cancer Fund at St. Olavs Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067497] Funding Source: NIH RePORTER	National Programme for Research in Functional Genomics in Norway (FUGE)(Research Council of Norway); FUGE Mid-Norway; Research Council of Norway(Research Council of Norway); Faculty of Medicine, Norwegian University of Science and Technology; Cancer Fund at St. Olavs Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Programme for Research in Functional Genomics in Norway (FUGE) (to M. W. A.), FUGE Mid-Norway (to M. W. A.), the Research Council of Norway (to M. W. A.), the Faculty of Medicine, Norwegian University of Science and Technology (to I. B. J. and M. W. A.), and the Cancer Fund at St. Olavs Hospital (to M. W. A.). at ISI, Thomson Scientific on July 7, 2009 www. jbc. org Downloaded from	Cai WJ, 2006, P NATL ACAD SCI USA, V103, P13801, DOI 10.1073/pnas.0600362103; Clement JF, 2008, J VIROL, V82, P3984, DOI 10.1128/JVI.02526-07; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Force WR, 1997, J BIOL CHEM, V272, P30835, DOI 10.1074/jbc.272.49.30835; Gao M, 2005, MOL CELL, V19, P581, DOI 10.1016/j.molcel.2005.08.017; Gatot JS, 2007, J BIOL CHEM, V282, P31131, DOI 10.1074/jbc.M701690200; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Ryzhakov G, 2007, EMBO J, V26, P3180, DOI 10.1038/sj.emboj.7601743; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Schneider K, 2006, NAT IMMUNOL, V7, P15, DOI 10.1038/ni0106-15; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Wagner AM, 2003, COMPARATIVE MED, V53, P173; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	36	27	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					19122	19131		10.1074/jbc.M808233200	http://dx.doi.org/10.1074/jbc.M808233200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19419966	hybrid, Green Published			2022-12-25	WOS:000267711500060
J	Bryan, KE; Rubenstein, PA				Bryan, Keith E.; Rubenstein, Peter A.			Allele-specific Effects of Human Deafness gamma-Actin Mutations (DFNA20/26) on the Actin/Cofilin Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUDITORY HAIR-CELLS; F-ACTIN; YEAST ACTIN; FILAMENT DYNAMICS; BINDING PROTEINS; LATERAL CONTACTS; CUTICULAR PLATE; RATE CONSTANTS; ADP-ACTIN; COFILIN	Auditory hair cell function requires proper assembly and regulation of the nonmuscle gamma isoactin-rich cytoskeleton, and six point mutations in this isoactin cause a type of delayed onset autosomal dominant nonsyndromic progressive hearing loss, DFNA20/26. The molecular basis underlying this actin-dependent hearing loss is unknown. To address this problem, the mutations have been introduced into yeast actin, and their effects on actin function were assessed in vivo and in vitro. Because we previously showed that polymerization was unaffected in five of the six mutants, we have focused on proteins that regulate actin, in particular cofilin, which severs F-actin and sequesters actin monomers. The mutations do not affect the interaction of cofilin with G-actin. However, T89I and V370A mutant F-actins are much more susceptible to cofilin disassembly than WT filaments in vitro. Conversely, P332A filaments demonstrate enhanced resistance. Wild type actin solutions containing T89I, K118M, or P332A mutant actins at mole fractions similar to those found in the hair cell respond in vitro toward cofilin in a manner proportional to the level of the mutant present. Finally, depression of cofilin action in vivo by elimination of the cofilin-activating protein, Aip1p, rescues the inability to grow on glycerol caused by K118M, T278I, P332A, and V370A. These results suggest that a filament instability caused by these mutations can be balanced by decreasing a system in vivo that promotes increased filament turnover. Such mutant-dependent filament destabilization could easily result in hair cell malfunction leading to the late-onset hearing loss observed in these patients.	[Bryan, Keith E.; Rubenstein, Peter A.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Rubenstein, PA (corresponding author), Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA.	peter-rubenstein@uiowa.edu		Rubenstein, Peter/0000-0003-1225-4414	National Institutes of Health [DC008803]; National Research Service Award Predoctoral Fellowship [F31DC008913]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R55DC008803, R01DC008803, F31DC008913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant DC008803 ( from the NIDCD; to P. A. R.) and National Research Service Award Predoctoral Fellowship F31DC008913 ( from the NIDCD; to K. E. B.).	ADAMS SB, 1994, BIOCHEMISTRY-US, V33, P14426, DOI 10.1021/bi00252a008; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Blanchoin L, 1998, J BIOL CHEM, V273, P25106, DOI 10.1074/jbc.273.39.25106; Bobkov AA, 2004, J MOL BIOL, V337, P93, DOI 10.1016/j.jmb.2004.01.014; Bryan KE, 2005, J BIOL CHEM, V280, P1696, DOI 10.1074/jbc.M410180200; Bryan KE, 2006, J BIOL CHEM, V281, P20129, DOI 10.1074/jbc.M601514200; Carlier MF, 1999, J BIOL CHEM, V274, P33827, DOI 10.1074/jbc.274.48.33827; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chen H, 2000, TRENDS BIOCHEM SCI, V25, P19, DOI 10.1016/S0968-0004(99)01511-X; COOK RK, 1992, PRACTICAL APPROACHES, P99; Costa CF, 2004, J CELL SCI, V117, P3367, DOI 10.1242/jcs.01172; DalleDonne I, 1998, BIOCHEM CELL BIOL, V76, P583, DOI 10.1139/bcb-76-4-583; DEROSIER DJ, 1989, J CELL BIOL, V109, P2853, DOI 10.1083/jcb.109.6.2853; DesMarais V, 2005, J CELL SCI, V118, P19, DOI 10.1242/jcs.01631; DRENCKHAHN D, 1991, J CELL BIOL, V112, P641, DOI 10.1083/jcb.112.4.641; Feng L, 1997, J BIOL CHEM, V272, P16829, DOI 10.1074/jbc.272.27.16829; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; Furness DN, 2005, HEARING RES, V207, P22, DOI 10.1016/j.heares.2005.05.006; Galkin VE, 2003, J CELL BIOL, V163, P1057, DOI 10.1083/jcb.200308144; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; Hofer D, 1997, J CELL SCI, V110, P765; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Iida K, 1999, GENES CELLS, V4, P21, DOI 10.1046/j.1365-2443.1999.00235.x; KAISER C, 1994, METHODS YEAST GENETI, P133; Kim E, 1996, BIOCHEMISTRY-US, V35, P16566, DOI 10.1021/bi9623892; Kudryashov DS, 2006, J MOL BIOL, V358, P785, DOI 10.1016/j.jmb.2006.02.029; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; MACIVER SK, 1994, FEBS LETT, V347, P251, DOI 10.1016/0014-5793(94)00552-4; McGough A, 1999, J MOL BIOL, V291, P513, DOI 10.1006/jmbi.1999.2968; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; McKane M, 2006, J BIOL CHEM, V281, P29916, DOI 10.1074/jbc.M602251200; MOON AL, 1993, J CELL BIOL, V120, P421, DOI 10.1083/jcb.120.2.421; MOORE PB, 1970, J MOL BIOL, V50, P279, DOI 10.1016/0022-2836(70)90192-0; Muller U, 2001, TRENDS CELL BIOL, V11, P334, DOI 10.1016/S0962-8924(01)02046-3; Okada K, 1999, J CELL SCI, V112, P1553; Paavilainen VO, 2004, TRENDS CELL BIOL, V14, P386, DOI 10.1016/j.tcb.2004.05.002; Page R, 1998, J MOL BIOL, V280, P463, DOI 10.1006/jmbi.1998.1879; Pavlov D, 2007, J MOL BIOL, V365, P1350, DOI 10.1016/j.jmb.2006.10.102; Pavlov D, 2006, CELL MOTIL CYTOSKEL, V63, P533, DOI 10.1002/cm.20142; POLLARD TD, 1981, J CELL BIOL, V88, P654, DOI 10.1083/jcb.88.3.654; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Prochniewicz E, 2005, J MOL BIOL, V353, P990, DOI 10.1016/j.jmb.2005.09.021; Rendtorff ND, 2006, EUR J HUM GENET, V14, P1097, DOI 10.1038/sj.ejhg.5201670; Renoult C, 1999, J BIOL CHEM, V274, P28893, DOI 10.1074/jbc.274.41.28893; Ressad F, 1998, J BIOL CHEM, V273, P20894, DOI 10.1074/jbc.273.33.20894; Rodal AA, 1999, J CELL BIOL, V145, P1251, DOI 10.1083/jcb.145.6.1251; RUBENSTEIN PA, 1990, BIOESSAYS, V12, P309, DOI 10.1002/bies.950120702; Stokasimov E, 2008, J BIOL CHEM, V283, P34844, DOI 10.1074/jbc.M804419200; STRZELECKAGOLASZEWSKA H, 1995, BIOCHEM J, V307, P527, DOI 10.1042/bj3070527; TILNEY LG, 1980, J CELL BIOL, V86, P244, DOI 10.1083/jcb.86.1.244; TILNEY LG, 1983, J CELL BIOL, V96, P822, DOI 10.1083/jcb.96.3.822; van Wijk E, 2003, J MED GENET, V40, P879, DOI 10.1136/jmg.40.12.879; Vartiainen MK, 2002, MOL BIOL CELL, V13, P183, DOI 10.1091/mbc.01-07-0331; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; Wen KK, 2005, J BIOL CHEM, V280, P24168, DOI 10.1074/jbc.M502024200; Wen KK, 2003, J BIOL CHEM, V278, P48386, DOI 10.1074/jbc.M308980200; Wen KK, 2008, J BIOL CHEM, V283, P9444, DOI 10.1074/jbc.M709806200; YONEZAWA N, 1985, J BIOL CHEM, V260, P4410; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286	63	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18260	18269		10.1074/jbc.M109.015818	http://dx.doi.org/10.1074/jbc.M109.015818			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19419963	Green Published, hybrid			2022-12-25	WOS:000267712400039
J	Voehler, MW; Eoff, RL; McDonald, WH; Guengerich, FP; Stone, MP				Voehler, Markus W.; Eoff, Robert L.; McDonald, W. Hayes; Guengerich, F. Peter; Stone, Michael P.			Modulation of the Structure, Catalytic Activity, and Fidelity of African Swine Fever Virus DNA Polymerase X by a Reversible Disulfide Switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-RESONANCE NMR; BASE-EXCISION-REPAIR; VIRAL-DNA; QUANTITATIVE-ANALYSIS; SUBSTRATE-SPECIFICITY; IMPROVED SENSITIVITY; FUNCTIONAL STRUCTURE; CHEMICAL-SHIFTS; CELL-CULTURES; ERROR-PRONE	African swine fever virus polymerase X (pol X) is the smallest DNA polymerase known (174 amino acids), and its tertiary structure resembles the C-terminal half of prototypical X-family pol beta, which includes a catalytic dNTP-binding site (palm domain) and a finger domain. This structural similarity and the presence of viral genes coding for other base excision repair proteins suggest that pol X functions in a manner similar to pol beta, but inconsistencies concerning pol X catalysis have been reported. We examined the structural and functional properties of two forms of pol X using spectroscopic and kinetic analysis. Using H-1-N-15 correlated NMR, we unambiguously demonstrated the slow interconversion of pol X between a reduced (pol X-red) and an oxidized form (pol X-ox), confirmed by mass spectrometry. Steady-state kinetic analysis revealed that pol X-ox, with a disulfide bond between Cys-81 and Cys-86, has similar to 10-fold lower fidelity than pol X-red during dNTP insertion opposite a template G. The disulfide linkage is located between two beta-strands in the palm domain, near the putative dNTP-binding site. Structural alignment of pol X with a pol beta ternary structure suggests that the disulfide switch may modulate fidelity by altering the ability of the palm domain to align and stabilize the primer terminus and catalytic metal ion for deprotonation of the 3'-OH group and subsequent phosphoryl transfer. Thus, DNA polymerase fidelity is altered by the redox state of the enzyme and its related conformational changes.	[Eoff, Robert L.; Guengerich, F. Peter; Stone, Michael P.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Eoff, Robert L.; Guengerich, F. Peter; Stone, Michael P.] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA; [Voehler, Markus W.; Stone, Michael P.] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA; [Voehler, Markus W.; Stone, Michael P.] Vanderbilt Univ, Ctr Mol Toxicol, Nashville, TN 37235 USA; [McDonald, W. Hayes] Vanderbilt Univ, Mass Spectrometry Res Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu	McDonald, W. Hayes/B-4109-2016	McDonald, W. Hayes/0000-0002-3510-426X; Stone, Michael/0000-0002-0922-0216	National Institutes of Health [R01 CA055678, R01 ES010375, F32 CA119776, P30 ES000267]; USPHS; Vanderbilt Centers for Structural Biology and Mass Spectrometry; NATIONAL CANCER INSTITUTE [F32CA119776, R01CA055678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, R01ES010375] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Vanderbilt Centers for Structural Biology and Mass Spectrometry; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA055678 (to M. P. S.), R01 ES010375 (to F. P. G.), F32 CA119776 (to R. L. E.), and P30 ES000267 (to M. W. V., F. P. G., and M. P. S.) from the USPHS. This work was also supported by Vanderbilt Centers for Structural Biology and Mass Spectrometry.	ALCAMI A, 1989, VIROLOGY, V171, P68, DOI 10.1016/0042-6822(89)90511-4; Andres G, 2002, J VIROL, V76, P2654, DOI 10.1128/JVI.76.6.2654-2666.2002; Andres G, 1997, J VIROL, V71, P2331; Andres G, 2001, J BIOL CHEM, V276, P780, DOI 10.1074/jbc.M006844200; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Bernardes C, 1995, BIOCHEM MOL BIOL INT, V37, P481; BLASCO R, 1989, VIROLOGY, V173, P251, DOI 10.1016/0042-6822(89)90241-9; BREESE SS, 1978, J GEN VIROL, V40, P499, DOI 10.1099/0022-1317-40-2-499; Brookes SM, 1998, VIROLOGY, V249, P175, DOI 10.1006/viro.1998.9308; Brookes SM, 1996, VIROLOGY, V224, P84, DOI 10.1006/viro.1996.0509; CARRASCOSA AL, 1985, J VIROL, V54, P337, DOI 10.1128/JVI.54.2.337-344.1985; CARRASCOSA JL, 1986, J VIROL, V58, P377, DOI 10.1128/JVI.58.2.377-384.1986; CHANG HW, 1980, ANAL BIOCHEM, V104, P112, DOI 10.1016/0003-2697(80)90283-3; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; CLUBB RT, 1992, J MAGN RESON, V97, P213, DOI 10.1016/0022-2364(92)90252-3; Cobbold C, 2007, J GEN VIROL, V88, P77, DOI 10.1099/vir.0.82257-0; CORTES HJ, 1987, J HIGH RES CHROMATOG, V10, P446, DOI 10.1002/jhrc.1240100805; DATE T, 1990, BIOCHEMISTRY-US, V29, P5027, DOI 10.1021/bi00473a005; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delarue M, 2002, EMBO J, V21, P427, DOI 10.1093/emboj/21.3.427; Dixon L.K., 2000, VIRUS TAXONOMY; Dixon LK, 2004, VET IMMUNOL IMMUNOP, V100, P117, DOI 10.1016/j.vetimm.2004.04.002; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; ENJUANES L, 1977, J GEN VIROL, V34, P455, DOI 10.1099/0022-1317-34-3-455; Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Garcia-Diaz M, 2004, MOL CELL, V13, P561, DOI 10.1016/S1097-2765(04)00061-9; Garcia-Escudero R, 2003, J MOL BIOL, V326, P1403, DOI 10.1016/S0022-2836(03)00019-6; GARCIABEATO R, 1992, VIROLOGY, V188, P637, DOI 10.1016/0042-6822(92)90518-T; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Hajduk PJ, 1997, J MED CHEM, V40, P3144, DOI 10.1021/jm9703404; Hernaez B, 2006, VIROLOGY, V350, P1, DOI 10.1016/j.virol.2006.01.021; Jezewska MJ, 2007, BIOCHEMISTRY-US, V46, P12909, DOI 10.1021/bi700677j; Jezewska MJ, 2007, J MOL BIOL, V373, P75, DOI 10.1016/j.jmb.2007.06.054; Jezewska MJ, 2006, J MOL BIOL, V356, P121, DOI 10.1016/j.jmb.2005.10.061; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnson PE, 1996, BIOCHEMISTRY-US, V35, P13895, DOI 10.1021/bi961186a; Jouvenet N, 2006, CELL MICROBIOL, V8, P1803, DOI 10.1111/j.1462-5822.2006.00750.x; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kraynov VS, 2000, BIOCHEMISTRY-US, V39, P16008, DOI 10.1021/bi0008480; Kumar S, 2008, BIOCHEMISTRY-US, V47, P7875, DOI 10.1021/bi800731m; Lamarche BJ, 2005, BIOCHEMISTRY-US, V44, P8408, DOI 10.1021/bi047706g; Lamarche BJ, 2006, BIOCHEMISTRY-US, V45, P14826, DOI 10.1021/bi0613325; Maciejewski MW, 2001, NAT STRUCT BIOL, V8, P936, DOI 10.1038/nsb1101-936; Maciejewski MW, 2001, J BIOMOL NMR, V21, P177, DOI 10.1023/A:1012426928104; MARION D, 1989, J MAGN RESON, V84, P425, DOI 10.1016/0022-2364(89)90391-0; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; MONTGOMERY R. Eustace, 1921, Journal of Comparative Pathology and Therapeutics, V34, P243; Moon AF, 2007, NAT STRUCT MOL BIOL, V14, P45, DOI 10.1038/nsmb1180; MOULTON J, 1968, AM J VET RES, V29, P219; MOURANUNES JF, 1975, ARCH VIROL, V49, P59, DOI 10.1007/BF02175596; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; NEWTON AC, 2003, PROTEIN KINASE C PRO; Oliveros M, 1997, J BIOL CHEM, V272, P30899, DOI 10.1074/jbc.272.49.30899; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; PAN IC, 1980, AM J VET RES, V41, P1357; Peng C, 2004, J BIOMOL NMR, V29, P491, DOI 10.1023/B:JNMR.0000034351.37982.9e; Piersen CE, 1996, J BIOL CHEM, V271, P17811, DOI 10.1074/jbc.271.30.17811; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Ren B, 2009, J BIOL CHEM, V284, P4829, DOI 10.1074/jbc.M807943200; Rojo G, 1999, VIROLOGY, V257, P524, DOI 10.1006/viro.1999.9704; Ross A, 2000, J BIOMOL NMR, V16, P139, DOI 10.1023/A:1008394910612; Rouiller I, 1998, J VIROL, V72, P2373, DOI 10.1128/JVI.72.3.2373-2387.1998; Salas M.L., 1999, ENCY VIROLOGY, P30; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Showalter AK, 2001, NAT STRUCT BIOL, V8, P942, DOI 10.1038/nsb1101-942; Showalter AK, 2001, J AM CHEM SOC, V123, P1776, DOI 10.1021/ja005758x; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Vallee I, 2001, J VIROL, V75, P10372, DOI 10.1128/JVI.75.21.10372-10382.2001; Voehler MW, 2006, J MAGN RESON, V183, P102, DOI 10.1016/j.jmr.2006.08.002; Walowsky C, 1999, J BIOL CHEM, V274, P7302, DOI 10.1074/jbc.274.11.7302; Wang ZH, 2002, GENETICS, V160, P381; WEBER DJ, 1992, PROTEINS, V13, P275, DOI 10.1002/prot.340130402; Wilson SH, 1998, MUTAT RES-DNA REPAIR, V407, P203, DOI 10.1016/S0921-8777(98)00002-0; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005; YANEZ RJ, 1995, VIROLOGY, V208, P249, DOI 10.1006/viro.1995.1149	86	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18434	18444		10.1074/jbc.M109.012542	http://dx.doi.org/10.1074/jbc.M109.012542			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19419958	hybrid, Green Published			2022-12-25	WOS:000267712400055
J	Choi, K; Ahn, YH; Gibbons, DL; Tran, HT; Creighton, CJ; Girard, L; Minna, JD; Qin, FXF; Kurie, JM				Choi, Kuicheon; Ahn, Young-Ho; Gibbons, Don L.; Tran, Hai T.; Creighton, Chad J.; Girard, Luc; Minna, John D.; Qin, F. Xiao-Feng; Kurie, Jonathan M.			Distinct Biological Roles for the Notch Ligands Jagged-1 and Jagged-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; HUMAN LUNG CANCERS; NUCLEAR TRANSLOCATION; MICROARRAY DATA; CELL; PROTEIN; ACTIVATION; GENE; IDENTIFICATION; INHIBITOR	Notch signaling is activated in a subset of non-small cell lung cancer cells because of overexpression of Notch3, but the role of Notch ligands has not been fully defined. On the basis of gene expression profiling of a panel of non-small cell lung cancer cell lines, we found that the predominant Notch ligands were JAG1, JAG2, DLL1, and DLL3. Given that Notch ligands reportedly have overlapping receptor binding specificities, we postulated that they have redundant biological roles. Arguing against this hypothesis, we found that JAG1 and JAG2 were differentially regulated; JAG1 expression was dependent upon epidermal growth factor receptor (EGFR) activation in HCC827 cells, which require EGFR for survival, whereas JAG2 expression was EGFR-independent in these cells. Furthermore, HCC827 cells underwent apoptosis following depletion of JAG1 but not JAG2, whereas co-culture experiments revealed that depletion of JAG2, but not JAG1, enhanced the ability of HCC827 cells to chemoattract THP-1 human monocytes. JAG2-depleted HCC827 cells expressed high levels of inflammation-related genes, including interleukin 1 (IL1) and a broad range of IL1-regulated cytokines, which was attenuated by inhibition of IL1 receptor (IL1R). Our findings suggest that JAG1 and JAG2 have distinct biological roles including a previously undiscovered role for JAG2 in regulating the expression of cytokines that can promote antitumor immunity.	[Kurie, Jonathan M.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Girard, Luc; Minna, John D.] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Qin, F. Xiao-Feng] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center	Kurie, JM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jkurie@mdanderson.org		QIN, FRANK XIAOFENG/0000-0002-5395-0304; Tran, Hai/0000-0003-4065-9355	National Institutes of Health [P50 CA70907, CA117965]; NATIONAL CANCER INSTITUTE [R01CA117965, P50CA070907] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 CA70907 and CA117965 (to J. M. K.).	Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Ascano JM, 2003, J BIOL CHEM, V278, P8771, DOI 10.1074/jbc.M211427200; Collins BJ, 2004, SEMIN CANCER BIOL, V14, P357, DOI 10.1016/j.semcancer.2004.04.015; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; Dang TP, 2000, J NATL CANCER I, V92, P1355, DOI 10.1093/jnci/92.16.1355; Ding LH, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn234; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fiuza UM, 2007, J ENDOCRINOL, V194, P459, DOI 10.1677/JOE-07-0242; Fujimoto N, 2005, CANCER RES, V65, P11478, DOI 10.1158/0008-5472.CAN-05-1977; Gallahan D, 1997, ONCOGENE, V14, P1883, DOI 10.1038/sj.onc.1201035; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Gray GE, 1999, AM J PATHOL, V154, P785, DOI 10.1016/S0002-9440(10)65325-4; Haruki N, 2005, CANCER RES, V65, P3555, DOI 10.1158/0008-5472.CAN-04-3132; Hsueh YP, 2000, NATURE, V404, P298, DOI 10.1038/35005118; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; Lee JH, 2005, J ENDOCRINOL, V187, P283, DOI 10.1677/joe.1.06305; LIAO Z, 1984, J EXP MED, V159, P126, DOI 10.1084/jem.159.1.126; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Mizuhara E, 2005, J BIOL CHEM, V280, P26499, DOI 10.1074/jbc.M500375200; Nakata A, 2004, GENES CELLS, V9, P1125, DOI 10.1111/j.1365-2443.2004.00795.x; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pfister S, 2003, J MOL BIOL, V333, P229, DOI 10.1016/j.jmb.2003.08.043; Pintar A, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-19; Quilliam LA, 1999, J BIOL CHEM, V274, P23850, DOI 10.1074/jbc.274.34.23850; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Rohn JL, 1996, J VIROL, V70, P8071, DOI 10.1128/JVI.70.11.8071-8080.1996; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shimizu K, 2000, MOL CELL BIOL, V20, P6913, DOI 10.1128/MCB.20.18.6913-6922.2000; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Shoji H, 2000, J BIOL CHEM, V275, P5485, DOI 10.1074/jbc.275.8.5485; Six EM, 2004, J BIOL CHEM, V279, P55818, DOI 10.1074/jbc.M408022200; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Weijzen S, 2002, NAT MED, V8, P979, DOI 10.1038/nm754; Wislez M, 2007, CLIN CANCER RES, V13, P3518, DOI 10.1158/1078-0432.CCR-06-2558; Wright GJ, 2004, DEVELOPMENT, V131, P5659, DOI 10.1242/dev.01417; Zayzafoon M, 2004, J BIOL CHEM, V279, P3662, DOI 10.1074/jbc.M308158200	41	43	47	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17766	17774		10.1074/jbc.M109.003111	http://dx.doi.org/10.1074/jbc.M109.003111			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19398556	hybrid, Green Published			2022-12-25	WOS:000267202500042
J	Ehira, S; Ogino, H; Teramoto, H; Inui, M; Yukawa, H				Ehira, Shigeki; Ogino, Hidetaka; Teramoto, Haruhiko; Inui, Masayuki; Yukawa, Hideaki			Regulation of Quinone Oxidoreductase by the Redox-sensing Transcriptional Regulator QorR in Corynebacterium glutamicum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; DNA-BINDING; ESCHERICHIA-COLI; DEHALORESPIRATION; IDENTIFICATION; ACTIVATION; REPRESSOR; PEROXIDE; PROTEIN; OHRR	Corynebacterium glutamicum cgR_1435 (cg1552) encodes a protein of the DUF24 protein family, which is a novel family of transcriptional regulators. CgR1435 (QorR) is a negative regulator of cgR 1436 (qor2), which is located upstream of cgR 1435 (qorR) in the opposite orientation, and its structural gene. QorR binds to the intergenic region between qor2 and qorR to repress their expression, which is induced by the thiol-specific oxidant diamide. The DNA-binding activity of QorR is impaired by oxidants such as diamide, H2O2, and cumene hydroperoxide in vitro, and its lone cysteine residue (Cys-17) is essential for redox-responsive regulation of QorR activity both in vivo and in vitro. Moreover, a disruptant of qor2, which is a homologue of the ytfG gene of Escherichia coli encoding quinone oxidoreductase, shows increased sensitivity to diamide. It is concluded that the redox-sensing transcriptional regulator QorR is involved in disulfide stress response of C. glutamicum by regulating qor2 expression.	[Ehira, Shigeki; Ogino, Hidetaka; Teramoto, Haruhiko; Inui, Masayuki; Yukawa, Hideaki] Res Inst Innovat Technol Earth, Kyoto 6190292, Japan	Research Institute of Innovative Technology for the Earth	Yukawa, H (corresponding author), Res Inst Innovat Technol Earth, 9-2 Kizugawadai, Kyoto 6190292, Japan.	mmg-lab@rite.or.jp	Ehira, Shigeki/D-6081-2013	Ehira, Shigeki/0000-0002-4121-7367; Inui, Masayuki/0000-0001-5953-7740	New Energy and Industrial Technology Development Organization	New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This study was partially supported by a grant from the New Energy and Industrial Technology Development Organization.	BABIYCHUK E, 1995, J BIOL CHEM, V270, P26224, DOI 10.1074/jbc.270.44.26224; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Brune I, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-86; Ehira S, 2008, APPL ENVIRON MICROB, V74, P5146, DOI 10.1128/AEM.00944-08; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fuangthong M, 2002, P NATL ACAD SCI USA, V99, P6690, DOI 10.1073/pnas.102483199; Gupta N, 2008, J BIOL CHEM, V283, P28721, DOI 10.1074/jbc.M800630200; Hermann T, 2003, J BIOTECHNOL, V104, P155, DOI 10.1016/S0168-1656(03)00149-4; Kim IK, 2008, J MOL BIOL, V379, P372, DOI 10.1016/j.jmb.2008.04.003; Kim TH, 2005, BIOCHEM BIOPH RES CO, V331, P1542, DOI 10.1016/j.bbrc.2005.04.073; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Leelakriangsak M, 2008, MOL MICROBIOL, V67, P1108, DOI 10.1111/j.1365-2958.2008.06110.x; Leelakriangsak M, 2007, J BACTERIOL, V189, P1736, DOI 10.1128/JB.01520-06; Liu X, 2001, Pac Symp Biocomput, P127; Mishra AK, 2007, MOL MICROBIOL, V65, P1503, DOI 10.1111/j.1365-2958.2007.05884.x; Nakunst D, 2007, J BACTERIOL, V189, P4696, DOI 10.1128/JB.00382-07; Ogino H, 2008, MOL MICROBIOL, V67, P597, DOI 10.1111/j.1365-2958.2007.06069.x; Pop SM, 2004, J BIOL CHEM, V279, P49910, DOI 10.1074/jbc.M409435200; Pop SM, 2006, J BIOL CHEM, V281, P26382, DOI 10.1074/jbc.M602158200; Suzuki N, 2006, APPL ENVIRON MICROB, V72, P3750, DOI 10.1128/AEM.72.5.3750-3755.2006; Terasawa M, 1993, Bioprocess Technol, V16, P37; Wang G, 2004, INFECT IMMUN, V72, P1391, DOI 10.1128/IAI.72.3.1391-1396.2004; Yukawa H, 2007, MICROBIOL-SGM, V153, P1042, DOI 10.1099/mic.0.2006/003657-0; Yurimoto H, 2005, MOL MICROBIOL, V57, P511, DOI 10.1111/j.1365-2958.2005.04702.x; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	27	32	33	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16736	16742		10.1074/jbc.M109.009027	http://dx.doi.org/10.1074/jbc.M109.009027			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19403527	Green Published, hybrid			2022-12-25	WOS:000266962400008
J	Kelly, E; Greene, CM; Carroll, TP; McElvaney, NG; O'Neill, SJ				Kelly, Emer; Greene, Catherine M.; Carroll, Tomas P.; McElvaney, Noel G.; O'Neill, Shane J.			Selenoprotein S/SEPS1 Modifies Endoplasmic Reticulum Stress in Z Variant alpha(1)-Antitrypsin Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED-PROTEIN RESPONSE; ER STRESS; ALPHA-1-ANTITRYPSIN DEFICIENCY; LIVER-DISEASE; SELENIUM; MECHANISM; ACTIVATION; PATHWAY; CELLS; GENE	Z alpha(1)-antitrypsin (ZAAT) deficiency is a disease associated with emphysematous lung disease and also with liver disease. The liver disease of AAT deficiency is associated with endoplasmic reticulum (ER) stress. SEPS1 is a selenoprotein that, through a chaperone activity, decreases ER stress. To determine the effect of SEPS1 on ER stress in ZAAT deficiency, we measured activity of the grp78 promoter and levels of active ATF6 as markers of the unfolded protein response in HepG2 cells transfected with the mutant form of AAT, a ZAAT transgene. We evaluated levels of NF kappa B activity as a marker of the ER overload response. To determine the effect of selenium supplementation on the function of SEPS1, we investigated glutathione peroxidase activity, grp78 promoter activity, and NF kappa B activity in the presence or absence of selenium. SEPS1 reduced levels of active ATF6. Overexpression of SEPS1 also inhibited grp78 promoter and NF kappa B activity, and this effect was enhanced in the presence of selenium supplementation. This finding demonstrates a role for SEPS1 in ZAAT deficiency and suggests a possible therapeutic potential for selenium supplementation.	[Kelly, Emer; Greene, Catherine M.; Carroll, Tomas P.; McElvaney, Noel G.; O'Neill, Shane J.] Royal Coll Surgeons Ireland, Dept Med, Resp Res Div, Beaumont Hosp,Educ & Res Ctr, Dublin 9, Ireland	Royal College of Surgeons - Ireland	Greene, CM (corresponding author), Royal Coll Surgeons Ireland, Dept Med, Resp Res Div, Beaumont Hosp,Educ & Res Ctr, Dublin 9, Ireland.	cmgreene@rcsi.ie	McElvaney, Noel/A-6809-2010; Greene, Catherine M/D-3513-2012	Greene, Catherine M/0000-0003-2549-2569; mcelvaney, Noel/0000-0002-0152-4370; Carroll, Tomas/0000-0002-0418-1641	Alpha One Foundation	Alpha One Foundation	This work was supported by a Pilot and Feasibility grant from the Alpha One Foundation.	Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; BRANTLY M, 1988, AM J MED, V84, P13; Castellano S, 2005, P NATL ACAD SCI USA, V102, P16188, DOI 10.1073/pnas.0505146102; CHAMBERS I, 1986, EMBO J, V5, P1221, DOI 10.1002/j.1460-2075.1986.tb04350.x; Curran JE, 2005, NAT GENET, V37, P1234, DOI 10.1038/ng1655; Gao Y, 2006, CYTOKINE, V33, P246, DOI 10.1016/j.cyto.2006.02.005; Gao Y, 2004, FEBS LETT, V563, P185, DOI 10.1016/S0014-5793(04)00296-0; Greene CM, 2008, J INHERIT METAB DIS, V31, P21, DOI 10.1007/s10545-007-0748-y; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Kim KH, 2007, BIOCHEM BIOPH RES CO, V354, P127, DOI 10.1016/j.bbrc.2006.12.183; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lawless MW, 2004, J IMMUNOL, V172, P5722, DOI 10.4049/jimmunol.172.9.5722; LE A, 1990, J BIOL CHEM, V265, P14001; LE AQ, 1992, J BIOL CHEM, V267, P1072; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; MULLINS C, 2005, BIOGENESIS CELLULAR, P63; PAHL HL, 1995, EMBO J, V14, P2580, DOI 10.1002/j.1460-2075.1995.tb07256.x; Rayman MP, 2005, P NUTR SOC, V64, P527, DOI 10.1079/PNS2005467; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SUNDE RA, 2008, BIOSCI REP IN PRESS; SVEGER T, 1976, NEW ENGL J MED, V294, P1316, DOI 10.1056/NEJM197606102942404; SVEGER T, 1988, ACTA PAEDIATR SCAND, V77, P847, DOI 10.1111/j.1651-2227.1988.tb10767.x; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Venkateswaran V, 2002, CANCER RES, V62, P2540; Vunta H, 2007, J BIOL CHEM, V282, P17964, DOI 10.1074/jbc.M703075200; Walder K, 2002, DIABETES, V51, P1859, DOI 10.2337/diabetes.51.6.1859; Welihinda AA, 1999, GENE EXPRESSION, V7, P293; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	33	47	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16891	16897		10.1074/jbc.M109.006288	http://dx.doi.org/10.1074/jbc.M109.006288			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19398551	Green Published, hybrid			2022-12-25	WOS:000266962400025
J	Goel, VK; Ibrahim, N; Jiang, G; Singhal, M; Fee, S; Flotte, T; Westmoreland, S; Haluska, FS; Hinds, PW; Haluska, FG				Goel, V. K.; Ibrahim, N.; Jiang, G.; Singhal, M.; Fee, S.; Flotte, T.; Westmoreland, S.; Haluska, F. S.; Hinds, P. W.; Haluska, F. G.			Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice	ONCOGENE			English	Article						BRAF; p53; CDKN2A; AKT; melanoma; senescence	BRAF MUTATIONS; TUMOR SUPPRESSION; P53; ACTIVATION; SENESCENCE; INK4A; LOCUS; MDM2; INACTIVATION; INHIBITION	BRAF, a cellular oncogene and effector of RAS-mediated signaling, is activated by mutation in similar to 60% of melanomas. Most of these mutations consist of a V600E substitution resulting in constitutive kinase activation. Mutant BRAF thus represents an important therapeutic target in melanoma. In an effort to produce a pre-clinical model of mutant BRAF function in melanoma, we have generated a mouse expressing BRAF V600E targeted to melanocytes. We show that in these transgenic mice, widespread benign melanocytic hyperplasia with histological features of nevi occurs, with biochemical evidence of senescence. Melanocytic hyperplasia progresses to overt melanoma with an incidence dependent on BRAF expression levels. Melanomas show CDKN2A loss, and genetic disruption of the CDKN2A locus greatly enhances melanoma formation, consistent with collaboration between BRAF activation and CDKN2A loss suggested from studies of human melanoma. The development of melanoma also involves activation of the Mapk and Akt signaling pathways and loss of senescence, findings that faithfully recapitulate those seen in human melanomas. This murine model of mutant BRAF-induced melanoma formation thus provides an important tool for identifying further genetic alterations that cooperates with BRAF and that may be useful in enhancing susceptibility to BRAF-targeted therapeutics in melanoma. Oncogene (2009) 28, 2289-2298; doi: 10.1038/onc.2009.95; published online 27 April 2009	[Goel, V. K.; Ibrahim, N.; Jiang, G.; Singhal, M.; Hinds, P. W.; Haluska, F. G.] Tufts Univ New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; [Fee, S.; Flotte, T.; Haluska, F. S.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Westmoreland, S.] Harvard Univ, Sch Med, New England Primate Res Ctr, Boston, MA USA	Tufts Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Goel, VK (corresponding author), Tufts Univ New England Med Ctr, Mol Oncol Res Inst, 750 Washington St, Boston, MA 02111 USA.	vkumargoel@gmail.com; frank.haluska@ARIAD.com			NIH [CA095798]; NATIONAL CANCER INSTITUTE [R01CA095798] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant CA095798 to FGH. We thank Mohammad Miri for technical assistance, Dr Louis Montoliu for the tyrosinase promoter, Dr Lynda Chin for the mouse strains, and Dr Philip Tsichlis, Dr Amit Deshpande and Dr Trevor Pemberton for useful discussions.	Ackermann J, 2005, CANCER RES, V65, P4005, DOI 10.1158/0008-5472.CAN-04-2970; Bardeesy N, 2001, MOL CELL BIOL, V21, P2144, DOI 10.1128/MCB.21.6.2144-2153.2001; CASTRESANA JS, 1993, INT J CANCER, V55, P562, DOI 10.1002/ijc.2910550407; Chang DLF, 2007, ONCOGENE, V26, P4627, DOI 10.1038/sj.onc.1210254; Chin L, 1997, GENE DEV, V11, P2822, DOI 10.1101/gad.11.21.2822; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Dai DL, 2005, J CLIN ONCOL, V23, P1473, DOI 10.1200/JCO.2005.07.168; Dhawan P, 2002, CANCER RES, V62, P7335; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eisen T, 2006, BRIT J CANCER, V95, P581, DOI 10.1038/sj.bjc.6603291; Goel VK, 2006, J INVEST DERMATOL, V126, P154, DOI 10.1038/sj.jid.5700026; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Haluska FG, 2006, CLIN CANCER RES, V12, p2301S, DOI 10.1158/1078-0432.CCR-05-2518; Hingorani SR, 2003, CANCER RES, V63, P5198; Laud K, 2006, J MED GENET, V43, P39, DOI 10.1136/jmg.2005.033498; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Muthusamy V, 2006, GENE CHROMOSOME CANC, V45, P447, DOI 10.1002/gcc.20310; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Pollock PM, 2002, CANCER CELL, V2, P5, DOI 10.1016/S1535-6108(02)00089-2; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharma A, 2005, CANCER RES, V65, P2412, DOI 10.1158/0008-5472.CAN-04-2423; Sharpless NE, 2003, ONCOGENE, V22, P5055, DOI 10.1038/sj.onc.1206809; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Sviderskaya EV, 2002, JNCI-J NATL CANCER I, V94, P446; TAMURA A, 1987, IN VITRO CELL DEV B, V23, P519; Tief K, 1998, MOL BRAIN RES, V53, P307, DOI 10.1016/S0169-328X(97)00301-X; Tonks ID, 2003, GENESIS, V37, P131, DOI 10.1002/gene.10242; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; Uribe P, 2006, J INVEST DERMATOL, V126, P161, DOI 10.1038/sj.jid.5700011; Wu H, 2003, ONCOGENE, V22, P3113, DOI 10.1038/sj.onc.1206451; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	36	112	121	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 11	2009	28	23					2289	2298		10.1038/onc.2009.95	http://dx.doi.org/10.1038/onc.2009.95			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	456XM	19398955	Green Accepted			2022-12-25	WOS:000266886300005
J	Larive, RM; Urbach, S; Poncet, J; Jouin, P; Mascre, G; Sahuquet, A; Mangeat, PH; Coopman, PJ; Bettache, N				Larive, R. M.; Urbach, S.; Poncet, J.; Jouin, P.; Mascre, G.; Sahuquet, A.; Mangeat, P. H.; Coopman, P. J.; Bettache, N.			Phosphoproteomic analysis of Syk kinase signaling in human cancer cells reveals its role in cell-cell adhesion	ONCOGENE			English	Article						Syk signaling; proteomics; tyrosine kinase; tumor suppressor; cell-cell adhesion	HUMAN BREAST-CANCER; SPLEEN TYROSINE KINASE; ENDOTHELIAL-CELLS; ANTIGEN RECEPTOR; CROSS-LINKING; PROTEIN; PHOSPHORYLATION; EXPRESSION; PROLIFERATION; PROGRESSION	The spleen tyrosine kinase Syk has predominantly been studied in hematopoietic cells in which it is involved in immunoreceptor-mediated signaling. Recently, Syk expression was evidenced in numerous nonhematopoietic cells and shown to be involved in tumor formation and progression. The Syk downstream signaling effectors in nonhematopoietic cells remain, however, to be uncovered, and were investigated using MS-based quantitative phosphoproteomics. Two strategies, based on the inhibition of the Syk catalytic activity and on the loss of Syk expression were employed to identify phosphotyrosine-dependent complexes. Quantitative measurements were obtained on 350 proteins purified with phosphotyrosine affinity columns using the SILAC method. Forty-one proteins are dependent on both Syk expression and catalytic activity and were selected as signaling effectors. They are involved in a variety of biological processes such as signal transduction, cell-cell adhesion and cell polarization. We investigated the functional involvement of Syk in cell-cell adhesion and demonstrated the phosphorylation of E-cadherin and alpha-catenin. In addition, Syk is localized at cell-cell contacts, and Syk-mediated phosphorylation of E-cadherin seems to be important for the proper localization of p120-catenin at adherens junctions. Identification of the biochemical pathways regulated by Syk in human cancer cells will help to uncover its role in tumor formation and progression. Oncogene (2009) 28, 2337-2347; doi:10.1038/onc.2009.99; published online 4 May 2009	[Bettache, N.] Univ Montpellier 2, UMR 5237, CRBM, CNRS, F-34095 Montpellier 5, France; [Larive, R. M.; Mascre, G.; Sahuquet, A.; Mangeat, P. H.; Coopman, P. J.; Bettache, N.] Univ Montpellier 1, UMR 5237, IFR 122, CNRS,CRBM,Equipe Labellisee Ligue Natl Canc 2007, F-34095 Montpellier 5, France; [Urbach, S.; Poncet, J.; Jouin, P.] Univ Montpellier 1, Inst Genom Fonct, UMR 5203, CNRS,INSERM,U661, F-34095 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Bettache, N (corresponding author), Univ Montpellier 2, UMR 5237, CRBM, CNRS, Cc 107,Pl Eugene Bataillon, F-34095 Montpellier 5, France.	bettache@univ-montp2.fr	; Coopman, Peter/G-7416-2019	Larive, Romain/0000-0001-8479-209X; Bettache, Nadir/0000-0001-5426-7024; Coopman, Peter/0000-0003-3720-523X	Centre National de la Recherche Scientifique; Institut National du Cancer [PL06-111]; Ligue Nationale contre le Cancer; LNCC; Association pour la Recherche sur le Cancer (ARC)	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National du Cancer(Institut National du Cancer (INCA) France); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); LNCC; Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	We thank A Morel and M Saen for skilled technical assistance; F Raynaud and C Roy for valuable technical advice; G Freiss for IRS-1 and S Baghdiguian for p65-NF-kappa B antibodies; M Dunach and A Garcia de Herreros for GST constructs; Montpellier RIO Imaging platform for image analysis. MS experiments were performed at the Functional Proteomics Platform located at the IGF. This study was supported by the Centre National de la Recherche Scientifique, the Institut National du Cancer (no. PL06-111 to PJ Coopman) and the Ligue Nationale contre le Cancer (LNCC; Equipe Labellisee Ligue 2007 to PJ Coopman). RM Larive is a recipient of a PhD fellowship funded by the LNCC and the Association pour la Recherche sur le Cancer (ARC).	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; Bijli KM, 2008, J BIOL CHEM, V283, P14674, DOI 10.1074/jbc.M802094200; Coopman PJ, 2006, CANCER LETT, V241, P159, DOI 10.1016/j.canlet.2005.11.004; Coopman PJP, 2000, NATURE, V406, P742, DOI 10.1038/35021086; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Feldman GJ, 2005, ADV DRUG DELIVER REV, V57, P883, DOI 10.1016/j.addr.2005.01.009; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Gonzalez-Mariscal L, 2007, PROG HISTOCHEM CYTO, V42, P1, DOI 10.1016/j.proghi.2007.01.001; Hoeller C, 2005, J INVEST DERMATOL, V124, P1293, DOI 10.1111/j.0022-202X.2005.23685.x; Lang ML, 2002, BIOCHEM J, V364, P517, DOI 10.1042/BJ20011696; Ma H, 2001, J IMMUNOL, V166, P1507, DOI 10.4049/jimmunol.166.3.1507; Maeda A, 1999, ONCOGENE, V18, P2291, DOI 10.1038/sj.onc.1202552; Maruyama S, 1996, J BIOL CHEM, V271, P6631, DOI 10.1074/jbc.271.12.6631; Moroni M, 2004, CANCER RES, V64, P7346, DOI 10.1158/0008-5472.CAN-03-3520; NAGAI K, 1995, J BIOL CHEM, V270, P6824, DOI 10.1074/jbc.270.12.6824; OLIVER JM, 1994, J BIOL CHEM, V269, P29697; Park J, 2001, J BIOL CHEM, V276, P37459, DOI 10.1074/jbc.M105916200; Peters JD, 1996, J BIOL CHEM, V271, P4755; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Sada K, 2001, J BIOCHEM-TOKYO, V130, P177, DOI 10.1093/oxfordjournals.jbchem.a002970; Schymeinsky J, 2006, BLOOD, V108, P3919, DOI 10.1182/blood-2005-12-030387; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Toyama T, 2003, CANCER LETT, V189, P97, DOI 10.1016/S0304-3835(02)00463-9; von Willebrand M, 1998, CELL SIGNAL, V10, P407, DOI 10.1016/S0898-6568(97)00139-3; Wang L, 2005, CANCER RES, V65, P10289, DOI 10.1158/0008-5472.CAN-05-2231; Xu JW, 2007, MOL ENDOCRINOL, V21, P564, DOI 10.1210/me.2006-0354; Yanagi S, 2001, BIOCHEM BIOPH RES CO, V288, P495, DOI 10.1006/bbrc.2001.5788; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022; Yuan YF, 2001, CANCER RES, V61, P5558; Zolodz MD, 2004, J PROTEOME RES, V3, P743, DOI 10.1021/pr049967i; Zyss D, 2005, CANCER RES, V65, P10872, DOI 10.1158/0008-5472.CAN-05-1270	33	36	40	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2009	28	24					2337	2347		10.1038/onc.2009.99	http://dx.doi.org/10.1038/onc.2009.99			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	459GJ	19421152				2022-12-25	WOS:000267089100004
J	Garthe, A; Behr, J; Kempermann, G				Garthe, Alexander; Behr, Joachim; Kempermann, Gerd			Adult-Generated Hippocampal Neurons Allow the Flexible Use of Spatially Precise Learning Strategies	PLOS ONE			English	Article							MORRIS WATER MAZE; SYNAPTIC PLASTICITY; DENTATE GYRUS; TRANSGENIC MICE; GRANULE CELLS; MUTANT MICE; NEUROGENESIS; MEMORY; ASTROCYTES; HYPOTHESIS	Despite enormous progress in the past few years the specific contribution of newly born granule cells to the function of the adult hippocampus is still not clear. We hypothesized that in order to solve this question particular attention has to be paid to the specific design, the analysis, and the interpretation of the learning test to be used. We thus designed a behavioral experiment along hypotheses derived from a computational model predicting that new neurons might be particularly relevant for learning conditions, in which novel aspects arise in familiar situations, thus putting high demands on the qualitative aspects of (re-)learning. In the reference memory version of the water maze task suppression of adult neurogenesis with temozolomide (TMZ) caused a highly specific learning deficit. Mice were tested in the hidden platform version of the Morris water maze (6 trials per day for 5 days with a reversal of the platform location on day 4). Testing was done at 4 weeks after the end of four cycles of treatment to minimize the number of potentially recruitable new neurons at the time of testing. The reduction of neurogenesis did not alter longterm potentiation in CA3 and the dentate gyrus but abolished the part of dentate gyrus LTP that is attributed to the new neurons. TMZ did not have any overt side effects at the time of testing, and both treated mice and controls learned to find the hidden platform. Qualitative analysis of search strategies, however, revealed that treated mice did not advance to spatially precise search strategies, in particular when learning a changed goal position ( reversal). New neurons in the dentate gyrus thus seem to be necessary for adding flexibility to some hippocampus-dependent qualitative parameters of learning. Our finding that a lack of adult-generated granule cells specifically results in the animal's inability to precisely locate a hidden goal is also in accordance with a specialized role of the dentate gyrus in generating a metric rather than just a configurational map of the environment. The discovery of highly specific behavioral deficits as consequence of a suppression of adult hippocampal neurogenesis thus allows to link cellular hippocampal plasticity to well-defined hypotheses from theoretical models.			Garthe, A (corresponding author), CRTD, Dresden, Germany.	gerd.kempermann@crt-dresden.de	Kempermann, Gerd/F-5416-2010	Kempermann, Gerd/0000-0002-5304-4061				Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; Balschun D, 2003, J NEUROSCI, V23, P6304; Becker S, 2005, HIPPOCAMPUS, V15, P722, DOI 10.1002/hipo.20095; Becker S, 2007, TRENDS COGN SCI, V11, P70, DOI 10.1016/j.tics.2006.10.013; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Chambers RA, 2004, NEUROPSYCHOPHARMACOL, V29, P747, DOI 10.1038/sj.npp.1300358; Chowdhury S, 1999, CANCER TREAT REV, V25, P259, DOI 10.1053/ctrv.1999.0138; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; *EMEA, 2005, EMEAHC0229; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Goodrich-Hunsaker NJ, 2008, BEHAV NEUROSCI, V122, P16, DOI 10.1037/0735-7044.122.1.16; Janus C, 2004, LEARN MEMORY, V11, P337, DOI 10.1101/lm.70104; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2002, EUR J NEUROSCI, V16, P129, DOI 10.1046/j.1460-9568.2002.02042.x; Kempermann G, 2002, DEV BRAIN RES, V134, P1, DOI 10.1016/S0165-3806(01)00224-3; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Kempermann G, 2008, TRENDS NEUROSCI, V31, P163, DOI 10.1016/j.tins.2008.01.002; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; LeMarec N, 1997, EXP BRAIN RES, V116, P131, DOI 10.1007/PL00005733; Mason WP, 2005, CAN J NEUROL SCI, V32, P18, DOI 10.1017/S0317167100016838; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2007, P NATL ACAD SCI USA, V104, P4642, DOI 10.1073/pnas.0611718104; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167; Wolfer DP, 2000, EXP PHYSIOL, V85, P627, DOI 10.1017/S0958067000020959; Wolfer DP, 1998, EUR J NEUROSCI, V10, P708, DOI 10.1046/j.1460-9568.1998.00089.x; Wolfer DP, 2001, PHYSIOL BEHAV, V73, P745, DOI 10.1016/S0031-9384(01)00531-5; ZHANG CL, 2000, NATURE	42	430	437	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2009	4	5							e5464	10.1371/journal.pone.0005464	http://dx.doi.org/10.1371/journal.pone.0005464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	442JH	19421325	Green Submitted, Green Published, gold			2022-12-25	WOS:000265837000004
J	Mukherjee, P; Cao, TV; Winter, SL; Alexandrow, MG				Mukherjee, Piyali; Cao, Thinh V.; Winter, Sherry L.; Alexandrow, Mark G.			Mammalian MCM Loading in Late-G(1) Coincides with Rb Hyperphosphorylation and the Transition to Post-Transcriptional Control of Progression into S-Phase	PLOS ONE			English	Article								Background: Control of the onset of DNA synthesis in mammalian cells requires the coordinated assembly and activation of the pre-Replication Complex. In order to understand the regulatory events controlling preRC dynamics, we have investigated how the timing of preRC assembly relates temporally to other biochemical events governing progress into S-phase. Methodology/Principal Finding: In murine and Chinese hamster (CHO) cells released from quiescence, the loading of the replicative MCM helicase onto chromatin occurs in the final 3-4 hrs of G(1). Cdc45 and PCNA, both of which are required for G(1)-S transit, bind to chromatin at the G(1)-S transition or even earlier in G(1), when MCMs load. An RNA polymerase II inhibitor (DRB) was added to synchronized murine keratinocytes to show that they are no longer dependent on new mRNA synthesis 3-4 hrs prior to S-phase entry, which is also true for CHO and human cells. Further, CHO cells can progress into S-phase on time, and complete S-phase, under conditions where new mRNA synthesis is significantly compromised, and such mRNA suppression causes no adverse effects on preRC dynamics prior to, or during, S-phase progression. Even more intriguing, hyperphosphorylation of Rb coincides with the start of MCM loading and, paradoxically, with the time in late-G(1) when de novo mRNA synthesis is no longer rate limiting for progression into S-phase. Conclusions/Significance: MCM, Cdc45, and PCNA loading, and the subsequent transit through G(1)-S, do not depend on concurrent new mRNA synthesis. These results indicate that mammalian cells pass through a distinct transition in late-G(1) at which time Rb becomes hyperphosphorylated and MCM loading commences, but that after this transition the control of MCM, Cdc45, and PCNA loading and the onset of DNA replication are regulated at the post-transcriptional level.			Mukherjee, P (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Program Mol Oncol, Tampa, FL USA.	Mark.Alexandrow@Moffitt.org						ALEXANDROW MG, 1995, CANCER RES, V55, P1452; Alexandrow MG, 2005, J CELL BIOL, V168, P875, DOI 10.1083/jcb.200409055; Alexandrow MG, 2004, MOL CELL BIOL, V24, P1614, DOI 10.1128/MCB.24.4.1614-1627.2004; ALEXANDROW MG, 1995, CANCER RES, V55, P3928; ALEXANDROW MG, 1995, P NATL ACAD SCI USA, V92, P3239, DOI 10.1073/pnas.92.8.3239; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Binne UK, 2007, NAT CELL BIOL, V9, P225, DOI 10.1038/ncb1532; Bosco G, 2001, NAT CELL BIOL, V3, P289, DOI 10.1038/35060086; Botz J, 1996, MOL CELL BIOL, V16, P3401; Braden WA, 2006, MOL CELL BIOL, V26, P7667, DOI 10.1128/MCB.00045-06; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; CAMPISI J, 1984, MOL CELL BIOL, V4, P1807, DOI 10.1128/MCB.4.9.1807; Cayirlioglu P, 2003, MOL CELL BIOL, V23, P2123, DOI 10.1128/MCB.23.6.2123-2134.2003; Chew YP, 1998, ONCOGENE, V17, P2177, DOI 10.1038/sj.onc.1202443; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Chow KNB, 1996, MOL CELL BIOL, V16, P7173; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; DOWDY SF, 1993, CELL, V73, P499, DOI 10.1016/0092-8674(93)90137-F; Ezhevsky SA, 1997, P NATL ACAD SCI USA, V94, P10699, DOI 10.1073/pnas.94.20.10699; Ezhevsky SA, 2001, MOL CELL BIOL, V21, P4773, DOI 10.1128/MCB.21.14.4773-4784.2001; Geng Y, 1996, ONCOGENE, V12, P1173; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Harlow E., 1988, ANTIBODIES LAB MANUA; Harvey KJ, 2003, J BIOL CHEM, V278, P48524, DOI 10.1074/jbc.M307661200; Hateboer G, 1998, MOL CELL BIOL, V18, P6679, DOI 10.1128/MCB.18.11.6679; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Ji P, 2004, MOL CELL, V16, P47, DOI 10.1016/j.molcel.2004.09.029; KEDINGER C, 1974, J CELL BIOL, V63, P831, DOI 10.1083/jcb.63.3.831; Keenan SM, 2004, J BIOL CHEM, V279, P5387, DOI 10.1074/jbc.M310383200; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Leone G, 1999, P NATL ACAD SCI USA, V96, P6626, DOI 10.1073/pnas.96.12.6626; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; MITTNACHT S, 1991, COLD SPRING HARB SYM, V56, P197; Nevins JR, 1997, J CELL PHYSIOL, V173, P233, DOI 10.1002/(SICI)1097-4652(199711)173:2<233::AID-JCP27>3.0.CO;2-F; Oehlmann M, 2004, J CELL BIOL, V165, P181, DOI 10.1083/jcb.200311044; Ohtsu M, 2008, DNA RES, V15, P241, DOI 10.1093/dnares/dsn015; Okuno Y, 2001, EMBO J, V20, P4263, DOI 10.1093/emboj/20.15.4263; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; PEI R, 1988, MOL CELL BIOL, V8, P2860, DOI 10.1128/MCB.8.7.2860; PERRY RP, 1970, J CELL PHYSIOL, V76, P127, DOI 10.1002/jcp.1040760202; PINES J, 1993, TRENDS BIOCHEM SCI, V18, P195, DOI 10.1016/0968-0004(93)90185-P; Royzman I, 1999, GENE DEV, V13, P827, DOI 10.1101/gad.13.7.827; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; SEHGAL PB, 1976, CELL, V9, P473, DOI 10.1016/0092-8674(76)90092-1; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Stoeber K, 1998, EMBO J, V17, P7219, DOI 10.1093/emboj/17.24.7219; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter JC, 2000, J BIOL CHEM, V275, P39773, DOI 10.1074/jbc.M008107200; WELLS DJ, 1979, J CELL PHYSIOL, V100, P199, DOI 10.1002/jcp.1041000202; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wu JR, 1997, MOL CELL BIOL, V17, P4312, DOI 10.1128/MCB.17.8.4312; YAMAGUCHI M, 1995, J BIOL CHEM, V270, P25159, DOI 10.1074/jbc.270.42.25159; Yan Z, 1998, P NATL ACAD SCI USA, V95, P3603, DOI 10.1073/pnas.95.7.3603; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zhang HS, 1999, CELL, V97, P53, DOI 10.1016/S0092-8674(00)80714-X; ZYLBER EA, 1971, P NATL ACAD SCI USA, V68, P2861, DOI 10.1073/pnas.68.11.2861	63	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2009	4	5							e5462	10.1371/journal.pone.0005462	http://dx.doi.org/10.1371/journal.pone.0005462			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JH	19421323	gold, Green Published, Green Submitted			2022-12-25	WOS:000265837000003
J	Salari, R; Aksay, C; Karakoc, E; Unrau, PJ; Hajirasouliha, I; Sahinalp, SC				Salari, Raheleh; Aksay, Cagri; Karakoc, Emre; Unrau, Peter J.; Hajirasouliha, Iman; Sahinalp, S. Cenk			smyRNA: A Novel Ab Initio ncRNA Gene Finder	PLOS ONE			English	Article								Background: Non-coding RNAs (ncRNAs) have important functional roles in the cell: for example, they regulate gene expression by means of establishing stable joint structures with target mRNAs via complementary sequence motifs. Sequence motifs are also important determinants of the structure of ncRNAs. Although ncRNAs are abundant, discovering novel ncRNAs on genome sequences has proven to be a hard task; in particular past attempts for ab initio ncRNA search mostly failed with the exception of tools that can identify micro RNAs. Methodology/Principal Findings: We present a very general ab initio ncRNA gene finder that exploits differential distributions of sequence motifs between ncRNAs and background genome sequences. Conclusions/Significance: Our method, once trained on a set of ncRNAs from a given species, can be applied to a genome sequences of other organisms to find not only ncRNAs homologous to those in the training set but also others that potentially belong to novel (and perhaps unknown) ncRNA families. Availability: http://compbio.cs.sfu.ca/taverna/smyrna			Sahinalp, SC (corresponding author), Simon Fraser Univ, Sch Comp Sci, Burnaby, BC V5A 1S6, Canada.	cenk@cs.sfu.ca	Sahinalp, Suleyman Cenk/X-7843-2018; Hajirasouliha, Iman/E-2984-2010	Sahinalp, Suleyman Cenk/0000-0002-5050-0682; 				Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carter RJ, 2001, NUCLEIC ACIDS RES, V29, P3928, DOI 10.1093/nar/29.19.3928; Coventry A, 2004, P NATL ACAD SCI USA, V101, P12102, DOI 10.1073/pnas.0404193101; di Bernardo D, 2003, BIOINFORMATICS, V19, P1606, DOI 10.1093/bioinformatics/btg229; Dieterich C, 2003, NUCLEIC ACIDS RES, V31, P55, DOI 10.1093/nar/gkg007; Eddy SR, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-18; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; FONTAINE A, 2005, JOBIM; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hofacker IL, 2004, BIOINFORMATICS, V20, P186, DOI 10.1093/bioinformatics/btg388; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MEYER IM, 2007, BRIEF BIOINFORM; Meyer IM, 2007, PLOS COMPUT BIOL, V3, P1441, DOI 10.1371/journal.pcbi.0030149; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Rivas E, 2000, BIOINFORMATICS, V16, P583, DOI 10.1093/bioinformatics/16.7.583; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Yao Z, 2007, PLOS COMPUT BIOL, V3, P1212, DOI 10.1371/journal.pcbi.0030126	24	8	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2009	4	5							e5433	10.1371/journal.pone.0005433	http://dx.doi.org/10.1371/journal.pone.0005433			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JE	19415115	Green Submitted, Green Published, gold			2022-12-25	WOS:000265836700006
J	Zhang, B; Chang, JF; Fu, M; Huang, J; Kashyap, R; Salavaggione, E; Jain, S; Shashikant, K; Deardorff, MA; Uzielli, MLG; Dorsett, D; Beebe, DC; Jay, PY; Heuckeroth, RO; Krantz, I; Milbrandt, J				Zhang, Bin; Chang, Jufang; Fu, Ming; Huang, Jie; Kashyap, Rakesh; Salavaggione, Ezequiel; Jain, Sanjay; Shashikant, Kulkarni; Deardorff, Matthew A.; Uzielli, Maria L. Giovannucci; Dorsett, Dale; Beebe, David C.; Jay, Patrick Y.; Heuckeroth, Robert O.; Krantz, Ian; Milbrandt, Jeffrey			Dosage Effects of Cohesin Regulatory Factor PDS5 on Mammalian Development: Implications for Cohesinopathies	PLOS ONE			English	Article								Cornelia de Lange syndrome (CdLS), a disorder caused by mutations in cohesion proteins, is characterized by multisystem developmental abnormalities. PDS5, a cohesion protein, is important for proper chromosome segregation in lower organisms and has two homologues in vertebrates (PDS5A and PDS5B). Pds5B mutant mice have developmental abnormalities resembling CdLS; however the role of Pds5A in mammals and the association of PDS5 proteins with CdLS are unknown. To delineate genetic interactions between Pds5A and Pds5B and explore mechanisms underlying phenotypic variability, we generated Pds5A-deficient mice. Curiously, these mice exhibit multiple abnormalities that were previously observed in Pds5B-deficient mice, including cleft palate, skeletal patterning defects, growth retardation, congenital heart defects and delayed migration of enteric neuron precursors. They also frequently display renal agenesis, an abnormality not observed in Pds5B(-/-) mice. While Pds5A(-/-) and Pds5B(-/-) mice die at birth, embryos harboring 3 mutant Pds5 alleles die between E11.5 and E12.5 most likely of heart failure, indicating that total Pds5 gene dosage is critical for normal development. In addition, characterization of these compound homozygous-heterozygous mice revealed a severe abnormality in lens formation that does not occur in either Pds5A(-/-) or Pds5B(-/-) mice. We further identified a functional missense mutation (R1292Q) in the PDS5B DNA-binding domain in a familial case of CdLS, in which affected individuals also develop megacolon. This study shows that PDS5A and PDS5B functions other than those involving chromosomal dynamics are important for normal development, highlights the sensitivity of key developmental processes on PDS5 signaling, and provides mechanistic insights into how PDS5 mutations may lead to CdLS.			Zhang, B (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	jmilbrandt@wustl.edu	Huang, Jie/D-7728-2014	Milbrandt, Jeffrey/0000-0002-5477-7689; Heuckeroth, Robert/0000-0002-3282-1765; Dorsett, Dale/0000-0002-0507-2762; jain, sanjay/0000-0003-2804-127X	NCI NIH HHS [CA111966, R01 CA111966] Funding Source: Medline; NEI NIH HHS [EY04853, R01 EY004853] Funding Source: Medline; NIA NIH HHS [RF1 AG013730, R01 AG013730, AG13730] Funding Source: Medline; NICHD NIH HHS [HD001487, HD047396, K08 HD047396-03, P01 HD052860-040003, P01 HD052860, K08 HD047396-05, K08 HD047396, L40 HD045452, P01 HD052860-030003, L40 HD045452-04, K12 HD001487, K08 HD047396-04] Funding Source: Medline; NIDDK NIH HHS [DK57038, R01 DK057038, DK6459201] Funding Source: Medline; NIGMS NIH HHS [R01 GM055683-08, R01 GM055683, R01 GM055683-09] Funding Source: Medline; NINDS NIH HHS [P30 NS057105] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD052860] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD047396, K12HD001487] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA111966] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY004853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057038, R01DK064592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG013730, R01AG013730] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANGRIST M, 1995, HUM MOL GENET, V4, P821, DOI 10.1093/hmg/4.5.821; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Auricchio A, 1999, AM J HUM GENET, V64, P1216, DOI 10.1086/302329; Benard CY, 2004, DEVELOPMENT, V131, P5947, DOI 10.1242/dev.01433; Broeker PL, 1996, CURR TOP MICROBIOL, V211, P259; Chen F, 2002, J BIOL CHEM, V277, P16775, DOI 10.1074/jbc.M201322200; Deardorff MA, 2007, AM J HUM GENET, V80, P485, DOI 10.1086/511888; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Dorsett D, 2005, DEVELOPMENT, V132, P4743, DOI 10.1242/dev.02064; Dorsett D, 1999, CURR OPIN GENET DEV, V9, P505, DOI 10.1016/S0959-437X(99)00002-7; DORSETT D, 2006, CHROMOSOMA; FitzPatrick DR, 2003, HUM MOL GENET, V12, P2491, DOI 10.1093/hmg/ddg248; Gause M, 2008, BIOESSAYS, V30, P715, DOI 10.1002/bies.20787; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Gillis LA, 2004, AM J HUM GENET, V75, P610, DOI 10.1086/424698; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Honaramooz A, 2002, NATURE, V418, P778, DOI 10.1038/nature00918; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Horsfield JA, 2007, DEVELOPMENT, V134, P2639, DOI 10.1242/dev.002485; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; Hutson MR, 2007, SEMIN CELL DEV BIOL, V18, P101, DOI 10.1016/j.semcdb.2006.12.004; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; JACKSON L, 1993, AM J MED GENET, V47, P940, DOI 10.1002/ajmg.1320470703; Jain S, 2004, DEVELOPMENT, V131, P5503, DOI 10.1242/dev.01421; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Khadake JR, 1997, FEBS LETT, V400, P193, DOI 10.1016/S0014-5793(96)01393-2; Kline AD, 2007, AM J MED GENET C, V145C, P248, DOI 10.1002/ajmg.c.30137; Kozma C, 1996, AM J MED GENET, V66, P445, DOI 10.1002/(SICI)1096-8628(19961230)66:4<445::AID-AJMG12>3.3.CO;2-S; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Kumar D, 2004, GENE, V328, P187, DOI 10.1016/j.gene.2003.12.013; Lalatta F, 2007, GENET MED, V9, P188, DOI 10.1097/GIM.0b013e31803183dd; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Losada A, 2005, J CELL SCI, V118, P2133, DOI 10.1242/jcs.02355; Maher JF, 1996, P NATL ACAD SCI USA, V93, P6716, DOI 10.1073/pnas.93.13.6716; Mehta AV, 1997, AM J MED GENET, V71, P434, DOI 10.1002/(SICI)1096-8628(19970905)71:4<434::AID-AJMG12>3.0.CO;2-H; Metcalf CE, 2006, J BIOL CHEM, V281, P30015, DOI 10.1074/jbc.M606289200; MISULOVIN Z, 2007, CHROMOSOMA; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Panizza S, 2000, CURR BIOL, V10, P1557, DOI 10.1016/S0960-9822(00)00854-X; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; PTACEK LJ, 1963, J PEDIATR-US, V63, P1000, DOI 10.1016/S0022-3476(63)80234-6; Ritchie K, 2008, J CELL BIOL, V180, P315, DOI 10.1083/jcb.200706083; ROBINSON LK, 1985, AM J MED GENET, V22, P109, DOI 10.1002/ajmg.1320220112; Russell KL, 2001, AM J MED GENET, V104, P267, DOI 10.1002/ajmg.10066; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Schule B, 2005, AM J HUM GENET, V77, P1117, DOI 10.1086/498695; Seitan VC, 2006, PLOS BIOL, V4, P1411, DOI 10.1371/journal.pbio.0040242; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Tanaka K, 2001, EMBO J, V20, P5779, DOI 10.1093/emboj/20.20.5779; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; Wan LB, 2008, DEVELOPMENT, V135, P2729, DOI 10.1242/dev.024539; Wang F, 2003, MOL CELL BIOL, V23, P7698, DOI 10.1128/MCB.23.21.7698-7707.2003; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Zhang B, 2007, DEVELOPMENT, V134, P3191, DOI 10.1242/dev.005884	59	65	66	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5232	10.1371/journal.pone.0005232	http://dx.doi.org/10.1371/journal.pone.0005232			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440GG	19412548	Green Published, Green Submitted, gold			2022-12-25	WOS:000265688200001
J	Zhu, WZ; Santana, LF; Laflamme, MA				Zhu, Wei-Zhong; Santana, Luis F.; Laflamme, Michael A.			Local Control of Excitation-Contraction Coupling in Human Embryonic Stem Cell-Derived Cardiomyocytes	PLOS ONE			English	Article							INTRACELLULAR CA2+ OSCILLATIONS; RABBIT VENTRICULAR MYOCYTES; RAT-HEART CELLS; SARCOPLASMIC-RETICULUM; CALCIUM-RELEASE; CARDIAC-CELLS; DEVELOPMENTAL-CHANGES; FUNCTIONAL-PROPERTIES; MUSCLE; CHANNEL	We investigated the mechanisms of excitation-contraction (EC) coupling in human embryonic stem cell-derived cardiomyocytes (hESC-CMs) and fetal ventricular myocytes (hFVMs) using patch-clamp electrophysiology and confocal microscopy. We tested the hypothesis that Ca2+ influx via voltage-gated L-type Ca2+ channels activates Ca2+ release from the sarcoplasmic reticulum (SR) via a local control mechanism in hESC-CMs and hFVMs. Field-stimulated, whole-cell [Ca2+] i transients in hESC-CMs required Ca2+ entry through L-type Ca2+ channels, as evidenced by the elimination of such transients by either removal of extracellular Ca2+ or treatment with diltiazem, an L-type channel inhibitor. Ca2+ release from the SR also contributes to the [Ca2+] i transient in these cells, as evidenced by studies with drugs interfering with either SR Ca2+ release (i. e. ryanodine and caffeine) or reuptake (i. e. thapsigargin and cyclopiazonic acid). As in adult ventricular myocytes, membrane depolarization evoked large L-type Ca2+ currents (ICa) and corresponding whole-cell [Ca2+] i transients in hESCCMs and hFVMs, and the amplitude of both ICa and the [Ca2+] i transients were finely graded by the magnitude of the depolarization. hESC-CMs exhibit a decreasing EC coupling gain with depolarization to more positive test potentials, "tail'' [Ca2+] i transients upon repolarization from extremely positive test potentials, and co-localized ryanodine and sarcolemmal Ltype Ca2+ channels, all findings that are consistent with the local control hypothesis. Finally, we recorded Ca2+ sparks in hESC-CMs and hFVMs. Collectively, these data support a model in which tight, local control of SR Ca2+ release by the ICa during EC coupling develops early in human cardiomyocytes.			Zhu, WZ (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	santana@u.washington.edu; laflamme@u.washington.edu	Laflamme, Michael/AAV-6791-2021; Santana, Luis/AAF-9298-2019; Zhu, Wei-Zhong/G-4919-2011	Laflamme, Michael/0000-0001-5908-880X; Santana, Luis/0000-0002-4297-8029; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085686, R01HL064387, R24HL064387, K08HL080431] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08 HL080431, HL064387, HL085686, R01 HL064387, R24 HL064387, HL080431, R01 HL085686] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BALKE CW, 1994, J PHYSIOL-LONDON, V474, P447, DOI 10.1113/jphysiol.1994.sp020036; Bers D.M., 2001, EXCITATION CONTRACTI, V2nd ed.; BEUCKELMANN DJ, 1988, J PHYSIOL-LONDON, V405, P233, DOI 10.1113/jphysiol.1988.sp017331; CANNELL MB, 1987, SCIENCE, V238, P1419, DOI 10.1126/science.2446391; Cannell MB, 1997, BIOPHYS J, V73, P112, DOI 10.1016/S0006-3495(97)78052-4; CANNELL MB, 1995, SCIENCE, V268, P1045, DOI 10.1126/science.7754384; Cheng H, 1999, BIOPHYS J, V76, P606, DOI 10.1016/S0006-3495(99)77229-2; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; CLEEMANN L, 1991, J PHYSIOL-LONDON, V432, P283, DOI 10.1113/jphysiol.1991.sp018385; Collier ML, 2000, J GEN PHYSIOL, V115, P653, DOI 10.1085/jgp.115.5.653; Dilly KW, 2006, J PHYSIOL-LONDON, V572, P227, DOI 10.1113/jphysiol.2005.102020; Dolnikov K, 2006, STEM CELLS, V24, P236, DOI 10.1634/stemcells.2005-0036; Escobar AL, 2004, AM J PHYSIOL-HEART C, V286, pH971, DOI 10.1152/ajpheart.00308.2003; FABIATO A, 1979, NATURE, V281, P146, DOI 10.1038/281146a0; Franzini-Armstrong C, 1999, BIOPHYS J, V77, P1528, DOI 10.1016/S0006-3495(99)77000-1; Fu JD, 2005, FASEB J, V19, P181, DOI 10.1096/fj.05-4501fje; Galli GLJ, 2006, AM J PHYSIOL-REG I, V291, pR1781, DOI 10.1152/ajpregu.00421.2006; Haddock PS, 1999, CIRC RES, V85, P415, DOI 10.1161/01.RES.85.5.415; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Huang J, 2008, AM J PHYSIOL-CELL PH, V294, pC516, DOI 10.1152/ajpcell.00417.2007; Itzhaki I, 2006, ANN NY ACAD SCI, V1080, P207, DOI 10.1196/annals.1380.017; Janowski E, 2006, ANN NY ACAD SCI, V1080, P154, DOI 10.1196/annals.1380.014; Johnson BD, 1997, J GEN PHYSIOL, V110, P135, DOI 10.1085/jgp.110.2.135; Katsube Y, 1996, EUR J PHARMACOL, V317, P391, DOI 10.1016/S0014-2999(96)00745-5; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Laflamme MA, 1999, AM J PHYSIOL-HEART C, V277, pH1841, DOI 10.1152/ajpheart.1999.277.5.H1841; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Li GR, 1998, AM J PHYSIOL-HEART C, V275, pH369, DOI 10.1152/ajpheart.1998.275.2.H369; LIU J, 2007, STEM CELLS; Liu WR, 2002, LIFE SCI, V71, P1279, DOI 10.1016/S0024-3205(02)01826-X; LOPEZLOPEZ JR, 1995, SCIENCE, V268, P1042, DOI 10.1126/science.7754383; Lukyanenko V, 2001, BIOPHYS J, V81, P785, DOI 10.1016/S0006-3495(01)75741-4; MALTSEV VA, 1994, CIRC RES, V75, P233, DOI 10.1161/01.RES.75.2.233; MILEDI R, 1983, J PHYSIOL-LONDON, V340, P649, DOI 10.1113/jphysiol.1983.sp014785; MORAD M, 1983, NATURE, V304, P635, DOI 10.1038/304635a0; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; NABAUER M, 1992, J PHYSIOL-LONDON, V457, P627; NABAUER M, 1989, SCIENCE, V244, P800, DOI 10.1126/science.2543067; NIGGLI E, 1990, SCIENCE, V250, P565, DOI 10.1126/science.2173135; Passier R, 2005, STEM CELLS, V23, P772, DOI 10.1634/stemcells.2004-0184; Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B; Pieske B, 1999, CIRC RES, V85, P38; Reinecke H, 2008, CIRC RES, V103, P1058, DOI 10.1161/CIRCRESAHA.108.180588; ROSE WC, 1992, J PHYSIOL-LONDON, V456, P267, DOI 10.1113/jphysiol.1992.sp019336; Santana LF, 2002, J PHYSIOL-LONDON, V544, P57, DOI 10.1113/jphysiol.2002.020552; Santana LF, 1997, J PHYSIOL-LONDON, V503, P21, DOI 10.1111/j.1469-7793.1997.021bi.x; Santana LF, 1996, CIRC RES, V78, P166, DOI 10.1161/01.RES.78.1.166; Santana LF, 1997, HEART VESSELS, P44; Sartiani L, 2007, STEM CELLS, V25, P1136, DOI 10.1634/stemcells.2006-0466; Sasse P, 2007, J GEN PHYSIOL, V130, P133, DOI 10.1085/jgp.200609575; Satin J, 2008, STEM CELLS, V26, P1961, DOI 10.1634/stemcells.2007-0591; Soeller C, 1997, BIOPHYS J, V73, P97, DOI 10.1016/S0006-3495(97)78051-2; STERN MD, 1992, BIOPHYS J, V63, P497, DOI 10.1016/S0006-3495(92)81615-6; TANAKA H, 1989, J MOL CELL CARDIOL, V21, P1305, DOI 10.1016/0022-2828(89)90676-7; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Ufret-Vincenty CA, 2001, J BIOL CHEM, V276, P28197, DOI 10.1074/jbc.M102548200; Viatchenko-Karpinski S, 1999, P NATL ACAD SCI USA, V96, P8259, DOI 10.1073/pnas.96.14.8259; WIER WG, 1994, J PHYSIOL-LONDON, V474, P463, DOI 10.1113/jphysiol.1994.sp020037; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Zhu Wei-Zhong, 2009, Transplant Rev (Orlando), V23, P53, DOI 10.1016/j.trre.2008.05.005	61	60	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5407	10.1371/journal.pone.0005407	http://dx.doi.org/10.1371/journal.pone.0005407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404384	Green Submitted, gold, Green Published			2022-12-25	WOS:000265614900018
J	Arnsdorf, EJ; Tummala, P; Jacobs, CR				Arnsdorf, Emily J.; Tummala, Padmaja; Jacobs, Christopher R.			Non-Canonical Wnt Signaling and N-Cadherin Related beta-Catenin Signaling Play a Role in Mechanically Induced Osteogenic Cell Fate	PLOS ONE			English	Article								Background: Understanding how the mechanical microenvironment influences cell fate, and more importantly, by what molecular mechanisms, will enhance not only the knowledge of mesenchymal stem cell biology but also the field of regenerative medicine. Mechanical stimuli, specifically loading induced oscillatory fluid flow, plays a vital role in promoting healthy bone development, homeostasis and morphology. Recent studies suggest that such loading induced fluid flow has the potential to regulate osteogenic differentiation via the upregulation of multiple osteogenic genes; however, the molecular mechanisms involved in the transduction of a physical signal into altered cell fate have yet to be determined. Methods and Principal Findings: Using immuno-staining, western blot analysis and luciferase assays, we demonstrate the oscillatory fluid flow regulates beta-catenin nuclear translocation and gene transcription. Additionally, real time RT-PCR analysis suggests that flow induces Wnt5a and Ror2 upregulation, both of which are essential for activating the small GTPase, RhoA, upon flow exposure. Furthermore, although beta-catenin phosphorylation is not altered by flow, its association with N-cadherin is, indicating that flow-induced beta-catenin signaling is initiated by adherens junction signaling. Conclusion: We propose that the mechanical microenvironment of bone has the potential to regulate osteogenic differentiation by initiating multiple key molecular pathways that are essential for such lineage commitment. Specifically, non-canonical Wnt5a signaling involving Ror2 and RhoA as well as N-cadherin mediated beta-catenin signaling are necessary for mechanically induced osteogenic differentiation.			Arnsdorf, EJ (corresponding author), VA Palo Alto Hlth Care Syst, Bone & Joint R&D Ctr, Palo Alto, CA USA.	emily.arnsdorf@gmail.com			NIAMS NIH HHS [AR45989, R01 AR045989] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045989] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293; Bain G, 2003, BIOCHEM BIOPH RES CO, V301, P84, DOI 10.1016/S0006-291X(02)02951-0; Baksh D, 2007, J CELL BIOCHEM, V101, P1109, DOI 10.1002/jcb.21097; Baksh D, 2007, J CELL PHYSIOL, V212, P817, DOI 10.1002/jcp.21080; Baron R, 2006, CURR TOP DEV BIOL, V76, P103, DOI 10.1016/S0070-2153(06)76004-5; Batra NN, 2005, J BIOMECH, V38, P1909, DOI 10.1016/j.jbiomech.2004.08.009; Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; BROWN TD, 1990, J BIOMECH, V23, P893, DOI 10.1016/0021-9290(90)90354-6; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CARTER DR, 1989, J BIOMECH, V22, P231, DOI 10.1016/0021-9290(89)90091-2; Carter DR, 1998, CLIN ORTHOP RELAT R, pS41; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Chen Y, 2007, J BIOL CHEM, V282, P526, DOI 10.1074/jbc.M602700200; Dehority W, 1999, AM J PHYSIOL-ENDOC M, V276, pE62; Dong YF, 2006, J CELL PHYSIOL, V208, P77, DOI 10.1002/jcp.20656; DU SJ, 1995, MOL CELL BIOL, V15, P2625; El-Tanani M, 2001, CANCER RES, V61, P5619; FROST HM, 1988, CALCIFIED TISSUE INT, V42, P145, DOI 10.1007/BF02556327; FROST HM, 1987, BONE MINER, V2, P73; Ganz A, 2006, BIOL CELL, V98, P721, DOI 10.1042/BC20060039; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hanai J, 2002, J CELL BIOL, V158, P529, DOI 10.1083/jcb.200203064; Hay E, 2009, MOL CELL BIOL, V29, P953, DOI 10.1128/MCB.00349-08; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Huang W, 2007, FRONT BIOSCI-LANDMRK, V12, P3068, DOI 10.2741/2296; Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6; Katoh M, 2005, ONCOL REP, V14, P1583; Katoh M, 2006, CANCER BIOL THER, V5, P1059, DOI 10.4161/cbt.5.9.3151; Katoh Y, 2005, INT J ONCOL, V27, P275; Kim CH, 2006, BONE, V39, P1043, DOI 10.1016/j.bone.2006.05.017; Kim JB, 2007, J BONE MINER RES, V22, P1913, DOI 10.1359/JBMR.070802; Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330; KRAHL H, 1994, AM J SPORT MED, V22, P751, DOI 10.1177/036354659402200605; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Lamb KJ, 2003, INT J EXP PATHOL, V84, P191, DOI 10.1046/j.1365-2613.2003.00353.x; Li YJ, 2004, J ORTHOP RES, V22, P1283, DOI 10.1016/j.orthres.2004.04.002; Liu Y., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P323; Liu Y, 2007, MOL ENDOCRINOL, V21, P376, DOI 10.1210/me.2006-0342; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Muller T, 2002, EXP CELL RES, V280, P119, DOI 10.1006/excr.2002.5630; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Norvell SM, 2004, CALCIFIED TISSUE INT, V75, P396, DOI 10.1007/s00223-004-0213-y; OBERLENDER SA, 1994, CELL ADHES COMMUN, V2, P521, DOI 10.3109/15419069409014216; OBERLENDER SA, 1994, DEVELOPMENT, V120, P177; Orsulic S, 1999, J CELL SCI, V112, P1237; Papkoff J, 1996, MOL CELL BIOL, V16, P2128; Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284; Reinhold MI, 2007, J BIOL CHEM, V282, P3653, DOI 10.1074/jbc.M608995200; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Riddle RC, 2006, AM J PHYSIOL-CELL PH, V290, pC776, DOI 10.1152/ajpcell.00082.2005; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; Saunders MM, 2003, BONE, V32, P350, DOI 10.1016/S8756-3282(03)00025-5; Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200; Shimokawa T, 2003, CANCER RES, V63, P6116; Smith JC, 2000, PHILOS T ROY SOC B, V355, P923, DOI 10.1098/rstb.2000.0627; Spater D, 2006, EUR CELLS MATER, V12, P71; Srinivasan S, 2000, MED ENG PHYS, V22, P127, DOI 10.1016/S1350-4533(00)00021-7; Steck R, 2000, MED ENG PHYS, V22, P117, DOI 10.1016/S1350-4533(00)00017-5; Tate MLK, 2000, J EXP BIOL, V203, P2737; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Toyofuku T, 2000, J CELL BIOL, V150, P225, DOI 10.1083/jcb.150.1.225; Triplett Jason W., 2007, Molecular & Cellular Biomechanics, V4, P13; Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200; Turner CH, 2006, ANN NY ACAD SCI, V1068, P429, DOI 10.1196/annals.1346.039; Wang FS, 2007, BONE, V40, P485, DOI 10.1016/j.bone.2006.09.004; Wang Y, 2007, J TISSUE ENG REGEN M, V1, P39, DOI 10.1002/term.6; Wolff J., 1986, LAW BONE REMODELING; Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200; Woods A, 2006, J BIOL CHEM, V281, P13134, DOI 10.1074/jbc.M509433200; Woods A, 2007, J BIOL CHEM, V282, P23500, DOI 10.1074/jbc.M700680200; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhong N, 2006, BONE, V39, P5, DOI 10.1016/j.bone.2005.12.008; Zhu SZ, 2006, CELL SIGNAL, V18, P359, DOI 10.1016/j.cellsig.2005.05.019; Zou LJ, 2006, ADV EXP MED BIOL, V585, P431	84	129	136	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5388	10.1371/journal.pone.0005388	http://dx.doi.org/10.1371/journal.pone.0005388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401766	Green Published, Green Submitted, gold			2022-12-25	WOS:000265601100022
J	Eswarappa, SM				Eswarappa, Sandeepa M.			Location of Pathogenic Bacteria during Persistent Infections: Insights from an Analysis Using Game Theory	PLOS ONE			English	Article							LYSOSOME FUSION; MACROPHAGES; TUBERCULOSIS; EVOLUTION	Bacterial persistent infections are responsible for a significant amount of the human morbidity and mortality. Unlike acute bacterial infections, it is very difficult to treat persistent bacterial infections (e.g. tuberculosis). Knowledge about the location of pathogenic bacteria during persistent infection will help to treat such conditions by designing novel drugs which can reach such locations. In this study, events of bacterial persistent infections were analyzed using game theory. A game was defined where the pathogen and the host are the two players with a conflict of interest. Criteria for the establishment of Nash equilibrium were calculated for this game. This theoretical model, which is very simple and heuristic, predicts that during persistent infections pathogenic bacteria stay in both intracellular and extracellular compartments of the host. The result of this study implies that a bacterium should be able to survive in both intracellular and extracellular compartments of the host in order to cause persistent infections. This explains why persistent infections are more often caused by intracellular pathogens like Mycobacterium and Salmonella. Moreover, this prediction is in consistence with the results of previous experimental studies.			Eswarappa, SM (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Ctr Infect Dis, Res Lab, Bangalore 560012, Karnataka, India.	sandeep@mcbl.iisc.ernet.in	Eswarappa, Sandeep/AFG-1997-2022	Muthanegere Eswarappa, Sandeepa/0000-0003-4479-5354; Eswarappa, Sandeep/0000-0002-7903-5198				Alizon S, 2005, AM NAT, V165, pE155, DOI 10.1086/430053; Amieva MR, 2002, CELL MICROBIOL, V4, P677, DOI 10.1046/j.1462-5822.2002.00222.x; Anderson RM, 1998, INT J PARASITOL, V28, P551, DOI 10.1016/S0020-7519(97)00207-5; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Bentrup KHZ, 2001, TRENDS MICROBIOL, V9, P597, DOI 10.1016/S0966-842X(01)02238-7; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; Blaser MJ, 2007, NATURE, V449, P843, DOI 10.1038/nature06198; BUCHMEIER NA, 1991, INFECT IMMUN, V59, P2232, DOI 10.1128/IAI.59.7.2232-2238.1991; Fenton A, 2006, P ROY SOC B-BIOL SCI, V273, P2083, DOI 10.1098/rspb.2006.3552; HELLRIEGEL B, 1992, P ROY SOC B-BIOL SCI, V250, P249, DOI 10.1098/rspb.1992.0156; HOF H, 2002, OPPORTUNITIES INTRAC; KAZI JL, 1990, J PATHOL, V161, P65, DOI 10.1002/path.1711610111; Kreikemeyer B, 2004, INT J MED MICROBIOL, V294, P177, DOI 10.1016/j.ijmm.2004.06.017; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P2387; Read JM, 2006, THEOR POPUL BIOL, V70, P201, DOI 10.1016/j.tpb.2006.04.006; TIMOTHY L, 2001, PRINCIPLES BACTERIAL, P509; Young D, 2008, NAT REV MICROBIOL, V6, P520, DOI 10.1038/nrmicro1919; Zheng PY, 2003, CELL MICROBIOL, V5, P25, DOI 10.1046/j.1462-5822.2003.00250.x	21	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5383	10.1371/journal.pone.0005383	http://dx.doi.org/10.1371/journal.pone.0005383			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401783	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000265601100020
J	Osman, F; Gaskell, L; Whitby, MC				Osman, Fekret; Gaskell, Louise; Whitby, Matthew C.			Efficient Second Strand Cleavage during Holliday Junction Resolution by RuvC Requires Both Increased Junction Flexibility and an Exposed 5 ' Phosphate	PLOS ONE			English	Article								Background: Holliday junction (HJ) resolution is a critical step during homologous recombination. In Escherichia coli this job is performed by a member of the RNase H/Integrase superfamily called RuvC, whereas in Schizosaccharomyces pombe it has been attributed to the XPF family member Mus81-Eme1. HJ resolution is achieved through the sequential cleavage of two strands of like polarity at or close to the junction crossover point. RuvC functions as a dimer, whereas Mus81-Eme1 is thought to function as a dimer of heterodimers. However, in both cases the multimer contains two catalytic sites, which act independently and sequentially during the resolution reaction. To ensure that both strands are cleaved before the nuclease dissociates from the junction, the rate of second strand cleavage is greatly enhanced compared to that of the first. The enhancement of second strand cleavage has been attributed to the increased flexibility of the nicked HJ, which would facilitate rapid engagement of the second active site and scissile bond. Here we have investigated whether other properties of the nicked HJ are important for enhancing second strand cleavage. Principal Findings: A comparison of the efficiency of cleavage of nicked HJs with and without a 59 phosphate at the nick site shows that a 59 phosphate is required for most of the enhancement of second strand cleavage by RuvC. In contrast Mus81-Eme1 cleaves nicked HJs with and without a 59 phosphate with equal efficiency, albeit there are differences in cleavage site selection. Conclusions: Our data show that efficient HJ resolution by RuvC depends on the 59 phosphate revealed by incision of the first strand. This is a hitherto unappreciated factor in promoting accelerated second strand cleavage. However, a 59 phosphate is not a universal requirement since efficient cleavage by Mus81-Eme1 appears to depend solely on the increased junction flexibility that is developed by the first incision.			Osman, F (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	matthew.whitby@bioch.ox.ac.uk		Whitby, Matthew/0000-0003-0951-3374	Wellcome Trust [057586/Z/99/A] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bastin-Shanower SA, 2003, MOL CELL BIOL, V23, P3487, DOI 10.1128/MCB.23.10.3487-3496.2003; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Ceschini S, 2001, EMBO J, V20, P6601, DOI 10.1093/emboj/20.23.6601; Chang JH, 2008, GENE DEV, V22, P1093, DOI 10.1101/gad.1618708; Ciccia A, 2003, J BIOL CHEM, V278, P25172, DOI 10.1074/jbc.M302882200; Declais AC, 2008, CURR OPIN STRUC BIOL, V18, P86, DOI 10.1016/j.sbi.2007.11.001; DUNDERDALE HJ, 1994, J BIOL CHEM, V269, P5187; Fogg JM, 2000, BIOCHEMISTRY-US, V39, P16125, DOI 10.1021/bi001886m; Gaillard PHL, 2003, MOL CELL, V12, P747, DOI 10.1016/S1097-2765(03)00342-3; Gaskell LJ, 2007, EMBO J, V26, P1891, DOI 10.1038/sj.emboj.7601645; Hollingsworth NM, 2004, GENE DEV, V18, P117, DOI 10.1101/gad.1165904; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Klenchin VA, 2008, NUCLEIC ACIDS RES, V36, P5855, DOI 10.1093/nar/gkn577; Lilley DMJ, 2001, NAT REV MOL CELL BIO, V2, P433, DOI 10.1038/35073057x; Liu J, 2004, J MOL BIOL, V343, P851, DOI 10.1016/j.jmb.2004.08.079; Mullen JR, 2001, GENETICS, V157, P103; Ogrunc M, 2003, J BIOL CHEM, V278, P21715, DOI 10.1074/jbc.M302484200; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; Osman F, 2007, DNA REPAIR, V6, P1004, DOI 10.1016/j.dnarep.2007.02.019; PARSONS PA, 1990, FUNCT ECOL, V4, P265; Sha RJ, 2000, BIOCHEMISTRY-US, V39, P11982, DOI 10.1021/bi001037z; Shah R, 1997, EMBO J, V16, P1464, DOI 10.1093/emboj/16.6.1464; SHAH R, 1994, CELL, V79, P853, DOI 10.1016/0092-8674(94)90074-4; Sharples GJ, 2001, MOL MICROBIOL, V39, P823, DOI 10.1046/j.1365-2958.2001.02284.x; Taylor ER, 2008, P NATL ACAD SCI USA, V105, P3757, DOI 10.1073/pnas.0710291105; Whitby MC, 1998, J BIOL CHEM, V273, P35063, DOI 10.1074/jbc.273.52.35063	26	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5347	10.1371/journal.pone.0005347	http://dx.doi.org/10.1371/journal.pone.0005347			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399178	Green Submitted, Green Published, gold			2022-12-25	WOS:000265514900011
J	Cornelissen, PL; Kringelbach, ML; Ellis, AW; Whitney, C; Holliday, IE; Hansen, PC				Cornelissen, Piers L.; Kringelbach, Morten L.; Ellis, Andrew W.; Whitney, Carol; Holliday, Ian E.; Hansen, Peter C.			Activation of the Left Inferior Frontal Gyrus in the First 200 ms of Reading: Evidence from Magnetoencephalography (MEG)	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; TIME-COURSE; SPATIAL-DISTRIBUTION; LETTER STRINGS; FORM AREA; BRAIN; ORGANIZATION; PERCEPTION; DYNAMICS; CORTEX	Background: It is well established that the left inferior frontal gyrus plays a key role in the cerebral cortical network that supports reading and visual word recognition. Less clear is when in time this contribution begins. We used magnetoencephalography (MEG), which has both good spatial and excellent temporal resolution, to address this question. Methodology/Principal Findings: MEG data were recorded during a passive viewing paradigm, chosen to emphasize the stimulus-driven component of the cortical response, in which right-handed participants were presented words, consonant strings, and unfamiliar faces to central vision. Time-frequency analyses showed a left-lateralized inferior frontal gyrus (pars opercularis) response to words between 100-250 ms in the beta frequency band that was significantly stronger than the response to consonant strings or faces. The left inferior frontal gyrus response to words peaked at,130 ms. This response was significantly later in time than the left middle occipital gyrus, which peaked at,115 ms, but not significantly different from the peak response in the left mid fusiform gyrus, which peaked at,140 ms, at a location coincident with the fMRI defined visual word form area (VWFA). Significant responses were also detected to words in other parts of the reading network, including the anterior middle temporal gyrus, the left posterior middle temporal gyrus, the angular and supramarginal gyri, and the left superior temporal gyrus. Conclusions/Significance: These findings suggest very early interactions between the vision and language domains during visual word recognition, with speech motor areas being activated at the same time as the orthographic word-form is being resolved within the fusiform gyrus. This challenges the conventional view of a temporally serial processing sequence for visual word recognition in which letter forms are initially decoded, interact with their phonological and semantic representations, and only then gain access to a speech code.			Cornelissen, PL (corresponding author), Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England.	p.cornelissen@psych.york.ac.uk	Kringelbach, Morten L/AAF-5508-2020; Cornelissen, Piers/F-5391-2010; Kringelbach, Morten/AAW-5847-2021; Cornelissen, Piers L/K-4914-2012; Hansen, Peter C/F-3163-2010	Kringelbach, Morten/0000-0002-3908-6898; Cornelissen, Piers L/0000-0002-2695-9581; Hansen, Peter C/0000-0002-4948-1007	Wellcome Trust [GR068580] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ashby J, 2009, BIOL PSYCHOL, V80, P84, DOI 10.1016/j.biopsycho.2008.03.009; Assadollahi R, 2003, NEUROREPORT, V14, P1183, DOI 10.1097/00001756-200306110-00016; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Ben-Shachar M, 2007, NEUROIMAGE, V37, P1396, DOI 10.1016/j.neuroimage.2007.05.060; Bokde ALW, 2001, NEURON, V30, P609, DOI 10.1016/S0896-6273(01)00288-4; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Brookes MJ, 2005, NEUROIMAGE, V26, P302, DOI 10.1016/j.neuroimage.2005.01.050; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Burton MW, 2005, NEUROIMAGE, V26, P647, DOI 10.1016/j.neuroimage.2005.02.024; Carreiras M, 2005, PSYCHOL SCI, V16, P585, DOI 10.1111/j.1467-9280.2005.01579.x; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; CORNELISSEN P, 1995, VISION RES, V35, P1483, DOI 10.1016/0042-6989(95)98728-R; Cornelissen P, 2003, J COGNITIVE NEUROSCI, V15, P731, DOI 10.1162/jocn.2003.15.5.731; Cornelissen PL, 1998, VISION RES, V38, P471, DOI 10.1016/S0042-6989(97)00199-5; David Milner A, 1995, MAG VISUAL BRAIN ACT; DEHAENE S, 1995, NEUROREPORT, V6, P2153, DOI 10.1097/00001756-199511000-00014; Dejerine J., 1895, ANATOMIE CTR NERVEUX, VVol. 1; Dhond RP, 2001, J NEUROSCI, V21, P3564, DOI 10.1523/JNEUROSCI.21-10-03564.2001; Dhond RP, 2007, HUM BRAIN MAPP, V28, P355, DOI 10.1002/hbm.20282; Ellis AW, 2006, NEUROIMAGE, V33, P958, DOI 10.1016/j.neuroimage.2006.07.040; FERRERA VP, 1992, NATURE, V358, P756, DOI 10.1038/358756a0; Fiebach CJ, 2002, J COGNITIVE NEUROSCI, V14, P11, DOI 10.1162/089892902317205285; Fiez JA, 1998, P NATL ACAD SCI USA, V95, P914, DOI 10.1073/pnas.95.3.914; Fink G. R., 2006, BROCAS REGION; Gold BT, 2007, J COGNITIVE NEUROSCI, V19, P1983, DOI 10.1162/jocn.2007.19.12.1983; Hadjipapas A, 2005, CLIN NEUROPHYSIOL, V116, P1300, DOI 10.1016/j.clinph.2005.01.014; Halgren E, 2006, NEUROIMAGE, V30, P1401, DOI 10.1016/j.neuroimage.2005.10.053; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P51, DOI 10.1016/0928-4257(94)90093-0; Hansen PC, 2001, NEUROREPORT, V12, P1527, DOI 10.1097/00001756-200105250-00045; Harm MW, 2004, PSYCHOL REV, V111, P662, DOI 10.1037/0033-295X.111.3.662; Hauk O, 2006, NEUROIMAGE, V30, P1383, DOI 10.1016/j.neuroimage.2005.11.048; Heim S, 2005, COGNITIVE BRAIN RES, V25, P982, DOI 10.1016/j.cogbrainres.2005.09.022; Hillebrand A, 2005, INT REV NEUROBIOL, V68, P149, DOI 10.1016/S0074-7742(05)68006-3; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Hirata M, 2002, NEUROSCI LETT, V318, P73, DOI 10.1016/S0304-3940(01)02483-1; Ioannides AA, 2006, NEUROSCIENTIST, V12, P524, DOI 10.1177/1073858406293696; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Joubert S, 2004, BRAIN LANG, V89, P9, DOI 10.1016/S0093-934X(03)00403-6; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Kober H, 2001, HUM BRAIN MAPP, V14, P236, DOI 10.1002/hbm.1056; Kujala J, 2007, CEREB CORTEX, V17, P1476, DOI 10.1093/cercor/bhl059; Lachaux JP, 2008, CEREB CORTEX, V18, P443, DOI 10.1093/cercor/bhm085; Lee HW, 1999, PSYCHON B REV, V6, P624, DOI 10.3758/BF03212971; Liu LC, 1996, BRAIN TOPOGR, V8, P385, DOI 10.1007/BF01186914; LUKATELA G, 1994, J EXP PSYCHOL GEN, V123, P331, DOI 10.1037/0096-3445.123.4.331; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Maratos FA, 2007, NEUROIMAGE, V34, P371, DOI 10.1016/j.neuroimage.2006.09.017; Marinkovic K, 2003, NEURON, V38, P487, DOI 10.1016/S0896-6273(03)00197-1; Martin-Loeches M, 1999, BRAIN LANG, V70, P364, DOI 10.1006/brln.1999.2178; MAUNSELL JHR, 1990, J NEUROSCI, V10, P3323; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; NOBRE AC, 1994, NATURE, V372, P260, DOI 10.1038/372260a0; Pammer K, 2004, NEUROIMAGE, V22, P1819, DOI 10.1016/j.neuroimage.2004.05.004; PATTON HD, 1982, PHYSL BIOPHYSICS, V4, P101; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Press W. H., 1992, ART SCI COMPUTING; Pugh KR, 1996, BRAIN, V119, P1221, DOI 10.1093/brain/119.4.1221; Pugh KR, 1997, J EXP PSYCHOL HUMAN, V23, P299, DOI 10.1037/0096-1523.23.2.299; PULVERMULLER F, 1995, ELECTROEN CLIN NEURO, V94, P357, DOI 10.1016/0013-4694(94)00291-R; Pulvermuller F, 2001, EUR J NEUROSCI, V13, P201, DOI 10.1046/j.0953-816X.2000.01380.x; Rizzolatti G, 1996, EXP BRAIN RES, V111, P246; Robinson S.E., 1999, RECENT ADV BIOMAGNET, P302; Rossell SL, 2003, NEUROPSYCHOLOGIA, V41, P550, DOI 10.1016/S0028-3932(02)00181-1; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; Salmelin R, 2000, BRAIN, V123, P1184, DOI 10.1093/brain/123.6.1184; Salmelin R, 2007, CLIN NEUROPHYSIOL, V118, P237, DOI 10.1016/j.clinph.2006.07.316; Sekihara K, 2002, IEEE T BIO-MED ENG, V49, P1534, DOI 10.1109/TBME.2002.805485; Seteno S. C., 1998, NEUROREPORT, V9, P2195; Singh KD, 2002, NEUROIMAGE, V16, P103, DOI 10.1006/nimg.2001.1050; Singh KD, 2006, METHODS MIND, P291; Snyder HR, 2007, J COGNITIVE NEUROSCI, V19, P761, DOI 10.1162/jocn.2007.19.5.761; Sperling AJ, 2003, NEUROPSYCHOLOGIA, V41, P1422, DOI 10.1016/S0028-3932(03)00044-7; Talcott JB, 2000, P NATL ACAD SCI USA, V97, P2952, DOI 10.1073/pnas.040546597; Taniguchi M, 2000, NEUROIMAGE, V12, P298, DOI 10.1006/nimg.2000.0611; Tarkiainen A, 1999, BRAIN, V122, P2119, DOI 10.1093/brain/122.11.2119; Tarkiainen A, 2003, NEUROIMAGE, V19, P1194, DOI 10.1016/S1053-8119(03)00161-7; Ukai S, 2002, NEUROSCI LETT, V334, P9, DOI 10.1016/S0304-3940(02)01002-9; Van Veen B. D., 1988, IEEE ASSP Magazine, V5, P4, DOI 10.1109/53.665; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vinckier F, 2007, NEURON, V55, P143, DOI 10.1016/j.neuron.2007.05.031; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wilson T, 2005, EXP BRAIN RES, V162, P1, DOI 10.1007/s00221-004-2099-3; YOUNG MP, 1995, PHILOS T ROY SOC B, V348, P281, DOI 10.1098/rstb.1995.0069	89	105	105	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2009	4	4							e5359	10.1371/journal.pone.0005359	http://dx.doi.org/10.1371/journal.pone.0005359			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VI	19396362	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000265514600006
J	Gliozzi, AS; Guiot, C; Delsanto, PP				Gliozzi, Antonio S.; Guiot, Caterina; Delsanto, Pier Paolo			A New Computational Tool for the Phenomenological Analysis of Multipassage Tumor Growth Curves	PLOS ONE			English	Article							CANCER; SPHEROIDS; MODEL; BIOLOGY	Multipassage experiments are performed by subcutaneous implantation in lab animals (usually mice) of a small number of cells from selected human lines. Tumor cells are then passaged from one mouse to another by harvesting them from a growing tumor and implanting them into other healthy animals. This procedure may be extremely useful to investigate the various mechanisms involved in the long term evolution of tumoral growth. It has been observed by several researchers that, contrary to what happens in in vitro experiments, there is a significant growth acceleration at each new passage. This result is explained by a new method of analysis, based on the Phenomenological Universalities approach. It is found that, by means of a simple rescaling of time, it is possible to collapse all the growth curves, corresponding to the successive passages, into a single curve, belonging to the Universality Class U2. Possible applications are proposed and the need of further experimental evidence is discussed.			Gliozzi, AS (corresponding author), Politecn Torino, Dept Phys, Turin, Italy.	antonio.gliozzi@polito.it	Gliozzi, Antonio/G-7769-2012; guiot, caterina/C-6708-2009	guiot, caterina/0000-0001-8529-1625; GLIOZZI, ANTONIO/0000-0003-1084-0444				BENIERS AJMC, 1992, AM J PATHOL, V140, P483; BOGDEN AE, 1978, CANCER RES, V38, P59; Castorina P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.188701; Chignola R, 2000, CELL PROLIFERAT, V33, P219, DOI 10.1046/j.1365-2184.2000.00174.x; Delsanto PP, 2008, J THEOR BIOL, V250, P16, DOI 10.1016/j.jtbi.2007.09.023; Delsanto PP, 2009, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-5; Delsanto PP, 2000, PHYS REV E, V62, P2547, DOI 10.1103/PhysRevE.62.2547; Delsanto PP, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.148105; Delsanto PP, 2005, PHYS SCRIPTA, VT118, P157, DOI 10.1238/Physica.Topical.118a00157; Delsanto PP, 2004, APPL PHYS LETT, V85, P4225, DOI 10.1063/1.1812842; Delsanto PP, 2007, UNIVERSALITY NONCLAS; DELSANTO PP, 2008, APPL PHYS LETT UNPUB; FIDLER IJ, 1978, CANCER RES, V38, P2651; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; FREYER JP, 1986, CANCER RES, V46, P3504; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; Gompertz B, 1825, PHILOS T ROY SOC LON, V31, P513, DOI [10.1098/rstl.1825.0026, DOI 10.1098/RSTL.1825.0026]; Guiot C, 2003, J THEOR BIOL, V225, P147, DOI 10.1016/S0022-5193(03)00221-2; Guiot C, 2007, PHYS BIOL, V4, pP1, DOI 10.1088/1478-3975/4/4/P01; Kerbel RS, 2003, CANCER BIOL THER, V2, pS134; MCCREDIE JA, 1971, CANCER, V27, P635, DOI 10.1002/1097-0142(197103)27:3<635::AID-CNCR2820270319>3.0.CO;2-F; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Pugno N, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046103; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Sansone BC, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.021903; Savage VM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000171; Scalerandi M, 1999, PHYS REV E, V59, P2206, DOI 10.1103/PhysRevE.59.2206; Shen XH, 2006, CANCER BIOL THER, V5, P1313, DOI 10.4161/cbt.5.10.3157; Steel GG, 1977, GROWTH KINETICS TUMO; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 2004, PHYS TODAY, V57, P36, DOI 10.1063/1.1809090	33	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2009	4	4							e5358	10.1371/journal.pone.0005358	http://dx.doi.org/10.1371/journal.pone.0005358			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VI	19396358	Green Published, Green Submitted, gold			2022-12-25	WOS:000265514600005
J	Koenig, JE; Sharp, C; Dlutek, M; Curtis, B; Joss, M; Boucher, Y; Doolittle, WF				Koenig, Jeremy E.; Sharp, Christine; Dlutek, Marlena; Curtis, Bruce; Joss, Michael; Boucher, Yan; Doolittle, W. Ford			Integron Gene Cassettes and Degradation of Compounds Associated with Industrial Waste: The Case of the Sydney Tar Ponds	PLOS ONE			English	Article								Integrons are genetic platforms that accelerate lateral gene transfer (LGT) among bacteria. They were first detected on plasmids bearing single and multiple drug resistance determinants in human pathogens, and it is abundantly clear that integrons have played a major role in the evolution of this public health menace. Similar genetic elements can be found in nonpathogenic environmental bacteria and in metagenomic environmental DNA samples, and it is reasonable to suppose that integrons have facilitated microbial adaptation through LGT in niches outside infectious disease wards. Here we show that a heavily impacted estuary, exposed for almost a century to products of coal and steel industries, has developed a rich and unique cassette metagenome, containing genes likely to aid in the catabolism of compounds associated with industrial waste found there. In addition, we report that the most abundant cassette recovered in this study is one that encodes a putative LysR protein. This autoregulatory transcriptional regulator is known to activate transcription of linked target genes or unlinked regulons encoding diverse functions including chlorocatechol and dichlorophenol catabolism. Finally, only class 1 integrase genes were amplified in this study despite using different primer sets, and it may be that the cassettes present in the Tar Ponds will prove to be associated with class 1 integrase genes. Nevertheless, our cassette library provides a snapshot of a complex evolutionary process involving integron-meditated LGT likely to be important in natural bioremediation.			Koenig, JE (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	j.edmund.koenig@gmail.com	Boucher, Yan/A-5505-2010; Boucher, Yann Felix/H-4576-2019; Sharp, Christine/L-1439-2014; Boucher, Yan/A-2618-2014	Boucher, Yann Felix/0000-0002-0036-6083; Doolittle, W. Ford/0000-0002-4675-8832				Atlas RM, 2005, HDB MEDIA ENV MICROB; ATWELL PHP, 1982, AMBIENT AIR PAH STUD; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; BAND PCM, 2003, MORTALITY RATES SYDN, P1961; Boucher Y, 2007, TRENDS MICROBIOL, V15, P301, DOI 10.1016/j.tim.2007.05.004; CHAO A, 1984, SCAND J STAT, V11, P265; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; COCO WM, 1993, J BACTERIOL, V175, P417, DOI 10.1128/JB.175.2.417-427.1993; Collis CM, 2002, MOL MICROBIOL, V46, P1415, DOI 10.1046/j.1365-2958.2002.03260.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dodds L, 2001, CAN J PUBLIC HEALTH, V92, P331, DOI 10.1007/BF03404991; Elsaied H, 2007, ENVIRON MICROBIOL, V9, P2298, DOI 10.1111/j.1462-2920.2007.01344.x; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Ferraroni M, 2006, J MOL BIOL, V360, P788, DOI 10.1016/j.jmb.2006.05.046; FERRY JG, 1992, J BACTERIOL, V174, P5489, DOI 10.1128/JB.174.17.5489-5495.1992; Furimsky E, 2002, ENVIRON MANAGE, V30, P872, DOI 10.1007/s00267-002-2649-z; Gillings M, 2008, J BACTERIOL, V190, P5095, DOI 10.1128/JB.00152-08; GORDON D, 2004, CURRENT PROTOCOLS BI; Guernsey JR, 2000, CAN J PUBLIC HEALTH, V91, P285, DOI 10.1007/BF03404291; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Holmes AJ, 2003, ENVIRON MICROBIOL, V5, P383, DOI 10.1046/j.1462-2920.2003.00429.x; Hong SH, 2006, P NATL ACAD SCI USA, V103, P117, DOI 10.1073/pnas.0507245102; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jackson BE, 1999, ARCH MICROBIOL, V171, P107, DOI 10.1007/s002030050685; *JDAC LE, 2000, PHAS 2 3 ENV SIT ASS; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Katz LA, 2000, MOL PHYLOGENET EVOL, V14, P318, DOI 10.1006/mpev.1999.0695; KOENIG JE, 2008, ENV MICROBIOL; Lambert TW, 2004, ENVIRON HEALTH PERSP, V112, P35, DOI 10.1289/ehp.6423; Lawrence JG, 1996, GENETICS, V143, P1843; LEVESQUE C, 1994, GENE, V142, P49, DOI 10.1016/0378-1119(94)90353-0; Lovley DR, 2001, SCIENCE, V293, P1444, DOI 10.1126/science.1063294; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; Mongodin EF, 2006, PLOS GENET, V2, P2094, DOI 10.1371/journal.pgen.0020214; Nemergut DR, 2004, APPL ENVIRON MICROB, V70, P1160, DOI 10.1128/AEM.70.2.1160-1168.2004; ORNSTON LN, 1966, J BIOL CHEM, V241, P3795; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; PLATT A, 1995, MICROBIOL-UK, V141, P2223, DOI 10.1099/13500872-141-9-2223; QIU R, 2008, J HAZARD MAT; ROTHMEL RK, 1990, J BACTERIOL, V172, P922, DOI 10.1128/jb.172.2.922-931.1990; Rowe-Magnus DA, 2003, GENOME RES, V13, P428, DOI 10.1101/gr.617103; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Shen XH, 2005, SCI CHINA SER C, V48, P241, DOI 10.1360/062004-32; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STOKES HW, 1989, MOL MICROBIOL, V3, P1669, DOI 10.1111/j.1365-2958.1989.tb00153.x; Stokes HW, 2001, APPL ENVIRON MICROB, V67, P5240, DOI 10.1128/AEM.67.11.5240-5246.2001; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timmis KN, 1999, TRENDS BIOTECHNOL, V17, P201, DOI 10.1016/S0167-7799(98)01295-5; Wright MS, 2008, ISME J, V2, P417, DOI 10.1038/ismej.2008.8; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708	54	35	37	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5276	10.1371/journal.pone.0005276	http://dx.doi.org/10.1371/journal.pone.0005276			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390587	Green Published, gold, Green Submitted			2022-12-25	WOS:000265514200007
J	Altieri, AH; Trussell, GC; Ewanchuk, PJ; Bernatchez, G; Bracken, MES				Altieri, Andrew H.; Trussell, Geoffrey C.; Ewanchuk, Patrick J.; Bernatchez, Genevieve; Bracken, Matthew E. S.			Consumers Control Diversity and Functioning of a Natural Marine Ecosystem	PLOS ONE			English	Article								Background: Our understanding of the functional consequences of changes in biodiversity has been hampered by several limitations of previous work, including limited attention to trophic interactions, a focus on species richness rather than evenness, and the use of artificially assembled communities. Methodology and Principal Findings: In this study, we manipulated the density of an herbivorous snail in natural tide pools and allowed seaweed communities to assemble in an ecologically relevant and non-random manner. Seaweed species evenness and biomass-specific primary productivity (mg O-2 h(-1) g(-1)) were higher in tide pools with snails because snails preferentially consumed an otherwise dominant seaweed species that can reduce biomass-specific productivity rates of algal assemblages. Although snails reduced overall seaweed biomass in tide pools, they did not affect gross primary productivity at the scale of tide pools (mg O-2 h(-1) pool(-1) or mg O-2 h(-1) m(-2)) because of the enhanced biomass-specific productivity associated with grazer-mediated increases in algal evenness. Significance: Our results suggest that increased attention to trophic interactions, diversity measures other than richness, and particularly the effects of consumers on evenness and primary productivity, will improve our understanding of the relationship between diversity and ecosystem functioning and allow more effective links between experimental results and real-world changes in biodiversity.			Altieri, AH (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	g.trussell@neu.edu	Bracken, Matthew E S/B-1259-2008; Altieri, Andrew H/P-1738-2017; Bracken, Matthew E.S./I-9359-2019; Trussell, Geoffrey/AAQ-9165-2020	Bracken, Matthew E S/0000-0002-0068-7485; Bracken, Matthew E.S./0000-0002-0068-7485; Altieri, Andrew/0000-0001-7439-8742				Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Binzer T, 2005, MAR ECOL PROG SER, V287, P65, DOI 10.3354/meps287065; Bjork M, 2004, MAR ECOL PROG SER, V284, P109, DOI 10.3354/meps284109; Bracken MES, 2008, P NATL ACAD SCI USA, V105, P924, DOI 10.1073/pnas.0704103105; Bracken MES, 2007, ECOLOGY, V88, P2211, DOI 10.1890/06-0881.1; Bruno JF, 2005, ECOL LETT, V8, P1048, DOI 10.1111/j.1461-0248.2005.00808.x; Bruno JF, 2006, OIKOS, V115, P170, DOI 10.1111/j.2006.0030-1299.14927.x; Brush MJ, 2003, ESTUARIES, V26, P916, DOI 10.1007/BF02803350; CARPENTER RC, 1986, ECOL MONOGR, V56, P345, DOI 10.2307/1942551; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Duffy JE, 2002, OIKOS, V99, P201, DOI 10.1034/j.1600-0706.2002.990201.x; Duffy JE, 2005, ECOL LETT, V8, P301, DOI 10.1111/j.1461-0248.2005.00725.x; Flombaum P, 2008, P NATL ACAD SCI USA, V105, P6087, DOI 10.1073/pnas.0704801105; Gruner DS, 2008, ECOL LETT, V11, P740, DOI 10.1111/j.1461-0248.2008.01192.x; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; Hillebrand H, 2007, P NATL ACAD SCI USA, V104, P10904, DOI 10.1073/pnas.0701918104; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; JOHNSON WS, 1974, ECOLOGY, V55, P450, DOI 10.2307/1935235; Kirwan L, 2007, J ECOL, V95, P530, DOI 10.1111/j.1365-2745.2007.01225.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; LUBCHENCO J, 1978, AM NAT, V112, P23, DOI 10.1086/283250; Mulder CPH, 1999, ECOL LETT, V2, P237; Mulder CPH, 2004, OIKOS, V107, P50, DOI 10.1111/j.0030-1299.2004.13110.x; Nielsen KJ, 2003, P NATL ACAD SCI USA, V100, P7660, DOI 10.1073/pnas.0932534100; Nielsen KJ, 2001, ECOL MONOGR, V71, P187, DOI 10.1890/0012-9615(2001)071[0187:BUATDF]2.0.CO;2; Nijs I, 2000, OIKOS, V88, P57, DOI 10.1034/j.1600-0706.2000.880107.x; Paine RT, 2002, SCIENCE, V296, P736, DOI 10.1126/science.1069811; Pfister CA, 2007, ECOLOGY, V88, P1647, DOI 10.1890/06-1913.1; Quinn GP, 2003, EXPT DESIGN DATA ANA; SANDEEN MI, 1954, PHYSIOL ZOOL, V27, P350, DOI 10.1086/physzool.27.4.30152371; Schmitz OJ, 2003, ECOL LETT, V6, P156, DOI 10.1046/j.1461-0248.2003.00412.x; Schmitz OJ, 2006, ECOLOGY, V87, P1432, DOI 10.1890/0012-9658(2006)87[1432:PHLEOE]2.0.CO;2; Schmitz OJ, 2008, ANNU REV ECOL EVOL S, V39, P133, DOI 10.1146/annurev.ecolsys.39.110707.173418; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Stachowicz JJ, 2008, P NATL ACAD SCI USA, V105, P18842, DOI 10.1073/pnas.0806425105; Stachowicz JJ, 2008, ECOLOGY, V89, P3008, DOI 10.1890/07-1873.1; STEINAUER EM, 1995, ECOLOGY, V76, P1195, DOI 10.2307/1940926; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Wilsey BJ, 2005, ECOLOGY, V86, P1178, DOI 10.1890/04-0394; Wilsey BJ, 2000, ECOLOGY, V81, P887, DOI 10.1890/0012-9658(2000)081[0887:BAEFIO]2.0.CO;2; Witman JD, 2004, P NATL ACAD SCI USA, V101, P15664, DOI 10.1073/pnas.0404300101; Zavaleta ES, 2004, SCIENCE, V306, P1175, DOI 10.1126/science.1102643	45	24	24	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5291	10.1371/journal.pone.0005291	http://dx.doi.org/10.1371/journal.pone.0005291			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384410	Green Published, gold, Green Submitted			2022-12-25	WOS:000265513900018
J	Angulo, E; Courchamp, F				Angulo, Elena; Courchamp, Franck			Rare Species Are Valued Big Time	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; RARITY; TRADE	Background: It has recently been postulated that the value humans place on rarity could cause the extinction of rare species. This is because people are willing to pay the high costs of exploiting the last individuals. Many hobbies, such as ecotourism or the keeping of exotic pets may cause this effect-known as the anthropogenic Allee effect. However, the entire theory relies on the insofar undemonstrated assumption that people do value rarity. Methodology/Principal Findings: In order to quantify how much people valued rare species relative to common ones, we created online slideshows of photographs of either rare or common species on an Internet web site. The slideshow with photographs of rare species attracted more visitors, and visitors spent, in general, more time waiting to view it. Conclusions/Significance: We provide evidence that people value rare more than common species. As we did not target consumers of a specific market, this finding suggests that the anthropogenic Allee effect is likely be driven by a large part of the population. Given the substantial participation in our online experiment, we highlight the potential of the world wide web resource as a tool for conservation action. However, the evidence presented here that the general public value rare species, combined with the assumption that anthropogenic Allee effect is operating, implies that conservationists should be prudent when using rarity to promote conservation.			Angulo, E (corresponding author), Univ Paris 11, CNRS, UMR 8079, F-91405 Orsay, France.	franck.courchamp@u-psud.fr	Angulo, Elena/A-8107-2013; Courchamp, Franck/ABE-7204-2020	Angulo, Elena/0000-0001-5545-4032; Courchamp, Franck/0000-0001-7605-4548				BAIN DE, 2002, MODEL LINKING ENERGE; Barnes JI, 1996, ECOL ECON, V18, P215, DOI 10.1016/0921-8009(96)00035-3; Brook BW, 2006, NATURE, V444, P555, DOI 10.1038/444555a; Clark C.W., 1990, MATH BIOECONOMICS OP; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Duarte-Quiroga A, 2003, AM J PRIMATOL, V61, P53, DOI 10.1002/ajp.10108; GAULT A, CONSERVATION LETT, V1, P199; Hall RJ, 2008, CONSERV LETT, V1, P75, DOI 10.1111/j.1755-263X.2008.00013.x; Jepson P, 2005, ORYX, V39, P442, DOI 10.1017/S0030605305001110; Li YM, 2000, BIODIVERS CONSERV, V9, P901; Martin-Lopez B, 2007, BIOL CONSERV, V139, P67, DOI 10.1016/j.biocon.2007.06.005; Ojea E, 2007, ECOL ECON, V63, P807, DOI 10.1016/j.ecolecon.2007.02.003; Rivalan P, 2007, NATURE, V447, P529, DOI 10.1038/447529a; SAS Institute Inc, 2004, SAS 9 1 3 HELP DOC; Slone TH, 1997, ECOL ECON, V21, P77, DOI 10.1016/S0921-8009(96)00096-1; StatSoft Inc. Statistica, 2001, DAT AN SOFTW SYST VE; Torgler B, 2007, ECOL ECON, V63, P536, DOI 10.1016/j.ecolecon.2006.12.013	17	35	35	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5215	10.1371/journal.pone.0005215	http://dx.doi.org/10.1371/journal.pone.0005215			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437VB	19384416	Green Published, Green Submitted, gold			2022-12-25	WOS:000265513900003
J	Boland, C; Hayes, P; Santa-Maria, I; Nishimura, S; Kelly, VP				Boland, Coilin; Hayes, Patti; Santa-Maria, Ismael; Nishimura, Susumu; Kelly, Vincent P.			Queuosine Formation in Eukaryotic tRNA Occurs via a Mitochondria-localized Heteromeric Transglycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER RIBONUCLEIC-ACID; NUCLEAR-EXPORT SIGNALS; GUANINE TRANSGLYCOSYLASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; BIOCHEMICAL-CHARACTERIZATION; ERYTHROLEUKEMIA-CELLS; QUEUINE; BASE; PURIFICATION	tRNA guanine transglycosylase (TGT) enzymes are responsible for the formation of queuosine in the anticodon loop ( position 34) of tRNAAsp, tRNAAsn, tRNAHis, and tRNATyr; an almost universal event in eubacterial and eukaryotic species. Despite extensive characterization of the eubacterial TGT the eukaryotic activity has remained undefined. Our search of mouse EST and cDNA data bases identified a homologue of the Escherichia coli TGT and three spliced variants of the queuine tRNA guanine transglycosylase domain containing 1 (QTRTD1) gene. QTRTD1 variant_1 (Qv1) was found to be the predominant adult form. Functional cooperativity of TGT and Qv1 was suggested by their coordinate mRNA expression in Northern blots and from their association in vivo by immunoprecipitation. Neither TGT nor Qv1 alone could complement a tgt mutation in E. coli. However, transglycosylase activity could be obtained when the proteins were combined in vitro. Confocal and immunoblot analysis suggest that TGT weakly interacts with the outer mitochondrial membrane possibly through association with Qv1, which was found to be stably associated with the organelle.	[Boland, Coilin; Hayes, Patti; Kelly, Vincent P.] Trinity Coll Dublin, Coll Green, Sch Biochem & Immunol, Dublin 2, Ireland; [Santa-Maria, Ismael] Univ Autonoma Madrid, Fac Ciencias, Ctr Biol Mol Severo Ochoa CSIC UAM, E-28049 Madrid, Spain; [Nishimura, Susumu] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan	Trinity College Dublin; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); University of Tsukuba	Kelly, VP (corresponding author), Trinity Coll Dublin, Coll Green, Sch Biochem & Immunol, Dublin 2, Ireland.	kellyvp@tcd.ie	Kelly, Vincent P/I-2151-2017; Santa-Maria, Ismael/AAI-7630-2020	Kelly, Vincent P/0000-0001-7067-5407; Boland, Coilin/0000-0001-6763-3767; Santa-Maria Perez, Ismael/0000-0003-2801-5020	Science Foundation Ireland [05-IN3-I761, BIMF318]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Programme Grant 05-IN3-I761 and Research Frontiers Grant BIMF318 from the Science Foundation Ireland.	Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; BARANOWSKI W, 1994, CANCER RES, V54, P4468; CARBON P, 1982, NUCLEIC ACIDS RES, V10, P3715, DOI 10.1093/nar/10.12.3715; CHEN YL, 1994, CANCER RES, V54, P2192; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Deshpande KL, 1996, ARCH BIOCHEM BIOPHYS, V326, P1, DOI 10.1006/abbi.1996.0039; Deshpande KL, 2001, GENE, V265, P205, DOI 10.1016/S0378-1119(01)00368-7; Dineshkumar TK, 2002, MICROBIOL-SGM, V148, P3779, DOI 10.1099/00221287-148-12-3779; DIRHEIMER G, 1995, BIOCHIMIE, V77, P99, DOI 10.1016/0300-9084(96)88111-9; Eppig JT, 2007, NUCLEIC ACIDS RES, V35, pD630, DOI 10.1093/nar/gkl940; Garcia GA, 2005, BIOORG CHEM, V33, P229, DOI 10.1016/j.bioorg.2005.01.001; GARCIA GA, 1993, J MOL BIOL, V231, P489, DOI 10.1006/jmbi.1993.1296; GREGSON JM, 1993, J BIOL CHEM, V268, P10076; GUNDUZ U, 1984, J BIOL CHEM, V259, P1110; GUNDUZ U, 1992, BIOCHIM BIOPHYS ACTA, V1139, P229, DOI 10.1016/0925-4439(92)90139-E; HAUMONT E, 1987, EUR J BIOCHEM, V168, P219, DOI 10.1111/j.1432-1033.1987.tb13408.x; HOOPS GC, 1995, BIOCHEMISTRY-US, V34, P15381, DOI 10.1021/bi00046a047; HOWES NK, 1978, J BIOL CHEM, V253, P9082; Ishitani R, 2002, J MOL BIOL, V318, P665, DOI 10.1016/S0022-2836(02)00090-6; Iwata-Reuyl D, 2003, BIOORG CHEM, V31, P24, DOI 10.1016/S0045-2068(02)00513-8; KASAI H, 1975, BIOCHEMISTRY-US, V14, P4198, DOI 10.1021/bi00690a008; KATZE JR, 1982, SCIENCE, V216, P55; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Marks T, 1997, BIOCHEM BIOPH RES CO, V230, P233, DOI 10.1006/bbrc.1996.5768; MORL M, 1995, NUCLEIC ACIDS RES, V23, P3380, DOI 10.1093/nar/23.17.3380; MORRIS RC, 1995, NUCLEIC ACIDS RES, V23, P2492, DOI 10.1093/nar/23.13.2492; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; NISHIKURA K, 1981, J MOL BIOL, V145, P405, DOI 10.1016/0022-2836(81)90212-6; NISHIMURA S, 1983, PROG NUCLEIC ACID RE, V28, P49, DOI 10.1016/S0079-6603(08)60082-3; OKADA N, 1979, J BIOL CHEM, V254, P3061; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; RANDERATH E, 1984, CANCER RES, V44, P1167; REUTER K, 1995, J BACTERIOL, V177, P5284, DOI 10.1128/jb.177.18.5284-5288.1995; Romier C, 1996, EMBO J, V15, P2850, DOI 10.1002/j.1460-2075.1996.tb00646.x; SHINDOOKADA N, 1980, BIOCHEMISTRY-US, V19, P395, DOI 10.1021/bi00543a023; SHINDOOKADA N, 1981, EUR J BIOCHEM, V115, P423, DOI 10.1111/j.1432-1033.1981.tb05254.x; SINGHAL RP, 1981, BIOCHEM BIOPH RES CO, V99, P120, DOI 10.1016/0006-291X(81)91721-6; SLANY RK, 1995, EUR J BIOCHEM, V230, P221, DOI 10.1111/j.1432-1033.1995.0221i.x; Stengl B, 2005, CHEMBIOCHEM, V6, P1926, DOI 10.1002/cbic.200500063; Thanaraj TA, 2004, NUCLEIC ACIDS RES, V32, pD64, DOI 10.1093/nar/gkh030; WALDEN TL, 1982, J BIOL CHEM, V257, P13218; Xie W, 2003, NAT STRUCT BIOL, V10, P781, DOI 10.1038/nsb976; Yang W. K., 1971, METHOD ENZYMOL, V20, P44	44	47	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18218	18227		10.1074/jbc.M109.002477	http://dx.doi.org/10.1074/jbc.M109.002477			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19414587	Green Published, hybrid			2022-12-25	WOS:000267712400034
J	Maruyama, Y; Nakamichi, Y; Itoh, T; Mikami, B; Hashimoto, W; Murata, K				Maruyama, Yukie; Nakamichi, Yusuke; Itoh, Takafumi; Mikami, Bunzo; Hashimoto, Wataru; Murata, Kousaku			Substrate Specificity of Streptococcal Unsaturated Glucuronyl Hydrolases for Sulfated Glycosaminoglycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SP GL1; CRYSTAL-STRUCTURE; HYALURONIDASE GENE; ESCHERICHIA-COLI; GENOME SEQUENCE; DEGRADATION; PNEUMONIAE; AGALACTIAE; ENZYME; PURIFICATION	Unsaturated glucuronyl hydrolase (UGL) categorized into the glycoside hydrolase family 88 catalyzes the hydrolytic release of an unsaturated glucuronic acid from glycosaminoglycan disaccharides, which are produced from mammalian extracellular matrices through the beta-elimination reaction of polysaccharide lyases. Here, we show enzyme characteristics of pathogenic streptococcal UGLs and structural determinants for the enzyme substrate specificity. The putative genes for UGL and phosphotransferase system for amino sugar, a component of glycosaminoglycans, are assembled into a cluster in the genome of pyogenic and hemolytic streptococci such as Streptococcus agalactiae, Streptococcus pneumoniae, and Streptococcus pyogenes, which produce extracellular hyaluronate lyase as a virulent factor. The UGLs of these three streptococci were overexpressed in Escherichia coli cells, purified, and characterized. Streptococcal UGLs degraded unsaturated hyaluronate and chondroitin disaccharides most efficiently at approximately pH 5.5 and 37 degrees C. Distinct from Bacillus sp. GL1 UGL, streptococcal UGLs preferred sulfated substrates. DNA microarray and Western blotting indicated that the enzyme was constitutively expressed in S. agalactiae cells, although the expression level increased in the presence of glycosaminoglycan. The crystal structure of S. agalactiae UGL (SagUGL) was determined at 1.75 A resolution by x-ray crystallography. SagUGL adopts alpha(6)/alpha(6)-barrel structure as a basic scaffold similar to Bacillus UGL, but the arrangement of amino acid residues in the active site differs between the two. SagUGL Arg-236 was found to be one of the residues involved in its activity for the sulfated substrate through structural comparison and site-directed mutagenesis. This is the first report on the structure and function of streptococcal UGLs.	[Maruyama, Yukie; Nakamichi, Yusuke; Itoh, Takafumi; Hashimoto, Wataru; Murata, Kousaku] Kyoto Univ, Grad Sch Agr, Lab Basic & Appl Mol Biotechnol, Kyoto 6110011, Japan; [Mikami, Bunzo] Kyoto Univ, Grad Sch Agr, Lab Appl Struct Biol, Kyoto 6110011, Japan	Kyoto University; Kyoto University	Murata, K (corresponding author), Kyoto Univ, Grad Sch Agr, Lab Basic & Appl Mol Biotechnol, Kyoto 6110011, Japan.	kmurata@kais.kyoto-u.ac.jp	Nakamichi, Yusuke/Y-2830-2019; Nakamichi, Yusuke/H-1221-2018	Nakamichi, Yusuke/0000-0001-7089-663X; Nakamichi, Yusuke/0000-0001-7089-663X	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science for Young Scientists	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants-in-aid from the Japan Society for the Promotion of Science (to K. M. and W. H.) and by Targeted Proteins Research Program (to W. H.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. This work was also supported in part by Research Fellowships from the Japan Society for the Promotion of Science for Young Scientists (to Y. M.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BERRY AM, 1994, INFECT IMMUN, V62, P1101, DOI 10.1128/IAI.62.3.1101-1108.1994; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brinkkotter A, 2000, MOL MICROBIOL, V37, P125, DOI 10.1046/j.1365-2958.2000.01969.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Gase K, 1998, BBA-GENE STRUCT EXPR, V1398, P86, DOI 10.1016/S0167-4781(98)00045-1; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Gunther E, 1996, ZBL BAKT-INT J MED M, V285, P64; Hashimoto W, 1997, ARCH BIOCHEM BIOPHYS, V339, P17, DOI 10.1006/abbi.1996.9851; HASHIMOTO W, 1995, J BIOCHEM-TOKYO, V118, P75, DOI 10.1093/oxfordjournals.jbchem.a124894; Hashimoto W, 1999, ARCH BIOCHEM BIOPHYS, V368, P367, DOI 10.1006/abbi.1999.1305; Hashimoto W, 2007, INT MICROBIOL, V10, P233, DOI 10.2436/20.1501.01.32; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Hynes WL, 2000, FEMS MICROBIOL LETT, V184, P109, DOI 10.1016/S0378-1097(00)00029-X; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Itoh T, 2000, J MOL BIOL, V303, P733, DOI 10.1006/jmbi.2000.4188; Itoh T, 2004, J BIOL CHEM, V279, P31804, DOI 10.1074/jbc.M403288200; Itoh T, 2006, J BIOL CHEM, V281, P29807, DOI 10.1074/jbc.M604975200; Itoh T, 2006, J MOL BIOL, V360, P573, DOI 10.1016/j.jmb.2006.04.047; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; JUY M, 1992, NATURE, V357, P89, DOI 10.1038/357089a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; LINDAHL U, 1978, ANNU REV BIOCHEM, V47, P385, DOI 10.1146/annurev.bi.47.070178.002125; Linhardt RJ, 2006, ADV PHARMACOL, V53, P187, DOI 10.1016/S1054-3589(05)53009-6; LINKER A, 1955, J BIOL CHEM, V213, P237; Mello LV, 2002, J BIOL CHEM, V277, P36678, DOI 10.1074/jbc.M205140200; Mori S, 2003, PROTEIN EXPRES PURIF, V29, P77, DOI 10.1016/S1046-5928(03)00019-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Myette JR, 2002, BIOCHEMISTRY-US, V41, P7424, DOI 10.1021/bi012147o; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATON JC, 1993, ANNU REV MICROBIOL, V47, P89, DOI 10.1146/annurev.mi.47.100193.000513; PRITCHARD DG, 1994, ARCH BIOCHEM BIOPHYS, V315, P431, DOI 10.1006/abbi.1994.1521; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sawitzky D, 1996, MED MICROBIOL IMMUN, V184, P155, DOI 10.1007/BF02456129; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yoshinari S, 2006, BIOCHEM BIOPH RES CO, V346, P1024, DOI 10.1016/j.bbrc.2006.06.011; Yum DY, 1999, APPL ENVIRON MICROB, V65, P3341	50	28	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18059	18069		10.1074/jbc.M109.005660	http://dx.doi.org/10.1074/jbc.M109.005660			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19416976	Green Published, hybrid			2022-12-25	WOS:000267712400017
J	Wu, JX; Prindle, MJ; Dressler, GR; Yu, XC				Wu, Jiaxue; Prindle, Marc J.; Dressler, Gregory R.; Yu, Xiaochun			PTIP Regulates 53BP1 and SMC1 at the DNA Damage Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H2AX PHOSPHORYLATION; DOUBLE-STRAND BREAKS; BRCT-DOMAIN; ATM ACTIVATION; CELLULAR-RESPONSES; GENOMIC STABILITY; PROTEIN PTIP; MDC1; REPAIR; BINDING	Although PTIP is implicated in the DNA damage response, through interactions with 53BP1, the function of PTIP in the DNA damage response remain elusive. Here, we show that RNF8 controls DNA damage-induced nuclear foci formation of PTIP, which in turn regulates 53BP1 localization to the DNA damage sites. In addition, SMC1, a substrate of ATM, could not be phosphorylated at the DNA damage sites in the absence of PTIP. The PTIP-dependent pathway is important for DNA double strand breaks repair and DNA damage-induced intra-S phase checkpoint activation. Taken together, these results suggest that the role of PTIP in the DNA damage response is downstream of RNF8 and upstream of 53BP1. Thus, PTIP regulates 53BP1-dependent signaling pathway following DNA damage.	[Prindle, Marc J.; Dressler, Gregory R.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Wu, Jiaxue; Yu, Xiaochun] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Dressler, GR (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	dressler@umich.edu; xiayu@umich.edu			National Institutes of Health [CA132755, CA130899, DK054740]; University of Michigan Cancer Center; GI Peptide Research Center of the University of Michigan; NATIONAL CANCER INSTITUTE [R01CA130899, R01CA132755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Cancer Center(University of Michigan System); GI Peptide Research Center of the University of Michigan(University of Michigan System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA132755 and CA130899 (to X. Y.) and DK054740 (to G. R. D.). This work was also supported by the University of Michigan Cancer Center and the GI Peptide Research Center of the University of Michigan.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Caldecott KW, 2003, SCIENCE, V302, P579, DOI 10.1126/science.1091463; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Charier G, 2004, STRUCTURE, V12, P1551, DOI 10.1016/j.str.2004.06.014; Cho EA, 2003, MOL CELL BIOL, V23, P1666, DOI 10.1128/MCB.23.5.1666-1673.2003; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Daniel JA, 2008, J CELL BIOL, V183, P777, DOI 10.1083/jcb.200805154; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Gong ZH, 2009, J BIOL CHEM, V284, P7284, DOI 10.1074/jbc.M809158200; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Jowsey PA, 2004, J BIOL CHEM, V279, P55562, DOI 10.1074/jbc.M411021200; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Lechner MS, 2000, NUCLEIC ACIDS RES, V28, P2741, DOI 10.1093/nar/28.14.2741; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Minter-Dykhouse K, 2008, J CELL BIOL, V181, P727, DOI 10.1083/jcb.200801083; Mochan TA, 2003, CANCER RES, V63, P8586; Munoz IM, 2007, NUCLEIC ACIDS RES, V35, P5312, DOI 10.1093/nar/gkm493; Nakamura K, 2006, DNA REPAIR, V5, P741, DOI 10.1016/j.dnarep.2006.03.008; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Patel SR, 2007, DEV CELL, V13, P580, DOI 10.1016/j.devcel.2007.09.004; Pellegrini M, 2006, NATURE, V443, P222, DOI 10.1038/nature05112; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Schar P, 2004, NUCLEIC ACIDS RES, V32, P3921, DOI 10.1093/nar/gkh716; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stracker TH, 2007, NATURE, V447, P218, DOI 10.1038/nature05740; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753	66	30	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18078	18084		10.1074/jbc.M109.002527	http://dx.doi.org/10.1074/jbc.M109.002527			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19414588	hybrid, Green Published			2022-12-25	WOS:000267712400019
J	Adair, JE; Stober, V; Sobhany, M; Zhuo, LS; Roberts, JD; Negishi, M; Kimata, K; Garantziotis, S				Adair, Jennifer E.; Stober, Vandy; Sobhany, Mack; Zhuo, Lisheng; Roberts, John D.; Negishi, Masahiko; Kimata, Koji; Garantziotis, Stavros			Inter-alpha-trypsin Inhibitor Promotes Bronchial Epithelial Repair after Injury through Vitronectin Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; SHAP-HYALURONAN COMPLEX; LUNG INJURY; CELLS; MIGRATION; INTEGRIN; PROVIDES; CD44; GENE; KEY	Pulmonary epithelial injury is central to the pathogenesis of many lung diseases, such as asthma, pulmonary fibrosis, and the acute respiratory distress syndrome. Regulated epithelial repair is crucial for lung homeostasis and prevents scar formation and inflammation that accompany dysregulated healing. The extracellular matrix (ECM) plays an important role in epithelial repair after injury. Vitronectin is a major ECM component that promotes epithelial repair. However, the factors that modify cell-vitronectin interactions after injury and help promote epithelial repair are not well studied. Inter-alpha-trypsin inhibitor (IaI) is an abundant serum protein. IaI heavy chains contain von Willebrand A domains that can bind the arginine-glycine-aspartate domain of vitronectin. We therefore hypothesized that IaI can bind vitronectin and promote vitronectin-induced epithelial repair after injury. We show that IaI binds vitronectin at the arginine-glycine-aspartate site, thereby promoting epithelial adhesion and migration in vitro. Furthermore, we show that IaI-deficient mice have a dysregulated response to epithelial injury in vivo, consisting of decreased proliferation and epithelial metaplasia. We conclude that IaI interacts not only with hyaluronan, as previously reported, but also other ECM components like vitronectin and is an important regulator of cellular repair after injury.	[Garantziotis, Stavros] NIEHS, Res Triangle Pk, NC 27709 USA; [Zhuo, Lisheng; Kimata, Koji] Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Aichi Medical University	Garantziotis, S (corresponding author), NIEHS, Res Triangle Pk, NC 27709 USA.	garantziotis@niehs.nih.gov	Negishi, Masahiko/F-7805-2019; Garantziotis, Stavros/A-6903-2009	Negishi, Masahiko/0000-0002-2076-8928; Garantziotis, Stavros/0000-0003-4007-375X; Adair, Jennifer/0000-0003-4599-016X	National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES102605, ZIAES102605, ZIAES080040, Z01ES080040, Z01ES023018] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program.	Bayram H, 2002, CLIN EXP ALLERGY, V32, P1285, DOI 10.1046/j.1365-2745.2002.01435.x; Bloemendal HJ, 2004, CANCER IMMUNOL IMMUN, V53, P799, DOI 10.1007/s00262-004-0506-z; Casey RC, 2000, CLIN EXP METASTAS, V18, P67, DOI 10.1023/A:1026519016213; Craig D, 2004, STRUCTURE, V12, P2049, DOI 10.1016/j.str.2004.09.009; Fedorov IA, 2005, THORAX, V60, P389, DOI 10.1136/thx.2004.030262; Forrest IA, 2005, EUR RESPIR J, V26, P1080, DOI 10.1183/09031936.05.00141404; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Garantziotis S, 2008, AM J RESP CRIT CARE, V178, P939, DOI 10.1164/rccm.200803-386OC; Garantziotis S, 2007, J IMMUNOL, V179, P4187, DOI 10.4049/jimmunol.179.6.4187; JALKANEN S, 1992, J CELL BIOL, V116, P817, DOI 10.1083/jcb.116.3.817; Lazar MH, 2004, AM J RESP CELL MOL, V31, P672, DOI 10.1165/rcmb.2004-0025OC; Lechner J F, 1985, J TISSUE CULT METHOD, V9, P43; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Minor KH, 2005, J BIOL CHEM, V280, P28711, DOI 10.1074/jbc.M500478200; Miyazaki T, 2004, J BIOL CHEM, V279, P44667, DOI 10.1074/jbc.M408101200; PREISSNER KT, 1990, BIOCHEM BIOPH RES CO, V168, P966, DOI 10.1016/0006-291X(90)91123-A; PRESS WH, 1989, NUMERICAL RECIPES FO; Puchelle Edith, 2006, Proc Am Thorac Soc, V3, P726, DOI 10.1513/pats.200605-126SF; Redondo-Munoz J, 2008, BLOOD, V112, P169, DOI 10.1182/blood-2007-08-109249; SEIFFERT D, 1991, BIOCHIM BIOPHYS ACTA, V1078, P23, DOI 10.1016/0167-4838(91)90087-G; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Selman Moises, 2006, Proc Am Thorac Soc, V3, P364, DOI 10.1513/pats.200601-003TK; Stripp BR, 1995, AM J PHYSIOL-LUNG C, V269, pL791, DOI 10.1152/ajplung.1995.269.6.L791; Tomashefski JF, 2000, CLIN CHEST MED, V21, P435, DOI 10.1016/S0272-5231(05)70158-1; Wadsworth SJ, 2004, AM J PHYSIOL-LUNG C, V286, pL596, DOI 10.1152/ajplung.00217.2003; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhuo LS, 2004, J BIOL CHEM, V279, P38079, DOI 10.1074/jbc.R300039200; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	29	26	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16922	16930		10.1074/jbc.M808560200	http://dx.doi.org/10.1074/jbc.M808560200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19395377	Green Published, hybrid			2022-12-25	WOS:000266962400029
J	Ardura, MI; Banchereau, R; Mejias, A; Di Pucchio, T; Glaser, C; Allantaz, F; Pascual, V; Banchereau, J; Chaussabel, D; Ramilo, O				Ardura, Monica I.; Banchereau, Romain; Mejias, Asuncion; Di Pucchio, Tiziana; Glaser, Casey; Allantaz, Florence; Pascual, Virginia; Banchereau, Jacques; Chaussabel, Damien; Ramilo, Octavio			Enhanced Monocyte Response and Decreased Central Memory T Cells in Children with Invasive Staphylococcus aureus Infections	PLOS ONE			English	Article								Staphylococcus aureus has emerged as a significant pathogen causing severe invasive disease in otherwise healthy people. Despite considerable advances in understanding the epidemiology, resistance mechanisms, and virulence factors produced by the bacteria, there is limited knowledge of the in vivo host immune response to acute, invasive S. aureus infections. Herein, we report that peripheral blood mononuclear cells from patients with severe S. aureus infections demonstrate a distinctive and robust gene expression profile which is validated in a distinct group of patients and on a different microarray platform. Application of a systems-wide modular analysis framework reveals significant over-expression of innate immunity genes and under-expression of genes related to adaptive immunity. Simultaneous flow cytometry analyses demonstrated marked alterations in immune cell numbers, with decreased central memory CD4 and CD8 T cells and increased numbers of monocytes. CD14+ monocyte numbers significantly correlated with the gene expression levels of genes related to the innate immune response. These results demonstrate the value of applying a systems biology approach that reveals the significant alterations in the components of circulating blood lymphocytes and monocytes in invasive S. aureus infections.			Ardura, MI (corresponding author), Univ Texas SW Med Ctr Dallas, Div Pediat Infect Dis, Dept Pediat, Dallas, TX 75390 USA.	octavio.ramilo@utsouthwestern.edu	Chaussabel, Damien/AAX-1909-2020; Mejias, Asuncion/AAC-5998-2019; Pascual, Virginia/ABD-3099-2020; Mejias, Maria Asuncion/E-3659-2011; Ardura, Monica/AHA-7339-2022	Mejias, Asuncion/0000-0002-5983-8006; Ardura, Monica/0000-0002-2853-2581; Chaussabel, Damien/0000-0002-6131-7242	NCI NIH HHS [P01 CA084512, R01 CA078846] Funding Source: Medline; NCRR NIH HHS [KL2 RR024983, KL2RR024983, UL1 RR024982, UL1RR024982] Funding Source: Medline; NIAID NIH HHS [U19 AI057234] Funding Source: Medline; NIAMS NIH HHS [P50 AR054083, R01 AR050770-01, R01 AR050770] Funding Source: Medline; PHS HHS [R01 I068842, U19 AIO57234-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA084512, R01CA078846] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024982, KL2RR024983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR054083, R01AR050770] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Baran Jaroslaw, 1999, Medycyna Doswiadczalna i Mikrobiologia, V51, P37; Barnes MG, 2004, RHEUMATOLOGY, V43, P973, DOI 10.1093/rheumatology/keh224; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Benoist C, 2006, IMMUNOL REV, V210, P229, DOI 10.1111/j.0105-2896.2006.00374.x; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Bueno C, 2001, CYTOMETRY, V46, P33, DOI 10.1002/1097-0320(20010215)46:1<33::AID-CYTO1035>3.0.CO;2-S; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Clement S, 2005, J INFECT DIS, V192, P1023, DOI 10.1086/432735; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Hadley JS, 2005, INFECT IMMUN, V73, P7613, DOI 10.1128/IAI.73.11.7613-7619.2005; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Holub M, 2003, CLIN MICROBIOL INFEC, V9, P202, DOI 10.1046/j.1469-0691.2003.00518.x; Jeffrey Stefanie S, 2002, Mol Interv, V2, P101, DOI 10.1124/mi.2.2.101; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Lanzavecchia A, 2005, CURR OPIN IMMUNOL, V17, P326, DOI 10.1016/j.coi.2005.04.010; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mobley JL, 2007, INFLAMMATION, V30, P189, DOI 10.1007/s10753-007-9036-0; Montet D, 2006, MICROBIAL BIOTECHNOLOGY IN HORTICULTURE, VOL 1, P309; Pascual V, 2005, J EXP MED, V201, P1479, DOI 10.1084/jem.20050473; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Rubins KH, 2004, P NATL ACAD SCI USA, V101, P15190, DOI 10.1073/pnas.0405759101; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schaner ME, 2003, MOL BIOL CELL, V14, P4376, DOI 10.1091/mbc.e03-05-0279; Simmons CP, 2007, J INFECT DIS, V195, P1097, DOI 10.1086/512162; Sundstedt A, 1998, IMMUNOLOGY, V95, P76; Viau M, 2005, J IMMUNOL, V175, P7719, DOI 10.4049/jimmunol.175.11.7719; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Yoh K, 2000, NEPHROL DIAL TRANSPL, V15, P1170, DOI 10.1093/ndt/15.8.1170; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2	39	63	69	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5446	10.1371/journal.pone.0005446	http://dx.doi.org/10.1371/journal.pone.0005446			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424507	gold, Green Published, Green Submitted			2022-12-25	WOS:000265933800009
J	Balasu, MC; Spiridon, LN; Miron, S; Craescu, CT; Scheidig, AJ; Petrescu, AJ; Szedlacsek, SE				Balasu, Mihaela C.; Spiridon, Laurentiu N.; Miron, Simona; Craescu, Constantin T.; Scheidig, Axel J.; Petrescu, Andrei-Jose; Szedlacsek, Stefan E.			Interface Analysis of the Complex between ERK2 and PTP-SL	PLOS ONE			English	Article								The activity of ERK2, an essential component of MAP-kinase pathway, is under the strict control of various effector proteins. Despite numerous efforts, no crystal structure of ERK2 complexed with such partners has been obtained so far. PTP-SL is a major regulator of ERK2 activity. To investigate the ERK2-PTP-SL complex we used a combined method based on cross-linking, MALDI-TOF analysis, isothermal titration calorimetry, molecular modeling and docking. Hence, new insights into the stoichiometry, thermodynamics and interacting regions of the complex are obtained and a structural model of ERK2-PTP-SL complex in a state consistent with PTP-SL phosphatase activity is developed incorporating all the experimental constraints available at hand to date. According to this model, part of the N-terminal region of PTP-SL has propensity for intrinsic disorder and becomes structured within the complex with ERK2. The proposed model accounts for the structural basis of several experimental findings such as the complex-dissociating effect of ATP, or PTP-SL blocking effect on the ERK2 export to the nucleus. A general observation emerging from this model is that regions involved in substrate binding in PTP-SL and ERK2, respectively are interacting within the interface of the complex.			Balasu, MC (corresponding author), Inst Biochem, Dept Enzymol, Bucharest, Romania.	stefan.szedlacsek@biochim.ro	Miron, Simona/M-9223-2018; Scheidig, Axel/C-9141-2011; Szedlacsek, Stefan Eugen/F-1830-2010; Petrescu, Andrei-Jose J/G-4576-2016; Spiridon, Laurentiu N/A-3352-2017	Szedlacsek, Stefan Eugen/0000-0002-3416-5036; Petrescu, Andrei-Jose J/0000-0002-4478-3946; Spiridon, Laurentiu N/0000-0003-3080-1610				Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; Blanco-Aparicio C, 1999, J CELL BIOL, V147, P1129, DOI 10.1083/jcb.147.6.1129; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Buist P, 1999, BIOCHEMISTRY-US, V38, P914, DOI 10.1021/bi981936b; Bystroff Christopher, 2002, Bioinformatics, V18 Suppl 1, pS54; Camacho CJ, 2005, BIOINFORMATICS, V21, P2534, DOI 10.1093/bioinformatics/bti322; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Chu FX, 2004, P NATL ACAD SCI USA, V101, P16454, DOI 10.1073/pnas.0407456101; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Eswaran J, 2006, BIOCHEM J, V395, P483, DOI 10.1042/BJ20051931; Fan H, 2005, P NATL ACAD SCI USA, V102, P6760, DOI 10.1073/pnas.0408857102; Farmer TB, 1998, J MASS SPECTROM, V33, P697, DOI 10.1002/(SICI)1096-9888(199808)33:8<697::AID-JMS711>3.0.CO;2-H; FERRERAS M, 1993, ANAL BIOCHEM, V213, P206, DOI 10.1006/abio.1993.1410; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Gross S, 2002, J BIOL CHEM, V277, P48139, DOI 10.1074/jbc.M208228200; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; Janin J, 2003, PROTEINS, V52, P1, DOI 10.1002/prot.10398; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lim KL, 1999, BBA-PROTEIN STRUCT M, V1434, P275, DOI 10.1016/S0167-4838(99)00189-2; Liu SJ, 2006, P NATL ACAD SCI USA, V103, P5326, DOI 10.1073/pnas.0510506103; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mouradov D, 2006, PROTEIN ENG DES SEL, V19, P9, DOI 10.1093/protein/gzi070; Mouradov Dmitri, 2008, V426, P459, DOI 10.1007/978-1-60327-058-8_31; Munoz JJ, 2003, BIOCHEM J, V372, P193, DOI 10.1042/BJ20021941; Nam HJ, 1999, CELL, V97, P449, DOI 10.1016/S0092-8674(00)80755-2; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; RESZKA AA, 1995, P NATL ACAD SCI USA, V92, P8881, DOI 10.1073/pnas.92.19.8881; SHARMA E, 1995, J BIOL CHEM, V270, P49, DOI 10.1074/jbc.270.1.49; SHIOZUKA K, 1995, GENE, V162, P279, DOI 10.1016/0378-1119(95)00306-Q; Song HW, 2001, MOL CELL, V7, P615, DOI 10.1016/S1097-2765(01)00208-8; Szedlacsek SE, 2001, J MOL BIOL, V311, P557, DOI 10.1006/jmbi.2001.4890; Tarrega C, 2005, J BIOL CHEM, V280, P37885, DOI 10.1074/jbc.M504366200; Wang ZH, 2005, PRES VES P, V2, P307; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wefing S, 2006, ANAL CHEM, V78, P1235, DOI 10.1021/ac051634x; WEFING S, 2001, SEARCHXLINKS; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; ZHANG XD, 1994, IEEE PARALL DISTRIB, V2, P3; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006; Zuniga A, 1999, J BIOL CHEM, V274, P21900, DOI 10.1074/jbc.274.31.21900	49	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5432	10.1371/journal.pone.0005432	http://dx.doi.org/10.1371/journal.pone.0005432			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424502	Green Published, Green Submitted, gold			2022-12-25	WOS:000265933800007
J	Piwko-Czuchra, A; Koegel, H; Meyer, H; Bauer, M; Werner, S; Brakebusch, C; Fassler, R				Piwko-Czuchra, Aleksandra; Koegel, Heidi; Meyer, Hannelore; Bauer, Martina; Werner, Sabine; Brakebusch, Cord; Faessler, Reinhard			beta 1 Integrin-Mediated Adhesion Signalling Is Essential for Epidermal Progenitor Cell Expansion	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; MESSENGER-RNA DECAY; BETA-1-INTEGRIN FUNCTION; GENE-MUTATIONS; MICE; EXPRESSION; DIFFERENTIATION; SKIN; KERATINOCYTES; MIGRATION	Background: There is a major discrepancy between the in vitro and in vivo results regarding the role of beta 1 integrins in the maintenance of epidermal stem/progenitor cells. Studies of mice with skin-specific ablation of beta 1 integrins suggested that epidermis can form and be maintained in their absence, while in vitro data have shown a fundamental role for these adhesion receptors in stem/progenitor cell expansion and differentiation. Methodology/Principal Findings: To elucidate this discrepancy we generated hypomorphic mice expressing reduced beta 1 integrin levels on keratinocytes that developed similar, but less severe defects than mice with beta 1-deficient keratinocytes. Surprisingly we found that upon aging these abnormalities attenuated due to a rapid expansion of cells, which escaped or compensated for the down-regulation of beta 1 integrin expression. A similar phenomenon was observed in aged mice with a complete, skin-specific ablation of the beta 1 integrin gene, where cells that escaped Cre-mediated recombination repopulated the mutant skin in a very short time period. The expansion of beta 1 integrin expressing keratinocytes was even further accelerated in situations of increased keratinocyte proliferation such as wound healing. Conclusions/Significance: These data demonstrate that expression of beta 1 integrins is critically important for the expansion of epidermal progenitor cells to maintain epidermal homeostasis.			Piwko-Czuchra, A (corresponding author), Max Planck Inst Biochem, Dept Mol Med, Klopferspitz 18A, D-82152 Martinsried, Germany.	faessler@biochem.mpg.de		Werner, Sabine/0000-0001-7397-8710; Brakebusch, Cord/0000-0002-9342-1634				Bouvard D, 2001, CIRC RES, V89, P211, DOI 10.1161/hh1501.094874; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Brakebusch C, 2005, CANCER METAST REV, V24, P403, DOI 10.1007/s10555-005-5132-5; Campos LS, 2005, BIOESSAYS, V27, P698, DOI 10.1002/bies.20256; CARROLL JM, 1995, CELL, V83, P957, DOI 10.1016/0092-8674(95)90211-2; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Czuchra A, 2006, J CELL BIOL, V174, P889, DOI 10.1083/jcb.200604060; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Grose R, 2002, DEVELOPMENT, V129, P2303; Hirsch E, 1996, NATURE, V380, P171, DOI 10.1038/380171a0; Holtkotter O, 2002, J BIOL CHEM, V277, P10789, DOI 10.1074/jbc.M112307200; Huusko P, 2004, NAT GENET, V36, P979, DOI 10.1038/ng1408; Ionov Y, 2004, ONCOGENE, V23, P639, DOI 10.1038/sj.onc.1207178; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Jensen UB, 1999, DEVELOPMENT, V126, P2409; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Jones PH, 2007, CELL STEM CELL, V1, P371, DOI 10.1016/j.stem.2007.09.014; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701; Montanez E, 2007, METHOD ENZYMOL, V426, P239, DOI 10.1016/S0076-6879(07)26012-4; Noensie EN, 2001, NAT BIOTECHNOL, V19, P434, DOI 10.1038/88099; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; Romero MR, 1999, EXP DERMATOL, V8, P53, DOI 10.1111/j.1600-0625.1999.tb00348.x; Sixt M, 2006, CURR OPIN CELL BIOL, V18, P482, DOI 10.1016/j.ceb.2006.08.007; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; Wan H, 2003, J CELL SCI, V116, P4239, DOI 10.1242/jcs.00701; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639	37	37	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5488	10.1371/journal.pone.0005488	http://dx.doi.org/10.1371/journal.pone.0005488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424505	Green Published, Green Submitted, gold			2022-12-25	WOS:000265933800018
J	Sijbrands, EJG; Tornij, E; Homsma, SJ				Sijbrands, Eric J. G.; Tornij, Erik; Homsma, Sietske J.			Mortality Risk Prediction by an Insurance Company and Long-Term Follow-Up of 62,000 Men	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; DIABETICS; ONSET	Background: Insurance companies use medical information to classify the mortality risk of applicants. Adding genetic tests to this assessment is currently being debated. This debate would be more meaningful, if results of present-day risk prediction were known. Therefore, we compared the predicted with the observed mortality of men who applied for life insurance, and determined the prognostic value of the risk assessment. Methods: Long-term follow-up was available for 62,334 male applicants whose mortality risk was predicted with medical evaluation and they were assigned to five groups with increasing risk from 1 to 5. We calculated all cause standardized mortality ratios relative to the Dutch population and compared groups with Cox's regression. We compared the discriminative ability of risk assessments as indicated by a concordance index (c). Results: In 844,815 person years we observed 3,433 deaths. The standardized mortality relative to the Dutch male population was 0.76 (95 percent confidence interval, 0.73 to 0.78). The standardized mortality ratios ranged from 0.54 in risk group 1 to 2.37 in group 5. A large number of risk factors and diseases were significantly associated with increased mortality. The algorithm of prediction was significantly, but only slightly better than summation of the number of disorders and risk factors (c-index, 0.64 versus 0.60, P<0.001). Conclusions: Men applying for insurance clearly had better survival relative to the general population. Readily available medical evaluation enabled accurate prediction of the mortality risk of large groups, but the deceased men could not have been identified with the applied prediction method.			Sijbrands, EJG (corresponding author), Erasmus MC, Div Pharmacol Vasc & Metab Dis, Dept Internal Med, Rotterdam, Netherlands.	e.sijbrands@erasmusmc.nl	Sijbrands, Eric/A-1065-2009	Sijbrands, Eric/0000-0001-8857-7389				[Anonymous], 1988, ARCH INTERN MED, V148, P1023; Asao K, 2003, DIABETES CARE, V26, P2037, DOI 10.2337/diacare.26.7.2037; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Bourassa M G, 1985, Circulation, V72, pV71; Carragee EJ, 2005, NEW ENGL J MED, V352, P1891, DOI 10.1056/NEJMcp042054; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Clayton EW, 2003, NEW ENGL J MED, V349, P562, DOI 10.1056/NEJMra012577; COLEMAN MP, 1989, PERSON YEARS PYRS FU; FULLER JH, 1983, DIABETOLOGIA, V24, P336; GLEESON RK, 2004, GENETICS LIFE INSURA, P73; HOES AW, 1993, EUR J EPIDEMIOL, V9, P285, DOI 10.1007/BF00146265; KENDAL DG, 1962, RANK CORRELATION MET; Khoury MJ, 2003, NEW ENGL J MED, V348, P50, DOI 10.1056/NEJMra013182; KLEINMAN JC, 1988, AM J EPIDEMIOL, V128, P389, DOI 10.1093/oxfordjournals.aje.a114979; KROLEWSKI AS, 1987, AM J CARDIOL, V59, P750, DOI 10.1016/0002-9149(87)91086-1; Mayor S, 2005, BRIT MED J, V330, P617, DOI 10.1136/bmj.330.7492.617; Morrison PJ, 2005, LANCET, V366, P877, DOI 10.1016/S0140-6736(05)67298-4; Nishimura R, 2001, DIABETES CARE, V24, P823, DOI 10.2337/diacare.24.5.823; Ossa Diego F, 2004, Eur J Health Econ, V5, P116, DOI 10.1007/s10198-003-0213-2; Raithatha N, 2004, LANCET, V363, P395, DOI 10.1016/S0140-6736(04)15442-1; ROTHENBERG RB, 1994, EPIDEMIOLOGY, V5, P197, DOI 10.1097/00001648-199403000-00010; Sijbrands EJG, 2001, BMJ-BRIT MED J, V322, P1019, DOI 10.1136/bmj.322.7293.1019; SINGER RB, 1998, MED SELECTION LIFE R, P37; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; SYTKOWSKI PA, 1990, NEW ENGL J MED, V322, P1635, DOI 10.1056/NEJM199006073222304; TUNBRIDGE WMG, 1981, LANCET, V2, P569; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	29	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5457	10.1371/journal.pone.0005457	http://dx.doi.org/10.1371/journal.pone.0005457			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421319	Green Published, Green Submitted, gold			2022-12-25	WOS:000265836900013
J	Kanie, Y; Yamamoto-Hino, M; Karino, Y; Yokozawa, H; Nishihara, S; Ueda, R; Goto, S; Kanie, O				Kanie, Yoshimi; Yamamoto-Hino, Miki; Karino, Yayoi; Yokozawa, Hiroki; Nishihara, Shoko; Ueda, Ryu; Goto, Satoshi; Kanie, Osamu			Insight into the Regulation of Glycan Synthesis in Drosophila Chaoptin Based on Mass Spectrometry	PLOS ONE			English	Article							N-ACETYLGLUCOSAMINYLTRANSFERASE-I; LINKED OLIGOSACCHARIDES; MONOCLONAL-ANTIBODIES; MANNOSIDASE-II; GLYCOPROTEIN; GLYCOSYLATION; MELANOGASTER; SPECIFICITY; MUTATIONS; PROTEINS	Background: A variety of N-glycans attached to protein are known to involve in many important biological functions. Endoplasmic reticulum (ER) and Golgi localized enzymes are responsible to this template-independent glycan synthesis resulting glycoforms at each asparagine residues. The regulation mechanism such glycan synthesis remains largely unknown. Methodology/Principal Findings: In order to investigate the relationship between glycan structure and protein conformation, we analyzed a glycoprotein of Drosophila melanogaster, chaoptin (Chp), which is localized in photoreceptor cells and is bound to the cell membrane via a glycosylphosphatidylinositol anchor. Detailed analysis based on mass spectrometry revealed the presence of 13 N-glycosylation sites and the composition of the glycoform at each site. The synthetic pathway of glycans was speculated from the observed glycan structures and the composition at each N-glycosylation site, where the presence of novel routes were suggested. The distribution of glycoforms on a Chp polypeptide suggested that various processing enzymes act on the exterior of Chp in the Golgi apparatus, although virtually no enzyme can gain access to the interior of the horseshoe-shaped scaffold, hence explaining the presence of longer glycans within the interior. Furthermore, analysis of Chp from a mutant (RNAi against dolichyl-phosphate a-D-mannosyltransferase), which affects N-glycan synthesis in the ER, revealed that truncated glycan structures were processed. As a result, the distribution of glycoforms was affected for the high-mannose-type glycans only, whereas other types of glycans remained similar to those observed in the control and wild-type. Conclusions/Significance: These results indicate that glycan processing depends largely on the backbone structure of the parent polypeptide. The information we obtained can be applied to other members of the LRR family of proteins.			Kanie, O (corresponding author), Mitsubishi Kagaku Inst Life Sci MITILS, Tokyo, Japan.	kokanee@mitils.jp	Kanie, Osamu/D-1741-2010	Kanie, Osamu/0000-0003-4147-6868; Nishihara, Shoko/0000-0002-1668-2603; Kanie, Yoshimi/0000-0002-8476-2234				ALTMANN F, 1993, GLYCOBIOLOGY, V3, P619, DOI 10.1093/glycob/3.6.619; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Brancia FL, 2000, RAPID COMMUN MASS SP, V14, P2070, DOI 10.1002/1097-0231(20001115)14:21<2070::AID-RCM133>3.0.CO;2-G; Branza-Nichita N, 2000, J BIOL CHEM, V275, P8169, DOI 10.1074/jbc.275.11.8169; Bykova NV, 2006, ANAL CHEM, V78, P1093, DOI 10.1021/ac0512711; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Chui D, 1997, CELL, V90, P157, DOI 10.1016/S0092-8674(00)80322-0; Cointe D, 2000, GLYCOBIOLOGY, V10, P511, DOI 10.1093/glycob/10.5.511; CUMMING D A, 1991, Glycobiology, V1, P115, DOI 10.1093/glycob/1.2.115; Dell A, 2001, SCIENCE, V291, P2351, DOI 10.1126/science.1058890; Fabini G, 2001, J BIOL CHEM, V276, P28058, DOI 10.1074/jbc.M100573200; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; GAY NJ, 1991, FEBS LETT, V291, P87, DOI 10.1016/0014-5793(91)81110-T; Hale JE, 2000, ANAL BIOCHEM, V287, P110, DOI 10.1006/abio.2000.4834; Harazono A, 2005, GLYCOBIOLOGY, V15, P447, DOI 10.1093/glycob/cwi033; HASE S, 1978, BIOCHEM BIOPH RES CO, V85, P257, DOI 10.1016/S0006-291X(78)80037-0; HASE S, 1990, ANAL BIOCHEM, V184, P135, DOI 10.1016/0003-2697(90)90025-5; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hirai-Fujita Y, 2008, FEBS LETT, V582, P2572, DOI 10.1016/j.febslet.2008.06.028; Ito Y, 2005, CURR OPIN STRUC BIOL, V15, P481, DOI 10.1016/j.sbi.2005.08.012; KAJAVA AV, 1995, STRUCTURE, V3, P867, DOI 10.1016/S0969-2126(01)00222-2; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Kolarich D, 2006, BBA-GEN SUBJECTS, V1760, P715, DOI 10.1016/j.bbagen.2005.11.012; KRANTZ DD, 1991, J BIOL CHEM, V266, P16801; KRANTZ DE, 1990, EMBO J, V9, P1969, DOI 10.1002/j.1460-2075.1990.tb08325.x; LIS H, 1993, EUR J BIOCHEM, V218, P1, DOI 10.1111/j.1432-1033.1993.tb18347.x; LOWE JB, 1999, ESSENTIALS GLYCOBIOL, P486; Nishihara S, 2004, GLYCOCONJUGATE J, V21, P63, DOI 10.1023/B:GLYC.0000043750.80389.14; Paschinger K, 2005, GLYCOBIOLOGY, V15, P463, DOI 10.1093/glycob/cwi028; POLLOCK JA, 1990, GENE DEV, V4, P806, DOI 10.1101/gad.4.5.806; REINKE R, 1988, CELL, V52, P291, DOI 10.1016/0092-8674(88)90518-1; Rendic D, 2006, J BIOL CHEM, V281, P3343, DOI 10.1074/jbc.M508334200; Rosenbaum EE, 2006, NEURON, V49, P229, DOI 10.1016/j.neuron.2005.12.011; Sarkar M, 2006, J BIOL CHEM, V281, P12776, DOI 10.1074/jbc.M512769200; Staudacher E, 1998, GLYCOCONJUGATE J, V15, P355, DOI 10.1023/A:1006969701231; Tanner S, 2008, J PROTEOME RES, V7, P170, DOI 10.1021/pr070444v; TARENTINO AL, 1994, METHOD ENZYMOL, V230, P44; TULSIANI DRP, 1982, J BIOL CHEM, V257, P3660; VANVACTOR D, 1988, CELL, V52, P281, DOI 10.1016/0092-8674(88)90517-X; Wada Y, 2004, ANAL CHEM, V76, P6560, DOI 10.1021/ac049062o; Wada Y, 2007, GLYCOBIOLOGY, V17, P411, DOI 10.1093/glycob/cwl086; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wilson IBH, 1998, GLYCOBIOLOGY, V8, P651, DOI 10.1093/glycob/8.7.651; WUHER M, 2004, RAPID COMMUN MASS SP, V18, P1741; Wuhrer M, 2007, J CHROMATOGR B, V849, P115, DOI 10.1016/j.jchromb.2006.09.041; YAMAWAKIKATAOKA Y, 1989, P NATL ACAD SCI USA, V86, P5693, DOI 10.1073/pnas.86.15.5693; Yano H, 2009, CELL TISSUE RES, V336, P137, DOI 10.1007/s00441-009-0753-6; Zelhof AC, 2006, NATURE, V443, P696, DOI 10.1038/nature05128; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2; ZIPURSKY SL, 1985, P NATL ACAD SCI USA, V82, P1855, DOI 10.1073/pnas.82.6.1855	50	18	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2009	4	5							e5434	10.1371/journal.pone.0005434	http://dx.doi.org/10.1371/journal.pone.0005434			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JE	19415110	Green Submitted, Green Published, gold			2022-12-25	WOS:000265836700007
J	Leclerc, PM; Matthews, AP; Garenne, ML				Leclerc, Pauline M.; Matthews, Alan P.; Garenne, Michel L.			Fitting the HIV Epidemic in Zambia: A Two-Sex Micro-Simulation Model	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; FEMALE SEX WORKERS; HETEROSEXUAL TRANSMISSION; COMMERCIAL SEX; COTE-DIVOIRE; COITAL ACT; CONDOM USE; INFECTION; COUPLES; IMPACT	Background: In describing and understanding how the HIV epidemic spreads in African countries, previous studies have not taken into account the detailed periods at risk. This study is based on a micro-simulation model (individual-based) of the spread of the HIV epidemic in the population of Zambia, where women tend to marry early and where divorces are not frequent. The main target of the model was to fit the HIV seroprevalence profiles by age and sex observed at the Demographic and Health Survey conducted in 2001. Methods and Findings: A two-sex micro-simulation model of HIV transmission was developed. Particular attention was paid to precise age-specific estimates of exposure to risk through the modelling of the formation and dissolution of relationships: marriage (stable union), casual partnership, and commercial sex. HIV transmission was exclusively heterosexual for adults or vertical (mother-to-child) for children. Three stages of HIV infection were taken into account. All parameters were derived from empirical population-based data. Results show that basic parameters could not explain the dynamics of the HIV epidemic in Zambia. In order to fit the age and sex patterns, several assumptions were made: differential susceptibility of young women to HIV infection, differential susceptibility or larger number of encounters for male clients of commercial sex workers, and higher transmission rate. The model allowed to quantify the role of each type of relationship in HIV transmission, the proportion of infections occurring at each stage of disease progression, and the net reproduction rate of the epidemic (R-0 = 1.95). Conclusions: The simulation model reproduced the dynamics of the HIV epidemic in Zambia, and fitted the age and sex pattern of HIV seroprevalence in 2001. The same model could be used to measure the effect of changing behaviour in the future.			Garenne, ML (corresponding author), Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France.	mgarenne@pasteur.fr	GARENNE, Michel/A-7712-2013	GARENNE, Michel/0000-0001-6073-7803				ANDERSON RM, 1991, NATURE, V352, P581, DOI 10.1038/352581a0; [Anonymous], 2008, OPEN DEMOGRAPHY J, DOI [DOI 10.2174/1874918600801010001, 10.2174/1874918600801010001]; Artzrouni M, 2002, AIDS, V16, pW1; Auvert B, 2000, COMPUT BIOMED RES, V33, P84, DOI 10.1006/cbmr.1999.1533; Boily MC, 1996, SEX TRANSM DIS, V23, P312, DOI 10.1097/00007435-199607000-00012; Boily MC, 2002, SEX TRANSM INFECT, V78, pI78, DOI 10.1136/sti.78.suppl_1.i78; Bongaarts J, 2007, POP STUD-J DEMOG, V61, P73, DOI 10.1080/00324720601048343; Brewis A, 2005, J BIOSOC SCI, V37, P499, DOI 10.1017/S002193200400690X; BROUARD N, 1991, BROUARD APPROACH FOR; CARPENTER G, 1899, LANCET, V1, P13; *CENTR STAT OFF ZA, 2003, ZAMB DHS 2001 02; *CENTR STAT OFF ZA, 1997, ZAMB DHS 1996; *CENTR STAT OFF ZA, 1993, ZAMB DHS 1992; Cowan FM, 2005, JAIDS-J ACQ IMM DEF, V40, P371, DOI 10.1097/01.qai.0000162420.93243.ff; Dabis F, 2002, LANCET, V359, P2097, DOI 10.1016/S0140-6736(02)08909-2; Desgrees-du-Lou A, 2008, REPROD HEALTH MATTER, V16, P151, DOI 10.1016/S0968-8080(08)32407-0; DJOMAND G, 1995, J ACQ IMMUN DEF SYND, V10, P358; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Garenne M, 2004, INT J STD AIDS, V15, P65, DOI 10.1258/095646204322637326; GARENNE M, 2003, PREMARITAL FERTILITY; GARENNE M, 2005, 35 INFECT YOUNG WOME; Ghys PD, 2002, AIDS, V16, P251, DOI 10.1097/00002030-200201250-00015; Ghys PD, 2001, AIDS, V15, P1421, DOI 10.1097/00002030-200107270-00012; Gisselquist D, 2003, INT J STD AIDS, V14, P148, DOI 10.1258/095646203762869151; Glynn JR, 2003, JAIDS-J ACQ IMM DEF, V33, P526, DOI 10.1097/00126334-200308010-00015; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Hallett TB, 2007, SEX TRANSM INFECT, V83, pI50, DOI 10.1136/sti.2006.023606; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Hugonnet S, 2002, J ACQ IMMUN DEF SYND, V30, P73, DOI 10.1097/00042560-200205010-00010; Hunter SC, 2003, J BIOSOC SCI, V35, P189, DOI 10.1017/S0021932003001895; Isingo R, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000299405.06658.a8; KAMLA VC, 2008, 10 INT C ZAR PAU APP, V17; KAMLA VC, 2008, INDIVIDUAL BASE MODE; Korenromp EL, 2000, AIDS, V14, P573, DOI 10.1097/00002030-200003310-00013; Korenromp EL, 2005, J INFECT DIS, V191, pS168, DOI 10.1086/425274; Korenromp EL, 2000, MATH POPUL STUD, V8, P135, DOI DOI 10.1080/08898480009525479; Leclerc PM, 2008, INT J STD AIDS, V19, P660, DOI 10.1258/ijsa.2008.008099; Leclerc PM, 2007, DEMOGR RES, V16, P121, DOI 10.4054/DemRes.2007.16.5; LECLERC PM, 2008, AJUSTEMENT PROFILS S; Leonard L, 2000, AIDS EDUC PREV, V12, P21; LERIDON H, 1993, POPULATION, V48, P1381, DOI 10.2307/1534182; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; MATTHEWS A, 2008, PICRATE MODEL FITTIN; Mindel A, 2001, BRIT MED J, V322, P1290, DOI 10.1136/bmj.322.7297.1290; Mishra V, 2006, B WORLD HEALTH ORGAN, V84, P537, DOI 10.2471/BLT.05.029520; Morison L, 2001, AIDS, V15, pS61, DOI 10.1097/00002030-200108004-00007; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; NGBICHI JM, 1995, AIDS, V9, P951, DOI 10.1097/00002030-199508000-00018; Orroth KK, 2007, SEX TRANSM INFECT, V83, pI5, DOI 10.1136/sti.2006.023531; Padian NS, 1997, AM J EPIDEMIOL, V146, P350, DOI 10.1093/oxfordjournals.aje.a009276; Pinkerton SD, 2008, AIDS BEHAV, V12, P677, DOI 10.1007/s10461-007-9329-1; PIOT P, 1988, SOZ PRAVENTIV MED, V33, P336, DOI 10.1007/BF02084300; PIOT P, 1987, J INFECT DIS, V155, P1108, DOI 10.1093/infdis/155.6.1108; Poonia B, 2006, J ENDOCRINOL, V190, P829, DOI 10.1677/joe.1.06873; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Quinn TC, 2005, SCIENCE, V308, P1582, DOI 10.1126/science.1112489; SERWADDA D, 1995, AIDS, V9, P745, DOI 10.1097/00002030-199507000-00012; SEWANKAMBO NK, 1987, AIDS, V1, P113; Stover J, 1998, AIDS, V12, pS29; Talbott JR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000543; *UNAIDS WHO UNICEF, 2008, EP FACT SHEET HIV AI; Van der Ploeg CPB, 1998, INTERFACES, V28, P84, DOI 10.1287/inte.28.3.84; van Vliet C, 2001, B WORLD HEALTH ORGAN, V79, P442; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262	67	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2009	4	5							e5439	10.1371/journal.pone.0005439	http://dx.doi.org/10.1371/journal.pone.0005439			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	442JE	19415113	Green Published, gold, Green Submitted			2022-12-25	WOS:000265836700011
J	Dobson, J; Bowtell, R; Garcia-Prieto, A; Pankhurst, Q				Dobson, Jon; Bowtell, Richard; Garcia-Prieto, Ana; Pankhurst, Quentin			Safety Implications of High-Field MRI: Actuation of Endogenous Magnetic Iron Oxides in the Human Body	PLOS ONE			English	Article							BIOGENIC MAGNETITE; ELECTROMAGNETIC-FIELDS; EXPOSURE; TISSUE; 9.4T	Background: Magnetic Resonance Imaging scanners have become ubiquitous in hospitals and high-field systems (greater than 3 Tesla) are becoming increasingly common. In light of recent European Union moves to limit high-field exposure for those working with MRI scanners, we have evaluated the potential for detrimental cellular effects via nanomagnetic actuation of endogenous iron oxides in the body. Methodology: Theoretical models and experimental data on the composition and magnetic properties of endogenous iron oxides in human tissue were used to analyze the forces on iron oxide particles. Principal Finding and Conclusions: Results show that, even at 9.4 Tesla, forces on these particles are unlikely to disrupt normal cellular function via nanomagnetic actuation.			Dobson, J (corresponding author), Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England.	bea22@keele.ac.uk	Dobson, Jon P/C-8323-2009; Garcia-Prieto, Ana/F-2079-2012	Dobson, Jon P/0000-0002-8108-5362; Garcia-Prieto, Ana/0000-0001-7080-3974; Bowtell, Richard/0000-0001-8656-412X	MRC [G9900259] Funding Source: UKRI; Medical Research Council [G9900259] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ANDRIOLASILVA AK, 2006, RADIAT ENVIRON BIOPH, V45, P245; Atkinson IC, 2007, J MAGN RESON IMAGING, V26, P1222, DOI 10.1002/jmri.21150; Bassen H, 2005, HEALTH PHYS, V89, P684, DOI 10.1097/01.HP.0000172545.71238.15; Cartmell Sarah H, 2002, IEEE Trans Nanobioscience, V1, P92, DOI 10.1109/TNB.2002.806945; Collingwood JF, 2005, J ALZHEIMERS DIS, V7, P267; de Vocht F, 2006, J MAGN RESON IMAGING, V23, P291, DOI 10.1002/jmri.20510; Dobson J, 1996, BIOCHEM BIOPH RES CO, V227, P718, DOI 10.1006/bbrc.1996.1575; Dobson J, 2002, EXP BRAIN RES, V144, P122, DOI 10.1007/s00221-002-1066-0; Dobson J, 2008, NAT NANOTECHNOL, V3, P139, DOI 10.1038/nnano.2008.39; Dobson J, 2006, IEEE T NANOBIOSCI, V5, P173, DOI 10.1109/TNB.2006.880823; Glover PM, 2007, BIOELECTROMAGNETICS, V28, P349, DOI 10.1002/bem.20316; Hautot D, 2003, P ROY SOC B-BIOL SCI, V270, pS62, DOI 10.1098/rsbl.2003.0012; Hayden ME, 2006, J PHYS-CONDENS MAT, V18, pS2877, DOI 10.1088/0953-8984/18/38/S23; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; KIRSCHVINK JL, 1992, PHYS REV A, V46, P2178, DOI 10.1103/PhysRevA.46.2178; KIRSCHVINK JL, 1992, P NATL ACAD SCI USA, V89, P7683, DOI 10.1073/pnas.89.16.7683; Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201; Pankhurst Q, 2008, J ALZHEIMERS DIS, V13, P49; Pannalal SJ, 2005, EARTH PLANET SC LETT, V236, P856, DOI 10.1016/j.epsl.2005.05.019; Schultheiss-Grassi PP, 1999, BBA-GEN SUBJECTS, V1426, P212, DOI 10.1016/S0304-4165(98)00160-3; Schulz TK, 1997, J TRAUMA STRESS, V10, P351, DOI 10.1002/jts.2490100217; Vaughan T, 2006, MAGN RESON MED, V56, P1274, DOI 10.1002/mrm.21073; Walker LM, 1999, FEBS LETT, V459, P39, DOI 10.1016/S0014-5793(99)01169-2; [No title captured]	24	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2009	4	5							e5431	10.1371/journal.pone.0005431	http://dx.doi.org/10.1371/journal.pone.0005431			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440RC	19412550	Green Published, gold, Green Submitted			2022-12-25	WOS:000265716400004
J	Gibbons, DL; Lin, W; Creighton, CJ; Zheng, SL; Berel, D; Yang, YA; Raso, MG; Liu, DD; Wistuba, II; Lozano, G; Kurie, JM				Gibbons, Don L.; Lin, Wei; Creighton, Chad J.; Zheng, Shuling; Berel, Dror; Yang, Yanan; Raso, Maria Gabriela; Liu, Diane D.; Wistuba, Ignacio I.; Lozano, Guillermina; Kurie, Jonathan M.			Expression Signatures of Metastatic Capacity in a Genetic Mouse Model of Lung Adenocarcinoma	PLOS ONE			English	Article								Background: Non-small cell lung cancer (NSCLC) is the foremost cause of cancer-related death in Western countries, which is due partly to the propensity of NSCLC cells to metastasize. The biologic basis for NSCLC metastasis is not well understood. Methodology/Principal Findings: Here we addressed this deficiency by transcriptionally profiling tumors from a genetic mouse model of human lung adenocarcinoma that develops metastatic disease owing to the expression of K-ras(G12D) and p53(R172H). We identified 2,209 genes that were differentially expressed in distant metastases relative to matched lung tumors. Mining of publicly available data bases revealed this expression signature in a subset of NSCLC patients who had a poorer prognosis than those without the signature. Conclusions/Significance: These findings provide evidence that K-ras(G12D); p53(R172H) mice recapitulate features of human NSCLC metastasis and will provide a useful platform on which to study the biologic basis for lung adenocarcinoma metastasis and its prevention by novel agents.			Gibbons, DL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA.	creighto@bcm.edu; jkurie@mdanderson.org	Yang, Yanan/F-1592-2010; Raso, Maria Gabriela/J-9898-2019; raso, maria/AAS-2118-2020	raso, maria/0000-0003-2105-5556	NCI NIH HHS [R01 CA122608, R01 CA132608, P50 CA070907, T32 CA009666, R01 CA1322608, 5 T32 CA009666, P30 CA125123, P50 CA70907] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009666, P50CA070907, P30CA125123] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Creighton CJ, 2008, RNA, V14, P2290, DOI 10.1261/rna.1188208; Creighton CJ, 2008, J CLIN ONCOL, V26, P4078, DOI 10.1200/JCO.2007.13.4429; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Ji H, 2006, ONCOGENE, V25, P2105, DOI 10.1038/sj.onc.1209237; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu G, 2000, P NATL ACAD SCI USA, V97, P4174, DOI 10.1073/pnas.97.8.4174; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Zheng S, 2007, ONCOGENE, V26, P6896, DOI 10.1038/sj.onc.1210493	19	57	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5401	10.1371/journal.pone.0005401	http://dx.doi.org/10.1371/journal.pone.0005401			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404390	gold, Green Published, Green Submitted			2022-12-25	WOS:000265614900012
J	Hansen, CA; Barnett, AG; Jalaludin, BB; Morgan, GG				Hansen, Craig A.; Barnett, Adrian G.; Jalaludin, Bin B.; Morgan, Geoffrey G.			Ambient Air Pollution and Birth Defects in Brisbane, Australia	PLOS ONE			English	Article							ADVERSE PREGNANCY OUTCOMES; HAZARDOUS-WASTE SITES; RESIDENTIAL-MOBILITY; CONGENITAL-ANOMALIES; LANDFILL SITES; RISK; HEALTH; EXPOSURE; PROXIMITY; CHILDREN	Background: Birth defects are a major public health concern as they are the leading cause of neonatal and infant mortality. Observational studies have linked environmental pollution to adverse birth outcomes, including congenital anomalies. This study examined potential associations between ambient air pollution and congenital heart defects and cleft lip or palate among births in Brisbane, Australia (1998-2004). Methods: Ambient air pollution levels were averaged over weeks 3-8 of pregnancy among 150,308 births. Using a case control design, we used conditional logistic regression and matched cases to 5 controls. Analyses were conducted using all births, and then births where the mother resided within 6 and 12 kilometers of an ambient air quality monitor. Findings: When analyzing all births there was no indication that ambient air pollution in Brisbane was associated with a higher risk of cardiac defects. Among births where the mother resided within 6 kilometers of an ambient air quality monitor, a 5 ppb increase in O-3 was associated with an increased risk of pulmonary artery and valve defects (OR 2.96, 95% CI: 1.34, 7.52) while a 0.6 ppb increase in SO2 was associated with an increased risk of aortic artery and valve defects (OR 10.76, 95% CI: 1.50, 179.8). For oral cleft defects among all births, the only adverse association was between SO2 and cleft lip with or without cleft palate (OR 1.27, 95% CI: 1.01, 1.62). However, various significant inverse associations were also found between air pollutants and birth defects. Conclusions: This study found mixed results and it is difficult to conclude whether ambient air pollution in Brisbane has an adverse association with the birth defects examined. Studies using more detailed estimates of air pollution exposure are needed.			Hansen, CA (corresponding author), US EPA, Natl Ctr Environm Assessment, Durham, NC USA.	a.barnett@qut.edu.au	Jalaludin, Bin/ABC-1066-2020; Hansen, Craig/C-7543-2014	Jalaludin, Bin/0000-0001-7664-9621; Hansen, Craig/0000-0002-5227-0155; Morgan, Geoffrey/0000-0003-4046-2405; Barnett, Adrian/0000-0001-6339-0374				[Anonymous], NATL VITAL STAT REPO; Australian Bureau of Statistics, 2001, ASGC; Australian Bureau of Statistics, 2001, 2039055001 AUSTR BUR; Barnett AG, 2006, ENVIRON HEALTH PERSP, V114, P1018, DOI 10.1289/ehp.8674; Barnett AG, 2005, AM J RESP CRIT CARE, V171, P1272, DOI 10.1164/rccm.200411-1586OC; Boothe VL, 2008, J ENVIRON HEALTH, V70, P33; BOOTHE VL, 2008, J ENV HLTH, V70, P55; Canfield MA, 2006, J EXPO SCI ENV EPID, V16, P538, DOI 10.1038/sj.jes.7500501; Cordier S, 2004, OCCUP ENVIRON MED, V61, P8; De la Vega Alberto, 2006, P R Health Sci J, V25, P343; Dolk H, 2003, BRIT MED BULL, V68, P25, DOI 10.1093/bmb/ldg024; Dolk H, 1998, LANCET, V352, P423, DOI 10.1016/S0140-6736(98)01352-X; Dummer TJB, 2003, ARCH ENVIRON HEALTH, V58, P692, DOI 10.3200/AEOH.58.11.692-698; Dummer TJB, 2003, J EPIDEMIOL COMMUN H, V57, P456, DOI 10.1136/jech.57.6.456; Elliott P, 2001, BRIT MED J, V323, P363, DOI 10.1136/bmj.323.7309.363; Fell DB, 2004, PAEDIATR PERINAT EP, V18, P408, DOI 10.1111/j.1365-3016.2004.00580.x; Finnell RH, 2002, ANNU REV PHARMACOL, V42, P181, DOI 10.1146/annurev.pharmtox.42.083001.110955; Garry VF, 2002, ENVIRON HEALTH PERSP, V110, P441, DOI 10.1289/ehp.02110s3441; Gilboa SM, 2005, AM J EPIDEMIOL, V162, P238, DOI 10.1093/aje/kwi189; Glinianaia SV, 2004, EPIDEMIOLOGY, V15, P36, DOI 10.1097/01.ede.0000101023.41844.ac; Hanke Wojciech, 2004, Int J Occup Med Environ Health, V17, P223; Hansen C, 2006, BJOG-INT J OBSTET GY, V113, P935, DOI 10.1111/j.1471-0528.2006.01010.x; Hansen CA, 2008, ENVIRON HEALTH PERSP, V116, P362, DOI 10.1289/ehp.10720; Hwang BF, 2008, ENVIRON HEALTH PERSP, V116, P1411, DOI 10.1289/ehp.11311; KHOURY MJ, 1988, J CLIN EPIDEMIOL, V41, P15, DOI 10.1016/0895-4356(88)90004-2; Krost B, 2006, INT J ORAL MAX SURG, V35, P215, DOI 10.1016/j.ijom.2005.08.007; Kuehn CM, 2007, ENVIRON RES, V103, P405, DOI 10.1016/j.envres.2006.08.008; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Lacasana M, 2005, EUR J EPIDEMIOL, V20, P183, DOI 10.1007/s10654-004-3005-9; LUBIN JH, 1988, STAT MED, V7, P363, DOI 10.1002/sim.4780070302; Maisonet M, 2004, ENVIRON RES, V95, P106, DOI 10.1016/j.envres.2004.01.001; NEALE D, 2001, 38 QUEENSL GOV ENV P; Orr M, 2002, INT J HYG ENVIR HEAL, V205, P19, DOI 10.1078/1438-4639-00126; Palmer SR, 2005, ENVIRON HEALTH PERSP, V113, P1362, DOI 10.1289/ehp.7487; PLUMMER M, 2008, JAGS VERSION 1 0 3 M; Ritz B, 2002, AM J EPIDEMIOL, V155, P17, DOI 10.1093/aje/155.1.17; Ritz B, 2008, BASIC CLIN PHARMACOL, V102, P182, DOI 10.1111/j.1742-7843.2007.00161.x; RUSHTON L, 1999, AIR POLLUTION HLTH; SELLER M, 2004, GENETIC CAUSES CONGE; SHAW GM, 1992, ARCH ENVIRON HEALTH, V47, P236, DOI 10.1080/00039896.1992.9938355; Siffel C, 2005, BIRTH DEFECTS RES A, V73, P655, DOI 10.1002/bdra.20207; Slama R, 2008, ENVIRON HEALTH PERSP, V116, P791, DOI 10.1289/ehp.11074; Sram RJ, 2005, ENVIRON HEALTH PERSP, V113, P375, DOI 10.1289/ehp.6362; Stillerman KP, 2008, REPROD SCI, V15, P631, DOI 10.1177/1933719108322436; STRICKLAND MJ, 2009, AM J EPIDEM IN PRESS; Suarez L, 2007, ANN EPIDEMIOL, V17, P772, DOI 10.1016/j.annepidem.2007.05.005	46	98	104	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5408	10.1371/journal.pone.0005408	http://dx.doi.org/10.1371/journal.pone.0005408			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404385	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000265614900019
J	Marcos, S; Moreau, J; Backer, S; Job, D; Andrieux, A; Bloch-Gallego, E				Marcos, Severine; Moreau, Julie; Backer, Stephanie; Job, Didier; Andrieux, Annie; Bloch-Gallego, Evelyne			Tubulin Tyrosination Is Required for the Proper Organization and Pathfinding of the Growth Cone	PLOS ONE			English	Article								Background: During development, neuronal growth cones integrate diffusible and contact guidance cues that are conveyed to both actin and microtubule (MT) cytoskeletons and ensure axon outgrowth and pathfinding. Although several post-translational modifications of tubulin have been identified and despite their strong conservation among species, their physiological roles during development, especially in the nervous sytem, are still poorly understood. Methodology/Findings: Here, we have dissected the role of a post-translational modification of the last amino acid of the alpha-tubulin on axonal growth by analyzing the phenotype of precerebellar neurons in Tubulin tyrosin ligase knock-out mice (TTL(-/-)) through in vivo, ex vivo and in vitro analyses. TTL(-/-) neurons are devoid of tyrosinated tubulin. Their pathway shows defects in vivo, ex vivo, in hindbrains open-book preparations or in vitro, in a collagen matrix. Their axons still orient toward tropic cues, but they emit supernumerary branches and their growth cones are enlarged and exhibit an emission of mis-oriented filopodia. Further analysis of the TTL(-/-) growth cone intracellular organization also reveals that the respective localization of actin and MT filaments is disturbed, with a decrease in the distal accumulation of Myosin IIB, as well as a concomitant Rac1 over-activation in the hindbrain. Pharmacological inhibition of Rac1 over-activation in TTL(-/-) neurons can rescue Myosin IIB localization. Conclusions/Significance: In the growth cone, we propose that tubulin tyrosination takes part in the relative arrangement of actin and MT cytoskeletons, in the regulation of small GTPases activity, and consequently, in the proper morphogenesis, organization and pathfinding of the growth cone during development.			Marcos, S (corresponding author), Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France.	evelyne.bloch-gallego@inserm.fr	Bloch-Gallego, Evelyne/P-5072-2017; ANDRIEUX, ANNIE/B-2134-2017	ANDRIEUX, ANNIE/0000-0002-4022-6405; Bloch-Gallego, Evelyne/0000-0003-2779-6187; Moreau, Julie Liliane Marguerite/0000-0003-1559-7703				Alcantara S, 2000, DEVELOPMENT, V127, P1359; Backer S, 2002, NEUROSCIENCE, V113, P743, DOI 10.1016/S0306-4522(02)00221-X; Backer S, 2007, J NEUROSCI, V27, P10323, DOI 10.1523/JNEUROSCI.1102-07.2007; Bloch-Gallego E, 2005, BRAIN RES REV, V49, P253, DOI 10.1016/j.brainresrev.2005.01.003; Bloch-Gallego E, 1999, J NEUROSCI, V19, P4407; Bouquet C, 2004, J NEUROSCI, V24, P7204, DOI 10.1523/JNEUROSCI.2254-04.2004; Bridgman PC, 2001, J NEUROSCI, V21, P6159, DOI 10.1523/JNEUROSCI.21-16-06159.2001; Brown J, 2003, J HISTOCHEM CYTOCHEM, V51, P421, DOI 10.1177/002215540305100403; Burnette DT, 2008, DEV CELL, V15, P163, DOI 10.1016/j.devcel.2008.05.016; Causeret F, 2004, DEVELOPMENT, V131, P2841, DOI 10.1242/dev.01162; Causeret F, 2002, DEV BIOL, V246, P429, DOI 10.1006/dbio.2002.0681; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Erck C, 2005, P NATL ACAD SCI USA, V102, P7853, DOI 10.1073/pnas.0409626102; Gallo G, 2006, J CELL SCI, V119, P3413, DOI 10.1242/jcs.03084; Gonzalez-Billault C, 2002, J NEUROSCI RES, V67, P713, DOI 10.1002/jnr.10161; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; Grabham PW, 2003, J CELL SCI, V116, P3739, DOI 10.1242/jcs.00686; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; Kalil K, 2005, CURR OPIN NEUROBIOL, V15, P521, DOI 10.1016/j.conb.2005.08.005; Kaverina I, 2000, CURR BIOL, V10, P739, DOI 10.1016/S0960-9822(00)00544-3; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; KENNEDY TE, 1994, CELL, V78, P435; Kodama A, 2004, J CELL BIOL, V167, P203, DOI 10.1083/jcb.200408047; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kuhn TB, 1998, J NEUROBIOL, V37, P524, DOI 10.1002/(SICI)1097-4695(199812)37:4<524::AID-NEU3>3.0.CO;2-H; LAMOUREUX P, 1989, Nature (London), V340, P159, DOI 10.1038/340159a0; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; MANSFIELD SG, 1991, J NEUROCYTOL, V20, P654, DOI 10.1007/BF01187067; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; PATURLE L, 1989, BIOCHEMISTRY-US, V28, P2698, DOI 10.1021/bi00432a050; PATURLELAFANECHERE L, 1994, J CELL SCI, V107, P1529; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; Ren Y, 1998, J BIOL CHEM, V273, P34954, DOI 10.1074/jbc.273.52.34954; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Schaefer AW, 2008, DEV CELL, V15, P146, DOI 10.1016/j.devcel.2008.05.003; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Sibarita JB, 2005, ADV BIOCHEM ENG BIOT, V95, P201, DOI 10.1007/b102215; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Utreras E, 2008, DEV NEUROSCI-BASEL, V30, P200, DOI 10.1159/000109863; van Leeuwen FN, 1999, NAT CELL BIOL, V1, P242, DOI 10.1038/12068; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Watanabe Takashi, 2005, Novartis Found Symp, V269, P92; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; WEBSTER DR, 1990, J CELL BIOL, V111, P113, DOI 10.1083/jcb.111.1.113; WEHLAND J, 1987, J CELL SCI, V88, P185; Wittmann T, 2001, J CELL SCI, V114, P3795; Woo S, 2006, J NEUROSCI, V26, P1418, DOI 10.1523/JNEUROSCI.4209-05.2006; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2; Zhou FQ, 2004, J NEUROBIOL, V58, P84, DOI 10.1002/neu.10278; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014	58	45	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5405	10.1371/journal.pone.0005405	http://dx.doi.org/10.1371/journal.pone.0005405			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404406	Green Published, Green Submitted, gold			2022-12-25	WOS:000265614900016
J	Widder, S; Macia, J; Sole, R				Widder, Stefanie; Macia, Javier; Sole, Ricard			Monomeric Bistability and the Role of Autoloops in Gene Regulation	PLOS ONE			English	Article							POSITIVE FEEDBACK; NETWORKS; DIFFERENTIATION; BIOLOGY; LAMBDA; MODELS; SWITCH	Genetic toggle switches are widespread in gene regulatory networks (GRN). Bistability, namely the ability to choose among two different stable states, is an essential feature of switching and memory devices. Cells have many regulatory circuits able to provide bistability that endow a cell with efficient and reliable switching between different physiological modes of operation. It is often assumed that negative feedbacks with cooperative binding (i.e. the formation of dimers or multimers) are a prerequisite for bistability. Here we analyze the relation between bistability in GRN under monomeric regulation and the role of autoloops under a deterministic setting. Using a simple geometric argument, we show analytically that bistability can also emerge without multimeric regulation, provided that at least one regulatory autoloop is present.			Widder, S (corresponding author), Complex Syst Lab ICREA UPF, Barcelona Biomed Res Pk PRBB GRIB, Barcelona, Spain.	javier.macia@upf.edu	Widder, Stefanie/B-9584-2014; Solé, Ricard/I-3379-2015	Widder, Stefanie/0000-0003-0733-5666; Sole, Ricard/0000-0001-6974-1008	ICREA Funding Source: Custom	ICREA(ICREA)		Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bundschuh R, 2003, J THEOR BIOL, V220, P261, DOI 10.1006/jtbi.2003.3164; Cherry JL, 2000, J THEOR BIOL, V203, P117, DOI 10.1006/jtbi.2000.1068; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hasty J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.148101; Hasty J, 2001, CHAOS, V11, P207, DOI 10.1063/1.1345702; Isalan M, 2001, NAT BIOTECHNOL, V19, P656, DOI 10.1038/90264; Laurent M, 1999, TRENDS BIOCHEM SCI, V24, P418, DOI 10.1016/S0968-0004(99)01473-5; Lipshtat A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.188101; LOINGER A, 2007, PHYS REV E; LOINGER A, 2007, ANNU REV GENET, P409; Lopes FJP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000184; McClean MN, 2007, NAT GENET, V39, P409, DOI 10.1038/ng1957; McDaniel R, 2005, CURR OPIN BIOTECH, V16, P476, DOI 10.1016/j.copbio.2005.07.002; Noireaux V, 2003, P NATL ACAD SCI USA, V100, P12672, DOI 10.1073/pnas.2135496100; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Santillan M, 2004, BIOPHYS J, V86, P75, DOI 10.1016/S0006-3495(04)74085-0; Sole RV, 2007, PHILOS T R SOC B, V362, P1727, DOI 10.1098/rstb.2007.2065; Tian TH, 2004, J THEOR BIOL, V227, P229, DOI 10.1016/j.jtbi.2003.11.003; Tian TH, 2006, P NATL ACAD SCI USA, V103, P8372, DOI 10.1073/pnas.0507818103; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; TYSON JJ, 1978, PROGR THEORETICAL BI, V11, P1; Walczak AM, 2005, BIOPHYS J, V88, P828, DOI 10.1529/biophysj.104.050666; Warren PB, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.128101; Warren PB, 2005, J PHYS CHEM B, V109, P6812, DOI 10.1021/jp045523y; Widder S, 2007, J THEOR BIOL, V246, P395, DOI 10.1016/j.jtbi.2007.01.004; Wolf DM, 1998, J THEOR BIOL, V195, P167, DOI 10.1006/jtbi.1998.0790	35	12	12	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5399	10.1371/journal.pone.0005399	http://dx.doi.org/10.1371/journal.pone.0005399			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404388	Green Published, Green Submitted, gold			2022-12-25	WOS:000265614900011
J	Pezzotti, A; Kraft, P; Hankinson, SE; Hunter, DJ; Buring, J; Cox, DG				Pezzotti, Annamaria; Kraft, Peter; Hankinson, Susan E.; Hunter, David J.; Buring, Julie; Cox, David G.			The Mitochondrial A10398G Polymorphism, Interaction with Alcohol Consumption, and Breast Cancer Risk	PLOS ONE			English	Article								Polymorphisms in the mitochondrial genome are hypothesized to be associated with risk of various diseases, including cancer. However, there has been conflicting evidence for associations between a common polymorphism in the mitochondrial genome (A10398G, G10398A in some prior reports) and breast cancer risk. Reactive oxygen species, a by-product of mitochondrial energy production, can lead to oxidative stress and DNA damage in both the mitochondria and their cells. Alcohol consumption, which may also lead to oxidative stress, is associated with breast cancer risk. Therefore, we hypothesized that polymorphisms in the mitochondrial genome interact with alcohol consumption to alter breast cancer risk. We genotyped the A10398G polymorphism in a case-control study nested within the Nurses' Health Study (NHS, 1,561 cases, 2,209 controls). We observed an interaction between alcohol consumption (yes/no) and A10398G on breast cancer risk (p-int = 0.03). The risk associated with alcohol consumption was limited to carriers of the 10398G allele (Odds Ratio 1.52, 95% Confidence Interval 1.10-2.08 comparing drinkers to non-drinkers). However, we were unable to replicate these findings in the Women's Health Study (WHS, 678 cases, 669 controls), although the power to detect this interaction in the WHS was low (power = 0.57). Further examination of this interaction, such as sufficiently powered epidemiological studies of cancer risk or associations with biomarkers of oxidative stress, may provide further evidence for GxE interactions between the A10398G mitochondrial polymorphism and alcohol consumption on breast cancer risk.			Pezzotti, A (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA.	COX@lyon.fnclcc.fr	Cox, David/ABA-7454-2020; Cox, David G/A-2023-2009	Cox, David G/0000-0002-2152-9259; Cox, David/0000-0003-2047-4687	NATIONAL CANCER INSTITUTE [P01CA087969, U01CA049449, R01CA065725, R01CA049449, R03CA130050] Funding Source: NIH RePORTER; NCI NIH HHS [CA65725, U01 CA049449, R03 CA130050, R01 CA065725, CA87969, P01 CA087969, CA49449, CA130050, R01 CA049449] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bai RK, 2007, CANCER RES, V67, P4687, DOI 10.1158/0008-5472.CAN-06-3554; BONDY SC, 1992, TOXICOL LETT, V63, P231, DOI 10.1016/0378-4274(92)90086-Y; Canter JA, 2005, CANCER RES, V65, P8028, DOI 10.1158/0008-5472.CAN-05-1428; DARVISHI K, 2006, CANC LETT; Edland SD, 2002, ALZ DIS ASSOC DIS, V16, P1, DOI 10.1097/00002093-200201000-00001; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Giacchetti M, 2004, J MED GENET, V41, P293, DOI 10.1136/jmg.2003.015289; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Ishii H, 1997, J GASTROEN HEPATOL, V12, pS272, DOI 10.1111/j.1440-1746.1997.tb00510.x; Latsoudis H, 2008, J HUM GENET, V53, P349, DOI 10.1007/s10038-008-0259-1; Mancuso M, 2004, NEUROSCI LETT, V371, P158, DOI 10.1016/j.neulet.2004.08.060; Mohlke KL, 2005, HUM GENET, V118, P245, DOI 10.1007/s00439-005-0046-4; NORDMANN R, 1992, FREE RADICAL BIO MED, V12, P219, DOI 10.1016/0891-5849(92)90030-K; REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; Setiawan VW, 2008, CANCER GENET CYTOGEN, V181, P16, DOI 10.1016/j.cancergencyto.2007.10.019; SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299; Suzuki R, 2005, JNCI-J NATL CANCER I, V97, P1601, DOI 10.1093/jnci/dji341; t Hart LM, 2005, DIABETES, V54, P1892, DOI 10.2337/diabetes.54.6.1892; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; Zsurka G, 1998, BIOL PSYCHIAT, V44, P371, DOI 10.1016/S0006-3223(97)00461-7	24	40	41	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5356	10.1371/journal.pone.0005356	http://dx.doi.org/10.1371/journal.pone.0005356			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390621	Green Published, Green Submitted, gold			2022-12-25	WOS:000265514400021
J	Liu, JF; Gu, X; Robbins, D; Li, G; Shi, RH; McCord, JM; Zhao, YF				Liu, Jianfeng; Gu, Xin; Robbins, Delira; Li, Guohong; Shi, Runhua; McCord, Joe M.; Zhao, Yunfeng			Protandim, a Fundamentally New Antioxidant Approach in Chemoprevention Using Mouse Two-Stage Skin Carcinogenesis as a Model	PLOS ONE			English	Article							NF-KAPPA-B; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; GENE-EXPRESSION; PROTEIN-KINASE; CANCER; 12-O-TETRADECANOYLPHORBOL-13-ACETATE; INFLAMMATION; APOPTOSIS; CYTOKINES	Oxidative stress is an important contributor to cancer development. Consistent with that, antioxidant enzymes have been demonstrated to suppress tumorigenesis when being elevated both in vitro and in vivo, making induction of these enzymes a more potent approach for cancer prevention. Protandim, a well-defined combination of widely studied medicinal plants, has been shown to induce superoxide dismutase (SOD) and catalase activities and reduce superoxide generation and lipid peroxidation in healthy human subjects. To investigate whether Protandim can suppress tumor formation by a dietary approach, a two-stage mouse skin carcinogenesis study was performed. At the end of the study, the mice on a Protandim-containing basal diet had similar body weight compared with those on the basal diet, which indicated no overt toxicity by Protandim. After three weeks on the diets, there was a significant increase in the expression levels of SOD and catalase, in addition to the increases in SOD activities. Importantly, at the end of the carcinogenesis study, both skin tumor incidence and multiplicity were reduced in the mice on the Protandim diet by 33% and 57% respectively, compared with those on basal diet. Biochemical and histological studies revealed that the Protandim diet suppressed tumor promoter-induced oxidative stress (evidenced by reduction of protein carbonyl levels), cell proliferation (evidenced by reduction of skin hyperplasia and suppression of PKC/JNK/Jun pathway), and inflammation (evidenced by reduction of ICAM-1/VCAM-1 expression, NF-kappa B binding activity, and nuclear p65/p50 levels). Overall, induction of antioxidant enzymes by Protandim may serve as a practical and potent approach for cancer prevention.			Liu, JF (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA.	yzhao1@lsuhsc.edu	McCord, Joe/GWU-8607-2022		NHLBI NIH HHS [R01 HL087990] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087990] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Avila GE, 2005, J PHARMACOL EXP THER, V315, P170, DOI 10.1124/jpet.105.087585; Ballaz Santiago, 2003, Clin Lung Cancer, V5, P46, DOI 10.3816/CLC.2003.n.021; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bauer JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001313; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Cataisson C, 2005, J IMMUNOL, V174, P1686, DOI 10.4049/jimmunol.174.3.1686; Chaurasia SS, 2000, PHARMACOL RES, V41, P663, DOI 10.1006/phrs.1999.0634; Chowdhuri DK, 2002, PHYTOTHER RES, V16, P639, DOI 10.1002/ptr.1023; Clark J, 2006, MOL NUTR FOOD RES, V50, P144, DOI 10.1002/mnfr.200500135; Das KC, 1997, AM J RESP CELL MOL, V17, P713, DOI 10.1165/ajrcmb.17.6.2809; Das M, 2002, PHYTOTHER RES, V16, pS40, DOI 10.1002/ptr.797; DiDonato JA, 2000, METHOD ENZYMOL, V322, P393; DIKSHIT M, 1995, INDIAN J MED RES, V101, P31; Dressler J, 2000, FORENSIC SCI INT, V113, P173, DOI 10.1016/S0379-0738(00)00258-9; Farrow B, 2002, SURG ONCOL, V10, P153, DOI 10.1016/S0960-7404(02)00015-4; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Fujiki H, 2005, CHEM REC, V5, P119, DOI 10.1002/tcr.20039; FUJISAWA H, 1992, Journal of Dermatology (Tokyo), V19, P78; Gazak R, 2007, CURR MED CHEM, V14, P315, DOI 10.2174/092986707779941159; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Hoshiyama Y, 2005, J EPIDEMIOL, V15, pS109, DOI 10.2188/jea.15.S109; Israel A, 2003, NATURE, V423, P596, DOI 10.1038/423596a; Jakubikova J, 2006, J AGR FOOD CHEM, V54, P1656, DOI 10.1021/jf052717h; Jayaprakasam B, 2003, LIFE SCI, V74, P125, DOI 10.1016/j.lfs.2003.07.007; Lu YP, 1997, CANCER RES, V57, P1468; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Marks Friedrich, 2007, V174, P37; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Na HK, 2008, ARCH BIOCHEM BIOPHYS, V476, P171, DOI 10.1016/j.abb.2008.04.003; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Narayanan BA, 2006, CURR CANCER DRUG TAR, V6, P711, DOI 10.2174/156800906779010218; Nelson SK, 2006, FREE RADICAL BIO MED, V40, P341, DOI 10.1016/j.freeradbiomed.2005.08.043; Oberley LW, 2005, BIOMED PHARMACOTHER, V59, P143, DOI 10.1016/j.biopha.2005.03.006; OBERLEY LW, 1984, METHOD ENZYMOL, V105, P457; OBERLEY LW, 1979, CANCER RES, V39, P1141; Pries R, 2006, EXPERT REV ANTICANC, V6, P1195, DOI 10.1586/14737140.6.9.1195; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rose-John Stefan, 2007, V174, P57; Ruckert R, 2000, BRIT J DERMATOL, V143, P1036, DOI 10.1046/j.1365-2133.2000.03784.x; Russo A, 2005, PHYTOMEDICINE, V12, P305, DOI 10.1016/j.phymed.2003.12.008; Schaar D, 2006, CANCER CHEMOTH PHARM, V57, P789, DOI 10.1007/s00280-005-0125-1; Seril DN, 2003, CARCINOGENESIS, V24, P353, DOI 10.1093/carcin/24.3.353; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Singh RP, 2006, ENDOCR-RELAT CANCER, V13, P751, DOI 10.1677/erc.1.01126; Singh Sarvjeet, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P259, DOI 10.2174/187152006776930918; Soto C, 2003, COMP BIOCHEM PHYS C, V136, P205, DOI 10.1016/S1532-0456(03)00214-X; Stuart EC, 2006, LIFE SCI, V79, P2329, DOI 10.1016/j.lfs.2006.07.036; Velmurugan K, 2009, FREE RADICAL BIO MED, V46, P430, DOI 10.1016/j.freeradbiomed.2008.10.050; Wright TI, 2006, J AM ACAD DERMATOL, V54, P933, DOI 10.1016/j.jaad.2005.08.062; Zhang XP, 2007, CLIN CANCER RES, V13, P7181, DOI 10.1158/1078-0432.CCR-07-1133; Zhao YF, 2001, CANCER RES, V61, P6082; Zhao YF, 2005, CANCER RES, V65, P3745, DOI 10.1158/0008-5472.CAN-04-3835; Zhao YF, 2001, ANTIOXID REDOX SIGN, V3, P375, DOI 10.1089/15230860152409022; Zhao Yunfeng, 2003, Methods Mol Biol, V218, P177; Zheng X, 2006, CLIN CANCER RES, V12, P3444, DOI 10.1158/1078-0432.CCR-05-2823	56	37	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5284	10.1371/journal.pone.0005284	http://dx.doi.org/10.1371/journal.pone.0005284			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384424	Green Published, gold, Green Submitted			2022-12-25	WOS:000265513900017
J	Vojtova-Vodolanova, J; Basler, M; Osicka, R; Knapp, O; Maier, E; Cerny, J; Benada, O; Benz, R; Sebo, P				Vojtova-Vodolanova, Jana; Basler, Marek; Osicka, Radim; Knapp, Oliver; Maier, Elke; Cerny, Jan; Benada, Oldrich; Benz, Roland; Sebo, Peter			Oligomerization is involved in pore formation by Bordetella adenylate cyclase toxin	FASEB JOURNAL			English	Article						blue native electrophoresis; planar lipid bilayer membranes; pore-forming activity; pulldown; repeats in toxin	BLUE NATIVE ELECTROPHORESIS; CELL-INVASIVE ACTIVITY; MEMBRANE TRANSLOCATION; HEMOLYTIC ACTIVITIES; ESCHERICHIA-COLI; PERTUSSIS TOXIN; SHEEP ERYTHROCYTES; FATTY-ACYLATION; DENDRITIC CELLS; TARGET-CELLS	The Bordetella adenylate cyclase-hemolysin (CyaA, ACT, or AC-Hly) is a multifunctional toxin. Simultaneously with promoting calcium ion entry, CyaA delivers into host cells an adenylate cyclase enzyme (AC) and permeabilizes cell membrane by forming small cation-selective pores. Indirect evidence suggested that these two activities were accomplished by different membrane-inserted CyaA conformers, one acting as an AC-delivering monomer and the other as an uncharacterized poreforming oligomer. We tested this model by directly detecting toxin oligomers in cell membrane and by assessing oligomerization of specific mutants with altered poreforming properties. CyaA oligomers were revealed in sheep erythrocyte membranes by immunogold labeling and directly demonstrated by pulldown of membrane-inserted CyaA together with biotinylated CyaA-AC(-) toxoid. Membrane oligomers of CyaA could also be resolved by nondenaturing electrophoresis of mild detergent extracts of erythrocytes. Furthermore, CyaA mutants exhibiting enhanced (E581K) or reduced (E570K + E581P) specific hemolytic and pore-forming activity were found to exhibit also a correspondingly enhanced or reduced propensity to form oligomers in erythrocyte membranes. On the other hand, processed CyaA, with the AC domain cleaved off by erythrocyte proteases, was detected only in a monomeric form excluded from the oligomers of unprocessed CyaA. These results provide the first direct evidence that oligomerization is involved in formation of CyaA pores in target membranes and that translocation of the AC domain across cell membrane may be accomplished by monomeric CyaA.-Vojtova-Vodolanova, J., Basler, M., Osicka, R., Knapp, O., Maier, E., Cerny, J., Benada, O., Benz, R., Sebo, P. Oligomerization is involved in pore formation by Bordetella adenylate cyclase toxin. FASEB J. 23, 2831-2843 (2009). www.fasebj.org	[Vojtova-Vodolanova, Jana; Basler, Marek; Osicka, Radim; Benada, Oldrich; Sebo, Peter] Acad Sci Czech Republic, Inst Microbiol, CAS, CZ-14220 Prague 4, Czech Republic; [Knapp, Oliver; Maier, Elke; Benz, Roland] Univ Wurzburg, Lehrstuhl Biotechnol, Theodor Boveri Inst, Biozentrum, Wurzburg, Germany; [Cerny, Jan] Charles Univ Prague, Dept Cell Biol, Fac Sci, Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Wurzburg; Charles University Prague	Vojtova-Vodolanova, J (corresponding author), Acad Sci Czech Republic, Inst Microbiol, CAS, Videnska 1083, CZ-14220 Prague 4, Czech Republic.	sebo@biomed.cas.cz	SEBO, Peter/F-7423-2011; Basler, Marek/A-3559-2012; Vojtova, Jana/G-6520-2019; Cerny, Jan/C-1887-2012; Osicka, Radim/H-6776-2014; SEBO, Peter/N-2043-2019; Benada, Oldřich/H-2437-2014	SEBO, Peter/0000-0002-9755-7715; Basler, Marek/0000-0001-5414-2088; Vojtova, Jana/0000-0003-0174-9331; Cerny, Jan/0000-0002-5624-2215; Osicka, Radim/0000-0003-2626-5456; SEBO, Peter/0000-0002-9755-7715; Benada, Oldřich/0000-0002-4592-6216; Benz, Roland/0000-0002-9510-9265	EU 6th FP [LSHB-CT-2003-503582 THERAVAC]; Deutsche Forschungsgemeinschaft SFB 487 [A5]; Institutional Research Concept [AVOZ50200510]; Academy of Sciences [IAA50020091h]; Ministry of Education, Youth and Sports of the Czech Republic [1M0506];  [MSM0021620858]	EU 6th FP(European Commission); Deutsche Forschungsgemeinschaft SFB 487(German Research Foundation (DFG)); Institutional Research Concept; Academy of Sciences(Egyptian Academy of Scientific Research & Technology (ASRT)); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); 	The generous gift of monoclonal antibodies by Erik L. Hewlett (University of Virginia School of Medicine, Charlottesville, VA, USA) and protein A-gold by Jan Slot (University Medical Center, Utrecht, The Netherlands), as well as insightful advice of P. Hozak on pair correlation function analysis, are gratefully acknowledged. This work was supported by EU 6th FP contract LSHB-CT-2003-503582 THERAVAC; Deutsche Forschungsgemeinschaft SFB 487 project A5; Institutional Research Concept AVOZ50200510; Academy of Sciences grant IAA50020091h; and grant MSM0021620858 and Center of Molecular Immunology grant 1M0506 from the Ministry of Education, Youth and Sports of the Czech Republic.	Bagley KC, 2002, J LEUKOCYTE BIOL, V72, P962; BARRY EM, 1991, J BACTERIOL, V173, P720, DOI 10.1128/jb.173.2.720-726.1991; Basar T, 1999, J BIOL CHEM, V274, P10777, DOI 10.1074/jbc.274.16.10777; Basler M, 2006, INFECT IMMUN, V74, P2207, DOI 10.1128/IAI.74.4.2207-2214.2006; Basler M, 2007, J BIOL CHEM, V282, P12419, DOI 10.1074/jbc.M611226200; Bejerano M, 1999, MOL MICROBIOL, V31, P381, DOI 10.1046/j.1365-2958.1999.01183.x; BENZ R, 1979, BIOCHIM BIOPHYS ACTA, V551, P238, DOI 10.1016/0005-2736(89)90002-3; BENZ R, 1994, J BIOL CHEM, V269, P27231; BETSOU F, 1993, INFECT IMMUN, V61, P3583, DOI 10.1128/IAI.61.9.3583-3589.1993; CONFER DL, 1982, SCIENCE, V217, P948, DOI 10.1126/science.6287574; EHRMANN IE, 1991, FEBS LETT, V278, P79, DOI 10.1016/0014-5793(91)80088-K; Fiser R, 2007, J BIOL CHEM, V282, P2808, DOI 10.1074/jbc.M609979200; FRIEDMAN RL, 1987, INFECT IMMUN, V55, P135, DOI 10.1128/IAI.55.1.135-140.1987; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; FUSSLE R, 1981, J CELL BIOL, V91, P83, DOI 10.1083/jcb.91.1.83; GLASER P, 1988, EMBO J, V7, P3997, DOI 10.1002/j.1460-2075.1988.tb03288.x; GOODWIN MS, 1990, INFECT IMMUN, V58, P3445, DOI 10.1128/IAI.58.10.3445-3447.1990; GORDON VM, 1988, INFECT IMMUN, V56, P1066, DOI 10.1128/IAI.56.5.1066-1069.1988; Gray M, 1998, J BIOL CHEM, V273, P18260, DOI 10.1074/jbc.273.29.18260; Gray MC, 2004, MOL MICROBIOL, V53, P1709, DOI 10.1111/j.1365-2958.2004.04227.x; Griffon N, 1999, EMBO J, V18, P4711, DOI 10.1093/emboj/18.17.4711; GROSS MK, 1992, P NATL ACAD SCI USA, V89, P4898, DOI 10.1073/pnas.89.11.4898; Guermonprez P, 1999, J IMMUNOL, V162, P1910; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; HACKETT M, 1994, SCIENCE, V266, P433, DOI 10.1126/science.7939682; HACKETT M, 1995, J BIOL CHEM, V270, P20250, DOI 10.1074/jbc.270.35.20250; HAINFELD JF, 1987, SCIENCE, V236, P450, DOI 10.1126/science.3563522; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; HEWLETT EL, 1991, J BIOL CHEM, V266, P17503; HEWLETT EL, 1989, J BIOL CHEM, V264, P19379; Horiuchi M, 2001, P NATL ACAD SCI USA, V98, P1448, DOI 10.1073/pnas.041329498; IWAKI M, 1995, MOL MICROBIOL, V17, P1015, DOI 10.1111/j.1365-2958.1995.mmi_17061015.x; Iwaki M, 2000, INFECT IMMUN, V68, P3727, DOI 10.1128/IAI.68.6.3727-3730.2000; Kang DS, 2004, J BIOL CHEM, V279, P22102, DOI 10.1074/jbc.M402572200; Kang DS, 2005, MOL PHARMACOL, V67, P309, DOI 10.1124/mol.104.002840; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; KHELEF N, 1992, MICROB PATHOGENESIS, V12, P227, DOI 10.1016/0882-4010(92)90057-U; KHELEF N, 1993, INFECT IMMUN, V61, P4064, DOI 10.1128/IAI.61.10.4064-4071.1993; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; LADANT D, 1988, J BIOL CHEM, V263, P2612; Lee SJ, 2005, ARCH BIOCHEM BIOPHYS, V438, P80, DOI 10.1016/j.abb.2005.04.001; Lee SJ, 1999, INFECT IMMUN, V67, P2090, DOI 10.1128/IAI.67.5.2090-2095.1999; Masin J, 2004, BBA-BIOMEMBRANES, V1660, P144, DOI 10.1016/j.bbamem.2003.11.008; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Osickova A, 1999, J BIOL CHEM, V274, P37644; PEARSON RD, 1987, J IMMUNOL, V139, P2749; Philimonenko VV, 2001, EXP CELL RES, V264, P201, DOI 10.1006/excr.2001.5150; ROGEL A, 1989, EMBO J, V8, P2755, DOI 10.1002/j.1460-2075.1989.tb08417.x; ROGEL A, 1992, J BIOL CHEM, V267, P22599; ROGEL A, 1991, J BIOL CHEM, V266, P3154; Roos N., 1990, CRYOPREPARATION THIN; ROSE T, 1995, J BIOL CHEM, V270, P26370, DOI 10.1074/jbc.270.44.26370; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schlecht G, 2004, J IMMUNOL, V173, P6089, DOI 10.4049/jimmunol.173.10.6089; Skinner JA, 2004, J IMMUNOL, V173, P1934, DOI 10.4049/jimmunol.173.3.1934; SLOT JW, 1989, AM J ANAT, V185, P271, DOI 10.1002/aja.1001850220; SZABO G, 1994, J BIOL CHEM, V269, P22496; Vojtova J, 2006, MICROSC RES TECHNIQ, V69, P119, DOI 10.1002/jemt.20277; Weingart CL, 2000, INFECT IMMUN, V68, P7152, DOI 10.1128/IAI.68.12.7152-7155.2000; WEISS AA, 1984, J INFECT DIS, V150, P219, DOI 10.1093/infdis/150.2.219	61	45	46	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2009	23	9					2831	2843		10.1096/fj.09-131250	http://dx.doi.org/10.1096/fj.09-131250			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19417082				2022-12-25	WOS:000270241000006
J	Sampath, H; Flowers, MT; Liu, XQ; Paton, CM; Sullivan, R; Chu, KK; Zhao, MH; Ntambi, JM				Sampath, Harini; Flowers, Matthew T.; Liu, Xueqing; Paton, Chad M.; Sullivan, Ruth; Chu, Kiki; Zhao, Minghui; Ntambi, James M.			Skin-specific Deletion of Stearoyl-CoA Desaturase-1 Alters Skin Lipid Composition and Protects Mice from High Fat Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; SKELETAL-MUSCLE; INSULIN-RESISTANCE; THYROID-HORMONE; UNCOUPLING PROTEIN-3; SEBACEOUS GLAND; MITOCHONDRIAL BIOGENESIS; ENERGY-EXPENDITURE; LIPOPROTEIN-LIPASE; METABOLIC SYNDROME	Stearoyl-CoA desaturase-1 (SCD1) catalyzes the synthesis of monounsaturated fatty acids and is an important regulator of whole body energy homeostasis. Severe cutaneous changes in mice globally deficient in SCD1 also indicate a role for SCD1 in maintaining skin lipids. We have generated mice with a skin-specific deletion of SCD1 (SKO) and report here that SKO mice display marked sebaceous gland hypoplasia and depletion of sebaceous lipids. In addition, SKO mice have significantly increased energy expenditure and are protected from high fat diet-induced obesity, thereby recapitulating the hypermetabolic phenotype of global SCD1 deficiency. Genes of fat oxidation, lipolysis, and thermogenesis, including uncoupling proteins and peroxisome proliferator-activated receptor-gamma co-activator-1 alpha, are up-regulated in peripheral tissues of SKO mice. However, unlike mice globally deficient in SCD1, SKO mice have an intact hepatic lipogenic response to acute high carbohydrate feeding. Despite increased basal thermogenesis, SKO mice display severe cold intolerance because of rapid depletion of fuel substrates, including hepatic glycogen, to maintain core body temperature. These data collectively indicate that SKO mice have increased cold perception because of loss of insulating factors in the skin. This results in up-regulation of thermogenic processes for temperature maintenance at the expense of fuel economy, illustrating cross-talk between the skin and peripheral tissues in maintaining energy homeostasis.	[Sampath, Harini; Ntambi, James M.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; [Flowers, Matthew T.; Liu, Xueqing; Paton, Chad M.; Chu, Kiki; Zhao, Minghui; Ntambi, James M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Sullivan, Ruth] Univ Wisconsin, Res Anim Resources Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ntambi, JM (corresponding author), Univ Wisconsin, Dept Nutr Sci, 433 Babcock Dr, Madison, WI 53706 USA.	ntambi@biochem.wisc.edu			National Institutes of Health [RO1DK-62388]; Wisconsin Distinguished Graduate Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wisconsin Distinguished Graduate Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1DK-62388 (to J.M.N.). This work was also supported by a Wisconsin Distinguished Graduate Fellowship (to H. S.).	Althage MC, 2008, J BIOL CHEM, V283, P18365, DOI 10.1074/jbc.M710466200; Binczek E, 2007, BIOL CHEM, V388, P405, DOI 10.1515/BC.2007.046; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Brown JM, 2008, CIRCULATION, V118, P1467, DOI 10.1161/CIRCULATIONAHA.108.793182; Chen HC, 2002, J CLIN INVEST, V109, P175, DOI 10.1172/JCI0213880; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Crooke S.T, 2008, ANTISENSE DRUG TECHN, V2nd, P183; Dassule HR, 2000, DEVELOPMENT, V127, P4775; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; ELIAS PM, 1992, SEMIN DERMATOL, V11, P176; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Fluhr JW, 2003, J INVEST DERMATOL, V120, P728, DOI 10.1046/j.1523-1747.2003.12134.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gereben B, 2008, CELL MOL LIFE SCI, V65, P570, DOI 10.1007/s00018-007-7396-0; Grundy SM, 2007, J CLIN ENDOCR METAB, V92, P399, DOI 10.1210/jc.2006-0513; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; Han DH, 2004, AM J PHYSIOL-ENDOC M, V286, pE347, DOI 10.1152/ajpendo.00434.2003; Harper ME, 2008, ANNU REV NUTR, V28, P13, DOI 10.1146/annurev.nutr.28.061807.155357; Hillenius WJ, 2007, ANN ANAT, V189, P423, DOI 10.1016/j.aanat.2006.10.008; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Jensen DR, 2008, J LIPID RES, V49, P870, DOI 10.1194/jlr.M700519-JLR200; Jiang GQ, 2005, J CLIN INVEST, V115, P1030, DOI 10.1172/JCI200523962; Jong MC, 2001, DIABETES, V50, P2779, DOI 10.2337/diabetes.50.12.2779; Jong MC, 1998, J CLIN INVEST, V101, P145, DOI 10.1172/JCI791; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Karnik P, 2009, J INVEST DERMATOL, V129, P1243, DOI 10.1038/jid.2008.369; Kim B, 2008, THYROID, V18, P141, DOI 10.1089/thy.2007.0266; Lee SH, 2004, J LIPID RES, V45, P1674, DOI 10.1194/jlr.M400039-JLR200; Li B, 2000, NAT MED, V6, P1115, DOI 10.1038/80450; Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737; Lo Celso C, 2008, STEM CELLS, V26, P1241, DOI 10.1634/stemcells.2007-0651; Lodhi IJ, 2009, CELL METAB, V9, P111, DOI 10.1016/j.cmet.2009.01.004; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Lu Y, 2004, MOL GENET GENOMICS, V272, P129, DOI 10.1007/s00438-004-1043-3; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Mensah GA, 2004, CARDIOL CLIN, V22, P485, DOI 10.1016/j.ccl.2004.06.005; Michalik L, 2007, BBA-MOL CELL BIOL L, V1771, P991, DOI 10.1016/j.bbalip.2007.02.004; Mirza R, 2006, J INVEST DERMATOL, V126, P638, DOI 10.1038/sj.jid.5700111; Miyazaki M, 2004, J BIOL CHEM, V279, P25164, DOI 10.1074/jbc.M402781200; Miyazaki M, 2005, P NATL ACAD SCI USA, V102, P12501, DOI 10.1073/pnas.0503132102; Miyazaki M, 2003, J BIOL CHEM, V278, P33904, DOI 10.1074/jbc.M304724200; Miyazaki M, 2001, J BIOL CHEM, V276, P39455, DOI 10.1074/jbc.M106442200; Miyazaki M, 2001, J NUTR, V131, P2260, DOI 10.1093/jn/131.9.2260; Miyazaki M, 2001, J LIPID RES, V42, P1018; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Narvaez CJ, 2009, ENDOCRINOLOGY, V150, P651, DOI 10.1210/en.2008-1118; Neschen S, 2008, PHYSIOL GENOMICS, V33, P333, DOI 10.1152/physiolgenomics.00226.2007; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Overton JM, 2004, PHYSIOL BEHAV, V81, P749, DOI 10.1016/j.physbeh.2004.04.025; PAYNE AP, 1994, J ANAT, V185, P1; Pelletier P, 2008, ENDOCRINOLOGY, V149, P6471, DOI 10.1210/en.2008-0718; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rahman SM, 2005, AM J PHYSIOL-ENDOC M, V288, pE381, DOI 10.1152/ajpendo.00314.2004; Rahman SM, 2003, P NATL ACAD SCI USA, V100, P11110, DOI 10.1073/pnas.1934571100; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130; Sampath H, 2007, J BIOL CHEM, V282, P2483, DOI 10.1074/jbc.M610158200; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Shih MYS, 2009, J BIOL CHEM, V284, P4292, DOI 10.1074/jbc.M807503200; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005; Smith KR, 2008, J LIPID RES, V49, P271, DOI 10.1194/jlr.R700015-JLR200; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Son C, 2004, DIABETOLOGIA, V47, P47, DOI 10.1007/s00125-003-1272-8; Strom K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001793; Sundberg JP, 2000, AM J PATHOL, V156, P2067, DOI 10.1016/S0002-9440(10)65078-X; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wondisford FE, 2006, CELL METAB, V3, P81, DOI 10.1016/j.cmet.2006.01.008; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xie ZJ, 2002, J INVEST DERMATOL, V118, P11, DOI 10.1046/j.1523-1747.2002.01644.x; Yagyu H, 2000, J BIOL CHEM, V275, P21324, DOI 10.1074/jbc.M002541200; Zheng Y, 2001, GENOMICS, V71, P182, DOI 10.1006/geno.2000.6429	81	110	114	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19961	19973		10.1074/jbc.M109.014225	http://dx.doi.org/10.1074/jbc.M109.014225			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19429677	Green Published, hybrid			2022-12-25	WOS:000268097400023
J	Mathew, S; Fu, LZ; Fiorentino, M; Matsuda, H; Das, B; Shi, YB				Mathew, Smita; Fu, Liezhen; Fiorentino, Maria; Matsuda, Hiroki; Das, Biswajit; Shi, Yun-Bo			Differential Regulation of Cell Type-specific Apoptosis by Stromelysin-3 A POTENTIAL MECHANISM VIA THE CLEAVAGE OF THE LAMININ RECEPTOR DURING TAIL RESORPTION IN XENOPUS LAEVIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX-METALLOPROTEINASE STROMELYSIN-3; HORMONE RESPONSE GENES; THYROID-HORMONE; MOUSE STROMELYSIN-3; EXPRESSION PATTERN; BREAST-CANCER; GELATINASE-A; TADPOLE TAIL; METAMORPHOSIS; GROWTH	Matrix metalloproteinases (MMPs) have been extensively studied because of their functional attributes in development and diseases. However, relatively few in vivo functional studies have been reported on the roles of MMPs in postembryonic organ development. Amphibian metamorphosis is a unique model for studying MMP function during vertebrate development because of its dependence on thyroid hormone (T3) and the ability to easily manipulate this process with exogenous T3. The MMP stromelysin-3 (ST3) is induced by T3, and its expression correlates with cell death during metamorphosis. We have previously shown that ST3 is both necessary and sufficient for larval epithelial cell death in the remodeling intestine. To investigate the roles of ST3 in other organs and especially on different cell types, we have analyzed the effect of transgenic overexpression of ST3 in the tail of premetamorphic tadpoles. We report for the first time that ST3 expression, in the absence of T3, caused significant muscle cell death in the tail of premetamorphic transgenic tadpoles. On the other hand, only relatively low levels of epidermal cell death were induced by precocious ST3 expression in the tail, contrasting what takes place during natural and T3-induced metamorphosis when ST3 expression is high. This cell type-specific apoptotic response to ST3 in the tail suggests distinct mechanisms regulating cell death in different tissues. Furthermore, our analyses of laminin receptor, an in vivo substrate of ST3 in the intestine, suggest that laminin receptor cleavage may be an underlying mechanism for the cell type-specific effects of ST3.	[Mathew, Smita; Fu, Liezhen; Fiorentino, Maria; Matsuda, Hiroki; Das, Biswajit; Shi, Yun-Bo] NICHD, Sect Mol Morphogenesis, LGRD, PCRM,NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Fu, LZ (corresponding author), NICHD, Sect Mol Morphogenesis, LGRD, PCRM,NIH, Bldg 18T,Rm 106, Rockville, MD 20852 USA.	fuliez@helix.nih.gov; shi@helix.nih.gov	Matsuda, Hiroki/K-5055-2019; Fiorentino, Maria/AAV-9514-2020	Shi, Yun-Bo/0000-0002-6330-0639; Fiorentino, Maria R/0000-0001-5318-7313	National Institutes of Health NICHD Intramural Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008859, ZIAHD008859] Funding Source: NIH RePORTER	National Institutes of Health NICHD Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the National Institutes of Health NICHD Intramural Research Program.	Ahmad A, 1998, AM J PATHOL, V152, P721; Alexander CM, 1991, CELL BIOL EXTRACELLU, P255; Amano T, 2005, DEV DYNAM, V234, P190, DOI 10.1002/dvdy.20511; Amano T, 2005, CELL RES, V15, P150, DOI 10.1038/sj.cr.7290280; ANDERSON IC, 1995, CANCER RES, V55, P4120; Basset P, 1997, CRIT REV ONCOL HEMAT, V26, P43, DOI 10.1016/S1040-8428(97)00010-3; BASSET P, 1990, NATURE, V348, P699, DOI 10.1038/348699a0; Berry DL, 1998, DEV BIOL, V203, P12, DOI 10.1006/dbio.1998.8974; Berry DL, 1998, DEV BIOL, V203, P24, DOI 10.1006/dbio.1998.8975; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Buchholz DR, 2004, MOL CELL BIOL, V24, P9026, DOI 10.1128/MCB.24.20.9026-9037.2004; CASTRONOVO V, 1991, J BIOL CHEM, V266, P20440; Chenard MP, 1996, INT J CANCER, V69, P448, DOI 10.1002/(SICI)1097-0215(19961220)69:6<448::AID-IJC5>3.3.CO;2-4; Chin JR, 1997, DEVELOPMENT, V124, P1519; Damjanovski S, 1999, CELL RES, V9, P91, DOI 10.1038/sj.cr.7290009; Das B, 2002, P NATL ACAD SCI USA, V99, P12230, DOI 10.1073/pnas.182430599; Fingleton BM, 1999, APMIS, V107, P102, DOI 10.1111/j.1699-0463.1999.tb01532.x; Fiorentino M, 2009, INT J MOL MED, V23, P389, DOI 10.3892/ijmm_00000143; FOX H, 1972, Archives de Biologie, V83, P395; Fu LZ, 2006, J BIOL CHEM, V281, P16870, DOI 10.1074/jbc.M603041200; Fu LZ, 2005, J BIOL CHEM, V280, P27856, DOI 10.1074/jbc.M413275200; Fu LZ, 2002, MOL REPROD DEV, V62, P470, DOI 10.1002/mrd.10137; Fujimoto K, 2006, DEV GROWTH DIFFER, V48, P223, DOI 10.1111/j.1440-169x.2006.00859.x; Fujimoto K, 2007, DEV GROWTH DIFFER, V49, P131, DOI 10.1111/j.1440-169x.2007.00916.x; Gilbert L.I., 1996, METAMORPHOSIS POSTEM; Hasebe T, 2006, CELL TISSUE RES, V324, P105, DOI 10.1007/s00441-005-0099-7; Hay E.D., 1991, CELL BIOL EXTRACELLU, DOI 10.1007/978-1-4615-3770-0; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Ishizuya-Oka A, 2000, J CELL BIOL, V150, P1177, DOI 10.1083/jcb.150.5.1177; IshizuyaOka A, 1996, CELL TISSUE RES, V283, P325, DOI 10.1007/s004410050542; KERR JFR, 1974, J CELL SCI, V14, P571; KIKUYAMA S, 1993, INT REV CYTOL, V145, P105, DOI 10.1016/S0074-7696(08)60426-X; Lee MH, 2004, J CELL SCI, V117, P4015, DOI 10.1242/jcs.01223; LEFEBVRE O, 1992, J CELL BIOL, V119, P997, DOI 10.1083/jcb.119.4.997; LEFEBVRE O, 1995, DEVELOPMENT, V121, P947; Lochter A, 1999, APMIS, V107, P128, DOI 10.1111/j.1699-0463.1999.tb01535.x; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Lynch CC, 2007, CANCER RES, V67, P6760, DOI 10.1158/0008-5472.CAN-07-0026; MALINOFF HL, 1983, J CELL BIOL, V96, P1475, DOI 10.1083/jcb.96.5.1475; Manes S, 1997, J BIOL CHEM, V272, P25706, DOI 10.1074/jbc.272.41.25706; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; Masson R, 1998, J CELL BIOL, V140, P1535, DOI 10.1083/jcb.140.6.1535; Matsuda H, 2001, DEV BIOL, V229, P351, DOI 10.1006/dbio.2000.9973; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; MURPHY G, 1993, J BIOL CHEM, V268, P15435; Nagase H, 1998, Cell Res, V8, P179; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Parks WC, 1998, BIOL EXTRAC, P263; PATTERTON D, 1995, DEV BIOL, V167, P252, DOI 10.1006/dbio.1995.1021; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; Pei DQ, 1999, CELL RES, V9, P291, DOI 10.1038/sj.cr.7290028; PEI DQ, 1994, J BIOL CHEM, V269, P25849; RAO NC, 1983, BIOCHEM BIOPH RES CO, V111, P804, DOI 10.1016/0006-291X(83)91370-0; Shi Y.-B., 1999, AMPHIBIAN METAMORPHO; Shi YB, 2001, PROG NUCLEIC ACID RE, V65, P53; SHI YB, 1993, J BIOL CHEM, V268, P20312; SHI YB, 1994, BBA-GENE STRUCT EXPR, V1217, P227, DOI 10.1016/0167-4781(94)90042-6; Starkey JR, 1999, CYTOMETRY, V35, P37, DOI 10.1002/(SICI)1097-0320(19990101)35:1<37::AID-CYTO6>3.0.CO;2-C; Stolow MA, 1996, MOL BIOL CELL, V7, P1471, DOI 10.1091/mbc.7.10.1471; Tetu B, 1998, HUM PATHOL, V29, P979, DOI 10.1016/S0046-8177(98)90204-0; Uria J A, 1998, Cell Res, V8, P187; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; WANG Z, 1993, J BIOL CHEM, V268, P16270; Woessner JF, 2004, HDB PROTEOLYTIC ENZY; YOSHIZATO K, 1989, INT REV CYTOL, V119, P97	65	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18545	18556		10.1074/jbc.M109.017723	http://dx.doi.org/10.1074/jbc.M109.017723			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19429683	Green Published, hybrid			2022-12-25	WOS:000267712400065
J	Kochaniak, AB; Habuchi, S; Loparo, JJ; Chang, DJ; Cimprich, KA; Walter, JC; van Oijen, AM				Kochaniak, Anna B.; Habuchi, Satoshi; Loparo, Joseph J.; Chang, Debbie J.; Cimprich, Karlene A.; Walter, Johannes C.; van Oijen, Antoine M.			Proliferating Cell Nuclear Antigen Uses Two Distinct Modes to Move along DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION FACTOR-C; DOUBLE-STRANDED DNA; ONE-DIMENSIONAL DIFFUSION; PROCESSIVITY FACTOR; POLYMERASE-DELTA; RNA-POLYMERASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ATP UTILIZATION; PROTEINS	Proliferating cell nuclear antigen (PCNA) plays an important role in eukaryotic genomic maintenance by topologically binding DNA and recruiting replication and repair proteins. The ring-shaped protein forms a closed circle around double-stranded DNA and is able to move along the DNA in a random walk. The molecular nature of this diffusion process is poorly understood. We use single-molecule imaging to visualize the movement of individual, fluorescently labeled PCNA molecules along stretched DNA. Measurements of diffusional properties as a function of viscosity and protein size suggest that PCNA moves along DNA using two different sliding modes. Most of the time, the clamp moves while rotationally tracking the helical pitch of the DNA duplex. In a less frequently used second mode of diffusion, the movement of the protein is uncoupled from the helical pitch, and the clamp diffuses at much higher rates.	Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Kochaniak, Anna B.; Loparo, Joseph J.; Walter, Johannes C.; van Oijen, Antoine M.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Habuchi, Satoshi] Tokyo Inst Technol, Grad Sch Sci & Engn, Tokyo 1528552, Japan; [Chang, Debbie J.; Cimprich, Karlene A.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Harvard University; Harvard University; Harvard Medical School; Tokyo Institute of Technology; Stanford University	van Oijen, AM (corresponding author), 250 Longwood Ave,SGM Bldg,Rm 204A, Boston, MA 02115 USA.	antoine_van_oijen@hms.harvard.edu	van Oijen, Antoine/I-3167-2014; Habuchi, Satoshi/N-6037-2018	van Oijen, Antoine/0000-0002-1794-5161; Habuchi, Satoshi/0000-0002-6663-2807; Walter, Johannes/0000-0002-4186-7570; Loveland, Anna B./0000-0001-9172-7747	National Institutes of Health [ES016486, GM62267]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062267, R01GM077248] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES016486 (to K.A.C.) and GM62267 ( to J.C.W.).	Bagchi B, 2008, J PHYS CHEM B, V112, P6282, DOI 10.1021/jp077568f; BERG HC, 1993, RANDOM WALKS BIOL, P9; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; BURGERS PMJ, 1993, J BIOL CHEM, V268, P19923; Cai JS, 1996, P NATL ACAD SCI USA, V93, P12896, DOI 10.1073/pnas.93.23.12896; Chang DJ, 2006, J BIOL CHEM, V281, P32081, DOI 10.1074/jbc.M606799200; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; FIEN K, 1992, MOL CELL BIOL, V12, P155, DOI 10.1128/MCB.12.1.155; FUKUDA K, 1995, J BIOL CHEM, V270, P22527, DOI 10.1074/jbc.270.38.22527; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Gomes XV, 2001, J BIOL CHEM, V276, P34776, DOI 10.1074/jbc.M011743200; Gomes XV, 2001, J BIOL CHEM, V276, P34768, DOI 10.1074/jbc.M011631200; Gorman J, 2008, NAT STRUCT MOL BIOL, V15, P768, DOI 10.1038/nsmb.1441; Gorman J, 2007, MOL CELL, V28, P359, DOI 10.1016/j.molcel.2007.09.008; Graneli A, 2006, P NATL ACAD SCI USA, V103, P1221, DOI 10.1073/pnas.0508366103; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Harada Y, 1999, BIOPHYS J, V76, P709, DOI 10.1016/S0006-3495(99)77237-1; Ivanov I, 2006, NUCLEIC ACIDS RES, V34, P6023, DOI 10.1093/nar/gkl744; KABATA H, 1993, SCIENCE, V262, P1561, DOI 10.1126/science.8248804; Kim JH, 2007, NUCLEIC ACIDS RES, V35, P3848, DOI 10.1093/nar/gkm332; Komazin-Meredith G, 2008, P NATL ACAD SCI USA, V105, P10721, DOI 10.1073/pnas.0802676105; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Laurence TA, 2008, J BIOL CHEM, V283, P22895, DOI 10.1074/jbc.M800174200; Lavalette D, 1999, BIOPHYS J, V76, P2744, DOI 10.1016/S0006-3495(99)77427-8; Lavalette D, 2006, EUR BIOPHYS J BIOPHY, V35, P517, DOI 10.1007/s00249-006-0060-z; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; MECHALI M, 1982, CELL, V30, P93, DOI 10.1016/0092-8674(82)90015-0; MEI LH, 1995, J CHEM ENG DATA, V40, P1168, DOI 10.1021/je00022a002; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; NG L, 1993, J BIOL CHEM, V268, P13571; PODUST LM, 1995, MOL CELL BIOL, V15, P3072; PODUST VN, 1995, BIOCHEMISTRY-US, V34, P5003, DOI 10.1021/bi00015a011; Podust VN, 1998, J BIOL CHEM, V273, P31992, DOI 10.1074/jbc.273.48.31992; Randell JCW, 2004, J MOL BIOL, V335, P409, DOI 10.1016/j.jmb.2003.10.064; SCHURR JM, 1979, BIOPHYS CHEM, V9, P413, DOI 10.1016/0301-4622(75)80057-3; Schurtenberger P, 1998, J MOL BIOL, V275, P123, DOI 10.1006/jmbi.1997.1435; Sheely ML, 1932, IND ENG CHEM, V24, P1060, DOI 10.1021/ie50273a022; Tafvizi A, 2008, BIOPHYS J, V95, pL1, DOI 10.1529/biophysj.108.134122; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; TINKER RL, 1994, EMBO J, V13, P5330, DOI 10.1002/j.1460-2075.1994.tb06867.x; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1950; Uhlmann F, 1997, J BIOL CHEM, V272, P10058; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wang YM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.048302; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Zuccola HJ, 2000, MOL CELL, V5, P267, DOI 10.1016/S1097-2765(00)80422-0	49	96	96	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17700	17710		10.1074/jbc.M109.008706	http://dx.doi.org/10.1074/jbc.M109.008706			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19411704	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000267202500036
J	Larder, R; Mellon, PL				Larder, Rachel; Mellon, Pamela L.			Otx2 Induction of the Gonadotropin-releasing Hormone Promoter Is Modulated by Direct Interactions with Grg Co-repressors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUCHO-RELATED GENE; NEURON-SPECIFIC ENHANCER; HOMEODOMAIN PROTEIN; GNRH RECEPTOR; ANTERIOR NEUROECTODERM; TRANSCRIPTION FACTORS; REGULATES EXPRESSION; DROSOPHILA-ENHANCER; TRANSGENIC MICE; NERVOUS-SYSTEM	Hormonal communication between the hypothalamus, pituitary, and gonads orchestrates the development and regulation of mammalian reproductive function. In mice, gonadotropin-releasing hormone (GnRH) expression is limited to similar to 1000 neurons that originate in the olfactory placode then migrate to specific positions scattered throughout the hypothalamus. Coordination of the hypothalamic-pituitary-gonadal axis is dependent upon correct migration of GnRH neurons into the hypothalamus followed by the appropriate synthesis and pulsatile secretion of GnRH. Defects in any one of these processes can cause infertility. Recently, substantial progress has been made in identifying transcription factors, and their cofactors, that regulate not only adult expression of GnRH, but also the maturation of GnRH neurons. Here, we show that expression of Otx2, a homeodomain protein required for the formation of the forebrain, is dramatically up-regulated during GnRH neuronal maturation and that overexpression of Otx2 increases GnRH promoter activity in GnRH neuronal cell lines. Furthermore, Otx2 transcriptional activity is modulated by Grg4, a member of the Groucho-related-gene (Grg) family. Using mutational analysis, we show that a WRPW peptide motif within the Otx2 protein is required for physical interaction between Otx2 and Grg4. Without this physical interaction, Grg4 cannot repress Otx2-dependent activation of GnRH gene transcription. Taken together, these data show that Otx2 is important for GnRH expression and that direct interaction between Otx2 and Grg co-repressors regulates GnRH gene expression in hypothalamic neurons.	Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Reprod Sci & Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Mellon, PL (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	pmellon@ucsd.edu		Larder, Rachel/0000-0003-1697-9455	National Institutes of Health [R01 DK044838, HD020377]; NICHD/NIH [U54 HD012303]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD012303, U54HD012303, R01HD072754] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD020377, R01HD020377] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK044838 and HD020377 (to P. L. M.). This work was also supported by NICHD/NIH through a cooperative agreement (U54 HD012303) as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research (to P. L. M.).	ACAMPORA D, 1995, DEVELOPMENT, V121, P3279; Ang SL, 1996, DEVELOPMENT, V122, P243; Briata P, 1999, FEBS LETT, V445, P160, DOI 10.1016/S0014-5793(99)00113-1; Buscarlet M, 2008, J BIOL CHEM, V283, P24881, DOI 10.1074/jbc.M800722200; Buscarlet M, 2007, TRENDS CELL BIOL, V17, P353, DOI 10.1016/j.tcb.2007.07.002; Cai Y, 2003, EMBO J, V22, P5522, DOI 10.1093/emboj/cdg536; Chatelain G, 2006, J MOL MED, V84, P604, DOI 10.1007/s00109-006-0048-2; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Cherrington BD, 2008, MOL CELL ENDOCRINOL, V295, P106, DOI 10.1016/j.mce.2008.07.017; Cinnamon E, 2008, CURR OPIN GENET DEV, V18, P435, DOI 10.1016/j.gde.2008.07.010; Danno H, 2008, P NATL ACAD SCI USA, V105, P5408, DOI 10.1073/pnas.0710954105; Dasen JS, 2001, GENE DEV, V15, P3193, DOI 10.1101/gad.932601; DEHNI G, 1995, MECH DEVELOP, V53, P369, DOI 10.1016/0925-4773(95)00452-1; Diaczok D, 2008, J CLIN ENDOCR METAB, V93, P4351, DOI 10.1210/jc.2008-1189; ERALY SA, 1995, MOL ENDOCRINOL, V9, P848, DOI 10.1210/me.9.7.848; Fossat N, 2005, DEV DYNAM, V233, P154, DOI 10.1002/dvdy.20287; Fossat N, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-122; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; Gasperowicz M, 2005, J CELL BIOCHEM, V95, P670, DOI 10.1002/jcb.20476; Givens ML, 2005, J BIOL CHEM, V280, P19156, DOI 10.1074/jbc.M502004200; Givens ML, 2004, MOL ENDOCRINOL, V18, P2950, DOI 10.1210/me.2003-0437; Grbavec D, 1996, BIOCHEM BIOPH RES CO, V223, P701, DOI 10.1006/bbrc.1996.0959; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Heimbucher T, 2007, MOL CELL BIOL, V27, P340, DOI 10.1128/MCB.00811-06; Jennings BH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-205; Kelley CG, 2000, MOL ENDOCRINOL, V14, P1246, DOI 10.1210/me.14.8.1246; Kepa JK, 1996, NUCLEIC ACIDS RES, V24, P3614, DOI 10.1093/nar/24.18.3614; Kim HH, 2007, MOL ENDOCRINOL, V21, P457, DOI 10.1210/me.2005-0216; Koop KE, 1996, MECH DEVELOP, V59, P73, DOI 10.1016/0925-4773(96)00582-5; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Larder R, 2004, BIOL REPROD, V71, P828, DOI 10.1095/biolreprod.104.030569; Larder R, 2006, ENDOCRINOLOGY, V147, P5676, DOI 10.1210/en.2006-0383; Lawson MA, 1996, MOL CELL BIOL, V16, P3596; Leon C, 1997, DEV DYNAM, V208, P11, DOI 10.1002/(SICI)1097-0177(199701)208:1<11::AID-AJA2>3.0.CO;2-4; Lepourcelet M, 2002, J BIOL CHEM, V277, P47732, DOI 10.1074/jbc.M208154200; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Malin S, 2005, NUCLEIC ACIDS RES, V33, P4618, DOI 10.1093/nar/gki744; Mallamaci A, 1996, MECH DEVELOP, V58, P165, DOI 10.1016/S0925-4773(96)00571-0; MALLO M, 1993, MECH DEVELOP, V42, P67, DOI 10.1016/0925-4773(93)90099-J; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; McGillivray SM, 2005, ENDOCRINOLOGY, V146, P2180, DOI 10.1210/en.2004-1566; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; MIYASAKA H, 1993, EUR J BIOCHEM, V216, P343, DOI 10.1111/j.1432-1033.1993.tb18151.x; Mochizuki T, 2000, DEV BIOL, V224, P470, DOI 10.1006/dbio.2000.9778; Nakano T, 2000, BIOCHEM BIOPH RES CO, V267, P64, DOI 10.1006/bbrc.1999.1872; Nelson SB, 1998, MOL CELL ENDOCRINOL, V140, P151, DOI 10.1016/S0303-7207(98)00043-4; Nuthall HN, 2004, MOL CELL BIOL, V24, P8395, DOI 10.1128/MCB.24.19.8395-8407.2004; On ZS, 2008, AM J MED GENET A, V146A, P2480, DOI 10.1002/ajmg.a.32398; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Pinto M, 1996, J BIOL CHEM, V271, P33026, DOI 10.1074/jbc.271.51.33026; Puelles E, 2004, DEVELOPMENT, V131, P2037, DOI 10.1242/dev.01107; Puelles E, 2006, J NEUROSCI, V26, P5955, DOI 10.1523/JNEUROSCI.1097-06.2006; RADOVICK S, 1991, P NATL ACAD SCI USA, V88, P3402, DOI 10.1073/pnas.88.8.3402; Ragge NK, 2005, AM J HUM GENET, V76, P1008, DOI 10.1086/430721; Rave-Harel N, 2005, J BIOL CHEM, V280, P30975, DOI 10.1074/jbc.M502315200; Rave-Harel N, 2004, J BIOL CHEM, V279, P30287, DOI 10.1074/jbc.M402960200; Rhinn M, 1998, DEVELOPMENT, V125, P845; SCHWANZELFUKUDA M, 1992, ENDOCR REV, V13, P623, DOI 10.1210/er.13.4.623; SCHWANZELFUKUDA M, 1989, NATURE, V338, P161, DOI 10.1038/338161a0; Sekiya T, 2007, MOL CELL, V28, P291, DOI 10.1016/j.molcel.2007.10.002; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; Swingler TE, 2004, J BIOL CHEM, V279, P34938, DOI 10.1074/jbc.M404488200; Tolkunova EN, 1998, MOL CELL BIOL, V18, P2804, DOI 10.1128/MCB.18.5.2804; Wang WF, 2004, DEV BIOL, V270, P364, DOI 10.1016/j.ydbio.2004.03.003; WETSEL WC, 1991, ENDOCRINOLOGY, V129, P1584, DOI 10.1210/endo-129-3-1584; WETSEL WC, 1992, P NATL ACAD SCI USA, V89, P4149, DOI 10.1073/pnas.89.9.4149; WHYTE DB, 1995, MOL ENDOCRINOL, V9, P467, DOI 10.1210/me.9.4.467; Wyatt A, 2008, HUM MUTAT, V29, pE278, DOI 10.1002/humu.20869; Yao J, 2000, MECH DEVELOP, V93, P105, DOI 10.1016/S0925-4773(00)00278-1; Yu X, 2001, MOL CELL BIOL, V21, P4614, DOI 10.1128/MCB.21.14.4614-4625.2001; Zhu CQC, 2002, DEVELOPMENT, V129, P2835	72	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16966	16978		10.1074/jbc.M109.002485	http://dx.doi.org/10.1074/jbc.M109.002485			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19401468	Green Published, hybrid			2022-12-25	WOS:000266962400034
J	Walker, M; Black, EJ; Oehler, V; Gillespie, DA; Scott, MT				Walker, M.; Black, E. J.; Oehler, V.; Gillespie, D. A.; Scott, M. T.			Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation by de-repression of Chk1 catalytic activity	ONCOGENE			English	Article						Chk1; ATR; kinase activity	DNA-DAMAGE CHECKPOINT; DOUBLE-STRAND BREAKS; IONIZING-RADIATION; GENOTOXIC STRESS; REQUIRES ATM; S-PHASE; KINASE; REPLICATION; RECRUITMENT; CHROMATIN	Chk1 is phosphorylated within its C-terminal regulatory domain by the upstream ATM/ATR kinases during checkpoint activation; however, how this modulates Chk1 function is poorly understood. Here, we show that Chk1 kinase activity is rapidly stimulated in a cell-cycle phase-specific manner in response to both DNA damage and replication arrest, and that the extent and duration of activation correlates closely with regulatory phosphorylation at serines (S) S317, S345 and S366. Despite their evident co-regulation, substitutions of individual Chk1 regulatory sites with alanine (A) residues have differential effects on checkpoint proficiency and kinase activation. Thus, whereas Chk1 S345 is essential for all functions tested, mutants lacking S317 or S366 retain partial proficiency for G2/M and S/M checkpoint arrests triggered by DNA damage or replication arrest. These phenotypes reflect defects in Chk1 kinase induction, as the mutants are either partially (317A and 366A) or completely (345A) resistant to kinase activation. Importantly, S345 phosphorylation is impaired in Chk1 S317A and S366A mutants, suggesting that modi. cation of adjacent SQ sites promotes this key regulatory event. Finally, we provide biochemical evidence that Chk1 catalytic activity is stimulated by a de-repression mechanism. Oncogene (2009) 28, 2314-2323; doi:10.1038/onc.2009.102; published online 4 May 2009	[Walker, M.; Black, E. J.; Oehler, V.; Gillespie, D. A.; Scott, M. T.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Gillespie, D. A.] Univ Glasgow, Fac Biomed & Life Sci, Glasgow, Lanark, Scotland	Beatson Institute; University of Glasgow	Scott, MT (corresponding author), Beatson Inst Canc Res, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	m.scott@beatson.gla.ac.uk	Gillespie, David/R-4771-2019	Gillespie, David/0000-0002-6338-0544; Scott, Mary/0000-0002-7177-6960	Cancer Research UK [A3674] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Adams KE, 2006, ONCOGENE, V25, P3894, DOI 10.1038/sj.onc.1209426; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bonilla CY, 2008, MOL CELL, V30, P267, DOI 10.1016/j.molcel.2008.03.023; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Chen YH, 2004, DNA REPAIR, V3, P1025, DOI 10.1016/j.dnarep.2004.03.003; Cross DAE, 1998, EXP CELL RES, V241, P12, DOI 10.1006/excr.1998.4023; Dart DA, 2004, J BIOL CHEM, V279, P16433, DOI 10.1074/jbc.M314212200; Feijoo C, 2001, J CELL BIOL, V154, P913, DOI 10.1083/jcb.200104099; Gatei M, 2003, J BIOL CHEM, V278, P14806, DOI 10.1074/jbc.M210862200; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Jiang KC, 2003, J BIOL CHEM, V278, P25207, DOI 10.1074/jbc.M300070200; Kaneko Y, 1999, ONCOGENE, V18, P3673, DOI 10.1038/sj.onc.1202706; Katsuragi Y, 2004, MOL BIOL CELL, V15, P1680, DOI 10.1091/mbc.E03-12-0874; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Liu QH, 2000, GENE DEV, V14, P1448; Lupardus PJ, 2002, GENE DEV, V16, P2327, DOI 10.1101/gad.1013502; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Niida H, 2007, MOL CELL BIOL, V27, P2572, DOI 10.1128/MCB.01611-06; Oe T, 2001, DEV BIOL, V229, P250, DOI 10.1006/dbio.2000.9968; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Puc J, 2005, CANCER CELL, V7, P193, DOI 10.1016/j.ccr.2005.01.009; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Smith GCM, 1999, P NATL ACAD SCI USA, V96, P11134, DOI 10.1073/pnas.96.20.11134; Smits VAJ, 2006, CURR BIOL, V16, P150, DOI 10.1016/j.cub.2005.11.066; Suzuki K, 1999, J BIOL CHEM, V274, P25571, DOI 10.1074/jbc.274.36.25571; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; Wilsker D, 2008, P NATL ACAD SCI USA, V105, P20752, DOI 10.1073/pnas.0806917106; Zachos G, 2005, MOL CELL BIOL, V25, P563, DOI 10.1128/MCB.25.2.563-574.2005; Zachos G, 2003, EMBO J, V22, P713, DOI 10.1093/emboj/cdg060; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	36	60	62	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2009	28	24					2314	2323		10.1038/onc.2009.102	http://dx.doi.org/10.1038/onc.2009.102			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	459GJ	19421147	Green Accepted			2022-12-25	WOS:000267089100002
J	DeVaney, SC; McNyset, KM; Williams, JB; Peterson, AT; Wiley, EO				DeVaney, Shannon C.; McNyset, Kristina M.; Williams, Justin B.; Peterson, A. Townsend; Wiley, Edward O.			A Tale of Four "Carp'': Invasion Potential and Ecological Niche Modeling	PLOS ONE			English	Article							BLACK CARP; GEOGRAPHIC DISTRIBUTIONS; SPECIES DISTRIBUTIONS; BIOLOGICAL INVASIONS; SAMPLE-SIZE; GRASS CARP; PREDICTION; RANGE; RISK; OCCURRENCES	Background: Invasive species are a serious problem in ecosystems, but are difficult to eradicate once established. Predictive methods can be key in determining which areas are of concern regarding invasion by such species to prevent establishment [1]. We assessed the geographic potential of four Eurasian cyprinid fishes (common carp, tench, grass carp, black carp) as invaders in North America via ecological niche modeling (ENM). These "carp'' represent four stages of invasion of the continent (a long-established invader with a wide distribution, a long-established invader with a limited distribution, a spreading invader whose distribution is expanding, and a newly introduced potential invader that is not yet established), and as such illustrate the progressive reduction of distributional disequilibrium over the history of species' invasions. Methodology/Principal Findings: We used ENM to estimate the potential distributional area for each species in North America using models based on native range distribution data. Environmental data layers for native and introduced ranges were imported from state, national, and international climate and environmental databases. Models were evaluated using independent validation data on native and invaded areas. We calculated omission error for the independent validation data for each species: all native range tests were highly successful (all omission values,7%); invaded-range predictions were predictive for common and grass carp (omission values 8.8 and 19.8%, respectively). Model omission was high for introduced tench populations (54.7%), but the model correctly identified some areas where the species has been successful; distributional predictions for black carp show that large portions of eastern North America are at risk. Conclusions/Significance: ENMs predicted potential ranges of carp species accurately even in regions where the species have not been present until recently. ENM can forecast species' potential geographic ranges with reasonable precision and within the short screening time required by proposed U. S. invasive species legislation.			DeVaney, SC (corresponding author), Nat Hist Museum Los Angeles Cty, Los Angeles, CA USA.	sdevaney@nhm.org	Peterson, A. Townsend/I-5697-2013	Peterson, A. Townsend/0000-0003-0243-2379				Allan J.D., 2021, STREAM ECOLOGY STRUC, DOI DOI 10.1007/978-3-030-61286-3; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Angermeier PL, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P519; BAIN MB, 1993, ENVIRON MANAGE, V107, P221; Banarescu P., 1964, PISCES OSTEICHTHYES; BAUGHMAN JL, 1947, J WILDLIFE MANAGE, V11, P197, DOI 10.2307/3796278; BELLRICHARD SJ, 1996, EFFECTS COMMON CARP; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; BERG LS, 1949, FRESHWATER FISHES US; BIRO P, 1999, FRESHWATER FISHES EU; Bowden GJ, 2003, ECOLOGICAL INFORMATICS -BOOK, P215; BROENNIMANN O, 2007, ECOLOGY LETT; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; CENTOR RM, 1991, MED DECIS MAKING, V11, P102, DOI 10.1177/0272989X9101100205; *CENTR INT AG, 1979, CHIN; Chick JH, 2003, SCIENCE, V300, P1876, DOI 10.1126/science.300.5627.1876; COURTENAY WR, 1993, INDIANA U PURDUE U; Courtenay WR, 2004, SNAKEHEADS PISCES CH; Cox GW, 1993, CONSERVATION ECOLOGY; Drake JA, 1989, BIOL INVASIONS GLOBA; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; EVTUSHENKO N. Y., 1994, HYDROBIOL J, V30, P1; Ferber D, 2001, SCIENCE, V292, P203, DOI 10.1126/science.292.5515.203; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; FROESE R, 2008, FISHBASE; Fuller PL, 1999, NONINDIGENOUS FISHES; Grinnell J., 1917, Auk Cambridge Mass, V34; GUILLORY V, 1978, T AM FISH SOC, V107, P105, DOI 10.1577/1548-8659(1978)107&lt;105:ZOTGCI&gt;2.0.CO;2; Guisan A, 2007, ECOL MONOGR, V77, P615, DOI 10.1890/06-1060.1; GUISAN A, 2000, ECOLOGICAL MODELLING, V135; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANSEN CM, 2003, GLOBAL PERCENT TREE; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Iguchi K, 2004, T AM FISH SOC, V133, P845, DOI 10.1577/T03-172.1; IPCC, 2001, CLIM DAT ARCH; Jeschke JM, 2005, P NATL ACAD SCI USA, V102, P7198, DOI 10.1073/pnas.0501271102; Keith P., 2001, ATLAS POISSONS EAU D; Kolar CS, 2002, SCIENCE, V298, P1233, DOI 10.1126/science.1075753; Lachner EA, 1970, SMITHSONIAN CONTRIB, V59, P1, DOI DOI 10.5479/SI.00810282.59; LAMBRECHT B, 2000, INVASION ASIAN CARP; LOBO JM, 2007, GLOBAL ECOLOGY BIOGE; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Loo SE, 2007, ECOL APPL, V17, P181, DOI 10.1890/1051-0761(2007)017[0181:FNZMIR]2.0.CO;2; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Marchetti MP, 2004, ECOL APPL, V14, P1507, DOI 10.1890/03-5173; Marsh-Matthews E, 2000, ECOL FRESHW FISH, V9, P9, DOI 10.1034/j.1600-0633.2000.90103.x; Masuda H., 1984, FISHES JAPANESE ARCH; McNyset KM, 2005, ECOL FRESHW FISH, V14, P243, DOI 10.1111/j.1600-0633.2005.00101.x; Mohamed KI, 2006, AMBIO, V35, P281, DOI 10.1579/05-R-051R.1; *NAS, 2002, PRED INV NON PLANTS; Naylor RL, 2001, SCIENCE, V294, P1655, DOI 10.1126/science.1064875; Nichols J.T., 1943, FRESHWATER FISHES CH; Nico L., 1996, RISK ASSESSMENT BLAC; NICO LG, 2001, CARP MYLOPHARYNGODON; Nyari A, 2006, J AVIAN BIOL, V37, P306, DOI 10.1111/j.2006.0908-8857.03686.x; Olden JD, 2002, FRESHWATER BIOL, V47, P1976, DOI 10.1046/j.1365-2427.2002.00945.x; PANETTA FD, 1987, J AUST I AGR SCI, V53, P11; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 1999, ECOL MODEL, V117, P159, DOI 10.1016/S0304-3800(99)00023-X; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 2005, CURR SCI INDIA, V89, P9; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; PETERSON AT, 2008, PLOS ONE; Pflieger W.L., 1975, FISHES MISSOURI CONS; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; SCACHETTIPEREIR.R, 2002, DESKTOP GARP VERSION; Scott WB, 1998, FRESHWATER FISHES CA; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; STANLEY JG, 1978, T AM FISH SOC, V107, P119, DOI 10.1577/1548-8659(1978)107&lt;119:RRALFN&gt;2.0.CO;2; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; STOCKWELL DRB, 1992, MATH COMPUT SIMULAT, V33, P385, DOI 10.1016/0378-4754(92)90126-2; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; TONN WM, 1990, T AM FISH SOC, V119, P337, DOI 10.1577/1548-8659(1990)119<0337:CCAFCA>2.3.CO;2; *U KANS, 2005, SPEC AN; *US GEOL SURV, 2008, NON AQ SPEC; *US NAT GEOSP INT, 2008, GEONET NAM SERV; *USGS, 2008, GEOGR NAM INF SYST; USGS, 2001, HYDRO1K EL DER DAT; Vander Zanden MJ, 2004, ECOL APPL, V14, P132; Venable DL, 2000, J WORLD AQUACULT SOC, V31, P158, DOI 10.1111/j.1749-7345.2000.tb00349.x; Wiley E. O., 2003, OCEANOGRAPHY, V16, P120, DOI [http://dx.doi.org/10.5670/oceanog.2003.42, DOI 10.5670/OCEANOG.2003.42, 10.5670/oceanog.2003.42]; Williams J., 2005, STATUS TRENDS NATION; Williamson M., 1996, BIOL INVASIONS; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Zambrano L, 2006, CAN J FISH AQUAT SCI, V63, P1903, DOI 10.1139/F06-088; 1999, FED REG, P6183	93	33	36	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5451	10.1371/journal.pone.0005451	http://dx.doi.org/10.1371/journal.pone.0005451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421314	Green Published, Green Submitted, gold			2022-12-25	WOS:000265836900009
J	Suzan, G; Marce, E; Giermakowski, JT; Mills, JN; Ceballos, G; Ostfeld, RS; Armien, B; Pascale, JM; Yates, TL				Suzan, Gerardo; Marce, Erika; Giermakowski, J. Tomasz; Mills, James N.; Ceballos, Gerardo; Ostfeld, Richard S.; Armien, Blas; Pascale, Juan M.; Yates, Terry L.			Experimental Evidence for Reduced Rodent Diversity Causing Increased Hantavirus Prevalence	PLOS ONE			English	Article								Emerging and re-emerging infectious diseases have become a major global environmental problem with important public health, economic, and political consequences. The etiologic agents of most emerging infectious diseases are zoonotic, and anthropogenic environmental changes that affect wildlife communities are increasingly implicated in disease emergence and spread. Although increased disease incidence has been correlated with biodiversity loss for several zoonoses, experimental tests in these systems are lacking. We manipulated small-mammal biodiversity by removing non-reservoir species in replicated field plots in Panama, where zoonotic hantaviruses are endemic. Both infection prevalence of hantaviruses in wild reservoir (rodent) populations and reservoir population density increased where small-mammal species diversity was reduced. Regardless of other variables that affect the prevalence of directly transmitted infections in natural communities, high biodiversity is important in reducing transmission of zoonotic pathogens among wildlife hosts. Our results have wide applications in both conservation biology and infectious disease management.			Suzan, G (corresponding author), Univ Nacl Autonoma Mexico, Fac Med Vet & Zootecnia, Ciudad Univ, Mexico City 04510, DF, Mexico.	rostfeld@caryinstitute.org	Giermakowski, Jacek T/B-3689-2009	Giermakowski, Jacek T/0000-0002-6422-157X; Suzan, Gerardo/0000-0003-2508-6376; Ostfeld, Richard/0000-0002-3707-9301; Ceballos, Gerardo/0000-0001-8374-2656				Alam M, 2004, INFECT MED, V21, P327; Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; [Anonymous], 2003, PATCH ANAL EXTENSION; ANTONOVICS J, 1995, AM NAT, V145, P661, DOI 10.1086/285761; Begon Michael, 2008, P12; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Daily GC, 2003, CONSERV BIOL, V17, P1814, DOI 10.1111/j.1523-1739.2003.00298.x; Dobson A, 2006, PLOS MED, V3, P714, DOI 10.1371/journal.pmed.0030231; Ezenwa VO, 2006, P ROY SOC B-BIOL SCI, V273, P109, DOI 10.1098/rspb.2005.3284; Hall SR, 2009, ECOLOGY, V90, P791, DOI 10.1890/08-0838.1; Hjelle B, 1997, J CLIN MICROBIOL, V35, P600, DOI 10.1128/JCM.35.3.600-608.1997; Jackson LE, 2006, INT J EPIDEMIOL, V35, P315, DOI 10.1093/ije/dyi284; Johnson PTJ, 2008, ECOL LETT, V11, P1017, DOI 10.1111/j.1461-0248.2008.01212.x; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; Lehmer EM, 2008, OECOLOGIA, V155, P429, DOI 10.1007/s00442-007-0922-9; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Logiudice K, 2008, ECOLOGY, V89, P2841, DOI 10.1890/07-1047.1; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; Norman R, 1999, J THEOR BIOL, V200, P111, DOI 10.1006/jtbi.1999.0982; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; Ostfeld RS, 2003, ECOLOGY, V84, P1421, DOI 10.1890/02-3125; Peixoto ID, 2006, ECOLOGY, V87, P873, DOI 10.1890/0012-9658(2006)87[873:TEOBOT]2.0.CO;2; Roscher C, 2007, OECOLOGIA, V153, P173, DOI 10.1007/s00442-007-0713-3; Ruedas LA, 2004, J VECTOR ECOL, V29, P177; Suzan G, 2008, J MAMMAL, V89, P684, DOI 10.1644/07-MAMM-A-015R1.1; Suzan G, 2006, AM J TROP MED HYG, V74, P1103, DOI 10.4269/ajtmh.2006.74.1103; Swaddle JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002488; Tersago K, 2008, VECTOR-BORNE ZOONOT, V8, P235, DOI 10.1089/vbz.2007.0160; Woolhouse M, 2001, NATURE, V411, P258, DOI 10.1038/35077149; YAMADA T, 1995, J VIROL, V69, P1939, DOI 10.1128/JVI.69.3.1939-1943.1995; Yates TL, 2002, BIOSCIENCE, V52, P989, DOI 10.1641/0006-3568(2002)052[0989:TEAEHO]2.0.CO;2	33	147	151	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5461	10.1371/journal.pone.0005461	http://dx.doi.org/10.1371/journal.pone.0005461			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421313	Green Submitted, Green Published, gold			2022-12-25	WOS:000265836900016
J	Guerin, A; d'Aubenton-Carafa, Y; Marrakchi, E; Da Silva, C; Wincker, P; Mazan, S; Retaux, S				Guerin, Adele; d'Aubenton-Carafa, Yves; Marrakchi, Emna; Da Silva, Corinne; Wincker, Patrick; Mazan, Sylvie; Retaux, Sylvie			Neurodevelopment Genes in Lampreys Reveal Trends for Forebrain Evolution in Craniates	PLOS ONE			English	Article							LIM-HOMEODOMAIN; EVO-DEVO; EXPRESSION; CELL; BRAIN; PROLIFERATION; TELENCEPHALON; TRANSCRIPTION; VERTEBRATE; MIGRATION	The forebrain is the brain region which has undergone the most dramatic changes through vertebrate evolution. Analyses conducted in lampreys are essential to gain insight into the broad ancestral characteristics of the forebrain at the dawn of vertebrates, and to understand the molecular basis for the diversifications that have taken place in cyclostomes and gnathostomes following their splitting. Here, we report the embryonic expression patterns of 43 lamprey genes, coding for transcription factors or signaling molecules known to be involved in cell proliferation, stemcellness, neurogenesis, patterning and regionalization in the developing forebrain. Systematic expression patterns comparisons with model organisms highlight conservations likely to reflect shared features present in the vertebrate ancestors. They also point to changes in signaling systems-pathways which control the growth and patterning of the neuroepithelium-, which may have been crucial in the evolution of forebrain anatomy at the origin of vertebrates.			Guerin, A (corresponding author), Inst Alfred Fessard, CNRS, UPR2197, Equipe Dev Evolut Cerveau Anterieur, Gif Sur Yvette, France.	retaux@inaf.cnrs-gif.fr		DA SILVA, Corinne/0000-0002-7618-7831				Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; Baston E, 2007, RECENT PAT ANTI-CANC, V2, P31, DOI 10.2174/157489207779561453; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; BULLOCK TH, 1984, NEUROSCI LETT, V48, P145, DOI 10.1016/0304-3940(84)90010-7; BUTLER AB, 1996, COMP VERTEBRATE NEUR, P349; Carrera I, 2008, BRAIN RES BULL, V75, P405, DOI 10.1016/j.brainresbull.2007.10.013; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Cobos I, 2001, DEV BIOL, V239, P30, DOI 10.1006/dbio.2001.0422; Derobert Y, 2002, DEV BIOL, V247, P390, DOI 10.1006/dbio.2002.0700; Erwin DH, 2002, DEVELOPMENT, V129, P3021; Fischer T, 2007, NEUROSCIENCE, V147, P693, DOI 10.1016/j.neuroscience.2007.04.060; Fiuza UM, 2007, J ENDOCRINOL, V194, P459, DOI 10.1677/JOE-07-0242; Hammond KL, 2006, DEVELOPMENT, V133, P1347, DOI 10.1242/dev.02306; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; Joly JS, 2007, SEMIN CELL DEV BIOL, V18, P512, DOI 10.1016/j.semcdb.2007.06.001; Jones SE, 2002, BIOESSAYS, V24, P811, DOI 10.1002/bies.10136; Kadomatsu KJ, 2004, CANCER LETT, V204, P127, DOI 10.1016/S0304-3835(03)00450-6; Kawauchi H, 2006, GEN COMP ENDOCR, V148, P3, DOI 10.1016/j.ygcen.2005.10.011; Kim AS, 2001, MECH DEVELOP, V103, P167, DOI 10.1016/S0925-4773(01)00342-2; Kim SH, 1998, MECH DEVELOP, V78, P193, DOI 10.1016/S0925-4773(98)00137-3; Kuratani S, 2002, GENESIS, V34, P175, DOI 10.1002/gene.10142; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; McCauley DW, 2008, ZOOL SCI, V25, P982, DOI 10.2108/zsj.25.982; McCauley DW, 2002, GENE, V287, P129, DOI 10.1016/S0378-1119(01)00894-0; Metin C, 2007, DEVELOPMENT, V134, P2815, DOI 10.1242/dev.02869; Meulemans D, 2003, DEV BIOL, V264, P430, DOI 10.1016/j.ydbio.2003.09.006; Miyake A, 2005, DEV BIOL, V288, P259, DOI 10.1016/j.ydbio.2005.09.042; Moreno N, 2008, DEV NEUROBIOL, V68, P504, DOI 10.1002/dneu.20603; Murakami Y, 2001, DEVELOPMENT, V128, P3521; Muruganandan S, 2008, CLIN PHARMACOL THER, V83, P818, DOI 10.1038/clpt.2008.50; Myojin M, 2001, J EXP ZOOL, V291, P68, DOI 10.1002/jez.6; Nakayama Y, 2008, DEV BIOL, V313, P752, DOI 10.1016/j.ydbio.2007.11.013; Ogasawara M, 2001, GENESIS, V30, P51, DOI 10.1002/gene.1032; Ohtanii K, 2008, J EXP ZOOL PART B, V310B, P596, DOI 10.1002/jez.b.21231; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Osorio J, 2005, DEV BIOL, V288, P100, DOI 10.1016/j.ydbio.2005.08.042; Osorio J, 2008, DEV GENES EVOL, V218, P221, DOI 10.1007/s00427-008-0208-1; Osorio J, 2006, GENE EXPR PATTERNS, V6, P873, DOI 10.1016/j.modgep.2006.02.007; Ota KG, 2006, ZOOL SCI, V23, P403, DOI 10.2108/zsj.23.403; Pellegrini E, 2007, J COMP NEUROL, V501, P150, DOI 10.1002/cne.21222; Peng G, 2006, DEVELOPMENT, V133, P3191, DOI 10.1242/dev.02485; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Sauka-Spengler T, 2007, DEV CELL, V13, P405, DOI 10.1016/j.devcel.2007.08.005; Stoilov I, 2001, DRUG METAB DRUG INTE, V18, P33, DOI DOI 10.1515/DMDI.2001.18.1.33); Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Suda Y, 2009, DEV BIOL, V325, P282, DOI 10.1016/j.ydbio.2008.09.018; TAHARA Y, 1988, ZOOL SCI, V5, P109; Tendeng C, 2006, GENE EXPR PATTERNS, V6, P761, DOI 10.1016/j.modgep.2006.01.006; Tessmar-Raible K, 2007, SEMIN CELL DEV BIOL, V18, P492, DOI 10.1016/j.semcdb.2007.04.007; Ueki T, 1998, DEV GENES EVOL, V208, P223, DOI 10.1007/s004270050176; vanderWees J, 1996, MECH DEVELOP, V54, P173, DOI 10.1016/0925-4773(95)00471-8; Villar-Cheda B, 2006, J COMP NEUROL, V494, P986, DOI 10.1002/cne.20851; Walshe J, 2003, DEVELOPMENT, V130, P4337, DOI 10.1242/dev.00660; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Weigle C, 1999, EUR J MORPHOL, V37, P122, DOI 10.1076/ejom.37.2.122.4751; Winkler C, 2003, GENOME RES, V13, P1067, DOI 10.1101/gr.1097503; Wullimann MF, 2000, ANAT EMBRYOL, V202, P385, DOI 10.1007/s004290000115; Wullimann MF, 1999, ANAT EMBRYOL, V199, P329, DOI 10.1007/s004290050232	62	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5374	10.1371/journal.pone.0005374	http://dx.doi.org/10.1371/journal.pone.0005374			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399187	Green Published, Green Submitted, gold			2022-12-25	WOS:000265514900023
J	Zingaretti, MC; Crosta, F; Vitali, A; Guerrieri, M; Frontini, A; Cannon, B; Nedergaard, J; Cinti, S				Zingaretti, Maria Cristina; Crosta, Francesca; Vitali, Alessandra; Guerrieri, Mario; Frontini, Andrea; Cannon, Barbara; Nedergaard, Jan; Cinti, Saverio			The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue	FASEB JOURNAL			English	Article						uncoupling protein; obesity; sympathetic nervous system; tyrosine hydroxylase immunoreactivity; capillaries; precursor cells	THERMOGENESIS; PROPRANOLOL	Classically, adult humans have been considered not to possess active brown adipose tissue ( BAT). However, positron-emission-tomography has shown fluorodeoxyglucose uptake that is distributed in such a way (e.g., in the neck) that it would seem to be BAT. Until now this has not been supported by direct evidence that these areas truly represented BAT, that is, the presence of the BAT-unique uncoupling protein-1 (UCP1). Samples of adipose tissue from the neck of 35 patients undergoing surgery for thyroid diseases were obtained and analyzed. In 1/3 of the subjects ( the younger and leaner), distinct islands composed of UCP1 immunoreactive brown adipocytes could clearly be discerned, accounting for up to 1/3 of all adipocytes. The brown-adipose islands were richly sympathetically innervated ( indicating acute central control); adjacent white adipose areas were not. The capillary density was high, implying a high capacity for oxygen delivery. Cells with features of brown adipocyte precursors were found in pericapillary areas. These data demonstrate that human adults indeed possess BAT and thus imply possibilities of future therapeutic strategies for the treatment of obesity, including maintenance of brown adipocytes and stimulation of the growth of preexisting brown precursors.-Zingaretti, M. C., Crosta, F., Vitali, A., Guerrieri, M., Frontini, A., Cannon, B., Nedergaard, J., Cinti, S. The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue. FASEB J. 23, 3113-3120 ( 2009). www.fasebj.org	[Zingaretti, Maria Cristina; Vitali, Alessandra; Frontini, Andrea; Cinti, Saverio] Univ Ancona, Osped Riuniti Ancona, Dept Mol Pathol & Innovat Therapies, Politecn Marche,Fac Med, IT-60020 Ancona, Italy; [Crosta, Francesca; Guerrieri, Mario] Univ Ancona, Osped Riuniti Ancona, Clin Chirurg Gen & Metodol Chirurg, Politecn Marche, IT-60020 Ancona, Italy; [Cannon, Barbara; Nedergaard, Jan] Stockholm Univ, Dept Physiol, Wenner Gren Inst, Arrhenius Labs F3, S-10691 Stockholm, Sweden	Marche Polytechnic University; Marche Polytechnic University; Stockholm University	Cinti, S (corresponding author), Univ Ancona, Osped Riuniti Ancona, Dept Mol Pathol & Innovat Therapies, Politecn Marche,Fac Med, Via Tronto 10 A, IT-60020 Ancona, Italy.	cinti@univpm.it	Nedergaard, Jan/A-1706-2010; Frontini, A/AAB-8767-2021; Nedergaard, Jan/Q-8286-2019; Cannon, Barbara/B-3089-2016	Nedergaard, Jan/0000-0003-2070-1587; Cannon, Barbara/0000-0001-6594-2363; CINTI, Saverio/0000-0003-0362-5017; Frontini, Andrea/0000-0002-7381-4107	EU [COFIN 2007 BBR57M_005]; Swedish Research Council.	EU(European Commission); Swedish Research Council.(Swedish Research CouncilEuropean Commission)	This study was supported by EU grant COFIN 2007 BBR57M_005 and the Swedish Research Council.	AHERNE W, 1966, J PATHOL BACTERIOL, V91, P223, DOI 10.1002/path.1700910126; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Christensen CR, 2006, CLIN NUCL MED, V31, P193, DOI 10.1097/01.rlu.0000204199.33136.05; Cinti S, 1995, ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY, VOL 100 - SUPPLEMENT N.1 - 1995, P75; Cinti S, 1999, ADIPOSE ORGAN; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Frontini A, 2007, J HISTOCHEM CYTOCHEM, V55, P183, DOI 10.1369/jhc.6A7013.2006; Gelfand MJ, 2004, PEDIATR RADIOL, V34, P577, DOI 10.1007/s00247-003-1136-x; Lean M. E. J., 1986, BROWN ADIPOSE TISSUE, P339; LEAN MEJ, 1989, P NUTR SOC, V48, P243, DOI 10.1079/PNS19890036; Murano I, 2009, J ANAT, V214, P171, DOI 10.1111/j.1469-7580.2008.01001.x; Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Okuyama C, 2003, J NUCL MED, V44, P1421; Parysow O, 2007, CLIN NUCL MED, V32, P351, DOI 10.1097/01.rlu.0000259570.69163.04; Soderlund V, 2007, EUR J NUCL MED MOL I, V34, P1018, DOI 10.1007/s00259-006-0318-9	16	555	571	1	32	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					3113	3120		10.1096/fj.09-133546	http://dx.doi.org/10.1096/fj.09-133546			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19417078				2022-12-25	WOS:000270241000033
J	Yabu, T; Shimuzu, A; Yamashita, M				Yabu, Takeshi; Shimuzu, Akio; Yamashita, Michiaki			A Novel Mitochondrial Sphingomyelinase in Zebrafish Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MG2+-DEPENDENT NEUTRAL SPHINGOMYELINASE; SUBCELLULAR-LOCALIZATION; SPHINGOLIPID METABOLISM; PARTIAL-PURIFICATION; CERAMIDE GENERATION; INDUCED APOPTOSIS; BACILLUS-CEREUS; PHOSPHOLIPASE-C; HL-60 CELLS; ACTIVATION	Sphingolipids are important signaling molecules in many biological processes, but little is known regarding their physiological roles in the mitochondrion. We focused on the biochemical characters of a novel sphingomyelinase (SMase) and its function in mitochondrial ceramide generation in zebrafish embryonic cells. The cloned SMase cDNA encoded a polypeptide of 545 amino acid residues (putative molecular weight, 61,300) containing a mitochondrial localization signal (MLS) and a predicted transmembrane domain. The mature endogenous enzyme was predicted to have a molecular weight of 57,000, and matrix-assisted laser desorption ionization time-of-flight mass spectrometry analysis indicated that the N-terminal amino acid residue of the mature enzyme was Ala-36. The purified enzyme optimally hydrolyzed [C-14] sphingomyelin in the presence of 10 mM Mg2+ at pH 7.5. In HEK293 cells that overexpressed SMase cDNA, the enzyme was localized to the mitochondrial fraction, whereas mutant proteins lacking MLS or both the MLS and the transmembrane domain were absent from the mitochondrial fraction. Endogenous SMase protein co-localized with a mitochondrial cytostaining marker. Using a protease protection assay, we found that SMase was distributed throughout the intermembrane space and/or the inner membrane of the mitochondrion. Furthermore, the overexpression of SMase in HEK293 cells induced ceramide generation and sphingomyelin hydrolysis in the mitochondrial fraction. Antisense phosphorothioate oligonucleotide-induced knockdown repressed ceramide generation and sphingomyelin hydrolysis in the mitochondrial fraction in zebrafish embryonic cells. These observations indicate that SMase catalyzes the hydrolysis of sphingomyelin and generates ceramide in mitochondria in fish cells.	[Yabu, Takeshi; Shimuzu, Akio; Yamashita, Michiaki] Natl Res Inst Fisheries Sci, Kanagawa 2368648, Japan	Japan Fisheries Research & Education Agency (FRA)	Yamashita, M (corresponding author), Natl Res Inst Fisheries Sci, Kanagawa 2368648, Japan.	mic@affrc.go.jp			Japan Science and Technology Corporation; Japan Society for Promotion of Science; Ministry of Agriculture, Forestry, and Fisheries of Japan	Japan Science and Technology Corporation(Japan Science & Technology Agency (JST)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported in part by grants from the Japan Science and Technology Corporation, the Japan Society for Promotion of Science, and the Ministry of Agriculture, Forestry, and Fisheries of Japan.	Ardail D, 2003, BIOCHEM J, V371, P1013, DOI 10.1042/BJ20021834; Ardail D, 2001, FEBS LETT, V488, P160, DOI 10.1016/S0014-5793(00)02332-2; Aubin I, 2005, NAT GENET, V37, P803, DOI 10.1038/ng1603; Bernardo K, 2000, J BIOL CHEM, V275, P7641, DOI 10.1074/jbc.275.11.7641; Bionda C, 2004, BIOCHEM J, V382, P527, DOI 10.1042/BJ20031819; Birbes H, 2005, BIOCHEM J, V386, P445, DOI 10.1042/BJ20041627; Birbes H, 2001, FASEB J, V15, P2669, DOI 10.1096/fj.01-0539com; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; COLBEAU A, 1971, BIOCHIM BIOPHYS ACTA, V249, P462, DOI 10.1016/0005-2736(71)90123-4; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; Fujii S, 1998, J BIOCHEM-TOKYO, V124, P1178, DOI 10.1093/oxfordjournals.jbchem.a022236; Fujii S, 1999, J BIOCHEM-TOKYO, V126, P90, DOI 10.1093/oxfordjournals.jbchem.a022441; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; Hayashi Y, 1997, J BIOL CHEM, V272, P18082, DOI 10.1074/jbc.272.29.18082; Hofmann K, 2000, P NATL ACAD SCI USA, V97, P5895, DOI 10.1073/pnas.97.11.5895; Jana A, 2004, J BIOL CHEM, V279, P51451, DOI 10.1074/jbc.M404635200; KALRA J, 1974, J BIOL CHEM, V249, P3255; Karakashian AA, 2004, FASEB J, V18, P968, DOI 10.1096/fj.03-0875fje; Kitagaki H, 2007, BBA-BIOMEMBRANES, V1768, P2849, DOI 10.1016/j.bbamem.2007.07.019; Krut O, 2006, J BIOL CHEM, V281, P13784, DOI 10.1074/jbc.M511306200; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Levade T, 2002, NEUROCHEM RES, V27, P601, DOI 10.1023/A:1020215815013; Levy M, 2006, BIOCHEM BIOPH RES CO, V344, P900, DOI 10.1016/j.bbrc.2006.04.013; Liu B, 1998, J BIOL CHEM, V273, P34472, DOI 10.1074/jbc.273.51.34472; Liu H, 2003, J BIOL CHEM, V278, P40330, DOI 10.1074/jbc.M304455200; Marchesini N, 2004, J BIOL CHEM, V279, P25101, DOI 10.1074/jbc.M313662200; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; Matsuo Y, 1996, PROTEIN SCI, V5, P2459, DOI 10.1002/pro.5560051208; Neto ED, 2000, P NATL ACAD SCI USA, V97, P3491; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Okamoto Y, 2003, BIOCHEMISTRY-US, V42, P7855, DOI 10.1021/bi0341354; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; OKAZAKI T, 1994, J BIOL CHEM, V269, P4070; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Ruvolo PP, 1999, J BIOL CHEM, V274, P20296, DOI 10.1074/jbc.274.29.20296; Sawai H, 1999, J BIOL CHEM, V274, P38131, DOI 10.1074/jbc.274.53.38131; SAWAI H, 1995, J BIOL CHEM, V270, P27326, DOI 10.1074/jbc.270.45.27326; Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200; SHIAO YJ, 1995, J BIOL CHEM, V270, P11190, DOI 10.1074/jbc.270.19.11190; Shimeno H, 1998, LIPIDS, V33, P601, DOI 10.1007/s11745-998-0246-2; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Stoffel W, 2005, P NATL ACAD SCI USA, V102, P4554, DOI 10.1073/pnas.0406380102; SUGIURA Y, 1981, J BIOL CHEM, V256, P664; Tani M, 2007, J BIOL CHEM, V282, P10047, DOI 10.1074/jbc.M611249200; Tepper AD, 1999, J CLIN INVEST, V103, P971, DOI 10.1172/JCI5457; Thongboonkerd V, 2002, J BIOL CHEM, V277, P16599, DOI 10.1074/jbc.M200746200; Tomiuk S, 1998, P NATL ACAD SCI USA, V95, P3638, DOI 10.1073/pnas.95.7.3638; Yabu T, 2005, BLOOD, V106, P125, DOI 10.1182/blood-2004-09-3679; Yabu T, 2001, BIOCHEM J, V360, P39, DOI 10.1042/0264-6021:3600039; Yabu T, 2008, J BIOL CHEM, V283, P29971, DOI 10.1074/jbc.M805402200; YAMASHITA M, 1991, J AGR FOOD CHEM, V39, P1402, DOI 10.1021/jf00008a009; Zumbansen M, 2002, MOL CELL BIOL, V22, P3633, DOI 10.1128/MCB.22.11.3633-3638.2002	59	26	27	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20349	20363		10.1074/jbc.M109.004580	http://dx.doi.org/10.1074/jbc.M109.004580			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19429680	Green Published, hybrid			2022-12-25	WOS:000268097400061
J	Cho, G; Lim, Y; Golden, JA				Cho, Ginam; Lim, Youngshin; Golden, Jeffrey A.			SUMO Interaction Motifs in Sizn1 Are Required for Promyelocytic Leukemia Protein Nuclear Body Localization and for Transcriptional Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB-BINDING-PROTEIN; PML; BODIES; BAX; IDENTIFICATION; DOMAINS; SITES; CELLS; MAP-1; DAXX	Mutations in Sizn1 (Zcchc12), a novel transcriptional co-activator in the BMP signaling pathway, are associated with X-linked mental retardation. Previously, we demonstrated that Sizn1 positively modulates the BMP signal by interacting with Smad family members and cAMP-responsive element-binding protein-binding protein. To further define the molecular basis of Sizn1 function, we have explored its subcellular localization and generated various deletion mutants to carry out domain analyses. Here, we report that Sizn1 localizes to promyelocytic leukemia protein nuclear bodies (PML-NBs). Sizn1 deletion mutants that disrupt the MA homologous domain or the middle region fail to target to the PML-NB. We show that two SUMO interaction motifs (SIMs) in Sizn1 can bind to SUMO and govern SUMO conjugation to Sizn1 in the absence of the consensus motif for SUMO attachment. Interestingly, the SIM mutant Sizn1 localizes to nuclear bodies, but not to PML-NBs. Thus, SIMs mediate the localization of Sizn1 to PML-NB. Interestingly, mutations in SIM sequences and deletion of the MA homologous domain also affected the transcriptional co-activation function of a Sizn1. Taken together, our data indicate that the SIMs in Sizn1 are required for its PML-NB localization and for the full transcriptional co-activation function in BMP signaling.	[Cho, Ginam; Lim, Youngshin; Golden, Jeffrey A.] Childrens Hosp Philadelphia, Dept Pathol, Philadelphia, PA 19072 USA; [Golden, Jeffrey A.] Univ Penn, Sch Med, Dept Pathol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Golden, JA (corresponding author), Childrens Hosp Philadelphia, Dept Pathol, ARC 516G,34th Civ Ctr Blvd, Philadelphia, PA 19072 USA.	youngshl@mail.med.upenn.edu; goldenj@mail.med.upenn.edu	Lim, Youngshin/HGV-0369-2022	Lim, Youngshin/0000-0002-7842-3244; Golden, Jeffrey/0000-0001-9933-5502	National Institutes of Health [NS45034]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045034, R56NS045034, R01NS046616] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS45034.	ASCOLI CA, 1991, J CELL BIOL, V112, P785, DOI 10.1083/jcb.112.5.785; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Boisvert FM, 2000, J CELL BIOL, V148, P283, DOI 10.1083/jcb.148.2.283; Caspary T, 2003, NAT REV NEUROSCI, V4, P289, DOI 10.1038/nrn1073; Cho G, 2008, AM J MED GENET A, V146A, P2644, DOI 10.1002/ajmg.a.32472; Cho G, 2008, MOL CELL BIOL, V28, P1565, DOI 10.1128/MCB.01038-07; Dalmau J, 1999, BRAIN, V122, P27, DOI 10.1093/brain/122.1.27; Dalmau J, 2004, BRAIN, V127, P1831, DOI 10.1093/brain/awh203; Doucas V, 1999, P NATL ACAD SCI USA, V96, P2627, DOI 10.1073/pnas.96.6.2627; Eladad S, 2005, HUM MOL GENET, V14, P1351, DOI 10.1093/hmg/ddi145; Eskiw CH, 2004, J BIOL CHEM, V279, P9577, DOI 10.1074/jbc.M312580200; Gambacorta M, 1996, AM J PATHOL, V149, P2023; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hsieh J, 2005, CURR OPIN CELL BIOL, V17, P664, DOI 10.1016/j.ceb.2005.09.002; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Kiesslich A, 2002, J STRUCT BIOL, V140, P167, DOI 10.1016/S1047-8477(02)00571-3; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lopez-Coviella I, 2000, SCIENCE, V289, P313, DOI 10.1126/science.289.5477.313; Maul GG, 1995, J CELL BIOCHEM, V59, P498, DOI 10.1002/jcb.240590410; Mauri F, 2008, J BIOL CHEM, V283, P20848, DOI 10.1074/jbc.M710186200; Navascues J, 2007, CHROMOSOMA, V116, P441, DOI 10.1007/s00412-007-0107-7; Negorev D, 2001, J CELL SCI, V114, P59; Rosenfeld MR, 2001, ANN NEUROL, V50, P339, DOI 10.1002/ana.1288; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Spector DL, 2001, J CELL SCI, V114, P2891; Suzuki H, 2001, BIOCHEM BIOPH RES CO, V286, P322, DOI 10.1006/bbrc.2001.5387; Tan KO, 2005, P NATL ACAD SCI USA, V102, P14623, DOI 10.1073/pnas.0503524102; Tan KO, 2001, J BIOL CHEM, V276, P2802, DOI 10.1074/jbc.M008955200; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Vos MD, 2006, J BIOL CHEM, V281, P4557, DOI 10.1074/jbc.M512128200; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wang ZG, 1998, SCIENCE, V279, P1547; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200	37	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19592	19600		10.1074/jbc.M109.010181	http://dx.doi.org/10.1074/jbc.M109.010181			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19416967	Green Published, hybrid			2022-12-25	WOS:000267908300051
J	Bippes, CA; Zeltina, A; Casagrande, F; Ratera, M; Palacin, M; Muller, DJ; Fotiadis, D				Bippes, Christian A.; Zeltina, Antra; Casagrande, Fabio; Ratera, Merce; Palacin, Manuel; Muller, Daniel J.; Fotiadis, Dimitrios			Substrate Binding Tunes Conformational Flexibility and Kinetic Stability of an Amino Acid Antiporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ATOMIC-FORCE MICROSCOPY; DETECTING MOLECULAR-INTERACTIONS; LYSINURIC PROTEIN INTOLERANCE; NATIVE MEMBRANE-PROTEINS; DYNAMIC ENERGY LANDSCAPE; UNFOLDING PATHWAYS; SINGLE PROTEIN; TRANSPORTER SUPERFAMILY; TRANSMEMBRANE HELICES; MECHANICAL-PROPERTIES	We used single molecule dynamic force spectroscopy to unfold individual serine/threonine antiporters SteT from Bacillus subtilis. The unfolding force patterns revealed interactions and energy barriers that stabilized structural segments of SteT. Substrate binding did not establish strong localized interactions but appeared to be facilitated by the formation of weak interactions with several structural segments. Upon substrate binding, all energy barriers of the antiporter changed thereby describing the transition from brittle mechanical properties of SteT in the unbound state to structurally flexible conformations in the substrate-bound state. The lifetime of the unbound state was much shorter than that of the substrate-bound state. This leads to the conclusion that the unbound state of SteT shows a reduced conformational flexibility to facilitate specific substrate binding and a reduced kinetic stability to enable rapid switching to the bound state. In contrast, the bound state of SteT showed an increased conformational flexibility and kinetic stability such as required to enable transport of substrate across the cell membrane. This result supports the working model of antiporters in which alternate substrate access from one to the other membrane surface occurs in the substrate-bound state.	[Bippes, Christian A.; Zeltina, Antra; Muller, Daniel J.] Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany; [Casagrande, Fabio] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Ratera, Merce; Palacin, Manuel] Univ Barcelona, Inst Res Biomed, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; [Fotiadis, Dimitrios] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland	Technische Universitat Dresden; University of California System; University of California San Diego; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; University of Bern	Muller, DJ (corresponding author), Tech Univ Dresden, Ctr Biotechnol, Tatzberg 47-51, D-01307 Dresden, Germany.	mueller@biotec.tu-dresden.de	Müller, Daniel J./A-5967-2010; Palacín, Manuel/G-9786-2015	Müller, Daniel J./0000-0003-3075-0665; Zeltina, Antra/0000-0002-5485-5480; Palacin, Manuel/0000-0002-8670-293X; Ratera, Merce/0000-0001-5224-9172	European Union; Deutsche Forschungsgemeinschaft; Berne University Research Foundation; Swiss National Foundation for Scientific Research; Spanish Ministry of Science and Education	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Berne University Research Foundation; Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF)); Spanish Ministry of Science and Education(Spanish Government)	This work was supported by the European Union, the Deutsche Forschungsgemeinschaft, the Berne University Research Foundation, the Swiss National Foundation for Scientific Research, and the Spanish Ministry of Science and Education.	Allende D, 2005, BIOPHYS J, V88, P1828, DOI 10.1529/biophysj.104.049817; Aranda-Espinoza H, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.208301; Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; Bassi MT, 2001, PFLUG ARCH EUR J PHY, V442, P286, DOI 10.1007/s004240100537; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000; Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Borsani G, 1999, NAT GENET, V21, P297, DOI 10.1038/6815; Bosshart PD, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384014; BUSTAMANTE C, 1994, SCIENCE, V265, P1600; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; CALONGE MT, 1994, NAT GENET, V6, P420, DOI 10.1038/ng0494-420; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Casagrande F, 2008, J BIOL CHEM, V283, P33240, DOI 10.1074/jbc.M806917200; Cisneros DA, 2005, STRUCTURE, V13, P235, DOI 10.1016/j.str.2004.12.005; Cisneros DA, 2008, STRUCTURE, V16, P1206, DOI 10.1016/j.str.2008.04.014; Dammer U, 1996, BIOPHYS J, V70, P2437, DOI 10.1016/S0006-3495(96)79814-4; Dietz H, 2004, P NATL ACAD SCI USA, V101, P16192, DOI 10.1073/pnas.0404549101; Dietz H, 2006, P NATL ACAD SCI USA, V103, P12724, DOI 10.1073/pnas.0602995103; DILL KA, 1995, PROTEIN SCI, V4, P561; DILL KA, 1997, NAT STRUCT BIOL, V4, P19, DOI DOI 10.1038/NSB0197-10; Engel A, 2008, ANNU REV BIOCHEM, V77, P127, DOI 10.1146/annurev.biochem.77.062706.154450; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 2000, J PHYS-CONDENS MAT, V12, pA315, DOI 10.1088/0953-8984/12/8A/341; Evans E, 1998, FARADAY DISCUSS, V111, P1; Feliubadalo L, 1999, NAT GENET, V23, P52, DOI 10.1038/12652; Fisher TE, 2000, NAT STRUCT BIOL, V7, P719; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Fotiadis D, 2002, MICRON, V33, P385, DOI 10.1016/S0968-4328(01)00026-9; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Gasol E, 2004, J BIOL CHEM, V279, P31228, DOI 10.1074/jbc.M402428200; Grater F, 2007, J STRUCT BIOL, V157, P557, DOI 10.1016/j.jsb.2006.11.005; GRUSZECKI WI, 1990, BIOCHIM BIOPHYS ACTA, V1023, P405, DOI 10.1016/0005-2736(90)90133-9; HAMMOND GS, 1955, J AM CHEM SOC, V77, P338, DOI 10.1021/ja01607a028; Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; HOWARD J, 2001, MARXIST SHAKESPEARES, P9; Hu YL, 2008, J MOL BIOL, V382, P99, DOI 10.1016/j.jmb.2008.06.091; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; Janovjak H, 2005, EUR BIOPHYS J BIOPHY, V34, P91, DOI 10.1007/s00249-004-0430-3; Janovjak H, 2004, STRUCTURE, V12, P871, DOI 10.1016/j.str.2004.03.016; Janovjak H, 2007, J AM CHEM SOC, V129, P246, DOI 10.1021/ja065684a; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kedrov A, 2005, EMBO REP, V6, P668, DOI 10.1038/sj.embor.7400455; Kedrov A, 2004, J MOL BIOL, V340, P1143, DOI 10.1016/j.jmb.2004.05.026; Kedrov A, 2008, J MOL BIOL, V375, P1258, DOI 10.1016/j.jmb.2007.11.032; Kedrov A, 2007, J STRUCT BIOL, V159, P290, DOI 10.1016/j.jsb.2007.02.010; Kedrov A, 2007, ANNU REV BIOPH BIOM, V36, P233, DOI 10.1146/annurev.biophys.36.040306.132640; Kessler M, 2006, STRUCTURE, V14, P521, DOI 10.1016/j.str.2005.11.023; Klyszejko AL, 2008, J MOL BIOL, V376, P35, DOI 10.1016/j.jmb.2007.11.030; Krieger F, 2003, J MOL BIOL, V332, P265, DOI 10.1016/S0022-2836(03)00892-1; Kumar S, 2000, PROTEIN SCI, V9, P10; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; LEE GU, 1994, LANGMUIR, V10, P354, DOI 10.1021/la00014a003; LEE GU, 1994, SCIENCE, V266, P771, DOI 10.1126/science.7973628; Li LW, 2005, J MOL BIOL, V345, P817, DOI 10.1016/j.jmb.2004.11.021; Lolkema JS, 2008, MOL MEMBR BIOL, V25, P567, DOI 10.1080/09687680802541177; Ludwig T, 2008, PFLUG ARCH EUR J PHY, V456, P29, DOI 10.1007/s00424-007-0398-9; MATOUSCHEK A, 1993, P NATL ACAD SCI USA, V90, P7814, DOI 10.1073/pnas.90.16.7814; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Muller DJ, 2007, NAT PROTOC, V2, P2191, DOI 10.1038/nprot.2007.309; Muller DJ, 2008, BIOCHEMISTRY-US, V47, P7986, DOI 10.1021/bi800753x; Muller DJ, 2002, BIOPHYS J, V83, P3578, DOI 10.1016/S0006-3495(02)75358-7; Oberhauser AF, 2001, P NATL ACAD SCI USA, V98, P468, DOI 10.1073/pnas.021321798; Oberhauser AF, 1999, NAT STRUCT BIOL, V6, P1025; Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Palacin M, 2005, PHYSIOLOGY, V20, P112, DOI 10.1152/physiol.00051.2004; Peng Q, 2008, P NATL ACAD SCI USA, V105, P1885, DOI 10.1073/pnas.0706775105; Prajapati RS, 2007, BIOCHEMISTRY-US, V46, P10339, DOI 10.1021/bi700577m; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Reig N, 2007, J BIOL CHEM, V282, P13270, DOI 10.1074/jbc.M610695200; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Sanchez IE, 2003, BIOPHYS CHEM, V100, P397, DOI 10.1016/S0301-4622(02)00294-6; Sanchez IE, 2003, J MOL BIOL, V327, P867, DOI 10.1016/S0022-2836(03)00171-2; Sanders CR, 2000, CURR OPIN STRUC BIOL, V10, P438, DOI 10.1016/S0959-440X(00)00112-3; Sapra KT, 2008, BIOPHYS J, V95, P3407, DOI 10.1529/biophysj.108.131904; Sapra KT, 2008, J MOL BIOL, V376, P1076, DOI 10.1016/j.jmb.2007.12.027; Sapra KT, 2008, LANGMUIR, V24, P1330, DOI 10.1021/la702299z; Sapra KT, 2006, J MOL BIOL, V358, P255, DOI 10.1016/j.jmb.2006.02.008; Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Schlierf M, 2005, J MOL BIOL, V354, P497, DOI 10.1016/j.jmb.2005.09.070; Sobczak I, 2004, J BIOL CHEM, V279, P31113, DOI 10.1074/jbc.M404283200; Soksawatmaekhin W, 2006, J BIOL CHEM, V281, P29213, DOI 10.1074/jbc.M600754200; Torrents D, 1999, NAT GENET, V21, P293, DOI 10.1038/6809; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Uchino H, 2002, MOL PHARMACOL, V61, P729, DOI 10.1124/mol.61.4.729; Verrey F, 1999, J MEMBRANE BIOL, V172, P181, DOI 10.1007/s002329900595; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; West IC, 1997, BBA-REV BIOMEMBRANES, V1331, P213, DOI 10.1016/S0304-4157(97)00007-5; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Williams PM, 2003, NATURE, V422, P446, DOI 10.1038/nature01517; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Yu JS, 2007, J BIOL CHEM, V282, P8895, DOI 10.1074/jbc.M609317200	102	28	28	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18651	18663		10.1074/jbc.M109.004267	http://dx.doi.org/10.1074/jbc.M109.004267			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19419962	Green Published, hybrid			2022-12-25	WOS:000267711500014
J	Martens, EC; Roth, R; Heuser, JE; Gordon, JI				Martens, Eric C.; Roth, Robyn; Heuser, John E.; Gordon, Jeffrey I.			Coordinate Regulation of Glycan Degradation and Polysaccharide Capsule Biosynthesis by a Prominent Human Gut Symbiont	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTEROIDES-THETAIOTAOMICRON; BACTERIA; EVOLUTION; MUCIN	Bacteria in the distal human gut have evolved diverse abilities to metabolize complex glycans, including the capacity to degrade these compounds as nutrients and to assemble their component sugars into new polymers such as extracellular capsules. The human gut bacterium Bacteroides thetaiotaomicron is well endowed with the ability to metabolize both host-and diet-derived glycans. Its genome contains 88 different polysaccharide utilization loci (PULs) for complex glycan catabolism and eight different gene clusters for capsular polysaccharide biosynthesis. Here, we investigate one of the prominent mechanisms by which this gut symbiont regulates many PULs involved in host mucin O-glycan degradation; namely, transcriptional regulation via the concerted interactions of cell-envelope-localized TonB-dependent transporters, extra-cytoplasmic function sigma factors and anti-sigma factors, which participate together in a regulatory pathway termed trans-envelope signaling. Unexpectedly, we found that several different trans-envelope signaling switches involved in PUL-mediated O-glycan degradation also modulate capsular polysaccharide synthesis. A novel regulatory pathway, which is dependent on expression of O-glycan-targeting outer membrane proteins, governs this coordinated regulation of glycan catabolism and capsule synthesis. This latter finding provides a new link in the dynamic interplay between complex glycan metabolism, microbial physiology, and host responses that occurs during colonization of the gut.	[Martens, Eric C.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci, St Louis, MO 63108 USA; [Roth, Robyn; Heuser, John E.] Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63108 USA	Washington University (WUSTL); Washington University (WUSTL)	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci, Campus Box 8510,4444 Forest Pk Ave, St Louis, MO 63108 USA.	jgordon@wustl.edu	Heuser, John/H-5940-2012		National Institutes of Health [DK30292]; Missouri Life Sciences Trust Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI073060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030292, R01DK030292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Missouri Life Sciences Trust Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK30292. This work is also supported by the Missouri Life Sciences Trust Fund.	Bjursell MK, 2006, J BIOL CHEM, V281, P36269, DOI 10.1074/jbc.M606509200; BOOTH SJ, 1979, REV INFECT DIS, V1, P325; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Clements A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003817; Coyne MJ, 2008, P NATL ACAD SCI USA, V105, P13099, DOI 10.1073/pnas.0804220105; Coyne MJ, 2008, J BACTERIOL, V190, P736, DOI 10.1128/JB.01559-07; Coyne MJ, 2005, SCIENCE, V307, P1778, DOI 10.1126/science.1106469; Della JN, 1996, J BACTERIOL, V178, P7180; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Gardy JL, 2003, NUCLEIC ACIDS RES, V31, P3613, DOI 10.1093/nar/gkg602; HEUSER J, 1981, TRENDS BIOCHEM SCI, V6, P64, DOI 10.1016/0968-0004(81)90024-4; Heuser J E, 1989, Prog Clin Biol Res, V295, P71; HEUSER JE, 1979, J CELL BIOL, V82, P150, DOI 10.1083/jcb.82.1.150; Holdeman L.V., 1975, ANAEROBE LAB MANUAL; Karlsson NG, 1997, BIOCHEM J, V326, P911, DOI 10.1042/bj3260911; Koebnik R, 2005, TRENDS MICROBIOL, V13, P343, DOI 10.1016/j.tim.2005.06.005; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Llobet E, 2008, MICROBIOL-SGM, V154, P3877, DOI 10.1099/mic.0.2008/022301-0; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; OCHS M, 1995, MOL MICROBIOL, V15, P119, DOI 10.1111/j.1365-2958.1995.tb02226.x; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; SALYERS AA, 1977, APPL ENVIRON MICROB, V33, P319, DOI 10.1128/AEM.33.2.319-322.1977; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vingadassalom D, 2005, MOL MICROBIOL, V56, P888, DOI 10.1111/j.1365-2958.2005.04590.x; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156	33	119	121	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18445	18457		10.1074/jbc.M109.008094	http://dx.doi.org/10.1074/jbc.M109.008094			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19403529	Green Published, hybrid			2022-12-25	WOS:000267712400056
J	Wang, HY; Zhang, XS; Geng, LY; Teng, LS; Legerski, RJ				Wang, Haiyong; Zhang, Xiaoshan; Geng, Liyi; Teng, Lisong; Legerski, Randy J.			Artemis Regulates Cell Cycle Recovery from the S Phase Checkpoint by Promoting Degradation of Cyclin E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE CHECKPOINT; STRAND BREAK REPAIR; POLO-LIKE KINASE-1; F-BOX PROTEIN; GENOTOXIC STRESS; PROTEASOME PATHWAY; MAMMALIAN-CELLS; PHOSPHORYLATION; ATM; ACTIVATION	Artemis, a member of the SNM1 gene family, is a known phosphorylation target of ATM, ATR, and DNA-PKcs. We have previously identified two serine residues in Artemis (Ser(516) and Ser(645)) that are subject to phosphorylation by ATM and are involved in mediating recovery from the G(2)/M checkpoint in response to ionizing radiation. Here we show that these same sites are also phosphorylated by ATR in response to various types of replication stress including UVC, aphidicolin, and hydroxyurea. We also show that mutation of the Ser(516) and Ser(645) residues causes a prolonged S phase checkpoint recovery after treatment with UV or aphidicolin, and that this delayed recovery process coincides with a prolonged stabilization of cyclin E and down-regulation of Cdk2 kinase activity. Furthermore, we show that Artemis interacts with the F-box protein Fbw7, and that this interaction regulates cyclin E degradation through the SCFFbw7 E3 ubiquitin ligase complex. The interaction between Artemis and Fbw7 is regulated by phosphorylation of Ser(516) and Ser(645) sites that occur in response to replication stress. Thus, our findings suggest a novel pathway of recovery from the S phase checkpoint in that in response to replication stress phosphorylation of Artemis by ATR enhances its interaction with Fbw7, which in turn promotes ubiquitylation and the ultimate degradation of cyclin E.	[Wang, Haiyong; Geng, Liyi; Legerski, Randy J.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Wang, Haiyong; Teng, Lisong] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Oncol, Hangzhou 310003, Zhejiang, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Zhejiang University	Legerski, RJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.	rlegersk@mdanderson.org		Wang, Haiyong/0000-0003-0124-5301	National Institutes of Health NCI [CA096574, CA097175]; Cancer Center Support [CA16672]; NATIONAL CANCER INSTITUTE [R01CA096574, P01CA097175, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health NCI Grants CA096574 and CA097175 ( to R. J. L.). This work was also supported by DNA sequencing resources from Cancer Center Support Grant CA16672.	Bansal P, 2007, CANCER RES, V67, P3356, DOI 10.1158/0008-5472.CAN-06-3685; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Chen L, 2005, CANCER SCI, V96, P134, DOI 10.1111/j.1349-7006.2005.00019.x; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Dahm K, 2007, J CELL BIOCHEM, V100, P1346, DOI 10.1002/jcb.21226; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Freire R, 2006, CELL CYCLE, V5, P2831, DOI 10.4161/cc.5.24.3559; Geng LY, 2007, MOL CELL BIOL, V27, P2625, DOI 10.1128/MCB.02072-06; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Lambert S, 2005, BIOCHIMIE, V87, P591, DOI 10.1016/j.biochi.2004.10.020; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Ma YM, 2005, J BIOL CHEM, V280, P33839, DOI 10.1074/jbc.M507113200; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Neganova I, 2008, J ANAT, V213, P30, DOI 10.1111/j.1469-7580.2008.00931.x; Niewolik D, 2006, J BIOL CHEM, V281, P33900, DOI 10.1074/jbc.M606023200; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Pannicke U, 2004, EMBO J, V23, P1987, DOI 10.1038/sj.emboj.7600206; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Poinsignon C, 2004, EUR J IMMUNOL, V34, P3146, DOI 10.1002/eji.200425455; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rooney S, 2002, MOL CELL, V10, P1379, DOI 10.1016/S1097-2765(02)00755-4; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Soubeyrand S, 2006, J MOL BIOL, V358, P1200, DOI 10.1016/j.jmb.2006.02.061; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Wang JH, 2005, DNA REPAIR, V4, P556, DOI 10.1016/j.dnarep.2005.02.001; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; WIMMEL A, 1994, ONCOGENE, V9, P995; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Woo RA, 2003, CELL CYCLE, V2, P316, DOI 10.4161/cc.2.4.468; Yin MB, 1999, EXP CELL RES, V247, P189, DOI 10.1006/excr.1998.4346; Zhang XS, 2004, MOL CELL BIOL, V24, P9207, DOI 10.1128/MCB.24.20.9207-9220.2004; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019	47	23	24	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18236	18243		10.1074/jbc.M109.002584	http://dx.doi.org/10.1074/jbc.M109.002584			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19423708	hybrid, Green Published			2022-12-25	WOS:000267712400036
J	Wang, Q; Liu-Chen, LY; Traynor, JR				Wang, Qin; Liu-Chen, Lee-Yuan; Traynor, John R.			Differential Modulation of mu- and delta-Opioid Receptor Agonists by Endogenous RGS4 Protein in SH-SY5Y Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; INTRACELLULAR CALCIUM; SIGNALING PROTEINS; MESSENGER-RNA; DRUG TARGETS; RAT-BRAIN; EXPRESSION; BINDING; REGULATOR; TOLERANCE	Regulator of G-protein signaling (RGS) proteins are a family of molecules that control the duration of G protein signaling. A variety of RGS proteins have been reported to modulate opioid receptor signaling. Here we show that RGS4 is abundantly expressed in human neuroblastoma SH-SY5Y cells that endogenously express mu- and delta-opioid receptors and test the hypothesis that the activity of opioids in these cells is modulated by RGS4. Endogenous RGS4 protein was reduced by similar to 90% in SH-SY5Y cells stably expressing short hairpin RNA specifically targeted to RGS4. In these cells, the potency and maximal effect of delta-opioid receptor agonist (SNC80)-mediated inhibition of forskolin-stimulated cAMP accumulation was increased compared with control cells. This effect was reversed by transient transfection of a stable RGS4 mutant (HA-RGS4C2S). Furthermore, MAPK activation by SNC80 was increased in cells with knockdown of RGS4. In contrast, there was no change in the mu-opioid ( morphine) response at adenylyl cyclase or MAPK. FLAG-tagged opioid receptors and HA-RGS4C2S were transiently expressed in HEK293T cells, and co-immunoprecipitation experiments showed that the delta-opioid receptor but not the mu-opioid receptor could be precipitated together with the stable RGS4. Using chimeras of the delta- and mu-opioid receptors, the C-tail and third intracellular domain of the delta-opioid receptor were suggested to be the sites of interaction with RGS4. The findings demonstrate a role for endogenous RGS4 protein in modulating delta-opioid receptor signaling in SH-SY5Y cells and provide evidence for a receptor-specific effect of RGS4.	[Wang, Qin; Traynor, John R.] Univ Michigan, Dept Pharmacol, Sch Med, Ann Arbor, MI 48109 USA; [Traynor, John R.] Univ Michigan, Subst Abuse Res Ctr, Sch Med, Ann Arbor, MI 48109 USA; [Liu-Chen, Lee-Yuan] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Traynor, JR (corresponding author), Univ Michigan, Dept Pharmacol, Sch Med, 1303 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	jtraynor@umich.edu			National Institutes of Health [DA04087, DA17302]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017302, R01DA004087, P30DA013429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA04087 ( to J. R. T.) and DA17302 ( to L. Y.- L. C.).	Alt A, 2002, BRIT J PHARMACOL, V135, P217, DOI 10.1038/sj.bjp.0704430; Bodenstein J, 2007, MOL PHARMACOL, V71, P1040, DOI 10.1124/mol.106.029397; Chaturvedi K, 2001, J BIOL CHEM, V276, P12345, DOI 10.1074/jbc.M008054200; Clark MJ, 2003, J BIOL CHEM, V278, P9418, DOI 10.1074/jbc.M208885200; Clark MJ, 2004, METHOD ENZYMOL, V389, P155; Connor M, 1996, BRIT J PHARMACOL, V117, P333, DOI 10.1111/j.1476-5381.1996.tb15195.x; COSTA T, 1989, P NATL ACAD SCI USA, V86, P7321, DOI 10.1073/pnas.86.19.7321; Dhawan BN, 1996, PHARMACOL REV, V48, P567; Elenko E, 2003, MOL PHARMACOL, V64, P11, DOI 10.1124/mol.64.1.11; Garnier M, 2003, J PHARMACOL EXP THER, V304, P1299, DOI 10.1124/jpet.102.043471; Garzon J, 2005, NEUROPSYCHOPHARMACOL, V30, P1632, DOI 10.1038/sj.npp.1300726; Garzon J, 2004, NEUROPSYCHOPHARMACOL, V29, P1091, DOI 10.1038/sj.npp.1300408; Georgoussi Z, 2006, CELL SIGNAL, V18, P771, DOI 10.1016/j.cellsig.2005.07.003; Gold SJ, 1997, J COMP NEUROL, V385, P491, DOI 10.1002/(SICI)1096-9861(19970908)385:4<491::AID-CNE1>3.0.CO;2-Z; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hooks SB, 2008, BIOCHEM PHARMACOL, V75, P76, DOI 10.1016/j.bcp.2007.07.045; Huang P, 2007, BRAIN RES, V1184, P46, DOI 10.1016/j.brainres.2007.09.096; Ippolito DL, 2002, J BIOL CHEM, V277, P32692, DOI 10.1074/jbc.M204407200; Krumins AM, 2004, J BIOL CHEM, V279, P2593, DOI 10.1074/jbc.M311600200; LAW PY, 1991, J PHARMACOL EXP THER, V256, P710; MANSOUR A, 1995, TRENDS NEUROSCI, V18, P22, DOI 10.1016/0166-2236(95)93946-U; Markkanen PMH, 2008, J BIOL CHEM, V283, P29086, DOI 10.1074/jbc.M801880200; Neill JD, 1997, ENDOCRINOLOGY, V138, P843, DOI 10.1210/en.138.2.843; Neitzel KL, 2006, SEMIN CELL DEV BIOL, V17, P383, DOI 10.1016/j.semcdb.2006.03.002; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Psifogeorgou K, 2007, J NEUROCHEM, V103, P617, DOI 10.1111/j.1471-4159.2007.04812.x; SADEE W, 1987, CANCER RES, V47, P5207; Schwendt M, 2006, J NEUROCHEM, V96, P1606, DOI 10.1111/j.1471-4159.2006.03669.x; Siderovski DP, 1999, CRIT REV BIOCHEM MOL, V34, P215, DOI 10.1080/10409239991209273; Snow BE, 2002, METHOD ENZYMOL, V344, P740; Szekeres PG, 1997, J PHARMACOL EXP THER, V283, P1276; Traynor JR, 2005, MOL INTERV, V5, P30, DOI 10.1124/mi.5.1.7; UHL GR, 1994, TRENDS NEUROSCI, V17, P89, DOI 10.1016/0166-2236(94)90110-4; Ulens C, 2000, LIFE SCI, V67, P2305, DOI 10.1016/S0024-3205(00)00820-1; Wang Q, 2004, METHOD ENZYMOL, V389, P244; Wang Q, 2002, J BIOL CHEM, V277, P24949, DOI 10.1074/jbc.M203802200; Wang XH, 2005, NAT CELL BIOL, V7, P405, DOI 10.1038/ncb1237; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Xie GX, 2005, ANESTH ANALG, V100, P1034, DOI 10.1213/01.ANE.0000147711.51122.4B; Xie ZH, 2007, EUR J PHARMACOL, V565, P45, DOI 10.1016/j.ejphar.2007.03.005; Xu W, 2000, BIOCHEMISTRY-US, V39, P13904, DOI 10.1021/bi001099p; Xu X, 1999, J BIOL CHEM, V274, P3549, DOI 10.1074/jbc.274.6.3549; YU VC, 1988, J PHARMACOL EXP THER, V245, P350; YU VC, 1990, J NEUROCHEM, V55, P1390, DOI 10.1111/j.1471-4159.1990.tb03151.x; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zeng WZ, 1998, J BIOL CHEM, V273, P34687, DOI 10.1074/jbc.273.52.34687; Zheng B, 1999, TRENDS BIOCHEM SCI, V24, P411, DOI 10.1016/S0968-0004(99)01474-7; Zhong HL, 2001, J PHARMACOL EXP THER, V297, P837	49	45	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18357	18367		10.1074/jbc.M109.015453	http://dx.doi.org/10.1074/jbc.M109.015453			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19416973	Green Published, hybrid			2022-12-25	WOS:000267712400048
J	Haid, S; Pietschmann, T; Pecheur, EI				Haid, Sibylle; Pietschmann, Thomas; Pecheur, Eve-Isabelle			Low pH-dependent Hepatitis C Virus Membrane Fusion Depends on E2 Integrity, Target Lipid Composition, and Density of Virus Particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	15th International Symposium on Hepatitis C Virus and Related Viruses	OCT 05-09, 2008	San Antonio, TX				HUMAN MONOCLONAL-ANTIBODIES; B TYPE-I; SEMLIKI-FOREST-VIRUS; SCAVENGER-RECEPTOR; CELL-CULTURE; NEUTRALIZING ANTIBODIES; CONFORMATIONAL EPITOPES; HYPERVARIABLE REGION-1; LIPOPROTEIN RECEPTOR; ENVELOPE PROTEIN	Hepatitis C virus (HCV) is an enveloped, positive strand RNA virus of about 9.6 kb. Like all enveloped viruses, the HCV membrane fuses with the host cell membrane during the entry process and thereby releases the genome into the cytoplasm, initiating the viral replication cycle. To investigate the features of HCV membrane fusion, we developed an in vitro fusion assay using cell culture-produced HCV and fluorescently labeled liposomes. With this model we could show that HCV-mediated fusion can be triggered in a receptor-independent but pH-dependent manner and that fusion of the HCV particles with liposomes is dependent on the viral dose and on the lipid composition of the target membranes. In addition CBH-5, an HCV E2-specific antibody, inhibited fusion in a dose-dependent manner. Interestingly, point mutations in E2, known to abrogate HCV glycoprotein-mediated fusion in a cell-based assay, altered or even abolished fusion in the liposome-based assay. When assaying the fusion properties of HCV particles with different buoyant density, we noted higher fusogenicity of particles with lower density. This could be attributable to inherently different properties of low density particles, to association of these particles with factors stimulating fusion, or to co-floatation of factors enhancing fusion activity in trans. Taken together, these data show the important role of lipids of both the viral and target membranes in HCV-mediated fusion, point to a crucial role played by the E2 glycoprotein in the process of HCV fusion, and reveal an important behavior of HCV of different densities with regard to fusion.	[Haid, Sibylle; Pietschmann, Thomas] Hannover Med Sch & Helmholtz Ctr Infect Res, Ctr Expt & Clin Infect Res, TWINCORE, Dept Expt Virol, D-30625 Hannover, Germany; [Pecheur, Eve-Isabelle] Univ Lyon 1, CNRS, Inst Biol & Chim Prot, IFR Lyon Biosci Gerland 182,UMR 5086, F-69367 Lyon, France	Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Pietschmann, T (corresponding author), Hannover Med Sch & Helmholtz Ctr Infect Res, Ctr Expt & Clin Infect Res, TWINCORE, Dept Expt Virol, D-30625 Hannover, Germany.	thomas.pietschmann@twincore.de; e.pecheur@ibcp.fr	Pietschmann, Thomas/E-9241-2015	Pietschmann, Thomas/0000-0001-5138-6239; Pecheur, Eve/0000-0002-8613-862X				Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Ahn A, 2002, J VIROL, V76, P3267, DOI 10.1128/JVI.76.7.3267-3275.2002; Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Andre P, 2005, SEMIN LIVER DIS, V25, P93, DOI 10.1055/s-2005-864785; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Barth H, 2006, J VIROL, V80, P10579, DOI 10.1128/JVI.00941-06; Bartosch B, 2006, VIROLOGY, V348, P1, DOI 10.1016/j.virol.2005.12.027; Bartosch B, 2005, J VIROL, V79, P8217, DOI 10.1128/JVI.79.13.8217-8229.2005; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bartosch B, 2003, P NATL ACAD SCI USA, V100, P14199, DOI 10.1073/pnas.2335981100; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bertaux C, 2006, J VIROL, V80, P4940, DOI 10.1128/JVI.80.10.4940-4948.2006; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Boriskin YS, 2008, CURR MED CHEM, V15, P997, DOI 10.2174/092986708784049658; Boriskin YS, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-56; BRADLEY D, 1991, J MED VIROL, V34, P206, DOI 10.1002/jmv.1890340315; Brooks MJ, 2004, CURR OPIN PULM MED, V10, P197, DOI 10.1097/00063198-200405000-00009; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Combet C, 2007, NUCLEIC ACIDS RES, V35, pD363, DOI 10.1093/nar/gkl970; Corver J, 2000, VIROLOGY, V269, P37, DOI 10.1006/viro.1999.0172; Diaz O, 2006, J GEN VIROL, V87, P2983, DOI 10.1099/vir.0.82033-0; Drummer HE, 2003, FEBS LETT, V546, P385, DOI 10.1016/S0014-5793(03)00635-5; Drummer HE, 2007, J GEN VIROL, V88, P1144, DOI 10.1099/vir.0.82567-0; Farci P, 1996, P NATL ACAD SCI USA, V93, P15394, DOI 10.1073/pnas.93.26.15394; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; GOLLINS SW, 1986, J GEN VIROL, V67, P157, DOI 10.1099/0022-1317-67-1-157; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Hadlock KG, 2000, J VIROL, V74, P10407, DOI 10.1128/JVI.74.22.10407-10416.2000; Helle F, 2008, CELL MOL LIFE SCI, V65, P100, DOI 10.1007/s00018-007-7291-8; Helle F, 2007, J VIROL, V81, P8101, DOI 10.1128/JVI.00127-07; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Icard V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004233; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; KARBER G, 1951, N-S ARCH EX PATH PH, V212, P509; Keck ZY, 2008, J VIROL, V82, P6061, DOI 10.1128/JVI.02475-07; Keck ZY, 2007, J VIROL, V81, P1043, DOI 10.1128/JVI.01710-06; Keck ZY, 2005, J VIROL, V79, P13199, DOI 10.1128/JVI.79.21.13199-13208.2005; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Kobayashi M, 2006, J VIROL, V80, P1817, DOI 10.1128/JVI.80.4.1817-1825.2006; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Lavillette D, 2006, J BIOL CHEM, V281, P3909, DOI 10.1074/jbc.M509747200; Lavillette D, 2007, J VIROL, V81, P8752, DOI 10.1128/JVI.02642-06; Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; LINDENBACH BD, 2001, FIELDS VIROLOGY, V1, P991; Maillard P, 2006, FASEB J, V20, P735, DOI 10.1096/fj.05-4728fje; Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; MOESBY L, 1995, BIOCHEMISTRY-US, V34, P10319, DOI 10.1021/bi00033a001; Molina S, 2007, J HEPATOL, V46, P411, DOI 10.1016/j.jhep.2006.09.024; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Murphy D, 2007, HEPATOLOGY, V46, p623A; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Owsianka AM, 2008, J GEN VIROL, V89, P653, DOI 10.1099/vir.0.83386-0; Pecheur EI, 2007, BIOCHEMISTRY-US, V46, P6050, DOI 10.1021/bi700181j; Penin F, 2001, J VIROL, V75, P5703, DOI 10.1128/JVI.75.12.5703-5710.2001; Perotti M, 2008, J VIROL, V82, P1047, DOI 10.1128/JVI.01986-07; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; SHIMIZU YK, 1994, J VIROL, V68, P1494, DOI 10.1128/JVI.68.3.1494-1500.1994; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Smit JM, 1999, J VIROL, V73, P8476, DOI 10.1128/JVI.73.10.8476-8484.1999; SMITH LC, 1978, ANNU REV BIOCHEM, V47, P751, DOI 10.1146/annurev.bi.47.070178.003535; SPEARMAN C, 1987, AM J PSYCHOL, V100, P441, DOI 10.2307/1422689; Stamataki Z, 2008, CLIN LIVER DIS, V12, P693, DOI 10.1016/j.cld.2008.03.008; STEGMANN T, 1986, J BIOL CHEM, V261, P966; Stiasny K, 2003, J VIROL, V77, P7856, DOI 10.1128/JVI.77.14.7856-7862.2003; Tarr AW, 2006, HEPATOLOGY, V43, P592, DOI 10.1002/hep.21088; Teissier E, 2007, EUR BIOPHYS J BIOPHY, V36, P887, DOI 10.1007/s00249-007-0201-z; THOMSSEN R, 1992, MED MICROBIOL IMMUN, V181, P293, DOI 10.1007/BF00198849; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Umashankar M, 2008, J VIROL, V82, P9245, DOI 10.1128/JVI.00975-08; Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005; van den Hoff M J, 1995, Methods Mol Biol, V48, P185; Voisset C, 2008, CELL MICROBIOL, V10, P606, DOI 10.1111/j.1462-5822.2007.01070.x; von Hahn T, 2006, HEPATOLOGY, V43, P932, DOI 10.1002/hep.21139; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	83	72	79	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17657	17667		10.1074/jbc.M109.014647	http://dx.doi.org/10.1074/jbc.M109.014647			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	460QP	19411248	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000267202500032
J	Lu, BB; Benning, C				Lu, Binbin; Benning, Christoph			A 25-Amino Acid Sequence of the Arabidopsis TGD2 Protein Is Sufficient for Specific Binding of Phosphatidic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID TRAFFICKING; RAF-1 KINASE; METABOLISM; CELLS; IDENTIFICATION; TRANSLOCATION; MEMBRANE; DOMAINS; PLANTS	Genetic analysis suggests that the TGD2 protein of Arabidopsis is required for the biosynthesis of endoplasmic reticulum derived thylakoid lipids. TGD2 is proposed to be the substrate-binding protein of a presumed lipid transporter consisting of the TGD1 (permease) and TGD3 (ATPase) proteins. The TGD1, -2, and -3 proteins are localized in the inner chloroplast envelope membrane. TGD2 appears to be anchored with an N-terminal membrane-spanning domain into the inner envelope membrane, whereas the C-terminal domain faces the intermembrane space. It was previously shown that the C-terminal domain of TGD2 binds phosphatidic acid (PtdOH). To investigate the PtdOH binding site of TGD2 in detail, the C-terminal domain of the TGD2 sequence lacking the transit peptide and transmembrane sequences was fused to the C terminus of the Discosoma sp. red fluorescent protein (DR). This greatly improved the solubility of the resulting DR-TGD2C fusion protein following production in Escherichia coli. The DR-TGD2C protein bound PtdOH with high specificity, as demonstrated by membrane lipid-protein overlay and liposome association assays. Internal deletion and truncation mutagenesis identified a previously undescribed minimal 25-amino acid fragment in the C-terminal domain of TGD2 that is sufficient for PtdOH binding. Binding characteristics of this 25-mer were distinctly different from those of TGD2C, suggesting that additional sequences of TGD2 providing the proper context for this 25-mer are needed for wild type-like PtdOH binding.	[Lu, Binbin; Benning, Christoph] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Lu, Binbin] Michigan State Univ, Dept Energy Plant Res Lab, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Benning, C (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, Biochem 215, E Lansing, MI 48824 USA.	benning@msu.edu	Benning, Christoph/Y-2528-2019	Benning, Christoph/0000-0001-8585-3667	National Science Foundation [MCB-0741395]; Michigan Agricultural Experiment Station	National Science Foundation(National Science Foundation (NSF)); Michigan Agricultural Experiment Station	This work was supported in part by a grant from the National Science Foundation (MCB-0741395) and the Michigan Agricultural Experiment Station.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anthony RG, 2004, EMBO J, V23, P572, DOI 10.1038/sj.emboj.7600068; Awai K, 2006, P NATL ACAD SCI USA, V103, P10817, DOI 10.1073/pnas.0602754103; Benning C, 2008, PROG LIPID RES, V47, P381, DOI 10.1016/j.plipres.2008.04.001; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWSE J, 1986, BIOCHEM J, V235, P25, DOI 10.1042/bj2350025; Chitale S, 2001, CELL MICROBIOL, V3, P247, DOI 10.1046/j.1462-5822.2001.00110.x; Deak M, 1999, FEBS LETT, V451, P220, DOI 10.1016/S0014-5793(99)00556-6; Frank C, 1999, BIOCHEMISTRY-US, V38, P11993, DOI 10.1021/bi982586w; Ghosh S, 2003, J BIOL CHEM, V278, P45690, DOI 10.1074/jbc.M302933200; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; Jones JA, 2002, J BIOL CHEM, V277, P15530, DOI 10.1074/jbc.M111555200; Kooijman EE, 2007, J BIOL CHEM, V282, P11356, DOI 10.1074/jbc.M609737200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Lopez-Andreo MJ, 2003, MOL BIOL CELL, V14, P4885, DOI 10.1091/mbc.E03-05-0295; Lu BB, 2007, J BIOL CHEM, V282, P35945, DOI 10.1074/jbc.M704063200; Mamedov TG, 2005, PLANT J, V42, P832, DOI 10.1111/j.1365-313X.2005.02416.x; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; ORR JW, 1992, BIOCHEMISTRY-US, V31, P4661, DOI 10.1021/bi00134a018; ROUGHAN PG, 1980, BIOCHEM J, V188, P17, DOI 10.1042/bj1880017; ROUGHAN PG, 1982, ANNU REV PLANT PHYS, V33, P97, DOI 10.1146/annurev.pp.33.060182.000525; Sano H, 1998, J BIOL CHEM, V273, P4783, DOI 10.1074/jbc.273.8.4783; Testerink C, 2004, PLANT J, V39, P527, DOI 10.1111/j.1365-313X.2004.02152.x; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Xu CC, 2005, PLANT CELL, V17, P3094, DOI 10.1105/tpc.105.035592; Xu CC, 2003, EMBO J, V22, P2370, DOI 10.1093/emboj/cdg234; Xu CC, 2008, PLANT CELL, V20, P2190, DOI 10.1105/tpc.108.061176; Zhang WH, 2004, P NATL ACAD SCI USA, V101, P9508, DOI 10.1073/pnas.0402112101	31	54	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17420	17427		10.1074/jbc.M109.016014	http://dx.doi.org/10.1074/jbc.M109.016014			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19416982	hybrid, Green Published			2022-12-25	WOS:000267202500008
J	Yanagida, K; Masago, K; Nakanishi, H; Kihara, Y; Hamano, F; Tajima, Y; Taguchi, R; Shimizu, T; Ishii, S				Yanagida, Keisuke; Masago, Kayo; Nakanishi, Hiroki; Kihara, Yasuyuki; Hamano, Fumie; Tajima, Yoko; Taguchi, Ryo; Shimizu, Takao; Ishii, Satoshi			Identification and Characterization of a Novel Lysophosphatidic Acid Receptor, p2y5/LPA(6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; AUTOSOMAL RECESSIVE HYPOTRICHOSIS; HUMAN HAIR-GROWTH; ENDOTHELIAL-CELLS; EDG-FAMILY; SPHINGOSINE 1-PHOSPHATE; MORPHOLOGICAL-CHANGES; MOLECULAR-CLONING; WOOLLY HAIR; ROCK-I	p2y5 is an orphan G protein-coupled receptor that is closely related to the fourth lysophosphatidic acid (LPA) receptor, LPA(4). Here we report that p2y5 is a novel LPA receptor coupling to the G(13)-Rho signaling pathway. "LPA receptor-null" RH7777 and B103 cells exogenously expressing p2y5 showed [H-3] LPA binding, LPA-induced [S-35] guanosine 5'-3-O-(thio) triphosphate binding, Rho-dependent alternation of cellular morphology, and G(s/13) chimeric protein-mediated cAMP accumulation. LPA-induced contraction of human umbilical vein endothelial cells was suppressed by small interfering RNA knockdown of endogenously expressed p2y5. We also found that 2-acyl-LPA had higher activity to p2y5 than 1-acyl-LPA. A recent study has suggested that p2y5 is an LPA receptor essential for human hair growth. We confirmed that p2y5 is a functional LPA receptor and propose to designate this receptor LPA(6).	[Shimizu, Takao; Ishii, Satoshi] Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan; [Nakanishi, Hiroki; Tajima, Yoko; Taguchi, Ryo] Univ Tokyo, Fac Med, Dept Metabolome, Bunkyo Ku, Tokyo 1130033, Japan; [Taguchi, Ryo] CREST, Kawaguchi, Saitama 3328613, Japan; [Ishii, Satoshi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3328613, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Ishii, S (corresponding author), Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mame@m.u-tokyo.ac.jp	Kihara, Yasuyuki/C-8801-2011; Shimizu, Takao/AAV-7052-2021	Kihara, Yasuyuki/0000-0001-7462-3006; Nakanishi, Hiroki/0000-0002-5108-1598	Ministry of Education, Science, Sports, Culture, and Technology of Japan; Ministry of Health, Labor, and Welfare, Japan; Global Centers of Excellence Program; Japan Society for the Promotion of Science	Ministry of Education, Science, Sports, Culture, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Global Centers of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Science, Sports, Culture, and Technology of Japan (to S. I. and T. S.); a grant to the Respiratory Failure Research Group from the Ministry of Health, Labor, and Welfare, Japan (to S. I.); grants-in-aid for comprehensive research on aging and health from the Ministry of Health, Labor, and Welfare, Japan (to S. I.) and the Global Centers of Excellence Program (to T. S.); and research fellowships of the Japan Society for the Promotion of Science (to K. Y. and Y. K.).	Ali G, 2007, HUM GENET, V121, P319, DOI 10.1007/s00439-007-0344-0; An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Azeem Z, 2008, HUM GENET, V123, P515, DOI 10.1007/s00439-008-0507-7; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Bandoh K, 2000, FEBS LETT, V478, P159, DOI 10.1016/S0014-5793(00)01827-5; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Cooper MA, 2004, J MOL RECOGNIT, V17, P286, DOI 10.1002/jmr.675; Fukushima N, 1998, P NATL ACAD SCI USA, V95, P6151, DOI 10.1073/pnas.95.11.6151; Gu JL, 2002, P NATL ACAD SCI USA, V99, P9352, DOI 10.1073/pnas.102291599; Hara T, 2009, MOL PHARMACOL, V75, P85, DOI 10.1124/mol.108.052225; Harrison C, 2003, LIFE SCI, V74, P489, DOI 10.1016/j.lfs.2003.07.005; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Herr DR, 2007, CURR DRUG TARGETS, V8, P155, DOI 10.2174/138945007779315669; Hirakawa M, 2004, J PHYSIOL-LONDON, V558, P479, DOI 10.1113/jphysiol.2004.065334; Hsu SH, 2007, AM J PHYSIOL-ENDOC M, V293, pE1021, DOI 10.1152/ajpendo.00003.2007; Im DS, 2004, J LIPID RES, V45, P410, DOI 10.1194/jlr.R300006-JLR200; Im DS, 2000, MOL PHARMACOL, V57, P753, DOI 10.1124/mol.57.4.753; Ishii I, 2000, MOL PHARMACOL, V58, P895, DOI 10.1124/mol.58.5.895; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Jelani M, 2008, CLIN GENET, V74, P184, DOI 10.1111/j.1399-0004.2008.01011.x; Kazantseva A, 2006, SCIENCE, V314, P982, DOI 10.1126/science.1133276; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; Lee CW, 2007, J BIOL CHEM, V282, P4310, DOI 10.1074/jbc.M610826200; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lee H, 2000, AM J PHYSIOL-CELL PH, V278, pC612, DOI 10.1152/ajpcell.2000.278.3.C612; Lin CL, 2007, BIOCHEM BIOPH RES CO, V363, P1001, DOI 10.1016/j.bbrc.2007.09.081; Milligan G, 2003, TRENDS PHARMACOL SCI, V24, P87, DOI 10.1016/S0165-6147(02)00027-5; Milligan G, 1996, TRENDS PHARMACOL SCI, V17, P235, DOI 10.1016/0165-6147(96)10026-2; Mills JC, 1998, J CELL BIOL, V140, P627, DOI 10.1083/jcb.140.3.627; Murph M, 2006, CLIN CANCER RES, V12, P6598, DOI 10.1158/1078-0432.CCR-06-1721; NAHUM S, 2009, ARCH DERMAT IN PRESS; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Panetti TS, 2002, BBA-MOL CELL BIOL L, V1582, P190, DOI 10.1016/S1388-1981(02)00155-5; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Petukhova L, 2008, GENOMICS, V92, P273, DOI 10.1016/j.ygeno.2008.06.009; PLUCKTHUN A, 1982, BIOCHEMISTRY-US, V21, P1743; Qian L, 2006, CHEMMEDCHEM, V1, P376, DOI 10.1002/cmdc.200500042; ROGALSKA E, 1993, J BIOL CHEM, V268, P792; Ruppel KM, 2005, P NATL ACAD SCI USA, V102, P8281, DOI 10.1073/pnas.0503326102; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Shimomura Y, 2008, NAT GENET, V40, P335, DOI 10.1038/ng.100; Shimomura Y, 2009, EXP DERMATOL, V18, P218, DOI 10.1111/j.1600-0625.2008.00788.x; Shimomura Y, 2009, J INVEST DERMATOL, V129, P622, DOI 10.1038/jid.2008.290; Smyth SS, 2008, BBA-MOL CELL BIOL L, V1781, P563, DOI 10.1016/j.bbalip.2008.05.008; Sonoda H, 2002, J BIOL CHEM, V277, P34254, DOI 10.1074/jbc.M201659200; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Tokumura A, 2002, BIOCHEM J, V365, P617, DOI 10.1042/BJ20020348; TOKUMURA A, 1995, PROG LIPID RES, V34, P151, DOI 10.1016/0163-7827(95)00001-G; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Watterson KR, 2007, WOUND REPAIR REGEN, V15, P607, DOI 10.1111/j.1524-475X.2007.00292.x; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Xu Y, 2005, J MED CHEM, V48, P3319, DOI 10.1021/jm049186t; Yanagida K, 2007, J BIOL CHEM, V282, P5814, DOI 10.1074/jbc.M610767200; Ye XQ, 2008, HUM REPROD UPDATE, V14, P519, DOI 10.1093/humupd/dmn023; Yu NC, 2006, ANAL CHEM, V78, P35, DOI 10.1021/ac051695v	60	189	198	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17731	17741		10.1074/jbc.M808506200	http://dx.doi.org/10.1074/jbc.M808506200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19386608	hybrid, Green Published			2022-12-25	WOS:000267202500039
J	Bogani, F; Chua, CN; Boehmer, PE				Bogani, Federica; Chua, Chian New; Boehmer, Paul E.			Reconstitution of Uracil DNA Glycosylase-initiated Base Excision Repair in Herpes Simplex Virus-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN ICP8; VIRAL REPLICATION; STRAND EXCHANGE; HUMAN-CELLS; POLYMERASE; TYPE-1; IDENTIFICATION; PURIFICATION; GENES; PROCESSIVITY	Herpes simplex virus-1 is a large double-stranded DNA virus that is self-sufficient in a number of genome transactions. Hence, the virus encodes its own DNA replication apparatus and is capable of mediating recombination reactions. We recently reported that the catalytic subunit of the HSV-1 DNA polymerase (UL30) exhibits apurinic/apyrimidinic and 5'-deoxyribose phosphate lyase activities that are integral to base excision repair. Base excision repair is required to maintain genome stability as a means to counter the accumulation of unusual bases and to protect from the loss of DNA bases. Here we have reconstituted a system with purified HSV-1 and human proteins that perform all the steps of uracil DNA glycosylase-initiated base excision repair. In this system nucleotide incorporation is dependent on the HSV-1 uracil DNA glycosylase (UL2), human AP endonuclease, and the HSV-1 DNA polymerase. Completion of base excision repair can be mediated by T4 DNA ligase as well as human DNA ligase I or ligase III alpha-XRCC1 complex. Of these, ligase III alpha-XRCC1 is the most efficient. Moreover, ligase III alpha-XRCC1 confers specificity onto the reaction in as much as it allows ligation to occur in the presence of the HSV-1 DNA polymerase processivity factor (UL42) and prevents base excision repair from occurring with heterologous DNA polymerases. Completion of base excision repair in this system is also dependent on the incorporation of the correct nucleotide. These findings demonstrate that the HSV-1 proteins in combination with cellular factors that are not encoded by the virus are capable of performing base excision repair. These results have implications on the role of base excision repair in viral genome maintenance during lytic replication and reactivation from latency.	[Bogani, Federica; Chua, Chian New; Boehmer, Paul E.] Arizona State Univ, Univ Arizona, Coll Med Phoenix, Dept Basic Med Sci, Phoenix, AZ 85004 USA	Arizona State University; Arizona State University-Downtown Phoenix; University of Arizona	Boehmer, PE (corresponding author), 425 N 5th St, Phoenix, AZ USA.	boehmer@email.arizona.edu		Boehmer, Paul/0000-0003-4479-0529	National Institutes of Health [GM62643]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62643.	Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Boehmer PE, 2003, PROG NUCLEIC ACID RE, V75, P139, DOI 10.1016/S0079-6603(03)75005-3; Boehmer PE, 2003, IUBMB LIFE, V55, P13, DOI 10.1080/1521654031000070645; Boehmer PE, 1996, METHOD ENZYMOL, V275, P16; Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347; Bogani F, 2008, P NATL ACAD SCI USA, V105, P11709, DOI 10.1073/pnas.0806375105; Courcelle CT, 2001, J VIROL, V75, P7592, DOI 10.1128/JVI.75.16.7592-7601.2001; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; FOCHER F, 1992, CHROMOSOMA, V102, pS67, DOI 10.1007/BF02451788; GALLO ML, 1988, J VIROL, V62, P2874, DOI 10.1128/JVI.62.8.2874-2883.1988; GALLO ML, 1989, J VIROL, V63, P5023, DOI 10.1128/JVI.63.12.5023-5029.1989; GOTTLIEB J, 1990, J VIROL, V64, P5976, DOI 10.1128/JVI.64.12.5976-5987.1990; HERNANDEZ TR, 1990, J BIOL CHEM, V265, P11227; KNOPF KW, 1979, EUR J BIOCHEM, V98, P231, DOI 10.1111/j.1432-1033.1979.tb13181.x; Komazin-Meredith G, 2008, P NATL ACAD SCI USA, V105, P10721, DOI 10.1073/pnas.0802676105; Lehman IR, 1999, J BIOL CHEM, V274, P28059, DOI 10.1074/jbc.274.40.28059; MCGEOCH DJ, 1988, J VIROL, V62, P444, DOI 10.1128/JVI.62.2.444-453.1988; MULLANEY J, 1989, J GEN VIROL, V70, P449, DOI 10.1099/0022-1317-70-2-449; Muylaert I, 2007, J BIOL CHEM, V282, P10865, DOI 10.1074/jbc.M611834200; Nimonkar AV, 2003, NUCLEIC ACIDS RES, V31, P5275, DOI 10.1093/nar/gkg740; Nimonkar AV, 2002, J BIOL CHEM, V277, P15182, DOI 10.1074/jbc.M109988200; Prichard MN, 1996, J VIROL, V70, P3018, DOI 10.1128/JVI.70.5.3018-3025.1996; PURIFOY DJM, 1977, NATURE, V269, P621, DOI 10.1038/269621a0; PYLES RB, 1994, J VIROL, V68, P4963, DOI 10.1128/JVI.68.8.4963-4972.1994; Qi JY, 2005, NUCLEIC ACIDS RES, V33, P3185, DOI 10.1093/nar/gki632; QUINN JP, 1985, NUCLEIC ACIDS RES, V13, P8143, DOI 10.1093/nar/13.22.8143; Reuven NB, 2004, J MOL BIOL, V342, P57, DOI 10.1016/j.jmb.2004.07.012; Severini A, 1996, J VIROL, V70, P3169, DOI 10.1128/JVI.70.5.3169-3175.1996; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; STOW ND, 1992, J GEN VIROL, V73, P313, DOI 10.1099/0022-1317-73-2-313; Tomkinson AE, 2001, PROG NUCLEIC ACID RE, V68, P151; VAUGHAN PJ, 1985, J VIROL, V53, P501, DOI 10.1128/JVI.53.2.501-508.1985; Wang YF, 2008, BIOORG MED CHEM LETT, V18, P3597, DOI 10.1016/j.bmcl.2008.04.076; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; WILLIAMS MV, 1984, J BIOL CHEM, V259, P80; WOLTERS M, 1989, NUCLEIC ACIDS RES, V17, P5163, DOI 10.1093/nar/17.13.5163; WU CA, 1988, J VIROL, V62, P435, DOI 10.1128/JVI.62.2.435-443.1988; Zhu Y, 2008, DNA REPAIR, V7, P95, DOI 10.1016/j.dnarep.2007.08.001	40	24	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16784	16790		10.1074/jbc.M109.010413	http://dx.doi.org/10.1074/jbc.M109.010413			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19411250	Green Published, hybrid			2022-12-25	WOS:000266962400014
J	D'mello, V; Singh, S; Wu, Y; Birge, RB				D'mello, Veera; Singh, Sukhwinder; Wu, Yi; Birge, Raymond B.			The Urokinase Plasminogen Activator Receptor Promotes Efferocytosis of Apoptotic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; ALPHA-V-BETA-5 INTEGRIN; SURFACE CALRETICULIN; PROSTATIC CARCINOMAS; RAC1 ACTIVATION; VITRONECTIN; ADHESION; PHAGOCYTOSIS; MIGRATION; BINDING	The urokinase receptor (uPAR), expressed on the surface of many cell types, coordinates plasmin-mediated cell surface proteolysis for matrix remodeling and promotes cell adhesion by acting as a binding protein for vitronectin. There is great clinical interest in uPAR in the cancer field as numerous reports have demonstrated that up-regulation of the uPA system is correlated with malignancy of various carcinomas. Using both stable cell lines overexpressing uPAR and transient gene transfer, here we provide evidence for a non-reported role of uPAR in the phagocytosis of apoptotic cells, a process that has recently been termed efferocytosis. When uPAR was expressed in human embryonic kidney cells, hamster melanoma cells, or breast cancer cells (BCCs), there was a robust enhancement in the efferocytosis of apoptotic cells. uPAR-expressing cells failed to stimulate engulfment of viable cells, suggesting that uPAR enhances recognition of one or more determinant on the surface of the apoptotic cell. uPAR-mediated engulfment was not inhibited by expression of mutant beta 5 integrin, nor was alpha v beta 5 integrin-mediated engulfment modulated by cleavage of uPAR by phosphatidylinositol-specific phospholipase C. Further, we found that the more aggressive BCCs had a higher phagocytic capacity that correlated with uPAR expression and cleavage of membrane-associated uPAR in MDA-MB231 BCCs significantly impaired phagocytic activity. Because efferocytosis is critical for the resolution of inflammation and production of anti-inflammatory cytokines, overexpression of uPAR in tumor cells may promote a tolerogenic microenvironment that favors tumor progression.	[Birge, Raymond B.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; [Singh, Sukhwinder] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Pathol & Lab Med, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Birge, RB (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, 185 S Orange Ave, Newark, NJ 07103 USA.	birgera@umdnj.edu	D'Mello, Veera/GNM-5247-2022	Singh, Sukhwinder/0000-0002-7061-0096				Akakura S, 2004, EXP CELL RES, V292, P403, DOI 10.1016/j.yexcr.2003.09.011; Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Alfano M, 2003, J LEUKOCYTE BIOL, V74, P750, DOI 10.1189/jlb.0403176; BLASI F, 1993, BIOESSAYS, V15, P105, DOI 10.1002/bies.950150206; Carriero MV, 1999, CANCER RES, V59, P5307; Chapman HA, 1999, THROMB HAEMOSTASIS, V82, P291; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; Croucher DR, 2007, BIOCHEM J, V408, P203, DOI 10.1042/BJ20070767; Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Franco P, 2006, J CELL SCI, V119, P3424, DOI 10.1242/jcs.03067; Furlan F, 2004, J CELL SCI, V117, P2909, DOI 10.1242/jcs.01149; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Golpon HA, 2004, FASEB J, V18, P1716, DOI 10.1096/fj.04-1853fje; GYETKO MR, 1995, J LEUKOCYTE BIOL, V58, P533, DOI 10.1002/jlb.58.5.533; HIENERT G, 1988, J UROLOGY, V140, P1466, DOI 10.1016/S0022-5347(17)42074-X; HOYERHANSEN G, 1992, J BIOL CHEM, V267, P18224; Huai Q, 2006, SCIENCE, V311, P656, DOI 10.1126/science.1121143; Huai Q, 2008, NAT STRUCT MOL BIOL, V15, P422, DOI 10.1038/nsmb.1404; KIRCHHEIMER JC, 1985, INVAS METAST, V5, P344; Kjoller L, 2002, BIOL CHEM, V383, P5, DOI 10.1515/BC.2002.002; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Ma Z, 2002, J CELL BIOL, V159, P1061, DOI 10.1083/jcb.200207070; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Miyake H, 1999, PROSTATE, V39, P123, DOI 10.1002/(SICI)1097-0045(19990501)39:2<123::AID-PROS7>3.0.CO;2-2; Nakaya M, 2008, P NATL ACAD SCI USA, V105, P9198, DOI 10.1073/pnas.0803677105; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Park YJ, 2008, P NATL ACAD SCI USA, V105, P11784, DOI 10.1073/pnas.0801394105; Patel VA, 2007, AUTOIMMUNITY, V40, P274, DOI 10.1080/08916930701357463; Petzinger J, 2007, CELL COMMUN ADHES, V14, P137, DOI 10.1080/15419060701557487; PLOUG M, 1991, J BIOL CHEM, V266, P1926; Pollanen J, 1988, Adv Exp Med Biol, V233, P187; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; Reuning U, 1998, INT J ONCOL, V13, P893; ROLDAN AL, 1990, EMBO J, V9, P467, DOI 10.1002/j.1460-2075.1990.tb08132.x; Romer J, 1996, NAT MED, V2, P725, DOI 10.1038/nm0796-725a; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; Schmitt M, 1995, J Obstet Gynaecol (Tokyo 1995), V21, P151; Sidenius N, 2003, CANCER METAST REV, V22, P205, DOI 10.1023/A:1023099415940; Singh S, 2007, BIOCHEM BIOPH RES CO, V364, P540, DOI 10.1016/j.bbrc.2007.10.049; Smith HW, 2008, J CELL BIOL, V182, P777, DOI 10.1083/jcb.200712050; Stefansson S, 1996, NATURE, V383, P441, DOI 10.1038/383441a0; Tang H, 1998, J BIOL CHEM, V273, P18268, DOI 10.1074/jbc.273.29.18268; VAHERI A, 1990, CELL DIFFER DEV, V32, P255, DOI 10.1016/0922-3371(90)90038-X; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; WEI Y, 1994, J BIOL CHEM, V269, P32380; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Wei Y, 1999, J CELL BIOL, V144, P1285, DOI 10.1083/jcb.144.6.1285; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632; WUN TC, 1987, J BIOL CHEM, V262, P3646; Yebra M, 1996, J BIOL CHEM, V271, P29393, DOI 10.1074/jbc.271.46.29393	56	31	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17030	17038		10.1074/jbc.M109.010066	http://dx.doi.org/10.1074/jbc.M109.010066			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19383607	Green Published, hybrid			2022-12-25	WOS:000266962400041
J	Betzenhauser, MJ; Wagner, LE; Park, HS; Yule, DI				Betzenhauser, Matthew J.; Wagner, Larry E., II; Park, Hyung Seo; Yule, David I.			ATP Regulation of Type-1 Inositol 1,4,5-Trisphosphate Receptor Activity Does Not Require Walker A-type ATP-binding Motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ RELEASE CHANNELS; RYANODINE RECEPTOR; FUNCTIONAL-CHARACTERIZATION; TRISPHOSPHATE RECEPTORS; SIGNAL-TRANSDUCTION; SKELETAL-MUSCLE; CALCIUM; EXPRESSION; SENSITIVITY; CEREBELLUM	ATP is known to increase the activity of the type-1 inositol 1,4,5-trisphosphate receptor (InsP(3)R1). This effect is attributed to the binding of ATP to glycine rich Walker A-type motifs present in the regulatory domain of the receptor. Only two such motifs are present in neuronal S2+ splice variant of InsP(3)R1 and are designated the ATPA and ATPB sites. The ATPA site is unique to InsP(3)R1, and the ATPB site is conserved among all three InsP(3)R isoforms. Despite the fact that both the ATPA and ATPB sites are known to bind ATP, the relative contribution of these two sites to the enhancing effects of ATP on InsP(3)R1 function is not known. We report here a mutational analysis of the ATPA and ATPB sites and conclude neither of these sites is required for ATP modulation of InsP(3)R1. ATP augmented InsP(3)-induced Ca2+ release from permeabilized cells expressing wild type and ATP-binding site-deficient InsP(3)R1. Similarly, ATP increased the single channel open probability of the mutated InsP(3)R1 to the same extent as wild type. ATP likely exerts its effects on InsP(3)R1 channel function via a novel and as yet unidentified mechanism.	[Betzenhauser, Matthew J.; Wagner, Larry E., II; Park, Hyung Seo; Yule, David I.] Univ Rochester, Med Ctr, Sch Med & Dent, Dept Physiol & Pharmacol,Med Ctr, Rochester, NY 14642 USA; [Park, Hyung Seo] Konyang Univ, Coll Med, Dept Physiol, Taejon 302718, South Korea	University of Rochester; Konyang University; Konyang University Hospital	Yule, DI (corresponding author), 601 Elmwood Ave,Box 711, Rochester, NY 14642 USA.	David_Yule@urmc.rochester.edu			National Institutes of Health [R01-DK054568, R01-DE016999]; National Institutes of Health, NIDCR [T32-DE07202]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007202, R01DE016999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK054568 and R01-DE016999 (to D. I. Y.). 1; Supported by National Institutes of Health, NIDCR Training Grant T32-DE07202.	ABE K, 1987, J NEUROCHEM, V48, P503, DOI 10.1111/j.1471-4159.1987.tb04121.x; Anyatonwu G, 2009, J BIOL CHEM, V284, P8093, DOI 10.1074/jbc.M806932200; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Betzenhauser MJ, 2008, J BIOL CHEM, V283, P21579, DOI 10.1074/jbc.M801680200; Betzenhauser MJ, 2008, METHODS, V46, P177, DOI 10.1016/j.ymeth.2008.09.014; BEZPROZVANNY I, 1993, NEURON, V10, P1175, DOI 10.1016/0896-6273(93)90065-Y; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; Boehning D, 2001, BIOPHYS J, V81, P117, DOI 10.1016/S0006-3495(01)75685-8; Dias JM, 2006, BIOCHEMISTRY-US, V45, P9408, DOI 10.1021/bi060623a; Du GG, 2001, BIOCHEM J, V360, P97, DOI 10.1042/0264-6021:3600097; ERECINSKA M, 1994, PROG NEUROBIOL, V43, P37, DOI 10.1016/0301-0082(94)90015-9; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Foskett JK, 2004, BIOL RES, V37, P513, DOI 10.4067/s0716-97602004000400004; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; IINO M, 1991, J GEN PHYSIOL, V98, P681, DOI 10.1085/jgp.98.4.681; Kaplin AI, 1996, J NEUROSCI, V16, P2002; MAEDA N, 1991, J BIOL CHEM, V266, P1109; Maes K, 2001, J BIOL CHEM, V276, P3492, DOI 10.1074/jbc.M006082200; Maes K, 2000, CELL CALCIUM, V27, P257, DOI 10.1054/ceca.2000.0121; MAK DOD, 1994, J BIOL CHEM, V269, P29375; Mak DOD, 1999, J BIOL CHEM, V274, P22231, DOI 10.1074/jbc.274.32.22231; Mak DOD, 2001, J GEN PHYSIOL, V117, P447, DOI 10.1085/jgp.117.5.447; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; Park HS, 2008, J BIOL CHEM, V283, P26081, DOI 10.1074/jbc.M804184200; Patel S, 1999, CELL CALCIUM, V25, P247, DOI 10.1054/ceca.1999.0021; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Street VA, 1997, J NEUROSCI, V17, P635; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; Tu HP, 2005, BIOPHYS J, V88, P1046, DOI 10.1529/biophysj.104.049593; Tu HP, 2002, BIOPHYS J, V82, P1995, DOI 10.1016/S0006-3495(02)75548-3; Wagner LE, 2006, J BIOL CHEM, V281, P17410, DOI 10.1074/jbc.M601340200; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang Wenyan, 2002, Methods Mol Biol, V182, P37; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; ZARKA A, 1993, EUR J BIOCHEM, V213, P147, DOI 10.1111/j.1432-1033.1993.tb17744.x	40	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16156	16163		10.1074/jbc.M109.006452	http://dx.doi.org/10.1074/jbc.M109.006452			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19386591	Green Published, hybrid			2022-12-25	WOS:000266730900012
J	Husain, M; Meggs, LG; Vashistha, H; Simoes, S; Griffiths, KO; Kumar, D; Mikulak, J; Mathieson, PW; Saleem, MA; Del Valle, L; Pina-Oviedo, S; Wang, JY; Seshan, SV; Malhotra, A; Reiss, K; Singhal, PC				Husain, Mohammad; Meggs, Leonard G.; Vashistha, Himanshu; Simoes, Sonia; Griffiths, Kevin O.; Kumar, Dileep; Mikulak, Joanna; Mathieson, Peter W.; Saleem, Moin A.; Del Valle, Luis; Pina-Oviedo, Sergio; Wang, Jin Ying; Seshan, Surya V.; Malhotra, Ashwani; Reiss, Krzysztof; Singhal, Pravin C.			Inhibition of p66ShcA Longevity Gene Rescues Podocytes from HIV-1-induced Oxidative Stress and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-ASSOCIATED NEPHROPATHY; SMALL INTERFERING RNA; BIOCHEMICAL-MECHANISMS; TRANSCRIPTION FACTORS; BASEMENT-MEMBRANE; TRANSGENIC MICE; CELL APOPTOSIS; EXPRESSION; DELETION; SURVIVAL	Glomerular visceral epithelial cells (podocytes) play a critical role in the pathogenesis of human immunodeficiency virus (HIV)-associated nephropathy. A key question concerns the mechanism(s) by which the HIV-1 genome alters the phenotype of the highly specialized, terminally differentiated podocytes. Here, using an in vitro system of conditionally immortalized differentiated human podocytes (CIDHPs), we document a pivotal role for the p66ShcA protein in HIV-1-induced reactive oxygen species generation and CIDHP apoptosis. CIDHP transfected with truncated HIV-1 construct (NL4-3) exhibit increased reactive oxygen species metabolism, DNA strand breaks, and a 5-fold increase in apoptosis, whereas the opposite was true for NL4-3/CIDHP co-transfected with mu-36p66ShcA (mu-36) dominant negative expression vector or isoform-specific p66-small interfering RNA. Phosphorylation at Ser-36 of the wild type p66ShcA protein, required for p66ShcA redox function and inhibition of the potent stress response regulator Foxo3a, was unchanged in mu-36/NL4-3/CIDHP but increased in NL4-3/CIDHP. Acute knockdown of Foxo3a by small interfering RNA induced a 50% increase in mu-36/NL4-3/CIDHP apoptosis, indicating that Foxo3a-dependent responses promote the survival phenotype in mu-36 cells. We conclude that inhibition of p66ShcA redox activity prevents generation of HIV-1 stress signals and activation of the CIDHP apoptosis program.	[Husain, Mohammad; Kumar, Dileep; Mikulak, Joanna; Singhal, Pravin C.] N Shore Long Isl Jewish Hlth Syst, Div Kidney Dis & Hypertens, Dept Med, New Hyde Pk, NY 11040 USA; [Meggs, Leonard G.; Vashistha, Himanshu; Simoes, Sonia; Griffiths, Kevin O.; Malhotra, Ashwani] Univ Med & Dent New Jersey, New Jersey Med Sch, Div Nephrol & Hypertens, Dept Med, Newark, NJ 07103 USA; [Mathieson, Peter W.; Saleem, Moin A.] Univ Bristol, Childrens Renal Unit, Bristol BS1 5NB, Avon, England; [Del Valle, Luis; Pina-Oviedo, Sergio; Wang, Jin Ying; Reiss, Krzysztof] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA; [Seshan, Surya V.] Weil Cornell Med Sch, Dept Surg Pathol, New York, NY 10065 USA	Northwell Health; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Bristol; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Singhal, PC (corresponding author), Div Kidney Dis & Hypertens, 100 Community Dr, Great Neck, NY 11021 USA.	singhal@lij.edu	Del Valle, Luis/J-4085-2015; mikulak, joanna/AAB-3070-2022; Oviedo, Sergio Pina/AAV-8814-2021	Del Valle, Luis/0000-0003-3894-9206; mikulak, joanna/0000-0001-8310-9543; Saleem, Moin/0000-0002-9808-4518; Singhal, Pravin/0000-0002-6898-358X; Husain, Mohammad/0000-0003-3876-8181	National Institutes of Health [RO1DA12111, 1RO1 HL072852, 1RO1 DK073793]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS043980, R01NS055644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012111] Funding Source: NIH RePORTER; Medical Research Council [G0800200] Funding Source: researchfish; MRC [G0800200] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1DA12111 (to P.C.S.), 1RO1 HL072852 (to A.M.), and 1RO1 DK073793 (to L.G.M.).	Abid R, 2004, ARTERIOSCL THROM VAS, V24, P294, DOI 10.1161/01.ATV.0000110502.10593.06; Barisoni L, 1999, J AM SOC NEPHROL, V10, P51; Barisoni L, 2000, KIDNEY INT, V58, P173, DOI 10.1046/j.1523-1755.2000.00152.x; Bruggeman LA, 1997, J CLIN INVEST, V100, P84, DOI 10.1172/JCI119525; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Camici GG, 2007, P NATL ACAD SCI USA, V104, P5217, DOI 10.1073/pnas.0609656104; Chen JH, 2007, NUCLEIC ACIDS RES, V35, P7417, DOI 10.1093/nar/gkm681; Chintapalli J, 2007, AM J PHYSIOL-RENAL, V292, pF523, DOI 10.1152/ajprenal.00215.2006; Coward RJM, 2007, DIABETES, V56, P1127, DOI 10.2337/db06-0693; Cui M, 2008, J IMMUNOL, V180, P898, DOI 10.4049/jimmunol.180.2.898; DICKIE P, 1991, VIROLOGY, V185, P109, DOI 10.1016/0042-6822(91)90759-5; Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200; GOTTLIEB MS, 1986, MED CLIN N AM, V70, P651, DOI 10.1016/S0025-7125(16)30944-0; Gray F, 2000, J NEUROVIROL, V6, pS38; Hu YY, 2005, MOL BIOL CELL, V16, P3705, DOI 10.1091/mbc.E05-04-0301; Husain M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019642.55998.69; Kanmogne GD, 2005, BIOCHEM BIOPH RES CO, V333, P1107, DOI 10.1016/j.bbrc.2005.05.198; Kerjaschki D, 1996, J AM SOC NEPHROL, V7, P2518; Kisielow M, 2002, BIOCHEM J, V363, P1, DOI 10.1042/0264-6021:3630001; Kojima K, 2004, J AM SOC NEPHROL, V15, P2079, DOI 10.1097/01.ASN.0000133531.43177.21; KOPP JB, 1992, P NATL ACAD SCI USA, V89, P1577, DOI 10.1073/pnas.89.5.1577; Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x; Li JJ, 2007, KIDNEY INT, V72, pS36, DOI 10.1038/sj.ki.5002384; Macho A, 1999, ONCOGENE, V18, P7543, DOI 10.1038/sj.onc.1203095; Marras D, 2002, NAT MED, V8, P522, DOI 10.1038/nm0502-522; Mattson MP, 2005, CELL DEATH DIFFER, V12, P893, DOI 10.1038/sj.cdd.4401577; Menini S, 2006, DIABETES, V55, P1642, DOI 10.2337/db05-1477; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Monks TJ, 2006, DRUG METAB REV, V38, P755, DOI 10.1080/03602530600959649; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Passes JF, 2007, BIOESSAYS, V29, P908, DOI 10.1002/bies.20634; Perry SW, 2005, J IMMUNOL, V174, P4333, DOI 10.4049/jimmunol.174.7.4333; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Selliah N, 2001, CELL DEATH DIFFER, V8, P127, DOI 10.1038/sj.cdd.4400822; Wang HY, 2008, J BIOL CHEM, V283, P15845, DOI 10.1074/jbc.M800834200; Wei YH, 1998, P SOC EXP BIOL MED, V217, P53; Yang L, 2006, P NATL ACAD SCI USA, V103, P11479, DOI 10.1073/pnas.0604993103; Zhong JY, 2005, KIDNEY INT, V68, P1048, DOI 10.1111/j.1523-1755.2005.00497.x	41	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16648	16658		10.1074/jbc.M109.008482	http://dx.doi.org/10.1074/jbc.M109.008482			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19383602	Green Published, hybrid			2022-12-25	WOS:000266730900060
J	Lindberg, N; Kastemar, M; Olofsson, T; Smits, A; Uhrbom, L				Lindberg, Nanna; Kastemar, M.; Olofsson, T.; Smits, A.; Uhrbom, L.			Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma	ONCOGENE			English	Article						glioma; cell of origin; neural stem cell; oligodendrocyte progenitor cell; glial cell; PDGF	NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR RECEPTOR; PDGF ALPHA-RECEPTOR; IN-VIVO; GENE-TRANSFER; NG2 PROTEOGLYCAN; SONIC HEDGEHOG; NUCLEOTIDE 3'-PHOSPHODIESTERASE; MEDULLOBLASTOMA FORMATION	Gliomas are primary brain tumors mainly affecting adults. The cellular origin is unknown. The recent identification of tumor-initiating cells in glioma, which share many similarities with normal neural stem cells, has suggested the cell of origin to be a transformed neural stem cell. In previous studies, using the RCAS/tv-a mouse model, platelet-derived growth factor B (PDGF-B)induced gliomas have been generated from nestin or glial fibrillary acidic protein-expressing cells, markers of neural stem cells. To investigate if committed glial progenitor cells could be the cell of origin for glioma, we generated the Ctv-a mouse where tumor induction would be restricted to myelinating oligodendrocyte progenitor cells (OPCs) expressing 2',3'-cyclic nucleotide 3'-phosphodiesterase. We showed that PDGF-B transfer to OPCs could induce gliomas with an incidence of 33%. The majority of tumors resembled human WHO grade II oligodendroglioma based on close similarities in histopathology and expression of cellular markers. Thus, with the Ctv-a mouse we have showed that the cell of origin for glioma may be a committed glial progenitor cell. Oncogene (2009) 28, 2266-2275; doi: 10.1038/onc.2009.76; published online 27 April 2009	[Lindberg, Nanna; Kastemar, M.; Olofsson, T.; Uhrbom, L.] Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, SE-75185 Uppsala, Uppland, Sweden; [Smits, A.] Univ Uppsala Hosp, Dept Neurosci, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University Hospital	Uhrbom, L (corresponding author), Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, Dag Hammarskoldsvag 20, SE-75185 Uppsala, Uppland, Sweden.	lene.uhrbom@genpat.uu.se	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763	Swedish Cancer Society; Swedish Research Council; Association for International Cancer Research; Lars Hiertas Minne; Jeansson's Foundation; Magn. Bergvall's Foundation; Ake Wiberg's Foundation; Department of Genetics and Pathology; Medical Faculty of Uppsala University	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Association for International Cancer Research; Lars Hiertas Minne; Jeansson's Foundation; Magn. Bergvall's Foundation; Ake Wiberg's Foundation; Department of Genetics and Pathology; Medical Faculty of Uppsala University	We thank Michel Gravel for the mouse Cnp promoter DNA and Karin Forsberg-Nilsson for the pTG8 plasmid. This work was supported by grants from The Swedish Cancer Society, The Swedish Research Council, Association for International Cancer Research, Lars Hiertas Minne, Jeansson's Foundation, Magn. Bergvall's Foundation, Ake Wiberg's Foundation, the Department of Genetics and Pathology and the Medical Faculty of Uppsala University.	BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Binning MJ, 2008, CANCER RES, V68, P7838, DOI 10.1158/0008-5472.CAN-08-1899; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Chandross KJ, 1999, J NEUROSCI, V19, P759, DOI 10.1523/jneurosci.19-02-00759.1999; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dunlap SM, 2007, P NATL ACAD SCI USA, V104, P11736, DOI 10.1073/pnas.0703145104; Ferletta M, 2007, MOL CANCER RES, V5, P891, DOI 10.1158/1541-7786.MCR-07-0113; Fults D, 2002, NEOPLASIA, V4, P32, DOI 10.1038/sj.neo.7900200; Gravel M, 1998, J NEUROSCI RES, V53, P393; Holland EC, 1998, P NATL ACAD SCI USA, V95, P1218, DOI 10.1073/pnas.95.3.1218; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Holland EC, 2000, AM J PATHOL, V157, P1031, DOI 10.1016/S0002-9440(10)64615-9; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Ling BC, 2005, CANCER CELL, V7, P65, DOI 10.1016/j.ccr.2004.10.016; Liu Y, 2007, EMBO J, V26, P4683, DOI 10.1038/sj.emboj.7601886; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; ONeill RC, 1997, J NEUROSCI RES, V50, P248; Polito A, 2005, J ANAT, V207, P707, DOI 10.1111/j.1469-7580.2005.00454.x; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; Rao G, 2004, ONCOGENE, V23, P6156, DOI 10.1038/sj.onc.1207818; Rao G, 2003, NEOPLASIA, V5, P198, DOI 10.1016/S1476-5586(03)80052-0; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; SCHERER SS, 1994, NEURON, V12, P1363, DOI 10.1016/0896-6273(94)90451-0; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; STALLCUP WB, 1987, J NEUROSCI, V7, P2737; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; TCHOUGOUNOVA E, 2007, ONCOGENE; Uhrbom L, 2001, J NEURO-ONCOL, V53, P297, DOI 10.1023/A:1012208314436; Uhrbom L, 2005, CANCER RES, V65, P2065, DOI 10.1158/0008-5472.CAN-04-3588; Uhrbom L, 2002, CANCER RES, V62, P5551; VOGEL US, 1988, J NEUROCHEM, V50, P1667, DOI 10.1111/j.1471-4159.1988.tb02461.x; Yuan XQ, 2002, J NEUROSCI RES, V70, P529, DOI 10.1002/jnr.10368	45	127	130	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 11	2009	28	23					2266	2275		10.1038/onc.2009.76	http://dx.doi.org/10.1038/onc.2009.76			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	456XM	19421151				2022-12-25	WOS:000266886300003
J	Kitagawa, K; Hiramatsu, Y; Uchida, C; Isobe, T; Hattori, T; Oda, T; Shibata, K; Nakamura, S; Kikuchi, A; Kitagawa, M				Kitagawa, K.; Hiramatsu, Y.; Uchida, C.; Isobe, T.; Hattori, T.; Oda, T.; Shibata, K.; Nakamura, S.; Kikuchi, A.; Kitagawa, M.			Fbw7 promotes ubiquitin-dependent degradation of c-Myb: involvement of GSK3-mediated phosphorylation of Thr-572 in mouse c-Myb	ONCOGENE			English	Article						c-Myb; ubiquitin-proteasome; Fbw7; phosphorylation; GSK3	F-BOX PROTEIN; ACUTE LYMPHOBLASTIC-LEUKEMIA; GLYCOGEN-SYNTHASE KINASE-3; T-CELL LEUKEMIA; CYCLIN-E; TUMOR-SUPPRESSOR; FBXW7 ACTS; DIFFERENTIATION; LIGASE; PROTEOLYSIS	Expression of oncoprotein c-Myb oscillates during hematopoiesis and hematological malignancies. Its quantity is not only regulated through transcriptional control but also through the ubiquitin-proteasome pathway, accompanied by phosphorylation, although the mechanisms are poorly understood. In this report, we tried to identify an E3 ubiquitin ligase, which targets c-Myb for ubiquitin-dependent degradation. We found that an F-box protein, Fbw7, interacted with c-Myb, which is mutated in numerous cancers. Fbw7 facilitated ubiquitylation and degradation of c-Myb in intact cells. Moreover, depletion of Fbw7 by RNA interference delayed turnover and increased the abundance of c-Myb in myeloid leukemia cells concomitantly, and suppressed the transcriptional level of gamma-globin, which receives transcriptional repression from c-Myb. In addition, we analysed sites required for both ubiquitylation and degradation of c-Myb. We found that Thr-572 is critical for Fbw7-mediated ubiquitylation in mouse c-Myb using site-directed mutagenesis. Fbw7 recognized the phosphorylation of Thr-572, which was mediated by glycogen synthase kinase 3 (GSK3). In consequence, the c-Myb protein was markedly stabilized by the substitution of Thr-572 to Ala. These observations suggest that SCFFbw7 ubiquitin ligase regulates phosphorylation-dependent degradation of c-Myb protein. Oncogene (2009) 28, 2393-2405; doi:10.1038/onc.2009.111; published online 4 May 2009	[Kitagawa, K.; Hiramatsu, Y.; Uchida, C.; Isobe, T.; Hattori, T.; Oda, T.; Kitagawa, M.] Hamamatsu Univ Sch Med, Dept Biochem 1, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Hiramatsu, Y.] Hamamatsu Univ Sch Med, Dept Surg, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Shibata, K.] Hamamatsu Univ Sch Med, Res Equipment Ctr, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Nakamura, S.] Hamamatsu Univ Sch Med, Dept Internal Med 3, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Kikuchi, A.] Hiroshima Univ, Dept Biochem, Grad Sch Biomed Sci, Minami Ku, Hiroshima, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hiroshima University	Kitagawa, M (corresponding author), Hamamatsu Univ Sch Med, Dept Biochem 1, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	kitamasa@hama-med.ac.jp		Hiramatsu, Yoshihiro/0000-0003-1448-1610	Ministry of Education, Science, Sports, Culture and Technology of Japan; COE program of Hamamatsu University School of Medicine	Ministry of Education, Science, Sports, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); COE program of Hamamatsu University School of Medicine	We thank Yojiro Kotake, Keiichi I Nakayama, Masaki Matsumoto, Akinobu Matsumoto and Issay Kitabayashi for providing plasmids and useful discussions, and Sayuri Suzuki, Tomomi Abe, Ning Liu, Harumi Shiratori, Daisuke Hiraoka, Daizo Ueno, Yasue Kirita, Tatsuya Kobayashi, Konomi Mizuguchi, Erina Nihashi, Syuhei Iizuka, Daisuke Ichikawa and Naohiro Takamoto for their technical assistance. This study was supported in part by grants from the Ministry of Education, Science, Sports, Culture and Technology of Japan (MK and KK), by a COE program of Hamamatsu University School of Medicine from the Ministry of Education, Science, Sports, Culture and Technology of Japan (MK).	Bies J, 2000, ONCOGENE, V19, P2846, DOI 10.1038/sj.onc.1203613; Bies J, 1999, J VIROL, V73, P2038, DOI 10.1128/JVI.73.3.2038-2044.1999; BIES J, 1995, CELL GROWTH DIFFER, V6, P59; Bies J, 2001, BLOOD CELL MOL DIS, V27, P422, DOI 10.1006/bcmd.2001.0400; Bies J, 1997, ONCOGENE, V14, P203, DOI 10.1038/sj.onc.1200828; Charrasse S, 2000, ONCOGENE, V19, P2986, DOI 10.1038/sj.onc.1203618; Clappier E, 2007, BLOOD, V110, P1251, DOI 10.1182/blood-2006-12-064683; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Corradini F, 2005, J BIOL CHEM, V280, P30254, DOI 10.1074/jbc.M504703200; Emambokus N, 2003, EMBO J, V22, P4478, DOI 10.1093/emboj/cdg434; Feikova S, 2000, NEOPLASMA, V47, P212; Friedman AD, 2002, J CELL BIOCHEM, V86, P624, DOI 10.1002/jcb.10271; Goto H, 2007, NAT PROTOC, V2, P2574, DOI 10.1038/nprot.2007.374; Hatakeyama S, 1999, P NATL ACAD SCI USA, V96, P3859, DOI 10.1073/pnas.96.7.3859; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hiramatsu Y, 2006, CANCER RES, V66, P8477, DOI 10.1158/0008-5472.CAN-06-1603; Jiang J, 2006, BLOOD, V108, P1077, DOI 10.1182/blood-2006-01-008912; Kanei-Ishii C, 2004, J BIOL CHEM, V279, P44582, DOI 10.1074/jbc.M407831200; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Kanei-Ishii C, 2008, J BIOL CHEM, V283, P30540, DOI 10.1074/jbc.M804340200; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Lahortiga I, 2007, NAT GENET, V39, P593, DOI 10.1038/ng2025; Lieu YK, 2004, P NATL ACAD SCI USA, V101, P14853, DOI 10.1073/pnas.0405338101; Matsumoto A, 2006, BIOCHEM BIOPH RES CO, V350, P114, DOI 10.1016/j.bbrc.2006.09.003; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Minella AC, 2005, CELL CYCLE, V4, P1356, DOI 10.4161/cc.4.10.2058; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Onoyama I, 2007, J EXP MED, V204, P2875, DOI 10.1084/jem.20062299; RAMSAY RG, 1986, P NATL ACAD SCI USA, V83, P6849, DOI 10.1073/pnas.83.18.6849; Sakamoto H, 2006, BLOOD, V108, P896, DOI 10.1182/blood-2005-09-3846; SELVAKUMARAN M, 1992, MOL CELL BIOL, V12, P2493, DOI 10.1128/MCB.12.6.2493; Sharma VM, 2007, CELL CYCLE, V6, P927, DOI 10.4161/cc.6.8.4134; SIEGERT W, 1990, EUR J CANCER, V26, P733, DOI 10.1016/0277-5379(90)90130-L; SLAMON DJ, 1986, SCIENCE, V233, P347, DOI 10.1126/science.3014652; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Tanikawa J, 2000, J BIOL CHEM, V275, P15578, DOI 10.1074/jbc.M000372200; Tanji C, 2002, J BIOL CHEM, V277, P36955, DOI 10.1074/jbc.M206210200; Tetzlaff MT, 2004, P NATL ACAD SCI USA, V101, P3338, DOI 10.1073/pnas.0307875101; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; Vegiopoulos A, 2006, BLOOD, V107, P4703, DOI 10.1182/blood-2005-07-2968; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yamamoto H, 2007, GENES CELLS, V12, P1215, DOI 10.1111/j.1365-2443.2007.01128.x	56	49	52	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2009	28	25					2393	2405		10.1038/onc.2009.111	http://dx.doi.org/10.1038/onc.2009.111			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	462HS	19421138				2022-12-25	WOS:000267342400004
J	Nelis, M; Esko, T; Magi, R; Zimprich, F; Zimprich, A; Toncheva, D; Karachanak, S; Piskackova, T; Balascak, I; Peltonen, L; Jakkula, E; Rehnstrom, K; Lathrop, M; Heath, S; Galan, P; Schreiber, S; Meitinger, T; Pfeufer, A; Wichmann, HE; Melegh, B; Polgar, N; Toniolo, D; Gasparini, P; D'Adamo, P; Klovins, J; Nikitina-Zake, L; Kucinskas, V; Kasnauskiene, J; Lubinski, J; Debniak, T; Limborska, S; Khrunin, A; Estivill, X; Rabionet, R; Marsal, S; Julia, A; Antonarakis, SE; Deutsch, S; Borel, C; Attar, H; Gagnebin, M; Macek, M; Krawczak, M; Remm, M; Metspalu, A				Nelis, Mari; Esko, Tonu; Magi, Reedik; Zimprich, Fritz; Zimprich, Alexander; Toncheva, Draga; Karachanak, Sena; Piskackova, Tereza; Balascak, Ivan; Peltonen, Leena; Jakkula, Eveliina; Rehnstrom, Karola; Lathrop, Mark; Heath, Simon; Galan, Pilar; Schreiber, Stefan; Meitinger, Thomas; Pfeufer, Arne; Wichmann, H-Erich; Melegh, Bela; Polgar, Noemi; Toniolo, Daniela; Gasparini, Paolo; D'Adamo, Pio; Klovins, Janis; Nikitina-Zake, Liene; Kucinskas, Vaidutis; Kasnauskiene, Jurate; Lubinski, Jan; Debniak, Tadeusz; Limborska, Svetlana; Khrunin, Andrey; Estivill, Xavier; Rabionet, Raquel; Marsal, Sara; Julia, Antonio; Antonarakis, Stylianos E.; Deutsch, Samuel; Borel, Christelle; Attar, Homa; Gagnebin, Maryline; Macek, Milan; Krawczak, Michael; Remm, Maido; Metspalu, Andres			Genetic Structure of Europeans: A View from the North-East	PLOS ONE			English	Article								Using principal component (PC) analysis, we studied the genetic constitution of 3,112 individuals from Europe as portrayed by more than 270,000 single nucleotide polymorphisms (SNPs) genotyped with the Illumina Infinium platform. In cohorts where the sample size was >100, one hundred randomly chosen samples were used for analysis to minimize the sample size effect, resulting in a total of 1,564 samples. This analysis revealed that the genetic structure of the European population correlates closely with geography. The first two PCs highlight the genetic diversity corresponding to the northwest to southeast gradient and position the populations according to their approximate geographic origin. The resulting genetic map forms a triangular structure with a) Finland, b) the Baltic region, Poland and Western Russia, and c) Italy as its vertexes, and with d) Central- and Western Europe in its centre. Inter- and intra- population genetic differences were quantified by the inflation factor lambda (lambda) (ranging from 1.00 to 4.21), fixation index (F(st)) (ranging from 0.000 to 0.023), and by the number of markers exhibiting significant allele frequency differences in pair-wise population comparisons. The estimated lambda was used to assess the real diminishing impact to association statistics when two distinct populations are merged directly in an analysis. When the PC analysis was confined to the 1,019 Estonian individuals (0.1% of the Estonian population), a fine structure emerged that correlated with the geography of individual counties. With at least two cohorts available from several countries, genetic substructures were investigated in Czech, Finnish, German, Estonian and Italian populations. Together with previously published data, our results allow the creation of a comprehensive European genetic map that will greatly facilitate inter-population genetic studies including genome wide association studies (GWAS).			Nelis, M (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Ulikooli 18, EE-50090 Tartu, Estonia.	andres@ebc.ee	borel, christelle/AAC-9645-2019; Antonarakis, Stylianos E/N-8866-2014; Klovins, Janis/C-5695-2011; Meitinger, Thomas/O-1318-2015; Karachanak-Yankova, Sena/AAL-2721-2021; Nelis, Mari/ABG-7775-2020; Estivill, Xavier/E-2957-2012; rabionet, raquel/A-7407-2009; Rabionet, Raquel/C-8379-2009; Remm, Maido/L-9072-2019; Wichmann, Heinz Erich/AAA-5695-2022; Limborska, Svetlana/S-2961-2019; Limborska, Svetlana/A-5633-2016; Gasparini, Paolo/B-6173-2014; Zimprich, Fritz/O-1406-2019; Estivill, Xavier/A-3125-2013; Krawczak, Michael/A-8964-2010; Polgar, Noemi/B-3948-2013; Zimprich, Alexander/A-5232-2017; Heath, Simon C/J-4138-2012; KUČINSKAS, Vaidutis/A-4798-2013; Toniolo, Daniela/AAE-2969-2019; Pfeufer, Arne/B-6634-2013; Mägi, Reedik/AAJ-9679-2021; Zimprich, Fritz/W-1738-2017; d'Adamo, Adamo Pio/G-4064-2011	Antonarakis, Stylianos E/0000-0001-8907-5823; Karachanak-Yankova, Sena/0000-0001-6441-629X; Nelis, Mari/0000-0001-9748-1020; rabionet, raquel/0000-0001-5006-8140; Rabionet, Raquel/0000-0001-5006-8140; Remm, Maido/0000-0003-3966-8422; Limborska, Svetlana/0000-0002-1697-6820; Zimprich, Fritz/0000-0002-6998-5480; Estivill, Xavier/0000-0002-0723-2256; Krawczak, Michael/0000-0003-2603-1502; Zimprich, Alexander/0000-0002-1668-5177; Heath, Simon C/0000-0002-9550-0897; Toniolo, Daniela/0000-0001-9545-6032; Zimprich, Fritz/0000-0002-6998-5480; d'Adamo, Adamo Pio/0000-0001-9367-4909; Magi, Reedik/0000-0002-2964-6011; Polgar, Noemi/0000-0002-8400-162X; Meitinger, Thomas/0000-0002-8838-8403; Julia Cano, Antonio/0000-0001-6064-3620; Gasparini, Paolo/0000-0002-0859-0856; Deutsch, Samuel/0000-0001-9456-7101; Venkatasubramanian, Siddharth/0000-0002-5860-0768; marsal, sara/0000-0001-5515-3854; Klovins, Janis/0000-0001-8362-5505; s, hema/0000-0002-3440-9475; Toncheva, Draga/0000-0002-7451-6363; Esko, Tonu/0000-0003-1982-6569; Lubinski, Jan/0000-0003-2931-3003				Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Barbujani G, 2004, ANNU REV GENOM HUM G, V5, P119, DOI 10.1146/annurev.genom.5.061903.180021; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Burton PR, 2009, INT J EPIDEMIOL, V38, P263, DOI 10.1093/ije/dyn147; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Heath SC, 2008, EUR J HUM GENET, V16, P1413, DOI 10.1038/ejhg.2008.210; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Li QZ, 2008, GENET EPIDEMIOL, V32, P215, DOI 10.1002/gepi.20296; Lowel H, 2005, GESUNDHEITSWESEN, V67, pS13, DOI 10.1055/s-2005-858234; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roewer L, 2005, HUM GENET, V116, P279, DOI 10.1007/s00439-004-1201-z; Salmela E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003519; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; Simoni L, 2000, AM J HUM GENET, V66, P262, DOI 10.1086/302706; Steffens M, 2006, HUM HERED, V62, P20, DOI 10.1159/000095850; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Varilo T, 2000, EUR J HUM GENET, V8, P604, DOI 10.1038/sj.ejhg.5200482; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	35	234	239	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5472	10.1371/journal.pone.0005472	http://dx.doi.org/10.1371/journal.pone.0005472			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424496	Green Submitted, Green Published, gold			2022-12-25	WOS:000265933800011
J	Smith, CE; Tucker, KL; Scott, TM; Van Rompay, M; Mattei, J; Lai, CQ; Parnell, LD; Junyent, M; Lee, YC; Garcia-Bailo, B; Ordovas, JM				Smith, Caren E.; Tucker, Katherine L.; Scott, Tammy M.; Van Rompay, Maria; Mattei, Josiemer; Lai, Chao-Qiang; Parnell, Laurence D.; Junyent, Mireia; Lee, Yu-Chi; Garcia-Bailo, Bibiana; Ordovas, Jose M.			Apolipoprotein C3 Polymorphisms, Cognitive Function and Diabetes in Caribbean Origin Hispanics	PLOS ONE			English	Article								Background: Apolipoprotein C3 (APOC3) modulates triglyceride metabolism through inhibition of lipoprotein lipase, but is itself regulated by insulin, so that APOC3 represents a potential mechanism by which glucose metabolism may affect lipid metabolism. Unfavorable lipoprotein profiles and impaired glucose metabolism are linked to cognitive decline, and all three conditions may decrease lifespan. Associations between apolipoprotein C3 (APOC3) gene polymorphisms and impaired lipid and glucose metabolism are well-established, but potential connections between APOC3 polymorphisms, cognitive decline and diabetes deserve further attention. Methods: We examined whether APOC3 single nucleotide polymorphisms (SNPs) m482 (rs2854117) and 3u386 (rs5128) were related to cognitive measures, whether the associations between cognitive differences and genotype were related to metabolic differences, and how diabetes status affected these associations. Study subjects were Hispanics of Caribbean origin (n = 991, aged 45-74) living in the Boston metropolitan area. Results: Cognitive and metabolic measures differed substantially by type II diabetes status. In multivariate regression models, APOC3 m482 AA subjects with diabetes exhibited lower executive function (P = 0.009), Stroop color naming score (P = 0.014) and Stroop color-word score (P = 0.022) compared to AG/GG subjects. APOC3 m482 AA subjects with diabetes exhibited significantly higher glucose (P = 0.032) and total cholesterol (P = 0.028) compared to AG/GG subjects. APOC3 3u386 GC/GG subjects with diabetes exhibited significantly higher triglyceride (P = 0.004), total cholesterol (P = 0.003) and glucose (P = 0.016) compared to CC subjects. Conclusions: In summary, we identified significant associations between APOC3 polymorphisms, impaired cognition and metabolic dysregulation in Caribbean Hispanics with diabetes. Further research investigating these relationships in other populations is warranted.			Smith, CE (corresponding author), Tufts Univ, Human Nutr Res Ctr Aging, Jean Mayer US Dept, Boston, MA 02111 USA.	jose.ordovas@tufts.edu	Mattei, Josiemer/H-1800-2016; Tucker, Katherine L/A-4545-2010; Van Rompay, Maria/G-9452-2012; Ordovas, Jose/B-8727-2013	Mattei, Josiemer/0000-0001-5424-8245; Lai, Chao-Qiang/0000-0003-1107-8375; Tucker, Katherine/0000-0001-7640-662X; Parnell, Laurence/0000-0001-9718-1335; Ordovas, Jose/0000-0002-7581-5680	NHLBI NIH HHS [R01 HL054776, HL54776, T32 HL069772] Funding Source: Medline; NIA NIH HHS [5P01AG023394, P01 AG023394] Funding Source: Medline; NIDDK NIH HHS [DK075030, R01 DK075030, T32 DK007651-19, DK007651-19, T32 DK062032, T32 DK007651] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054776, T32HL069772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK062032, T32DK007651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG023394] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Altomonte J, 2004, J CLIN INVEST, V114, P1493, DOI 10.1172/JCI200419992; Atzmon G, 2006, PLOS BIOL, V4, P562, DOI 10.1371/journal.pbio.0040113; Atzmon G, 2002, J GERONTOL A-BIOL, V57, pM712, DOI 10.1093/gerona/57.11.M712; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barzilai N, 2006, NEUROLOGY, V67, P2170, DOI 10.1212/01.wnl.0000249116.50854.65; Brown CM, 2006, J MOL MED, V84, P561, DOI 10.1007/s00109-005-0037-x; Choudhry S, 2006, HUM GENET, V118, P652, DOI 10.1007/s00439-005-0071-3; Dallinga-Thie GM, 2001, J LIPID RES, V42, P1450; Falush D, 2003, GENETICS, V164, P1567; FU YX, 1993, GENETICS, V133, P693; Gervaise N, 2000, DIABETOLOGIA, V43, P703, DOI 10.1007/s001250051366; Haan MN, 1999, JAMA-J AM MED ASSOC, V282, P40, DOI 10.1001/jama.282.1.40; Hallman DM, 2006, METABOLISM, V55, P1574, DOI 10.1016/j.metabol.2006.07.018; HAVILAND MB, 1991, AM J HUM GENET, V49, P350; Hong SH, 1997, CLIN CHEM, V43, P13; HOULDEN H, 1995, NEUROSCI LETT, V188, P202, DOI 10.1016/0304-3940(95)11422-S; Imae M, 2003, J MOL ENDOCRINOL, V30, P253, DOI 10.1677/jme.0.0300253; Kawakami A, 2006, CIRCULATION, V114, P681, DOI 10.1161/CIRCULATIONAHA.106.622514; Kivipelto M, 2001, NEUROLOGY, V56, P1683, DOI 10.1212/WNL.56.12.1683; Ko YL, 1997, HUM GENET, V100, P327, DOI 10.1007/s004390050511; Lai CQ, 2009, HUM GENET, V125, P199, DOI 10.1007/s00439-008-0612-7; Lai CQ, 2005, CURR OPIN LIPIDOL, V16, P153, DOI 10.1097/01.mol.0000162320.54795.68; Li WW, 1995, J CLIN INVEST, V96, P2601, DOI 10.1172/JCI118324; Manschot SM, 2007, DIABETOLOGIA, V50, P2388, DOI 10.1007/s00125-007-0792-z; MOSS SE, 1991, AM J PUBLIC HEALTH, V81, P1158, DOI 10.2105/AJPH.81.9.1158; Muendlein A, 2008, ATHEROSCLEROSIS, V199, P179, DOI 10.1016/j.atherosclerosis.2007.10.030; ORDOVAS JM, 1991, ATHEROSCLEROSIS, V87, P75, DOI 10.1016/0021-9150(91)90234-T; Paolisso G, 2001, EXP GERONTOL, V37, P149, DOI 10.1016/S0531-5565(01)00148-6; Perez-Jimenez F, 2002, DIABETOLOGIA, V45, P1196, DOI 10.1007/s00125-002-0884-8; Pollex RL, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-80; Qi L, 2007, ATHEROSCLEROSIS, V192, P204, DOI 10.1016/j.atherosclerosis.2006.05.006; ROGERS RL, 1989, ANGIOLOGY, V40, P260, DOI 10.1177/000331978904000404; Schupf N, 2004, NEUROBIOL AGING, V25, P1231, DOI 10.1016/j.neurobiolaging.2003.11.010; Sun Y, 2005, NEUROSCI LETT, V380, P219, DOI 10.1016/j.neulet.2005.01.038; Tsai HJ, 2005, HUM GENET, V118, P424, DOI 10.1007/s00439-005-0067-z; WANG CS, 1985, J CLIN INVEST, V75, P384, DOI 10.1172/JCI111711; Wang J, 2008, AM J HUM GENET, V83, P53, DOI 10.1016/j.ajhg.2008.06.010; Waterworth DM, 2001, DIABETOLOGIA, V44, P245, DOI 10.1007/s001250051607	38	15	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5465	10.1371/journal.pone.0005465	http://dx.doi.org/10.1371/journal.pone.0005465			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424489	Green Published, Green Submitted, gold			2022-12-25	WOS:000265933800003
J	Kashiwagi, T; Leung, BW; Deng, T; Chen, HL; Brownlee, GG				Kashiwagi, Takahito; Leung, Bo Wah; Deng, Tao; Chen, Hualan; Brownlee, George G.			The N-Terminal Region of the PA Subunit of the RNA Polymerase of Influenza A/HongKong/156/97 (H5N1) Influences Promoter Binding	PLOS ONE			English	Article							SINGLE AMINO-ACID; A VIRUS; HEMAGGLUTININ GENE; COMPLETE SEQUENCE; MESSENGER-RNA; CAP-BINDING; REPLICATION; PROTEIN; PB2; TRANSCRIPTION	Background: The RNA polymerase of influenza virus is a heterotrimeric complex of PB1, PB2 and PA subunits which cooperate in the transcription and replication of the viral genome. Previous research has shown that the N-terminal region of the PA subunit of influenza A/WSN/33 (H1N1) virus is involved in promoter binding. Methodology/Principal Findings: Here we extend our studies of the influenza RNA polymerase to that of influenza strains A/HongKong/156/97 (H5N1) and A/Vietnam/1194/04 (H5N1). Both H5N1 strains, originally isolated from patients in 1997 and 2004, showed significantly higher polymerase activity compared with two classical human strains, A/WSN/33 (H1N1) and A/NT/60/68 (H3N2) in vitro. This increased polymerase activity correlated with enhanced promoter binding. The N-terminal region of the PA subunit was the major determinant of this enhanced promoter activity. Conclusions/Significance: Overall we suggest that the N-terminal region of the PA subunit of two recent H5N1 strains can influence promoter binding and we speculate this may be a factor in their virulence.			Kashiwagi, T (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	george.brownlee@path.ox.ac.uk			MRC [G9523972] Funding Source: UKRI; Medical Research Council [G9523972, G9901312] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Area E, 2004, P NATL ACAD SCI USA, V101, P308, DOI 10.1073/pnas.0307127101; BISHOP DHL, 1982, VIROLOGY, V120, P481, DOI 10.1016/0042-6822(82)90049-6; BISHOP DHL, 1982, NUCLEIC ACIDS RES, V10, P1335, DOI 10.1093/nar/10.4.1335; BISWAS SK, 1994, J VIROL, V68, P1819, DOI 10.1128/JVI.68.3.1819-1826.1994; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BOULOY M, 1978, P NATL ACAD SCI USA, V75, P4886, DOI 10.1073/pnas.75.10.4886; Brownlee GG, 2002, J VIROL, V76, P7103, DOI 10.1128/JVI.76.14.7103-7113.2002; Chan AY, 2006, VIROLOGY, V351, P210, DOI 10.1016/j.virol.2006.03.005; Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; Claas ECJ, 1998, VACCINE, V16, P977, DOI 10.1016/S0264-410X(98)00005-X; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; DE BK, 1988, NUCLEIC ACIDS RES, V16, P4181, DOI 10.1093/nar/16.9.4181; Deng T, 2006, J VIROL, V80, P2337, DOI 10.1128/JVI.80.5.2337-2348.2006; Deng T, 2005, J VIROL, V79, P8669, DOI 10.1128/JVI.79.13.8669-8674.2005; Deng T, 2006, J GEN VIROL, V87, P3373, DOI 10.1099/vir.0.82199-0; DIAS A, 2009, NATURE IN PRESS; Fan SF, 2009, VIROLOGY, V384, P28, DOI 10.1016/j.virol.2008.11.044; Fechter P, 2005, J GEN VIROL, V86, P1239, DOI 10.1099/vir.0.80755-0; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Fodor E, 2004, J VIROL, V78, P9144, DOI 10.1128/JVI.78.17.9144-9153.2004; Fodor E, 2003, J VIROL, V77, P5017, DOI 10.1128/JVI.77.8.5017-5020.2003; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Fodor E, 2002, PERSP MED V, V7, P1; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hara K, 2001, GENES CELLS, V6, P87, DOI 10.1046/j.1365-2443.2001.00399.x; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Hiromoto Y, 2000, VIROLOGY, V272, P429, DOI 10.1006/viro.2000.0371; Honda A, 2002, P NATL ACAD SCI USA, V99, P13166, DOI 10.1073/pnas.152456799; Huarte M, 2001, J VIROL, V75, P8597, DOI 10.1128/JVI.75.18.8597-8604.2001; Hulse-Post DJ, 2007, J VIROL, V81, P8515, DOI 10.1128/JVI.00435-07; Ito T, 2000, J VIROL, V74, P9300, DOI 10.1128/JVI.74.19.9300-9305.2000; JONES KL, 1983, NUCLEIC ACIDS RES, V11, P1555, DOI 10.1093/nar/11.5.1555; Kawaguchi A, 2007, EMBO J, V26, P4566, DOI 10.1038/sj.emboj.7601881; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Lee MTM, 2002, NUCLEIC ACIDS RES, V30, P429, DOI 10.1093/nar/30.2.429; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li ML, 2001, EMBO J, V20, P2078, DOI 10.1093/emboj/20.8.2078; Li Y, 2006, ARCH VIROL, V151, P1615, DOI 10.1007/s00705-006-0738-7; Maier HJ, 2008, VIROLOGY, V370, P194, DOI 10.1016/j.virol.2007.08.029; Massin P, 2005, J VIROL, V79, P13811, DOI 10.1128/JVI.79.21.13811-13816.2005; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; Neumann G, 2007, ANTIVIR THER, V12, P617; Ortin J, 2006, ANNU REV MICROBIOL, V60, P305, DOI 10.1146/annurev.micro.60.080805.142248; Palese P., 2007, FIELDS VIROLOGY, P1647; Perales B, 2000, J VIROL, V74, P1307, DOI 10.1128/JVI.74.3.1307-1312.2000; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; PLOTCH SJ, 1979, P NATL ACAD SCI USA, V76, P1618, DOI 10.1073/pnas.76.4.1618; Rodriguez A, 2007, J VIROL, V81, P5315, DOI 10.1128/JVI.02129-06; Shortridge KF, 1998, VIROLOGY, V252, P331, DOI 10.1006/viro.1998.9488; Suarez DL, 1998, J VIROL, V72, P6678, DOI 10.1128/JVI.72.8.6678-6688.1998; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Torreira E, 2007, NUCLEIC ACIDS RES, V35, P3774, DOI 10.1093/nar/gkm336; TREANOR J, 1994, J VIROL, V68, P7684, DOI 10.1128/JVI.68.12.7684-7688.1994; Uyeki TM, 2008, RESPIROLOGY, V13, pS2, DOI 10.1111/j.1440-1843.2008.01246.x; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; Wasilenko JL, 2008, J VIROL, V82, P4544, DOI 10.1128/JVI.02642-07; Webster RG, 2002, J VIROL, V76, P118, DOI 10.1128/JVI.76.1.118-126.2002; WOOD GW, 1993, ARCH VIROL, V130, P209, DOI 10.1007/BF01319010; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; YUAN P, 2009, NATURE IN PRESS	66	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2009	4	5							e5473	10.1371/journal.pone.0005473	http://dx.doi.org/10.1371/journal.pone.0005473			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JH	19421324	Green Published, gold, Green Submitted			2022-12-25	WOS:000265837000008
J	Liu, TT; Lin, YH; Hung, CS; Liu, TJ; Chen, Y; Huang, YC; Tsai, TH; Wang, HH; Wang, DW; Wang, JK; Wang, YL; Lin, CH				Liu, Ting-Ting; Lin, You-Hsuan; Hung, Chia-Sui; Liu, Tian-Jiun; Chen, Yu; Huang, Yung-Ching; Tsai, Tsung-Heng; Wang, Huai-Hsien; Wang, Da-Wei; Wang, Juen-Kai; Wang, Yuh-Lin; Lin, Chi-Hung			A High Speed Detection Platform Based on Surface-Enhanced Raman Scattering for Monitoring Antibiotic-Induced Chemical Changes in Bacteria Cell Wall	PLOS ONE			English	Article							GROWTH-PHASE; SERS; DISCRIMINATION; NANOPARTICLES; SPECTRA	Rapid and accurate diagnosis for pathogens and their antibiotic susceptibility is critical for controlling bacterial infections. Conventional methods for determining bacterium's sensitivity to antibiotic depend mostly on measuring the change of microbial proliferation in response to the drug. Such "biological assay'' inevitably takes time, ranging from days for fast-growing bacteria to weeks for slow-growers. Here, a novel tool has been developed to detect the "chemical features'' of bacterial cell wall that enables rapid identification of drug resistant bacteria within hours. The surface-enhanced Raman scattering (SERS) technique based on our newly developed SERS-active substrate was applied to assess the fine structures of the bacterial cell wall. The SERS profiles recorded by such a platform are sensitive and stable, that could readily reflect different bacterial cell walls found in Gram-positive, Gram-negative, or mycobacteria groups. Moreover, characteristic changes in SERS profile were noticed in the drug-sensitive bacteria at the early period (i.e., similar to 1 hr) of antibiotic exposure, which could be used to differentiate them from the drug-resistant ones. The SERS-based diagnosis could be applied to a single bacterium. The high-speed SERS detection represents a novel approach for microbial diagnostics. The single-bacterium detection capability of SERS makes possible analyses directly on clinical specimen instead of pure cultured bacteria.			Liu, TT (corresponding author), Natl Yang Ming Univ, Div Res & Dev, Taipei 112, Taiwan.	jkwang@ntu.edu.tw; ylwnag@pub.iams.sinica.edu.tw; linch@ym.edu.tw	Wang, Juen-Kai/F-7932-2012; Wang, Yuh-Lin/F-7910-2012	Wang, Yuh-Lin/0000-0001-5920-3468; Tsai, Tsung-Heng/0000-0001-5211-2985				Efrima S, 1998, J PHYS CHEM B, V102, P5947, DOI 10.1021/jp9813903; Franklin T.J., 2005, BIOCH MOL BIOL ANTIM; GLASER L, 1977, J BACTERIOL, V130, P610, DOI 10.1128/JB.130.2.610-619.1977; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Jarvis RM, 2006, FARADAY DISCUSS, V132, P281, DOI 10.1039/b506413a; Jarvis RM, 2004, ANAL CHEM, V76, P40, DOI 10.1021/ac034689c; Jiang W, 2004, LANGMUIR, V20, P11433, DOI 10.1021/la049043+; Kahraman M, 2007, APPL SPECTROSC, V61, P479, DOI 10.1366/000370207780807731; Kennedy BJ, 1999, J PHYS CHEM B, V103, P3640, DOI 10.1021/jp984454i; KNEIP K, 2006, PHYS APPL TOPICS APP, V103, P1; Mothershed EA, 2006, CLIN CHIM ACTA, V363, P206, DOI 10.1016/j.cccn.2005.05.050; Naja G, 2007, ANALYST, V132, P679, DOI 10.1039/b701160a; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Premasiri WR, 2005, J PHYS CHEM B, V109, P312, DOI 10.1021/jp040442n; PREMASIRI WR, 2005, VIBRATIONAL FINGERPR; Rolain JM, 2004, J ANTIMICROB CHEMOTH, V54, P538, DOI 10.1093/jac/dkh324; Sengupta A, 2005, APPL SPECTROSC, V59, P1016, DOI 10.1366/0003702054615124; SFRIMA S, 2008, J RAMAN SPECTROSC, V40, P277; SHOCKMAN GD, 1958, J BIOL CHEM, V230, P961; Szeghalmi A, 2007, J PHYS CHEM B, V111, P12916, DOI 10.1021/jp075422a; Walker SL, 2005, APPL ENVIRON MICROB, V71, P3093, DOI 10.1128/AEM.71.6.3093-3099.2005; Wang HH, 2006, ADV MATER, V18, P491, DOI 10.1002/adma.200501875	22	143	151	2	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2009	4	5							e5470	10.1371/journal.pone.0005470	http://dx.doi.org/10.1371/journal.pone.0005470			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JH	19421405	Green Published, gold, Green Submitted			2022-12-25	WOS:000265837000006
J	Champion, CI; Kickhoefer, VA; Liu, GC; Moniz, RJ; Freed, AS; Bergmann, LL; Vaccari, D; Raval-Fernandes, S; Chan, AM; Rome, LH; Kelly, KA				Champion, Cheryl I.; Kickhoefer, Valerie A.; Liu, Guangchao; Moniz, Raymond J.; Freed, Amanda S.; Bergmann, Liisa L.; Vaccari, Dana; Raval-Fernandes, Sujna; Chan, Ann M.; Rome, Leonard H.; Kelly, Kathleen A.			A Vault Nanoparticle Vaccine Induces Protective Mucosal Immunity	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; NALP3 INFLAMMASOME; CHLAMYDIA INFECTION; ANTIBODY-RESPONSES; OVIDUCT PATHOLOGY; GENITAL-INFECTION; DENDRITIC CELLS; MOUSE MODEL; IMMUNIZATION; RESISTANCE	Background: Generation of robust cell-mediated immune responses at mucosal surfaces while reducing overall inflammation is a primary goal for vaccination. Here we report the use of a recombinant nanoparticle as a vaccine delivery platform against mucosal infections requiring T cell-mediated immunity for eradication. Methodology/Principal Findings: We encapsulated an immunogenic protein, the major outer membrane protein (MOMP) of Chlamydia muridarum, within hollow, vault nanocapsules (MOMP-vaults) that were engineered to bind IgG for enhanced immunity. Intranasal immunization (i.n) with MOMP-vaults induced anti-chlamydial immunity plus significantly attenuated bacterial burden following challenge infection. Vault immunization induced anti-chlamydial immune responses and inflammasome formation but did not activate toll-like receptors. Moreover, MOMP-vault immunization enhanced microbial eradication without the inflammation usually associated with adjuvants. Conclusions/Significance: Vault nanoparticles containing immunogenic proteins delivered to the respiratory tract by the i.n. route can act as "smart adjuvants'' for inducing protective immunity at distant mucosal surfaces while avoiding destructive inflammation.			Champion, CI (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA.	kkelly@mednet.ucla.edu	LIU, GUANGCHAO/F-2810-2011; Rome, Leonard H/E-8786-2016	Rome, Leonard H/0000-0002-1236-2063; Kickhoefer, Valerie/0000-0002-0048-0580	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI026328, R01AI026328, R01AI079004] Funding Source: NIH RePORTER; NIAID NIH HHS [AI026328, R01 AI026328, R21 AI026328] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; Darville T, 2003, J IMMUNOL, V171, P6187, DOI 10.4049/jimmunol.171.11.6187; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hansen J, 2008, J INFECT DIS, V198, P758, DOI 10.1086/590670; He Q, 2007, IMMUNOLOGY, V122, P28, DOI 10.1111/j.1365-2567.2007.02608.x; Heijnen IAFM, 1996, J CLIN INVEST, V97, P331, DOI 10.1172/JCI118420; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Ifere Godwin O., 2007, Journal of Microbiology Immunology and Infection, V40, P188; Izquierdo MA, 1996, AM J PATHOL, V148, P877; KEDERSHA NL, 1991, J CELL BIOL, V112, P225, DOI 10.1083/jcb.112.2.225; Kelly KA, 1996, INFECT IMMUN, V64, P4976, DOI 10.1128/IAI.64.12.4976-4983.1996; Kickhoefer VA, 2005, P NATL ACAD SCI USA, V102, P4348, DOI 10.1073/pnas.0500929102; Kickhoefer VA, 1999, J CELL BIOL, V146, P917, DOI 10.1083/jcb.146.5.917; Kickhoefer VA, 2001, J CELL BIOL, V152, P157, DOI 10.1083/jcb.152.1.157; Kickhoefer VA, 2009, ACS NANO, V3, P27, DOI 10.1021/nn800638x; Kong LB, 1999, STRUCT FOLD DES, V7, P371, DOI 10.1016/S0969-2126(99)80050-1; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Kowalski MP, 2007, SCIENCE, V317, P130, DOI 10.1126/science.1142311; Kozlowski PA, 2002, J IMMUNOL, V169, P566, DOI 10.4049/jimmunol.169.1.566; Lamkanfi M, 2007, J LEUKOCYTE BIOL, V82, P220, DOI 10.1189/jlb.1206756; Liu W, 2008, IMMUNOLOGY, V123, P290, DOI 10.1111/j.1365-2567.2007.02642.x; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Maxion HK, 2004, INFECT IMMUN, V72, P6330, DOI 10.1128/IAI.72.11.6330-6340.2004; Maxion HK, 2002, INFECT IMMUN, V70, P1538, DOI 10.1128/IAI.70.3.1538-1546.2002; MESTECKY J, 1987, J CLIN IMMUNOL, V7, P265, DOI 10.1007/BF00915547; Mikyas Y, 2004, J MOL BIOL, V344, P91, DOI 10.1016/j.jmb.2004.09.021; Moore T, 2003, J INFECT DIS, V188, P617, DOI 10.1086/377134; Murthy AK, 2007, INFECT IMMUN, V75, P666, DOI 10.1128/IAI.01280-06; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; O'Connell CM, 2007, J IMMUNOL, V179, P4027, DOI 10.4049/jimmunol.179.6.4027; Oliveira MLS, 2007, EXPERT REV VACCINES, V6, P419, DOI 10.1586/14760584.6.3.419; Pal S, 2006, VACCINE, V24, P766, DOI 10.1016/j.vaccine.2005.08.074; Pal S, 2005, INFECT IMMUN, V73, P8153, DOI 10.1128/IAI.73.12.8153-8160.2005; Poderycki MJ, 2006, BIOCHEMISTRY-US, V45, P12184, DOI 10.1021/bi0610552; RANK RG, 1999, MODELS IMMUNITY, P239; Stephen AG, 2001, J BIOL CHEM, V276, P23217, DOI 10.1074/jbc.C100226200; Tanaka H, 2009, SCIENCE, V323, P384, DOI 10.1126/science.1164975; *US DEP HHS, 2000, SEX TRANSM DIS SURV; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; *WHO DOHA, 2001, GLOB PREV INC SEL CU; Zuercher AW, 2002, J IMMUNOL, V168, P1796, DOI 10.4049/jimmunol.168.4.1796	43	89	99	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5409	10.1371/journal.pone.0005409	http://dx.doi.org/10.1371/journal.pone.0005409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404403	gold, Green Published			2022-12-25	WOS:000265614900020
J	Chaouche-Drider, N; Kaparakis, M; Karrar, A; Fernandez, MI; Carneiro, LAM; Viala, J; Boneca, IG; Moran, AP; Philpott, DJ; Ferrero, RL				Chaouche-Drider, Nadia; Kaparakis, Maria; Karrar, Abdulgader; Fernandez, Maria-Isabel; Carneiro, Letitia A. M.; Viala, Jerome; Boneca, Ivo Gomperts; Moran, Anthony P.; Philpott, Dana J.; Ferrero, Richard L.			A Commensal Helicobacter sp of the Rodent Intestinal Flora Activates TLR2 and NOD1 Responses in Epithelial Cells	PLOS ONE			English	Article								Helicobacter spp. represent a proportionately small but significant component of the normal intestinal microflora of animal hosts. Several of these intestinal Helicobacter spp. are known to induce colitis in mouse models, yet the mechanisms by which these bacteria induce intestinal inflammation are poorly understood. To address this question, we performed in vitro co-culture experiments with mouse and human epithelial cell lines stimulated with a selection of Helicobacter spp., including known pathogenic species as well as ones for which the pathogenic potential is less clear. Strikingly, a member of the normal microflora of rodents, Helicobacter muridarum, was found to be a particularly strong inducer of CXC chemokine (Cxcl1/KC, Cxcl2/MIP-2) responses in a murine intestinal epithelial cell line. Time-course studies revealed a biphasic pattern of chemokine responses in these cells, with H. muridarum lipopolysaccharide (LPS) mediating early (24-48 h) responses and live bacteria seeming to provoke later (48-72 h) responses. H. muridarum LPS per se was shown to induce CXC chemokine production in HEK293 cells stably expressing Toll-like receptor 2 (TLR2), but not in those expressing TLR4. In contrast, live H. muridarum bacteria were able to induce NF-kappa B reporter activity and CXC chemokine responses in TLR2-deficient HEK293 and in AGS epithelial cells. These responses were attenuated by transient transfection with a dominant negative construct to NOD1, and by stable expression of NOD1 siRNA, respectively. Thus, the data suggest that both TLR2 and NOD1 may be involved in innate immune sensing of H. muridarum by epithelial cells. This work identifies H. muridarum as a commensal bacterium with pathogenic potential and underscores the potential roles of ill-defined members of the normal flora in the initiation of inflammation in animal hosts. We suggest that H. muridarum may act as a confounding factor in colitis model studies in rodents.			Chaouche-Drider, N (corresponding author), Inst Pasteur, Unite Pathogenie Bacterienne Muqueuses, Paris, France.	Richard.Ferrero@med.monash.edu.au	Boneca, Ivo G/H-1677-2014; Carneiro, Leticia/T-8978-2019; Kaparakis-Liaskos, Maria/R-9321-2019; Kaparakis-Liaskos, Maria/I-6511-2013; Ferrero, Richard/U-1332-2017	Boneca, Ivo G/0000-0001-8122-509X; Carneiro, Leticia/0000-0001-5870-8288; Kaparakis-Liaskos, Maria/0000-0002-8964-4456; Kaparakis-Liaskos, Maria/0000-0002-8964-4456; Ferrero, Richard/0000-0001-6817-6211	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Bens M, 1996, AM J PHYSIOL-CELL PH, V270, pC1666, DOI 10.1152/ajpcell.1996.270.6.C1666; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Blumberg RS, 1999, CURR OPIN IMMUNOL, V11, P648, DOI 10.1016/S0952-7915(99)00032-1; Boutin SR, 2005, INFECT IMMUN, V73, P8449, DOI 10.1128/IAI.73.12.8449-8452.2005; Cahill RJ, 1997, INFECT IMMUN, V65, P3126, DOI 10.1128/IAI.65.8.3126-3131.1997; Cario E, 2002, AM J PATHOL, V160, P165, DOI 10.1016/S0002-9440(10)64360-X; Dieleman LA, 2000, INFECT IMMUN, V68, P5107, DOI 10.1128/IAI.68.9.5107-5113.2000; Fernandez MI, 2003, IMMUNITY, V18, P739, DOI 10.1016/S1074-7613(03)00122-5; FERRERO RL, 2001, HELICOBACTER PYLORI, P565; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Garhart CA, 2003, INFECT IMMUN, V71, P910, DOI 10.1128/IAI.71.2.910-921.2003; Ge ZM, 2008, MICROBES INFECT, V10, P726, DOI 10.1016/j.micinf.2008.03.011; Gewirtz AT, 2004, J INFECT DIS, V189, P1914, DOI 10.1086/386289; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Girardin SE, 2002, TRENDS MICROBIOL, V10, P193, DOI 10.1016/S0966-842X(02)02334-X; Hisamatsu T, 2003, J BIOL CHEM, V278, P32962, DOI 10.1074/jbc.M304355200; Hornef MW, 2002, J EXP MED, V195, P559, DOI 10.1084/jem.20011788; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Jiang HQ, 2002, GASTROENTEROLOGY, V122, P1346, DOI 10.1053/gast.2002.32959; Kullberg MC, 1998, INFECT IMMUN, V66, P5157, DOI 10.1128/IAI.66.11.5157-5166.1998; Kurt-Jones EA, 2004, J ENDOTOXIN RES, V10, P419, DOI 10.1179/096805104225006516; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; LEE A, 1993, ZBL BAKT-INT J MED M, V280, P38; Lee SK, 2003, MICROBES INFECT, V5, P1345, DOI 10.1016/j.micinf.2003.09.018; MacDonald TT, 2000, INFLAMM BOWEL DIS, V6, P116, DOI 10.1097/00054725-200005000-00008; Maggio-Price L, 2002, AM J PATHOL, V160, P739, DOI 10.1016/S0002-9440(10)64894-8; Mandell L, 2004, INFECT IMMUN, V72, P6446, DOI 10.1128/IAI.72.11.6446-6454.2004; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; MAZZUCCHELLI L, 1994, AM J PATHOL, V144, P997; MORAN AP, 1992, J BACTERIOL, V174, P1370, DOI 10.1128/jb.174.4.1370-1377.1992; Odenbreit S, 2001, CELL MICROBIOL, V3, P21, DOI 10.1046/j.1462-5822.2001.00088.x; Ohtsuka Y, 2001, GUT, V49, P526, DOI 10.1136/gut.49.4.526; Ortega-Cava CF, 2003, J IMMUNOL, V170, P3977, DOI 10.4049/jimmunol.170.8.3977; PHILLIPS MW, 1983, APPL ENVIRON MICROB, V45, P675, DOI 10.1128/AEM.45.2.675-683.1983; Philpott DJ, 2002, CELL MICROBIOL, V4, P285, DOI 10.1046/j.1462-5822.2002.00189.x; QUEIROZ DMM, 1992, LAB ANIM, V26, P288, DOI 10.1258/002367792780745760; Remick DG, 2001, AM J PATHOL, V159, P1149, DOI 10.1016/S0002-9440(10)61791-9; Savard Christopher E, 2002, BMC Gastroenterol, V2, P23, DOI 10.1186/1471-230X-2-23; Shomer NH, 1997, INFECT IMMUN, V65, P4858, DOI 10.1128/IAI.65.11.4858-4864.1997; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Sterzenbach T, 2007, INFECT IMMUN, V75, P2717, DOI 10.1128/IAI.01935-06; Triantafilou M, 2007, CELL MICROBIOL, V9, P2030, DOI 10.1111/j.1462-5822.2007.00935.x; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131	46	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5396	10.1371/journal.pone.0005396	http://dx.doi.org/10.1371/journal.pone.0005396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401779	Green Published, Green Submitted, gold			2022-12-25	WOS:000265601100024
J	Dey, D; Saxena, M; Paranjape, AN; Krishnan, V; Giraddi, R; Kumar, MV; Mukherjee, G; Rangarajan, A				Dey, Devaveena; Saxena, Meera; Paranjape, Anurag N.; Krishnan, Visalakshi; Giraddi, Rajashekhar; Kumar, M. Vijaya; Mukherjee, Geetashree; Rangarajan, Annapoorni			Phenotypic and Functional Characterization of Human Mammary Stem/Progenitor Cells in Long Term Culture	PLOS ONE			English	Article								Background: Cancer stem cells exhibit close resemblance to normal stem cells in phenotype as well as function. Hence, studying normal stem cell behavior is important in understanding cancer pathogenesis. It has recently been shown that human breast stem cells can be enriched in suspension cultures as mammospheres. However, little is known about the behavior of these cells in long-term cultures. Since extensive self-renewal potential is the hallmark of stem cells, we undertook a detailed phenotypic and functional characterization of human mammospheres over long-term passages. Methodology: Single cell suspensions derived from human breast 'organoids' were seeded in ultra low attachment plates in serum free media. Resulting primary mammospheres after a week (termed T1 mammospheres) were subjected to passaging every 7th day leading to the generation of T2, T3, and T4 mammospheres. Principal Findings: We show that primary mammospheres contain a distinct side-population (SP) that displays a CD24(low)/CD44(low) phenotype, but fails to generate mammospheres. Instead, the mammosphere-initiating potential rests within the CD44(high)/CD24(low) cells, in keeping with the phenotype of breast cancer-initiating cells. In serial sphere formation assays we find that even though primary (T1) mammospheres show telomerase activity and fourth passage T4 spheres contain label-retaining cells, they fail to initiate new mammospheres beyond T5. With increasing passages, mammospheres showed an increase in smaller sized spheres, reduction in proliferation potential and sphere forming efficiency, and increased differentiation towards the myoepithelial lineage. Significantly, staining for senescence-associated beta-galactosidase activity revealed a dramatic increase in the number of senescent cells with passage, which might in part explain the inability to continuously generate mammospheres in culture. Conclusions: Thus, the self-renewal potential of human breast stem cells is exhausted within five in vitro passages of mammospheres, suggesting the need for further improvisation in culture conditions for their long-term maintenance.			Dey, D (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	anu@mrdg.iisc.ernet.in	Paranjape, Anurag N./P-1255-2018	Paranjape, Anurag N./0000-0001-6119-0766; Saxena, Meera/0000-0002-4060-4218; Giraddi, Rajshekhar/0000-0001-9728-7674; Mukherjee, Geetashree/0000-0003-4954-0035				Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alvi AJ, 2003, BREAST CANCER RES, V5, DOI 10.1186/bcr563; Betts DH, 2008, BIOGERONTOLOGY, V9, P19, DOI 10.1007/s10522-007-9113-7; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Braun KM, 2004, J INVEST DERM SYMP P, V9, P196, DOI 10.1111/j.1087-0024.2004.09313.x; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Clarke RB, 2003, CELL PROLIFERAT, V36, P45, DOI 10.1046/j.1365-2184.36.s.1.5.x; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Deng GR, 1996, SCIENCE, V274, P2057, DOI 10.1126/science.274.5295.2057; DEOME KB, 1959, CANCER RES, V19, P515; Diallo R, 2001, J PATHOL, V193, P27, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH747>3.0.CO;2-H; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Ebbesen P, 2004, ACTA ONCOL, V43, P598, DOI 10.1080/02841860410020220; FLORES I, 2006, CURRENT OPINION CELL, V18, P1; Forsyth NR, 2003, AGING CELL, V2, P235, DOI 10.1046/j.1474-9728.2003.00057.x; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hiyama E, 1996, J NATL CANCER I, V88, P116, DOI 10.1093/jnci/88.2.116; KALIRAI H, 2006, J PATHOLOGY; Kim M, 2002, CLIN CANCER RES, V8, P22; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lakhani SR, 1999, J PATHOL, V189, P496, DOI 10.1002/(SICI)1096-9896(199912)189:4&lt;496::AID-PATH485&gt;3.0.CO;2-D; Lan L, 2007, J CLIN ENDOCR METAB, V92, P3681, DOI 10.1210/jc.2007-0281; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Lin TT, 2006, CELL RES, V16, P857, DOI 10.1038/sj.cr.7310107; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; LYNCH MD, 2006, BREAST CANC RES, V8; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Mouthon MA, 2006, J NEUROCHEM, V99, P807, DOI 10.1111/j.1471-4159.2006.04118.x; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shi XD, 2007, DEV BIOL, V312, P396, DOI 10.1016/j.ydbio.2007.09.042; Singh SK, 2003, CANCER RES, V63, P5821; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Smith GH, 2001, MICROSC RES TECHNIQ, V52, P190, DOI 10.1002/1097-0029(20010115)52:2<190::AID-JEMT1005>3.0.CO;2-O; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Stingl J, 2006, NATURE, P1; Storms RW, 2000, BLOOD, V96, P2125; Triel C, 2004, EXP CELL RES, V295, P79, DOI 10.1016/j.yexcr.2003.11.032; Tsai YC, 1996, CANCER RES, V56, P402; Uchida N, 1996, BLOOD, V88, P1297, DOI 10.1182/blood.V88.4.1297.bloodjournal8841297; Villadsen R, 2005, APMIS, V113, P903, DOI 10.1111/j.1600-0463.2005.apm_344.x; Wagner M, 2000, EXP GERONTOL, V35, P729, DOI 10.1016/S0531-5565(00)00141-8; Woodward WA, 2005, J CELL SCI, V118, P3585, DOI 10.1242/jcs.02532; Wright WE, 2001, CURR OPIN GENET DEV, V11, P98, DOI 10.1016/S0959-437X(00)00163-5; Zipori D, 2004, NAT REV GENET, V5, P873, DOI 10.1038/nrg1475	54	86	99	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5329	10.1371/journal.pone.0005329	http://dx.doi.org/10.1371/journal.pone.0005329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390630	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000265514400015
J	Gupta, S; Salam, N; Srivastava, V; Singla, R; Behera, D; Khayyam, KU; Korde, R; Malhotra, P; Saxena, R; Natarajan, K				Gupta, Shashank; Salam, Nasir; Srivastava, Varsha; Singla, Rupak; Behera, Digamber; Khayyam, Khalid U.; Korde, Reshma; Malhotra, Pawan; Saxena, Rajiv; Natarajan, Krishnamurthy			Voltage Gated Calcium Channels Negatively Regulate Protective Immunity to Mycobacterium tuberculosis	PLOS ONE			English	Article							DENDRITIC CELLS; PHAGOSOME MATURATION; GENE-EXPRESSION; ACTIVATION; RESPONSES; ANTIGEN; DIFFERENTIATION; MACROPHAGES; INHIBITION; IMMUNOLOGY	Mycobacterium tuberculosis modulates levels and activity of key intracellular second messengers to evade protective immune responses. Calcium release from voltage gated calcium channels (VGCC) regulates immune responses to pathogens. In this study, we investigated the roles of VGCC in regulating protective immunity to mycobacteria in vitro and in vivo. Inhibiting L-type or R-type VGCC in dendritic cells (DCs) either using antibodies or by siRNA increased calcium influx in an inositol 1,4,5-phosphate and calcium release calcium activated channel dependent mechanism that resulted in increased expression of genes favoring pro-inflammatory responses. Further, VGCC-blocked DCs activated T cells that in turn mediated killing of M. tuberculosis inside macrophages. Likewise, inhibiting VGCC in infected macrophages and PBMCs induced calcium influx, upregulated the expression of pro-inflammatory genes and resulted in enhanced killing of intracellular M. tuberculosis. Importantly, compared to healthy controls, PBMCs of tuberculosis patients expressed higher levels of both VGCC, which were significantly reduced following chemotherapy. Finally, blocking VGCC in vivo in M. tuberculosis infected mice using specific antibodies increased intracellular calcium and significantly reduced bacterial loads. These results indicate that L-type and R-type VGCC play a negative role in M. tuberculosis infection by regulating calcium mobilization in cells that determine protective immunity.			Gupta, S (corresponding author), Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi, India.	natrajan@icgeb.res.in	Salam, Nasir/C-8049-2015; Tuluc, Petronel/C-2527-2011; Gupta, Shashank/E-7382-2016	Salam, Nasir/0000-0001-9133-1304; Gupta, Shashank/0000-0003-0445-5195				Balkhi MY, 2004, J INFECT DIS, V189, P1598, DOI 10.1086/383328; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Berggren PO, 2004, CELL, V119, P273, DOI 10.1016/j.cell.2004.09.033; BERRIDGE MJ, 1993, NATURE, V365, P388, DOI 10.1038/365388a0; Brodin P, 2005, J BIOL CHEM, V280, P33953, DOI 10.1074/jbc.M503515200; CANTRELL D, 1993, ANNU REV IMMUNOL, V14, P259; Cattaruzza M, 2000, BRIT J PHARMACOL, V129, P1155, DOI 10.1038/sj.bjp.0703192; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Foote S, 1999, NAT GENET, V21, P345, DOI 10.1038/7663; Henderson RA, 1997, J IMMUNOL, V159, P635; Hidalgo P, 2006, J BIOL CHEM, V281, P24104, DOI 10.1074/jbc.M605930200; Hsu SF, 2001, J IMMUNOL, V166, P6126, DOI 10.4049/jimmunol.166.10.6126; Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043; Kaufmann SHE, 2000, NAT MED, V6, P955, DOI 10.1038/79631; Kincaid EZ, 2003, J IMMUNOL, V171, P2042, DOI 10.4049/jimmunol.171.4.2042; Latchumanan VK, 2005, TUBERCULOSIS, V85, P377, DOI 10.1016/j.tube.2005.08.007; Latchumanan VK, 2002, J IMMUNOL, V169, P6856, DOI 10.4049/jimmunol.169.12.6856; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Ma XJ, 1997, J BIOL CHEM, V272, P10389; Malik ZA, 2003, J IMMUNOL, V170, P2811, DOI 10.4049/jimmunol.170.6.2811; Matza D, 2008, IMMUNITY, V28, P64, DOI 10.1016/j.immuni.2007.11.020; Mu TW, 2008, PLOS BIOL, V6, P253, DOI 10.1371/journal.pbio.0060026; Noble A, 2000, J IMMUNOL, V164, P1807, DOI 10.4049/jimmunol.164.4.1807; Pai RK, 2004, INFECT IMMUN, V72, P6603, DOI 10.1128/IAI.72.11.6603-6614.2004; Poggi A, 1998, J BIOL CHEM, V273, P7205, DOI 10.1074/jbc.273.13.7205; Premkumar DRD, 2000, J APPL PHYSIOL, V88, P1898, DOI 10.1152/jappl.2000.88.5.1898; Rajadhyaksha A, 1999, J NEUROSCI, V19, P6348; Salam N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002869; Singhal A, 2007, INFECT IMMUN, V75, P2500, DOI 10.1128/IAI.01743-06; Sinha A, 2006, J IMMUNOL, V177, P468, DOI 10.4049/jimmunol.177.1.468; SNUTCH TP, 2004, VOLTAGE GATED CALCIU, P1; Sousa CRE, 2001, IMMUNITY, V14, P495; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Tantral L, 2004, CELL BIOCHEM FUNCT, V22, P35, DOI 10.1002/cbf.1050; Tian T, 2005, J IMMUNOL, V175, P3268, DOI 10.4049/jimmunol.175.5.3268; Vergne I, 2003, J EXP MED, V198, P653, DOI 10.1084/jem.20030527; Verhasselt V, 1999, J IMMUNOL, V162, P2569; *WHO, 2002, WHO FACT SHEET; Wieland H, 2006, FEMS IMMUNOL MED MIC, V47, P296, DOI 10.1111/j.1574-695X.2006.00092.x	42	42	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5305	10.1371/journal.pone.0005305	http://dx.doi.org/10.1371/journal.pone.0005305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390594	Green Published, Green Submitted, gold			2022-12-25	WOS:000265514200016
J	Banks, G; Kemenes, I; Schofield, M; O'Shea, M; Korneev, SA				Banks, Gareth; Kemenes, Ildiko; Schofield, Michael; O'Shea, Michael; Korneev, Sergei A.			Acetylcholine binding protein of mollusks is unlikely to act as a regulator of cholinergic neurotransmission at neurite-neurite synaptic sites in vivo	FASEB JOURNAL			English	Article						nonsynaptic signaling; glial cells; snail	CENTRAL-NERVOUS-SYSTEM; SNAIL LYMNAEA-STAGNALIS; CRYSTAL-STRUCTURE; RELEASE; NEURONS; ACHBP; INNERVATION; RECEPTORS; REVEALS; COMPLEX	A population of glial cells in the central nervous system of the gastropod mollusk Lymnaea stagnalis produces a soluble protein that specifically binds acetylcholine. This protein is named the acetylcholine binding protein (AChBP). Experiments performed in vitro indicated that AChBP inactivates released acetylcholine at cholinergic synapses. On the basis of these observations, a similar in vivo role for AChBP was hypothesized. To fulfill this function, AChBP-expressing glia ought to be located in close proximity to cholinergic synapses in vivo. To examine this, we have analyzed the cellular and subcellular expression of AChBP in the intact CNS. Using a variety of molecular techniques, we demonstrate here that AChBP expression is confined to a subpopulation of glial cells located within the peripheral zone of each of the ganglia constituting the CNS. This zone contains the cell bodies of neurons, but few synapses. Conversely, glial cells that do not express the AChBP are predominantly located in the synapse-rich central neuropile zone but are rare in the cell body zone. Thus, our findings are not compatible with the previous conclusions drawn from in vitro studies and suggest that AChBP functions in vivo as a regulator of nonsynaptic cholinergic transmission.-Banks, G., Kemenes, I., Schofield, M., O'Shea, M., Korneev, S. A. Acetylcholine binding protein of mollusks is unlikely to act as a regulator of cholinergic neurotransmission at neurite-neurite synaptic sites in vivo. FASEB J. 23, 3030-3036 (2009). www.fasebj.org	[Banks, Gareth; Kemenes, Ildiko; Schofield, Michael; O'Shea, Michael; Korneev, Sergei A.] Univ Sussex, Sussex Ctr Neurosci, De Biol & Environm Sci, Sch Life Sci, Brighton BN1 9QG, E Sussex, England	University of Sussex	Korneev, SA (corresponding author), Univ Sussex, Sussex Ctr Neurosci, De Biol & Environm Sci, Sch Life Sci, Brighton BN1 9QG, E Sussex, England.	s.korneev@sussex.ac.uk		Kemenes, Ildiko/0000-0002-8722-8766; Banks, Gareth/0000-0002-8647-667X	UK Biotechnology and Biological Sciences Research Council (BBSRC)	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a grant from the UK Biotechnology and Biological Sciences Research Council (BBSRC).	BOCHAROVA LS, 1976, BRAIN RES, V101, P185, DOI 10.1016/0006-8993(76)90262-6; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; BUMA P, 1986, NEUROSCIENCE, V17, P867, DOI 10.1016/0306-4522(86)90051-5; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; CHASE R, 1992, J COMP NEUROL, V318, P93, DOI 10.1002/cne.903180107; ELEKES K, 1993, J NEUROCYTOL, V22, P1, DOI 10.1007/BF01183971; ELLIOTT CJH, 1992, PHILOS T ROY SOC B, V336, P167, DOI 10.1098/rstb.1992.0054; Granvogl B, 2007, PROTEOMICS, V7, P642, DOI 10.1002/pmic.200600607; KERKHOVEN RM, 1991, BRAIN RES, V565, P8, DOI 10.1016/0006-8993(91)91730-O; Korneev SA, 1998, J NEUROBIOL, V35, P65, DOI 10.1002/(SICI)1097-4695(199804)35:1<65::AID-NEU6>3.0.CO;2-9; Magoski NS, 1997, J NEUROBIOL, V33, P247, DOI 10.1002/(SICI)1097-4695(199709)33:3<247::AID-NEU4>3.3.CO;2-F; Nagy T, 2000, J NEUROCYTOL, V29, P43, DOI 10.1023/A:1007112130414; SCHMIDT ED, 1987, NEUROSCIENCE, V20, P247, DOI 10.1016/0306-4522(87)90017-0; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Smit AB, 2006, J MOL NEUROSCI, V30, P9, DOI 10.1385/JMN:30:1:9; van Nierop P, 2006, J BIOL CHEM, V281, P1680, DOI 10.1074/jbc.M508571200; VIZI ES, 1983, NEUROSCIENCE, V10, P967, DOI 10.1016/0306-4522(83)90234-8; Vulfius CA, 2005, NEUROSCI LETT, V373, P232, DOI 10.1016/j.neulet.2004.10.010; VULFIUS EA, 1967, NATURE, V216, P400, DOI 10.1038/216400a0	21	8	8	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					3030	3036		10.1096/fj.08-117135	http://dx.doi.org/10.1096/fj.08-117135			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19395478				2022-12-25	WOS:000270241000025
J	Sorg, H; Krueger, C; Schulz, T; Menger, MD; Schmitz, F; Vollmar, B				Sorg, Heiko; Krueger, Christian; Schulz, Torsten; Menger, Michael D.; Schmitz, Frank; Vollmar, Brigitte			Effects of erythropoietin in skin wound healing are dose related	FASEB JOURNAL			English	Article						microcirculation; cell migration; apoptosis; angiogenesis; epithelialization; pericytes	MICE OVEREXPRESSING ERYTHROPOIETIN; MYOCARDIAL-INFARCTION; STIMULATES ANGIOGENESIS; IMPROVES ANGIOGENESIS; GRANULATION-TISSUE; DARBEPOETIN-ALPHA; APOPTOSIS; INJURY; INFLAMMATION; PROTECTS	The hematopoietic growth factor erythropoietin (EPO) attracts attention due to its all-tissue-protective pleiotropic properties. We studied the effect of EPO on dermal regeneration using intravital microscopy in a model of full dermal thickness wounds in the skin-fold chamber of hairless mice. Animals received repetitive low doses or high doses of EPO (RLD-EPO or RHD-EPO) or a single high dose of EPO (SHD-EPO). SHD-EPO accelerated wound epithelialization, reduced wound cellularity, and induced maturation of newly formed microvascular networks. In contrast, RHD-EPO impaired the healing process, as indicated by delayed epithelialization, high wound cellularity, and lack of maturation of microvascular networks. Also, RHD-EPO caused an excessive erythrocyte mass and rheological malfunction, further deteriorating vessel and tissue maturation. Moreover, RHD-EPO altered fibroblast and keratinocyte migration in vitro, while both cell types exposed to RLD-EPO, and, in particular, to SHD-EPO showed accelerated wound scratch closure. In summary, our data show that a single application of a high dose of EPO accelerates and improves skin wound healing.-Sorg, H., Krueger, C., Schulz, T., Menger, M. D., Schmitz, F., Vollmar, B. Effects of erythropoietin in skin wound healing are dose related. FASEB J. 23, 3049-3058 ( 2009). www.fasebj.org	[Sorg, Heiko; Krueger, Christian; Schulz, Torsten; Vollmar, Brigitte] Univ Rostock, Inst Expt Surg, D-18055 Rostock, Germany; [Menger, Michael D.] Univ Saarland, Inst Clin & Expt Surg, D-6650 Homburg, Germany; [Schmitz, Frank] Univ Saarland, Inst Anat, D-6650 Homburg, Germany	University of Rostock; Saarland University; Saarland University	Vollmar, B (corresponding author), Univ Rostock, Inst Expt Surg, Schillingallee 69A, D-18055 Rostock, Germany.	brigitte.vollmar@med.uni-rostock.de		Sorg, Heiko/0000-0001-6827-0857	Deutsche Forschungsgemeinschaft; Bonn-Bad Godesberg [Vo 450/10-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bonn-Bad Godesberg	We thank Berit Blendow, Doris Butzlaff, Dorothea Frenz, and Maren Nerowski ( Institute for Experimental Surgery, University of Rostock) for excellent technical assistance; Karin Gerber and Kathrin Sievert-Kuchenmeister ( Institute for Experimental Surgery, University of Rostock) for help with the animal care; Christina Marx ( Institute for Clinical and Experimental Surgery, University of Saarland) for assistance in sample preparation for transmission electron microscopy; Gerlinde Kuhnreich ( Institute for Anatomy, University of Saarland) for making ultrathin sections; and Marika Fleischer ( Language Center, University of Rostock) for critical editing of the manuscript. This work was supported by a grant from the Deutsche Forschungsgemeinschaft, Bonn-Bad Godesberg (Vo 450/10-1). We declare no conflicts of interest.	Arcasoy MO, 2008, BRIT J HAEMATOL, V141, P14, DOI 10.1111/j.1365-2141.2008.07014.x; Ashley RA, 2002, PEDIATR RES, V51, P472, DOI 10.1203/00006450-200204000-00012; Au K, 2007, PLAST RECONSTR SURG, V120, P91, DOI 10.1097/01.prs.0000263363.28474.e9; Ben-Dor I, 2007, CARDIOVASC DRUG THER, V21, P339, DOI 10.1007/s10557-007-6049-8; Blann AD, 2001, THROMB RES, V101, P321, DOI 10.1016/S0049-3848(00)00419-9; Bor-Kucukatay M, 2000, BRIT J HAEMATOL, V110, P82, DOI 10.1046/j.1365-2141.2000.02150.x; Bordel R, 2005, CELL TISSUE RES, V320, P427, DOI 10.1007/s00441-005-1078-8; Buemi M, 2004, SHOCK, V22, P169, DOI 10.1097/01.shk.0000133591.47776.bd; Chernyavsky AI, 2007, EXP CELL RES, V313, P3542, DOI 10.1016/j.yexcr.2007.07.011; Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715; Contaldo C, 2007, AM J PHYSIOL-HEART C, V293, pH274, DOI 10.1152/ajpheart.01031.2006; Desmouliere A, 1997, INT J BIOCHEM CELL B, V29, P19, DOI 10.1016/S1357-2725(96)00117-3; DESMOULIERE A, 1995, AM J PATHOL, V146, P56; DYSON M, 1992, J INVEST DERMATOL, V99, P729, DOI 10.1111/1523-1747.ep12614460; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Fisher JW, 2003, EXP BIOL MED, V228, P1; Furlani D, 2008, TRANSPL P, V40, P962, DOI 10.1016/j.transproceed.2008.03.033; Galeano M, 2006, CRIT CARE MED, V34, P1139, DOI 10.1097/01.CCM.0000206468.18653.EC; Galeano M, 2004, DIABETES, V53, P2509, DOI 10.2337/diabetes.53.9.2509; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Ghezzi P, 2004, CELL DEATH DIFFER, V11, pS37, DOI 10.1038/sj.cdd.4401450; Greenhalgh DG, 1998, INT J BIOCHEM CELL B, V30, P1019, DOI 10.1016/S1357-2725(98)00058-2; Haroon ZSA, 2003, AM J PATHOL, V163, P993, DOI 10.1016/S0002-9440(10)63459-1; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Heinicke K, 2006, AM J PHYSIOL-REG I, V291, pR947, DOI 10.1152/ajpregu.00152.2006; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hosokawa R, 2005, J INVEST DERMATOL, V125, P1302, DOI 10.1111/j.0022-202X.2005.23963.x; Imamura R, 2008, CELL TRANSPLANT, V17, P135, DOI 10.3727/000000008783907044; Jelkmann W, 2004, ANN HEMATOL, V83, P673, DOI 10.1007/s00277-004-0911-6; Jelkmann W, 2004, INTERNAL MED, V43, P649, DOI 10.2169/internalmedicine.43.649; Kwaan HC, 2003, SEMIN THROMB HEMOST, V29, P451; Le Minh K, 2007, AM J PATHOL, V170, P1954, DOI 10.2353/ajpath.2007.061056; Lindenblatt N, 2007, ARTERIOSCL THROM VAS, V27, P1191, DOI 10.1161/ATVBAHA.107.141580; Lipsic E, 2004, J CARDIOVASC PHARM, V44, P473, DOI 10.1097/01.fjc.0000140209.04675.c3; Lipsic E, 2008, EUR J HEART FAIL, V10, P22, DOI 10.1016/j.ejheart.2007.10.008; Luster AD, 1998, P ASSOC AM PHYSICIAN, V110, P183; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Moon C, 2006, CARDIOVASC DRUG THER, V20, P245, DOI 10.1007/s10557-006-0080-z; Muller-Ehmsen J, 2006, AM J PHYSIOL-HEART C, V290, pH331, DOI 10.1152/ajpheart.01269.2004; Papetti M, 2002, AM J PHYSIOL-CELL PH, V282, pC947, DOI 10.1152/ajpcell.00389.2001; Park SH, 2007, J AM SOC NEPHROL, V18, P1497, DOI 10.1681/ASN.2005080866; Quaschning T, 2002, FASEB J, V16, P259, DOI 10.1096/fj.02-0296fje; Ribatti D, 2003, EUR J CLIN INVEST, V33, P891, DOI 10.1046/j.1365-2362.2003.01245.x; Rico RM, 2002, J SURG RES, V102, P193, DOI 10.1006/jsre.2001.6316; ROGER SD, 1993, CLIN NEPHROL, V39, P103; Savino R, 2004, CELL DEATH DIFFER, V11, pS2, DOI 10.1038/sj.cdd.4401469; Sayan H, 2006, J INVEST SURG, V19, P163, DOI 10.1080/08941930600674694; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Sorg H, 2007, J ANAT, V211, P810, DOI 10.1111/j.1469-7580.2007.00822.x; Spiess BD, 1998, J THORAC CARDIOV SUR, V116, P460, DOI 10.1016/S0022-5223(98)70012-1; STAIANOCOICO L, 2000, OSTOMY WOUND MANAG S, V46, P85; Taylor JE, 1996, INT ANGIOL, V15, P33; Tobu M, 2004, CLIN APPL THROMB-HEM, V10, P225, DOI 10.1177/107602960401000304; Tredget EE, 1997, SURG CLIN N AM, V77, P701, DOI 10.1016/S0039-6109(05)70576-4; Vajkoczy Peter, 1999, Neoplasia (New York), V1, P31, DOI 10.1038/sj.neo.7900006; Vesey DA, 2004, NEPHROL DIAL TRANSPL, V19, P348, DOI 10.1093/ndt/gfg547; Wassermann RJ, 1998, J SURG RES, V75, P74, DOI 10.1006/jsre.1998.5267; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wiessner C, 2001, J CEREBR BLOOD F MET, V21, P857, DOI 10.1097/00004647-200107000-00011; Yamasaki K, 1998, J CLIN INVEST, V101, P967, DOI 10.1172/JCI2067	60	60	62	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					3049	3058		10.1096/fj.08-109991	http://dx.doi.org/10.1096/fj.08-109991			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19403513				2022-12-25	WOS:000270241000027
J	Bezaire, V; Mairal, A; Ribet, C; Lefort, C; Girousse, A; Jocken, J; Laurencikiene, J; Anesia, R; Rodriguez, AM; Ryden, M; Stenson, BM; Dani, C; Ailhaud, G; Arner, P; Langin, D				Bezaire, Veronic; Mairal, Aline; Ribet, Carole; Lefort, Corinne; Girousse, Amandine; Jocken, Johan; Laurencikiene, Jurga; Anesia, Rodica; Rodriguez, Anne-Marie; Ryden, Mikael; Stenson, Britta M.; Dani, Christian; Ailhaud, Gerard; Arner, Peter; Langin, Dominique			Contribution of Adipose Triglyceride Lipase and Hormone-sensitive Lipase to Lipolysis in hMADS Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN WHITE ADIPOCYTES; STIMULATED LIPOLYSIS; PROTEIN TRAFFICKING; TISSUE LIPOLYSIS; LIPID DROPLETS; FATTY-ACIDS; EXPRESSION; OBESITY; TRIACYLGLYCEROL; VITRO	Lipolysis is the catabolic pathway by which triglycerides are hydrolyzed into fatty acids. Adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) have the capacity to hydrolyze in vitro the first ester bond of triglycerides, but their respective contributions to whole cell lipolysis in human adipocytes is unclear. Here, we have investigated the roles of HSL, ATGL, and its coactivator CGI-58 in basal and forskolin-stimulated lipolysis in a human white adipocyte model, the hMADS cells. The hMADS adipocytes express the various components of fatty acid metabolism and show lipolytic capacity similar to primary cultured adipocytes. We show that lipolysis and fatty acid esterification are tightly coupled except in conditions of stimulated lipolysis. Immunocytochemistry experiments revealed that acute forskolin treatment promotes HSL translocation from the cytosol to small lipid droplets and redistribution of ATGL from the cytosol and large lipid droplets to small lipid droplets, resulting in enriched colocalization of the two lipases. HSL or ATGL overexpression resulted in increased triglyceride-specific hydrolase capacity, but only ATGL overexpression increased whole cell lipolysis. HSL silencing had no effect on basal lipolysis and only partially reduced forskolin-stimulated lipolysis. Conversely, silencing of ATGL or CGI-58 significantly reduced basal lipolysis and essentially abolished forskolin-stimulated lipolysis. Altogether, these results suggest that ATGL/CGI-58 acts independently of HSL and precedes its action in the sequential hydrolysis of triglycerides in human hMADS adipocytes.	[Bezaire, Veronic; Mairal, Aline; Ribet, Carole; Lefort, Corinne; Girousse, Amandine; Anesia, Rodica; Langin, Dominique] Equipe 4, U858, INSERM, Lab Rech Obesites,I2MR, F-31432 Toulouse 4, France; [Bezaire, Veronic; Mairal, Aline; Ribet, Carole; Lefort, Corinne; Girousse, Amandine; Anesia, Rodica; Langin, Dominique] Univ Toulouse, UPS, Inst Med Mol Rangueil, IFR150, F-31432 Toulouse, France; [Jocken, Johan; Laurencikiene, Jurga; Ryden, Mikael; Stenson, Britta M.; Arner, Peter] Karolinska Univ Hosp, Karolinska Inst, Dept Med, S-14186 Huddinge, Sweden; [Rodriguez, Anne-Marie] Fac Med, INSERM, U955, F-94010 Creteil, France; [Dani, Christian; Ailhaud, Gerard] Univ Nice Sophia Antipolis, Inst Signalisat Biol Dev & Canc, F-06100 Nice, France; [Langin, Dominique] CHU Toulouse, Inst Federatif Biol Purpan, Biochim Lab, F-31059 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Karolinska Institutet; Karolinska University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universite Cote d'Azur; CHU de Toulouse	Langin, D (corresponding author), Equipe 4, U858, INSERM, Lab Rech Obesites,I2MR, 1 Ave Jean Poulhes,BP 84225, F-31432 Toulouse 4, France.	dominique.langin@inserm.fr	girousse, amandine/GYD-3740-2022; Rodriguez, Anne-Marie/M-1190-2018; DANI, Christian/G-3639-2014	girousse, amandine/0000-0001-6142-4710; Rodriguez, Anne-Marie/0000-0001-5557-8975; DANI, Christian/0000-0003-3228-0230; Langin, Dominique/0000-0002-2669-7825; Ailhaud, Gerard/0000-0003-0596-2906; Arner, Peter/0000-0002-6208-6220; , Jurga/0000-0002-7032-2924	INSERM; YSL BEAUTE/BRI; Swedish Research Council; Commission of the European Communities Integrated Project HEPADIP [LSHM-CT-2005-018734]; ADAPT Contract [HEALTH-F2-2008-201100]; Natural Sciences and Engineering Research Council of Canada; Netherlands Organization for Scientific Research Grant NWO Rubicon [820.07.025]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); YSL BEAUTE/BRI; Swedish Research Council(Swedish Research CouncilEuropean Commission); Commission of the European Communities Integrated Project HEPADIP; ADAPT Contract; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Netherlands Organization for Scientific Research Grant NWO Rubicon(Netherlands Organization for Scientific Research (NWO))	This work was supported by INSERM, YSL BEAUTE/BRI, the Swedish Research Council, and the Commission of the European Communities Integrated Project HEPADIP Contract LSHM-CT-2005-018734 and Collaborative Project ADAPT Contract HEALTH-F2-2008-201100. This work was also supported by funds from the Natural Sciences and Engineering Research Council of Canada ( to V. B.) and The Netherlands Organization for Scientific Research Grant NWO Rubicon 820.07.025 ( to J. J.).	Belfrage P, 1978, Adv Exp Med Biol, V101, P113; Berndt J, 2008, EXP CLIN ENDOCR DIAB, V116, P203, DOI 10.1055/s-2007-993148; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bougneres P, 1997, J CLIN INVEST, V99, P2568, DOI 10.1172/JCI119444; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; EDENS NK, 1990, J LIPID RES, V31, P1351; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; FREDRIKSON G, 1986, BIOCHIM BIOPHYS ACTA, V876, P288, DOI 10.1016/0005-2760(86)90286-9; Ghosh AK, 2008, J BIOL CHEM, V283, P24525, DOI 10.1074/jbc.M801783200; Granneman JG, 2008, TRENDS ENDOCRIN MET, V19, P3, DOI 10.1016/j.tem.2007.10.006; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hellstrom L, 1996, DIABETOLOGIA, V39, P921; Holm C, 2001, ADIPOSE TISSUE PROTO, P97; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; JENSEN MD, 1989, J CLIN INVEST, V83, P1168, DOI 10.1172/JCI113997; Jocken JWE, 2008, DIABETOLOGIA, V51, P320, DOI 10.1007/s00125-007-0866-y; Jocken JWE, 2007, J CLIN ENDOCR METAB, V92, P2292, DOI 10.1210/jc.2006-1318; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; KHOO JC, 1974, J CLIN INVEST, V53, P1124, DOI 10.1172/JCI107650; Langin D, 2005, DIABETES, V54, P3190, DOI 10.2337/diabetes.54.11.3190; Langin D, 2006, TRENDS ENDOCRIN MET, V17, P314, DOI 10.1016/j.tem.2006.08.003; Large V, 1999, J LIPID RES, V40, P2059; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Lowe DB, 2004, BIOORG MED CHEM LETT, V14, P3155, DOI 10.1016/j.bmcl.2004.04.015; Lucas S, 2003, J LIPID RES, V44, P154, DOI 10.1194/jlr.M200250-JLR200; Mairal A, 2006, DIABETOLOGIA, V49, P1629, DOI 10.1007/s00125-006-0272-x; Mazzucotelli A, 2007, DIABETES, V56, P2467, DOI 10.2337/db06-1465; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Miyoshi H, 2006, J BIOL CHEM, V281, P15837, DOI 10.1074/jbc.M601097200; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Raclot T, 2001, BBA-MOL CELL BIOL L, V1532, P88, DOI 10.1016/S1388-1981(01)00119-6; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; Rodriguez AM, 2004, BIOCHEM BIOPH RES CO, V315, P255, DOI 10.1016/j.bbrc.2004.01.053; Schweiger M, 2008, J BIOL CHEM, V283, P17211, DOI 10.1074/jbc.M710566200; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Sengenes C, 2003, J BIOL CHEM, V278, P48617, DOI 10.1074/jbc.M303713200; STRALFORS P, 1985, FEBS LETT, V180, P280, DOI 10.1016/0014-5793(85)81086-3; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; VAUGHAN M, 1962, J BIOL CHEM, V237, P3354; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang MH, 2006, CHEM BIOL, V13, P1019, DOI 10.1016/j.chembiol.2006.09.010; Wang T, 2003, OBES RES, V11, P880, DOI 10.1038/oby.2003.121; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	50	155	158	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18282	18291		10.1074/jbc.M109.008631	http://dx.doi.org/10.1074/jbc.M109.008631			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19433586	Green Published, hybrid			2022-12-25	WOS:000267712400041
J	Stanisic, V; Malovannaya, A; Qin, J; Lonard, DM; O'Malley, BW				Stanisic, Vladimir; Malovannaya, Anna; Qin, Jun; Lonard, David M.; O'Malley, Bert W.			OTU Domain-containing Ubiquitin Aldehyde-binding Protein 1 (OTUB1) Deubiquitinates Estrogen Receptor (ER) alpha and Affects ER alpha Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME; DEGRADATION; COACTIVATOR; TURNOVER; COREGULATORS; MECHANISMS; PATHWAYS; ENZYMES; H2A	Estrogen receptor (ER)alpha is an essential component in human physiology and is a key factor involved in the development of breast and endometrial cancers. ER alpha protein levels and transcriptional activity are tightly controlled by the ubiquitin proteasome system. Deubiquitinating enzymes, a class of proteases capable of removing ubiquitin from proteins, are increasingly being seen as key modulators of the ubiquitin proteasome system, regulating protein stability and other functions by countering the actions of ubiquitin ligases. Using mass spectrometry analysis of an ER alpha protein complex, we identified OTU domain containing ubiquitin aldehyde-binding protein 1 (OTUB1) as a novel ER alpha-interacting protein capable of deubiquitinating ER alpha in cells and in vitro. We show that OTUB1 negatively regulates transcription mediated by ER alpha in transient reporter gene assays and transcription mediated by endogenous ER alpha in Ishikawa endometrial cancer cells. We also show that OTUB1 regulates the availability and functional activity of ER alpha in Ishikawa cells by affecting the transcription of the ER alpha gene and by stabilizing the ER alpha protein in the chromatin.	[Stanisic, Vladimir; Malovannaya, Anna; Qin, Jun; Lonard, David M.; O'Malley, Bert W.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	O'Malley, BW (corresponding author), 1 Baylor Plaza,BCM502, Houston, TX 77030 USA.	berto@bcm.tmc.edu			National Institutes of Health [HD08818, HD07857]; Welch Foundation [FY09-Q1521]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD007857] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD007857] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health Grants HD08818 and HD07857 and Welch Foundation Grant FY09-Q1521.	Alarid ET, 2006, MOL ENDOCRINOL, V20, P1972, DOI 10.1210/me.2005-0481; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Anderson C, 2005, J NEUROCHEM, V95, P724, DOI 10.1111/j.1471-4159.2005.03409.x; Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Berry NB, 2008, MOL ENDOCRINOL, V22, P1535, DOI 10.1210/me.2007-0449; Callige Mathilde, 2006, Nucl Recept Signal, V4, pe004; Dahlman-Wright K, 2006, PHARMACOL REV, V58, P773, DOI 10.1124/pr.58.4.8; Dhananjayan SC, 2005, ESSAYS BIOCHEM, V41, P69, DOI 10.1042/EB0410069; Eakin CM, 2007, P NATL ACAD SCI USA, V104, P5794, DOI 10.1073/pnas.0610887104; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Fan MY, 2005, MOL ENDOCRINOL, V19, P2901, DOI 10.1210/me.2005-0111; Faus H, 2005, MOL CELL ENDOCRINOL, V245, P138, DOI 10.1016/j.mce.2005.11.011; Glass CK, 2000, GENE DEV, V14, P121; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Herynk MH, 2004, ENDOCR REV, V25, P869, DOI 10.1210/er.2003-0010; Kim JH, 2003, J BIOCHEM, V134, P9, DOI 10.1093/jb/mvg107; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; Laios I, 2005, J STEROID BIOCHEM, V94, P347, DOI 10.1016/j.jsbmb.2005.02.005; Li L, 2006, J BIOL CHEM, V281, P1978, DOI 10.1074/jbc.M508545200; Lonard DM, 2008, NATURE, V452, P946, DOI 10.1038/452946a; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Lonard DM, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.113pe16; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; McKenna NJ, 1999, J STEROID BIOCHEM, V69, P3, DOI 10.1016/S0960-0760(98)00144-7; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nakajima A, 2007, BIOCHEM BIOPH RES CO, V357, P245, DOI 10.1016/j.bbrc.2007.03.134; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Pinzone JJ, 2004, MOL CELL BIOL, V24, P4605, DOI 10.1128/MCB.24.11.4605-4612.2004; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Saji S, 2001, BIOCHEM BIOPH RES CO, V281, P259, DOI 10.1006/bbrc.2001.4339; SHAN TL, 2008, MOL BIOL RE IN PRESS; Shao WL, 2004, P NATL ACAD SCI USA, V101, P11599, DOI 10.1073/pnas.0402997101; Soares L, 2004, NAT IMMUNOL, V5, P45, DOI 10.1038/ni1017; Tateishi Y, 2004, EMBO J, V23, P4813, DOI 10.1038/sj.emboj.7600472; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wijayaratne AL, 2001, J BIOL CHEM, V276, P35684, DOI 10.1074/jbc.M101097200; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Yi P, 2008, MOL CELL, V29, P465, DOI 10.1016/j.molcel.2007.12.030; Zhang H, 2006, EMBO J, V25, P4223, DOI 10.1038/sj.emboj.7601306; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011; Zheng L, 2001, P NATL ACAD SCI USA, V98, P9587, DOI 10.1073/pnas.171174298; Zhou W, 2008, MOL CELL, V29, P69, DOI 10.1016/j.molcel.2007.11.002	51	65	69	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16135	16145		10.1074/jbc.M109.007484	http://dx.doi.org/10.1074/jbc.M109.007484			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19383985	hybrid, Green Published			2022-12-25	WOS:000266730900010
J	Spinello, I; Quaranta, MT; Pasquini, L; Pelosi, E; Petrucci, E; Pagliuca, A; Castelli, G; Mariani, G; Diverio, D; Foa, R; Testa, U; Labbaye, C				Spinello, I.; Quaranta, M. T.; Pasquini, L.; Pelosi, E.; Petrucci, E.; Pagliuca, A.; Castelli, G.; Mariani, G.; Diverio, D.; Foa, R.; Testa, U.; Labbaye, C.			PLZF-mediated control on c-kit expression in CD34(+) cells and early erythropoiesis	ONCOGENE			English	Article						PLZF; c-kit; hematopoietic progenitor cells; erythropoiesis	RECEPTOR TYROSINE KINASE; ACUTE MYELOID-LEUKEMIA; PROMYELOCYTIC LEUKEMIA; TRANSCRIPTION FACTORS; GERM-CELLS; STEM-CELLS; PROTEIN; CD117; DIFFERENTIATION; IDENTIFICATION	The promyelocytic leukemia zinc-finger protein (PLZF) is a transcription factor and c-kit is a receptor tyrosine kinase associated with human disease, particularly in hematopoietic cells. MicroRNAs (miRs) are post-transcriptional regulators of gene expression, and c-kit has been described as a target of miRs-221 and -222 in erythropoiesis. In the present study, we identified c-kit as a target of PLZF in normal and leukemic cells. Particularly, in erythropoietic (E) culture of CD34(+) progenitors, PLZF is downregulated, whereas c-kit expression at both the mRNA and protein levels inversely increases during the first days of E differentiation. In functional experiments, PLZF transfection induces c-kit downregulation, inhibits E proliferation and delays differentiation, whereas PLZF knockdown induces opposite effects, independently of miRs-221 and -222 expression. The inverse correlation between PLZF and c-kit expression was found in normal CD34(+)38(+/-) hematopoietic progenitor/stem cells and in acute myeloid leukemias of M0/M1 French-American-British subtypes, suggesting that the control of PLZF on c-kit expression may be crucial at the level of the stem cell/progenitor compartment. Altogether, our data indicate a new mechanism of regulation of c-kit expression that involves a transcriptional control by PLZF in CD34(+) cells and early erythropoiesis. Oncogene (2009) 28, 2276-2288; doi: 10.1038/onc.2009.87; published online 4 May 2009	[Spinello, I.; Quaranta, M. T.; Pasquini, L.; Pelosi, E.; Petrucci, E.; Pagliuca, A.; Castelli, G.; Mariani, G.; Testa, U.; Labbaye, C.] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Diverio, D.; Foa, R.] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Div Hematol, Rome, Italy	Istituto Superiore di Sanita (ISS); Sapienza University Rome	Labbaye, C (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	catherine.labbaye@iss.it	pagliuca, alfredo/J-3107-2012; Pagliuca, Alfredo/AAI-3689-2020; pelosi, elvira/J-7298-2016; Testa, Ugo/J-6472-2016; Quaranta, Maria Teresa/AAC-2134-2019; PETRUCCI, ELEONORA/J-8778-2016; Labbaye, Catherine/J-9930-2016; SPINELLO, ISABELLA/J-8779-2016; pasquini, luca/J-8319-2016; castelli, germana/J-7244-2016	pagliuca, alfredo/0000-0002-8703-2077; pelosi, elvira/0000-0002-3043-6249; Testa, Ugo/0000-0001-7900-8942; Quaranta, Maria Teresa/0000-0002-5886-507X; PETRUCCI, ELEONORA/0000-0001-6459-490X; pasquini, luca/0000-0002-3484-6288; Labbaye, Catherine/0000-0003-1255-4396; castelli, germana/0000-0002-3593-1230	Italian Ministry of Health; Associazione Italiana per la Ricerca sul Cancro (AIRC); 'Fondazione Roma', Rome, Italy	Italian Ministry of Health(Ministry of Health, Italy); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); 'Fondazione Roma', Rome, Italy(Fondazione Roma)	We thank Dr F Spadaro, from the Department of Cell Biology and Neuroscience, for her help with confocal microscopy and G Loreto for graphics. This work was supported by institutional grants from the Italian Ministry of Health to UT and CL, from Associazione Italiana per la Ricerca sul Cancro ( AIRC) to RF, and from 'Fondazione Roma', Rome, Italy to UT.	Ball HJ, 1999, NUCLEIC ACIDS RES, V27, P4106, DOI 10.1093/nar/27.20.4106; Bene MC, 1998, BLOOD, V92, P596, DOI 10.1182/blood.V92.2.596.414k05_596_599; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Cascavilla N, 1998, HAEMATOLOGICA, V83, P392; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; Edling CE, 2007, INT J BIOCHEM CELL B, V39, P1995, DOI 10.1016/j.biocel.2006.12.005; Felicetti F, 2004, ONCOGENE, V23, P4567, DOI 10.1038/sj.onc.1207597; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Filipponi D, 2007, MOL CELL BIOL, V27, P6770, DOI 10.1128/MCB.00479-07; Gabbianelli M, 2000, BLOOD, V95, P3555, DOI 10.1182/blood.V95.11.3555.011k16_3555_3561; Gazitt Y, 2004, LEUKEMIA, V18, P1, DOI 10.1038/sj.leu.2403173; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Isken F, 2008, BRIT J HAEMATOL, V140, P153, DOI 10.1111/j.1365-2141.2007.06915.x; Ivins S, 2003, ONCOGENE, V22, P3685, DOI 10.1038/sj.onc.1206328; Jing HI, 2008, MOL CELL, V29, P232, DOI 10.1016/j.molcel.2007.11.020; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Labbaye C, 2002, ONCOGENE, V21, P6669, DOI 10.1038/sj.onc.1205884; Labbaye C, 2008, NAT CELL BIOL, V10, P788, DOI 10.1038/ncb1741; Lennartsson J, 2005, STEM CELLS, V23, P16, DOI 10.1634/stemcells.2004-0117; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Munugalavadla V, 2005, CRIT REV ONCOL HEMAT, V54, P63, DOI 10.1016/j.critrevonc.2004.11.005; MUTA K, 1995, BLOOD, V86, P572, DOI 10.1182/blood.V86.2.572.bloodjournal862572; Parrado A, 2000, Hematol J, V1, P15, DOI 10.1038/sj.thj.6200012; Patnaik MM, 2007, CURR CANCER DRUG TAR, V7, P492; Quaranta MT, 2006, ONCOGENE, V25, P399, DOI 10.1038/sj.onc.1209060; Scolnik MP, 2002, LEUKEMIA RES, V26, P615, DOI 10.1016/S0145-2126(01)00182-5; Sperling C, 1997, HAEMATOLOGICA, V82, P617; Tsuzuki S, 2002, BLOOD, V99, P3404, DOI 10.1182/blood.V99.9.3404; Wessely O, 1997, CELL GROWTH DIFFER, V8, P481; YAMAMOTO K, 1993, JPN J CANCER RES, V84, P1136, DOI 10.1111/j.1349-7006.1993.tb02813.x	33	25	27	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 11	2009	28	23					2276	2288		10.1038/onc.2009.87	http://dx.doi.org/10.1038/onc.2009.87			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	456XM	19421145				2022-12-25	WOS:000266886300004
J	Kato, M; Paranjape, T; Ullrich, R; Nallur, S; Gillespie, E; Keane, K; Esquela-Kerscher, A; Weidhaas, JB; Slack, FJ				Kato, M.; Paranjape, T.; Ullrich, R.; Nallur, S.; Gillespie, E.; Keane, K.; Esquela-Kerscher, A.; Weidhaas, J. B.; Slack, F. J.			The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells	ONCOGENE			English	Article						miRNA; DNA damage response; radiation; cancer; C. elegans	P53 NETWORK; RESISTANCE; APOPTOSIS	MicroRNAs (miRNAs) are important regulators of cell fate determination and homeostasis. Expression of these small RNA genes is tightly regulated during development and in normal tissues, but they are often misregulated in cancer. MiRNA expression is also affected by DNA damaging agents, such as radiation. In particular, mammalian miR-34 is upregulated by p53 in response to radiation, but little is known about the role of this miRNA in vivo. Here we show that Caenorhabditis elegans with loss-of-function mutations in the mir-34 gene have an abnormal cellular survival response to radiation; these animals are highly radiosensitive in the soma and radioresistant in the germline. These findings show a role for mir-34 in both apoptotic and non-apoptotic cell death in vivo, much like that of cep-1, the C. elegans p53 homolog. These results have been additionally validated in vitro in breast cancer cells, wherein exogenous addition of miR-34 alters cell survival post-radiation. These observations confirm that mir-34 is required for a normal cellular response to DNA damage in vivo resulting in altered cellular survival post-irradiation, and point to a potential therapeutic use for anti-miR-34 as a radio-sensitizing agent in p53-mutant breast cancer. Oncogene (2009) 28, 2419-2424; doi:10.1038/onc.2009.106; published online 4 May 2009	[Kato, M.; Esquela-Kerscher, A.; Slack, F. J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Paranjape, T.; Ullrich, R.; Nallur, S.; Gillespie, E.; Keane, K.; Weidhaas, J. B.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA	Yale University; Yale University	Slack, FJ (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, KBT 936,POB 208103,266 Whitney Ave, New Haven, CT 06520 USA.	joanne.weidhaas@yale.edu; frank.slack@yale.edu	Paranjape, Trupti/E-4338-2012; Gillespie, Erin/AAZ-8543-2021	Gillespie, Erin/0000-0002-1386-1542; Weidhaas, Joanne/0000-0002-5096-3281; Slack, Frank/0000-0001-8263-0409	Uehara Life Science Foundation; Breast Cancer Alliance; NIH [CA124484, CA131301-01A1]; American Cancer Society Institutional Research; ASTRO Junior Faculty Career Research Training Award; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [R01CA131301, K08CA124484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM071157] Funding Source: NIH RePORTER	Uehara Life Science Foundation; Breast Cancer Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Institutional Research(American Cancer Society); ASTRO Junior Faculty Career Research Training Award; Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the CGC for strains. MK was supported by a postdoctoral fellowship from the Uehara Life Science Foundation. JW was supported by the Breast Cancer Alliance and a K08 grant (CA124484) from the NIH and by an American Cancer Society Institutional Research Grant to the Yale Cancer Center and by the ASTRO Junior Faculty Career Research Training Award. FS was supported by a grant from the Ellison Medical Foundation. FS and JW were supported by a grant from the NIH (CA131301-01A1).	Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Hui L, 2006, ONCOGENE, V25, P7305, DOI 10.1038/sj.onc.1209735; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; RUNNEBAUM IB, 1991, P NATL ACAD SCI USA, V88, P10657, DOI 10.1073/pnas.88.23.10657; Salter KH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001908; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Weidhaas JB, 2006, P NATL ACAD SCI USA, V103, P9946, DOI 10.1073/pnas.0603791103; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858	17	179	191	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2009	28	25					2419	2424		10.1038/onc.2009.106	http://dx.doi.org/10.1038/onc.2009.106			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	462HS	19421141	Green Accepted			2022-12-25	WOS:000267342400006
J	Martin, V; Xu, J; Pabbisetty, SK; Alonso, MM; Liu, D; Lee, OH; Gumin, J; Bhat, KP; Colman, H; Lang, FF; Fueyo, J; Gomez-Manzano, C				Martin, V.; Xu, J.; Pabbisetty, S. K.; Alonso, M. M.; Liu, D.; Lee, O-H; Gumin, J.; Bhat, K. P.; Colman, H.; Lang, F. F.; Fueyo, J.; Gomez-Manzano, C.			Tie2-mediated multidrug resistance in malignant gliomas is associated with upregulation of ABC transporters	ONCOGENE			English	Article						Tie2; gliomas; chemoresistance; ABC transporters; brain tumor stem cells	TUMOR STEM-CELLS; DRUG-RESISTANCE; EXPRESSION; CANCER; CHEMORESISTANCE; GLIOBLASTOMA; RECEPTOR; GENES; TIE2	Resistance and relapse are still primary causes that result in poor effectiveness of chemotherapy in malignant gliomas. Therefore, development of new therapeutic strategies requires the identification of key molecular pathways regulating chemoresistance. We previously found that abnormal high expression of the Tie2 receptor in gliomas was associated with tumor malignancy. Here, we studied the role of Tie2 activation in drug resistance by testing the cytotoxicity of several chemotherapeutic drugs in a panel of human glioma cell lines and brain tumor stem cells and found that Tie2 activation was significantly related to chemoresistance. The essential role of Tie2 in this phenotype was illustrated by silencing Tie2 using specific siRNA, and the subsequent abrogation of the angiopoietin 1 (Ang1)-mediated chemoresistance. Using quantitative real-time PCR and functional drug efflux studies, we observed that Tie2 activation resulted in increased expression of ATP-binding cassette (ABC) transporters. Consistent with these results, downmodulation of ABCG2 or ABCC2 resulted in the inability of Tie2 activation to induce a chemoresistant phenotype. Our results indicate that Tie2 activation may be important in modifying the evolution of gliomas during conventional chemotherapy regimens, and open new avenues for the search of more effective therapies to avoid the inevitable brain tumor recurrence. Oncogene (2009) 28, 2358-2363; doi:10.1038/onc.2009.103; published online 4 May 2009	[Gomez-Manzano, C.] Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Dept Neurooncol, Unit 1002, Houston, TX 77030 USA; [Gumin, J.; Lang, F. F.] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Bhat, K. P.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Gomez-Manzano, C.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Gomez-Manzano, C (corresponding author), Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Dept Neurooncol, Unit 1002, 1515 Holcombe Blvd, Houston, TX 77030 USA.	cmanzano@mdanderson.org	Alonso, Marta M/AAI-9457-2020; Pabbisetty, Sudheer Kumar/H-3338-2019; MARTIN, VANESA/A-7312-2012; Colman, Howard/L-5433-2019	Alonso, Marta M/0000-0002-7520-7351; Pabbisetty, Sudheer Kumar/0000-0001-7490-1352; MARTIN, VANESA/0000-0001-6923-2529; Fueyo, Juan/0000-0001-6941-2335; Gomez-Manzano, Candelaria/0000-0002-1259-2133	Department of Education and Science, Spain; American Brain Tumor Association; Elsa U Pardee Foundation; NIH/Developmental Research Program [P50CA127001]; NATIONAL CANCER INSTITUTE [P50CA127001] Funding Source: NIH RePORTER	Department of Education and Science, Spain; American Brain Tumor Association; Elsa U Pardee Foundation; NIH/Developmental Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Alyson Todd (Department of Scientific Publications, The University of Texas MD Anderson Cancer Center) for editorial assistance. This work was supported by a postdoctoral fellowship from the Department of Education and Science, Spain (to VM), an American Brain Tumor Association postdoctoral fellowship (to DL), Elsa U Pardee Foundation Award (to CGM), and an NIH/Developmental Research Program P50CA127001 (to CGM).	Alonso MM, 2007, CANCER RES, V67, P11499, DOI 10.1158/0008-5472.CAN-07-5312; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bredel M, 2001, BRAIN RES REV, V35, P161, DOI 10.1016/S0165-0173(01)00045-5; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Decleves X, 2006, CURR CANCER DRUG TAR, V6, P433, DOI 10.2174/156800906777723930; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Jiang H, 2007, J NATL CANCER I, V99, P1410, DOI 10.1093/jnci/djm102; Jin F, 2008, NEUROSCIENCE, V154, P541, DOI 10.1016/j.neuroscience.2008.03.054; Lee OH, 2008, ONCOGENE, V27, P1310, DOI 10.1038/sj.onc.1210731; Lee OH, 2006, MOL CANCER RES, V4, P915, DOI 10.1158/1541-7786.MCR-06-0184; Lu C, 2008, MOL CELL BIOCHEM, V312, P71, DOI 10.1007/s11010-008-9722-8; Martin V, 2008, HISTOL HISTOPATHOL, V23, P773, DOI 10.14670/HH-23.773; Shervington A, 2008, CANCER INVEST, V26, P535, DOI 10.1080/07357900801904140; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Zadeh G, 2004, AM J PATHOL, V164, P467, DOI 10.1016/S0002-9440(10)63137-9; Zhang WD, 2003, FASEB J, V17, P2085, DOI 10.1096/fj.02-1131fje	17	36	40	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2009	28	24					2358	2363		10.1038/onc.2009.103	http://dx.doi.org/10.1038/onc.2009.103			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	459GJ	19421150	Green Accepted			2022-12-25	WOS:000267089100006
J	Campo, CG; Sinagra, M; Verrier, D; Manzoni, OJ; Chavis, P				Campo, Cecilia Gonzalez; Sinagra, Melanie; Verrier, Daniele; Manzoni, Olivier J.; Chavis, Pascale			Reelin Secreted by GABAergic Neurons Regulates Glutamate Receptor Homeostasis	PLOS ONE			English	Article								Background: Reelin is a large secreted protein of the extracellular matrix that has been proposed to participate to the etiology of schizophrenia. During development, reelin is crucial for the correct cytoarchitecture of laminated brain structures and is produced by a subset of neurons named Cajal-Retzius. After birth, most of these cells degenerate and reelin expression persists in postnatal and adult brain. The phenotype of neurons that bind secreted reelin and whether the continuous secretion of reelin is required for physiological functions at postnatal stages remain unknown. Methodology/Principal Findings: Combining immunocytochemical and pharmacological approaches, we first report that two distinct patterns of reelin expression are present in cultured hippocampal neurons. We show that in hippocampal cultures, reelin is secreted by GABAergic neurons displaying an intense reelin immunoreactivity (IR). We demonstrate that secreted reelin binds to receptors of the lipoprotein family on neurons with a punctate reelin IR. Secondly, using calcium imaging techniques, we examined the physiological consequences of reelin secretion blockade. Blocking protein secretion rapidly and reversibly changes the subunit composition of N-methyl-D-aspartate glutamate receptors (NMDARs) to a predominance of NR2B-containing NMDARs. Addition of recombinant or endogenously secreted reelin rescues the effects of protein secretion blockade and reverts the fraction of NR2B-containing NMDARs to control levels. Therefore, the continuous secretion of reelin is necessary to control the subunit composition of NMDARs in hippocampal neurons. Conclusions/Significance: Our data show that the heterogeneity of reelin immunoreactivity correlates with distinct functional populations: neurons synthesizing and secreting reelin and/or neurons binding reelin. Furthermore, we show that continuous reelin secretion is a strict requirement to maintain the composition of NMDARs. We propose that reelin is a trans-neuronal messenger secreted by GABAergic neurons that regulates NMDARs homeostasis in postnatal hippocampus. Defects in reelin secretion could play a major role in the development of neuropsychiatric disorders, particularly those associated with deregulation of NMDARs such as schizophrenia.			Campo, CG (corresponding author), INSERM, Neuroctr Magendie Pathophysiol Synapt Plast, U862, Bordeaux, France.	pascale.chavis@inserm.fr	Chavis, Pascale/M-8312-2016; Manzoni, Olivier/M-7899-2016	Chavis, Pascale/0000-0002-3038-1014; Manzoni, Olivier/0000-0002-5579-6208				Alcantara S, 1998, J NEUROSCI, V18, P7779; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; De A, 2003, BRAIN RES, V981, P133, DOI 10.1016/S0006-8993(03)02997-4; DERER P, 1990, NEUROSCIENCE, V36, P839, DOI 10.1016/0306-4522(90)90027-2; Drakew A, 1998, NEUROSCIENCE, V82, P1079; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Groc L, 2007, J NEUROSCI, V27, P10165, DOI 10.1523/JNEUROSCI.1772-07.2007; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; HERZ J, 1991, J BIOL CHEM, V266, P21232; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Hevner RF, 2003, DEV BRAIN RES, V141, P39, DOI 10.1016/S0165-3806(02)00641-7; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Ikeda Y, 1997, DEV DYNAM, V210, P157, DOI 10.1002/(SICI)1097-0177(199710)210:2<157::AID-AJA8>3.0.CO;2-F; Ina A, 2007, EUR J NEUROSCI, V26, P615, DOI 10.1111/j.1460-9568.2007.05703.x; Jossin Y, 2007, J NEUROSCI, V27, P4243, DOI 10.1523/JNEUROSCI.0023-07.2007; Lacor PN, 2000, P NATL ACAD SCI USA, V97, P3556, DOI 10.1073/pnas.050589597; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Martinez-Cerdeno V, 2002, CEREB CORTEX, V12, P1298, DOI 10.1093/cercor/12.12.1298; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Pesold C, 1998, P NATL ACAD SCI USA, V95, P3221, DOI 10.1073/pnas.95.6.3221; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Qiu SF, 2006, J NEUROSCI, V26, P12943, DOI 10.1523/JNEUROSCI.2561-06.2006; Ramos-Moreno T, 2006, EUR J NEUROSCI, V23, P401, DOI 10.1111/j.1460-9568.2005.04567.x; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sinagra M, 2005, J NEUROSCI, V25, P6127, DOI 10.1523/JNEUROSCI.1757-05.2005; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Tovar KR, 1999, J NEUROSCI, V19, P4180; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Wisco D, 2003, J CELL BIOL, V162, P1317, DOI 10.1083/jcb.200307069	41	69	69	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2009	4	5							e5505	10.1371/journal.pone.0005505	http://dx.doi.org/10.1371/journal.pone.0005505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VY	19430527	Green Published, gold, Green Submitted			2022-12-25	WOS:000266009700010
J	Whitehead, K; Pan, M; Masumura, K; Bonneau, R; Baliga, NS				Whitehead, Kenia; Pan, Min; Masumura, Ken-ichi; Bonneau, Richard; Baliga, Nitin S.			Diurnally Entrained Anticipatory Behavior in Archaea	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; HALOBACTERIUM-HALOBIUM; GENOME SEQUENCE; RHODOPSIN-II; GENE; MECHANISM; PHOTOSYNTHESIS; TRANSCRIPTS; TEMPERATURE; EXPRESSION	By sensing changes in one or few environmental factors biological systems can anticipate future changes in multiple factors over a wide range of time scales (daily to seasonal). This anticipatory behavior is important to the fitness of diverse species, and in context of the diurnal cycle it is overall typical of eukaryotes and some photoautotrophic bacteria but is yet to be observed in archaea. Here, we report the first observation of light-dark (LD)-entrained diurnal oscillatory transcription in up to 12% of all genes of a halophilic archaeon Halobacterium salinarum NRC-1. Significantly, the diurnally entrained transcription was observed under constant darkness after removal of the LD stimulus (free-running rhythms). The memory of diurnal entrainment was also associated with the synchronization of oxic and anoxic physiologies to the LD cycle. Our results suggest that under nutrient limited conditions halophilic archaea take advantage of the causal influence of sunlight (via temperature) on O-2 diffusivity in a closed hypersaline environment to streamline their physiology and operate oxically during nighttime and anoxically during daytime.			Whitehead, K (corresponding author), Inst Syst Biol, Seattle, WA USA.	nbaliga@systemsbiology.org	Bonneau, Richard/ABD-6737-2021; Bonneau, Richard/GZL-2900-2022; Masumura, Kenichi/J-7936-2019	Masumura, Kenichi/0000-0002-7907-164X; baliga, nitin/0000-0001-9157-5974	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077398, P50GM076547] Funding Source: NIH RePORTER; NIGMS NIH HHS [1R01GM077398-01A2, P50 GM076547, R01 GM077398, P50GM076547] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASHTON PJ, 1983, HYDROBIOLOGIA, V99, P61, DOI 10.1007/BF00013718; Baliga NS, 2008, SCIENCE, V320, P1297, DOI 10.1126/science.1159485; Baliga NS, 2004, GENOME RES, V14, P2221, DOI 10.1101/gr.2700304; Baliga NS, 2002, P NATL ACAD SCI USA, V99, P14913, DOI 10.1073/pnas.192558999; Baliga NS, 2001, P NATL ACAD SCI USA, V98, P2521, DOI 10.1073/pnas.051632498; Bare JC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-456; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; BETLACH MC, 1989, CAN J MICROBIOL, V35, P134, DOI 10.1139/m89-020; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; DasSarma S, 2001, PHOTOSYNTH RES, V70, P3, DOI 10.1023/A:1013879706863; DASSARMA S, 1999, HALOPHILES ENCY LIFE, P458; *DEP MET, DEP MET UOU ANN TEMP; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dvornyk V, 2003, P NATL ACAD SCI USA, V100, P2495, DOI 10.1073/pnas.0130099100; Falb M, 2005, GENOME RES, V15, P1336, DOI 10.1101/gr.3952905; Geiduschek EP, 2005, MOL MICROBIOL, V56, P1397, DOI 10.1111/j.1365-2958.2005.04627.x; Glynn EF, 2006, BIOINFORMATICS, V22, P310, DOI 10.1093/bioinformatics/bti789; Han P, 1996, J PHYS CHEM-US, V100, P5597, DOI 10.1021/jp952903y; HARTMANN R, 1980, P NATL ACAD SCI-BIOL, V77, P3821, DOI 10.1073/pnas.77.7.3821; Hoff WD, 1997, ANNU REV BIOPH BIOM, V26, P223, DOI 10.1146/annurev.biophys.26.1.223; HORNE JH, 1986, ASTROPHYS J, V302, P757, DOI 10.1086/164037; Ideker T, 2000, J COMPUT BIOL, V7, P805, DOI 10.1089/10665270050514945; Johnson CH, 2008, CURR BIOL, V18, pR816, DOI 10.1016/j.cub.2008.07.012; KREBS MP, 1993, J BACTERIOL, V175, P1555, DOI 10.1128/JB.175.6.1555-1560.1993; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; LOMB NR, 1976, ASTROPHYS SPACE SCI, V39, P447, DOI 10.1007/BF00648343; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Moreno-Hagelsieb Gabriel, 2002, Bioinformatics, V18 Suppl 1, pS329; Mori T, 1996, P NATL ACAD SCI USA, V93, P10183, DOI 10.1073/pnas.93.19.10183; Muller JA, 2005, J BACTERIOL, V187, P1659, DOI 10.1128/JB.187.5.1659-1667.2005; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; Oren A, 2001, HYDROBIOLOGIA, V466, P61, DOI 10.1023/A:1014557116838; Oren Aharon, 2008, Saline Syst, V4, P2, DOI 10.1186/1746-1448-4-2; PINCKNEY J, 1995, J EXP MAR BIOL ECOL, V187, P223, DOI 10.1016/0022-0981(94)00185-G; Press W. H., 1992, ART SCI COMPUTING; Ruepp A, 1996, J BACTERIOL, V178, P4942, DOI 10.1128/jb.178.16.4942-4947.1996; Saenger Casey, 2006, Saline Syst, V2, P8, DOI 10.1186/1746-1448-2-8; SCARGLE JD, 1982, APJ, V263, P835, DOI DOI 10.1086/160554; Schmid AK, 2007, GENOME RES, V17, P1399, DOI 10.1101/gr.6728007; SHAND RF, 1991, J BACTERIOL, V173, P4692, DOI 10.1128/jb.173.15.4692-4699.1991; Shannon PT, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-176; SPUDICH EN, 1989, P NATL ACAD SCI USA, V86, P7746, DOI 10.1073/pnas.86.20.7746; Spudich JL, 2002, CURR OPIN STRUC BIOL, V12, P540, DOI 10.1016/S0959-440X(02)00359-7; SPUDICH JL, 1984, NATURE, V312, P509, DOI 10.1038/312509a0; SPUDICH JL, 1993, J BACTERIOL, V175, P7755, DOI 10.1128/JB.175.24.7755-7761.1993; Stumm W., 1981, AQUAT CHEM, P780; SUMPER M, 1976, ANGEW CHEM INT EDIT, V15, P187, DOI 10.1002/anie.197601871; TAGKOPOULOS I, 2008, SCIENCE; Taniguchi Y, 2007, GENE DEV, V21, P60, DOI 10.1101/gad.1488107; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Twellmeyer J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001064; Valdez-Holguin Jose, 1994, Ciencias Marinas, V20, P123; Vityazev VV, 1997, ASTR SOC P, V125, P166; Wichert S, 2004, BIOINFORMATICS, V20, P5, DOI 10.1093/bioinformatics/btg364; Wieland A, 2006, FEMS MICROBIOL ECOL, V55, P195, DOI 10.1111/j.1574-6941.2005.00031.x	55	39	41	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5485	10.1371/journal.pone.0005485	http://dx.doi.org/10.1371/journal.pone.0005485			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424498	Green Submitted, gold, Green Published			2022-12-25	WOS:000265933800015
J	Pradhan, AAA; Becker, JAJ; Scherrer, G; Tryoen-Toth, P; Filliol, D; Matifas, A; Massotte, D; Gaveriaux-Ruff, C; Kieffer, BL				Pradhan, Amynah A. A.; Becker, Jerome A. J.; Scherrer, Gregory; Tryoen-Toth, Petra; Filliol, Dominique; Matifas, Audrey; Massotte, Dominique; Gaveriaux-Ruff, Claire; Kieffer, Brigitte L.			In Vivo Delta Opioid Receptor Internalization Controls Behavioral Effects of Agonists	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; NEUROPATHIC PAIN; MEMBRANE TRAFFICKING; CHRONIC INFLAMMATION; MORPHINE-TOLERANCE; KNOCKOUT MICE; SPINAL-CORD; MU; ENDOCYTOSIS; DESENSITIZATION	Background: GPCRs regulate a remarkable diversity of biological functions, and are thus often targeted for drug therapies. Stimulation of a GPCR by an extracellular ligand triggers receptor signaling via G proteins, and this process is highly regulated. Receptor activation is typically accompanied by desensitization of receptor signaling, a complex feedback regulatory process of which receptor internalization is postulated as a key event. The in vivo significance of GPCR internalization is poorly understood. In fact, the majority of studies have been performed in transfected cell systems, which do not adequately model physiological environments and the complexity of integrated responses observed in the whole animal. Methods and Findings: In this study, we used knock-in mice expressing functional fluorescent delta opioid receptors (DOR-eGFP) in place of the native receptor to correlate receptor localization in neurons with behavioral responses. We analyzed the pain-relieving effects of two delta receptor agonists with similar signaling potencies and efficacies, but distinct internalizing properties. An initial treatment with the high (SNC80) or low (AR-M100390) internalizing agonist equally reduced CFA-induced inflammatory pain. However, subsequent drug treatment produced highly distinct responses. Animals initially treated with SNC80 showed no analgesic response to a second dose of either delta receptor agonist. Concomitant receptor internalization and G-protein uncoupling were observed throughout the nervous system. This loss of function was temporary, since full DOR-eGFP receptor responses were restored 24 hours after SNC80 administration. In contrast, treatment with AR-M100390 resulted in retained analgesic response to a subsequent agonist injection, and ex vivo analysis showed that DOR-eGFP receptor remained G protein-coupled on the cell surface. Finally SNC80 but not AR-M100390 produced DOR-eGFP phosphorylation, suggesting that the two agonists produce distinct active receptor conformations in vivo which likely lead to differential receptor trafficking. Conclusions: Together our data show that delta agonists retain full analgesic efficacy when receptors remain on the cell surface. In contrast, delta agonist-induced analgesia is abolished following receptor internalization, and complete behavioral desensitization is observed. Overall these results establish that, in the context of pain control, receptor localization fully controls receptor function in vivo. This finding has both fundamental and therapeutic implications for slow-recycling GPCRs.			Pradhan, AAA (corresponding author), Univ Strasbourg 1, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, Illkirch Graffenstaden, France.	briki@igbmc.u-strasbg.fr	GAVERIAUX-RUFF, Claire/A-9671-2017; Pradhan, Amynah/AAX-7719-2020; Becker, Jerome/I-7879-2016	GAVERIAUX-RUFF, Claire/0000-0002-3523-8102; Becker, Jerome/0000-0002-0039-0067; massotte, dominique/0000-0002-8758-1009; Toth, Petra/0000-0003-4573-4705; Scherrer, Gregory/0000-0002-1983-5126	NIDA NIH HHS [P50 DA005010, DA05010] Funding Source: Medline	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Audet N, 2008, J BIOL CHEM, V283, P15078, DOI 10.1074/jbc.M707941200; Befort K, 2001, J BIOL CHEM, V276, P3130, DOI 10.1074/jbc.M006352200; Bernard W, 2006, TRENDS NEUROSCI, V29, P140, DOI 10.1016/j.tins.2006.01.006; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Brandt MR, 2001, J PHARMACOL EXP THER, V299, P629; Cahill CM, 2003, PAIN, V101, P199, DOI 10.1016/S0304-3959(02)00333-0; CALDERON SN, 1994, J MED CHEM, V37, P2125, DOI 10.1021/jm00040a002; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Filliol D, 2000, NAT GENET, V25, P195, DOI 10.1038/76061; Fraser GL, 2000, BRIT J PHARMACOL, V129, P1668, DOI 10.1038/sj.bjp.0703248; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gastard M, 2000, BMC NEUROSCI, V1, DOI 10.1186/1471-2202-1-1; Gaveriaux-Ruff C, 2008, EUR J NEUROSCI, V27, P2558, DOI 10.1111/j.1460-9568.2008.06223.x; Gendron L, 2006, J NEUROSCI, V26, P953, DOI 10.1523/JNEUROSCI.3598-05.2006; Hasbi A, 2000, J PHARMACOL EXP THER, V293, P237; He L, 2002, CELL, V108, P271, DOI 10.1016/S0092-8674(02)00613-X; Hurley RW, 2000, J NEUROSCI, V20, P1249, DOI 10.1523/JNEUROSCI.20-03-01249.2000; Jutkiewicz EM, 2005, J PHARMACOL EXP THER, V315, P414, DOI 10.1124/jpet.105.088831; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Kieffer BL, 2002, CELL, V108, P587, DOI 10.1016/S0092-8674(02)00666-9; Kieffer BL, 2002, PROG NEUROBIOL, V66, P285, DOI 10.1016/S0301-0082(02)00008-4; Ko JL, 1999, MOL BRAIN RES, V69, P171, DOI 10.1016/S0169-328X(99)00094-7; Law PY, 2000, J BIOL CHEM, V275, P32057, DOI 10.1074/jbc.M002395200; Law PY, 2004, DELTA RECEPTOR, P61; Maestri-El Kouhen O, 2000, J BIOL CHEM, V275, P36659, DOI 10.1074/jbc.M006788200; Malatynska E, 1996, J PHARMACOL EXP THER, V278, P1083; Marie N, 2003, LIFE SCI, V73, P1691, DOI 10.1016/S0024-3205(03)00489-2; Mika J, 2001, EUR J PHARMACOL, V415, P31, DOI 10.1016/S0014-2999(01)00814-7; Morinville A, 2004, J NEUROSCI, V24, P5549, DOI 10.1523/JNEUROSCI.2719-03.2004; Nadal X, 2006, EUR J NEUROSCI, V23, P830, DOI 10.1111/j.1460-9568.2006.04569.x; Perry SJ, 2002, TRENDS CELL BIOL, V12, P130, DOI 10.1016/S0962-8924(01)02239-5; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Scherrer G, 2006, P NATL ACAD SCI USA, V103, P9691, DOI 10.1073/pnas.0603359103; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Sternini C, 1996, P NATL ACAD SCI USA, V93, P9241, DOI 10.1073/pnas.93.17.9241; Tan CM, 2004, ANNU REV PHARMACOL, V44, P559, DOI 10.1146/annurev.pharmtox.44.101802.121558; Tappe-Theodor A, 2007, J NEUROSCI, V27, P4165, DOI 10.1523/JNEUROSCI.5648-06.2007; Trapaidze N, 1996, J BIOL CHEM, V271, P29279, DOI 10.1074/jbc.271.46.29279; Trapaidze N, 2000, MOL BRAIN RES, V76, P220, DOI 10.1016/S0169-328X(00)00002-4; Van Bockstaele EJ, 2001, NEUROSCIENCE, V108, P467, DOI 10.1016/S0306-4522(01)00426-2; von Zastrow M, 2003, LIFE SCI, V74, P217, DOI 10.1016/j.lfs.2003.09.008; Wei ZY, 2000, J MED CHEM, V43, P3895, DOI 10.1021/jm000229p; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5	46	148	148	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5425	10.1371/journal.pone.0005425	http://dx.doi.org/10.1371/journal.pone.0005425			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440GG	19412545	Green Published, gold			2022-12-25	WOS:000265688200012
J	Huang, YL; Walstrom, A; Zhang, LW; Zhao, Y; Cui, M; Ye, L; Zheng, JLC				Huang, Yunlong; Walstrom, Angelique; Zhang, Luwen; Zhao, Yong; Cui, Min; Ye, Ling; Zheng, Jialin C.			Type I Interferons and Interferon Regulatory Factors Regulate TNF-Related Apoptosis-Inducing Ligand (TRAIL) in HIV-1-Infected Macrophages	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RIG-I; TRANSCRIPTION FACTOR; T-CELLS; TARGETED DISRUPTION; MEDIATED APOPTOSIS; ANTIVIRAL RESPONSE; POSITIVE FEEDBACK; ALPHA-INTERFERON; INNATE IMMUNITY	TNF-related apoptosis-inducing ligand (TRAIL) is a member of the TNF family that participates in HIV-1 pathogenesis through the depletion of CD4(+) T cells. TRAIL is expressed on the cell membrane of peripheral immune cells and can be cleaved into a soluble, secreted form. The regulation of TRAIL in macrophages during HIV-1 infection is not completely understood. In this study, we investigated the mechanism(s) of TRAIL expression in HIV-1-infected macrophages, an important cell type in HIV-1 pathogenesis. A human monocyte-derived macrophage (MDM) culture system was infected with macrophage-tropic HIV-1ADA, HIV-1JR-FL, or HIV-1BAL strains. TRAIL, predominantly the membrane-bound form, increased following HIV-1 infection. We found that HIV-1 infection also induced interferon regulatory factor (IRF)-1, IRF-7 gene expression and signal transducers and activators of transcription 1 (STAT1) activation. Small interfering RNA knockdown of IRF-1 or IRF-7, but not IRF-3, reduced STAT1 activation and TRAIL expression. Furthermore, the upregulation of IRF-1, IRF-7, TRAIL, and the activation of STAT1 by HIV-1 infection was reduced by the treatment of type I interferon (IFN)-neutralizing antibodies. In addition, inhibition of STAT1 by fludarabine abolished IRF-1, IRF-7, and TRAIL upregulation. We conclude that IRF-1, IRF-7, type I IFNs, and STAT1 form a signaling feedback loop that is critical in regulating TRAIL expression in HIV-1-infected macrophages.			Huang, YL (corresponding author), Univ Nebraska, Med Ctr, Dept Pharmacol & Expt Neurosci, Lab Neurotoxicol, Omaha, NE 68182 USA.	jzheng@unmc.edu	cui, min/HGD-8340-2022; Huang, Yunlong/J-6554-2015	Huang, Yunlong/0000-0002-3328-1924	NCRR NIH HHS [P20RR15635, P20 RR015635] Funding Source: Medline; NIMH NIH HHS [R21 MH083525, R21MH83525] Funding Source: Medline; NINDS NIH HHS [R01 NS061642, R01 NS41858, P01NS43985, R01 NS041858, P01 NS043985, R01NS61642] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041858, P01NS043985, R01NS061642] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbate I, 2000, CLIN EXP IMMUNOL, V122, P374, DOI 10.1046/j.1365-2249.2000.01378.x; Almasan A, 2003, CYTOKINE GROWTH F R, V14, P337, DOI 10.1016/S1359-6101(03)00029-7; Battistini A, 2002, J INTERF CYTOK RES, V22, P27, DOI 10.1089/107999002753452638; Bovolenta C, 1999, BLOOD, V94, P4202, DOI 10.1182/blood.V94.12.4202.424k22_4202_4209; Brown JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003664; Clarke N, 2004, EMBO J, V23, P3051, DOI 10.1038/sj.emboj.7600302; Cotter RL, 2001, J VIROL, V75, P4308, DOI 10.1128/JVI.75.9.4308-4320.2001; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Diehl GE, 2004, IMMUNITY, V21, P877, DOI 10.1016/j.immuni.2004.11.008; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Ehrlich S, 2003, CYTOKINE, V24, P244, DOI 10.1016/S1043-4666(03)00094-2; Esser R, 1996, BLOOD, V88, P3474, DOI 10.1182/blood.V88.9.3474.bloodjournal8893474; Federico M, 2001, BLOOD, V98, P2752, DOI 10.1182/blood.V98.9.2752; Fischl MA, 1997, J ACQ IMMUN DEF SYND, V16, P247, DOI 10.1097/00042560-199712010-00005; Frank DA, 1999, NAT MED, V5, P444, DOI 10.1038/7445; GABUZDA DH, 1986, ANN NEUROL, V20, P289, DOI 10.1002/ana.410200304; GARTNER S, 1990, AIDS RES HUM RETROV, V6, P1017, DOI 10.1089/aid.1990.6.1017; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; GENDELMAN HE, 1989, AIDS, V3, P475, DOI 10.1097/00002030-198908000-00001; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; GESSANI S, 1994, J VIROL, V68, P1983, DOI 10.1128/JVI.68.3.1983-1986.1994; Gong B, 2000, BIOCHEM BIOPH RES CO, V278, P747, DOI 10.1006/bbrc.2000.3872; Griffith TS, 1999, J EXP MED, V189, P1343, DOI 10.1084/jem.189.8.1343; Halaas O, 2000, SCAND J IMMUNOL, V51, P244; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Herbeuval JP, 2006, P NATL ACAD SCI USA, V103, P7000, DOI 10.1073/pnas.0600363103; Herbeuval JP, 2005, BLOOD, V106, P3524, DOI 10.1182/blood-2005-03-1243; Herbeuval JP, 2005, BLOOD, V105, P2458, DOI 10.1182/blood-2004-08-3058; Herbeuval JP, 2005, P NATL ACAD SCI USA, V102, P13974, DOI 10.1073/pnas.0505251102; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huang YL, 2006, J IMMUNOL, V177, P2304, DOI 10.4049/jimmunol.177.4.2304; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kayagaki N, 1999, J IMMUNOL, V162, P2639; Kirshner JR, 2005, J VIROL, V79, P9320, DOI 10.1128/JVI.79.14.9320-9324.2005; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Leaman DW, 1996, FASEB J, V10, P1578, DOI 10.1096/fasebj.10.14.9002549; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li XX, 1996, J BIOL CHEM, V271, P5790, DOI 10.1074/jbc.271.10.5790; Lin RT, 1999, MOL CELL BIOL, V19, P959; Lohoff M, 1997, IMMUNITY, V6, P681, DOI 10.1016/S1074-7613(00)80444-6; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; Negishi H, 2006, P NATL ACAD SCI USA, V103, P15136, DOI 10.1073/pnas.0607181103; Okumura A, 2008, VIROLOGY, V373, P85, DOI 10.1016/j.virol.2007.10.042; Oritani K, 2001, CYTOKINE GROWTH F R, V12, P337, DOI 10.1016/S1359-6101(01)00009-0; Park SY, 2004, EUR J BIOCHEM, V271, P4222, DOI 10.1111/j.1432-1033.2004.04362.x; Peng H, 2005, J NEUROSCI RES, V82, P295, DOI 10.1002/jnr.20629; Romieu-Mourez R, 2006, CANCER RES, V66, P10576, DOI 10.1158/0008-5472.CAN-06-1279; Ryan LA, 2004, J NEUROIMMUNOL, V148, P127, DOI 10.1016/j.jneuroim.2003.11.019; Sato K, 2001, EUR J IMMUNOL, V31, P3138, DOI 10.1002/1521-4141(200111)31:11<3138::AID-IMMU3138>3.0.CO;2-B; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Sgarbanti M, 2002, J EXP MED, V195, P1359, DOI 10.1084/jem.20010753; SGARBANTI M, 2008, J VIROL; Shieh JTC, 1998, J VIROL, V72, P4243, DOI 10.1128/JVI.72.5.4243-4249.1998; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; SZEBENI J, 1991, J VIROL, V65, P6362, DOI 10.1128/JVI.65.11.6362-6364.1991; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; TECCHIO C, 2004, BLOOD; VEALS SA, 1992, MOL CELL BIOL, V12, P3315, DOI 10.1128/MCB.12.8.3315; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Yang YD, 2003, J VIROL, V77, P6700, DOI 10.1128/JVI.77.12.6700-6708.2003; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang MJ, 2001, J BIOMED SCI, V8, P290, DOI 10.1159/000054045; Zhao ML, 2001, J NEUROIMMUNOL, V115, P182, DOI 10.1016/S0165-5728(00)00463-X	73	33	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5397	10.1371/journal.pone.0005397	http://dx.doi.org/10.1371/journal.pone.0005397			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404407	Green Published, gold			2022-12-25	WOS:000265614900010
J	Cox, KH; Ruiz-Bustos, E; Courtney, HS; Dale, JB; Pence, MA; Nizet, V; Aziz, RK; Gerling, I; Price, SM; Hasty, DL				Cox, Kathleen H.; Ruiz-Bustos, Eduardo; Courtney, Harry S.; Dale, James B.; Pence, Morgan A.; Nizet, Victor; Aziz, Ramy K.; Gerling, Ivan; Price, Susan M.; Hasty, David L.			Inactivation of DltA Modulates Virulence Factor Expression in Streptococcus pyogenes	PLOS ONE			English	Article							GROUP-A STREPTOCOCCI; ALANYL-LIPOTEICHOIC ACID; TEICHOIC-ACIDS; D-ALANINE; STAPHYLOCOCCUS-AUREUS; M-PROTEIN; LACTOCOCCUS-LACTIS; PHOSPHOLIPASE A(2); BACILLUS-SUBTILIS; RESISTANCE	Background: D-alanylated lipoteichoic acid is a virtually ubiquitous component of Gram-positive cell walls. Mutations in the dltABCD operon of numerous species exhibit pleiotropic effects, including reduced virulence, which has been attributed to increased binding of cationic antimicrobial peptides to the more negatively charged cell surface. In this study, we have further investigated the effects that mutating dltA has on virulence factor expression in Streptococcus pyogenes. Methodology/Principal Findings: Isogenic Delta dltA mutants had previously been created in two distinct M1T1 isolates of S. pyogenes. Immunoblots, flow cytometry, and immunofluorescence were used to quantitate M protein levels in these strains, as well as to assess their ability to bind complement. Bacteria were tested for their ability to interact with human PMN and to grow in whole human blood. Message levels for emm, sic, and various regulatory elements were assessed by quantitative RT-PCR. Cell walls of Delta dltA mutants contained much less M protein than cell walls of parent strains and this correlated with reduced levels of emm transcripts, increased deposition of complement, increased association of bacteria with polymorphonuclear leukocytes, and reduced bacterial growth in whole human blood. Transcription of at least one other gene of the mga regulon, sic, which encodes a protein that inactivates antimicrobial peptides, was also dramatically reduced in Delta dltA mutants. Concomitantly, ccpA and rofA were unaffected, while rgg and arcA were up-regulated. Conclusions/Significance: This study has identified a novel mechanism for the reduced virulence of dltA mutants of Streptococcus pyogenes in which gene regulatory networks somehow sense and respond to the loss of DltA and lack of D-alanine esterification of lipoteichoic acid. The mechanism remains to be determined, but the data indicate that the status of D-alanine-lipoteichoic acid can significantly influence the expression of at least some streptococcal virulence factors and provide further impetus to targeting the dlt operon of Gram-positive pathogens in the search for novel antimicrobial compounds.			Cox, KH (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA.	dhasty@utmem.edu	Nizet, Victor/AAF-3190-2019; Pence, Morgan A./N-1620-2019; Aziz, Ramy/B-2918-2009	Pence, Morgan A./0000-0003-0239-0228; Nizet, Victor/0000-0003-3847-0422; Ruiz-Bustos, Eduardo/0000-0002-9539-3569; Dale, James/0000-0001-9860-9233; Aziz, Ramy/0000-0002-4448-7100	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI010085, R55AI010085, R01AI077780, R01AI010085] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abachin E, 2002, MOL MICROBIOL, V43, P1, DOI 10.1046/j.1365-2958.2002.02723.x; Akesson P, 1996, J BIOL CHEM, V271, P1081, DOI 10.1074/jbc.271.2.1081; Almengor AC, 2007, J BACTERIOL, V189, P8405, DOI 10.1128/JB.01038-07; ARCHIBALD AR, 1973, BIOCHIM BIOPHYS ACTA, V291, P629; Biswas I, 2001, INFECT IMMUN, V69, P7029, DOI 10.1128/IAI.69.11.7029-7038.2001; Boyd DA, 2000, J BACTERIOL, V182, P6055, DOI 10.1128/JB.182.21.6055-6065.2000; CAPARON MG, 1992, J BACTERIOL, V174, P5693, DOI 10.1128/JB.174.17.5693-5701.1992; CAPARON MG, 1987, P NATL ACAD SCI USA, V84, P8677, DOI 10.1073/pnas.84.23.8677; Chatellier S, 2000, INFECT IMMUN, V68, P3523, DOI 10.1128/IAI.68.6.3523-3534.2000; Chaussee MS, 1999, INFECT IMMUN, V67, P1715; Chaussee MS, 2003, J BACTERIOL, V185, P6016, DOI 10.1128/JB.185.20.6016-6024.2003; Chaussee MS, 2002, INFECT IMMUN, V70, P762, DOI 10.1128/IAI.70.2.762-770.2002; Clemans DL, 1999, INFECT IMMUN, V67, P2464, DOI 10.1128/IAI.67.5.2464-2474.1999; Courtney HS, 1997, INFECT IMMUN, V65, P2472, DOI 10.1128/IAI.65.6.2472-2474.1997; Craynest M, 2003, LETT APPL MICROBIOL, V37, P75, DOI 10.1046/j.1472-765X.2003.01357.x; Fabretti F, 2006, INFECT IMMUN, V74, P4164, DOI 10.1128/IAI.00111-06; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Fernie-King BA, 2004, IMMUNOLOGY, V111, P444, DOI 10.1111/j.0019-2805.2004.01837.x; FISCHETTI VA, 1990, MOL MICROBIOL, V4, P1603, DOI 10.1111/j.1365-2958.1990.tb02072.x; Frick IM, 2003, J BIOL CHEM, V278, P16561, DOI 10.1074/jbc.M301995200; Gross M, 2001, INFECT IMMUN, V69, P3423, DOI 10.1128/IAI.69.5.3423-3426.2001; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; Gryllos I, 2007, MOL MICROBIOL, V65, P671, DOI 10.1111/j.1365-2958.2007.05818.x; Hartas J, 1999, MICROB PATHOGENESIS, V26, P25, DOI 10.1006/mpat.1998.0244; Hasty DL, 2006, J IMMUNOL, V176, P5567, DOI 10.4049/jimmunol.176.9.5567; Hoe NP, 2002, P NATL ACAD SCI USA, V99, P7646, DOI 10.1073/pnas.112039899; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; HORSTMANN RD, 1992, INFECT IMMUN, V60, P5036, DOI 10.1128/IAI.60.12.5036-5041.1992; Hunt CL, 2006, J IMMUNOL, V176, P4987, DOI 10.4049/jimmunol.176.8.4987; Hyyrylainen HL, 2000, J BIOL CHEM, V275, P26696; JACKSWEIS J, 1982, J IMMUNOL, V128, P1897; Jeng A, 2003, J BACTERIOL, V185, P1208, DOI 10.1128/JB.185.4.1208-1217.2003; Kazmi SU, 2001, INFECT IMMUN, V69, P4988, DOI 10.1128/IAI.69.8.4988-4995.2001; Koprivnjak T, 2002, J BIOL CHEM, V277, P47636, DOI 10.1074/jbc.M205104200; Koprivnjak T, 2006, J BACTERIOL, V188, P3622, DOI 10.1128/JB.188.10.3622-3630.2006; Kovacs M, 2006, J BACTERIOL, V188, P5797, DOI 10.1128/JB.00336-06; KRAUS W, 1987, J IMMUNOL, V139, P3084; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Kristian SA, 2005, J BACTERIOL, V187, P6719, DOI 10.1128/JB.187.19.6719-6725.2005; LAMBERT PA, 1975, BIOCHEM J, V151, P671, DOI 10.1042/bj1510671; Lancefield RC, 1928, J EXP MED, V47, P91, DOI 10.1084/jem.47.1.91; LANCEFIELD RC, 1957, J EXP MED, V106, P525, DOI 10.1084/jem.106.4.525; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; May JJ, 2005, FEBS J, V272, P2993, DOI 10.1111/j.1742-4658.2005.04700.x; MCIVER KS, 1995, INFECT IMMUN, V63, P4540, DOI 10.1128/IAI.63.11.4540-4542.1995; McIver KS, 1997, J BACTERIOL, V179, P5178, DOI 10.1128/jb.179.16.5178-5187.1997; McLellan DGJ, 2001, INFECT IMMUN, V69, P2943, DOI 10.1128/IAI.69.5.2943-2949.2001; Morfeldt E, 2001, J IMMUNOL, V167, P3870, DOI 10.4049/jimmunol.167.7.3870; Neely MN, 2003, J BACTERIOL, V185, P5166, DOI 10.1128/JB.185.17.5166-5174.2003; Nelson D, 2006, P NATL ACAD SCI USA, V103, P10765, DOI 10.1073/pnas.0604521103; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Nouaille S, 2004, APPL ENVIRON MICROB, V70, P1600, DOI 10.1128/AEM.70.3.1600-1607.2004; Palumbo E, 2006, J BACTERIOL, V188, P3709, DOI 10.1128/JB.188.10.3709-3715.2006; Pandiripally V, 2002, INFECT IMMUN, V70, P6206, DOI 10.1128/IAI.70.11.6206-6214.2002; PEREGO M, 1995, J BIOL CHEM, V270, P15598, DOI 10.1074/jbc.270.26.15598; Perez-Caballero D, 2000, EUR J IMMUNOL, V30, P1243, DOI 10.1002/(SICI)1521-4141(200004)30:4<1243::AID-IMMU1243>3.0.CO;2-D; Peschel A, 2000, ANTIMICROB AGENTS CH, V44, P2845, DOI 10.1128/AAC.44.10.2845-2847.2000; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Steen A, 2005, J BACTERIOL, V187, P114, DOI 10.1128/JB.187.1.114-124.2005; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Thwaite JE, 2002, APPL ENVIRON MICROB, V68, P227, DOI 10.1128/AEM.68.1.227-234.2002; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; WHITNACK E, 1985, J EXP MED, V162, P1983, DOI 10.1084/jem.162.6.1983; WHITNACK E, 1982, J CLIN INVEST, V69, P1042, DOI 10.1172/JCI110508	65	33	35	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5366	10.1371/journal.pone.0005366	http://dx.doi.org/10.1371/journal.pone.0005366			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401780	Green Published, Green Submitted			2022-12-25	WOS:000265601100010
J	Ganguli-Indra, G; Wasylyk, C; Liang, XB; Millon, R; Leid, M; Wasylyk, B; Abecassis, J; Indra, A				Ganguli-Indra, Gitali; Wasylyk, Christine; Liang, Xiaobo; Millon, Regine; Leid, Mark; Wasylyk, Bohdan; Abecassis, Joseph; Indra, Arup			CTIP2 Expression in Human Head and Neck Squamous Cell Carcinoma Is Linked to Poorly Differentiated Tumor Status	PLOS ONE			English	Article							STEM-CELLS; NURD COMPLEX; ORAL-CANCER; BCL11B; GENE; PROMOTER; BMI-1; MARKERS; PROLIFERATION; EPIDEMIOLOGY	Background: We have demonstrated earlier that CTIP2 is highly expressed in mouse skin during embryogenesis and in adulthood. CTIP2 mutant mice die at birth with epidermal differentiation defects and a compromised epidermal permeability barrier suggesting its role in skin development and/or homeostasis. CTIP2 has also been suggested to function as tumor suppressor in cells, and several reports have described a link between chromosomal rearrangements of CTIP2 and human T cell acute lymphoblast leukemia (T-ALL). The aim of the present study was to look into the pattern of CTIP2 expression in Head and Neck Squamous Cell Carcinoma (HNSCC). Methodology/Principal Findings: In the present study, we analyzed CTIP2 expression in human HNSCC cell lines by western blotting, in paraffin embedded archival specimens by immunohistochemistry (IHC), and in cDNA samples of human HNSCC by qRT-PCR. Elevated levels of CTIP2 protein was detected in several HNSCC cell lines. CTIP2 staining was mainly detected in the basal layer of the head and neck normal epithelium. CTIP2 expression was found to be significantly elevated in HNSCC (p, 0.01), and increase in CTIP2 expression was associated with poorly differentiated tumor status. Nuclear co-localization of CTIP2 protein and cancer stem cell (CSC) marker BMI1 was observed in most, if not all of the cells expressing BMI1 in moderately and poorly differentiated tumors. Conclusions/Significance: We report for the first time expression of transcriptional regulator CTIP2 in normal human head and neck epithelia. A statistically significant increase in the expression of CTIP2 was detected in the poorly differentiated samples of the human head and neck tumors. Actual CTIP2, rather than the long form of CTIP2 (CTIP2L) was found to be more relevant to the differentiation state of the tumors. Results demonstrated existence of distinct subsets of cancer cells, which express CTIP2 and underscores the use of CTIP2 and BMI1 co-labeling to distinguish tumor initiating cells or cancer stem cells (CSCs) from surrounding cancer cells.			Ganguli-Indra, G (corresponding author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	indrag@onid.orst.edu; arup.indra@oregonstate.edu	Indra, Gitali/G-2963-2016; Wasylyk, Bohdan/ABG-6778-2020; Indra, Arup/AAG-2376-2019	Wasylyk, Bohdan/0000-0002-1718-1237; Indra, Arup/0000-0001-6137-7555	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR056008] Funding Source: Medline; NIEHS NIH HHS [P30 ES000210, ES00210] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; Avram D, 2002, BIOCHEM J, V368, P555, DOI 10.1042/BJ20020496; Chang SS, 2008, J SURG ONCOL, V97, P640, DOI 10.1002/jso.21023; Chiba T, 2008, CANCER RES, V68, P7742, DOI 10.1158/0008-5472.CAN-07-5882; Cismasiu VB, 2005, ONCOGENE, V24, P6753, DOI 10.1038/sj.onc.1208904; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Friedlander PL, 2003, ARCH OTOLARYNGOL, V129, P363, DOI 10.1001/archotol.129.3.363; GANGULIINDRA G, 2009, EXP DERMATO IN PRESS; Glinsky GV, 2008, J CLIN ONCOL, V26, P2846, DOI 10.1200/JCO.2008.17.0266; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; GOLONZHKA O, 2008, J INVEST DERMATOL; Golonzhka O, 2007, GENE EXPR PATTERNS, V7, P754, DOI 10.1016/j.modgep.2007.06.002; Indra AK, 2005, DEV BIOL, V285, P28, DOI 10.1016/j.ydbio.2005.05.043; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kamimura K, 2007, ONCOGENE, V26, P5840, DOI 10.1038/sj.onc.1210388; Korkaya H, 2007, BIODRUGS, V21, P299, DOI 10.2165/00063030-200721050-00002; Leid M, 2004, GENE EXPR PATTERNS, V4, P733, DOI 10.1016/j.modgep.2004.03.009; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li Y, 2004, CLIN CANCER RES, V10, P8442, DOI 10.1158/1078-0432.CCR-04-1167; Lu SL, 2006, HEAD NECK-J SCI SPEC, V28, P945, DOI 10.1002/hed.20397; Mack B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003360; MacLeod RAF, 2004, CANCER GENET CYTOGEN, V153, P88, DOI 10.1016/j.cancergencyto.2004.02.020; Marur S, 2008, MAYO CLIN PROC, V83, P489, DOI 10.4065/83.4.489; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nowak K, 2006, NUCLEIC ACIDS RES, V34, P1745, DOI 10.1093/nar/gkl119; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Patel V, 2001, CRIT REV ORAL BIOL M, V12, P55, DOI 10.1177/10454411010120010401; Pietersen AM, 2008, CURR BIOL, V18, P1094, DOI 10.1016/j.cub.2008.06.070; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Prince MEP, 2008, J CLIN ONCOL, V26, P2871, DOI 10.1200/JCO.2007.15.1613; Przybylski GK, 2005, LEUKEMIA, V19, P201, DOI 10.1038/sj.leu.2403619; Rodrigo JP, 2003, ACTA OTO-LARYNGOL, V123, P100, DOI 10.1080/0036554021000028073; Satterwhite E, 2001, BLOOD, V98, P3413, DOI 10.1182/blood.V98.12.3413; Schliephake H, 2003, INT J ORAL MAX SURG, V32, P233, DOI 10.1054/ijom.2002.0383; Seghatoleslam A, 2006, BIOCHEM BIOPH RES CO, V339, P422, DOI 10.1016/j.bbrc.2005.11.026; Senawong T, 2005, ARCH BIOCHEM BIOPHYS, V434, P316, DOI 10.1016/j.abb.2004.10.028; SPITZ MR, 1994, SEMIN ONCOL, V21, P281; Topark-Ngarm A, 2006, J BIOL CHEM, V281, P32272, DOI 10.1074/jbc.M602776200; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927	42	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5367	10.1371/journal.pone.0005367	http://dx.doi.org/10.1371/journal.pone.0005367			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399189	Green Published, gold			2022-12-25	WOS:000265514900020
J	Mongiat, LA; Esposito, MS; Lombardi, G; Schinder, AF				Mongiat, Lucas A.; Esposito, M. Soledad; Lombardi, Gabriela; Schinder, Alejandro F.			Reliable Activation of Immature Neurons in the Adult Hippocampus	PLOS ONE			English	Article								Neurons born in the adult dentate gyrus develop, mature, and connect over a long interval that can last from six to eight weeks. It has been proposed that, during this period, developing neurons play a relevant role in hippocampal signal processing owing to their distinctive electrical properties. However, it has remained unknown whether immature neurons can be recruited into a network before synaptic and functional maturity have been achieved. To address this question, we used retroviral expression of green fluorescent protein to identify developing granule cells of the adult mouse hippocampus and investigate the balance of afferent excitation, intrinsic excitability, and firing behavior by patch clamp recordings in acute slices. We found that glutamatergic inputs onto young neurons are significantly weaker than those of mature cells, yet stimulation of cortical excitatory axons elicits a similar spiking probability in neurons at either developmental stage. Young neurons are highly efficient in transducing ionic currents into membrane depolarization due to their high input resistance, which decreases substantially in mature neurons as the inward rectifier potassium (Kir) conductance increases. Pharmacological blockade of Kir channels in mature neurons mimics the high excitability characteristic of young neurons. Conversely, Kir overexpression induces mature-like firing properties in young neurons. Therefore, the differences in excitatory drive of young and mature neurons are compensated by changes in membrane excitability that render an equalized firing activity. These observations demonstrate that the adult hippocampus continuously generates a population of highly excitable young neurons capable of information processing.			Mongiat, LA (corresponding author), Consejo Nacl Invest Cient & Tecn, Leloir Inst, Lab Neuronal Plast, RA-1033 Buenos Aires, DF, Argentina.	aschinder@leloir.org.ar	Mongiat, Lucas/GXG-5680-2022	Mongiat, Lucas/0000-0003-2643-8062; Esposito, Maria Soledad/0000-0003-0673-4219; Schinder, Alejandro/0000-0003-4863-8348	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Ambrogini P, 2004, BRAIN RES, V1017, P21, DOI 10.1016/j.brainres.2004.05.039; Atherton JF, 2005, J NEUROSCI, V25, P8272, DOI 10.1523/JNEUROSCI.1475-05.2005; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Cathala L, 2003, J NEUROSCI, V23, P6074, DOI 10.1523/JNEUROSCI.23-14-06074.2003; Couillard-Despres S, 2006, EUR J NEUROSCI, V24, P1535, DOI 10.1111/j.1460-9568.2006.05039.x; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Enikolopov Grigori, 2008, V52, P81; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Faulkner RL, 2008, P NATL ACAD SCI USA, V105, P14157, DOI 10.1073/pnas.0806658105; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Hille B., 2001, ION CHANNELS EXCITAB, P131; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; Karschin C, 1996, J NEUROSCI, V16, P3559; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Laplagne DA, 2007, EUR J NEUROSCI, V25, P2973, DOI 10.1111/j.1460-9568.2007.05549.x; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Owen JM, 1999, EXP PHYSIOL, V84, P471, DOI 10.1017/S0958067099018060; Pratt KG, 2007, J NEUROSCI, V27, P8268, DOI 10.1523/JNEUROSCI.1738-07.2007; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Schmidt-Hieber C, 2008, J PHYSIOL-LONDON, V586, P1849, DOI 10.1113/jphysiol.2007.150151; Schulz DJ, 2006, J EXP BIOL, V209, P4821, DOI 10.1242/jeb.02567; Takigawa T, 2002, J PHYSIOL-LONDON, V539, P67, DOI 10.1113/jphysiol.2001.012883; Tanaka S, 2003, J NEUROPHYSIOL, V89, P1288, DOI 10.1152/jn.00850.2002; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Treves A, 2008, NEUROSCIENCE, V154, P1155, DOI 10.1016/j.neuroscience.2008.04.073; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	46	177	180	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5320	10.1371/journal.pone.0005320	http://dx.doi.org/10.1371/journal.pone.0005320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399173	Green Submitted, Green Published, gold			2022-12-25	WOS:000265514900002
J	Adam, R; Gunturkun, O				Adam, Ruth; Guentuerkuen, Onur			When One Hemisphere Takes Control: Metacontrol in Pigeons (Columba livia)	PLOS ONE			English	Article							INTERHEMISPHERIC INTERACTION; INFORMATION; DOMINANCE; CUES	Background: Vertebrate brains are composed of two hemispheres that receive input, compute, and interact to form a unified response. How the partially different processes of both hemispheres are integrated to create a single output is largely unknown. In some cases one hemisphere takes charge of the response selection-a process known as metacontrol. Thus far, this phenomenon has only been shown in a handful of studies with primates, mostly conducted in humans. Metacontrol, however, is even more relevant for animals like birds with laterally placed eyes and complete chiasmatic decussation since visual input to the hemispheres is largely different. Methodology/Principal Findings: Homing pigeons (Columba livia) were trained with a color discrimination task. Each hemisphere was trained with a different color pair and therefore had a different experience. Subsequently, the pigeons were binocularly examined with two additional stimuli that combined the positive color of one hemisphere with a negative color that had been shown to the other, omitting the availability of a coherent solution and confronting the pigeons with a conflicting situation. Some of the pigeons responded to both stimuli, indicating that none of the hemispheres dominated the overall preference. Some birds, however, responded primarily to one of the conflicting stimuli, showing that they based their choice on the left-or right-monocularly learned color pair, indicating hemispheric metacontrol. Conclusions/Significance: We could demonstrate for the first time that metacontrol is a widespread phenomenon that also exists in birds, and thus in principle requires no corpus callosum. Our results are closely similar to those in humans: monocular performance was higher than binocular one and animals displayed different modes of hemispheric dominance. Thus, metacontrol is a dynamic and widely distributed process that possibly constitutes a requirement for all animals with a bipartite brain to confront the problem of choosing between two hemisphere-bound behavioral options.			Adam, R (corresponding author), Max Planck Inst Biol Cybernet, Tubingen, Germany.	ruth.adam@tuebingen.mpg.de		Gunturkun, Onur/0000-0003-4173-5233				BELGER A, 1992, NEUROPSYCHOLOGIA, V30, P923, DOI 10.1016/0028-3932(92)90036-L; Bloom JS, 2005, NEUROPSYCHOL REV, V15, P59, DOI 10.1007/s11065-005-6252-y; Gunturkun Onur, 2000, P1, DOI 10.1016/B978-012747605-6/50002-X; HARDY O, 1984, BRAIN RES, V311, P65, DOI 10.1016/0006-8993(84)91399-4; HELLIGE JB, 1990, ANNU REV PSYCHOL, V41, P55, DOI 10.1146/annurev.ps.41.020190.000415; HELLIGE JB, 1989, J EXP PSYCHOL HUMAN, V15, P711, DOI 10.1037/0096-1523.15.4.711; HELLIGE JB, 1988, BRAIN COGNITION, V7, P39, DOI 10.1016/0278-2626(88)90020-6; HELLIGE JB, 1989, MEM COGNITION, V17, P770, DOI 10.3758/BF03202638; HERRNSTEIN RJ, 1976, J EXP PSYCHOL ANIM B, V2, P285, DOI 10.1037/0097-7403.2.4.285; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Jimenez Ortega L, 2008, BEHAV BRAIN RES, V193, P69, DOI 10.1016/j.bbr.2008.04.022; Kavcic V, 2000, BEHAV BRAIN RES, V111, P71, DOI 10.1016/S0166-4328(00)00141-8; LAZARUSMAINKA G, 1978, PSYCHOL RES-PSYCH FO, V40, P15, DOI 10.1007/BF00308460; LEVY J, 1976, J EXP PSYCHOL HUMAN, V2, P299, DOI 10.1037/0096-1523.2.3.299; Prior H, 2001, LEARN MEMORY, V8, P44, DOI 10.1101/lm.36201; ROBERT F, 1969, EXP BRAIN RES, V9, P123; Rose J, 2008, J NEUROSCI METH, V175, P104, DOI 10.1016/j.jneumeth.2008.08.006; Skiba M, 2000, BRAIN LANG, V73, P254, DOI 10.1006/brln.2000.2306; Theiss MPH, 2003, NEUROREPORT, V14, P879, DOI 10.1097/00001756-200305060-00021; Urgesi C, 2005, COGNITIVE BRAIN RES, V24, P513, DOI 10.1016/j.cogbrainres.2005.03.005; Weekes NY, 1997, NEUROPSYCHOLOGIA, V35, P37, DOI 10.1016/S0028-3932(96)00042-5; WEIDNER C, 1985, BRAIN RES, V340, P99, DOI 10.1016/0006-8993(85)90778-4; Yamazaki Y, 2007, COGNITION, V104, P315, DOI 10.1016/j.cognition.2006.07.004	23	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5307	10.1371/journal.pone.0005307	http://dx.doi.org/10.1371/journal.pone.0005307			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437VE	19390578	Green Submitted, Green Published, gold			2022-12-25	WOS:000265514200018
J	Jain, R; Kumar, S; Gourinath, S; Bhattacharya, S; Bhattacharya, A				Jain, Ruchi; Kumar, Shivesh; Gourinath, Samudrala; Bhattacharya, Sudha; Bhattacharya, Alok			N- and C-Terminal Domains of the Calcium Binding Protein EhCaBP1 of the Parasite Entamoeba histolytica Display Distinct Functions	PLOS ONE			English	Article								Entamoeba histolytica, a protozoan parasite, is the causative agent of amoebiasis, and calcium signaling is thought to be involved in amoebic pathogenesis. EhCaBP1, a Ca(2+) binding protein of E. histolytica, is essential for parasite growth. High resolution crystal structure of EhCaBP1 suggested an unusual arrangement of the EF-hand domains in the N-terminal part of the structure, while C-terminal part of the protein was not traced. The structure revealed a trimer with amino terminal domains of the three molecules interacting in a head-to-tail manner forming an assembled domain at the interface with EF1 and EF2 motifs of different molecules coming close to each other. In order to understand the specific roles of the two domains of EhCaBP1, the molecule was divided into two halves, and each half was separately expressed. The domains were characterized with respect to their structure, as well as specific functional features, such as ability to activate kinase and bind actin. The domains were also expressed in E. histolytica cells along with green fluorescent protein. The results suggest that the N-terminal domain retains some of the properties, such as localization in phagocytic cups and activation of kinase. Crystal structure of EhCaBP1 with Phenylalanine revealed that the assembled domains, which are similar to Calmodulin N-terminal domain, bind to Phenylalanine revealing the binding mode to the target proteins. The C-terminal domain did not show any of the activities tested. However, over-expression in amebic cells led to a dominant negative phenotype. The results suggest that the two domains of EhCaBP1 are functionally and structurally different from each other. Both the domains are required for structural stability and full range of functional diversity.			Jain, R (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	alok.bhattacharya@gmail.com						BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bhattacharya A, 2006, ARCH MED RES, V37, P221, DOI 10.1016/j.arcmed.2005.10.002; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chakrabarty P, 2004, J BIOL CHEM, V279, P12898, DOI 10.1074/jbc.M304716200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Gopal B, 1997, BIOCHEMISTRY-US, V36, P10910, DOI 10.1021/bi9702546; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; Hirata KK, 2007, EXP PARASITOL, V115, P192, DOI 10.1016/j.exppara.2006.08.004; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Jain R, 2008, CELL MICROBIOL, V10, P1373, DOI 10.1111/j.1462-5822.2008.01134.x; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Kumar S, 2007, PROTEINS, V68, P990, DOI 10.1002/prot.21455; KUNG C, 1992, CELL CALCIUM, V13, P413, DOI 10.1016/0143-4160(92)90054-V; Mohan PMK, 2008, PROTEINS, V70, P1147, DOI 10.1002/prot.21751; Moreno SNJ, 2003, CURR OPIN MICROBIOL, V6, P359, DOI 10.1016/S1369-5274(03)00091-2; Mukherjee S, 2007, BIOCHEMISTRY-US, V46, P9911, DOI 10.1021/bi700477h; OROZCO E, 1983, J EXP MED, V158, P1511, DOI 10.1084/jem.158.5.1511; PRASAD J, 1992, MOL BIOCHEM PARASIT, V52, P137, DOI 10.1016/0166-6851(92)90044-K; Sahoo N, 2004, J CELL SCI, V117, P3625, DOI 10.1242/jcs.01198; Sahoo N, 2003, MOL BIOCHEM PARASIT, V126, P281, DOI 10.1016/S0166-6851(02)00284-0; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; SUNDARALINGAM M, 1985, SCIENCE, V227, P945, DOI 10.1126/science.3969570; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Yadava N, 1997, MOL BIOCHEM PARASIT, V84, P69, DOI 10.1016/S0166-6851(96)02782-X; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33	29	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5269	10.1371/journal.pone.0005269	http://dx.doi.org/10.1371/journal.pone.0005269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384409	Green Published, gold, Green Submitted			2022-12-25	WOS:000265513900013
J	Lanaspa, MA; Andres-Hernando, A; Rivard, CJ; Dai, Y; Li, NX; Berl, T				Lanaspa, Miguel A.; Andres-Hernando, Ana; Rivard, Christopher J.; Dai, Yue; Li, Nanxing; Berl, Tomas			ZAC1 Is Up-regulated by Hypertonicity and Decreases Sorbitol Dehydrogenase Expression, Allowing Accumulation of Sorbitol in Kidney Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING PROTEIN; ALDOSE REDUCTASE; OSMOTIC-STRESS; CELLULAR-RESPONSE; DIABETIC-RATS; RENAL-CELLS; GENE; TONICITY; ADAPTATION; MEDULLA	Affymetrix GeneChip technology was employed to detect differentially expressed genes in inner medullary collecting duct (IMCD3) cells grown under isotonic and hypertonic conditions. A marked up-regulation was found for the zinc-finger protein ZAC1 under hypertonic stress (219-fold, p < 0.001). Changes in expression for ZAC1 were verified by quantitative PCR for message and Western blotting for protein. In mouse and human kidney tissues, ZAC1 expression was substantial in the papilla and was absent in the cortex. Furthermore, ZAC1 expression significantly increased in the papilla of mice following 36 h of fluid restriction and decreased in polyuric mice consuming sucrose in water. Because ZAC1 has been described to be a potential negative regulator of sorbitol dehydrogenase (SDH) in hippocampal cells, we examined whether this relationship also occurs in kidney cells under hypertonic stress. We found that stable IMCD3 clones silenced for ZAC1 to varying levels demonstrated an inverse effect on SDH expression. ZAC1 binds to a consensus repression site within the promoter of SDH, pointing to a mechanism whereby ZAC1 acts by repressing SDH transcriptional activity during hypertonic conditions. Taken together, these data strongly suggest that ZAC1 is up-regulated under hypertonic stress and negatively regulates expression of SDH, allowing for accumulation of sorbitol as a compatible organic osmolyte.	[Lanaspa, Miguel A.; Andres-Hernando, Ana; Rivard, Christopher J.; Dai, Yue; Li, Nanxing; Berl, Tomas] Univ Colorado, Dept Renal Dis & Hypertens, Hlth Sci Ctr, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Berl, T (corresponding author), Univ Colorado, Dept Renal Dis & Hypertens, Hlth Sci Ctr, 12700 E 19th Ave,C281, Aurora, CO 80045 USA.	tomas.berl@ucdenver.edu	Lanaspa, Miguel/AAO-4971-2020	Andres-Hernando, Ana/0000-0002-0676-0188	National Institutes of Health [DK-19928, DK-66544]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK019928, R01DK066544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-19928 and DK-66544 (to T.B.).	Abdollahi A, 1997, CANCER RES, V57, P2029; Abdollahi A, 2007, J CELL PHYSIOL, V210, P16, DOI 10.1002/jcp.20835; Andres-Hernando A, 2008, J BIOL CHEM, V283, P25082, DOI 10.1074/jbc.M802381200; Barz T, 2006, CANCER RES, V66, P11975, DOI 10.1158/0008-5472.CAN-06-1529; Beck FX, 1998, PFLUG ARCH EUR J PHY, V436, P814, DOI 10.1007/s004240050710; Berl T, 2000, AM J KIDNEY DIS, V35, pXLVII, DOI 10.1016/S0272-6386(00)70035-7; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; Burger-Kentischer A, 1999, KIDNEY INT, V55, P1417, DOI 10.1046/j.1523-1755.1999.00382.x; Capasso JM, 2003, ANN NY ACAD SCI, V986, P410, DOI 10.1111/j.1749-6632.2003.tb07222.x; Capasso JM, 2001, AM J PHYSIOL-RENAL, V280, pF768, DOI 10.1152/ajprenal.2001.280.5.F768; Dmitrieva NI, 2005, MUTAT RES-FUND MOL M, V569, P65, DOI 10.1016/j.mrfmmm.2004.06.053; Flogel U, 1996, DEV NEUROSCI-BASEL, V18, P449, DOI 10.1159/000111440; Grunewald RW, 1998, CELL PHYSIOL BIOCHEM, V8, P293, DOI 10.1159/000016291; Handler JS, 2001, KIDNEY INT, V60, P408, DOI 10.1046/j.1523-1755.2001.060002408.x; Handler JS, 2001, NEPHRON, V87, P106, DOI 10.1159/000045897; Handler JS, 1996, KIDNEY INT, V49, P1682, DOI 10.1038/ki.1996.246; Hoffmann A, 2003, MOL CELL BIOL, V23, P988, DOI 10.1128/MCB.23.3.988-1003.2003; Hoffmann A, 1998, ANN NY ACAD SCI, V865, P49, DOI 10.1111/j.1749-6632.1998.tb11162.x; Huang SM, 2001, ONCOGENE, V20, P2134, DOI 10.1038/sj.onc.1204298; Jeon US, 2006, ACTA PHYSIOL, V187, P241, DOI 10.1111/j.1748-1716.2006.01551.x; Kador PF, 1998, EXP EYE RES, V67, P203, DOI 10.1006/exer.1998.0502; Klawitter J, 2008, NEPHRON PHYSIOL, V109, pP1, DOI 10.1159/000129074; Lanaspa MA, 2007, P NATL ACAD SCI USA, V104, P13672, DOI 10.1073/pnas.0702752104; LEE AYW, 1995, P NATL ACAD SCI USA, V92, P2780, DOI 10.1073/pnas.92.7.2780; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; MORIYAMA T, 1989, J BIOL CHEM, V264, P16810; Pagotto U, 1999, ENDOCRINOLOGY, V140, P987, DOI 10.1210/en.140.2.987; Petrash JM, 2004, CELL MOL LIFE SCI, V61, P737, DOI 10.1007/s00018-003-3402-3; Piras G, 2000, MOL CELL BIOL, V20, P3308, DOI 10.1128/MCB.20.9.3308-3315.2000; Raccah D, 1998, J DIABETES COMPLICAT, V12, P154, DOI 10.1016/S1056-8727(97)00093-7; RAUCHMAN MI, 1993, AM J PHYSIOL, V265, pF416, DOI 10.1152/ajprenal.1993.265.3.F416; Rivard CJ, 2007, J BIOL CHEM, V282, P6644, DOI 10.1074/jbc.M609432200; Spengler D, 1997, EMBO J, V16, P2814, DOI 10.1093/emboj/16.10.2814; Woo SK, 2000, AM J PHYSIOL-RENAL, V278, pF1006; Woo SK, 2002, INT REV CYTOL, V215, P189	36	9	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19974	19981		10.1074/jbc.M109.001792	http://dx.doi.org/10.1074/jbc.M109.001792			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19423711	Green Published, hybrid			2022-12-25	WOS:000268097400024
J	Diouf, B; Collazos, A; Labesse, G; Macari, F; Choquet, A; Clair, P; Gauthier-Rouviere, C; Guerineau, NC; Jay, P; Hollande, F; Joubert, D				Diouf, Barthelemy; Collazos, Alejandra; Labesse, Gilles; Macari, Francoise; Choquet, Armelle; Clair, Philippe; Gauthier-Rouviere, Cecile; Guerineau, Nathalie C.; Jay, Philippe; Hollande, Frederic; Joubert, Dominique			A 20-Amino Acid Module of Protein Kinase C epsilon Involved in Translocation and Selective Targeting at Cell-Cell Contacts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PKC-EPSILON; 14-3-3 BINDING; V3 REGION; T-CELLS; DOMAIN; ALPHA; ACTIVATION; PITUITARY; IDENTIFICATION; GOLGI	In the pituitary gland, activated protein kinase C (PKC) isoforms accumulate either selectively at the cell-cell contact (alpha and epsilon) or at the entire plasma membrane (beta 1 and delta). The molecular mechanisms underlying these various subcellular locations are not known. Here, we demonstrate the existence within PKC epsilon of a cell-cell contact targeting sequence (3CTS) that, upon stimulation, is capable of targeting PKC delta, chimerin-alpha 1, and the PKC epsilon C1 domain to the cell-cell contact. We show that this selective targeting of PKC epsilon is lost upon overexpression of 3CTS fused to a (R-Ahx-R)(4) (where Ahx is 6-aminohexanoic acid) vectorization peptide, reflecting a dominant-negative effect of the overexpressed 3CTS on targeting selectivity. 3CTS contains a putative amphipathic alpha-helix, a 14-3-3-binding site, and the Glu-374 amino acid, involved in targeting selectivity. We show that the integrity of the alpha-helix is important for translocation but that 14-3-3 is not involved in targeting selectivity. However, PKC epsilon translocation is increased when PKC epsilon/14-3-3 interaction is abolished, suggesting that phorbol 12-myristate 13-acetate activation may initiate two sets of PKC epsilon functions, those depending on 14-3-3 and those depending on translocation to cell-cell contacts. Thus, 3CTS is involved in the modulation of translocation via its 14-3-3-binding site, in cytoplasmic desequestration via the alpha-helix, and in selective PKC epsilon targeting at the cell-cell contact via Glu-374.	[Diouf, Barthelemy; Collazos, Alejandra; Macari, Francoise; Choquet, Armelle; Jay, Philippe; Hollande, Frederic; Joubert, Dominique] Univ Montpellier 1, INSERM, CNRS, UMR5203,U661, F-34094 Montpellier 5, France; [Diouf, Barthelemy; Collazos, Alejandra; Macari, Francoise; Choquet, Armelle; Jay, Philippe; Hollande, Frederic; Joubert, Dominique] Univ Montpellier 2, INSERM, CNRS, UMR5203,U661, F-34094 Montpellier 5, France; [Diouf, Barthelemy; Collazos, Alejandra; Macari, Francoise; Choquet, Armelle; Jay, Philippe; Hollande, Frederic; Joubert, Dominique] Inst Genom Fonct, Dept Cellular & Mol Oncol, F-34094 Montpellier 5, France; [Guerineau, Nathalie C.] Inst Genom Fonct, Dept Endocrinol, F-34094 Montpellier 5, France; [Labesse, Gilles] Univ Montpellier 1, INSERM, CNRS, Struct Biol Ctr,UMR5048,U554, F-34094 Montpellier 5, France; [Clair, Philippe] Univ Montpellier 2, Plateforme qPCR Haut Debit, F-34095 Montpellier, France; [Gauthier-Rouviere, Cecile] CNRS Format Rech, Ctr Rech Biochim Macromol, F-34293 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Hollande, F (corresponding author), Univ Montpellier 1, INSERM, CNRS, UMR5203,U661, 141 Rue Cardonille, F-34094 Montpellier 5, France.	frederic.hollande@univ-montpl.fr; dominique.joubert@igf.cnrs.fr	macari, francoise/E-9941-2014; Hollande, Frederic/GLS-4120-2022; Jay, Philippe/I-7116-2016; Wegglin, Reto/AAV-4341-2021; Hollande, Frederic/E-3133-2013; Jay, Philippe/ABD-9223-2020	macari, francoise/0000-0001-8942-1845; Hollande, Frederic/0000-0002-7046-8392; Jay, Philippe/0000-0003-0156-5700; Jay, Philippe/0000-0003-0156-5700; Labesse, Gilles/0000-0002-6861-3300; Choquet, armelle/0000-0002-6959-9387; GAUTHIER-ROUVIERE, Cecile/0000-0002-8364-3882; Guerineau, Nathalie/0000-0003-2517-4210	Ministere de la Recherche et de la pour la Recherche contre le Cancer [5695]	Ministere de la Recherche et de la pour la Recherche contre le Cancer	This work was supported by the Ministere de la Recherche et de la pour la Recherche contre le Cancer Grant 5695.	Abes S, 2006, J CONTROL RELEASE, V116, P304, DOI 10.1016/j.jconrel.2006.09.011; ALVARO V, 1993, J CLIN ENDOCR METAB, V77, P1125, DOI 10.1210/jc.77.5.1125; Aschrafi A, 2003, BBA-MOL CELL BIOL L, V1634, P30, DOI 10.1016/j.bbalip.2003.08.004; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Collazos A, 2006, MOL CELL BIOL, V26, P2247, DOI 10.1128/MCB.26.6.2247-2261.2006; Csukai M, 1997, J BIOL CHEM, V272, P29200, DOI 10.1074/jbc.272.46.29200; Douguet D, 2001, BIOINFORMATICS, V17, P752, DOI 10.1093/bioinformatics/17.8.752; Durgan J, 2008, BIOCHEM J, V411, P319, DOI [10.1042/BJ20071348, 10.1042/bj20071348]; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Guerineau NC, 1998, J BIOL CHEM, V273, P10389, DOI 10.1074/jbc.273.17.10389; HOCEVAR BA, 1991, J BIOL CHEM, V266, P28; Huang JY, 2002, P NATL ACAD SCI USA, V99, P9369, DOI 10.1073/pnas.142298399; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Johnson JE, 2000, BIOCHEMISTRY-US, V39, P11360, DOI 10.1021/bi000902c; Larsen EC, 2000, J IMMUNOL, V165, P2809, DOI 10.4049/jimmunol.165.5.2809; LEHEL C, 1995, P NATL ACAD SCI USA, V92, P1406, DOI 10.1073/pnas.92.5.1406; Louis K, 2005, J BIOL CHEM, V280, P1272, DOI 10.1074/jbc.M405482200; MattoYelin M, 1997, MOL BIOL CELL, V8, P1889, DOI 10.1091/mbc.8.10.1889; Meller N, 1996, MOL CELL BIOL, V16, P5782; Mochly-Rosen D, 1998, FASEB J, V12, P35; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; NEWTON AC, 1993, ANNU REV BIOPH BIOM, V22, P1, DOI 10.1146/annurev.bb.22.060193.000245; Nishizuka Y, 2003, J BIOCHEM, V133, P155, DOI 10.1093/jb/mvg035; O'Keefe JP, 2004, P NATL ACAD SCI USA, V101, P9351, DOI 10.1073/pnas.0305965101; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Pauken CM, 1999, MOL REPROD DEV, V54, P135, DOI 10.1002/(SICI)1098-2795(199910)54:2&lt;135::AID-MRD5&gt;3.0.CO;2-A; PREVOSTEL C, 1995, ONCOGENE, V11, P669; Quittau-Prevostel C, 2004, J CELL SCI, V117, P63, DOI 10.1242/jcs.00832; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Saurin AT, 2008, NAT CELL BIOL, V10, P891, DOI 10.1038/ncb1749; Schmalz D, 1998, J CELL SCI, V111, P1823; Schultz A, 2004, J BIOL CHEM, V279, P31750, DOI 10.1074/jbc.M313017200; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Takahashi M, 2000, J BIOL CHEM, V275, P34592, DOI 10.1074/jbc.M005285200; Vallentin A, 2001, MOL CELL BIOL, V21, P3351, DOI 10.1128/MCB.21.10.3351-3363.2001; Watkins JL, 2008, P NATL ACAD SCI USA, V105, P18378, DOI 10.1073/pnas.0809661105; Zhu YM, 2005, CANCER RES, V65, P4520, DOI 10.1158/0008-5472.CAN-04-4506	39	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18808	18815		10.1074/jbc.M109.004614	http://dx.doi.org/10.1074/jbc.M109.004614			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19429675	Green Published, hybrid			2022-12-25	WOS:000267711500030
J	Hurley, JM; Woychik, NA				Hurley, Jennifer M.; Woychik, Nancy A.			Bacterial Toxin HigB Associates with Ribosomes and Mediates Translation-dependent mRNA Cleavage at A-rich Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; PROGRAMMED CELL-DEATH; ESCHERICHIA-COLI; MULTIDRUG TOLERANCE; PROTEUS-MIRABILIS; ANTITOXIN MODULE; VIBRIO-CHOLERAE; PLASMID RTS1; IN-VIVO; LOCI	Most pathogenic Proteus species are primarily associated with urinary tract infections, especially in persons with indwelling catheters or functional/anatomic abnormalities of the urinary tract. Urinary tract infections caused by Proteus vulgaris typically form biofilms and are resistant to commonly used antibiotics. The Rts1 conjugative plasmid from a clinical isolate of P. vulgaris carries over 300 predicted open reading frames, including antibiotic resistance genes. The maintenance of the Rts1 plasmid is ensured in part by the HigBA toxin-antitoxin system. We determined the precise mechanism of action of the HigB toxin in vivo, which is distinct from other known toxins. We demonstrate that HigB is an endoribonuclease whose enzymatic activity is dependent on association with ribosomes through the 50 S subunit. Using primer extension analysis of several test mRNAs, we showed that HigB cleaved extensively across the entire length of coding regions only at specific recognition sequences. HigB mediated cleavage of 100% of both in-frame and out-of-frame AAA sequences. In addition, HigB cleaved similar to 20% of AA sequences in coding regions and occasionally cut single As. Remarkably, the cleavage specificity of HigB coincided with one of the most frequently used codons in the AT-rich Proteus spp., AAA (lysine). Therefore, the HigB-mediated plasmid maintenance system for the Rts1 plasmid highlights the intimate relationship between host cells and extrachromosomal DNA that enables the dynamic acquisition of genes that impart a spectrum of survival advantages, including those encoding multidrug resistance and virulence factors.	[Hurley, Jennifer M.; Woychik, Nancy A.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Woychik, NA (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, 675 Hoes La, Piscataway, NJ 08854 USA.	nancy.woychik@umdnj.edu		Hurley, Jennifer/0000-0002-1085-9391	National Institutes of Health [GM74097, U54, GM74958]; Takara Bio, Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074958, R01GM074097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takara Bio, Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM74097 and U54 Grant GM74958 (NE Structural Genomics Consortium). This work was also supported by Takara Bio, Inc.	Amitai S, 2004, J BACTERIOL, V186, P8295, DOI 10.1128/JB.186.24.8295-8300.2004; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brock JE, 2007, J BACTERIOL, V189, P501, DOI 10.1128/JB.01356-06; Budde PP, 2007, J BACTERIOL, V189, P491, DOI 10.1128/JB.00909-06; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; EHRETSMANN CP, 1992, GENE DEV, V6, P149, DOI 10.1101/gad.6.1.149; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; FALKOW S, 1962, J BACTERIOL, V83, P1318, DOI 10.1128/JB.83.6.1318-1321.1962; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; HIRASHIMA A, 1973, NATURE, V242, P405, DOI 10.1038/242405a0; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Motiejunaite R, 2007, FEMS MICROBIOL LETT, V268, P112, DOI 10.1111/j.1574-6968.2006.00563.x; Munoz-Gomez AJ, 2004, FEBS LETT, V567, P316, DOI 10.1016/j.febslet.2004.05.005; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pearson MM, 2008, J BACTERIOL, V190, P4027, DOI 10.1128/JB.01981-07; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Redko Y, 2003, J BIOL CHEM, V278, P44001, DOI 10.1074/jbc.M306760200; SARMIENTOS P, 1983, CELL, V32, P1337, DOI 10.1016/0092-8674(83)90314-8; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Stenstrom CM, 2001, GENE, V263, P273, DOI 10.1016/S0378-1119(00)00550-3; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; TERAWAKI Y, 1972, J BACTERIOL, V109, P492, DOI 10.1128/JB.109.2.492-498.1972; TERAWAKI Y, 1967, J BACTERIOL, V94, P687, DOI 10.1128/JB.94.3.687-690.1967; Tian QB, 1996, BIOCHEM BIOPH RES CO, V220, P280, DOI 10.1006/bbrc.1996.0396; Tian QB, 1996, BIOCHEM BIOPH RES CO, V225, P679, DOI 10.1006/bbrc.1996.1229; Wang HC, 2002, NUCLEIC ACIDS RES, V30, P2501, DOI 10.1093/nar/30.11.2501; Zhang YL, 2005, J BIOL CHEM, V280, P26080, DOI 10.1074/jbc.M502050200; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang YL, 2005, J BIOL CHEM, V280, P3143, DOI 10.1074/jbc.M411811200; Zhang Y, 2009, J BIOL CHEM, V284, P6627, DOI 10.1074/jbc.M808779200	40	95	101	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18605	18613		10.1074/jbc.M109.008763	http://dx.doi.org/10.1074/jbc.M109.008763			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19423702	Green Published, hybrid			2022-12-25	WOS:000267711500009
J	Winkler, L; Gehring, C; Wenzel, A; Muller, SL; Piehl, C; Krause, G; Blasig, IE; Piontek, J				Winkler, Lars; Gehring, Claudia; Wenzel, Ariane; Mueller, Sebastian L.; Piehl, Christian; Krause, Gerd; Blasig, Ingolf E.; Piontek, Joerg			Molecular Determinants of the Interaction between Clostridium perfringens Enterotoxin Fragments and Claudin-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL FRAGMENT; TIGHT JUNCTION REGULATION; DRUG DISCOVERY; AMINO-ACIDS; ABSORPTION; PROTEINS; MODULATOR; MEMBRANE; OCCLUDIN; BARRIER	Clostridium perfringens enterotoxin (CPE) binds to the extracellular loop 2 of a subset of claudins, e. g. claudin-3. Here, the molecular mechanism of the CPE-claudin interaction was analyzed. Using peptide arrays, recombinant CPE-(116-319) bound to loop 2 peptides of mouse claudin-3, -6, -7, -9, and -14 but not of 1, 2, 4, 5, 8, 10-13, 15, 16, 18-20, and 22. Substitution peptide mapping identified the central motif (NPLVP)-N-148-V-150, supposed to represent a turn region in the loop 2, as essential for the interaction between CPE and murine claudin-3 peptides. CPE-binding assays with claudin-3 mutant- transfected HEK293 cells or lysates thereof demonstrated the involvement of Asn(148) and Leu(150) of full-length claudin-3 in the binding. CPE-(116-319) and CPE-(194-319) bound to HEK293 cells expressing claudin-3, whereas CPE-(116-319) bound to claudin-5-expressing HEK293 cells, also. This binding was inhibited by substitutions T151A and Q156E in claudin-5. In contrast, removal of the aromatic side chains in the loop 2 of claudin-3 and -5, involved in trans-interaction between claudins, increased the amount of CPE-(116-319) bound. These findings and molecular modeling indicate different molecular mechanisms of claudin-claudin trans-interaction and claudin-CPE interaction. Confocal microscopy showed that CPE-(116-319) and CPE-(194-319) bind to claudin-3 at the plasma membrane, outside cell-cell contacts. Together, these findings demonstrate that CPE binds to the hydrophobic turn and flanking polar residues in the loop 2 of claudin-3 outside tight junctions. The data can be used for the specific design of CPE- based modulators of tight junctions, to improve drug delivery, and as chemotherapeutics for tumors overexpressing claudins.	[Winkler, Lars; Gehring, Claudia; Wenzel, Ariane; Mueller, Sebastian L.; Piehl, Christian; Krause, Gerd; Blasig, Ingolf E.; Piontek, Joerg] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Blasig, IE (corresponding author), Leibniz Inst Mol Pharmacol, Robert Rossle Str 10, D-13125 Berlin, Germany.	iblasig@fmp-berlin.de; piontek@fmp-berlin.de	Winkler, Lars/M-6134-2014; Piontek, Joerg/K-6305-2013; Piontek, Joerg/F-8549-2011; Winkler, Lars/D-1949-2012	Winkler, Lars/0000-0003-3350-1189; Piontek, Joerg/0000-0002-0880-8915; Piehl, Christian/0000-0002-1054-0081				Adak GK, 2002, GUT, V51, P832, DOI 10.1136/gut.51.6.832; Andreeva AY, 2001, J BIOL CHEM, V276, P38480, DOI 10.1074/jbc.M104923200; Aungst BJ, 2000, J PHARM SCI, V89, P429, DOI 10.1002/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO;2-J; Blasig IE, 2006, CELL MOL LIFE SCI, V63, P505, DOI 10.1007/s00018-005-5472-x; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; Coyne CB, 2003, AM J PHYSIOL-LUNG C, V285, pL1166, DOI 10.1152/ajplung.00182.2003; Ebihara C, 2006, J PHARMACOL EXP THER, V316, P255, DOI 10.1124/jpet.105.093351; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Fujita K, 2000, FEBS LETT, V476, P258, DOI 10.1016/S0014-5793(00)01744-0; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; HANNA PC, 1991, J BIOL CHEM, V266, P11037; Harada M, 2007, BIOCHEM PHARMACOL, V73, P206, DOI 10.1016/j.bcp.2006.10.002; HOCHMAN J, 1994, J CONTROL RELEASE, V29, P253, DOI 10.1016/0168-3659(94)90072-8; Kokai-Kun JF, 1999, INFECT IMMUN, V67, P5634, DOI 10.1128/IAI.67.11.5634-5641.1999; Kominsky SL, 2007, CANCER RES, V67, P7977, DOI 10.1158/0008-5472.CAN-07-1314; Kondoh M, 2005, MOL PHARMACOL, V67, P749, DOI 10.1124/mol.104.008375; Kondoh M, 2006, BIOL PHARM BULL, V29, P1783, DOI 10.1248/bpb.29.1783; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Ling J, 2008, J BIOL CHEM, V283, P30585, DOI 10.1074/jbc.M803548200; Masuyama A, 2005, J PHARMACOL EXP THER, V314, P789, DOI 10.1124/jpet.105.085399; Mitic LL, 2003, PROTEIN SCI, V12, P218, DOI 10.1110/ps.0233903; Mizuno N, 2003, PHARMACOL REV, V55, P425, DOI 10.1124/pr.55.3.1; Morin PJ, 2007, DIS MARKERS, V23, P453, DOI 10.1155/2007/674058; Nishikawa K, 2006, FASEB J, V20, P2597, DOI 10.1096/fj.06-6572fje; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; Robertson SL, 2007, CELL MICROBIOL, V9, P2734, DOI 10.1111/j.1462-5822.2007.00994.x; Salama NN, 2006, ADV DRUG DELIVER REV, V58, P15, DOI 10.1016/j.addr.2006.01.003; Santin AD, 2007, CANCER, V109, P1312, DOI 10.1002/cncr.22536; Schmidt A, 2004, CELL MOL LIFE SCI, V61, P1354, DOI 10.1007/s00018-004-4010-6; Schreibelt G, 2007, FASEB J, V21, P3666, DOI 10.1096/fj.07-8329com; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Takahashi A, 2008, BIOCHEM PHARMACOL, V75, P1639, DOI 10.1016/j.bcp.2007.12.016; Van Itallie CM, 2008, J BIOL CHEM, V283, P268, DOI 10.1074/jbc.M708066200; White RE, 2000, ANNU REV PHARMACOL, V40, P133, DOI 10.1146/annurev.pharmtox.40.1.133; Yamamoto A, 1996, J PHARM PHARMACOL, V48, P1285, DOI 10.1111/j.2042-7158.1996.tb03937.x	38	91	93	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18863	18872		10.1074/jbc.M109.008623	http://dx.doi.org/10.1074/jbc.M109.008623			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19429681	Green Published, hybrid			2022-12-25	WOS:000267711500036
J	D'Souza, DR; Salib, MM; Bennett, J; Mochin-Peters, M; Asrani, K; Goldblum, SE; Renoud, KJ; Shapiro, P; Passaniti, A				D'Souza, David R.; Salib, Maryann M.; Bennett, Jessica; Mochin-Peters, Maria; Asrani, Kaushal; Goldblum, Simeon E.; Renoud, Keli J.; Shapiro, Paul; Passaniti, Antonino			Hyperglycemia Regulates RUNX2 Activation and Cellular Wound Healing through the Aldose Reductase Polyol Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; TRANSCRIPTION FACTOR; GROWTH-FACTOR; OSTEOBLAST DIFFERENTIATION; DIABETIC COMPLICATIONS; GLUCOSE-HOMEOSTASIS; ANGIOGENIC ACTIVITY; OXIDATIVE DAMAGE; PROTEIN-KINASE; EXPRESSION	Diabetes mellitus accelerates cardiovascular microangiopathies and atherosclerosis, which are a consequence of hyperglycemia. The aldose reductase (AR) polyol pathway contributes to these microvascular complications, but how it mediates vascular damage in response to hyperglycemia is less understood. The RUNX2 transcription factor, which is repressed in diabetic animals, promotes vascular endothelial cell (EC) migration, proliferation, and angiogenesis. Here we show that physiological levels of glucose (euglycemia) increase RUNX2 DNA binding and transcriptional activity, whereas hyperglycemia does not. However, inhibition of AR reverses hyperglycemic suppression of RUNX2. IGF-1 secretion and IGF receptor phosphorylation by autocrine IGF-1 occur equally in euglycemic or hyperglycemic conditions, suggesting that reduced RUNX2 activity in response to hyperglycemia is not because of altered IGF-1/IGF receptor activation. AR also negatively regulates RUNX2-dependent vascular remodeling in an EC wounded monolayer assay, which is reversed by specific AR inhibition in hyperglycemia. Thus, euglycemia supports RUNX2 activity and promotes normal microvascular EC migration and wound healing, which are repressed under hyperglycemic conditions through the AR polyol pathway.	[D'Souza, David R.; Salib, Maryann M.; Bennett, Jessica; Mochin-Peters, Maria; Asrani, Kaushal; Renoud, Keli J.; Passaniti, Antonino] Univ Maryland, Sch Med, Dept Pathol,Marlene & Stewart Greenebaum Canc Ctr, Grad Program Life Sci, Baltimore, MD 21201 USA; [D'Souza, David R.; Salib, Maryann M.; Bennett, Jessica; Mochin-Peters, Maria; Asrani, Kaushal; Renoud, Keli J.; Passaniti, Antonino] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Dept Biochem & Mol Biol,Grad Program Life Sci, Baltimore, MD 21201 USA; [Goldblum, Simeon E.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Goldblum, Simeon E.; Passaniti, Antonino] Univ Maryland, Sch Med, Mucosal Biol Res Ctr, Baltimore, MD 21201 USA; [Shapiro, Paul] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Passaniti, A (corresponding author), Univ Maryland, Sch Med, Greenebaum Canc Ctr, 655 W Baltimore St, Baltimore, MD 21201 USA.	apass001@umaryland.edu			National Institutes of Health [RO1CA108846, RO1CA120215, RO1HL084223]; University of Maryland Greenebaum Cancer; Cigarette Restitution Fund of the State of Maryland; NATIONAL CANCER INSTITUTE [R01CA108846, R01CA120215] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland Greenebaum Cancer; Cigarette Restitution Fund of the State of Maryland; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1CA108846 (to A. P.), RO1CA120215 (to P. S.), and RO1HL084223 (to S. E. G.). This work was also supported by a University of Maryland Greenebaum Cancer Center pilot grant from the Cigarette Restitution Fund of the State of Maryland (to A. P.).	Abu-Abid Subhi, 2002, Journal of Medicine (Westbury), V33, P73; Aronson D, 2008, ADV CARDIOL, V45, P1, DOI 10.1159/000115118; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Campbell M, 2005, CIRC RES, V96, P197, DOI 10.1161/01.RES.0000152966.88353.9d; Chen FM, 2008, J CELL COMMUN SIGNAL, V2, P81, DOI 10.1007/s12079-008-0034-2; Cumbie BC, 2007, VASC HEALTH RISK MAN, V3, P823; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Facchiano F, 2002, AM J PATHOL, V161, P531, DOI 10.1016/S0002-9440(10)64209-5; Fowlkes JL, 2008, ENDOCRINOLOGY, V149, P1697, DOI 10.1210/en.2007-1408; Gatenby RA, 2007, INT J BIOCHEM CELL B, V39, P1358, DOI 10.1016/j.biocel.2007.03.021; Hamuro M, 2002, ATHEROSCLEROSIS, V162, P277, DOI 10.1016/S0021-9150(01)00719-5; Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027; Jain RK, 2008, SCI AM, V298, P56, DOI 10.1038/scientificamerican0108-56; Juttner KV, 2007, BONE, V41, P25, DOI 10.1016/j.bone.2007.03.012; Kang ES, 2007, FREE RADICAL BIO MED, V43, P535, DOI 10.1016/j.freeradbiomed.2007.05.006; Kuki S, 2006, CIRC J, V70, P1076, DOI 10.1253/circj.70.1076; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; LeRoith D, 2007, NAT CLIN PRACT ENDOC, V3, P302, DOI 10.1038/ncpendmet0427; Li JH, 2003, KIDNEY INT, V63, P2010, DOI 10.1046/j.1523-1755.2003.00016.x; Lorenzi M, 2007, EXP DIABETES RES, DOI 10.1155/2007/61038; Lu HF, 2003, ENDOCRINOLOGY, V144, P346, DOI 10.1210/en.2002-220072; Luo B, 2008, ARTERIOSCL THROM VAS, V28, P651, DOI 10.1161/ATVBAHA.107.159533; Meugnier E, 2007, CURR OPIN CLIN NUTR, V10, P518, DOI 10.1097/MCO.0b013e3281298fef; Namba K, 2000, ONCOGENE, V19, P106, DOI 10.1038/sj.onc.1203257; Obrosova IG, 2003, DIABETES, V52, P864, DOI 10.2337/diabetes.52.3.864; Oyama T, 2006, DIABETES RES CLIN PR, V73, P227, DOI 10.1016/j.diabres.2006.02.010; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Pladzyk A, 2006, INVEST OPHTH VIS SCI, V47, P5395, DOI 10.1167/iovs.06-0469; Pratap J, 2006, CANCER METAST REV, V25, P589, DOI 10.1007/s10555-006-9032-0; Qiao M, 2006, J BIOL CHEM, V281, P7118, DOI 10.1074/jbc.M508162200; Qiao M, 2004, J BIOL CHEM, V279, P42709, DOI 10.1074/jbc.M404480200; Ramana KV, 2004, FEBS LETT, V570, P189, DOI 10.1016/j.febslet.2004.06.046; Rask-Madsen C, 2008, ARTERIOSCL THROM VAS, V28, P608, DOI 10.1161/ATVBAHA.108.162057; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ruef J, 2000, ARTERIOSCL THROM VAS, V20, P1745, DOI 10.1161/01.ATV.20.7.1745; Spalding AC, 2008, TRANSL ONCOL, V1, P195, DOI 10.1593/tlo.08151; Srivastava SK, 2005, ENDOCR REV, V26, P380, DOI 10.1210/er.2004-0028; Sun LX, 2004, ONCOGENE, V23, P4722, DOI 10.1038/sj.onc.1207589; Sun LX, 2001, CANCER RES, V61, P4994; Teixeira AS, 1999, LIFE SCI, V64, P655, DOI 10.1016/S0024-3205(98)00607-9; Tsuji K, 2004, J BONE MINER RES, V19, P1481, DOI 10.1359/JBMR.040601; Vikramadithyan RK, 2005, J CLIN INVEST, V115, P2434, DOI 10.1172/JCI24819; Vitolol MI, 2007, CANCER BIOL THER, V6, P856, DOI 10.4161/cbt.6.6.4241; Wilkinson-Berka JL, 2006, CURR MED CHEM, V13, P3307, DOI 10.2174/092986706778773086; Zelzer E, 2001, MECH DEVELOP, V106, P97, DOI 10.1016/S0925-4773(01)00428-2	46	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					17947	17955		10.1074/jbc.M109.002378	http://dx.doi.org/10.1074/jbc.M109.002378			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19383984	hybrid, Green Published			2022-12-25	WOS:000267712400006
J	Qamar, I; Park, E; Gong, EY; Lee, HJ; Lee, K				Qamar, Imteyaz; Park, Eunsook; Gong, Eun-Yeung; Lee, Hyun Joo; Lee, Keesook			ARR19 (Androgen Receptor Corepressor of 19 kDa), an Antisteroidogenic Factor, Is Regulated by GATA-1 in Testicular Leydig Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; CREB-BINDING PROTEIN; DNA-BINDING; LUTEINIZING-HORMONE; MOUSE TESTIS; HISTONE ACETYLTRANSFERASE; FUNCTIONAL-ANALYSIS; GENE-TRANSCRIPTION; SIGNALING PATHWAY; MOLECULAR-CLONING	ARR19 (androgen receptor corepressor of 19 kDa), which encodes for a leucine-rich protein, is expressed abundantly in the testis. Further analyses revealed that ARR19 was expressed in Leydig cells, and its expression was differentially regulated during Leydig cell development. Adenovirus-mediated overexpression of ARR19 in Leydig cells inhibited testicular steroidogenesis, down-regulating the expression of steroidogenic enzymes, which suggests that ARR19 is an antisteroidogenic factor. Interestingly, cAMP/luteinizing hormone attenuated ARR19 expression in a fashion similar to that of GATA-1, which was previously reported to be down-regulated by cAMP. Sequence analysis of the Arr19 promoter revealed the presence of two putative GATA-1 binding motifs. Further analyses with 5' deletion and point mutants of putative GATA-1 binding motifs showed that these GATA-1 binding sites were critical for high promoter activity. CREB-binding protein coactivated GATA-1 and markedly increased the activity of the Arr19 promoter. Both GATA-1 and CREB-binding proteins occupied the GATA-1 motifs within the Arr19 promoter, which was repressed by cAMP treatment. Altogether, these findings demonstrate that ARR19 is the target gene of GATA-1 and suggest that ARR19 gene expression in testicular Leydig cells is regulated by luteinizing hormone/cAMP signaling via the control of GATA-1 expression, resulting in the control of testicular steroidogenesis.	[Qamar, Imteyaz; Park, Eunsook; Gong, Eun-Yeung; Lee, Hyun Joo; Lee, Keesook] Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea	Chonnam National University	Lee, K (corresponding author), Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea.	klee@chonnam.ac.kr		Qamar, Imteyaz/0000-0003-2390-1808	Chonnam National University; Korea Research Foundation, Korean Government [KRF-2006005-J03002]	Chonnam National University; Korea Research Foundation, Korean Government(National Research Foundation of KoreaKorean Government)	This work was supported by Chonnam National University and by a Korea Research Foundation grant funded by the Korean Government (KRF-2006005-J03002).	Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Barrett DM, 2004, MOL CELL BIOL, V24, P6194, DOI 10.1128/MCB.24.14.6194-6204.2004; Blobel GA, 1998, P NATL ACAD SCI USA, V95, P2061, DOI 10.1073/pnas.95.5.2061; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Campbell SE, 2002, GENE, V286, P233, DOI 10.1016/S0378-1119(02)00436-5; Carninci P, 1997, DNA Res, V4, P61, DOI 10.1093/dnares/4.1.61; CHEN CLC, 1996, 78 ANN M END SOC SAN, P564; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; COOKE BA, 1996, LEYDIG CELL, P352; Davidoff MS, 2004, J CELL BIOL, V167, P935, DOI 10.1083/jcb.200409107; Eacker SM, 2008, MOL ENDOCRINOL, V22, P623, DOI 10.1210/me.2006-0534; EVANS T, 1988, P NATL ACAD SCI USA, V85, P5976, DOI 10.1073/pnas.85.16.5976; Fan WQ, 2007, J BIOL CHEM, V282, P7329, DOI 10.1074/jbc.M610447200; Feng ZM, 2000, MOL ENDOCRINOL, V14, P1820, DOI 10.1210/me.14.11.1820; Feng ZM, 1998, MOL ENDOCRINOL, V12, P378, DOI 10.1210/me.12.3.378; Fox AH, 1998, J BIOL CHEM, V273, P33595, DOI 10.1074/jbc.273.50.33595; Fox AH, 1999, EMBO J, V18, P2812, DOI 10.1093/emboj/18.10.2812; GE R, 1996, LEYDIG CELL, V1, P159; Ge RS, 2006, P NATL ACAD SCI USA, V103, P2719, DOI 10.1073/pnas.0507692103; Ge RS, 2005, BIOL REPROD, V72, P1405, DOI 10.1095/biolreprod.104.037499; HAIDER S, 1986, GEN COMP ENDOCR, V64, P321, DOI 10.1016/0016-6480(86)90065-1; Haider SG, 2004, INT REV CYTOL, V233, P181, DOI 10.1016/S0074-7696(04)33005-6; Han WL, 2003, GENOMICS, V81, P609, DOI 10.1016/S0888-7543(03)00095-8; Han WL, 2001, BIOCHEM J, V357, P127, DOI 10.1042/0264-6021:3570127; Hernandez-Hernandez A, 2006, EMBO J, V25, P3264, DOI 10.1038/sj.emboj.7601228; Hong CY, 2004, MOL CELL BIOL, V24, P2593, DOI 10.1128/MCB.24.7.2593-2604.2004; Hung HL, 1999, MOL CELL BIOL, V19, P3496; ITO E, 1993, NATURE, V362, P466, DOI 10.1038/362466a0; Jeong BC, 2004, MOL ENDOCRINOL, V18, P13, DOI 10.1210/me.2003-0065; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Ketola I, 1999, ENDOCRINOLOGY, V140, P1470, DOI 10.1210/en.140.3.1470; Ketola I, 2002, EUR J ENDOCRINOL, V147, P397, DOI 10.1530/eje.0.1470397; Kim JY, 2004, MOL ENDOCRINOL, V18, P2880, DOI 10.1210/me.2004-0211; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lamonica JM, 2006, BLOOD, V108, P3736, DOI 10.1182/blood-2006-07-032847; Li T, 2006, INT J BIOCHEM CELL B, V38, P420, DOI 10.1016/j.biocel.2005.10.003; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; Lo KC, 2004, ENDOCRINOLOGY, V145, P4011, DOI 10.1210/en.2003-1729; Manna PR, 2002, MOL ENDOCRINOL, V16, P184, DOI 10.1210/me.16.1.184; MARTIN DIK, 1990, GENE DEV, V4, P1886, DOI 10.1101/gad.4.11.1886; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mendis-Handagama SMLC, 2001, BIOL REPROD, V65, P660, DOI 10.1095/biolreprod65.3.660; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; Moraga PF, 1997, J ENDOCRINOL, V154, P201, DOI 10.1677/joe.0.1540201; Nishikawa K, 2003, MOL CELL BIOL, V23, P8295, DOI 10.1128/MCB.23.22.8295-8305.2003; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Onodera K, 1997, J BIOCHEM, V121, P251; Shi SR, 2002, APPL IMMUNOHISTO M M, V10, P368, DOI 10.1097/00022744-200212000-00014; Song F, 2002, GENE, V290, P115, DOI 10.1016/S0378-1119(02)00584-X; Song KH, 2004, MOL ENDOCRINOL, V18, P1929, DOI 10.1210/me.2004-0043; Tremblay JJ, 2003, J BIOL CHEM, V278, P22128, DOI 10.1074/jbc.M213149200; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; TSAI SF, 1991, GENE DEV, V5, P919, DOI 10.1101/gad.5.6.919; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Viger RS, 1998, DEVELOPMENT, V125, P2665; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; WALL L, 1988, GENE DEV, V2, P1089, DOI 10.1101/gad.2.9.1089; WHYATT DJ, 1993, EMBO J, V12, P4993, DOI 10.1002/j.1460-2075.1993.tb06193.x; WING TY, 1985, ENDOCRINOLOGY, V117, P1779, DOI 10.1210/endo-117-5-1779; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; YOMOGIDA K, 1994, DEVELOPMENT, V120, P1759; Zhang ZF, 2002, ENDOCRINOLOGY, V143, P829, DOI 10.1210/en.143.3.829; Zhao W, 2006, BLOOD, V107, P907, DOI 10.1182/blood-2005-06-2516	65	20	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18021	18032		10.1074/jbc.M900896200	http://dx.doi.org/10.1074/jbc.M900896200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19398553	Green Published, hybrid			2022-12-25	WOS:000267712400014
J	Suhasini, AN; Sommers, JA; Mason, AC; Voloshin, ON; Camerini-Otero, RD; Wold, MS; Brosh, RM				Suhasini, Avvaru N.; Sommers, Joshua A.; Mason, Aaron C.; Voloshin, Oleg N.; Camerini-Otero, R. Daniel; Wold, Marc S.; Brosh, Robert M., Jr.			FANCJ Helicase Uniquely Senses Oxidative Base Damage in Either Strand of Duplex DNA and Is Stimulated by Replication Protein A to Unwind the Damaged DNA Substrate in a Strand-specific Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; ESCHERICHIA-COLI; ANEMIA PATHWAY; GENOMIC STABILITY; MAMMALIAN-CELLS; BINDING PROTEIN; THYMINE GLYCOL; WRN HELICASE; HUMAN RECQ1; REPAIR	FANCJ mutations are genetically linked to the Fanconi anemia complementation group J and predispose individuals to breast cancer. Understanding the role of FANCJ in DNA metabolism and how FANCJ dysfunction leads to tumorigenesis requires mechanistic studies of FANCJ helicase and its protein partners. In this work, we have examined the ability of FANCJ to unwind DNA molecules with specific base damage that can be mutagenic or lethal. FANCJ was inhibited by a single thymine glycol, but not 8-oxoguanine, in either the translocating or nontranslocating strands of the helicase substrate. In contrast, the human RecQ helicases (BLM, RECQ1, and WRN) display strand-specific inhibition of unwinding by the thymine glycol damage, whereas other DNA helicases (DinG, DnaB, and UvrD) are not significantly inhibited by thymine glycol in either strand. In the presence of replication protein A (RPA), but not Escherichia coli single-stranded DNA-binding protein, FANCJ efficiently unwound the DNA substrate harboring the thymine glycol damage in the nontranslocating strand; however, inhibition of FANCJ helicase activity by the translocating strand thymine glycol was not relieved. Strand-specific stimulation of human RECQ1 helicase activity was also observed, and RPA bound with high affinity to single-stranded DNA containing a single thymine glycol. Based on the biochemical studies, we propose a model for the specific functional interaction between RPA and FANCJ on the thymine glycol substrates. These studies are relevant to the roles of RPA, FANCJ, and other DNA helicases in the metabolism of damaged DNA that can interfere with basic cellular processes of DNA metabolism.	[Suhasini, Avvaru N.; Sommers, Joshua A.; Brosh, Robert M., Jr.] NIA, Lab Mol Gerontol, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA; [Mason, Aaron C.; Wold, Marc S.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Voloshin, Oleg N.; Camerini-Otero, R. Daniel] NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Brosh, RM (corresponding author), NIA, Lab Mol Gerontol, Biomed Res Ctr, NIH, 251 Bayview Blvd,Ste 100,Rm 06B125, Baltimore, MD 21224 USA.	BroshR@mail.nih.gov	Wold, Marc/F-5806-2010; Brosh, Robert/AAR-6124-2020	Wold, Marc/0000-0002-4580-1624	National Institutes of Health Research [GM44721]; NIA; NIDDK National Institutes of Health Intramural Research Program; Fanconi Anemia Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK052032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000741, ZIAAG000753] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Fanconi Anemia Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Research Grant GM44721 (to M. S. W.) and the NIA and NIDDK National Institutes of Health Intramural Research Program. This work was also supported by the Fanconi Anemia Research Fund (to R. M. B.).	Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; BROSH RM, 1995, J BACTERIOL, V177, P5612, DOI 10.1128/jb.177.19.5612-5621.1995; Cadman CJ, 2006, J MOL BIOL, V362, P18, DOI 10.1016/j.jmb.2006.06.032; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cui S, 2003, J BIOL CHEM, V278, P1424, DOI 10.1074/jbc.M209407200; Cui S, 2004, NUCLEIC ACIDS RES, V32, P2158, DOI 10.1093/nar/gkh540; De Nicolo A, 2008, CLIN CANCER RES, V14, P4672, DOI 10.1158/1078-0432.CCR-08-0087; Du W, 2008, ANTIOXID REDOX SIGN, V10, P1909, DOI 10.1089/ars.2008.2129; Greenberger JS, 2006, EXP HEMATOL, V34, P46; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Gupta R, 2007, BLOOD, V110, P2390, DOI 10.1182/blood-2006-11-057273; Gupta R, 2006, NUCLEIC ACIDS RES, V34, P6673, DOI 10.1093/nar/gkl964; Haring SJ, 2008, J BIOL CHEM, V283, P19095, DOI 10.1074/jbc.M800881200; Hazra TK, 2007, DNA REPAIR, V6, P470, DOI 10.1016/j.dnarep.2006.10.011; Howlett NG, 2005, HUM MOL GENET, V14, P693, DOI 10.1093/hmg/ddi065; Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1; KIM CS, 1994, BIOCHEMISTRY-US, V33, P14197, DOI 10.1021/bi00251a031; Kumaraswamy E, 2007, MOL CELL BIOL, V27, P6733, DOI 10.1128/MCB.00961-07; Kung HC, 1997, J BIOL CHEM, V272, P9227; Lao Y, 2000, BIOCHEMISTRY-US, V39, P850, DOI 10.1021/bi991704s; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levitus M, 2006, CELL ONCOL, V28, P3; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; MATSON SW, 1994, BIOESSAYS, V16, P13, DOI 10.1002/bies.950160103; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Patrick SM, 1999, J BIOL CHEM, V274, P14972, DOI 10.1074/jbc.274.21.14972; Peng M, 2006, ONCOGENE, V25, P2245, DOI 10.1038/sj.onc.1209257; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Sharma S, 2004, MOL BIOL CELL, V15, P734, DOI 10.1091/mbc.E03-08-0567; Sharma S, 2008, CELL CYCLE, V7, P989, DOI 10.4161/cc.7.8.5707; Sharma S, 2006, BIOCHEM J, V398, P319, DOI 10.1042/BJ20060450; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Thompson LH, 2005, ENVIRON MOL MUTAGEN, V45, P128, DOI 10.1002/em.20109; Tornaletti S, 2001, J BIOL CHEM, V276, P45367, DOI 10.1074/jbc.M105282200; Voloshin ON, 2007, J BIOL CHEM, V282, P18437, DOI 10.1074/jbc.M700376200; Voloshin ON, 2003, J BIOL CHEM, V278, P28284, DOI 10.1074/jbc.M301188200; Wallace SS, 2002, FREE RADICAL BIO MED, V33, P1, DOI 10.1016/S0891-5849(02)00827-4; Wang LC, 2008, DNA REPAIR, V7, P1973, DOI 10.1016/j.dnarep.2008.08.005; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07	48	41	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18458	18470		10.1074/jbc.M109.012229	http://dx.doi.org/10.1074/jbc.M109.012229			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19419957	Green Published, hybrid			2022-12-25	WOS:000267712400057
J	Johnson, RP; El-Yazbi, AF; Hughes, MF; Schriemer, DC; Walsh, EJ; Walsh, MP; Cole, WC				Johnson, Rosalyn P.; El-Yazbi, Ahmed F.; Hughes, Morgan F.; Schriemer, David C.; Walsh, Emma J.; Walsh, Michael P.; Cole, William C.			Identification and Functional Characterization of Protein Kinase A-catalyzed Phosphorylation of Potassium Channel Kv1.2 at Serine 449	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; RECTIFIER K+ CHANNELS; CYCLIC-AMP; CORONARY ARTERIOLES; CEREBRAL-ARTERIES; ACTIVATION; CELLS; RELAXATION; ROLES; 4-AMINOPYRIDINE	Vascular smooth muscle Kv1 delayed rectifier K+ channels (K-DR) containing Kv1.2 control membrane potential and thereby regulate contractility. Vasodilatory agonists acting via protein kinase A (PKA) enhance vascule smooth muscle Kv1 activity, but the molecular basis of this regulation is uncertain. We characterized the role of a C-terminal phosphorylation site, Ser-449, in Kv1.2 expressed in HEK 293 cells by biochemical and electrophysiological methods. We found that 1) in vitro phosphorylation of Kv1.2 occurred exclusively at serine residues, 2) one major phosphopeptide that co-migrated with (449)pSASTISK was generated by proteolysis of in vitro phosphorylated Kv1.2, 3) the peptide (445)KKSRSASTISK exhibited stoichiometric phosphorylation by PKA in vitro, 4) matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectroscopy (MS) and MS/MS confirmed in vitro Ser-449 phosphorylation by PKA, 5) in situ phosphorylation at Ser-449 was detected in HEK 293 cells by MALDI-TOF MS followed by MS/MS. MIDAS (multiple reaction monitoring-initiated detection and sequencing) analysis revealed additional phosphorylated residues, Ser-440 and Ser-441, 6) in vitro P-32 incorporation was significantly reduced in Kv1.2-S449A, Kv1.2-S449D, and Kv1.2-S440A/S441A/S449A mutant channels, but Kv1.2-S440A/S441A was identical to wild-type Kv1.2 (Kv1.2-WT), and 7) bath applied 8-Br-cAMP or dialysis with PKA catalytic subunit (cPKA) increased Kv1.2-WT but not Kv1.2-S449A current amplitude. cPKA increased Kv1.2-WT current in inside-out patches. Rp-CPT-cAMPS reduced Kv1.2-WT current, blocked the increase due to 8-Br-cAMP, but had no effect on Kv1.2-S449A. cPKA increased current due to double mutant Kv1.2-S440A/S441A but had no effect on Kv1.2-S449D or Kv1.2-S440A/S441A/S449A. We conclude that Ser-449 in Kv1.2 is a site of PKA phosphorylation and a potential molecular mechanism for Kv1-containing K-DR channel modulation by agonists via PKA activation.	[Johnson, Rosalyn P.; El-Yazbi, Ahmed F.; Walsh, Emma J.; Walsh, Michael P.; Cole, William C.] Univ Calgary, Smooth Muscle Res Grp, Calgary, AB T2N 4N1, Canada; [Hughes, Morgan F.; Schriemer, David C.] Univ Calgary, So Alberta Mass Spectrometry Ctr, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Cole, WC (corresponding author), Univ Calgary, Smooth Muscle Res Grp, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	wcole@ucalgary.ca	El-Yazbi, Ahmed/AAT-6837-2021	El-Yazbi, Ahmed/0000-0003-3432-3038	Canadian Institutes of Health Research [MOP-10569]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-10569 (to W.C.C. and M.P.W.).	Aiello EA, 1996, AM J PHYSIOL-HEART C, V271, pH109, DOI 10.1152/ajpheart.1996.271.1.H109; AIELLO EA, 1995, AM J PHYSIOL-HEART C, V268, pH926, DOI 10.1152/ajpheart.1995.268.2.H926; Aiello EA, 1998, AM J PHYSIOL-HEART C, V275, pH448, DOI 10.1152/ajpheart.1998.275.2.H448; Albarwani S, 2003, J PHYSIOL-LONDON, V551, P751, DOI 10.1113/jphysiol.2003.040014; ALLEN BG, 1994, J BIOL CHEM, V269, P29288; Anderson AE, 2000, J BIOL CHEM, V275, P5337, DOI 10.1074/jbc.275.8.5337; Berg T, 2003, EUR J PHARMACOL, V466, P301, DOI 10.1016/S0014-2999(03)01555-3; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Chen TT, 2006, CIRC RES, V99, P53, DOI 10.1161/01.RES.0000229654.45090.57; COLBURN JC, 1988, J BIOL CHEM, V263, P19166; Cole WC, 1996, BIOCHEM CELL BIOL, V74, P439, DOI 10.1139/o96-048; Connors EC, 2008, J BIOL CHEM, V283, P3445, DOI 10.1074/jbc.M708875200; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; DEMAILLE JG, 1978, FEBS LETT, V86, P113, DOI 10.1016/0014-5793(78)80110-0; Dong H, 1998, BRIT J PHARMACOL, V123, P821, DOI 10.1038/sj.bjp.0701680; DU C, 1994, J PHARMACOL EXP THER, V268, P208; ERICKSON AC, 1993, J NEUROSCI METH, V46, P245, DOI 10.1016/0165-0270(93)90073-Z; Hayabuchi Y, 2001, AM J PHYSIOL-HEART C, V281, pH2480, DOI 10.1152/ajpheart.2001.281.6.H2480; Heaps CL, 2005, AM J PHYSIOL-HEART C, V288, pH568, DOI 10.1152/ajpheart.00157.2004; Heaps CL, 2002, J APPL PHYSIOL, V92, P550, DOI 10.1152/japplphysiol.00566.2001; HUANG XY, 1994, P NATL ACAD SCI USA, V91, P624, DOI 10.1073/pnas.91.2.624; Ju M, 2003, J BIOL CHEM, V278, P12769, DOI 10.1074/jbc.M212973200; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kerr PM, 2001, CIRC RES, V89, P1038, DOI 10.1161/hh2301.100803; KNOT HJ, 1995, AM J PHYSIOL-HEART C, V269, pH348, DOI 10.1152/ajpheart.1995.269.1.H348; Koh SD, 1996, PFLUG ARCH EUR J PHY, V432, P401, DOI 10.1007/s004240050151; Li HW, 2003, AM J PHYSIOL-HEART C, V285, pH1213, DOI 10.1152/ajpheart.00226.2003; Luykenaar KD, 2004, AM J PHYSIOL-HEART C, V286, pH1088, DOI 10.1152/ajpheart.00903.2003; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; Plane F, 2005, CIRC RES, V96, P216, DOI 10.1161/01.RES.0000154070.06421.25; Satake N, 1996, BRIT J PHARMACOL, V119, P505, DOI 10.1111/j.1476-5381.1996.tb15700.x; Shuttleworth CWR, 1996, J PHYSIOL-LONDON, V493, P651, DOI 10.1113/jphysiol.1996.sp021412; Thorneloe KS, 2001, CIRC RES, V89, P1030, DOI 10.1161/hh2301.100817; Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P1134, DOI 10.1074/mcp.M500113-MCP200; VANDONGEN AMJ, 1990, NEURON, V5, P433, DOI 10.1016/0896-6273(90)90082-Q; Xiao BL, 2005, CIRC RES, V96, P847, DOI 10.1161/01.RES.0000163276.26083.e8; Yang JW, 2007, P NATL ACAD SCI USA, V104, P20055, DOI 10.1073/pnas.0708574104; Zhao LL, 2009, MOL MEMBR BIOL, V26, P186, DOI 10.1080/09687680802714741	39	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16562	16574		10.1074/jbc.M109.010918	http://dx.doi.org/10.1074/jbc.M109.010918			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19389710	Green Published, hybrid			2022-12-25	WOS:000266730900053
J	Zemskov, EA; Loukinova, E; Mikhailenko, I; Coleman, RA; Strickland, DK; Belkin, AM				Zemskov, Evgeny A.; Loukinova, Elena; Mikhailenko, Irina; Coleman, Richard A.; Strickland, Dudley K.; Belkin, Alexey M.			Regulation of Platelet-derived Growth Factor Receptor Function by Integrin-associated Cell Surface Transglutaminase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE TRANSGLUTAMINASE; STIMULATORY AUTOANTIBODIES; EXTRACELLULAR-MATRIX; PDGF RECEPTOR; CROSS-LINKING; PHOSPHORYLATION; ACTIVATION; ADHESION; SHP-2; EXPRESSION	A functional collaboration between growth factor receptors such as platelet derived growth factor receptor (PDGFR) and integrins is required for effective signal transduction in response to soluble growth factors. However, the mechanisms of synergistic PDGFR/integrin signaling remain poorly understood. Our previous work showed that cell surface tissue transglutaminase (tTG) induces clustering of integrins and amplifies integrin signaling by acting as an integrin binding adhesion coreceptor for fibronectin. Here we report that in fibroblasts tTG enhances PDGFR-integrin association by interacting with PDGFR and bridging the two receptors on the cell surface. The interaction between tTG and PDGFR reduces cellular levels of the receptor by accelerating its turnover. Moreover, the association of PDGFR with tTG causes receptor clustering, increases PDGF binding, promotes adhesion-mediated and growth factor-induced PDGFR activation, and up-regulates downstream signaling. Importantly, tTG is required for efficient PDGF-dependent proliferation and migration of fibroblasts. These results reveal a previously unrecognized role for cell surface tTG in the regulation of the joint PDGFR/integrin signaling and PDGFR-dependent cell responses.	[Zemskov, Evgeny A.; Belkin, Alexey M.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Zemskov, Evgeny A.; Loukinova, Elena; Mikhailenko, Irina; Strickland, Dudley K.; Belkin, Alexey M.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Loukinova, Elena; Mikhailenko, Irina; Coleman, Richard A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; [Belkin, Alexey M.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Belkin, AM (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	abelkin@som.umaryland.edu			National Institutes of Health [GM62895, HL50784, HL54710]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050784, P01HL054710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062895] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM62895 (to A.M.B.) and HL50784 and HL54710 (to D.K.S.).	Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Akimov SS, 2001, J CELL SCI, V114, P2989; Akimov SS, 2001, BLOOD, V98, P1567, DOI 10.1182/blood.V98.5.1567; Bakker ENTP, 2008, J VASC RES, V45, P271, DOI 10.1159/000113599; Ball SG, 2007, J CELL BIOL, V177, P489, DOI 10.1083/jcb.200608093; Barillari G, 2001, ATHEROSCLEROSIS, V154, P377, DOI 10.1016/S0021-9150(00)00506-2; Baron W, 2003, CURR BIOL, V13, P151, DOI 10.1016/S0960-9822(02)01437-9; Baroni SS, 2006, NEW ENGL J MED, V354, P2667; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; DeMali KA, 1999, J BIOL CHEM, V274, P19551, DOI 10.1074/jbc.274.28.19551; Ekman S, 2002, ONCOGENE, V21, P1870, DOI 10.1038/sj.onc.1205210; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; Grenard P, 2001, J HEPATOL, V35, P367, DOI 10.1016/S0168-8278(01)00135-0; Haroon ZA, 1999, FASEB J, V13, P1787, DOI 10.1096/fasebj.13.13.1787; Haroon ZA, 2001, LAB INVEST, V81, P83, DOI 10.1038/labinvest.3780214; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Janiak A, 2006, MOL BIOL CELL, V17, P1606, DOI 10.1091/mbc.E05-06-0549; Lacalle RA, 2002, J CELL BIOL, V157, P277, DOI 10.1083/jcb.200109031; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Molberg O, 2006, TRENDS IMMUNOL, V27, P188, DOI 10.1016/j.it.2006.02.006; Ostman A, 2004, CYTOKINE GROWTH F R, V15, P275, DOI 10.1016/j.cytogfr.2004.03.002; Raines EW, 2000, ANN NY ACAD SCI, V902, P39; Ronnstrand L, 1999, ONCOGENE, V18, P3696, DOI 10.1038/sj.onc.1202705; Sheppard D, 2000, MATRIX BIOL, V19, P203, DOI 10.1016/S0945-053X(00)00065-2; Sundberg C, 1996, J CELL BIOL, V132, P741, DOI 10.1083/jcb.132.4.741; Svegliati S, 2007, BLOOD, V110, P237, DOI 10.1182/blood-2007-01-071043; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; Verderio EAM, 2005, PROG EXP TUMOR RES, V38, P89; Verma A, 2008, CLIN CANCER RES, V14, P2476, DOI 10.1158/1078-0432.CCR-07-4529; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yamada KM, 2002, NAT CELL BIOL, V4, pE75, DOI 10.1038/ncb0402-e75; Zemskov EA, 2006, FRONT BIOSCI-LANDMRK, V11, P1057, DOI 10.2741/1863; Zemskov EA, 2007, J CELL SCI, V120, P3188, DOI 10.1242/jcs.010397	36	53	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16693	16703		10.1074/jbc.M109.010769	http://dx.doi.org/10.1074/jbc.M109.010769			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19386600	Green Published, hybrid			2022-12-25	WOS:000266730900064
J	Kelber, JA; Panopoulos, AD; Shani, G; Booker, EC; Belmonte, JC; Vale, WW; Gray, PC				Kelber, J. A.; Panopoulos, A. D.; Shani, G.; Booker, E. C.; Belmonte, J. C.; Vale, W. W.; Gray, P. C.			Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways	ONCOGENE			English	Article						Cripto; GRP78; TGF-beta; MAPK; Akt; stem cell; cancer	MAMMARY EPITHELIAL-CELLS; CANCER-CELLS; TGF-BETA; TYROSINE PHOSPHORYLATION; CHAPERONE GRP78/BIP; ACTIVIN RECEPTOR; GROWTH; IDENTIFICATION; PROLIFERATION; SUPPRESSES	Cripto is a developmental oncoprotein that signals via mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK), phosphatidylinositol 3-kinase (PI3K)/Akt and Smad2/3 pathways. However, the molecular basis for Cripto coupling to these pathways during embryogenesis and tumorigenesis is not fully understood. In this regard, we recently demonstrated that Cripto forms a cell surface complex with the HSP70 family member glucose-regulated protein-78 (GRP78). Here, we provide novel functional evidence demonstrating that cell surface GRP78 is a necessary mediator of Cripto signaling in human tumor, mammary epithelial and embryonic stem cells. We show that targeted disruption of the cell surface Cripto/GRP78 complex using shRNAs or GRP78 immunoneutralization precludes Cripto activation of MAPK/PI3K pathways and modulation of activin-A, activin-B, Nodal and transforming growth factor-beta 1 signaling. We further demonstrate that blockade of Cripto binding to cell surface GRP78 prevents Cripto from increasing cellular proliferation, downregulating E-Cadherin, decreasing cell adhesion and promoting proproliferative responses to activin-A and Nodal. Thus, disrupting the Cripto/GRP78 binding interface blocks oncogenic Cripto signaling and may have important therapeutic value in the treatment of cancer. Oncogene (2009) 28, 2324-2336; doi:10.1038/onc.2009.97; published online 4 May 2009	[Gray, P. C.] Salk Inst Biol Studies, Vale Lab, Clayton Fdn Labs Peptide Biol, PBL, La Jolla, CA 92037 USA; [Kelber, J. A.] Univ San Diego, Dept Chem & Biochem, La Jolla, CA USA; [Panopoulos, A. D.; Belmonte, J. C.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Shani, G.] Burnham Inst Med Res, Tumor Microenvironm Program, La Jolla, CA USA; [Booker, E. C.] Univ San Diego, Dept Biol, La Jolla, CA USA	Salk Institute; University of San Diego; Salk Institute; Sanford Burnham Prebys Medical Discovery Institute; University of San Diego	Gray, PC (corresponding author), Salk Inst Biol Studies, Vale Lab, Clayton Fdn Labs Peptide Biol, PBL, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gray@salk.edu		Panopoulos, Athanasia/0000-0002-9610-2604; Kelber, Jonathan/0000-0002-4606-1445	NCI, National Institutes of Health [R01CA107420]; Foundation for Medical research, Inc.; Robert J Jr and Helen Kleberg Foundaton; NIH [T32 CA009370]; G Harold and Leila Y Mathers Charitable Foundation; Foundation for Medical Research, Inc; NATIONAL CANCER INSTITUTE [R01CA107420, T32CA009370] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Foundation for Medical research, Inc.; Robert J Jr and Helen Kleberg Foundaton; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G Harold and Leila Y Mathers Charitable Foundation; Foundation for Medical Research, Inc; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI, National Institutes of Health, Grant R01CA107420, the Foundation for Medical research, Inc., and the Robert J Jr and Helen Kleberg Foundaton. A portion of this work was also supported by an NIH training grant T32 CA009370 (to ADP) and the G Harold and Leila Y Mathers Charitable Foundation (to JCIB). Wylie W Vale is a senior investigator of the Foundation for Medical Research, Inc. and is a cofounder, consultant, equity holder and member of the Board of Directors of Neurocrine Biosciences and Acceleron Pharma. We thank Dr Travis Berggren and Margaret Lutz of The Salk Institute Stem Cell Core for valuable technical assistance.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Adkins HB, 2003, J CLIN INVEST, V112, P575, DOI 10.1172/JCI200317788; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Bianco C, 2003, CANCER RES, V63, P1192; Bianco C, 2002, MOL CELL BIOL, V22, P2586, DOI 10.1128/MCB.22.8.2586-2597.2002; Bianco C, 1999, J BIOL CHEM, V274, P8624, DOI 10.1074/jbc.274.13.8624; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; Fu Y, 2008, P NATL ACAD SCI USA, V105, P19444, DOI 10.1073/pnas.0807691105; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Gray PC, 2000, J BIOL CHEM, V275, P3206, DOI 10.1074/jbc.275.5.3206; Gray PC, 2003, P NATL ACAD SCI USA, V100, P5193, DOI 10.1073/pnas.0531290100; Gray PC, 2006, MOL CELL BIOL, V26, P9268, DOI 10.1128/MCB.01168-06; Harms PW, 2003, GENE DEV, V17, P2624, DOI 10.1101/gad.1127703; Harrison CA, 2004, J BIOL CHEM, V279, P28036, DOI 10.1074/jbc.M402782200; Jakobsen CG, 2007, CANCER RES, V67, P9507, DOI 10.1158/0008-5472.CAN-06-4686; Kannan S, 1997, J BIOL CHEM, V272, P3330, DOI 10.1074/jbc.272.6.3330; Kelber JA, 2008, J BIOL CHEM, V283, P4490, DOI 10.1074/jbc.M704960200; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Liu Y, 2007, MOL PHARMACEUT, V4, P435, DOI 10.1021/mp060122j; Minchiotti G, 2005, ONCOGENE, V24, P5668, DOI 10.1038/sj.onc.1208917; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Philippova M, 2008, MOL CELL BIOL, V28, P4004, DOI 10.1128/MCB.00157-08; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Reissmann E, 2001, GENE DEV, V15, P2010, DOI 10.1101/gad.201801; Shani G, 2008, MOL CELL BIOL, V28, P666, DOI 10.1128/MCB.01716-07; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shukla A, 2008, MOL CANCER RES, V6, P509, DOI 10.1158/1541-7786.MCR-07-0396; Strizzi L, 2005, ONCOGENE, V24, P5731, DOI 10.1038/sj.onc.1208918; Strizzi L, 2004, J CELL PHYSIOL, V201, P266, DOI 10.1002/jcp.20062; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; Wechselberger C, 2005, ONCOGENE, V24, P4094, DOI 10.1038/sj.onc.1208417; Xing PX, 2004, CANCER RES, V64, P4018, DOI 10.1158/0008-5472.CAN-03-3888; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0	39	139	144	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2009	28	24					2324	2336		10.1038/onc.2009.97	http://dx.doi.org/10.1038/onc.2009.97			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	459GJ	19421146	Green Accepted			2022-12-25	WOS:000267089100003
J	Takizawa, R; Tochigi, M; Kawakubo, Y; Marumo, K; Sasaki, T; Fukuda, M; Kasai, K				Takizawa, Ryu; Tochigi, Mamoru; Kawakubo, Yuki; Marumo, Kohei; Sasaki, Tsukasa; Fukuda, Masato; Kasai, Kiyoto			Association between Catechol-O-Methyltrasferase Val108/158Met Genotype and Prefrontal Hemodynamic Response in Schizophrenia	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; VAL(108/158) MET GENOTYPE; WORKING-MEMORY DEFICITS; FRONTAL-LOBE FUNCTION; VERBAL FLUENCY TASK; HUMAN BRAIN; BIPOLAR DISORDER; BLOOD-FLOW; COMT; METHYLTRANSFERASE	Background: "Imaging genetics'' studies have shown that brain function by neuroimaging is a sensitive intermediate phenotype that bridges the gap between genes and psychiatric conditions. Although the evidence of association between functional val108/158met polymorphism of the catechol-O-methyltransferase gene (COMT) and increasing risk for developing schizophrenia from genetic association studies remains to be elucidated, one of the most topical findings from imaging genetics studies is the association between COMT genotype and prefrontal function in schizophrenia. The next important step in the translational approach is to establish a useful neuroimaging tool in clinical settings that is sensitive to COMT variation, so that the clinician could use the index to predict clinical response such as improvement in cognitive dysfunction by medication. Here, we investigated spatiotemporal characteristics of the association between prefrontal hemodynamic activation and the COMT genotype using a noninvasive neuroimaging technique, near-infrared spectroscopy (NIRS). Methodology/Principal Findings: Study participants included 45 patients with schizophrenia and 60 healthy controls matched for age and gender. Signals that are assumed to reflect regional cerebral blood volume were monitored over prefrontal regions from 52-channel NIRS and compared between two COMT genotype subgroups (Met carriers and Val/Val individuals) matched for age, gender, premorbid IQ, and task performance. The [oxy-Hb] increase in the Met carriers during the verbal fluency task was significantly greater than that in the Val/Val individuals in the frontopolar prefrontal cortex of patients with schizophrenia, although neither medication nor clinical symptoms differed significantly between the two subgroups. These differences were not found to be significant in healthy controls. Conclusions/Significance: These data suggest that the prefrontal NIRS signals can noninvasively detect the impact of COMT variation in patients with schizophrenia. NIRS may be a promising candidate translational approach in psychiatric neuroimaging.			Takizawa, R (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan.	takizawar-tky@umin.ac.jp		Kasai, Kiyoto/0000-0002-4443-4535				Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Bassett AS, 2005, AM J MED GENET A, V138A, P307, DOI 10.1002/ajmg.a.30984; Bertolino A, 2004, AM J PSYCHIAT, V161, P1798, DOI 10.1176/appi.ajp.161.10.1798; Bertolino A, 2007, SCHIZOPHR RES, V95, P253, DOI 10.1016/j.schres.2007.06.014; Bilder RM, 2002, BIOL PSYCHIAT, V52, P701, DOI 10.1016/S0006-3223(02)01416-6; Boas DA, 2004, NEUROIMAGE, V23, pS275, DOI 10.1016/j.neuroimage.2004.07.011; Brahmbhatt SB, 2006, SCHIZOPHR RES, V87, P191, DOI 10.1016/j.schres.2006.05.019; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Callicott JH, 2000, CEREB CORTEX, V10, P1078, DOI 10.1093/cercor/10.11.1078; DESIMONE R, 1995, NATURE, V376, P549, DOI 10.1038/376549a0; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Ehlis AC, 2007, NEUROPSYCHOPHARMACOL, V32, P162, DOI 10.1038/sj.npp.1301151; Elfgren CI, 1998, NEUROPSYCHOLOGIA, V36, P505, DOI 10.1016/S0028-3932(97)00146-2; First M. B., 1997, STRUCTURED CLIN INTE; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Goldman-Rakic PS, 2000, BRAIN RES REV, V31, P295, DOI 10.1016/S0165-0173(99)00045-4; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Ho BC, 2005, MOL PSYCHIATR, V10, P287, DOI 10.1038/sj.mp.4001616; Hock C, 1997, BRAIN RES, V755, P293, DOI 10.1016/S0006-8993(97)00122-4; Hollingshead AB, 1965, 2 FACTOR INDEX SOCIA; Hoshi Y, 2003, PSYCHOPHYSIOLOGY, V40, P511, DOI 10.1111/1469-8986.00053; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; Joober R, 2002, ARCH GEN PSYCHIAT, V59, P662, DOI 10.1001/archpsyc.59.7.662; Kameyama M, 2006, NEUROIMAGE, V29, P172, DOI 10.1016/j.neuroimage.2005.07.025; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kuwabara H, 2006, BEHAV BRAIN RES, V172, P272, DOI 10.1016/j.bbr.2006.05.020; Lee J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001760; Lee SG, 2005, HUM GENET, V116, P319, DOI 10.1007/s00439-004-1239-y; Li T, 2000, MOL PSYCHIATR, V5, P452, DOI 10.1038/sj.mp.4000752; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Lu BY, 2007, BIOL PSYCHIAT, V62, P822, DOI 10.1016/j.biopsych.2006.11.030; Malhotra AK, 2002, AM J PSYCHIAT, V159, P652, DOI 10.1176/appi.ajp.159.4.652; Matsuo K, 2003, PSYCHOPHYSIOLOGY, V40, P492, DOI 10.1111/1469-8986.00051; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Meyer-Lindenberg A, 2006, MOL PSYCHIATR, V11, P867, DOI 10.1038/sj.mp.4001860; Meyer-Lindenberg A, 2008, NEUROIMAGE, V40, P655, DOI 10.1016/j.neuroimage.2007.11.058; Moore H, 1999, BIOL PSYCHIAT, V46, P40, DOI 10.1016/S0006-3223(99)00078-5; Munafo MR, 2005, MOL PSYCHIATR, V10, P765, DOI 10.1038/sj.mp.4001664; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Ohnishi T, 2006, BRAIN, V129, P399, DOI 10.1093/brain/awh702; Okada E, 2003, APPL OPTICS, V42, P2915, DOI 10.1364/AO.42.002915; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palmatier MA, 1999, BIOL PSYCHIAT, V46, P557, DOI 10.1016/S0006-3223(99)00098-0; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Roffman JL, 2006, HARVARD REV PSYCHIAT, V14, P78, DOI 10.1080/10673220600642945; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.0.CO;2-I; Sesack SR, 1998, J NEUROSCI, V18, P2697; SHAM PC, 1994, BRIT J PSYCHIAT, V165, P466, DOI 10.1192/bjp.165.4.466; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; Singh AK, 2006, NEUROIMAGE, V33, P542, DOI 10.1016/j.neuroimage.2006.06.047; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Strangman G, 2002, BIOL PSYCHIAT, V52, P679, DOI 10.1016/S0006-3223(02)01550-0; Suto T, 2004, BIOL PSYCHIAT, V55, P501, DOI 10.1016/j.biopsych.2003.09.008; Takizawa R, 2008, SCHIZOPHR RES, V99, P250, DOI 10.1016/j.schres.2007.10.025; Tsuzuki D, 2007, NEUROIMAGE, V34, P1506, DOI 10.1016/j.neuroimage.2006.10.043; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Tunbridge EM, 2004, J NEUROSCI, V24, P5331, DOI 10.1523/JNEUROSCI.1124-04.2004; Weickert TW, 2004, BIOL PSYCHIAT, V56, P677, DOI 10.1016/j.biopsych.2004.08.012; Weinberger DR, 2001, BIOL PSYCHIAT, V50, P825, DOI 10.1016/S0006-3223(01)01252-5; Williams HJ, 2005, AM J PSYCHIAT, V162, P1736, DOI 10.1176/appi.ajp.162.9.1736; Winterer G, 2004, TRENDS NEUROSCI, V27, P683, DOI 10.1016/j.tins.2004.08.002; Woodward ND, 2007, SCHIZOPHR RES, V90, P86, DOI 10.1016/j.schres.2006.10.002; Yamashita Y, 1996, OPT ENG, V35, P1046, DOI 10.1117/1.600721	67	33	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5495	10.1371/journal.pone.0005495	http://dx.doi.org/10.1371/journal.pone.0005495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	443TN	19424500	Green Submitted, Green Published, gold			2022-12-25	WOS:000265933800022
J	Rauch, M; Tussiwand, R; Bosco, N; Rolink, AG				Rauch, Melanie; Tussiwand, Roxane; Bosco, Nabil; Rolink, Antonius G.			Crucial Role for BAFF-BAFF-R Signaling in the Survival and Maintenance of Mature B Cells	PLOS ONE			English	Article							NF-KAPPA-B; LYMPHOCYTE STIMULATOR; CUTTING EDGE; MONOCLONAL-ANTIBODY; AUTOIMMUNE-DISEASE; RECEPTOR; MICE; EXPRESSION; MATURATION; APOPTOSIS	Defects in the expression of either BAFF (B cell activating factor) or BAFF-R impairs B cell development beyond the immature, transitional type-1 stage and thus, prevents the formation of follicular and marginal zone B cells, whereas B-1 B cells remain unaffected. The expression of BAFF-R on all mature B cells might suggest a role for BAFF-R signaling also for their in vivo maintenance. Here, we show that, 14 days following a single injection of an anti-BAFF-R mAb that prevents BAFF binding, both follicular and marginal zone B cell numbers are drastically reduced, whereas B-1 cells are not affected. Injection of control, isotype-matched but non-blocking anti-BAFF-R mAbs does not result in B cell depletion. We also show that this depletion is neither due to antibody-dependent cellular cytotoxicity nor to complement-mediated lysis. Moreover, prevention of BAFF binding leads to a decrease in the size of the B cell follicles, an impairment of a T cell dependent humoral immune response and a reduction in the formation of memory B cells. Collectively, these results establish a central role for BAFF-BAFF-R signaling in the in vivo survival and maintenance of both follicular and marginal zone B cell pools.			Rauch, M (corresponding author), Univ Basel, Dept Biomed DBM, Basel, Switzerland.	antonius.rolink@unibas.ch	Bosco, Nabil/AAD-1579-2022	Tussiwand, Roxane/0000-0002-1712-868X				Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; ALLMAN DM, 1992, J IMMUNOL, V149, P2533; Anzelon AN, 2003, NAT IMMUNOL, V4, P287, DOI 10.1038/ni892; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Benson MJ, 2008, J IMMUNOL, V180, P3655, DOI 10.4049/jimmunol.180.6.3655; Caamano JH, 1998, J EXP MED, V187, P185, DOI 10.1084/jem.187.2.185; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; Clayton E, 2002, J EXP MED, V196, P753, DOI 10.1084/jem.20020805; Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953; Domen J, 1998, BLOOD, V91, P2272, DOI 10.1182/blood.V91.7.2272.2272_2272_2282; FORSTER I, 1990, P NATL ACAD SCI USA, V87, P4781, DOI 10.1073/pnas.87.12.4781; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Gerondakis S, 2003, SEMIN IMMUNOL, V15, P159, DOI 10.1016/S1044-5323(03)00036-8; Gorelik L, 2004, J IMMUNOL, V172, P762, DOI 10.4049/jimmunol.172.2.762; GORONZY J, 1986, J EXP MED, V164, P911, DOI 10.1084/jem.164.3.911; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; GROSS TM, 2000, DIABETES TECHNOL THE, V2, P19, DOI DOI 10.1089/15209150050214087; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; He B, 2004, J IMMUNOL, V172, P3268, DOI 10.4049/jimmunol.172.5.3268; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Hsu BL, 2002, J IMMUNOL, V168, P5993, DOI 10.4049/jimmunol.168.12.5993; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; Kalled SL, 2005, IMMUNOL REV, V204, P43, DOI 10.1111/j.0105-2896.2005.00219.x; Kern C, 2004, BLOOD, V103, P679, DOI 10.1182/blood-2003-02-0540; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lin WY, 2007, BLOOD, V110, P3959, DOI 10.1182/blood-2007-04-088088; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mecklenbrauker I, 2004, NATURE, V431, P456, DOI 10.1038/nature02955; Merrell KT, 2006, IMMUNITY, V25, P953, DOI 10.1016/j.immuni.2006.10.017; NIMAN HL, 1983, P NATL ACAD SCI-BIOL, V80, P4949, DOI 10.1073/pnas.80.16.4949; Novak AJ, 2004, BLOOD, V103, P689, DOI 10.1182/blood-2003-06-2043; Novak AJ, 2002, BLOOD, V100, P2973, DOI 10.1182/blood-2002-02-0558; OSMOND DG, 1993, IMMUNOL TODAY, V14, P34, DOI 10.1016/0167-5699(93)90322-C; OSMOND DG, 1991, CURR OPIN IMMUNOL, V3, P179, DOI 10.1016/0952-7915(91)90047-5; Otero DC, 2003, J IMMUNOL, V170, P73, DOI 10.4049/jimmunol.170.1.73; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Rolink AG, 2002, EUR J IMMUNOL, V32, P2004, DOI 10.1002/1521-4141(200207)32:7<2004::AID-IMMU2004>3.0.CO;2-5; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Sasaki Y, 2004, J IMMUNOL, V173, P2245, DOI 10.4049/jimmunol.173.4.2245; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shulga-Morskaya S, 2004, J IMMUNOL, V173, P2331, DOI 10.4049/jimmunol.173.4.2331; Siebenlist U, 2005, NAT REV IMMUNOL, V5, P435, DOI 10.1038/nri1629; STELLER H, 1985, EMBO J, V4, P167, DOI 10.1002/j.1460-2075.1985.tb02332.x; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tardivel A, 2004, EUR J IMMUNOL, V34, P509, DOI 10.1002/eji.200324692; WALLNY HJ, 1995, EUR J IMMUNOL, V25, P1262, DOI 10.1002/eji.1830250520; Weih F, 1997, J EXP MED, V185, P1359, DOI 10.1084/jem.185.7.1359; Yan MH, 2001, CURR BIOL, V11, P1547, DOI 10.1016/S0960-9822(01)00481-X; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6	58	87	94	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5456	10.1371/journal.pone.0005456	http://dx.doi.org/10.1371/journal.pone.0005456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421318	Green Published, gold, Green Submitted			2022-12-25	WOS:000265836900012
J	Dupuis, L; de Aguilar, JLG; Echaniz-Laguna, A; Eschbach, J; Rene, F; Oudart, H; Halter, B; Huze, C; Schaeffer, L; Bouillaud, F; Loeffler, JP				Dupuis, Luc; de Aguilar, Jose-Luis Gonzalez; Echaniz-Laguna, Andoni; Eschbach, Judith; Rene, Frederique; Oudart, Hugues; Halter, Benoit; Huze, Caroline; Schaeffer, Laurent; Bouillaud, Frederic; Loeffler, Jean-Philippe			Muscle Mitochondrial Uncoupling Dismantles Neuromuscular Junction and Triggers Distal Degeneration of Motor Neurons	PLOS ONE			English	Article								Background: Amyotrophic lateral sclerosis (ALS), the most frequent adult onset motor neuron disease, is associated with hypermetabolism linked to defects in muscle mitochondrial energy metabolism such as ATP depletion and increased oxygen consumption. It remains unknown whether muscle abnormalities in energy metabolism are causally involved in the destruction of neuromuscular junction (NMJ) and subsequent motor neuron degeneration during ALS. Methodology/Principal Findings: We studied transgenic mice with muscular overexpression of uncoupling protein 1 (UCP1), a potent mitochondrial uncoupler, as a model of muscle restricted hypermetabolism. These animals displayed age-dependent deterioration of the NMJ that correlated with progressive signs of denervation and a mild late-onset motor neuron pathology. NMJ regeneration and functional recovery were profoundly delayed following injury of the sciatic nerve and muscle mitochondrial uncoupling exacerbated the pathology of an ALS animal model. Conclusions/Significance: These findings provide the proof of principle that a muscle restricted mitochondrial defect is sufficient to generate motor neuron degeneration and suggest that therapeutic strategies targeted at muscle metabolism might prove useful for motor neuron diseases.			Dupuis, L (corresponding author), INSERM, Lab Signalisat Mol & Neurodegenerescence, U692, Strasbourg, France.	ldupuis@unistra.fr; loeffler@unistra.fr	Bouillaud, Frédéric R/L-3238-2017; Dupuis, Luc/A-6981-2012; LOEFFLER, Jean-Philippe/AAS-4401-2020	Bouillaud, Frédéric R/0000-0002-7518-9237; schaeffer, laurent/0000-0001-6600-503X; Dupuis, Luc/0000-0002-0902-5824				Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Couplan E, 2002, J BIOL CHEM, V277, P43079, DOI 10.1074/jbc.M206726200; De Souza AS, 2004, J NEUROTRAUM, V21, P627, DOI 10.1089/089771504774129955; DEAGUILAR JLG, 2007, J NEUROCHEM; Desport JC, 2001, AM J CLIN NUTR, V74, P328; Desport JC, 2005, NEURODEGENER DIS, V2, P202, DOI 10.1159/000089626; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Dupuis L, 2003, FASEB J, V17, P2091, DOI 10.1096/fj.02-1182fje; Dupuis L, 2002, NEUROBIOL DIS, V10, P358, DOI 10.1006/nbdi.2002.0522; Dupuis L, 2000, NEUROBIOL DIS, V7, P274, DOI 10.1006/nbdi.2000.0292; DUPUIS L, 2008, NEUROLOGY; Dupuis L, 2004, NEURODEGENER DIS, V1, P245, DOI 10.1159/000085063; Fergani A, 2007, J LIPID RES, V48, P1571, DOI 10.1194/jlr.M700017-JLR200; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; FUNALOT B, 2008, AMYOTROPH LATERAL SC, P1; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Hamer PW, 2002, J ANAT, V200, P69, DOI 10.1046/j.0021-8782.2001.00008.x; Han DH, 2004, AM J PHYSIOL-ENDOC M, V286, pE347, DOI 10.1152/ajpendo.00434.2003; Hoerter J, 2004, CIRCULATION, V110, P528, DOI 10.1161/01.CIR.0000137824.30476.0E; Jimenez-Mallebrera C, 2005, CELL MOL LIFE SCI, V62, P809, DOI 10.1007/s00018-004-4510-4; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Mattson MP, 2007, NEUROMOL MED, V9, P17, DOI 10.1385/NMM:9:1:17; Meier T, 1998, EUR J NEUROSCI, V10, P3141, DOI 10.1046/j.1460-9568.1998.00320.x; Miller TM, 2006, P NATL ACAD SCI USA, V103, P19546, DOI 10.1073/pnas.0609411103; Pedersen WA, 1999, BRAIN RES, V833, P117, DOI 10.1016/S0006-8993(99)01471-7; Ricquier D, 2005, P NUTR SOC, V64, P47, DOI 10.1079/PNS2004408; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; Rouaux C, 2007, J NEUROSCI, V27, P5535, DOI 10.1523/JNEUROSCI.1139-07.2007; Towne C, 2008, MOL THER, V16, P1018, DOI 10.1038/mt.2008.73; You SJ, 1997, GLIA, V20, P87, DOI 10.1002/(SICI)1098-1136(199706)20:2<87::AID-GLIA1>3.0.CO;2-1	34	153	157	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5390	10.1371/journal.pone.0005390	http://dx.doi.org/10.1371/journal.pone.0005390			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404401	gold, Green Published, Green Submitted			2022-12-25	WOS:000265614900007
J	Ferrara, G; Argenyi, Z; Argenziano, G; Cerio, R; Cerroni, L; Di Blasi, A; Feudale, EAA; Giorgio, CM; Massone, C; Nappi, O; Tomasini, C; Urso, C; Zalaudek, I; Kittler, H; Soyer, HP				Ferrara, Gerardo; Argenyi, Zsolt; Argenziano, Giuseppe; Cerio, Rino; Cerroni, Lorenzo; Di Blasi, Arturo; Feudale, Elisa A. A.; Giorgio, Caterina M.; Massone, Cesare; Nappi, Oscar; Tomasini, Carlo; Urso, Carmelo; Zalaudek, Iris; Kittler, Harald; Soyer, H. Peter			The Influence of Clinical Information in the Histopathologic Diagnosis of Melanocytic Skin Neoplasms	PLOS ONE			English	Article							MELANOMA; LESIONS; ACCURACY; HISTORY; READ; NEVI	Background: We tested the relevance of clinical information in the histopathologic evaluation of melanocytic skin neoplasm (MSN). Methods: Histopathologic specimens from 99 clinically atypical MSN were circulated among ten histopathologists; each case had clinical information available in a database with a five-step procedure (no information; age/sex/location; clinical diagnosis; clinical image; dermoscopic image); each step had a histopathologic diagnosis (D1 through D5); each diagnostic step had a level of diagnostic confidence (LDC) ranging from 1 (no diagnostic certainty) to 5 (absolute diagnostic certainty). The comparison of the LDC was employed with an analysis of variance (ANOVA) for repeated measures. Findings: In D1 (no information), 36/99 cases (36.3%) had unanimous diagnosis; in D5 (full information available), 51/99 cases (51.5%) had unanimous diagnosis (p for difference between proportions <0.001). The observer agreement expressed as kappa increased significantly from D1 to D5. The mean LDC linearly increased for each observer from D1 through D5 (p for linear trend <0.001). On average, each histopathologist changed his initial diagnosis in 7 cases (range: 2-23). Most diagnostic changes were in D2 (age/sex/location). Interpretation: The histopathologic criteria for the diagnosis of MSN can work as such, but the final histopathologic diagnosis is a clinically-aided interpretation. Clinical data sometimes reverse the initial histopathologic evaluation.			Ferrara, G (corresponding author), Gaetano Rummo Gen Hosp, Dept Pathol, Benevento, Italy.	p.soyer@uq.edu.au	Zalaudek, Iris/AAL-5436-2020; Zalaudek, Iris/E-5910-2010; Soyer, H. Peter/W-3791-2017; Kittler, Harald/K-7574-2013; Argenziano, Giuseppe/E-5926-2010; Soyer, H. Peter/E-6000-2010; Kittler, Harald/AAK-1502-2020	Zalaudek, Iris/0000-0002-7878-4955; Zalaudek, Iris/0000-0002-7878-4955; Soyer, H. Peter/0000-0002-4770-561X; Argenziano, Giuseppe/0000-0003-1413-8214; Soyer, H. Peter/0000-0002-4770-561X; KITTLER, HARALD/0000-0002-0051-8016; URSO, CARMELO/0000-0002-3746-2917; massone, cesare/0000-0002-0996-643X				Abbey LM, 1998, ORAL SURG ORAL MED O, V85, P74, DOI 10.1016/S1079-2104(98)90401-2; Argenziano G, 2006, J CLIN ONCOL, V24, P1877, DOI 10.1200/JCO.2005.05.0864; Argenziano G, 2000, INTERACTIVE ATLAS DE; Barnhill RL, 2006, AM J DERMATOPATH, V28, P75, DOI 10.1097/01.dad.0000188868.19869.3b; Bauer J, 2001, ARCH DERMATOL, V137, P1338; Cerroni L, 2001, AM J DERMATOPATH, V23, P370, DOI 10.1097/00000372-200108000-00015; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Corona R, 1996, J CLIN ONCOL, V14, P1218, DOI 10.1200/JCO.1996.14.4.1218; Drut R, 1999, PEDIATR DEVEL PATHOL, V2, P473, DOI 10.1007/s100249900151; Elder DE, 2004, PATHOLOGY, V36, P428, DOI 10.1080/00313020412331283905; Farmer ER, 1996, HUM PATHOL, V27, P528, DOI 10.1016/S0046-8177(96)90157-4; Ferrara G, 2008, HISTOPATHOLOGY, V52, P523, DOI 10.1111/j.1365-2559.2008.02943.x; Ferrara G, 2005, ARCH DERMATOL, V141, P1381, DOI 10.1001/archderm.141.11.1381; Ferrara G, 2004, J TELEMED TELECARE, V10, P34, DOI 10.1258/135763304322764176; Ferrara G, 2002, CANCER, V95, P1094, DOI 10.1002/cncr.10768; Ferrara G, 2002, CLIN DERMATOL, V20, P228, DOI 10.1016/S0738-081X(02)00230-4; FLEISS JL, 1969, PSYCHOL BULL, V72, P323, DOI 10.1037/h0028106; FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619; Fleiss JL, 1981, STAT METHODS RATES P, P2; Griscom NT, 2002, RADIOLOGY, V223, P9, DOI 10.1148/radiol.2231011274; Lowes M A, 2000, Australas J Dermatol, V41, P109, DOI 10.1046/j.1440-0960.2000.00406.x; Loy CT, 2004, JAMA-J AM MED ASSOC, V292, P1602, DOI 10.1001/jama.292.13.1602; Meghini C., 1993, SIGIR Forum, P298; Raab SS, 2000, AM J CLIN PATHOL, V114, P78, DOI 10.1309/4099-QALD-NVGF-TM4G; SCHREIBER MH, 1963, JAMA-J AM MED ASSOC, V185, P399, DOI 10.1001/jama.1963.03060050077027; SHITABATA PK, DO CLIN HIST SUBMITT; Soyer HP, 2005, ARCH DERMATOL, V141, P209, DOI 10.1001/archderm.141.2.209; SOYER HP, 1989, AM J DERMATOPATH, V11, P1, DOI 10.1097/00000372-198902000-00001; Soyer HP, 2000, EUR J DERMATOL, V10, P22; Weedon D, 2002, SKIN PATHOLOGY, P803; Zalaudek I, 2004, BRIT J DERMATOL, V150, P64, DOI 10.1111/j.1365-2133.2004.05657.x	31	53	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5375	10.1371/journal.pone.0005375	http://dx.doi.org/10.1371/journal.pone.0005375			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404399	Green Submitted, gold, Green Published			2022-12-25	WOS:000265614900003
J	Friedman, S; Lu, M; Schultz, A; Thomas, D; Lin, RY				Friedman, Susan; Lu, Min; Schultz, Atara; Thomas, Dolly; Lin, Reigh-Yi			CD133(+) Anaplastic Thyroid Cancer Cells Initiate Tumors in Immunodeficient Mice and Are Regulated by Thyrotropin	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; STEM-LIKE CELLS; HEMATOPOIETIC STEM; IDENTIFICATION; EXPRESSION; MARKER; GENE; LINE	Background: Anaplastic thyroid cancer (ATC) is one of the most lethal human malignancies. Its rapid onset and resistance to conventional therapeutics contribute to a mean survival of six months after diagnosis and make the identification of thyroid-cancer-initiating cells increasingly important. Methodology/Principal Findings: In prior studies of ATC cell lines, CD133(+) cells exhibited stem-cell-like features such as high proliferation, self-renewal and colony-forming ability in vitro. Here we show that transplantation of CD133(+) cells, but not CD133(-) cells, into immunodeficient NOD/SCID mice is sufficient to induce growth of tumors in vivo. We also describe how the proportion of ATC cells that are CD133(+) increases dramatically over three months of culture, from 7% to more than 80% of the total. This CD133(+) cell pool can be further separated by flow cytometry into two distinct populations: CD133(+/high) and CD133(+/low). Although both subsets are capable of long-term tumorigenesis, the rapidly proliferating CD133(+/high) cells are by far the most efficient. They also express high levels of the stem cell antigen Oct4 and the receptor for thyroid stimulating hormone, TSHR. Treating ATC cells with TSH causes a three-fold increase in the numbers of CD133(+) cells and elicits a dose-dependent up-regulation of the expression of TSHR and Oct4 in these cells. More importantly, immunohistochemical analysis of tissue specimens from ATC patients indicates that CD133 is highly expressed on tumor cells but not on neighboring normal thyroid cells. Conclusions/Significance: To our knowledge, this is the first report indicating that CD133(+) ATC cells are solely responsible for tumor growth in immunodeficient mice. Our data also give a unique insight into the regulation of CD133 by TSH. These highly tumorigenic CD133(+) cells and the activated TSH signaling pathway may be useful targets for future ATC therapies.			Friedman, S (corresponding author), Mt Sinai Sch Med, Dept Med, New York, NY USA.	reigh-yi.lin@mssm.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068057] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK068057] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		*ACS, 2008, CANC FACTS FIG; Ahn SH, 2008, ARCH OTOLARYNGOL, V134, P190, DOI 10.1001/archoto.2007.36; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Chen ST, 2002, J ENDOCRINOL, V175, P459, DOI 10.1677/joe.0.1750459; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; De Falco V, 2007, CANCER RES, V67, P11821, DOI 10.1158/0008-5472.CAN-07-0899; De Vita G, 2005, MOL ENDOCRINOL, V19, P76, DOI 10.1210/me.2004-0172; Dou J, 2007, CELL MOL IMMUNOL, V4, P467; Fagin JA, 1996, CANCER RES, V56, P765; FAGIN JA, 1993, J CLIN INVEST, V91, P179, DOI 10.1172/JCI116168; FERRANDINA G, 2007, INT J GYNECOL CANC; Fiore L, 1997, J CLIN ENDOCR METAB, V82, P4094, DOI 10.1210/jc.82.12.4094; Florek M, 2005, CELL TISSUE RES, V319, P15, DOI 10.1007/s00441-004-1018-z; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Hwang JH, 2003, J CLIN ENDOCR METAB, V88, P408, DOI 10.1210/jc.2002-021381; Katoh Y, 2007, INT J MOL MED, V19, P967; Klein WM, 2007, MODERN PATHOL, V20, P102, DOI 10.1038/modpathol.3800720; Lin RY, 2007, THYROID, V17, P1019, DOI 10.1089/thy.2007.0183; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Ma YH, 2008, J NEURO-ONCOL, V86, P31, DOI 10.1007/s11060-007-9439-7; METAYE T, 2008, J ENDOCRINOL; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Piccirillo SGM, 2007, ERNST SCHERING FOUND, V5, P59, DOI 10.1007/2789_2007_044; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Pierie JPEN, 2002, ANN SURG ONCOL, V9, P57, DOI 10.1245/aso.2002.9.1.57; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rountree CB, 2008, HEPATOLOGY, V47, P1288, DOI 10.1002/hep.22141; Schuppert F, 1996, THYROID, V6, P575, DOI 10.1089/thy.1996.6.575; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Singh SK, 2003, CANCER RES, V63, P5821; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; Thomas D, 2008, ENDOCR-RELAT CANCER, V15, P51, DOI 10.1677/ERC-07-0210; van Staveren WCG, 2007, CANCER RES, V67, P8113, DOI 10.1158/0008-5472.CAN-06-4026; Yano Y, 2007, ONCOL REP, V18, P441; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Zito G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003544	41	61	66	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5395	10.1371/journal.pone.0005395	http://dx.doi.org/10.1371/journal.pone.0005395			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404394	Green Published, gold, Green Submitted			2022-12-25	WOS:000265614900009
J	Cai, X; Nash, Z; Conley, SM; Fliesler, SJ; Cooper, MJ; Naash, MI				Cai, Xue; Nash, Zack; Conley, Shannon M.; Fliesler, Steven J.; Cooper, Mark J.; Naash, Muna I.			A Partial Structural and Functional Rescue of a Retinitis Pigmentosa Model with Compacted DNA Nanoparticles	PLOS ONE			English	Article								Previously we have shown that compacted DNA nanoparticles can drive high levels of transgene expression after subretinal injection in the mouse eye. Here we delivered compacted DNA nanoparticles containing a therapeutic gene to the retinas of a mouse model of retinitis pigmentosa. Nanoparticles containing the wild-type retinal degeneration slow (Rds) gene were injected into the subretinal space of rds(+/-) mice on postnatal day 5. Gene expression was sustained for up to four months at levels up to four times higher than in controls injected with saline or naked DNA. The nanoparticles were taken up into virtually all photoreceptors and mediated significant structural and biochemical rescue of the disease without histological or functional evidence of toxicity. Electroretinogram recordings showed that nanoparticle-mediated gene transfer restored cone function to a near-normal level in contrast to transfer of naked plasmid DNA. Rod function was also improved. These findings demonstrate that compacted DNA nanoparticles represent a viable option for development of gene-based interventions for ocular diseases and obviate major barriers commonly encountered with non-viral based therapies.			Cai, X (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA.	muna-naash@ouhsc.edu	Fliesler, Steven J./AAE-9243-2020	Fliesler, Steven/0000-0002-2557-142X	NATIONAL EYE INSTITUTE [R01EY007361, R55EY010609, R01EY018656, R56EY010609, R01EY010609] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY018656, R01 EY010609, EY018656, R01 EY007361, EY007361, R01 EY018656-02, R01 EY010609-09, EY10609, R56 EY010609] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Ali RR, 2000, NAT GENET, V25, P306, DOI 10.1038/77068; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Cai X, 2008, VISION RES, V48, P319, DOI 10.1016/j.visres.2007.07.012; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chen X, 2008, MOL THER, V16, P333, DOI 10.1038/sj.mt.6300365; Cheng T, 1997, J NEUROSCI, V17, P8118, DOI 10.1523/jneurosci.17-21-08118.1997; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; CONNELL G, 1991, P NATL ACAD SCI USA, V88, P723, DOI 10.1073/pnas.88.3.723; CONNELL GJ, 1990, BIOCHEMISTRY-US, V29, P4691, DOI 10.1021/bi00471a025; COOPER MJ, 2007, MOL THERAPY S, V15, P315; Davis PB, 2007, AAPS J, V9, pE11, DOI 10.1208/aapsj0901002; Ding XQ, 2004, HUM MOL GENET, V13, P2075, DOI 10.1093/hmg/ddh211; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Farjo R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000038; FARRAR GJ, 1991, NATURE, V354, P478, DOI 10.1038/354478a0; Fink TL, 2006, GENE THER, V13, P1048, DOI 10.1038/sj.gt.3302761; HAWKINS RK, 1985, EXP EYE RES, V41, P701, DOI 10.1016/0014-4835(85)90179-4; Justilien V, 2007, INVEST OPHTH VIS SCI, V48, P4407, DOI 10.1167/iovs.07-0432; Kedzierski W, 1999, J NEUROCHEM, V72, P430, DOI 10.1046/j.1471-4159.1999.0720430.x; Khoubian FJ, 2005, RETINA-J RET VIT DIS, V25, P999, DOI 10.1097/00006982-200512000-00008; Konstan MW, 2004, HUM GENE THER, V15, P1255, DOI 10.1089/hum.2004.15.1255; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; LAM BL, 1995, AM J OPHTHALMOL, V119, P65, DOI 10.1016/S0002-9394(14)73815-2; Lee ES, 2006, INVEST OPHTH VIS SCI, V47, P2150, DOI 10.1167/iovs.05-0919; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Li C, 2003, INVEST OPHTH VIS SCI, V44, P2433, DOI 10.1167/iovs.02-1152; Li CB, 2001, OPTOMETRY VISION SCI, V78, P425, DOI 10.1097/00006324-200106000-00015; LIOU GI, 1990, J BIOL CHEM, V265, P8373; Liu G, 2003, J BIOL CHEM, V278, P32578, DOI 10.1074/jbc.M305776200; Luo D, 2000, NAT BIOTECHNOL, V18, P893, DOI 10.1038/78523; MA JS, 1995, GENOMICS, V28, P212, DOI 10.1006/geno.1995.1133; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; Nour M, 2004, INVEST OPHTH VIS SCI, V45, P2514, DOI 10.1167/iovs.04-0065; Nour M, 2003, INVEST OPHTH VIS SCI, V44, P4505, DOI 10.1167/iovs.03-0453; Pang JJ, 2006, MOL VIS, V12, P756; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Sarra GM, 2001, HUM MOL GENET, V10, P2353, DOI 10.1093/hmg/10.21.2353; Schlichtenbrede FC, 2003, J GENE MED, V5, P757, DOI 10.1002/jgm.401; Stricker HM, 2005, BIOCHEM J, V388, P605, DOI 10.1042/BJ20041960; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; YUREK DM, 2005, MOL THERAPUETICS, V11, pS253; Ziady AG, 2003, MOL THER, V8, P936, DOI 10.1016/j.ymthe.2003.07.007; Ziady AG, 2003, MOL THER, V8, P948, DOI 10.1016/j.ymthe.2003.09.002	50	82	85	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5290	10.1371/journal.pone.0005290	http://dx.doi.org/10.1371/journal.pone.0005290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390689	Green Published, Green Submitted, gold			2022-12-25	WOS:000265514400001
J	Page, N; Schall, N; Strub, JM; Quinternet, M; Chaloin, O; Decossas, M; Cung, MT; Van Dorsselaer, A; Briand, JP; Muller, S				Page, Nicolas; Schall, Nicolas; Strub, Jean-Marc; Quinternet, Marc; Chaloin, Olivier; Decossas, Marion; Cung, Manh Thong; Van Dorsselaer, Alain; Briand, Jean-Paul; Muller, Sylviane			The Spliceosomal Phosphopeptide P140 Controls the Lupus Disease by Interacting with the HSC70 Protein and via a Mechanism Mediated by gamma delta T Cells	PLOS ONE			English	Article								The phosphopeptide P140 issued from the spliceosomal U1-70K snRNP protein is recognized by lupus CD4(+) T cells, transiently abolishes T cell reactivity to other spliceosomal peptides in P140-treated MRL/lpr mice, and ameliorates their clinical features. P140 modulates lupus patients' T cell response ex vivo and is currently included in phase IIb clinical trials. Its underlying mechanism of action remains elusive. Here we show that P140 peptide binds a unique cell-surface receptor, the constitutively-expressed chaperone HSC70 protein, known as a presenting-protein. P140 induces apoptosis of activated MRL/lpr CD4(+) T cells. In P140-treated mice, it increases peripheral blood lymphocyte apoptosis and decreases B cell, activated T cell, and CD4(-)CD8(-)B220(+) T cell counts via a specific mechanism strictly depending on gamma delta T cells. Expression of inflammation-linked genes is rapidly regulated in CD4(+) T cells. This work led us to identify a powerful pathway taken by a newly-designed therapeutic peptide to immunomodulate lupus autoimmunity.			Page, N (corresponding author), Inst Biol Mol & Cellulaire, CNRS, UPR9021, F-67084 Strasbourg, France.	s.muller@ibmc.u-strasbg.fr	Muller, Sylviane/J-5319-2014	Strub, Jean-Marc/0000-0001-6224-3428; decossas, marion/0000-0003-0810-4309; QUINTERNET, Marc/0000-0002-8299-7136				Auger I, 1996, NAT MED, V2, P306, DOI 10.1038/nm0396-306; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Callebaut C, 1997, J BIOL CHEM, V272, P7159, DOI 10.1074/jbc.272.11.7159; Catusse J, 2008, P NATL ACAD SCI USA, V105, P10262, DOI 10.1073/pnas.0800585105; CLORE GM, 1986, J MOL BIOL, V191, P523, DOI 10.1016/0022-2836(86)90146-4; Craft J, 1999, IMMUNOL RES, V19, P245, DOI 10.1007/BF02786492; Diegel ML, 2002, INT IMMUNOPHARMACOL, V2, P1451, DOI 10.1016/S1567-5769(02)00090-5; Ellis S, 2000, J HISTOCHEM CYTOCHEM, V48, P321, DOI 10.1177/002215540004800302; Fournel S, 2005, NAT CHEM BIOL, V1, P377, DOI 10.1038/nchembio746; GOODMAN T, 1989, J EXP MED, V170, P1569, DOI 10.1084/jem.170.5.1569; Goulvestre C, 2005, J IMMUNOL, V175, P6959, DOI 10.4049/jimmunol.175.10.6959; GRONENBORN AM, 1995, CRIT REV BIOCHEM MOL, V30, P351, DOI 10.3109/10409239509083489; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; ITO S, 1990, CLIN EXP IMMUNOL, V81, P446; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KUMAR A, 1981, J AM CHEM SOC, V103, P3654, DOI 10.1021/ja00403a008; Lorenz HM, 2005, ANN RHEUM DIS, V64, P1517, DOI 10.1136/ard.2005.035329; LUNARDI C, 1991, CLIN EXP IMMUNOL, V86, P203; MANDELL RB, 1992, EXP CELL RES, V198, P164, DOI 10.1016/0014-4827(92)90163-3; Monneaux F, 2000, EUR J IMMUNOL, V30, P2191; Monneaux F, 2005, J IMMUNOL, V175, P5839, DOI 10.4049/jimmunol.175.9.5839; Monneaux F, 2004, ARTHRITIS RHEUM-US, V50, P3232, DOI 10.1002/art.20510; Monneaux F, 2003, EUR J IMMUNOL, V33, P287, DOI 10.1002/immu.200310002; Monneaux F, 2001, INT IMMUNOL, V13, P1155, DOI 10.1093/intimm/13.9.1155; Monneaux F, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2317; Muller S, 2008, ARTHRITIS RHEUM-US, V58, P3873, DOI 10.1002/art.24027; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NILGES M, 1988, FEBS LETT, V229, P317, DOI 10.1016/0014-5793(88)81148-7; Nisole S, 1999, J BIOL CHEM, V274, P27875, DOI 10.1074/jbc.274.39.27875; O'Brien RL, 2007, IMMUNOL REV, V215, P77, DOI 10.1111/j.1600-065X.2006.00477.x; Panjwani N, 1999, J IMMUNOL, V163, P1936; PARK K, 1993, PROTEIN SCI, V2, P325; Peng SL, 1996, J IMMUNOL, V157, P5689; PETERMAN GM, 1993, J IMMUNOL, V151, P6546; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Renno T, 1998, EUR J IMMUNOL, V28, P540, DOI 10.1002/(SICI)1521-4141(199802)28:02<540::AID-IMMU540>3.3.CO;2-P; Riccieri V, 2000, LUPUS, V9, P333, DOI 10.1191/096120300678828460; Robak E, 2001, MEDIAT INFLAMM, V10, P179, DOI 10.1080/09629350120080300; Rus V, 2007, J IMMUNOL, V178, P3962, DOI 10.4049/jimmunol.178.6.3962; SCHEEK RM, 1989, METHOD ENZYMOL, V177, P204; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; SKOURI M, 1991, FEBS LETT, V295, P84, DOI 10.1016/0014-5793(91)81391-K; TAMURA Y, 1993, J IMMUNOL, V151, P5516; Thedrez A, 2007, IMMUNOL REV, V215, P123, DOI 10.1111/j.1600-065X.2006.00468.x; Watanabe H, 1998, CLIN IMMUNOL IMMUNOP, V88, P91, DOI 10.1006/clin.1998.4553; Wei YQ, 1996, CANCER RES, V56, P1104; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Yi YJ, 2000, J IMMUNOL, V165, P6627, DOI 10.4049/jimmunol.165.11.6627	54	51	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5273	10.1371/journal.pone.0005273	http://dx.doi.org/10.1371/journal.pone.0005273			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390596	Green Published, Green Submitted, gold			2022-12-25	WOS:000265514200006
J	Bromberg, Y; Overton, J; Vaisse, C; Leibel, RL; Rost, B				Bromberg, Yana; Overton, John; Vaisse, Christian; Leibel, Rudolph L.; Rost, Burkhard			In silico mutagenesis: a case study of the melanocortin 4 receptor	FASEB JOURNAL			English	Article						MC4R; MC1R; SNAP; active functional site; obesity; diabetes	AGOUTI-RELATED PROTEIN; CELL-SURFACE EXPRESSION; STRUCTURE PREDICTION; STIMULATING-HORMONE; FUNCTIONAL ANALYSES; MOLECULAR-BASIS; MUTATIONS; OBESITY; POLYMORPHISMS; SUBSTITUTION	The melanocortin 4 receptor (MC4R) is a G-protein-coupled receptor ( GPCR) and a key molecule in the regulation of energy homeostasis. At least 159 substitutions in the coding region of human MC4R (hMC4R) have been described experimentally; over 80 of those occur naturally, and many have been implicated in obesity. However, assessment of the presumably functionally essential residues remains incomplete. Here we have performed a complete in silico mutagenesis analysis to assess the functional essentiality of all possible nonnative point mutants in the entire hMC4R protein ( 332 residues). We applied SNAP, which is a method for quantifying functional consequences of single amino acid ( AA) substitutions, to calculate the effects of all possible substitutions at each position in the hMC4R AA sequence. We compiled a mutability score that reflects the degree to which a particular residue is likely to be functionally important. We performed the same experiment for a paralogue human melanocortin receptor (hMC1R) and a mouse orthologue (mMC4R) in order to compare computational evaluations of highly related sequences. Three results are most salient: 1) our predictions largely agree with the available experimental annotations; 2) this analysis identified several AAs that are likely to be functionally critical, but have not yet been studied experimentally; and 3) the differential analysis of the receptors implicates a number of residues as specifically important to MC4Rs vs. other GPCRs, such as hMC1R.-Bromberg, Y., Overton, J., Vaisse, C., Leibel, R. L., Rost, B. In silico mutagenesis: a case study of the melanocortin 4 receptor. FASEB J. 23, 3059-3069 ( 2009). www.fasebj.org	[Bromberg, Yana; Rost, Burkhard] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Bromberg, Yana; Rost, Burkhard] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Overton, John; Leibel, Rudolph L.] Columbia Univ, Div Mol Genet, Naomi Berrie Diabet Ctr, New York, NY 10032 USA; [Rost, Burkhard] Columbia Univ, NE Struct Genom Consortium, New York, NY 10032 USA; [Rost, Burkhard] Columbia Univ, New York Consortium Membrane Prot Struct, New York, NY 10032 USA; [Vaisse, Christian] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Vaisse, Christian] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bromberg, Y (corresponding author), Columbia Univ, Ctr Computat Biol & Bioinformat, 1130 St Nicholas Ave,Room 802, New York, NY 10032 USA.	bromberg@rostlab.org	Bromberg, Yana/AAA-7801-2020; Rost, Burkhard/A-1908-2016; Vaisse, Christian/F-1067-2011	Bromberg, Yana/0000-0002-8351-0844; Rost, Burkhard/0000-0003-0179-8424; 	National Library of Medicine [R01-LM07329-01]; National Institutes of Health (NIH) [RO1-DK52431-15, RO1-DK60540, RO1-DK068152]; American Heart Association's Established Investigator Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060540, R01DK052431, R01DK068152] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM007329] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association's Established Investigator Award(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank Cedric Govaerts ( University of California, San Francisco) for providing us with an annotated data set of hMC4R variants and Guy Yachdav ( Columbia University) for help with maintenance of the SNAP web server. We also thank all those who deposit their experimental results into public databases. The work of Y.B. and B. R. was supported by grant R01-LM07329-01 from the National Library of Medicine; that of J.D.O. and R. L. L. by National Institutes of Health (NIH) grant RO1-DK52431-15; and that of C. V. by NIH grants RO1-DK60540 and RO1-DK068152 and by the American Heart Association's Established Investigator Award.	Adan RAH, 2003, TRENDS PHARMACOL SCI, V24, P315, DOI 10.1016/S0165-6147(03)00130-5; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bromberg Y, 2008, BIOINFORMATICS, V24, P2397, DOI 10.1093/bioinformatics/btn435; Bromberg Y, 2008, BIOINFORMATICS, V24, pI207, DOI 10.1093/bioinformatics/btn268; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Burstein ES, 1998, J BIOL CHEM, V273, P24322, DOI 10.1074/jbc.273.38.24322; Calton MA, 2009, HUM MOL GENET, V18, P1140, DOI 10.1093/hmg/ddn431; Carroll L, 2005, PEPTIDES, V26, P1871, DOI 10.1016/j.peptides.2004.12.031; Chai BX, 2005, BIOCHEMISTRY-US, V44, P3418, DOI 10.1021/bi0478704; Chai BX, 2003, PEPTIDES, V24, P603, DOI 10.1016/S0196-9781(03)00104-9; Chen M, 2007, J BIOL CHEM, V282, P21712, DOI 10.1074/jbc.M702285200; Chen M, 2006, REGUL PEPTIDES, V136, P40, DOI 10.1016/j.regpep.2006.04.010; Dinulescu DM, 2000, J BIOL CHEM, V275, P6695, DOI 10.1074/jbc.275.10.6695; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Frandberg PA, 2001, BIOCHEM BIOPH RES CO, V281, P851, DOI 10.1006/bbrc.2001.4429; Geller F, 2004, AM J HUM GENET, V74, P572, DOI 10.1086/382490; Govaerts C, 2005, PEPTIDES, V26, P1909, DOI 10.1016/j.peptides.2004.11.042; Haskell-Luevano C, 2001, BIOCHEMISTRY-US, V40, P6164, DOI 10.1021/bi010025q; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kawabata T, 1999, NUCLEIC ACIDS RES, V27, P355, DOI 10.1093/nar/27.1.355; Kim DH, 2008, BIOCHEM BIOPH RES CO, V365, P439, DOI 10.1016/j.bbrc.2007.10.170; Kishi T, 2003, J COMP NEUROL, V457, P213, DOI 10.1002/cne.10454; Kopp J, 2004, PHARMACOGENOMICS, V5, P405, DOI 10.1517/14622416.5.4.405; Larsen LH, 2005, J CLIN ENDOCR METAB, V90, P219, DOI 10.1210/jc.2004-0497; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Lubrano-Berthelier C, 2004, J CLIN ENDOCR METAB, V89, P2028, DOI 10.1210/jc.2003-031993; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Mossner R, 2007, ARCH DERMATOL RES, V298, P371, DOI 10.1007/s00403-006-0708-7; Mohammad S, 2007, J BIOL CHEM, V282, P4963, DOI [10.1074/jbc.m608283200, 10.1074/jbc.M608283200]; Moult J, 2007, PROTEINS, V69, P3, DOI 10.1002/prot.21767; Newman EA, 2006, J SURG RES, V132, P201, DOI 10.1016/j.jss.2006.02.003; Ng PC, 2000, BIOINFORMATICS, V16, P760, DOI 10.1093/bioinformatics/16.9.760; Nickolls SA, 2003, J PHARMACOL EXP THER, V304, P1217, DOI 10.1124/jpet.102.044974; Nijenhuis WAJ, 2003, J BIOL CHEM, V278, P22939, DOI 10.1074/jbc.M211326200; Ofran Y, 2005, DRUG DISCOV TODAY, V10, P1475, DOI 10.1016/S1359-6446(05)03621-4; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Patten CS, 2007, REGUL PEPTIDES, V142, P111, DOI 10.1016/j.regpep.2007.02.005; Punta M, 2007, METHODS, V41, P460, DOI 10.1016/j.ymeth.2006.07.026; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Schioth HB, 2005, ANN NY ACAD SCI, V1040, P460, DOI 10.1196/annals.1327.090; Srinivasan S, 2004, J CLIN INVEST, V114, P1158, DOI 10.1172/JCI200421927; Tan K, 2009, ENDOCRINOLOGY, V150, P114, DOI 10.1210/en.2008-0721; Tao YX, 2006, PHARMACOL THERAPEUT, V111, P949, DOI 10.1016/j.pharmthera.2006.02.008; Tao YX, 2005, J CLIN ENDOCR METAB, V90, P5632, DOI 10.1210/jc.2005-0519; Tao YX, 2005, MOL CELL ENDOCRINOL, V239, P1, DOI 10.1016/j.mce.2005.04.012; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VanLeeuwen D, 2003, J BIOL CHEM, V278, P15935, DOI 10.1074/jbc.M211546200; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Wachira SJ, 2003, NEUROPEPTIDES, V37, P201, DOI 10.1016/S0143-4179(03)00026-X; Xiang ZM, 2006, BIOCHEMISTRY-US, V45, P7277, DOI 10.1021/bi0600300; Yamano Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1369, DOI 10.1271/bbb.68.1369; Yang Y, 2003, MOL PHARMACOL, V64, P94, DOI 10.1124/mol.64.1.94; Yang YK, 1997, J BIOL CHEM, V272, P23000, DOI 10.1074/jbc.272.37.23000	57	32	34	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					3059	3069		10.1096/fj.08-127530	http://dx.doi.org/10.1096/fj.08-127530			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19417090	Green Published			2022-12-25	WOS:000270241000028
J	Ortiz-Munoz, G; Houard, X; Martin-Ventura, JL; Ishida, BY; Loyau, S; Rossignol, P; Moreno, JA; Kane, JP; Chalkley, RJ; Burlingame, AL; Michel, JB; Meilhac, O				Ortiz-Munoz, Guadalupe; Houard, Xavier; Martin-Ventura, Jose-Luis; Ishida, Brian Y.; Loyau, Stephane; Rossignol, Patrick; Moreno, Juan-Antonio; Kane, John P.; Chalkley, Robert J.; Burlingame, Alma L.; Michel, Jean-Baptiste; Meilhac, Olivier			HDL antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property	FASEB JOURNAL			English	Article							HIGH-DENSITY-LIPOPROTEINS; APOLIPOPROTEIN-A-I; 2-DIMENSIONAL GEL-ELECTROPHORESIS; ABDOMINAL AORTIC-ANEURYSMS; MASS-SPECTROMETRY; INTRAPLAQUE HEMORRHAGE; NEUTROPHIL ELASTASE; EDINBURGH ARTERY; MURAL THROMBUS; ACTIVATION	Various studies using proteomic approaches have shown that HDL can carry many proteins other than its constitutive apolipoprotein A-I (apoA-I). Using mass spectrometry and Western blotting, we showed the presence of alpha(1)-antitrypsin (AAT) (SERPINA1, serpin peptidase inhibitor, clade A, an elastase inhibitor) in HDL, isolated either by ultracentrifugation or by selected-affinity immunosorption using an anti-apoA-I column. Furthermore, we report that HDL possesses potent antielastase activity. We further showed that only HDL but not LDL is able to bind AAT. HDL-associated AAT was able to inhibit extracellular matrix degradation, cell detachment, and apoptosis induced by elastase in human vascular smooth muscle cells (VSMCs) and in mammary artery cultured ex vivo. Degradation of fibronectin by elastase used as a marker of pericellular proteolysis was prevented by addition of HDL. Elastase present in aortic abdominal aneurysm ( AAA) thrombus samples was also able to induce apoptosis of VSMCs in culture. This phenomenon was prevented by addition of HDL but not of LDL. Finally, we report that the proportion of AAT in HDL isolated from patients with an AAA is decreased relative to that from matched control subjects, suggesting a reduced capacity of HDL to inhibit elastase in these patients. In conclusion, our data provide evidence of a new potential antiatherogenic property of HDL attributable to AAT and its antielastase activity.-Ortiz-Munoz, G., Houard, X., Martin-Ventura, J.-L., Ishida, B. Y., Loyau, S., Rossignol, P., Moreno, J.-A., Kane, J. P., Chalkley, R. J., Burlingame, A. L., Michel, J.-B., Meilhac, O. High-density lipoprotein antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property. FASEB J. 23, 3129-3139 (2009). www.fasebj.org	[Ortiz-Munoz, Guadalupe; Houard, Xavier; Martin-Ventura, Jose-Luis; Loyau, Stephane; Moreno, Juan-Antonio; Michel, Jean-Baptiste; Meilhac, Olivier] Hop X Bichat, INSERM, U698, F-75877 Paris 18, France; [Ortiz-Munoz, Guadalupe; Houard, Xavier; Martin-Ventura, Jose-Luis; Loyau, Stephane; Moreno, Juan-Antonio; Michel, Jean-Baptiste; Meilhac, Olivier] Univ Paris 07, Paris, France; [Ortiz-Munoz, Guadalupe; Houard, Xavier; Martin-Ventura, Jose-Luis; Loyau, Stephane; Moreno, Juan-Antonio; Michel, Jean-Baptiste; Meilhac, Olivier] Ctr Hosp Univ X Bichat, Paris, France; [Ishida, Brian Y.; Kane, John P.; Chalkley, Robert J.; Burlingame, Alma L.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Rossignol, Patrick] Hop Jeanne Darc, Ctr Hosp Univ Nancy, Dommartin Les Toul, France; [Rossignol, Patrick] Ctr Invest Clin Nancy CIC P 9501, INSERM, Dommartin Les Toul, France; [Rossignol, Patrick] Nancy Univ, Fac Med, Vandoeuvre Les Nancy, France; [Rossignol, Patrick] INSERM, U961, F-54511 Vandoeuvre Les Nancy, France; [Rossignol, Patrick] Hop Europeen Georges Pompidou, Serv Med Vasc & Hypertens Arterielle, AP HP, Paris, France; [Rossignol, Patrick] Hop Europeen Georges Pompidou, Ctr Invest Clin, AP HP, Paris, France; [Rossignol, Patrick] Fac Med Rene Descartes Paris 5, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; University of California System; University of California San Francisco; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Meilhac, O (corresponding author), Hop X Bichat, INSERM, U698, 46,Rue Henri Huchard, F-75877 Paris 18, France.	olivier.meilhac@inserm.fr	munoz, guadalupe ortiz/B-4969-2019; Michel, Jean-Baptiste/AAH-9336-2020; MARTIN-VENTURA, JOSE LUIS/Z-2386-2019; Meilhac, Olivier/N-4385-2017; Moreno, Juan Antonio/B-3487-2018	munoz, guadalupe ortiz/0000-0002-8928-0576; Moreno, Juan Antonio/0000-0002-7468-2871; MARTIN-VENTURA, JOSE LUIS/0000-0003-2090-8641; Loyau, stephane/0000-0001-8748-501X; Chalkley, Robert/0000-0002-9757-7302; Meilhac, Olivier/0000-0002-3740-7539	Leducq Foundation; European Community FAD [200647]; National Institutes of Health National Center for Research Resources [RR01614]; Fondation Lefoulon-Delalande; Fondation pour la Recherche Medicale; Fondation de France, Region Lorraine; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER	Leducq Foundation(Leducq Foundation); European Community FAD; National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Fondation Lefoulon-Delalande; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation de France, Region Lorraine(Fondation de FranceRegion Grand-Est); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by the Leducq Foundation, the European Community FAD project (FP-7, 200647), and National Institutes of Health National Center for Research Resources grant RR01614. X. H. was supported by a grant from the Fondation Lefoulon-Delalande. The RESAA study was promoted by Assistance Publique-Hopitaux de Paris, whereas the AMETHYST cohort is promoted by INSERM and supported by the Fondation pour la Recherche Medicale and the Fondation de France, Region Lorraine. We thank P. Julia, M. Sapoval, and D. Mouradian for help in recruiting patients for AMETHYST (Hopital Europeen Georges Pompidou, Paris, France), P. Julia for technical help ( RESAA operative samples), and Michel Azizi and D. Mouradian for enrollment of healthy volunteers (Hopital Europeen Georges Pompidou-INSERM Clinical Investigation Centre, Paris, France). We also thank Dr. Mary Osborne-Pellegrin for editing this article.	Aldonyte R, 2008, COPD, V5, P153, DOI 10.1080/15412550802092936; Asztalos BF, 2000, ARTERIOSCL THROM VAS, V20, P2670, DOI 10.1161/01.ATV.20.12.2670; Barter P, 2003, ATHEROSCLEROSIS, V168, P195, DOI 10.1016/S0021-9150(03)00006-6; BIHARIVARGA M, 1984, ATHEROSCLEROSIS, V50, P273, DOI 10.1016/0021-9150(84)90075-3; Bonnefoy A, 2000, THROMB RES, V98, P323, DOI 10.1016/S0049-3848(99)00242-X; Caligiuri G, 2006, ARTERIOSCL THROM VAS, V26, P618, DOI 10.1161/01.ATV.0000200380.73876.d9; CHEUNG MC, 1988, J LIPID RES, V29, P15; Cohen J R, 1991, J Invest Surg, V4, P423, DOI 10.3109/08941939109141172; Dollery CM, 2003, CIRCULATION, V107, P2829, DOI 10.1161/01.CIR.0000072792.65250.4A; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Fontaine V, 2004, AM J PATHOL, V164, P2077, DOI 10.1016/S0002-9440(10)63766-2; Fontaine V, 2002, AM J PATHOL, V161, P1701, DOI 10.1016/S0002-9440(10)64447-1; Frankfurt OS, 2001, J HISTOCHEM CYTOCHEM, V49, P369, DOI 10.1177/002215540104900311; GALDSTON M, 1979, AM REV RESPIR DIS, V119, P435; Gechtman Z, 1997, BIOCHEM J, V325, P339, DOI 10.1042/bj3250339; Hobbs SD, 2003, EUR J VASC ENDOVASC, V26, P618, DOI 10.1016/S1078-5884(03)00412-X; Karlsson H, 2005, PROTEOMICS, V5, P1431, DOI 10.1002/pmic.200401010; Karlsson H, 2005, PROTEOMICS, V5, P551, DOI 10.1002/pmic.200300938; Katayama H, 2003, RAPID COMMUN MASS SP, V17, P1071, DOI 10.1002/rcm.1024; Kolodgie FD, 2003, NEW ENGL J MED, V349, P2316, DOI 10.1056/NEJMoa035655; Kovanen PT, 1997, HEART VESSELS, P125; KUNITAKE ST, 1992, P NATL ACAD SCI USA, V89, P6993, DOI 10.1073/pnas.89.15.6993; Leclercq A, 2007, J LEUKOCYTE BIOL, V82, P1420, DOI 10.1189/jlb.1106671; Lindstedt L, 2001, ATHEROSCLEROSIS, V155, P87, DOI 10.1016/S0021-9150(00)00544-X; Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658; LOWE GDO, 1993, CIRCULATION, V87, P1915, DOI 10.1161/01.CIR.87.6.1915; Martin-Ventura JL, 2007, ATHEROSCLEROSIS, V194, P334, DOI 10.1016/j.atherosclerosis.2006.10.030; MCVICAR JP, 1984, P NATL ACAD SCI-BIOL, V81, P1356, DOI 10.1073/pnas.81.5.1356; Meilhac O, 2003, FASEB J, V17, P1301, DOI 10.1096/fj.02-0687fje; Michel JB, 2003, ARTERIOSCL THROM VAS, V23, P2146, DOI 10.1161/01.ATV.0000099882.52647.E4; Mtairag EM, 2002, ARTERIOSCL THROM VAS, V22, P1824, DOI 10.1161/01.ATV.0000037102.31086.F4; NORRGARD O, 1985, BRIT J SURG, V72, P113, DOI 10.1002/bjs.1800720215; Petrache I, 2006, AM J PATHOL, V169, P1155, DOI 10.2353/ajpath.2006.060058; Rossignol P, 2004, EXP CELL RES, V299, P279, DOI 10.1016/j.yexcr.2004.05.034; Simoni G, 1996, Cardiovasc Surg, V4, P445, DOI 10.1016/0967-2109(95)00140-9; Sun J, 2007, J CLIN INVEST, V117, P3359, DOI 10.1172/JCI31311; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Tzoulaki I, 2007, CIRCULATION, V115, P2119, DOI 10.1161/CIRCULATIONAHA.106.635029; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206	39	75	80	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					3129	3139		10.1096/fj.08-127928	http://dx.doi.org/10.1096/fj.08-127928			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19417089	Green Published			2022-12-25	WOS:000270241000035
J	Schneider, M; Forster, H; Boersma, A; Seiler, A; Wehnes, H; Sinowatz, F; Neumuller, C; Deutsch, MJ; Walch, A; de Angelis, MH; Wurst, W; Ursini, F; Roveri, A; Maleszewski, M; Maiorino, M; Conrad, M				Schneider, Manuela; Foerster, Heidi; Boersma, Auke; Seiler, Alexander; Wehnes, Helga; Sinowatz, Fred; Neumueller, Christine; Deutsch, Manuel J.; Walch, Axel; de Angelis, Martin Hrabe; Wurst, Wolfgang; Ursini, Fulvio; Roveri, Antonella; Maleszewski, Marek; Maiorino, Matilde; Conrad, Marcus			Mitochondrial glutathione peroxidase 4 disruption causes male infertility	FASEB JOURNAL			English	Article						PHGPx; redox metabolism; selenoprotein; spermatogenesis	FUNCTIONAL INTERACTION; SELENOPROTEIN PHGPX; SPERM MATURATION; NUCLEAR FORM; VITAMIN-E; MOUSE; INJECTION; SELENIUM; CELLS; EXPRESSION	Selenium is linked to male fertility. Glutathione peroxidase 4 (GPx4), first described as an antioxidant enzyme, is the predominant selenoenzyme in testis and has been suspected of being vital for spermatogenesis. Cytosolic, mitochondrial, and nuclear isoforms are all encoded by the same gene. While disruption of entire GPx4 causes early embryonic lethality in mice, inactivation of nuclear GPx4 does not impair embryonic development or fertility. Here, we show that deletion of mitochondrial GPx4 (mGPx4) allows both normal embryogenesis and postnatal development, but causes male infertility. Infertility was associated with impaired sperm quality and severe structural abnormalities in the midpiece of spermatozoa. Knockout sperm display higher protein thiol content and recapitulate features typical of severe selenodeficiency. Interestingly, male infertility induced by mGPx4 depletion could be bypassed by intracytoplasmic sperm injection. We also show for the first time that mGPx4 is the prevailing GPx4 product in male germ cells and that mGPx4 disruption has no effect on proliferation or apoptosis of germinal or somatic tissue. Our study finally establishes that mitochondrial GPx4 confers the vital role of selenium in mammalian male fertility and identifies cytosolic GPx4 as the only GPx4 isoform being essential for embryonic development and apoptosis regulation.-Schneider, M., Forster, H., Boersma, A., Seiler, A., Wehnes, H., Sinowatz, F., Neumuller, C., Deutsch, M. J., Walch, A., Hrabe de Angelis, M., Wurst, W., Ursini, F., Roveri, A., Maleszewski, M., Maiorino, M. Conrad, M. Mitochondrial glutathione peroxidase 4 disruption causes male infertility. FASEB J. 23, 3233-3242 ( 2009). www.fasebj.org	[Schneider, Manuela; Foerster, Heidi; Seiler, Alexander; Conrad, Marcus] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Clin Mol Biol & Tumor Genet, Neuherberg, Germany; [Boersma, Auke; de Angelis, Martin Hrabe] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Expt Genet, Neuherberg, Germany; [Wehnes, Helga; Walch, Axel] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Pathol, Neuherberg, Germany; [Deutsch, Manuel J.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Dept Gene Vectors, Neuherberg, Germany; [Wurst, Wolfgang] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [Sinowatz, Fred; Neumueller, Christine] Univ Munich, Dept Vet Anat 2, Munich, Germany; [Ursini, Fulvio; Roveri, Antonella; Maiorino, Matilde] Univ Padua, Dept Biol Chem, Padua, Italy; [Maleszewski, Marek] Univ Warsaw, Inst Zool, Dept Embryol, Warsaw, Poland	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Padua; University of Warsaw	Conrad, M (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Clin Mol Biol & Tumor Genet, Marchioninistr 25, D-81377 Munich, Germany.	marcus.conrad@helmholtz-muenchen.de	Sinowatz, Fred/V-1575-2019; de Angelis, Martin Hrabe/F-5531-2012; Walch, Axel/B-4554-2012; Conrad, Marcus/E-8792-2015; Roveri, Antonella/AAF-3669-2019	de Angelis, Martin Hrabe/0000-0002-7898-2353; Walch, Axel/0000-0001-5578-4023; Conrad, Marcus/0000-0003-1140-5612; Roveri, Antonella/0000-0002-3252-0559; Maleszewski, Marek/0000-0002-6699-0452; Wurst, Wolfgang/0000-0003-4422-7410	Deutsche Forschungsgemeinschaft (DFG) [CO 291/2-1]; DFG-Priority Programme [SPP1087]; Italian Ministry of University and Scientific Research	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG-Priority Programme(German Research Foundation (DFG)); Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR))	The authors are most grateful to Pierluigi Mauri and Louise Benazzi at the National Research Council (CNR), Milan, Italy, for the LC ESI MS/MS analysis. This work was supported by the Deutsche Forschungsgemeinschaft (DFG) ( CO 291/2-1) to M. C., the DFG-Priority Programme SPP1087 to M. C., and the Italian Ministry of University and Scientific Research.	Arai M, 1999, J BIOL CHEM, V274, P4924, DOI 10.1074/jbc.274.8.4924; Arai M, 1996, BIOCHEM BIOPH RES CO, V227, P433, DOI 10.1006/bbrc.1996.1525; Borchert A, 2006, J BIOL CHEM, V281, P19655, DOI 10.1074/jbc.M601195200; Conrad M, 2005, MOL CELL BIOL, V25, P7637, DOI 10.1128/MCB.25.17.7637-7644.2005; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Conrad M, 2003, BIOTECHNIQUES, V34, P1136, DOI 10.2144/03346bm03; Conrad M, 2007, BIOL CHEM, V388, P1019, DOI 10.1515/BC.2007.130; FULTON BP, 1978, NATURE, V273, P149, DOI 10.1038/273149a0; GUNN SA, 1967, P SOC EXP BIOL MED, V124, P1260; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Hurst R, 2001, FREE RADICAL BIO MED, V31, P1051, DOI 10.1016/S0891-5849(01)00685-2; JACOBSSO.SO, 1965, ACTA VET SCAND, V6, P287; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Maiorino M, 1998, FASEB J, V12, P1359, DOI 10.1096/fasebj.12.13.1359; Maiorino M, 2005, J BIOL CHEM, V280, P38395, DOI 10.1074/jbc.M505983200; Maiorino M, 2003, J BIOL CHEM, V278, P34286, DOI 10.1074/jbc.M305327200; MAIORINO M, 1989, LIPIDS, V24, P721, DOI 10.1007/BF02535211; Moreno SG, 2003, BIOL CHEM, V384, P635, DOI 10.1515/BC.2003.070; Nomura K, 1999, J BIOL CHEM, V274, P29294, DOI 10.1074/jbc.274.41.29294; Olson GE, 2005, BIOL REPROD, V73, P201, DOI 10.1095/biolreprod.105.040360; Pfeifer H, 2001, FASEB J, V15, P1236, DOI 10.1096/fj.00-0655fje; PUSHPAREKHA TR, 1995, J BIOL CHEM, V270, P26993, DOI 10.1074/jbc.270.45.26993; QUINN P, 1985, FERTIL STERIL, V44, P493; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; SHALGI R, 1989, BIOL REPROD, V40, P1037, DOI 10.1095/biolreprod40.5.1037; Ufer C, 2008, GENE DEV, V22, P1838, DOI 10.1101/gad.466308; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; URSINI F, 1982, BIOCHIM BIOPHYS ACTA, V710, P197, DOI 10.1016/0005-2760(82)90150-3; WALLACE E, 1983, GAMETE RES, V4, P389; Wang HP, 2001, FREE RADICAL BIO MED, V30, P825, DOI 10.1016/S0891-5849(01)00469-5; WU SH, 1973, BIOL REPROD, V8, P625, DOI 10.1093/biolreprod/8.5.625; Yagi K, 1998, BIOCHEM BIOPH RES CO, V245, P528, DOI 10.1006/bbrc.1998.8417; Yanagimachi R, 2005, REPROD BIOMED ONLINE, V10, P247, DOI 10.1016/S1472-6483(10)60947-9; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6	35	193	203	3	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					3233	3242		10.1096/fj.09-132795	http://dx.doi.org/10.1096/fj.09-132795			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19417079				2022-12-25	WOS:000270241000045
J	Tian, G; Zhou, Y; Hajkova, D; Miyagi, M; Dinculescu, A; Hauswirth, WW; Palczewski, K; Geng, R; Alagramam, KN; Isosomppi, J; Sankila, EM; Flannery, JG; Imanishi, Y				Tian, Guilian; Zhou, Yun; Hajkova, Dagmar; Miyagi, Masaru; Dinculescu, Astra; Hauswirth, William W.; Palczewski, Krzysztof; Geng, Ruishuang; Alagramam, Kumar N.; Isosomppi, Juha; Sankila, Eeva-Marja; Flannery, John G.; Imanishi, Yoshikazu			Clarin-1, Encoded by the Usher Syndrome III Causative Gene, Forms a Membranous Microdomain POSSIBLE ROLE OF CLARIN-1 IN ORGANIZING THE ACTIN CYTOSKELETON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAIR CELL-DEVELOPMENT; ANKLE-LINK COMPLEX; AMES WALTZER MICE; LIPID RAFTS; MYOSIN VIIA; QUANTITATIVE PROTEOMICS; TETRASPANIN PROTEINS; PLASMA-MEMBRANE; E-CADHERIN; INNER-EAR	Clarin-1 is the protein product encoded by the gene mutated in Usher syndrome III. Although the molecular function of clarin-1 is unknown, its primary structure predicts four transmembrane domains similar to a large family of membrane proteins that include tetraspanins. Here we investigated the role of clarin-1 by using heterologous expression and in vivo model systems. When expressed in HEK293 cells, clarin-1 localized to the plasma membrane and concentrated in low density compartments distinct from lipid rafts. Clarin-1 reorganized actin filament structures and induced lamellipodia. This actin-reorganizing function was absent in the modified protein encoded by the most prevalent North American Usher syndrome III mutation, the N48K form of clarin-1 deficient in N-linked glycosylation. Proteomics analyses revealed a number of clarin-1-interacting proteins involved in cell-cell adhesion, focal adhesions, cell migration, tight junctions, and regulation of the actin cytoskeleton. Consistent with the hypothesized role of clarin-1 in actin organization, F-actin-enriched stereocilia of auditory hair cells evidenced structural disorganization in Clrn1(-/-) mice. These observations suggest a possible role for clarin-1 in the regulation and homeostasis of actin filaments, and link clarin-1 to the interactive network of Usher syndrome gene products.	[Imanishi, Yoshikazu] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Hajkova, Dagmar; Miyagi, Masaru] Case Western Reserve Univ, Case Ctr Prote, Cleveland, OH 44106 USA; [Dinculescu, Astra; Hauswirth, William W.] Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA; [Geng, Ruishuang; Alagramam, Kumar N.] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Dept Otolaryngol Head & Neck Surg, Cleveland, OH 44106 USA; [Isosomppi, Juha; Sankila, Eeva-Marja] Univ Helsinki, Folkhalsan Inst Genet, Dept Mol Genet, FIN-00014 Helsinki, Finland; [Isosomppi, Juha] Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; [Sankila, Eeva-Marja] Univ Helsinki, Dept Ophthalmol, FIN-00014 Helsinki, Finland; [Flannery, John G.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Case Western Reserve University; Case Western Reserve University; State University System of Florida; University of Florida; Case Western Reserve University; Case Western Reserve University Hospital; University of Helsinki; University of Helsinki; University of Helsinki; University of California System; University of California Berkeley	Imanishi, Y (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, Wood Bldg,10900 Euclid Ave, Cleveland, OH 44106 USA.	yxi19@case.edu	Imanishi, Yoshikazu/E-8178-2010; Geng, Ruishuang/F-8255-2013	Imanishi, Yoshikazu/0000-0003-4696-4836; hauswirth, william/0000-0002-3244-4947; Flannery, John/0000-0002-0720-8897	Hope for Vision Foundation; Elden Foundation	Hope for Vision Foundation; Elden Foundation	This work was supported by the Hope for Vision Foundation and the Elden Foundation.	Adato A, 2002, EUR J HUM GENET, V10, P339, DOI 10.1038/sj.ejhg.5200831; Adato A, 1999, AM J HUM GENET, V65, P261, DOI 10.1086/302438; Andre M, 2006, PROTEOMICS, V6, P1437, DOI 10.1002/pmic.200500180; Berditchevski F, 2002, J BIOL CHEM, V277, P36991, DOI 10.1074/jbc.M205265200; Berditchevski F, 2001, J BIOL CHEM, V276, P41165, DOI 10.1074/jbc.M104041200; Blonder J, 2004, ELECTROPHORESIS, V25, P1307, DOI 10.1002/elps.200405891; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Butchbach MER, 2004, J BIOL CHEM, V279, P34388, DOI 10.1074/jbc.M403938200; Charrin S, 2002, FEBS LETT, V516, P139, DOI 10.1016/S0014-5793(02)02522-X; Claas C, 2001, J BIOL CHEM, V276, P7974, DOI 10.1074/jbc.M008650200; DUKSIN D, 1977, J BIOL CHEM, V252, P955; Evans AL, 2000, NAT GENET, V24, P424, DOI 10.1038/74286; Fields RR, 2002, AM J HUM GENET, V71, P607, DOI 10.1086/342098; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; FUJIMOTO T, 1993, J CELL BIOL, V120, P1147, DOI 10.1083/jcb.120.5.1147; Geng RS, 2009, HUM MOL GENET, V18, P2748, DOI 10.1093/hmg/ddp210; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Herrera W, 2008, INVEST OPHTH VIS SCI, V49, P2651, DOI 10.1167/iovs.07-1505; Inoue A, 2003, J BIOL CHEM, V278, P5478, DOI 10.1074/jbc.M210489200; Israels SJ, 2007, THROMB HAEMOSTASIS, V98, P1081, DOI 10.1160/TH06-08-0455; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Joensuu T, 2001, AM J HUM GENET, V69, P673, DOI 10.1086/323610; Johnson E, 2004, J BIOL CHEM, V279, P31041, DOI 10.1074/jbc.M400024200; Kikkawa YS, 2008, ANAT REC, V291, P224, DOI 10.1002/ar.20632; Kiser JZ, 2009, J PROTEOME RES, V8, P1810, DOI 10.1021/pr8004919; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Kremer H, 2006, HUM MOL GENET, V15, pR262, DOI 10.1093/hmg/ddl205; Lazo PA, 2007, CANCER SCI, V98, P1666, DOI 10.1111/j.1349-7006.2007.00584.x; Le Naour F, 2006, PROTEOMICS, V6, P6447, DOI 10.1002/pmic.200600282; Lefevre G, 2008, DEVELOPMENT, V135, P1427, DOI 10.1242/dev.012922; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Maeda M, 2006, ONCOGENE, V25, P4595, DOI 10.1038/sj.onc.1209396; Mburu P, 2006, P NATL ACAD SCI USA, V103, P10973, DOI 10.1073/pnas.0600923103; McGee J, 2006, J NEUROSCI, V26, P6543, DOI 10.1523/JNEUROSCI.0693-06.2006; McMahon KA, 2006, PROTEOMICS, V6, P143, DOI 10.1002/pmic.200500208; Michalski N, 2007, J NEUROSCI, V27, P6478, DOI 10.1523/JNEUROSCI.0342-07.2007; Miyagi M, 2007, MASS SPECTROM REV, V26, P121, DOI 10.1002/mas.20116; Mogensen MM, 2007, CELL MOTIL CYTOSKEL, V64, P496, DOI 10.1002/cm.20199; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Pawlowski KS, 2006, JARO-J ASSOC RES OTO, V7, P83, DOI 10.1007/s10162-005-0024-5; Reiners J, 2006, EXP EYE RES, V83, P97, DOI 10.1016/j.exer.2005.11.010; RIZZOLO LJ, 1995, J CELL SCI, V108, P3623; Saihan Z, 2009, CURR OPIN NEUROL, V22, P19, DOI 10.1097/WCO.0b013e3283218807; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; TAKATSUKI A, 1971, J ANTIBIOT, V24, P785, DOI 10.7164/antibiotics.24.785; Tian GL, 2007, J BIOL CHEM, V282, P1727, DOI 10.1074/jbc.M609822200; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Udovichenko IP, 2002, J CELL SCI, V115, P445; Williams DS, 2008, VISION RES, V48, P433, DOI 10.1016/j.visres.2007.08.015; Yang XW, 2002, MOL BIOL CELL, V13, P767, DOI 10.1091/mbc.01-05-0275; Yuan C, 2008, AM J PHYSIOL-HEART C, V295, pH647, DOI 10.1152/ajpheart.00357.2008; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16	56	60	63	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18980	18993		10.1074/jbc.M109.003160	http://dx.doi.org/10.1074/jbc.M109.003160			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19423712	hybrid, Green Published			2022-12-25	WOS:000267711500048
J	Gupta, R; Srivastava, OP				Gupta, Ratna; Srivastava, Om P.			Identification of Interaction Sites between Human beta A3-and alpha A/alpha B-crystallins by Mammalian Two-hybrid and Fluorescence Resonance Energy Transfer Acceptor Photobleaching Methods	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; WATER-INSOLUBLE FRACTION; CATARACTOUS HUMAN LENSES; CONGENITAL CATARACT; INHIBITOR ACTIVITY; BETA-CRYSTALLINS; A-CRYSTALLIN; LIVING CELLS; BOVINE LENS; IN-VITRO	Our recent study has shown that beta A3-crystallin along with beta B1- and beta B2-crystallins were part of high molecular weight complex obtained from young, old, and cataractous lenses suggesting potential interactions between alpha- and beta-crystallins (Srivastava, O. P., Srivastava, K., and Chaves, J. M. (2008) Mol. Vis. 14, 1872-1885). To investigate this further, this study was carried out to determine the interaction sites of beta A3-crystallin with alpha A- and alpha B-crystallins. The study employed a mammalian two-hybrid method, an in vivo assay to determine the regions of beta A3-crystallin that interact with alpha A- and alpha B-crystallins. Five regional truncated mutants of beta A3-crystallin were generated using specific primers with deletions of N-terminal extension (NT) (named beta A3-NT), N-terminal extension plus motif I (named beta A3-NT + I), N-terminal extension plus motifs I and II (named beta A3-NT + I + II), motif III plus IV (named beta A3-III + IV), and motif IV (named beta A3-IV). The mammalian two-hybrid studies were complemented with fluorescence resonance energy transfer acceptor photobleaching studies using the above described mutant proteins, fused with DsRed (Red) and AcGFP fluorescent proteins. The results showed that the motifs III and IV of beta A3-crystallin were interactive with alpha A-crystallin, and motifs II and III of beta A3-crystallin primarily interacted with alpha B-crystallin.	[Gupta, Ratna; Srivastava, Om P.] Univ Alabama, Dept Vis Sci, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Srivastava, OP (corresponding author), Univ Alabama, Dept Vis Sci, Worrell Bldg,924 S 18th St, Birmingham, AL 35294 USA.	srivasta@uab.edu			National Institutes of Health [EY06400, P30 EY0303, P50 AT00477]; University of Alabama at Birmingham; EyeSight Foundation of Alabama; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P50AT000477] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY006400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham; EyeSight Foundation of Alabama; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in whole, or in part, by National Institutes of Health Grants EY06400, P30 EY0303, and P50 AT00477 (to C. Weaver). This work was also supported by a faculty development grant from the University of Alabama at Birmingham and the EyeSight Foundation of Alabama.	Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; BAX B, 1990, NATURE, V347, P776, DOI 10.1038/347776a0; Bhat SP, 2004, EXP EYE RES, V79, P809, DOI 10.1016/j.exer.2004.08.020; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Carver JA, 2002, J MOL BIOL, V318, P815, DOI 10.1016/S0022-2836(02)00144-4; Cohen D, 2007, INVEST OPHTH VIS SCI, V48, P2208, DOI 10.1167/iovs.06-1019; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Feil IK, 2001, J BIOL CHEM, V276, P12024, DOI 10.1074/jbc.M010856200; Ferrini W, 2004, INVEST OPHTH VIS SCI, V45, P1436, DOI 10.1167/iovs.03-0760; Fu L, 2003, INVEST OPHTH VIS SCI, V44, P1155, DOI 10.1167/iovs.02-0950; Fu L, 2002, J BIOL CHEM, V277, P4255, DOI 10.1074/jbc.M110027200; Ghosh JG, 2005, PROTEIN SCI, V14, P684, DOI 10.1110/ps.041152805; Gupta R, 2006, BIOCHEMISTRY-US, V45, P9964, DOI 10.1021/bi060499v; Gupta R, 2004, J BIOL CHEM, V279, P44258, DOI 10.1074/jbc.M405648200; Harrington V, 2007, MOL VIS, V13, P1680; Harrington V, 2004, MOL VIS, V10, P476; Kamei A, 2002, BIOL PHARM BULL, V25, P611, DOI 10.1248/bpb.25.611; Kamradt MC, 2005, J BIOL CHEM, V280, P11059, DOI 10.1074/jbc.M413382200; Kamradt MC, 2002, J BIOL CHEM, V277, P38731, DOI 10.1074/jbc.M201770200; Krivandin A V, 2004, Dokl Biochem Biophys, V394, P1, DOI 10.1023/B:DOBI.0000017141.52122.57; Lampi KJ, 1997, J BIOL CHEM, V272, P2268; Liang JJ, 2006, PROTEIN SCI, V15, P1619, DOI 10.1110/ps.062216006; Liu BF, 2006, J BIOL CHEM, V281, P2624, DOI 10.1074/jbc.M509017200; Liu BF, 2005, MOL VIS, V11, P321; Liu BF, 2008, J CELL BIOCHEM, V104, P51, DOI 10.1002/jcb.21598; Liu BF, 2007, FEBS LETT, V581, P3936, DOI 10.1016/j.febslet.2007.07.022; Liu BF, 2007, MOL VIS, V13, P854; Lu SS, 2007, MOL VIS, V13, P1154; Ma ZX, 1998, EXP EYE RES, V67, P21, DOI 10.1006/exer.1998.0482; Marin-Vinader L, 2006, FEBS J, V273, P3172, DOI 10.1111/j.1742-4658.2006.05326.x; ORTWERTH BJ, 1992, EXP EYE RES, V54, P103, DOI 10.1016/0014-4835(92)90074-3; ORTWERTH BJ, 1992, EXP EYE RES, V54, P573, DOI 10.1016/0014-4835(92)90136-G; Ponce A, 2005, MOL VIS, V11, P752; Ponce A, 2006, MOL VIS, V12, P879; Rajan S, 2006, BIOCHEMISTRY-US, V45, P15684, DOI 10.1021/bi060705z; Robertson LJG, 2008, INVEST OPHTH VIS SCI, V49, P1016, DOI 10.1167/iovs.07-0792; SHARMA KK, 1987, BIOCHIM BIOPHYS ACTA, V915, P284; Song SH, 2008, MOL VIS, V14, P1282; Sreelakshmi Y, 2006, MOL VIS, V12, P581; Srivastava OP, 2008, MOL VIS, V14, P1872; SRIVASTAVA OP, 1989, EXP EYE RES, V48, P25, DOI 10.1016/0014-4835(89)90015-8; Srivastava OP, 2004, J BIOL CHEM, V279, P10901, DOI 10.1074/jbc.M308884200; Srivastava OP, 2003, MOL VIS, V9, P644; SRIVASTAVA OP, 1983, EXP EYE RES, V36, P363, DOI 10.1016/0014-4835(83)90118-5; Srivastava OP, 1999, BIOCHEM BIOPH RES CO, V258, P632, DOI 10.1006/bbrc.1999.0506; Srivastava OP, 1999, BBA-PROTEIN STRUCT M, V1434, P331, DOI 10.1016/S0167-4838(99)00183-1; Takemoto L, 2008, EXP EYE RES, V87, P496, DOI 10.1016/j.exer.2008.08.018; Weinreb O, 2000, INVEST OPHTH VIS SCI, V41, P3893; Xia JZ, 1996, BIOPHYS J, V71, P2815, DOI 10.1016/S0006-3495(96)79477-8; Zhang ZL, 2003, EXP EYE RES, V77, P259, DOI 10.1016/S0014-4835(03)00159-3	50	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18481	18492		10.1074/jbc.M109.013789	http://dx.doi.org/10.1074/jbc.M109.013789			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19401464	Green Published, hybrid			2022-12-25	WOS:000267712400059
J	Han, YH; Zhou, H; Kim, JH; Yan, TD; Lee, KH; Wu, H; Lin, F; Lu, N; Liu, J; Zeng, JZ; Zhang, XK				Han, Young-Hoon; Zhou, Hu; Kim, Jin-Hee; Yan, Ting-dong; Lee, Kee-Ho; Wu, Hua; Lin, Feng; Lu, Na; Liu, Jie; Zeng, Jin-zhang; Zhang, Xiao-kun			A Unique Cytoplasmic Localization of Retinoic Acid Receptor-gamma and Its Regulations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-TYPE PROTEASE; X-RECEPTOR; NUCLEAR EXPORT; RAR-GAMMA; THYROID-HORMONE; CELL-DENSITY; INTRACELLULAR-LOCALIZATION; SUBCELLULAR-LOCALIZATION; SIGNALING PATHWAY; LIVING CELLS	Recent evidence suggests that extranuclear action of retinoid receptors is involved in mediating the pleiotropic effects of retinoids. However, whether they reside in the cytoplasm remains elusive. Here, we showed that retinoic acid receptor-gamma (RAR gamma) was cytoplasmic in confluent cells, or when cells were released from serum depletion or treated with growth factors. In studying the regulation of RAR gamma subcellular localization, we observed that ectopically overexpressed RAR gamma was mainly cytoplasmic irrespective of serum concentration and cell density. The cytoplasmic retention of RAR gamma was inhibited by ligand retinoic acid (RA). In addition, coexpression of retinoid X receptor-alpha (RXR alpha) resulted in nuclear localization of RAR gamma through their heterodimerization. Mutagenesis studies revealed that a C-terminal fragment of RXR alpha potently prevents RA-induced RAR gamma nuclear localization and transcriptional function. Furthermore, our results showed that the cytoplasmic retention of RAR gamma was due to the presence of its unique N-terminal A/B domain, which was subject to regulation by p38 MAPK-mediated phosphorylation. Deletion or mutation of the N-terminal A/B domain largely impaired its cytoplasmic localization. Together, our data demonstrate that the subcellular localization of RAR gamma is regulated by complex interactions among ligand binding, receptor phosphorylation, and receptor dimerizations.	[Han, Young-Hoon; Kim, Jin-Hee; Lee, Kee-Ho] Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul 139706, South Korea; [Han, Young-Hoon; Zhou, Hu; Lin, Feng; Liu, Jie; Zhang, Xiao-kun] Burnham Inst Med Res, Ctr Canc, La Jolla, CA 92037 USA; [Yan, Ting-dong; Wu, Hua; Lu, Na; Liu, Jie; Zeng, Jin-zhang; Zhang, Xiao-kun] Xiamen Univ, Inst Biomed Res, Xiamen 361005, Peoples R China	Korea Institute of Radiological & Medical Sciences; Sanford Burnham Prebys Medical Discovery Institute; Xiamen University	Han, YH (corresponding author), Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Gon Gneung Dong 215-4, Seoul 139706, South Korea.	yhhan@kcch.re.kr; xzhang@burnham.org	Wu, Hua/W-4204-2019; Zeng, JZ/G-3377-2010		National Institutes of Health [CA87000, CA107039, GM60544, CA109345]; Korean Ministry of Sciences and Technology; Susan G. Komen Breast Cancer Foundation; U.S. Army Medical Research and Material Command; California Tobacco-Related Diseases Research Program; California Breast Cancer Research Program; Xiamen University [2007AA09Z404]; NATIONAL CANCER INSTITUTE [R01CA107039, R01CA109345, R01CA087000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Ministry of Sciences and Technology; Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); U.S. Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); California Tobacco-Related Diseases Research Program; California Breast Cancer Research Program; Xiamen University(Xiamen University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA87000, CA107039, GM60544, and CA109345 (to X.-k. Z.). This work was also supported by a grant from the national nuclear R & D program funded by the Korean Ministry of Sciences and Technology, the Susan G. Komen Breast Cancer Foundation, the U.S. Army Medical Research and Material Command, the California Tobacco-Related Diseases Research Program, the California Breast Cancer Research Program, and the 985 Project and 863 Program (No. 2007AA09Z404) from Xiamen University.	Aggarwal S, 2006, MOL BIOL CELL, V17, P566, DOI 10.1091/mbc.E05-06-0519; Aschrafi A, 2006, BBA-MOL CELL RES, V1763, P805, DOI 10.1016/j.bbamcr.2006.05.006; Bastien J, 2000, J BIOL CHEM, V275, P21896, DOI 10.1074/jbc.M001985200; Batchelor CL, 2004, EXP CELL RES, V296, P208, DOI 10.1016/j.yexcr.2004.02.010; Baumann CT, 2001, J BIOL CHEM, V276, P11237, DOI 10.1074/jbc.M011112200; Bour G, 2005, J BIOL CHEM, V280, P17027, DOI 10.1074/jbc.M501344200; Bour G, 2007, TRENDS CELL BIOL, V17, P302, DOI 10.1016/j.tcb.2007.04.003; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; Canon E, 2004, MOL BIOL CELL, V15, P5583, DOI 10.1091/mbc.E04-05-0439; Cao XH, 2004, MOL CELL BIOL, V24, P9705, DOI 10.1128/MCB.24.22.9705-9725.2004; Chakravarti N, 2007, CLIN CANCER RES, V13, P4817, DOI 10.1158/1078-0432.CCR-06-3026; Chen CF, 2004, ONCOGENE, V23, P5350, DOI 10.1038/sj.onc.1207682; Dey N, 2007, MOL CELL BIOL, V27, P4179, DOI 10.1128/MCB.01352-06; Dufour JM, 1999, BIOL REPROD, V61, P1300, DOI 10.1095/biolreprod61.5.1300; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukunaka K, 2001, MOL HUM REPROD, V7, P437, DOI 10.1093/molehr/7.5.437; Georget V, 1997, MOL CELL ENDOCRINOL, V129, P17, DOI 10.1016/S0303-7207(97)04034-3; Ghose Romi, 2004, Nucl Recept, V2, P4, DOI 10.1186/1478-1336-2-4; Gianni M, 2002, EMBO J, V21, P3760, DOI 10.1093/emboj/cdf374; Glass CK, 2000, GENE DEV, V14, P121; Hager GL, 2000, J STEROID BIOCHEM, V74, P249, DOI 10.1016/S0960-0760(00)00100-X; Han YH, 2006, ONCOGENE, V25, P2974, DOI 10.1038/sj.onc.1209358; Holaska JM, 2001, J CELL BIOL, V152, P127, DOI 10.1083/jcb.152.1.127; Htun H, 1996, P NATL ACAD SCI USA, V93, P4845, DOI 10.1073/pnas.93.10.4845; HUSMANN M, 1991, MOL CELL BIOL, V11, P4097, DOI 10.1128/MCB.11.8.4097; Ikuta T, 2004, J BIOL CHEM, V279, P19209, DOI 10.1074/jbc.M310492200; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; Katagiri Y, 2000, NAT CELL BIOL, V2, P435, DOI 10.1038/35017072; Kim SW, 2007, MOL CELL BIOL, V27, P6933, DOI 10.1128/MCB.02385-06; Kolluri SK, 2008, CANCER CELL, V14, P285, DOI 10.1016/j.ccr.2008.09.002; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Liu JM, 2000, MOL ENDOCRINOL, V14, P40, DOI 10.1210/me.14.1.40; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Masia S, 2007, MOL ENDOCRINOL, V21, P2391, DOI 10.1210/me.2007-0062; MatsushimaNishiwaki R, 1996, BIOCHEM BIOPH RES CO, V225, P946, DOI 10.1006/bbrc.1996.1276; Mey J, 2007, GLIA, V55, P152, DOI 10.1002/glia.20444; Mohan S, 2003, ONCOGENE, V22, P5270, DOI 10.1038/sj.onc.1206592; Moraes LA, 2007, BLOOD, V109, P3741, DOI 10.1182/blood-2006-05-022566; Nagaya T, 1998, J BIOL CHEM, V273, P33166, DOI 10.1074/jbc.273.50.33166; Nomura Y, 1999, BIOCHEM BIOPH RES CO, V254, P388, DOI 10.1006/bbrc.1998.9941; Prufer K, 2002, MOL ENDOCRINOL, V16, P1738, DOI 10.1210/me.2001-0345; Prufer K, 2000, J BIOL CHEM, V275, P41114, DOI 10.1074/jbc.M003791200; Purton LE, 2006, J EXP MED, V203, P1283, DOI 10.1084/jem.20052105; Rastinejad F, 2000, EMBO J, V19, P1045, DOI 10.1093/emboj/19.5.1045; Rochette-Egly C, 2000, MOL ENDOCRINOL, V14, P1398, DOI 10.1210/me.14.9.1398; Sommer KM, 1999, P NATL ACAD SCI USA, V96, P8651, DOI 10.1073/pnas.96.15.8651; Su D, 2008, BIOCHEM PHARMACOL, V75, P1129, DOI 10.1016/j.bcp.2007.11.006; Takiyama Y, 2004, J CLIN ENDOCR METAB, V89, P5851, DOI 10.1210/jc.2003-032036; TANEJA R, 1995, P NATL ACAD SCI USA, V92, P7854, DOI 10.1073/pnas.92.17.7854; Taneja R, 1997, EMBO J, V16, P6452, DOI 10.1093/emboj/16.21.6452; Tyagi RK, 1998, MOL ENDOCRINOL, V12, P1684, DOI 10.1210/me.12.11.1684; Wang JG, 2006, FASEB J, V20, P2142, DOI 10.1096/fj.06-5900fje; Yen A, 1998, CANCER RES, V58, P3163; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8; Zhang F, 2001, MOL CELL BIOL, V21, P8143, DOI 10.1128/MCB.21.23.8143-8156.2001; ZHANG XK, 1994, MOL CELL BIOL, V14, P4311, DOI 10.1128/MCB.14.6.4311; ZHANG XK, 1993, RECEPTOR, V3, P183; ZHANG XK, 1992, NATURE, V358, P587, DOI 10.1038/358587a0; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0	62	24	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18503	18514		10.1074/jbc.M109.007708	http://dx.doi.org/10.1074/jbc.M109.007708			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19416983	Green Published, hybrid			2022-12-25	WOS:000267712400061
J	Lobo, S; Wiczer, BM; Bernlohr, DA				Lobo, Sandra; Wiczer, Brian M.; Bernlohr, David A.			Functional Analysis of Long-chain Acyl-CoA Synthetase 1 in 3T3-L1 Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID TRANSPORT; ACTIVATED PROTEIN-KINASE; INSULIN-RESISTANCE; VECTORIAL ACYLATION; PLASMA-MEMBRANE; MICE; METABOLISM; OBESITY; SENSITIVITY; LIPOGENESIS	ACSL1 (acyl-CoA synthetase 1), the major acyl-CoA synthetase of adipocytes, has been proposed to function in adipocytes as mediating free fatty acid influx, esterification, and storage as triglyceride. To test this hypothesis, ACSL1 was stably silenced (knockdown (kd)) in 3T3-L1 cells, differentiated into adipocytes, and evaluated for changes in lipid metabolism. Surprisingly, ACSL1-silenced adipocytes exhibited no significant changes in basal or insulin-stimulated long-chain fatty acid uptake, lipid droplet size, or tri-, di-, or monoacylglycerol levels when compared with a control adipocyte line. However, ACSL1 kd adipocytes displayed a 7-fold increase in basal and a similar to 15% increase in forskolin-stimulated fatty acid efflux without any change in glycerol release, indicating a role for the protein in fatty acid reesterification following lipolysis. Consistent with this proposition, ACSL1 kd cells exhibited a decrease in activation and phosphorylation of AMP-activated protein kinase and its primary substrate acetyl-CoA carboxylase. Moreover, ACSL1 kd adipocytes displayed an increase in phosphorylated protein kinase C theta and phosphorylated JNK, attenuated insulin signaling, and a decrease in insulin-stimulated glucose uptake. These findings identify a primary role of ACSL1 in adipocytes not in control of lipid influx, as previously considered, but in lipid efflux and fatty acid-induced insulin resistance.	[Lobo, Sandra; Wiczer, Brian M.; Bernlohr, David A.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Bernlohr, DA (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, 6-155 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	bernl001@umn.edu			American Diabetes Association [7-06RA-12]; Minnesota Obesity Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049807] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Minnesota Obesity Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by American Diabetes Association Grant 7-06RA-12 ( to D. A. B.) and the Minnesota Obesity Center.	Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Chabowski A, 2007, PROSTAG LEUKOTR ESS, V77, P345, DOI 10.1016/j.plefa.2007.10.017; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484; de Ferranti S, 2008, CLIN CHEM, V54, P945, DOI 10.1373/clinchem.2007.100156; Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383; Gargiulo CE, 1999, J LIPID RES, V40, P881; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hall AM, 2005, J BIOL CHEM, V280, P11948, DOI 10.1074/jbc.M412629200; Hall AM, 2003, J BIOL CHEM, V278, P43008, DOI 10.1074/jbc.M306575200; Hertzel AV, 2006, AM J PHYSIOL-ENDOC M, V290, pE814, DOI 10.1152/ajpendo.00465.2005; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; KALUZNY MA, 1985, J LIPID RES, V26, P135; Li LO, 2006, J BIOL CHEM, V281, P37246, DOI 10.1074/jbc.M604427200; Lobo S, 2007, J LIPID RES, V48, P609, DOI 10.1194/jlr.M600441-JLR200; MACKALL JC, 1976, J BIOL CHEM, V251, P6462; Mater MK, 1998, J LIPID RES, V39, P1327; Meshulam T, 2006, BIOCHEMISTRY-US, V45, P2882, DOI 10.1021/bi051999b; NAGAMATSU K, 1985, BIOCHIM BIOPHYS ACTA, V836, P80, DOI 10.1016/0005-2760(85)90223-1; Pinent M, 2008, GENOMICS, V92, P26, DOI 10.1016/j.ygeno.2008.03.010; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Shim J, 2009, J LIPID RES, V50, P491, DOI 10.1194/jlr.M800400-JLR200; Sleeman MW, 1998, J BIOL CHEM, V273, P3132, DOI 10.1074/jbc.273.6.3132; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Tong FM, 2006, ARCH BIOCHEM BIOPHYS, V447, P46, DOI 10.1016/j.abb.2006.01.005; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Wei EH, 2007, J BIOL CHEM, V282, P8027, DOI 10.1074/jbc.M605789200; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Zou ZY, 2003, J BIOL CHEM, V278, P16414, DOI 10.1074/jbc.M210557200	36	52	54	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18347	18356		10.1074/jbc.M109.017244	http://dx.doi.org/10.1074/jbc.M109.017244			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19429676	Green Published, hybrid			2022-12-25	WOS:000267712400047
J	Kopanja, D; Stoyanova, T; Okur, MN; Huang, E; Bagchi, S; Raychaudhuri, P				Kopanja, D.; Stoyanova, T.; Okur, M. N.; Huang, E.; Bagchi, S.; Raychaudhuri, P.			Proliferation defects and genome instability in cells lacking Cul4A	ONCOGENE			English	Article						Cul4A; proliferation; genome instability; p53	PROTEOLYSIS; PROTEIN; DDB1; AMPLIFICATION; DEGRADATION; TARGETS; MOUSE; GENE; P53; STABILITY	The Cul4A gene, which encodes a core component of a cullin-based E3 ubiquitin ligase complex, is overexpressed in breast and hepatocellular cancers. In breast cancers, overexpression of Cul4A strongly correlates with poor prognosis. In addition, Cul4A is required for early embryonic development. The early lethality of mouse embryos prevented a detailed analysis of the functions of Cul4A. Here, we used a strain of mice carrying floxed alleles of Cul4A to study its role in cell division, in vitro and in vivo. Embryonic fibroblasts (MEFs) show a severe deficiency in cell proliferation after deletion of Cul4A. We observed that the Cul4A protein is abundantly expressed in the brain, liver and the mammary tissue of pregnant mice. Deletion of Cul4A in the liver impairs hepatocyte proliferation during regeneration after carbon tetrachloride (CCl4)-induced injury. The Cul4A-deleted cells are slow in entering the S phase, and are deficient in progressing through the early M phase. Several cell-cycle regulators, including p53 and p27Kip1, are deregulated in the Cul4A-deleted cells. Expression of a dominant negative mutant of p53 causes significant reversal of the proliferation defects in Cul4A-deleted cells. The Cul4A-deleted cells show an aberrant number of centrosome, multipolar spindles and micronuclei formation. Furthermore, those cells are sensitive to UV irradiation and show reduced levels of unscheduled DNA synthesis (UDS). Together, our observations indicate that Cul4A is required for efficient cell proliferation, control of centrosome amplification and genome stability. Oncogene (2009) 28, 2456-2465; doi:10.1038/onc.2009.86; published online 11 May 2009	[Kopanja, D.; Stoyanova, T.; Okur, M. N.; Huang, E.; Raychaudhuri, P.] Univ Illinois, Dept Biochem & Mol Genet, Coll Med, Chicago, IL 60607 USA; [Bagchi, S.] Univ Illinois, Ctr Mol Biol Oral Dis, Coll Dent, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Raychaudhuri, P (corresponding author), Univ Illinois, Dept Biochem & Mol Genet MC 699, Coll Med, 900 S Ashland Ave,2302 MBRB, Chicago, IL 60607 USA.	sbagchi@uic.edu; pradip@uic.edu			National Institute of Health [CA 77637, AG 02413]; NATIONAL CANCER INSTITUTE [R01CA077637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024138] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Cul4A fl/fl mouse strain was generated in collaboration with Xenogen Biosciences, NJ, USA. The work was supported by grants from the National Institute of Health (CA 77637 to PR and AG 02413 to PR and SB).	Abba MC, 2007, CANCER RES, V67, P4104, DOI 10.1158/0008-5472.CAN-06-4672; Banks D, 2006, CELL CYCLE, V5, P1719, DOI 10.4161/cc.5.15.3150; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Bergametti F, 2002, J VIROL, V76, P6495, DOI 10.1128/JVI.76.13.6495-6501.2002; Bondar T, 2006, MOL CELL BIOL, V26, P2531, DOI 10.1128/MCB.26.7.2531-2539.2006; Bondar T, 2004, J BIOL CHEM, V279, P9937, DOI 10.1074/jbc.M312570200; Cang Y, 2006, CELL, V127, P929, DOI 10.1016/j.cell.2006.09.045; Chen LC, 1998, CANCER RES, V58, P3677; El-Mahdy MA, 2006, J BIOL CHEM, V281, P13404, DOI 10.1074/jbc.M511834200; FAUSTO N, 1996, HEPATOLOGY TXB LIVER, P32; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Higa LA, 2006, CELL CYCLE, V5, P71, DOI 10.4161/cc.5.1.2266; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Holmberg C, 2005, GENE DEV, V19, P853, DOI 10.1101/gad.329905; Kim Y, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-18; Li BH, 2002, MOL CELL BIOL, V22, P4997, DOI 10.1128/MCB.22.14.4997-5005.2002; Li BH, 2006, BLOOD, V107, P4291, DOI 10.1182/blood-2005-08-3349; Nag A, 2004, CANCER RES, V64, P8152, DOI 10.1158/0008-5472.CAN-04-2598; Nag A, 2001, MOL CELL BIOL, V21, P6738, DOI 10.1128/MCB.21.20.6738-6747.2001; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Schindl M, 2007, ANTICANCER RES, V27, P949; Serfas MS, 1997, CELL GROWTH DIFFER, V8, P951; Shinmura K, 2007, ONCOGENE, V26, P2939, DOI 10.1038/sj.onc.1210085; Smith ML, 2000, MOL CELL BIOL, V20, P3705, DOI 10.1128/MCB.20.10.3705-3714.2000; Ulane CM, 2002, VIROLOGY, V304, P160, DOI 10.1006/viro.2002.1773; Waning DL, 2008, BLOOD, V112, P320, DOI 10.1182/blood-2007-11-126300; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Yasui K, 2002, HEPATOLOGY, V35, P1476, DOI 10.1053/jhep.2002.33683; Zhang Y, 2003, EMBO J, V22, P6057, DOI 10.1093/emboj/cdg577	29	33	33	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2009	28	26					2456	2465		10.1038/onc.2009.86	http://dx.doi.org/10.1038/onc.2009.86			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	465QH	19430492	Green Accepted			2022-12-25	WOS:000267601400004
J	Abeyweera, TP; Chen, XY; Rotenberg, SA				Abeyweera, Thushara P.; Chen, Xiangyu; Rotenberg, Susan A.			Phosphorylation of alpha 6-Tubulin by Protein Kinase C alpha Activates Motility of Human Breast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNNATURAL NUCLEOTIDE SPECIFICITY; MASS-SPECTROMETRY; BETA-TUBULIN; CANCER CELLS; MICROTUBULE DYNAMICS; TYROSINE KINASES; PKC-ALPHA; IDENTIFICATION; MIGRATION; GROWTH	Engineered overexpression of protein kinase C alpha (PKC alpha) was previously shown to endow nonmotile MCF-10A human breast cells with aggressive motility. A traceable mutant of PKC alpha (Abeyweera, T. P., and Rotenberg, S. A. (2007) Biochemistry 46, 2364-2370) revealed that alpha 6-tubulin is phosphorylated in cells expressing traceable PKC alpha and in vitro by wild type PKC alpha. Gain-of-function, single site mutations (Ser -> Asp) were constructed at each PKC consensus site in alpha 6-tubulin (Ser(158), Ser(165), Ser(241), and Thr(337)) to simulate phosphorylation. Following expression of each construct in MCF-10A cells, motility assays identified Ser(165) as the only site in alpha 6-tubulin whose pseudophosphorylation reproduced the motile behavior engendered by PKC alpha. Expression of a phosphorylation-resistant mutant (S165N-alpha 6-tubulin) resulted in suppression of MCF-10A cell motility stimulated either by expression of PKC alpha or by treatment with PKC alpha-selective activator diacylglycerol-lactone. MCF-10A cells treated with diacylglycerol-lactone showed strong phosphorylation of endogenous alpha-tubulin that could be blocked when S165N-alpha 6-tubulin was expressed. The S165N mutant also inhibited intrinsically motile human breast tumor cells that express high endogenous PKC alpha levels (MDA-MB-231 cells) or lack PKC alpha and other conventional isoforms (MDA-MB-468 cells). Comparison of Myc-tagged wild type alpha 6-tubulin and S165N-alpha 6-tubulin expressed in MDA-MB-468 cells demonstrated that Ser(165) is also a major site of phosphorylation for endogenously active, nonconventional PKC isoforms. PKC-stimulated motility of MCF-10A cells was nocodazole-sensitive, thereby implicating microtubule elongation in the mechanism. These findings support a model in which PKC phosphorylates alpha-tubulin at Ser(165), leading to microtubule elongation and motility.	[Rotenberg, Susan A.] CUNY Queens Coll, Dept Chem & Biochem, Flushing, NY 11367 USA; [Abeyweera, Thushara P.; Chen, Xiangyu] CUNY, Grad Ctr, Flushing, NY 11367 USA	City University of New York (CUNY) System; Queens College NY (CUNY); City University of New York (CUNY) System	Rotenberg, SA (corresponding author), CUNY Queens Coll, Dept Chem & Biochem, 65-30 Kissena Blvd, Flushing, NY 11367 USA.	Susan.Rotenberg@qc.cuny.edu		Rotenberg, Susan/0000-0002-6618-686X	National Institutes of Health [CA125632]; Breast Cancer Alliance (Greenwich, CT); Professional Staff Congress of The City University of New York; NATIONAL CANCER INSTITUTE [R15CA125632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Alliance (Greenwich, CT); Professional Staff Congress of The City University of New York; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA125632 (to S. A. R.) from NCI. This work was also supported by The Breast Cancer Alliance ( Greenwich, CT) (to S.A.R.) and the Professional Staff Congress of The City University of New York. This work was carried out by T. P. A. and X. C. in partial fulfillment of the requirements for the Ph.D. degree in Biochemistry administered by The City University of New York.	Abeyweera TP, 2007, BIOCHEMISTRY-US, V46, P2364, DOI 10.1021/bi0622017; Ballestrem C, 2000, MOL BIOL CELL, V11, P2999, DOI 10.1091/mbc.11.9.2999; Banan A, 2004, AM J PHYSIOL-CELL PH, V287, pC218, DOI 10.1152/ajpcell.00575.2003; Banan A, 1998, AM J PHYSIOL-GASTR L, V274, pG111, DOI 10.1152/ajpgi.1998.274.1.G111; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Downing KH, 1998, CURR OPIN CELL BIOL, V10, P16, DOI 10.1016/S0955-0674(98)80082-3; Duan D, 2008, J MED CHEM, V51, P5198, DOI 10.1021/jm8001907; Eblen ST, 2003, J BIOL CHEM, V278, P14926, DOI 10.1074/jbc.M300485200; Farhadi A, 2006, J PHARMACOL EXP THER, V316, P1, DOI 10.1124/jpet.105.085449; Fourest-Lieuvin A, 2006, MOL BIOL CELL, V17, P1041, DOI 10.1091/mbc.E05-07-0621; Garcia-Bermejo ML, 2004, J BIOL CHEM, V279, P23846; Garcia-Bermejo ML, 2002, J BIOL CHEM, V277, P645, DOI 10.1074/jbc.M107639200; Gauthier ML, 2003, BIOCHEM BIOPH RES CO, V307, P839, DOI 10.1016/S0006-291X(03)01273-7; GOODNIGHT J, 1995, J BIOL CHEM, V270, P9991, DOI 10.1074/jbc.270.17.9991; Habelhah H, 2001, J BIOL CHEM, V276, P18090, DOI 10.1074/jbc.M011396200; Hindley AD, 2004, FEBS LETT, V556, P26, DOI 10.1016/S0014-5793(03)01352-8; Hu YL, 2002, J VASC RES, V39, P465, DOI 10.1159/000067202; Hudder A, 2003, MOL CELL BIOL, V23, P9318, DOI 10.1128/MCB.23.24.9318-9326.2003; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kuntziger T, 2001, MOL BIOL CELL, V12, P437, DOI 10.1091/mbc.12.2.437; LAMB NJC, 1990, CELL, V60, P151, DOI 10.1016/0092-8674(90)90725-T; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; LIEUVIN A, 1994, J CELL BIOL, V124, P985, DOI 10.1083/jcb.124.6.985; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Mao ML, 2000, BIOCHEM J, V352, P475, DOI 10.1042/0264-6021:3520475; McKean PG, 2001, J CELL SCI, V114, P2723; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Piehl M, 2003, MOL BIOL CELL, V14, P916, DOI 10.1091/mbc.E02-09-0607; Rabinovitz I, 2004, MOL CELL BIOL, V24, P4351, DOI 10.1128/MCB.24.10.4351-4360.2004; Rao S, 2001, BIOCHEMISTRY-US, V40, P2096, DOI 10.1021/bi002323d; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; Salaycik KJ, 2005, J CELL SCI, V118, P4113, DOI 10.1242/jcs.02531; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Shah K, 2002, CHEM BIOL, V9, P35, DOI 10.1016/S1074-5521(02)00086-8; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; SOULE HD, 1990, CANCER RES, V50, P6075; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Sun XG, 1999, CELL GROWTH DIFFER, V10, P343; Takano T, 2001, CANCER LETT, V168, P51, DOI 10.1016/S0304-3835(01)00509-2; Tan M, 2006, ONCOGENE, V25, P3286, DOI 10.1038/sj.onc.1209361; Ting AY, 2001, BIOPOLYMERS, V60, P220, DOI 10.1002/1097-0282(2001)60:3<220::AID-BIP10035>3.0.CO;2-C; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Verdier-Pinard P, 2003, BIOCHEMISTRY-US, V42, P12019, DOI 10.1021/bi0350147; Verdier-Pinard P, 2003, BIOCHEMISTRY-US, V42, P5349, DOI 10.1021/bi027293o; WANDOSELL F, 1987, J BIOL CHEM, V262, P8268; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Wittmann T, 2001, J CELL SCI, V114, P3795; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; Witucki LA, 2002, CHEM BIOL, V9, P25, DOI 10.1016/S1074-5521(02)00091-1; Yoshida N, 2003, EUR J BIOCHEM, V270, P1154, DOI 10.1046/j.1432-1033.2003.03465.x; Yu BW, 2002, BREAST CANCER RES TR, V76, P181, DOI 10.1023/A:1020895504260	56	28	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17648	17656		10.1074/jbc.M902005200	http://dx.doi.org/10.1074/jbc.M902005200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19406749	Green Published, hybrid			2022-12-25	WOS:000267202500031
J	Boots, AW; Hristova, M; Kasahara, DI; Haenen, GRMM; Bast, A; van der Vliet, A				Boots, Agnes W.; Hristova, Milena; Kasahara, David I.; Haenen, Guido R. M. M.; Bast, Aalt; van der Vliet, Albert			ATP-mediated Activation of the NADPH Oxidase DUOX1 Mediates Airway Epithelial Responses to Bacterial Stimuli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING-ENZYME; NF-KAPPA-B; GROWTH-FACTOR RECEPTOR; PSEUDOMONAS-AERUGINOSA; HYDROGEN-PEROXIDE; SIGNALING CASCADE; GENE-EXPRESSION; HOST-DEFENSE; MUCIN EXPRESSION; OXIDATIVE STRESS	Activation of the NADPH oxidase homolog dual oxidase 1 (DUOX1) within the airway epithelium represents a key mechanism of innate airway host defense, through enhanced production of H2O2, which mediates cellular signaling pathways that regulate the production of various inflammatory mediators. Production of the CXC chemokine interleukin (IL)-8/CXCL8 forms a common epithelial response to many diverse stimuli, including bacterial and viral triggers, environmental oxidants, and other biological mediators, suggesting the potential involvement of a common signaling pathway that may involve DUOX1-dependent H2O2 production. Following previous reports showing that DUOX1 is activated by extracellular ATP and purinergic receptor stimulation, this study demonstrates that airway epithelial IL-8 production in response to several bacterial stimuli involves ATP release and DUOX1 activation. ATP-mediated DUOX1 activation resulted in the activation of ERK1/2 and NF-kappa B pathways, which was associated with epidermal growth factor receptor (EGFR) ligand shedding by ADAM17 (a disintegrin and metalloproteinase-17). Although ATP-mediated ADAM17 activation and IL-8 release were not prevented by extracellular H2O2 scavenging by catalase, these responses were attenuated by intracellular scavengers of H2O2 or related oxidants, suggesting an intracellular redox signaling mechanism. Both ADAM17 activation and IL-8 release were suppressed by inhibitors of EGFR/ERK1/2 signaling, which can regulate ADAM17 activity by serine/threonine phosphorylation. Collectively, our results indicate that ATP-mediated DUOX1 activation represents a common response mechanism to several environmental stimuli, involving H2O2-dependent EGFR/ERK activation, ADAM17 activation, and EGFR ligand shedding, leading to amplified epithelial EGFR activation and IL-8 production.	[van der Vliet, Albert] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; [Boots, Agnes W.; Haenen, Guido R. M. M.; Bast, Aalt] Maastricht Univ, Fac Med, Dept Pharmacol & Toxicol, NL-6200 Maastricht, Netherlands	University of Vermont; Maastricht University	van der Vliet, A (corresponding author), Univ Vermont, Dept Pathol, D205 Given Bldg,89 Beaumont Ave, Burlington, VT 05405 USA.	Albert.van-der-Vliet@uvm.edu	Haenen, Guido/H-9209-2013; Bast, Aalt/I-7809-2013	Haenen, Guido/0000-0001-6986-290X; Bast, Aalt/0000-0002-5383-2789	National Institutes of Health [HL068865, HL074295, HL089646]; Kootstra fellowship; Niels Stensen Stipendium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085646, R01HL068865, R01HL074295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kootstra fellowship; Niels Stensen Stipendium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL068865, HL074295, and HL089646 (to A. v. d. V.). This work was also supported by a Kootstra fellowship and a Niels Stensen Stipendium (to A. W. B.).	Ahmad S, 2006, FREE RADICAL BIO MED, V41, P29, DOI 10.1016/j.freeradbiomed.2006.03.004; Ameziane-El-Hassani R, 2005, J BIOL CHEM, V280, P30046, DOI 10.1074/jbc.M500516200; Bevelander M, 2007, J IMMUNOL, V179, P3680, DOI 10.4049/jimmunol.179.6.3680; Biagioli MC, 1999, FREE RADICAL BIO MED, V26, P454, DOI 10.1016/S0891-5849(98)00233-0; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Booth BW, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-51; Boucher I, 2007, EXP EYE RES, V85, P130, DOI 10.1016/j.exer.2007.03.009; Buvinic S, 2007, J CELL SCI, V120, P4289, DOI 10.1242/jcs.03490; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Communi D, 1999, BRIT J PHARMACOL, V127, P562, DOI 10.1038/sj.bjp.0702560; Coraux C, 2005, J PATHOL, V206, P160, DOI 10.1002/path.1757; Donepudi M, 2008, CELL SIGNAL, V20, P1359, DOI 10.1016/j.cellsig.2008.03.007; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; Fan HZ, 2003, J BIOL CHEM, V278, P18617, DOI 10.1074/jbc.M300331200; Fischer H, 2007, AM J PHYSIOL-LUNG C, V292, pL1506, DOI 10.1152/ajplung.00029.2007; Forteza R, 2005, AM J RESP CELL MOL, V32, P462, DOI 10.1165/rcmb.2004-0302OC; Fu Z, 2007, AM J PHYSIOL-LUNG C, V292, pL353, DOI 10.1152/ajplung.00042.2006; Geary C, 2005, AM J PHYSIOL-LUNG C, V289, pL890, DOI 10.1152/ajplung.00428.2004; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Gomez MI, 2008, PEDIATR PULM, V43, P11, DOI 10.1002/ppul.20735; Gomez MI, 2007, EMBO J, V26, P701, DOI 10.1038/sj.emboj.7601554; Hamilton LM, 2005, EUR RESPIR J, V25, P978, DOI 10.1183/09031936.05.00098604; Harper RW, 2005, FEBS LETT, V579, P4911, DOI 10.1016/j.febslet.2005.08.002; Joseph T, 2005, AM J PHYSIOL-LUNG C, V288, pL471, DOI 10.1152/ajplung.00066.2004; Khan EM, 2006, J BIOL CHEM, V281, P14486, DOI 10.1074/jbc.M509332200; Kim HJ, 2008, AM J RESP CELL MOL, V39, P598, DOI 10.1165/rcmb.2007-0262OC; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Koff JL, 2008, AM J PHYSIOL-LUNG C, V294, pL1068, DOI 10.1152/ajplung.00025.2008; Koff JL, 2006, J IMMUNOL, V177, P8693, DOI 10.4049/jimmunol.177.12.8693; Kuwahara I, 2007, AM J RESP CELL MOL, V37, P691, DOI 10.1165/rcmb.2007-0072OC; Kuwahara I, 2006, AM J PHYSIOL-LUNG C, V291, pL407, DOI 10.1152/ajplung.00471.2005; Laroux FS, 2005, J IMMUNOL, V175, P5596, DOI 10.4049/jimmunol.175.9.5596; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Leonard JD, 2005, BIOCHEM J, V387, P797, DOI 10.1042/BJ20041727; Li J, 2003, AM J PHYSIOL-LUNG C, V284, pL307, DOI 10.1152/ajplung.00086.2002; Li J, 2002, AM J PHYSIOL-LUNG C, V283, pL690, DOI 10.1152/ajplung.00060.2002; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Li Q, 2008, BIOCHEM J, V411, P531, DOI 10.1042/BJ20071534; Lin CH, 2006, J IMMUNOL, V177, P3427, DOI 10.4049/jimmunol.177.5.3427; Liu J, 2004, J BIOL CHEM, V279, P8212, DOI 10.1074/jbc.M312230200; Liu K, 2008, AM J RESP CELL MOL, V39, P305, DOI 10.1165/rcmb.2007-0458OC; Look DC, 2005, J IMMUNOL, V175, P4017, DOI 10.4049/jimmunol.175.6.4017; Luxen S, 2008, CANCER RES, V68, P1037, DOI 10.1158/0008-5472.CAN-07-5782; McNamara N, 2006, AM J RESP CELL MOL, V34, P653, DOI 10.1165/rcmb.2005-0441OC; McNamara N, 2001, P NATL ACAD SCI USA, V98, P9086, DOI 10.1073/pnas.161290898; Milla ME, 2006, CELL BIOCHEM BIOPHYS, V44, P342, DOI 10.1385/CBB:44:3:342; Moskwa P, 2007, AM J RESP CRIT CARE, V175, P174, DOI 10.1164/rccm.200607-1029OC; Nagai K, 2008, ANTIOXID REDOX SIGN, V10, P705, DOI 10.1089/ars.2007.1941; Nakanaga T, 2007, AM J PHYSIOL-LUNG C, V292, pL1289, DOI 10.1152/ajplung.00356.2006; Pacquelet S, 2008, J BIOL CHEM, V283, P24649, DOI 10.1074/jbc.M709108200; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Pelaia G, 2004, J CELL BIOCHEM, V93, P142, DOI 10.1002/jcb.20124; Richter A, 2002, AM J RESP CELL MOL, V27, P85, DOI 10.1165/ajrcmb.27.1.4789; Roger T, 1998, BIOCHEM J, V330, P429, DOI 10.1042/bj3300429; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; Sethi G, 2007, ONCOGENE, V26, P7324, DOI 10.1038/sj.onc.1210544; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Shao MXG, 2005, P NATL ACAD SCI USA, V102, P767, DOI 10.1073/pnas.0408932102; Shao MXG, 2003, P NATL ACAD SCI USA, V100, P11618, DOI 10.1073/pnas.1534804100; Song Y, 2007, J CLIN ENDOCR METAB, V92, P3764, DOI 10.1210/jc.2007-0660; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Strieter RM, 2002, AM J PHYSIOL-LUNG C, V283, pL688, DOI 10.1152/ajplung.00146.2002; Tephly LA, 2007, AM J PHYSIOL-LUNG C, V293, pL1143, DOI 10.1152/ajplung.00114.2007; van der Vliet A, 2008, FREE RADICAL BIO MED, V44, P938, DOI 10.1016/j.freeradbiomed.2007.11.016; Wesley UV, 2007, J BIOL CHEM, V282, P3213, DOI 10.1074/jbc.M606533200; Yu YM, 2006, J IMMUNOL, V176, P6194, DOI 10.4049/jimmunol.176.10.6194; Zhang Q, 2006, P NATL ACAD SCI USA, V103, P6901, DOI 10.1073/pnas.0509719103; Zhao YT, 2006, J BIOL CHEM, V281, P19501, DOI 10.1074/jbc.M511224200; Zheng YF, 2002, J BIOL CHEM, V277, P42463, DOI 10.1074/jbc.M207459200; Zhougang SG, 2004, AM J PHYSIOL-RENAL, V286, pF858, DOI 10.1152/ajprenal.00282.2003	72	83	83	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17858	17867		10.1074/jbc.M809761200	http://dx.doi.org/10.1074/jbc.M809761200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19386603	hybrid, Green Published			2022-12-25	WOS:000267202500051
J	Ji, BA; Gaiser, S; Chen, XQ; Ernst, SA; Logsdon, CD				Ji, Baoan; Gaiser, Sebastian; Chen, Xueqing; Ernst, Stephen A.; Logsdon, Craig D.			Intracellular Trypsin Induces Pancreatic Acinar Cell Death but Not NF-kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT; CHOLECYSTOKININ; EXPRESSION; PROTEASES; ETHIONINE; RESPONSES; CLONING; SITES; FURIN	Premature intracellular activation of the digestive enzyme trypsinogen is considered to be the initiating event in pancreatitis. However, the direct consequences of intracellular trypsin activity have not previously been examined. In the current study, a mutant trypsinogen (paired basic amino acid cleaving enzyme (PACE)-trypsinogen), which is activated intracellularly by the endogenous protease PACE, was developed. This new construct allowed for the first time direct examination of the effects of intracellular trypsin on pancreatic acinar cells. We found that PACE-trypsinogen was expressed in the secretory pathway and was activated within acinar cells. Expression of PACE-trypsinogen induced apoptosis of HEK293 cells and pancreatic acinar cells, as indicated by histology, DNA laddering, PARP cleavage, and caspase-3 activation. Cell death was blocked by the trypsin inhibitor Pefabloc but not by the pan-caspase inhibitor benzyloxycarbonyl-VAD, indicating that caspase-independent pathways were also involved. However, intracellular trypsin had no significant effect on the activity of the proinflammatory transcription factor NF-kappa B. In contrast, extracellular trypsin caused cell damage and dramatically increased NF-kappa B activity. These data indicate that localization of active trypsin determines its effects on pancreatic acinar cells. This new model will greatly improve our understanding of the role of active trypsin in pancreatitis and its associated inflammatory response.	[Logsdon, Craig D.] Univ Texas MD Anderson Canc Ctr, Unit 953, Dept Canc Biol, Houston, TX 77030 USA; [Logsdon, Craig D.] Univ Texas MD Anderson Canc Ctr, Dept Med Oncol, Houston, TX 77030 USA; [Chen, Xueqing] Affiliated Hosp 1, Guangzhou Med Coll, Dept Gastroenterol, Guangzhou 510120, Peoples R China; [Ernst, Stephen A.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Guangzhou Medical University; University of Michigan System; University of Michigan	Logsdon, CD (corresponding author), Univ Texas MD Anderson Canc Ctr, Unit 953, Dept Canc Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	clogsdon@mdanderson.org			National Institutes of Health [DK52067-05, R21 DK068414-02, 2P30 DK034933-20, P30 DK-34933, P60 DK-20572]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK068414, P60DK020572, R01DK052067, P30DK034933] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK52067-05 (to C. D. L.), R21 DK068414-02 (to B. J.), and 2P30 DK034933-20 (to B. J.). Resources from the combined Morphology and Image Analysis Core of the Michigan Gastrointestinal Peptide Center (National Institutes of Health Grant P30 DK-34933) and the Michigan Diabetes and Research Training Center (National Institutes of Health Grant P60 DK-20572) further contributed to this research.	BANERJEE AK, 1994, BRIT J SURG, V81, P1096, DOI 10.1002/bjs.1800810805; Baumann B, 2007, J CLIN INVEST, V117, P1502, DOI 10.1172/JCI30876; Berndt W, 1970, Pol Arch Med Wewn, V4, P535; BIALEK R, 1991, SCAND J GASTROENTERO, V26, P190, DOI 10.3109/00365529109025030; Bohm SK, 1996, BIOCHEM J, V314, P1009; Cavallini G, 1996, NEW ENGL J MED, V335, P919, DOI 10.1056/NEJM199609263351302; Chen XQ, 2002, GASTROENTEROLOGY, V122, P448, DOI 10.1053/gast.2002.31060; Chiari H., 1896, ZEITSCHRIFTFURHEILKU, V17, P69; GEOKAS MC, 1974, AM J DIG DIS, V19, P591, DOI 10.1007/BF01073012; GILLILAND L, 1980, AM J PHYSIOL, V239, pG418, DOI 10.1152/ajpgi.1980.239.5.G418; Grady T, 1997, GASTROENTEROLOGY, V113, P1966, DOI 10.1016/S0016-5085(97)70017-9; Grady T, 1998, AM J PHYSIOL-GASTR L, V275, pG1010, DOI 10.1152/ajpgi.1998.275.5.G1010; GRAF L, 1988, INT J PEPT PROT RES, V32, P512; Gukovskaya AS, 2002, J BIOL CHEM, V277, P22595, DOI 10.1074/jbc.M202929200; Gukovskaya AS, 2002, GASTROENTEROLOGY, V122, P974, DOI 10.1053/gast.2002.32409; Gukovsky I, 1998, AM J PHYSIOL-GASTR L, V275, pG1402, DOI 10.1152/ajpgi.1998.275.6.G1402; Han B, 2001, AM J PHYSIOL-CELL PH, V280, pC465, DOI 10.1152/ajpcell.2001.280.3.C465; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hietaranta AJ, 2001, BIOCHEM BIOPH RES CO, V280, P388, DOI 10.1006/bbrc.2000.4120; Ji B, 2001, GASTROENTEROLOGY, V121, P1380, DOI 10.1053/gast.2001.29557; Ji BA, 2000, J BIOL CHEM, V275, P19115, DOI 10.1074/jbc.M001685200; KAISER AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1295, DOI 10.1152/ajpcell.1995.269.5.C1295; Kawabata A, 2000, BRIT J PHARMACOL, V129, P1808, DOI 10.1038/sj.bjp.0703274; KAWABATA SI, 1988, EUR J BIOCHEM, V172, P17, DOI 10.1111/j.1432-1033.1988.tb13849.x; KOIKE H, 1982, AM J PHYSIOL, V242, pG297, DOI 10.1152/ajpgi.1982.242.4.G297; Kubisch CH, 2007, AM J PHYSIOL-GASTR L, V292, pG1804, DOI 10.1152/ajpgi.00078.2007; LEACH SD, 1991, J CLIN INVEST, V87, P362, DOI 10.1172/JCI114995; Lerch MM, 2000, ADV EXP MED BIOL, V477, P403; Mareninova OA, 2006, J BIOL CHEM, V281, P3370, DOI 10.1074/jbc.M511276200; Mitchell RMS, 2003, LANCET, V361, P1447, DOI 10.1016/S0140-6736(03)13139-X; Nguyen TD, 1999, J CLIN INVEST, V103, P261, DOI 10.1172/JCI2539; NIEDERAU C, 1988, J CLIN INVEST, V81, P229, DOI 10.1172/JCI113300; Pandol SJ, 2005, CURR OPIN GASTROEN, V21, P538, DOI 10.1097/01.mog.0000174221.92708.50; Saluja AK, 1997, GASTROENTEROLOGY, V113, P304, DOI 10.1016/S0016-5085(97)70108-2; Senftleben U, 2002, CRIT CARE MED, V30, pS18, DOI 10.1097/00003246-200201001-00003; STEER ML, 1988, ANNU REV MED, V39, P95, DOI 10.1146/annurev.me.39.020188.000523; Steinle AU, 1999, GASTROENTEROLOGY, V116, P420, DOI 10.1016/S0016-5085(99)70140-X; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; YANAGITA M, 1993, ENDOCRINOLOGY, V133, P639, DOI 10.1210/en.133.2.639	41	59	61	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17488	17498		10.1074/jbc.M109.005520	http://dx.doi.org/10.1074/jbc.M109.005520			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19383608	hybrid, Green Published			2022-12-25	WOS:000267202500015
J	McBryant, SJ; Klonoski, J; Sorensen, TC; Norskog, SS; Williams, S; Resch, MG; Toombs, JA; Hobdey, SE; Hansen, JC				McBryant, Steven J.; Klonoski, Joshua; Sorensen, Troy C.; Norskog, Sarah S.; Williams, Sere; Resch, Michael G.; Toombs, James A., III; Hobdey, Sarah E.; Hansen, Jeffrey C.			Determinants of Histone H4 N-terminal Domain Function during Nucleosomal Array Oligomerization ROLES OF AMINO ACID SEQUENCE, DOMAIN LENGTH, AND CHARGE DENSITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; SEDIMENTATION-VELOCITY ANALYSIS; REGULATES CHROMATIN COMPACTION; TAIL DOMAINS; H4-K16 ACETYLATION; SELF-ASSOCIATION; RECOMBINANT HISTONES; DIVALENT-CATIONS; CORE PARTICLE; IN-VITRO	Mg2+-dependent oligomerization of nucleosomal arrays is correlated with higher order folding transitions that stabilize chromosome structure beyond the 30-nm diameter fiber. In the present studies, we have employed a novel mutagenesis-based approach to identify the macromolecular determinants that control H4 N-terminal domain (NTD) function during oligomerization. Core histones were engineered in which 1) the H2A, H2B, and H3 NTDs were swapped onto the H4 histone fold; 2) the length of the H4 NTD and the H2A NTD on the H4 histone fold, were increased; 3) the charge density of the NTDs on the H4 histone fold was increased or decreased; and 4) the H4 NTD was placed on the H2B histone fold. Model nucleosomal arrays were assembled from wild type and mutant core histone octamers, and Mg2+-dependent oligomerization was characterized. The results demonstrated that the H2B and H3 NTDs could replace the H4NTD, as could the H2A NTD if it was duplicated to the length of the native H4NTD. Arrays oligomerized at lower salt concentrations as the length of the NTD on the H4 histone fold was increased. Mutations that decreased the NTD charge density required more Mg2+ to oligomerize, whereas mutants that increased the charge density required less salt. Finally, the H4 NTD functioned differently when attached to the H2B histone fold than the H4 histone fold. These studies have revealed new insights into the biochemical basis for H4 NTD effects on genome architecture as well as the protein chemistry that underlies the function of the intrinsically disordered H4 NTD.	[McBryant, Steven J.; Klonoski, Joshua; Sorensen, Troy C.; Norskog, Sarah S.; Williams, Sere; Resch, Michael G.; Toombs, James A., III; Hobdey, Sarah E.; Hansen, Jeffrey C.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Colorado State University	Hansen, JC (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, 381 MRB, Ft Collins, CO 80523 USA.	jeffrey.c.hansen@colostate.edu		Toombs, James/0000-0002-1601-5675	National Institutes of Health [GM45916]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045916, R29GM045916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM45916 (to J.C.H.).	AARONSON RP, 1981, J CELL BIOL, V90, P181, DOI 10.1083/jcb.90.1.181; Arya G, 2006, BIOPHYS J, V91, P133, DOI 10.1529/biophysj.106.083006; Bartova E, 2008, J HISTOCHEM CYTOCHEM, V56, P711, DOI 10.1369/jhc.2008.951251; Baxevanis AD, 1996, NUCLEIC ACIDS RES, V24, P245, DOI 10.1093/nar/24.1.245; BELMONT AS, 1994, J CELL BIOL, V127, P287, DOI 10.1083/jcb.127.2.287; BELMONT AS, 1989, CHROMOSOMA, V98, P129, DOI 10.1007/BF00291049; Carruthers LM, 2000, J BIOL CHEM, V275, P37285, DOI 10.1074/jbc.M006801200; Carruthers LM, 2000, METHOD ENZYMOL, V321, P66; Chodaparambil JV, 2007, NAT STRUCT MOL BIOL, V14, P1105, DOI 10.1038/nsmb1334; CLARK DJ, 1990, J MOL BIOL, V211, P883, DOI 10.1016/0022-2836(90)90081-V; Cosgrove MS, 2005, BIOCHEM CELL BIOL, V83, P468, DOI 10.1139/O05-137; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; DIXON DK, 1985, EUR J CELL BIOL, V36, P315; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Faye G, 2005, J BIOL CHEM, V280, P33701, DOI 10.1074/jbc.M507048200; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; FLETCHER TM, 1995, J BIOL CHEM, V270, P25359, DOI 10.1074/jbc.270.43.25359; Fletcher TM, 1996, CRIT REV EUKAR GENE, V6, P149, DOI 10.1615/CritRevEukarGeneExpr.v6.i2-3.40; Fuxreiter M, 2008, NAT CHEM BIOL, V4, P728, DOI 10.1038/nchembio.127; GARCIARAMIREZ M, 1992, J BIOL CHEM, V267, P19587; GARCIARAMIREZ M, 1995, J BIOL CHEM, V270, P17923, DOI 10.1074/jbc.270.30.17923; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; Hansen JC, 2006, J BIOL CHEM, V281, P1853, DOI 10.1074/jbc.R500022200; HANSEN JC, 1989, BIOCHEMISTRY-US, V28, P9129, DOI 10.1021/bi00449a026; HANSEN JC, 1993, J BIOL CHEM, V268, P5840; Hansen JC, 1998, BIOCHEMISTRY-US, V37, P17637, DOI 10.1021/bi982409v; Hansen JC, 2006, ACS CHEM BIOL, V1, P69, DOI 10.1021/cb6000894; Kan PY, 2007, MOL CELL BIOL, V27, P2084, DOI 10.1128/MCB.02181-06; Kan PY, 2009, MOL CELL BIOL, V29, P538, DOI 10.1128/MCB.01343-08; Krebs JE, 2007, MOL BIOSYST, V3, P590, DOI 10.1039/b703923a; Lu X, 2008, NAT STRUCT MOL BIOL, V15, P1122, DOI 10.1038/nsmb.1489; Lu X, 2006, BIOCHEM CELL BIOL, V84, P411, DOI 10.1139/O06-068; Lu X, 2009, BIOCHEMISTRY-US, V48, P164, DOI 10.1021/bi801636y; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Luger K, 1998, CURR OPIN STRUC BIOL, V8, P33, DOI 10.1016/S0959-440X(98)80007-9; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; Meszaros B, 2007, J MOL BIOL, V372, P549, DOI 10.1016/j.jmb.2007.07.004; Moore SC, 1997, BIOCHEM BIOPH RES CO, V230, P136, DOI 10.1006/bbrc.1996.5903; OLINS DE, 1972, J CELL BIOL, V53, P715, DOI 10.1083/jcb.53.3.715; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Pollard KJ, 1999, EMBO J, V18, P5622, DOI 10.1093/emboj/18.20.5622; Robinson PJJ, 2008, J MOL BIOL, V381, P816, DOI 10.1016/j.jmb.2008.04.050; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; SCHWARZ PM, 1994, J BIOL CHEM, V269, P16284; Sharma S, 2007, BIOPHYS J, V92, P1457, DOI 10.1529/biophysj.106.094805; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Shogren-Knaak M, 2006, CELL CYCLE, V5, P1361, DOI 10.4161/cc.5.13.2891; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; Tse C, 1997, BIOCHEMISTRY-US, V36, P11381, DOI 10.1021/bi970801n; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Turner BM, 2007, NAT CELL BIOL, V9, P2, DOI 10.1038/ncb0107-2; Villar-Garea A, 2006, BBA-PROTEINS PROTEOM, V1764, P1932, DOI 10.1016/j.bbapap.2006.08.009; Wang XD, 2008, MOL CELL BIOL, V28, P227, DOI 10.1128/MCB.01245-07; WEITH A, 1983, EXP CELL RES, V146, P199, DOI 10.1016/0014-4827(83)90338-5; Widom J, 1998, ANNU REV BIOPH BIOM, V27, P285, DOI 10.1146/annurev.biophys.27.1.285; Zheng CY, 2003, J BIOL CHEM, V278, P24217, DOI 10.1074/jbc.M302817200; Zhou JS, 2007, NAT STRUCT MOL BIOL, V14, P1070, DOI 10.1038/nsmb1323	70	29	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16716	16722		10.1074/jbc.M109.011288	http://dx.doi.org/10.1074/jbc.M109.011288			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19395382	Green Published, hybrid			2022-12-25	WOS:000266962400006
J	Morioka, S; Omori, E; Kajino, T; Kajino-Sakamoto, R; Matsumoto, K; Ninomiya-Tsuji, J				Morioka, S.; Omori, E.; Kajino, T.; Kajino-Sakamoto, R.; Matsumoto, K.; Ninomiya-Tsuji, J.			TAK1 kinase determines TRAIL sensitivity by modulating reactive oxygen species and cIAP	ONCOGENE			English	Article						TAK1; TRAIL; reactive oxygen species; cIAP; apoptosis	NF-KAPPA-B; APOPTOSIS-INDUCING LIGAND; HUMAN CANCER-CELLS; INDUCED DEATH; CASPASE-8 ACTIVATION; SIGNALING PATHWAYS; DECOY RECEPTORS; TARGETING DEATH; JNK ACTIVATION; UP-REGULATION	TNF-related apoptosis-inducing ligand (TRAIL) is a potent inducer of cell death in several cancer cells, but many cells are resistant to TRAIL. The mechanism that determines sensitivity to TRAIL-killing is still elusive. Here we report that deletion of TAK1 kinase greatly increased activation of caspase-3 and cell death after TRAIL stimulation in keratinocytes, fibroblasts and cancer cells. Although TAK1 kinase is involved in NF-kappa B pathway, ablation of NF-kappa B did not alter sensitivity to TRAIL. We found that TRAIL could induce accumulation of reactive oxygen species (ROS) when TAK1 was deleted. Furthermore, we found that TAK1 deletion induced TRAIL-dependent downregulation of cIAP, which enhanced activation of caspase-3. These results show that TAK1 deletion facilitates TRAIL-induced cell death by activating caspase through ROS and downregulation of cIAP. Thus, inhibition of TAK1 can be an effective approach to increase TRAIL sensitivity. Oncogene (2009) 28, 2257-2265; doi: 10.1038/onc.2009.110; published online 4 May 2009	[Morioka, S.; Omori, E.; Kajino-Sakamoto, R.; Ninomiya-Tsuji, J.] N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA; [Morioka, S.; Kajino, T.; Matsumoto, K.] Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Nagoya, Aichi 4648601, Japan; [Matsumoto, K.] Japan Sci & Technol Agcy, SORST, Tokyo, Japan	University of North Carolina; North Carolina State University; Nagoya University; Japan Science & Technology Agency (JST)	Ninomiya-Tsuji, J (corresponding author), N Carolina State Univ, Dept Environm & Mol Toxicol, Campus Box 7633, Raleigh, NC 27695 USA.	Jun_Tsuji@ncsu.edu	Morioka, Sho/I-2074-2019	Morioka, Sho/0000-0002-1153-4919; Ninomiya-Tsuji, Jun/0000-0002-5584-0176	NIH [GM068812]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068812] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs Akira, Karin, Ballard and Wang for materials. This work was supported by a grant ( GM068812) from NIH to JN-T.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen ZJ, 2006, CELL DEATH DIFFER, V13, P687, DOI 10.1038/sj.cdd.4401869; Choo MK, 2006, MOL CANCER THER, V5, P2970, DOI 10.1158/1535-7163.MCT-06-0379; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Kajino T, 2007, J BIOL CHEM, V282, P9475, DOI 10.1074/jbc.M700875200; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kim JY, 2008, J BIOL CHEM, V283, P137, DOI 10.1074/jbc.M704746200; Kim SH, 2008, CANCER RES, V68, P2062, DOI 10.1158/0008-5472.CAN-07-6278; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Kurbanov BM, 2007, ONCOGENE, V26, P3364, DOI 10.1038/sj.onc.1210134; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Meng XW, 2007, J BIOL CHEM, V282, P29831, DOI 10.1074/jbc.M706110200; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Omori E, 2008, J BIOL CHEM, V283, P26161, DOI 10.1074/jbc.M804513200; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Reed JC, 2006, NAT CLIN PRACT ONCOL, V3, P388, DOI 10.1038/ncponc0538; Ricci MS, 2007, CANCER CELL, V12, P66, DOI 10.1016/j.ccr.2007.05.006; Rudolph D, 2000, GENE DEV, V14, P854; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Siegmund D, 2001, J BIOL CHEM, V276, P32585, DOI 10.1074/jbc.M100444200; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Takeda K, 2007, ONCOGENE, V26, P3745, DOI 10.1038/sj.onc.1210374; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Ventura JJ, 2004, GENE DEV, V18, P2905, DOI 10.1101/gad.1223004; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Xiao C, 2002, J BIOL CHEM, V277, P25020, DOI 10.1074/jbc.M202946200	40	30	31	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 11	2009	28	23					2257	2265		10.1038/onc.2009.110	http://dx.doi.org/10.1038/onc.2009.110			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	456XM	19421137	Green Accepted			2022-12-25	WOS:000266886300002
J	Cox, D; Fox, L; Tian, RY; Bardet, W; Skaley, M; Mojsilovic, D; Gumperz, J; Hildebrand, W				Cox, Daryl; Fox, Lisa; Tian, Runying; Bardet, Wilfried; Skaley, Matthew; Mojsilovic, Danijela; Gumperz, Jenny; Hildebrand, William			Determination of Cellular Lipids Bound to Human CD1d Molecules	PLOS ONE			English	Article								CD1 molecules are glycoproteins that present lipid antigens at the cell surface for immunological recognition by specialized populations of T lymphocytes. Prior experimental data suggest a wide variety of lipid species can bind to CD1 molecules, but little is known about the characteristics of cellular ligands that are selected for presentation. Here we have molecularly characterized lipids bound to the human CD1d isoform. Ligands were eluted from secreted CD1d molecules and separated by normal phase HPLC, then characterized by mass spectroscopy. A total of 177 lipid species were molecularly identified, comprising glycerophospholipids and sphingolipids. The glycerophospholipids included common diacylglycerol species, reduced forms known as plasmalogens, lyso-phospholipids (monoacyl species), and cardiolipins (tetraacyl species). The sphingolipids included sphingomyelins and glycosylated forms, such as the ganglioside GM3. These results demonstrate that human CD1d molecules bind a surprising diversity of lipid structures within the secretory pathway, including compounds that have been reported to play roles in cancer, autoimmune diseases, lipid signaling, and cell death.			Gumperz, J (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	jegumperz@wisc.edu			NHLBI NIH HHS [R01 HL071590] Funding Source: Medline; NIAID NIH HHS [R01 AI074940, HHSN266200400027C] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074940] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agea E, 2005, J EXP MED, V202, P295, DOI 10.1084/jem.20050773; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Brites P, 2004, BBA-MOL CELL BIOL L, V1636, P219, DOI 10.1016/j.bbalip.2003.12.010; Chang DH, 2008, BLOOD, V112, P1308, DOI 10.1182/blood-2008-04-149831; Chen XX, 2007, J IMMUNOL, V178, P6181, DOI 10.4049/jimmunol.178.10.6181; Christiansen D, 2008, PLOS BIOL, V6, P1527, DOI 10.1371/journal.pbio.0060172; De Silva AD, 2002, J IMMUNOL, V168, P723, DOI 10.4049/jimmunol.168.2.723; DOMON B, 1988, BIOCHEMISTRY-US, V27, P1534, DOI 10.1021/bi00405a021; Giabbai B, 2005, J IMMUNOL, V175, P977, DOI 10.4049/jimmunol.175.2.977; Goff RD, 2004, J AM CHEM SOC, V126, P13602, DOI 10.1021/ja045385q; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Gumperz JE, 2006, TRAFFIC, V7, P2, DOI 10.1111/j.1600-0854.2005.00364.x; HAX WMA, 1977, J CHROMATOGR, V142, P735, DOI 10.1016/S0021-9673(01)92081-3; Hickman HD, 2004, J IMMUNOL, V172, P2944, DOI 10.4049/jimmunol.172.5.2944; Hickman HD, 2000, HUM IMMUNOL, V61, P1339, DOI 10.1016/S0198-8859(00)00216-0; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P892, DOI 10.1016/S1044-0305(00)00159-8; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P797, DOI 10.1016/S1044-0305(00)00151-3; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P437, DOI 10.1016/S1044-0305(99)00150-6; Hsu FF, 2005, J AM SOC MASS SPECTR, V16, P1510, DOI 10.1016/j.jasms.2005.04.018; Hsu FF, 2004, J AM SOC MASS SPECTR, V15, P1, DOI 10.1016/j.jasms.2003.08.006; Hsu FF, 2003, J MASS SPECTROM, V38, P752, DOI 10.1002/jms.491; Hsu FF, 2002, J AM SOC MASS SPECTR, V13, P558, DOI 10.1016/S1044-0305(02)00358-6; Hsu FF, 2002, J AM SOC MASS SPECTR, V13, P680, DOI 10.1016/S1044-0305(02)00362-8; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P986, DOI 10.1016/S1044-0305(00)00172-0; Hsu FF, 2003, J AM SOC MASS SPECTR, V14, P352, DOI 10.1016/S1044-0305(03)00064-3; Hsu FF, 2006, J AM SOC MASS SPECTR, V17, P420, DOI 10.1016/j.jasms.2005.11.019; Hsu FF, 2007, J AM SOC MASS SPECTR, V18, P2065, DOI 10.1016/j.jasms.2007.08.019; Hsu FF, 2007, J AM SOC MASS SPECTR, V18, P783, DOI 10.1016/j.jasms.2006.12.012; Im JS, 2004, J BIOL CHEM, V279, P299, DOI 10.1074/jbc.M308803200; Joyce S, 1998, SCIENCE, V279, P1541, DOI 10.1126/science.279.5356.1541; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; McCarthy C, 2007, J EXP MED, V204, P1131, DOI 10.1084/jem.20062342; Metelmann W, 2001, J MASS SPECTROM, V36, P21, DOI 10.1002/jms.100; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Park JJ, 2004, P NATL ACAD SCI USA, V101, P1022, DOI 10.1073/pnas.0307847100; Park JE, 2008, IMMUNOLOGY, V123, P145, DOI 10.1111/j.1365-2567.2007.02760.x; Prilliman K, 1997, IMMUNOGENETICS, V45, P379, DOI 10.1007/s002510050219; Roy KC, 2008, J IMMUNOL, V180, P2942, DOI 10.4049/jimmunol.180.5.2942; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; SHIMIZU Y, 1986, MOL CELL BIOL, V6, P1074, DOI 10.1128/MCB.6.4.1074; Sorensen LK, 2006, RAPID COMMUN MASS SP, V20, P3625, DOI 10.1002/rcm.2775; Tsuji M, 2006, CELL MOL LIFE SCI, V63, P1889, DOI 10.1007/s00018-006-6073-z; Vukelic Z, 2001, BIOL CHEM, V382, P259, DOI 10.1515/BC.2001.033; Wu D, 2005, P NATL ACAD SCI USA, V102, P1351, DOI 10.1073/pnas.0408696102; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; Zajonc DM, 2008, J MOL BIOL, V377, P1104, DOI 10.1016/j.jmb.2008.01.061; Zajonc DM, 2006, J IMMUNOL, V177, P4577, DOI 10.4049/jimmunol.177.7.4577; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	55	109	110	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2009	4	5							e5325	10.1371/journal.pone.0005325	http://dx.doi.org/10.1371/journal.pone.0005325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JE	19415116	gold, Green Submitted, Green Published			2022-12-25	WOS:000265836700003
J	Bryhn, AC				Bryhn, Andreas C.			Sustainable Phosphorus Loadings from Effective and Cost-Effective Phosphorus Management Around the Baltic Sea	PLOS ONE			English	Article								Nutrient over-enrichment of the Baltic Sea, accompanied by intensified algal blooms and decreasing water clarity, has aroused widespread concern in the surrounding countries during the last four decades. This work has used a well-tested dynamic mass-balance model to investigate which decrease in total phosphorus loading would be required to meet the environmental goal to restore the trophic state in the Baltic Sea to pre-1960s levels. Furthermore, the extent to which various abatement options may decrease the phosphorus loading in a cost-effective manner has been studied. Upgrading urban sewage treatment in the catchment could, alone or in combination with banning phosphates in detergents, be sufficient to meet the set environmental goal, at an estimated annual basin-wide cost of 0.21-0.43 billion euro. Such a plan would potentially decrease the total phosphorus loading to the Baltic Sea with 6,650-10,200 tonnes per year.			Bryhn, AC (corresponding author), Uppsala Univ, Dept Earth Sci, Uppsala, Sweden.	andreas.bryhn@geo.uu.se						Aarup T, 2002, OCEANOLOGIA, V44, P323; Bergstrom L., 2007, REPORT FOOD, V21, P4; BOESCH D, 2006, 5529 SWED EPA; Bowes MJ, 2008, SCI TOTAL ENVIRON, V395, P125, DOI 10.1016/j.scitotenv.2008.01.054; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Conley DJ, 2002, ENVIRON SCI TECHNOL, V36, P5315, DOI 10.1021/es025763w; Finni T, 2001, AMBIO, V30, P172, DOI 10.1639/0044-7447(2001)030[0172:THOCBI]2.0.CO;2; Fleming-Lehtinen V., 2009, WATER TRANSPARENCY B; Gren IM, 2001, ENVIRON RESOUR ECON, V20, P41, DOI 10.1023/A:1017512113454; GREN IM, 2008, 5877 SWED EPA; Hakanson L., 2008, EUTROPHICATION BALTI; HAKANSON L, 2009, OPEN MAR BIOL J, V3, P36; *HELCOM, 2007, BALT SEA UN EUTR; *HELCOM NEFCO, 2007, EC AN BSAP FOC EUTR; KIIRIKKI M, 1999, COST EFFECTIVE WATER; Kohler J, 2006, J BUS CHEM, V2, P15; LARSSON U, 1985, AMBIO, V14, P9; PITKANEN H, 2007, 15 FINN ENV; Savchuk OP, 2008, J MARINE SYST, V74, P485, DOI 10.1016/j.jmarsys.2008.03.008; Schernewski G, 2005, J MARINE SYST, V53, P109, DOI 10.1016/j.jmarsys.2004.03.007; Schindler D.W., 2008, PNAS, V105, P11039; Schou J.S., 2006, 592 NERI; Stalnacke P, 1999, ENVIRON MONIT ASSESS, V58, P173, DOI 10.1023/A:1006073015871; *SWED EPA, 2008, 5840 SWED EPA; Tonderski KS, 2005, AMBIO, V34, P544, DOI 10.1639/0044-7447(2005)034[0544:MTIOPW]2.0.CO;2; Turner RK, 1999, ECOL ECON, V30, P333, DOI 10.1016/S0921-8009(99)00046-4; Vahtera E, 2007, AMBIO, V36, P186, DOI 10.1579/0044-7447(2007)36[186:IEFENC]2.0.CO;2	27	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2009	4	5							e5417	10.1371/journal.pone.0005417	http://dx.doi.org/10.1371/journal.pone.0005417			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440RC	19412551	gold, Green Published			2022-12-25	WOS:000265716400001
J	Young, JD; Martel, J; Young, D; Young, A; Hung, CM; Young, L; Chao, YJ; Young, J; Wu, CY				Young, John D.; Martel, Jan; Young, David; Young, Andrew; Hung, Chin-Ming; Young, Lena; Chao, Ying-Jie; Young, James; Wu, Cheng-Yeu			Characterization of Granulations of Calcium and Apatite in Serum as Pleomorphic Mineralo-Protein Complexes and as Precursors of Putative Nanobacteria	PLOS ONE			English	Article							HUMAN ALPHA-2-HS GLYCOPROTEIN; FETUIN-A; RANDALLS PLAQUE; MATRIX VESICLES; CALCIFYING NANOPARTICLES; VASCULAR CALCIFICATION; HYDROXYAPATITE CRYSTALS; MEDIATED CALCIFICATION; TUMORAL CALCINOSIS; AORTIC-STENOSIS	Calcium and apatite granulations are demonstrated here to form in both human and fetal bovine serum in response to the simple addition of either calcium or phosphate, or a combination of both. These granulations are shown to represent precipitating complexes of protein and hydroxyapatite (HAP) that display marked pleomorphism, appearing as round, laminated particles, spindles, and films. These same complexes can be found in normal untreated serum, albeit at much lower amounts, and appear to result from the progressive binding of serum proteins with apatite until reaching saturation, upon which the mineralo-protein complexes precipitate. Chemically and morphologically, these complexes are virtually identical to the so-called nanobacteria (NB) implicated in numerous diseases and considered unusual for their small size, pleomorphism, and the presence of HAP. Like NB, serum granulations can seed particles upon transfer to serum-free medium, and their main protein constituents include albumin, complement components 3 and 4A, fetuin-A, and apolipoproteins A1 and B100, as well as other calcium and apatite binding proteins found in the serum. However, these serum mineralo-protein complexes are formed from the direct chemical binding of inorganic and organic phases, bypassing the need for any biological processes, including the long cultivation in cell culture conditions deemed necessary for the demonstration of NB. Thus, these serum granulations may result from physiologically inherent processes that become amplified with calcium phosphate loading or when subjected to culturing in medium. They may be viewed as simple mineralo-protein complexes formed from the deployment of calcification-inhibitory pathways used by the body to cope with excess calcium phosphate so as to prevent unwarranted calcification. Rather than representing novel pathophysiological mechanisms or exotic lifeforms, these results indicate that the entities described earlier as NB most likely originate from calcium and apatite binding factors in the serum, presumably calcification inhibitors, that upon saturation, form seeds for HAP deposition and growth. These calcium granulations are similar to those found in organisms throughout nature and may represent the products of more general calcium regulation pathways involved in the control of calcium storage, retrieval, tissue deposition, and disposal.			Young, JD (corresponding author), Chang Gung Univ, Lab Nanomat, Gueishan, Taiwan.	dingeyoung@hotmail.com		Young, David/0000-0002-8290-5561; Martel, Jan/0000-0003-0879-109X				Abbott A, 2000, NATURE, V408, P394, DOI 10.1038/35044241; Abbott A, 1999, NATURE, V401, P105, DOI 10.1038/43525; Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Aizenberg J, 1996, ADV MATER, V8, P222, DOI 10.1002/adma.19960080307; ALI SY, 1970, P NATL ACAD SCI USA, V67, P1513, DOI 10.1073/pnas.67.3.1513; Anderson HC, 2005, FRONT BIOSCI-LANDMRK, V10, P822, DOI 10.2741/1576; ANDERSON L, 1946, SURG GYNECOL OBSTET, V82, P275; AOKI H, 1996, T ANN M SOC BIOM CON; ASHTON BA, 1974, EUR J BIOCHEM, V45, P525, DOI 10.1111/j.1432-1033.1974.tb03577.x; Ayman A, 2008, EUR PHYS J-SPEC TOP, V153, P497, DOI 10.1140/epjst/e2008-00493-5; Barralet J, 1998, J BIOMED MATER RES, V41, P79, DOI 10.1002/(SICI)1097-4636(199807)41:1<79::AID-JBM10>3.0.CO;2-C; Barrere F, 2006, INT J NANOMED, V1, P317; Benesch J, 2008, TISSUE ENG PART B-RE, V14, P433, DOI 10.1089/ten.teb.2008.0121; Benzerara K, 2003, P NATL ACAD SCI USA, V100, P7438, DOI 10.1073/pnas.0832464100; Benzerara K, 2006, J INVEST MED, V54, P367, DOI 10.2310/6650.2006.06016; BLUMENTHAL NC, 1989, CLIN ORTHOP RELAT R, P279; Bonucci E, 2002, J BONE MINER METAB, V20, P249, DOI 10.1007/s007740200037; BOSKEY AL, 1983, CLIN ORTHOP RELAT R, P258; Boskey AL, 1998, J CELL BIOCHEM, P83, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<83::AID-JCB12>3.0.CO;2-F; Bradbury J, 1998, LANCET, V352, P121, DOI 10.1016/S0140-6736(98)85032-0; Bratos-Perez MA, 2008, EUR HEART J, V29, P371, DOI 10.1093/eurheartj/ehm592; BROWN WM, 1992, BIOESSAYS, V14, P749, DOI 10.1002/bies.950141105; Cantet S, 2001, VIRCHOWS ARCH, V439, P683, DOI 10.1007/s004280100425; Carden A, 2000, J BIOMED OPT, V5, P259, DOI 10.1117/1.429994; CARR R J, 1954, Br J Urol, V26, P105, DOI 10.1111/j.1464-410X.1954.tb06073.x; Carson DA, 1998, P NATL ACAD SCI USA, V95, P7846, DOI 10.1073/pnas.95.14.7846; Chen CW, 2004, J MATER CHEM, V14, P2425, DOI 10.1039/b315095j; Chin WC, 1998, NATURE, V391, P568, DOI 10.1038/35345; Ciftcioglu N, 1999, KIDNEY INT, V56, P1893, DOI 10.1046/j.1523-1755.1999.00755.x; Ciftcioglu N, 2002, ANTIMICROB AGENTS CH, V46, P2077, DOI 10.1128/AAC.46.7.2077-2086.2002; Ciftcioglu N, 1998, PATHOPHYSIOLOGY, V4, P259, DOI DOI 10.1016/S0928-4680(97)10001-3; Ciftcioglu N, 2006, J INVEST MED, V54, P385, DOI 10.2310/6650.2006.06018; Ciftcioglu N, 2007, LANCET, V369, P2078, DOI 10.1016/S0140-6736(07)60977-5; Ciftcioglu N, 2008, INT J NANOMED, V3, P105; Cisar JO, 2000, P NATL ACAD SCI USA, V97, P11511, DOI 10.1073/pnas.97.21.11511; Coe FL, 2005, J CLIN INVEST, V115, P2598, DOI 10.1172/JCI26662; Colfen H, 2005, ANGEW CHEM INT EDIT, V44, P5576, DOI 10.1002/anie.200500496; DAVEAU M, 1988, FEBS LETT, V241, P191, DOI 10.1016/0014-5793(88)81059-7; Day M, 1998, NEW SCI, V159, P11; de Puala AR, 2005, MED ENG PHYS, V27, P237, DOI 10.1016/j.medengphy.2004.10.007; DEMUL FFM, 1986, J DENT RES, V65, P437, DOI 10.1177/00220345860650031301; DERESINSKI S, 2008, CLIN INFECT DIS, V46, pR5; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; Doherty TM, 2003, P NATL ACAD SCI USA, V100, P11201, DOI 10.1073/pnas.1932554100; Domingue GJ, 1997, CLIN MICROBIOL REV, V10, P320, DOI 10.1128/CMR.10.2.320; Dorrell S, 1999, MOL MED TODAY, V5, P373, DOI 10.1016/S1357-4310(99)01553-1; Evan A, 2006, KIDNEY INT, V69, P1313, DOI 10.1038/sj.ki.5000238; Evan AP, 2007, ANAT REC, V290, P1315, DOI 10.1002/ar.20580; Evan AP, 2003, J CLIN INVEST, V111, P607, DOI 10.1172/JCI200317038; FLEISCH H, 1972, J DENT RES, V51, P324; FOLK RL, 1993, J SEDIMENT PETROL, V63, P990, DOI 10.1306/D4267C67-2B26-11D7-8648000102C1865D; Frost RL, 2007, SPECTROCHIM ACTA A, V66, P979, DOI 10.1016/j.saa.2006.04.036; Garcia-Ruiz JM, 2003, SCIENCE, V302, P1194, DOI 10.1126/science.1090163; Garcia-Ruiz JM, 2009, SCIENCE, V323, P362, DOI 10.1126/science.1165349; GARNETT J, 1990, BIOCHEM J, V266, P863; GENGE BR, 1990, J BIOL CHEM, V265, P4703; Genge BR, 2007, J BIOL CHEM, V282, P26035, DOI 10.1074/jbc.M701057200; Ghadially FN, 2001, ULTRASTRUCT PATHOL, V25, P243; Goodman WG, 2002, J NEPHROL, V15, pS82; Gupta HS, 2006, P NATL ACAD SCI USA, V103, P17741, DOI 10.1073/pnas.0604237103; HAGGITT RC, 1971, J UROLOGY, V106, P342, DOI 10.1016/S0022-5347(17)61284-9; Hamilton A, 2000, MICROBIOL TODAY, V27, P182; Harasawa R, 2006, IN VITRO CELL DEV-AN, V42, P13; Hatori M, 1996, TOHOKU J EXP MED, V180, P359, DOI 10.1620/tjem.180.359; Heiss A, 2007, BIOINTERPHASES, V2, P16, DOI 10.1116/1.2714924; Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200; Heiss A, 2008, J BIOL CHEM, V283, P14815, DOI 10.1074/jbc.M709938200; Hendig D, 2006, CLIN CHEM, V52, P227, DOI 10.1373/clinchem.2005.059253; HIRSCHMAN A, 1983, CALCIFIED TISSUE INT, V35, P791, DOI 10.1007/BF02405125; Hjelle JT, 2000, KIDNEY INT, V57, P2360, DOI 10.1046/j.1523-1755.2000.00096.x; HOGAN J, 2003, NEW SCI, V2422, P14; HOPKINS M, 2008, NANOBACTERIA THEORY; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ix JH, 2007, CIRCULATION, V115, P2533, DOI 10.1161/CIRCULATIONAHA.106.682450; Jahnen-Dechent W, 2001, Z Kardiol, V90 Suppl 3, P47; Jahnen-Dechent W, 2008, J MOL MED, V86, P379, DOI 10.1007/s00109-007-0294-y; JAHNENDECHENT W, 2004, PROGR BIOL MOL BIOL, P243; Jersmann HPA, 2003, CLIN SCI, V105, P273, DOI 10.1042/CS20030126; Johansson L, 2003, CYTOTECHNOLOGY, V42, P67, DOI 10.1023/B:CYTO.0000009820.72920.cf; Kajander EO, 2006, LETT APPL MICROBIOL, V42, P549, DOI 10.1111/j.1472-765X.2006.01945.x; Kajander EO, 1997, P SOC PHOTO-OPT INS, V3111, P420, DOI 10.1117/12.278796; Kajander EO, 2003, UROL RES, V31, P47, DOI 10.1007/s002440-003-0304-7; Kajander EO, 1998, P NATL ACAD SCI USA, V95, P8274, DOI 10.1073/pnas.95.14.8274; Kale S, 2000, NAT BIOTECHNOL, V18, P954, DOI 10.1038/79439; Ketteler M, 2005, PEDIATR NEPHROL, V20, P383, DOI 10.1007/s00467-004-1614-x; Ketteler M, 2005, NEPHROL DIAL TRANSPL, V20, P673, DOI 10.1093/ndt/gfh734; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; KHAN SR, 1984, UROLOGY, V23, P194, DOI 10.1016/0090-4295(84)90021-9; Kirkland BL, 1999, GEOLOGY, V27, P347, DOI 10.1130/0091-7613(1999)027<0347:AOFNLO>2.3.CO;2; Kokubun S, 1996, SPINE, V21, P249, DOI 10.1097/00007632-199601150-00017; Kumar V, 2006, J INVEST MED, V54, P412, DOI 10.2310/6650.2006.06021; LEBRETON JP, 1979, J CLIN INVEST, V64, P1118, DOI 10.1172/JCI109551; LEE YS, 1993, J ELECTRON MICROSC, V42, P156; LEWIS JG, 1980, IMMUNOLOGY, V39, P317; Lieske JC, 2008, NAT CLIN PRACT NEPHR, V4, P308, DOI 10.1038/ncpneph0794; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Martel J, 2008, P NATL ACAD SCI USA, V105, P5549, DOI 10.1073/pnas.0711744105; MATSUZAWA T, 1971, J HISTOCHEM CYTOCHEM, V19, P801, DOI 10.1177/19.12.801; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924; MEYER JL, 1984, ARCH BIOCHEM BIOPHYS, V231, P1, DOI 10.1016/0003-9861(84)90356-4; Miller VM, 2004, AM J PHYSIOL-HEART C, V287, pH1115, DOI 10.1152/ajpheart.00075.2004; Narasimhulu KV, 2005, BIOPHYS CHEM, V114, P137, DOI 10.1016/j.bpc.2004.11.013; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; OHNISHI T, 1991, J BIOL CHEM, V266, P14636; Olson RE, 1998, J NUTR, V128, p439S, DOI 10.1093/jn/128.2.439S; Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001; Penel G, 1998, CALCIFIED TISSUE INT, V63, P475, DOI 10.1007/s002239900561; Pigino G, 2005, TISSUE CELL, V37, P223, DOI 10.1016/j.tice.2005.02.001; PLATE U, 1994, CELL TISSUE RES, V278, P543; Potter K, 2002, J BONE MINER RES, V17, P652, DOI 10.1359/jbmr.2002.17.4.652; Price PA, 2006, ARTERIOSCL THROM VAS, V26, P1079, DOI 10.1161/01.ATV.0000216406.44762.7c; Price PA, 2004, J BIOL CHEM, V279, P19169, DOI 10.1074/jbc.M307880200; Price PA, 2004, J BIOL CHEM, V279, P1594, DOI 10.1074/jbc.M305199200; Price PA, 2003, J BIOL CHEM, V278, P22153, DOI 10.1074/jbc.M300739200; Price PA, 2003, J BIOL CHEM, V278, P22144, DOI 10.1074/jbc.M300744200; Price PA, 2002, J BIOL CHEM, V277, P3926, DOI 10.1074/jbc.M106366200; Price PA, 2009, J BIOL CHEM, V284, P4594, DOI 10.1074/jbc.M803205200; QUELCH KJ, 1984, CALCIFIED TISSUE INT, V36, P545, DOI 10.1007/BF02405363; Raoult D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040041; Raz S, 2002, BIOL BULL-US, V203, P269, DOI 10.2307/1543569; Reynolds JL, 2005, J AM SOC NEPHROL, V16, P2920, DOI 10.1681/ASN.2004100895; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Robinson C, 2007, J DENT RES, V86, P677, DOI 10.1177/154405910708600801; ROBINSON C, 1981, J CRYST GROWTH, V53, P160, DOI 10.1016/0022-0248(81)90062-2; Rochette CN, 2009, CHEMBIOCHEM, V10, P735, DOI 10.1002/cbic.200800719; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; Russell RGG, 1999, J BONE MINER RES, V14, P53, DOI 10.1002/jbmr.5650140212; Ryall RL, 2008, UROL RES, V36, P77, DOI 10.1007/s00240-007-0131-3; Saey TH, 2008, SCI NEWS, V173, P6; Samoylov AM, 2005, CELLS TISSUES ORGANS, V179, P115, DOI 10.1159/000085003; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; Schoppet M, 2008, KIDNEY INT, V73, P384, DOI 10.1038/sj.ki.5002696; Schwartz MAK, 2008, INT J NANOMED, V3, P243; Shiekh FA, 2009, CLIN NEPHROL, V71, P1; Sillitoe RH, 1996, SCIENCE, V272, P1153, DOI 10.1126/science.272.5265.1153; Singh S, 2008, J COLLOID INTERF SCI, V319, P322, DOI 10.1016/j.jcis.2007.09.059; Stenvinkel P, 2005, KIDNEY INT, V67, P2383, DOI 10.1111/j.1523-1755.2005.00345.x; TERKELTAUB RA, 1988, ARTHRITIS RHEUM, V31, P1081, DOI 10.1002/art.1780310901; Thiele L, 2003, BIOMATERIALS, V24, P1409, DOI 10.1016/S0142-9612(02)00525-2; Travis J, 1998, SCI NEWS, V154, P75; Travis J, 2000, SCI NEWS, V158, P328; Urbano P, 2007, PLOS PATHOG, V3, P567, DOI 10.1371/journal.ppat.0030055; Vali H, 2001, GEOCHIM COSMOCHIM AC, V65, P63, DOI 10.1016/S0016-7037(00)00525-1; Vallet-Regi M, 2000, CHEM MATER, V12, P961, DOI 10.1021/cm991110b; Vandenbulcke F, 1998, ECOTOX ENVIRON SAFE, V41, P258, DOI 10.1006/eesa.1998.1706; Wainwright M, 1999, MICROBIOL-SGM, V145, P2623, DOI 10.1099/00221287-145-10-2623; WALTON AG, 1970, CALC TISS RES, V6, P162, DOI 10.1007/BF02196195; Wang AYM, 2005, NEPHROL DIAL TRANSPL, V20, P1676, DOI 10.1093/ndt/gfh891; Westenfeld R, 2007, TRENDS CARDIOVAS MED, V17, P124, DOI 10.1016/j.tcm.2007.02.005; Wiesmann HP, 2003, J ORAL MAXIL SURG, V61, P1455, DOI 10.1016/j.joms.2003.05.001; Wong F, 2007, NAT CLIN PRACT GASTR, V4, P43, DOI 10.1038/ncpgasthep0680; WUTHIER RE, 1978, BIOCHEMISTRY-US, V17, P1431, DOI 10.1021/bi00601a011; Young JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004417; Zhou HY, 2007, ANN NY ACAD SCI, V1116, P323, DOI 10.1196/annals.1402.023; Zhou L, 2008, SMALL, V4, P1566, DOI 10.1002/smll.200800520; Ziegler A, 2005, MICRON, V36, P137, DOI 10.1016/j.micron.2004.09.006	157	49	57	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2009	4	5							e5421	10.1371/journal.pone.0005421	http://dx.doi.org/10.1371/journal.pone.0005421			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440GG	19412552	Green Published, Green Submitted, gold			2022-12-25	WOS:000265688200008
J	Sato, K; Sakamoto, KQ; Watanuki, Y; Takahashi, A; Katsumata, N; Bost, CA; Weimerskirch, H				Sato, Katsufumi; Sakamoto, Kentaro Q.; Watanuki, Yutaka; Takahashi, Akinori; Katsumata, Nobuhiro; Bost, Charles-Andre; Weimerskirch, Henri			Scaling of Soaring Seabirds and Implications for Flight Abilities of Giant Pterosaurs	PLOS ONE			English	Article							WANDERING ALBATROSSES	The flight ability of animals is restricted by the scaling effects imposed by physical and physiological factors. In comparisons of the power available from muscle and the mechanical power required to fly, it is predicted that the margin between the powers should decrease with body size and that flying animals have a maximum body size. However, predicting the absolute value of this upper limit has proven difficult because wing morphology and flight styles varies among species. Albatrosses and petrels have long, narrow, aerodynamically efficient wings and are considered soaring birds. Here, using animal-borne accelerometers, we show that soaring seabirds have two modes of flapping frequencies under natural conditions: vigorous flapping during takeoff and sporadic flapping during cruising flight. In these species, high and low flapping frequencies were found to scale with body mass (mass(-0.30) and mass(-0.18)) in a manner similar to the predictions from biomechanical flight models (mass(-1/3) and mass(-1/6)). These scaling relationships predicted that the maximum limits on the body size of soaring animals are a body mass of 41 kg and a wingspan of 5.1 m. Albatross-like animals larger than the limit will not be able to flap fast enough to stay aloft under unfavourable wind conditions. Our result therefore casts doubt on the flying ability of large, extinct pterosaurs. The largest extant soarer, the wandering albatross, weighs about 12 kg, which might be a pragmatic limit to maintain a safety margin for sustainable flight and to survive in a variable environment.	[Sato, Katsufumi; Katsumata, Nobuhiro] Univ Tokyo, Ocean Res Inst, Int Coastal Res Ctr, Otsuchi, Iwate, Japan; [Sakamoto, Kentaro Q.] Hokkaido Univ, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Watanuki, Yutaka] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido, Japan; [Takahashi, Akinori] Natl Inst Polar Res, Itabashi Ku, Tachikawa, Tokyo 1908518, Japan; [Bost, Charles-Andre; Weimerskirch, Henri] CNRS, Ctr Etud Biol Chize, Beauvoir Sur Niort, France	University of Tokyo; Hokkaido University; Hokkaido University; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; Centre National de la Recherche Scientifique (CNRS)	Sato, K (corresponding author), Univ Tokyo, Ocean Res Inst, Int Coastal Res Ctr, Otsuchi, Iwate, Japan.	katsu@ori.u-tokyo.ac.jp	Sakamoto, Kentaro/A-4843-2012; Weimerskirch, Henri/K-7306-2019; Weimerskirch, Henri/F-5562-2013; Sakamoto, Kentaro/N-7424-2019	Sakamoto, Kentaro/0000-0002-8499-799X; Weimerskirch, Henri/0000-0002-0457-586X; Sakamoto, Kentaro/0000-0002-8499-799X				Alexander RM., 2003, PRINCIPLES ANIMAL LO; Attenborough D., 1998, LIFE BIRDS; BRAMWELL CD, 1974, PHILOS T R SOC B, V267, P503, DOI 10.1098/rstb.1974.0007; Brooke M, 2004, ALBATROSSES PETRELS; Calder WA., 1984, SIZE FUNCTION LIFE H; Chatterjee S., 2004, GEOLOGICAL SOC AM SP, V376, P1, DOI DOI 10.1130/0-8137-2376-0.1; GREENEWALT CH, 1975, SCIENCE, V188, P676, DOI 10.1126/science.188.4189.676; Hill A. V., 1950, Science Progress London, V38, P209; JOUVENTIN P, 1990, NATURE, V343, P746, DOI 10.1038/343746a0; LAWSON DA, 1975, SCIENCE, V187, P947, DOI 10.1126/science.187.4180.947; MARDEN JH, 1994, AM J PHYSIOL, V266, pR1077, DOI 10.1152/ajpregu.1994.266.4.R1077; NORBERG RA, 1996, AVIAN ENERGETICS NUT, P199; PENNYCUICK CJ, 1982, PHILOS T ROY SOC B, V300, P75, DOI 10.1098/rstb.1982.0158; PENNYCUICK CJ, 1968, J EXP BIOL, V49, P527; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Pennycuick CJ., 1975, AVIAN BIOL, P1971; RAYNER JMV, 1987, CURRENT ORNITHOLOGY, V5, P1; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Sato K, 2008, J EXP BIOL, V211, P58, DOI 10.1242/jeb.009811; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Shaffer SA, 2001, J ANIM ECOL, V70, P864, DOI 10.1046/j.0021-8790.2001.00548.x; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Unwin DM., 2006, PTEROSAURS DEEP TIME; VIDELER JJ, 2005, AVIAN FLIGH; VONHELMHOLTZ H, 1874, MBER K AKAD WISS BER, P501; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; Witton MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002271	29	35	36	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5400	10.1371/journal.pone.0005400	http://dx.doi.org/10.1371/journal.pone.0005400			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401767	gold, Green Published			2022-12-25	WOS:000265601100026
J	Abdelalim, EM; Tooyama, I				Abdelalim, Essam Mohamed; Tooyama, Ikuo			BNP Signaling Is Crucial For Embryonic Stem Cell Proliferation	PLOS ONE			English	Article							NATRIURETIC PEPTIDE RECEPTOR; ENDOCHONDRAL OSSIFICATION; TRANSGENIC MICE; ACTIVATION; EXPRESSION; LACKING; PLURIPOTENCY; ROLES; GENE; H2AX	Background: Embryonic stem (ES) cells have unlimited proliferation potential, and can differentiate into several cell types, which represent ideal sources for cell-based therapy. This high-level proliferative ability is attributed to an unusual type of cell cycle. The Signaling pathways that regulate the proliferation of ES cells are of great interest. Methodology/Principal Findings: In this study, we show that murine ES cells specifically express brain natriuretic peptide (BNP), and its signaling is essential for ES cell proliferation. We found that BNP and its receptor (NPR-A, natriuretic peptide receptor-A) were highly expressed in self-renewing murine ES cells, whereas the levels were markedly reduced after ES cell differentiation by the withdrawal of LIF. Targeting of BNP with short interfering RNA ( siRNA) resulted in the inhibition of ES cell proliferation, as indicated by a marked reduction in the cell number and colony size, a significant reduction in DNA synthesis, and decreased numbers of cells in S phase. BNP knockdown in ES cells led to the up-regulation of gamma-aminobutyric acid receptor A (GABAAR) genes, and activation of phosphorylated histone (gamma-H2AX), which negatively affects ES cell proliferation. In addition, knockdown of BNP increased the rate of apoptosis and reduced the expression of the transcription factor Ets-1. Conclusions/Significance: Appropriate BNP expression is essential for the maintenance of ES cell propagation. These findings establish BNP as a novel endogenous regulator of ES cell proliferation.			Abdelalim, EM (corresponding author), Shiga Univ Med Sci, Mol Neurosci Res Ctr, Setatsukinowa Cho, Otsu, Shiga 52021, Japan.	essam@belle.shiga-med.ac.jp	Abdelalim, Essam M./Q-8275-2019	Abdelalim, Essam M./0000-0001-7764-6772; Tooyama, Ikuo/0000-0001-8054-9666				Abdelalim EM, 2006, BIOCHEM BIOPH RES CO, V340, P689, DOI 10.1016/j.bbrc.2005.12.057; Abdelalim EM, 2006, PEPTIDES, V27, P1886, DOI 10.1016/j.peptides.2006.01.001; ABELL TJ, 1989, BIOCHEM BIOPH RES CO, V160, P1392, DOI 10.1016/S0006-291X(89)80158-5; Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; GARBERS DL, 1992, CELL, V71, P1; Heo JS, 2006, AM J PHYSIOL-CELL PH, V290, pC123, DOI 10.1152/ajpcell.00142.2005; HOHN SWM, 1995, SCIENCE, V267, P679; Ichijima Y, 2005, BIOCHEM BIOPH RES CO, V336, P807, DOI 10.1016/j.bbrc.2005.08.164; KOLLER KJ, 1991, SCIENCE, V252, P120, DOI 10.1126/science.1672777; Kong X, 2008, CANCER RES, V68, P249, DOI 10.1158/0008-5472.CAN-07-3086; Kumar P, 2009, BIOSCIENCE REP, V29, P57, DOI 10.1042/BSR20080094; Levin ER, 1998, NEW ENGL J MED, V339, P321; Lianguzova MS, 2007, CELL BIOL INT, V31, P330, DOI 10.1016/j.cellbi.2007.01.019; MINAMINO N, 1988, BIOCHEM BIOPH RES CO, V155, P470; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Ogawa K, 2004, GENES CELLS, V9, P471, DOI 10.1111/j.1356-9597.2004.00736.x; Oliver PM, 1997, P NATL ACAD SCI USA, V94, P14730, DOI 10.1073/pnas.94.26.14730; Pikkarainen S, 2003, J BIOL CHEM, V278, P3969, DOI 10.1074/jbc.M205616200; SAVATIER P, 1994, ONCOGENE, V9, P809; Schulz S, 2005, PEPTIDES, V26, P1024, DOI 10.1016/j.peptides.2004.08.027; Silberbach M, 2001, CELL SIGNAL, V13, P221, DOI 10.1016/S0898-6568(01)00139-5; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; STEINHELPER ME, 1990, HYPERTENSION, V16, P301, DOI 10.1161/01.HYP.16.3.301; Suda M, 1998, P NATL ACAD SCI USA, V95, P2337, DOI 10.1073/pnas.95.5.2337; SUDA Y, 1987, J CELL PHYSIOL, V133, P197, DOI 10.1002/jcp.1041330127; SUGA SI, 1992, ENDOCRINOLOGY, V130, P229, DOI 10.1210/en.130.1.229; Tamura N, 2004, P NATL ACAD SCI USA, V101, P17300, DOI 10.1073/pnas.0407894101; Tamura N, 2000, P NATL ACAD SCI USA, V97, P4239, DOI 10.1073/pnas.070371497; Yasoda A, 1998, J BIOL CHEM, V273, P11695, DOI 10.1074/jbc.273.19.11695; Yu YC, 2006, J NEUROSCI, V26, P696, DOI 10.1523/JNEUROSCI.3653-05.2006	34	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5341	10.1371/journal.pone.0005341	http://dx.doi.org/10.1371/journal.pone.0005341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399180	Green Submitted, gold, Green Published			2022-12-25	WOS:000265514900006
J	Sani, MA; Keech, O; Gardestrom, P; Dufourc, EJ; Grobner, G				Sani, Marc-Antoine; Keech, Olivier; Gardestrom, Per; Dufourc, Erick J.; Grobner, Gerhard			Magic-angle phosphorus NMR of functional mitochondria: in situ monitoring of lipid response under apoptotic-like stress	FASEB JOURNAL			English	Article						respiration; oxidative stress; membrane integrity; cardiolipin; magnetic resonance; programmed cell death	CYTOCHROME-C RELEASE; POTATO-TUBER MITOCHONDRIA; RAT-LIVER MITOCHONDRIA; LOW-FREQUENCY MOTION; PERMEABILITY TRANSITION; P-31 NMR; SUBMITOCHONDRIAL PARTICLES; RESPIRATORY-CHAIN; CELL-DEATH; MEMBRANE	Using a noninvasive, solid-state magicangle spinning nuclear magnetic resonance (MAS NMR) approach, we track ex vivo the behavior of individual membrane components in isolated, active mitochondria (model system: potato tubers) during physiological processes. The individual phosphatidylcholine (PC), phosphatidylethanolamine (PE), and cardiolipin (CL) membrane constituents were identified as distinct lines by applying MAS (31)P NMR on extracted lipid membranes. However, the CL NMR signal appeared to be very broad in functional mitochondria, indicating a tight complex formation with membrane protein. Calcium stress induced severe membrane degradation without recovery of a single CL NMR resonance. This suggests that calcium overload destroys the outer mitochondrial membrane and does not modify strongly the CL protein complexes in the inner membrane; a conclusion confirmed by respiratory controls. Conversely, mitochondrial membrane disruption on time degradation or mechanical stress generates clearly visible identical CL NMR signals, similar to those observed in rehydrated lipid extracts. Similarly, noninvasive based NMR tracking of lipids in response to diverse physiological stimuli can easily be used for other organelles and whole living cells. Sani, M.-A., Keech, O., Gardestrom, P., Dufourc, E. J., Grobner, G. Magic-angle phosphorus NMR of functional mitochondria: in situ monitoring of lipid response under apoptotic-like stress. FASEB J. 23, 2872-2878 (2009). www.fasebj.org	[Sani, Marc-Antoine; Grobner, Gerhard] Umea Univ, Dept Chem, S-90187 Umea, Sweden; [Keech, Olivier; Gardestrom, Per] Umea Univ, Umea Plant Sci Ctr, Dept Plant Physiol, S-90187 Umea, Sweden; [Dufourc, Erick J.] Univ Bordeaux 1, UMR Chim & Biol Membranes & Nanoobjets 5248, CNRS, Pessac, France	Umea University; Umea University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Sani, MA (corresponding author), Umea Univ, Dept Chem, S-90187 Umea, Sweden.	marco.sani@chem.umu.se; gerhard.grobner@chem.umu.se	Sani, Marc-Antoine/B-7707-2013; DUFOURC, Erick Joel/AAA-4992-2020	Sani, Marc-Antoine/0000-0003-3284-2176; DUFOURC, Erick Joel/0000-0002-8221-9326	Knut and Alice Wallenberg Foundation; Kempe Foundation; Swedish Research Council; Umea University Insamlingsstiftelse; Centre National de la Recherche Scientifique (CNRS); Swedish Graduate Research School in Functional Genomics and Bioinformatics; Universities of Bordeaux 1 and Umea	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Kempe Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Umea University Insamlingsstiftelse; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Swedish Graduate Research School in Functional Genomics and Bioinformatics; Universities of Bordeaux 1 and Umea	This work was supported by the Knut and Alice Wallenberg Foundation, the Kempe Foundation, the Swedish Research Council, Umea University Insamlingsstiftelse, and the Centre National de la Recherche Scientifique (CNRS). Financial support was provided by the Swedish Graduate Research School in Functional Genomics and Bioinformatics. The Universities of Bordeaux 1 and Umea are acknowledged for setting up a cotutoring PhD program.	ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Arnoult D, 2002, J CELL BIOL, V159, P923, DOI 10.1083/jcb.200207071; Arpagaus S, 2002, J BIOL CHEM, V277, P1780, DOI 10.1074/jbc.M109416200; Balk J, 1999, FEBS LETT, V463, P151, DOI 10.1016/S0014-5793(99)01611-7; Bayir H, 2006, BBA-BIOENERGETICS, V1757, P648, DOI 10.1016/j.bbabio.2006.03.002; Clayton R, 2005, J NEUROCHEM, V92, P840, DOI 10.1111/j.1471-4159.2004.02918.x; CORNELL BA, 1983, BIOCHIM BIOPHYS ACTA, V732, P473, DOI 10.1016/0005-2736(83)90065-2; CORNELL BA, 1982, BIOCHIM BIOPHYS ACTA, V689, P337, DOI 10.1016/0005-2736(82)90267-X; CULLIS PR, 1980, BIOCHIM BIOPHYS ACTA, V600, P625, DOI 10.1016/0005-2736(80)90466-6; deKroon AIPM, 1997, BBA-BIOMEMBRANES, V1325, P108, DOI 10.1016/S0005-2736(96)00240-4; DEKRUIJFF B, 1982, BIOCHIM BIOPHYS ACTA, V684, P47, DOI 10.1016/0005-2736(82)90047-5; DUFOURC EJ, 1993, PHOSPHORUS SULFUR, V77, P673; EDMAN K, 1987, BIOCHEM J, V243, P575, DOI 10.1042/bj2430575; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fortes F, 2001, J BIOENERG BIOMEMBR, V33, P43, DOI 10.1023/A:1005672623709; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Grijalba MT, 1999, BIOCHEMISTRY-US, V38, P13279, DOI 10.1021/bi9828674; Grobner G, 1999, J MAGN RESON, V141, P335, DOI 10.1006/jmre.1999.1894; Jacotot E, 1999, ANN NY ACAD SCI, V887, P18, DOI 10.1111/j.1749-6632.1999.tb07919.x; Kagan VE, 2006, CHEM-BIOL INTERACT, V163, P15, DOI 10.1016/j.cbi.2006.04.019; Keech O, 2005, PHYSIOL PLANTARUM, V124, P403, DOI 10.1111/j.1399-3054.2005.00521.x; Kim TH, 2004, MOL BIOL CELL, V15, P3061, DOI 10.1091/mbc.E03-12-0864; Kowaltowski AJ, 1996, J BIOL CHEM, V271, P2929, DOI 10.1074/jbc.271.6.2929; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Lindstrom F, 2005, J AM CHEM SOC, V127, P6610, DOI 10.1021/ja042325b; Loeffler M, 2000, EXP CELL RES, V256, P19, DOI 10.1006/excr.2000.4833; MACDONALD PM, 1991, BIOCHEMISTRY-US, V30, P3558, DOI 10.1021/bi00228a029; Maciel EN, 2004, J NEUROCHEM, V90, P1025, DOI 10.1111/j.1471-4159.2004.02565.x; Malisan F, 2003, CURR MED CHEM, V10, P1573, DOI 10.2174/0929867033457188; Marchetti P, 1996, J EXP MED, V184, P1155, DOI 10.1084/jem.184.3.1155; Mariano AB, 2005, PLANT PHYSIOL BIOCH, V43, P61, DOI 10.1016/j.plaphy.2004.12.008; PETIT PX, 1987, BIOCHIM BIOPHYS ACTA, V890, P377, DOI 10.1016/0005-2728(87)90166-6; Petrosillo G, 2004, J BIOL CHEM, V279, P53103, DOI 10.1074/jbc.M407500200; Petrosillo G, 2006, FEBS LETT, V580, P6311, DOI 10.1016/j.febslet.2006.10.036; PINHEIRO TJT, 1994, BIOCHEMISTRY-US, V33, P2451, DOI 10.1021/bi00175a013; SEELIG J, 1978, BIOCHIM BIOPHYS ACTA, V515, P105, DOI 10.1016/0304-4157(78)90001-1; SPOONER PJR, 1991, BIOCHEMISTRY-US, V30, P3880, DOI 10.1021/bi00230a011; SWAIRJO MA, 1994, BBA-BIOMEMBRANES, V1191, P354, DOI 10.1016/0005-2736(94)90186-4; TUPPER JOSEPH T., 1967, LIFE SCI, V6, P2021, DOI 10.1016/0024-3205(67)90220-2; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zhang DW, 2008, J BIOL CHEM, V283, P3476, DOI 10.1074/jbc.M707528200	42	14	14	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2009	23	9					2872	2878		10.1096/fj.09-134114	http://dx.doi.org/10.1096/fj.09-134114			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19395474				2022-12-25	WOS:000270241000010
J	Das, S; Cano, J; Kalpana, GV				Das, Supratik; Cano, Jennifer; Kalpana, Ganjam V.			Multimerization and DNA Binding Properties of INI1/hSNF5 and Its Functional Significance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REPLICATION; SWI/SNF COMPLEX; NUCLEAR EXPORT; MINOR-GROOVE; MUTATIONS; HSNF5/INI1; INTEGRASE; PROTEINS; GENE; INHIBITION	INI1/hSNF5/BAF47/SMARCB1 is an HIV-1 integrase (IN)binding protein that modulates viral replication in multiple ways. A minimal IN-binding domain of INI1, S6 (amino acids 183-294), transdominantly inhibits late events, and down-modulation of INI1 stimulates early events of HIV-1 replication. INI1 both stimulates and inhibits in vitro integration depending on IN concentration. To gain further insight into its role in HIV-1 replication, we purified and biochemically characterized INI1. We found that INI1 forms multimeric structures. Deletion analysis indicated that the Rpt1 and Rpt2 motifs form the minimal multimerization domain. We isolated mutants of INI1 that are defective for multimerization using a reverse yeast two-hybrid system. Our results revealed that INI1 residues involved in multimerization overlap with IN-binding and nuclear export domains and are required for nuclear retention and co-localization with IN. Multimerization-defective mutants are also defective for mediating the transdominant effect of INI1-S6-(183-294). Furthermore, we found that INI1 is a minor groove DNA-binding protein. Although IN binding and multimerization are required for INI1-mediated inhibition, the acceptor DNA binding property of INI1 may be required for stimulation of in vitro strand transfer activities of IN. Binding of INI1 to IN results in the formation of presumably inactive high molecular weight IN-INI1 complexes, and the multimerization-defective mutant was unable to form these complexes. These results indicate that the multimerization and IN binding properties of INI1 are necessary for its ability to both inhibit integration and influence assembly and particle production, providing insights into the mechanism of INI1-mediated effects in HIV-1 replication.	Albert Einstein Coll Med, Dept Mol Genet, New York, NY 10461 USA; [Kalpana, Ganjam V.] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY 10461 USA	Yeshiva University; Yeshiva University	Kalpana, GV (corresponding author), 1300 Morris Pk Ave,Ullman 821, Bronx, NY 10461 USA.	kalpana@aecom.yu.edu		Kalpana, Ganjam/0000-0003-4111-0604	National Institutes of Health [R01 AI039951-11]; Irma T. Hirchl/Monique Weill-Caulier scholar award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007501, R01AI039951] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirchl/Monique Weill-Caulier scholar award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI039951-11. This work was also supported by an Irma T. Hirchl/Monique Weill-Caulier scholar award (to G. V. K.).	Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Craig E, 2002, EMBO J, V21, P31, DOI 10.1093/emboj/21.1.31; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; Hulsebos TJM, 2007, AM J HUM GENET, V80, P805, DOI 10.1086/513207; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lee D, 1999, NATURE, V399, P487, DOI 10.1038/20966; Maroun M, 2006, J BIOL CHEM, V281, P22736, DOI 10.1074/jbc.M604849200; MCHUGH MM, 1989, BIOCHEM PHARMACOL, V38, P2323, DOI 10.1016/0006-2952(89)90472-3; Modena P, 2005, CANCER RES, V65, P4012, DOI 10.1158/0008-5472.CAN-04-3050; Morozov A, 1998, P NATL ACAD SCI USA, V95, P1120, DOI 10.1073/pnas.95.3.1120; Rozenblatt-Rosen O, 1998, P NATL ACAD SCI USA, V95, P4152, DOI 10.1073/pnas.95.8.4152; Schmitz U, 2001, BRIT J CANCER, V84, P199, DOI 10.1054/bjoc.2000.1583; Sevenet N, 1999, AM J HUM GENET, V65, P1342, DOI 10.1086/302639; Sevenet N, 1999, HUM MOL GENET, V8, P2359, DOI 10.1093/hmg/8.13.2359; Sorin M, 2006, CURR HIV RES, V4, P117, DOI 10.2174/157016206776055048; Sorin M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-56; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Van Maele B, 2006, TRENDS BIOCHEM SCI, V31, P98, DOI 10.1016/j.tibs.2005.12.002; Vandegraaff N, 2006, VIROLOGY, V346, P415, DOI 10.1016/j.virol.2005.11.022; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wei Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002600; Wu DY, 1996, J VIROL, V70, P6020, DOI 10.1128/JVI.70.9.6020-6028.1996; Yuge M, 2000, CANCER GENET CYTOGEN, V122, P37, DOI 10.1016/S0165-4608(00)00274-0; Yung E, 2004, J VIROL, V78, P2222, DOI 10.1128/JVI.78.5.2222-2231.2004; Yung E, 2001, NAT MED, V7, P920, DOI 10.1038/90959	27	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19903	19914		10.1074/jbc.M808141200	http://dx.doi.org/10.1074/jbc.M808141200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19398554	Green Published, hybrid			2022-12-25	WOS:000268097400017
J	Paiva, S; Vieira, N; Nondier, I; Haguenauer-Tsapis, R; Casal, M; Urban-Grimal, D				Paiva, Sandra; Vieira, Neide; Nondier, Isabelle; Haguenauer-Tsapis, Rosine; Casal, Margarida; Urban-Grimal, Daniele			Glucose-induced Ubiquitylation and Endocytosis of the Yeast Jen1 Transporter ROLE OF LYSINE 63-LINKED UBIQUITIN CHAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RSP5 UBIQUITIN LIGASE; CASEIN KINASE-I; AMINO-ACID PERMEASE; SACCHAROMYCES-CEREVISIAE; URACIL PERMEASE; MEMBRANE-PROTEINS; PLASMA-MEMBRANE; DOWN-REGULATION; DEUBIQUITINATING ENZYME; DEPENDENT TRAFFICKING	Protein ubiquitylation is essential for many events linked to intracellular protein trafficking. Despite the significance of this process, the molecular mechanisms that govern the regulation of ubiquitylation remain largely unknown. Plasma membrane transporters are subjected to tightly regulated endocytosis, and ubiquitylation is a key signal at several stages of the endocytic pathway. The yeast monocarboxylate transporter Jen1 displays glucose-regulated endocytosis. We show here that casein kinase 1-dependent phosphorylation and HECT-ubiquitin ligase Rsp5-dependent ubiquitylation are required for Jen1 endocytosis. Ubiquitylation and endocytosis of Jen1 are induced within minutes in response to glucose addition. Jen1 is modified at the cell surface by oligo-ubiquitylation with ubiquitin-Lys(63) linked chain(s), and Jen1-Lys(338) is one of the target residues. Ubiquitin-Lys(63)-linked chain( s) are also required directly or indirectly to sort Jen1 into multivesicular bodies. Jen1 is one of the few examples for which ubiquitin-Lys(63)-linked chain(s) was shown to be required for correct trafficking at two stages of endocytosis: endocytic internalization and sorting at multivesicular bodies.	[Paiva, Sandra; Vieira, Neide; Casal, Margarida] Univ Minho, Mol & Environm Biol Ctr, Dept Biol, P-4710057 Braga, Portugal; [Nondier, Isabelle; Haguenauer-Tsapis, Rosine; Urban-Grimal, Daniele] Univ Paris 07, CNRS, Inst Jacques Monod, F-75013 Paris, France	Universidade do Minho; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Paiva, S (corresponding author), Univ Minho, Mol & Environm Biol Ctr, Dept Biol, Campus Gualtar, P-4710057 Braga, Portugal.	spaiva@bio.uminho.pt; haguenauer.rosine@ijm.univ-paris-diderot.fr	CASAL, MARGARIDA/B-6386-2009; Paiva, Sandra Cristina Almeida/H-8864-2013; Vieira, Neide/K-7702-2015; Haguenauer-Tsapis, Rosine/C-5446-2012	CASAL, MARGARIDA/0000-0002-0143-9758; Paiva, Sandra Cristina Almeida/0000-0003-2270-4546; Vieira, Neide/0000-0002-7166-4336; 	CNRS; Association pour la Recherche sur le Cancer [3298]; Ministere de l'Enseignement et de la Recherche and the Action Concertee Incitative [183]; European Network VI Framework [018683]; Portuguese Grant QCAIII-FEDER [POCI/BIA-BCM/57812/2004]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ministere de l'Enseignement et de la Recherche and the Action Concertee Incitative; European Network VI Framework; Portuguese Grant QCAIII-FEDER	Experiments performed in the laboratory of R. H.-T. were supported by CNRS-University Paris Diderot Paris 7, by Association pour la Recherche sur le Cancer Grant 3298, a grant from the Ministere de l'Enseignement et de la Recherche and the Action Concertee Incitative (BCMS; contrat 183), and a grant from the European Network VI Framework (RUBICON; contract 018683). Experiments performed in the laboratory of M. C. were supported by Portuguese Grant POCI/BIA-BCM/57812/2004 (Eixo 2, Medida 2.3, QCAIII-FEDER).	Andrade RP, 2005, BIOCHEM BIOPH RES CO, V332, P254, DOI 10.1016/j.bbrc.2005.04.119; Andrade RP, 2001, FUNGAL GENET BIOL, V32, P105, DOI 10.1006/fgbi.2001.1254; Ansaldi M, 1996, ANAL BIOCHEM, V234, P110, DOI 10.1006/abio.1996.0060; Barriere H, 2007, MOL BIOL CELL, V18, P3952, DOI 10.1091/mbc.E07-07-0678; Blondel MO, 2004, MOL BIOL CELL, V15, P883, DOI 10.1091/mbc.E03-04-0202; Bugnicourt A, 2004, MOL BIOL CELL, V15, P4203, DOI 10.1091/mbc.E04-05-0420; Casal M, 1996, MICROBIOL-UK, V142, P1385, DOI 10.1099/13500872-142-6-1385; Casal M, 1999, J BACTERIOL, V181, P2620, DOI 10.1128/JB.181.8.2620-2623.1999; Casal M, 2008, FEMS MICROBIOL REV, V32, P974, DOI 10.1111/j.1574-6976.2008.00128.x; CASSIO F, 1987, APPL ENVIRON MICROB, V53, P509; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; De Antoni A, 2000, GENE, V246, P179, DOI 10.1016/S0378-1119(00)00083-4; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Dupre S, 2004, BBA-MOL CELL RES, V1695, P89, DOI 10.1016/j.bbamcr.2004.09.024; Erpapazoglou Z, 2008, TRAFFIC, V9, P1372, DOI 10.1111/j.1600-0854.2008.00766.x; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Haguenauer-Tsapis R, 2004, TOP CURR GENET, V9, P273; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Horak J, 2003, BBA-BIOMEMBRANES, V1614, P139, DOI 10.1016/S0005-2736(03)00195-0; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Kee Y, 2006, J BIOL CHEM, V281, P36724, DOI 10.1074/jbc.M608756200; Kim Y, 2007, MOL BIOL CELL, V18, P1790, DOI 10.1091/mbc.E06-09-0861; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Liu JX, 2007, TRAFFIC, V8, P1375, DOI 10.1111/j.1600-0854.2007.00616.x; Marchal C, 2000, J BIOL CHEM, V275, P23608, DOI 10.1074/jbc.M001735200; Marchal C, 1998, MOL CELL BIOL, V18, P314, DOI 10.1128/MCB.18.1.314; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Morvan J, 2004, TRAFFIC, V5, P383, DOI 10.1111/j.1398-9219.2004.00183.x; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Paiva S, 2004, YEAST, V21, P201, DOI 10.1002/yea.1056; Paiva S, 2002, BIOCHEM J, V363, P737, DOI 10.1042/0264-6021:3630737; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Reinders J, 2007, MOL CELL PROTEOMICS, V6, P1896, DOI 10.1074/mcp.M700098-MCP200; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Rubio-Texeira M, 2006, MOL BIOL CELL, V17, P3031, DOI 10.1091/mbc.E05-07-0669; Soares-Silva I, 2003, BIOCHEM J, V376, P781, DOI 10.1042/BJ20031180; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Springael JY, 1999, J CELL SCI, V112, P1375; Stawiecka-Mirota M, 2007, TRAFFIC, V8, P1280, DOI 10.1111/j.1600-0854.2007.00610.x; Strochlic TI, 2007, J CELL BIOL, V177, P115, DOI 10.1083/jcb.200609161; THOMAS BJ, 1989, GENETICS, V123, P725; Umebayashi K, 2003, J CELL BIOL, V161, P1117, DOI 10.1083/jcb.200303088; VANCURA A, 1994, J BIOL CHEM, V269, P19271; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; WACH A, 1994, YEAST, V10, P1808; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041	58	62	62	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19228	19236		10.1074/jbc.M109.008318	http://dx.doi.org/10.1074/jbc.M109.008318			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19433580	Green Published, hybrid			2022-12-25	WOS:000267908300013
J	Torii, S; Kobayashi, K; Takahashi, M; Katahira, K; Goryo, K; Matsushita, N; Yasumoto, KI; Fujii-Kuriyama, Y; Sogawa, K				Torii, Satoru; Kobayashi, Kentaro; Takahashi, Masayuki; Katahira, Kasumi; Goryo, Kenji; Matsushita, Natsuki; Yasumoto, Ken-ichi; Fujii-Kuriyama, Yoshiaki; Sogawa, Kazuhiro			Magnesium Deficiency Causes Loss of Response to Intermittent Hypoxia in Paraganglion Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCARDIAL-ISCHEMIA-REPERFUSION; CALCIUM-CHANNEL GENE; KAPPA-B ACTIVATION; PAS DOMAIN PROTEIN; INDUCIBLE FACTOR; SLEEP-APNEA; CAROTID-BODY; NEUROENDOCRINE CELLS; OXIDATIVE STRESS; EXPRESSION	Magnesium deficiency is suggested to contribute to many age-related diseases. Hypoxia-inducible factor 1 alpha (HIF-1 alpha) is known to be a master regulator of hypoxic response. Here we show that hypomagnesemia suppresses reactive oxygen species (ROS)-induced HIF-1 alpha activity in paraganglion cells of the adrenal medulla and carotid body. In PC12 cells cultured in the low magnesium medium and treated with cobalt chloride (CoCl2) or exposed to intermittent hypoxia, ROS-mediated HIF-1 alpha activity was suppressed. This suppression was due to up-regulation of inhibitory PAS (Per/Arnt/Sim) domain protein (IPAS) that was caused by NF-kappa B activation, which resulted from ROS and calcium influx mainly through the T-type calcium channels. Induction of tyrosine hydroxylase, a target of HIF-1, by CoCl2 injection was suppressed in the adrenal medulla of magnesium-deficient mice because of up-regulation of IPAS. Also in the carotid body of magnesium-deficient mice, CoCl2 and chronic intermittent hypoxia failed to enhance the tyrosine hydroxylase expression. These results demonstrate that serum magnesium levels are a key determinant for ROS-induced hypoxic responses.	[Torii, Satoru; Kobayashi, Kentaro; Takahashi, Masayuki; Katahira, Kasumi; Goryo, Kenji; Yasumoto, Ken-ichi; Sogawa, Kazuhiro] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Matsushita, Natsuki] Ehime Univ, Grad Sch Med, Dept Biochem & Mol Genet, Matsuyama, Ehime 7910295, Japan; [Fujii-Kuriyama, Yoshiaki] Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; [Fujii-Kuriyama, Yoshiaki] Univ Tsukuba, SORST Project, Japan Sci & Technol Agcy, Tsukuba, Ibaraki 3058577, Japan	Tohoku University; Ehime University; University of Tsukuba; Japan Science & Technology Agency (JST); University of Tsukuba	Sogawa, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan.	sogawa@mail.tains.tohoku.ac.jp	Takahashi, Masayuki/AAM-7033-2021	Torii, Satoru/0000-0003-4841-7131; Yasumoto, Ken-ichi/0000-0002-8090-1161	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ALTURA BM, 1984, SCIENCE, V223, P1315, DOI 10.1126/science.6701524; Bourinet E, 2005, EMBO J, V24, P315, DOI 10.1038/sj.emboj.7600515; CACERES AI, 2007, ACTA PHYSIOL SCAND, V190, P655; Chachami G, 2004, AM J RESP CELL MOL, V31, P544, DOI 10.1165/rcmb.2003-0426OC; Chen L, 2005, AM J RESP CRIT CARE, V172, P915, DOI 10.1164/rccm.200504-560OC; Del Toro R, 2003, J BIOL CHEM, V278, P22316, DOI 10.1074/jbc.M212576200; Griguer CE, 2006, CANCER RES, V66, P2257, DOI 10.1158/0008-5472.CAN-05-3364; Ha H, 2008, DIABETES RES CLIN PR, V82, pS42, DOI 10.1016/j.diabres.2008.09.017; Hirota K, 2005, BIOCHEM BIOPH RES CO, V338, P610, DOI 10.1016/j.bbrc.2005.08.193; Hui AS, 2003, HYPERTENSION, V42, P1130, DOI 10.1161/01.HYP.0000101691.12358.26; Kaelin WG, 2005, BIOCHEM BIOPH RES CO, V338, P627, DOI 10.1016/j.bbrc.2005.08.165; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Loor G, 2008, CELL DEATH DIFFER, V15, P686, DOI 10.1038/cdd.2008.13; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; Makino Y, 2007, J BIOL CHEM, V282, P14073, DOI 10.1074/jbc.M700732200; Natarajan R, 2006, CIRC RES, V98, P133, DOI 10.1161/01.RES.0000197816.63513.27; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Parati G, 2007, AM J PHYSIOL-REG I, V293, pR1671, DOI 10.1152/ajpregu.00400.2007; Pardal R, 2007, CELL, V131, P364, DOI 10.1016/j.cell.2007.07.043; Parry RV, 2007, TRENDS IMMUNOL, V28, P161, DOI 10.1016/j.it.2007.02.004; Paulding WR, 2002, MICROSC RES TECHNIQ, V59, P178, DOI 10.1002/jemt.10192; PEERS C, 1995, J MEMBRANE BIOL, V144, P1; Peng YJ, 2006, J PHYSIOL-LONDON, V577, P705, DOI 10.1113/jphysiol.2006.114033; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Rude RK, 1998, J BONE MINER RES, V13, P749, DOI 10.1359/jbmr.1998.13.4.749; Schmitz ML, 2003, FASEB J, V17, P2187, DOI 10.1096/fj.02-1100rev; Schofield CJ, 2005, BIOCHEM BIOPH RES CO, V338, P617, DOI 10.1016/j.bbrc.2005.08.111; Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906; Shin HS, 2008, CURR OPIN PHARMACOL, V8, P33, DOI 10.1016/j.coph.2007.12.003; Sogawa K, 1998, P NATL ACAD SCI USA, V95, P7368, DOI 10.1073/pnas.95.13.7368; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Springael C, 2007, BIOCHEM PHARMACOL, V73, P515, DOI 10.1016/j.bcp.2006.10.034; Tong Garrison M, 2005, J Intensive Care Med, V20, P3, DOI 10.1177/0885066604271539; TURLAPATY PDMV, 1980, SCIENCE, V208, P198, DOI 10.1126/science.7361117; Vinet R, 1999, AM J PHYSIOL-HEART C, V276, pH1313, DOI 10.1152/ajpheart.1999.276.4.H1313; Xu W, 2004, NEUROSCIENCE, V126, P313, DOI 10.1016/j.neuroscience.2004.03.055; Yunker AMR, 2003, J BIOENERG BIOMEMBR, V35, P533, DOI 10.1023/B:JOBB.0000008024.77488.48	41	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					19077	19089		10.1074/jbc.M109.004424	http://dx.doi.org/10.1074/jbc.M109.004424			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19433582	hybrid, Green Published			2022-12-25	WOS:000267711500056
J	Zhao, WQ; Lacor, PN; Chen, H; Lambert, MP; Quon, MJ; Krafft, GA; Klein, WL				Zhao, Wei-Qin; Lacor, Pascale N.; Chen, Hui; Lambert, Mary P.; Quon, Michael J.; Krafft, Grant A.; Klein, William L.			Insulin Receptor Dysfunction Impairs Cellular Clearance of Neurotoxic Oligomeric A beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; HIPPOCAMPAL SYNAPTIC PLASTICITY; AMYLOID PRECURSOR PROTEIN; TYROSINE KINASE-ACTIVITY; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; DEGRADING ENZYME; SIGNAL-TRANSDUCTION; APOLIPOPROTEIN-E	Accumulation of amyloid beta (A beta) oligomers in the brain is toxic to synapses and may play an important role in memory loss in Alzheimer disease. However, how these toxins are built up in the brain is not understood. In this study we investigate whether impairments of insulin and insulin-like growth factor-1 (IGF-1) receptors play a role in aggregation of A beta. Using primary neuronal culture and immortal cell line models, we show that expression of normal insulin or IGF-1 receptors confers cells with abilities to reduce exogenously applied A beta oligomers (also known as ADDLs) to monomers. In contrast, transfection of malfunctioning human insulin receptor mutants, identified originally from patient with insulin resistance syndrome, or inhibition of insulin and IGF-1 receptors via pharmacological reagents increases ADDL levels by exacerbating their aggregation. In healthy cells, activation of insulin and IGF-1 receptor reduces the extracellular ADDLs applied to cells via seemingly the insulin-degrading enzyme activity. Although insulin triggers ADDL internalization, IGF-1 appears to keep ADDLs on the cell surface. Nevertheless, both insulin and IGF-1 reduce ADDL binding, protect synapses from ADDL synaptotoxic effects, and prevent the ADDL-induced surface insulin receptor loss. Our results suggest that dysfunctions of brain insulin and IGF-1 receptors contribute to A beta aggregation and subsequent synaptic loss.	[Zhao, Wei-Qin; Lacor, Pascale N.; Lambert, Mary P.; Klein, William L.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Zhao, Wei-Qin] Blanchette Rockefeller Neurosci Inst, Rockville, MD 20680 USA; [Krafft, Grant A.] Acumen Pharmaceut Inc, Livermore, CA 94080 USA; [Chen, Hui; Quon, Michael J.] NIH, NCCAM, Bethesda, MD 20892 USA	Northwestern University; National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine	Zhao, WQ (corresponding author), Merck & Co Inc, Alzheimers Res, Merck Res Labs, West Point, PA 19486 USA.	wei-qin_zhao@merck.com		QUON, MICHAEL/0000-0002-5289-3707; Quon, Michael/0000-0002-9601-9915	National Institutes of Health [RO1-AG022547]; NIA; Intramural funding at Blanchette Rockefeller Neurosciences Institute, Rockville, MD; American Health Assistance Foundation; Alzheimer's Association; Acumen Pharmaceuticals, Inc., South; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [ZIAAT000002, ZIAAT000001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural funding at Blanchette Rockefeller Neurosciences Institute, Rockville, MD; American Health Assistance Foundation; Alzheimer's Association(Alzheimer's Association); Acumen Pharmaceuticals, Inc., South; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-AG022547 from NIA. This work was also supported by Intramural funding at Blanchette Rockefeller Neurosciences Institute, Rockville, MD, the American Health Assistance Foundation, the Alzheimer's Association, Acumen Pharmaceuticals, Inc., South	Biessels GJ, 1996, DIABETES, V45, P1259, DOI 10.2337/diabetes.45.9.1259; Bulloj A, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-22; Butler AE, 2004, DIABETES, V53, P1509, DOI 10.2337/diabetes.53.6.1509; CAMA A, 1992, J BIOL CHEM, V267, P8383; CAMA A, 1991, J CLIN ENDOCR METAB, V73, P894, DOI 10.1210/jcem-73-4-894; Carro E, 2006, NEUROBIOL AGING, V27, P1618, DOI 10.1016/j.neurobiolaging.2005.09.039; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Craft S, 2005, NEUROBIOL AGING, V26, pS65, DOI 10.1016/j.neurobiolaging.2005.08.021; de la Monte SM, 2005, J ALZHEIMERS DIS, V7, P45; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Deane R, 2007, CURR ALZHEIMER RES, V4, P191, DOI 10.2174/156720507780362245; Del Rio MJ, 2006, GROWTH FACTORS, V24, P67, DOI 10.1080/08977190500361788; Donahue JE, 2008, J NEUROPATH EXP NEUR, V67, P261, DOI 10.1097/NEN.0b013e31816a0dc8; Dupont J, 2001, HORM RES, V55, P22, DOI 10.1159/000063469; EBINA Y, 1987, P NATL ACAD SCI USA, V84, P704, DOI 10.1073/pnas.84.3.704; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; Fitzjohn SM, 2001, J NEUROSCI, V21, P4691, DOI 10.1523/JNEUROSCI.21-13-04691.2001; FOSTER NL, 1984, ANN NEUROL, V16, P649, DOI 10.1002/ana.410160605; Frolich L, 1999, ANN NY ACAD SCI, V893, P290, DOI 10.1111/j.1749-6632.1999.tb07839.x; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Gasparini L, 2001, J NEUROSCI, V21, P2561, DOI 10.1523/JNEUROSCI.21-08-02561.2001; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022; HARADA S, 1993, ENDOCRINOLOGY, V132, P2293, DOI 10.1210/en.132.6.2293; Harris-White M. E., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P469, DOI 10.2174/156800705774322102; Hersh LB, 2008, CURR ALZHEIMER RES, V5, P225, DOI 10.2174/156720508783954703; Hoyer S, 2002, J NEURAL TRANSM, V109, P341, DOI 10.1007/s007020200028; Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200; Hutton M, 1997, HUM MOL GENET, V6, P1639, DOI 10.1093/hmg/6.10.1639; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Klein William L., 2008, P103, DOI 10.1007/978-3-540-76330-7_9; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; KNAUER MF, 1992, P NATL ACAD SCI USA, V89, P7437, DOI 10.1073/pnas.89.16.7437; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2007, CURR GENOMICS, V8, P486, DOI 10.2174/138920207783769530; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lee CC, 2009, NEUROBIOL AGING, V30, P377, DOI 10.1016/j.neurobiolaging.2007.06.014; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lin CY, 2007, DIABETES, V56, P1324, DOI 10.2337/db06-1579; Mattson MP, 1997, BRAIN RES REV, V23, P47, DOI 10.1016/S0165-0173(96)00014-8; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Messier C, 2003, EXP GERONTOL, V38, P941, DOI 10.1016/S0531-5565(03)00153-0; Messier Claude, 2005, Neural Plasticity, V12, P311, DOI 10.1155/NP.2005.311; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Moir Robert D., 2005, Current Alzheimer Research, V2, P269, DOI 10.2174/1567205053585918; MOLONEY AM, 2008, NEUROBIOL A IN PRESS; Morelli L, 2003, J BIOL CHEM, V278, P23221, DOI 10.1074/jbc.M300276200; Nalivaeva NN, 2008, CURR ALZHEIMER RES, V5, P212, DOI 10.2174/156720508783954785; Parrizas M, 1997, ENDOCRINOLOGY, V138, P1427, DOI 10.1210/en.138.4.1427; Pedersen WA, 2006, EXP NEUROL, V199, P265, DOI 10.1016/j.expneurol.2006.01.018; Qiu WQ, 2006, NEUROBIOL AGING, V27, P190, DOI 10.1016/j.neurobiolaging.2005.01.004; Ram TG, 1996, MOL CARCINOGEN, V15, P227, DOI 10.1002/(SICI)1098-2744(199603)15:3<227::AID-MC8>3.0.CO;2-E; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Reger MA, 2008, J ALZHEIMERS DIS, V13, P323, DOI 10.3233/jad-2008-13309; RELKIN NR, 2008, NEUROBIOL A IN PRESS; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Smith MA, 2000, BBA-MOL BASIS DIS, V1502, P139, DOI 10.1016/S0925-4439(00)00040-5; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Watson GS, 2006, NEUROBIOL AGING, V27, P38, DOI 10.1016/j.neurobiolaging.2004.11.011; Watson GS, 2003, CNS DRUGS, V17, P27, DOI 10.2165/00023210-200317010-00003; Xie L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0001.2002; Xing CH, 2005, NEUROSCI LETT, V384, P93, DOI 10.1016/j.neulet.2005.04.063; Younkin SG, 1998, J PHYSIOLOGY-PARIS, V92, P289, DOI 10.1016/S0928-4257(98)80035-1; Zhao J, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-4; Zhao LX, 2004, J NEUROSCI, V24, P11120, DOI 10.1523/JNEUROSCI.2860-04.2004; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com; Zhao WQ, 2009, BBA-MOL BASIS DIS, V1792, P482, DOI 10.1016/j.bbadis.2008.10.014; Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893; Zhao WQ, 2004, EUR J PHARMACOL, V490, P71, DOI 10.1016/j.ejphar.2004.02.045	86	119	122	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18742	18753		10.1074/jbc.M109.011015	http://dx.doi.org/10.1074/jbc.M109.011015			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19406747	hybrid, Green Published			2022-12-25	WOS:000267711500024
J	Wen, KK; Rubenstein, PA				Wen, Kuo-Kuang; Rubenstein, Peter A.			Differential Regulation of Actin Polymerization and Structure by Yeast Formin Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-ACTIN; CRYSTAL-STRUCTURES; CAPPING PROTEIN; MOUSE FORMIN; MECHANISM; PROFILIN; CYTOKINESIS; BNI1; DESTABILIZATION; ELONGATION	The budding yeast formins, Bnr1 and Bni1, behave very differently with respect to their interactions with muscle actin. However, the mechanisms underlying these differences are unclear, and these formins do not interact with muscle actin in vivo. We use yeast wild type and mutant actins to further assess these differences between Bnr1 and Bni1. Low ionic strength G-buffer does not promote actin polymerization. However, Bnr1, but not Bni1, causes the polymerization of pyrene-labeled Mg-G-actin in G-buffer into single filaments based on fluorometric and EM observations. Polymerization by Bnr1 does not occur with Ca-G-actin. By cosedimentation, maximum filament formation occurs at a Bnr1: actin ratio of 1:2. The interaction of Bnr1 with pyrene-labeled S265C Mg-actin yields a pyrene excimer peak, from the cross-strand interaction of pyrene probes, which only occurs in the context of F-actin. In F-buffer, Bnr1 promotes much faster yeast actin polymerization than Bni1. It also bundles the F-actin in contrast to the low ionic strength situation where only single filaments form. Thus, the differences previously observed with muscle actin are not actin isoform-specific. The binding of both formins to F-actin saturate at an equimolar ratio, but only about 30% of each formin cosediments with F-actin. Finally, addition of Bnr1 but not Bni1 to pyrene-labeled wild type and S265C Mg-F actins enhanced the pyrene- and pyrene- excimer fluorescence, respectively, suggesting Bnr1 also alters F-actin structure. These differences may facilitate the ability of Bnr1 to form the actin cables needed for polarized delivery of nutrients and organelles to the growing yeast bud.	[Wen, Kuo-Kuang; Rubenstein, Peter A.] Univ Iowa, Dept Biochem, Roy A & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Rubenstein, PA (corresponding author), Univ Iowa, Dept Biochem, Roy A & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	peter-rubenstein@uiowa.edu		Rubenstein, Peter/0000-0003-1225-4414	National Institutes of Health [GM211105]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant GM211105 (to P. A. R.).	Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; Bugyi B, 2006, J BIOL CHEM, V281, P10727, DOI 10.1074/jbc.M510252200; Buzan JM, 1996, P NATL ACAD SCI USA, V93, P91, DOI 10.1073/pnas.93.1.91; Conchaudron AP, 2006, J BIOL CHEM, V281, P24036, DOI 10.1074/jbc.M602747200; Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611; Evangelista Marie, 2002, Nature Cell Biology, V4, P260; Ezezika OC, 2009, J BIOL CHEM, V284, P2088, DOI 10.1074/jbc.M807073200; Feng L, 1997, J BIOL CHEM, V272, P16829, DOI 10.1074/jbc.272.27.16829; GERSHMAN LC, 1994, ADV EXP MED BIOL, V358, P35; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Hosek M, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051907; Kim E, 1996, BIOCHEMISTRY-US, V35, P16566, DOI 10.1021/bi9623892; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Kovar DR, 2005, MOL BIOL CELL, V16, P2313, DOI 10.1091/mbc.E04-09-0781; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Kuang B, 1997, J BIOL CHEM, V272, P1237, DOI 10.1074/jbc.272.2.1237; Kudryashov DS, 2004, BIOPHYS J, V87, P1136, DOI 10.1529/biophysj.104.042242; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; McKane M, 2006, J BIOL CHEM, V281, P29916, DOI 10.1074/jbc.M602251200; Melki R, 1996, BIOCHEMISTRY-US, V35, P12038, DOI 10.1021/bi961325o; Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200; Moseley JB, 2006, METHOD ENZYMOL, V406, P215, DOI 10.1016/S0076-6879(06)06016-2; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Neidt EM, 2008, J BIOL CHEM, V283, P23872, DOI 10.1074/jbc.M803734200; Neidt EM, 2009, J BIOL CHEM, V284, P673, DOI 10.1074/jbc.M804201200; ORLOVA A, 1992, J MOL BIOL, V227, P1043, DOI 10.1016/0022-2836(92)90520-T; Ozaki-Kuroda K, 2001, MOL CELL BIOL, V21, P827, DOI 10.1128/MCB.21.3.827-839.2001; Pruyne D, 2004, MOL BIOL CELL, V15, P4971, DOI 10.1091/mbc.E04-04-0296; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; RUBENSTEIN PA, 1990, BIOESSAYS, V12, P309, DOI 10.1002/bies.950120702; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; Vallen EA, 2000, MOL BIOL CELL, V11, P593, DOI 10.1091/mbc.11.2.593; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Wen KK, 2000, BIOCHEMISTRY-US, V39, P8638, DOI 10.1021/bi000241j; Wen KK, 2005, J BIOL CHEM, V280, P24168, DOI 10.1074/jbc.M502024200; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yao XY, 2001, J BIOL CHEM, V276, P25598, DOI 10.1074/jbc.M011797200; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	42	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16776	16783		10.1074/jbc.M109.006981	http://dx.doi.org/10.1074/jbc.M109.006981			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19386598	hybrid, Green Published			2022-12-25	WOS:000266962400013
J	Somanath, PR; Vijai, J; Kichina, JV; Byzova, T; Kandel, ES				Somanath, P. R.; Vijai, J.; Kichina, J. V.; Byzova, T.; Kandel, E. S.			The role of PAK-1 in activation of MAP kinase cascade and oncogenic transformation by Akt	ONCOGENE			English	Article						extracellular signal-regulated MAP kinases; protein kinase B; neoplastic cell transformation; p21-activated kinases	PHOSPHATIDYLINOSITOL 3-KINASE; HEMATOPOIETIC-CELLS; PLASMA-MEMBRANE; SERINE 338; RAF; PHOSPHORYLATION; AKT/PKB; CANCER; CYCLE; DEPENDENCE	The activity of protein kinase B, also known as Akt, is commonly elevated in human malignancies and plays a crucial role in oncogenic transformation. The relationship between Akt and the mitogen-activated protein kinase cascade, which is also frequently associated with oncogenesis, remains controversial. We report here examples of cooperation between Akt and cRaf in oncogenic transformation, which was accompanied by elevated activity of extracellular signal-regulated mitogen-activated protein kinases. The effect of Akt on extracellular signal-regulated kinases depended on the status of p21-activated kinase (PAK). Importantly, disruption of the function of PAK not only uncoupled the activation of Akt from that of extracellular signal-regulated kinases, but also greatly reduced the capacity of Akt to act as a transforming oncogene. For the malignancies with hyperactive Akt, our observations support the role for PAK-1 as a potential target for therapeutic intervention. Oncogene (2009) 28, 2365 2369; doi:10.1038/onc.2009.114; published online 4 May 2009	[Vijai, J.; Kichina, J. V.; Kandel, E. S.] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA; [Somanath, P. R.; Byzova, T.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA	Roswell Park Cancer Institute; Cleveland Clinic Foundation	Kandel, ES (corresponding author), Roswell Pk Canc Inst, Dept Cell Stress Biol, BLSC L3-318,Elm & Carlton St, Buffalo, NY 14263 USA.	eugene.kandel@RoswellPark.org	Joseph, Vijai/J-9158-2013	Joseph, Vijai/0000-0002-7933-151X; Byzova, Tatiana/0000-0002-2615-875X; Rammohan Shenoy, Somanath/0000-0003-3017-0230	Howard Temin Award to ESK; NIH [HL071625]; American Heart Association [0830326N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071625] Funding Source: NIH RePORTER	Howard Temin Award to ESK; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Dr Nikolay Neznanov for the Ets-reporter construct, Dr Channing Der for RIE-1 cells, Dr George Stark for the MEF cells and Dr Nissim Hay for various Akt-expressing constructs. This work was supported by the Howard Temin Award to ESK, NIH Grant HL071625 to TB and American Heart Association grant 0830326N to PRS.	Bereiter-Hahn J, 1998, CELL STRUCT FUNCT, V23, P85, DOI 10.1247/csf.23.85; Chaudhary A, 2000, CURR BIOL, V10, P551, DOI 10.1016/S0960-9822(00)00475-9; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Galang CK, 1996, J BIOL CHEM, V271, P7992, DOI 10.1074/jbc.271.14.7992; Galetic I, 2003, J BIOL CHEM, V278, P4416, DOI 10.1074/jbc.M210578200; Gartel AL, 2006, BIOMOL ENG, V23, P17, DOI 10.1016/j.bioeng.2006.01.002; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kandel ES, 2002, MOL CELL BIOL, V22, P7831, DOI 10.1128/MCB.22.22.7831-7841.2002; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; McCubrey JA, 2001, CANCER DETECT PREV, V25, P375; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Mirza AM, 2004, MOL CELL BIOL, V24, P10868, DOI 10.1128/MCB.24.24.10868-10881.2004; Mirza AM, 2000, CELL GROWTH DIFFER, V11, P279; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Nheu T, 2004, CELL CYCLE, V3, P71; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Shelton JG, 2004, CELL CYCLE, V3, P503; Sheng HM, 2001, J BIOL CHEM, V276, P14498, DOI 10.1074/jbc.M010093200; Somanath PR, 2009, J CELL PHYSIOL, V218, P394, DOI 10.1002/jcp.21612; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Sun HY, 2000, CURR BIOL, V10, P281, DOI 10.1016/S0960-9822(00)00359-6; Tang Y, 1997, MOL CELL BIOL, V17, P4454, DOI 10.1128/MCB.17.8.4454; Weinberg RA, 2007, BIOL CANC; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	28	50	53	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2009	28	25					2365	2369		10.1038/onc.2009.114	http://dx.doi.org/10.1038/onc.2009.114			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	462HS	19421139	Green Accepted			2022-12-25	WOS:000267342400001
J	Stallings, CD				Stallings, Christopher D.			Fishery-Independent Data Reveal Negative Effect of Human Population Density on Caribbean Predatory Fish Communities	PLOS ONE			English	Article							CORAL-REEF FISH; NORTHERN LINE ISLANDS; MARINE FOOD WEBS; CLIMATE-CHANGE; PACIFIC; ATLANTIC; DECLINE; IMPACTS; BIODIVERSITY; ECOSYSTEMS	Background: Understanding the current status of predatory fish communities, and the effects fishing has on them, is vitally important information for management. However, data are often insufficient at region-wide scales to assess the effects of extraction in coral reef ecosystems of developing nations. Methodology/Principal Findings: Here, I overcome this difficulty by using a publicly accessible, fisheries-independent database to provide a broad scale, comprehensive analysis of human impacts on predatory reef fish communities across the greater Caribbean region. Specifically, this study analyzed presence and diversity of predatory reef fishes over a gradient of human population density. Across the region, as human population density increases, presence of large-bodied fishes declines, and fish communities become dominated by a few smaller-bodied species. Conclusions/Significance: Complete disappearance of several large-bodied fishes indicates ecological and local extinctions have occurred in some densely populated areas. These findings fill a fundamentally important gap in our knowledge of the ecosystem effects of artisanal fisheries in developing nations, and provide support for multiple approaches to data collection where they are commonly unavailable.			Stallings, CD (corresponding author), Florida State Univ, Coastal & Marine Lab, St Teresa, FL USA.	stallings@bio.fsu.edu		Stallings, Christopher/0000-0002-3410-4540				Abesamis RA, 2005, ECOL APPL, V15, P1798, DOI 10.1890/05-0174; Albins MA, 2008, MAR ECOL PROG SER, V367, P233, DOI 10.3354/meps07620; Allen G.R, 1985, FAO SPECIES CATALOGU; [Anonymous], COASTAL RESOURCE MAN; Aronson RB, 2003, SCIENCE, V302, P1502; Bellwood DR, 2005, ECOL LETT, V8, P643, DOI 10.1111/j.1461-0248.2005.00763.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bouchon-Navaro Y, 2005, J EXP MAR BIOL ECOL, V315, P31, DOI 10.1016/j.jembe.2004.08.028; Briggs J, 1974, MARINE ZOOGEOGRAPHY, DOI 10.2307/1442613; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Bruno JF, 2008, FRONT ECOL ENVIRON, V6, P539, DOI 10.1890/070136; *CAR TOUR ORG, 2008, TOUR STOP ARR; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; *CENTR INT AG, 2008, WORLD FACTB; Cheal AJ, 2008, MAR ECOL PROG SER, V372, P211, DOI 10.3354/meps07708; Christensen V, 2003, FISH FISH, V4, P1, DOI 10.1046/j.1467-2979.2003.00103.x; Cinner JE, 2009, CURR BIOL, V19, P206, DOI 10.1016/j.cub.2008.11.055; Cohen JE, 1997, SCIENCE, V278, P1211; Cohn JP, 2008, BIOSCIENCE, V58, P192, DOI 10.1641/B580303; Coleman FC, 2004, SCIENCE, V305, P1958, DOI 10.1126/science.1100397; Crowder LB, 2008, ANNU REV ECOL EVOL S, V39, P259, DOI 10.1146/annurev.ecolsys.39.110707.173406; Dampier W, 1729, NEW VOYAGE WORLD, V7th; Dandonneau Y, 2004, DEEP-SEA RES PT II, V51, P303, DOI 10.1016/j.dsr2.2003.07.018; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; ELTON CS, 1958, ECOLOGY INVASIONS PL; Essington TE, 2006, P NATL ACAD SCI USA, V103, P3171, DOI 10.1073/pnas.0510964103; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Fogarty MJ, 1998, ECOL APPL, V8, pS6, DOI 10.2307/2641359; Francis RC, 2007, FISHERIES, V32, P217, DOI 10.1577/1548-8446(2007)32[217:TCFBFS]2.0.CO;2; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Froese R, 2005, FISHBASE; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Hawkins JP, 2004, CONSERV BIOL, V18, P215, DOI 10.1111/j.1523-1739.2004.00328.x; Heemstra P.C., 1993, FAO SPECIES CATALOGU, V125; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Hixon MA, 1997, SCIENCE, V277, P946, DOI 10.1126/science.277.5328.946; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Humann P., 2002, REEF FISH IDENTIFICA; HUNTSMAN GR, 1999, GROUPERS SERRANIDAE; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 1997, CORAL REEFS, V16, pS23, DOI 10.1007/s003380050238; Jackson JBC, 2001, P NATL ACAD SCI USA, V98, P5411, DOI 10.1073/pnas.091092898; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Jennings S, 1996, J APPL ECOL, V33, P400, DOI 10.2307/2404761; Jennings S, 1999, CONSERV BIOL, V13, P1466, DOI 10.1046/j.1523-1739.1999.98324.x; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P115, DOI 10.1007/BF02289694; Leichter JJ, 2006, J MAR RES, V64, P563, DOI 10.1357/002224006778715711; Levin Phillip S., 2002, P377, DOI 10.1016/B978-012615185-5/50022-0; LEVIN PS, 2002, CORAL REEF FISHES DY; Luck GW, 2007, BIOL REV, V82, P607, DOI 10.1111/j.1469-185X.2007.00028.x; MAC ARTHUR ROBERT H., 1967; Macpherson E, 2002, P ROY SOC B-BIOL SCI, V269, P1715, DOI 10.1098/rspb.2002.2091; Mather P. M., 1976, COMPUTATIONAL METHOD; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McClanahan TR, 2008, ECOL APPL, V18, P1516, DOI 10.1890/07-0876.1; McCune B., 2011, PC ORD MULTIVARIATE; McLeod K.L., 2005, SCI CONSENSUS STATEM; Miller MW, 2002, BIOL CONSERV, V106, P37, DOI 10.1016/S0006-3207(01)00227-0; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Munro JL., 1983, CARIBBEAN CORAL REEF, V2, P1; MUNRO JL, 1996, REEF FISHERIES, P1; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; PADDACK MJ, CURRENT BIOL; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pinnegar JK, 2008, REV FISH BIOL FISHER, V18, P1, DOI 10.1007/s11160-007-9058-6; POLUNIN NVC, 1996, REEF FISHERIES CHAPM; Roberts CM, 1997, TRENDS ECOL EVOL, V12, P35, DOI 10.1016/S0169-5347(96)20109-0; Rogers C, 2009, P R SOC B, V276, P197, DOI 10.1098/rspb.2008.0606; Russ G.R., 1991, P601; Russ GR, 1996, ECOL APPL, V6, P947, DOI 10.2307/2269497; Ruttenberg BI, 2001, CONSERV BIOL, V15, P1691, DOI 10.1046/j.1523-1739.2001.99556.x; Sadovy Y, 2005, FISH FISH, V6, P167, DOI 10.1111/j.1467-2979.2005.00186.x; Sadovy Y, 2005, CORAL REEFS, V24, P254, DOI 10.1007/s00338-005-0474-6; Sala E, 2001, FISHERIES, V26, P23, DOI 10.1577/1548-8446(2001)026<0023:RDONGS>2.0.CO;2; Sandin SA, 2008, GLOBAL ECOL BIOGEOGR, V17, P770, DOI 10.1111/j.1466-8238.2008.00418.x; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Schmitt EF, 1996, B MAR SCI, V59, P404; Schmitt EF, 2002, CORAL REEFS, V21, P216, DOI 10.1007/s00338-002-0216-y; Spalding M. D., 2001, WORLD ATLAS CORAL RE; STALLINGS CD, MARINE ECOL IN PRESS; Stallings CD, 2008, ECOLOGY, V89, P2090, DOI 10.1890/07-1671.1; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; Syms C, 2000, ECOLOGY, V81, P2714, DOI 10.1890/0012-9658(2000)081[2714:DHSATD]2.0.CO;2; *UN, 2005, WORLD POPULATIONS PR; Walters C, 1997, REV FISH BIOL FISHER, V7, P139, DOI 10.1023/A:1018479526149; WATSON M, 1994, MAR ECOL PROG SER, V109, P115, DOI 10.3354/meps109115; Whitfield PE, 2007, BIOL INVASIONS, V9, P53, DOI 10.1007/s10530-006-9005-9; Williams ID, 2008, ENVIRON CONSERV, V35, P261, DOI 10.1017/S0376892908004876; Wing SR, 2001, CORAL REEFS, V20, P1; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Wormald C. L., 2007, THESIS U RHODE ISLAN	102	143	143	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5333	10.1371/journal.pone.0005333	http://dx.doi.org/10.1371/journal.pone.0005333			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421312	Green Published, gold, Green Submitted			2022-12-25	WOS:000265836900002
J	Azad, P; Zhou, D; Russo, E; Haddad, GG				Azad, Priti; Zhou, Dan; Russo, Erilynn; Haddad, Gabriel G.			Distinct Mechanisms Underlying Tolerance to Intermittent and Constant Hypoxia in Drosophila melanogaster	PLOS ONE			English	Article								Background: Constant hypoxia (CH) and intermittent hypoxia (IH) occur during several pathological conditions such as asthma and obstructive sleep apnea. Our research is focused on understanding the molecular mechanisms that lead to injury or adaptation to hypoxic stress using Drosophila as a model system. Our current genome-wide study is designed to investigate gene expression changes and identify protective mechanism(s) in D. melanogaster after exposure to severe (1% O-2) intermittent or constant hypoxia. Methodology/Principal Findings: Our microarray analysis has identified multiple gene families that are up- or down-regulated in response to acute CH or IH. We observed distinct responses to IH and CH in gene expression that varied in the number of genes and type of gene families. We then studied the role of candidate genes (up- or down-regulated) in hypoxia tolerance (adult survival) for longer periods (CH-7 days, IH-10 days) under severe CH or IH. Heat shock proteins up-regulation (specifically Hsp23 and Hsp70) led to a significant increase in adult survival (as compared to controls) of P-element lines during CH. In contrast, during IH treatment the up- regulation of Mdr49 and l(2) 08717 genes (P-element lines) provided survival advantage over controls. This suggests that the increased transcript levels following treatment with either paradigm play an important role in tolerance to severe hypoxia. Furthermore, by over-expressing Hsp70 in specific tissues, we found that up- regulation of Hsp70 in heart and brain play critical role in tolerance to CH in flies. Conclusions/Significance: We observed that the gene expression response to IH or CH is specific and paradigm-dependent. We have identified several genes Hsp23, Hsp70, CG1600, l(2) 08717 and Mdr49 that play an important role in hypoxia tolerance whether it is in CH or IH. These data provide further clues about the mechanisms by which IH or CH lead to cell injury and morbidity or adaptation and survival.			Azad, P (corresponding author), Univ Calif San Diego, Dept Pediat, Sect Resp Med, La Jolla, CA 92093 USA.	ghaddad@ucsd.edu	Zhou, Dan/T-7203-2017	Zhou, Dan/0000-0001-6401-9040; Azad, Priti/0000-0002-7615-9507	NINDS NIH HHS [R01 NS037756] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037756] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beere HM, 2001, TRENDS CELL BIOL, V11, P6, DOI 10.1016/S0962-8924(00)01874-2; Bianchi-Frias D, 2004, PLOS BIOL, V2, P975, DOI 10.1371/journal.pbio.0020178; Chandel NS, 2007, FREE RADICAL BIO MED, V42, P165, DOI 10.1016/j.freeradbiomed.2006.10.048; Chen L, 2004, MOL BRAIN RES, V131, P93, DOI 10.1016/j.molbrainres.2004.08.013; DAHLQUIST KD, 2004, CURR PROTOC BIOINFOR, pCH7; Dermaut B, 2005, J CELL BIOL, V170, P127, DOI 10.1083/jcb.200412001; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Douglas RM, 2007, AM J PHYSIOL-REG I, V292, pR1254, DOI 10.1152/ajpregu.00404.2006; Fan CH, 2005, PHYSIOL GENOMICS, V22, P292, DOI 10.1152/physiolgenomics.00217.2004; Farahani R, 2008, PEDIATR PULM, V43, P20, DOI 10.1002/ppul.20729; Fortini ME, 2000, J CELL BIOL, V150, pF23, DOI 10.1083/jcb.150.2.F23; Fortini ME, 2000, TRENDS GENET, V16, P161, DOI 10.1016/S0168-9525(99)01939-3; Gabai VL, 2002, MOL CELL BIOL, V22, P3415, DOI 10.1128/MCB.22.10.3415-3424.2002; Giffard RG, 2004, J EXP BIOL, V207, P3213, DOI 10.1242/jeb.01034; HADDAD GG, 1993, PROG NEUROBIOL, V40, P277, DOI 10.1016/0301-0082(93)90014-J; Haddad GG, 1997, P NATL ACAD SCI USA, V94, P10809, DOI 10.1073/pnas.94.20.10809; Han Z, 2006, DEVELOPMENT, V133, P1175, DOI 10.1242/dev.02285; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Hsiao A, 2005, NUCLEIC ACIDS RES, V33, pW627, DOI 10.1093/nar/gki443; Huang H, 2007, PHYSIOL GENOMICS, V29, P260, DOI 10.1152/physiolgenomics.00166.2006; Iacobas DA, 2008, FUNCT INTEGR GENOMIC, V8, P265, DOI 10.1007/s10142-008-0082-y; Iacobas DA, 2006, BIOCHEM BIOPH RES CO, V349, P329, DOI 10.1016/j.bbrc.2006.08.056; Kanaan A, 2006, AM J PHYSIOL-REG I, V290, pR1105, DOI 10.1152/ajpregu.00535.2005; Krishnan SN, 1997, J INSECT PHYSIOL, V43, P203, DOI 10.1016/S0022-1910(96)00084-4; Laridon B, 2008, GENE EXPR PATTERNS, V8, P275, DOI 10.1016/j.gep.2007.12.003; Latchman DS, 2001, CARDIOVASC RES, V51, P637, DOI 10.1016/S0008-6363(01)00354-6; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lipton SA, 2001, NATURE, V413, P118, DOI 10.1038/35093186; Liu JC, 2007, CHINESE MED J-PEKING, V120, P578, DOI 10.1097/00029330-200704010-00010; Ma E, 2001, J CLIN INVEST, V107, P685, DOI 10.1172/JCI11625; Ma E, 1997, MOL BRAIN RES, V46, P325, DOI 10.1016/S0169-328X(97)00074-0; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Nanduri J, 2007, ESSAYS BIOCHEM, V43, P91, DOI 10.1042/bse0430091; Ratcliffe PJ, 2006, CLIN MED, V6, P573, DOI 10.7861/clinmedicine.6-6-573; SCHMAUSS C, 2002, SCI STKE, pPE26; Simonsen A, 2007, GENETICS, V176, P1283, DOI 10.1534/genetics.106.065011; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; Trivedi Seema, 2007, Recent Pat DNA Gene Seq, V1, P134; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Wreden CC, 2005, J BIOL CHEM, V280, P1408, DOI 10.1074/jbc.M411295200; WU CT, 1991, MOL CELL BIOL, V11, P3940, DOI 10.1128/MCB.11.8.3940; Wu W, 2008, PHYSIOL GENOMICS, V36, P24, DOI 10.1152/physiolgenomics.00258.2007; Xia SL, 2005, PHYSIOL GENOMICS, V20, P195, DOI 10.1152/physiolgenomics.00093.2003; YANG MY, 1995, NEURON, V15, P45; YAO KM, 1994, J NEUROCHEM, V63, P41; Yenari MA, 2002, ADV EXP MED BIOL, V513, P281; Yi P, 2006, SCIENCE, V313, P1301, DOI 10.1126/science.1127704; Yin J, 2006, CANCER RES, V66, P2937, DOI 10.1158/0008-5472.CAN-05-2615; Zhou D, 2008, PHYSIOL GENOMICS, V32, P370, DOI 10.1152/physiolgenomics.00147.2007; Zhou D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000490	50	68	70	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5371	10.1371/journal.pone.0005371	http://dx.doi.org/10.1371/journal.pone.0005371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401761	Green Published, gold, Green Submitted			2022-12-25	WOS:000265601100013
J	Yamauchi, K; Hasegawa, K; Chuma, S; Nakatsuji, N; Suemori, H				Yamauchi, Kaori; Hasegawa, Kouichi; Chuma, Shinichiro; Nakatsuji, Norio; Suemori, Hirofumi			In Vitro Germ Cell Differentiation from Cynomolgus Monkey Embryonic Stem Cells	PLOS ONE			English	Article								Background: Mouse embryonic stem (ES) cells can differentiate into female and male germ cells in vitro. Primate ES cells can also differentiate into immature germ cells in vitro. However, little is known about the differentiation markers and culture conditions for in vitro germ cell differentiation from ES cells in primates. Monkey ES cells are thus considered to be a useful model to study primate gametogenesis in vitro. Therefore, in order to obtain further information on germ cell differentiation from primate ES cells, this study examined the ability of cynomolgus monkey ES cells to differentiate into germ cells in vitro. Methods and Findings: To explore the differentiation markers for detecting germ cells differentiated from ES cells, the expression of various germ cell marker genes was examined in tissues and ES cells of the cynomolgus monkey (Macaca fascicularis). VASA is a valuable gene for the detection of germ cells differentiated from ES cells. An increase of VASA expression was observed when differentiation was induced in ES cells via embryoid body (EB) formation. In addition, the expression of other germ cell markers, such as NANOS and PIWIL1 genes, was also up-regulated as the EB differentiation progressed. Immunocytochemistry identified the cells expressing stage-specific embryonic antigen (SSEA) 1, OCT-4, and VASA proteins in the EBs. These cells were detected in the peripheral region of the EBs as specific cell populations, such as SSEA1-positive, OCT-4-positive cells, OCT-4-positive, VASA-positive cells, and OCT-4-negative, VASA-positive cells. Thereafter, the effect of mouse gonadal cell-conditioned medium and growth factors on germ cell differentiation from monkey ES cells was examined, and this revealed that the addition of BMP4 to differentiating ES cells increased the expression of SCP1, a meiotic marker gene. Conclusion: VASA is a valuable gene for the detection of germ cells differentiated from ES cells in monkeys, and the identification and characterization of germ cells derived from ES cells are possible by using reported germ cell markers in vivo, including SSEA1, OCT-4, and VASA, in vitro as well as in vivo. These findings are thus considered to help elucidate the germ cell developmental process in primates.			Yamauchi, K (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Stem Cell Res Ctr,Lab Embryon Stem Cell Res, Sakyo Ku, Kyoto, Japan.	hsuemori@frontier.kyoto-u.ac.jp	Hasegawa, Kouichi/Y-9349-2019	Hasegawa, Kouichi/0000-0001-5947-5471; Suemori, Hirofumi/0000-0002-3565-3111				Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bowles J, 2003, CYTOGENET GENOME RES, V101, P261, DOI 10.1159/000074346; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Bucay N, 2009, STEM CELLS, V27, P68, DOI 10.1634/stemcells.2007-1018; Cairns LA, 2003, BLOOD, V102, P3954, DOI 10.1182/blood-2003-04-1296; Capela A, 2006, DEV BIOL, V291, P300, DOI 10.1016/j.ydbio.2005.12.030; Caricasole AAD, 1998, ONCOGENE, V16, P95, DOI 10.1038/sj.onc.1201515; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Chuma S, 2001, DEV BIOL, V229, P468, DOI 10.1006/dbio.2000.9989; Clark AT, 2004, HUM MOL GENET, V13, P727, DOI 10.1093/hmg/ddh088; Clark AT, 2004, STEM CELLS, V22, P169, DOI 10.1634/stemcells.22-2-169; Cooke HJ, 1996, HUM MOL GENET, V5, P513, DOI 10.1093/hmg/5.4.513; Costa Y, 2005, J CELL SCI, V118, P2755, DOI 10.1242/jcs.02402; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; DOBSON MJ, 1994, J CELL SCI, V107, P2749; Dong LW, 1996, J MOL RECOGNIT, V9, P383, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<383::AID-JMR269>3.0.CO;2-Z; FOX N, 1981, DEV BIOL, V83, P391, DOI 10.1016/0012-1606(81)90487-5; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; HAY B, 1988, CELL, V55, P577, DOI 10.1016/0092-8674(88)90216-4; HEYTING C, 1988, CHROMOSOMA, V96, P325, DOI 10.1007/BF00286921; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Jaruzelska J, 2003, DEV GENES EVOL, V213, P120, DOI 10.1007/s00427-003-0303-2; Kee K, 2006, STEM CELLS DEV, V15, P831, DOI 10.1089/scd.2006.15.831; Kerr CL, 2008, HUM REPROD, V23, P589, DOI 10.1093/humrep/dem411; Kerr CL, 2008, STEM CELLS, V26, P412, DOI 10.1634/stemcells.2007-0605; KOSHIMIZU U, 1995, DEV BIOL, V168, P683, DOI 10.1006/dbio.1995.1113; Kuramochi-Miyagawa S, 2001, MECH DEVELOP, V108, P121, DOI 10.1016/S0925-4773(01)00499-3; Lacham-Kaplan O, 2004, REPRODUCTION, V128, P147, DOI 10.1530/rep.1.00220; Lacham-Kaplan O, 2006, STEM CELLS, V24, P266, DOI 10.1634/stemcells.2005-0204; LAMMERS JHM, 1994, MOL CELL BIOL, V14, P1137, DOI 10.1128/MCB.14.2.1137; Lange U C, 2003, BMC Dev Biol, V3, P1, DOI 10.1186/1471-213X-3-1; Larsson M, 2000, EUR J CELL BIOL, V79, P718, DOI 10.1078/0171-9335-00097; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; Lee JH, 2006, HUM MOL GENET, V15, P201, DOI 10.1093/hmg/ddi430; MATSUI Y, 1991, NATURE, V353, P750, DOI 10.1038/353750a0; MCPHERRON AC, 1993, J BIOL CHEM, V268, P3444; MEUWISSEN RLJ, 1992, EMBO J, V11, P5091, DOI 10.1002/j.1460-2075.1992.tb05616.x; Meuwissen RLJ, 1997, GENOMICS, V39, P377, DOI 10.1006/geno.1996.4373; Molyneaux KA, 2003, DEVELOPMENT, V130, P4279, DOI 10.1242/dev.00640; Mossman AK, 2005, STEM CELLS DEV, V14, P656, DOI 10.1089/scd.2005.14.656; Noce T, 2001, CELL STRUCT FUNCT, V26, P131, DOI 10.1247/csf.26.131; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ohta H, 2000, DEVELOPMENT, V127, P2125; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; Polisetty N, 2008, MOL VIS, V14, P431; Ponchel F, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-18; Qiao D, 2002, ONCOGENE, V21, P3988, DOI 10.1038/sj.onc.1205505; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo R, 1996, GENOMICS, V35, P346, DOI 10.1006/geno.1996.0366; Reijo RA, 2000, BIOL REPROD, V63, P1490, DOI 10.1095/biolreprod63.5.1490; SAGE J, 1995, BBA-GENE STRUCT EXPR, V1263, P258, DOI 10.1016/0167-4781(95)00126-2; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; Stoop H, 2001, LAB INVEST, V81, P919, DOI 10.1038/labinvest.3780302; Suemori H, 2001, DEV DYNAM, V222, P273, DOI 10.1002/dvdy.1191; Suzuki A, 2007, DEVELOPMENT, V134, P77, DOI 10.1242/dev.02697; Teramura T, 2007, CLONING STEM CELLS, V9, P144, DOI 10.1089/clo.2006.0070; Tilgner K, 2008, STEM CELLS, V26, P3075, DOI 10.1634/stemcells.2008-0289; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Tsuneyoshi N, 2008, BIOCHEM BIOPH RES CO, V367, P899, DOI 10.1016/j.bbrc.2007.12.189; Xu EY, 2001, P NATL ACAD SCI USA, V98, P7414, DOI 10.1073/pnas.131090498; Xu M, 2001, INT J BIOCHEM CELL B, V33, P1172, DOI 10.1016/S1357-2725(01)00089-9; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Ying Y, 2001, P NATL ACAD SCI USA, V98, P7858, DOI 10.1073/pnas.151242798; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594	71	47	53	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5338	10.1371/journal.pone.0005338	http://dx.doi.org/10.1371/journal.pone.0005338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399191	Green Submitted, Green Published, gold			2022-12-25	WOS:000265514900005
J	Hunt, WG; Watson, RT; Oaks, JL; Parish, CN; Burnham, KK; Tucker, RL; Belthoff, JR; Hart, G				Hunt, W. Grainger; Watson, Richard T.; Oaks, J. Lindsay; Parish, Chris N.; Burnham, Kurt K.; Tucker, Russell L.; Belthoff, James R.; Hart, Garret			Lead Bullet Fragments in Venison from Rifle-Killed Deer: Potential for Human Dietary Exposure	PLOS ONE			English	Article							BLOOD-LEAD; COGNITIVE FUNCTION; NORTHERN ONTARIO; 1ST NATIONS; BONE LEAD; MU-G/DL; SHOT; CHILDREN; PEOPLE; ADULTS	Human consumers of wildlife killed with lead ammunition may be exposed to health risks associated with lead ingestion. This hypothesis is based on published studies showing elevated blood lead concentrations in subsistence hunter populations, retention of ammunition residues in the tissues of hunter-killed animals, and systemic, cognitive, and behavioral disorders associated with human lead body burdens once considered safe. Our objective was to determine the incidence and bioavailability of lead bullet fragments in hunter-killed venison, a widely-eaten food among hunters and their families. We radiographed 30 eviscerated carcasses of White-tailed Deer (Odocoileus virginianus) shot by hunters with standard lead-core, copper-jacketed bullets under normal hunting conditions. All carcasses showed metal fragments (geometric mean = 136 fragments, range = 15-409) and widespread fragment dispersion. We took each carcass to a separate meat processor and fluoroscopically scanned the resulting meat packages; fluoroscopy revealed metal fragments in the ground meat packages of 24 (80%) of the 30 deer; 32% of 234 ground meat packages contained at least one fragment. Fragments were identified as lead by ICP in 93% of 27 samples. Isotope ratios of lead in meat matched the ratios of bullets, and differed from background lead in bone. We fed fragment-containing venison to four pigs to test bioavailability; four controls received venison without fragments from the same deer. Mean blood lead concentrations in pigs peaked at 2.29 mg/dL (maximum 3.8 mg/dL) 2 days following ingestion of fragment-containing venison, significantly higher than the 0.63 mg/dL averaged by controls. We conclude that people risk exposure to bioavailable lead from bullet fragments when they eat venison from deer killed with standard lead-based rifle bullets and processed under normal procedures. At risk in the U. S. are some ten million hunters, their families, and low-income beneficiaries of venison donations.			Hunt, WG (corresponding author), Peregrine Fund, Boise, ID USA.	grainger@peregrinefund.org	Fazli, Ghazal/AAE-8320-2022					AVERY D, 2009, INGESTION LEAD SPENT, DOI DOI 10.4080/ILSA.2009.0114; Bjerregaard P, 2004, ENVIRON HEALTH PERSP, V112, P1496, DOI 10.1289/ehp.7083; Borja-Aburto VH, 1999, AM J EPIDEMIOL, V150, P590, DOI 10.1093/oxfordjournals.aje.a010057; Braun JM, 2006, ENVIRON HEALTH PERSP, V114, P1904, DOI 10.1289/ehp.9478; Burger J, 1998, RISK ANAL, V18, P563, DOI 10.1023/B:RIAN.0000005931.39844.35; CARTER A, 2007, SHOOTING ILLUSTA JUL; *CDCP US, 1991, PREV LEAD POIS YOUNG; Cecil KM, 2008, PLOS MED, V5, P741, DOI 10.1371/journal.pmed.0050112; CORNATZER WE, 2009, INGESTION LEAD SPENT, DOI DOI 10.4080/ILSA.2009.0111; Dobrowolska A, 2008, EUR J WILDLIFE RES, V54, P231, DOI 10.1007/s10344-007-0134-y; Ekong EB, 2006, KIDNEY INT, V70, P2074, DOI 10.1038/sj.ki.5001809; Gilbert SG, 2006, NEUROTOXICOLOGY, V27, P693, DOI 10.1016/j.neuro.2006.06.008; Hanning RM, 2003, J ENVIRON MONITOR, V5, P241, DOI 10.1039/b208220a; Hauser R, 2008, ENVIRON HEALTH PERSP, V116, P976, DOI 10.1289/ehp.10516; Hunt WG, 2006, WILDLIFE SOC B, V34, P167, DOI 10.2193/0091-7648(2006)34[167:BFIDRI]2.0.CO;2; Iqbal S., 2008, EPI AID TRIP REPORT; Johansen P, 2004, ENVIRON POLLUT, V127, P125, DOI 10.1016/S0269-7491(03)00255-0; Johansen P, 2006, ENVIRON POLLUT, V142, P93, DOI 10.1016/j.envpol.2005.09.015; Jusko TA, 2008, ENVIRON HEALTH PERSP, V116, P243, DOI 10.1289/ehp.10424; Krone O., 2009, INGESTION LEAD SPENT; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Levesque B, 2003, OCCUP ENVIRON MED, V60, P693, DOI 10.1136/oem.60.9.693; Levin R, 2008, ENVIRON HEALTH PERSP, V116, P1285, DOI 10.1289/ehp.11241; Lustberg M, 2002, ARCH INTERN MED, V162, P2443, DOI 10.1001/archinte.162.21.2443; Mateo R, 2007, SCI TOTAL ENVIRON, V372, P480, DOI 10.1016/j.scitotenv.2006.10.022; Menke A, 2006, CIRCULATION, V114, P1388, DOI 10.1161/CIRCULATIONAHA.106.628321; Needleman H, 2004, ANNU REV MED, V55, P209, DOI 10.1146/annurev.med.55.091902.103653; Needleman HL, 2002, NEUROTOXICOL TERATOL, V24, P711, DOI 10.1016/S0892-0362(02)00269-6; Schnaas L, 2006, ENVIRON HEALTH PERSP, V114, P791, DOI 10.1289/ehp.8552; Schwartz BS, 2007, INT REV PSYCHIATR, V19, P671, DOI 10.1080/09540260701797936; Shih RA, 2007, ENVIRON HEALTH PERSP, V115, P483, DOI 10.1289/ehp.9786; STROUD RK, 2009, INGESTION LEAD SPENT, DOI DOI 10.4080/ILSA.2009.0109; Tellez-Rojo MM, 2004, AM J EPIDEMIOL, V160, P668, DOI 10.1093/aje/kwh271; Titus K., 2009, INGESTION LEAD SPENT, P137; Tsuji LJS, 2008, B ENVIRON CONTAM TOX, V80, P14, DOI 10.1007/s00128-007-9281-9; Tsuji LJS, 2008, SCI TOTAL ENVIRON, V405, P180, DOI 10.1016/j.scitotenv.2008.06.048; Tsuji LJS, 2008, SCI TOTAL ENVIRON, V393, P291, DOI 10.1016/j.scitotenv.2008.01.022; *US EPA, 2007, EST REL BIOAV LEAD S; US Fish and Wildlife Service, 2006, 2006 NAT SURV FISH H; Warren C, 2000, BRUSH DEATH SOCIAL H; WATSON RT, 2009, INGESTION LEAD SPENT, DOI DOI 10.4080/ILSA.2009.0117; Wright JP, 2008, PLOS MED, V5, P732, DOI 10.1371/journal.pmed.0050101	42	115	118	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5330	10.1371/journal.pone.0005330	http://dx.doi.org/10.1371/journal.pone.0005330			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390698	Green Published, gold			2022-12-25	WOS:000265514400016
J	Cooper, KG; Zarnowski, R; Woods, JP				Cooper, Kendal G.; Zarnowski, Robert; Woods, Jon P.			Histoplasma capsulatum Encodes a Dipeptidyl Peptidase Active against the Mammalian Immunoregulatory Peptide, Substance P	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS; ASPERGILLUS-FUMIGATUS; AMINOPEPTIDASE-M; GENE-EXPRESSION; IV; INFLAMMATION; DIPEPTIDYL(AMINO)PEPTIDASE-IV; PROTEINASES; SPECIFICITY; VIRULENCE	The pathogenic fungus Histoplasma capsulatum secretes dipeptidyl peptidase (Dpp) IV enzyme activity and has two putative DPPIV homologs (HcDPPIVA and HcDPPIVB). We previously showed that HcDPPIVB is the gene responsible for the majority of secreted DppIV activity in H. capsulatum culture supernatant, while we could not detect any functional contribution from HcDPPIVA. In order to determine whether HcDPPIVA encodes a functional DppIV enzyme, we expressed HcDPPIVA in Pichia pastoris and purified the recombinant protein. The recombinant enzyme cleaved synthetic DppIV substrates and had similar biochemical properties to other described DppIV enzymes, with temperature and pH optima of 42 degrees C and 8, respectively. Recombinant HcDppIVA cleaved the host immunoregulatory peptide substance P, indicating the enzyme has the potential to affect the immune response during infection. Expression of HcDPPIVA under heterologous regulatory sequences in H. capsulatum resulted in increased secreted DppIV activity, indicating that the encoded protein can be expressed and secreted by its native organism. However, HcDPPIVA was not required for virulence in a murine model of histoplasmosis. This work reports a fungal enzyme that can function to cleave the immunomodulatory host peptide substance P.			Woods, JP (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA.	jpwoods@wisc.edu	Zarnowski, Robert/A-2786-2009	Zarnowski, Robert/0000-0001-6343-1500	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052303] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01HL55949, R01 HL055949] Funding Source: Medline; NIAID NIH HHS [R01 AI52303, R01 AI052303] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aertgeerts K, 2004, PROTEIN SCI, V13, P145, DOI 10.1110/ps.03352504; AHMAD S, 1992, J PHARMACOL EXP THER, V260, P1257; Beauvais A, 1997, INFECT IMMUN, V65, P3042, DOI 10.1128/IAI.65.8.3042-3047.1997; Bhatia M, 2006, AM J PHYSIOL-LUNG C, V291, pL896, DOI 10.1152/ajplung.00053.2006; BLUM AM, 1993, J IMMUNOL, V151, P225; Bohse ML, 2007, INFECT IMMUN, V75, P2811, DOI 10.1128/IAI.00304-07; Cano M V, 2001, Semin Respir Infect, V16, P109; CASCIERI MA, 1992, MOL PHARMACOL, V41, P1096; Chien CH, 2006, BIOCHEMISTRY-US, V45, P7006, DOI 10.1021/bi060401c; Christensen JE, 2003, J BACTERIOL, V185, P3297, DOI 10.1128/JB.185.11.3297-3306.2003; Dickerson C, 1998, J LEUKOCYTE BIOL, V63, P602, DOI 10.1002/jlb.63.5.602; Gorrell MD, 2001, SCAND J IMMUNOL, V54, P249, DOI 10.1046/j.1365-3083.2001.00984.x; Grouzmann E, 2002, FASEB J, V16, P1132, DOI 10.1096/fj.01-0939fje; HUBE B, 1994, MOL MICROBIOL, V14, P87, DOI 10.1111/j.1365-2958.1994.tb01269.x; Kaufman G, 2005, INFECT IMMUN, V73, P6584, DOI 10.1128/IAI.73.10.6584-6590.2005; Kumagai Y, 2005, INFECT IMMUN, V73, P2655, DOI 10.1128/IAI.73.5.2655-2664.2005; Kumagai Y, 2000, INFECT IMMUN, V68, P716, DOI 10.1128/IAI.68.2.716-724.2000; Lambeir AM, 2001, FEBS LETT, V507, P327, DOI 10.1016/S0014-5793(01)02982-9; Landis BN, 2008, RESPIRATION, V75, P89, DOI 10.1159/000106267; Naglik J, 2004, CELL MICROBIOL, V6, P915, DOI 10.1111/j.1462-5822.2004.00439.x; Oravecz T, 1997, J EXP MED, V186, P1865, DOI 10.1084/jem.186.11.1865; Reinke E, 2006, IMMUNOL LETT, V104, P102, DOI 10.1016/j.imlet.2005.11.009; Rementeria Aitor, 2005, Revista Iberoamericana de Micologia, V22, P1, DOI 10.1016/S1130-1406(05)70001-2; Retallack DM, 1999, GENE, V230, P181, DOI 10.1016/S0378-1119(99)00071-2; Sandor M, 2003, TRENDS IMMUNOL, V24, P44, DOI 10.1016/S1471-4906(02)00006-6; Struyf S, 1999, J IMMUNOL, V162, P4903; Tartar A, 2004, MYCOPATHOLOGIA, V158, P201, DOI 10.1023/B:MYCO.0000041905.17948.42; WANG LH, 1991, PEPTIDES, V12, P1357, DOI 10.1016/0196-9781(91)90220-J; Weinstock JV, 2004, FRONT BIOSCI, V9, P1936, DOI 10.2741/1375; Weinstock JV, 1998, ANN NY ACAD SCI, V840, P532, DOI 10.1111/j.1749-6632.1998.tb09592.x; Woods JP, 1998, INFECT IMMUN, V66, P1697, DOI 10.1128/IAI.66.4.1697-1707.1998; Yagishita H, 2001, INFECT IMMUN, V69, P7159, DOI 10.1128/IAI.69.11.7159-7161.2001; Zarnowski R, 2008, MOL MICROBIOL, V70, P352, DOI 10.1111/j.1365-2958.2008.06410.x; Zarnowski R, 2007, DIAGN MICR INFEC DIS, V59, P39, DOI 10.1016/j.diagmicrobio.2007.03.020	34	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5281	10.1371/journal.pone.0005281	http://dx.doi.org/10.1371/journal.pone.0005281			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VB	19384411	Green Published, Green Submitted, gold			2022-12-25	WOS:000265513900016
J	Frey, S; Balu, S; Greusing, S; Rothen, N; Cajochen, C				Frey, Sylvia; Balu, Silvia; Greusing, Sarah; Rothen, Nicolas; Cajochen, Christian			Consequences of the Timing of Menarche on Female Adolescent Sleep Phase Preference	PLOS ONE			English	Article							MORNINGNESS-EVENINGNESS; RECALLED AGE; MELATONIN; ACCURACY; PUBERTY; PATTERNS; ASSOCIATION; TEMPERATURE; EXCRETION; BEHAVIOR	Most parents experience their children's puberty as a dramatic change in family life. This is not surprising considering the dynamics of physical and psychosocial maturation which occur during adolescence. A reasonable question, particularly from the parents' perspective, is: when does this vibrant episode end and adulthood finally start? The aim of the present study was to assess the relationship between puberty and the changes in sleep phase preferences during female maturation and adulthood by a cross-sectional survey. The results from 1'187 females aged 5 to 51 years based on self-report measures of sleep preferences on weekdays and on free days as well as the occurrence of menarche, show that in contrast to prepubertal children, adolescent females exhibit a striking progression in delaying their sleep phase preference until 5 years after menarche. Thereafter, the sleep phase preference switches to advancing. The current study provides evidence that a clear shift in sleep-wake cycles temporally linked to menarche heralds the beginning of "adult-like'' sleep-wake behaviour in women and can be used as a (chrono) biological marker for the onset of adulthood.			Frey, S (corresponding author), Univ Basel, Ctr Chronobiol, Psychiat Univ Hosp, Basel, Switzerland.	silvia.frey@upkbs.ch	Rothen, Nicolas/A-2620-2012; Cajochen, Christian/N-6748-2014	Rothen, Nicolas/0000-0002-8874-8341; 				Acebo C, 2003, SLEEP, V26, pA113; AKERSTEDT T, 1976, BIOL PSYCHOL, V4, P277, DOI 10.1016/0301-0511(76)90019-3; BERGSTENBRUCEFORS A, 1976, ANN HUM BIOL, V3, P71, DOI 10.1080/03014467600001151; Biro FM, 2006, J PEDIATR-US, V148, P234, DOI 10.1016/j.jpeds.2005.10.020; Bogaert AF, 2005, J ADOLESCENCE, V28, P541, DOI 10.1016/j.adolescence.2004.10.008; Carrier J, 1997, J SLEEP RES, V6, P230, DOI 10.1111/j.1365-2869.1997.00230.x; CARSKADON M A, 1990, Pediatrician, V17, P5; CARSKADON MA, 1993, SLEEP, V16, P258, DOI 10.1093/sleep/16.3.258; Carskadon MA, 2004, ANN NY ACAD SCI, V1021, P276, DOI 10.1196/annals.1308.032; CARSKADON MA, 1980, SLEEP, V2, P453; CAVALLO A, 1992, NEUROENDOCRINOLOGY, V55, P372, DOI 10.1159/000126147; CROWLEY SJ, 2008, PRACTICAL WEEKEND CA; Czeisler CA, 2000, PRINCIPLES PRACTICE, P353; DAMON A, 1974, HUM BIOL, V46, P381; DAMON A, 1969, HUM BIOL, V41, P161; Duffy JF, 2002, NEUROSCI LETT, V318, P117, DOI 10.1016/S0304-3940(01)02427-2; Duffy JF, 1999, J INVEST MED, V47, P141; Giannotti F, 2002, J SLEEP RES, V11, P191, DOI 10.1046/j.1365-2869.2002.00302.x; Griefahn B, 2003, J PINEAL RES, V34, P26, DOI 10.1034/j.1600-079X.2003.02931.x; Gupta NK, 2002, AM J HUM BIOL, V14, P762, DOI 10.1002/ajhb.10093; HAGG U, 1980, ACTA ODONTOL SCAND, V38, P179, DOI 10.3109/00016358009004718; Hansen M, 2005, PEDIATRICS, V115, P1555, DOI 10.1542/peds.2004-1649; Kerkhof GA, 1996, NEUROSCI LETT, V218, P153, DOI 10.1016/S0304-3940(96)13140-2; Knutson KL, 2005, AM J HUM BIOL, V17, P418, DOI 10.1002/ajhb.20405; KOLATA G, 1984, SCIENCE, V223, P272, DOI 10.1126/science.6701512; Koo MM, 1997, ANN HUM BIOL, V24, P61, DOI 10.1080/03014469700004782; Laberge L, 2001, J SLEEP RES, V10, P59, DOI 10.1046/j.1365-2869.2001.00242.x; LARGO RH, 1983, HELV PAEDIATR ACTA, V38, P229; LIVSON N, 1962, HUM BIOL, V34, P218; Mongrain V, 2004, J BIOL RHYTHM, V19, P248, DOI 10.1177/0748730404264365; PETTA D, 1984, SLEEP RES, V13, P86, DOI DOI 10.1080/15402000903425462; Roenneberg T, 2004, CURR BIOL, V14, pR1038, DOI 10.1016/j.cub.2004.11.039; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; von Schantz M, 2003, J ROY SOC MED, V96, P486, DOI 10.1258/jrsm.96.10.486; Waldhauser F, 1998, EXP GERONTOL, V33, P759, DOI 10.1016/S0531-5565(98)00054-0; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Wolfson AR, 1998, CHILD DEV, V69, P875, DOI 10.2307/1132351	38	42	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2009	4	4							e5217	10.1371/journal.pone.0005217	http://dx.doi.org/10.1371/journal.pone.0005217			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437VB	19384418	Green Published, gold, Green Submitted			2022-12-25	WOS:000265513900004
J	Riccio, G; Esposito, G; Leoncini, E; Contu, R; Condorelli, G; Chiariello, M; Laccetti, P; Hrelia, S; D'Alessio, G; De Lorenzo, C				Riccio, Gennaro; Esposito, Giovanni; Leoncini, Emanuela; Contu, Riccardo; Condorelli, Gianluigi; Chiariello, Massimo; Laccetti, Paolo; Hrelia, Silvana; D'Alessio, Giuseppe; De Lorenzo, Claudia			Cardiotoxic effects, or lack thereof, of anti-ErbB2 immunoagents	FASEB JOURNAL			English	Article						immunotherapy; immunoRNase; Herceptin; trastuzumab; Her2; heart failure	BREAST-CANCER; MONOCLONAL-ANTIBODIES; TRASTUZUMAB HERCEPTIN; CARDIAC DEVELOPMENT; ERBB2; RECEPTOR; CARDIOMYOPATHY; CARCINOMAS; SURVIVAL; COMPACT	This study investigated potential cardiotoxicity as exerted by Erbicin-derived-immunoagents (EDIAs), novel human anti-ErbB2 immunoagents engineered by fusion of a human anti-ErbB2 scFv, Erbicin, with either a human RNase or the Fc region of a human IgG1. EDIAs are strongly cytotoxic on ErbB2-positive cells in vitro and in vivo and bind to an epitope different from that of Herceptin, a humanized anti-ErbB2 mAb effective in the therapy of breast carcinoma, but cardiotoxic in a high percentage of cases. Toxicity and apoptosis were tested in vitro by 3-(4,5-dimethyl-2-thizolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT), DNA fragmentation, and immunoblotting analyses. Echocardiography was measured in mice after treatment with each immunoagent. Cardiac fibrosis and detection of apoptosis were examined by Sirius red staining of collagen and TUNEL assay, respectively. EDIAs were found in vitro to have no adverse effects on cardiac cells for which Herceptin is severely toxic. In vivo studies on a mouse model showed that the EDIAs did not alter cardiac function, whereas Herceptin and doxorubicin, used as positive controls, significantly reduced the fractional shortening parameter. Cardiac fibrosis and apoptosis were not significantly affected in mice treated with EDIAs. Thus, EDIAs could fulfill the therapeutic need of patients ineligible for Herceptin treatment due to cardiac dysfunction.-Riccio, G., Esposito, G., Leoncini, E., Contu, R., Condorelli, G., Chiariello, M., Laccetti, P., Hrelia, S., D'Alessio, G., De Lorenzo, C. Cardiotoxic effects, or lack thereof, of anti-ErbB2 immunoagents. FASEB J. 23, 3171-3178 ( 2009). www.fasebj.org	[Riccio, Gennaro; Laccetti, Paolo; D'Alessio, Giuseppe; De Lorenzo, Claudia] Univ Naples Federico II, Dipartimento Biol Strutturale & Funz, I-80126 Naples, Italy; [Esposito, Giovanni; Chiariello, Massimo] Univ Naples Federico II, Dipartimento Med Clin Sci Cardiovasc & Immunol, I-80126 Naples, Italy; [Leoncini, Emanuela; Hrelia, Silvana] Univ Bologna, Dipartimento Biochim G Moruzzi, Bologna, Italy; [Contu, Riccardo; Condorelli, Gianluigi] Multimedica, Ist Ricovero & Cura Carattere Sci, Milan, Italy	University of Naples Federico II; University of Naples Federico II; University of Bologna; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Multimedica	De Lorenzo, C (corresponding author), Univ Naples Federico II, Dipartimento Biol Strutturale & Funz, Via Cinthia, I-80126 Naples, Italy.	cladelor@unina.it	Riccio, Gennaro/AAH-6275-2020; Hrelia, Silvana/P-2864-2015; Esposito, Giovanni/F-2880-2010; Condorelli, Gianluigi/Q-6736-2017	Hrelia, Silvana/0000-0001-7857-4512; Esposito, Giovanni/0000-0003-0565-7127; Condorelli, Gianluigi/0000-0003-0481-6843; Riccio, Gennaro/0000-0003-2541-5790; De Lorenzo, Claudia/0000-0002-6195-5631	Associazione Italiana per la Ricerca sul Cancro, Milan, Italy; Ministero dell'Universita e della Ricerca, Rome, Italy; Biotecnol, S. A., Lisbon, Portugal	Associazione Italiana per la Ricerca sul Cancro, Milan, Italy(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Universita e della Ricerca, Rome, Italy(Ministry of Education, Universities and Research (MIUR)); Biotecnol, S. A., Lisbon, Portugal	This work was financially supported by the Associazione Italiana per la Ricerca sul Cancro, Milan, Italy; the Ministero dell'Universita e della Ricerca, Rome, Italy; and Biotecnol, S. A., Lisbon, Portugal. We thank Dr. Rosanna Cozzolino for skilled assistance.	Angeloni C, 2008, AM J PHYSIOL-HEART C, V294, pH1233, DOI 10.1152/ajpheart.01091.2007; Baselga J, 2000, SEMIN ONCOL, V27, P27; Baselga J, 2001, SEMIN ONCOL, V28, P4, DOI 10.1053/sonc.2001.28544; BORDONI A, 1991, BIOCHEM BIOPH RES CO, V174, P869, DOI 10.1016/0006-291X(91)91498-2; Burris HA, 2005, J CLIN ONCOL, V23, P5305, DOI 10.1200/JCO.2005.16.584; Chien KR, 2000, SEMIN ONCOL, V27, P9, DOI 10.1053/sonc.2000.19892; Crone SA, 2002, NAT MED, V8, P459, DOI 10.1038/nm0502-459; De Lorenzo C, 2007, BRIT J CANCER, V97, P1354, DOI 10.1038/sj.bjc.6604022; De Lorenzo C, 2005, CARCINOGENESIS, V26, P1890, DOI 10.1093/carcin/bgi146; De Lorenzo C, 2004, BRIT J CANCER, V91, P1200, DOI 10.1038/sj.bjc.6602110; De Lorenzo C, 2004, CANCER RES, V64, P4870; De Lorenzo C, 2002, CLIN CANCER RES, V8, P1710; Erickson SL, 1997, DEVELOPMENT, V124, P4999; Force T, 2007, NAT REV CANCER, V7, P332, DOI 10.1038/nrc2106; Kauraniemi P, 2004, ONCOGENE, V23, P1010, DOI 10.1038/sj.onc.1207200; Klapper LN, 1997, ONCOGENE, V14, P2099, DOI 10.1038/sj.onc.1201029; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Perez EA, 2006, J CLIN ONCOL, V24, P3032, DOI 10.1200/JCO.2005.03.4744; Schneider JW, 2001, SEMIN ONCOL, V28, P18, DOI 10.1053/sonc.2001.28546; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sparano JA, 2001, SEMIN ONCOL, V28, P20, DOI 10.1053/sonc.2001.22813; SRINIVAS U, 1993, CANCER IMMUNOL IMMUN, V36, P397, DOI 10.1007/BF01742256; Stebbing J, 2000, CANCER TREAT REV, V26, P287, DOI 10.1053/ctrv.2000.0182; Troise F, 2008, FEBS J, V275, P4967, DOI 10.1111/j.1742-4658.2008.06625.x; Vander Heiden MG, 1999, MOL CELL, V3, P159; Zhang HT, 1999, EXP MOL PATHOL, V67, P15, DOI 10.1006/exmp.1999.2266	28	59	59	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					3171	3178		10.1096/fj.09-131383	http://dx.doi.org/10.1096/fj.09-131383			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19417081				2022-12-25	WOS:000270241000039
J	Sohrab, S; Petrusca, DN; Lockett, AD; Schweitzer, KS; Rush, NI; Gu, Y; Kamocki, K; Garrison, J; Petrache, I				Sohrab, Sadaf; Petrusca, Daniela N.; Lockett, Angelia D.; Schweitzer, Kelly S.; Rush, Natalia I.; Gu, Yuan; Kamocki, Krzysztof; Garrison, Jana; Petrache, Irina			Mechanism of alpha-1 antitrypsin endocytosis by lung endothelium	FASEB JOURNAL			English	Article						vascular; serpin; cigarette smoke; caveolin; COPD; apoptosis	CIGARETTE-SMOKE; GOLGI-APPARATUS; ALPHA(1)-ANTITRYPSIN; INTERNALIZATION; APOPTOSIS; RECEPTOR; DEFICIENCY; GLYCOSPHINGOLIPIDS; DEGRADATION; EXPRESSION	The integrity of lung alveoli is maintained by proper circulating levels of alpha-1 antitrypsin (A1AT). Next to cigarette smoking, A1AT deficiency is a major risk factor for lung emphysema development. We recently reported that in addition to neutralizing neutrophil elastases in the extracellular compartment, A1AT is internalized by lung endothelial cells and inhibits apoptosis. We hypothesized that the intracellular uptake of A1AT by endothelial cells may be required for its protective function; therefore, we studied the mechanisms of A1AT internalization by primary rat lung microvascular endothelial cells and the effect of cigarette smoke on this process both in vitro and in vivo ( in mice). Purified A1AT was taken up intracellularly by endothelial cells in a time-dependent, dose-dependent, and conformer-specific manner and was detected in the cytoplasm of endothelial cells of nondiseased human lung sections. Despite a critical role for caveoli in endothelial cell endocytosis in general, specific inhibition of clathrin-mediated, but not caveoli-mediated, endocytosis profoundly decreased A1AT internalization and reversed the A1AT's antiapoptotic action. Further more, A1AT associated with clathrin heavy chains, but not with caveolin-1 in the plasma membrane fraction of endothelial cells. Interestingly, cigarette smoke exposure significantly inhibited A1AT uptake both in endothelial cells and in the mouse lung and altered the intracellular distribution of clathrin heavy chains. Our results suggest that clathrin-mediated endocytosis regulates A1AT intracellular function in the lung endothelium and may be an important determinant of the serpin's protection against developing cigarette smoke-induced emphysema. Sohrab, S., Petrusca, D. N., Lockett, A. D., Schweitzer, K. S., Rush, N. I., Gu, Y., Kamocki, K., Garrison, J., Petrache, I. Mechanism of alpha-1 antitrypsin endocytosis by lung endothelium. FASEB J. 23, 3149-3158 (2009). www.fasebj.org	[Sohrab, Sadaf; Petrusca, Daniela N.; Lockett, Angelia D.; Schweitzer, Kelly S.; Rush, Natalia I.; Gu, Yuan; Kamocki, Krzysztof; Garrison, Jana; Petrache, Irina] Indiana Univ, Div Pulm Allergy Crit Care & Occupat Med, Dept Med, Indianapolis, IN 46202 USA; [Lockett, Angelia D.] Indiana Univ, Dept Microbiol & Immunol, Indianapolis, IN 46204 USA; [Kamocki, Krzysztof; Petrache, Irina] Indiana Univ, Dept Biochem & Mol Biol, Indianapolis, IN 46204 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Petrache, I (corresponding author), Indiana Univ, Div Pulm Allergy Crit Care & Occupat Med, Dept Med, Walther Hall R3,C400,980 W Walnut St, Indianapolis, IN 46202 USA.	ipetrach@iupui.edu	Petrache, Irina/AAZ-9648-2020		Flight Attendent Medical Research Institute (FAMRI); National Institutes of Health, National Heart, Lung, and Blood Institute [1P50 HL084945]; VA Merit Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060519] Funding Source: NIH RePORTER	Flight Attendent Medical Research Institute (FAMRI); National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); VA Merit Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Mary Van Demark and Jeremy Adamowicz for superb technical assistance with caspase-3 and elastase activity assays and mouse tail-vein injection, respectively. This study was supported by the Flight Attendent Medical Research Institute (FAMRI); the National Institutes of Health, National Heart, Lung, and Blood Institute grant 1P50 HL084945; and a VA Merit Award.	Aldonyte R, 2008, COPD, V5, P153, DOI 10.1080/15412550802092936; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Campos MA, 2005, CHEST, V128, P1179, DOI 10.1378/chest.128.3.1179; CARLSON JA, 1988, J CLIN INVEST, V82, P26, DOI 10.1172/JCI113580; CARP H, 1980, EXP LUNG RES, V1, P225, DOI 10.3109/01902148009065462; CARRELL RW, 1986, J CLIN INVEST, V78, P1427, DOI 10.1172/JCI112731; Dabbagh K, 2001, J CELL PHYSIOL, V186, P73, DOI 10.1002/1097-4652(200101)186:1<73::AID-JCP1002>3.0.CO;2-Q; GADEK JE, 1981, J CLIN INVEST, V68, P1158, DOI 10.1172/JCI110360; HANOVER JA, 1984, CELL, V39, P283, DOI 10.1016/0092-8674(84)90006-0; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Huang HH, 2004, INT J CANCER, V112, P1042, DOI 10.1002/ijc.20494; HUBBARD RC, 1990, LUNG, V168, P565, DOI 10.1007/BF02718179; JANOFF A, 1979, SCIENCE, V206, P1313, DOI 10.1126/science.316187; Kounnas MZ, 1996, J BIOL CHEM, V271, P6523, DOI 10.1074/jbc.271.11.6523; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; MARTIN OC, 1994, J CELL BIOL, V125, P769, DOI 10.1083/jcb.125.4.769; Miller SDW, 2007, HEPATOLOGY, V46, P496, DOI 10.1002/hep.21689; MOLMENTI EP, 1993, J CLIN INVEST, V92, P2022, DOI 10.1172/JCI116797; Mulgrew AT, 2004, CHEST, V125, P1952, DOI 10.1378/chest.125.5.1952; PERLMUTTER DH, 1990, J BIOL CHEM, V265, P16713; Petrache I, 2008, AM J PHYSIOL-LUNG C, V295, pL44, DOI 10.1152/ajplung.00448.2007; Petrache I, 2006, AM J PATHOL, V169, P1155, DOI 10.2353/ajpath.2006.060058; Petrache L, 2006, AM J RESP CRIT CARE, V173, P1222, DOI 10.1164/rccm.200512-1842OC; PREDESCU D, 1993, AM J PHYSIOL, V265, pH725, DOI 10.1152/ajpheart.1993.265.2.H725; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; ROTHBERG KG, 1990, J CELL BIOL, V111, P2931, DOI 10.1083/jcb.111.6.2931; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Sharma DK, 2003, J BIOL CHEM, V278, P7564, DOI 10.1074/jbc.M210457200; Simone E, 2009, CELL TISSUE RES, V335, P283, DOI 10.1007/s00441-008-0676-7; Singh RD, 2003, MOL BIOL CELL, V14, P3254, DOI 10.1091/mbc.E02-12-0809; SMITH KF, 1990, BIOCHEM J, V267, P203, DOI 10.1042/bj2670203; SOFER A, 1995, J BIOL CHEM, V270, P12117, DOI 10.1074/jbc.270.20.12117; Subramaniyam D, 2008, INT J BIOCHEM CELL B, V40, P258, DOI 10.1016/j.biocel.2007.07.016; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Taggart C, 2000, J BIOL CHEM, V275, P27258; Talmud PJ, 2003, ARTERIOSCL THROM VAS, V23, P644, DOI 10.1161/01.ATV.0000065196.61663.8D; Tuder RM, 2007, AM J RESP CELL MOL, V37, P130, DOI 10.1165/rcmb.2007-0163TR; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107	38	43	44	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2009	23	9					3149	3158		10.1096/fj.09-129304	http://dx.doi.org/10.1096/fj.09-129304			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	499QZ	19423638	Green Published			2022-12-25	WOS:000270241000037
J	Cheli, Y; Luciani, F; Khaled, M; Beuret, L; Bille, K; Gounon, P; Ortonne, JP; Bertolotto, C; Ballotti, R				Cheli, Yann; Luciani, Flavie; Khaled, Mehdi; Beuret, Laurent; Bille, Karine; Gounon, Pierre; Ortonne, Jean-Paul; Bertolotto, Corine; Ballotti, Robert			alpha MSH and Cyclic AMP Elevating Agents Control Melanosome pH through a Protein Kinase A-independent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PINK-EYED DILUTION; OCULOCUTANEOUS ALBINISM; H+-ATPASE; INHIBITION; TYROSINASE; GENE; MELANOGENESIS; MELANOCYTES; ACTIVATION; MITF	Melanins are synthesized in melanocytes within specialized organelles called melanosomes. Numerous studies have shown that the pH of melanosome plays a key role in the regulation of melanin synthesis. However, until now, acute regulation of melanosome pH by a physiological stimulus has never been demonstrated. In the present study, we show that the activation of the cAMP pathway by alpha MSH or forskolin leads to an alkalinization of melanosomes and a concomitant regulation of vacuolar ATPases and ion transporters of the solute carrier family. The solute carrier family members include SLC45A2, which is mutated in oculocutaneous albinism type IV, SLC24A4 and SLC24A5, proteins implicated in the control of eye, hair, and skin pigmentation, and the P protein, encoded by the oculocutaneous albinism type II locus. Interestingly, H89, a pharmacological inhibitor of protein kinase A (PKA), prevents the cAMP-induced pigmentation and induces acidification of melanosomes. The drastic depigmenting effect of H89 is not due to an inhibition of tyrosinase expression. Indeed, H89 blocks the induction of melanogenesis induced by LY294002, a potent inhibitor of the PI 3-kinase pathway, without any effect on tyrosinase expression. Furthermore, PKA is not involved in the inhibition of pigmentation promoted by H89 because LY294002 induces pigmentation independently of PKA. Also, other PKA inhibitors do not affect pigmentation. Taken together, our results strengthen the support for a key role of melanosome pH in the regulation of melanin synthesis and, for the first time, demonstrate that melanosome pH is regulated by cAMP and alpha MSH. Notably, these are both mediators of the response to solar UV radiation, the main physiological stimulus of skin pigmentation.	[Cheli, Yann; Luciani, Flavie; Khaled, Mehdi; Beuret, Laurent; Bille, Karine; Ortonne, Jean-Paul; Bertolotto, Corine; Ballotti, Robert] C3M, INSERM, U895, Equipe 1, F-06204 Nice 3, France; [Ortonne, Jean-Paul; Bertolotto, Corine; Ballotti, Robert] CHU Nice, Dept Dermatol, F-06202 Nice 3, France; [Cheli, Yann; Luciani, Flavie; Khaled, Mehdi; Beuret, Laurent; Bille, Karine; Bertolotto, Corine; Ballotti, Robert] Univ Nice Sophia Antipolis, UFR Med, F-06107 Nice 2, France; [Gounon, Pierre] Univ Nice Sophia Antipolis, Ctr Commun Microscopie Appl, F-06108 Nice 2, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Ballotti, R (corresponding author), INSERM, Equipe 1, U895, 28 Ave Valombrose, F-06107 Nice 2, France.	ballotti@unice.fr	Bertolotto, Corine/AAF-6634-2021; khaled, mehdi/C-4854-2012; Cheli, Yann/O-5783-2016; Bertolotto-Ballotti, Corine/O-2155-2016; BALLOTTI, Robert/F-8825-2013	Bertolotto, Corine/0000-0001-6971-7753; khaled, mehdi/0000-0002-9880-858X; Cheli, Yann/0000-0001-9839-4332; Luciani, Flavie/0000-0002-6130-0889; BALLOTTI, Robert/0000-0002-7322-4908				Ancans J, 2000, FEBS LETT, V478, P57, DOI 10.1016/S0014-5793(00)01795-6; Ancans J, 2001, EXP CELL RES, V268, P26, DOI 10.1006/excr.2001.5251; ASANO T, 1989, BRIT J PHARMACOL, V98, P1091, DOI 10.1111/j.1476-5381.1989.tb12652.x; Basrur V, 2003, J PROTEOME RES, V2, P69, DOI 10.1021/pr025562r; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; BHATNAGAR V, 1993, ARCH BIOCHEM BIOPHYS, V307, P183, DOI 10.1006/abbi.1993.1577; Brilliant MH, 2001, PIGM CELL RES, V14, P86, DOI 10.1034/j.1600-0749.2001.140203.x; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; Busca R, 1998, MOL BIOL CELL, V9, P1367, DOI 10.1091/mbc.9.6.1367; Busca R, 1996, J BIOL CHEM, V271, P31824, DOI 10.1074/jbc.271.50.31824; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Chi A, 2006, J PROTEOME RES, V5, P3135, DOI 10.1021/pr060363j; Chiaverini C, 2008, J BIOL CHEM, V283, P12635, DOI 10.1074/jbc.M800130200; Costin GE, 2003, J CELL SCI, V116, P3203, DOI 10.1242/jcs.00598; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Du JY, 2003, AM J PATHOL, V163, P333, DOI 10.1016/S0002-9440(10)63657-7; Englaro W, 1998, J BIOL CHEM, V273, P9966, DOI 10.1074/jbc.273.16.9966; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Fuller BB, 2001, EXP CELL RES, V262, P197, DOI 10.1006/excr.2000.5092; Ginger RS, 2008, J BIOL CHEM, V283, P5486, DOI 10.1074/jbc.M707521200; Hearing VJ, 1999, J INVEST DERM SYMP P, V4, P24, DOI 10.1038/sj.jidsp.5640176; Hearing VJ, 2005, J DERMATOL SCI, V37, P3, DOI 10.1016/j.jdermsci.2004.08.014; HIDAKA H, 1984, ADV CYCLIC NUCL PROT, V16, P245; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Le Brigand K, 2007, BIOINFORMATICS, V23, P1304, DOI 10.1093/bioinformatics/btm106; Le Brigand K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl485; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Newton JM, 2001, AM J HUM GENET, V69, P981, DOI 10.1086/324340; Ortonne JP, 2002, BRIT J DERMATOL, V146, P7, DOI 10.1046/j.1365-2133.146.s61.3.x; Passeron T, 2004, FASEB J, V18, P989, DOI 10.1096/fj.03-1240fje; Puri N, 2000, J INVEST DERMATOL, V115, P607, DOI 10.1046/j.1523-1747.2000.00108.x; SAEKI H, 1985, J INVEST DERMATOL, V85, P423, DOI 10.1111/1523-1747.ep12277091; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Tabata H, 2008, CELL TISSUE RES, V332, P447, DOI 10.1007/s00441-008-0597-5; Toyofuku K, 2002, PIGM CELL RES, V15, P217, DOI 10.1034/j.1600-0749.2002.02007.x; Vetrini F, 2004, MOL CELL BIOL, V24, P6550, DOI 10.1128/mcb.24.15.6550-6559.2004; Wu M, 2000, GENE DEV, V14, P301; Xu WD, 2000, EXP CELL RES, V255, P135, DOI 10.1006/excr.2000.4803	40	54	60	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18699	18706		10.1074/jbc.M109.005819	http://dx.doi.org/10.1074/jbc.M109.005819			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19389708	hybrid, Green Published			2022-12-25	WOS:000267711500019
J	Handa, N; Amitani, I; Gumlaw, N; Sandler, SJ; Kowalczykowski, SC				Handa, Naofumi; Amitani, Ichiro; Gumlaw, Nathan; Sandler, Steven J.; Kowalczykowski, Stephen C.			Single Molecule Analysis of a Red Fluorescent RecA Protein Reveals a Defect in Nucleoprotein Filament Nucleation That Relates to Its Reduced Biological Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA STRAND EXCHANGE; DEPENDENT ATPASE ACTIVITY; ESCHERICHIA-COLI RECF; GENETIC-RECOMBINATION; SSB PROTEIN; BINDING-PROTEIN; CHI-RECOGNITION; MUTANT; MUTATIONS; RECBCD	Fluorescent fusion proteins are exceedingly useful for monitoring protein localization in situ or visualizing protein behavior at the single molecule level. Unfortunately, some proteins are rendered inactive by the fusion. To circumvent this problem, we fused a hyperactive RecA protein (RecA803 protein) to monomeric red fluorescent protein (mRFP1) to produce a functional protein (RecA-RFP) that is suitable for in vivo and in vitro analysis. In vivo, the RecA-RFP partially restores UV resistance, conjugational recombination, and SOS induction to recA(-) cells. In vitro, the purified RecA-RFP protein forms a nucleoprotein filament whose k(cat) for single-stranded DNA-dependent ATPase activity is reduced similar to 3-fold relative to wild-type protein, and which is largely inhibited by single-stranded DNA-binding protein. However, RecA protein is also a dATPase; dATP supports RecA-RFP nucleoprotein filament formation in the presence of single-stranded DNA-binding protein. Furthermore, as for the wild-type protein, the activities of RecA-RFP are further enhanced by shifting the pH to 6.2. As a consequence, RecA-RFP is proficient for DNA strand exchange with dATP or at lower pH. Finally, using single molecule visualization, RecA-RFP was seen to assemble into a continuous filament on duplex DNA, and to extend the DNA similar to 1.7-fold. Consistent with its attenuated activities, RecA-RFP nucleates onto double-stranded DNA similar to 3-fold more slowly than the wild-type protein, but still requires similar to 3 monomers to form the rate-limited nucleus needed for filament assembly. Thus, RecA-RFP reveals that its attenuated biological functions correlate with a reduced frequency of nucleoprotein filament nucleation at the single molecule level.	[Handa, Naofumi; Amitani, Ichiro; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Handa, Naofumi; Amitani, Ichiro; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Handa, Naofumi] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo 1088639, Japan; [Gumlaw, Nathan; Sandler, Steven J.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Tokyo; University of Massachusetts System; University of Massachusetts Amherst	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Dept Microbiol, 1 Shields Ave,Briggs Hall,Rm 310, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu	Handa, Naofumi/H-6640-2017	Handa, Naofumi/0000-0003-3695-1871	National Institutes of Health [GM-62653]; Japan Society for the Promotion of Science (JSPS) [1770001, 19790316]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [17049008, 19037006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062653, R01GM062653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-62653 (to S. C. K.). This work was also supported by " Grants-inaid for Scientific Research" from the Japan Society for the Promotion of Science (JSPS) (1770001 and 19790316) and Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grants 17049008 and 19037006 to N.H.).	Amitani I, 2006, MOL CELL, V23, P143, DOI 10.1016/j.molcel.2006.05.009; Anderson DG, 1999, J BIOL CHEM, V274, P27139, DOI 10.1074/jbc.274.38.27139; Arenson TA, 1999, J MOL BIOL, V288, P391, DOI 10.1006/jmbi.1999.2705; Bachmann B.J., 1987, ESCHERICHIA COLI SAL, P1190; Beernink HTH, 1999, TRENDS BIOCHEM SCI, V24, P385, DOI 10.1016/S0968-0004(99)01451-6; Bianco P R, 1998, Front Biosci, V3, pD570; BRENNER SL, 1990, J MOL BIOL, V216, P949, DOI 10.1016/S0022-2836(99)80013-8; BRYANT FR, 1988, J BIOL CHEM, V263, P8716; Campbell MJ, 1999, J MOL BIOL, V286, P437, DOI 10.1006/jmbi.1998.2457; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; CLARK AJ, 1973, ANNU REV GENET, V7, P67, DOI 10.1146/annurev.ge.07.120173.000435; DUTREIX M, 1985, J BACTERIOL, V161, P1080, DOI 10.1128/JB.161.3.1080-1085.1985; EGELMAN EH, 1986, J MOL BIOL, V191, P677, DOI 10.1016/0022-2836(86)90453-5; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; Handa N, 2005, MOL CELL, V17, P745, DOI 10.1016/j.molcel.2005.02.011; HORII ZI, 1973, J MOL BIOL, V80, P327, DOI 10.1016/0022-2836(73)90176-9; KARASAKI Y, 1987, SANGYO IKA DAIGAKU Z, V9, P141; Katz FS, 2001, BIOCHEMISTRY-US, V40, P11082, DOI 10.1021/bi011030x; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; KOWALCZYKOWSKI SC, 1991, BIOCHIMIE, V73, P289, DOI 10.1016/0300-9084(91)90216-N; KOWALCZYKOWSKI SC, 1986, BIOCHEMISTRY-US, V25, P5872, DOI 10.1021/bi00368a006; KOWALCZYKOWSKI SC, 1989, J MOL BIOL, V207, P719, DOI 10.1016/0022-2836(89)90239-8; KOWALCZYKOWSKI SC, 1987, P NATL ACAD SCI USA, V84, P3127, DOI 10.1073/pnas.84.10.3127; KOWALCZYKOWSKI SC, 1991, ANNU REV BIOPHYS BIO, V20, P539, DOI 10.1146/annurev.bb.20.060191.002543; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; LAVERY PE, 1992, J BIOL CHEM, V267, P20648; LAVERY PE, 1992, J BIOL CHEM, V267, P9307; LAVERY PE, 1990, J BIOL CHEM, V265, P4004; LEBOWITZ J, 1985, BIOCH MECH STRAND IN; Lin ZG, 2006, P NATL ACAD SCI USA, V103, P10328, DOI 10.1073/pnas.0604232103; MADIRAJU MVVS, 1988, P NATL ACAD SCI USA, V85, P6592, DOI 10.1073/pnas.85.18.6592; McCool JD, 2001, P NATL ACAD SCI USA, V98, P8203, DOI 10.1073/pnas.121007698; MCENTEE K, 1981, J BIOL CHEM, V256, P8835; MEAH YS, 1993, J BIOL CHEM, V268, P23991; MENETSKI JP, 1989, BIOCHEMISTRY-US, V28, P5871, DOI 10.1021/bi00440a025; MENETSKI JP, 1990, J MOL BIOL, V211, P845, DOI 10.1016/0022-2836(90)90078-Z; MIKAWA T, 1995, J MOL BIOL, V250, P471, DOI 10.1006/jmbi.1995.0391; Mirshad JK, 2003, BIOCHEMISTRY-US, V42, P5945, DOI 10.1021/bi027233i; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; MUENCH KA, 1991, J BIOL CHEM, V266, P844; NIE SM, 1994, SCIENCE, V266, P1018, DOI 10.1126/science.7973650; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; PINSINCE JM, 1993, J MOL BIOL, V233, P59, DOI 10.1006/jmbi.1993.1484; PUGH BF, 1987, J BIOL CHEM, V262, P1337; Renzette N, 2005, MOL MICROBIOL, V57, P1074, DOI 10.1111/j.1365-2958.2005.04755.x; Sandler SJ, 1996, GENETICS, V143, P5; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; SKIBA MC, 1994, J BIOL CHEM, V269, P3823; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; Spies Maria, 2005, P389; STASIAK A, 1982, NATURE, V299, P185, DOI 10.1038/299185a0; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; UMEZU K, 1994, J BIOL CHEM, V269, P30005; VOLKERT MR, 1984, J BACTERIOL, V157, P498, DOI 10.1128/JB.157.2.498-506.1984; West SC, 1996, J BACTERIOL, V178, P1237, DOI 10.1128/jb.178.5.1237-1241.1996; Zaitsev EN, 1999, MOL MICROBIOL, V34, P1, DOI 10.1046/j.1365-2958.1999.01552.x; Zaitsev EN, 1998, NUCLEIC ACIDS RES, V26, P650, DOI 10.1093/nar/26.2.650	65	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18664	18673		10.1074/jbc.M109.004895	http://dx.doi.org/10.1074/jbc.M109.004895			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19419960	Green Published, hybrid			2022-12-25	WOS:000267711500015
J	Thomas, JT; Canelos, P; Luyten, FP; Moos, M				Thomas, J. Terrig; Canelos, Paola; Luyten, Frank P.; Moos, Malcolm, Jr.			Xenopus SMOC-1 Inhibits Bone Morphogenetic Protein Signaling Downstream of Receptor Binding and Is Essential for Postgastrulation Development in Xenopus.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; SPEMANN ORGANIZER; NEURAL INDUCTION; EXPRESSION; BMP; FAMILY; LAEVIS; NOGGIN	The bone morphogenetic protein (BMP) family of signaling molecules and their antagonists are involved in patterning of the body axis and numerous aspects of organogenesis. Classical biochemical purification and protein sequencing of highly purified fractions containing potent bone forming activity from bovine cartilage identified several BMPs together with a number of other proteins. One such protein was SMOC-2 (secreted modular calcium-binding protein-2), classified as belonging to the BM-40 family of modular extracellular proteins. Data regarding the biological function of SMOC-2 and closely related SMOC-1 remain limited, and their expression or function during embryological development is unknown. We therefore isolated the Xenopus ortholog of human SMOC-1 (XSMOC-1) and explored its function in Xenopus embryos. In gain-of-function assays, XSMOC-1 acted similarly to a BMP antagonist. However, in contrast to known extracellular ligand-binding BMP antagonists, such as noggin, SMOC antagonizes BMP activity in the presence of a constitutively active BMP receptor, indicating a mechanism of action downstream of the receptor. We provide several lines of evidence to suggest that SMOC acts downstream of the BMP receptor via MAPK-mediated phosphorylation of the Smad linker region. Loss-of-function studies, using antisense morpholino oligonucleotides, revealed XSMOC-1 to be essential for postgastrulation development. The catastrophic developmental failure observed following XSMOC knockdown resembles that observed following simultaneous depletion of three ligand-binding BMP antagonists described in prior studies. These findings provide a direct link between the extracellular matrix-associated protein SMOC and a signaling pathway of general importance in anatomic patterning and cell or tissue fate specification.	[Thomas, J. Terrig; Canelos, Paola; Moos, Malcolm, Jr.] US FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; [Luyten, Frank P.] Katholieke Univ Leuven, Dept Musculoskeletal Sci, Div Rheumatol, Lab Skeletal Dev & Joint Disorders, B-3000 Louvain, Belgium	US Food & Drug Administration (FDA); KU Leuven	Thomas, JT (corresponding author), US FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA.	john.thomas@fda.hhs.gov; malcolm.moos@fda.hhs.gov	Luyten, Frank/GPS-7793-2022; Moos, Malcolm C/F-3673-2011	Moos, Malcolm C/0000-0002-9575-9938				Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; Chang CB, 1999, DEVELOPMENT, V126, P3347; CHANG SC, 1994, J BIOL CHEM, V269, P28227; CLEMENT JH, 1995, MECH DEVELOP, V52, P357, DOI 10.1016/0925-4773(95)00413-U; COOKE J, 1979, J EMBRYOL EXP MORPH, V51, P165; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Francki A, 1999, J BIOL CHEM, V274, P32145, DOI 10.1074/jbc.274.45.32145; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; Gurdon J. B., 1967, METHODS DEV BIOL, P75; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HASSELAAR P, 1992, J CELL BIOCHEM, V49, P272, DOI 10.1002/jcb.240490310; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; HEMMATIBRIVANLOU A, 1995, DEV GENET, V17, P78, DOI 10.1002/dvg.1020170109; HemmatiBrivanlou A, 1997, CELL, V88, P13, DOI 10.1016/S0092-8674(00)81853-X; Hoang B, 1996, J BIOL CHEM, V271, P26131, DOI 10.1074/jbc.271.42.26131; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; KAO KR, 1988, DEV BIOL, V127, P64, DOI 10.1016/0012-1606(88)90189-3; KELLER R, 1991, METHOD CELL BIOL, V36, P61; Khokha MK, 2005, DEV CELL, V8, P401, DOI 10.1016/j.devcel.2005.01.013; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Lallier TE, 2000, DEV BIOL, V225, P135, DOI 10.1006/dbio.2000.9833; Lallier TE, 1996, DEVELOPMENT, V122, P2539; Lin JM, 2005, NAT MED, V11, P387, DOI 10.1038/nm1217; Liu PJ, 2008, MOL BIOL CELL, V19, P248, DOI 10.1091/mbc.E07-05-0510; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Moos M, 1995, DEVELOPMENT, V121, P4293; PAULSSON M, 1992, CRIT REV BIOCHEM MOL, V27, P93; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; Rocnik EF, 2006, J BIOL CHEM, V281, P22855, DOI 10.1074/jbc.M513463200; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Vannahme C, 2003, BIOCHEM J, V373, P805, DOI 10.1042/BJ20030532; Vannahme C, 2002, J BIOL CHEM, V277, P37977, DOI 10.1074/jbc.M203830200; Vonica A, 2006, SEMIN CELL DEV BIOL, V17, P117, DOI 10.1016/j.semcdb.2005.11.013; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wang Shouwen, 1997, Genes and Function, V1, P259; Weinstein DC, 1999, ANNU REV CELL DEV BI, V15, P411, DOI 10.1146/annurev.cellbio.15.1.411; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Yamada KM, 2002, NAT CELL BIOL, V4, pE75, DOI 10.1038/ncb0402-e75; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	48	31	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18994	19005		10.1074/jbc.M807759200	http://dx.doi.org/10.1074/jbc.M807759200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19414592	Green Published, hybrid			2022-12-25	WOS:000267711500049
J	Kostan, J; Gregor, M; Walko, G; Wiche, G				Kostan, Julius; Gregor, Martin; Walko, Gernot; Wiche, Gerhard			Plectin Isoform-dependent Regulation of Keratin-Integrin alpha 6 beta 4 Anchorage via Ca2+/Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING DOMAIN; F-ACTIN; EPIDERMOLYSIS-BULLOSA; BETA-4 INTEGRIN; CULTURED-CELLS; IN-VIVO; HEMIDESMOSOMES; MIGRATION; RECEPTOR; IDENTIFICATION	The detachment of epithelial cells from the basal matrix during wound healing and differentiation of keratinocytes requires the disassembly of the hemidesmosomal multiprotein adhesion complex. Integrin alpha 6 beta 4-plectin interaction plays a major role in the formation of hemidesmosomes, and thus the mechanisms regulating this interaction should be critical also for the disassembly process. Here we show that a particular plectin isoform (1a) interacts with the Ca2+-sensing protein calmodulin in a Ca2+-dependent manner. As a result of this interaction, binding of the hemidesmosome-associated plectin isoform 1a to integrin beta 4 is substantially diminished. Calmodulin-binding inhibits also the interaction of plectin with F-actin. Further, we found that, during Ca2+-induced keratinocyte differentiation, plectin 1a is first relocated within the cell and later down-regulated, suggesting that Ca2+ affects the fate of plectin 1a upon its release from hemidesmosomes. We propose a novel model for the disassembly of hemidesmosomes during keratinocyte differentiation, where both, binding of calmodulin to plectin 1a and phosphorylation of integrin beta 4 by protein kinases, are required for disruption of the integrin alpha 6 beta 4-plectin complex.	[Kostan, Julius; Gregor, Martin; Walko, Gernot; Wiche, Gerhard] Univ Vienna, Max F Perutz Labs, Dept Mol Cell Biol, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Wiche, G (corresponding author), Univ Vienna, Max F Perutz Labs, Dept Mol Cell Biol, Waehringer Guertel 18, A-1030 Vienna, Austria.	gerhard.wiche@univie.ac.at	WICHE, Gerhard/AAA-3227-2021; Gregor, Martin/G-4411-2014	Gregor, Martin/0000-0001-6841-9527; Kostan, Julius/0000-0002-8347-111X; Wiche, Gerhard/0000-0001-9550-5463; Walko, Gernot/0000-0002-8504-1738	Austrian Science Research Fund [P20744-B11]; Dystrophic Epidermolysis Research Association, UK	Austrian Science Research Fund(Austrian Science Fund (FWF)); Dystrophic Epidermolysis Research Association, UK	This work was supported by the Austrian Science Research Fund (Grant P20744-B11) and from Dystrophic Epidermolysis Research Association, UK.	Ackerl R, 2007, J CELL SCI, V120, P2435, DOI 10.1242/jcs.004481; Andra K, 2003, J INVEST DERMATOL, V120, P189, DOI 10.1046/j.1523-1747.2003.12027.x; Andra K, 1998, GENE DEV, V12, P3442, DOI 10.1101/gad.12.21.3442; Andra K, 1997, GENE DEV, V11, P3143, DOI 10.1101/gad.11.23.3143; BONETKERRACHE A, 1994, FEBS LETT, V355, P49, DOI 10.1016/0014-5793(94)01162-1; Eger A, 1997, J CELL SCI, V110, P1307; Elliott CE, 1997, GENOMICS, V42, P115, DOI 10.1006/geno.1997.4724; Fuchs P, 1999, HUM MOL GENET, V8, P2461, DOI 10.1093/hmg/8.13.2461; Garcia-Alvarez B, 2003, STRUCTURE, V11, P615, DOI 10.1016/S0969-2126(03)00090-X; Geerts D, 1999, J CELL BIOL, V147, P417, DOI 10.1083/jcb.147.2.417; GIPSON IK, 1993, EXP CELL RES, V207, P86, DOI 10.1006/excr.1993.1166; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; JARRETT HW, 1995, J BIOL CHEM, V270, P5578, DOI 10.1074/jbc.270.10.5578; Jones JCR, 1998, BIOESSAYS, V20, P488, DOI 10.1002/(SICI)1521-1878(199806)20:6<488::AID-BIES7>3.0.CO;2-I; Jones SM, 2006, NAT REV CANCER, V6, P175, DOI 10.1038/nrc1817; KITAJIMA Y, 1992, EXP CELL RES, V203, P17, DOI 10.1016/0014-4827(92)90034-6; Konieczny P, 2008, J CELL BIOL, V181, P667, DOI 10.1083/jcb.200711058; Koss-Harnes D, 2002, J INVEST DERMATOL, V118, P87, DOI 10.1046/j.0022-202x.2001.01591.x; Koster J, 2004, MOL BIOL CELL, V15, P1211, DOI 10.1091/mbc.E03-09-0697; Lee Karen Ying, 2004, J Med, V35, P141; Litjens SHM, 2006, TRENDS CELL BIOL, V16, P376, DOI 10.1016/j.tcb.2006.05.004; Litjens SHM, 2003, MOL BIOL CELL, V14, P4039, DOI 10.1091/mbc.E03-05-0268; Margadant C, 2008, CURR OPIN CELL BIOL, V20, P589, DOI 10.1016/j.ceb.2008.05.001; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Nakamura F, 2005, J BIOL CHEM, V280, P32426, DOI 10.1074/jbc.M502203200; Nikolic B, 1996, J CELL BIOL, V134, P1455, DOI 10.1083/jcb.134.6.1455; Osmanagic-Myers S, 2004, J BIOL CHEM, V279, P18701, DOI 10.1074/jbc.M312382200; Osmanagic-Myers S, 2006, J CELL BIOL, V174, P557, DOI 10.1083/jcb.200605172; Pfendner E, 2005, EXP DERMATOL, V14, P241, DOI 10.1111/j.0906-6705.2005.00324.x; Rabinovitz I, 2004, MOL CELL BIOL, V24, P4351, DOI 10.1128/MCB.24.10.4351-4360.2004; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Rezniczek GA, 2004, METHOD CELL BIOL, V78, P721; Rezniczek GA, 2003, HUM MOL GENET, V12, P3181, DOI 10.1093/hmg/ddg345; Rezniczek GA, 1998, J CELL BIOL, V141, P209, DOI 10.1083/jcb.141.1.209; Rezniczek GA, 2007, J CELL BIOL, V176, P965, DOI 10.1083/jcb.200604179; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; Sevcik J, 2004, EUR J BIOCHEM, V271, P1873, DOI 10.1111/j.1432-1033.2004.04095.x; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stegh AH, 2000, MOL CELL BIOL, V20, P5665, DOI 10.1128/MCB.20.15.5665-5679.2000; Stepp MA, 1996, INVEST OPHTH VIS SCI, V37, P1593; Tennenbaum T, 1996, CELL GROWTH DIFFER, V7, P615; Toivola DM, 2002, MOL BIOL CELL, V13, P1857, DOI 10.1091/mbc.01-12-0591; Wiche G, 1998, J CELL SCI, V111, P2477; WICHE G, 1984, EXP CELL RES, V155, P43, DOI 10.1016/0014-4827(84)90766-3; Wilhelmsen K, 2007, MOL BIOL CELL, V18, P3512, DOI 10.1091/mbc.E07-04-0306; WINDER SJ, 1995, FEBS LETT, V357, P125, DOI 10.1016/0014-5793(94)01347-4; Winter L, 2008, J CELL BIOL, V181, P903, DOI 10.1083/jcb.200710151	47	38	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18525	18536		10.1074/jbc.M109.008474	http://dx.doi.org/10.1074/jbc.M109.008474			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19419971	Green Published, hybrid			2022-12-25	WOS:000267712400063
J	Zunino, R; Braschi, E; Xu, LQ; McBride, HM				Zunino, Rodolfo; Braschi, Emelie; Xu, Liqun; McBride, Heidi M.			Translocation of SenP5 from the Nucleoli to the Mitochondria Modulates DRP1-dependent Fission during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CELL-CYCLE PROGRESSION; SUMO-SPECIFIC PROTEASE; E3 UBIQUITIN LIGASE; IN-VIVO; TOPORS FUNCTIONS; DRP1; SUMOYLATION; PHOSPHORYLATION; MORPHOLOGY	The mechanisms that ensure an equal inheritance of cellular organelles during mitosis are an important area of study in cell biology. For the mitochondria fragment during mitosis, however, the cellular links that signal these changes are largely unknown. Werecently identified a SUMO protease, SenP5, that deSUMOylates a number of mitochondrial targets, including the dynamin-related fission GTPase, DRP1. In interphase, SenP5 resides primarily within the nucleoli, in addition to a cytosolic pool. Here we report the relocalization of SenP5 from the nucleoli to the mitochondrial surface at G(2)/M transition prior to nuclear envelope breakdown. The recruitment of SenP5 results in a significant loss in mitochondrial SUMOylation, and a concomitant increase in the labile pool of DRP1 that drives mitochondrial fragmentation. Importantly, silencing of SenP5 leads to an arrest in the cell cycle precisely at the time when the protease is translocated to the mitochondria. These data indicate that transition of SenP5 to the mitochondria plays an important role in mitochondrial fragmentation during mitosis. The altered intracellular localization of SenP5 represents the first example of the mitochondrial recruitment of a SUMO protease and provides new insights into the mechanisms of interorganellar communication during the cell cycle.	[Zunino, Rodolfo; Braschi, Emelie; Xu, Liqun; McBride, Heidi M.] Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada	University of Ottawa; University of Ottawa Heart Institute	McBride, HM (corresponding author), Rm H445A,40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.	hmcbride@ottawaheart.ca	McBride, Heidi M./ABD-5774-2021; McBride, Heidi M/C-1162-2008	McBride, Heidi M./0000-0003-4666-2280; McBride, Heidi M/0000-0003-4666-2280	Canadian Institutes of Health Research [68833]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research Grant 68833.	Bhar D, 2006, J BIOL CHEM, V281, P17312, DOI 10.1074/jbc.M513530200; Bischof O, 2006, MOL CELL, V22, P783, DOI 10.1016/j.molcel.2006.05.016; Blagosklonny MV, 2007, CELL CYCLE, V6, P70, DOI 10.4161/cc.6.1.3682; Boldogh IR, 2005, GENE, V354, P28, DOI 10.1016/j.gene.2005.03.049; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Di Bacco A, 2006, MOL CELL BIOL, V26, P4489, DOI 10.1128/MCB.02301-05; Felberbaum R, 2008, CELL CYCLE, V7, P52, DOI 10.4161/cc.7.1.5218; Fukushima NH, 2001, MOL BIOL CELL, V12, P2756, DOI 10.1091/mbc.12.9.2756; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Hammer E, 2007, FEBS LETT, V581, P5418, DOI 10.1016/j.febslet.2007.10.040; Harder Z, 2004, CURR BIOL, V14, P340, DOI 10.1016/j.cub.2004.02.004; Ihara M, 2007, J BIOL CHEM, V282, P16465, DOI 10.1074/jbc.M610723200; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064; Li SJ, 2003, J CELL BIOL, V160, P1069, DOI 10.1083/jcb.200212052; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Makhnevych T, 2007, J CELL BIOL, V177, P39, DOI 10.1083/jcb.200608066; Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Matic I, 2008, J PROTEOME RES, V7, P4050, DOI 10.1021/pr800368m; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Mukhopadhyay D, 2006, J CELL BIOL, V174, P939, DOI 10.1083/jcb.200510103; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Pungaliya P, 2007, J PROTEOME RES, V6, P3918, DOI 10.1021/pr0703674; Rajendra R, 2004, J BIOL CHEM, V279, P36440, DOI 10.1074/jbc.C400300200; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shin HW, 1999, J BIOL CHEM, V274, P2780, DOI 10.1074/jbc.274.5.2780; STEIN GS, 1972, J CELL BIOL, V52, P292, DOI 10.1083/jcb.52.2.292; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Taylor DL, 2002, J CELL SCI, V115, P1113; Varadi A, 2004, J CELL SCI, V117, P4389, DOI 10.1242/jcs.01299; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Xu Z, 2006, BIOCHEM J, V398, P345, DOI 10.1042/BJ20060526; Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493; Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013; Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418	50	117	122	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17783	17795		10.1074/jbc.M901902200	http://dx.doi.org/10.1074/jbc.M901902200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19411255	hybrid, Green Published			2022-12-25	WOS:000267202500044
J	Kawada, J; Zou, P; Mazitschek, R; Bradner, JE; Cohen, JI				Kawada, Junichi; Zou, Ping; Mazitschek, Ralph; Bradner, James E.; Cohen, Jeffrey I.			Tubacin Kills Epstein-Barr Virus (EBV)-Burkitt Lymphoma Cells by Inducing Reactive Oxygen Species and EBV Lymphoblastoid Cells by Inducing Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; BURKITTS-LYMPHOMA; IN-VIVO; MULTIPLE-MYELOMA; PROTEASOME; BORTEZOMIB; LINE; EXPRESSION; INDUCTION; ESTABLISHMENT	Tubacin is a small molecule inhibitor of histone deacetylase 6 and blocks aggresome activity. We found that Epstein-Barr virus (EBV)-positive Burkitt lymphoma (BL) cells were generally killed by lower doses of tubacin than EBV-transformed lymphoblastoid cells (LCLs) or EBV-negative BL cells. Tubacin induced apoptosis of LCLs, which was inhibited by pretreatment with a pancaspase inhibitor but not by butylated hydroxyanisole, which inhibits reactive oxygen species. In contrast, tubacin killed EBV-positive BL cells in a caspase-3-independent pathway that involved reactive oxygen species and was blocked by butylated hydroxyanisole. Previously, we showed that bortezomib, a proteasome inhibitor, induces apoptosis of EBV LCLs and that LCLs are killed by lower doses of bortezomib than EBV-positive BL cells. Here we found that the combination of bortezomib and tubacin acted in synergy to kill EBV-positive BL cells and LCLs. Tubacin or the combination of bortezomib and tubacin did not induce EBV lytic replication. These findings suggest that the combination of a proteasome inhibitor and an HDAC6 inhibitor may represent a useful strategy for the treatment of certain EBV-associated B cell lymphomas.	[Kawada, Junichi; Zou, Ping; Cohen, Jeffrey I.] NIAID, Med Virol Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Mazitschek, Ralph; Bradner, James E.] Harvard Univ, Broad Inst, Chem Biol Program, Cambridge, MA 02142 USA; [Mazitschek, Ralph; Bradner, James E.] MIT, Cambridge, MA 02142 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Cohen, JI (corresponding author), NIAID, Med Virol Sect, Lab Clin Infect Dis, NIH, 10 Ctr Dr,Bldg 10,Rm 11N234, Bethesda, MD 20892 USA.	jcohen@niaid.nih.gov	Kawada, Jun-ichi/I-7322-2014; Kawada, Jun-ichi/AGA-5782-2022; Mazitschek, Ralph/E-3741-2013	Kawada, Jun-ichi/0000-0003-1553-2539; Kawada, Jun-ichi/0000-0003-1553-2539; Mazitschek, Ralph/0000-0002-1105-689X	National Institutes of Health [K08CA128972, P01CA078048]; NATIONAL CANCER INSTITUTE [P01CA078048, K08CA128972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of NIAID and National Institutes of Health Grants K08CA128972 (to J. E. B.) and P01CA078048 (to R. M.).	Adams J, 2002, TRENDS MOL MED, V8, pS49, DOI 10.1016/S1471-4914(02)02315-8; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; CALENDER A, 1987, P NATL ACAD SCI USA, V84, P8060, DOI 10.1073/pnas.84.22.8060; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; DeBiasi RL, 2004, J VIROL, V78, P11040, DOI 10.1128/JVI.78.20.11040-11050.2004; Faller DV, 2001, CURR OPIN ONCOL, V13, P360, DOI 10.1097/00001622-200109000-00008; Feng WH, 2006, CANCER RES, V66, P8762, DOI 10.1158/0008-5472.CAN-06-1006; GREGORY CD, 1990, J GEN VIROL, V71, P1481, DOI 10.1099/0022-1317-71-7-1481; Haggarty SJ, 2003, CHEM BIOL, V10, P383, DOI 10.1016/S1074-5521(03)00095-4; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Han ZY, 1997, J BIOL CHEM, V272, P13432, DOI 10.1074/jbc.272.20.13432; Hideshima T, 2005, P NATL ACAD SCI USA, V102, P8567, DOI 10.1073/pnas.0503221102; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Johnston JA, 2002, CELL MOTIL CYTOSKEL, V53, P26, DOI 10.1002/cm.10057; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; MENEZES J, 1975, BIOMEDICINE, V22, P276; Nawrocki ST, 2006, CANCER RES, V66, P3773, DOI 10.1158/0008-5472.CAN-05-2961; Park JH, 2002, VIROLOGY, V303, P345, DOI 10.1006/viro.2002.1638; Pei XY, 2004, CLIN CANCER RES, V10, P3839, DOI 10.1158/1078-0432.CCR-03-0561; RICKINSON AB, 2007, FIELDS VIROLOGY, P2655; Roychowdhury S, 2004, JNCI-J NATL CANCER I, V96, P1447, DOI 10.1093/jnci/djh271; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Son YO, 2006, J CELL BIOCHEM, V99, P1420, DOI 10.1002/jcb.21022; TAKADA K, 1991, VIRUS GENES, V5, P147, DOI 10.1007/BF00571929; Ungerstedt JS, 2005, P NATL ACAD SCI USA, V102, P673, DOI 10.1073/pnas.0408732102; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; WANG F, 1990, J VIROL, V64, P2309, DOI 10.1128/JVI.64.5.2309-2318.1990; Yu CR, 2003, BLOOD, V102, P3765, DOI 10.1182/blood-2003-03-0737; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zou P, 2007, J VIROL, V81, P10029, DOI 10.1128/JVI.02241-06	35	27	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17102	17109		10.1074/jbc.M809090200	http://dx.doi.org/10.1074/jbc.M809090200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19386607	hybrid, Green Published			2022-12-25	WOS:000266962400048
J	Peyot, ML; Guay, C; Latour, MG; Lamontagne, J; Lussier, R; Pineda, M; Ruderman, NB; Haemmerle, G; Zechner, R; Joly, E; Madiraju, SRM; Poitout, V; Prentki, M				Peyot, Marie-Line; Guay, Claudiane; Latour, Martin G.; Lamontagne, Julien; Lussier, Roxane; Pineda, Marco; Ruderman, Neil B.; Haemmerle, Guenter; Zechner, Rudolf; Joly, Erik; Madiraju, S. R. Murthy; Poitout, Vincent; Prentki, Marc			Adipose Triglyceride Lipase Is Implicated in Fuel- and Non-fuel-stimulated Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; GLUCAGON-LIKE PEPTIDE-1; PANCREATIC BETA-CELLS; LIPID STORAGE DISEASE; FREE FATTY-ACIDS; RAT ISLETS; GLYCEROLIPID METABOLISM; SIGNALING PATHWAYS; GLUCOSE-METABOLISM; HYDROLASE ACTIVITY	Reduced lipolysis in hormone-sensitive lipase-deficient mice is associated with impaired glucose-stimulated insulin secretion (GSIS), suggesting that endogenous beta-cell lipid stores provide signaling molecules for insulin release. Measurements of lipolysis and triglyceride (TG) lipase activity in islets from HSL-/- mice indicated the presence of other TG lipase(s) in the beta-cell. Using real time-quantitative PCR, adipose triglyceride lipase (ATGL) was found to be the most abundant TG lipase in rat islets and INS832/13 cells. To assess its role in insulin secretion, ATGL expression was decreased in INS832/13cells(ATGL-knock-down (KD)) by small hairpin RNA. ATGL-KD increased the esterification of free fatty acid (FFA) into TG. ATGL-KD cells showed decreased glucose- or Gln + Leu-induced insulin release, as well as reduced response to KCl or palmitate at high, but not low, glucose. The K-ATP-independent/amplification pathway of GSIS was considerably reduced in ATGL-KD cells. ATGL(-/-) mice were hypoinsulinemic and hypoglycemic and showed decreased plasma TG and FFAs. A hyperglycemic clamp revealed increased insulin sensitivity and decreased GSIS and arginine-induced insulin secretion in ATGL(-/-) mice. Accordingly, isolated islets from ATGL(-/-) mice showed reduced insulin secretion in response to glucose, glucose + palmitate, and KCl. Islet TG content and FFA esterification into TG were increased by 2-fold in ATGL(-/-) islets, but glucose usage and oxidation were unaltered. The results demonstrate the importance of ATGL and intracellular lipid signaling for fuel-and nonfuel-induced insulin secretion.	[Joly, Erik; Madiraju, S. R. Murthy; Poitout, Vincent; Prentki, Marc] Univ Montreal, Ctr Rech, Ctr Hosp, Montreal Diabet Res Ctr, Montreal, PQ H1W 4A4, Canada; [Joly, Erik; Madiraju, S. R. Murthy; Poitout, Vincent; Prentki, Marc] Univ Montreal, Ctr Rech, Ctr Hosp, Mol Nutr Unit, Montreal, PQ H1W 4A4, Canada; [Poitout, Vincent; Prentki, Marc] Univ Montreal, Dept Nutr, Montreal, PQ H1W 4A4, Canada; [Poitout, Vincent] Univ Montreal, Dept Med, Montreal, PQ H1W 4A4, Canada; [Ruderman, Neil B.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Ruderman, Neil B.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Ruderman, Neil B.] Boston Univ, Sch Med, Endocrinol Sect, Diabet Unit, Boston, MA 02118 USA; [Haemmerle, Guenter; Zechner, Rudolf] Karl Franzens Univ Graz, Inst Mol Biosci, A-8010 Graz, Austria	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Boston University; Boston University; Boston University; University of Graz	Prentki, M (corresponding author), Univ Montreal, Ctr Rech, Ctr Hosp, Montreal Diabet Res Ctr, Technopole Angus Rm 401,2901 Rachel E St, Montreal, PQ H1W 4A4, Canada.	marc.prentki@umontreal.ca	Guay, Claudiane/AAF-5381-2019	Ruderman, Neil/0000-0002-6589-6587; Zechner, Rudolf/0000-0001-5483-1182; Haemmerle, Guenter/0000-0001-9900-5896; Guay, Claudiane/0000-0002-6478-8744; Poitout, Vincent/0000-0002-6555-5053	National Institutes of Health; Canadian Diabetes Association; Canadian Institute of Health Research; Austrian Science Fund (FWF) [F 3002, Z 136] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Diabetes Association; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported, in whole or in part, by a National Institutes of Health grant (to N.R., V. P., and M. P.). This work was also supported by grants from the Canadian Diabetes Association and the Canadian Institute of Health Research (to M. P.).	Akiyama M, 2007, MUSCLE NERVE, V36, P856, DOI 10.1002/mus.20869; Brun T, 2007, ONCOGENE, V26, P4261, DOI 10.1038/sj.onc.1210205; Chapman ER, 1996, BIOCHEM BIOPH RES CO, V225, P326, DOI 10.1006/bbrc.1996.1174; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; Deeney JT, 2000, J BIOL CHEM, V275, P9363, DOI 10.1074/jbc.275.13.9363; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Delghingaro-Augusto V, 2009, DIABETOLOGIA, V52, P1122, DOI 10.1007/s00125-009-1317-8; Dobbins RL, 1998, J CLIN INVEST, V101, P2370, DOI 10.1172/JCI1813; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Fex M, 2004, ENDOCRINOLOGY, V145, P3746, DOI 10.1210/en.2003-1673; Fex M, 2009, DIABETOLOGIA, V52, P271, DOI 10.1007/s00125-008-1191-9; Fex M, 2006, DIABETES, V55, pS24, DOI 10.2337/db06-S004; Fischer J, 2007, M S-MED SCI, V23, P575, DOI 10.1051/medsci/20072367575; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; Gonzalo S, 1998, MOL BIOL CELL, V9, P585, DOI 10.1091/mbc.9.3.585; GOTOH M, 1987, TRANSPLANTATION, V43, P725, DOI 10.1097/00007890-198705000-00024; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; HAHN P, 1975, J LIPID RES, V16, P79; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; HUTTON JC, 1983, BIOCHEM J, V210, P235, DOI 10.1042/bj2100235; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jensen MD, 2001, AM J PHYSIOL-ENDOC M, V281, pE789; Kobayashi K, 2008, J CLIN ENDOCR METAB, V93, P2877, DOI 10.1210/jc.2007-2247; Koyama K, 1997, DIABETES, V46, P1276, DOI 10.2337/diabetes.46.8.1276; Kwan EP, 2006, DIABETES, V55, P1421, DOI 10.2337/db05-1263; Lindvall H, 2004, J BIOL CHEM, V279, P3828, DOI 10.1074/jbc.M311365200; Masiello P, 2002, METABOLISM, V51, P110, DOI 10.1053/meta.2002.28969; Massa ML, 2001, J ENDOCRINOL, V171, P551, DOI 10.1677/joe.0.1710551; Mulder H, 2004, DIABETES, V53, P122, DOI 10.2337/diabetes.53.1.122; Mulder H, 1999, DIABETES, V48, P228, DOI 10.2337/diabetes.48.1.228; Mziaut H, 2006, NAT CELL BIOL, V8, P435, DOI 10.1038/ncb1395; NEWSHOLME EA, 1976, BIOCH SOC S, V61, P109; Nolan CJ, 2006, DIABETOLOGIA, V49, P2120, DOI 10.1007/s00125-006-0305-5; Nolan CJ, 2008, TRENDS ENDOCRIN MET, V19, P285, DOI 10.1016/j.tem.2008.07.006; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Olofsson CS, 2004, J PHYSIOL-LONDON, V557, P935, DOI 10.1113/jphysiol.2004.066258; Peyot ML, 2004, DIABETES, V53, P1733, DOI 10.2337/diabetes.53.7.1733; Poitout V, 2006, J NUTR, V136, P873, DOI 10.1093/jn/136.4.873; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; Roduit R, 2001, DIABETES, V50, P1970, DOI 10.2337/diabetes.50.9.1970; Roduit R, 2000, J BIOL CHEM, V275, P35799, DOI 10.1074/jbc.M006001200; SADDIK M, 1991, J BIOL CHEM, V266, P8162; Schoenborn V, 2006, DIABETES, V55, P1270, DOI 10.2337/db05-1498; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Segall L, 1999, AM J PHYSIOL-ENDOC M, V277, pE521, DOI 10.1152/ajpendo.1999.277.3.E521; Shu YL, 2008, J NEUROSCI, V28, P21, DOI 10.1523/JNEUROSCI.2352-07.2008; Solimena M, 1996, EMBO J, V15, P2102, DOI 10.1002/j.1460-2075.1996.tb00564.x; Soni KG, 2004, J BIOL CHEM, V279, P40683, DOI 10.1074/jbc.M400541200; Stein DT, 1997, J CLIN INVEST, V100, P398, DOI 10.1172/JCI119546; Stein DT, 1996, J CLIN INVEST, V97, P2728, DOI 10.1172/JCI118727; Straub SG, 1998, DIABETES, V47, P758, DOI 10.2337/diabetes.47.5.758; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Trajkovski M, 2004, J CELL BIOL, V167, P1063, DOI 10.1083/jcb.200408172; VAUGHAN M, 1962, J BIOL CHEM, V237, P3354; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Watt MJ, 2008, MOL ENDOCRINOL, V22, P1200, DOI 10.1210/me.2007-0485; Wei EH, 2007, J BIOL CHEM, V282, P8027, DOI 10.1074/jbc.M605789200; Winzell MS, 2006, NUTR METAB CARDIOVAS, V16, pS11, DOI 10.1016/j.numecd.2005.11.006; Winzell MS, 2004, HORM METAB RES, V36, P795, DOI 10.1055/s-2004-826166; Winzell MS, 2001, DIABETES, V50, P2225, DOI 10.2337/diabetes.50.10.2225; Yaney GC, 2001, DIABETES, V50, P56, DOI 10.2337/diabetes.50.1.56; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	69	69	72	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16848	16859		10.1074/jbc.M109.006650	http://dx.doi.org/10.1074/jbc.M109.006650			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19389712	Green Published, hybrid			2022-12-25	WOS:000266962400021
J	Kim, SM; Frank, LM				Kim, Steve M.; Frank, Loren M.			Hippocampal Lesions Impair Rapid Learning of a Continuous Spatial Alternation Task	PLOS ONE			English	Article								The hippocampus is essential for the formation of memories for events, but the specific features of hippocampal neural activity that support memory formation are not yet understood. The ideal experiment to explore this issue would be to monitor changes in hippocampal neural coding throughout the entire learning process, as subjects acquire and use new episodic memories to guide behavior. Unfortunately, it is not clear whether established hippocampally-dependent learning paradigms are suitable for this kind of experiment. The goal of this study was to determine whether learning of the W-track continuous alternation task depends on the hippocampal formation. We tested six rats with NMDA lesions of the hippocampal formation and four sham-operated controls. Compared to controls, rats with hippocampal lesions made a significantly higher proportion of errors and took significantly longer to reach learning criterion. The effect of hippocampal lesion was not due to a deficit in locomotion or motivation, because rats with hippocampal lesions ran well on a linear track for food reward. Rats with hippocampal lesions also exhibited a pattern of perseverative errors during early task experience suggestive of an inability to suppress behaviors learned during pretraining on a linear track. Our findings establish the W-track continuous alternation task as a hippocampally-dependent learning paradigm which may be useful for identifying changes in the neural representation of spatial sequences and reward contingencies as rats learn and apply new task rules.			Kim, SM (corresponding author), Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA.	loren@phy.ucsf.edu		Frank, Loren/0000-0002-1752-5677	NIMH NIH HHS [R01 MH080283, MH080283] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080283] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ainge JA, 2007, HIPPOCAMPUS, V17, P988, DOI 10.1002/hipo.20301; Ainge JA, 2007, J NEUROSCI, V27, P9769, DOI 10.1523/JNEUROSCI.2011-07.2007; Amaral David G., 1995, P443; Anderson MI, 2006, HIPPOCAMPUS, V16, P730, DOI 10.1002/hipo.20206; Bannerman DM, 1999, BEHAV NEUROSCI, V113, P1170, DOI 10.1037/0735-7044.113.6.1170; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Best PJ, 2001, ANNU REV NEUROSCI, V24, P459, DOI 10.1146/annurev.neuro.24.1.459; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Brun VH, 2001, J NEUROSCI, V21, P356, DOI 10.1523/JNEUROSCI.21-01-00356.2001; Brunner E, 2002, NONPARAMETRIC ANAL L; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; Clark RE, 2000, J NEUROSCI, V20, P8853; DAVIDSON TL, 2008, HIPPOCAMPUS; Day M, 2003, NATURE, V424, P205, DOI 10.1038/nature01769; Faraji J, 2008, BEHAV BRAIN RES, V189, P17, DOI 10.1016/j.bbr.2007.12.002; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Flaherty CF, 1998, BEHAV BRAIN RES, V93, P1, DOI 10.1016/S0166-4328(97)00138-1; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Foster DJ, 2000, HIPPOCAMPUS, V10, P1, DOI 10.1002/(SICI)1098-1063(2000)10:1<1::AID-HIPO1>3.0.CO;2-1; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Frank LM, 2004, J NEUROSCI, V24, P7681, DOI 10.1523/JNEUROSCI.1958-04.2004; Gluck MA, 2003, TRENDS COGN SCI, V7, P269, DOI 10.1016/S1364-6613(03)00105-0; Godsil BP, 2005, BEHAV NEUROSCI, V119, P1339, DOI 10.1037/0735-7044.119.5.1339; Good M, 1997, BEHAV NEUROSCI, V111, P487, DOI 10.1037/0735-7044.111.3.487; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hen I, 2004, J NEUROSCI METH, V133, P161, DOI 10.1016/j.jneumeth.2003.10.013; Hok V, 2007, J NEUROSCI, V27, P472, DOI 10.1523/JNEUROSCI.2864-06.2007; Holland PEC, 1999, HIPPOCAMPUS, V9, P143, DOI 10.1002/(SICI)1098-1063(1999)9:2<143::AID-HIPO6>3.0.CO;2-Z; Hollup SA, 2001, J NEUROSCI, V21, P4505, DOI 10.1523/JNEUROSCI.21-12-04505.2001; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Huxter JR, 2008, NAT NEUROSCI, V11, P587, DOI 10.1038/nn.2106; Jarrard LE, 2004, HIPPOCAMPUS, V14, P434, DOI 10.1002/hipo.10194; Jeffery KJ, 2003, HIPPOCAMPUS, V13, P175, DOI 10.1002/hipo.10047; Ji DY, 2008, J NEUROSCI, V28, P4679, DOI 10.1523/JNEUROSCI.4597-07.2008; Johnson A, 2005, NEURAL NETWORKS, V18, P1163, DOI 10.1016/j.neunet.2005.08.009; Karlsson MP, 2008, J NEUROSCI, V28, P14271, DOI 10.1523/JNEUROSCI.4261-08.2008; Kobayashi T, 1997, J NEUROPHYSIOL, V78, P597, DOI 10.1152/jn.1997.78.2.597; Kobayashi T, 2003, NEUROSCIENCE, V117, P1025, DOI 10.1016/S0306-4522(02)00700-5; Lee I, 2004, NEURON, V42, P803, DOI 10.1016/j.neuron.2004.05.010; Lee I, 2006, NEURON, V51, P639, DOI 10.1016/j.neuron.2006.06.033; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lipton PA, 2007, J NEUROSCI, V27, P5787, DOI 10.1523/JNEUROSCI.1063-07.2007; Manns JR, 2007, NEURON, V56, P530, DOI 10.1016/j.neuron.2007.08.017; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; McNish KA, 1997, J NEUROSCI, V17, P9353; Moita MAP, 2003, NEURON, V37, P485, DOI 10.1016/S0896-6273(03)00033-3; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Paxinos G., 2004, RAT BRAIN STEREOTAXI; Pouzet B, 1999, EUR J NEUROSCI, V11, P123, DOI 10.1046/j.1460-9568.1999.00413.x; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Schmelzeis MC, 1996, BEHAV NEUROSCI, V110, P1049; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Smith AC, 2004, J NEUROSCI, V24, P447, DOI 10.1523/JNEUROSCI.2908-03.2004; Smith DM, 2006, HIPPOCAMPUS, V16, P716, DOI 10.1002/hipo.20208; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Spiers HJ, 2001, NEUROCASE, V7, P357, DOI 10.1076/neur.7.5.357.16245; Whishaw IQ, 1997, HIPPOCAMPUS, V7, P361, DOI 10.1002/(SICI)1098-1063(1997)7:4<361::AID-HIPO2>3.0.CO;2-M; Wiebe SP, 1999, J NEUROSCI, V19, P10562; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; Zola SM, 2000, J NEUROSCI, V20, P451, DOI 10.1523/JNEUROSCI.20-01-00451.2000	73	49	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5494	10.1371/journal.pone.0005494	http://dx.doi.org/10.1371/journal.pone.0005494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424438	Green Submitted, gold, Green Published			2022-12-25	WOS:000265933800021
J	Seth, M; Lamont, EA; Janagama, HK; Widdel, A; Vulchanova, L; Stabel, JR; Waters, WR; Palmer, MV; Sreevatsan, S				Seth, Meetu; Lamont, Elise A.; Janagama, Harish K.; Widdel, Andrea; Vulchanova, Lucy; Stabel, Judith R.; Waters, W. Ray; Palmer, Mitchell V.; Sreevatsan, Srinand			Biomarker Discovery in Subclinical Mycobacterial Infections of Cattle	PLOS ONE			English	Article								Background: Bovine tuberculosis is a highly prevalent infectious disease of cattle worldwide; however, infection in the United States is limited to 0.01% of dairy herds. Thus detection of bovine TB is confounded by high background infection with M. avium subsp. paratuberculosis. The present study addresses variations in the circulating peptidome based on the pathogenesis of two biologically similar mycobacterial diseases of cattle. Methodology/Principal Findings: We hypothesized that serum proteomes of animals in response to either M. bovis or M. paratuberculosis infection will display several commonalities and differences. Sera prospectively collected from animals experimentally infected with either M. bovis or M. paratuberculosis were analyzed using high-resolution proteomics approaches. iTRAQ, a liquid chromatography and tandem mass spectrometry approach, was used to simultaneously identify and quantify peptides from multiple infections and contemporaneous uninfected control groups. Four comparisons were performed: 1) M. bovis infection versus uninfected controls, 2) M. bovis versus M. paratuberculosis infection, 3) early, and 4) advanced M. paratuberculosis infection versus uninfected controls. One hundred and ten differentially elevated proteins (P <= 0.05) were identified. Vitamin D binding protein precursor (DBP), alpha-1 acid glycoprotein, alpha-1B glycoprotein, fetuin, and serine proteinase inhibitor were identified in both infections. Transthyretin, retinol binding proteins, and cathelicidin were identified exclusively in M. paratuberculosis infection, while the serum levels of alpha-1-microglobulin/bikunin precursor (AMBP) protein, alpha-1 acid glycoprotein, fetuin, and alpha-1B glycoprotein were elevated exclusively in M. bovis infected animals. Conclusions/Significance: The discovery of these biomarkers has significant impact on the elucidation of pathogenesis of two mycobacterial diseases at the cellular and the molecular level and can be applied in the development of mycobacterium-specific diagnostic tools for the monitoring progression of disease, response to therapy, and/or vaccine based interventions.			Seth, M (corresponding author), Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA.	sreev001@umn.edu	Palmer, Mitchell/R-7091-2018; Sreevatsan, Srinand/V-6808-2019	Palmer, Mitchell/0000-0002-5902-3333; Sreevatsan, Srinand/0000-0002-5162-2403; Lamont, Elise/0000-0001-7085-9740; Vulchanova, Lucy/0000-0002-6577-4467				Agranoff D, 2006, LANCET, V368, P1012, DOI 10.1016/S0140-6736(06)69342-2; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Ceciliani F, 2007, VET IMMUNOL IMMUNOP, V116, P145, DOI 10.1016/j.vetimm.2007.01.006; Chang SJ, 2007, IET OPTOELECTRON, V1, P39, DOI 10.1049/iet-opt:20060025; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; CROWLE AJ, 1989, INFECT IMMUN, V57, P840, DOI 10.1128/IAI.57.3.840-844.1989; DAIGER SP, 1975, P NATL ACAD SCI USA, V72, P2076, DOI 10.1073/pnas.72.6.2076; Desvergne B, 2007, NAT MED, V13, P671, DOI 10.1038/nm0607-671; Evans JT, 2007, LANCET, V369, P1270, DOI 10.1016/S0140-6736(07)60598-4; Gomme PT, 2004, TRENDS BIOTECHNOL, V22, P340, DOI 10.1016/j.tibtech.2004.05.001; GRANGE JM, 1984, TUBERCLE, V65, P23, DOI 10.1016/0041-3879(84)90027-8; Hlavsa MC, 2008, CLIN INFECT DIS, V47, P168, DOI 10.1086/589240; Kisker O, 2003, NEOPLASIA, V5, P32, DOI 10.1016/S1476-5586(03)80015-5; Li LL, 2005, P NATL ACAD SCI USA, V102, P12344, DOI 10.1073/pnas.0505662102; Liu PT, 2007, TRENDS MOL MED, V13, P117, DOI 10.1016/j.molmed.2007.01.006; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Mackay C R, 1989, Int Immunol, V1, P540, DOI 10.1093/intimm/1.5.540; Munroe FA, 2000, PREV VET MED, V45, P247, DOI 10.1016/S0167-5877(00)00126-4; Nelsestuen GL, 2005, PROTEOMICS, V5, P4012, DOI 10.1002/pmic.200401234; Palmer MV, 2007, VET PATHOL, V44, P863, DOI 10.1354/vp.44-6-863; Palmer MV, 2006, CLIN VACCINE IMMUNOL, V13, P387, DOI 10.1128/CVI.13.3.387-394.2006; Palmer MV, 2002, TUBERCULOSIS, V82, P275, DOI 10.1054/tube.2002.0341; PETERSON PA, 1971, J BIOL CHEM, V246, P34; Shen Y, 2004, ANAL CHEM, V76, P144, DOI 10.1021/ac030096q; SONG X, 2008, J PROTEOME RES; STABEL JR, 2007, 9 INT C PAR TSUK JAP, P50; Thoen C., 2006, MYCOBACTERIUM BOVIS, P18; Trauger SA, 2004, ANAL CHEM, V76, P4484, DOI 10.1021/ac049657j; Wilkins MJ, 2008, EMERG INFECT DIS, V14, P657, DOI 10.3201/eid1404.070408; WONG CT, 1989, TROP GEOGR MED, V41, P218; Yamamoto N, 1996, J IMMUNOL, V157, P1744; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zasloff M, 2006, NAT MED, V12, P388, DOI 10.1038/nm0406-388; Zinsstag J., 2006, MYCOBACTERIUM BOVIS, P68, DOI DOI 10.1002/9780470344538.CH9	34	72	77	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5478	10.1371/journal.pone.0005478	http://dx.doi.org/10.1371/journal.pone.0005478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424492	Green Published, Green Submitted, gold			2022-12-25	WOS:000265933800012
J	Shimoni, Y; Altuvia, S; Margalit, H; Biham, O				Shimoni, Yishai; Altuvia, Shoshy; Margalit, Hanah; Biham, Ofer			Stochastic Analysis of the SOS Response in Escherichia coli	PLOS ONE			English	Article							BACTERIAL RECA PROTEIN; NETWORK MOTIFS; SIMULATION; CLEAVAGE; KINETICS; COMPLEX	Background: DNA damage in Escherichia coli evokes a response mechanism called the SOS response. The genetic circuit of this mechanism includes the genes recA and lexA, which regulate each other via a mixed feedback loop involving transcriptional regulation and protein-protein interaction. Under normal conditions, recA is transcriptionally repressed by LexA, which also functions as an auto-repressor. In presence of DNA damage, RecA proteins recognize stalled replication forks and participate in the DNA repair process. Under these conditions, RecA marks LexA for fast degradation. Generally, such mixed feedback loops are known to exhibit either bi-stability or a single steady state. However, when the dynamics of the SOS system following DNA damage was recently studied in single cells, ordered peaks were observed in the promoter activity of both genes (Friedman et al., 2005, PLoS Biol. 3(7):e238). This surprising phenomenon was masked in previous studies of cell populations. Previous attempts to explain these results harnessed additional genes to the system and deployed complex deterministic mathematical models that were only partially successful in explaining the results. Methodology/Principal Findings: Here we apply stochastic methods, which are better suited for dynamic simulations of single cells. We show that a simple model, involving only the basic components of the circuit, is sufficient to explain the peaks in the promoter activities of recA and lexA. Notably, deterministic simulations of the same model do not produce peaks in the promoter activities. Conclusion/Significance: We conclude that the double negative mixed feedback loop with auto-repression accounts for the experimentally observed peaks in the promoter activities. In addition to explaining the experimental results, this result shows that including additional regulations in a mixed feedback loop may dramatically change the dynamic functionality of this regulatory module. Furthermore, our results suggests that stochastic fluctuations strongly affect the qualitative behavior of important regulatory modules even under biologically relevant conditions, thus emphasizing the importance of stochastic analysis of regulatory circuits.			Shimoni, Y (corresponding author), Hebrew Univ Jerusalem, Fac Med, Dept Mol Genet & Biotechnol, Jerusalem, Israel.	yshimoni@phys.huji.ac.il	Margalit, Hanah/H-1651-2013					Alon U., 2006, INTRO SYSTEMS BIOL D; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; BRASH DE, 1985, J BIOL CHEM, V260, P1438; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; dAri R., 1990, BIOL FEEDBACK; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Francois P, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031908; Friedman N, 2005, PLOS BIOL, V3, P1261, DOI 10.1371/journal.pbio.0030238; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Henriksson-Peltola P, 2007, NUCLEIC ACIDS RES, V35, P3181, DOI 10.1093/nar/gkm172; INGRAHAM J, 1987, ESCHERICHIA COLI SAL, V1, pCH89; INGRAHAM J, 1987, ESCHERICHIA COLI SAL, V2, pCH89; Kozer N, 2004, J MOL BIOL, V336, P763, DOI 10.1016/j.jmb.2003.12.008; Krishna S, 2007, PLOS COMPUT BIOL, V3, P451, DOI 10.1371/journal.pcbi.0030041; Li DF, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011903; Lipshtat A, 2005, GENE, V347, P265, DOI 10.1016/j.gene.2004.12.016; LITTLE JW, 1983, J MOL BIOL, V167, P791, DOI 10.1016/S0022-2836(83)80111-9; LITTLE JW, 1980, P NATL ACAD SCI-BIOL, V77, P3225, DOI 10.1073/pnas.77.6.3225; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; MCCLURE WR, 1980, P NATL ACAD SCI-BIOL, V77, P5634, DOI 10.1073/pnas.77.10.5634; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MILO R, 2007, BIONUMBERS; Ni M, 2007, BIOPHYS J, V93, P62, DOI 10.1529/biophysj.106.090712; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; SASSANFAR M, 1990, J MOL BIOL, V212, P79, DOI 10.1016/0022-2836(90)90306-7; SETLOW RB, 1964, P NATL ACAD SCI USA, V51, P226, DOI 10.1073/pnas.51.2.226; SHINAGAWA H, 1988, P NATL ACAD SCI USA, V85, P1806, DOI 10.1073/pnas.85.6.1806; TAKAHASHI M, 1994, ADV BIOPHYS, V30, P1, DOI 10.1016/0065-227X(94)90009-4; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101	33	38	38	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5363	10.1371/journal.pone.0005363	http://dx.doi.org/10.1371/journal.pone.0005363			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424504	Green Published, Green Submitted, gold			2022-12-25	WOS:000265933800006
J	Groger, M; Pasteiner, W; Ignatyev, G; Matt, U; Knapp, S; Atrasheuskaya, A; Bukin, E; Friedl, P; Zinkl, D; Hofer-Warbinek, R; Zacharowski, K; Petzelbauer, P; Reingruber, S				Groeger, Marion; Pasteiner, Waltraud; Ignatyev, George; Matt, Ulrich; Knapp, Sylvia; Atrasheuskaya, Alena; Bukin, Eugenij; Friedl, Peter; Zinkl, Daniela; Hofer-Warbinek, Renate; Zacharowski, Kai; Petzelbauer, Peter; Reingruber, Sonja			Peptide B beta(15-42) Preserves Endothelial Barrier Function in Shock	PLOS ONE			English	Article								Loss of vascular barrier function causes leak of fluid and proteins into tissues, extensive leak leads to shock and death. Barriers are largely formed by endothelial cell-cell contacts built up by VE-cadherin and are under the control of RhoGTPases. Here we show that a natural plasmin digest product of fibrin, peptide B beta 15-42 (also called FX06), significantly reduces vascular leak and mortality in animal models for Dengue shock syndrome. The ability of B beta 15-42 to preserve endothelial barriers is confirmed in rats i.v.-injected with LPS. In endothelial cells, B beta 15-42 prevents thrombin-induced stress fiber formation, myosin light chain phosphorylation and RhoA activation. The molecular key for the protective effect of B beta 15-42 is the src kinase Fyn, which associates with VE-cadherin-containing junctions. Following exposure to B beta 15-42 Fyn dissociates from VE-cadherin and associates with p190RhoGAP, a known antagonists of RhoA activation. The role of Fyn in transducing effects of B beta 15-42 is confirmed in Fyn(-/-) mice, where the peptide is unable to reduce LPS-induced lung edema, whereas in wild type littermates the peptide significantly reduces leak. Our results demonstrate a novel function for B beta 15-42. Formerly mainly considered as a degradation product occurring after fibrin inactivation, it has now to be considered as a signaling molecule. It stabilizes endothelial barriers and thus could be an attractive adjuvant in the treatment of shock.			Groger, M (corresponding author), Med Univ Vienna, Dept Dermatol, Vienna, Austria.	peter.petzelbauer@meduniwien.ac.at; sonja.reingruber@fibrexmedical.com	petzelbauer, peter/GLU-3941-2022; Knapp, Sylvia/J-3973-2013	Knapp, Sylvia/0000-0001-9016-5244; Ignatyev, George/0000-0002-9731-3681; Petzelbauer, Peter/0000-0001-7080-5259; Atrasheuskaya, Alena/0000-0002-9603-9895; Matt, Ulrich/0000-0002-1786-365X				Amerongen GPV, 2004, CIRC RES, V94, P1041, DOI 10.1161/01.RES.0000125627.77235.0C; Atar D, 2009, J AM COLL CARDIOL, V53, P720, DOI 10.1016/j.jacc.2008.12.017; Atrasheuskaya A, 2003, FEMS IMMUNOL MED MIC, V35, P33, DOI 10.1111/j.1574-695X.2003.tb00646.x; Bach TL, 1998, J BIOL CHEM, V273, P30719, DOI 10.1074/jbc.273.46.30719; Bannerman DD, 1999, LAB INVEST, V79, P1181; BEGGS HE, 1994, J CELL BIOL, V127, P825, DOI 10.1083/jcb.127.3.825; Broman MT, 2007, TRENDS CARDIOVAS MED, V17, P151, DOI 10.1016/j.tcm.2007.03.004; Brunton VG, 2004, BBA-MOL CELL RES, V1692, P121, DOI 10.1016/j.bbamcr.2004.04.010; Bukin Ye. K., 2007, Voprosy Virusologii, V52, P32; Cary LA, 1996, J CELL SCI, V109, P1787; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Dejana E, 2001, THROMB HAEMOSTASIS, V86, P308; Diamond MS, 2000, J VIROL, V74, P7814, DOI 10.1128/JVI.74.17.7814-7823.2000; Fareed J, 1998, CLIN CHEM, V44, P1845; Faust SN, 2001, NEW ENGL J MED, V345, P408, DOI 10.1056/NEJM200108093450603; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; Gorlatov S, 2002, BIOCHEMISTRY-US, V41, P4107, DOI 10.1021/bi0160314; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; GRANT SGN, 1995, GENE DEV, V9, P1909, DOI 10.1101/gad.9.15.1909; GREEN TP, 1988, J LAB CLIN MED, V111, P173; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Holinstat M, 2006, J BIOL CHEM, V281, P2296, DOI 10.1074/jbc.M511248200; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Konstantoulaki M, 2003, AM J PHYSIOL-LUNG C, V285, pL434, DOI 10.1152/ajplung.00075.2003; Liang XQ, 2004, J NEUROSCI, V24, P7140, DOI 10.1523/JNEUROSCI.5319-03.2004; Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365; Matsuda Naoyuki, 2007, Journal of Smooth Muscle Research, V43, P117, DOI 10.1540/jsmr.43.117; Minshall R. D., 2006, V176, P107; Nelson CM, 2004, MOL BIOL CELL, V15, P2943, DOI 10.1091/mbc.E03-10-0745; Noren NK, 2003, J BIOL CHEM, V278, P13615, DOI 10.1074/jbc.C200657200; Ohkawara H, 2005, J BIOL CHEM, V280, P10182, DOI 10.1074/jbc.M409547200; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Petzelbauer P, 2005, NAT MED, V11, P298, DOI 10.1038/nm1198; Roesner JP, 2007, CRIT CARE MED, V35, P1730, DOI 10.1097/01.CCM.0000269035.30231.76; Schaller MD, 1999, MOL BIOL CELL, V10, P3489, DOI 10.1091/mbc.10.10.3489; Schaphorst KL, 1997, AM J RESP CELL MOL, V17, P443, DOI 10.1165/ajrcmb.17.4.2502; Sohn RH, 2005, BLOOD, V105, P3910, DOI 10.1182/blood-2004-03-0928; Srikiatkhachorn A, 2007, PEDIATR INFECT DIS J, V26, P283, DOI 10.1097/01.inf.0000258612.26743.10; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983; van Hinsbergh VWM, 2002, J ANAT, V200, P549, DOI 10.1046/j.1469-7580.2002.00060.x; Amerongen GPV, 2007, ARTERIOSCL THROM VAS, V27, P2332, DOI 10.1161/ATVBAHA.107.152322; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Vouret-Craviari V, 1998, MOL BIOL CELL, V9, P2639, DOI 10.1091/mbc.9.9.2639; Wills BA, 2002, CLIN INFECT DIS, V35, P277, DOI 10.1086/341410; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; Wu MH, 2005, J PHYSIOL-LONDON, V569, P359, DOI 10.1113/jphysiol.2005.096537; Yap AS, 2003, J CELL BIOL, V160, P11, DOI 10.1083/jcb.200208156	51	70	73	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5391	10.1371/journal.pone.0005391	http://dx.doi.org/10.1371/journal.pone.0005391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401765	Green Published, Green Submitted, gold			2022-12-25	WOS:000265601100023
J	Haag, KL; Gottstein, B; Ayala, FJ				Haag, Karen Luisa; Gottstein, Bruno; Ayala, Francisco Jose			The EG95 Antigen of Echinococcus spp. Contains Positively Selected Amino Acids, which May Influence Host Specificity and Vaccine Efficacy	PLOS ONE			English	Article							TAENIA-SOLIUM; GRANULOSUS; PREDICTION; CYSTICERCOSIS; DIVERSITY; RESPONSES; MODELS; DOMAIN; STAGE	Echinococcosis is a worldwide zoonotic parasitic disease of humans and various herbivorous domestic animals (intermediate hosts) transmitted by the contact with wild and domestic carnivores (definitive hosts), mainly foxes and dogs. Recently, a vaccine was developed showing high levels of protection against one parasite haplotype (G1) of Echinococcus granulosus, and its potential efficacy against distinct parasite variants or species is still unclear. Interestingly, the EG95 vaccine antigen is a secreted glycosylphosphatydilinositol (GPI)-anchored protein containing a fibronectin type III domain, which is ubiquitous in modular proteins involved in cell adhesion. EG95 is highly expressed in oncospheres, the parasite life cycle stage which actively invades the intermediate hosts. After amplifying and sequencing the complete CDS of 57 Echinococcus isolates belonging to 7 distinct species, we uncovered a large amount of genetic variability, which may influence protein folding. Two positively selected sites are outside the vaccine epitopes, but are predicted to alter protein conformation. Moreover, phylogenetic analyses indicate that EG95 isoform evolution is convergent with regard to the number of beta-sheets and alpha-helices. We conclude that having a variety of EG95 isoforms is adaptive for Echinococcus parasites, in terms of their ability to invade different hosts, and we propose that a mixture of isoforms could possibly maximize vaccine efficacy.			Haag, KL (corresponding author), Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil.	karen.haag@ufrgs.br	Haag, Karen/R-1382-2016	Haag, Karen/0000-0003-1162-0152				Bonay P, 2002, MOL BIOCHEM PARASIT, V121, P269, DOI 10.1016/S0166-6851(02)00037-3; BORK P, 1992, P NATL ACAD SCI USA, V89, P8990, DOI 10.1073/pnas.89.19.8990; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Chow C, 2004, EXP PARASITOL, V106, P183, DOI 10.1016/j.exppara.2004.03.009; Chow C, 2001, MOL BIOCHEM PARASIT, V118, P83, DOI 10.1016/S0166-6851(01)00373-5; Chow C, 2008, EXP PARASITOL, V119, P499, DOI 10.1016/j.exppara.2008.01.004; Filip LC, 2004, MOL BIOL EVOL, V21, P1504, DOI 10.1093/molbev/msh111; Gauci C, 2002, INFECT IMMUN, V70, P3969, DOI 10.1128/IAI.70.7.3969-3972.2002; Gauci CG, 2001, MOL BIOCHEM PARASIT, V112, P173, DOI 10.1016/S0166-6851(00)00364-9; Haag KL, 2008, TRENDS PARASITOL, V24, P96, DOI 10.1016/j.pt.2007.11.004; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kanagawa T, 2003, J BIOSCI BIOENG, V96, P317, DOI 10.1263/jbb.96.317; Kyngdon CT, 2006, PARASITE IMMUNOL, V28, P191, DOI 10.1111/j.1365-3024.2006.00820.x; Lightowlers MW, 2006, PARASITOL INT, V55, pS39, DOI 10.1016/j.parint.2005.11.005; Lightowlers MW, 2003, INT J PARASITOL, V33, P1207, DOI 10.1016/S0020-7519(03)00174-7; Nakao M, 2007, PARASITOLOGY, V134, P713, DOI 10.1017/S0031182006001934; Nielsen R, 1998, GENETICS, V148, P929; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Suzuki Y, 2004, GENE, V328, P127, DOI 10.1016/j.gene.2003.11.020; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Waterkeyn J, 1997, MOL BIOCHEM PARASIT, V86, P75, DOI 10.1016/S0166-6851(97)90007-4; Woollard DJ, 2000, VACCINE, V19, P498, DOI 10.1016/S0264-410X(00)00192-4; Woollard DJ, 1999, VACCINE, V18, P785, DOI 10.1016/S0264-410X(99)00350-3; Woollard DJ, 2000, PARASITOLOGY, V121, P145, DOI 10.1017/S0031182099006186; Yang ZH, 2000, GENETICS, V155, P431; Zhang WB, 2003, AM J TROP MED HYG, V68, P40, DOI 10.4269/ajtmh.2003.68.40	29	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5362	10.1371/journal.pone.0005362	http://dx.doi.org/10.1371/journal.pone.0005362			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401778	Green Published, gold			2022-12-25	WOS:000265601100009
J	Mellet, P; Massot, P; Madelin, G; Marque, SRA; Harte, E; Franconi, JM; Thiaudiere, E				Mellet, Philippe; Massot, Philippe; Madelin, Guillaume; Marque, Sylvain R. A.; Harte, Etienne; Franconi, Jean-Michel; Thiaudiere, Eric			New Concepts in Molecular Imaging: Non-Invasive MRI Spotting of Proteolysis Using an Overhauser Effect Switch	PLOS ONE			English	Article								Background: Proteolysis, involved in many processes in living organisms, is tightly regulated in space and time under physiological conditions. However deregulation can occur with local persistent proteolytic activities, e. g. in inflammation, cystic fibrosis, tumors, or pancreatitis. Furthermore, little is known about the role of many proteases, hence there is a need of new imaging methods to visualize specifically normal or disease-related proteolysis in intact bodies. Methodology/Principal Findings: In this paper, a new concept for non invasive proteolysis imaging is proposed. Overhauser-enhanced Magnetic Resonance Imaging (OMRI) at 0.2 Tesla was used to monitor the enzymatic hydrolysis of a nitroxide-labeled protein. In vitro, image intensity switched from 1 to 25 upon proteolysis due to the associated decrease in the motional correlation time of the substrate. The OMRI experimental device used in this study is consistent with protease imaging in mice at 0.2 T without significant heating. Simulations show that this enzymatic-driven OMRI signal switch can be obtained at lower frequencies suitable for larger animals or humans. Conclusions/Significance: The method is highly sensitive and makes possible proteolysis imaging in three dimensions with a good spatial resolution. Any protease could be targeted specifically through the use of taylor-made cleavable macromolecules. At short term OMRI of proteolysis may be applied to basic research as well as to evaluate therapeutic treatments in small animal models of experimental diseases.			Mellet, P (corresponding author), Univ Victor Segalen Bordeaux, INSERM, IFR 004, Bordeaux, France.	philippe.mellet@rmsb.u-bordeaux2.fr	Marque, Sylvain R.A./L-7096-2017	Marque, Sylvain R.A./0000-0002-3050-8468; Thiaudiere, Eric/0000-0002-9993-4035; Mellet, Philippe/0000-0001-5499-9735; Madelin, Guillaume/0000-0002-5556-5792				ABRAGAM A, 1957, COMPT REND ACAD SCI; Berliner L J, 2003, VIVO EPR ESR THEORY; Cui WN, 2004, MAGN RESON MED, V51, P616, DOI 10.1002/mrm.10719; Deng YM, 2006, COMPUT METH PROG BIO, V82, P67, DOI 10.1016/j.cmpb.2006.02.002; Freed JH, 1976, SPIN LABELING THEORY; Grant GPG, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm240; Grimm J, 2005, P NATL ACAD SCI USA, V102, P14404, DOI 10.1073/pnas.0503920102; GRUCKER D, 1990, MAGNET RESON MED, V14, P140, DOI 10.1002/mrm.1910140113; Krishna MC, 2002, P NATL ACAD SCI USA, V99, P2216, DOI 10.1073/pnas.042671399; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lancelot E, 2008, ARTERIOSCL THROM VAS, V28, P425, DOI 10.1161/ATVBAHA.107.149666; Li HH, 2006, MAGN RESON MED, V55, P669, DOI 10.1002/mrm.20804; Li HH, 2002, MAGNET RESON MED, V48, P530, DOI 10.1002/mrm.10222; Liebgott T, 2003, MAGNET RESON MED, V50, P391, DOI 10.1002/mrm.10534; Louie AY, 2000, NAT BIOTECHNOL, V18, P321, DOI 10.1038/73780; LURIE DJ, 1988, J MAGN RESON, V76, P366, DOI 10.1016/0022-2364(88)90123-0; McIntyre JO, 2003, J CELL BIOCHEM, V90, P1087, DOI 10.1002/jcb.10713; Mizukami S, 2008, J AM CHEM SOC, V130, P794, DOI 10.1021/ja077058z; OVERHAUSER AW, 1953, PHYS REV, V92, P411, DOI 10.1103/PhysRev.92.411; Scherer RL, 2008, CANCER METAST REV, V27, P679, DOI 10.1007/s10555-008-9152-9; Southan C, 2001, DRUG DISCOV TODAY, V6, P681, DOI 10.1016/S1359-6446(01)01793-7; Spinney L, 2006, NATURE, V442, P736, DOI 10.1038/442736a; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Woessner JF, 2004, HDB PROTEOLYTIC ENZY; Yigit MV, 2008, BIOCONJUGATE CHEM, V19, P412, DOI 10.1021/bc7003928; Yoo B, 2007, CONTRAST MEDIA MOL I, V2, P189, DOI 10.1002/cmmi.145; Zhao M, 2003, ANGEW CHEM INT EDIT, V42, P1375, DOI 10.1002/anie.200390352	27	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2009	4	4							e5244	10.1371/journal.pone.0005244	http://dx.doi.org/10.1371/journal.pone.0005244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VI	19396361	Green Submitted, Green Published, gold			2022-12-25	WOS:000265514600001
J	Silhan, J; Vacha, P; Strnadova, P; Vecer, J; Herman, P; Sulc, M; Teisinger, J; Obsilova, V; Obsil, T				Silhan, Jan; Vacha, Petr; Strnadova, Pavla; Vecer, Jaroslav; Herman, Petr; Sulc, Miroslav; Teisinger, Jan; Obsilova, Veronika; Obsil, Tomas			14-3-3 Protein Masks the DNA Binding Interface of Forkhead Transcription Factor FOXO4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; LIGAND-BINDING; AFFINITY PURIFICATION; PHOSPHORYLATION; 14-3-3-PROTEINS; COMPLEX; DOMAIN; CONFORMATION; RECOGNITION; INHIBITION	The role of 14-3-3 proteins in the regulation of FOXO fork-head transcription factors is at least 2-fold. First, the 14-3-3 binding inhibits the interaction between the FOXO and the target DNA. Second, the 14-3-3 proteins prevent nuclear reimport of FOXO factors by masking their nuclear localization signal. The exact mechanisms of these processes are still unclear, mainly due to the lack of structural data. In this work, we used fluorescence spectroscopy to investigate the mechanism of the 14-3-3 protein-dependent inhibition of FOXO4 DNA-binding properties. Time-resolved fluorescence measurements revealed that the 14-3-3 binding affects fluorescence properties of 5-(((acetylamino) ethyl) amino) naphthalene-1-sulfonic acid moiety attached at four sites within the forkhead domain of FOXO4 that represent important parts of the DNA binding interface. Observed changes in 5-(((acetylamino) ethyl) amino) naphthalene-1-sulfonic acid fluorescence strongly suggest physical contacts between the 14-3-3 protein and labeled parts of the FOXO4 DNA binding interface. The 14-3-3 protein binding, however, does not cause any dramatic conformational change of FOXO4 as documented by the results of tryptophan fluorescence experiments. To build a realistic model of the FOXO4 center dot 14-3-3 complex, we measured six distances between 14-3-3 and FOXO4 using Forster resonance energy transfer time-resolved fluorescence experiments. The model of the complex suggests that the forkhead domain of FOXO4 is docked within the central channel of the 14-3-3 protein dimer, consistent with our hypothesis that 14-3-3 masks the DNA binding interface of FOXO4.	[Silhan, Jan; Vacha, Petr; Strnadova, Pavla; Obsil, Tomas] Charles Univ Prague, Fac Sci, Dept Phys & Macromol Chem, Prague 12843, Czech Republic; [Sulc, Miroslav] Charles Univ Prague, Fac Sci, Dept Biochem, Prague 12843, Czech Republic; [Vacha, Petr; Teisinger, Jan; Obsilova, Veronika; Obsil, Tomas] Acad Sci Czech Republic, Inst Physiol, CR-14220 Prague, Czech Republic; [Sulc, Miroslav] Acad Sci Czech Republic, Inst Microbiol, CR-14220 Prague, Czech Republic; [Vecer, Jaroslav; Herman, Petr] Charles Univ Prague, Fac Math & Phys, Inst Phys, CR-12116 Prague, Czech Republic	Charles University Prague; Charles University Prague; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague	Obsil, T (corresponding author), Charles Univ Prague, Fac Sci, Dept Phys & Macromol Chem, Prague 12843, Czech Republic.	obsil@natur.cuni.cz	Obsil, Tomas/B-7142-2012; Sulc, Miroslav/K-1029-2014; Herman, Petr/A-2626-2008; Obsilova, Veronika/B-7116-2012; Teisinger, Jan/B-7122-2012	Obsil, Tomas/0000-0003-4602-1272; Sulc, Miroslav/0000-0002-2659-0489; Herman, Petr/0000-0001-6918-2576; Obsilova, Veronika/0000-0003-4887-0323; 	Grant Agency of the Czech Republic [204/06/0565]; Grant Agency of the Academy of Sciences of the Czech Republic Grant [IAA501110801]; Ministry of Education, Youth, and Sports of the Czech Republic Research Projects [MSM0021620857, MSM0021620835]; Centre of Neurosciences [LC554]; Academy of Sciences of the Czech Republic Research Project [AV0Z50110509]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Grant Agency of the Academy of Sciences of the Czech Republic Grant(Grant Agency of the Czech Republic); Ministry of Education, Youth, and Sports of the Czech Republic Research Projects(Ministry of Education, Youth & Sports - Czech Republic); Centre of Neurosciences; Academy of Sciences of the Czech Republic Research Project(Czech Academy of Sciences)	This work was supported by Grant Agency of the Czech Republic Grant 204/06/0565; Grant Agency of the Academy of Sciences of the Czech Republic Grant IAA501110801; Ministry of Education, Youth, and Sports of the Czech Republic Research Projects MSM0021620857 and MSM0021620835 and Centre of Neurosciences LC554; and Academy of Sciences of the Czech Republic Research Project AV0Z50110509.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Boura E, 2007, J BIOL CHEM, V282, P8265, DOI 10.1074/jbc.M605682200; Bridges D, 2004, SCI STKE, pre10; BROCHON JC, 1994, METHOD ENZYMOL, V240, P262; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BRYAN RK, 1990, EUR BIOPHYS J, V18, P165, DOI 10.1007/BF02427376; Cahill CM, 2001, J BIOL CHEM, V276, P13402, DOI 10.1074/jbc.M010042200; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; EFTINK MR, 1991, TOPICS FLUORESCENCE, V2, P55; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Kaestner KH, 2000, GENE DEV, V14, P142; Kohler JJ, 2001, BIOCHEMISTRY-US, V40, P130, DOI 10.1021/bi001881p; Lakowicz J. R., 1983, PRINCIPLES FLUORESCE, P305; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Mazet F, 2003, GENE, V316, P79, DOI 10.1016/S0378-1119(03)00741-8; MELHUISH WH, 1961, J PHYS CHEM-US, V65, P229, DOI 10.1021/j100820a009; Milne FC, 2002, BIOCHEM SOC T, V30, P379, DOI 10.1042/bst0300379; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Obsil T, 2008, ONCOGENE, V27, P2263, DOI 10.1038/onc.2008.20; Obsil T, 2003, BIOCHEMISTRY-US, V42, P15264, DOI 10.1021/bi0352724; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Obsilova V, 2005, BIOCHEMISTRY-US, V44, P11608, DOI 10.1021/bi050618r; Obsilova V, 2004, J BIOL CHEM, V279, P4531, DOI 10.1074/jbc.M306939200; Obsilova V, 2008, BIOCHEMISTRY-US, V47, P1768, DOI 10.1021/bi7019468; Rena G, 2001, BIOCHEM J, V354, P605, DOI 10.1042/0264-6021:3540605; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Sadilkova L, 2008, PROTEIN SCI, V17, P1834, DOI 10.1110/ps.035733.108; Silhan J, 2004, J BIOL CHEM, V279, P49113, DOI 10.1074/jbc.M408671200; Sunayama J, 2005, J CELL BIOL, V170, P295, DOI 10.1083/jcb.200409117; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; WEIGEL D, 1990, CELL, V63, P455, DOI 10.1016/0092-8674(90)90439-L; Woodcock JM, 2003, J BIOL CHEM, V278, P36323, DOI 10.1074/jbc.M304689200; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450	41	51	52	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19349	19360		10.1074/jbc.M109.002725	http://dx.doi.org/10.1074/jbc.M109.002725			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19416966	hybrid, Green Published			2022-12-25	WOS:000267908300026
J	Luo, H; Hallen-Adams, HE; Walton, JD				Luo, Hong; Hallen-Adams, Heather E.; Walton, Jonathan D.			Processing of the Phalloidin Proprotein by Prolyl Oligopeptidase from the Mushroom Conocybe albipes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; ENDOPEPTIDASE; PROTEINS; PEPTIDE; IDENTIFICATION; PURIFICATION; BASIDIOMYCETE; SPECIFICITY; PATHWAY; LACTEA	The peptide toxins of poisonous Amanita mushrooms are bicyclic octapeptides (amatoxins) or heptapeptides (phallotoxins). In Amanita bisporigera, alpha-amanitin and phallacidin are synthesized as 35-and 34-amino acid proproteins, respectively, in which the amino acid sequences found in the mature toxins are flanked by conserved amino acid sequences. The presence of invariant Pro residues immediately upstream of the toxin regions and as the last predicted amino acid in the toxin regions themselves suggests that a Pro-specific peptidase is responsible for the initial post-translational processing of the Amanita toxin proproteins. We purified an enzyme from the phalloidin-producing mushroom Conocybe albipes that cleaves a synthetic 22-mer phalloidin peptide to release the mature toxin peptide (AWLATCP). Mass spectrometric analysis of the purified protein combined with isolation and sequencing of the encoding gene indicates that the responsible processing enzyme is a member of the prolyl oligopeptidase (POP) subfamily of proteases (EC 3.4.21.26). The processing enzyme was able to use the chromogenic POP substrate benzyloxycarbonyl-Gly-Pro-p-nitroanilide and was inhibited by the specific POP inhibitor benzyloxycarbonyl-Pro-prolinal. Both Pro bonds in the proprotein are cleaved by the same enzyme, with the C-terminal Pro bond cleaved first or much faster than the N-terminal Pro bond. Transient accumulation of the N-terminal intermediate indicates that cleavage is not strongly processive. A synthetic peptide representing the phallacidin proprotein was also cleaved by the POP of C. albipes, but a precursor of amanitin (which is not made by C. albipes) was cleaved inefficiently.	[Luo, Hong; Hallen-Adams, Heather E.; Walton, Jonathan D.] Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA	Michigan State University	Walton, JD (corresponding author), Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA.	walton@msu.edu			Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences; Office of Science, United States Department of Energy [DE-FG02-91ER20021]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088274] Funding Source: NIH RePORTER	Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Office of Science, United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy Grant DE-FG02-91ER20021 (to the Plant Research Laboratory).	BRADY LR, 1975, LLOYDIA, V38, P172; Brandt I, 2007, CLIN CHIM ACTA, V377, P50, DOI 10.1016/j.cca.2006.09.001; Bushnell DA, 2002, P NATL ACAD SCI USA, V99, P1218, DOI 10.1073/pnas.251664698; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Craik DJ, 2007, CURR OPIN DRUG DISC, V10, P176; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cunningham DF, 1997, BBA-PROTEIN STRUCT M, V1343, P160, DOI 10.1016/S0167-4838(97)00134-9; Duquesne S, 2007, CHEM BIOL, V14, P793, DOI 10.1016/j.chembiol.2007.06.004; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Enjalbert F, 2004, MYCOLOGIA, V96, P720, DOI 10.2307/3762106; Escoubas P, 2006, MOL DIVERS, V10, P545, DOI 10.1007/s11030-006-9050-4; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Garcia-Horsman JA, 2007, NEUROPEPTIDES, V41, P1, DOI 10.1016/j.npep.2006.10.004; Gass J, 2007, CELL MOL LIFE SCI, V64, P345, DOI 10.1007/s00018-006-6317-y; Hallen HE, 2003, MYCOL RES, V107, P969, DOI 10.1017/S0953756203008190; Hallen HE, 2007, P NATL ACAD SCI USA, V104, P19097, DOI 10.1073/pnas.0707340104; Hutchison LJ, 1996, CAN J BOT, V74, P431, DOI 10.1139/b96-053; KOIDA M, 1976, J BIOL CHEM, V251, P7593; May JP, 2007, BIOPOLYMERS, V88, P714, DOI 10.1002/bip.20807; Milne BF, 2006, ORG BIOMOL CHEM, V4, P631, DOI 10.1039/b515938e; Milne TJ, 2003, J BIOL CHEM, V278, P31105, DOI 10.1074/jbc.M304843200; MORIYAMA A, 1988, J BIOCHEM, V104, P112, DOI 10.1093/oxfordjournals.jbchem.a122404; Muraoka S, 2000, J BIOSCI BIOENG, V89, P73, DOI 10.1016/S1389-1723(00)88053-6; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; NOMURA K, 1986, FEBS LETT, V209, P235, DOI 10.1016/0014-5793(86)81118-8; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Olivera BM, 2006, J BIOL CHEM, V281, P31173, DOI 10.1074/jbc.R600020200; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Polgar L, 2002, CELL MOL LIFE SCI, V59, P349, DOI 10.1007/s00018-002-8427-5; Qiu RD, 2005, J BIOL CHEM, V280, P16695, DOI 10.1074/jbc.M411372200; Saska I, 2007, J BIOL CHEM, V282, P29721, DOI 10.1074/jbc.M705185200; SATTAR AKMA, 1990, J BIOCHEM, V107, P256, DOI 10.1093/oxfordjournals.jbchem.a123035; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; Shan L, 2005, P NATL ACAD SCI USA, V102, P3599, DOI 10.1073/pnas.0408286102; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Simmaco M, 1998, BIOPOLYMERS, V47, P435, DOI 10.1002/(SICI)1097-0282(1998)47:6<435::AID-BIP3>3.3.CO;2-#; Szeltner Z, 2008, CURR PROTEIN PEPT SC, V9, P96; Wieland T, 1986, PEPTIDES POISONOUS A; Williams RSB, 2005, PROG NEURO-PSYCHOPH, V29, P1029, DOI 10.1016/j.pnpbp.2005.03.020; WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498; YOSHIMOTO T, 1988, J BIOCHEM, V104, P622, DOI 10.1093/oxfordjournals.jbchem.a122522	41	32	36	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18070	18077		10.1074/jbc.M109.006460	http://dx.doi.org/10.1074/jbc.M109.006460			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19389704	Green Published, hybrid			2022-12-25	WOS:000267712400018
J	Tan, SH; Pal, M; Tan, MJ; Wong, MHL; Tam, FU; Teo, JWT; Chong, HC; Tan, CK; Goh, YY; Tang, MBY; Cheung, PCF; Tan, NS				Tan, Siew Hwey; Pal, Mintu; Tan, Ming Jie; Wong, Marc Hai Liang; Tam, Fong U.; Teo, Jamie Wei Ting; Chong, Han Chung; Tan, Chek Kun; Goh, Yan Yih; Tang, Mark Boon Yang; Cheung, Peter Ching For; Tan, Nguan Soon			Regulation of Cell Proliferation and Migration by TAK1 via Transcriptional Control of von Hippel-Lindau Tumor Suppressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-B-CHAIN; I-KAPPA-B; GROWTH-FACTOR; MEDIATED ACTIVATION; HUMAN KERATINOCYTES; SIGNALING PATHWAY; GENE-EXPRESSION; PPAR-BETA/DELTA; SKIN-DISEASE; KINASE TAK1	Skin maintenance and healing after wounding requires complex epithelial-mesenchymal interactions purportedly mediated by growth factors and cytokines. We show here that, for wound healing, transforming growth factor-Beta-activated kinase 1 (TAK1) in keratinocytes activates von Hippel-Lindau tumor suppressor expression, which in turn represses the expression of platelet-derived growth factor-B (PDGF-B), integrin beta 1, and integrin beta 5 via inhibition of the Sp1-mediated signaling pathway in the keratinocytes. The reduced production of PDGF-B leads to a paracrine-decreased expression of hepatocyte growth factor in the underlying fibroblasts. This TAK1 regulation of the double paracrine PDGF/hepatocyte growth factor signaling can regulate keratinocyte cell proliferation and is required for proper wound healing. Strikingly, TAK1 deficiency enhances cell migration. TAK1-deficient keratinocytes displayed lamellipodia formation with distinct microspike protrusion, associated with an elevated expression of integrins beta 1 and beta 5 and sustained activation of cdc42, Rac1, and RhoA. Our findings provide evidence for a novel homeostatic control of keratinocyte proliferation and migration mediated via TAK1 regulation of von Hippel-Lindau tumor suppressor. Dysfunctional regulation of TAK1 may contribute to the pathology of non-healing chronic inflammatory wounds and psoriasis.	[Tan, Siew Hwey; Pal, Mintu; Tan, Ming Jie; Wong, Marc Hai Liang; Tam, Fong U.; Teo, Jamie Wei Ting; Chong, Han Chung; Tan, Chek Kun; Goh, Yan Yih; Cheung, Peter Ching For; Tan, Nguan Soon] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Tang, Mark Boon Yang] Natl Skin Ctr, Singapore 308205, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Skin Centre	Tan, NS (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	nstan@ntu.edu.sg	Goh, Yan Yih/J-1926-2015; Cheung, Peter/A-2213-2011; Tan, Nguan Soon/A-2220-2011	Goh, Yan Yih/0000-0002-8922-9869; Tan, Nguan Soon/0000-0003-0136-7341	Ministry of Education, Singapore [ARC 8/06]; Nanyang Technological University, Singapore [RG 127/05, 158/06]	Ministry of Education, Singapore(Ministry of Education, Singapore); Nanyang Technological University, Singapore(Nanyang Technological University)	This work was supported in part by the Ministry of Education, Singapore (ARC 8/06) and Nanyang Technological University, Singapore ( Grants RG 127/05 and 158/06).	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Ahmed T, 2008, CELL SIGNAL, V20, P1320, DOI 10.1016/j.cellsig.2008.02.021; ANSEL JC, 1993, J CLIN INVEST, V92, P671, DOI 10.1172/JCI116636; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; CERVELLA P, 1993, J BIOL CHEM, V268, P5148; Cheng N, 2005, ONCOGENE, V24, P5053, DOI 10.1038/sj.onc.1208685; Chong HC, 2009, J CELL BIOL, V184, P817, DOI 10.1083/jcb.200809028; Delaney JR, 2006, CELL CYCLE, V5, P2852, DOI 10.4161/cc.5.24.3558; FUSENIG NE, 1994, KERATINOCYTE HDB, P71; IJpenberg A, 2004, EMBO J, V23, P2083, DOI 10.1038/sj.emboj.7600209; KRUEGER JG, 1990, J INVEST DERMATOL S, V94, P135; Lai CF, 2000, J BIOL CHEM, V275, P36400, DOI 10.1074/jbc.M002131200; Lederle W, 2006, AM J PATHOL, V169, P1767, DOI 10.2353/ajpath.2006.060120; Liu XY, 2008, FEBS LETT, V582, P4023, DOI 10.1016/j.febslet.2008.10.053; Lolkema MP, 2004, EXP CELL RES, V301, P139, DOI 10.1016/j.yexcr.2004.07.016; Maas-Szabowski N, 1999, J CELL SCI, V112, P1843; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Mukhopadhyay D, 1997, MOL CELL BIOL, V17, P5629, DOI 10.1128/MCB.17.9.5629; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; O'Toole EA, 2008, J CELL PHYSIOL, V214, P47, DOI 10.1002/jcp.21160; Omori E, 2008, J BIOL CHEM, V283, P26161, DOI 10.1074/jbc.M804513200; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Rafty LA, 2002, J CELL BIOCHEM, V85, P490, DOI 10.1002/jcb.10152; REUTERDAHL C, 1993, J CLIN INVEST, V91, P2065, DOI 10.1172/JCI116429; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sayama K, 2006, J BIOL CHEM, V281, P22013, DOI 10.1074/jbc.M601065200; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Tan NS, 2007, MOL CELL BIOL, V27, P7161, DOI 10.1128/MCB.00436-07; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Tovar-Castillo LE, 2007, INT J DERMATOL, V46, P239, DOI 10.1111/j.1365-4632.2006.02962.x; Trouba KJ, 2002, ANTIOXID REDOX SIGN, V4, P665, DOI 10.1089/15230860260220175; VILLAGARCIA M, 1994, BLOOD, V83, P668, DOI 10.1182/blood.V83.3.668.bloodjournal833668; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Xia YP, 2001, J INVEST DERMATOL, V116, P50, DOI 10.1046/j.1523-1747.2001.00209.x; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yao JH, 2007, J BIOL CHEM, V282, P6075, DOI 10.1074/jbc.M609039200; Young CN, 2008, J INVEST DERMATOL, V128, P2606, DOI 10.1038/jid.2008.122; Zatyka M, 2002, J MED GENET, V39, P463, DOI 10.1136/jmg.39.7.463; Zia MK, 2007, INT J MOL MED, V20, P605	42	19	22	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18047	18058		10.1074/jbc.M109.002691	http://dx.doi.org/10.1074/jbc.M109.002691			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19419968	hybrid, Green Published			2022-12-25	WOS:000267712400016
J	Watanabe, J; Grijalva, V; Hama, S; Barbour, K; Berger, FG; Navab, M; Fogelman, AM; Reddy, ST				Watanabe, Junji; Grijalva, Victor; Hama, Susan; Barbour, Karen; Berger, Franklin G.; Navab, Mohamad; Fogelman, Alan M.; Reddy, Srinivasa T.			Hemoglobin and Its Scavenger Protein Haptoglobin Associate with ApoA-1-containing Particles and Influence the Inflammatory Properties and Function of High Density Lipoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; CORONARY HEART-DISEASE; CHOLESTEROL LEVELS; MIMETIC PEPTIDES; OXIDIZED PHOSPHOLIPIDS; PLASMA HEMOGLOBIN; FENTON REAGENT; RECEPTOR CD163; HEME UPTAKE; INHIBITS 3	Hemoglobin (Hb) uniquely associates with proinflammatory HDL in atherogenic mice and coronary heart disease (CHD) patients. In this paper, we report that Hb and its scavenger proteins, haptoglobin ( Hp) and hemopexin (Hx) are significantly increased in apoA-1-containing particles of HDL both in mouse models of hyperlipidemia and in CHD patients, when compared with wild type mice and healthy donors, respectively. We further demonstrate that the association of Hb, Hp, and Hx proteins with HDL positively correlates with inflammatory properties of HDL and systemic inflammation in CHD patients. Interestingly, HDL from Hp(-/-) mice under atherogenic conditions does not accumulate Hb and is anti-inflammatory, suggesting that(i) Hp is required for the association of Hb with HDL and (ii) Hb . Hp complexes regulate the inflammatory properties of HDL. Moreover, treatment of apoE(-/-) mice with an apoA-1 mimetic peptide resulted in significant dissociation of Hb.Hp complexes from HDL and improvement of HDL inflammatory properties. Our data strongly suggest that HDL can become proinflammatory via the Hb.Hp pathway in mice and humans, and dissociation of Hb.Hp.Hx complexes from apoA-1-containing particles of HDL may be a novel target for the treatment of CHD.	[Reddy, Srinivasa T.] Univ Calif Los Angeles, Dept Med Cardiol, CHS, Atherosclerosis Res Unit, Los Angeles, CA 90095 USA; [Reddy, Srinivasa T.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Barbour, Karen; Berger, Franklin G.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Reddy, ST (corresponding author), Univ Calif Los Angeles, Dept Med Cardiol, CHS, Atherosclerosis Res Unit, 650 Charles E Young Dr S,A8-131, Los Angeles, CA 90095 USA.	sreddy@mednet.ucla.edu			National Institutes of Health, NHLBI [HL-30568, 1R01HL082823]; Laubisch; Castera; UCLA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568, R01HL082823] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Laubisch; Castera; UCLA(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI, Grants HL-30568 (to A.M.F., M.N., and S.T.R.) and 1R01HL082823 (to S.T.R.). This work was also supported by the Laubisch, Castera, and M.K. Grey Funds at UCLA. M.N., S.T.R., and A.M.F. are principals in Bruin Pharma, and A.M.F. is an officer in Bruin Pharma.	Abraham NG, 2006, CIRC RES, V99, P911, DOI 10.1161/01.RES.0000249616.10603.d6; ALTRUDA F, 1985, NUCLEIC ACIDS RES, V13, P3841, DOI 10.1093/nar/13.11.3841; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Asleh R, 2008, DIABETES, V57, P2794, DOI 10.2337/db08-0450; BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488; BOWMAN BH, 1982, ADV HUM GENET, V12, P189; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Cigliano L, 2001, STEROIDS, V66, P889, DOI 10.1016/S0039-128X(01)00124-6; Delanghe J, 1998, BLOOD, V91, P3524, DOI 10.1182/blood.V91.9.3524.3524_3524_3524; Fabriek BO, 2005, IMMUNOBIOLOGY, V210, P153, DOI 10.1016/j.imbio.2005.05.010; GARBY L, 1959, J CLIN INVEST, V38, P1479, DOI 10.1172/JCI103925; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Guetta J, 2007, ATHEROSCLEROSIS, V191, P48, DOI 10.1016/j.atherosclerosis.2006.04.032; HAYEK T, 1994, BIOCHEM BIOPH RES CO, V205, P1072, DOI 10.1006/bbrc.1994.2775; Hunt RC, 1996, J CELL PHYSIOL, V168, P71, DOI 10.1002/(SICI)1097-4652(199607)168:1<71::AID-JCP9>3.0.CO;2-5; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; KEENE WR, 1965, BLOOD-J HEMATOL, V26, P705, DOI 10.1182/blood.V26.6.705.705; Kozak KR, 2003, P NATL ACAD SCI USA, V100, P12343, DOI 10.1073/pnas.2033602100; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; KUNITAKE ST, 1994, BIOCHEMISTRY-US, V33, P1988, DOI 10.1021/bi00174a003; Levy AP, 2007, ARTERIOSCL THROM VAS, V27, P134, DOI 10.1161/01.ATV.0000251020.24399.a2; Lim SK, 1998, BLOOD, V92, P1870, DOI 10.1182/blood.V92.6.1870.418k38_1870_1877; Mackness Michael I, 2004, Am J Cardiovasc Drugs, V4, P211, DOI 10.2165/00129784-200404040-00002; Navab M, 1997, J CLIN INVEST, V99, P2005, DOI 10.1172/JCI119369; Navab M, 2000, J LIPID RES, V41, P1481; Navab M, 2000, J LIPID RES, V41, P1495; Navab M, 2005, ARTERIOSCL THROM VAS, V25, P1325, DOI 10.1161/01.ATV.0000165694.39518.95; Navab M, 2005, ANN MED, V37, P173, DOI 10.1080/07853890510007322; Navab M, 2004, CURR OPIN LIPIDOL, V15, P645, DOI 10.1097/00041433-200412000-00004; Navab M, 2004, CIRCULATION, V109, P3215, DOI 10.1161/01.CIR.0000134275.90823.87; NAVAB M, 1991, J CLIN INVEST, V88, P2039, DOI 10.1172/JCI115532; Navab M, 2001, J LIPID RES, V42, P1308; Navab M, 2001, ARTERIOSCL THROM VAS, V21, P481, DOI 10.1161/01.ATV.21.4.481; Navab M, 1996, ARTERIOSCL THROM VAS, V16, P831, DOI 10.1161/01.ATV.16.7.831; Navab M, 2006, NAT CLIN PRACT CARD, V3, P540, DOI 10.1038/ncpcardio0661; Philippidis P, 2004, CIRC RES, V94, P119, DOI 10.1161/01.RES.0000109414.78907.F9; Porta A, 1999, ZYGOTE, V7, P67, DOI 10.1017/S0967199499000416; PUPPO A, 1988, BIOCHEM J, V249, P185, DOI 10.1042/bj2490185; RADEMACHER BE, 1987, ANAL BIOCHEM, V160, P119, DOI 10.1016/0003-2697(87)90621-X; Ridker PM, 2002, CIRCULATION, V105, P2, DOI 10.1161/circ.105.1.2; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; SADRZADEH SMH, 1984, J BIOL CHEM, V259, P4354; Schaer CA, 2006, CIRC RES, V99, P943, DOI 10.1161/01.RES.0000247067.34173.1b; Schaer DJ, 2006, BLOOD, V107, P373, DOI 10.1182/blood-2005-03-1014; Spagnuolo MS, 2005, J BIOL CHEM, V280, P1193, DOI 10.1074/jbc.M411390200; Van Lenten BJ, 2001, CIRCULATION, V103, P2283; Van Lenten BJ, 2007, J LIPID RES, V48, P2344, DOI 10.1194/jlr.M700138-JLR200; VanLenten BJ, 1995, J CLIN INVEST, V96, P2758, DOI 10.1172/JCI118345; Watanabe J, 2007, J BIOL CHEM, V282, P23698, DOI 10.1074/jbc.M702163200; WEINSTEIN MB, 1984, BIOCHEM BIOPH RES CO, V123, P489, DOI 10.1016/0006-291X(84)90257-2; Witztum JL, 2001, TRENDS CARDIOVAS MED, V11, P93, DOI 10.1016/S1050-1738(01)00111-6; WITZTUM JL, 1991, J CLIN INVEST, V88, P1785, DOI 10.1172/JCI115499	52	93	96	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18292	18301		10.1074/jbc.M109.017202	http://dx.doi.org/10.1074/jbc.M109.017202			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19433579	Green Published, hybrid			2022-12-25	WOS:000267712400042
J	Borland, G; Bird, RJ; Palmer, TM; Yarwood, SJ				Borland, Gillian; Bird, Rebecca J.; Palmer, Timothy M.; Yarwood, Stephen J.			Activation of Protein Kinase C alpha by EPAC1 Is Required for the ERK- and CCAAT/Enhancer-binding Protein beta-dependent Induction of the SOCS-3 Gene by Cyclic AMP in COS1 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL BARRIER FUNCTION; EXCHANGE FACTOR; TRANSCRIPTION FACTORS; CAMP; RAP1; FAMILY; PHOSPHORYLATION; RECEPTOR; CADHERIN; HORMONE	We recently found that induction of the anti-inflammatory SOCS-3 gene by cyclic AMP occurs through novel cyclic AMP-dependent protein kinase-independent mechanisms involving activation of CCAAT/enhancer-binding protein (C/EBP) transcription factors, notably C/EBP beta, by the cyclic AMP GEF EPAC1 and the Rap1 GTPase. In this study we show that down-regulation of phospholipase (PL) C epsilon with small interfering RNA or blockade of PLC activity with chemical inhibitors ablates exchange protein directly activated by cyclic AMP (EPAC)-dependent induction of SOCS-3 in COS1 cells. Consistent with this, stimulation of cells with 1-oleoyl-2-acetyl-sn-glycerol and phorbol 12-myristate 13-acetate, both cell-permeable analogues of the PLC product diacylglycerol, are sufficient to induce SOCS-3 expression in a Ca2+-dependent manner. Moreover, the diacylglycerol- and Ca2+-dependent protein kinase C (PKC) isoform PKC alpha becomes activated following cyclic AMP elevation or EPAC stimulation. Conversely, down-regulation of PKC activity with chemical inhibitors or small interfering RNA-mediated depletion of PKC alpha or -delta blocks EPAC-dependent SOCS-3 induction. Using the MEK inhibitor U0126, we found that activation of ERK MAPKs is essential for SOCS-3 induction by either cyclic AMP or PKC. C/EBP beta is known to be phosphorylated and activated by ERK. Accordingly, we found ERK activation to be essential for cyclic AMP-dependent C/EBP activation and C/EBP beta-dependent SOCS-3 induction by cyclic AMP and PKC. Moreover, overexpression of a mutant form of C/EBP beta (T235A), which lacks the ERK phosphorylation site, blocks SOCS-3 induction by cyclic AMP and PKC in a dominant-negative manner. Together, these results indicate that EPAC mediates novel regulatory cross-talk between the cyclic AMP and PKC signaling pathways leading to ERK- and C/EBP beta-dependent induction of the SOCS-3 gene.	[Borland, Gillian; Bird, Rebecca J.; Palmer, Timothy M.; Yarwood, Stephen J.] Univ Glasgow, Div Mol & Cellular Biol, Fac Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Yarwood, SJ (corresponding author), Univ Glasgow, Div Mol & Cellular Biol, Fac Biomed & Life Sci, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	S.Yarwood@bio.gla.ac.uk	Palmer, Timothy/C-4975-2009; Palmer, Timothy/E-7290-2013	Palmer, Timothy/0000-0002-9803-7164; Yarwood, Stephen/0000-0001-9489-9253	Biotechnology and Biological Sciences Research Council [BB/D015324/1]; British Heart Foundation [PG/08/125]; BBSRC [BB/D015324/1] Funding Source: UKRI; British Heart Foundation [PG/08/125/26415] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	This work was supported in part by Biotechnology and Biological Sciences Research Council Grant BB/D015324/1 (to S. J. Y. and T. M. P.) and British Heart Foundation Grant PG/08/125 (to T. M. P. and S. J. Y.).	BLUMBERG PM, 1988, CANCER RES, V48, P1; BORLAND G, 2009, BR J PHARM IN PRESS; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Engh RA, 2001, ADV ENZYME REGUL, V41, P121, DOI 10.1016/S0065-2571(00)00010-8; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Gekel I, 2008, J NEUROSCI, V28, P7991, DOI 10.1523/JNEUROSCI.0268-08.2008; Gronning LM, 1999, ENDOCRINOLOGY, V140, P835, DOI 10.1210/en.140.2.835; Hucho TB, 2005, J NEUROSCI, V25, P6119, DOI 10.1523/JNEUROSCI.0285-05.2005; Islam D, 2009, AM J PHYSIOL-ENDOC M, V296, pE174, DOI 10.1152/ajpendo.90419.2008; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Kuiperij HB, 2003, BBA-MOL CELL RES, V1593, P141, DOI 10.1016/S0167-4889(02)00365-8; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Oestreich EA, 2009, J BIOL CHEM, V284, P1514, DOI 10.1074/jbc.M806994200; Ohba Y, 2000, MOL CELL BIOL, V20, P6074, DOI 10.1128/MCB.20.16.6074-6083.2000; Pham N, 2000, CURR BIOL, V10, P555, DOI 10.1016/S0960-9822(00)00473-5; Piwien-Pilipuk G, 2002, J BIOL CHEM, V277, P44557, DOI 10.1074/jbc.M206886200; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sands WA, 2006, MOL CELL BIOL, V26, P6333, DOI 10.1128/MCB.00207-06; Sehrawat S, 2008, MOL BIOL CELL, V19, P1261, DOI 10.1091/mbc.E06-10-0972; Wang CY, 2007, J PHYSIOL-LONDON, V584, P191, DOI 10.1113/jphysiol.2007.135616; Yarwood SJ, 2008, J BIOL CHEM, V283, P6843, DOI 10.1074/jbc.M710342200	30	46	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17391	17403		10.1074/jbc.M109.015370	http://dx.doi.org/10.1074/jbc.M109.015370			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19423709	hybrid, Green Published			2022-12-25	WOS:000267202500005
J	Calandria, JM; Marcheselli, VL; Mukherjee, PK; Uddin, J; Winkler, JW; Petasis, NA; Bazan, NG				Calandria, Jorgelina M.; Marcheselli, Victor L.; Mukherjee, Pranab K.; Uddin, Jasim; Winkler, Jeremy W.; Petasis, Nicos A.; Bazan, Nicolas G.			Selective Survival Rescue in 15-Lipoxygenase-1-deficient Retinal Pigment Epithelial Cells by the Novel Docosahexaenoic Acid-derived Mediator, Neuroprotectin D1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; EXPRESSION; PHOTORECEPTORS; DISEASE; ROD; INFLAMMATION; APOPTOSIS; CALCIUM; BINDING; BRAIN	The integrity of the retinal pigment epithelial (RPE) cell is essential for the survival of rod and cone photoreceptor cells. Several stressors, including reactive oxygen species, trigger apoptotic damage in RPE cells preceded by an anti-inflammatory, pro-survival response, the formation of neuroprotectin D1 (NPD1), an oxygenation product derived from the essential omega-3 fatty acid family member docosahexaenoic acid. To define the ability of NPD1 and other endogenous novel lipid mediators in cell survival, we generated a stable knockdown human RPE (ARPE-19) cell line using short hairpin RNA to target 15-lipoxygenase-1. The 15-lipoxygenase-1-deficient cells exhibited 30% of the protein expression, and 15-lipoxygenase-2 remained unchanged, as compared with an ARPE-19 cell line control established using nonspecific short hairpin RNA transfected cells. NPD1 synthesis was stimulated by tumor necrosis factor alpha/H2O2-mediated oxidative stress in nonspecific cells (controls), whereas in silenced cells, negligible amounts of NPD1, 12(S)- and 15(S)-hydroxyeicosatetraenoic acid, and lipoxin A(4) were found under these conditions. Neither control nor the deficient cells showed an increase in 15-lipoxygenase-1 protein content after 16 h of oxidative stress, suggesting that the increased activity of 15-lipoxygenase-1 is due to activation of pre-existing proteins. 15-Lipoxygenase-silenced cells also displayed an exacerbated sensitivity to oxidative stress-induced apoptosis when compared with the control cells. NPD1 selectively and potently rescued 15-lipoxygenase-silenced cells from oxidative stress-induced apoptosis. These results demonstrate that 15-lipoxygenase-1 is activated by oxidative stress in ARPE-19 cells and that NPD1 is part of an early survival signaling in RPE cells.	[Calandria, Jorgelina M.; Marcheselli, Victor L.; Mukherjee, Pranab K.; Bazan, Nicolas G.] Louisiana State Univ, Neurosci Ctr Excellence, Hlth Sci Ctr, Sch Med, New Orleans, LA 70112 USA; [Uddin, Jasim; Winkler, Jeremy W.; Petasis, Nicos A.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Southern California	Bazan, NG (corresponding author), Louisiana State Univ, Neurosci Ctr Excellence, Hlth Sci Ctr, Sch Med, 2020 Gravier St, New Orleans, LA 70112 USA.	nbazan@lsuhsc.edu	Winkler, Jeremy/C-3198-2008; Bazan, Nicolas/AAN-4121-2020; Petasis, Nicos/B-3162-2009	Bazan, Nicolas/0000-0002-9243-5444; Petasis, Nicos/0000-0002-8864-4446	National Institutes of Health [R01 EY005121, P20 RR016816]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016816] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY005121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 EY005121 and P20 RR016816.	Aleem AM, 2008, J MOL BIOL, V376, P193, DOI 10.1016/j.jmb.2007.11.086; Ariel A, 2005, J BIOL CHEM, V280, P43079, DOI 10.1074/jbc.M509796200; Bazan NG, 2007, INVEST OPHTH VIS SCI, V48, P4866, DOI 10.1167/iovs.07-0918; Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; Bharti K, 2005, J INVEST DERMATOL, V125, pX, DOI 10.1111/j.0022-202X.2005.23876.x; BOK D, 1993, J CELL SCI, P189; Brash AR, 1997, P NATL ACAD SCI USA, V94, P6148, DOI 10.1073/pnas.94.12.6148; Brinckmann R, 1998, BLOOD, V91, P64, DOI 10.1182/blood.V91.1.64.64_64_74; Chang MS, 2005, INVEST OPHTH VIS SCI, V46, P849, DOI 10.1167/iovs.04-1166; Chen BL, 2006, J BIOL CHEM, V281, P18296, DOI 10.1074/jbc.M603484200; Engelhardt M, 2005, BRAIN RES, V1040, P98, DOI 10.1016/j.brainres.2005.01.075; Gan QF, 1996, J BIOL CHEM, V271, P25412, DOI 10.1074/jbc.271.41.25412; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; KUHN H, 1993, BIOCHIM BIOPHYS ACTA, V1168, P73, DOI 10.1016/0005-2760(93)90268-E; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanning JL, 2005, J INVEST DERMATOL, V125, P805, DOI 10.1111/j.0022-202X.2005.23819.x; LAVAIL MM, 1980, INVEST OPHTH VIS SCI, V19, P407; Liang LN, 2008, INVEST OPHTH VIS SCI, V49, P4145, DOI 10.1167/iovs.07-1380; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; McKay BS, 2006, EXP NEUROL, V201, P234, DOI 10.1016/j.expneurol.2006.04.016; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Mukherjee PK, 2007, P NATL ACAD SCI USA, V104, P13158, DOI 10.1073/pnas.0705963104; Mukherjee PK, 2007, P NATL ACAD SCI USA, V104, P13152, DOI 10.1073/pnas.0705949104; Organisciak DT, 1996, INVEST OPHTH VIS SCI, V37, P2243; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Rattner A, 2006, NAT REV NEUROSCI, V7, P860, DOI 10.1038/nrn2007; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; SCOTT BL, 1989, P NATL ACAD SCI USA, V86, P2903, DOI 10.1073/pnas.86.8.2903; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Tombran-Tink J, 2003, NAT REV NEUROSCI, V4, P628, DOI 10.1038/nrn1176; Walther M, 2004, J BIOL CHEM, V279, P3717, DOI 10.1074/jbc.M309564200	33	78	81	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17877	17882		10.1074/jbc.M109.003988	http://dx.doi.org/10.1074/jbc.M109.003988			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19403949	Green Published, hybrid			2022-12-25	WOS:000267202500053
J	Unal, ES; Zhao, RB; Chang, MH; Fiser, A; Romero, MF; Goldman, ID				Unal, Ersin Selcuk; Zhao, Rongbao; Chang, Min-Hwang; Fiser, Andras; Romero, Michael F.; Goldman, I. David			The Functional Roles of the His(247) and His(281) Residues in Folate and Proton Translocation Mediated by the Human Proton-coupled Folate Transporter SLC46A1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR FACILITATOR SUPERFAMILY; AMINO-ACID TRANSPORTER; METAL-ION TRANSPORTER; BRUSH-BORDER MEMBRANE; NOREPINEPHRINE TRANSPORTERS; CONFORMATIONAL FLEXIBILITY; HISTIDINE-RESIDUES; CHLORIDE TRANSPORT; ESCHERICHIA-COLI; LACTOSE PERMEASE	This report addresses the functional role of His residues in the proton-coupled folate transporter (PCFT; SLC46A1), which mediates intestinal folate absorption. Of ten His residues, only H247A and H281A mutations altered function. The folic acid influx K-t at pH 5.5 for H247A was down arrow 28.4-fold. Although wild type (WT)-PCFT K-i values varied among the folates, K-i values were much lower and comparable for H247-A, -R, -Q, or -E mutants. Homology modeling localized His(247) to the large loop separating transmembrane domains 6 and 7 at the cytoplasmic entrance of the translocation pathway in hydrogen-bond distance to Ser(172). The folic acid influx K-t for S172A-PCFT was decreased similar to H247A. His(281) faces the extracellular region in the seventh transmembrane domain. H281A-PCFT results in loss-of-function due to similar to 12-fold up arrow in the folic acid influx K-t. When the pH was decreased from 5.5 to 4.5, the WT-PCFT folic acid influx K-t was unchanged, but the K-t decreased 4-fold for H281A. In electrophysiological studies in Xenopus oocytes, both WT-PCFT- and H281A-PCFT-mediated folic acid uptake produced current and acidification, and both exhibited a low level of folate-independent proton transport (slip-page). Slippage was markedly increased for the H247A-PCFT mutant. The data suggest that disruption of the His(247) to Ser(172) interaction results in a PCFT conformational alteration causing a loss of selectivity, increased substrate access to a high affinity binding pocket, and proton transport in the absence of a folate gradient. The His(281) residue is not essential for proton coupling but plays an important role in PCFT protonation, which, in turn, augments folate binding to the carrier.	[Unal, Ersin Selcuk; Zhao, Rongbao; Goldman, I. David] Albert Einstein Canc Ctr, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Zhao, Rongbao; Goldman, I. David] Albert Einstein Canc Ctr, Dept Med, Bronx, NY 10461 USA; [Fiser, Andras] Albert Einstein Canc Ctr, Dept Syst & Computat Biol, Bronx, NY 10461 USA; [Fiser, Andras] Albert Einstein Canc Ctr, Dept Biochem, Bronx, NY 10461 USA; [Chang, Min-Hwang; Romero, Michael F.] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA	Yeshiva University; Yeshiva University; Yeshiva University; Yeshiva University; Mayo Clinic	Goldman, ID (corresponding author), Albert Einstein Canc Ctr, Dept Mol Pharmacol, Chanin 2,1300 Morris Pk Ave, Bronx, NY 10461 USA.	igoldman@aecom.yu.edu			National Institutes of Health [CA-082621, EY-017732]; NATIONAL CANCER INSTITUTE [R01CA082621] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-082621 (to I. D. G.) and EY-017732 (to M. F. R.). Data in this report are from Ersin Selcuk Unal's thesis to be submitted in partial fulfillment of the requirements for the Degree of Doctor of Philosophy in the Graduate Division of Medical Sciences, Albert Einstein College of Medicine, Yeshiva University.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Alexov EG, 1997, BIOPHYS J, V72, P2075, DOI 10.1016/S0006-3495(97)78851-9; Andrews NC, 2007, CELL METAB, V5, P5, DOI 10.1016/j.cmet.2006.12.004; Boll M, 2003, GENOMICS, V82, P47, DOI 10.1016/S0888-7543(03)00099-5; Carvelli L, 2008, P NATL ACAD SCI USA, V105, P14192, DOI 10.1073/pnas.0802214105; Chang MH, 2008, J BIOL CHEM, V283, P18402, DOI 10.1074/jbc.M709819200; Chang MH, 2009, J MEMBRANE BIOL, V228, P125, DOI 10.1007/s00232-009-9165-5; Chen XZ, 1999, J BIOL CHEM, V274, P35089, DOI 10.1074/jbc.274.49.35089; Choi I, 2000, NATURE, V405, P571, DOI 10.1038/35014615; COHEN LA, 1968, ANNU REV BIOCHEM, V37, P695, DOI 10.1146/annurev.bi.37.070168.003403; CRANE RK, 1977, REV PHYSIOL BIOCH P, V78, P99, DOI 10.1007/BFb0027722; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DeFelice LJ, 2007, ANNU REV PHYSIOL, V69, P87, DOI 10.1146/annurev.physiol.69.031905.164816; Fairman WA, 1998, NAT NEUROSCI, V1, P105, DOI 10.1038/355; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Fei YJ, 1997, BIOCHEMISTRY-US, V36, P452, DOI 10.1021/bi962058p; Fei YJ, 2000, J BIOL CHEM, V275, P9563, DOI 10.1074/jbc.275.13.9563; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Foltz M, 2005, BIOCHEM J, V386, P607, DOI 10.1042/BJ20041519; FRY DW, 1982, J BIOL CHEM, V257, P1890; Galic S, 2003, BIOCHEM J, V376, P413, DOI 10.1042/BJ20030799; Galli A, 1998, P NATL ACAD SCI USA, V95, P13260, DOI 10.1073/pnas.95.22.13260; Galli A, 1996, P NATL ACAD SCI USA, V93, P8671, DOI 10.1073/pnas.93.16.8671; Geller J, 2002, MEDICINE, V81, P51, DOI 10.1097/00005792-200201000-00004; Georgescu RE, 2002, BIOPHYS J, V83, P1731, DOI 10.1016/S0006-3495(02)73940-4; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; HORNE DW, 1992, ARCH BIOCHEM BIOPHYS, V298, P121, DOI 10.1016/0003-9861(92)90102-3; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430; Lam-Yuk-Tseung S, 2003, BLOOD, V101, P3699, DOI 10.1182/blood-2002-07-2108; Lasry I, 2008, BLOOD, V112, P2055, DOI 10.1182/blood-2008-04-150276; Lemieux MJ, 2007, MOL MEMBR BIOL, V24, P333, DOI 10.1080/09687680701496507; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Mackenzie B, 2006, PFLUG ARCH EUR J PHY, V451, P544, DOI 10.1007/s00424-005-1494-3; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meredith D, 2006, J MEMBRANE BIOL, V213, P79, DOI 10.1007/s00232-006-0876-6; Metzner L, 2008, BBA-BIOMEMBRANES, V1778, P1042, DOI 10.1016/j.bbamem.2007.12.026; Miles E W, 1977, Methods Enzymol, V47, P431; MULLERBERGER S, 1995, BIOCHEMISTRY-US, V34, P9325; MULLERBERGER S, 1995, BIOCHEMISTRY-US, V34, P9315; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Qiu A, 2007, AM J PHYSIOL-CELL PH, V293, pC1669, DOI 10.1152/ajpcell.00202.2007; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Raghunand N, 1999, BIOCHEM PHARMACOL, V57, P309, DOI 10.1016/S0006-2952(98)00306-2; Rai BK, 2006, PROTEINS, V63, P644, DOI 10.1002/prot.20835; Rai BK, 2006, BIOINFORMATICS, V22, P2691, DOI 10.1093/bioinformatics/btl449; SAID HM, 1993, BIOCHEM J, V290, P237, DOI 10.1042/bj2900237; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHRON CM, 1985, J CLIN INVEST, V76, P2030, DOI 10.1172/JCI112205; SCHRON CM, 1991, J MEMBRANE BIOL, V120, P192, DOI 10.1007/BF01872403; Sharina IG, 2002, BIOCHEM PHARMACOL, V63, P1717, DOI 10.1016/S0006-2952(02)00955-3; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Sonders MS, 1996, CURR OPIN NEUROBIOL, V6, P294, DOI 10.1016/S0959-4388(96)80111-5; Steel A, 1997, J PHYSIOL-LONDON, V498, P563, DOI 10.1113/jphysiol.1997.sp021883; Tao Z, 2005, BIOCHEMISTRY-US, V44, P3466, DOI 10.1021/bi047812i; Thwaites DT, 2007, EXP PHYSIOL, V92, P603, DOI 10.1113/expphysiol.2005.029959; Unal ES, 2008, BBA-BIOMEMBRANES, V1778, P1407, DOI 10.1016/j.bbamem.2008.03.009; WIDDAS WF, 1952, J PHYSIOL-LONDON, V118, P23, DOI 10.1113/jphysiol.1952.sp004770; Xu HX, 2004, PLOS BIOL, V2, P378, DOI 10.1371/journal.pbio.0020050; Yang HS, 2009, J BIOL CHEM, V284, P15970, DOI 10.1074/jbc.M109.001438; Yang J, 2007, J PHARMACOL EXP THER, V321, P462, DOI 10.1124/jpet.106.117648; Zhao RB, 2004, CLIN CANCER RES, V10, P8735, DOI 10.1158/1078-0432.CCR-04-0932; Zhao RB, 2008, MOL PHARMACOL, V74, P854, DOI 10.1124/mol.108.045443; Zhao R, 2007, BLOOD, V110, P1147, DOI 10.1182/blood-2007-02-077099; Zhao RB, 2009, J BIOL CHEM, V284, P4267, DOI 10.1074/jbc.M807665200	72	53	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17846	17857		10.1074/jbc.M109.008060	http://dx.doi.org/10.1074/jbc.M109.008060			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19389703	Green Published, hybrid			2022-12-25	WOS:000267202500050
J	Liu, YL; Zhao, Y; Dai, ZM; Chen, HM; Yang, WJ				Liu, Yu-Lei; Zhao, Yang; Dai, Zhong-Min; Chen, Han-Min; Yang, Wei-Jun			Formation of Diapause Cyst Shell in Brine Shrimp, Artemia parthenogenetica, and Its Resistance Role in Environmental Stresses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKING PROTEIN; ENCYSTED EMBRYOS; CRYSTALLIN PROTEIN; CHAPERONE ACTIVITY; FRANCISCANA; TEMPERATURE; TERMINATION; EXPRESSION; MORTALITY; MEMBRANES	Artemia has attracted much attention for its ability to produce encysted embryos wrapped in a protective shell when subject to extremely harsh environmental conditions. However, what the cyst shell is synthesized from and how the formative process is performed remains, as yet, largely unknown. Over 20 oviparous specifically expressed genes were identified through screening the subtracted cDNA library enriched between oviparous and ovoviviparous Artemia ovisacs. Among them, a shell gland-specifically expressed gene (SGEG) has been found to be involved in the cyst shell formation. Lacking SGEG protein (by RNA interference) caused the cyst shell to become translucent and the chorion layer of the shell to become less compact and pultaceous and to show a marked decrease of iron composition within the shell. The RNA interference induced defective diapause cysts with a totally compromised resistibility to UV irradiation, extremely large temperature differences, osmotic pressure, dryness, and organic solvent stresses. In contrast, the natural cyst would provide adequate protection from all such factors. SGEG contains a 345-bp open reading frame, and its consequentially translated peptide consists of a 33-amino acid residue putative signal peptide and an 81-amino acid residue mature peptide. The results of Northern blotting and in situ hybridization indicate that the gene is specifically expressed in the cells of shell glands during the period of diapause cyst formation of oviparous Artemia. This investigation adds strong insight into the mechanism of cyst shell formation of Artemia and may be applicable to other areas of research in extremophile biology.	[Liu, Yu-Lei; Zhao, Yang; Dai, Zhong-Min; Yang, Wei-Jun] Zhejiang Univ, Coll Life Sci, Inst Cell Biol & Genet, Hangzhou 310058, Zhejiang, Peoples R China; [Chen, Han-Min] Zhejiang Univ, Coll Life Sci, Equipment & Technol Serv Platform, Hangzhou 310058, Zhejiang, Peoples R China; [Yang, Wei-Jun] Minist Educ, State Conservat Ctr Gene Resources Wildlife, Hangzhou 310058, Zhejiang, Peoples R China; [Yang, Wei-Jun] Minist Educ, Key Lab Conservat Genet & Reprod Biol Wild Anim, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yang, WJ (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Cell Biol & Genet, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China.	w_jyang@cls.zju.edu.cn		Yang, Wei-Jun/0000-0002-4591-8830; Dai, Zhong-Min/0000-0003-4083-1901	National Natural Sciences Foundation of China [40730212, 40876069];  [2007AA09Z426]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); 	This work was supported by National Natural Sciences Foundation of China Grants 40730212 and 40876069 and 863 Program of China Grant 2007AA09Z426.	ADAMKOVA I, 1999, HATCHING QUALITY ART; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clegg JS, 2006, COMP BIOCHEM PHYS B, V145, P119, DOI 10.1016/j.cbpb.2006.04.014; Clegg James S., 2002, P129; CLEGG JS, 1978, J CELL PHYSIOL, V94, P123, DOI 10.1002/jcp.1040940202; Clegg JS, 2005, INTEGR COMP BIOL, V45, P715, DOI 10.1093/icb/45.5.715; CLEGG JS, 1995, EXP CELL RES, V219, P1, DOI 10.1006/excr.1995.1197; Clegg JS, 1997, J EXP BIOL, V200, P467; CLEGG JS, 1980, BRINE SHRIMP ARTEMIA, V2, P11; Criel Godelievre R.J., 2002, P1; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; Crowe LM, 1996, BIOPHYS J, V71, P2087, DOI 10.1016/S0006-3495(96)79407-9; Dai JQ, 2008, J BIOL CHEM, V283, P1705, DOI 10.1074/jbc.M707853200; Dattilo AM, 2005, INT J BIOMETEOROL, V49, P388, DOI 10.1007/s00484-005-0255-5; Drinkwater L.E., 1991, P93; DUTRIEU JANINE, 1960, ARCH ZOOL EXPTL ET GEN, V99, P1; FINAMORE FJ, 1969, CELL CYCLE GENE ENZY, P249; HAND SC, 1988, SCIENCE, V239, P1425, DOI 10.1126/science.239.4846.1425; HOFMANN GE, 1990, J EXP ZOOL, V253, P287, DOI 10.1002/jez.1402530308; Lavens P., 1987, P27; Liang P, 1997, J BIOL CHEM, V272, P19051, DOI 10.1074/jbc.272.30.19051; Liang P, 1997, EUR J BIOCHEM, V243, P225, DOI 10.1111/j.1432-1033.1997.0225a.x; LIU FQ, 2002, ANIM SCI VET MED, V83, P10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacRae TH, 2003, SEMIN CELL DEV BIOL, V14, P251, DOI 10.1016/j.semcdb.2003.09.019; MORRIS JE, 1967, J ULTRA MOL STRUCT R, V20, P244, DOI 10.1016/S0022-5320(67)90285-7; NAKANISHI Yu.H., 1962, ANNOT ZOOL JAPON, V35, P223; Nambu Z, 2004, J EXP ZOOL PART A, V301A, P542, DOI 10.1002/jez.a.80; Nambu Z, 2008, J EXP ZOOL PART A, V309A, P17, DOI 10.1002/jez.428; Oulton MM, 2003, EUR J BIOCHEM, V270, P4962, DOI 10.1046/j.1432-1033.2003.03898.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sugumar V, 2006, MICROSC RES TECHNIQ, V69, P957, DOI 10.1002/jemt.20371; Tanguay JA, 2004, J BIOSCIENCES, V29, P489, DOI 10.1007/BF02712121; VANDERLINDEN A, 1987, ARTEMIA RES ITS APPL, V2, P181; Versichele D., 1980, P231; Warner AH, 2004, ARCH BIOCHEM BIOPHYS, V424, P189, DOI 10.1016/j.abb.2004.02.022; Yodmuang S, 2006, BIOCHEM BIOPH RES CO, V341, P351, DOI 10.1016/j.bbrc.2005.12.186; YOSEFALI A, 1999, BIOTECHNOLOGICAL APP; ZHANG JS, 1994, J BIOL CHEM, V269, P3053; Zhu XJ, 2007, STRESS, V10, P53, DOI 10.1080/10253890601130773	40	35	36	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16931	16938		10.1074/jbc.M109.004051	http://dx.doi.org/10.1074/jbc.M109.004051			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19395704	hybrid, Green Published			2022-12-25	WOS:000266962400030
J	Walters, KR; Pan, QF; Serianni, AS; Duman, JG				Walters, Kent R., Jr.; Pan, Qingfeng; Serianni, Anthony S.; Duman, John G.			Cryoprotectant Biosynthesis and the Selective Accumulation of Threitol in the Freeze-tolerant Alaskan Beetle, Upis ceramboides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD TOLERANCE; BOMBYX-MORI; POLYOL DEHYDROGENASES; ENZYMATIC PATHWAYS; DIAPAUSING EGG; BARK BEETLE; INSECTS; TREHALOSE; SILKWORM; GLYCEROL	Adult Upis ceramboides do not survive freezing in the summer but tolerate freezing to -60 degrees C in midwinter. The accumulation of two cryoprotective polyols, sorbitol and threitol, is integral to the extraordinary cold-hardiness of this beetle. U. ceramboides are the only animals known to accumulate high concentrations of threitol; however, the biosynthetic pathway has not been studied. A series of C-13-labeled compounds was employed to investigate this biosynthetic pathway using C-13{H-1} NMR spectroscopy. In vivo metabolism of C-13-labeled glucose isotopomers demonstrates that C-3-C-6 of glucose become C-1-C-4 of threitol. This labeling pattern is expected for 4-carbon saccharides arising from the pentose phosphate pathway. In vitro experiments show that threitol is synthesized from erythrose 4-phosphate, a C-4 intermediate in the PPP. Erythrose 4-phosphate is epimerized and/or isomerized to threose 4-phosphate, which is subsequently reduced by a NADPH-dependent polyol dehydrogenase and dephosphorylated by a sugar phosphatase to form threitol. Threitol 4-phosphate appears to be the preferred substrate of the sugar phosphatase(s), promoting threitol synthesis over that of erythritol. In contrast, the NADPH-dependent polyol dehydrogenase exhibits broad substrate specificity. Efficient erythritol catabolism under conditions that promote threitol synthesis, coupled with preferential threitol biosynthesis, appear to be responsible for the accumulation of high concentrations of threitol (250 mM) without concomitant accumulation of erythritol.	[Walters, Kent R., Jr.; Duman, John G.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Pan, Qingfeng; Serianni, Anthony S.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Pan, Qingfeng; Serianni, Anthony S.] Omicron Biochem Inc, South Bend, IN 46617 USA	University of Notre Dame; University of Notre Dame	Walters, KR (corresponding author), Univ Notre Dame, Dept Biol Sci, Galvin Biol Sci Bldg, Notre Dame, IN 46556 USA.	kwalter2@nd.edu			National Science Foundation [OPP-0117104, IOS-0618342]	National Science Foundation(National Science Foundation (NSF))	This study was supported by National Science Foundation Grants OPP-0117104 and IOS-0618342.	Bennett VA, 2005, J EXP BIOL, V208, P4467, DOI 10.1242/jeb.01892; BLOCK W, 1990, PHILOS T ROY SOC B, V326, P613, DOI 10.1098/rstb.1990.0035; CHINO H, 1960, J INSECT PHYSIOL, V5, P1, DOI 10.1016/0022-1910(60)90018-4; CHINO H, 1961, J INSECT PHYSIOL, V6, P231, DOI 10.1016/0022-1910(61)90067-1; CROWE JH, 1987, BIOCHEM J, V242, P1, DOI 10.1042/bj2420001; CSONKA LN, 1991, ANNU REV MICROBIOL, V45, P569, DOI 10.1146/annurev.mi.45.100191.003033; Duman JG, 2001, ANNU REV PHYSIOL, V63, P327, DOI 10.1146/annurev.physiol.63.1.327; Fields PG, 1998, J INSECT PHYSIOL, V44, P955, DOI 10.1016/S0022-1910(98)00055-9; GARRETT EC, 1990, CARBOHYD RES, V208, P23, DOI 10.1016/0008-6215(90)80082-E; GEHRKEN U, 1984, J INSECT PHYSIOL, V30, P421, DOI 10.1016/0022-1910(84)90100-8; HAYAKAWA Y, 1982, INSECT BIOCHEM, V12, P639, DOI 10.1016/0020-1790(82)90050-6; JONES RGW, 1981, PHYSL BIOCH DROUGHT, P172; KAGEYAMA T, 1973, INSECT BIOCHEM, V3, P373, DOI 10.1016/0020-1790(73)90071-1; Kostal V, 2007, J INSECT PHYSIOL, V53, P580, DOI 10.1016/j.jinsphys.2007.02.009; KUKAL O, 1988, J COMP PHYSIOL B, V158, P175, DOI 10.1007/BF01075831; Lee R.E. Jr, 1991, P17; LELOIR LF, 1957, METHOD ENZYMOL, V3, P840, DOI 10.1016/S0076-6879(57)03459-X; MILLER K, 1982, COMP BIOCHEM PHYS A, V73, P595, DOI 10.1016/0300-9629(82)90266-3; MILLER LK, 1978, J INSECT PHYSIOL, V24, P791, DOI 10.1016/0022-1910(78)90097-5; MILLER LK, 1975, NATURE, V258, P519, DOI 10.1038/258519a0; PITKANEN E, 1977, CLIN CHIM ACTA, V80, P49, DOI 10.1016/0009-8981(77)90262-5; Prade RA, 1996, BIOTECHNOL GENET ENG, V13, P101, DOI 10.1080/02648725.1996.10647925; Ramlov H, 1999, J COMP PHYSIOL B, V169, P224, DOI 10.1007/s003600050215; RUDOLPH AS, 1985, CRYOBIOLOGY, V22, P367, DOI 10.1016/0011-2240(85)90184-1; SERIANNI AS, 1979, BIOCHEMISTRY-US, V18, P1192, DOI 10.1021/bi00574a012; SHIMADA K, 1990, CRYO-LETT, V11, P243; Storey K.B., 1991, P64; STOREY KB, 1990, PHILOS T R SOC B, V326, P635, DOI 10.1098/rstb.1990.0036; STOREY KB, 1988, PHYSIOL REV, V68, P27, DOI 10.1152/physrev.1988.68.1.27; TAKAHASHI SY, 1974, INSECT BIOCHEM, V4, P33, DOI 10.1016/0020-1790(74)90040-7; TERADA T, 1985, EUR J BIOCHEM, V148, P345, DOI 10.1111/j.1432-1033.1985.tb08845.x; WALUM E, 1982, ANAL BIOCHEM, V120, P8, DOI 10.1016/0003-2697(82)90310-4; ZACHARIASSEN KE, 1985, PHYSIOL REV, V65, P799, DOI 10.1152/physrev.1985.65.4.799	33	23	25	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16822	16831		10.1074/jbc.M109.013870	http://dx.doi.org/10.1074/jbc.M109.013870			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19403530	Green Published, hybrid			2022-12-25	WOS:000266962400018
J	Liu, HY; Kohane, IS				Liu, Hongye; Kohane, Issac S.			Tissue and Process Specific microRNA-mRNA Co-Expression in Mammalian Development and Malignancy	PLOS ONE			English	Article								An association between enrichment and depletion of microRNA (miRNA) binding sites, 3' UTR length, and mRNA expression has been demonstrated in various developing tissues and tissues from different mature organs; but functional, context-dependent miRNA regulations have yet to be elucidated. Towards that goal, we examined miRNA-mRNA interactions by measuring miRNA and mRNA in the same tissue during development and also in malignant conditions. We identified significant miRNA-mediated biological process categories in developing mouse cerebellum and lung using non-targeted mRNA expression as the negative control. Although miRNAs in general suppress target mRNA messages, many predicted miRNA targets demonstrate a significantly higher level of co-expression than non-target genes in developing cerebellum. This phenomenon is tissue specific since it is not observed in developing lungs. Comparison of mouse cerebellar development and medulloblastoma demonstrates a shared miRNA-mRNA co-expression program for brain-specific neurologic processes such as synaptic transmission and exocytosis, in which miRNA target expression increases with the accumulation of multiple miRNAs in developing cerebellum and decreases with the loss of these miRNAs in brain tumors. These findings demonstrate the context-dependence of miRNA-mRNA co-expression.			Liu, HY (corresponding author), Childrens Hosp, Informat Program, 300 Longwood Ave, Boston, MA 02115 USA.	hongye.liu@childrens.harvard.edu	Kohane, Isaac Kohane/K-3716-2012	Kohane, Isaac Kohane/0000-0003-2192-5160	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS040828, P01NS047572] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH085143-01, R01 MH085143] Funding Source: Medline; NINDS NIH HHS [P01 NS047572-01A, P01 NS047572, P50 NS040828-08, P50 NS040828] Funding Source: Medline; NLM NIH HHS [5U54 LM008748-02, U54 LM008748] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cardoso WV, 2000, DEV DYNAM, V219, P121, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1053>3.3.CO;2-8; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hohjoh H, 2007, GENE, V391, P39, DOI 10.1016/j.gene.2006.11.018; Iwama H, 2007, FEBS LETT, V581, P1805, DOI 10.1016/j.febslet.2007.03.066; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kho AT, 2004, GENE DEV, V18, P629, DOI 10.1101/gad.1182504; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mariani TJ, 2002, AM J RESP CELL MOL, V26, P541, DOI 10.1165/ajrcmb.26.5.2001-00080c; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; Mignone F, 2005, NUCLEIC ACIDS RES, V33, pD141, DOI 10.1093/nar/gki021; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; PURVES GJ, 1997, NEUROSCIENCE; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; THOMSON JM, 2006, GENES DEV; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Williams AE, 2007, DEV DYNAM, V236, P572, DOI 10.1002/dvdy.21047; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhao Q, 2002, P NATL ACAD SCI USA, V99, P5704, DOI 10.1073/pnas.082092399; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	48	56	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2009	4	5							e5436	10.1371/journal.pone.0005436	http://dx.doi.org/10.1371/journal.pone.0005436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JE	19415117	Green Published, gold			2022-12-25	WOS:000265836700009
J	Prabhakaran, S; Liang, XW; Skare, JT; Potts, JR; Hook, M				Prabhakaran, Sabitha; Liang, Xiaowen; Skare, Jonathan T.; Potts, Jennifer R.; Hook, Magnus			A Novel Fibronectin Binding Motif in MSCRAMMs Targets F3 Modules	PLOS ONE			English	Article								Background: BBK32 is a surface expressed lipoprotein and fibronectin (Fn)-binding microbial surface component recognizing adhesive matrix molecule (MSCRAMM) of Borrelia burgdorferi, the causative agent of Lyme disease. Previous studies from our group showed that BBK32 is a virulence factor in experimental Lyme disease and located the Fn-binding region to residues 21-205 of the lipoprotein. Methodology/Principal Findings: Studies aimed at identifying interacting sites between BBK32 and Fn revealed an interaction between the MSCRAMM and the Fn F3 modules. Further analysis of this interaction showed that BBK32 can cause the aggregation of human plasma Fn in a similar concentration-dependent manner to that of anastellin, the superfibronectin (sFn) inducing agent. The resulting Fn aggregates are conformationally distinct from plasma Fn as indicated by a change in available thermolysin cleavage sites. Recombinant BBK32 and anastellin affect the structure of Fn matrices formed by cultured fibroblasts and inhibit endothelial cell proliferation similarly. Within BBK32, we have located the sFn-forming activity to a region between residues 160 and 175 which contains two sequence motifs that are also found in anastellin. Synthetic peptides mimicking these motifs induce Fn aggregation, whereas a peptide with a scrambled sequence motif was inactive, suggesting that these motifs represent the sFn-inducing sequence. Conclusions/Significance: We conclude that BBK32 induces the formation of Fn aggregates that are indistinguishable from those formed by anastellin. The results of this study provide evidence for how bacteria can target host proteins to manipulate host cell activities.			Prabhakaran, S (corresponding author), Texas A & M Hlth Sci Ctr, Inst Biosci & Technol, College Stn, TX USA.			Liang, Xiaowen/0000-0002-6174-2951	British Heart Foundation Funding Source: Medline; NIAID NIH HHS [AI058086, AI20624, AI020624, R01 AI058086, R56 AI020624, R01 AI020624] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020624, R56AI020624, R01AI058086] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akerman ME, 2005, P NATL ACAD SCI USA, V102, P2040, DOI 10.1073/pnas.0409844102; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambesi A, 2005, CANCER RES, V65, P148; Briknarova K, 2003, J MOL BIOL, V332, P205, DOI 10.1016/S0022-2836(03)00890-8; CARNEMOLLA B, 1987, FEBS LETT, V215, P269, DOI 10.1016/0014-5793(87)80160-6; COMSTOCK LE, 1991, MICROB PATHOGENESIS, V10, P137, DOI 10.1016/0882-4010(91)90074-K; COMSTOCK LE, 1989, INFECT IMMUN, V57, P1626, DOI 10.1128/IAI.57.5.1626-1628.1989; DZAMBA BJ, 1993, J CELL BIOL, V121, P1165, DOI 10.1083/jcb.121.5.1165; Fikrig E, 2000, J IMMUNOL, V164, P5344, DOI 10.4049/jimmunol.164.10.5344; Heikkila T, 2002, J CLIN MICROBIOL, V40, P1174, DOI 10.1128/JCM.40.4.1174-1180.2002; Hussain M, 2001, J BACTERIOL, V183, P6778, DOI 10.1128/JB.183.23.6778-6786.2001; Ingham KC, 1997, J BIOL CHEM, V272, P1718, DOI 10.1074/jbc.272.3.1718; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; Kim JH, 2004, J BIOL CHEM, V279, P41706, DOI 10.1074/jbc.M401691200; Kingsley RA, 2004, MOL MICROBIOL, V52, P345, DOI 10.1111/j.1365-2958.2004.03995.x; Klein RM, 2003, J CELL SCI, V116, P4663, DOI 10.1242/jcs.00778; Liao YF, 2002, J BIOL CHEM, V277, P14467, DOI 10.1074/jbc.M201100200; Liao YF, 1999, J BIOL CHEM, V274, P17876, DOI 10.1074/jbc.274.25.17876; MA Y, 1991, INFECT IMMUN, V59, P671, DOI 10.1128/IAI.59.2.671-678.1991; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; MCGAVIN MJ, 1993, J BIOL CHEM, V268, P23946; Molinari G, 1997, INFECT IMMUN, V65, P1357, DOI 10.1128/IAI.65.4.1357-1363.1997; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; Mosher DF, 1989, FIBRONECTIN; Norman MU, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000169; Ohashi T, 2005, J BIOL CHEM, V280, P39143, DOI 10.1074/jbc.M509082200; Ozeri V, 1996, EMBO J, V15, P989, DOI 10.1002/j.1460-2075.1996.tb00435.x; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; Pasqualini R, 1996, NAT MED, V2, P1197, DOI 10.1038/nm1196-1197; Plaxco KW, 1997, J MOL BIOL, V270, P763, DOI 10.1006/jmbi.1997.1148; Plaxco KW, 1996, P NATL ACAD SCI USA, V93, P10703, DOI 10.1073/pnas.93.20.10703; Probert WS, 1998, MOL MICROBIOL, V30, P1003, DOI 10.1046/j.1365-2958.1998.01127.x; Raibaud S, 2005, J BIOL CHEM, V280, P18803, DOI 10.1074/jbc.M501731200; Sechler JL, 2000, J CELL SCI, V113, P1491; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; SZCZEPANSKI A, 1990, J CLIN INVEST, V85, P1637, DOI 10.1172/JCI114615; Talay SR, 2000, CELL MICROBIOL, V2, P521, DOI 10.1046/j.1462-5822.2000.00076.x; TALAY SR, 1992, INFECT IMMUN, V60, P3837, DOI 10.1128/IAI.60.9.3837-3844.1992; THOMAS DD, 1989, INFECT IMMUN, V57, P1324, DOI 10.1128/IAI.57.4.1324-1326.1989; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; VUENTO M, 1979, BIOCHEM J, V183, P331, DOI 10.1042/bj1830331; Yi M, 2001, P NATL ACAD SCI USA, V98, P620, DOI 10.1073/pnas.98.2.620	42	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2009	4	4							e5412	10.1371/journal.pone.0005412	http://dx.doi.org/10.1371/journal.pone.0005412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439GF	19404402	Green Published, gold, Green Submitted			2022-12-25	WOS:000265614900022
J	Jugessur, A; Shi, M; Gjessing, HK; Lie, RT; Wilcox, AJ; Weinberg, CR; Christensen, K; Boyles, AL; Daack-Hirsch, S; Trung, TN; Bille, C; Lidral, AC; Murray, JC				Jugessur, Astanand; Shi, Min; Gjessing, Hakon Kristian; Lie, Rolv Terje; Wilcox, Allen James; Weinberg, Clarice Ring; Christensen, Kaare; Boyles, Abee Lowman; Daack-Hirsch, Sandra; Trung, Truc Nguyen; Bille, Camilla; Lidral, Andrew Carl; Murray, Jeffrey Clark			Genetic Determinants of Facial Clefting: Analysis of 357 Candidate Genes Using Two National Cleft Studies from Scandinavia	PLOS ONE			English	Article								Background: Facial clefts are common birth defects with a strong genetic component. To identify fetal genetic risk factors for clefting, 1536 SNPs in 357 candidate genes were genotyped in two population-based samples from Scandinavia (Norway: 562 case-parent and 592 control-parent triads; Denmark: 235 case-parent triads). Methodology/Principal Findings: We used two complementary statistical methods, TRIMM and HAPLIN, to look for associations across these two national samples. TRIMM tests for association in each gene by using multi-SNP genotypes from case-parent triads directly without the need to infer haplotypes. HAPLIN on the other hand estimates the full haplotype distribution over a set of SNPs and estimates relative risks associated with each haplotype. For isolated cleft lip with or without cleft palate (I-CL/P), TRIMM and HAPLIN both identified significant associations with IRF6 and ADH1C in both populations, but only HAPLIN found an association with FGF12. For isolated cleft palate (I-CP), TRIMM found associations with ALX3, MKX, and PDGFC in both populations, but only the association with PDGFC was identified by HAPLIN. In addition, HAPLIN identified an association with ETV5 that was not detected by TRIMM. Conclusion/Significance: Strong associations with seven genes were replicated in the Scandinavian samples and our approach effectively replicated the strongest previously known association in clefting-with IRF6. Based on two national cleft cohorts of similar ancestry, two robust statistical methods and a large panel of SNPs in the most promising cleft candidate genes to date, this study identified a previously unknown association with clefting for ADH1C and provides additional candidates and analytic approaches to advance the field.			Jugessur, A (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	jeff-murray@uiowa.edu	Gjessing, Hakon K/A-5871-2012; Christensen, Kaare/C-2360-2009; Shi, Min/GXM-3977-2022; Wilcox, Allen J/C-7723-2019	Christensen, Kaare/0000-0002-5429-5292; Wilcox, Allen J/0000-0002-3376-1311; Daack-Hirsch, Sandra/0000-0003-1192-7154; Weinberg, Clarice/0000-0002-7713-8556; Boyles, Abee/0000-0002-8711-2077	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE008559, K02DE015291, R01DE011948, P60DE013076, R01DE014667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605, ZIAES045005, ZIAES049027] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NHGRI NIH HHS [N01HG65403] Funding Source: Medline; NIDCR NIH HHS [R01 DE011948, K02 DE015291, R01 DE014667-07, K02 DE015291-03, DE08559, R01 DE014667-04, R01 DE014667, R01 DE-11948-04, P60 DE013076, R01 DE014667-01, K02 DE015291-05, K02 DE015291-01, R01 DE014667-02, P60 DE13076, R01 DE014667-08, R01 DE014667-03, K02 DE015291-02, R01 DE008559, R37 DE008559, R01 DE014667-06, R01 DE014667-05, K02 DE015291-04] Funding Source: Medline; NIEHS NIH HHS [P30 ES05605, P30 ES005605] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Anderson DM, 2006, DEV DYNAM, V235, P792, DOI 10.1002/dvdy.20671; ARDINGER HH, 1989, AM J HUM GENET, V45, P348; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beier DR, 2004, GENETICA, V122, P65, DOI 10.1007/s10709-004-1437-5; BEIRAGHI S, 1994, CLIN GENET, V46, P255; Ben J, 2005, GENE EXPR PATTERNS, V5, P629, DOI 10.1016/j.modgep.2005.03.002; Beverdam A, 2001, MECH DEVELOP, V107, P163, DOI 10.1016/S0925-4773(01)00450-6; Beverdam A, 2001, DEVELOPMENT, V128, P3975; Bille C, 2005, CLEFT PALATE-CRAN J, V42, P255, DOI 10.1597/03-139.1; Blanton SH, 2004, AM J MED GENET A, V125A, P23, DOI 10.1002/ajmg.a.20426; BOYLES AL, 2008, GENET EPIDE IN PRESS; Brewer C, 1999, AM J HUM GENET, V64, P1702, DOI 10.1086/302410; Brewer C, 1998, AM J HUM GENET, V63, P1153, DOI 10.1086/302041; Brown NL, 2003, DEV GROWTH DIFFER, V45, P153; Cai JL, 2005, HUM MOL GENET, V14, P903, DOI 10.1093/hmg/ddi083; Cardon LR, 2003, TRENDS GENET, V19, P135, DOI 10.1016/S0168-9525(03)00022-2; Chevrier C, 2005, BIRTH DEFECTS RES A, V73, P114, DOI 10.1002/bdra.20103; Chiquet BT, 2007, HUM MOL GENET, V16, P2241, DOI 10.1093/hmg/ddm176; Choi SJ, 2008, EUR J HUM GENET; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; DEROO LA, 2008, AM J EPIDEMIOL; DIEWERT VM, 1985, AM J ORTHOD DENTOFAC, V88, P64, DOI 10.1016/0002-9416(85)90107-1; Ding H, 2004, NAT GENET, V36, P1111, DOI 10.1038/ng1415; Edenberg HJ, 2007, ALCOHOL RES HEALTH, V30, P5; Fisher R.A., 1958, STAT METHODS RES WOR; Garavelli L, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-42; GJESSING HK, 2006, ANN HUM GENET, P1; Gong SG, 2005, J DENT RES, V84, P69, DOI 10.1177/154405910508400112; Han J, 2006, BIRTH DEFECTS RES B, V77, P438, DOI 10.1002/bdrb.20094; Higgins AW, 2008, AM J HUM GENET, V82, P712, DOI 10.1016/j.ajhg.2008.01.011; HOOG JO, 1986, EUR J BIOCHEM, V159, P215, DOI 10.1111/j.1432-1033.1986.tb09855.x; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Jezewski PA, 2003, J MED GENET, V40, P399, DOI 10.1136/jmg.40.6.399; Jin JZ, 2008, CELL TISSUE RES, V333, P29, DOI 10.1007/s00441-008-0612-x; Jugessur A, 2005, CURR OPIN GENET DEV, V15, P270, DOI 10.1016/j.gde.2005.03.003; Jugessur A, 2008, GENET EPIDEMIOL, V32, P413, DOI 10.1002/gepi.20314; Knight AS, 2006, DEV DYNAM, V235, P1441, DOI 10.1002/dvdy.20598; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Lee WC, 2003, INT J EPIDEMIOL, V32, P1120, DOI 10.1093/ije/dyg301; Lidral AC, 2005, CURR OPIN PEDIATR, V17, P731, DOI 10.1097/01.mop.0000185138.65820.7f; Lidral AC, 2004, BIRTH DEFECTS RES A, V70, P893, DOI 10.1002/bdra.20096; LIE RT, 1994, NEW ENGL J MED, V331, P1, DOI 10.1056/NEJM199407073310101; Liu H, 2006, GENE EXPR PATTERNS, V6, P632, DOI 10.1016/j.modgep.2005.11.012; Marazita M, 2002, CLEFT LIP PALATE ORI; Marazita ML, 2004, AM J HUM GENET, V75, P161, DOI 10.1086/422475; Marazita ML, 2002, AM J HUM GENET, V71, P349, DOI 10.1086/341944; MARAZITA ML, 2009, HUMAN HERED IN PRESS; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Meijlink F, 1999, INT J DEV BIOL, V43, P651; MITCHELL LE, 1995, AM J HUM GENET, V57, P1130; Miyoshi T, 2006, DEV DYNAM, V235, P1941, DOI 10.1002/dvdy.20799; Mossey PA, 2002, CLEFT LIP PALATE ORI; Mowat DR, 2003, J MED GENET, V40, P305, DOI 10.1136/jmg.40.5.305; Mukherjee K, 2007, J MOL EVOL, V65, P137, DOI 10.1007/s00239-006-0023-0; Mukhopadhyay P, 2004, BIRTH DEFECTS RES A, V70, P912, DOI 10.1002/bdra.20095; Nie XG, 2006, ORAL DIS, V12, P102, DOI 10.1111/j.1601-0825.2005.01176.x; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Park JW, 2006, J MED GENET, V43, P598, DOI 10.1136/jmg.2005.040162; Pauws E, 2007, TRENDS GENET, V23, P631, DOI 10.1016/j.tig.2007.09.002; R Development Core Team, 2006, R LANG ENV STAT COMP; RAHIMOV F, 2008, NAT GENET IN PRESS; Rice TK, 2008, ADV GENET, V60, P293, DOI 10.1016/S0065-2660(07)00412-9; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; Riley BM, 2007, AM J MED GENET A, V143A, P3228, DOI 10.1002/ajmg.a.31965; Riley BM, 2007, P NATL ACAD SCI USA, V104, P4512, DOI 10.1073/pnas.0607956104; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SCHWEDER T, 1982, BIOMETRIKA, V69, P493; Sebastiani P, 2003, P NATL ACAD SCI USA, V100, P9900, DOI 10.1073/pnas.1633613100; Shi M, 2007, AM J HUM GENET, V81, P53, DOI 10.1086/518670; Sivertsen A, 2008, BRIT MED J, V336, P432, DOI 10.1136/bmj.39458.563611.AE; *STATACORP, 2003, STAT STAT SOFTW REL; Takagi T, 1998, DEVELOPMENT, V125, P21; ten Berge D, 1998, DEV BIOL, V199, P11, DOI 10.1006/dbio.1998.8921; Van de Putte T, 2003, AM J HUM GENET, V72, P465, DOI 10.1086/346092; Vieira AR, 2005, PLOS GENET, V1, P651, DOI 10.1371/journal.pgen.0010064; Washbourne BJ, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-18; Welsh IC, 2007, MECH DEVELOP, V124, P746, DOI 10.1016/j.mod.2007.06.007; Wilcox AJ, 2007, BMJ-BRIT MED J, V334, P464, DOI 10.1136/bmj.39079.618287.0B; Wittke-Thompson JK, 2005, AM J HUM GENET, V76, P967, DOI 10.1086/430507	81	75	76	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5385	10.1371/journal.pone.0005385	http://dx.doi.org/10.1371/journal.pone.0005385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401770	Green Published, gold			2022-12-25	WOS:000265601100021
J	Sanbe, A; Daicho, T; Mizutani, R; Endo, T; Miyauchi, N; Yamauchi, J; Tanonaka, K; Glabe, C; Tanoue, A				Sanbe, Atsushi; Daicho, Takuya; Mizutani, Reiko; Endo, Toshiya; Miyauchi, Noriko; Yamauchi, Junji; Tanonaka, Kouichi; Glabe, Charles; Tanoue, Akito			Protective Effect of Geranylgeranylacetone via Enhancement of HSPB8 Induction in Desmin-Related Cardiomyopathy	PLOS ONE			English	Article								Background: An arg120gly (R120G) missense mutation in HSPB5 (alpha-beta-crystallin), which belongs to the small heat shock protein (HSP) family, causes desmin-related cardiomyopathy (DRM), a muscle disease that is characterized by the formation of inclusion bodies, which can contain pre-amyloid oligomer intermediates (amyloid oligomer). While we have shown that small HSPs can directly interrupt amyloid oligomer formation, the in vivo protective effects of the small HSPs on the development of DRM is still uncertain. Methodology/Principal Findings: In order to extend the previous in vitro findings to in vivo, we used geranylgeranylacetone (GGA), a potent HSP inducer. Oral administration of GGA resulted not only in up-regulation of the expression level of HSPB8 and HSPB1 in the heart of HSPB5 R120G transgenic (R120G TG) mice, but also reduced amyloid oligomer levels and aggregates. Furthermore, R120G TG mice treated with GGA exhibited decreased heart size and less interstitial fibrosis, as well as improved cardiac function and survival compared to untreated R120G TG mice. To address possible mechanism(s) for these beneficial effects, cardiac-specific transgenic mice expressing HSPB8 were generated. Overexpression of HSPB8 led to a reduction in amyloid oligomer and aggregate formation, resulting in improved cardiac function and survival. Treatment with GGA as well as the overexpression of HSPB8 also inhibited cytochrome c release from mitochondria, activation of caspase-3 and TUNEL-positive cardiomyocyte death in the R120G TG mice. Conclusions/Significance: Expression of small HSPs such as HSPB8 and HSPB1 by GGA may be a new therapeutic strategy for patients with DRM.			Sanbe, A (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Tokyo, Japan.	asanbe@nch.go.jp	Longo, Kenneth A/A-5631-2010					Aron Y, 2001, CELL MOL LIFE SCI, V58, P1522, DOI 10.1007/PL00000792; Carra S, 2005, HUM MOL GENET, V14, P1659, DOI 10.1093/hmg/ddi174; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Glembotski CC, 2008, J MOL CELL CARDIOL, V44, P453, DOI 10.1016/j.yjmcc.2007.10.017; Hansson O, 2003, BRAIN RES, V970, P47, DOI 10.1016/S0006-8993(02)04275-0; Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144; Katsuno M, 2005, P NATL ACAD SCI USA, V102, P16801, DOI 10.1073/pnas.0506249102; Kawahara Y, 2005, J PHARMACOL SCI, V99, P95, DOI 10.1254/jphs.FP0050343; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lee JS, 1998, BIOCHEM BIOPH RES CO, V244, P379, DOI 10.1006/bbrc.1998.8272; Lubitz SA, 2008, PROG CARDIOVASC DIS, V51, P58, DOI 10.1016/j.pcad.2007.10.003; Maloyan A, 2005, CIRCULATION, V112, P3451, DOI 10.1161/CIRCULATIONAHA.105.572552; Matt P, 2007, J MOL CELL CARDIOL, V43, P792, DOI 10.1016/j.yjmcc.2007.08.011; Mochida S, 2007, J CLIN BIOCHEM NUTR, V41, P115, DOI 10.3164/jcbn.2007016; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; NAGINENI CN, 1989, FEBS LETT, V249, P89, DOI 10.1016/0014-5793(89)80022-5; Nishida K, 1998, JPN J PHARMACOL, V78, P519, DOI 10.1254/jjp.78.519; Ooie T, 2001, CIRCULATION, V104, P1837, DOI 10.1161/hc3901.095771; Otaka M, 2007, BIOCHEM BIOPH RES CO, V353, P399, DOI 10.1016/j.bbrc.2006.12.031; Sakabe M, 2008, CARDIOVASC RES, V78, P63, DOI 10.1093/cvr/cvn019; Sanbe A, 2005, P NATL ACAD SCI USA, V102, P13592, DOI 10.1073/pnas.0503324102; Sanbe A, 2005, CIRCULATION, V111, P2330, DOI 10.1161/01.CIR.0000164234.24957.75; Sanbe A, 2004, P NATL ACAD SCI USA, V101, P10132, DOI 10.1073/pnas.0401900101; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Sanbe A, 2007, J BIOL CHEM, V282, P555, DOI 10.1074/jbc.M605481200; Santoro MG, 2000, BIOCHEM PHARMACOL, V59, P55, DOI 10.1016/S0006-2952(99)00299-3; Simar D, 2007, J GERONTOL A-BIOL, V62, P1413, DOI 10.1093/gerona/62.12.1413; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang XJ, 2001, CIRC RES, V89, P84, DOI 10.1161/hh1301.092688; Yamanaka K, 2003, J MOL CELL CARDIOL, V35, P785, DOI 10.1016/S0022-2828(03)00133-0; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173	34	87	96	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5351	10.1371/journal.pone.0005351	http://dx.doi.org/10.1371/journal.pone.0005351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19399179	gold, Green Published, Green Submitted			2022-12-25	WOS:000265514900013
J	Himmelreich, U; Malik, R; Kuhn, T; Daniel, HM; Somorjai, RL; Dolenko, B; Sorrell, TC				Himmelreich, Uwe; Malik, Richard; Kuhn, Till; Daniel, Heide-Marie; Somorjai, Ray L.; Dolenko, Brion; Sorrell, Tania C.			Rapid Etiological Classification of Meningitis by NMR Spectroscopy Based on Metabolite Profiles and Host Response	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; ACQUIRED BACTERIAL-MENINGITIS; CEREBROSPINAL-FLUID; IDENTIFICATION; MR; MICROORGANISMS; ADULTS; CSF; STRATEGY; H-1-NMR	Bacterial meningitis is an acute disease with high mortality that is reduced by early treatment. Identification of the causative microorganism by culture is sensitive but slow. Large volumes of cerebrospinal fluid (CSF) are required to maximise sensitivity and establish a provisional diagnosis. We have utilised nuclear magnetic resonance (NMR) spectroscopy to rapidly characterise the biochemical profile of CSF from normal rats and animals with pneumococcal or cryptococcal meningitis. Use of a miniaturised capillary NMR system overcame limitations caused by small CSF volumes and low metabolite concentrations. The analysis of the complex NMR spectroscopic data by a supervised statistical classification strategy included major, minor and unidentified metabolites. Reproducible spectral profiles were generated within less than three minutes, and revealed differences in the relative amounts of glucose, lactate, citrate, amino acid residues, acetate and polyols in the three groups. Contributions from microbial metabolism and inflammatory cells were evident. The computerised statistical classification strategy is based on both major metabolites and minor, partially unidentified metabolites. This data analysis proved highly specific for diagnosis (100% specificity in the final validation set), provided those with visible blood contamination were excluded from analysis; 6-8% of samples were classified as indeterminate. This proof of principle study suggests that a rapid etiologic diagnosis of meningitis is possible without prior culture. The method can be fully automated and avoids delays due to processing and selective identification of specific pathogens that are inherent in DNA-based techniques.			Himmelreich, U (corresponding author), Katholieke Univ Leuven, Fac Med, Biomed NMR Unit, Leuven, Belgium.	uwe.himmelreich@med.kuleuven.be	Sorrell, Tania/AAZ-5286-2020; Malik, Richard/I-2009-2019; Daniel, Heide-Marie/B-3161-2010	Sorrell, Tania/0000-0001-9460-0960; Himmelreich, Uwe/0000-0002-2060-8895				Allen J, 2003, NAT BIOTECHNOL, V21, P692, DOI 10.1038/nbt823; Aronin SI, 1998, ANN INTERN MED, V129, P862, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00004; BELL JD, 1987, CLIN SCI, V72, P563, DOI 10.1042/cs0720563; Coen M, 2005, CLIN INFECT DIS, V41, P1582, DOI 10.1086/497836; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; Dekker LJ, 2005, MOL CELL PROTEOMICS, V4, P1341, DOI 10.1074/mcp.M500081-MCP200; Dunn WB, 2005, ANALYST, V130, P606, DOI 10.1039/b418288j; Dunne VG, 2005, NMR BIOMED, V18, P24, DOI 10.1002/nbm.918; Efron B., 1994, INTRO BOOTSTRAP; Fenselau C, 2001, MASS SPECTROM REV, V20, P157, DOI 10.1002/mas.10004; Fishman RA., 1992, CEREBROSPINAL FLUID; Griffin JL, 2002, ANALYST, V127, P582, DOI 10.1039/b201207c; Himmelreich U., 2004, Trends in Applied Spectroscopy, V5, P269; Himmelreich U, 2005, RADIOLOGY, V236, P261, DOI 10.1148/radiol.2361040869; Himmelreich U, 2003, APPL ENVIRON MICROB, V69, P4566, DOI 10.1128/AEM.69.8.4566-4574.2003; Himmelreich U, 2003, MICROBES INFECT, V5, P285, DOI 10.1016/S1286-4579(03)00028-5; Himmelreich U, 2001, RADIOLOGY, V220, P122, DOI 10.1148/radiology.220.1.r01jl25122; HIRAOKA A, 1994, BIOL PHARM BULL, V17, P1; Hu Y, 2005, MOL CELL PROTEOMICS, V4, P2000, DOI 10.1074/mcp.M500207-MCP200; Levine J, 2000, J NEURAL TRANSM, V107, P843, DOI 10.1007/s007020070064; Lewczuk P, 2003, RAPID COMMUN MASS SP, V17, P1291, DOI 10.1002/rcm.1048; Lu CH, 2002, CLIN NEUROL NEUROSUR, V104, P352, DOI 10.1016/S0303-8467(02)00052-5; Maillet S, 1998, BRAIN RES PROTOC, V3, P123, DOI 10.1016/S1385-299X(98)00033-6; Maquelin K, 2002, J MICROBIOL METH, V51, P255, DOI 10.1016/S0167-7012(02)00127-6; Mariey L, 2001, VIB SPECTROSC, V26, P151, DOI 10.1016/S0924-2031(01)00113-8; NICHOLSON JK, 1989, PROG NUCL MAG RES SP, V21, P449, DOI 10.1016/0079-6565(89)80008-1; NICOLI F, 1993, NEUROSCI LETT, V154, P47, DOI 10.1016/0304-3940(93)90168-K; Nikulin AE, 1998, NMR BIOMED, V11, P209, DOI 10.1002/(SICI)1099-1492(199806/08)11:4/5<209::AID-NBM510>3.0.CO;2-5; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Pfyffer GE, 1996, J CLIN MICROBIOL, V34, P834, DOI 10.1128/JCM.34.4.834-841.1996; Pope GA, 2007, YEAST, V24, P667, DOI 10.1002/yea.1499; Raamsdonk LM, 2001, NAT BIOTECHNOL, V19, P45, DOI 10.1038/83496; Schlegel H. G., 1992, ALLGEMEINE MIKROBIOL; Schlotterbeck G, 2002, ANAL CHEM, V74, P4464, DOI 10.1021/ac025556e; Selle H, 2005, COMB CHEM HIGH T SCR, V8, P801, DOI 10.2174/138620705774962391; Somorjai RL, 2004, COMPU BIOL, V5, P67; Somorjai RL, 2002, VIB SPECTROSC, V28, P97, DOI 10.1016/S0924-2031(01)00148-5; Subramanian A, 2005, NMR BIOMED, V18, P213, DOI 10.1002/nbm.944; TUNKEL AR, 2000, MANDELL DOUGLAS BENN, P959; Urbanczyk-Wochniak E, 2003, EMBO REP, V4, P989, DOI 10.1038/sj.embor.embor944; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; WEVERS RA, 1995, CLIN CHEM, V41, P744; WOOD M, 1998, MAJOR PROBLEMS NEURO; Yuan XL, 2005, J MASS SPECTROM, V40, P176, DOI 10.1002/jms.737	44	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2009	4	4							e5328	10.1371/journal.pone.0005328	http://dx.doi.org/10.1371/journal.pone.0005328			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VG	19390697	Green Submitted, Green Published, gold			2022-12-25	WOS:000265514400014
J	van Leuken, R; Clijsters, L; van Zon, W; Lim, D; Yao, XB; Wolthuis, RMF; Yaffe, MB; Medema, RH; van Vugt, MATM				van Leuken, Renske; Clijsters, Linda; van Zon, Wouter; Lim, Dan; Yao, XueBiao; Wolthuis, Rob M. F.; Yaffe, Michael B.; Medema, Rene H.; van Vugt, Marcel A. T. M.			Polo-Like Kinase-1 Controls Aurora A Destruction by Activating APC/C-Cdh1	PLOS ONE			English	Article								Polo-like kinase-1 (Plk1) is activated before mitosis by Aurora A and its cofactor Bora. In mitosis, Bora is degraded in a manner dependent on Plk1 kinase activity and the E3 ubiquitin ligase SCF-beta TrCP. Here, we show that Plk1 is also required for the timely destruction of its activator Aurora A in late anaphase. It has been shown that Aurora A destruction is controlled by the auxiliary subunit Cdh1 of the Anaphase-Promoting Complex/Cyclosome (APC/C). Remarkably, we found that Plk1-depletion prevented the efficient dephosphorylation of Cdh1 during mitotic exit. Plk1 mediated its effect on Cdh1, at least in part, through direct phosphorylation of the human phosphatase Cdc14A, controlling the phosphorylation state of Cdh1. We conclude that Plk1 facilitates efficient Aurora A degradation through APC/C-Cdh1 activation after mitosis, with a potential role for hCdc14A.			van Leuken, R (corresponding author), Univ Med Ctr Utrecht, Dept Med Oncol, Utrecht, Netherlands.	r.h.medema@umcutrecht.nl; m.vugt@onco.umcg.nl	Medema, Rene H/G-5415-2011; Medema, Rene H/E-2981-2013; Yao, Xuebiao/P-5771-2014	Medema, Rene/0000-0002-6754-0381; Wolthuis, Rob/0000-0002-3109-1588; Clijsters, Linda/0000-0002-3118-9702				Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Bembenek J, 2001, J BIOL CHEM, V276, P48237, DOI 10.1074/jbc.M108126200; Bothos J, 2005, CANCER RES, V65, P6568, DOI 10.1158/0008-5472.CAN-05-0862; Chan EHY, 2008, CHROMOSOMA, V117, P457, DOI 10.1007/s00412-008-0165-5; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Chestukhin A, 2003, P NATL ACAD SCI USA, V100, P4574, DOI 10.1073/pnas.0730733100; Cuif MH, 1999, EMBO J, V18, P1772, DOI 10.1093/emboj/18.7.1772; DeBonis S, 2004, MOL CANCER THER, V3, P1079; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Descombes P, 1998, EMBO J, V17, P1328, DOI 10.1093/emboj/17.5.1328; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Geymonat M, 2002, CURR BIOL, V12, pR482, DOI 10.1016/S0960-9822(02)00963-6; Golan A, 2002, J BIOL CHEM, V277, P15552, DOI 10.1074/jbc.M111476200; Gromley A, 2003, J CELL BIOL, V161, P535, DOI 10.1083/jcb.200301105; Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Hames RS, 2001, EMBO J, V20, P7117, DOI 10.1093/emboj/20.24.7117; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; Hu FH, 2001, CELL, V107, P655, DOI 10.1016/S0092-8674(01)00580-3; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Kaiser BK, 2002, MOL BIOL CELL, V13, P2289, DOI 10.1091/mbc.01-11-0535; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Lee SE, 2001, CURR BIOL, V11, P784, DOI 10.1016/S0960-9822(01)00228-7; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Li LW, 1997, J BIOL CHEM, V272, P29403, DOI 10.1074/jbc.272.47.29403; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Lorca T, 1998, EMBO J, V17, P3565, DOI 10.1093/emboj/17.13.3565; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Mailand N, 2002, NAT CELL BIOL, V4, P317, DOI 10.1038/ncb777; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Mamely I, 2006, CURR BIOL, V16, P1950, DOI 10.1016/j.cub.2006.08.026; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Morisaki T, 2002, FEBS LETT, V529, P319, DOI 10.1016/S0014-5793(02)03360-4; Moshe Y, 2004, P NATL ACAD SCI USA, V101, P7937, DOI 10.1073/pnas.0402442101; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Ohi MD, 2007, MOL CELL, V28, P871, DOI 10.1016/j.molcel.2007.10.003; Pereira G, 2002, J CELL BIOL, V157, P367, DOI 10.1083/jcb.200112085; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Pfleger CM, 2000, GENE DEV, V14, P655; Potapova TA, 2006, NATURE, V440, P954, DOI 10.1038/nature04652; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Schmidt M, 2005, EMBO REP, V6, P866, DOI 10.1038/sj.embor.7400483; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Seki A, 2008, J CELL BIOL, V181, P65, DOI 10.1083/jcb.200712027; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Yoshida S, 2002, BIOCHEM BIOPH RES CO, V294, P687, DOI 10.1016/S0006-291X(02)00544-2; Yuan K, 2007, J BIOL CHEM, V282, P27414, DOI 10.1074/jbc.M703555200; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721; Zur A, 2002, EMBO J, V21, P4500, DOI 10.1093/emboj/cdf452; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	74	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2009	4	4							e5282	10.1371/journal.pone.0005282	http://dx.doi.org/10.1371/journal.pone.0005282			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VE	19390576	Green Published, Green Submitted, gold			2022-12-25	WOS:000265514200010
J	Tian, HG; Peng, H; Yao, Q; Chen, HX; Xie, Q; Tang, B; Zhang, WQ				Tian, Honggang; Peng, Han; Yao, Qiong; Chen, Hongxin; Xie, Qi; Tang, Bin; Zhang, Wenqing			Developmental Control of a Lepidopteran Pest Spodoptera exigua by Ingestion of Bacteria Expressing dsRNA of a Non-Midgut Gene	PLOS ONE			English	Article							CHITIN SYNTHASE GENE; RNA INTERFERENCE; AMINOPEPTIDASE-N; SYSTEMIC RNAI	Background: RNA interference (RNAi) induced through double stranded RNA (dsRNA) has been used widely to study gene function in insects. Recently, it has been reported that gene knockdown in several insects can be induced successfully through feeding with dsRNA. However, it is still unknown whether phenotypic silencing of genes not expressed in the midgut occurs after ingestion of insect dsRNA. Principal Findings: Using chitin synthase gene A (SeCHSA) as the target gene, which is expressed in the cuticle and tracheae of the lepidopteran pest Spodoptera exigua, we showed that the growth and development of S. exigua larvae fed Escherichia coli expressing dsRNA of SeCHSA was disturbed, resulting in lethality. In the 4th and 5th larval instars, prepupae, and pupae, the mean survival rates of insects fed the dsRNA-containing diet were 88.64%, 74.24%, 68.43% and 62.63% respectively. The survival rates in the 5(th) instar larvae, prepupae and pupae stages were significantly lower than those of all controls, and significant lethality differences were also found between dsSeCHSA treatment and dsControl or ddH(2)O control in the 4(th) instar larvae. The effects of ingesting bacterially expressed dsRNA on transcription of the target gene, tissue structure, and survival rates of insects were dose-dependent. Conclusions: Our results suggest that SeCHSA dsRNA may be useful as a means of insect pest control.			Tian, HG (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	lsszwq@mail.sysu.edu.cn	Galdzicki, Michal/F-5682-2010; Kohane, Isaac Kohane/K-3716-2012; Tian, Honggang/AAW-4772-2020; zhang, wenqing/GYA-0786-2022; tian, ze/HDM-4308-2022; Yao, Huiqin/AAX-3787-2020	Galdzicki, Michal/0000-0002-8392-8183; Kohane, Isaac Kohane/0000-0003-2192-5160; Tian, Honggang/0000-0002-2205-0784; Yao, Huiqin/0000-0003-4742-8971; Chen, Hongxin/0000-0002-2955-4619; Wu, Erxi/0000-0002-1680-3639	NIGMS NIH HHS [R01 GM081871] Funding Source: Medline; NLM NIH HHS [2 T15 LM007092-16, T15 LM007092] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081871] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007092] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Arakane Y, 2005, INSECT MOL BIOL, V14, P453, DOI 10.1111/j.1365-2583.2005.00576.x; Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Chen X, 2008, B ENTOMOL RES, V98, P613, DOI 10.1017/S0007485308005932; Chen XF, 2007, INSECT BIOCHEM MOLEC, V37, P409, DOI 10.1016/j.ibmb.2007.01.006; Cruz J, 2007, MECH DEVELOP, V124, P180, DOI 10.1016/j.mod.2006.12.003; Cruz J, 2006, DEV BIOL, V297, P158, DOI 10.1016/j.ydbio.2006.06.048; Eleftherianos I, 2006, DEV COMP IMMUNOL, V30, P1099, DOI 10.1016/j.dci.2006.02.008; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gordon KHJ, 2007, NAT BIOTECHNOL, V25, P1231, DOI 10.1038/nbt1107-1231; Gura T, 2000, NATURE, V404, P804, DOI 10.1038/35009245; Huang JH, 2007, FEBS LETT, V581, P697, DOI 10.1016/j.febslet.2007.01.034; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kato N, 2006, INSECT BIOCHEM MOLEC, V36, P1, DOI 10.1016/j.ibmb.2005.09.003; Kooter JM, 1999, TRENDS PLANT SCI, V4, P340, DOI 10.1016/S1360-1385(99)01467-3; Lennefors BL, 2006, MOL BREEDING, V18, P313, DOI 10.1007/s11032-006-9030-5; Li Guanghong, 2002, Chinese Journal of Biological Control, V18, P132; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Merzendorfer H, 2006, J COMP PHYSIOL B, V176, P1, DOI 10.1007/s00360-005-0005-3; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Meyering-Vos M, 2007, J INSECT PHYSIOL, V53, P840, DOI 10.1016/j.jinsphys.2007.04.003; Mito T, 2007, DEV BIOL, V303, P202, DOI 10.1016/j.ydbio.2006.11.003; Newmark PA, 2003, P NATL ACAD SCI USA, V100, P11861, DOI 10.1073/pnas.1834205100; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Orii H, 2003, DEV GENES EVOL, V213, P138, DOI 10.1007/s00427-003-0310-3; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; Retnakaran A., 1987, Chitin and benzoylphenyl ureas., P205; Ronco M, 2008, DEV BIOL, V313, P80, DOI 10.1016/j.ydbio.2007.09.059; Sivakumar S, 2007, J BIOL CHEM, V282, P7312, DOI 10.1074/jbc.M607442200; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tenllado F, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-3; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Zhou XG, 2008, INSECT BIOCHEM MOLEC, V38, P805, DOI 10.1016/j.ibmb.2008.05.005; Zimoch L, 2005, INSECT BIOCHEM MOLEC, V35, P515, DOI 10.1016/j.ibmb.2005.01.008	38	261	309	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2009	4	7							e6225	10.1371/journal.pone.0006225	http://dx.doi.org/10.1371/journal.pone.0006225			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DO	19381341	Green Submitted, gold, Green Published			2022-12-25	WOS:000268035400009
J	Ballhorn, DJ; Kautz, S; Heil, M; Hegeman, AD				Ballhorn, Daniel J.; Kautz, Stefanie; Heil, Martin; Hegeman, Adrian D.			Cyanogenesis of Wild Lima Bean (Phaseolus lunatus L.) Is an Efficient Direct Defence in Nature	PLOS ONE			English	Article							TRIFOLIUM-REPENS-L; INSECT HERBIVORY; PLANT DEFENSE; VOLATILES INDUCE; HOST PLANTS; POLYMORPHISM; RESPONSES; OVIPOSITION; EVOLUTION; SORGHUM	In natural systems plants face a plethora of antagonists and thus have evolved multiple defence strategies. Lima bean (Phaseolus lunatus L.) is a model plant for studies of inducible indirect anti-herbivore defences including the production of volatile organic compounds (VOCs) and extrafloral nectar (EFN). In contrast, studies on direct chemical defence mechanisms as crucial components of lima beans' defence syndrome under natural conditions are nonexistent. In this study, we focus on the cyanogenic potential (HCNp; concentration of cyanogenic glycosides) as a crucial parameter determining lima beans' cyanogenesis, i.e. the release of toxic hydrogen cyanide from preformed precursors. Quantitative variability of cyanogenesis in a natural population of wild lima bean in Mexico was significantly correlated with missing leaf area. Since existing correlations do not by necessity mean causal associations, the function of cyanogenesis as efficient plant defence was subsequently analysed in feeding trials. We used natural chrysomelid herbivores and clonal lima beans with known cyanogenic features produced from field-grown mother plants. We show that in addition to extensively investigated indirect defences, cyanogenesis has to be considered as an important direct defensive trait affecting lima beans' overall defence in nature. Our results indicate the general importance of analysing 'multiple defence syndromes' rather than single defence mechanisms in future functional analyses of plant defences.			Ballhorn, DJ (corresponding author), Univ Duisburg Essen, Dept Gen Bot Plant Ecol, Essen, Germany.	daniel.ballhorn@uni-due.de	Heil, Martin/T-3960-2019; Heil, Martin/AAC-2730-2022; Hegeman, Adrian/D-5984-2013	Heil, Martin/0000-0001-8036-8697; Hegeman, Adrian/0000-0003-1008-6066				Agrawal AA, 2008, ENTOMOL EXP APPL, V128, P126, DOI 10.1111/j.1570-7458.2008.00690.x; Agrawal AA, 2008, P NATL ACAD SCI USA, V105, P10057, DOI 10.1073/pnas.0802368105; Agrawal AA, 2006, ECOLOGY, V87, pS132, DOI 10.1890/0012-9658(2006)87[132:PDS]2.0.CO;2; Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072; Arimura G, 2002, PLANT J, V29, P87, DOI 10.1046/j.1365-313x.2002.01198.x; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Ball JP, 2000, J APPL ECOL, V37, P247, DOI 10.1046/j.1365-2664.2000.00487.x; Ballhorn DJ, 2007, J CHEM ECOL, V33, P2195, DOI 10.1007/s10886-007-9380-4; Ballhorn DJ, 2008, J ECOL, V96, P971, DOI 10.1111/j.1365-2745.2008.01404.x; Ballhorn DJ, 2006, J CHEM ECOL, V32, P1861, DOI 10.1007/s10886-006-9114-z; Ballhorn DJ, 2006, J CHEM ECOL, V32, P261, DOI 10.1007/s10886-005-9001-z; Ballhorn DJ, 2005, J CHEM ECOL, V31, P1445, DOI 10.1007/s10886-005-5791-2; Becerra JX, 2001, AM ZOOL, V41, P865, DOI 10.1668/0003-1569(2001)041[0865:IBCAMD]2.0.CO;2; Bouwmeester HJ, 1999, PLANT PHYSIOL, V121, P173, DOI 10.1104/pp.121.1.173; BURGER JC, 1994, OECOLOGIA, V99, P79, DOI 10.1007/BF00317086; Busk PK, 2002, PLANT PHYSIOL, V129, P1222, DOI 10.1104/pp.000687; CAHN MG, 1976, HEREDITY, V37, P309, DOI 10.1038/hdy.1976.95; Choh Y, 2006, OECOLOGIA, V147, P455, DOI 10.1007/s00442-005-0289-8; Dicke M, 1999, ENTOMOL EXP APPL, V91, P131, DOI 10.1023/A:1003608019062; DIRZO R, 1982, J ECOL, V70, P119, DOI 10.2307/2259868; FLOSS HG, 1965, NATURE, V208, P1207, DOI 10.1038/2081207a0; Gleadow RM, 2000, AUST J PLANT PHYSIOL, V27, P693, DOI 10.1071/PP00004; Goodger JQD, 2002, BIOCHEM SYST ECOL, V30, P617, DOI 10.1016/S0305-1978(01)00141-7; Heil M, 2004, J ECOL, V92, P527, DOI 10.1111/j.0022-0477.2004.00890.x; Heil M, 2004, J CHEM ECOL, V30, P1289, DOI 10.1023/B:JOEC.0000030299.59863.69; Heil M, 2008, J CHEM ECOL, V34, P601, DOI 10.1007/s10886-008-9464-9; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Heil M, 2006, ECOL LETT, V9, P813, DOI 10.1111/j.1461-0248.2006.00932.x; Horiuchi J, 2003, APPL ENTOMOL ZOOL, V38, P109, DOI 10.1303/aez.2003.109; HUGHES MA, 1991, HEREDITY, V66, P105, DOI 10.1038/hdy.1991.13; Iason G, 2005, P NUTR SOC, V64, P123, DOI 10.1079/PNS2004415; Jenrich R, 2007, P NATL ACAD SCI USA, V104, P18848, DOI 10.1073/pnas.0709315104; Jones DA, 1998, PHYTOCHEMISTRY, V47, P155, DOI 10.1016/S0031-9422(97)00425-1; JONES DA, 1962, NATURE, V193, P1109, DOI 10.1038/1931109a0; Kost C, 2006, J ECOL, V94, P619, DOI 10.1111/j.1365-2745.2006.01120.x; KOST C, 2005, BASIC APPL ECOL, V94, P619; Kursar TA, 2003, BIOCHEM SYST ECOL, V31, P929, DOI 10.1016/S0305-1978(03)00087-5; LOUGHRIN JH, 1995, J CHEM ECOL, V21, P1457, DOI 10.1007/BF02035145; LOYD RC, 1970, AGRON J, V62, P394, DOI 10.2134/agronj1970.00021962006200030025x; Masumoto T, 2000, POPUL ECOL, V42, P145, DOI 10.1007/PL00011993; Meiners SJ, 2000, PLANT ECOL, V151, P161, DOI 10.1023/A:1026509529570; Mithofer A, 2004, J PLANT GROWTH REGUL, V23, P170, DOI 10.1007/s00344-004-0034-2; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; NAHRSTEDT A, 1985, PLANT SYST EVOL, V150, P35, DOI 10.1007/BF00985566; NOTTINGHAM SF, 1988, J INSECT PHYSIOL, V34, P227, DOI 10.1016/0022-1910(88)90053-4; Paul ND, 2000, TRENDS PLANT SCI, V5, P220, DOI 10.1016/S1360-1385(00)01603-4; Piotrowski M, 2001, J BIOL CHEM, V276, P2616, DOI 10.1074/jbc.M007890200; Rand TA, 1999, OECOLOGIA, V121, P39, DOI 10.1007/s004420050905; Rodriguez-Saona C, 2005, ECOL ENTOMOL, V30, P156, DOI 10.1111/j.0307-6946.2005.00682.x; Romeo JT, 1998, ECOSCIENCE, V5, P287, DOI 10.1080/11956860.1998.11682475; SHURE DJ, 1991, OECOLOGIA, V86, P325, DOI 10.1007/BF00317597; Skaloudova B, 2007, ANIM BEHAV, V74, P813, DOI 10.1016/j.anbehav.2007.02.005; Tentelier C, 2006, BEHAV ECOL, V17, P515, DOI 10.1093/beheco/arj062; Thomsen K, 1997, BOT J LINN SOC, V124, P273, DOI 10.1006/bojl.1997.0100; van der Meijden E, 2000, OIKOS, V89, P202, DOI 10.1034/j.1600-0706.2000.890123.x; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195	57	50	51	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5450	10.1371/journal.pone.0005450	http://dx.doi.org/10.1371/journal.pone.0005450			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424497	gold, Green Published			2022-12-25	WOS:000265933800010
J	Tian, Z; Palmer, N; Schmid, P; Yao, H; Galdzicki, M; Berger, B; Wu, EX; Kohane, IS				Tian, Ze; Palmer, Nathan; Schmid, Patrick; Yao, Hui; Galdzicki, Michal; Berger, Bonnie; Wu, Erxi; Kohane, Isaac S.			A Practical Platform for Blood Biomarker Study by Using Global Gene Expression Profiling of Peripheral Whole Blood	PLOS ONE			English	Article							OLIGONUCLEOTIDE ARRAY DATA; MESSENGER-RNA REDUCTION; SAMPLES; CELLS; PCR	Background: Although microarray technology has become the most common method for studying global gene expression, a plethora of technical factors across the experiment contribute to the variable of genome gene expression profiling using peripheral whole blood. A practical platform needs to be established in order to obtain reliable and reproducible data to meet clinical requirements for biomarker study. Methods and Findings: We applied peripheral whole blood samples with globin reduction and performed genome-wide transcriptome analysis using Illumina BeadChips. Real-time PCR was subsequently used to evaluate the quality of array data and elucidate the mode in which hemoglobin interferes in gene expression profiling. We demonstrated that, when applied in the context of standard microarray processing procedures, globin reduction results in a consistent and significant increase in the quality of beadarray data. When compared to their pre-globin reduction counterparts, post-globin reduction samples show improved detection statistics, lowered variance and increased sensitivity. More importantly, gender gene separation is remarkably clearer in post-globin reduction samples than in pre-globin reduction samples. Our study suggests that the poor data obtained from pre-globin reduction samples is the result of the high concentration of hemoglobin derived from red blood cells either interfering with target mRNA binding or giving the pseudo binding background signal. Conclusion: We therefore recommend the combination of performing globin mRNA reduction in peripheral whole blood samples and hybridizing on Illumina BeadChips as the practical approach for biomarker study.			Tian, Z (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Informat Program, Boston, MA 02115 USA.	bab@mit.edu; erxi.wu@ndsu.edu	Galdzicki, Michal/F-5682-2010; Kohane, Isaac Kohane/K-3716-2012; Tian, Honggang/AAW-4772-2020; zhang, wenqing/GYA-0786-2022; tian, ze/HDM-4308-2022; Yao, Huiqin/AAX-3787-2020	Galdzicki, Michal/0000-0002-8392-8183; Kohane, Isaac Kohane/0000-0003-2192-5160; Tian, Honggang/0000-0002-2205-0784; Yao, Huiqin/0000-0003-4742-8971; Chen, Hongxin/0000-0002-2955-4619; Wu, Erxi/0000-0002-1680-3639	NIGMS NIH HHS [R01 GM081871] Funding Source: Medline; NLM NIH HHS [2 T15 LM007092-16, T15 LM007092] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081871] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007092] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Chal V, 2005, J CLIN LAB ANAL, V19, P182, DOI 10.1002/jcla.20075; Debey S, 2004, PHARMACOGENOMICS J, V4, P193, DOI 10.1038/sj.tpj.6500240; Debey S, 2006, GENOMICS, V87, P653, DOI 10.1016/j.ygeno.2005.11.010; Feezor RJ, 2004, PHYSIOL GENOMICS, V19, P247, DOI 10.1152/physiolgenomics.00020.2004; Field LA, 2007, CLIN BIOCHEM, V40, P499, DOI 10.1016/j.clinbiochem.2007.01.004; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Kuhn K, 2004, GENOME RES, V14, P2347, DOI 10.1101/gr.2739104; Liu J, 2006, J MOL DIAGN, V8, P551, DOI 10.2353/jmoldx.2006.060021; Martin KJ, 2001, P NATL ACAD SCI USA, V98, P2646, DOI 10.1073/pnas.041622398; Osman I, 2006, CLIN CANCER RES, V12, P3374, DOI 10.1158/1078-0432.CCR-05-2081; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qin LX, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-23; Rainen L, 2002, CLIN CHEM, V48, P1883; Team. RDC, 2007, R LANG ENV STAT COMP; Thach DC, 2003, J IMMUNOL METHODS, V283, P269, DOI 10.1016/j.jim.2003.10.004; TIAN Z, 2008, CANC CHEMOTHER PHARM; Witten I. H., 2005, DATA MINING PRACTICA; Wright C, 2008, CLIN CHEM, V54, P396, DOI 10.1373/clinchem.2007.093419; Wu EX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003794	22	261	309	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5157	10.1371/journal.pone.0005157	http://dx.doi.org/10.1371/journal.pone.0005157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381341	Green Published, gold, Green Submitted			2022-12-25	WOS:000265510800002
